Citrus Sinensis ID: 042809
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 241 | 2.2.26 [Sep-21-2011] | |||||||
| Q54R82 | 942 | Mitogen-activated protein | yes | no | 0.921 | 0.235 | 0.38 | 2e-41 | |
| O22042 | 651 | Mitogen-activated protein | no | no | 0.954 | 0.353 | 0.369 | 3e-41 | |
| Q9FZ36 | 651 | Mitogen-activated protein | no | no | 0.975 | 0.360 | 0.354 | 9e-41 | |
| O22040 | 666 | Mitogen-activated protein | no | no | 0.975 | 0.352 | 0.354 | 2e-39 | |
| Q99759 | 626 | Mitogen-activated protein | yes | no | 0.887 | 0.341 | 0.380 | 3e-35 | |
| Q61084 | 626 | Mitogen-activated protein | yes | no | 0.887 | 0.341 | 0.376 | 2e-34 | |
| Q13233 | 1512 | Mitogen-activated protein | no | no | 0.912 | 0.145 | 0.382 | 4e-34 | |
| P53349 | 1493 | Mitogen-activated protein | no | no | 0.912 | 0.147 | 0.382 | 4e-34 | |
| Q62925 | 1493 | Mitogen-activated protein | no | no | 0.912 | 0.147 | 0.378 | 1e-33 | |
| Q56UN5 | 1328 | Mitogen-activated protein | no | no | 0.883 | 0.160 | 0.384 | 1e-33 |
| >sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 169 bits (427), Expect = 2e-41, Method: Composition-based stats.
Identities = 95/250 (38%), Positives = 143/250 (57%), Gaps = 28/250 (11%)
Query: 1 MNKGTGALFVVKSAE-----SEAGVQ----ALRNEAEIRQSLNSPNIGRN-----GEKTV 46
+NK TG LF VK E S+ ++ + E E+ +SL NI R + +
Sbjct: 188 LNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRSLRHDNIVRYLGTSLDQSFL 247
Query: 47 NIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLG 100
++F+EY+ GGS+ + KFG VI++YTK+IL H N I+H D+K N+L+
Sbjct: 248 SVFLEYIPGGSISSLLGKFGA-FSENVIKVYTKQILQGLSFLHANSIIHRDIKGANILID 306
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGC 160
+ G VKL D GC+ K+ + ++S+ GT WMAPEV++ G ++DIWSLGC
Sbjct: 307 TKGIVKLSDFGCS------KSFSGIVSQFKSMQGTPYWMAPEVIKQTGHGRSSDIWSLGC 360
Query: 161 MVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS 220
+++EMAT +PPW + I+ AA + IA SN P+ P+ ++ DFL C +R P++R
Sbjct: 361 VIVEMATAQPPWSN-ITELAAVMYHIASSNSIPNIPSHMSQEAFDFLNLCFKRDPKERPD 419
Query: 221 AEELLNHTFI 230
A +LL H FI
Sbjct: 420 ANQLLKHPFI 429
|
Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5 |
| >sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 168 bits (426), Expect = 3e-41, Method: Compositional matrix adjust.
Identities = 95/257 (36%), Positives = 142/257 (55%), Gaps = 27/257 (10%)
Query: 1 MNKGTGALFVVKSA----------ESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKT 45
MN +G L +K +++ ++ L E ++ ++L+ PNI R +
Sbjct: 86 MNLDSGELLAIKQVLIAPSSASKEKTQGHIRELEEEVQLLKNLSHPNIVRYLGTVRESDS 145
Query: 46 VNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLL 99
+NI ME++ GGS+ + EKFG + VI +YTK E LH NGI+H D+K N+L+
Sbjct: 146 LNILMEFVPGGSISSLLEKFG-SFPEPVIIMYTKQLLLGLEYLHNNGIMHRDIKGANILV 204
Query: 100 GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
+ G ++L D G +++V +L K S+ GT WMAPEV+ G F+ DIWS+G
Sbjct: 205 DNKGCIRLADFGASKKVVELATVNGAK----SMKGTPYWMAPEVILQTGHSFSADIWSVG 260
Query: 160 CMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219
C VIEMATG+PPW ++ AA +L I + P P + DFL KCL ++P R
Sbjct: 261 CTVIEMATGKPPWSEQYQQFAA-VLHIGRTKAHPPIPEDLSPEAKDFLMKCLHKEPSLRL 319
Query: 220 SAEELLNHTFISGNAKK 236
SA ELL H F++G ++
Sbjct: 320 SATELLQHPFVTGKRQE 336
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 166 bits (421), Expect = 9e-41, Method: Compositional matrix adjust.
Identities = 93/262 (35%), Positives = 143/262 (54%), Gaps = 27/262 (10%)
Query: 1 MNKGTGALFVVKSA----------ESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKT 45
MN +G L VK +++A +Q L E ++ ++L+ PNI R ++T
Sbjct: 86 MNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKNLSHPNIVRYLGTVREDET 145
Query: 46 VNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLL 99
+NI +E++ GGS+ + EKFG V+R YT E LH + I+H D+K N+L+
Sbjct: 146 LNILLEFVPGGSISSLLEKFGA-FPESVVRTYTNQLLLGLEYLHNHAIMHRDIKGANILV 204
Query: 100 GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
+ G +KL D G +++V +L K S+ GT WMAPEV+ G F+ DIWS+G
Sbjct: 205 DNQGCIKLADFGASKQVAELATISGAK----SMKGTPYWMAPEVILQTGHSFSADIWSVG 260
Query: 160 CMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219
C VIEM TG+ PW + AA + I + P P DFL KCL+++P R
Sbjct: 261 CTVIEMVTGKAPWSQQYKEIAA-IFHIGTTKSHPPIPDNISSDANDFLLKCLQQEPNLRP 319
Query: 220 SAEELLNHTFISGNAKKNSTEE 241
+A ELL H F++G K++++++
Sbjct: 320 TASELLKHPFVTGKQKESASKD 341
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 162 bits (410), Expect = 2e-39, Method: Compositional matrix adjust.
Identities = 93/262 (35%), Positives = 138/262 (52%), Gaps = 27/262 (10%)
Query: 1 MNKGTGALFVVKSA----------ESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKT 45
MN +G L VK +++A +Q L E ++ ++L+ PNI R + T
Sbjct: 87 MNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKNLSHPNIVRYLGTVREDDT 146
Query: 46 VNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLL 99
+NI +E++ GGS+ + EKFG V+R YT+ E LH + I+H D+K N+L+
Sbjct: 147 LNILLEFVPGGSISSLLEKFG-PFPESVVRTYTRQLLLGLEYLHNHAIMHRDIKGANILV 205
Query: 100 GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
+ G +KL D G +++V +L K S+ GT WMAPEV+ G F+ DIWS+G
Sbjct: 206 DNKGCIKLADFGASKQVAELATMTGAK----SMKGTPYWMAPEVILQTGHSFSADIWSVG 261
Query: 160 CMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219
C VIEM TG+ PW + AA I + P P DFL KCL+ P R
Sbjct: 262 CTVIEMVTGKAPWSQQYKEVAAIFF-IGTTKSHPPIPDTLSSDAKDFLLKCLQEVPNLRP 320
Query: 220 SAEELLNHTFISGNAKKNSTEE 241
+A ELL H F+ G K++++ +
Sbjct: 321 TASELLKHPFVMGKHKESASTD 342
|
May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q99759|M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens GN=MAP3K3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 148 bits (374), Expect = 3e-35, Method: Compositional matrix adjust.
Identities = 89/234 (38%), Positives = 124/234 (52%), Gaps = 20/234 (8%)
Query: 9 FVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDV 61
F S E+ V AL E ++ ++L I + EKT+ IFMEYM GGS+ D
Sbjct: 395 FDPDSPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQ 454
Query: 62 AEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115
+ +G L V R YT++IL H N I+H D+K N+L S G+VKL D G ++R
Sbjct: 455 LKAYGA-LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 513
Query: 116 VNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDK 175
+ + +G +S+ GT WM+PEV+ EG D+WSLGC V+EM T +PPW +
Sbjct: 514 LQTICMSGT---GMRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 570
Query: 176 ISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTF 229
A A + KIA P P+ + DFL + + +R SAEELL H F
Sbjct: 571 --EAMAAIFKIATQPTNPQLPSHISEHGRDFLRRIFV-EARQRPSAEELLTHHF 621
|
Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q61084|M3K3_MOUSE Mitogen-activated protein kinase kinase kinase 3 OS=Mus musculus GN=Map3k3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 145 bits (367), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 88/234 (37%), Positives = 123/234 (52%), Gaps = 20/234 (8%)
Query: 9 FVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDV 61
F S E+ V AL E ++ ++L I + EK + IFMEYM GGS+ D
Sbjct: 395 FDPDSPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKILTIFMEYMPGGSVKDQ 454
Query: 62 AEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115
+ +G L V R YT++IL H N I+H D+K N+L S G+VKL D G ++R
Sbjct: 455 LKAYGA-LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 513
Query: 116 VNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDK 175
+ + +G +S+ GT WM+PEV+ EG D+WSLGC V+EM T +PPW +
Sbjct: 514 LQTICMSGT---GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 570
Query: 176 ISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTF 229
A A + KIA P P+ + DFL + + +R SAEELL H F
Sbjct: 571 --EAMAAIFKIATQPTNPQLPSHISEHGRDFLRRIFV-EARQRPSAEELLTHHF 621
|
Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q13233|M3K1_HUMAN Mitogen-activated protein kinase kinase kinase 1 OS=Homo sapiens GN=MAP3K1 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 144 bits (364), Expect = 4e-34, Method: Compositional matrix adjust.
Identities = 94/246 (38%), Positives = 135/246 (54%), Gaps = 26/246 (10%)
Query: 4 GTGALFVVK--------SAESEAGVQALRNEAEIRQSLNSPNI----GRNGEKT-VNIFM 50
GTG L VK S+E E V+ALR E + LN PNI G EK+ N+F+
Sbjct: 1264 GTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMSHLNHPNIIRMLGATCEKSNYNLFI 1323
Query: 51 EYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD 104
E+MAGGS+ + K+G ++ VI YT+++L H N I+H D+K N+L+ S G
Sbjct: 1324 EWMAGGSVAHLLSKYGAFKESVVIN-YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ 1382
Query: 105 -VKLPDLGCARRVNDLKNNGNLKQSWQ-SIGGTQLWMAPEVLRNEGLDFATDIWSLGCMV 162
+++ D G A R L + G +Q + GT +MAPEVLR + + D+WS+GC +
Sbjct: 1383 RLRIADFGAAAR---LASKGTGAGEFQGQLLGTIAFMAPEVLRGQQYGRSCDVWSVGCAI 1439
Query: 163 IEMATGRPPW-GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221
IEMA +PPW +K SN A + KIA + P P+ + D +CLE +P+ R +
Sbjct: 1440 IEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVALRCLELQPQDRPPS 1499
Query: 222 EELLNH 227
ELL H
Sbjct: 1500 RELLKH 1505
|
Component of a protein kinase signal transduction cascade. Activates the ERK and JNK kinase pathways by phosphorylation of MAP2K1 and MAP2K4. Activates CHUK and IKBKB, the central protein kinases of the NF-kappa-B pathway. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|P53349|M3K1_MOUSE Mitogen-activated protein kinase kinase kinase 1 OS=Mus musculus GN=Map3k1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 144 bits (364), Expect = 4e-34, Method: Compositional matrix adjust.
Identities = 94/246 (38%), Positives = 135/246 (54%), Gaps = 26/246 (10%)
Query: 4 GTGALFVVK--------SAESEAGVQALRNEAEIRQSLNSPNI----GRNGEKT-VNIFM 50
GTG L VK S+E E V+ALR E + LN PNI G EK+ N+F+
Sbjct: 1245 GTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFI 1304
Query: 51 EYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD 104
E+MAGGS+ + K+G ++ VI YT+++L H N I+H D+K N+L+ S G
Sbjct: 1305 EWMAGGSVAHLLSKYGAFKESVVIN-YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ 1363
Query: 105 -VKLPDLGCARRVNDLKNNGNLKQSWQ-SIGGTQLWMAPEVLRNEGLDFATDIWSLGCMV 162
+++ D G A R L + G +Q + GT +MAPEVLR + + D+WS+GC +
Sbjct: 1364 RLRIADFGAAAR---LASKGTGAGEFQGQLLGTIAFMAPEVLRGQQYGRSCDVWSVGCAI 1420
Query: 163 IEMATGRPPW-GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221
IEMA +PPW +K SN A + KIA + P P+ + D +CLE +P+ R +
Sbjct: 1421 IEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVAVRCLELQPQDRPPS 1480
Query: 222 EELLNH 227
ELL H
Sbjct: 1481 RELLKH 1486
|
Component of a protein kinase signal transduction cascade. Activates the ERK and JNK kinase pathways by phosphorylation of MAP2K1 and MAP2K4. Activates CHUK and IKBKB, the central protein kinases of the NF-kappa-B pathway. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q62925|M3K1_RAT Mitogen-activated protein kinase kinase kinase 1 OS=Rattus norvegicus GN=Map3k1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 143 bits (360), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 93/246 (37%), Positives = 134/246 (54%), Gaps = 26/246 (10%)
Query: 4 GTGALFVVK--------SAESEAGVQALRNEAEIRQSLNSPNI----GRNGEKT-VNIFM 50
GTG L VK S+E E V+ALR E + LN PNI G EK+ N+F+
Sbjct: 1245 GTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMSHLNHPNIIRMLGATCEKSNYNLFI 1304
Query: 51 EYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD 104
E+MAG S+ + K+G ++ VI YT+++L H N I+H D+K N+L+ S G
Sbjct: 1305 EWMAGASVAHLLSKYGAFKESVVIN-YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ 1363
Query: 105 -VKLPDLGCARRVNDLKNNGNLKQSWQ-SIGGTQLWMAPEVLRNEGLDFATDIWSLGCMV 162
+++ D G A R L + G +Q + GT +MAPEVLR + + D+WS+GC +
Sbjct: 1364 RLRIADFGAAAR---LASKGTGAGEFQGQLLGTIAFMAPEVLRGQQYGRSCDVWSVGCAI 1420
Query: 163 IEMATGRPPW-GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221
IEMA +PPW +K SN A + KIA + P P+ + D +CLE +P+ R +
Sbjct: 1421 IEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVALRCLELQPQDRPPS 1480
Query: 222 EELLNH 227
ELL H
Sbjct: 1481 RELLKH 1486
|
Component of a protein kinase signal transduction cascade. Activates the ERK and JNK kinase pathways by phosphorylation of MAP2K1 and MAP2K4. Activates CHUK and IKBKB, the central protein kinases of the NF-kappa-B pathway. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q56UN5|M3K19_HUMAN Mitogen-activated protein kinase kinase kinase 19 OS=Homo sapiens GN=MAP3K19 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 142 bits (359), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 87/226 (38%), Positives = 120/226 (53%), Gaps = 13/226 (5%)
Query: 16 SEAGVQALRNEAEIRQSLNSPNIGRN-----GEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70
+E + L+ E ++ ++L NI E TV+IFME++ GGS+ + +FG L
Sbjct: 1101 AEKEYRKLQEEVDLLKALKHVNIVAYLGTCLQENTVSIFMEFVPGGSISSIINRFGP-LP 1159
Query: 71 AGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGN 124
V YTK+IL H N ++H D+K NNV+L G +KL D GCARR+ NG
Sbjct: 1160 EMVFCKYTKQILQGVAYLHENCVVHRDIKGNNVMLMPTGIIKLIDFGCARRLAWAGLNGT 1219
Query: 125 LKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLL 184
+S+ GT WMAPEV+ G +DIWS+GC V EMATG+PP + AA
Sbjct: 1220 HSDMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS-MDRMAAMFY 1278
Query: 185 KIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
A P P F + DF+ CL R +R SA +LL H+F+
Sbjct: 1279 IGAHRGLMPPLPDHFSENAADFVRMCLTRDQHERPSALQLLKHSFL 1324
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 241 | ||||||
| 224074992 | 355 | predicted protein [Populus trichocarpa] | 0.979 | 0.664 | 0.619 | 7e-85 | |
| 255575900 | 357 | ATP binding protein, putative [Ricinus c | 0.991 | 0.669 | 0.605 | 5e-84 | |
| 359486231 | 363 | PREDICTED: mitogen-activated protein kin | 0.958 | 0.636 | 0.603 | 2e-80 | |
| 356560123 | 336 | PREDICTED: mitogen-activated protein kin | 0.962 | 0.690 | 0.555 | 3e-69 | |
| 356541850 | 329 | PREDICTED: mitogen-activated protein kin | 0.921 | 0.674 | 0.528 | 5e-66 | |
| 92893674 | 373 | Protein kinase [Medicago truncatula] gi| | 0.941 | 0.608 | 0.518 | 1e-62 | |
| 357445203 | 416 | Mitogen-activated protein kinase kinase | 0.941 | 0.545 | 0.518 | 1e-62 | |
| 302767270 | 272 | hypothetical protein SELMODRAFT_86715 [S | 0.921 | 0.816 | 0.462 | 7e-51 | |
| 302755056 | 272 | hypothetical protein SELMODRAFT_74353 [S | 0.921 | 0.816 | 0.458 | 2e-50 | |
| 255554817 | 344 | ATP binding protein, putative [Ricinus c | 0.908 | 0.636 | 0.432 | 1e-48 |
| >gi|224074992|ref|XP_002304509.1| predicted protein [Populus trichocarpa] gi|222841941|gb|EEE79488.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 319 bits (817), Expect = 7e-85, Method: Compositional matrix adjust.
Identities = 156/252 (61%), Positives = 189/252 (75%), Gaps = 16/252 (6%)
Query: 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNI----------GRNGEKTVNIFM 50
+NK TG LFV KSA S + L +EA I +SL+SP + G +G+ +N+F+
Sbjct: 34 INKVTGGLFVAKSALSGVDSKYLEHEANILESLDSPYMIRCMGKGWQKGSDGDAKLNVFI 93
Query: 51 EYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLLGSHGD 104
EYMAGGSL D+AEKFGG L+ VIRLYTK+IL+G NGI+HCDLKC NVLLG G+
Sbjct: 94 EYMAGGSLSDMAEKFGGALEEEVIRLYTKQILNGLKYLHENGIVHCDLKCKNVLLGLSGN 153
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIE 164
+KL D GCA+R+ DL NG SWQS+GGT LWMAPEVLR EGLDFA+DIWSLGC VIE
Sbjct: 154 IKLADFGCAKRLKDLDRNGKFAYSWQSVGGTPLWMAPEVLRKEGLDFASDIWSLGCAVIE 213
Query: 165 MATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
MATGRPPWG K SN A +LKIACSNE+P+FP F ++ +DFLAKCLER PE RW+AEEL
Sbjct: 214 MATGRPPWGYKASNPMAVVLKIACSNERPNFPVHFSEEGMDFLAKCLERNPESRWTAEEL 273
Query: 225 LNHTFISGNAKK 236
L+H FI+GN++K
Sbjct: 274 LDHPFITGNSQK 285
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255575900|ref|XP_002528847.1| ATP binding protein, putative [Ricinus communis] gi|223531698|gb|EEF33521.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 316 bits (810), Expect = 5e-84, Method: Compositional matrix adjust.
Identities = 155/256 (60%), Positives = 189/256 (73%), Gaps = 17/256 (6%)
Query: 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNI----GRNGEK-------TVNIF 49
MNK TG LF+VK ++S+ +++L NEA +SLNSP + GRN K T++IF
Sbjct: 33 MNKSTGELFIVKYSQSKNSIRSLENEANFLESLNSPYVVRYLGRNSSKGSSNDGKTLSIF 92
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHG 103
MEYM GGSL DVAEKFGG LD VIRLYT+EIL H GI+HCD+KC NVLLGS G
Sbjct: 93 MEYMPGGSLSDVAEKFGGALDQEVIRLYTREILCGLKYIHEQGIVHCDVKCKNVLLGSSG 152
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163
++KL D GCA+R+ D+ NG+ S Q IGGT LWMAPEVLR E LDFA+DIWSLGC VI
Sbjct: 153 NIKLADFGCAKRIKDVDINGDFSDSCQDIGGTPLWMAPEVLRKEELDFASDIWSLGCTVI 212
Query: 164 EMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223
EMATG+ PW ++S+ A +LKIACS+EKP FPT F K+ LDFLAKCLER PE+RW+AEE
Sbjct: 213 EMATGKAPWCGQVSDPMAAVLKIACSDEKPKFPTHFSKEGLDFLAKCLERNPERRWTAEE 272
Query: 224 LLNHTFISGNAKKNST 239
LL+H FISG +++ S
Sbjct: 273 LLDHPFISGKSQRKSA 288
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486231|ref|XP_002264624.2| PREDICTED: mitogen-activated protein kinase kinase kinase A-like [Vitis vinifera] gi|297739498|emb|CBI29680.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 304 bits (779), Expect = 2e-80, Method: Compositional matrix adjust.
Identities = 149/247 (60%), Positives = 181/247 (73%), Gaps = 16/247 (6%)
Query: 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNI----------GRNGEKTVNIFM 50
M+K TG LFVVKSA+ G+++L NEA + + L+SP I GR GE +N+FM
Sbjct: 33 MSKATGGLFVVKSAQEGPGLKSLENEATMLEKLHSPYIVRCMGRDSFVGRQGEGRLNLFM 92
Query: 51 EYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD 104
EYMAGGSL +VA+KFGG L+ VIRLYT+EIL H N I+HCDLKC NVLLGS G+
Sbjct: 93 EYMAGGSLSNVADKFGGILEEKVIRLYTREILQGLEYLHKNEIVHCDLKCQNVLLGSSGN 152
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIE 164
VKL D GCA+R+ DLK+ G SWQSI GT LWMAPEVLRNEG+ A+DIWSLGC +IE
Sbjct: 153 VKLADFGCAKRLRDLKSKGASMTSWQSISGTPLWMAPEVLRNEGVTLASDIWSLGCTIIE 212
Query: 165 MATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
MATGRPPW ++SN A ++ IACSN+ P PT K+ LDFLAKCL+R P KRW+AEEL
Sbjct: 213 MATGRPPWSGEVSNPMAAVMMIACSNKIPQIPTHLSKEGLDFLAKCLDRNPAKRWTAEEL 272
Query: 225 LNHTFIS 231
L+H F+S
Sbjct: 273 LSHPFVS 279
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356560123|ref|XP_003548345.1| PREDICTED: mitogen-activated protein kinase kinase kinase ANP1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 267 bits (682), Expect = 3e-69, Method: Compositional matrix adjust.
Identities = 140/252 (55%), Positives = 168/252 (66%), Gaps = 20/252 (7%)
Query: 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSLNS-PNI----GRNGEKT--VNIFMEYM 53
MNK TG LFVVKS S G Q+L E +I +SLNS P I G E+ +NIFMEYM
Sbjct: 29 MNKYTGGLFVVKSPHSGVGRQSLDKEVKILKSLNSSPYIVKCLGTEEEEQGKLNIFMEYM 88
Query: 54 AGGSLLDVAEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLLGSHGDVKL 107
AGG+L D+A KFGG+LD V+R+YT+EILHG +GI+HCDLKC NVLL S G++KL
Sbjct: 89 AGGNLADMAHKFGGSLDEEVVRVYTREILHGLKHLHQHGIVHCDLKCKNVLLSSSGNIKL 148
Query: 108 PDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT 167
D G A+RV + WQSIGGT LWMAPEVLRNE LDFA DIWSLGC VIEMAT
Sbjct: 149 ADFGSAKRVKE-------ANCWQSIGGTPLWMAPEVLRNESLDFAADIWSLGCTVIEMAT 201
Query: 168 GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
G PPW ++SN +L IA + PHFP F K+ LDFL +C ER P KR + ++LL H
Sbjct: 202 GTPPWAHQVSNPTTAVLMIAHGHGIPHFPPHFSKEGLDFLTRCFERHPNKRPTVQDLLTH 261
Query: 228 TFISGNAKKNST 239
FI + S+
Sbjct: 262 PFIVSTKQYASS 273
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356541850|ref|XP_003539385.1| PREDICTED: mitogen-activated protein kinase kinase kinase 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 256 bits (655), Expect = 5e-66, Method: Compositional matrix adjust.
Identities = 130/246 (52%), Positives = 163/246 (66%), Gaps = 24/246 (9%)
Query: 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSLNS-PNIGR--------NGEKTVNIFME 51
MNK TG LFVVKS S A AL E +I +LNS P I + + +N+FME
Sbjct: 29 MNKTTGGLFVVKSPHSRAERHALDKEVKILNTLNSSPYIVQCLGTEEEEEDQGKLNVFME 88
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLLGSHGDV 105
YMAGG+L D+ KFGG+LD V+R+YT+EILHG +GI+HCDLKC NVLLGS G++
Sbjct: 89 YMAGGNLADMVHKFGGSLDEEVVRVYTREILHGLEHLHQHGIVHCDLKCKNVLLGSSGNI 148
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
KL D GCA+RV K+ + GGT LWMAPEVLRNE +DFA DIWSLGC VIEM
Sbjct: 149 KLADFGCAKRV---------KEDSANCGGTPLWMAPEVLRNESVDFAADIWSLGCTVIEM 199
Query: 166 ATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
ATG PPW ++SN +L IA + PHFP F K+ DFL++C +R+P KR + ++LL
Sbjct: 200 ATGTPPWAHQLSNPITAVLMIAHGDGIPHFPPHFSKEGFDFLSRCFQRQPNKRSTVQDLL 259
Query: 226 NHTFIS 231
H F+S
Sbjct: 260 THPFVS 265
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|92893674|gb|ABE91852.1| Protein kinase [Medicago truncatula] gi|92893918|gb|ABE91968.1| Protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 245 bits (625), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 137/264 (51%), Positives = 169/264 (64%), Gaps = 37/264 (14%)
Query: 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSLNS---PNIGR-------NGEKTVNIFM 50
MNK TG LFVVK A SEAG AL NE I +LNS P I + + + +++FM
Sbjct: 28 MNKSTGGLFVVKKAHSEAGRDALENEVNILNTLNSSPSPYIVQCLGTDYDHQDNQLHVFM 87
Query: 51 EYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLLGSHGD 104
EYM+GGSL DV+ KFGG+L+ V+R+YT++I+HG +GI+HCDLKC NVLL S G+
Sbjct: 88 EYMSGGSLADVSHKFGGSLNEDVVRVYTRQIVHGLYHLHQHGIVHCDLKCKNVLLASSGN 147
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSI---GGTQLWMAPEVL----------RNEGLDF 151
VKL D GCA+RV K N N+ +S I GGT LWMAPEVL + +DF
Sbjct: 148 VKLADFGCAKRV---KKNMNMNKSSSCIIANGGTPLWMAPEVLLMKNNSSINDESRVVDF 204
Query: 152 -ATDIWSLGCMVIEMATGRPPWGD----KISNAAATLLKIACSNEKPHFPTQFFKKVLDF 206
A DIWSLGC VIEMATGRPPW D ISN A + KIAC + P FP F ++ DF
Sbjct: 205 AAADIWSLGCTVIEMATGRPPWVDDDLISISNPMAAMFKIACGDGIPQFPIHFSQEGFDF 264
Query: 207 LAKCLERKPEKRWSAEELLNHTFI 230
L +CL R P+KR +A ELLNH F+
Sbjct: 265 LRRCLVRDPKKRSTALELLNHPFL 288
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357445203|ref|XP_003592879.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] gi|355481927|gb|AES63130.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 245 bits (625), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 137/264 (51%), Positives = 169/264 (64%), Gaps = 37/264 (14%)
Query: 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSLNS---PNIGR-------NGEKTVNIFM 50
MNK TG LFVVK A SEAG AL NE I +LNS P I + + + +++FM
Sbjct: 28 MNKSTGGLFVVKKAHSEAGRDALENEVNILNTLNSSPSPYIVQCLGTDYDHQDNQLHVFM 87
Query: 51 EYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLLGSHGD 104
EYM+GGSL DV+ KFGG+L+ V+R+YT++I+HG +GI+HCDLKC NVLL S G+
Sbjct: 88 EYMSGGSLADVSHKFGGSLNEDVVRVYTRQIVHGLYHLHQHGIVHCDLKCKNVLLASSGN 147
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSI---GGTQLWMAPEVL----------RNEGLDF 151
VKL D GCA+RV K N N+ +S I GGT LWMAPEVL + +DF
Sbjct: 148 VKLADFGCAKRV---KKNMNMNKSSSCIIANGGTPLWMAPEVLLMKNNSSINDESRVVDF 204
Query: 152 -ATDIWSLGCMVIEMATGRPPWGD----KISNAAATLLKIACSNEKPHFPTQFFKKVLDF 206
A DIWSLGC VIEMATGRPPW D ISN A + KIAC + P FP F ++ DF
Sbjct: 205 AAADIWSLGCTVIEMATGRPPWVDDDLISISNPMAAMFKIACGDGIPQFPIHFSQEGFDF 264
Query: 207 LAKCLERKPEKRWSAEELLNHTFI 230
L +CL R P+KR +A ELLNH F+
Sbjct: 265 LRRCLVRDPKKRSTALELLNHPFL 288
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302767270|ref|XP_002967055.1| hypothetical protein SELMODRAFT_86715 [Selaginella moellendorffii] gi|300165046|gb|EFJ31654.1| hypothetical protein SELMODRAFT_86715 [Selaginella moellendorffii] | Back alignment and taxonomy information |
|---|
Score = 206 bits (524), Expect = 7e-51, Method: Compositional matrix adjust.
Identities = 116/251 (46%), Positives = 149/251 (59%), Gaps = 29/251 (11%)
Query: 1 MNKGTGALFVVKSAE--SEAGVQALRNEAEIRQSLNSPNIGR--NGEKTV---------N 47
+N+ G+LF VKSAE + + AL NE +I +SL+ P + R G+ T N
Sbjct: 30 VNRADGSLFAVKSAEMGNSGEIAALENERQILESLDCPQVIRCLGGDDTAAEPSKPAMKN 89
Query: 48 IFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGS 101
+F+EYM GGSL+D+ K GG LD ++R+YT+ E LH +GI+HCD+K N+L+G
Sbjct: 90 VFLEYMPGGSLVDLMAKLGGKLDESLVRIYTRGILQGLEFLHRSGIVHCDIKGKNILVGC 149
Query: 102 HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCM 161
VKL D G A+RV G +K GT LWMAPE +R E A+DIWSLGC
Sbjct: 150 E-SVKLADFGAAKRVGAKSMAGGVK-------GTPLWMAPEAVRQEEQGAASDIWSLGCT 201
Query: 162 VIEMATGRPPWGDKI--SNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219
VIEM TG+ PWG+ + SN + KIACSNE P P+ DFLAKCL R P R
Sbjct: 202 VIEMLTGKAPWGEAVSGSNPMVAMYKIACSNEIPELPSFVSSAGRDFLAKCLCRDPCSRA 261
Query: 220 SAEELLNHTFI 230
SAEELL H F+
Sbjct: 262 SAEELLRHPFV 272
|
Source: Selaginella moellendorffii Species: Selaginella moellendorffii Genus: Selaginella Family: Selaginellaceae Order: Selaginellales Class: Isoetopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302755056|ref|XP_002960952.1| hypothetical protein SELMODRAFT_74353 [Selaginella moellendorffii] gi|300171891|gb|EFJ38491.1| hypothetical protein SELMODRAFT_74353 [Selaginella moellendorffii] | Back alignment and taxonomy information |
|---|
Score = 204 bits (520), Expect = 2e-50, Method: Compositional matrix adjust.
Identities = 115/251 (45%), Positives = 149/251 (59%), Gaps = 29/251 (11%)
Query: 1 MNKGTGALFVVKSAE--SEAGVQALRNEAEIRQSLNSPNIGR--NGEKTV---------N 47
+N+ G+LF VKSAE + + AL NE +I +SL+ P + R G+ T N
Sbjct: 30 VNRADGSLFAVKSAEMGNSGEIAALENERQILESLDCPQVIRCLGGDDTAAEPSKPAMKN 89
Query: 48 IFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGS 101
+F+EYM GGSL D+ K GG LD ++R+YT+ E LH +GI+HCD+K N+L+G
Sbjct: 90 VFLEYMPGGSLADLMAKLGGKLDESLVRIYTRGILLGLEFLHKSGIVHCDIKGKNILVGC 149
Query: 102 HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCM 161
VKL D G A+RV G +K GT LWMAPE +R E A+DIWSLGC
Sbjct: 150 E-SVKLADFGAAKRVGAKSMAGGVK-------GTPLWMAPEAVRQEEQGAASDIWSLGCT 201
Query: 162 VIEMATGRPPWGDKISNAA--ATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219
VIEM TG+ PWG+ +S ++ + KIACSNE P P+ DFLAKCL R P R
Sbjct: 202 VIEMLTGKAPWGEAVSGSSPMVAMYKIACSNEIPELPSFVSSAGRDFLAKCLCRDPCSRA 261
Query: 220 SAEELLNHTFI 230
SAEELL H F+
Sbjct: 262 SAEELLRHPFV 272
|
Source: Selaginella moellendorffii Species: Selaginella moellendorffii Genus: Selaginella Family: Selaginellaceae Order: Selaginellales Class: Isoetopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255554817|ref|XP_002518446.1| ATP binding protein, putative [Ricinus communis] gi|223542291|gb|EEF43833.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 198 bits (504), Expect = 1e-48, Method: Compositional matrix adjust.
Identities = 106/245 (43%), Positives = 144/245 (58%), Gaps = 26/245 (10%)
Query: 5 TGALFVVKSAESEAGVQALRNEAEIRQSLNSPNI---------GRNGEKTVNIFMEYMAG 55
+G F VKSAE + L+ E I +L+ P I +G+ NIF+EY G
Sbjct: 26 SGLAFAVKSAELSQS-ELLQKEQRILSTLSCPQIIAYEGYDVTREDGKLLFNIFLEYAPG 84
Query: 56 GSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPD 109
G+L+D K GG LD G+IR Y ++IL H NGI+HCD+K +N+L+ S G K+ D
Sbjct: 85 GTLIDTIRKHGGFLDEGMIRSYARDILLGLHHLHSNGIVHCDIKGHNILVTSDG-AKIAD 143
Query: 110 LGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGR 169
LGCAR+VN + I GT ++MAPEV R E F D+W+LGC +IEMATGR
Sbjct: 144 LGCARKVNQVSKT--------PIAGTPVYMAPEVARGEHQGFPADVWALGCTIIEMATGR 195
Query: 170 PPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTF 229
PPW IS+ + L +I S P P+ K+ +DF++KCL+R P +RWSA ELL H F
Sbjct: 196 PPW-TTISDPVSALYQIGYSGMVPEIPSFMSKQAIDFVSKCLKRDPVERWSASELLRHAF 254
Query: 230 ISGNA 234
++ A
Sbjct: 255 VTEEA 259
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 241 | ||||||
| TAIR|locus:2161690 | 448 | MAPKKK15 "mitogen-activated pr | 0.887 | 0.477 | 0.413 | 9.6e-41 | |
| TAIR|locus:2080394 | 651 | NP3 "NPK1-related protein kina | 0.954 | 0.353 | 0.377 | 2.7e-38 | |
| TAIR|locus:2116417 | 444 | MAPKKK16 "mitogen-activated pr | 0.925 | 0.502 | 0.382 | 4.3e-38 | |
| TAIR|locus:2060246 | 372 | MAPKKK17 "mitogen-activated pr | 0.892 | 0.577 | 0.380 | 3e-37 | |
| DICTYBASE|DDB_G0283265 | 1267 | mkkA "octicosapeptide/Phox/Bem | 0.921 | 0.175 | 0.388 | 3.4e-37 | |
| UNIPROTKB|Q40541 | 690 | Q40541 "Protein kinase" [Nicot | 0.871 | 0.304 | 0.392 | 6.2e-37 | |
| TAIR|locus:2035989 | 666 | NP1 "NPK1-related protein kina | 0.946 | 0.342 | 0.361 | 2.4e-36 | |
| TAIR|locus:2205523 | 339 | MAPKKK18 "mitogen-activated pr | 0.900 | 0.640 | 0.383 | 4.4e-36 | |
| TAIR|locus:2074835 | 342 | MAPKKK20 "mitogen-activated pr | 0.912 | 0.643 | 0.381 | 1.3e-34 | |
| TAIR|locus:2155568 | 344 | MAPKKK19 "mitogen-activated pr | 0.908 | 0.636 | 0.382 | 1.7e-34 |
| TAIR|locus:2161690 MAPKKK15 "mitogen-activated protein kinase kinase kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 433 (157.5 bits), Expect = 9.6e-41, P = 9.6e-41
Identities = 100/242 (41%), Positives = 142/242 (58%)
Query: 5 TGALFVVKSAESEAGVQALRNEAEIRQSLNSP--------NIGRNGEKTV-NIFMEYMAG 55
+G F VKSAE + L+ E I L+SP N+ + +K + N+ MEY++G
Sbjct: 27 SGDFFAVKSAEFSSSA-FLQREQSILSKLSSPYIVKYIGSNVTKENDKLMYNLLMEYVSG 85
Query: 56 GSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDV-KLP 108
GSL D+ + GG L +IR YT++IL H GI+HCD+K NV++G G++ K+
Sbjct: 86 GSLHDLIKNSGGKLPEPLIRSYTRQILKGLMYLHDQGIVHCDVKSQNVMIG--GEIAKIV 143
Query: 109 DLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATG 168
DLGCA+ V + N NL+ S GT +M+PEV R E F D+W+LGC VIEMATG
Sbjct: 144 DLGCAKTVEE---NENLEFS-----GTPAFMSPEVARGEEQSFPADVWALGCTVIEMATG 195
Query: 169 RPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHT 228
PW + +++ A + KI + E P P +K DFL KCL + P++RW+ EELL H
Sbjct: 196 SSPWPE-LNDVVAAIYKIGFTGESPVIPVWLSEKGQDFLRKCLRKDPKQRWTVEELLQHP 254
Query: 229 FI 230
F+
Sbjct: 255 FL 256
|
|
| TAIR|locus:2080394 NP3 "NPK1-related protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 414 (150.8 bits), Expect = 2.7e-38, P = 2.7e-38
Identities = 97/257 (37%), Positives = 143/257 (55%)
Query: 1 MNKGTGALFVVK---------SAESEAG-VQALRNEAEIRQSLNSPNIGR-----NGEKT 45
MN +G L +K S E G ++ L E ++ ++L+ PNI R +
Sbjct: 86 MNLDSGELLAIKQVLIAPSSASKEKTQGHIRELEEEVQLLKNLSHPNIVRYLGTVRESDS 145
Query: 46 VNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLL 99
+NI ME++ GGS+ + EKFG + VI +YTK++L H NGI+H D+K N+L+
Sbjct: 146 LNILMEFVPGGSISSLLEKFG-SFPEPVIIMYTKQLLLGLEYLHNNGIMHRDIKGANILV 204
Query: 100 GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
+ G ++L D G +++V +L K S+ GT WMAPEV+ G F+ DIWS+G
Sbjct: 205 DNKGCIRLADFGASKKVVELATVNGAK----SMKGTPYWMAPEVILQTGHSFSADIWSVG 260
Query: 160 CMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219
C VIEMATG+PPW ++ AA +L I + P P + DFL KCL ++P R
Sbjct: 261 CTVIEMATGKPPWSEQYQQFAA-VLHIGRTKAHPPIPEDLSPEAKDFLMKCLHKEPSLRL 319
Query: 220 SAEELLNHTFISGNAKK 236
SA ELL H F++G ++
Sbjct: 320 SATELLQHPFVTGKRQE 336
|
|
| TAIR|locus:2116417 MAPKKK16 "mitogen-activated protein kinase kinase kinase 16" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 408 (148.7 bits), Expect = 4.3e-38, P = 4.3e-38
Identities = 96/251 (38%), Positives = 139/251 (55%)
Query: 5 TGALFVVKSAESEAGVQALRNEAEIRQSLNSPN----IG----RNGEKTV-NIFMEYMAG 55
+G LF VKSA+ + L+ E I +L+SP+ IG R V NI MEY++G
Sbjct: 26 SGELFAVKSADLSSS-SLLQKEQSILSTLSSPHMVKYIGTGLTRESNGLVYNILMEYVSG 84
Query: 56 GSLLDVAEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLLGSHGDVKLPD 109
G+L D+ + GG L IR YT++IL+G GI+HCDLK +NVL+ +G +K+ D
Sbjct: 85 GNLHDLIKNSGGKLPEPEIRSYTRQILNGLVYLHERGIVHCDLKSHNVLVEENGVLKIAD 144
Query: 110 LGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGR 169
+GCA+ V+ GT +MAPEV R E F D+W+LGC +IEM TG
Sbjct: 145 MGCAKSVDK-----------SEFSGTPAFMAPEVARGEEQRFPADVWALGCTMIEMMTGS 193
Query: 170 PPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTF 229
PW + +++ A + KI S E P P K DFL CL+ ++RW+ EELL H F
Sbjct: 194 SPWPE-LNDVVAAMYKIGFSGESPAIPAWISDKAKDFLKNCLKEDQKQRWTVEELLKHPF 252
Query: 230 ISGNAKKNSTE 240
+ + + +++
Sbjct: 253 LDDDEESQTSD 263
|
|
| TAIR|locus:2060246 MAPKKK17 "mitogen-activated protein kinase kinase kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 400 (145.9 bits), Expect = 3.0e-37, P = 3.0e-37
Identities = 92/242 (38%), Positives = 136/242 (56%)
Query: 8 LFVVKSAESEAGVQALRNEAEIRQSLNSPN-IGRNGEKT---------VNIFMEYMAGGS 57
+ VKS+E + L+ EA+I SL+SP IG G +T N+ MEY G+
Sbjct: 28 ILAVKSSEVHRS-EFLQREAKILSSLSSPYVIGYRGSETKRESNGVVMYNLLMEYAPYGT 86
Query: 58 LLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLG 111
L D A K GG +D + YT++IL H GI+HCD+K +NV++ G+ K+ D G
Sbjct: 87 LTDAAAKDGGRVDETRVVKYTRDILKGLEYIHSKGIVHCDVKGSNVVISEKGEAKIADFG 146
Query: 112 CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPP 171
CA+RV+ + + + GT +MAPEV R E +DIW++GC +IEM TG PP
Sbjct: 147 CAKRVDPVFES--------PVMGTPAFMAPEVARGEKQGKESDIWAVGCTMIEMVTGSPP 198
Query: 172 W--GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTF 229
W D + + L ++ S+E P P ++ DFL KCL+R+ +RW+A +LLNH F
Sbjct: 199 WTKADSREDPVSVLYRVGYSSETPELPCLLAEEAKDFLEKCLKREANERWTATQLLNHPF 258
Query: 230 IS 231
++
Sbjct: 259 LT 260
|
|
| DICTYBASE|DDB_G0283265 mkkA "octicosapeptide/Phox/Bem1p domain-containing protein" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 412 (150.1 bits), Expect = 3.4e-37, P = 3.4e-37
Identities = 97/250 (38%), Positives = 146/250 (58%)
Query: 1 MNKGTGALFVVKSAE-----SEAGVQ----ALRNEAEIRQSLNSPNIGRN-G----EKTV 46
+NK TG LF VK E S+ ++ + E E+ +SL NI R G + +
Sbjct: 513 LNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRSLRHDNIVRYLGTSLDQSFL 572
Query: 47 NIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLG 100
++F+EY+ GGS+ + KFG VI++YTK+IL H N I+H D+K N+L+
Sbjct: 573 SVFLEYIPGGSISSLLGKFGA-FSENVIKVYTKQILQGLSFLHANSIIHRDIKGANILID 631
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGC 160
+ G VKL D GC++ + G + Q ++S+ GT WMAPEV++ G ++DIWSLGC
Sbjct: 632 TKGIVKLSDFGCSKSFS-----GIVSQ-FKSMQGTPYWMAPEVIKQTGHGRSSDIWSLGC 685
Query: 161 MVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS 220
+++EMAT +PPW + I+ AA + IA SN P+ P+ ++ DFL C +R P++R
Sbjct: 686 VIVEMATAQPPWSN-ITELAAVMYHIASSNSIPNIPSHMSQEAFDFLNLCFKRDPKERPD 744
Query: 221 AEELLNHTFI 230
A +LL H FI
Sbjct: 745 ANQLLKHPFI 754
|
|
| UNIPROTKB|Q40541 Q40541 "Protein kinase" [Nicotiana tabacum (taxid:4097)] | Back alignment and assigned GO terms |
|---|
Score = 403 (146.9 bits), Expect = 6.2e-37, P = 6.2e-37
Identities = 89/227 (39%), Positives = 131/227 (57%)
Query: 16 SEAGVQALRNEAEIRQSLNSPNI----GRNGEK-TVNIFMEYMAGGSLLDVAEKFGGTLD 70
++A V+ L E + ++L+ PNI G E ++NI +E++ GGS+ + KFG +
Sbjct: 123 AQAHVRELEEEVNLLKNLSHPNIVRYLGTAREAGSLNILLEFVPGGSISSLLGKFG-SFP 181
Query: 71 AGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGN 124
VIR+YTK++L H NGI+H D+K N+L+ + G +KL D G +++V +L
Sbjct: 182 ESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATMTG 241
Query: 125 LKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLL 184
K S+ GT WMAPEV+ G F+ DIWS+GC +IEMATG+PPW + AA L
Sbjct: 242 AK----SMKGTPYWMAPEVILQTGHSFSADIWSVGCTIIEMATGKPPWSQQYQEVAA-LF 296
Query: 185 KIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFIS 231
I + P P + DFL KCL+++P R SA LL H F++
Sbjct: 297 HIGTTKSHPPIPEHLSAESKDFLLKCLQKEPHLRHSASNLLQHPFVT 343
|
|
| TAIR|locus:2035989 NP1 "NPK1-related protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 397 (144.8 bits), Expect = 2.4e-36, P = 2.4e-36
Identities = 89/246 (36%), Positives = 135/246 (54%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDV 61
A F K +++A +Q L E ++ ++L+ PNI R + T+NI +E++ GGS+ +
Sbjct: 104 ANFASKE-KTQAHIQELEEEVKLLKNLSHPNIVRYLGTVREDDTLNILLEFVPGGSISSL 162
Query: 62 AEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115
EKFG V+R YT+++L H + I+H D+K N+L+ + G +KL D G +++
Sbjct: 163 LEKFG-PFPESVVRTYTRQLLLGLEYLHNHAIMHRDIKGANILVDNKGCIKLADFGASKQ 221
Query: 116 VNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDK 175
V +L K S+ GT WMAPEV+ G F+ DIWS+GC VIEM TG+ PW +
Sbjct: 222 VAELATMTGAK----SMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMVTGKAPWSQQ 277
Query: 176 ISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235
AA I + P P DFL KCL+ P R +A ELL H F+ G K
Sbjct: 278 YKEVAAIFF-IGTTKSHPPIPDTLSSDAKDFLLKCLQEVPNLRPTASELLKHPFVMGKHK 336
Query: 236 KNSTEE 241
++++ +
Sbjct: 337 ESASTD 342
|
|
| TAIR|locus:2205523 MAPKKK18 "mitogen-activated protein kinase kinase kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 389 (142.0 bits), Expect = 4.4e-36, P = 4.4e-36
Identities = 95/248 (38%), Positives = 134/248 (54%)
Query: 5 TGALFVVKSAESEAGVQALRNEAEIRQSLNSPN-IG------------RNGEKTV-NIFM 50
+G VKSAE + L+ EA+I SLNSP IG NGE T ++ M
Sbjct: 25 SGETLAVKSAEFHRS-EFLQREAKILSSLNSPYVIGYRGCEITREPFHNNGEATTYSLLM 83
Query: 51 EYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHG-------NGILHCDLKCNNVLLGSHG 103
EY G+L DVA K GG +D + YT++IL G GI HCD+K +NVL+G +G
Sbjct: 84 EYAPYGTLTDVATKNGGFIDEARVVKYTRQILLGLEYIHNSKGIAHCDIKGSNVLVGENG 143
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163
+ K+ D GCA+ V + + + GT +MAPE R E +DIW++GC VI
Sbjct: 144 EAKIADFGCAKWVEP--------EITEPVRGTPAFMAPEAARGERQGKESDIWAVGCTVI 195
Query: 164 EMATGRPPW-GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222
EM TG PW G ++ + L ++ E P P ++ DFL KCL+++ +RW+A
Sbjct: 196 EMVTGSQPWIGADFTDPVSVLYRVGYLGELPELPCSLTEQAKDFLGKCLKKEATERWTAS 255
Query: 223 ELLNHTFI 230
+LLNH F+
Sbjct: 256 QLLNHPFL 263
|
|
| TAIR|locus:2074835 MAPKKK20 "mitogen-activated protein kinase kinase kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 375 (137.1 bits), Expect = 1.3e-34, P = 1.3e-34
Identities = 93/244 (38%), Positives = 134/244 (54%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNS-PNIGR---------NGEKTVNIFMEYMAGG 56
AL VKS ++ G +L NE + SL P I R NGE+ N+ +EY + G
Sbjct: 31 ALIAVKSTDAY-GAASLSNEKSVLDSLGDCPEIIRCYGEDSTVENGEEMHNLLLEYASRG 89
Query: 57 SLLDVAEKFGGT-LDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPD 109
SL +K GG L +R +T +L H G HCD+K N+LL + G VK+ D
Sbjct: 90 SLASYMKKLGGEGLPESTVRRHTGSVLRGLRHIHAKGFAHCDIKLANILLFNDGSVKIAD 149
Query: 110 LGCARRVN-DLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATG 168
G A RV+ DL L++S + I GT L+MAPE + + A D+W+LGC V+EM +G
Sbjct: 150 FGLAMRVDGDLTA---LRKSVE-IRGTPLYMAPECVNDNEYGSAADVWALGCAVVEMFSG 205
Query: 169 RPPWGDKI-SNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
+ W K S+ + L++I +E P P ++ DFL+KC + P KRW+AE LLNH
Sbjct: 206 KTAWSVKEGSHFMSLLIRIGVGDELPKIPEMLSEEGKDFLSKCFVKDPAKRWTAEMLLNH 265
Query: 228 TFIS 231
+F++
Sbjct: 266 SFVT 269
|
|
| TAIR|locus:2155568 MAPKKK19 "mitogen-activated protein kinase kinase kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 374 (136.7 bits), Expect = 1.7e-34, P = 1.7e-34
Identities = 93/243 (38%), Positives = 131/243 (53%)
Query: 8 LFVVKSAESEAGVQALRNEAEIRQSLNSP--NIGR---------NGEKTVNIFMEYMAGG 56
L VKSA+S G +L NE + +L I R NGE+ N+F+EY + G
Sbjct: 33 LMAVKSADSY-GAASLANEKSVLDNLGDDCNEIVRCFGEDRTVENGEEMHNLFLEYASRG 91
Query: 57 SLLDVAEKFGGT-LDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPD 109
SL +K G + +R +T +L H NG HCDLK N+LL G VK+ D
Sbjct: 92 SLESYLKKLAGEGVPESTVRRHTGSVLRGLRHIHANGFAHCDLKLGNILLFGDGAVKIAD 151
Query: 110 LGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGR 169
G A+R+ DL L Q I GT L+MAPE + + D+W+LGC+V+EM +G+
Sbjct: 152 FGLAKRIGDLTA---LNYGVQ-IRGTPLYMAPESVNDNEYGSEGDVWALGCVVVEMFSGK 207
Query: 170 PPWGDKI-SNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHT 228
W K SN + LL+I +E P P + ++ DFL+KC + P+KRW+AE LLNH
Sbjct: 208 TAWSLKEGSNFMSLLLRIGVGDEVPMIPEELSEQGRDFLSKCFVKDPKKRWTAEMLLNHP 267
Query: 229 FIS 231
F++
Sbjct: 268 FVT 270
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 241 | |||
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-99 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-62 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-61 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-58 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-58 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-57 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-56 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-52 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-49 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-48 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-48 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-48 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-47 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-46 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-46 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-44 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-42 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-41 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-41 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-40 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-39 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-39 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-39 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-38 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-37 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-37 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-36 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-36 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-36 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-36 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-35 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-35 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-35 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-34 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-34 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-32 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-32 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-32 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-31 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-30 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-30 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-30 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-30 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-30 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-28 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-28 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-28 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-27 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-26 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-26 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-25 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-25 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-25 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-25 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-25 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-24 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-24 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-24 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-24 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-24 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-24 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-24 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-24 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-23 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-22 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-22 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-22 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-22 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-21 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-21 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-21 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-20 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-20 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-19 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-19 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-18 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-17 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-17 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-17 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-16 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-15 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-14 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-11 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-11 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-10 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-09 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-09 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-06 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-05 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 2e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.001 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.001 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.001 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.001 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.002 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.003 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.004 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 289 bits (741), Expect = 3e-99
Identities = 115/247 (46%), Positives = 147/247 (59%), Gaps = 23/247 (9%)
Query: 1 MNKGTGALFVVKSAE----SEAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIF 49
++K TG L VKS E SE ++AL E I SL PNI R + T+NIF
Sbjct: 20 LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHG 103
+EY++GGSL + +KFG L VIR YT++IL H NGI+H D+K N+L+ S G
Sbjct: 80 LEYVSGGSLSSLLKKFGK-LPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG 138
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163
VKL D GCA+R+ D++ S+ GT WMAPEV+R E A DIWSLGC VI
Sbjct: 139 VVKLADFGCAKRLGDIETGEGTG----SVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVI 194
Query: 164 EMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223
EMATG+PPW + + N A L KI S E P P ++ DFL KCL R P+KR +A+E
Sbjct: 195 EMATGKPPWSE-LGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADE 253
Query: 224 LLNHTFI 230
LL H F+
Sbjct: 254 LLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 3e-62
Identities = 80/243 (32%), Positives = 112/243 (46%), Gaps = 22/243 (9%)
Query: 2 NKGTGALFVVKS---AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYM 53
+K TG L +K + + + + E +I + L PNI R E + + MEY
Sbjct: 20 DKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYC 79
Query: 54 AGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKL 107
GG L D+ +K G L R Y ++I LH GI+H DLK N+LL G VKL
Sbjct: 80 EGGDLFDLLKKRGR-LSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKL 138
Query: 108 PDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT 167
D G AR+++ + + GT +MAPEVL +G A DIWSLG ++ E+ T
Sbjct: 139 ADFGLARQLDP-------GEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLT 191
Query: 168 GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
G+PP+ P + D + K L + PEKR +AEE L H
Sbjct: 192 GKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQH 251
Query: 228 TFI 230
F
Sbjct: 252 PFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 8e-61
Identities = 93/249 (37%), Positives = 126/249 (50%), Gaps = 29/249 (11%)
Query: 1 MNKGTGALFVVK-------SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNI 48
+N G F VK + V+ L E + L PNI + E + I
Sbjct: 20 LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYI 79
Query: 49 FMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSH 102
F+E + GGSL + +K+G + VIRLYT++IL H +H D+K N+L+ ++
Sbjct: 80 FLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN 138
Query: 103 GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL-DFATDIWSLGCM 161
G VKL D G A++V K S G+ WMAPEV+ +G A DIWSLGC
Sbjct: 139 GVVKLADFGMAKQV---VEFSFAK----SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCT 191
Query: 162 VIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221
V+EMATG+PPW AA + KI S E P P + DF+ KCL+R P R +A
Sbjct: 192 VLEMATGKPPWSQLEGVAA--VFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTA 249
Query: 222 EELLNHTFI 230
ELL H F+
Sbjct: 250 AELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 1e-58
Identities = 80/245 (32%), Positives = 126/245 (51%), Gaps = 25/245 (10%)
Query: 1 MNKGTGALFVVKSAE----SEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFME 51
+N TG +K E ++++ E ++ ++L PNI + ++ I +E
Sbjct: 20 LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDV 105
Y GSL + +KFG ++ +Y ++ LH G++H D+K N+L G V
Sbjct: 80 YAENGSLRQIIKKFGP-FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVV 138
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
KL D G A ++ND+ + S+ GT WMAPEV+ G A+DIWSLGC VIE+
Sbjct: 139 KLADFGVATKLNDVSKDDA------SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIEL 192
Query: 166 ATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
TG PP+ D N A L +I ++ P P ++ DFL +C ++ P R +A++LL
Sbjct: 193 LTGNPPYYDL--NPMAALFRI-VQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLL 249
Query: 226 NHTFI 230
H +I
Sbjct: 250 KHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 3e-58
Identities = 91/248 (36%), Positives = 128/248 (51%), Gaps = 33/248 (13%)
Query: 1 MNKGTGALFVVK--SAESEAGVQALRNEAEIRQSLNSPNI----G---RNGEKTVNIFME 51
+K TG +K ES+ + + NE +I + PNI G + E + I ME
Sbjct: 20 RHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE--LWIVME 77
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDV 105
+ +GGSL D+ + TL I KE+ LH NGI+H D+K N+LL S G+V
Sbjct: 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEV 137
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
KL D G + +++D K ++ GT WMAPEV+ + D+ DIWSLG IE+
Sbjct: 138 KLIDFGLSAQLSDTKAR-------NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIEL 190
Query: 166 ATGRPPWGDKISNAAATLLKIACSN----EKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221
A G+PP+ + L KIA + P + FK DFL KCL++ PEKR +A
Sbjct: 191 AEGKPPYSE--LPPMKALFKIATNGPPGLRNPEKWSDEFK---DFLKKCLQKNPEKRPTA 245
Query: 222 EELLNHTF 229
E+LL H F
Sbjct: 246 EQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 1e-57
Identities = 95/252 (37%), Positives = 136/252 (53%), Gaps = 29/252 (11%)
Query: 1 MNKGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFM 50
+N TG L VK ++ + +E ++ + L PN+ + + EK V IFM
Sbjct: 20 VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK-VYIFM 78
Query: 51 EYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD 104
EY +GG+L ++ E G LD VIR+YT ++L H +GI+H D+K N+ L +G
Sbjct: 79 EYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV 137
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSW-QSIGGTQLWMAPEVLRNEGLDF---ATDIWSLGC 160
+KL D GCA + LKNN QS+ GT +MAPEV+ A DIWSLGC
Sbjct: 138 IKLGDFGCAVK---LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGC 194
Query: 161 MVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPT--QFFKKVLDFLAKCLERKPEKR 218
+V+EMATG+ PW ++ N + + + KP P Q + DFL +CLE P+KR
Sbjct: 195 VVLEMATGKRPW-SELDNEFQIMFHV-GAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKR 252
Query: 219 WSAEELLNHTFI 230
+A ELL H F+
Sbjct: 253 PTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 2e-56
Identities = 81/253 (32%), Positives = 119/253 (47%), Gaps = 34/253 (13%)
Query: 1 MNKGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNI-------GRNGEKTVNIF 49
+KGTG + VK +E Q R E I + L+ PNI + +
Sbjct: 19 KHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDH--LYLV 76
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
MEY GG L D + GG L + +I LH NGI+H DLK N+LL +G
Sbjct: 77 MEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENG 135
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR-NEGLDFATDIWSLGCMV 162
VK+ D G A+++ K++ +L + GT +MAPEVL G D+WSLG ++
Sbjct: 136 VVKIADFGLAKKLL--KSSSSLT----TFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVIL 189
Query: 163 IEMATGRPPW-GDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEK 217
E+ TG+PP+ G+ I + + +I F + D + KCL + P K
Sbjct: 190 YELLTGKPPFSGENILDQLQLIRRILG--PPLEFDEPKWSSGSEEAKDLIKKCLNKDPSK 247
Query: 218 RWSAEELLNHTFI 230
R +AEE+L H +
Sbjct: 248 RPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 2e-52
Identities = 92/246 (37%), Positives = 131/246 (53%), Gaps = 26/246 (10%)
Query: 4 GTGALFVVK--------SAESEAGVQALRNEAEIRQSLNSPNIGRNGEKTV-----NIFM 50
TG L VK S+E E V+ALR E + LN P+I R T N+F+
Sbjct: 23 KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82
Query: 51 EYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG- 103
E+MAGGS+ + K+G +A +I YT+++ LH N I+H D+K N+L+ S G
Sbjct: 83 EWMAGGSVSHLLSKYGAFKEAVIIN-YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ 141
Query: 104 DVKLPDLGCARRVN-DLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMV 162
+++ D G A R+ G + + GT +MAPEVLR E + D+WS+GC++
Sbjct: 142 RLRIADFGAAARLAAKGTGAGEFQGQ---LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVI 198
Query: 163 IEMATGRPPWG-DKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221
IEMAT +PPW +K SN A + KIA + P P + D +CLE +PE R +
Sbjct: 199 IEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPS 258
Query: 222 EELLNH 227
ELL H
Sbjct: 259 RELLKH 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 7e-49
Identities = 88/252 (34%), Positives = 120/252 (47%), Gaps = 27/252 (10%)
Query: 2 NKGTG---ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGRNGEKTVN-----IFMEYM 53
+K T A+ V+ E+E ++ ++ E + SP I + + I MEY
Sbjct: 22 DKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81
Query: 54 AGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKL 107
GGS LD+ + G LD I +E+ LH G +H D+K N+LL GDVKL
Sbjct: 82 GGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKL 139
Query: 108 PDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT 167
D G + ++ + N + GT WMAPEV++ G D DIWSLG IE+A
Sbjct: 140 ADFGVSGQLTSTMSKRN------TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAK 193
Query: 168 GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVL-DFLAKCLERKPEKRWSAEELLN 226
G PP D L I N P F K DF++ CL + P++R SA+ELL
Sbjct: 194 GEPPLSDLHPMRV--LFLIP-KNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250
Query: 227 HTFISGNAKKNS 238
H FI AKK S
Sbjct: 251 HKFI-KKAKKTS 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 1e-48
Identities = 90/245 (36%), Positives = 127/245 (51%), Gaps = 21/245 (8%)
Query: 5 TGALFVVKSAE--------SEAGVQALRNEAEIRQSLNSPNIGRN-----GEKTVNIFME 51
G L VK E +E + L+ E ++ +SL NI + + T++IFME
Sbjct: 23 QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDV 105
++ GGS+ + +FG L V YTK+IL H N ++H D+K NNV+L +G +
Sbjct: 83 FVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGII 141
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
KL D GCARR+ + +G +S+ GT WMAPEV+ G +DIWS+GC V EM
Sbjct: 142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEM 201
Query: 166 ATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
ATG+PP + AA A P P F +DF+ CL R +R SA +LL
Sbjct: 202 ATGKPPLAS-MDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260
Query: 226 NHTFI 230
H F+
Sbjct: 261 RHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 2e-48
Identities = 85/229 (37%), Positives = 126/229 (55%), Gaps = 17/229 (7%)
Query: 13 SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG 67
S E++ V AL E ++ ++L I + ++T++IFMEYM GGS+ D + +G
Sbjct: 41 SPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG- 99
Query: 68 TLDAGVIRLYTKEILHG------NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKN 121
L V R YT++IL G N I+H D+K N+L S G+VKL D G ++R+ + +
Sbjct: 100 ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159
Query: 122 NGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAA 181
+G +S+ GT WM+PEV+ EG D+WS+GC V+EM T +PPW + A A
Sbjct: 160 SGT---GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE--FEAMA 214
Query: 182 TLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
+ KIA P P+ +FL + +KR SAEELL H F+
Sbjct: 215 AIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 5e-48
Identities = 79/249 (31%), Positives = 114/249 (45%), Gaps = 34/249 (13%)
Query: 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAG 55
++K TG + +K E +Q + E I + +SP I + + I MEY
Sbjct: 23 IHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82
Query: 56 GSLLDVAEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLLGSHGDVKLPD 109
GS+ D+ + TL I + L G N +H D+K N+LL G KL D
Sbjct: 83 GSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLAD 142
Query: 110 LGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGR 169
G + ++ D K+ ++ GT WMAPEV++ G + DIWSLG IEMA G+
Sbjct: 143 FGVSGQLTD----TMAKR--NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
Query: 170 PPWGD--------KISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221
PP+ D I N L P ++ + DF+ KCL + PE+R SA
Sbjct: 197 PPYSDIHPMRAIFMIPNKPPPTLSD---------PEKWSPEFNDFVKKCLVKDPEERPSA 247
Query: 222 EELLNHTFI 230
+LL H FI
Sbjct: 248 IQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 6e-47
Identities = 79/247 (31%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 2 NKGTGALFVVKS---AESEAGVQALRNEAEIRQSLNSPNI----G---RNGEKTVNIFME 51
+K TG ++ +K E + L E + +S SP + G + GE ++I +E
Sbjct: 22 HKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGE--ISIVLE 79
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHG-------NGILHCDLKCNNVLLGSHGD 104
YM GGSL D+ +K G + V+ ++IL G I+H D+K +N+L+ S G+
Sbjct: 80 YMDGGSLADLLKKVGK-IPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE 138
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIE 164
VK+ D G ++ L+N + ++ GT +M+PE ++ E +A DIWSLG ++E
Sbjct: 139 VKIADFGISK---VLENTLDQCNTFV---GTVTYMSPERIQGESYSYAADIWSLGLTLLE 192
Query: 165 MATGRPPWGDKISNAAATLLKIACSNEKPHFP-TQFFKKVLDFLAKCLERKPEKRWSAEE 223
A G+ P+ + L++ C P P +F + DF++ CL++ P+KR SA E
Sbjct: 193 CALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252
Query: 224 LLNHTFI 230
LL H FI
Sbjct: 253 LLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 3e-46
Identities = 87/259 (33%), Positives = 134/259 (51%), Gaps = 36/259 (13%)
Query: 1 MNKGTGALFVVKSAE---SEAG---------VQALRNEAEIRQSLNSPNIGR-----NGE 43
+N TG + VK E + AG V+ALR+E E + L+ NI + E
Sbjct: 21 LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE 80
Query: 44 KTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNV 97
+ ++IF+EY+ GGS+ +G + ++R +T+++L H GILH DLK +N+
Sbjct: 81 EYLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNL 139
Query: 98 LLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA--TDI 155
L+ + G K+ D G +++ +D+ +N S+ G+ WMAPEV+ + ++ DI
Sbjct: 140 LVDADGICKISDFGISKKSDDIYDN----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDI 195
Query: 156 WSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCL 211
WSLGC+V+EM GR PW D+ A A + K+ P P + LDFL C
Sbjct: 196 WSLGCVVLEMFAGRRPWSDE--EAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACF 253
Query: 212 ERKPEKRWSAEELLNHTFI 230
P+ R +A ELL H FI
Sbjct: 254 TINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 5e-46
Identities = 80/231 (34%), Positives = 111/231 (48%), Gaps = 36/231 (15%)
Query: 21 QALRNEAEIRQSLNSPNIGRNGEKTVNIF------------MEYMAGGSLLDVAEKFGGT 68
+ + NE I + PNI V+ + MEYM GGSL D+ +
Sbjct: 60 ELIINEILIMKDCKHPNI-------VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR 112
Query: 69 LDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNN 122
++ I +E+L H ++H D+K +N+LL G VKL D G A ++ K+
Sbjct: 113 MNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172
Query: 123 GNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAAT 182
N S+ GT WMAPEV++ + DIWSLG M IEMA G PP+ +
Sbjct: 173 RN------SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE--PPLRA 224
Query: 183 LLKIACSNEKPHF--PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFIS 231
L I + P P ++ + DFL KCL + PEKR SAEELL H F+
Sbjct: 225 LFLIT-TKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-45
Identities = 90/234 (38%), Positives = 125/234 (53%), Gaps = 20/234 (8%)
Query: 9 FVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDV 61
F +S E+ V AL E ++ ++L I + EKT+ IFMEYM GGS+ D
Sbjct: 37 FDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQ 96
Query: 62 AEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115
+ +G L V R YT++IL H N I+H D+K N+L S G+VKL D G ++R
Sbjct: 97 LKAYGA-LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155
Query: 116 VNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDK 175
+ + +G +S+ GT WM+PEV+ EG D+WSLGC V+EM T +PPW +
Sbjct: 156 LQTICMSGT---GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE- 211
Query: 176 ISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTF 229
A A + KIA P P+ + DFL C+ + R SAEELL H F
Sbjct: 212 -YEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 5e-44
Identities = 76/243 (31%), Positives = 111/243 (45%), Gaps = 57/243 (23%)
Query: 1 MNKGTGALFVVK---SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEY 52
+K TG +K +S + ++ L E EI + LN PNI + E + + MEY
Sbjct: 13 RDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEY 72
Query: 53 MAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS-HGDV 105
GGSL D+ ++ G L I +I LH NGI+H DLK N+LL S +G V
Sbjct: 73 CEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKV 132
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG-LDFATDIWSLGCMVIE 164
KL D G ++ + K+ +I GT +MAPEVL +G +DIWSLG ++ E
Sbjct: 133 KLADFGLSKLLTSDKSLLK------TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE 186
Query: 165 MATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
+ ++ D + K L++ PEKR SA+E+
Sbjct: 187 L-----------------------------------PELKDLIRKMLQKDPEKRPSAKEI 211
Query: 225 LNH 227
L H
Sbjct: 212 LEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 8e-42
Identities = 87/235 (37%), Positives = 126/235 (53%), Gaps = 20/235 (8%)
Query: 9 FVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDV 61
F +S E+ V AL E ++ ++L I + E+T++IFME+M GGS+ D
Sbjct: 37 FDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQ 96
Query: 62 AEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115
+ +G L V R YT++IL H N I+H D+K N+L S G+VKL D G ++R
Sbjct: 97 LKSYGA-LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKR 155
Query: 116 VNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDK 175
+ + +G +S+ GT WM+PEV+ EG DIWS+GC V+EM T +PPW +
Sbjct: 156 LQTICLSGT---GMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE- 211
Query: 176 ISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
A A + KIA P P DFL + + + R SA+ELL HTF+
Sbjct: 212 -FEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 4e-41
Identities = 81/255 (31%), Positives = 118/255 (46%), Gaps = 29/255 (11%)
Query: 2 NKGTGALFVVKSAE--SEAGVQALRNEAEIRQSLNSPNI-----GRNGEKTVNIFMEYMA 54
+K TG K + SE ++ E +I PNI E + I +E+
Sbjct: 26 HKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85
Query: 55 GGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLP 108
GG+L + + L IR +++ LH + ++H DLK N+LL GDVKL
Sbjct: 86 GGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLA 145
Query: 109 DLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL-----RNEGLDFATDIWSLGCMVI 163
D G + + N + Q + GT WMAPEV+ ++ D+ DIWSLG +I
Sbjct: 146 DFGVSAK------NKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLI 199
Query: 164 EMATGRPPWGDKISNAAATLLKIACSNEKPHF--PTQFFKKVLDFLAKCLERKPEKRWSA 221
E+A PP + N LLKI S E P P+++ DFL CL + P+ R +A
Sbjct: 200 ELAQMEPPHHE--LNPMRVLLKILKS-EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTA 256
Query: 222 EELLNHTFISGNAKK 236
ELL H F+S +
Sbjct: 257 AELLKHPFVSDQSDN 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 5e-41
Identities = 73/255 (28%), Positives = 102/255 (40%), Gaps = 44/255 (17%)
Query: 1 MNKGTGALFVVK-----SAESEAGVQALRNEAEIRQSLNSPNIGRNGEKTVNIF------ 49
K TG L+ +K V+ E I +N P I V +
Sbjct: 13 RKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI-------VKLHYAFQTE 65
Query: 50 ------MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNV 97
+EY GG L K G R Y EI LH GI++ DLK N+
Sbjct: 66 EKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENI 124
Query: 98 LLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWS 157
LL + G +KL D G A+ + + GT ++APEVL +G A D WS
Sbjct: 125 LLDADGHIKLTDFGLAKE------LSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWS 178
Query: 158 LGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEK 217
LG ++ EM TG+PP+ + KI + FP + D ++ L++ P K
Sbjct: 179 LGVLLYEMLTGKPPF--YAEDRKEIYEKIL--KDPLRFPEFLSPEARDLISGLLQKDPTK 234
Query: 218 R---WSAEELLNHTF 229
R AEE+ H F
Sbjct: 235 RLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-40
Identities = 79/231 (34%), Positives = 111/231 (48%), Gaps = 26/231 (11%)
Query: 20 VQALRNEAEIRQSLNSPNI-GRNGEKTVN----IFMEYMAGGSLLDV---AEKFGGTLDA 71
V LR E + N PN+ V + M Y++GGSLLD+ + GG LD
Sbjct: 43 VDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-LDE 101
Query: 72 GVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNL 125
+I KE+L H NG +H D+K N+LLG G VK+ D G + +
Sbjct: 102 AIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVS--ASLADGGDRT 159
Query: 126 KQSWQSIGGTQLWMAPEVL-RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLL 184
++ ++ GT WMAPEV+ + G DF DIWS G IE+ATG P K +L
Sbjct: 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP-YSKYPPMKVLML 218
Query: 185 KIACSNEKPHFPT-----QFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
+ N+ P T ++ K ++ CL++ P KR +AEELL H F
Sbjct: 219 TL--QNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-39
Identities = 78/252 (30%), Positives = 124/252 (49%), Gaps = 26/252 (10%)
Query: 1 MNKGTGALFVVKSAESEAG-----------VQALRNEAEIRQSLNSPNI----GRNGEKT 45
MN +G L VK E + + AL E + + L NI G + +
Sbjct: 20 MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD 79
Query: 46 -VNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVL 98
+NIF+EY+ GGS+ + +G + ++R + ++IL H GI+H D+K N+L
Sbjct: 80 HLNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANIL 138
Query: 99 LGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSL 158
+ + G +K+ D G ++++ + + S+ G+ WMAPEV++ DIWSL
Sbjct: 139 VDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSL 198
Query: 159 GCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
GC+V+EM TG+ P+ D + KI N P P+ + +DFL K E KR
Sbjct: 199 GCLVVEMLTGKHPFPD--CTQLQAIFKIG-ENASPEIPSNISSEAIDFLEKTFEIDHNKR 255
Query: 219 WSAEELLNHTFI 230
+A ELL H F+
Sbjct: 256 PTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 4e-39
Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 27/247 (10%)
Query: 2 NKGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEY 52
K G L+V+K S SE + NE +I + LN PNI + + + I MEY
Sbjct: 21 RKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80
Query: 53 MAGGSLLDV---AEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
GG L +K G I + ++ LH ILH D+K N+ L S+G
Sbjct: 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG 140
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163
VKL D G ++ ++ + +++ GT +++PE+ +N+ ++ +DIWSLGC++
Sbjct: 141 LVKLGDFGISKVLS------STVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLY 194
Query: 164 EMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223
E+ T + P+ + N LKI + P P+Q+ ++ + ++ L++ PE+R S +
Sbjct: 195 ELCTLKHPFEGE--NLLELALKI-LKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQ 251
Query: 224 LLNHTFI 230
+L FI
Sbjct: 252 ILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 8e-39
Identities = 84/231 (36%), Positives = 123/231 (53%), Gaps = 20/231 (8%)
Query: 13 SAESEAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKF 65
S E+ V AL E ++ ++L I + EK ++IF+EYM GGS+ D + +
Sbjct: 41 SQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY 100
Query: 66 GGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDL 119
G L V R YT++IL H N I+H D+K N+L S G+VKL D G ++R+ +
Sbjct: 101 GA-LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159
Query: 120 KNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNA 179
+G +S+ GT WM+PEV+ EG D+WS+ C V+EM T +PPW + A
Sbjct: 160 CMSGT---GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE--YEA 214
Query: 180 AATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
A + KIA KP P DFL K + + ++R +AE LL H F+
Sbjct: 215 MAAIFKIATQPTKPMLPDGVSDACRDFL-KQIFVEEKRRPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 1e-38
Identities = 87/244 (35%), Positives = 120/244 (49%), Gaps = 24/244 (9%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLD 60
A+ ++ E+E ++ ++ E + +SP I R G K + I MEY+ GGS LD
Sbjct: 33 AIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTK-LWIIMEYLGGGSALD 91
Query: 61 VAEKFGGTLDAGVIRLYTKEILHGNGILHC------DLKCNNVLLGSHGDVKLPDLGCAR 114
+ + G L+ I +EIL G LH D+K NVLL GDVKL D G A
Sbjct: 92 LLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAG 149
Query: 115 RVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGD 174
++ D + N + GT WMAPEV++ DF DIWSLG IE+A G PP D
Sbjct: 150 QLTDTQIKRN------TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203
Query: 175 KISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234
+L + N P Q+ K +F+ CL + P R +A+ELL H FI+
Sbjct: 204 L---HPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 260
Query: 235 KKNS 238
KK S
Sbjct: 261 KKTS 264
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 5e-37
Identities = 80/250 (32%), Positives = 119/250 (47%), Gaps = 34/250 (13%)
Query: 3 KGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNI----G---RNGEKTVNIFME 51
+ TG + VK Q LR E +I NSP I G NG+ ++I ME
Sbjct: 23 RPTGKIMAVKTIRLEINEAIQKQILR-ELDILHKCNSPYIVGFYGAFYNNGD--ISICME 79
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHG-------NGILHCDLKCNNVLLGSHGD 104
YM GGSL + ++ G + ++ +L G + I+H D+K +N+L+ S G
Sbjct: 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ 139
Query: 105 VKLPDLGCARR-VNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163
+KL D G + + VN L + GT +MAPE ++ +DIWSLG +I
Sbjct: 140 IKLCDFGVSGQLVNSLAK---------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLI 190
Query: 164 EMATGRPPWG--DKISNAAATLLKIACSNEKPHFPTQFFKKVL-DFLAKCLERKPEKRWS 220
E+ATGR P+ + + LL+ + P P+ F DF+ CL + P +R S
Sbjct: 191 ELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPS 250
Query: 221 AEELLNHTFI 230
+ELL H FI
Sbjct: 251 YKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-37
Identities = 80/253 (31%), Positives = 121/253 (47%), Gaps = 26/253 (10%)
Query: 2 NKGTGALFVVK-----SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFME 51
K TG ++ +K + V + E +I SP + + G+K + + ME
Sbjct: 14 KKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVME 73
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDV 105
Y+ GG L + E G +LD V R+Y EI LH NGI+H DLK +N+L+ S+G +
Sbjct: 74 YLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHL 132
Query: 106 KLPDLGCARR--VNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163
KL D G ++ V N + ++ + I GT ++APEV+ +G D WSLGC++
Sbjct: 133 KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILY 192
Query: 164 EMATGRPPWGDKISNAAATLLKIACSN-EKPHFPTQFFKKVLDFLAKCLERKPEKR---W 219
E G PP+ + I E P + + +D ++K L PEKR
Sbjct: 193 EFLVGIPPFHGE--TPEEIFQNILNGKIEWPEDV-EVSDEAIDLISKLLVPDPEKRLGAK 249
Query: 220 SAEELLNHTFISG 232
S EE+ NH F G
Sbjct: 250 SIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-36
Identities = 78/242 (32%), Positives = 109/242 (45%), Gaps = 30/242 (12%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDV 61
A+ V+K + + ++ E + + PNI + I MEY GGSL D+
Sbjct: 32 AIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDI 90
Query: 62 AEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115
+ G L I +E L H G +H D+K N+LL GDVKL D G + +
Sbjct: 91 YQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQ 150
Query: 116 VNDLKNNGNLKQSWQSIGGTQLWMAPEVL---RNEGLDFATDIWSLGCMVIEMATGRPPW 172
+ +S GT WMAPEV R G D DIW+LG IE+A +PP
Sbjct: 151 LT------ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM 204
Query: 173 GDKISNAAATLLKIACSNEKPHFPT-----QFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
D + L I+ SN P P ++ DF+ KCL + P+KR +A +LL H
Sbjct: 205 FD--LHPMRALFLISKSNFPP--PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260
Query: 228 TF 229
F
Sbjct: 261 PF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-36
Identities = 83/243 (34%), Positives = 119/243 (48%), Gaps = 22/243 (9%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGRN-----GEKTVNIFMEYMAGGSLLDV 61
A+ ++ E+E ++ ++ E + +SP + + + + I MEY+ GGS LD+
Sbjct: 33 AIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL 92
Query: 62 AEKFGGTLDAGVIRLYTKEILHGNGILHC------DLKCNNVLLGSHGDVKLPDLGCARR 115
E G LD I +EIL G LH D+K NVLL HG+VKL D G A +
Sbjct: 93 LEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ 150
Query: 116 VNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDK 175
+ D + N GT WMAPEV++ D DIWSLG IE+A G PP +
Sbjct: 151 LTDTQIKRNT------FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204
Query: 176 ISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235
+L + N P + K + +F+ CL ++P R +A+ELL H FI AK
Sbjct: 205 ---HPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261
Query: 236 KNS 238
K S
Sbjct: 262 KTS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 1e-36
Identities = 77/194 (39%), Positives = 104/194 (53%), Gaps = 25/194 (12%)
Query: 48 IFMEYMAGGSLLDVAEKFGGTLDAGVIR------LYTKEILHGNGILHCDLKCNNVLLGS 101
+ MEY+AGGSL DV + +D G I L E LH N ++H D+K +N+LLG
Sbjct: 93 VVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 150
Query: 102 HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCM 161
G VKL D G ++ ++ K+S ++ GT WMAPEV+ + DIWSLG M
Sbjct: 151 DGSVKLTDFGFCAQITPEQS----KRS--TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 204
Query: 162 VIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP-----TQFFKKVLDFLAKCLERKPE 216
IEM G PP+ ++ N L IA +N P + F+ DFL +CLE E
Sbjct: 205 AIEMVEGEPPYLNE--NPLRALYLIA-TNGTPELQNPEKLSAIFR---DFLNRCLEMDVE 258
Query: 217 KRWSAEELLNHTFI 230
KR SA+ELL H F+
Sbjct: 259 KRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-36
Identities = 79/228 (34%), Positives = 121/228 (53%), Gaps = 29/228 (12%)
Query: 27 AEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKE 80
+++RQS PNI + G + I MEY GGS+ + + G + I + +E
Sbjct: 54 SQLRQS-QPPNITKYYGSYLKG-PRLWIIMEYAEGGSVRTLMK--AGPIAEKYISVIIRE 109
Query: 81 IL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGG 134
+L H G++H D+K N+L+ + G+VKL D G A +N + K+S + G
Sbjct: 110 VLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN----QNSSKRS--TFVG 163
Query: 135 TQLWMAPEVLRNEG--LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK 192
T WMAPEV+ EG D DIWSLG + EMATG PP+ D + A L+ ++
Sbjct: 164 TPYWMAPEVIT-EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP---KSKP 219
Query: 193 PHFPTQFFKKVL-DFLAKCLERKPEKRWSAEELLNHTFISGNAKKNST 239
P + K+L +F+A CL+ +P++R SAEELL +I ++K +
Sbjct: 220 PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVS 267
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 2e-36
Identities = 78/239 (32%), Positives = 113/239 (47%), Gaps = 27/239 (11%)
Query: 20 VQALRNEAEIRQSLNSP-NIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG--GTLDA 71
V+ E +I SLN P NI + E ++ + MEY+ GGSL D+ +K G G L
Sbjct: 41 VERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSE 100
Query: 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGD-VKLPDLGCARRVNDLKNNGN 124
+I LH GI+H D+K N+LL G VKL D G A+ + D + +
Sbjct: 101 SEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS 160
Query: 125 LKQSWQSIGGTQLWMAPEVLR---NEGLDFATDIWSLGCMVIEMATGRPPW-GDKISNAA 180
+ + GT +MAPEVL ++DIWSLG + E+ TG PP+ G+K S+A
Sbjct: 161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT 220
Query: 181 ATLLKIACSNEKPHFPTQF--------FKKVLDFLAKCLERKPEKRWSAEELLNHTFIS 231
+ LKI P + K D L K L + P+ R S+ L+H ++
Sbjct: 221 SQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-35
Identities = 73/220 (33%), Positives = 104/220 (47%), Gaps = 22/220 (10%)
Query: 23 LRNEAEIRQSLNSPNIGRN-GEKTVN----IFMEYMAGGSLLDVAEKFGGTLD--AGVIR 75
L NE I + PNI V + ME++ GG+L D+ + A V
Sbjct: 63 LFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCL 122
Query: 76 --LYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLG-CARRVNDLKNNGNLKQSWQSI 132
L LH G++H D+K +++LL S G VKL D G CA+ ++ +S+
Sbjct: 123 AVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR-------KSL 175
Query: 133 GGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK 192
GT WMAPEV+ DIWSLG MVIEM G PP+ ++ A ++ N
Sbjct: 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR---DNLP 232
Query: 193 PHF--PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
P + ++ FL + L R P +R +A ELLNH F+
Sbjct: 233 PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-35
Identities = 88/244 (36%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLD 60
A+ ++ E+E ++ ++ E + +SP + + G K + I MEY+ GGS LD
Sbjct: 33 AIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTK-LWIIMEYLGGGSALD 91
Query: 61 VAEKFGGTLDAGVIRLYTKEILHGNGILHC------DLKCNNVLLGSHGDVKLPDLGCAR 114
+ G D I KEIL G LH D+K NVLL GDVKL D G A
Sbjct: 92 LLR--AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAG 149
Query: 115 RVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGD 174
++ D + N + GT WMAPEV++ D DIWSLG IE+A G PP D
Sbjct: 150 QLTDTQIKRN------TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203
Query: 175 KISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234
+ L I N P +F K +F+ CL + P R +A+ELL H FI NA
Sbjct: 204 M--HPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260
Query: 235 KKNS 238
KK S
Sbjct: 261 KKTS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-35
Identities = 78/227 (34%), Positives = 115/227 (50%), Gaps = 23/227 (10%)
Query: 20 VQALRNEAEIRQSLNSPNIGRN-GEKTVN----IFMEYMAGGSLLDVAE-KFGGTLD-AG 72
VQ L E + L NI + G + N IFME + GGSL + K+G D
Sbjct: 49 VQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQ 108
Query: 73 VIRLYTKEIL------HGNGILHCDLKCNNVLLGSH-GDVKLPDLGCARRVNDLKNNGNL 125
I YTK+IL H N I+H D+K +NVL+ ++ G VK+ D G ++R+ +
Sbjct: 109 TIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL------AGI 162
Query: 126 KQSWQSIGGTQLWMAPEVLRN--EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATL 183
++ GT +MAPEV+ G DIWSLGC ++EMATG+PP+ + + A +
Sbjct: 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE-LGEPQAAM 221
Query: 184 LKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
K+ P P + +F+ +C E P+KR SA +LL F+
Sbjct: 222 FKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-34
Identities = 73/269 (27%), Positives = 114/269 (42%), Gaps = 54/269 (20%)
Query: 3 KGTGALFVVKSAE-----SEAGVQALRNEAEIRQSLN-SPNIGRNGEKTVNIF------- 49
K T + +K + E V+ ++ E E+ LN P I + ++
Sbjct: 23 KETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI-------IKLYYTFQDEE 75
Query: 50 -----MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVL 98
+EY G LL K+G +LD R Y EIL H GI+H DLK N+L
Sbjct: 76 NLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENIL 134
Query: 99 LGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIG--------------GTQLWMAPEVL 144
L +K+ D G A+ ++ + + K +I GT +++PE+L
Sbjct: 135 LDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL 194
Query: 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVL 204
+ ++D+W+LGC++ +M TG+PP+ SN T KI + FP F
Sbjct: 195 NEKPAGKSSDLWALGCIIYQMLTGKPPFRG--SNEYLTFQKI--LKLEYSFPPNFPPDAK 250
Query: 205 DFLAKCLERKPEKR----WSAEELLNHTF 229
D + K L P+ R +EL H F
Sbjct: 251 DLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 8e-34
Identities = 89/255 (34%), Positives = 126/255 (49%), Gaps = 29/255 (11%)
Query: 2 NKGTGALFVVK--SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMA 54
NK TG L K +SE ++ E +I S + PNI + E + I +E+ A
Sbjct: 26 NKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85
Query: 55 GGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLP 108
GG++ V + L IR+ K+ L H N I+H DLK N+L GD+KL
Sbjct: 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLA 145
Query: 109 DLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL-----RNEGLDFATDIWSLGCMVI 163
D G + + N Q S GT WMAPEV+ ++ D+ D+WSLG +I
Sbjct: 146 DFGVSAK------NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 199
Query: 164 EMATGRPPWGDKISNAAATLLKIACSNEKPHF--PTQFFKKVLDFLAKCLERKPEKRWSA 221
EMA PP + N LLKIA S E P P+++ + DFL KCLE+ + RW+
Sbjct: 200 EMAQIEPPHHEL--NPMRVLLKIAKS-EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTT 256
Query: 222 EELLNHTFISGNAKK 236
+LL H F++ N+ K
Sbjct: 257 TQLLQHPFVTVNSNK 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-32
Identities = 86/220 (39%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 25 NEAEIRQSLNSPNIGRNGEK-----TVNIFMEYMAGGSLLDVAEKFGGTLD----AGVIR 75
NE + + L +PNI + + + MEY+AGGSL DV + +D A V R
Sbjct: 65 NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCR 122
Query: 76 --LYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQS-I 132
L E LH N ++H D+K +NVLLG G VKL D G ++ +QS +S +
Sbjct: 123 ECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP-------EQSKRSTM 175
Query: 133 GGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK 192
GT WMAPEV+ + DIWSLG M IEM G PP+ ++ N L IA +N
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIA-TNGT 232
Query: 193 PHF--PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
P P + DFL +CLE EKR SA+ELL H F+
Sbjct: 233 PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 7e-32
Identities = 78/252 (30%), Positives = 119/252 (47%), Gaps = 29/252 (11%)
Query: 2 NKGTGALFVVK----SAESEAGVQA-LRNEAEIRQSLNSPNIGR-----NGEKTVNIFME 51
K F +K E G Q + +E EI + N P I + +K + + ME
Sbjct: 14 VKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLME 73
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDV 105
Y GG L + G D R Y E LH GI++ DLK N+LL S+G V
Sbjct: 74 YCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYV 132
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
KL D G A+++ + +++W + GT ++APE++ N+G DF+ D WSLG ++ E+
Sbjct: 133 KLVDFGFAKKL------KSGQKTW-TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYEL 185
Query: 166 ATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----S 220
TGRPP+G+ + I N K FP K D + + L R PE+R
Sbjct: 186 LTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGG 245
Query: 221 AEELLNHTFISG 232
+++ H + +G
Sbjct: 246 IKDIKKHKWFNG 257
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-32
Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 28/227 (12%)
Query: 20 VQALRNEAEIRQSLNSP---NIGRNGEKTVNIFM--EYMAGGSL---LDVAEKFGGTLDA 71
V+ + NE I Q LN P N+ + + N+++ + + GG L L KF
Sbjct: 44 VRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKF----SE 99
Query: 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNL 125
++ + EI LH GI+H D+K +N+LL G V + D A +V
Sbjct: 100 EQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT--- 156
Query: 126 KQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLK 185
S GT +MAPEVL +G A D WSLG E G+ P+ S ++
Sbjct: 157 ----TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY-RGHSRTIRDQIR 211
Query: 186 IACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS--AEELLNHTFI 230
+P + + +D + K LER P+KR ++L NH +
Sbjct: 212 AKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 8e-31
Identities = 77/192 (40%), Positives = 102/192 (53%), Gaps = 21/192 (10%)
Query: 48 IFMEYMAGGSLLDVAEKFGGTLDAGVIR------LYTKEILHGNGILHCDLKCNNVLLGS 101
+ MEY+AGGSL DV + +D G I L E LH N ++H D+K +N+LLG
Sbjct: 94 VVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151
Query: 102 HGDVKLPDLGCARRVNDLKNNGNLKQSWQS-IGGTQLWMAPEVLRNEGLDFATDIWSLGC 160
G VKL D G ++ +QS +S + GT WMAPEV+ + DIWSLG
Sbjct: 152 DGSVKLTDFGFCAQITP-------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 161 MVIEMATGRPPWGDKISNAAATLLKIACSNEKPHF--PTQFFKKVLDFLAKCLERKPEKR 218
M IEM G PP+ ++ N L IA +N P P + DFL +CL+ EKR
Sbjct: 205 MAIEMIEGEPPYLNE--NPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261
Query: 219 WSAEELLNHTFI 230
SA+ELL H F+
Sbjct: 262 GSAKELLQHQFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 75/192 (39%), Positives = 102/192 (53%), Gaps = 21/192 (10%)
Query: 48 IFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGS 101
+ MEY+AGGSL DV + +D G I +E LH N ++H D+K +N+LLG
Sbjct: 93 VVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM 150
Query: 102 HGDVKLPDLGCARRVNDLKNNGNLKQSWQS-IGGTQLWMAPEVLRNEGLDFATDIWSLGC 160
G VKL D G ++ +QS +S + GT WMAPEV+ + DIWSLG
Sbjct: 151 DGSVKLTDFGFCAQITP-------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 161 MVIEMATGRPPWGDKISNAAATLLKIACSNEKPHF--PTQFFKKVLDFLAKCLERKPEKR 218
M IEM G PP+ ++ N L IA +N P P + DFL +CLE ++R
Sbjct: 204 MAIEMVEGEPPYLNE--NPLRALYLIA-TNGTPELQNPERLSAVFRDFLNRCLEMDVDRR 260
Query: 219 WSAEELLNHTFI 230
SA+ELL H F+
Sbjct: 261 GSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 68/204 (33%), Positives = 94/204 (46%), Gaps = 39/204 (19%)
Query: 50 MEYMAGGSLLDVAEKF---GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
ME GGS+ D+ + G L I +E LH N ++H D+K N+LL
Sbjct: 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT 147
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL-----RNEGLDFATDI 155
+ +VKL D G + L + + + I GT WMAPEV+ + D +D+
Sbjct: 148 KNAEVKLVDFGVSA---QLDSTLGRRNT--FI-GTPYWMAPEVIACDEQPDASYDARSDV 201
Query: 156 WSLGCMVIEMATGRPPWGD--------KI-SNAAATLLKIACSNEKPHFPTQFFKKVLDF 206
WSLG IE+A G+PP D KI N TL P + KK DF
Sbjct: 202 WSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS----------PENWSKKFNDF 251
Query: 207 LAKCLERKPEKRWSAEELLNHTFI 230
+++CL + E+R EELL H FI
Sbjct: 252 ISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 4e-30
Identities = 69/235 (29%), Positives = 104/235 (44%), Gaps = 30/235 (12%)
Query: 17 EAGVQALRNEAEIRQSLNSPNI-----GRNGEKTVNIFMEYMAGGSL--LDVAEKFGGTL 69
E+ + E +I SP I E V + MEYM GSL L +
Sbjct: 40 ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGI 99
Query: 70 DAGVIRLYTKEILHG-------NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNN 122
V+R T ++ G + I+H D+K NVL+ +G VKL D G +
Sbjct: 100 PEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS--------- 150
Query: 123 GNLKQSWQSIG-GTQLWMAPEVLRNEGLDFA------TDIWSLGCMVIEMATGRPPWGDK 175
GNL S G Q +MAPE +++ G + +D+WSLG ++EMA GR P+ +
Sbjct: 151 GNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210
Query: 176 ISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
L + P P+ + DF+AKCL + P +R + +LL H ++
Sbjct: 211 TYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-30
Identities = 90/250 (36%), Positives = 123/250 (49%), Gaps = 29/250 (11%)
Query: 2 NKGTGALFVVKSAE--SEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMA 54
NK TGAL K E SE ++ E EI + N P I + + + I +E+
Sbjct: 33 NKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92
Query: 55 GGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLP 108
GG++ + + L I++ +++L H I+H DLK NVLL GD+KL
Sbjct: 93 GGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLA 152
Query: 109 DLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL-----DFATDIWSLGCMVI 163
D G + KN L Q S GT WMAPEV+ E + D+ DIWSLG +I
Sbjct: 153 DFGVSA-----KNVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 206
Query: 164 EMATGRPPWGDKISNAAATLLKIACSNEKPHF--PTQFFKKVLDFLAKCLERKPEKRWSA 221
EMA PP + N LLKIA S E P P+++ + DFL L++ PE R SA
Sbjct: 207 EMAQIEPPHHE--LNPMRVLLKIAKS-EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSA 263
Query: 222 EELLNHTFIS 231
+LL H F+S
Sbjct: 264 AQLLEHPFVS 273
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 8e-30
Identities = 71/255 (27%), Positives = 112/255 (43%), Gaps = 38/255 (14%)
Query: 3 KGTGALFVVKSAE----SEAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFME 51
K G + V K + +E Q L +E I + L PNI R +T+ I ME
Sbjct: 22 KSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81
Query: 52 YMAGG---SLLDVAEKFGGTLDAGVIRLYTKEILH-----------GNGILHCDLKCNNV 97
Y GG L+ +K ++ I ++L GN +LH DLK N+
Sbjct: 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANI 141
Query: 98 LLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWS 157
L ++ +VKL D G A+ L ++ + +++ GT +M+PE L + D +DIWS
Sbjct: 142 FLDANNNVKLGDFGLAK---ILGHDSSFAKTYV---GTPYYMSPEQLNHMSYDEKSDIWS 195
Query: 158 LGCMVIEMATGRPPWGDKISNAA--ATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKP 215
LGC++ E+ PP+ A L + P ++ ++ + + L P
Sbjct: 196 LGCLIYELCALSPPF-----TARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDP 250
Query: 216 EKRWSAEELLNHTFI 230
+KR S EELL I
Sbjct: 251 DKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 6e-29
Identities = 65/232 (28%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 20 VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGG---SLLDVAEKFGGTLDA 71
V+ + NE I QS+ P + + + + MEY+ GG S L + +F
Sbjct: 45 VEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRF----PE 100
Query: 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNL 125
V R Y ++ LH I++ DLK N+LL S G +K+ D G A+RV
Sbjct: 101 PVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------- 153
Query: 126 KQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLK 185
+++ ++ GT ++APE++ ++G A D W+LG ++ EM G PP+ D N K
Sbjct: 154 -RTY-TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD--DNPIQIYEK 209
Query: 186 IACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----SAEELLNHTFISG 232
I + FP+ F D + L+ KR ++ NH + +G
Sbjct: 210 ILEGKVR--FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-28
Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 35/222 (15%)
Query: 25 NEAEIRQSLNSPNIGRNGEKTVN-----IFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTK 79
NE I S+N PNI E ++ I MEY G L K +L +
Sbjct: 48 NEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISK-----RKKKRKLIPE 102
Query: 80 EI--------------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNL 125
+ LH ILH DLK N+LL ++ VK+ DLG ++ LK N
Sbjct: 103 QEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKV---LKKNMAK 159
Query: 126 KQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLK 185
Q GT +MAPEV + + +DIWSLGC++ EMAT PP+ + + L
Sbjct: 160 TQI-----GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR---SMQDLRY 211
Query: 186 IACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
+ P P + + + +F+ L+ KP+ R + +++L
Sbjct: 212 KVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-28
Identities = 68/200 (34%), Positives = 98/200 (49%), Gaps = 37/200 (18%)
Query: 48 IFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI-------------LHGNGILHCDLKC 94
+ ME++ GG+L D+ + RL ++I LH G++H D+K
Sbjct: 95 VLMEFLQGGALTDIVSQ---------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145
Query: 95 NNVLLGSHGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT 153
+++LL G VKL D G CA+ D+ +S+ GT WMAPEV+
Sbjct: 146 DSILLTLDGRVKLSDFGFCAQISKDVPKR-------KSLVGTPYWMAPEVISRTPYGTEV 198
Query: 154 DIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFK--KVL-DFLAKC 210
DIWSLG MVIEM G PP+ A L+ + P K VL DFL +
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR----DSPPPKLKNAHKISPVLRDFLERM 254
Query: 211 LERKPEKRWSAEELLNHTFI 230
L R+P++R +A+ELL+H F+
Sbjct: 255 LTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-28
Identities = 77/228 (33%), Positives = 108/228 (47%), Gaps = 33/228 (14%)
Query: 21 QALRNEAEIRQSLNSPN-IGRNG----EKTVNIFMEYMAGGS--LLDVAEKFGGTLDAGV 73
Q + E Q L PN I G E T + MEY G + +L+V +K ++
Sbjct: 60 QDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA 119
Query: 74 I---RLYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQ 130
I L LH + +H D+K N+LL G VKL D G A +L
Sbjct: 120 ICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSA----------SLVSPAN 169
Query: 131 SIGGTQLWMAPEVL--RNEG-LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIA 187
S GT WMAPEV+ +EG D D+WSLG IE+A +PP + NA + L IA
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIA 227
Query: 188 CSNEKPHFPT----QFFKKVLDFLAKCLERKPEKRWSAEELLNHTFIS 231
N+ P + +F+ +F+ CL++ P+ R S+EELL H F+
Sbjct: 228 -QNDSPTLSSNDWSDYFR---NFVDSCLQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-27
Identities = 82/250 (32%), Positives = 122/250 (48%), Gaps = 28/250 (11%)
Query: 3 KGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFME 51
+ TG L+ +K + E Q R E EI + +N PN+ + NGE + + +E
Sbjct: 96 RPTGRLYALKVIYGNHEDTVRRQICR-EIEILRDVNHPNVVKCHDMFDHNGE--IQVLLE 152
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEI--LHGNGILHCDLKCNNVLLGSHGDVKLPD 109
+M GGSL L A V R I LH I+H D+K +N+L+ S +VK+ D
Sbjct: 153 FMDGGSLEGTHIADEQFL-ADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIAD 211
Query: 110 LGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR---NEGL--DFATDIWSLGCMVIE 164
G +R + + N S GT +M+PE + N G +A DIWSLG ++E
Sbjct: 212 FGVSRILAQTMDPCN------SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265
Query: 165 MATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
GR P+G A+L+ C ++ P P ++ F++ CL+R+P KRWSA +L
Sbjct: 266 FYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQL 325
Query: 225 LNHTFISGNA 234
L H FI
Sbjct: 326 LQHPFILRAQ 335
|
Length = 353 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 66/249 (26%), Positives = 103/249 (41%), Gaps = 39/249 (15%)
Query: 20 VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74
+ +R E +I +SP I + E+ + + MEYM GG L+++ +
Sbjct: 45 IAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD-VFPEETA 103
Query: 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLG-CAR------------- 114
R Y E+ +H G +H D+K +N+L+ + G +KL D G C +
Sbjct: 104 RFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLND 163
Query: 115 RVNDLKNNGNLKQSWQ---------SIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
N L + L + S GT ++APEVLR D WSLG ++ EM
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223
Query: 166 ATGRPPWGDKISNAAATLLKIACSNEKPHFPTQ--FFKKVLDFLAKCLERKPEKRWSAEE 223
G PP+ T KI E FP + +D + + L ++ S EE
Sbjct: 224 LYGFPPFYS--DTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEE 281
Query: 224 LLNHTFISG 232
+ +H F G
Sbjct: 282 IKSHPFFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-26
Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 21/213 (9%)
Query: 25 NEAEIRQSLNSPNIGRNGEKTV-----NIFMEYMAGGSLLDVAEKFGGT--LDAGVIRLY 77
+EA + L+S I R E + NI MEY G L + + G + V R +
Sbjct: 48 DEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF 107
Query: 78 TKEIL-----HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSI 132
+ +L H ILH D+K N+ L ++ +VK+ DLG A+ ++D N N + I
Sbjct: 108 IQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD---NTNFANT---I 161
Query: 133 GGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK 192
GT +++PE+ ++ + +D+W+LG ++ E TG+ P+ +N A +LKI
Sbjct: 162 VGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF--DANNQGALILKIIRGVFP 219
Query: 193 PHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
P + +++ + +CL + +R +LL
Sbjct: 220 P-VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-26
Identities = 61/196 (31%), Positives = 88/196 (44%), Gaps = 26/196 (13%)
Query: 50 MEYMAGG---SLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
MEY+ GG +LL+ G L R Y E+ LH G +H DLK N L+
Sbjct: 80 MEYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID 135
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGC 160
+ G +KL D G ++ + N S+ G+ +MAPEVLR +G DF D WSLGC
Sbjct: 136 ASGHIKLTDFGLSKGIVTYAN---------SVVGSPDYMAPEVLRGKGYDFTVDYWSLGC 186
Query: 161 MVIEMATGRPPW-GDKISNAAATLLKIACSNEKPHF--PTQFFKKVL-DFLAKCLERKPE 216
M+ E G PP+ G + L + ++P + P D + K +
Sbjct: 187 MLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSR 246
Query: 217 KRWSAEELLNHTFISG 232
+ S E++ NH F
Sbjct: 247 RFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-25
Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 25/233 (10%)
Query: 10 VVKSAESEAGVQALRNEAEIRQSLNSPNIGRN-----GEKTVNIFMEYMAGGSLLDVAEK 64
+K SE + EA I + L+ PNI R + + I EYM GG LLD K
Sbjct: 35 TLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK 94
Query: 65 FGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVND 118
G L + +I L +H DL N L+ + VK+ D G +R D
Sbjct: 95 HGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSR---D 151
Query: 119 LKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGD 174
+ + ++ GG +L WMAPE L++ +D+WS G ++ E+ T G P+
Sbjct: 152 IYEDDYYRKR----GGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPG 207
Query: 175 KISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
+ LL+ + P ++ + + +C PE R + EL+
Sbjct: 208 MSNEEVLELLE---DGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 80/264 (30%), Positives = 119/264 (45%), Gaps = 67/264 (25%)
Query: 21 QALRN----EAEIRQSLNSPNI-------GRNGEKTVNIFMEYMAGGSLLDVAEKFG--- 66
A+RN E ++ NSP I +GE ++I ME+M GGSL V +K G
Sbjct: 40 PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIP 97
Query: 67 ----GTLDAGVIR--LYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLK 120
G + V+R Y +E I+H D+K +N+L+ S G++KL D G + ++ D
Sbjct: 98 ENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154
Query: 121 NNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGR---PP------ 171
N S GT+ +M+PE L+ +DIWSLG ++EMA GR PP
Sbjct: 155 AN--------SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL 206
Query: 172 ---WGDKISNAAAT---------------------LLKIACSNEKPHFPTQFF-KKVLDF 206
+G +S A LL + P P+ F + DF
Sbjct: 207 EAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDF 266
Query: 207 LAKCLERKPEKRWSAEELLNHTFI 230
+ KCL++ P++R +EL H FI
Sbjct: 267 VDKCLKKNPKERADLKELTKHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 3e-25
Identities = 79/252 (31%), Positives = 124/252 (49%), Gaps = 34/252 (13%)
Query: 5 TGALFVVKSAESEAGVQALR---NEAEIRQSLNSPNI-GRNG----EKTVNIFMEYMAGG 56
T + VK + V+ + +E EI +SP I G G E ++I E+M GG
Sbjct: 25 TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGG 84
Query: 57 SLLDV----AEKFGGTLDAGVIRLYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGC 112
SL DV E G + V++ T L ILH D+K +N+L+ + G VKL D G
Sbjct: 85 SL-DVYRKIPEHVLGRIAVAVVKGLT--YLWSLKILHRDVKPSNMLVNTRGQVKLCDFGV 141
Query: 113 ARR-VNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPP 171
+ + VN + ++ GT +MAPE + E +D+WSLG +E+A GR P
Sbjct: 142 STQLVNSIA---------KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192
Query: 172 W----GDKISNAAATLLKIACSNEKPHFPT-QFFKKVLDFLAKCLERKPEKRWSAEELLN 226
+ ++ S LL+ + P P QF +K + F+ +C+ ++P++R + E L++
Sbjct: 193 YPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252
Query: 227 HTFI----SGNA 234
H FI GNA
Sbjct: 253 HPFIVQYNDGNA 264
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-25
Identities = 79/270 (29%), Positives = 120/270 (44%), Gaps = 53/270 (19%)
Query: 3 KGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFME 51
K TG +F +K + Q LR E EI +S SP I + ++ I ME
Sbjct: 23 KNTGMIFALKTITTDPNPDLQKQILR-ELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81
Query: 52 YMAGGSL-----------LDVAEKFGGTLDAGVIRLYTKEILHGNGILHCDLKCNNVLLG 100
Y GGSL + EK G + V++ + LH I+H D+K +N+LL
Sbjct: 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS--YLHSRKIIHRDIKPSNILLT 139
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQS-IGGTQLWMAPEVLRNEGLDFATDIWSLG 159
G VKL D G + G L S GT +MAPE ++ + +D+WSLG
Sbjct: 140 RKGQVKLCDFGVS---------GELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLG 190
Query: 160 CMVIEMATGR---PPWGDK----------ISNAAATLLKIACSNEKPHFPTQFFKKVLDF 206
++E+A R PP G+ I N LK ++P ++ ++ DF
Sbjct: 191 LTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK-----DEPGNGIKWSEEFKDF 245
Query: 207 LAKCLERKPEKRWSAEELLNHTFISGNAKK 236
+ +CLE+ P +R + ++L H +I KK
Sbjct: 246 IKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 5e-25
Identities = 72/276 (26%), Positives = 112/276 (40%), Gaps = 56/276 (20%)
Query: 1 MNKGTGALFVVK---SAESEAGVQ--ALRNEAEIRQSLNSPNIGRNGEK-----TVNIFM 50
NK TG + +K +E + V+ ALR E ++ + L NI E + +
Sbjct: 21 RNKATGEIVAIKKFKESEDDEDVKKTALR-EVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79
Query: 51 EYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD 104
EY +LL++ E G L +R Y ++L H + I+H D+K N+L+ G
Sbjct: 80 EY-VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV 138
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL---RNEGLDFATDIWSLGCM 161
+KL D G AR + T+ + APE+L N G D+W++GC+
Sbjct: 139 LKLCDFGFARAL-----RARPASPLTDYVATRWYRAPELLVGDTNYG--KPVDVWAIGCI 191
Query: 162 VIEMATGRPPW-GD-------KISNAAATLLK--IACSNEKPHF---------------- 195
+ E+ G P + GD I L + P F
Sbjct: 192 MAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLER 251
Query: 196 --PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTF 229
P + LDFL CL P++R + +ELL H +
Sbjct: 252 RYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 6e-25
Identities = 83/289 (28%), Positives = 118/289 (40%), Gaps = 79/289 (27%)
Query: 1 MNKGTGALFVVKSAESEAG-----VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFM 50
NK TG L +K E + A+R E ++ Q L PNI R + +I+M
Sbjct: 19 RNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPNIVRLKEIVTSKGKGSIYM 77
Query: 51 --EYM----AGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVL 98
EYM G LLD E I+ Y K++L H NGILH D+K +N+L
Sbjct: 78 VFEYMDHDLTG--LLDSPE---VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNIL 132
Query: 99 LGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQ----LWM-APEVLRNEGL-DFA 152
+ + G +KL D G AR +N+ + T LW PE+L
Sbjct: 133 INNDGVLKLADFGLARPYTK-RNSADY---------TNRVITLWYRPPELLLGATRYGPE 182
Query: 153 TDIWSLGCMVIEMATGRPPW-G-------DKISNAAATLLKIACSNEKPHF--------- 195
D+WS+GC++ E+ G+P + G +KI L P
Sbjct: 183 VDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE----LCGSPTDENWPGVSKLPWFENL 238
Query: 196 -PTQ--------FFKKV-----LDFLAKCLERKPEKRWSAEELLNHTFI 230
P + FFK + LD L K L P+KR SA++ L H +
Sbjct: 239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 6e-25
Identities = 62/227 (27%), Positives = 111/227 (48%), Gaps = 21/227 (9%)
Query: 16 SEAGVQALRNEAEIRQSLNSPNI-----GRNGEKTVNIFMEYMAGGSLLD-VAEKFGGTL 69
SE + NE I L PNI + T+ I MEY GG+L D + + G
Sbjct: 39 SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLF 98
Query: 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG 123
+ ++ Y +I +H GILH D+K N+ L G +KL D G ++ + +
Sbjct: 99 EEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158
Query: 124 NLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATL 183
+++ GT +M+PE+ + +F +DIW+LGC++ E+ T + + +N +
Sbjct: 159 ------ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF--DATNPLNLV 210
Query: 184 LKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
+KI N P + + +++ + L++ PEKR +A+E+L+ +
Sbjct: 211 VKIVQGNYTP-VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 8e-25
Identities = 70/253 (27%), Positives = 101/253 (39%), Gaps = 57/253 (22%)
Query: 21 QALRNEAEIRQSLNSPNIGRNGEKTVNIF---------MEYMAGGSLLDVAEKFGGTLDA 71
QALR E + Q+ P + K +++F MEYM L +V L
Sbjct: 45 QALR-EIKALQACQHPYV----VKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPE 98
Query: 72 GVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNL 125
++ Y + +L H NGI+H DLK N+L+ + G +K+ D G AR L +
Sbjct: 99 AQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLAR----LFSEEEP 154
Query: 126 KQSWQSIGGTQLWMAPEVL---RNEGLDFATDIWSLGCMVIEMATGRP--PWGDKISNAA 180
+ + T+ + APE+L R D+W++GC+ E+ G P P + I A
Sbjct: 155 RLYSHQV-ATRWYRAPELLYGARKYDP--GVDLWAVGCIFAELLNGSPLFPGENDIEQLA 211
Query: 181 ----------------ATLL----KIACSNEKPHFPTQFFKKV----LDFLAKCLERKPE 216
T L KI KP + F LD L L P
Sbjct: 212 IVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPS 271
Query: 217 KRWSAEELLNHTF 229
KR SA E L H +
Sbjct: 272 KRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-24
Identities = 68/247 (27%), Positives = 107/247 (43%), Gaps = 34/247 (13%)
Query: 14 AESEAGVQALRNEAEIRQSLNSPNI-----GRNGEKTVNIFMEYMAGGSLLDVAEKFGGT 68
A+S Q LR E +I SP I E + + ME+M GSL D K GG
Sbjct: 42 AKSSVRKQILR-ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGP 99
Query: 69 LDAGVIRLYTKEILHG-------NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKN 121
+ ++ ++ G + I+H D+K +N+L+ S G +KL D G +
Sbjct: 100 IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS-------- 151
Query: 122 NGNLKQS-WQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAA 180
G L S + GT +M+PE ++ +D+WSLG +IE+A G+ P+ +
Sbjct: 152 -GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD 210
Query: 181 AT--------LLKIACSNEKPHFPTQFFKKVL-DFLAKCLERKPEKRWSAEELL-NHTFI 230
LL+ P P+ F + L DF+ CL + P +R + ++L FI
Sbjct: 211 GQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270
Query: 231 SGNAKKN 237
N
Sbjct: 271 QALRASN 277
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-24
Identities = 70/209 (33%), Positives = 103/209 (49%), Gaps = 33/209 (15%)
Query: 43 EKTVNIFMEYMAGGSL---LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLK 93
+ +++ ++Y+ GG L L E F +R+Y EI LH GI++ D+K
Sbjct: 77 DTKLHLILDYVNGGELFTHLYQREHF----TESEVRVYIAEIVLALDHLHQLGIIYRDIK 132
Query: 94 CNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR--NEGLDF 151
N+LL S G V L D G ++ L S+ GT +MAPEV+R + G D
Sbjct: 133 LENILLDSEGHVVLTDFGLSKEF--LAEEEERAYSF---CGTIEYMAPEVIRGGSGGHDK 187
Query: 152 ATDIWSLGCMVIEMATGRPPW---GDKISNA--AATLLKIACSNEKPHFPTQFFKKVLDF 206
A D WSLG + E+ TG P+ G++ S + + +LK KP FP + DF
Sbjct: 188 AVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-----SKPPFPKTMSAEARDF 242
Query: 207 LAKCLERKPEKRW---SAEELLNHTFISG 232
+ K LE+ P+KR A+E+ NH F G
Sbjct: 243 IQKLLEKDPKKRLGANGADEIKNHPFFQG 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 2e-24
Identities = 60/248 (24%), Positives = 96/248 (38%), Gaps = 47/248 (18%)
Query: 10 VVKSAESEAGVQALRNEAEIRQSLNSPNIGRNGEKTVNIF------------MEYMAGGS 57
+K SE + EA + + L PN+ V + +EYM GG
Sbjct: 30 TLKEDASEEERKDFLKEARVMKKLGHPNV-------VRLLGVCTEEEPLYLVLEYMEGGD 82
Query: 58 LLD--------VAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
LLD TL + + +I L +H DL N L+G
Sbjct: 83 LLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL 142
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGC 160
VK+ D G +R V D ++ G +L WMAPE L++ +D+WS G
Sbjct: 143 VVKISDFGLSRDVYD-------DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGV 195
Query: 161 MVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219
++ E+ T G P+ +SN +L+ + P ++ + + C + PE R
Sbjct: 196 LLWEIFTLGATPYPG-LSN--EEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRP 252
Query: 220 SAEELLNH 227
+ EL+
Sbjct: 253 TFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 3e-24
Identities = 85/259 (32%), Positives = 122/259 (47%), Gaps = 41/259 (15%)
Query: 2 NKGTGALFVVKSAESEAGV-QALRNEAEIRQSL-NSPNIGR------NGEKTVN----IF 49
NK G+L VK + + V + + E I QSL N PN+ + +K V +
Sbjct: 43 NKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102
Query: 50 MEYMAGGSLLDVAE---KFGGTLDAGVIR--LYTKEI----LHGNGILHCDLKCNNVLLG 100
+E GGS+ ++ + G LD +I LY + LH N I+H D+K NN+LL
Sbjct: 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT 162
Query: 101 SHGDVKLPDLGCARRVND--LKNNGNLKQSWQSIGGTQLWMAPEVLRNE-----GLDFAT 153
+ G VKL D G + ++ L+ N ++ GT WMAPEV+ E D
Sbjct: 163 TEGGVKLVDFGVSAQLTSTRLRRNTSV--------GTPFWMAPEVIACEQQYDYSYDARC 214
Query: 154 DIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHF--PTQFFKKVLDFLAKCL 211
D+WSLG IE+ G PP D + TL KI N P P ++ + F+++CL
Sbjct: 215 DVWSLGITAIELGDGDPPLFDM--HPVKTLFKIP-RNPPPTLLHPEKWCRSFNHFISQCL 271
Query: 212 ERKPEKRWSAEELLNHTFI 230
+ E R S LL H FI
Sbjct: 272 IKDFEARPSVTHLLEHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-24
Identities = 63/192 (32%), Positives = 100/192 (52%), Gaps = 21/192 (10%)
Query: 48 IFMEYMAGGSLLDVA------EKFGGTLDAGVIRLYTKEILHGNGILHCDLKCNNVLLGS 101
+ ME++ GG+L D+ E+ T+ V+R + LH G++H D+K +++LL S
Sbjct: 96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALS--YLHNQGVIHRDIKSDSILLTS 153
Query: 102 HGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGC 160
G +KL D G CA+ ++ +S+ GT WMAPEV+ DIWSLG
Sbjct: 154 DGRIKLSDFGFCAQVSKEVPKR-------KSLVGTPYWMAPEVISRLPYGTEVDIWSLGI 206
Query: 161 MVIEMATGRPPWGDKISNAAATLLK--IACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
MVIEM G PP+ ++ A ++ + + H + + LD + L R+P +R
Sbjct: 207 MVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM---LVREPSQR 263
Query: 219 WSAEELLNHTFI 230
+A+ELL H F+
Sbjct: 264 ATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 4e-24
Identities = 82/284 (28%), Positives = 119/284 (41%), Gaps = 74/284 (26%)
Query: 1 MNKGTG---ALFVVKSAESEAGVQ--ALRNEAEIR--QSLNSPNIGR-----NGEKTVNI 48
+K TG AL ++ E G+ ALR EI + L PNI + + E+ + +
Sbjct: 19 RDKKTGEIVALKKIRLDNEEEGIPSTALR---EISLLKELKHPNIVKLLDVIHTERKLYL 75
Query: 49 FMEYMAGGSLLDVA---EKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLL 99
EY +D+ +K G L +I+ ++L H + ILH DLK N+L+
Sbjct: 76 VFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI 131
Query: 100 GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM-APEVL---RNEGLDFATDI 155
G +KL D G AR L+ + LW APE+L ++ A DI
Sbjct: 132 NRDGVLKLADFGLARAFGI-----PLRTYTHEV--VTLWYRAPEILLGSKHYST--AVDI 182
Query: 156 WSLGCMVIEMATGRPP-WGD-KISNAAATLLKI----------------ACSNEKPHFPT 197
WS+GC+ EM TG+P GD +I L KI + KP FP
Sbjct: 183 WSVGCIFAEMITGKPLFPGDSEID----QLFKIFQILGTPTEESWPGVTKLPDYKPTFPK 238
Query: 198 Q-----------FFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
+ +D L+K L+ P KR SA+E L H +
Sbjct: 239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 5e-24
Identities = 73/252 (28%), Positives = 109/252 (43%), Gaps = 35/252 (13%)
Query: 3 KGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNI-----GRNGEKTVNIFMEY 52
K TG ++ K + + G Q NE +I + ++S I + + + M
Sbjct: 15 KATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTL 74
Query: 53 MAGGSL-LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDV 105
M GG L + Y +I LH I++ DLK NVLL HG+V
Sbjct: 75 MNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNV 134
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
++ DLG A +LK +K GT +MAPEVL+ E DF+ D ++LGC + EM
Sbjct: 135 RISDLGLAV---ELKGGKKIKGR----AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEM 187
Query: 166 ATGRPPW---GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR---- 218
GR P+ +K+ LK +P +F + D L++ PEKR
Sbjct: 188 IAGRSPFRQRKEKVEKEE---LKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCR 244
Query: 219 -WSAEELLNHTF 229
SA+E+ H
Sbjct: 245 GGSADEVREHPL 256
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-24
Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 26 EAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKF---GGTLDAGVIR 75
E ++ + L+ PN+ + N E +NI +E G L + + F + I
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIENNE--LNIVLELADAGDLSRMIKHFKKQKRLIPERTIW 109
Query: 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSW 129
Y ++ +H I+H D+K NV + + G VKL DLG R +
Sbjct: 110 KYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA------ 163
Query: 130 QSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPP-WGDKISNAAATLLKIAC 188
S+ GT +M+PE + G +F +DIWSLGC++ EMA + P +GDK+ N + KI
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEK 222
Query: 189 SNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226
+ P + +++ D +++C+ PEKR +L
Sbjct: 223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 6e-24
Identities = 61/193 (31%), Positives = 98/193 (50%), Gaps = 21/193 (10%)
Query: 48 IFMEYMAGGSLLDVA------EKFGGTLDAGVIRLYTKEILHGNGILHCDLKCNNVLLGS 101
+ ME++ GG+L D+ E+ + V++ + +LH G++H D+K +++LL
Sbjct: 94 VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALS--VLHAQGVIHRDIKSDSILLTH 151
Query: 102 HGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGC 160
G VKL D G CA+ ++ +S+ GT WMAPE++ DIWSLG
Sbjct: 152 DGRVKLSDFGFCAQVSKEV-------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGI 204
Query: 161 MVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPT--QFFKKVLDFLAKCLERKPEKR 218
MVIEM G PP+ ++ A +++ N P + + FL + L R P +R
Sbjct: 205 MVIEMVDGEPPYFNEPPLKAMKMIR---DNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR 261
Query: 219 WSAEELLNHTFIS 231
+A ELL H F++
Sbjct: 262 ATAAELLKHPFLA 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 9e-24
Identities = 66/196 (33%), Positives = 95/196 (48%), Gaps = 22/196 (11%)
Query: 48 IFMEYMAGGSLLDVAEKF-GGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLG 100
+ ME+ GS+ D+ + G L I +EIL H + ++H D+K NVLL
Sbjct: 96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT 155
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR-----NEGLDFATDI 155
+ +VKL D G + +++ N + GT WMAPEV+ + D+ +DI
Sbjct: 156 ENAEVKLVDFGVSAQLDRTVGRRN------TFIGTPYWMAPEVIACDENPDATYDYRSDI 209
Query: 156 WSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPT-QFFKKVLDFLAKCLERK 214
WSLG IEMA G PP D A L+ N P + ++ KK +DF+ CL +
Sbjct: 210 WSLGITAIEMAEGAPPLCDMHPMRALFLIP---RNPPPKLKSKKWSKKFIDFIEGCLVKN 266
Query: 215 PEKRWSAEELLNHTFI 230
R S E+LL H FI
Sbjct: 267 YLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 7e-23
Identities = 68/251 (27%), Positives = 105/251 (41%), Gaps = 35/251 (13%)
Query: 3 KGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNI-----GRNGEKTVNIFMEY 52
KGTG + +K + VQ + E I L+ P I E V +E+
Sbjct: 40 KGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99
Query: 53 MAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVK 106
+ GG L K G V + Y E+ LH I++ DLK N+LL + G VK
Sbjct: 100 VVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVK 158
Query: 107 LPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMA 166
+ D G A++V D ++ GT ++APEV++++G A D W++G ++ E
Sbjct: 159 VTDFGFAKKVPDRT---------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209
Query: 167 TGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA----- 221
G PP+ D KI + FP F + D + L+ KR
Sbjct: 210 AGYPPFFDD--TPFRIYEKILAG--RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGV 265
Query: 222 EELLNHTFISG 232
++ NH + G
Sbjct: 266 ADVKNHPYFHG 276
|
Length = 329 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 9e-23
Identities = 60/177 (33%), Positives = 88/177 (49%), Gaps = 21/177 (11%)
Query: 50 MEYMAGGSLL-DVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH 102
MEY+ GG L+ + G D R Y EI LH GI++ DLK +NVLL
Sbjct: 75 MEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD 132
Query: 103 GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMV 162
G +K+ D G K N N + + GT ++APE+L+ + + + D WS G ++
Sbjct: 133 GHIKIADFGMC------KENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLL 186
Query: 163 IEMATGRPPW-GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
EM G+ P+ G+ ++L N++PHFP K+ D L+K ER P KR
Sbjct: 187 YEMLIGQSPFHGEDEDELFDSIL-----NDRPHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 1e-22
Identities = 75/224 (33%), Positives = 108/224 (48%), Gaps = 27/224 (12%)
Query: 21 QALRNEAEIRQSLNSPN-IGRNG----EKTVNIFMEYMAGGS--LLDVAEKFGGTLDAGV 73
Q + E + Q + PN I G E T + MEY G + LL+V +K ++
Sbjct: 70 QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 129
Query: 74 IR---LYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQ 130
I L LH + ++H D+K N+LL G VKL D G A ++
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA----------SIASPAN 179
Query: 131 SIGGTQLWMAPEVL--RNEG-LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIA 187
S GT WMAPEV+ +EG D D+WSLG IE+A +PP + NA + L IA
Sbjct: 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIA 237
Query: 188 CSNEKPHF-PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
NE P ++ +F+ CL++ P+ R ++EELL H F+
Sbjct: 238 -QNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-22
Identities = 76/227 (33%), Positives = 109/227 (48%), Gaps = 33/227 (14%)
Query: 21 QALRNEAEIRQSLNSPN-IGRNG----EKTVNIFMEYMAGGS--LLDVAEKFGGTLDAGV 73
Q + E + Q L PN I G E T + MEY G + LL+V +K ++
Sbjct: 66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 125
Query: 74 IR---LYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQ 130
I L LH + ++H D+K N+LL G VKL D G A + +
Sbjct: 126 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----------N 175
Query: 131 SIGGTQLWMAPEVL--RNEG-LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIA 187
S GT WMAPEV+ +EG D D+WSLG IE+A +PP + NA + L IA
Sbjct: 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIA 233
Query: 188 CSNEKPHFP----TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
N+ P T F+ +D+ CL++ P++R ++ ELL H F+
Sbjct: 234 -QNDSPTLQSNEWTDSFRGFVDY---CLQKIPQERPASAELLRHDFV 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-22
Identities = 64/223 (28%), Positives = 108/223 (48%), Gaps = 22/223 (9%)
Query: 21 QALRNEAEIRQSLNSPNI------GRNGEKTVNIFMEYMAGGSLLDVAEKFGGTL--DAG 72
+A EA++ L PNI + + I M + GG L ++ G L +
Sbjct: 44 KAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQ 103
Query: 73 VIRLYTK-----EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQ 127
V+ + + + LH ILH DLK NV L +K+ DLG AR L+N ++
Sbjct: 104 VVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARV---LENQCDMAS 160
Query: 128 SWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIA 187
+ + GT +M+PE+ N+ ++ +D+W+LGC V EMAT + + K N +L+
Sbjct: 161 T---LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLVYRI 214
Query: 188 CSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
+ P P + ++ + +A L ++PEKR S + +L +I
Sbjct: 215 IEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 4e-22
Identities = 69/207 (33%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 40 RNGEKTVNIFMEYMAGGSLLDVAEKF---GGTLDAGVIRLYTKEIL------HGNGILHC 90
+NG++ + + +E GGS+ D+ + F G ++ +I E L H N +H
Sbjct: 90 KNGDQ-LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHR 148
Query: 91 DLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE--- 147
D+K NN+LL + G VKL D G + ++ + N GT WMAPEV+ E
Sbjct: 149 DVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV------GTPFWMAPEVIACEQQL 202
Query: 148 --GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP--HFPTQFFKKV 203
D D+WSLG IE+ G PP D + L KI N P H P + +
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDPPLAD--LHPMRALFKIP-RNPPPTLHQPELWSNEF 259
Query: 204 LDFLAKCLERKPEKRWSAEELLNHTFI 230
DF+ KCL + EKR + +LL H FI
Sbjct: 260 NDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 4e-22
Identities = 63/235 (26%), Positives = 95/235 (40%), Gaps = 34/235 (14%)
Query: 10 VVKSAESEAGVQALRNEAEIRQSLNSPNI----G--RNGEKTVNIFMEYMAGGSLLDVAE 63
+K SE ++ EA I + L+ PN+ G E I MEYM GG LL
Sbjct: 35 TLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLY-IVMEYMEGGDLLSYLR 93
Query: 64 KFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVN 117
K L + + +I L +H DL N L+G + VK+ D G +R +
Sbjct: 94 KNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 153
Query: 118 D----LKNNGNL--KQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRP 170
D K G L + WMAPE L+ +D+WS G ++ E+ T G
Sbjct: 154 DDDYYRKRGGKLPIR-----------WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQ 202
Query: 171 PWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
P+ + LK + + P ++ D + +C PE R + EL+
Sbjct: 203 PYPGMSNEEVLEYLK---NGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 5e-22
Identities = 66/193 (34%), Positives = 92/193 (47%), Gaps = 19/193 (9%)
Query: 48 IFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHGNGILHC------DLKCNNVLLGS 101
I MEY GGSL D+ G L I +E L G LH D+K N+LL
Sbjct: 83 ICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTD 141
Query: 102 HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL---RNEGLDFATDIWSL 158
+GDVKL D G A ++ + + +S GT WMAPEV +N G + DIW++
Sbjct: 142 NGDVKLADFGVAAKI-----TATIAKR-KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAV 195
Query: 159 GCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHF--PTQFFKKVLDFLAKCLERKPE 216
G IE+A +PP D + A L + + P T++ +F+ L + P+
Sbjct: 196 GITAIELAELQPPMFD-LHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPK 254
Query: 217 KRWSAEELLNHTF 229
KR +AE LL H F
Sbjct: 255 KRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 7e-22
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 20 VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74
Q + NE + + ++ P I R + ++ + + MEY+ GG L + G
Sbjct: 45 EQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTG 103
Query: 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQS 128
Y EI LH I++ DLK N+LL G +KL D G A+++ D ++
Sbjct: 104 LFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--------RT 155
Query: 129 WQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIAC 188
W ++ GT ++APEV++++G + A D W+LG ++ EM G PP+ D N KI
Sbjct: 156 W-TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD--NPFGIYEKILA 212
Query: 189 SNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
K FP D + K L +R
Sbjct: 213 G--KLEFPRHLDLYAKDLIKKLLVVDRTRR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 2e-21
Identities = 64/196 (32%), Positives = 95/196 (48%), Gaps = 22/196 (11%)
Query: 48 IFMEYMAGGSLLDVAEKF-GGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLG 100
+ ME+ GS+ D+ + G TL I +EIL H + ++H D+K NVLL
Sbjct: 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 145
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR-----NEGLDFATDI 155
+ +VKL D G + +++ N + GT WMAPEV+ + DF +D+
Sbjct: 146 ENAEVKLVDFGVSAQLDRTVGRRN------TFIGTPYWMAPEVIACDENPDATYDFKSDL 199
Query: 156 WSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPT-QFFKKVLDFLAKCLERK 214
WSLG IEMA G PP D A L+ N P + ++ KK F+ CL +
Sbjct: 200 WSLGITAIEMAEGAPPLCDMHPMRALFLIP---RNPAPRLKSKKWSKKFQSFIESCLVKN 256
Query: 215 PEKRWSAEELLNHTFI 230
+R + E+L+ H FI
Sbjct: 257 HSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-21
Identities = 58/194 (29%), Positives = 89/194 (45%), Gaps = 26/194 (13%)
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
MEY+ GG + + GG L + Y E+ LH GI+H D+K N+L+ G
Sbjct: 76 MEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG 134
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163
+KL D G +R NG + GT ++APE + G D +D WSLGC++
Sbjct: 135 HLKLTDFGLSR-------NGLENKK---FVGTPDYLAPETILGVGDDKMSDWWSLGCVIF 184
Query: 164 EMATGRPPWGDKISNAA-ATLL--KIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS 220
E G PP+ + +A +L +I E F + + +D + + L P KR
Sbjct: 185 EFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCS---PEAVDLINRLLCMDPAKRLG 241
Query: 221 A---EELLNHTFIS 231
A +E+ +H F
Sbjct: 242 ANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 4e-21
Identities = 73/224 (32%), Positives = 106/224 (47%), Gaps = 27/224 (12%)
Query: 21 QALRNEAEIRQSLNSPN-IGRNG----EKTVNIFMEYMAGGS--LLDVAEKFGGTLDAGV 73
Q + E Q L PN I G E T + MEY G + LL+V +K ++
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 119
Query: 74 IR---LYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQ 130
+ L LH + ++H D+K N+LL G VKL D G A ++
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA----------SIMAPAN 169
Query: 131 SIGGTQLWMAPEVL--RNEG-LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIA 187
GT WMAPEV+ +EG D D+WSLG IE+A +PP + NA + L IA
Sbjct: 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIA 227
Query: 188 CSNEKPHFPT-QFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
NE P + + + +F+ CL++ P+ R ++E LL H F+
Sbjct: 228 -QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 4e-21
Identities = 58/193 (30%), Positives = 88/193 (45%), Gaps = 26/193 (13%)
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
MEY+ GG L+ ++ G D R Y EI LH GI++ DLK +NVLL S G
Sbjct: 75 MEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG 133
Query: 104 DVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMV 162
+K+ D G C K + + GT ++APE+L + A D W+LG ++
Sbjct: 134 HIKIADFGMC-------KEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLL 186
Query: 163 IEMATGRPPW-GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221
EM G+ P+ GD ++L ++ +P K+ L L + PEKR
Sbjct: 187 YEMLAGQSPFEGDDEDELFQSIL-----EDEVRYPRWLSKEAKSILKSFLTKNPEKRLGC 241
Query: 222 -----EELLNHTF 229
+++ H F
Sbjct: 242 LPTGEQDIKGHPF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 6e-21
Identities = 70/254 (27%), Positives = 103/254 (40%), Gaps = 32/254 (12%)
Query: 3 KGTGALFVVK-----SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEY 52
K TG ++ +K ++ V E +I NSP I + + + + MEY
Sbjct: 23 KATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82
Query: 53 MAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVK 106
GG LL + ++ D + + Y E+ +H G +H D+K NVL+ G +K
Sbjct: 83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIK 142
Query: 107 LPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR------NEGLDFATDIWSLGC 160
L D G A R+ N + + GT ++APEVL D WSLG
Sbjct: 143 LADFGSAARL-----TANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGV 197
Query: 161 MVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDF--LAKCLERKPEKR 218
+ EM GR P+ + +A T I FP K DF L + L ++R
Sbjct: 198 IAYEMIYGRSPFHE--GTSAKTYNNIMNFQRFLKFPED-PKVSSDFLDLIQSLLCGQKER 254
Query: 219 WSAEELLNHTFISG 232
E L H F S
Sbjct: 255 LGYEGLCCHPFFSK 268
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-20
Identities = 67/221 (30%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 42 GEKTVNIFMEYMAGGSL-----------LDVAEKFGGTLDAGVIRL--YTKEILHGNGIL 88
E V I ME M SL L + E G + +++ Y L ++
Sbjct: 71 REGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VI 126
Query: 89 HCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSI--GGTQLWMAPEVLRN 146
H D+K +NVL+ +G VKL D G + G L S G + +MAPE +
Sbjct: 127 HRDVKPSNVLINRNGQVKLCDFGIS---------GYLVDSVAKTIDAGCKPYMAPERINP 177
Query: 147 E----GLDFATDIWSLGCMVIEMATGRPP---WGDKISNAAATLLKIACSNEKPHFPTQF 199
E G D +D+WSLG +IE+ATGR P W LK P P +
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ-----LKQVVEEPSPQLPAEK 232
Query: 200 FK-KVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKNST 239
F + DF+ KCL++ ++R + ELL H F + KN+
Sbjct: 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTD 273
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 3e-20
Identities = 63/240 (26%), Positives = 94/240 (39%), Gaps = 41/240 (17%)
Query: 10 VVKSAESEAGVQALRNEAEIRQSLNSPNI----G--RNGEKTVNIFMEYMAGGSLLDV-- 61
+K SE ++ EA I + L+ PNI G E + I MEYM GG LLD
Sbjct: 35 TLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM-IVMEYMPGGDLLDYLR 93
Query: 62 --AEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCA 113
K D + + +I L +H DL N L+G + VK+ D G +
Sbjct: 94 KNRPKELSLSD---LLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS 150
Query: 114 RRVND----LKNNGNL--KQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT 167
R + D G L + WMAPE L+ +D+WS G ++ E+ T
Sbjct: 151 RDLYDDDYYKVKGGKLPIR-----------WMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
Query: 168 -GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226
G P+ + LK + P ++ + +C PE R + EL+
Sbjct: 200 LGEEPYPGMSNAEVLEYLK---KGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 3e-20
Identities = 67/251 (26%), Positives = 107/251 (42%), Gaps = 50/251 (19%)
Query: 20 VQALRNEAEIRQSLNSPNI-------GRNGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72
ALR E ++ + LN PNI G+ + + E+M L + + L
Sbjct: 43 KTALR-EIKLLKELNHPNIIKLLDVFRHKGD--LYLVFEFMDT-DLYKLIKDRQRGLPES 98
Query: 73 VIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLK 126
+I+ Y ++L H +GILH DLK N+L+ + G +KL D G AR G+
Sbjct: 99 LIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSF------GSPV 152
Query: 127 QSWQSIGGTQLWMAPEVL-RNEGLDFATDIWSLGCMVIEMATGRPPWG-----DKISNAA 180
+ + T+ + APE+L ++G DIWS+GC+ E+ + RP + D++
Sbjct: 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF 212
Query: 181 ATL-------LKIACSNEK------PHFPTQFFKKV--------LDFLAKCLERKPEKRW 219
TL S + P K+ LD L++ L P KR
Sbjct: 213 RTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI 272
Query: 220 SAEELLNHTFI 230
+AE+ L H +
Sbjct: 273 TAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-19
Identities = 80/280 (28%), Positives = 123/280 (43%), Gaps = 75/280 (26%)
Query: 22 ALRN----EAEIRQSLNSPNI-GRNG----EKTVNIFMEYMAGGSLLDVAEKFG------ 66
A+RN E ++ NSP I G G + ++I ME+M GGSL V +K G
Sbjct: 45 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI 104
Query: 67 -GTLDAGVIR--LYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG 123
G + VI+ Y +E + I+H D+K +N+L+ S G++KL D G + ++ D N
Sbjct: 105 LGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN- 160
Query: 124 NLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGR---PP--------- 171
S GT+ +M+PE L+ +DIWS+G ++EMA GR PP
Sbjct: 161 -------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM 213
Query: 172 WGDKISNAAAT-----------------------------LLKIACSNEKPHFPTQFFK- 201
+G + A LL + P P+ F
Sbjct: 214 FGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGA 273
Query: 202 KVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKNSTEE 241
+ DF+ KCL + P +R ++L+ H FI K++ EE
Sbjct: 274 EFQDFVNKCLIKNPAERADLKQLMVHAFI----KRSEAEE 309
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-19
Identities = 70/242 (28%), Positives = 119/242 (49%), Gaps = 29/242 (11%)
Query: 10 VVKSAESEAGVQALRNEAE-IRQS--LNSPNIGRNGEKTVNIFMEYMAGGSLLD-VAEKF 65
+V+ A++ + RN E +RQS L + + E +++ ++Y++GG + + ++
Sbjct: 41 LVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD 100
Query: 66 GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDL 119
+ D +R Y+ EI LH GI++ D+K N+LL S G V L D G ++
Sbjct: 101 NFSEDE--VRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158
Query: 120 KNNGNLKQSWQSIGGTQLWMAPEVLRNE-GLDFATDIWSLGCMVIEMATGRPPW---GDK 175
+ K+ S GT +MAPE++R + G A D WSLG ++ E+ TG P+ G++
Sbjct: 159 E-----KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER 213
Query: 176 ISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR-----WSAEELLNHTFI 230
+ + + + C P FP+ + D L K L + P+KR A E+ H F
Sbjct: 214 NTQSEVSRRILKCD---PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270
Query: 231 SG 232
G
Sbjct: 271 KG 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 5e-19
Identities = 72/246 (29%), Positives = 108/246 (43%), Gaps = 26/246 (10%)
Query: 2 NKGTGALFVVKSAESEAG--VQALRNEAEIRQSLNSPNI-----GRNGEKTVNIFMEYMA 54
N TG L +K + E G ++ E + + NI + I ME+
Sbjct: 30 NVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89
Query: 55 GGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLP 108
GGSL D+ G L I ++E L H G +H D+K N+LL +G VKL
Sbjct: 90 GGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLA 148
Query: 109 DLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL---RNEGLDFATDIWSLGCMVIEM 165
D G + ++ + + +S GT WMAPEV R G + DIW++G IE+
Sbjct: 149 DFGVSAQI-----TATIAKR-KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
Query: 166 ATGRPPWGDKISNAAATLLKIACSNEKPHF--PTQFFKKVLDFLAKCLERKPEKRWSAEE 223
A +PP D + A L + + P ++ F+ L + P+KR +AE+
Sbjct: 203 AELQPPMFD-LHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEK 261
Query: 224 LLNHTF 229
LL H F
Sbjct: 262 LLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 9e-19
Identities = 57/187 (30%), Positives = 83/187 (44%), Gaps = 47/187 (25%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIG------GT 135
+H ++H DLK +N+LL S VKL D G AR +++L+ N T
Sbjct: 123 IHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN-------PENPVLTDYVAT 175
Query: 136 QLWMAPEVL-RNEGLDFATDIWSLGCMVIEMATGRP--PWG-------DKI--------- 176
+ + APE+L + D+WS+GC++ EM G+P P G +KI
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP-GTSTLNQLEKIIEVIGPPSA 234
Query: 177 -------SNAAATLL-KIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEKRWSAEEL 224
S AAT+L + KP + K LD L K L P KR +AEE
Sbjct: 235 EDIESIKSPFAATMLDSLPSRPRKP--LDELLPKASDDALDLLKKLLVFNPNKRLTAEEA 292
Query: 225 LNHTFIS 231
L H +++
Sbjct: 293 LEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-18
Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 26/210 (12%)
Query: 26 EAEIRQSLNSPNIGRN-----GEKTVNIFMEYMAGGSLLDVAEKFGG--------TLDAG 72
E ++ + LN PN+ + + +NI +E G L + + F T+
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 73 VIRLYTK-EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQS 131
++L + E +H ++H D+K NV + + G VKL DLG R + + + S
Sbjct: 112 FVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS------SKTTAAHS 165
Query: 132 IGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPP-WGDKISNAAATLLKI-ACS 189
+ GT +M+PE + G +F +DIWSLGC++ EMA + P +GDK+ N + KI C
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQKIEQC- 223
Query: 190 NEKPHFPTQFF-KKVLDFLAKCLERKPEKR 218
+ P PT+ + +K+ + ++ C+ P++R
Sbjct: 224 -DYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-18
Identities = 57/178 (32%), Positives = 86/178 (48%), Gaps = 23/178 (12%)
Query: 50 MEYMAGGSLL-DVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH 102
ME++ GG L+ + +K G D Y EI LH GI++ DLK +NV+L
Sbjct: 75 MEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD 132
Query: 103 GDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCM 161
G +K+ D G C V G+ + S + GT ++APE+L+ F+ D WS G +
Sbjct: 133 GHIKIADFGMCKENVF-----GDNRAS--TFCGTPDYIAPEILQGLKYTFSVDWWSFGVL 185
Query: 162 VIEMATGRPPW-GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
+ EM G+ P+ GD ++ + PH+P K+ D L K ER P +R
Sbjct: 186 LYEMLIGQSPFHGDDEDELFESI-----RVDTPHYPRWITKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-18
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 26 EAEIRQSLNSPNIGRN-----GEKTVNIFMEYMAGGSLLDVAEKFGGTL----DAGVIRL 76
E ++ + LN PN+ + + +NI +E G L + + F + V +
Sbjct: 52 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY 111
Query: 77 YTK-----EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQS 131
+ + E +H ++H D+K NV + + G VKL DLG R + + + S
Sbjct: 112 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS------SKTTAAHS 165
Query: 132 IGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPP-WGDKISNAAATLLKIACSN 190
+ GT +M+PE + G +F +DIWSLGC++ EMA + P +GDK++ +L K
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQC 223
Query: 191 EKPHFPTQFFKKVLDFLAK-CLERKPEKR 218
+ P P+ + + L L C+ PEKR
Sbjct: 224 DYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-18
Identities = 75/238 (31%), Positives = 113/238 (47%), Gaps = 34/238 (14%)
Query: 10 VVKSAESEAGVQALRNEAEIRQSLNSPNIG------RNGEKTVNIFMEYMAGGSLLDVAE 63
+V++ + A +A RN I +++ P I + G K I +EY++GG L E
Sbjct: 37 IVRNQKDTAHTKAERN---ILEAVKHPFIVDLIYAFQTGGKLYLI-LEYLSGGELFMHLE 92
Query: 64 KFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLG-CARRV 116
+ G ++ Y EI LH GI++ DLK N+LL + G VKL D G C +
Sbjct: 93 REGIFME-DTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI 151
Query: 117 NDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKI 176
++ G + ++ GT +MAPE+L G A D WSLG ++ +M TG PP+ +
Sbjct: 152 HE----GTVTHTF---CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE- 203
Query: 177 SNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----SAEELLNHTF 229
N T+ KI K + P + D L K L+R P R A E+ +H F
Sbjct: 204 -NRKKTIDKIL--KGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-18
Identities = 64/209 (30%), Positives = 91/209 (43%), Gaps = 44/209 (21%)
Query: 57 SLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDL 110
++LD EK+ LD +R Y +IL H + I+H D+K N+L+ G VKL D
Sbjct: 85 TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDF 144
Query: 111 GCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL-RNEGLDFATDIWSLGCMVIEMATGR 169
G AR + + + T+ + APE+L + A DIW++GC+V EM TG
Sbjct: 145 GFARTLA------APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198
Query: 170 PPW-GD-------KISNAAATLLK----IACSN-----------------EKPHFPTQFF 200
P + GD I L+ I N EK FP
Sbjct: 199 PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEK-RFPK-LS 256
Query: 201 KKVLDFLAKCLERKPEKRWSAEELLNHTF 229
VLD +CL P+ R S+ +LL+H F
Sbjct: 257 GLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-18
Identities = 79/276 (28%), Positives = 115/276 (41%), Gaps = 65/276 (23%)
Query: 2 NKGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEY 52
N+ TG + +K AE A+R E + + L NI R + E + + EY
Sbjct: 21 NRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHDVIHTENKLMLVFEY 79
Query: 53 MAGGSLLDVAEKFG--GTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD 104
M L + G G LD ++ +T ++L H N +LH DLK N+L+ G+
Sbjct: 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE 138
Query: 105 VKLPDLGCARR----VNDLKNNGNLKQSWQSIGGTQLWM-APEVLR-NEGLDFATDIWSL 158
+KL D G AR VN N LW AP+VL + + DIWS+
Sbjct: 139 LKLADFGLARAFGIPVNTFSNE-----------VVTLWYRAPDVLLGSRTYSTSIDIWSV 187
Query: 159 GCMVIEMATGRPPWGDKISNAAATLLKI-------------------ACSNEKPHFPTQF 199
GC++ EM TGRP + +N LLKI P +P Q
Sbjct: 188 GCIMAEMITGRPLFPG--TNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQD 245
Query: 200 FKKV--------LDFLAKCLERKPEKRWSAEELLNH 227
+++ +D L + L+ PE R SA + L H
Sbjct: 246 LQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-18
Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 21/227 (9%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNSPNI-----GRNGEKTVNIFMEYMAGGSLLDVAEKF 65
++ +S + V+ R EA + + PNI + + I MEY GG L+ +
Sbjct: 33 IRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQ 92
Query: 66 GGTL--DAGVIRLYTKEIL-----HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVND 118
G L + +++ + + L H +LH D+K N+ L +G VKL D G AR
Sbjct: 93 RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL--- 149
Query: 119 LKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISN 178
L + G ++ GT ++ PE+ N + +DIWSLGC++ E+ T + P+ +N
Sbjct: 150 LTSPGAYACTYV---GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ---AN 203
Query: 179 AAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
+ L+ C P+ + ++ + + +R P R SA +L
Sbjct: 204 SWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-18
Identities = 63/255 (24%), Positives = 107/255 (41%), Gaps = 39/255 (15%)
Query: 2 NKGTGALFVVKSAESEAGVQA---LRNEAEIRQSLNSPNIGR-------NGEKTVNIFME 51
TG VKS Q E EI ++L+ NI + G +++ + ME
Sbjct: 29 GDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME 88
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDV 105
Y+ GSL D ++ ++ + L++ +I L +H DL N+L+ S V
Sbjct: 89 YLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLV 148
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
K+ D G A+ + + K+ +K+ +S W APE LR A+D+WS G + E+
Sbjct: 149 KISDFGLAKVLPEDKDYYYVKEPGES---PIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205
Query: 166 ATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFK----------------KVLDFLAK 209
T +GD + A L++ + T+ + +V D +
Sbjct: 206 FT----YGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKL 261
Query: 210 CLERKPEKRWSAEEL 224
C E +P+ R S +L
Sbjct: 262 CWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 4e-18
Identities = 66/256 (25%), Positives = 102/256 (39%), Gaps = 54/256 (21%)
Query: 22 ALRNEAEIR--QSLNSPNI----------GRNGEKTVNIFMEYMAGGSLLDVAEKFGGTL 69
LR EI+ + L NI V I E M + L K L
Sbjct: 46 ILR---EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM--ETDLHKVIKSPQPL 100
Query: 70 DAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG 123
I+ + +IL H ++H DLK +N+L+ S+ D+K+ D G AR V+ +
Sbjct: 101 TDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP---DE 157
Query: 124 NLKQSWQSIGGTQLWMAPEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWG--------D 174
+ K T+ + APE+L + A DIWS+GC+ E+ T +P + +
Sbjct: 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN 217
Query: 175 KISNAAAT-----LLKIACSN------EKPHFPTQFFKKV--------LDFLAKCLERKP 215
I T L I P P + K+ +D L K L P
Sbjct: 218 LIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDP 277
Query: 216 EKRWSAEELLNHTFIS 231
+KR +A+E L H +++
Sbjct: 278 KKRITADEALAHPYLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 8e-18
Identities = 69/242 (28%), Positives = 108/242 (44%), Gaps = 31/242 (12%)
Query: 3 KGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNI-----GRNGEKTVNIFMEY 52
K TG ++ K + + +G + E EI + +NSP I + + + M
Sbjct: 15 KNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSL 74
Query: 53 MAGGSL----LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH 102
M GG L +V E+ L+ + Y+ +I LH I++ D+K NVLL
Sbjct: 75 MNGGDLKYHIYNVGER---GLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ 131
Query: 103 GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMV 162
G+ +L DLG A + D K + GT +MAPE+L+ E + D +++GC +
Sbjct: 132 GNCRLSDLGLAVELKDGK-------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSI 184
Query: 163 IEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQ-FFKKVLDFLAKCLERKPEKRWSA 221
EM GR P+ D A LK ++ F Q F ++ D L +KPE R +
Sbjct: 185 YEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGS 244
Query: 222 EE 223
E
Sbjct: 245 RE 246
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 8e-18
Identities = 67/246 (27%), Positives = 108/246 (43%), Gaps = 27/246 (10%)
Query: 2 NKGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNIGRNGEK-----TVNIFMEY 52
+K G +V+K S S + R E + ++ PNI + E + I M+Y
Sbjct: 21 SKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80
Query: 53 MAGGSLLDVAEKFGGT-------LDAGV-IRLYTKEILHGNGILHCDLKCNNVLLGSHGD 104
GG L G LD V I L K + H ILH D+K N+ L G
Sbjct: 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHV-HDRKILHRDIKSQNIFLTKDGT 139
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIE 164
+KL D G AR +N + + ++ GT +++PE+ N + +DIW+LGC++ E
Sbjct: 140 IKLGDFGIARVLN------STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYE 193
Query: 165 MATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
M T + + + N +LKI P + + + + +++ +R P R S +
Sbjct: 194 MCTLKHAF--EAGNMKNLVLKI-IRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSI 250
Query: 225 LNHTFI 230
L FI
Sbjct: 251 LEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 1e-17
Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 31/202 (15%)
Query: 46 VNIFMEYMAGGSLLD---------VAEKFGGTLDAGVIR--LYTKEILHGNGILHCDLKC 94
V I ME M+ + LD + E G + +++ Y KE +G++H D+K
Sbjct: 89 VFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE---KHGVIHRDVKP 143
Query: 95 NNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL----RNEGLD 150
+N+LL + G+VKL D G + R+ D K + + G +MAPE + N D
Sbjct: 144 SNILLDASGNVKLCDFGISGRLVDSK--AKTRSA-----GCAAYMAPERIDPPDPNPKYD 196
Query: 151 FATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPT--QFFKKVLDFLA 208
D+WSLG ++E+ATG+ P+ K +L E P P F F+
Sbjct: 197 IRADVWSLGISLVELATGQFPY--KNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVD 254
Query: 209 KCLERKPEKRWSAEELLNHTFI 230
CL + KR ELL H FI
Sbjct: 255 LCLTKDHRKRPKYRELLQHPFI 276
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-17
Identities = 78/282 (27%), Positives = 121/282 (42%), Gaps = 77/282 (27%)
Query: 22 ALRN----EAEIRQSLNSPNI-GRNG----EKTVNIFMEYMAGGSLLDV-------AEKF 65
A+RN E ++ NSP I G G + ++I ME+M GGSL V E+
Sbjct: 45 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEI 104
Query: 66 GGTLDAGVIR--LYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG 123
G + V+R Y +E + I+H D+K +N+L+ S G++KL D G + ++ D N
Sbjct: 105 LGKVSIAVLRGLAYLRE---KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN- 160
Query: 124 NLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGR---PP--------- 171
S GT+ +M+PE L+ +DIWS+G ++E+A GR PP
Sbjct: 161 -------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI 213
Query: 172 WGDKISNAAAT-------------------------------LLKIACSNEKPHFPTQFF 200
+G + + LL + P P F
Sbjct: 214 FGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVF 273
Query: 201 KKVL-DFLAKCLERKPEKRWSAEELLNHTFISGNAKKNSTEE 241
+F+ KCL + P +R + L+NHTFI K++ EE
Sbjct: 274 TPDFQEFVNKCLIKNPAERADLKMLMNHTFI----KRSEVEE 311
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-17
Identities = 51/161 (31%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139
E LH I++ DLK NVLL + G+V++ DLG A + D ++ + GT +M
Sbjct: 111 EHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT------KGYAGTPGFM 164
Query: 140 APEVLRNEGLDFATDIWSLGCMVIEMATGRPPW---GDKISNAAATLLKIACSNEKPHFP 196
APE+L+ E DF+ D ++LG + EM R P+ G+K+ N LK N+ +P
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE---LKQRILNDSVTYP 221
Query: 197 TQFFKKVLDFLAKCLERKPEKRW-----SAEELLNHTFISG 232
+F F L + PEKR + + L H
Sbjct: 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-17
Identities = 69/244 (28%), Positives = 121/244 (49%), Gaps = 38/244 (15%)
Query: 10 VVKSAESEAGVQALRNEAE-IRQS--LNSPNIGRNGEKTVNIFMEYMAGGSL---LDVAE 63
+V+ A++ + R E IRQS L + + + +++ ++Y+ GG L L E
Sbjct: 41 IVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE 100
Query: 64 KFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVN 117
+F +++Y+ EI LH GI++ D+K N+LL S+G V L D G ++ +
Sbjct: 101 RF----KEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156
Query: 118 DLKNNGNLKQSWQSIGGTQLWMAPEVLR--NEGLDFATDIWSLGCMVIEMATGRPPW--- 172
+ + + S GT +MAP+++R + G D A D WS+G ++ E+ TG P+
Sbjct: 157 EDEV-----ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211
Query: 173 GDKISNA--AATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----SAEELL 225
G+K S A + +LK +P +P + D + + L + P+KR A+E+
Sbjct: 212 GEKNSQAEISRRILK-----SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266
Query: 226 NHTF 229
H F
Sbjct: 267 KHPF 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 2e-17
Identities = 58/224 (25%), Positives = 89/224 (39%), Gaps = 50/224 (22%)
Query: 44 KTVNIFMEYMAGGSLLDVAEKFGGT-LDAGVIRLYTKEIL------HGNGILHCDLKCNN 96
+ EYM G +L + + G VIR +IL H +G H DLK N
Sbjct: 71 DELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPEN 129
Query: 97 VLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV-LRNEGLDFATDI 155
+L+ VK+ D G AR + + + T+ + APE+ LR+ DI
Sbjct: 130 LLVSGPEVVKIADFGLAREIRS-------RPPYTDYVSTRWYRAPEILLRSTSYSSPVDI 182
Query: 156 WSLGCMVIEMATGRPPW-GDKISNAAATLLKIACS------NEK---------------P 193
W+LGC++ E+ T RP + G S+ L KI CS + P
Sbjct: 183 WALGCIMAELYTLRPLFPG---SSEIDQLYKI-CSVLGTPTKQDWPEGYKLASKLGFRFP 238
Query: 194 HFPTQFFKKVL--------DFLAKCLERKPEKRWSAEELLNHTF 229
F +++ D + L P+KR +A + L H +
Sbjct: 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-17
Identities = 77/280 (27%), Positives = 110/280 (39%), Gaps = 58/280 (20%)
Query: 3 KGTGALFVVK-----SAESEAGVQALRNEAEIRQSLNSPNI----GRNGEKTVNIF-MEY 52
KGTG LF +K V+ + E EI +L+ P + +T M+Y
Sbjct: 23 KGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82
Query: 53 MAGGSLLDVAEKF-GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDV 105
GG L + ++ G L V R Y E+ LH GI++ DLK N+LL G +
Sbjct: 83 CPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHI 142
Query: 106 KLPD------LGCA-RRVNDLKNNGNLKQSWQSIG----------------GTQLWMAPE 142
L D V+ G+ + S SI GT+ ++APE
Sbjct: 143 MLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE 202
Query: 143 VLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKK 202
V+ +G A D W+LG ++ EM G P+ K SN T I ++ FP
Sbjct: 203 VISGDGHGSAVDWWTLGILLYEMLYGTTPF--KGSNRDETFSNIL--KKEVTFP----GS 254
Query: 203 VL------DFLAKCLERKPEKR---WS-AEELLNHTFISG 232
D + K L + P KR A E+ H F G
Sbjct: 255 PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 3e-17
Identities = 71/283 (25%), Positives = 109/283 (38%), Gaps = 63/283 (22%)
Query: 3 KGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNIGRNGEKTVNIF--------- 49
K T L VK + S+ ++ L+ E + L PNI V F
Sbjct: 22 KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI----LPYVTSFIVDSELYVV 77
Query: 50 MEYMAGGSLLD-VAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSH 102
MA GS D + F L I K++L H G +H +K +++LL
Sbjct: 78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD 137
Query: 103 GDVKLPDLGCARRVNDLKNNGNLKQ----SWQSIGGTQLWMAPEVLRN--EGLDFATDIW 156
G V L L R + +G ++ +S W++PEVL+ +G + +DI+
Sbjct: 138 GKVVLSGL---RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIY 194
Query: 157 SLGCMVIEMATGRPPWGD---------KISNAAATLL-------------------KIAC 188
S+G E+A G P+ D K+ LL +
Sbjct: 195 SVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPN 254
Query: 189 SNEKPHFPTQ--FFKKVLDFLAKCLERKPEKRWSAEELLNHTF 229
+ + P F + F+ CL+R PE R SA +LLNH+F
Sbjct: 255 NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-17
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 34/198 (17%)
Query: 50 MEYMAGGSLL---DVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
MEY+ GG L+ + KF D R Y E+ LH +G+++ DLK +N+LL
Sbjct: 75 MEYVNGGDLMFQIQRSRKF----DEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD 130
Query: 101 SHGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
+ G KL D G C + NG ++ GT ++APE+L+ + D W+LG
Sbjct: 131 AEGHCKLADFGMCKEGIL----NGVTTTTF---CGTPDYIAPEILQELEYGPSVDWWALG 183
Query: 160 CMVIEMATGRPPW-GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
++ EM G+PP+ D + ++L ++ +P K+ + L + + P KR
Sbjct: 184 VLMYEMMAGQPPFEADNEDDLFESIL-----HDDVLYPVWLSKEAVSILKAFMTKNPNKR 238
Query: 219 WSA-------EELLNHTF 229
+ + H F
Sbjct: 239 LGCVASQGGEDAIKQHPF 256
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 5e-17
Identities = 77/275 (28%), Positives = 117/275 (42%), Gaps = 59/275 (21%)
Query: 2 NKGTGALFVVKS----AESEAGV--QALRNEAEIRQSLNSPNIGR-----NGEKTVNIFM 50
NK TG + +K E+E GV A+R E + + LN PNI + + E + +
Sbjct: 21 NKLTGEVVALKKIRLDTETE-GVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVF 78
Query: 51 EYMAGG--SLLDVAEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLLGSH 102
E++ +D + G + +I+ Y ++L G + +LH DLK N+L+ +
Sbjct: 79 EFLHQDLKKFMDASPLSG--IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE 136
Query: 103 GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF---ATDIWSLG 159
G +KL D G AR G +++ T + APE+L G + A DIWSLG
Sbjct: 137 GAIKLADFGLARAF------GVPVRTYTHEVVTLWYRAPEILL--GCKYYSTAVDIWSLG 188
Query: 160 CMVIEMATGRP--PWGDKISNAAATLLKIACSNEK---------------PHFPTQFFKK 202
C+ EM T R P +I + +E P + Q F K
Sbjct: 189 CIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSK 248
Query: 203 VL--------DFLAKCLERKPEKRWSAEELLNHTF 229
V+ D L++ L P KR SA+ L H F
Sbjct: 249 VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-17
Identities = 53/156 (33%), Positives = 74/156 (47%), Gaps = 17/156 (10%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
LH GI++ DLK N+LL G +KL D G ++ D + K+++ S GT +MAP
Sbjct: 114 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-----HEKKAY-SFCGTVEYMAP 167
Query: 142 EVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATL-LKIACSNEKPHFPTQFF 200
EV+ G + D WS G ++ EM TG P+ K T+ LK P F +
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG--MPQFLSPEA 225
Query: 201 KKVLDFLAKCLERKPEKRWSA-----EELLNHTFIS 231
+ +L L K R P R A EE+ H F S
Sbjct: 226 QSLLRALFK---RNPANRLGAGPDGVEEIKRHPFFS 258
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-16
Identities = 61/191 (31%), Positives = 85/191 (44%), Gaps = 20/191 (10%)
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHG 103
+ ++ GG L ++ G D R YT E+L H +++ DLK N+LL G
Sbjct: 72 LAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG 130
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163
+ L D G K N + GT ++APE+L G A D W+LG ++
Sbjct: 131 HIALCDFGLC------KLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLY 184
Query: 164 EMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW---S 220
EM TG PP+ D+ N KI E FP F + D L L R P +R
Sbjct: 185 EMLTGLPPFYDE--NVNEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNG 240
Query: 221 AEELLNHTFIS 231
A+E+ NH F S
Sbjct: 241 AQEIKNHPFFS 251
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-16
Identities = 71/275 (25%), Positives = 118/275 (42%), Gaps = 58/275 (21%)
Query: 2 NKGTGALFVVKS-AESEAGVQ----ALRNEAEIR--QSLNSPNIGRNGE-----KTVNIF 49
N+ TG + +K ESE ALR EIR + L PN+ E + +++
Sbjct: 22 NRETGQIVAIKKFVESEDDPVIKKIALR---EIRMLKQLKHPNLVNLIEVFRRKRKLHLV 78
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHG 103
EY ++L+ EK + +I+ + L H + +H D+K N+L+ G
Sbjct: 79 FEYC-DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG 137
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT--DIWSLGCM 161
+KL D G AR + ++ + T+ + APE+L + + D+W++GC+
Sbjct: 138 QIKLCDFGFARILTGPGDD------YTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCV 190
Query: 162 VIEMATGRPPWG-----DKISNAAATLLKIACSNEKPHFPTQFFKKV------------- 203
E+ TG+P W D++ TL + +++ QFFK +
Sbjct: 191 FAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLES 250
Query: 204 ---------LDFLAKCLERKPEKRWSAEELLNHTF 229
L FL CL+ P +R S EELL H +
Sbjct: 251 KFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-16
Identities = 64/224 (28%), Positives = 101/224 (45%), Gaps = 24/224 (10%)
Query: 21 QALRNEAEIRQSLNSPNI-----GRNGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG--- 72
+A + E + + PNI + I MEY GG L+ + G L +
Sbjct: 44 EASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI 103
Query: 73 -----VIRLYTKEILHGNGILHCDLKCNNVLLGSHGDV-KLPDLGCARRVNDLKNNGNLK 126
I L K I H ILH D+K N+ L +G V KL D G AR++ND
Sbjct: 104 LSWFVQISLGLKHI-HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM------ 156
Query: 127 QSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKI 186
+ + GT +++PE+ +N + TDIWSLGC++ E+ T + P+ + +N +LKI
Sbjct: 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF--EGNNLHQLVLKI 214
Query: 187 ACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
P P F + + +++ + P R S +L F+
Sbjct: 215 CQGYFAPISP-NFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-16
Identities = 56/192 (29%), Positives = 86/192 (44%), Gaps = 25/192 (13%)
Query: 50 MEYMAGGSLL-----DVAEKFGGTLDAGVIRLYTKEILHGNGILHCDLKCNNVLLGSHGD 104
MEY AGG L+ DV + A + L + LH N I++ DLK +N+LL + G
Sbjct: 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQ-YLHENKIVYRDLKLDNLLLDTEGF 139
Query: 105 VKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163
VK+ D G C K + GT ++APEVL A D W LG ++
Sbjct: 140 VKIADFGLC-------KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIY 192
Query: 164 EMATGRPPW-GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW--- 219
EM G P+ GD +++ N++ +P ++ + + + L R PE+R
Sbjct: 193 EMLVGESPFPGDDEEEVFDSIV-----NDEVRYPRFLSREAISIMRRLLRRNPERRLGSG 247
Query: 220 --SAEELLNHTF 229
AE++ F
Sbjct: 248 EKDAEDVKKQPF 259
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-16
Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 26 EAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLL------DVAEKFGGTLDAGVI 74
E +I NS I + +K + + MEYM GG L+ D+ EK+
Sbjct: 93 ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWA-------- 144
Query: 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQS 128
R YT E+ +H G +H D+K +N+LL G +KL D G +++ NG ++
Sbjct: 145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD---ANGMVRCD 201
Query: 129 WQSIGGTQLWMAPEVLRNEGLD----FATDIWSLGCMVIEMATGRPPWGDKISNAAATLL 184
+ GT +++PEVL+++G D D WS+G + EM G P+ + T
Sbjct: 202 --TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTYS 257
Query: 185 KIACSNEKPHFPT--QFFKKVLDFLAKCLERKPEK--RWSAEELLNHTF 229
KI FP + K+ D + L + + R +E+ +H F
Sbjct: 258 KIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-16
Identities = 52/170 (30%), Positives = 78/170 (45%), Gaps = 37/170 (21%)
Query: 77 YTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIG-- 133
Y KE L I+H D+K +N+LL +G++KL D G + V+ SI
Sbjct: 122 YLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD-------------SIAKT 165
Query: 134 ---GTQLWMAPEVL---RNEGLDFATDIWSLGCMVIEMATGR---PPWGDKISNAAATLL 184
G + +MAPE + +G D +D+WSLG + E+ATG+ P W N+ L
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW-----NSVFDQL 220
Query: 185 KIACSNEKPHFPT----QFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
+ P +F ++F+ CL + KR +ELL H FI
Sbjct: 221 TQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-16
Identities = 40/105 (38%), Positives = 58/105 (55%), Gaps = 14/105 (13%)
Query: 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLG-CARRVNDLKNNGNLKQ 127
R Y+ EI LH GI++ DLK +NVLL + G +KL D G C + G+
Sbjct: 99 RFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP----GDTTS 154
Query: 128 SWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPW 172
++ GT ++APE+LR E F+ D W+LG ++ EM GR P+
Sbjct: 155 TF---CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 7e-16
Identities = 82/281 (29%), Positives = 118/281 (41%), Gaps = 71/281 (25%)
Query: 2 NKGTGALFVVK----SAESEAGV--QALRNEAEIRQSLNSPNIGR-----NGEKTVNIFM 50
+K TG + +K E E GV A+R E + + LN PNI R + E + +
Sbjct: 20 DKLTGEIVALKKIRLETEDE-GVPSTAIR-EISLLKELNHPNIVRLLDVVHSENKLYLVF 77
Query: 51 EY--MAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSH 102
E+ + +D + G LD +I+ Y ++L H + +LH DLK N+L+
Sbjct: 78 EFLDLDLKKYMDSSPLTG--LDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE 135
Query: 103 GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM-APEVLRNEGLDFAT--DIWSLG 159
G +KL D G AR ++ + LW APE+L ++T DIWS+G
Sbjct: 136 GALKLADFGLARAFGV-----PVRTYTHEV--VTLWYRAPEILLG-SRQYSTPVDIWSIG 187
Query: 160 CMVIEMATGRPPW-GD-------KISNAAATLLKIACSNE------------KPHFP--- 196
C+ EM RP + GD +I T +E KP FP
Sbjct: 188 CIFAEMVNRRPLFPGDSEIDQLFRIFRTLGT------PDEDVWPGVTSLPDYKPTFPKWA 241
Query: 197 TQFFKKV--------LDFLAKCLERKPEKRWSAEELLNHTF 229
Q KV LD L+K L P KR SA+ L H +
Sbjct: 242 RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-15
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 21 QALRNEAEIRQSLNSPNIGRNGE-----KTVNIFMEYMAGGSLLDVAEKFGGT-LDAGVI 74
A +NE ++ + L+ PNI E K + I MEY GG+L + +K + LD I
Sbjct: 44 LAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTI 103
Query: 75 RLYTKEIL------HGNGILHCDLKCNNVLLGSHGDV-KLPDLGCARRVNDLKNNGNLKQ 127
+ +IL H ILH DLK N+LL H V K+ D G ++ ++ K
Sbjct: 104 LHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS-------KS 156
Query: 128 SWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIA 187
++ GT +++PE+ + + +DIW+LGC++ E+A+ + + + +N A +LKI
Sbjct: 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAF--EAANLPALVLKIM 214
Query: 188 CSNEKP---HFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
P + + +L L P KR +++
Sbjct: 215 SGTFAPISDRYSPDLRQLILSM----LNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-15
Identities = 52/196 (26%), Positives = 79/196 (40%), Gaps = 42/196 (21%)
Query: 74 IRLYTKEILHG------NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNN----- 122
I+ Y ++L G N ILH D+K N+L+ + G +K+ D G AR + N
Sbjct: 117 IKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 123 GNLKQSWQSIGGTQLWMAPEVL---RNEGLDFATDIWSLGCMVIEMATGRP--------P 171
G + + ++ T+ + PE+L R A DIW +GC+ EM T RP
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTT--AVDIWGIGCVFAEMFTRRPILQGKSDID 234
Query: 172 WGDKISNAAATL---------------LKIACSNEKPHFPTQFFK---KVLDFLAKCLER 213
I T + +N +F K + LD L+K L
Sbjct: 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSL 294
Query: 214 KPEKRWSAEELLNHTF 229
P KR +A + L H +
Sbjct: 295 DPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-15
Identities = 54/182 (29%), Positives = 83/182 (45%), Gaps = 21/182 (11%)
Query: 2 NKGTGALFVVKSAESEAGVQ---ALRNEAEIRQSLNSPNIGR-------NGEKTVNIFME 51
N GTG + VK+ + E G Q + E I ++L NI + G K + + ME
Sbjct: 29 NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDV 105
Y+ GSL D K L+ + L+ ++I LH +H DL NVLL + V
Sbjct: 89 YVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLV 146
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
K+ D G A+ V + +++ S W A E L+ +A+D+WS G + E+
Sbjct: 147 KIGDFGLAKAVPEGHEYYRVREDGDS---PVFWYAVECLKENKFSYASDVWSFGVTLYEL 203
Query: 166 AT 167
T
Sbjct: 204 LT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 1e-15
Identities = 78/253 (30%), Positives = 106/253 (41%), Gaps = 58/253 (22%)
Query: 22 ALRNEAEIRQSLNSPNI---------GRNGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72
ALR E ++ Q L PNI N +N+ E+M L V + L
Sbjct: 49 ALR-EIKLLQELKHPNIIGLLDVFGHKSN----INLVFEFMET-DLEKVIKDKSIVLTPA 102
Query: 73 VIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLK 126
I+ Y E LH N ILH DLK NN+L+ S G +KL D G AR N K
Sbjct: 103 DIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS----PNRK 158
Query: 127 QSWQSIGGTQLWMAPEVL---RNEGLDFATDIWSLGCMVIEMATGRP--PWGD------- 174
+ Q + T+ + APE+L R+ G D+WS+GC+ E+ P P GD
Sbjct: 159 MTHQVV--TRWYRAPELLFGARHYG--VGVDMWSVGCIFAELLLRVPFLP-GDSDIDQLG 213
Query: 175 KISNAAAT--------LLKIACSNEKPHFPTQFFKKV--------LDFLAKCLERKPEKR 218
KI A T + + E FP K++ LD L + L P KR
Sbjct: 214 KIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKR 273
Query: 219 WSAEELLNHTFIS 231
+A + L H + S
Sbjct: 274 ITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-15
Identities = 73/289 (25%), Positives = 107/289 (37%), Gaps = 83/289 (28%)
Query: 2 NKGTGALFVVKS---AESEAGVQA--LRNEAEIRQ--SLNSPNIGR----------NGEK 44
+ TG +K SE G+ LR A ++Q S PNI R + E
Sbjct: 20 DLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79
Query: 45 TVNIFMEYMAG--GSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNN 96
+ + E++ + L K G L I+ +++ LH + I+H DLK N
Sbjct: 80 KLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQN 137
Query: 97 VLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQ----SIGGTQLWMAPEVLRNEGLDFA 152
+L+ S G VK+ D G AR S++ S+ T + APEVL
Sbjct: 138 ILVTSDGQVKIADFGLAR-----------IYSFEMALTSVVVTLWYRAPEVLLQSSYATP 186
Query: 153 TDIWSLGCMVIEMA---------------------TGRPP---WGDKISNAAATLLKIAC 188
D+WS+GC+ E+ G P W +S ++
Sbjct: 187 VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSF----- 241
Query: 189 SNEKPHFPTQFFKKV--------LDFLAKCLERKPEKRWSAEELLNHTF 229
P + + FK LD L K L P KR SA E L H +
Sbjct: 242 ----PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-15
Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 15 ESEAGVQALRNEAE-IRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLD----VAE 63
E + + + +E I++ L PNI R ++ + I M+ + G L + + E
Sbjct: 47 ERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDR-LYIVMDLIEGAPLGEHFNSLKE 105
Query: 64 KFGGTLDAGVIRLYTKEIL-----HGNG-ILHCDLKCNNVLLGSHGDVKLPDLGCARRVN 117
K + + ++ + +L H I+H DL NN++LG V + D G A++
Sbjct: 106 KKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ 165
Query: 118 DLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKIS 177
L S+ GT L+ PE+++NE D+W+ GC++ +M T +PP+ +
Sbjct: 166 P---ESKLT----SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS--T 216
Query: 178 NAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
N + KI + +P + + V D + CL E R
Sbjct: 217 NMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-15
Identities = 54/187 (28%), Positives = 86/187 (45%), Gaps = 24/187 (12%)
Query: 3 KGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNI-----GRNGEKTVNIFMEY 52
+ TG ++ K E + G NE +I + +NS + + + + +
Sbjct: 22 RATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81
Query: 53 MAGGSL-LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDV 105
M GG L + + G Y EI LH I++ DLK N+LL HG +
Sbjct: 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHI 141
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
++ DLG A V + Q+ + GT +MAPEV++NE F+ D W+LGC++ EM
Sbjct: 142 RISDLGLAVHVPE-------GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 194
Query: 166 ATGRPPW 172
G+ P+
Sbjct: 195 IAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-15
Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 29/185 (15%)
Query: 47 NIF--MEYMAGGSLL---DVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCN 95
N+F MEY+ GG L+ KF D Y EI LH GI++ DLK +
Sbjct: 70 NLFFVMEYLNGGDLMFHIQSCHKF----DLPRATFYAAEIICGLQFLHSKGIVYRDLKLD 125
Query: 96 NVLLGSHGDVKLPDLGCARR--VNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT 153
N+LL + G +K+ D G + + D K + GT ++APE+L + + +
Sbjct: 126 NILLDTDGHIKIADFGMCKENMLGDAKTC--------TFCGTPDYIAPEILLGQKYNTSV 177
Query: 154 DIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLER 213
D WS G ++ EM G+ P+ +++ + P +P ++ D L K R
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM----DNPCYPRWLTREAKDILVKLFVR 233
Query: 214 KPEKR 218
+PE+R
Sbjct: 234 EPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-15
Identities = 52/176 (29%), Positives = 74/176 (42%), Gaps = 34/176 (19%)
Query: 83 HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142
H LH D+KC+N+LL + G +KL D G AR L N+ + + LW P
Sbjct: 133 HKKNFLHRDIKCSNILLNNKGQIKLADFGLAR----LYNSEESRPYTNKV--ITLWYRPP 186
Query: 143 --VLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN---------- 190
+L E A D+WS GC++ E+ T +P + A L+ C +
Sbjct: 187 ELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVI 246
Query: 191 EKPHFPTQFFKK----------------VLDFLAKCLERKPEKRWSAEELLNHTFI 230
+ P+F T KK LD L L P KR +AEE LN ++
Sbjct: 247 KLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-15
Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 28/200 (14%)
Query: 48 IFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS 101
+ +EY+ GG L+ ++ L R Y EI LH GI++ DLK +NVLL +
Sbjct: 73 LVIEYVNGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDA 131
Query: 102 HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCM 161
G +KL D G K + + GT ++APE+LR E F+ D W+LG +
Sbjct: 132 DGHIKLTDYGMC------KEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVL 185
Query: 162 VIEMATGRPPWGDKIS-----NAAATLLKIACSNEKP-HFPTQFFKKVLDFLAKCLERKP 215
+ EM GR P+ D I+ N L ++ EKP P K L L + P
Sbjct: 186 MFEMMAGRSPF-DIITDNPDMNTEDYLFQVIL--EKPIRIPRFLSVKASHVLKGFLNKDP 242
Query: 216 EKRWSAE------ELLNHTF 229
++R + ++ +HTF
Sbjct: 243 KERLGCQPQTGFSDIKSHTF 262
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 8e-15
Identities = 85/280 (30%), Positives = 116/280 (41%), Gaps = 68/280 (24%)
Query: 2 NKGTGALFVVKSA--ESE-AGV--QALRNEAEIRQSLNSPNIGR-----NGEKTVNIFME 51
NK TG + +K ESE GV A+R E + + L PNI E + + E
Sbjct: 21 NKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHPNIVCLQDVLMQESRLYLIFE 79
Query: 52 Y--MAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHG 103
+ M LD K G +DA +++ Y +IL H +LH DLK N+L+ + G
Sbjct: 80 FLSMDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG 138
Query: 104 DVKLPDLGCAR------RVNDLKNNGNLKQSWQSIGGTQLWM-APEVLRNEGLDFAT--D 154
+KL D G AR RV + LW APEVL ++T D
Sbjct: 139 VIKLADFGLARAFGIPVRVYTHE-------------VVTLWYRAPEVLLG-SPRYSTPVD 184
Query: 155 IWSLGCMVIEMATGRPPW-GD-KISNAAATLLKIACSNE------------KPHFP---- 196
IWS+G + EMAT +P + GD +I + E K FP
Sbjct: 185 IWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKK 244
Query: 197 ---TQFFKKV----LDFLAKCLERKPEKRWSAEELLNHTF 229
K + LD L K L P KR SA++ LNH +
Sbjct: 245 GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 9e-15
Identities = 79/278 (28%), Positives = 111/278 (39%), Gaps = 63/278 (22%)
Query: 1 MNKGTG---ALFVVKSAESEAG--VQALRNEAEIRQSLNSPNI--------GRNGEKTVN 47
+K TG AL +K + + G + +LR E I L PNI G N +K +
Sbjct: 25 RDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTVKEVVVGSNLDK-IY 82
Query: 48 IFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGS 101
+ MEY+ L + E ++ ++L H N ILH DLK +N+LL +
Sbjct: 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN 141
Query: 102 HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM-APEVLRNEGL-DFATDIWSLG 159
G +K+ D G AR LK Q + LW APE+L A D+WS+G
Sbjct: 142 RGILKICDFGLAREYGS-----PLKPYTQLV--VTLWYRAPELLLGAKEYSTAIDMWSVG 194
Query: 160 CMVIEMATGRPPWGDKISNAAATLLKIAC----SNEK--------PHFPTQFFKKV---- 203
C+ E+ T +P + K + L KI EK P + F K
Sbjct: 195 CIFAELLTKKPLFPGK--SEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQ 252
Query: 204 --------------LDFLAKCLERKPEKRWSAEELLNH 227
D L + L P KR SAE+ L H
Sbjct: 253 LRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-14
Identities = 48/139 (34%), Positives = 70/139 (50%), Gaps = 19/139 (13%)
Query: 43 EKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNN 96
E + +EY+ GG L+ ++ L R Y+ EI LH GI++ DLK +N
Sbjct: 68 ESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDN 126
Query: 97 VLLGSHGDVKLPDLGCAR---RVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT 153
VLL S G +KL D G + R D + + GT ++APE+LR E F+
Sbjct: 127 VLLDSEGHIKLTDYGMCKEGLRPGD---------TTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 154 DIWSLGCMVIEMATGRPPW 172
D W+LG ++ EM GR P+
Sbjct: 178 DWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-14
Identities = 55/195 (28%), Positives = 84/195 (43%), Gaps = 24/195 (12%)
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
MEY+ GG L + R Y EI LH I++ DLK N++L G
Sbjct: 74 MEYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG 132
Query: 104 DVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMV 162
+K+ D G C + D + ++ GT ++APEVL + A D W LG ++
Sbjct: 133 HIKITDFGLCKEGITD-------AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 185
Query: 163 IEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW--- 219
EM GR P+ ++ L+ + E FP L+ L + P KR
Sbjct: 186 YEMMCGRLPFYNQDHEKLFELILM----EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGG 241
Query: 220 --SAEELLNHTFISG 232
A+E++ H+F +G
Sbjct: 242 PDDAKEIMRHSFFTG 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-14
Identities = 60/250 (24%), Positives = 104/250 (41%), Gaps = 31/250 (12%)
Query: 3 KGTGALFVVKSAESE------AGVQALRNEAEIRQSLNSPNI-----GRNGEKTVNIFME 51
+ TG ++ K E + AL NE +I + +NS + + + + +
Sbjct: 22 RATGKMYACKKLEKKRIKKRKGEAMAL-NEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80
Query: 52 YMAGGSL-LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGD 104
M GG L + D Y EI LH I++ DLK N+LL +G
Sbjct: 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH 140
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIE 164
+++ DLG A + ++ ++G +MAPEV++NE F+ D W LGC++ E
Sbjct: 141 IRISDLGLAVEI---PEGETIRGRVGTVG----YMAPEVVKNERYTFSPDWWGLGCLIYE 193
Query: 165 MATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW----- 219
M G+ P+ + ++ ++ + +F + + L + P R
Sbjct: 194 MIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGE 253
Query: 220 SAEELLNHTF 229
AEE+ H F
Sbjct: 254 GAEEVKAHPF 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-14
Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 33/179 (18%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCAR-RVNDLKNNGNLKQSWQSIGGTQLWMA 140
+H +LH DLK +N+LL ++ D+K+ D G AR + + G L + T+ + A
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE----YVATRWYRA 177
Query: 141 PEV-LRNEGLDFATDIWSLGCMVIEMATGRP--PWGDKISN--------AAATLLKIAC- 188
PE+ L ++G A DIWS+GC++ EM + RP P D + + + C
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237
Query: 189 SNEK--------PHFPTQFFKKV--------LDFLAKCLERKPEKRWSAEELLNHTFIS 231
+ + P P + K+ LD L K L P KR + EE L H ++
Sbjct: 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 60/231 (25%), Positives = 94/231 (40%), Gaps = 52/231 (22%)
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
M+Y+ GG ++ + + G + + R Y E+ +H G +H D+K +N+L+ G
Sbjct: 80 MDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG 138
Query: 104 DVKLPDLG-CA--RRVNDLK---NNGNLKQ-------SWQSIG----------------- 133
+KL D G C R +D K + +Q W I
Sbjct: 139 HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQR 198
Query: 134 -------GTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKI 186
GT ++APEVL G D WS+G ++ EM G+PP+ A T LK+
Sbjct: 199 CLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA--DTPAETQLKV 256
Query: 187 ACSNEKPHFPTQ--FFKKVLDFLAKCLERKPEKRW---SAEELLNHTFISG 232
H P+Q ++ D + + L E R A+E+ H F G
Sbjct: 257 INWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFFKG 306
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-14
Identities = 60/251 (23%), Positives = 101/251 (40%), Gaps = 40/251 (15%)
Query: 4 GTGALFVVKSAE----SEAGVQALR----------NEAEIRQSLNSPNIGR-----NGEK 44
G+G VV + + ++ +R EA++ L+ PN+ + ++
Sbjct: 13 GSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72
Query: 45 TVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVL 98
+ I EYMA G LL+ + G L + ++ L NG +H DL N L
Sbjct: 73 PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCL 132
Query: 99 LGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDI 155
+G VK+ D G AR V L + S GT+ W PEV +D+
Sbjct: 133 VGEDNVVKVSDFGLARYV--------LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 156 WSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERK 214
WS G ++ E+ + G+ P+ ++ + +P +V + C K
Sbjct: 185 WSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAP---TEVYTIMYSCWHEK 241
Query: 215 PEKRWSAEELL 225
PE R + ++LL
Sbjct: 242 PEDRPAFKKLL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-14
Identities = 39/130 (30%), Positives = 65/130 (50%), Gaps = 15/130 (11%)
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
MEY+ GG L+ ++ G + Y EI LH GI++ DLK +NV+L + G
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEP-HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG 138
Query: 104 DVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMV 162
+K+ D G C + K ++ GT ++APE++ + + D W+ G ++
Sbjct: 139 HIKIADFGMCKENIFGGKTT-------RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191
Query: 163 IEMATGRPPW 172
EM G+PP+
Sbjct: 192 YEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 3e-14
Identities = 60/224 (26%), Positives = 87/224 (38%), Gaps = 17/224 (7%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-NG---EKTVNIFMEYMAGGSLLDVA 62
A+ +KS + + EA I SL+ N+ R G + + E GSLLD
Sbjct: 27 AVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGSLLDRL 86
Query: 63 EKFG-GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115
K G + Y +I L +H DL N+LL S VK+ D G R
Sbjct: 87 RKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRA 146
Query: 116 VNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGD 174
L N + + + W APE LR A+D+W G + EM T G PW
Sbjct: 147 ---LPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPW-- 201
Query: 175 KISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
+ + L KI E+ P + + + + +C P R
Sbjct: 202 AGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADR 245
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-14
Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 10/149 (6%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
+H ILH DLK N+ L + +K+ D G +R L + +L ++ GT +M+P
Sbjct: 122 MHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRL---LMGSCDLATTFT---GTPYYMSP 174
Query: 142 EVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFK 201
E L+++G D +DIWSLGC++ EM + N + +L+I P P + +
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG--QNFLSVVLRIV-EGPTPSLPETYSR 231
Query: 202 KVLDFLAKCLERKPEKRWSAEELLNHTFI 230
++ + L + P R SA E+L + FI
Sbjct: 232 QLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-14
Identities = 68/271 (25%), Positives = 114/271 (42%), Gaps = 51/271 (18%)
Query: 2 NKGTG---ALFVVKSAESEAGV--QALRNEAEIRQSLNSPNIGR-----NGEKTVNIFME 51
N+ T AL V+ + + GV ALR E + + L NI R + +K + + E
Sbjct: 21 NRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDV 105
Y L + G +D +++ + ++L H + +LH DLK N+L+ +G++
Sbjct: 80 Y-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGEL 138
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL-DFATDIWSLGCMVIE 164
KL D G AR G + + + T + P+VL L + D+WS GC+ E
Sbjct: 139 KLADFGLAR------AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAE 192
Query: 165 MAT-GRPPW-GDKISNAAATLLKI-ACSNEK--------------PHFPT---------Q 198
+A GRP + G+ + + + ++ E+ P +P +
Sbjct: 193 LANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPK 252
Query: 199 FFKKVLDFLAKCLERKPEKRWSAEELLNHTF 229
D L L P +R SAEE L H +
Sbjct: 253 LNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 5e-14
Identities = 55/228 (24%), Positives = 85/228 (37%), Gaps = 38/228 (16%)
Query: 25 NEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLL---------DVAEKFGGTL 69
NEA + + N ++ R G+ T+ + ME MA G L G
Sbjct: 58 NEASVMKEFNCHHVVRLLGVVSTGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLGPP 116
Query: 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG 123
EI L +H DL N ++ VK+ D G R + +
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE----- 171
Query: 124 NLKQSWQSIGGTQL----WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISN 178
+ GG L WMAPE L++ +D+WS G ++ EMAT P+ SN
Sbjct: 172 ---TDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL-SN 227
Query: 179 AAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226
LK P K+L+ + C + P+ R + E+++
Sbjct: 228 EEV--LKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-14
Identities = 58/225 (25%), Positives = 88/225 (39%), Gaps = 45/225 (20%)
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHG 103
MEY+ GG ++ + K T R Y E + H G +H D+K +N+LL + G
Sbjct: 80 MEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG 138
Query: 104 DVKLPDLG------CARR-------VNDLKNN-----------GNLKQSWQ--------S 131
+KL D G + R + L +N ++W+ S
Sbjct: 139 HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYS 198
Query: 132 IGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE 191
GT ++APEV G + D WSLG ++ EM G PP+ N T KI E
Sbjct: 199 TVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD--NPQETYRKIINWKE 256
Query: 192 KPHFPTQ--FFKKVLDFLAK--CLERKPEKRWSAEELLNHTFISG 232
FP + + D + + C + E+ +H F G
Sbjct: 257 TLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKG 301
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 7e-14
Identities = 49/178 (27%), Positives = 76/178 (42%), Gaps = 38/178 (21%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDV-KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138
+ +H NGI H D+K N+L+ D+ KL D G R + K + T+ +
Sbjct: 114 DHMHRNGIFHRDIKPENILI--KDDILKLADFGSCRGIYS-------KPPYTEYISTRWY 164
Query: 139 MAPEVLRNEGL-DFATDIWSLGCMVIEMATGRP--PWG-------DKISN-----AAATL 183
APE L +G DIW++GC+ E+ + P P G KI + A L
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP-GTNELDQIAKIHDVLGTPDAEVL 223
Query: 184 LKIACSNEK-PHFPTQ-----------FFKKVLDFLAKCLERKPEKRWSAEELLNHTF 229
K S +FP++ + LD L K L P++R +A++ L H +
Sbjct: 224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-14
Identities = 52/194 (26%), Positives = 85/194 (43%), Gaps = 22/194 (11%)
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
MEY GG L + R Y EI LH +++ DLK N++L G
Sbjct: 74 MEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG 132
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163
+K+ D G + + + +K + GT ++APEVL + A D W LG ++
Sbjct: 133 HIKITDFGLCKE--GISDGATMK----TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186
Query: 164 EMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW---- 219
EM GR P+ ++ L+ + E+ FP + LA L++ P++R
Sbjct: 187 EMMCGRLPFYNQDHEKLFELILM----EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGP 242
Query: 220 -SAEELLNHTFISG 232
A+E++ H F +
Sbjct: 243 EDAKEIMEHRFFAS 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-14
Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 34/200 (17%)
Query: 50 MEYMAGGSLL-----------DVAEKFGGTLDAGVIRLYTKEILHGNGILHCDLKCNNVL 98
MEY GG L + A +G + + + E LH +++ D+K N++
Sbjct: 74 MEYANGGELFFHLSRERVFTEERARFYGAEIVSAL------EYLHSRDVVYRDIKLENLM 127
Query: 99 LGSHGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWS 157
L G +K+ D G C ++D + ++ GT ++APEVL + A D W
Sbjct: 128 LDKDGHIKITDFGLCKEGISD-------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 180
Query: 158 LGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEK 217
LG ++ EM GR P+ ++ L+ + E+ FP + LA L++ P++
Sbjct: 181 LGVVMYEMMCGRLPFYNQDHERLFELILM----EEIRFPRTLSPEAKSLLAGLLKKDPKQ 236
Query: 218 RW-----SAEELLNHTFISG 232
R A+E++ H F
Sbjct: 237 RLGGGPSDAKEVMEHRFFLS 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-13
Identities = 78/282 (27%), Positives = 117/282 (41%), Gaps = 62/282 (21%)
Query: 1 MNKGTGALFVVKSAESEA---GV--QALRNEAEIRQSLN-SPNIGR----------NGEK 44
+K TG L +K E G+ ALR E + Q L+ S I R NG+
Sbjct: 21 RDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESIYIVRLLDVEHVEEKNGKP 79
Query: 45 TVNIFMEYMAGG--SLLDVAEKFGGT-LDAGVIRLYTKEIL------HGNGILHCDLKCN 95
++ + EY+ +D + G L A I+ + ++L H +G++H DLK
Sbjct: 80 SLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQ 139
Query: 96 NVLLGSHGDV-KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM-APEVLRNEGLDFAT 153
N+L+ + K+ DLG R + +K I LW APEVL ++T
Sbjct: 140 NLLVDKQKGLLKIADLGLGRAFSI-----PVKSYTHEI--VTLWYRAPEVLLG-STHYST 191
Query: 154 --DIWSLGCMVIEMATGRPPW-GD-------KISNAAAT--------LLKIACSNEKPHF 195
DIWS+GC+ EM+ +P + GD I T + K+ +E P +
Sbjct: 192 PVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQW 251
Query: 196 PTQFFKKV--------LDFLAKCLERKPEKRWSAEELLNHTF 229
Q + LD L K L P KR SA+ L H +
Sbjct: 252 KPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-13
Identities = 63/253 (24%), Positives = 100/253 (39%), Gaps = 39/253 (15%)
Query: 5 TGALFVVKSAESEAG---VQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMA 54
TG VKS + E+G + L+ E EI ++L NI + +G + + ME++
Sbjct: 32 TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91
Query: 55 GGSLLDVAEKFGGTLDAGVIRLYTKEILHGNGIL------HCDLKCNNVLLGSHGDVKLP 108
GSL + + ++ Y +I G L H DL NVL+ S VK+
Sbjct: 92 SGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIG 151
Query: 109 DLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATG 168
D G + + K +K S W APE L A+D+WS G + E+ T
Sbjct: 152 DFGLTKAIETDKEYYTVKDDLDS---PVFWYAPECLIQSKFYIASDVWSFGVTLYELLT- 207
Query: 169 RPPWGDKISNAAATLLKIACSNEKPHFPTQFFK----------------KVLDFLAKCLE 212
+ D S+ LK+ T+ + +V + KC E
Sbjct: 208 ---YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWE 264
Query: 213 RKPEKRWSAEELL 225
+P KR + + L+
Sbjct: 265 FQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-13
Identities = 53/181 (29%), Positives = 78/181 (43%), Gaps = 24/181 (13%)
Query: 5 TGALFVVKSAE--SEAGVQALRNEAEIRQSLNSPNI----------GRNGEKTVNIFMEY 52
TG + VK + + ++ E EI +SL NI GR + V MEY
Sbjct: 32 TGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV---MEY 88
Query: 53 MAGGSLLDVAEKFGGTLDAGVIRLYTKEILHGNGIL------HCDLKCNNVLLGSHGDVK 106
+ GSL D +K LD + LY +I G L H DL N+L+ S VK
Sbjct: 89 LPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVK 148
Query: 107 LPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMA 166
+ D G + + K +++ +S W APE L A+D+WS G ++ E+
Sbjct: 149 IGDFGLTKVLPQDKEYYKVREPGES---PIFWYAPESLTESKFSVASDVWSFGVVLYELF 205
Query: 167 T 167
T
Sbjct: 206 T 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-13
Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 37/178 (20%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
+H GI+H DLK +N+ + ++K+ D G AR +D + G + W + AP
Sbjct: 134 IHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD-EMTGYVATRW--------YRAP 184
Query: 142 EVLRNEG-LDFATDIWSLGCMVIEMATGRP--PWGD------KISNAAAT-----LLKIA 187
E++ N + DIWS+GC++ E+ TG+ P D +I N T L KI+
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244
Query: 188 CSNEK------PHFPTQFFKKV--------LDFLAKCLERKPEKRWSAEELLNHTFIS 231
+ + P P + FK+V +D L K L P+KR +A E L H +++
Sbjct: 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-13
Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 37/178 (20%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
+H G++H DLK +N+L+ + D+K+ D G A R+ D + G + T+ + AP
Sbjct: 124 VHSAGVVHRDLKPSNILINENCDLKICDFGLA-RIQDPQMTGYVS--------TRYYRAP 174
Query: 142 EV-LRNEGLDFATDIWSLGCMVIEMATGRP--------------------PWGDKISNAA 180
E+ L + D DIWS GC+ EM G+P P D I+
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234
Query: 181 AT-LLKIACSNEK--PHFPTQFFKKV----LDFLAKCLERKPEKRWSAEELLNHTFIS 231
+ L+ S K P ++ FK +D L K L P+KR SA E L H +++
Sbjct: 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-13
Identities = 38/144 (26%), Positives = 68/144 (47%), Gaps = 7/144 (4%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139
E LH ++ DLK N+LL +G +++ DLG A ++ + +S + GT +M
Sbjct: 116 EDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE-------GESIRGRVGTVGYM 168
Query: 140 APEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQF 199
APEVL N+ + D W LGC++ EM G+ P+ + + + + +F
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKF 228
Query: 200 FKKVLDFLAKCLERKPEKRWSAEE 223
++ L + P++R +E
Sbjct: 229 SEEAKSICKMLLTKDPKQRLGCQE 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-13
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 23/206 (11%)
Query: 43 EKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNN 96
E + + M+Y GG LL + KF L + R Y E+ +H G +H D+K +N
Sbjct: 73 ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDN 132
Query: 97 VLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR--NEGLDF--- 151
VLL +G ++L D G R+ +G + QS ++ GT +++PE+L+ +G
Sbjct: 133 VLLDKNGHIRLADFGSCLRLLA---DGTV-QSNVAV-GTPDYISPEILQAMEDGKGRYGP 187
Query: 152 ATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQ---FFKKVLDFLA 208
D WSLG + EM G P+ + T KI E FP ++ D +
Sbjct: 188 ECDWWSLGVCMYEMLYGETPF--YAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIR 245
Query: 209 KCLERKPEK--RWSAEELLNHTFISG 232
+ + + R ++ +H F G
Sbjct: 246 RLICSPETRLGRNGLQDFKDHPFFEG 271
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-13
Identities = 51/168 (30%), Positives = 84/168 (50%), Gaps = 34/168 (20%)
Query: 26 EAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLL------DVAEKFGGTLDAGVI 74
E +I NSP + + +K + + MEYM GG L+ DV EK+
Sbjct: 93 ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA-------- 144
Query: 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQS 128
+ YT E+ +H G++H D+K +N+LL HG +KL D G ++++ G ++
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE---TGMVR-- 199
Query: 129 WQSIGGTQLWMAPEVLRNEGLD----FATDIWSLGCMVIEMATGRPPW 172
+ GT +++PEVL+++G D D WS+G + EM G P+
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-13
Identities = 55/196 (28%), Positives = 86/196 (43%), Gaps = 25/196 (12%)
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
ME++ GG L+ +K D R Y EI LH GI++ DLK +NVLL G
Sbjct: 75 MEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG 133
Query: 104 DVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMV 162
KL D G C + + K + GT ++APE+L+ + D W++G ++
Sbjct: 134 HCKLADFGMCKEGIFNGKTTS-------TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLL 186
Query: 163 IEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA- 221
EM G P+ + + L A N++ +PT + +D L + + P R +
Sbjct: 187 YEMLCGHAPFEAENEDD----LFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSL 242
Query: 222 -----EELLNHTFISG 232
E +L H F
Sbjct: 243 TLGGEEAILRHPFFKE 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-13
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 49/226 (21%)
Query: 43 EKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNN 96
+KT+ + EY+ L + GG L +RL+ ++L H +LH DLK N
Sbjct: 75 KKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQN 133
Query: 97 VLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM-APEVLRNEGLDFAT-- 153
+L+ G++KL D G AR K+ + S + + LW P+VL +++T
Sbjct: 134 LLISERGELKLADFGLARA----KSVPSKTYSNEVV---TLWYRPPDVLLGS-TEYSTSL 185
Query: 154 DIWSLGCMVIEMATGRPPWGDKISNAAATLLKI--------------ACSNEK------P 193
D+W +GC+ EMATGRP + ++ L KI SN + P
Sbjct: 186 DMWGVGCIFYEMATGRPLF-PGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFP 244
Query: 194 HFPTQFFKKV----------LDFLAKCLERKPEKRWSAEELLNHTF 229
+P + + K L+ +P+KR SA E + H +
Sbjct: 245 FYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-13
Identities = 37/139 (26%), Positives = 66/139 (47%), Gaps = 7/139 (5%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139
E L I++ DLK N+LL G +++ DLG A ++ + ++ + GT +M
Sbjct: 116 EDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE-------GETVRGRVGTVGYM 168
Query: 140 APEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQF 199
APEV+ NE F+ D W LGC++ EM G+ P+ + + ++ + +F
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKF 228
Query: 200 FKKVLDFLAKCLERKPEKR 218
+ L + P++R
Sbjct: 229 SEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 21/177 (11%)
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
MEY+ GG L+ ++ G + + Y EI LH GI++ DLK +NV+L S G
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEPQAV-FYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG 138
Query: 104 DVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMV 162
+K+ D G C + D + ++ GT ++APE++ + + D W+ G ++
Sbjct: 139 HIKIADFGMCKEHMVD-------GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLL 191
Query: 163 IEMATGRPPW-GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
EM G+PP+ G+ ++++ S +P K+ + + + P KR
Sbjct: 192 YEMLAGQPPFDGEDEDELFQSIMEHNVS-----YPKSLSKEAVSICKGLMTKHPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-12
Identities = 73/264 (27%), Positives = 112/264 (42%), Gaps = 55/264 (20%)
Query: 11 VKSAESEAGV--QALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAE 63
V S ++E GV A+R EA + + L NI + ++T+ EYM + +
Sbjct: 37 VISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQ 95
Query: 64 KFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVN 117
GG L +RL+ ++L HG ILH DLK N+L+ G++KL D G AR
Sbjct: 96 HPGG-LHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLAR--- 151
Query: 118 DLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT--DIWSLGCMVIEMATGRPPWGDK 175
Q++ S T + P+VL D+++ DIW GC+ IEM G+P +
Sbjct: 152 ---AKSIPSQTYSSEVVTLWYRPPDVLLG-ATDYSSALDIWGAGCIFIEMLQGQPAFPG- 206
Query: 176 ISNAAATLLKI----------------ACSNEKPHF----PTQFFKKVLDFLAKC----- 210
+S+ L KI N KP + Q + V L++
Sbjct: 207 VSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAED 266
Query: 211 -----LERKPEKRWSAEELLNHTF 229
L P+ R SA++ L H +
Sbjct: 267 LASQMLMMFPKDRISAQDALLHPY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-12
Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 21/171 (12%)
Query: 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQ 127
+R Y EI +H +++ DLK N+LL HG V++ DLG A + K + ++
Sbjct: 99 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 156
Query: 128 SWQSIGGTQLWMAPEVL-RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKI 186
GT +MAPEVL + D + D +SLGCM+ ++ G P+ + + ++
Sbjct: 157 ------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210
Query: 187 ACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR-----WSAEELLNHTFISG 232
+ P F ++ L L+R +R A+E+ H F
Sbjct: 211 TLT-MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-12
Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 32/207 (15%)
Query: 50 MEYMAGGSLLDVAE--KFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS 101
MEY+ GG D A K G L + R+Y E LH GI+H DLK +N+L+ S
Sbjct: 80 MEYVEGG---DCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS 136
Query: 102 HGDVKLPDLGCARRVNDLKNNGNLKQSW----------QSIGGTQLWMAPEVLRNEGLDF 151
G +KL D G + ++ + NL + + + GT ++APEV+ +G
Sbjct: 137 MGHIKLTDFGLS-KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGK 195
Query: 152 ATDIWSLGCMVIEMATGRPP-WGDKISNAAATLL--KIACSNEKPHFPTQFFKKVLDFLA 208
D W++G ++ E G P +GD ++ I P D ++
Sbjct: 196 PVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPAD----AQDLIS 251
Query: 209 KCLERKPEKRW---SAEELLNHTFISG 232
+ L + P +R A E+ H F G
Sbjct: 252 RLLRQNPLERLGTGGAFEVKQHRFFLG 278
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHGNGILHC-------DLKCNNVLLGSH 102
MEY GG L + R Y EI+ LH DLK N++L
Sbjct: 74 MEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD 132
Query: 103 GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMV 162
G +K+ D G + +K+ +K + GT ++APEVL + A D W LG ++
Sbjct: 133 GHIKITDFGLCKE--GIKDGATMK----TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 186
Query: 163 IEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW--- 219
EM GR P+ ++ L+ + E+ FP + L+ L++ P++R
Sbjct: 187 YEMMCGRLPFYNQDHEKLFELILM----EEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGG 242
Query: 220 --SAEELLNHTFISGNAKKNSTEE 241
A+E++ H F +G ++ E+
Sbjct: 243 PDDAKEIMQHKFFAGIVWQDVYEK 266
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-12
Identities = 50/178 (28%), Positives = 81/178 (45%), Gaps = 34/178 (19%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
+H +LH DLK +N+LL ++ D+K+ D G AR ++ G+ + T+ + AP
Sbjct: 124 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE---KGDFMTEYVV---TRWYRAP 177
Query: 142 EVLRN-EGLDFATDIWSLGCMVIEMATGRP--PWGDKI-----------SNAAATLLKIA 187
E+L N A D+WS+GC+ E+ +P P D + S + L I
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237
Query: 188 CSNEK------PHFPTQFFKKV--------LDFLAKCLERKPEKRWSAEELLNHTFIS 231
+ P+ P Q F ++ +D L K L P KR + EE L H +++
Sbjct: 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-12
Identities = 54/170 (31%), Positives = 73/170 (42%), Gaps = 26/170 (15%)
Query: 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLG-CARRVNDLKNNGNLKQ 127
R Y E+ LH I++ DLK N+LL S G V L D G C V ++
Sbjct: 99 RFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-------EE 151
Query: 128 SWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPP-WGDKISNAAATLLKI 186
+ + GT ++APEVLR E D D W LG ++ EM G PP + +S +L
Sbjct: 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL-- 209
Query: 187 ACSNEKP-HFPTQFFKKVLDFLAKCLERKPEKRWSAE----ELLNHTFIS 231
KP P D L L + +R A+ E+ NH F S
Sbjct: 210 ----HKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-12
Identities = 50/180 (27%), Positives = 77/180 (42%), Gaps = 34/180 (18%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCAR--RVNDLKNNGNLKQSWQSIGGTQLWM 139
+H +LH DLK N+L+ + ++K+ D G AR N +N G + + T+ +
Sbjct: 121 IHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV----ATRWYR 176
Query: 140 APEV-LRNEGLDFATDIWSLGCMVIEMATGRPPWGDK--------ISNAAAT-----LLK 185
APE+ L + A D+WS+GC++ E+ +P + K I T L +
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236
Query: 186 IACSN-----------EKPHFPTQFFK---KVLDFLAKCLERKPEKRWSAEELLNHTFIS 231
I K F + F LD L K L P KR S EE L H +++
Sbjct: 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-12
Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 26 EAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKE 80
EA++ L+ + + ++ + I EYM+ G LL+ + G + K+
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 81 I------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGG 134
+ L +H DL N L+ G VK+ D G +R V L + S G
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV--------LDDEYTSSVG 160
Query: 135 TQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSN 190
++ W PEVL +D+W+ G ++ E+ + G+ P+ ++ +N + T+ K++
Sbjct: 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPY-ERFNN-SETVEKVS-QG 217
Query: 191 EKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
+ + P +KV + C K E+R + ++LL
Sbjct: 218 LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-12
Identities = 50/181 (27%), Positives = 76/181 (41%), Gaps = 23/181 (12%)
Query: 6 GALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLL 59
G VK +++A QA EA + L N+ + + + I EYMA GSL+
Sbjct: 29 GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 88
Query: 60 DVAEKFGGTLDAGVIRLY-------TKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGC 112
D G ++ G L E L N +H DL NVL+ K+ D G
Sbjct: 89 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGL 148
Query: 113 ARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPP 171
+ + ++ G L W APE LR + +D+WS G ++ E+ + GR P
Sbjct: 149 TKEASSTQDTGKLPVK---------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
Query: 172 W 172
+
Sbjct: 200 Y 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-12
Identities = 39/105 (37%), Positives = 51/105 (48%), Gaps = 14/105 (13%)
Query: 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLG-CARRVNDLKNNGNLKQ 127
R Y EI LH I++ DLK N+LL S G V L D G C K +
Sbjct: 99 RFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLC-------KEGIEHSK 151
Query: 128 SWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPW 172
+ + GT ++APEVLR + D D W LG ++ EM G PP+
Sbjct: 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-12
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 23/206 (11%)
Query: 43 EKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNN 96
E + + M+Y GG LL + KF L + R Y E+ +H +H D+K +N
Sbjct: 73 ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDN 132
Query: 97 VLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR--NEGLDF--- 151
VLL +G ++L D G ++N +G ++ S GT +++PE+L+ +G+
Sbjct: 133 VLLDMNGHIRLADFGSCLKMNQ---DGTVQSSVAV--GTPDYISPEILQAMEDGMGKYGP 187
Query: 152 ATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP---TQFFKKVLDFLA 208
D WSLG + EM G P+ + T KI E+ FP T ++ D +
Sbjct: 188 ECDWWSLGVCMYEMLYGETPF--YAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQ 245
Query: 209 K--CLERKPEKRWSAEELLNHTFISG 232
+ C + + E+ H F G
Sbjct: 246 RLICSRERRLGQNGIEDFKKHAFFEG 271
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-12
Identities = 59/195 (30%), Positives = 85/195 (43%), Gaps = 31/195 (15%)
Query: 51 EYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGD 104
+YM+GG L +K G + Y E+ LH I++ DLK N+LL + G
Sbjct: 76 DYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH 134
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE-GLDFATDIWSLGCMVI 163
+ L D G ++ +L +N ++ + GT ++APEVL +E G D WSLG +V
Sbjct: 135 IALCDFGLSKA--NLTDN----KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVF 188
Query: 164 EMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVL-----DFLAKCLERKPEKR 218
EM G W + + + K FP K VL F+ L R P+ R
Sbjct: 189 EMCCG---WSPFYAEDTQQMYRNIAFG-KVRFP----KNVLSDEGRQFVKGLLNRNPQHR 240
Query: 219 WSA----EELLNHTF 229
A EL H F
Sbjct: 241 LGAHRDAVELKEHPF 255
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-12
Identities = 46/146 (31%), Positives = 73/146 (50%), Gaps = 29/146 (19%)
Query: 43 EKTVNIFMEYMAGGSLL------DVAEKFGGTLDAGVIRLYTKEI------LHGNGILHC 90
++ + + MEYM GG L+ DV EK+ R YT E+ +H G +H
Sbjct: 115 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWA--------RFYTAEVVLALDAIHSMGFIHR 166
Query: 91 DLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD 150
D+K +N+LL G +KL D G ++N G ++ + GT +++PEVL+++G D
Sbjct: 167 DVKPDNMLLDKSGHLKLADFGTCMKMN---KEGMVR--CDTAVGTPDYISPEVLKSQGGD 221
Query: 151 ----FATDIWSLGCMVIEMATGRPPW 172
D WS+G + EM G P+
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-12
Identities = 50/193 (25%), Positives = 80/193 (41%), Gaps = 21/193 (10%)
Query: 43 EKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNN 96
+K + I E+M G LL+ + G L ++ +++ G N +H DL N
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARN 130
Query: 97 VLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFAT 153
L+ S G VK+ D G R V L + S G + W PEV +
Sbjct: 131 CLVSSTGVVKVSDFGMTRYV--------LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 154 DIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLE 212
D+WS G ++ E+ T G+ P+ K + ++ +P + V + + C
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLAS---MTVYEVMYSCWH 239
Query: 213 RKPEKRWSAEELL 225
KPE R + ELL
Sbjct: 240 EKPEGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-12
Identities = 39/130 (30%), Positives = 66/130 (50%), Gaps = 15/130 (11%)
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
MEY+ GG L+ ++ G + + Y EI LH GI++ DLK +NV+L S G
Sbjct: 80 MEYVNGGDLMYQIQQVGRFKEPHAV-FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG 138
Query: 104 DVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMV 162
+K+ D G C + D + ++ GT ++APE++ + + D W+ G ++
Sbjct: 139 HIKIADFGMCKENMWD-------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191
Query: 163 IEMATGRPPW 172
EM G+ P+
Sbjct: 192 YEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-12
Identities = 49/178 (27%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLK 120
G +R Y EI +H +++ DLK N+LL HG V++ DLG A + K
Sbjct: 92 GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151
Query: 121 NNGNLKQSWQSIGGTQLWMAPEVL-RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNA 179
+ ++ GT +MAPEVL + D + D +SLGCM+ ++ G P+ +
Sbjct: 152 PHASV--------GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
Query: 180 AATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----SAEELLNHTFISG 232
+ ++ + P F ++ L L+R KR A+E+ H F G
Sbjct: 204 KHEIDRMTLT-VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 37/178 (20%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
+H GI+H DLK +NV + ++++ D G AR+ +D + G + W + AP
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD-EMTGYVATRW--------YRAP 184
Query: 142 EVLRN-EGLDFATDIWSLGCMVIEMATGRP--PWGD------KISNAAAT-----LLKIA 187
E++ N + DIWS+GC++ E+ G+ P D +I T L KI+
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244
Query: 188 CSNEK------PHFPTQFFKKV--------LDFLAKCLERKPEKRWSAEELLNHTFIS 231
+ + PH P Q KK+ +D L K L +KR SA E L H + S
Sbjct: 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS 302
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-11
Identities = 61/239 (25%), Positives = 93/239 (38%), Gaps = 60/239 (25%)
Query: 48 IFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGS 101
+ ME++ GG L+ + K+ T V R Y E + H G +H D+K +N+L+
Sbjct: 78 LIMEFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR 136
Query: 102 HGDVKLPDLGCA---------------RRVNDLKNNGNLKQS------------------ 128
G +KL D G + + KN + + S
Sbjct: 137 GGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIAT 196
Query: 129 WQ--------SIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAA 180
W+ S GT ++APE+ +G D WSLG ++ E G PP+ + N+
Sbjct: 197 WKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSE--NSH 254
Query: 181 ATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERK----PEK---RWSAEELLNHTFISG 232
T KI E +FP L A+ L R+ E R A E+ +H F G
Sbjct: 255 ETYRKIINWRETLYFPDDIH---LSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRG 310
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-11
Identities = 49/174 (28%), Positives = 70/174 (40%), Gaps = 30/174 (17%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139
+ LH N I+H DLK N+L+ S G VKL D G AR + + + + T +
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY-------SCQMALTPVVVTLWYR 174
Query: 140 APEVLRNEGLDFATDIWSLGCMVIEMATGRPPW-GDKISNAAATLLK-IACSNEK----- 192
APEVL D+WS+GC+ EM +P + G+ ++ + I E
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234
Query: 193 ---PH--FPTQFFKKVLDF-----------LAKCLERKPEKRWSAEELLNHTFI 230
P F + + V L + L P KR SA L H F
Sbjct: 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-11
Identities = 55/224 (24%), Positives = 86/224 (38%), Gaps = 32/224 (14%)
Query: 26 EAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTK- 79
EA + + + PN+ + E I E+M G+LLD + V+ LY
Sbjct: 52 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111
Query: 80 ------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIG 133
E L +H DL N L+G + VK+ D G +R + ++ +
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--------DTYTAHA 163
Query: 134 GTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPW-GDKISNAAATLLKIAC 188
G + W APE L +D+W+ G ++ E+AT G P+ G +S L K
Sbjct: 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR 223
Query: 189 SNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL---LNHTF 229
P KV + + C + P R S E+ F
Sbjct: 224 MERPEGCPP----KVYELMRACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-11
Identities = 77/287 (26%), Positives = 107/287 (37%), Gaps = 69/287 (24%)
Query: 2 NKGTGALFVVKSA----ESEA-GVQALRNEAEIRQSLNSPNI------------GRNGEK 44
+K T + +K E E + ALR E +I Q L N+ N K
Sbjct: 33 HKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIEICRTKATPYNRYK 91
Query: 45 T----VNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKC 94
V F E+ G L + KF I+ K +L H N ILH D+K
Sbjct: 92 GSFYLVFEFCEHDLAGLLSNKNVKF----TLSEIKKVMKMLLNGLYYIHRNKILHRDMKA 147
Query: 95 NNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM-APEVL---RNEGLD 150
N+L+ G +KL D G AR + KN+ + + + + LW PE+L R+ G
Sbjct: 148 ANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV---TLWYRPPELLLGERDYGP- 203
Query: 151 FATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPH---------------F 195
D+W GC++ EM T P TL+ C + P
Sbjct: 204 -PIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMEL 262
Query: 196 PTQFFKKV-------------LDFLAKCLERKPEKRWSAEELLNHTF 229
P +KV LD + K L P KR A+ LNH F
Sbjct: 263 PQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-11
Identities = 56/192 (29%), Positives = 85/192 (44%), Gaps = 21/192 (10%)
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
++Y+ GG L ++ L+ R Y EI LH I++ DLK N+LL S G
Sbjct: 75 LDYINGGELFYHLQRERCFLEPRA-RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG 133
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163
+ L D G + ++++NG + + GT ++APEVL + D D W LG ++
Sbjct: 134 HIVLTDFGLCKE--NIEHNG----TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLY 187
Query: 164 EMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE- 222
EM G PP+ + N A I N+ L L++ KR A+
Sbjct: 188 EMLYGLPPFYSR--NTAEMYDNIL--NKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKD 243
Query: 223 ---ELLNHTFIS 231
E+ NH F S
Sbjct: 244 DFMEIKNHIFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-11
Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 46/231 (19%)
Query: 43 EKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNN 96
++ + + ME++ GG ++ + K TL + Y E +H G +H D+K +N
Sbjct: 73 KRNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDN 131
Query: 97 VLLGSHGDVKLPDLG-C-----ARRVNDLKN------------NGNLK---QSWQ----- 130
+LL + G VKL D G C A R +N N N K ++W+
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 131 ---SIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIA 187
S GT ++APEV G + D WSLG ++ EM G PP+ + T K+
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ--ETYRKVM 249
Query: 188 CSNEKPHFPTQ--FFKKVLDFLAK-CLERKPEKRW---SAEELLNHTFISG 232
E FP + +K D + + C + E R EE+ +H F G
Sbjct: 250 NWKETLVFPPEVPISEKAKDLILRFCTD--SENRIGSNGVEEIKSHPFFEG 298
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-11
Identities = 65/226 (28%), Positives = 95/226 (42%), Gaps = 46/226 (20%)
Query: 48 IFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS 101
+ ME++ GG ++ + K TL + Y E +H G +H D+K +N+LL S
Sbjct: 78 LIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS 136
Query: 102 HGDVKLPDLGC------ARRVNDLKN------------NGNLK---QSWQ--------SI 132
G VKL D G A R +N N N K ++W+ S
Sbjct: 137 KGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFST 196
Query: 133 GGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK 192
GT ++APEV G + D WSLG ++ EM G PP+ + T K+ E
Sbjct: 197 VGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ--ETYKKVMNWKET 254
Query: 193 PHFPTQ--FFKKVLDFLAK-CLERKPEKRWSA---EELLNHTFISG 232
FP + +K D + + C E E R A EE+ + F G
Sbjct: 255 LIFPPEVPISEKAKDLILRFCCEW--EHRIGAPGVEEIKTNPFFEG 298
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-11
Identities = 71/292 (24%), Positives = 118/292 (40%), Gaps = 72/292 (24%)
Query: 5 TGALFVVKSAE----SEAGVQALRNEAEIRQSLNSPNIGRNGEK--------TVNIFMEY 52
TG L V+ + +E ++AL+NE + PNI + ++ FM Y
Sbjct: 24 TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83
Query: 53 MAGGSLLD------VAEKFGGTLDAGVIRLYTKEILHGNGILHCDLKCNNVLLGSHGDVK 106
+ SLL ++E G + G +R LH NG +H ++K +++L+ G V
Sbjct: 84 GSANSLLKTYFPEGMSEALIGNILFGALR--GLNYLHQNGYIHRNIKASHILISGDGLVS 141
Query: 107 LPDLGCARRVNDLKNNGNLKQSW----QSIGGTQLWMAPEVLRNE--GLDFATDIWSLGC 160
L L + L NG + Q W++PE+LR + G + +DI+S+G
Sbjct: 142 LSGLS---HLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI 198
Query: 161 MVIEMATGRPPWGD-----------------------------KISNA------------ 179
E+ATGR P+ D ++ N+
Sbjct: 199 TACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESV 258
Query: 180 AATLLKIACSNEKPHFPTQ--FFKKVLDFLAKCLERKPEKRWSAEELLNHTF 229
A + ++E+ P+ F + + CL++ PEKR SA LL+H F
Sbjct: 259 VAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-11
Identities = 49/178 (27%), Positives = 74/178 (41%), Gaps = 37/178 (20%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
+H I+H DLK +N+ + ++K+ D G AR +D + G + W + AP
Sbjct: 136 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-EMTGYVATRW--------YRAP 186
Query: 142 EVLRN-EGLDFATDIWSLGCMVIEMATGRP--PWGDKISN----------AAATLLKIAC 188
E++ N + DIWS+GC++ E+ TGR P D I A LLK
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246
Query: 189 SNEK-------PHFPTQFFKKV--------LDFLAKCLERKPEKRWSAEELLNHTFIS 231
S P F V +D L K L +KR +A + L H + +
Sbjct: 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 304
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-11
Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 29/216 (13%)
Query: 20 VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLD-VAEKFGGTLDAGV 73
VQA EA + ++L + R E+ + I EYMA GSLLD + GG +
Sbjct: 45 VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPK 104
Query: 74 IRLYTKEILHG------NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQ 127
+ ++ +I G +H DL+ NVL+ K+ D G AR + D
Sbjct: 105 LIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED--------N 156
Query: 128 SWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATL 183
+ + G + W APE + +D+WS G ++ E+ T G+ P+ ++ +
Sbjct: 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA 216
Query: 184 LKIACSNEKP-HFPTQFFKKVLDFLAKCLERKPEKR 218
L+ + + P + + D + C + K E+R
Sbjct: 217 LQRGYRMPRMENCPDELY----DIMKTCWKEKAEER 248
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-11
Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 44/196 (22%)
Query: 74 IRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQ 127
++++ +IL H GILH D+K N+L+ S+ +K+ D G A RV + + ++ Q
Sbjct: 105 VKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA-RVEEPDESKHMTQ 163
Query: 128 SWQSIGGTQLWMAPEVL---RNEGLDFATDIWSLGCMVIEMATGRPPWG--------DKI 176
TQ + APE+L R+ A DIWS+GC+ E+ R + D I
Sbjct: 164 EVV----TQYYRAPEILMGSRHYTS--AVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217
Query: 177 SNAAAT----LLKIACSNEK------PHFP----------TQFFKKVLDFLAKCLERKPE 216
++ T ++ AC + PH P +Q + + L + L P+
Sbjct: 218 TDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPD 277
Query: 217 KRWSAEELLNHTFISG 232
KR SA + L H ++
Sbjct: 278 KRISAADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-11
Identities = 50/186 (26%), Positives = 73/186 (39%), Gaps = 38/186 (20%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
+H + H DLK N+L + +K+ D G AR N+ W T+ + AP
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAF---NDTPTAIFWTDYVATRWYRAP 175
Query: 142 EVLRNEGLDF-----ATDIWSLGCMVIEMATGRP--------------------PWGDKI 176
E+ G F A DIWS+GC+ E+ TG+P P + I
Sbjct: 176 ELC---GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232
Query: 177 SNAAATLLKIACSNEKPHFPTQFFKK-------VLDFLAKCLERKPEKRWSAEELLNHTF 229
S + S+ + P F +K L L + L P+ R +AEE L +
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292
Query: 230 ISGNAK 235
G AK
Sbjct: 293 FKGLAK 298
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 5e-11
Identities = 54/206 (26%), Positives = 74/206 (35%), Gaps = 72/206 (34%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGD----VKLPDLGCARRVND-----LKNNGNLKQSWQSI 132
LH N +LH DLK N+L+ G VK+ DLG AR N + + W
Sbjct: 124 LHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW--- 180
Query: 133 GGTQLWMAPEVL-------RNEGLDFATDIWSLGCMVIEMATGRPPW-GD----KISNA- 179
+ APE+L + A DIW++GC+ E+ T P + G K SN
Sbjct: 181 -----YRAPELLLGARHYTK------AIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF 229
Query: 180 -AATLLKI-------------------ACSNEKPHFPTQFF----------------KKV 203
L +I F T+ + +
Sbjct: 230 QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQG 289
Query: 204 LDFLAKCLERKPEKRWSAEELLNHTF 229
D L K LE P KR +AEE L H +
Sbjct: 290 FDLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-11
Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 42/221 (19%)
Query: 43 EKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNN 96
EK++ + EY+ L + G +++ ++L+ ++L H +LH DLK N
Sbjct: 76 EKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQN 134
Query: 97 VLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT--D 154
+L+ G++KL D G AR ++ S LW P + D++T D
Sbjct: 135 LLINERGELKLADFGLARA-------KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQID 187
Query: 155 IWSLGCMVIEMATGRPPW-GDKISNAAATLLKI-----------ACSNEK---PHFPTQF 199
+W +GC+ EM+TGRP + G + + +I SNE+ ++P
Sbjct: 188 MWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYR 247
Query: 200 FKKVL-----------DFLAKCLERKPEKRWSAEELLNHTF 229
+ + L+K L+ + KR SAEE + H +
Sbjct: 248 ADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-11
Identities = 59/225 (26%), Positives = 90/225 (40%), Gaps = 48/225 (21%)
Query: 45 TVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVL 98
+V I EYM L +V E+ G L RL+ ++L H +LH DLK NV
Sbjct: 90 SVYIVQEYMET-DLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVF 146
Query: 99 LGSHGDV-KLPDLGCARRVN-DLKNNGNLKQSWQSIGGTQLWMAPE-VLRNEGLDFATDI 155
+ + V K+ D G AR V+ + G L + T+ + +P +L A D+
Sbjct: 147 INTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV----TKWYRSPRLLLSPNNYTKAIDM 202
Query: 156 WSLGCMVIEMATGRPPWG---------------------DKISNAAATLLKIACSNEKPH 194
W+ GC+ EM TG+P + D+ + +P
Sbjct: 203 WAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPR 262
Query: 195 FPTQFFKKVL--------DFLAKCLERKPEKRWSAEELLNHTFIS 231
P + +L DFL + L P R +AEE L H ++S
Sbjct: 263 RP---LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-10
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 28/220 (12%)
Query: 21 QALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAE-KFGGTLDAGVIR 75
+A EA++ + L + + E+ + I EYM+ GSLLD + + G L +
Sbjct: 46 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV 105
Query: 76 LYTKEILHGNGIL------HCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSW 129
+I G + H DL+ N+L+G + K+ D G AR + D N +
Sbjct: 106 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-----NEYTAR 160
Query: 130 QSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLL---- 184
Q W APE +D+WS G ++ E+ T GR P+ ++ +
Sbjct: 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY 220
Query: 185 KIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
++ C E P + + D + +C ++PE+R + E L
Sbjct: 221 RMPCPPECP-------ESLHDLMCQCWRKEPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 47/188 (25%), Positives = 74/188 (39%), Gaps = 45/188 (23%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
LH GI+H DLK +N+++ S +K+ D G AR N + + T+ + AP
Sbjct: 139 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT-----NFMMTPYVV--TRYYRAP 191
Query: 142 EVLRNEGLDFATDIWSLGCMVIEMATGR---------PPWGDKISNAAATLLKIACS--- 189
EV+ G DIWS+GC++ E+ G W I +
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251
Query: 190 ------NEKPHFPTQFFKKVL--------------------DFLAKCLERKPEKRWSAEE 223
+P +P F+++ D L+K L P+KR S +E
Sbjct: 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311
Query: 224 LLNHTFIS 231
L H +I+
Sbjct: 312 ALRHPYIT 319
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 37/104 (35%), Positives = 49/104 (47%), Gaps = 12/104 (11%)
Query: 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQS 128
R Y EI LH I++ DLK N+LL S G V L D G K +
Sbjct: 99 RFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLC------KEGIAQSDT 152
Query: 129 WQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPW 172
+ GT ++APEV+R + D D W LG ++ EM G PP+
Sbjct: 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 70/253 (27%), Positives = 104/253 (41%), Gaps = 54/253 (21%)
Query: 20 VQALRNEAEIRQSLNSPNIGRNGEKTV-----NIF--MEYMAG--GSLLD-VAEKFGGTL 69
+ +LR E + +L PNI E V +IF MEY SLLD + F +
Sbjct: 51 ISSLR-EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQ 109
Query: 70 DAGVIR--LYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQ 127
++ L + LH N I+H DLK +N+LL G +K+ D G AR K
Sbjct: 110 VKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169
Query: 128 SWQSIGGTQLWM-APEVLRN-EGLDFATDIWSLGCMVIEMATGRP--------------- 170
LW APE+L A D+W++GC++ E+ +P
Sbjct: 170 -------VTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII 222
Query: 171 -----------PWGDKISNAAA-TLLKIACSNEKPHFP--TQFFKKVLDFLAKCLERKPE 216
P + TL K +N K FP ++ ++L+FL L P+
Sbjct: 223 QLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFL---LMYDPK 279
Query: 217 KRWSAEELLNHTF 229
KR +AEE L ++
Sbjct: 280 KRATAEEALESSY 292
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 41/182 (22%), Positives = 76/182 (41%), Gaps = 36/182 (19%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM-A 140
+H ++H DLK +N+L+ ++++ D G AR L ++ + + + W A
Sbjct: 123 IHSANVIHRDLKPSNLLVNEDCELRIGDFGMAR---GLSSSPTEHKYFMTEYVATRWYRA 179
Query: 141 PEVLRN-EGLDFATDIWSLGCMVIEM---------------------ATGRPPWGDKISN 178
PE+L + A D+WS+GC+ EM G P + ++
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS-EEVLNR 238
Query: 179 AAATLLKIACSNEKPH-----FPTQFFKK---VLDFLAKCLERKPEKRWSAEELLNHTFI 230
+ ++ P + F K LD L++ L+ PE+R + E+ L H F+
Sbjct: 239 IGSDRVR-KYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297
Query: 231 SG 232
+
Sbjct: 298 AQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-10
Identities = 49/178 (27%), Positives = 77/178 (43%), Gaps = 37/178 (20%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
+H GI+H DLK N+ + ++K+ D G AR+ D + G + W + AP
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT-DSEMTGYVVTRW--------YRAP 184
Query: 142 EVLRNEGLDFAT-DIWSLGCMVIEMATGRPPW-GDKISNAAATLLKIACSNEK------- 192
EV+ N T DIWS+GC++ EM TG+P + G + ++K+ + K
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244
Query: 193 -----------PHFPTQFFKKVL--------DFLAKCLERKPEKRWSAEELLNHTFIS 231
P F + F+ +L + L K L E R +A E L H +
Sbjct: 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 3e-10
Identities = 66/267 (24%), Positives = 104/267 (38%), Gaps = 50/267 (18%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDV 61
AL V++ E E EA + + L NI + ++T+ + EY+ L
Sbjct: 34 ALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQY 92
Query: 62 AEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115
+K G L ++L+ ++L H ILH DLK N+L+ G++KL D G AR
Sbjct: 93 MDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA 152
Query: 116 VNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT--DIWSLGCMVIEMATGR---P 170
++ S LW P + +++T D+W +GC+ +EM G P
Sbjct: 153 -------KSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFP 205
Query: 171 PWGDKISNAAATLLKIACSNEK--------PHFPTQFF------------------KKVL 204
D L + NE PHF + F
Sbjct: 206 GMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAE 265
Query: 205 DFLAKCLERKPEKRWSAEELLNHTFIS 231
D +K L+ P+ R SA+ L+H + S
Sbjct: 266 DLASKLLQCFPKNRLSAQAALSHEYFS 292
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-10
Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 7/91 (7%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139
+ LH + ++H DLK N+L+ S G +KL D G AR + + + S+ T +
Sbjct: 124 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-------SFQMALTSVVVTLWYR 176
Query: 140 APEVLRNEGLDFATDIWSLGCMVIEMATGRP 170
APEVL D+WS+GC+ EM +P
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-10
Identities = 67/277 (24%), Positives = 100/277 (36%), Gaps = 77/277 (27%)
Query: 20 VQALRNEAEIRQSLNSPNI--------GRNGEKTVNIFMEY-----------MAGGSLLD 60
V L+ E + + N PNI N V FM Y M G S L
Sbjct: 43 VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELA 102
Query: 61 VAEKFGGTLDAGVIRLYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLK 120
+A G L A + +H G +H +K +++L+ G V L L R +
Sbjct: 103 IAYILQGVLKA-------LDYIHHMGYVHRSVKASHILISVDGKVYLSGL---RSNLSMI 152
Query: 121 NNGNLKQSWQSIGGTQL----WMAPEVLRN--EGLDFATDIWSLGCMVIEMATGRPPWGD 174
N+G + + W++PEVL+ +G D +DI+S+G E+A G P+ D
Sbjct: 153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212
Query: 175 ---------KISNAAATLLK-------------------------IACSNEKPHFPTQ-- 198
K++ LL S +P
Sbjct: 213 MPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSS 272
Query: 199 ------FFKKVLDFLAKCLERKPEKRWSAEELLNHTF 229
F F+ +CL+R P+ R SA LLNH+F
Sbjct: 273 HPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-10
Identities = 52/154 (33%), Positives = 67/154 (43%), Gaps = 19/154 (12%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139
+ LH N I+H D+K N+ + GDV L D G A D+ N N W GT
Sbjct: 196 QYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI--NANKYYGW---AGTIATN 250
Query: 140 APEVLRNEGLDFATDIWSLGCMVIEMATGRPPW-------GDKISNAAATLLKIACS--- 189
APE+L + A DIWS G ++ EMAT GD S+ L+ I S
Sbjct: 251 APELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLI-IRRSGTH 309
Query: 190 -NEKPHFPTQFFKKVLDFLAKCLERKPEKR--WS 220
NE P ++ LAK RKP R W+
Sbjct: 310 PNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWT 343
|
Length = 391 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 6e-10
Identities = 48/167 (28%), Positives = 77/167 (46%), Gaps = 18/167 (10%)
Query: 43 EKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNN 96
E + + M+Y GG LL + KF L + R Y E+ +H +H D+K +N
Sbjct: 73 ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDN 132
Query: 97 VLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR--NEG---LDF 151
+L+ +G ++L D G + L +G ++ S GT +++PE+L+ +G
Sbjct: 133 ILMDMNGHIRLADFGSCLK---LMEDGTVQSSVAV--GTPDYISPEILQAMEDGKGKYGP 187
Query: 152 ATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQ 198
D WSLG + EM G P+ + T KI E+ FP Q
Sbjct: 188 ECDWWSLGVCMYEMLYGETPF--YAESLVETYGKIMNHKERFQFPAQ 232
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-10
Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 15/146 (10%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL-- 137
E L +H DL NVLL VK+ D G AR D+ ++ N + S G T L
Sbjct: 251 EFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR---DIMHDSN----YVSKGSTFLPV 303
Query: 138 -WMAPEVLRNEGLDFATDIWSLGCMVIEMAT--GRPPWGDKISNAAATLLKIACSNEKPH 194
WMAPE + + +D+WS G ++ E+ + G P G + + +K KP
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPD 363
Query: 195 FPTQFFKKVLDFLAKCLERKPEKRWS 220
TQ +V D + KC +PEKR S
Sbjct: 364 HATQ---EVYDIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-10
Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 22/233 (9%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVA 62
A+ V++ S + + +EA + S++ P++ R V + + M G LLD
Sbjct: 40 AIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYV 99
Query: 63 EKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLLGSHGDVKLPDLGCARRV 116
+ + + + +I G ++H DL NVL+ + VK+ D G A+ +
Sbjct: 100 RNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159
Query: 117 NDLKNNGNLKQSWQSIGGTQ--LWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWG 173
D+ + + GG WMA E + + +D+WS G V E+ T G P+
Sbjct: 160 -DVDEK-----EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
Query: 174 DKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226
+ LL+ +P T V L KC E R + +EL+N
Sbjct: 214 GIPAVEIPDLLEKGERLPQPPICTI---DVYMVLVKCWMIDAESRPTFKELIN 263
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 8e-10
Identities = 47/146 (32%), Positives = 68/146 (46%), Gaps = 18/146 (12%)
Query: 78 TKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVN---------DLKNNGNLKQS 128
T E +H G+LH DLK +N+LLG G+V + D G A D+ S
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 129 WQSIG---GTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPW----GDKIS--NA 179
G GT +MAPE L +TDI++LG ++ +M T P+ G KIS +
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDV 244
Query: 180 AATLLKIACSNEKPHFPTQFFKKVLD 205
+ +++A E P F +Q K L
Sbjct: 245 ILSPIEVAPYREIPPFLSQIAMKALA 270
|
Length = 932 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-10
Identities = 51/176 (28%), Positives = 77/176 (43%), Gaps = 37/176 (21%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
+H GI+H DLK N+ + ++K+ D G AR D + G + W + AP
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA-DAEMTGYVVTRW--------YRAP 183
Query: 142 EVLRN-EGLDFATDIWSLGCMVIEMATGR-----------------------PPWGDKI- 176
EV+ N + DIWS+GC++ EM TG+ P + K+
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243
Query: 177 SNAAATLLKIACSNEKPHFPTQFFK---KVLDFLAKCLERKPEKRWSAEELLNHTF 229
AA + +K + F T F K + +D L K LE +KR +A E L H +
Sbjct: 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-10
Identities = 59/230 (25%), Positives = 87/230 (37%), Gaps = 55/230 (23%)
Query: 46 VNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL---YTK----------EILHGNGILHCDL 92
+N+ M+ MA D+ + IRL K +LH +H DL
Sbjct: 95 INLVMDIMAS----DLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKWYFMHRDL 145
Query: 93 KCNNVLLGSHGDVKLPDLGCARR-VNDLKNNGNLKQSWQSIGG------TQLWM-APEVL 144
N+ + S G K+ D G ARR ++ K LW APE+L
Sbjct: 146 SPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELL 205
Query: 145 RN-EGLDFATDIWSLGCMVIEMATGRP--PWGDKI-------------SNAA---ATLLK 185
E FA D+WS+GC+ E+ TG+P P ++I + A L
Sbjct: 206 MGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLP 265
Query: 186 IAC--SNEKPHFPTQFFK----KVLDFLAKCLERKPEKRWSAEELLNHTF 229
+ + KP F +D L L+ P +R SA+E L H +
Sbjct: 266 LYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315
|
Length = 335 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 9e-10
Identities = 56/230 (24%), Positives = 92/230 (40%), Gaps = 20/230 (8%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDV 61
A+ +K AG + EA + L+ P I R GE + + ME G LL
Sbjct: 27 AVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLM-LVMELAPLGPLLKY 85
Query: 62 AEKFGGTLDAGVIRLYTK-----EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRV 116
+K + + L + L +H DL NVLL + K+ D G +R +
Sbjct: 86 LKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145
Query: 117 NDLKNNGNLKQSWQSIGGTQL-WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGD 174
G+ + G L W APE + +D+WS G + E + G P+G+
Sbjct: 146 ----GAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201
Query: 175 KISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
+L+ S E+ P + +++ + C + +PE R + EL
Sbjct: 202 MKGAEVIAMLE---SGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 59/232 (25%), Positives = 92/232 (39%), Gaps = 56/232 (24%)
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
M+Y+ GG ++ + + G + R Y E+ +H G +H D+K +N+L+ G
Sbjct: 80 MDYIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG 138
Query: 104 DVKLPDLG-CA--RRVNDLK----------NNGNLKQSW--------------------- 129
+KL D G C R +D K ++ + W
Sbjct: 139 HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAAR 198
Query: 130 -------QSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAAT 182
S+ GT ++APEVL G D WS+G ++ EM G+PP+ T
Sbjct: 199 QHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF--LAQTPLET 256
Query: 183 LLKIACSNEKPHFPTQ--FFKKVLDFLAKCLERKPEKRW---SAEELLNHTF 229
+K+ H P Q + D + K L R PE R A+E+ H F
Sbjct: 257 QMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADEIKAHPF 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 54/233 (23%), Positives = 89/233 (38%), Gaps = 54/233 (23%)
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
M+Y+ GG ++ + + + R Y E+ +H G +H D+K +N+L+ G
Sbjct: 80 MDYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG 138
Query: 104 DVKLPDLG--------------------------------------CARRVNDLKNNGNL 125
+KL D G C R+ L+
Sbjct: 139 HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATK 198
Query: 126 KQS---WQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAAT 182
+ S+ GT ++APEVL +G D WS+G ++ EM G+PP+ T
Sbjct: 199 QHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF--LAPTPTET 256
Query: 183 LLKIACSNEKPHFPTQ--FFKKVLDFLAK--CLERKPEKRWSAEELLNHTFIS 231
LK+ H P Q + +D + K C + R A+++ H F S
Sbjct: 257 QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFS 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-09
Identities = 59/242 (24%), Positives = 94/242 (38%), Gaps = 47/242 (19%)
Query: 16 SEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFG--- 66
SE+ Q + EAE+ L +I R G + +F EYM G L G
Sbjct: 47 SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF-EYMRHGDLNRFLRSHGPDA 105
Query: 67 ----GTLDAGVIRLYTKEILH-------------GNGILHCDLKCNNVLLGSHGDVKLPD 109
G D +L ++L +H DL N L+G VK+ D
Sbjct: 106 KILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGD 165
Query: 110 LGCARRVNDLKNNGNLKQSWQSIGGTQL----WMAPEVLRNEGLDFATDIWSLGCMVIEM 165
G +R + + +GG + WM PE + +DIWS G ++ E+
Sbjct: 166 FGMSRDI--------YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217
Query: 166 AT-GRPPWGDKISNAAATLLKIACSNEKPHF--PTQFFKKVLDFLAKCLERKPEKRWSAE 222
T G+ PW ++SN A I C + P +V + C +R+P++R +
Sbjct: 218 FTYGKQPWY-QLSNTEA----IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIK 272
Query: 223 EL 224
++
Sbjct: 273 DI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-09
Identities = 30/140 (21%), Positives = 54/140 (38%), Gaps = 16/140 (11%)
Query: 106 KLPDLGCARRVND-----LKNNGNLKQSWQSIG-GTQLWMAPEVLRNEGLDFATDIWSLG 159
+L + + LK +G++ +MAPEV++ + DI+SLG
Sbjct: 32 ELHRQAKSGNILLTWDGLLKLDGSVAFKTPEQSRPDPYFMAPEVIQGQSYTEKADIYSLG 91
Query: 160 CMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPT--QFFKKVL------DFLAKCL 211
+ E P+ ++ +A +L+I + P + V DF+ C
Sbjct: 92 ITLYEALDYELPYNEERELSA--ILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCA 149
Query: 212 ERKPEKRWSAEELLNHTFIS 231
R P++R +A L H
Sbjct: 150 SRLPQRREAANHYLAHCRAL 169
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 52/188 (27%), Positives = 74/188 (39%), Gaps = 46/188 (24%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
LH GI+H DLK +N+++ S +K+ D G AR + + + T+ + AP
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPYVV--TRYYRAP 186
Query: 142 EVLRNEGLDFATDIWSLGCMVIEMATGRP--PWGDKIS--NAAATLL------------- 184
EV+ G DIWS+GC++ EM G P D I N L
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246
Query: 185 --KIACSNEKPHFPTQF---FKKVL-----------------DFLAKCLERKPEKRWSAE 222
+ N + F F VL D L+K L PEKR S +
Sbjct: 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306
Query: 223 ELLNHTFI 230
+ L H +I
Sbjct: 307 DALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-09
Identities = 58/220 (26%), Positives = 85/220 (38%), Gaps = 33/220 (15%)
Query: 26 EAEIRQSLNSPNI----GRNGEKT-VNIFMEYMAGGSLLDVAEKFGGTL----------D 70
EAEI + + PNI G +K + I ME + GGSLL K L D
Sbjct: 42 EAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLD 101
Query: 71 AGVIRLYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVND--LKNNGNLKQS 128
A Y L +H DL N L+G + +K+ D G +R + LKQ
Sbjct: 102 AAAGMEY----LESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157
Query: 129 WQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIA 187
W APE L +D+WS G ++ E + G P+ + ++
Sbjct: 158 ------PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG 211
Query: 188 CSNEKP-HFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226
P P + ++ +L +C PE R S E+ N
Sbjct: 212 YRMPAPQLCPEEIYRLML----QCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-09
Identities = 42/145 (28%), Positives = 66/145 (45%), Gaps = 17/145 (11%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDV-KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL- 137
L +H DL NVLL +HG + K+ D G AR D+ N+ N + G +L
Sbjct: 155 AFLASKNCIHRDLAARNVLL-THGKIVKICDFGLAR---DIMNDSN----YVVKGNARLP 206
Query: 138 --WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAA-ATLLKIACSNEKP 193
WMAPE + N F +D+WS G ++ E+ + G P+ ++ L+K +P
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP 266
Query: 194 HFPTQFFKKVLDFLAKCLERKPEKR 218
++ D + C + P KR
Sbjct: 267 EHAP---AEIYDIMKTCWDADPLKR 288
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 42/221 (19%)
Query: 43 EKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNN 96
+K++ + EY+ L + G + ++++ +IL H +LH DLK N
Sbjct: 76 DKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQN 134
Query: 97 VLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT--D 154
+L+ G++KL D G AR ++ S LW P + +++T D
Sbjct: 135 LLINERGELKLADFGLARA-------KSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQID 187
Query: 155 IWSLGCMVIEMATGRPPW-GDKISNAAATLLKI-----------ACSNEK------PHFP 196
+W +GC+ EMA+GRP + G + + + ++ SN++ P +
Sbjct: 188 MWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYK 247
Query: 197 TQFF--------KKVLDFLAKCLERKPEKRWSAEELLNHTF 229
Q + ++ L K L+ + +KR SAEE + H +
Sbjct: 248 PQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 33/173 (19%)
Query: 83 HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142
H N I+H D+K N+L+ + +KL D G AR +++ +N N + T+ + +PE
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNAN----YTEYVATRWYRSPE 171
Query: 143 VLRNEGLDFATDIWSLGCMVIEMATGRP--PWGDKISN----------AAATLLKIACSN 190
+L A D+WS+GC++ E++ G+P P +I A +K+ SN
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231
Query: 191 EKPH---FPT----QFFKK---------VLDFLAKCLERKPEKRWSAEELLNH 227
+ H FP Q ++ +LD + L+ P R+ E+ LNH
Sbjct: 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-09
Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 26/157 (16%)
Query: 88 LHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL----WMAPEV 143
+H DL N L+G++ VK+ D G +R V + +GG + WM PE
Sbjct: 145 VHRDLATRNCLVGANLLVKIGDFGMSRDV--------YSTDYYRVGGHTMLPIRWMPPES 196
Query: 144 LRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSN-----EKPHFPT 197
+ +D+WS G ++ E+ T G+ PW ++SN I C E+P
Sbjct: 197 IMYRKFTTESDVWSFGVILWEIFTYGKQPWF-QLSNT----EVIECITQGRVLERPRVCP 251
Query: 198 QFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234
K+V D + C +R+P++R + +E+ G A
Sbjct: 252 ---KEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-09
Identities = 47/175 (26%), Positives = 74/175 (42%), Gaps = 35/175 (20%)
Query: 83 HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142
H ILH DLK N+L+ G++KL D G AR ++ S LW P
Sbjct: 120 HKRKILHRDLKPQNLLINEKGELKLADFGLARA-------KSVPTKTYSNEVVTLWYRPP 172
Query: 143 VLRNEGLDFAT--DIWSLGCMVIEMATGRPPW-GDKISNAAATLLKI-----------AC 188
+ +++T D+W +GC++ EMATGRP + G + + ++
Sbjct: 173 DVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232
Query: 189 SNEK------PHFPTQFFK--------KVLDFLAKCLERKPEKRWSAEELLNHTF 229
SNE+ P + Q +D L+ L + + R SAE L H++
Sbjct: 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 6e-09
Identities = 56/234 (23%), Positives = 91/234 (38%), Gaps = 34/234 (14%)
Query: 11 VKSAESEAG-VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEK 64
VK + ++ QA EA + +L PN+ + + I EYMA GSL+D
Sbjct: 34 VKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRS 93
Query: 65 FGGTLDAGVIRLYTK-------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVN 117
G + +L E L +H DL NVL+ K+ D G A+ +
Sbjct: 94 RGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153
Query: 118 DLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM-ATGRPPWG--- 173
+++G L W APE LR + +D+WS G ++ E+ + GR P+
Sbjct: 154 QGQDSGKLPVKW---------TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204
Query: 174 -DKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226
+ ++ P +V + C E P KR + ++L
Sbjct: 205 LKDVVPHVEKGYRMEAPEGCP-------PEVYKVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 10/106 (9%)
Query: 71 AGVIRLYTKEILHGNGILHCDLKCNNVLLGSHGDV-------KLPDLGCARRVNDLKNNG 123
GV Y LH ++H DLK N+L+ + V LP C R+ DL
Sbjct: 240 TGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCC 296
Query: 124 NLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGR 169
+ + S +I T+ + +PEV+ G ++TD+WS+GC++ E+ TG+
Sbjct: 297 DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139
E L I++ DLK N+LL G +K+ D G A+ V+ ++ GT ++
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT---------YTLCGTPEYI 195
Query: 140 APEVLRNEGLDFATDIWSLGCMVIEMATGRPPW 172
APE+L N G A D W+LG + E+ G PP+
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 52/181 (28%), Positives = 80/181 (44%), Gaps = 20/181 (11%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDV 61
A+ +K+ +E + +EA I + PNI K V I EYM GSL
Sbjct: 36 AIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAF 95
Query: 62 AEKFGGTLD----AGVIRLYTK--EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115
K G G++R + L G +H DL N+L+ S+ K+ D G +R
Sbjct: 96 LRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155
Query: 116 VNDLKNNGNLKQSWQSIGGT--QLWMAPEVLRNEGLDFATDIWSLGCMVIE-MATG-RPP 171
+ D + + ++ + GG W APE + A+D+WS G ++ E M+ G RP
Sbjct: 156 LED-----DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 210
Query: 172 W 172
W
Sbjct: 211 W 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 45/161 (27%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
LH GI+H DLK +N+++ S +K+ D G AR + + + T+ + AP
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----SFMMTPYVV--TRYYRAP 194
Query: 142 EVLRNEGLDFATDIWSLGCMVIEMATGRP--PWGDKIS--NAAATLLKIACSNEKPHFPT 197
EV+ G DIWS+GC++ EM G P D I N L C
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC--------P 246
Query: 198 QFFKKVLDFLAKCLERKPE-KRWSAEELLNHTFISGNAKKN 237
+F KK+ + +E +P+ +S E+L +++ N
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN 287
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-08
Identities = 45/183 (24%), Positives = 82/183 (44%), Gaps = 28/183 (15%)
Query: 58 LLDVAEKFGGTLDAGVIRLYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVN 117
+L +A++ AG++ L ++ +H DL N L+G + VK+ D G +R V
Sbjct: 122 MLHIAQQIA----AGMVYLASQHFVHR------DLATRNCLVGENLLVKIGDFGMSRDV- 170
Query: 118 DLKNNGNLKQSWQSIGGTQL----WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPW 172
+ +GG + WM PE + +D+WSLG ++ E+ T G+ PW
Sbjct: 171 -------YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 223
Query: 173 GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232
+N + ++P + +V D + C +R+P R + +E+ H+ +
Sbjct: 224 YQLSNNEVIECITQGRVLQRPRTCPK---EVYDLMLGCWQREPHMRLNIKEI--HSLLQN 278
Query: 233 NAK 235
AK
Sbjct: 279 LAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-08
Identities = 46/161 (28%), Positives = 68/161 (42%), Gaps = 22/161 (13%)
Query: 26 EAEIRQSLNSPN----IGRNGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI 81
EA I + + P+ IG E V I ME G L + +LD + LY+ ++
Sbjct: 57 EAYIMRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQL 116
Query: 82 ------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGT 135
L +H D+ NVL+ S VKL D G +R + D +S+
Sbjct: 117 STALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED--------ESYYKASKG 168
Query: 136 QL---WMAPEVLRNEGLDFATDIWSLG-CMVIEMATGRPPW 172
+L WMAPE + A+D+W G CM + G P+
Sbjct: 169 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-08
Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 43/223 (19%)
Query: 26 EAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT-- 78
EA+I + L P + + E+ + I E M GSLL+ + G ++L
Sbjct: 51 EAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAG----RALKLPQLI 106
Query: 79 ---KEILHGNGIL------HCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSW 129
++ G L H DL NVL+G + K+ D G AR + + +
Sbjct: 107 DMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE--------DIY 158
Query: 130 QSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPW----GDKISNAAA 181
++ G + W APE +D+WS G ++ E+ T GR P+ ++
Sbjct: 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218
Query: 182 TLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
++ C P P + + +LD C + P+ R + E L
Sbjct: 219 QGYRMPCP---PGCPKELYDIMLD----CWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-08
Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 26/215 (12%)
Query: 26 EAEIRQSLNSPNI----GRNGEKT-VNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKE 80
EA++ L+ P + G E++ + + E+M G L D G + +
Sbjct: 49 EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108
Query: 81 ILHG------NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGG 134
+ G + ++H DL N L+G + VK+ D G R V L + S G
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV--------LDDQYTSSTG 160
Query: 135 TQL---WMAPEVLRNEGLDFATDIWSLGCMVIEM-ATGRPPWGDKISNAAATLLKIACSN 190
T+ W +PEV +D+WS G ++ E+ + G+ P+ ++ ++ +
Sbjct: 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL 220
Query: 191 EKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
KP +Q V + + C + +PE R S LL
Sbjct: 221 YKPRLASQ---SVYELMQHCWKERPEDRPSFSLLL 252
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-08
Identities = 49/220 (22%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 20 VQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLD-VAEKFGGTLDAGVI 74
V+A EA + ++L + + ++ + I E+MA GSLLD + G +
Sbjct: 45 VEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL 104
Query: 75 RLYTKEILHG------NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQS 128
++ +I G +H DL+ N+L+ + K+ D G AR + D
Sbjct: 105 IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--------NE 156
Query: 129 WQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLL 184
+ + G + W APE + +D+WS G +++E+ T GR P+ + L
Sbjct: 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216
Query: 185 KIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
+ +P + ++ + + +C + +PE+R + E +
Sbjct: 217 ERGYRMPRPENCPE---ELYNIMMRCWKNRPEERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-08
Identities = 36/120 (30%), Positives = 56/120 (46%), Gaps = 11/120 (9%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIG--GTQLWM 139
LHG GI+H D+K N+ L + L D G A +++ + + Q G GT
Sbjct: 201 LHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD------TPQCYGWSGTLETN 254
Query: 140 APEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLK--IACSNEKP-HFP 196
+PE+L + TDIWS G ++ EM+ K ++++ L+ I C P FP
Sbjct: 255 SPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314
|
Length = 392 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 46/155 (29%), Positives = 68/155 (43%), Gaps = 23/155 (14%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL-- 137
E L +H DL NVL+ VK+ D G AR D+ + N + S G T L
Sbjct: 253 EFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR---DIMRDSN----YISKGSTFLPL 305
Query: 138 -WMAPEVLRNEGLDFATDIWSLGCMVIEMAT--GRP----PWGDKISNAAATLLKIACSN 190
WMAPE + N +D+WS G ++ E+ T G P P ++ NA ++A
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAK-- 363
Query: 191 EKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
P ++ + + KC E K E R +L+
Sbjct: 364 -----PAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-08
Identities = 54/235 (22%), Positives = 98/235 (41%), Gaps = 39/235 (16%)
Query: 9 FVVKSAESEAGVQALR------NEAEIRQSLNSPNIGRNGEKTVNIFMEYMAGGSLLDVA 62
F K + V + N ++RQ + ++ KT F E+ AG + V
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEI------KSRAKTNRTFREHEAGLLFIQV- 152
Query: 63 EKFGGTLDAGVIRLYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNN 122
L +H ++H D+K N+LL S+G VKL D G ++ +
Sbjct: 153 -------------LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK----MYAA 195
Query: 123 GNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPW-GDKISNAAA 181
++ GT ++APE+ R + D++SLG ++ E+ T + P+ G+ +
Sbjct: 196 TVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE--- 252
Query: 182 TLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN----HTFISG 232
++ + P ++ + + L P++R S+ +LLN FISG
Sbjct: 253 -VMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISG 306
|
Length = 496 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-08
Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 17/154 (11%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRV---NDLKNNGNLKQSWQSIGGTQ 136
E L +H DL N+LL + VK+ D G AR + D G+ + +
Sbjct: 193 EFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK------ 246
Query: 137 LWMAPEVLRNEGLDFATDIWSLGCMVIEM-ATGRPPW-GDKISNAAATLLKIACSNEKPH 194
WMAPE + + +D+WS G ++ E+ + G P+ G KI LK P
Sbjct: 247 -WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 305
Query: 195 FPT-QFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
+ T + ++ +LD C +P +R + EL+ H
Sbjct: 306 YTTPEMYQTMLD----CWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-08
Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 24/153 (15%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRV--ND---LKNNGN--LKQSWQSIGG 134
LH G++H D+ N ++ VK+ D +R + D L +N N +K
Sbjct: 133 LHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK-------- 184
Query: 135 TQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKP 193
WMA E L N+ A+D+WS G ++ E+ T G+ P+ + A LK +P
Sbjct: 185 ---WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP 241
Query: 194 -HFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
+ P + F +A C PE+R S +L+
Sbjct: 242 INCPDELF----AVMACCWALDPEERPSFSQLV 270
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-08
Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 28/218 (12%)
Query: 21 QALRNEAEIRQSLNS----PNIGRNGEKTVNIFMEYMAGGSLLD-VAEKFGGTLDAGVIR 75
+A EA+I + L P E+ + I E+M GSLLD + E G L +
Sbjct: 46 EAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV 105
Query: 76 LYTKEILHGNGIL------HCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSW 129
+I G + H DL+ N+L+G + K+ D G AR + D N +
Sbjct: 106 DMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED-----NEYTAR 160
Query: 130 QSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLL---- 184
Q W APE +D+WS G ++ E+ T GR P+ ++ +
Sbjct: 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY 220
Query: 185 KIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222
++ C P + + + + C ++ P++R + E
Sbjct: 221 RMPCPQGCP-------ESLHELMKLCWKKDPDERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-08
Identities = 46/185 (24%), Positives = 73/185 (39%), Gaps = 33/185 (17%)
Query: 10 VVKSAESEAGV---QALRNEAEIRQSLNSPNI----GR-NGEKTVNIFMEYMAGGSL--- 58
+K+ + A Q R EAE+ L PNI G E+ + EY+A G L
Sbjct: 39 AIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEF 98
Query: 59 ------------LDVAEKFGGTLDA-GVIRLYTK-----EILHGNGILHCDLKCNNVLLG 100
E +LD + + + E L + +H DL N L+G
Sbjct: 99 LVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGC 160
VK+ D G +R D+ + + +S+ + WM PE + +DIWS G
Sbjct: 159 EGLTVKISDFGLSR---DIYSADYYRVQSKSLLPVR-WMPPEAILYGKFTTESDIWSFGV 214
Query: 161 MVIEM 165
++ E+
Sbjct: 215 VLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-08
Identities = 32/92 (34%), Positives = 44/92 (47%), Gaps = 14/92 (15%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQS-----IGG 134
+ +HG GI+H D+K NVL+ D+ L D G A + SW + I G
Sbjct: 274 DYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA---------RGSWSTPFHYGIAG 324
Query: 135 TQLWMAPEVLRNEGLDFATDIWSLGCMVIEMA 166
T APEVL + + DIWS G ++ E A
Sbjct: 325 TVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 5e-08
Identities = 47/165 (28%), Positives = 67/165 (40%), Gaps = 24/165 (14%)
Query: 26 EAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKE 80
EA I + PNI R + V I EYM GSL + G G +
Sbjct: 55 EASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL----VG 110
Query: 81 ILHG----------NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQ 130
+L G +H DL N+L+ S+ K+ D G +RR+ D + K
Sbjct: 111 MLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI 170
Query: 131 SIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIE-MATGRPPWGD 174
I W APE + A+D+WS G ++ E M+ G P+ D
Sbjct: 171 PI----RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-08
Identities = 44/154 (28%), Positives = 64/154 (41%), Gaps = 27/154 (17%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCAR-RVNDLKNNGNLKQSWQSIGGTQLWMA 140
LH I+H D+K N+ + V + DLG A+ V G + GT A
Sbjct: 173 LHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--------LAGTVETNA 224
Query: 141 PEVLRNEGLDFATDIWSLGCMVIEMAT------GRPPWG--DKISNAAATLLKIACS--- 189
PEVL + + DIWS G ++ EM PP + + + + LLKI +
Sbjct: 225 PEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKV 284
Query: 190 --NEKPHFPTQFFKKVLDFL--AKCLERKPEKRW 219
E P P + V F+ A ER+P R+
Sbjct: 285 HPEEFPRDPGS--RLVRGFIEYASL-ERQPYTRY 315
|
Length = 357 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-08
Identities = 48/194 (24%), Positives = 79/194 (40%), Gaps = 24/194 (12%)
Query: 43 EKTVNIFMEYMAGGSLLDV-------AEKFGGTLDAGVIRLYTKEILHGNGILHCDLKCN 95
E+ + I EYM+ GSLLD A K +D + +H DL+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSA 131
Query: 96 NVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDI 155
N+L+G K+ D G AR + D N + Q W APE +D+
Sbjct: 132 NILVGDGLVCKIADFGLARLIED-----NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 156 WSLGCMVIEMAT-GRPPW----GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKC 210
WS G ++ E+ T GR P+ ++ ++ C + P + + + +C
Sbjct: 187 WSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCP-------ISLHELMLQC 239
Query: 211 LERKPEKRWSAEEL 224
++ PE+R + E L
Sbjct: 240 WKKDPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-07
Identities = 55/218 (25%), Positives = 86/218 (39%), Gaps = 32/218 (14%)
Query: 25 NEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEK----------FGGTL 69
+EA I + + PNI + + + I ME + GG L K L
Sbjct: 41 SEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL 100
Query: 70 DAGVIRLYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVND-LKNNGNLKQS 128
DA Y L +H DL N L+G + +K+ D G +R+ +D + ++ LKQ
Sbjct: 101 DAAAGMAY----LESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156
Query: 129 WQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIE-MATGRPPWGDKISNAAATLLKIA 187
W APE L +D+WS G ++ E + G P+ + A ++
Sbjct: 157 ------PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG 210
Query: 188 CSNEKP-HFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
P P +K + +C + KPE R EL
Sbjct: 211 YRMSCPQKCPDDVYK----VMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-07
Identities = 51/188 (27%), Positives = 74/188 (39%), Gaps = 45/188 (23%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
LH GI+H DLK +N+++ S +K+ D G AR + + + T+ + AP
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----SFMMTPYVV--TRYYRAP 187
Query: 142 EVLRNEGLDFATDIWSLGCMVIEMATGRP--PWGDKIS--NAAATLLKIACS-------- 189
EV+ G DIWS+GC++ EM + P D I N L C
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 190 ------NEKPH---------FPTQFF-----------KKVLDFLAKCLERKPEKRWSAEE 223
+P FP F + D L+K L P KR S +E
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDE 307
Query: 224 LLNHTFIS 231
L H +I+
Sbjct: 308 ALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 26/197 (13%)
Query: 48 IFMEYMAGGSL-----------LDVAEKFGGTLDAGVIRLYTKEILHGNGILHCDLKCNN 96
+ MEY +GG L L E G L ++ L E+ H ++H DLK N
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIV-LALDEV-HSRKMMHRDLKSAN 199
Query: 97 VLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIW 156
+ L G +KL D G +++ +D + +L + S GT ++APE+ + D+W
Sbjct: 200 IFLMPTGIIKLGDFGFSKQYSD---SVSLDVA-SSFCGTPYYLAPELWERKRYSKKADMW 255
Query: 157 SLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP---TQFFKKVLDFLAKCLER 213
SLG ++ E+ T P+ K + + ++ P FP + K +LD L L +
Sbjct: 256 SLGVILYELLTLHRPF--KGPSQREIMQQVLYGKYDP-FPCPVSSGMKALLDPL---LSK 309
Query: 214 KPEKRWSAEELLNHTFI 230
P R + ++LL+ F+
Sbjct: 310 NPALRPTTQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 45/186 (24%), Positives = 75/186 (40%), Gaps = 20/186 (10%)
Query: 5 TGALFVVK-----SAESEAGVQALRNEAEIRQSLNSPNI------GRNGEKTVNIFMEYM 53
TG +K + E E R E + L PNI G + EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 54 AGGSLLDVAEKFGGTLDAGVIRLYTKEI-----LHGNGILHCDLKCNNVLLGSHGD---V 105
G +L +V G RL + + H GI+H DLK N+++ G
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQS-IGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIE 164
K+ D G + +++ + + + GT + APE LR E + +D+++ G + +E
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
Query: 165 MATGRP 170
TG+
Sbjct: 182 CLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 32/173 (18%)
Query: 20 VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74
+A EA+I + L + + + E+ + I EYM+ GSLLD F + + +
Sbjct: 45 PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD----FLKSGEGKKL 100
Query: 75 RL-----YTKEILHGNGIL------HCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG 123
RL +I G L H DL N+L+G + K+ D G AR + D +
Sbjct: 101 RLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED--DEY 158
Query: 124 NLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPW 172
++ G + W APE +D+WS G ++ E+ T GR P+
Sbjct: 159 TARE------GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-07
Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 22/233 (9%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVA 62
A+ V++ S + + +EA + + SP + R TV + + M G LLD
Sbjct: 40 AIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYV 99
Query: 63 EKFGGTLDAGVIRLYTKEILHGNGIL------HCDLKCNNVLLGSHGDVKLPDLGCARRV 116
+ + + + + +I G L H DL NVL+ S VK+ D G AR +
Sbjct: 100 RENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
Query: 117 NDLKNNGNLKQSWQSIGGTQ--LWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWG 173
D+ + + + GG WMA E + + +D+WS G V E+ T G P+
Sbjct: 160 -DID-----ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
Query: 174 DKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226
+ LL+ E+ P V + KC E R EL++
Sbjct: 214 GIPAREIPDLLE---KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 43/153 (28%), Positives = 65/153 (42%), Gaps = 20/153 (13%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDL-----KNNGNLKQSWQSIGG 134
E L +H DL NVL+ +K+ D G AR ++ + NG L W
Sbjct: 146 EFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKW----- 200
Query: 135 TQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT--GRPPWGDKISNAAATLLKIACSNEK 192
MAPE L + +D+WS G ++ E+ T G P G + LLK EK
Sbjct: 201 ----MAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK-LLKEGYRMEK 255
Query: 193 PHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
P TQ ++ + C P +R + ++L+
Sbjct: 256 PQNCTQ---ELYHLMRDCWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-07
Identities = 61/236 (25%), Positives = 96/236 (40%), Gaps = 32/236 (13%)
Query: 5 TGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGS 57
TG VK+ + + QA E + L+ N+ R NG + I ME M+ G+
Sbjct: 28 TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG---LYIVMELMSKGN 84
Query: 58 LLDVAEKFGGTLDAGVIRLYT--------KEILHGNGILHCDLKCNNVLLGSHGDVKLPD 109
L++ G L VI+L E L ++H DL N+L+ G K+ D
Sbjct: 85 LVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSD 143
Query: 110 LGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM-ATG 168
G AR + +N L W APE L+++ +D+WS G ++ E+ + G
Sbjct: 144 FGLARVGSMGVDNSKLPVKW---------TAPEALKHKKFSSKSDVWSYGVLLWEVFSYG 194
Query: 169 RPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
R P+ ++ E P V + C E +P+KR S +L
Sbjct: 195 RAPYPKMSLKEVKECVEKGYRMEPPE---GCPADVYVLMTSCWETEPKKRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-07
Identities = 39/127 (30%), Positives = 54/127 (42%), Gaps = 11/127 (8%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139
E +H ++H D+K N+ L G + L D G A K W GT
Sbjct: 281 EYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE--KEREAFDYGWV---GTVATN 335
Query: 140 APEVLRNEGLDFATDIWSLGCMVIEMATGR-PPWGDKISNAAATLLKI-----ACSNEKP 193
+PE+L +G TDIWS G ++++M + P GD LLKI C E P
Sbjct: 336 SPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFP 395
Query: 194 HFPTQFF 200
P + F
Sbjct: 396 DPPCKLF 402
|
Length = 501 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 5e-07
Identities = 28/78 (35%), Positives = 42/78 (53%), Gaps = 13/78 (16%)
Query: 46 VNIFMEYMAGG---SLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNN 96
V + MEY+ GG SLL + G D + Y E+ LH +GI+H DLK +N
Sbjct: 79 VYLVMEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDN 134
Query: 97 VLLGSHGDVKLPDLGCAR 114
+L+ + G +KL D G ++
Sbjct: 135 MLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 51/191 (26%), Positives = 78/191 (40%), Gaps = 41/191 (21%)
Query: 73 VIRLYTKEIL------HGNGILHCDLKCNNVLLG-SHGDVKLPDLGCARRVNDLKNNGNL 125
+I+ Y +IL H + +LH DLK N+L+ +KL D G AR G
Sbjct: 103 LIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF------GIP 156
Query: 126 KQSWQSIGGTQLWMAPEVLRNEGLDFAT--DIWSLGCMVIEMATGRP--PWGDKISNAAA 181
+++ T + APE+L ++T DIWS+GC+ EM +P P +I
Sbjct: 157 VRTFTHEVVTLWYRAPEILLG-SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215
Query: 182 TLLKIACSNEK--------PHFPTQFFK---------------KVLDFLAKCLERKPEKR 218
+ NE+ P + + F K +D L+K L P KR
Sbjct: 216 IFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKR 275
Query: 219 WSAEELLNHTF 229
+A L H +
Sbjct: 276 ITARAALEHEY 286
|
Length = 294 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 50/176 (28%), Positives = 74/176 (42%), Gaps = 39/176 (22%)
Query: 26 EAEIRQSLNSPNIGRN-----GEKTVNIFMEYMAGGSLLDV-----AEKFGGTLDAGVIR 75
EA + + N PNI + + I ME M GG LL E+FG L
Sbjct: 49 EAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPL------ 102
Query: 76 LYTKEILH-----GNG--------ILHCDLKCNNVLLGSHGD-----VKLPDLGCARRVN 117
L KE+L G +H DL N L+ G VK+ D G AR
Sbjct: 103 LTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--- 159
Query: 118 DLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPW 172
D+ + ++ + + + WMAPE L + +D+WS G ++ E+ T G+ P+
Sbjct: 160 DIYKSDYYRKEGEGLLPVR-WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 35/95 (36%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 82 LHGNGILHCDLKCNNVLL----GSHGDVKLPDLGCARRVND-LKNNGNLKQSWQSIGGTQ 136
LH N +LH DLK N+L+ G VK+ D+G AR N LK +L + T
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL----DPVVVTF 179
Query: 137 LWMAPEVLRN-EGLDFATDIWSLGCMVIEMATGRP 170
+ APE+L A DIW++GC+ E+ T P
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 1e-06
Identities = 61/248 (24%), Positives = 104/248 (41%), Gaps = 54/248 (21%)
Query: 26 EAEIRQSLNSPNIGRNGEKTVN-------IFMEYMAGGSL---LDVAEKFGGTLDAGVIR 75
E + + L NI R ++ +N I ME+ G L + K G ++ I
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 76 LYTKEILH-------------GNGILHCDLKCNNVLLGSH----GDV------------- 105
T+++LH G +LH DLK N+ L + G +
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE--GLDFATDIWSLGCMVI 163
K+ D G L N ++ S GT + +PE+L +E D +D+W+LGC++
Sbjct: 182 KIGDFG-------LSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 164 EMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAK-CLERKPEKRWSAE 222
E+ +G+ P+ K +N + + ++ P P + K L+ L K L ++R SA
Sbjct: 235 ELCSGKTPF-HKANNFSQLISEL---KRGPDLPIKGKSKELNILIKNLLNLSAKERPSAL 290
Query: 223 ELLNHTFI 230
+ L + I
Sbjct: 291 QCLGYQII 298
|
Length = 1021 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 35/95 (36%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 82 LHGNGILHCDLKCNNVLL----GSHGDVKLPDLGCARRVND-LKNNGNLKQSWQSIGGTQ 136
LH N +LH DLK N+L+ G VK+ D+G AR N LK +L + T
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL----DPVVVTF 179
Query: 137 LWMAPEVLRN-EGLDFATDIWSLGCMVIEMATGRP 170
+ APE+L A DIW++GC+ E+ T P
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-06
Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 19/146 (13%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDV-KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL- 137
L +H DL N+LL +HG + K+ D G AR D++N+ N + G +L
Sbjct: 228 SFLASKNCIHRDLAARNILL-THGRITKICDFGLAR---DIRNDSN----YVVKGNARLP 279
Query: 138 --WMAPEVLRNEGLDFATDIWSLGCMVIEM-ATGRPPW-GDKISNAAATLLKIACSNEKP 193
WMAPE + N F +D+WS G ++ E+ + G P+ G + + ++K P
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP 339
Query: 194 HF-PTQFFKKVLDFLAKCLERKPEKR 218
P++ + D + C + P KR
Sbjct: 340 ECAPSEMY----DIMKSCWDADPLKR 361
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-06
Identities = 36/139 (25%), Positives = 67/139 (48%), Gaps = 8/139 (5%)
Query: 87 ILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146
++H DL NVL+ +K+ D G +R V + + +K+S I WMA E L +
Sbjct: 148 LVHRDLAARNVLVAEGRKMKISDFGLSRDV--YEEDSYVKRSKGRI--PVKWMAIESLFD 203
Query: 147 EGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLD 205
+D+WS G ++ E+ T G P+ LLK E+P ++ ++ +
Sbjct: 204 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSE---EMYN 260
Query: 206 FLAKCLERKPEKRWSAEEL 224
+ C +++P+KR + ++
Sbjct: 261 LMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 37/120 (30%), Positives = 52/120 (43%), Gaps = 15/120 (12%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDL-----KNNGNLKQSWQSIGG 134
E L +H DL NVL+ + +K+ D G AR VN++ NG L W
Sbjct: 151 EYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKW----- 205
Query: 135 TQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKP 193
MAPE L + +D+WS G ++ E+ T G P+ LLK +KP
Sbjct: 206 ----MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP 261
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-06
Identities = 43/160 (26%), Positives = 73/160 (45%), Gaps = 20/160 (12%)
Query: 25 NEAEIRQSLNSPNI----GRNGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKE 80
+EA I S++ P++ G T+ + + M G LLD + + + ++ + +
Sbjct: 58 DEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ 117
Query: 81 ILHG------NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGG 134
I G ++H DL NVL+ S VK+ D G AR + G+ K+ + + GG
Sbjct: 118 IAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL-----EGDEKE-YNADGG 171
Query: 135 TQ--LWMAPEVLRNEGLDFATDIWSLGCMVIEMAT--GRP 170
WMA E + +D+WS G + E+ T G+P
Sbjct: 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 54/251 (21%), Positives = 94/251 (37%), Gaps = 46/251 (18%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLD 60
A+ +K S + EAE+ + NI + G+ + +F EYM G L
Sbjct: 39 AVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVF-EYMEHGDLNK 97
Query: 61 VAE------KFGGTLDAGVIRLYTKEILH-------------GNGILHCDLKCNNVLLGS 101
F + D+ + L ++L +H DL N L+G
Sbjct: 98 FLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157
Query: 102 HGDVKLPDLGCARRV--NDLKNNGNLKQSWQSIGGTQL----WMAPEVLRNEGLDFATDI 155
VK+ D G +R V D + +GG + WM PE + +D+
Sbjct: 158 DLVVKIGDFGMSRDVYTTD----------YYRVGGHTMLPIRWMPPESIMYRKFTTESDV 207
Query: 156 WSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERK 214
WS G ++ E+ T G+ PW + + ++P V D + C +R
Sbjct: 208 WSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSE---VYDIMLGCWKRD 264
Query: 215 PEKRWSAEELL 225
P++R + +++
Sbjct: 265 PQQRINIKDIH 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 53/212 (25%), Positives = 83/212 (39%), Gaps = 33/212 (15%)
Query: 26 EAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG-VIRLYTK 79
EA I + + PNI R ++ + I ME + GG L G L +I++
Sbjct: 43 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVEN 102
Query: 80 -----EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVND--LKNNGNLKQSWQSI 132
E L +H DL N L+ +K+ D G +R D + G +KQ
Sbjct: 103 AAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI---- 158
Query: 133 GGTQLWMAPEVLRNEGLDFATDIWSLGCMVIE-MATGRPPWGDKISN-----AAATLLKI 186
W APE L +D+WS G ++ E + G P+ + +SN A +++
Sbjct: 159 --PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN-LSNQQTREAIEQGVRL 215
Query: 187 ACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
C P V + +C E P +R
Sbjct: 216 PCPELCP-------DAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 54/232 (23%), Positives = 99/232 (42%), Gaps = 22/232 (9%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVA 62
A+ ++ A S + + +EA + S+++P++ R TV + + M G LLD
Sbjct: 40 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV 99
Query: 63 EKFGGTLDAGVIRLYTKEILHGNGIL------HCDLKCNNVLLGSHGDVKLPDLGCARRV 116
+ + + + + +I G L H DL NVL+ + VK+ D G A+ +
Sbjct: 100 REHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159
Query: 117 NDLKNNGNLKQSWQSIGGTQ--LWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWG 173
G ++ + + GG WMA E + + +D+WS G V E+ T G P+
Sbjct: 160 ------GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
Query: 174 DKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
++ +++L+ E+ P V + KC + R EL+
Sbjct: 214 GIPASEISSILE---KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 32/99 (32%), Positives = 46/99 (46%), Gaps = 15/99 (15%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDL-----KNNGNLKQSWQSIGG 134
E L +H DL NVL+ +K+ D G AR V+D+ +NG L W
Sbjct: 148 EYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKW----- 202
Query: 135 TQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPW 172
MAPE L + +D+WS G ++ E+ T G P+
Sbjct: 203 ----MAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 52/230 (22%), Positives = 82/230 (35%), Gaps = 40/230 (17%)
Query: 25 NEAEIRQSLNSPN----IGRNGEKTVN-IFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTK 79
EA I N N IG + E+ I +E MAGG L + + L K
Sbjct: 58 MEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSS-LTMK 116
Query: 80 EILH-------------GNGILHCDLKCNNVLLGSHGD---VKLPDLGCARRVNDLKNNG 123
++L N +H D+ N LL G K+ D G AR +
Sbjct: 117 DLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI------- 169
Query: 124 NLKQSWQSIGGTQL----WMAPEVLRNEGLDFATDIWSLGCMVIE-MATGRPPWGDKISN 178
+ S+ GG + WM PE + TD+WS G ++ E + G P+ + +
Sbjct: 170 -YRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228
Query: 179 AAATLLKIACSNEKPH-FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
+ + P P ++ + C + PE R + +L
Sbjct: 229 EVMEFVTGGGRLDPPKGCPGPVYR----IMTDCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-06
Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 17/154 (11%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL-- 137
E L +H DL N+LL + VK+ D G AR D+ + + + G +L
Sbjct: 187 EFLASRKCIHRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVRK----GDARLPL 239
Query: 138 -WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPW-GDKISNAAATLLKIACSNEKPH 194
WMAPE + ++ +D+WS G ++ E+ + G P+ G +I LK P
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPE 299
Query: 195 FPT-QFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
+ T + + +LD C PE R + EL+
Sbjct: 300 YATPEIYSIMLD----CWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 41/152 (26%), Positives = 65/152 (42%), Gaps = 18/152 (11%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDL-----KNNGNLKQSWQSIGG 134
E L +H DL NVL+ +K+ D G AR V+++ NG L W
Sbjct: 148 EYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKW----- 202
Query: 135 TQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKP 193
MAPE L + +D+WS G ++ E+ T G P+ LLK +KP
Sbjct: 203 ----MAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP 258
Query: 194 HFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
T ++ + +C P +R + ++L+
Sbjct: 259 ANCTH---ELYMIMRECWHAVPSQRPTFKQLV 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-06
Identities = 53/188 (28%), Positives = 83/188 (44%), Gaps = 22/188 (11%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDV 61
A+ +KS +E + +EA I + PNI + V I E+M G+L
Sbjct: 36 AIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSF 95
Query: 62 AEKFGGTLDAGVIRL--YTKEILHGNGIL------HCDLKCNNVLLGSHGDVKLPDLGCA 113
+ G VI+L + I G L H DL N+L+ S+ K+ D G +
Sbjct: 96 LRQNDGQFT--VIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153
Query: 114 RRVNDLKNNGNLKQSWQSIGGT--QLWMAPEVLRNEGLDFATDIWSLGCMVIE-MATGRP 170
R L+++ + S+GG W APE + A+D+WS G ++ E M+ G
Sbjct: 154 RF---LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210
Query: 171 PWGDKISN 178
P+ D +SN
Sbjct: 211 PYWD-MSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-06
Identities = 53/228 (23%), Positives = 94/228 (41%), Gaps = 44/228 (19%)
Query: 21 QALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76
+A EA + + L P + R ++ + I EYM GSL+D F T + + +
Sbjct: 46 EAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMENGSLVD----FLKTPEGIKLTI 101
Query: 77 Y-----TKEILHGNGIL------HCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNL 125
+I G + H DL+ N+L+ K+ D G AR + ++N
Sbjct: 102 NKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLI---EDNEYT 158
Query: 126 KQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPW-----GDKI 176
+ G + W APE + +D+WS G ++ E+ T GR P+ + I
Sbjct: 159 ARE-----GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213
Query: 177 SNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
N ++ + P +++ + + C + KPE+R + E L
Sbjct: 214 QN-LERGYRMPRPDNCP-------EELYELMRLCWKEKPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-06
Identities = 49/181 (27%), Positives = 78/181 (43%), Gaps = 20/181 (11%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDV 61
A+ +K +E Q +EA I + NI R K I EYM G+L
Sbjct: 37 AIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKY 96
Query: 62 AEKFGGTLDA----GVIRLYTK--EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115
G + G++R + L +H DL N+L+ S+ + K+ D G +R
Sbjct: 97 LRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV 156
Query: 116 VNDLKNNGNLKQSWQSIGGTQ--LWMAPEVLRNEGLDFATDIWSLGCMVIE-MATG-RPP 171
+ D + + ++ + GG W APE + A+D+WS G ++ E M+ G RP
Sbjct: 157 LED-----DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211
Query: 172 W 172
W
Sbjct: 212 W 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 9e-06
Identities = 50/224 (22%), Positives = 94/224 (41%), Gaps = 24/224 (10%)
Query: 11 VKSAESEAGVQALRNE----AEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDV 61
VK +++ AL++E A + Q L++P I R E + + ME G L
Sbjct: 27 VKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWM-LVMELAELGPLNKF 85
Query: 62 AEKFGGTLDAGVIRLYTK-----EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRV 116
+K + + L + + L +H DL NVLL + K+ D G ++
Sbjct: 86 LQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKA- 144
Query: 117 NDLKNNGNLKQSWQSIGGTQL-WMAPEVLRNEGLDFATDIWSLGCMVIE-MATGRPPWGD 174
L + N ++ ++ G + W APE + +D+WS G ++ E + G+ P+
Sbjct: 145 --LGADENYYKA-KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201
Query: 175 KISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
N +++ S E+ P + ++ D + C ++R
Sbjct: 202 MKGNEVTQMIE---SGERMECPQRCPPEMYDLMKLCWTYGVDER 242
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 9e-06
Identities = 45/152 (29%), Positives = 66/152 (43%), Gaps = 18/152 (11%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQ--SWQSIGGTQL 137
E L +H DL N +L VK+ D G AR + D K+ S + G +L
Sbjct: 112 EYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYD-------KEYYSVHNHTGAKL 164
Query: 138 ---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKP 193
WMA E L+ + +D+WS G ++ E+ T G PP+ D S L +P
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQP 224
Query: 194 HF-PTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
+ P ++ +L C KPE R + EL
Sbjct: 225 EYCPDPLYEVML----SCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-05
Identities = 42/177 (23%), Positives = 68/177 (38%), Gaps = 18/177 (10%)
Query: 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGRN--GEKTVNIFMEYMAGGSL 58
M+ T F++K + R N + + E +V + +++ GG L
Sbjct: 13 MDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL 72
Query: 59 LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGC 112
KF + ++ + E+ LH GI+ DL NN+LL G ++L
Sbjct: 73 WSHISKFL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSR 131
Query: 113 ARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGR 169
V D S ++ APEV A D WSLG ++ E+ TG+
Sbjct: 132 WSEVED---------SCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 42/142 (29%), Positives = 63/142 (44%), Gaps = 25/142 (17%)
Query: 45 TVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHGN------GILHCDLKCNNVL 98
T+ I EYM+ G+L K G L AG + + G G +H L + VL
Sbjct: 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVL 139
Query: 99 LGSHGDVKLPDLGCA----RRVNDLKNNGNLKQSWQSIGGTQ--LWMAPEVLRNEGLDFA 152
+ S DL C RR+ + K + + ++ G LW APE ++ A
Sbjct: 140 VNS-------DLVCKISGFRRLQEDK----SEAIYTTMSGKSPVLWAAPEAIQYHHFSSA 188
Query: 153 TDIWSLGCMVIE-MATG-RPPW 172
+D+WS G ++ E M+ G RP W
Sbjct: 189 SDVWSFGIVMWEVMSYGERPYW 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 38/153 (24%), Positives = 63/153 (41%), Gaps = 20/153 (13%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDL-----KNNGNLKQSWQSIGG 134
E L +H DL NVL+ +K+ D G AR ++ + NG L W
Sbjct: 154 EYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW----- 208
Query: 135 TQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT--GRPPWGDKISNAAATLLKIACSNEK 192
MAPE L + +D+WS G ++ E+ T G P G + L K+ +
Sbjct: 209 ----MAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----LFKLLKEGHR 260
Query: 193 PHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
P+ ++ + C P +R + ++L+
Sbjct: 261 MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 35/135 (25%), Positives = 58/135 (42%), Gaps = 11/135 (8%)
Query: 45 TVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVL 98
++ + + GSLLD + +LD + + +I G + ++H +L N+L
Sbjct: 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNIL 141
Query: 99 LGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSL 158
L S V++ D G A DL + K + WMA E + +D+WS
Sbjct: 142 LKSDSIVQIADFGVA----DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSY 197
Query: 159 GCMVIEMAT-GRPPW 172
G V EM + G P+
Sbjct: 198 GVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 38/151 (25%), Positives = 66/151 (43%), Gaps = 15/151 (9%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRV---NDLKNNGNLKQSWQSIGGTQ 136
E L +H DL N+LL + VK+ D G AR + D G+ + +
Sbjct: 188 EFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK------ 241
Query: 137 LWMAPEVLRNEGLDFATDIWSLGCMVIEM-ATGRPPW-GDKISNAAATLLKIACSNEKPH 194
WMAPE + ++ +D+WS G ++ E+ + G P+ G +I+ LK P
Sbjct: 242 -WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPE 300
Query: 195 FPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
T ++ + C + P++R + L+
Sbjct: 301 NATPEIYRI---MLACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-05
Identities = 60/256 (23%), Positives = 104/256 (40%), Gaps = 63/256 (24%)
Query: 26 EAEIRQSLNSPNI-----------GRNGEKTV--NIFMEYMAGG--SLLDVAEKFGGTLD 70
E I ++LN NI + EK + N+ ME++ + + L
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALP 168
Query: 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLL--GSHGDVKLPDLGCARRVNDLKNN 122
+++LY+ ++ +H I H DLK N+L+ +H +KL D G A+
Sbjct: 169 LFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSAK-------- 219
Query: 123 GNLKQSWQSIG--GTQLWMAPEVLRNEGLDFAT--DIWSLGCMVIEMATGRP-------- 170
NL +S+ ++ + APE++ ++ T D+WSLGC++ EM G P
Sbjct: 220 -NLLAGQRSVSYICSRFYRAPELMLG-ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277
Query: 171 ------------PWGDKISNAAATLLKIACSNEKPH-----FPTQFFKKVLDFLAKCLER 213
P D++ I + KP FP ++F+++ L+
Sbjct: 278 DQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKY 337
Query: 214 KPEKRWSAEELLNHTF 229
+P KR + E L F
Sbjct: 338 EPLKRLNPIEALADPF 353
|
Length = 440 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 6e-05
Identities = 51/233 (21%), Positives = 90/233 (38%), Gaps = 39/233 (16%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLD- 60
A+ ++KS + Q + E + + L ++ + + V I E M GSLL
Sbjct: 34 AIKILKS-DDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAF 92
Query: 61 VAEKFGGTLD-AGVIRLYTK-----EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114
+ G L A +I + + L +H DL N+L+G K+ D G AR
Sbjct: 93 LRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLAR 152
Query: 115 RVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRP 170
+K+ ++ W APE + +D+WS G ++ EM T G+
Sbjct: 153 L---------IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQV 203
Query: 171 PWGDKISNAAATLL-----KIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
P+ ++N ++ C + P + + +C +PE R
Sbjct: 204 PY-PGMNNHEVYDQITAGYRMPCPAKCPQE-------IYKIMLECWAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 62/272 (22%), Positives = 98/272 (36%), Gaps = 60/272 (22%)
Query: 1 MNKGTGALFVVKS---AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEY 52
N L VK S+ + E +I L+ PNI R + + + MEY
Sbjct: 41 DNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEY 100
Query: 53 MAGGSL---LDVAEKFGGTLDAGVIRLYTKEILH-----GNGI--------LHCDLKCNN 96
M G L L L L +L+ +G+ +H DL N
Sbjct: 101 MENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160
Query: 97 VLLGSHGDVKLPDLGCARRVNDLKNNGNLKQS-WQSIGGTQL----WMAPE-VLRNEGLD 150
L+G + +K+ D G +R NL S + + G WMA E VL +
Sbjct: 161 CLVGKNYTIKIADFGMSR---------NLYSSDYYRVQGRAPLPIRWMAWESVLLGK--- 208
Query: 151 F--ATDIWSLGCMVIEMAT--GRPPWG-----DKISNAAATLLKIACSNEKPHF---PTQ 198
F +D+W+ G + E+ T P+ I NA + + + P
Sbjct: 209 FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAG----HFFRDDGRQIYLPRPPN 264
Query: 199 FFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
K + + + +C R E R + E+ H F+
Sbjct: 265 CPKDIYELMLECWRRDEEDRPTFREI--HLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-05
Identities = 36/151 (23%), Positives = 64/151 (42%), Gaps = 18/151 (11%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---- 137
L+ N +H DL N ++ VK+ D G R + + + GG L
Sbjct: 135 LNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--------TDYYRKGGKGLLPVR 186
Query: 138 WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKP-HF 195
WM+PE L++ +D+WS G ++ E+AT P+ + + +KP +
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNC 246
Query: 196 PTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226
P F + + C + P+ R S E+++
Sbjct: 247 PDMLF----ELMRMCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL-- 137
E L + ++H DL NVL+ +VK+ DLG R V ++ +G + L
Sbjct: 138 EFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA-------ADYYKLMGNSLLPI 190
Query: 138 -WMAPEVLRNEGLDFATDIWSLGCMVIEM 165
WM+PE + +DIWS G ++ E+
Sbjct: 191 RWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 18/44 (40%), Positives = 26/44 (59%)
Query: 132 IGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDK 175
I GT ++APE+L + A D W+LG + E TG PP+ D+
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDE 583
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 2e-04
Identities = 27/78 (34%), Positives = 36/78 (46%), Gaps = 12/78 (15%)
Query: 48 IFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS 101
I MEY+ G L D+ G ++EI LH GI+H DL +N++L S
Sbjct: 76 IVMEYIEGEPLKDLINSNGMEE-----LELSREIGRLVGKLHSAGIIHGDLTTSNMIL-S 129
Query: 102 HGDVKLPDLGCARRVNDL 119
G + L D G A DL
Sbjct: 130 GGKIYLIDFGLAEFSKDL 147
|
Length = 211 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 49/200 (24%), Positives = 75/200 (37%), Gaps = 36/200 (18%)
Query: 50 MEYMAGGSLLD---------------VAEKFGGTLDAGVIRLYTKEILHGNGIL------ 88
+EY G+LLD +A TL + + + ++ G L
Sbjct: 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI 146
Query: 89 HCDLKCNNVLLGSHGDVKLPDLGCAR--RVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146
H DL N+L+G + K+ D G +R V K G L WMA E L
Sbjct: 147 HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR---------WMAIESLNY 197
Query: 147 EGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLD 205
+D+WS G ++ E+ + G P+ L EK P +V D
Sbjct: 198 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK---PLNCDDEVYD 254
Query: 206 FLAKCLERKPEKRWSAEELL 225
+ +C KP +R S ++L
Sbjct: 255 LMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 2e-04
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 88 LHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVL 144
+H D+ NVLL K+ D G AR D+ N+ N + G +L WMAPE +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLAR---DIMNDSN----YVVKGNARLPVKWMAPESI 286
Query: 145 RNEGLDFATDIWSLGCMVIEM-ATGRPPW 172
+ +D+WS G ++ E+ + G+ P+
Sbjct: 287 FDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 4e-04
Identities = 47/200 (23%), Positives = 85/200 (42%), Gaps = 27/200 (13%)
Query: 44 KTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNV 97
K + M+Y+ G L D+ K G L ++ +++ LH + I+H D+K NV
Sbjct: 82 KGHVLIMDYIKDGDLFDLL-KKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENV 140
Query: 98 LLGSHGD-VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIW 156
L D + L D G + + + GT + +PE ++ D + D W
Sbjct: 141 LYDRAKDRIYLCDYGLCKIIG----------TPSCYDGTLDYFSPEKIKGHNYDVSFDWW 190
Query: 157 SLGCMVIEMATGRPPW----GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLE 212
++G + E+ TG+ P+ +++ +LLK +K F K DF+ L+
Sbjct: 191 AVGVLTYELLTGKHPFKEDEDEELD--LESLLK--RQQKKLPFIKNVSKNANDFVQSMLK 246
Query: 213 RKPEKRWSA-EELLNHTFIS 231
R + E++ H F+
Sbjct: 247 YNINYRLTNYNEIIKHPFLK 266
|
Length = 267 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 5e-04
Identities = 49/182 (26%), Positives = 82/182 (45%), Gaps = 24/182 (13%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNI----GRNGEKTVNIFMEYMAGGSLLDVA 62
A+ V+K+ ++ + EAEI L++P I G + + + ME +GG L
Sbjct: 26 AIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL---- 81
Query: 63 EKF-GGTLD----AGVIRLYTK-----EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGC 112
KF G D + V+ L + + L G +H DL NVLL + K+ D G
Sbjct: 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGL 141
Query: 113 ARRVNDLKNNGNLKQSWQSIGGTQL-WMAPEVLRNEGLDFATDIWSLGCMVIE-MATGRP 170
++ L + + ++ +S G L W APE + +D+WS G + E + G+
Sbjct: 142 SKA---LGADDSYYKA-RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQK 197
Query: 171 PW 172
P+
Sbjct: 198 PY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 6e-04
Identities = 51/228 (22%), Positives = 87/228 (38%), Gaps = 43/228 (18%)
Query: 23 LRNEAEIRQSLNSPNI-----GRNGEKTVNIFMEYMAGGSL----------------LDV 61
+ EA + L+ PNI E+ V + EY+ G L D
Sbjct: 54 FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113
Query: 62 AEKFGGTLDAG-----VIRLYT-KEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115
+LD G I++ E L + +H DL N+L+G VK+ DLG +R
Sbjct: 114 DGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSRE 173
Query: 116 VNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGD 174
+ +S I WM PE + +DIWS G ++ E+ + G P+
Sbjct: 174 IYSADYYRVQPKSLLPI----RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229
Query: 175 KISNAAATLLK----IACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
+ +++ + CS + P ++ + +C + P +R
Sbjct: 230 FSNQEVIEMVRKRQLLPCSEDCP-------PRMYSLMTECWQEGPSRR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 16/150 (10%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---- 137
L+ +H DL N ++ VK+ D G R + + + GG L
Sbjct: 135 LNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--------YETDYYRKGGKGLLPVR 186
Query: 138 WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFP 196
WMAPE L++ ++D+WS G ++ E+ + P+ +SN +LK P
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY-QGLSN--EQVLKFVMDGGYLDQP 243
Query: 197 TQFFKKVLDFLAKCLERKPEKRWSAEELLN 226
++V D + C + P+ R + E++N
Sbjct: 244 DNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.001
Identities = 37/155 (23%), Positives = 66/155 (42%), Gaps = 27/155 (17%)
Query: 77 YTKEILHGNGILHCDLKCNNVLLGSHGD--------VKLPDLGCARRVNDLKNNGNLKQS 128
+ L G+ H ++ NVLL D +KL D G + V L +
Sbjct: 111 WALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV--------LPKE 162
Query: 129 W--QSIGGTQLWMAPEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLK 185
+ I W+ PE + N + L A D WS G + E+ +G GDK +A + K
Sbjct: 163 ILLERIP----WVPPECIENPQNLSLAADKWSFGTTLWEIFSG----GDKPLSALDSQKK 214
Query: 186 IACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS 220
+ ++ P + ++ + + +C++ +P+ R S
Sbjct: 215 LQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.001
Identities = 30/101 (29%), Positives = 42/101 (41%), Gaps = 8/101 (7%)
Query: 24 RNEAEI-----RQSLNSPNIGRNGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78
R EA I + P + I MEY+ G L D E+ L V RL
Sbjct: 47 RREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEARPDLLREVGRLVG 106
Query: 79 KEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDL 119
K LH GI+H DL +N++L G + D G +++
Sbjct: 107 K--LHKAGIVHGDLTTSNIILSG-GRIYFIDFGLGEFSDEV 144
|
Length = 204 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.001
Identities = 44/193 (22%), Positives = 76/193 (39%), Gaps = 30/193 (15%)
Query: 51 EYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDL 110
+A + DV ++ + +G++ L H +H DL N L + VK+ D
Sbjct: 91 GMVAQMAQKDVLQRMACEVASGLLWL------HQADFIHSDLALRNCQLTADLSVKIGDY 144
Query: 111 GCA--RRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT-------DIWSLGCM 161
G A + D + + W+APE++ G D +IWSLG
Sbjct: 145 GLALEQYPEDYYITKD--CHAVPL----RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVT 198
Query: 162 VIEMAT-GRPPWGDKISNA---AATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEK 217
+ E+ T P+ D +S+ + + KP ++ + + + C PE
Sbjct: 199 MWELFTAADQPYPD-LSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPET 256
Query: 218 RWSAEE---LLNH 227
R +AEE LL +
Sbjct: 257 RPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 33/146 (22%), Positives = 61/146 (41%), Gaps = 8/146 (5%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139
E L +H DL N +L + +V + D G ++++ NG+ + + W+
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIY----NGDYYRQGRIAKMPVKWI 181
Query: 140 APEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQ 198
A E L + +D+WS G + E+AT G+ P+ ++ L+ + P
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR---QGNRLKQPPD 238
Query: 199 FFKKVLDFLAKCLERKPEKRWSAEEL 224
+ ++ C P+ R S E L
Sbjct: 239 CLDGLYSLMSSCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.003
Identities = 35/162 (21%), Positives = 60/162 (37%), Gaps = 51/162 (31%)
Query: 82 LHGNGILHCDLKCNNVLLGSHG-------DVKLPDLGCAR-------RVNDLKNNGNLKQ 127
L ++H ++ N+L+ +G +KL D G RV +
Sbjct: 117 LEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP------- 169
Query: 128 SWQSIGGTQLWMAPEVLRNEG--LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLK 185
W+APE +RN L A D WS G ++E+ + G++ + +
Sbjct: 170 ----------WIAPECIRNGQASLTIAADKWSFGTTLLEICS----NGEEPLSTLS---- 211
Query: 186 IACSNEKPHF-------PTQFFKKVLDFLAKCLERKPEKRWS 220
S+EK F P ++ + + +C P KR S
Sbjct: 212 ---SSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPS 250
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.004
Identities = 34/118 (28%), Positives = 56/118 (47%), Gaps = 12/118 (10%)
Query: 24 RNEAEI-----RQSLNSPNIGRNGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78
RNEA + + +N+P + I MEY+ G L DV E+ L + RL
Sbjct: 45 RNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGNDELLREIGRLVG 104
Query: 79 KEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGN----LKQSWQSI 132
K LH GI+H DL +N+++ + L D G + +++++ LK+S +S
Sbjct: 105 K--LHKAGIVHGDLTTSNIIVRD-DKLYLIDFGLGKYSDEIEDKAVDLHVLKRSLEST 159
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 241 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.75 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.64 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.63 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.59 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.54 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.53 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.45 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.39 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.35 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.34 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.26 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.15 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.08 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.0 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.92 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.89 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.87 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.87 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.58 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.58 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.5 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.43 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.2 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.11 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.1 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.09 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.03 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.81 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.71 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.69 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.66 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.64 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.62 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.6 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.56 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.49 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.47 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.4 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.28 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.16 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.0 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.94 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.82 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.51 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.46 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.12 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 96.12 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.12 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.05 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.95 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 95.85 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.73 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.7 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.55 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.98 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.85 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.83 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.52 | |
| PLN02236 | 344 | choline kinase | 94.43 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 94.33 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 93.95 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 93.46 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 92.96 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 92.89 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 92.59 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 92.38 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-53 Score=320.97 Aligned_cols=227 Identities=32% Similarity=0.500 Sum_probs=198.3
Q ss_pred CCCCCCcEEEEEecc---chHHHHHHHHHHHHHhhcCCCcccc-----cCCc-eeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 1 MNKGTGALFVVKSAE---SEAGVQALRNEAEIRQSLNSPNIGR-----NGEK-TVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~---~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
+|+.|++.+|+|++. .+...+++.+|+++++..+|||||. ..++ .++++||||++|+|.+++... +++++
T Consensus 99 ~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~-g~i~E 177 (364)
T KOG0581|consen 99 RHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV-GRIPE 177 (364)
T ss_pred EEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc-CCCCH
Confidence 478899999999985 4566788999999999999999998 4445 699999999999999999974 67888
Q ss_pred HHHHHHHHHH------hh-cCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 72 GVIRLYTKEI------LH-GNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 72 ~~~~~~~~~~------Lh-~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
.....++.++ || +.+|+||||||+|||+++.|.+||+|||.+....+. ....+.||..|||||.+
T Consensus 178 ~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--------~a~tfvGT~~YMsPERi 249 (364)
T KOG0581|consen 178 PVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--------IANTFVGTSAYMSPERI 249 (364)
T ss_pred HHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--------hcccccccccccChhhh
Confidence 8777777654 68 599999999999999999999999999999877652 33567799999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccc--hhchHHHHHHHHhcCCCCCCChh-hHHHHHHHHHHhhccCCCCCCCh
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDK--ISNAAATLLKIACSNEKPHFPTQ-FFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
.+..|+.++||||||++++|+.+|+.||... +.....+++.......+|..|.. .++++++|+..||++||.+|||+
T Consensus 250 ~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~ 329 (364)
T KOG0581|consen 250 SGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSA 329 (364)
T ss_pred cCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCH
Confidence 9999999999999999999999999999763 34456677777777788888887 99999999999999999999999
Q ss_pred HHHhcCCCCCCCCcc
Q 042809 222 EELLNHTFISGNAKK 236 (241)
Q Consensus 222 ~~~l~~p~~~~~~~~ 236 (241)
.++++|||++.....
T Consensus 330 ~qLl~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 330 KQLLQHPFIKKFEDP 344 (364)
T ss_pred HHHhcCHHHhhcccc
Confidence 999999999876654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-54 Score=328.29 Aligned_cols=225 Identities=30% Similarity=0.482 Sum_probs=185.2
Q ss_pred CCCCCcEEEEEeccchH---------HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC
Q 042809 2 NKGTGALFVVKSAESEA---------GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~ 67 (241)
+++||+.||||.+.+.. ......+|+++|++|.|||||+ +..+..|+||||++||+|.+++.. .+
T Consensus 193 e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~-nk 271 (475)
T KOG0615|consen 193 EKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVA-NK 271 (475)
T ss_pred EcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHh-cc
Confidence 57899999999988432 1122469999999999999998 677888999999999999999987 46
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecC---CCeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH---GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
.+.+...+.++.|+ ||++||+||||||+|||++.+ ..+||+|||+++..++ ..-....|||+.|
T Consensus 272 ~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~-------~sfm~TlCGTpsY 344 (475)
T KOG0615|consen 272 YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE-------GSFMKTLCGTPSY 344 (475)
T ss_pred ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc-------ceehhhhcCCccc
Confidence 67777767666655 799999999999999999877 5699999999998765 2334578899999
Q ss_pred cCcccccccCC--C-chhhHHHHHHHHHHHHhCCCCCccchhch-HHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccC
Q 042809 139 MAPEVLRNEGL--D-FATDIWSLGCMVIEMATGRPPWGDKISNA-AATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 139 ~aPE~~~~~~~--~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 214 (241)
.|||++.+..+ + .+.|+||+||++|-+++|.+||.+..... ..+.+........+.....++++..+||.+||..|
T Consensus 345 vAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~Vd 424 (475)
T KOG0615|consen 345 VAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVD 424 (475)
T ss_pred cChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeC
Confidence 99999976443 3 47899999999999999999998876555 44444433334444556778899999999999999
Q ss_pred CCCCCChHHHhcCCCCCCCC
Q 042809 215 PEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 215 p~~Rps~~~~l~~p~~~~~~ 234 (241)
|++|||++++|+||||+...
T Consensus 425 P~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 425 PENRPSADEALNHPWFKDAP 444 (475)
T ss_pred cccCcCHHHHhcChhhhccc
Confidence 99999999999999999665
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=322.65 Aligned_cols=221 Identities=32% Similarity=0.543 Sum_probs=195.7
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
|..+|..||+|++.+ ....+.+.+|+++.+.|.|||||. ++..++|+|+|+|..++|..+++. ..++++
T Consensus 39 ~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr-rk~ltE 117 (592)
T KOG0575|consen 39 DLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR-RKPLTE 117 (592)
T ss_pred EcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHh-cCCCCc
Confidence 568999999999774 456788999999999999999999 899999999999999999999994 789999
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..++.++.|| ||+++|+|||||..|+|++.+..+||+|||+|....... ......||||.|+|||++.
T Consensus 118 pEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~------Erk~TlCGTPNYIAPEVl~ 191 (592)
T KOG0575|consen 118 PEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG------ERKKTLCGTPNYIAPEVLN 191 (592)
T ss_pred HHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc------cccceecCCCcccChhHhc
Confidence 9999999988 699999999999999999999999999999999876521 2345678999999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
...++..+||||+||++|.|++|++||....-......++ ...+.+|...+.++.+||.++|+.+|.+|||++++|
T Consensus 192 k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik----~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL 267 (592)
T KOG0575|consen 192 KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK----LNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVL 267 (592)
T ss_pred cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH----hcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 9999999999999999999999999998764444433333 455677888999999999999999999999999999
Q ss_pred cCCCCCCC
Q 042809 226 NHTFISGN 233 (241)
Q Consensus 226 ~~p~~~~~ 233 (241)
.|+||+..
T Consensus 268 ~h~Ff~~g 275 (592)
T KOG0575|consen 268 DHPFFKSG 275 (592)
T ss_pred cCHhhhCC
Confidence 99999443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=310.06 Aligned_cols=229 Identities=29% Similarity=0.551 Sum_probs=193.6
Q ss_pred CCCCCCcEEEEEeccchHHH-----HHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCC
Q 042809 1 MNKGTGALFVVKSAESEAGV-----QALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTL 69 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 69 (241)
+++++++.||||++.++-.. +.+..|-..|.+| .||.|++ +++..+|+|+||+++|+|.++|... +.+
T Consensus 93 ~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~-Gsf 171 (604)
T KOG0592|consen 93 REKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKY-GSF 171 (604)
T ss_pred eecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHh-Ccc
Confidence 47889999999998865433 3467899999999 6999999 8899999999999999999999985 789
Q ss_pred CHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccC-----Cc--cccccccccCcc
Q 042809 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNN-----GN--LKQSWQSIGGTQ 136 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~-----~~--~~~~~~~~~~~~ 136 (241)
++...+.++.++ ||++|||||||||+|||++.++.++|+|||.+..+.+.... .. .......+.||.
T Consensus 172 de~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTA 251 (604)
T KOG0592|consen 172 DETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTA 251 (604)
T ss_pred hHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeee
Confidence 999999998866 79999999999999999999999999999999977553322 11 111125688999
Q ss_pred cccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 137 LWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 137 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
.|.+||.+.+...++.+|+|+|||++|.|+.|++||.+..+--.. +........++...++.+++||+++|..||.
T Consensus 252 eYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF----qkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~ 327 (604)
T KOG0592|consen 252 EYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF----QKIQALDYEFPEGFPEDARDLIKKLLVRDPS 327 (604)
T ss_pred cccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH----HHHHHhcccCCCCCCHHHHHHHHHHHccCcc
Confidence 999999999999999999999999999999999999875332222 2222455677888889999999999999999
Q ss_pred CCCChHHHhcCCCCCCCC
Q 042809 217 KRWSAEELLNHTFISGNA 234 (241)
Q Consensus 217 ~Rps~~~~l~~p~~~~~~ 234 (241)
+|+|+.+|.+||||.+-.
T Consensus 328 ~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 328 DRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred ccccHHHHhhCcccccCC
Confidence 999999999999997654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=293.99 Aligned_cols=222 Identities=31% Similarity=0.527 Sum_probs=187.1
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
+++|++.||+|++++. ...+...+|..+|.+++||.||. ++...+|+|+||+.||.|+..|+. .+.+++
T Consensus 46 k~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~-eg~F~E 124 (357)
T KOG0598|consen 46 KKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQR-EGRFSE 124 (357)
T ss_pred EcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHh-cCCcch
Confidence 4689999999998854 34566899999999999999998 899999999999999999999997 578899
Q ss_pred HHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..++.++.+ +||++||+||||||+|||+|.+|.++|+|||+++...... .....++||+.|+|||++.
T Consensus 125 ~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~------~~t~tfcGT~eYmAPEil~ 198 (357)
T KOG0598|consen 125 DRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG------DATRTFCGTPEYMAPEILL 198 (357)
T ss_pred hHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC------CccccccCCccccChHHHh
Confidence 988887764 4899999999999999999999999999999998543321 2223478999999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC----Ch
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW----SA 221 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~ 221 (241)
+..|+..+|.||||+++|+|++|.+||.+....... ........+..+.-.+.+.+++++++|..+|++|. .+
T Consensus 199 ~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~---~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~ 275 (357)
T KOG0598|consen 199 GKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY---DKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDA 275 (357)
T ss_pred cCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH---HHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCCh
Confidence 999999999999999999999999999875433322 22222223444555888999999999999999996 79
Q ss_pred HHHhcCCCCCCC
Q 042809 222 EELLNHTFISGN 233 (241)
Q Consensus 222 ~~~l~~p~~~~~ 233 (241)
+++-+||||+.-
T Consensus 276 ~~ik~HpfF~~i 287 (357)
T KOG0598|consen 276 EEIKRHPFFKGI 287 (357)
T ss_pred HHhhcCcccccC
Confidence 999999999764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=294.13 Aligned_cols=227 Identities=30% Similarity=0.538 Sum_probs=193.2
Q ss_pred CCCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 1 MNKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++++++..||||.+.+. ...+.+..|+++|+.++|||||. ..++.+|+|||||+||+|.+|++.. +.+++
T Consensus 30 ~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~-~~l~e 108 (429)
T KOG0595|consen 30 RHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRR-GRLPE 108 (429)
T ss_pred EeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHc-CCCCH
Confidence 36788999999998854 35677899999999999999998 7788999999999999999999984 68999
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecC------CCeeecCCCcchhhcccccCCccccccccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH------GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (241)
+.++.+.+|+ ||+++||||||||.|||++.+ -.+||+|||+++...+ .......+|++.||
T Consensus 109 ~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~-------~~~a~tlcGSplYM 181 (429)
T KOG0595|consen 109 ATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP-------GSMAETLCGSPLYM 181 (429)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc-------hhHHHHhhCCcccc
Confidence 9999888765 899999999999999999875 3489999999987654 23345678999999
Q ss_pred CcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC
Q 042809 140 APEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219 (241)
Q Consensus 140 aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 219 (241)
|||++....|+.++|+||+|+++|++++|+.||...+........+. .....+..+...+..+.+++...+..+|.+|.
T Consensus 182 APEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k-~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~ 260 (429)
T KOG0595|consen 182 APEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK-GNEIVPVLPAELSNPLRELLISLLQRNPKDRI 260 (429)
T ss_pred CHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc-cccccCchhhhccCchhhhhhHHHhcCccccC
Confidence 99999999999999999999999999999999988766665553332 22344455666777788999999999999999
Q ss_pred ChHHHhcCCCCCCCCcc
Q 042809 220 SAEELLNHTFISGNAKK 236 (241)
Q Consensus 220 s~~~~l~~p~~~~~~~~ 236 (241)
+..+-..|+++.....+
T Consensus 261 ~~~~~~~~~~l~~~p~~ 277 (429)
T KOG0595|consen 261 SFEDFFDHPFLAANPQD 277 (429)
T ss_pred chHHhhhhhhcccCccc
Confidence 99999999999877654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=292.58 Aligned_cols=230 Identities=47% Similarity=0.777 Sum_probs=189.3
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccccC------C-ceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGRNG------E-KTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~------~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++++|..+|||.+... ...+.+.+|+.+|++++|||||+.. . ..++++|||+++|+|.+++...++.+++.
T Consensus 38 ~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~ 117 (313)
T KOG0198|consen 38 NKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEP 117 (313)
T ss_pred ecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHH
Confidence 4566899999987743 1256799999999999999999822 2 26999999999999999999976689999
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeec-CCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGS-HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
.++.++.|+ ||++|++|+||||+|||++. ++.+||+|||.+..... ............||+.|+|||++.
T Consensus 118 ~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~---~~~~~~~~~~~~Gtp~~maPEvi~ 194 (313)
T KOG0198|consen 118 LVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES---KGTKSDSELSVQGTPNYMAPEVIR 194 (313)
T ss_pred HHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc---ccccccccccccCCccccCchhhc
Confidence 999999877 69999999999999999999 79999999999976543 111122233466999999999998
Q ss_pred cc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 146 NE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 146 ~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
.+ ...+.+|||||||++.||+||..||... ................|.+|..++.+.++|+.+|+..+|.+|||++++
T Consensus 195 ~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eL 273 (313)
T KOG0198|consen 195 NGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEEL 273 (313)
T ss_pred CCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHH
Confidence 53 3446999999999999999999999874 233344445554556678899999999999999999999999999999
Q ss_pred hcCCCCCCCCc
Q 042809 225 LNHTFISGNAK 235 (241)
Q Consensus 225 l~~p~~~~~~~ 235 (241)
|.|||.+....
T Consensus 274 L~hpf~~~~~~ 284 (313)
T KOG0198|consen 274 LEHPFLKQNSI 284 (313)
T ss_pred hhChhhhcccc
Confidence 99999977554
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=307.29 Aligned_cols=225 Identities=27% Similarity=0.463 Sum_probs=192.3
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
|-.||+.+|||++.+. .....+.+|+-+|+.+.||||+. ++..++|+|.||++||.|++++.. .+++.+
T Consensus 33 h~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~-kG~l~e 111 (786)
T KOG0588|consen 33 HAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVR-KGPLPE 111 (786)
T ss_pred cccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHh-hCCCCC
Confidence 5679999999998854 34566899999999999999988 788899999999999999999998 466777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|| +|..+++||||||+|++++..+.+||+|||+|....+ .......||++.|++||++.
T Consensus 112 ~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-------gklLeTSCGSPHYA~PEIV~ 184 (786)
T KOG0588|consen 112 REAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP-------GKLLETSCGSPHYAAPEIVS 184 (786)
T ss_pred HHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC-------CccccccCCCcccCCchhhc
Confidence 7777777766 6999999999999999999999999999999975433 23445678999999999999
Q ss_pred ccCCC-chhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 146 NEGLD-FATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 146 ~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
|.+|. .++||||+|+++|.|+||.+||.+. +...++... .....++|..++.++++|+.+|+..||..|+|++++
T Consensus 185 G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---Nir~LLlKV-~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI 260 (786)
T KOG0588|consen 185 GRPYDGRPSDVWSCGVILFALLTGKLPFDDD---NIRVLLLKV-QRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEI 260 (786)
T ss_pred CCCCCCCccccchhHHHHHHHHhCCCCCCCc---cHHHHHHHH-HcCcccCCCcCCHHHHHHHHHHhccCccccccHHHH
Confidence 99985 7899999999999999999999853 333333332 356678889999999999999999999999999999
Q ss_pred hcCCCCCCCCccCC
Q 042809 225 LNHTFISGNAKKNS 238 (241)
Q Consensus 225 l~~p~~~~~~~~~~ 238 (241)
+.|||+.+....++
T Consensus 261 ~kHP~l~g~~~~~~ 274 (786)
T KOG0588|consen 261 LKHPFLSGYTSLPS 274 (786)
T ss_pred hhCchhhcCCCCCh
Confidence 99999988766443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=299.68 Aligned_cols=220 Identities=28% Similarity=0.464 Sum_probs=188.2
Q ss_pred CCCCCcEEEEEeccch-------HHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAESE-------AGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-------~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
+..+|..||+|.+..+ ...+.+.+|+.++++++ ||||++ .....+|+||||+.||+|.+++.. .++
T Consensus 38 ~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~ 116 (370)
T KOG0583|consen 38 HRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGR 116 (370)
T ss_pred eccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCC
Confidence 5678899999977653 23456778999999999 999998 666779999999999999999999 788
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecC-CCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH-GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
+.+..++.+++|+ ||++|++||||||+||+++.+ +.+||+|||++.... .........+|++.|+||
T Consensus 117 l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~------~~~~~l~t~cGsp~Y~aP 190 (370)
T KOG0583|consen 117 LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP------GEDGLLKTFCGSPAYAAP 190 (370)
T ss_pred CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC------CCCCcccCCCCCcccCCH
Confidence 9999999999877 799999999999999999999 999999999998663 112344667899999999
Q ss_pred ccccccC-CC-chhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhh-HHHHHHHHHHhhccCCCCC
Q 042809 142 EVLRNEG-LD-FATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQF-FKKVLDFLAKCLERKPEKR 218 (241)
Q Consensus 142 E~~~~~~-~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~~p~~R 218 (241)
|++.+.. |+ .++||||+|++||-|++|..||.+......... .......+|..+ +.++.+|+.+||..+|.+|
T Consensus 191 Evl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k----i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R 266 (370)
T KOG0583|consen 191 EVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK----IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTR 266 (370)
T ss_pred HHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH----HhcCCccCCCCcCCHHHHHHHHHHcCCCcccC
Confidence 9999877 75 889999999999999999999987433332222 335556677777 9999999999999999999
Q ss_pred CChHHHhcCCCCCC
Q 042809 219 WSAEELLNHTFISG 232 (241)
Q Consensus 219 ps~~~~l~~p~~~~ 232 (241)
+|+.++++||||+.
T Consensus 267 ~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 267 ITLLEILEHPWFQK 280 (370)
T ss_pred CCHHHHhhChhhcc
Confidence 99999999999997
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=273.12 Aligned_cols=226 Identities=30% Similarity=0.455 Sum_probs=192.5
Q ss_pred CCCCCCcEEEEEecc----chHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 1 MNKGTGALFVVKSAE----SEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~----~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++..||+.+|+|.++ +....+.+.+|++|-+.|+||||++ ...+..|+|+|+|.|++|..-+-.+ ..+++
T Consensus 31 ~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySE 109 (355)
T KOG0033|consen 31 VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSE 109 (355)
T ss_pred HhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH-HHHHH
Confidence 367788889998866 3346788999999999999999998 6778899999999999998877653 56788
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCC---CeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG---DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
..+-++++|+ +|.+||||||+||+|+++.+.. .+||+|||++..... ........|+|.|+|||
T Consensus 110 a~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~-------g~~~~G~~GtP~fmaPE 182 (355)
T KOG0033|consen 110 ADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND-------GEAWHGFAGTPGYLSPE 182 (355)
T ss_pred HHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC-------ccccccccCCCcccCHH
Confidence 8888888887 4999999999999999996653 499999999986653 23344567999999999
Q ss_pred cccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 143 VLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 143 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
++...+|+..+|||+.|+++|-++.|.+||.+.+.....+.+.......+++....++++.++|+++||..||.+|+|+.
T Consensus 183 vvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~ 262 (355)
T KOG0033|consen 183 VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITAD 262 (355)
T ss_pred HhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHH
Confidence 99999999999999999999999999999999777776666665555555556677889999999999999999999999
Q ss_pred HHhcCCCCCCCC
Q 042809 223 ELLNHTFISGNA 234 (241)
Q Consensus 223 ~~l~~p~~~~~~ 234 (241)
|+|.|||+.+..
T Consensus 263 EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 263 EALKHPWICNRE 274 (355)
T ss_pred HHhCCchhcchH
Confidence 999999998753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=274.71 Aligned_cols=225 Identities=27% Similarity=0.510 Sum_probs=182.1
Q ss_pred CCCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 1 MNKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
+++.||++||||.+.. +...+-..+|+++|++++|+|+|. .....+++|+|||++ ++-+-+......++.
T Consensus 22 rnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~ 100 (396)
T KOG0593|consen 22 RNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPS 100 (396)
T ss_pred ccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCH
Confidence 5899999999999763 234556789999999999999988 678899999999987 666777776778888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ +|+++++||||||+||+++.+|.+||||||.|...... .........|+.|+|||.+.
T Consensus 101 ~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p------gd~YTDYVATRWYRaPELLv 174 (396)
T KOG0593|consen 101 ELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP------GDNYTDYVATRWYRAPELLV 174 (396)
T ss_pred HHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC------cchhhhhhhhhhccChhhhc
Confidence 8888888876 59999999999999999999999999999999877631 12223345689999999998
Q ss_pred c-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCC---------------CC------------h
Q 042809 146 N-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPH---------------FP------------T 197 (241)
Q Consensus 146 ~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~------------~ 197 (241)
| ..|...+||||+||++.||++|++-|.+..+-+..-.+........++ +| +
T Consensus 175 GDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p 254 (396)
T KOG0593|consen 175 GDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYP 254 (396)
T ss_pred ccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcc
Confidence 8 779999999999999999999999998765554444433333222210 00 2
Q ss_pred hhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 198 QFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 198 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
..+.-+.+|+++||..||.+|+|.++++.||||.+
T Consensus 255 ~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 255 KISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred cchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 23456899999999999999999999999999954
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=294.85 Aligned_cols=222 Identities=35% Similarity=0.560 Sum_probs=183.8
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
+..+++.||||.+.. ....+.+.+|+.+|+..+|+|||. ...+.+|+||||++||+|.+.+.. ..+++..+
T Consensus 294 ~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~--~~~~E~qI 371 (550)
T KOG0578|consen 294 KISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK--TRMTEGQI 371 (550)
T ss_pred eccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc--ccccHHHH
Confidence 457889999999773 334566899999999999999998 566899999999999999999986 45788887
Q ss_pred HHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..+++ ++||.+|++|||||.+||+++.+|.+||+|||++..+..... ......||+.|+|||++....
T Consensus 372 A~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~------KR~TmVGTPYWMAPEVvtrk~ 445 (550)
T KOG0578|consen 372 AAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS------KRSTMVGTPYWMAPEVVTRKP 445 (550)
T ss_pred HHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC------ccccccCCCCccchhhhhhcc
Confidence 77766 447999999999999999999999999999999987655222 334567999999999999999
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhc-CCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 149 LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACS-NEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
|+++.||||||++++||+.|++||-... ....+...... ......+..++..+++|+.+||..|+.+|+|+.++|+|
T Consensus 446 YG~KVDIWSLGIMaIEMveGEPPYlnE~--PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 446 YGPKVDIWSLGIMAIEMVEGEPPYLNEN--PLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCccccchhhhhHHHHHhcCCCCccCCC--hHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 9999999999999999999999998632 22222222222 22234467789999999999999999999999999999
Q ss_pred CCCCCC
Q 042809 228 TFISGN 233 (241)
Q Consensus 228 p~~~~~ 233 (241)
|||+.+
T Consensus 524 pFl~~a 529 (550)
T KOG0578|consen 524 PFLKMA 529 (550)
T ss_pred hhhhhc
Confidence 999543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=272.05 Aligned_cols=219 Identities=30% Similarity=0.546 Sum_probs=189.3
Q ss_pred CCCCCCcEEEEEeccchHH-----HHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 1 MNKGTGALFVVKSAESEAG-----VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
+++.+|..||+|++.+... .+-..+|..+|+.+.||.+++ .+.+.+|+||||++||.|+++++. .++++
T Consensus 64 r~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk-~~rF~ 142 (355)
T KOG0616|consen 64 REKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRK-SGRFS 142 (355)
T ss_pred EEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHh-cCCCC
Confidence 3578899999999986643 344789999999999999998 678899999999999999999998 57889
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+++++.|+ ||++++++|||||+||++|.+|.+||+|||.++.... .....||||.|+|||++
T Consensus 143 e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---------rT~TlCGTPeYLAPEii 213 (355)
T KOG0616|consen 143 EPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---------RTWTLCGTPEYLAPEII 213 (355)
T ss_pred chhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC---------cEEEecCCccccChHHh
Confidence 99988887755 7999999999999999999999999999999986544 24678899999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW----- 219 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----- 219 (241)
...++..++|.||||+++|||+.|.+||.+... .. + ..........+|.-.+.++++|++.+|+.|-.+|.
T Consensus 214 ~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~~-i-Y~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlkn 289 (355)
T KOG0616|consen 214 QSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--IQ-I-YEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKN 289 (355)
T ss_pred hcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--HH-H-HHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhhhcCcCC
Confidence 999999999999999999999999999987543 22 2 22223456678888999999999999999999994
Q ss_pred ChHHHhcCCCCCCC
Q 042809 220 SAEELLNHTFISGN 233 (241)
Q Consensus 220 s~~~~l~~p~~~~~ 233 (241)
...++..||||+..
T Consensus 290 G~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 290 GVEDIKNHPWFKGV 303 (355)
T ss_pred CccccccCcccccc
Confidence 67799999999854
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=289.10 Aligned_cols=231 Identities=28% Similarity=0.488 Sum_probs=189.5
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
.+.||.++|+|++++.. ..+-+..|-.+|....+|.||+ ++..++||||||++||++.++|.. ...+++
T Consensus 162 Kk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~-~~~L~e 240 (550)
T KOG0605|consen 162 KKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMR-KDTLTE 240 (550)
T ss_pred EccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHh-cCcCch
Confidence 47899999999988543 3455789999999999999999 899999999999999999999997 578999
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhccccc------------------CCccc-
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKN------------------NGNLK- 126 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~------------------~~~~~- 126 (241)
..+++++.+. ||+.|++||||||+|+|+|..|.+||+|||++........ .....
T Consensus 241 ~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (550)
T KOG0605|consen 241 DWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPK 320 (550)
T ss_pred HHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccc
Confidence 9998887754 7999999999999999999999999999999964321000 00000
Q ss_pred ----------------------cccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHH
Q 042809 127 ----------------------QSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLL 184 (241)
Q Consensus 127 ----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 184 (241)
.-.....|||-|+|||++.+..|+..+|.|||||++|||+.|.+||...+.......+
T Consensus 321 ~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI 400 (550)
T KOG0605|consen 321 FNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKI 400 (550)
T ss_pred cccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0112456999999999999999999999999999999999999999887766665555
Q ss_pred HHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC---ChHHHhcCCCCCCCC
Q 042809 185 KIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW---SAEELLNHTFISGNA 234 (241)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~~p~~~~~~ 234 (241)
.........+-....+.++++||.+|+. ||.+|. +++||..||||++..
T Consensus 401 ~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 401 VNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 5444334343344566899999999999 999998 699999999998753
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=282.20 Aligned_cols=228 Identities=32% Similarity=0.558 Sum_probs=183.8
Q ss_pred CCCCcEEEEEecc---chHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh-CCCCCHHH
Q 042809 3 KGTGALFVVKSAE---SEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDAGV 73 (241)
Q Consensus 3 ~~~~~~vaiK~~~---~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~ 73 (241)
+.++.+||||++. ++...+.+++|+..|+.+.||||+. ..+..+|+||.||.+|++.+.++.. ...+++..
T Consensus 48 ~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~ 127 (516)
T KOG0582|consen 48 IPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEAS 127 (516)
T ss_pred cccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHH
Confidence 4678999999987 3445788999999999999999998 7888999999999999999999874 44588888
Q ss_pred HHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc--
Q 042809 74 IRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR-- 145 (241)
Q Consensus 74 ~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-- 145 (241)
+..+++ .|||.+|.+|||||+.|||++.+|.+||+|||.+....... .+. ...+..+.|++.|+|||.+.
T Consensus 128 Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G-~R~-~~rf~tfvgtp~wmAPEvl~q~ 205 (516)
T KOG0582|consen 128 IATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG-DRQ-VTRFNTFVGTPCWMAPEVLMQQ 205 (516)
T ss_pred HHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC-cee-eEeeccccCcccccChHHhhhc
Confidence 777766 55899999999999999999999999999999887665532 111 12225678999999999964
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC---------CCChhhHHHHHHHHHHhhccCCC
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP---------HFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
...|+.++||||||++..|+.+|..||.....-. .+-....+.++ +.....+..++.++..||.+||.
T Consensus 206 ~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk---vLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~ 282 (516)
T KOG0582|consen 206 LHGYDFKADIWSFGITACELAHGHAPFSKYPPMK---VLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPS 282 (516)
T ss_pred ccCccchhhhhhhhHHHHHHhcCCCCcccCChHH---HHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcc
Confidence 3568999999999999999999999998753322 22222223333 22244567899999999999999
Q ss_pred CCCChHHHhcCCCCCCCCc
Q 042809 217 KRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 217 ~Rps~~~~l~~p~~~~~~~ 235 (241)
+|||+++++.|+||+....
T Consensus 283 kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 283 KRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred cCCCHHHHhccHHHhhccc
Confidence 9999999999999987654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=289.96 Aligned_cols=223 Identities=32% Similarity=0.532 Sum_probs=189.2
Q ss_pred CCCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 1 MNKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
+.|.|.++||+|.+.+ +...+.+.+|+++++.++||||+. +...++|+|+||+.| +|+.++.. .+.+++
T Consensus 22 rrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~-d~~lpE 99 (808)
T KOG0597|consen 22 RRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQ-DGKLPE 99 (808)
T ss_pred ccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHh-ccCCCH
Confidence 4688999999999874 345677999999999999999998 888999999999976 99999997 577888
Q ss_pred HHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
+.+..++. ++||+.+|.|||+||.||+++..|.+|++|||+++.....+ .......|||.|+|||.+.
T Consensus 100 e~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t------~vltsikGtPlYmAPElv~ 173 (808)
T KOG0597|consen 100 EQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT------SVLTSIKGTPLYMAPELVE 173 (808)
T ss_pred HHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc------eeeeeccCcccccCHHHHc
Confidence 88777765 45899999999999999999999999999999998765521 2223456999999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
+.+|+..+|+||+||++||+++|++||... ....+.+... ..+...|...+..+.+|++.+|.+||.+|.|+.+++
T Consensus 174 e~pyd~~sDlWslGcilYE~~~G~PPF~a~---si~~Lv~~I~-~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 174 EQPYDHTSDLWSLGCILYELYVGQPPFYAR---SITQLVKSIL-KDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLL 249 (808)
T ss_pred CCCccchhhHHHHHHHHHHHhcCCCCchHH---HHHHHHHHHh-cCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHh
Confidence 999999999999999999999999999764 3333333322 344455668889999999999999999999999999
Q ss_pred cCCCCCCCCc
Q 042809 226 NHTFISGNAK 235 (241)
Q Consensus 226 ~~p~~~~~~~ 235 (241)
.|||+++...
T Consensus 250 ~HpF~k~~~~ 259 (808)
T KOG0597|consen 250 GHPFWKGKIN 259 (808)
T ss_pred cChHHhhhhh
Confidence 9999987654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=267.45 Aligned_cols=211 Identities=27% Similarity=0.478 Sum_probs=178.1
Q ss_pred CCCCCcEEEEEecc----chHHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHh---CC
Q 042809 2 NKGTGALFVVKSAE----SEAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKF---GG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~----~~~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~---~~ 67 (241)
+..+|+.+|.|.+. .....+.+..|+.+|++|+|||||+ ++..-+++|||||++|+|+..++.. +.
T Consensus 40 ~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr 119 (375)
T KOG0591|consen 40 CLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKR 119 (375)
T ss_pred eccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccc
Confidence 56789999999877 3456778999999999999999998 4445599999999999999988653 56
Q ss_pred CCCHHHHHHHHHHH------hhc--CC--ccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccc
Q 042809 68 TLDAGVIRLYTKEI------LHG--NG--ILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL 137 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~--~~--~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (241)
.+++..++.++.|+ +|+ .. +.||||||.||+++.+|.+||+|||+++.+.... ....+..|||.
T Consensus 120 ~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~------tfA~S~VGTPy 193 (375)
T KOG0591|consen 120 LIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT------TFAHSLVGTPY 193 (375)
T ss_pred cCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh------HHHHhhcCCCc
Confidence 78999999888877 487 44 8999999999999999999999999998765421 12235679999
Q ss_pred ccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC-hhhHHHHHHHHHHhhccCCC
Q 042809 138 WMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP-TQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 138 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~ 216 (241)
|++||.+.+.+|++++||||+||++|||+.-+.||.+. +...+-+....+..++.| ..++.++..||..|+..||.
T Consensus 194 YMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~ 270 (375)
T KOG0591|consen 194 YMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPE 270 (375)
T ss_pred ccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcc
Confidence 99999999999999999999999999999999999885 445555555556666677 67899999999999999999
Q ss_pred CCCCh
Q 042809 217 KRWSA 221 (241)
Q Consensus 217 ~Rps~ 221 (241)
.||+.
T Consensus 271 ~RP~t 275 (375)
T KOG0591|consen 271 QRPDT 275 (375)
T ss_pred cCCCc
Confidence 99985
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=267.37 Aligned_cols=227 Identities=26% Similarity=0.385 Sum_probs=183.3
Q ss_pred CCCCCCcEEEEEeccc----------hHHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHH
Q 042809 1 MNKGTGALFVVKSAES----------EAGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEK 64 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~----------~~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~ 64 (241)
+++.||+.+|+|++.. ....+.-.+|+.||+++. ||||+. +.+..+++|+|.|+.|.|++++.+
T Consensus 37 i~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts 116 (411)
T KOG0599|consen 37 IHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTS 116 (411)
T ss_pred hhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhh
Confidence 3688999999998661 133455689999999996 999988 677889999999999999999998
Q ss_pred hCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 65 FGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 65 ~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
.-.+++...+.+.+|+ ||.++||||||||+||+++.+.+++|+|||.++...+ .......||||+|
T Consensus 117 -~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~-------GekLrelCGTPgY 188 (411)
T KOG0599|consen 117 -KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP-------GEKLRELCGTPGY 188 (411)
T ss_pred -heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC-------chhHHHhcCCCcc
Confidence 4667787777777755 7999999999999999999999999999999998766 3345567899999
Q ss_pred cCcccccc------cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhc
Q 042809 139 MAPEVLRN------EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLE 212 (241)
Q Consensus 139 ~aPE~~~~------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 212 (241)
+|||.+.. ..|+...|+|++|+++|.++.|.+||.-...-.+...+.........+...+.+..+.+||.+||+
T Consensus 189 LAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLq 268 (411)
T KOG0599|consen 189 LAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQ 268 (411)
T ss_pred cChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHe
Confidence 99999864 457789999999999999999999997643322222222221222223345677899999999999
Q ss_pred cCCCCCCChHHHhcCCCCCCCCc
Q 042809 213 RKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 213 ~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.||.+|.|++++|+||||.+-+.
T Consensus 269 Vdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 269 VDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred eCchhcccHHHHhcChHHHHHHH
Confidence 99999999999999999954433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=282.35 Aligned_cols=228 Identities=25% Similarity=0.406 Sum_probs=188.6
Q ss_pred CCCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhCCCC
Q 042809 1 MNKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGGTL 69 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 69 (241)
+|..||++||+|.++- +.......+|+.+|++|.||||++ ...+.+|+|+|||++ +|.-++...+-.+
T Consensus 137 r~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkf 215 (560)
T KOG0600|consen 137 RDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKF 215 (560)
T ss_pred eecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCccc
Confidence 4789999999999773 334567899999999999999988 335799999999987 9999999877889
Q ss_pred CHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
++..++.+..|+ ||++|+.|||||.+|||+|.+|.+||+|||+|.......... .....-|+.|+|||.
T Consensus 216 t~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-----~T~rVvTLWYRpPEL 290 (560)
T KOG0600|consen 216 TEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-----YTSRVVTLWYRPPEL 290 (560)
T ss_pred ChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcc-----cccceEEeeccChHH
Confidence 999999999887 599999999999999999999999999999998554422211 233446889999999
Q ss_pred ccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC-------------------------h
Q 042809 144 LRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP-------------------------T 197 (241)
Q Consensus 144 ~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~ 197 (241)
+.| ..|+.+.|+||+||++.||++|++.|.+.++..-.+.+...+......+. .
T Consensus 291 LLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~ 370 (560)
T KOG0600|consen 291 LLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFK 370 (560)
T ss_pred hcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhc
Confidence 988 55899999999999999999999999998877666666655543322211 1
Q ss_pred hhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 198 QFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 198 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
..+....+|+..+|..||.+|.|+.++|+++||....
T Consensus 371 ~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p 407 (560)
T KOG0600|consen 371 DFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEP 407 (560)
T ss_pred cCCHHHHHHHHHHhccCccccccHHHHhcCcccccCC
Confidence 2345789999999999999999999999999995443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=280.24 Aligned_cols=213 Identities=31% Similarity=0.466 Sum_probs=178.2
Q ss_pred CcE-EEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCc-eeeeeecccCCCCHHHHHHH-hCCCCCHHH
Q 042809 6 GAL-FVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEK-TVNIFMEYMAGGSLLDVAEK-FGGTLDAGV 73 (241)
Q Consensus 6 ~~~-vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~-~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~ 73 (241)
|.. ||+|.+... ...+.|.+|+.+|.+++|||||. .... .+++||||+++|+|..++.. ....++...
T Consensus 64 g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~ 143 (362)
T KOG0192|consen 64 GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKV 143 (362)
T ss_pred CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHH
Confidence 555 999998732 22678999999999999999998 2232 69999999999999999988 467888888
Q ss_pred HHHHHHH------HhhcCC-ccccCCCCCcEEeecCC-CeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 74 IRLYTKE------ILHGNG-ILHCDLKCNNVLLGSHG-DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 74 ~~~~~~~------~Lh~~~-~vH~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
+..++.+ |||+++ +|||||||+|||++.++ ++||+|||++....... .......||+.|+|||++.
T Consensus 144 ~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~------~~~~~~~GT~~wMAPEv~~ 217 (362)
T KOG0192|consen 144 RLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK------TSMTSVAGTYRWMAPEVLR 217 (362)
T ss_pred HHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc------ccccCCCCCccccChhhhc
Confidence 8877775 489999 99999999999999998 99999999997544311 1222356999999999999
Q ss_pred --ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH
Q 042809 146 --NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 146 --~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
...|+.++||||||+++||++||..||.+... ............++.++...++.+..++.+||..+|..||++.+
T Consensus 218 ~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~e 295 (362)
T KOG0192|consen 218 GEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLE 295 (362)
T ss_pred CCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHH
Confidence 56899999999999999999999999988644 33344444567788888889999999999999999999999999
Q ss_pred Hhc
Q 042809 224 LLN 226 (241)
Q Consensus 224 ~l~ 226 (241)
++.
T Consensus 296 i~~ 298 (362)
T KOG0192|consen 296 IVS 298 (362)
T ss_pred HHH
Confidence 874
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=277.96 Aligned_cols=218 Identities=28% Similarity=0.476 Sum_probs=178.5
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+... ...+.+.+|+.++++++||||++ .++...++||||+.+++|.+++.. ...+++
T Consensus 22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~ 100 (291)
T cd05612 22 DRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN-SGRFSN 100 (291)
T ss_pred EcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH-cCCCCH
Confidence 4678999999998643 23456889999999999999988 567889999999999999999987 356777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||+|+||+++.+|.++|+|||++...... .....|++.|+|||.+.
T Consensus 101 ~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---------~~~~~gt~~y~aPE~~~ 171 (291)
T cd05612 101 STGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---------TWTLCGTPEYLAPEVIQ 171 (291)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---------cccccCChhhcCHHHHc
Confidence 7766665544 79999999999999999999999999999998754321 12345899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC-----
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS----- 220 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----- 220 (241)
+..++.++||||||+++|+|++|..||............. .....++...+..+.+++++||+.||.+||+
T Consensus 172 ~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~ 247 (291)
T cd05612 172 SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL----AGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNG 247 (291)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCC
Confidence 8889999999999999999999999997754333222221 2334556667889999999999999999995
Q ss_pred hHHHhcCCCCCCC
Q 042809 221 AEELLNHTFISGN 233 (241)
Q Consensus 221 ~~~~l~~p~~~~~ 233 (241)
+++++.||||+..
T Consensus 248 ~~~~l~h~~~~~~ 260 (291)
T cd05612 248 ADDVKNHRWFKSV 260 (291)
T ss_pred HHHHhcCccccCC
Confidence 9999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=283.29 Aligned_cols=220 Identities=27% Similarity=0.465 Sum_probs=180.3
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+... .....+.+|+.++++++||||++ ...+..|+||||+.+++|.+++.. ...+++
T Consensus 16 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~ 94 (323)
T cd05571 16 EKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSE 94 (323)
T ss_pred ECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHH-cCCCCH
Confidence 5678999999998743 23456788999999999999987 677889999999999999999987 456777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||+.|++||||||+||+++.++.+||+|||++...... ........|++.|+|||.+.
T Consensus 95 ~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~------~~~~~~~~gt~~y~aPE~~~ 168 (323)
T cd05571 95 DRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD------GATMKTFCGTPEYLAPEVLE 168 (323)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC------CCcccceecCccccChhhhc
Confidence 7777666554 79999999999999999999999999999998642211 11123456899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----C
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----S 220 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s 220 (241)
+..++.++|+||+||++|+|++|..||............. .....++..++.++.+++++||..+|.+|| +
T Consensus 169 ~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 244 (323)
T cd05571 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL----MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPED 244 (323)
T ss_pred CCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH----cCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCC
Confidence 9889999999999999999999999997654433322222 233456677888999999999999999999 8
Q ss_pred hHHHhcCCCCCC
Q 042809 221 AEELLNHTFISG 232 (241)
Q Consensus 221 ~~~~l~~p~~~~ 232 (241)
+.++++||||+.
T Consensus 245 ~~~ll~h~~f~~ 256 (323)
T cd05571 245 AKEIMEHRFFAS 256 (323)
T ss_pred HHHHHcCCCcCC
Confidence 999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=269.85 Aligned_cols=232 Identities=26% Similarity=0.378 Sum_probs=183.0
Q ss_pred CCCCCCcEEEEEecc----chHHHHHHHHHHHHHhhcCCCcccc----------cCCceeeeeecccCCCCHHHHHHHhC
Q 042809 1 MNKGTGALFVVKSAE----SEAGVQALRNEAEIRQSLNSPNIGR----------NGEKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~----~~~~~~~~~~e~~~l~~l~h~~i~~----------~~~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
+|+.||+.||||.+. +....++..+|+++|+.++|+||+. ..-..+|+|+|+| +.+|...++. +
T Consensus 42 ~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~-~ 119 (359)
T KOG0660|consen 42 KDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKS-Q 119 (359)
T ss_pred EEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHc-C
Confidence 378899999999866 5567788999999999999999976 3456899999999 4799999997 4
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..++...+..+..|+ +|+.+++||||||+|++++.++.+||+|||+|...... .. .........|..|.|
T Consensus 120 ~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~-~~---~~~mTeYVaTRWYRA 195 (359)
T KOG0660|consen 120 QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF-FE---DGFMTEYVATRWYRA 195 (359)
T ss_pred ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-Cc---ccchhcceeeeeecC
Confidence 559999999999988 49999999999999999999999999999999877543 11 112233446889999
Q ss_pred ccccc-ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHh----------------------cCCCCCCC-
Q 042809 141 PEVLR-NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIAC----------------------SNEKPHFP- 196 (241)
Q Consensus 141 PE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------~~~~~~~~- 196 (241)
||++. ...|+.+.||||+||++.||++|++-|.+.+...-..++.... ....+..+
T Consensus 196 PElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f 275 (359)
T KOG0660|consen 196 PELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPF 275 (359)
T ss_pred HHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCH
Confidence 99985 4678999999999999999999999997643322222111111 11111111
Q ss_pred ----hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCccCC
Q 042809 197 ----TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKNS 238 (241)
Q Consensus 197 ----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~~~ 238 (241)
+..++.+.+|+.+||.+||.+|+|++++|+|||+..-..-+.
T Consensus 276 ~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 276 SSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred HHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 245578999999999999999999999999999987665433
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=290.59 Aligned_cols=219 Identities=29% Similarity=0.502 Sum_probs=188.3
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
.+.|++.+|||++++. +..+....|.+++.... ||.++. ++..++|.||||+.||++..+.+. ..++
T Consensus 389 ~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~--~~F~ 466 (694)
T KOG0694|consen 389 LKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHT--DVFS 466 (694)
T ss_pred EcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEec--cccc
Confidence 3678999999998853 45677889999988876 999988 899999999999999996555553 6789
Q ss_pred HHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..++.|+. |+||++||++||||.+||++|.+|.+||+|||+++..- ........++|||.|+|||++
T Consensus 467 e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m------~~g~~TsTfCGTpey~aPEil 540 (694)
T KOG0694|consen 467 EPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM------GQGDRTSTFCGTPEFLAPEVL 540 (694)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC------CCCCccccccCChhhcChhhh
Confidence 999888765 66899999999999999999999999999999997422 122345678999999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-C---
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-S--- 220 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s--- 220 (241)
.+..|+.++|.|||||++|+|+.|+.||.+.+++.....+. ...+.+|..++.+..++++++|.++|.+|. +
T Consensus 541 ~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~----~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~ 616 (694)
T KOG0694|consen 541 TEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV----NDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGER 616 (694)
T ss_pred ccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh----cCCCCCCCcccHHHHHHHHHHhccCcccccCCCCC
Confidence 99999999999999999999999999999876655544443 566778899999999999999999999999 3
Q ss_pred -hHHHhcCCCCCC
Q 042809 221 -AEELLNHTFISG 232 (241)
Q Consensus 221 -~~~~l~~p~~~~ 232 (241)
++++..||||+.
T Consensus 617 d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 617 DAEDIKKHPFFRS 629 (694)
T ss_pred CchhhhhCCcccc
Confidence 689999999975
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=276.46 Aligned_cols=227 Identities=25% Similarity=0.429 Sum_probs=181.6
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~ 70 (241)
++.+|+.||+|.+... .....+.+|+.++.++.|+||+. ..++..++|+||+++|+|.+++.... ..++
T Consensus 21 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~ 100 (285)
T cd05631 21 VRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD 100 (285)
T ss_pred EecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCC
Confidence 4678999999987643 22345778999999999999987 56778999999999999998886543 3577
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||+.|++||||||+||+++.++.++|+|||++...... .......|+..|+|||.+
T Consensus 101 ~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~g~~~y~aPE~~ 173 (285)
T cd05631 101 EQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-------ETVRGRVGTVGYMAPEVI 173 (285)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-------CeecCCCCCCCccCHhhh
Confidence 77776666544 79999999999999999999999999999998654321 111234589999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC----
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS---- 220 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---- 220 (241)
.+..++.++||||||+++|++++|+.||......................++...+.++.+|+++||+.+|.+||+
T Consensus 174 ~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~ 253 (285)
T cd05631 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGN 253 (285)
T ss_pred cCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCC
Confidence 9999999999999999999999999999765443332223323333344556677889999999999999999997
Q ss_pred -hHHHhcCCCCCCCCc
Q 042809 221 -AEELLNHTFISGNAK 235 (241)
Q Consensus 221 -~~~~l~~p~~~~~~~ 235 (241)
++++++||||++...
T Consensus 254 ~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 254 GAAGVKQHPIFKNINF 269 (285)
T ss_pred CHHHHhcCHhhcCCCH
Confidence 899999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=282.12 Aligned_cols=218 Identities=30% Similarity=0.524 Sum_probs=178.5
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+... ...+.+.+|+.++.+++||||++ ..++..|+||||+.+++|.+++.. ...+++
T Consensus 39 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~ 117 (329)
T PTZ00263 39 HKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK-AGRFPN 117 (329)
T ss_pred ECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH-cCCCCH
Confidence 4678999999998743 23456889999999999999998 677899999999999999999987 456677
Q ss_pred HHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++. ++||++|++||||||+||+++.++.+||+|||++...... .....|++.|+|||.+.
T Consensus 118 ~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---------~~~~~gt~~y~aPE~~~ 188 (329)
T PTZ00263 118 DVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---------TFTLCGTPEYLAPEVIQ 188 (329)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---------cceecCChhhcCHHHHc
Confidence 76665554 4489999999999999999999999999999998754321 12345899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC-----
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS----- 220 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----- 220 (241)
+..++.++|+||||+++|+|++|..||.+......... . ......++..++..+.+|+++||+.||.+||+
T Consensus 189 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---i-~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 264 (329)
T PTZ00263 189 SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK---I-LAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGG 264 (329)
T ss_pred CCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHH---H-hcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCC
Confidence 98899999999999999999999999976433222211 1 12334556667889999999999999999996
Q ss_pred hHHHhcCCCCCCC
Q 042809 221 AEELLNHTFISGN 233 (241)
Q Consensus 221 ~~~~l~~p~~~~~ 233 (241)
+++++.||||+..
T Consensus 265 ~~~ll~hp~f~~~ 277 (329)
T PTZ00263 265 VADVKNHPYFHGA 277 (329)
T ss_pred HHHHhcCCccCCC
Confidence 7999999999763
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=263.65 Aligned_cols=230 Identities=27% Similarity=0.377 Sum_probs=184.7
Q ss_pred CCCCCCcEEEEEeccchHHH----HHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhCCCC
Q 042809 1 MNKGTGALFVVKSAESEAGV----QALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGGTL 69 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 69 (241)
+|+.|+.+||+|.++.+... -...+|+.+|.+++|||||. .+-+.+|+|||||++ +|.+++....+++
T Consensus 96 kdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F 174 (419)
T KOG0663|consen 96 KDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPF 174 (419)
T ss_pred ccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCC
Confidence 58999999999998854322 23579999999999999987 455679999999986 9999999988899
Q ss_pred CHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
....++.+..|+ ||.+.|+|||||++|++++..|.+||+|||+|..++... .......-|..|+|||.
T Consensus 175 ~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~------k~~T~lVVTLWYRaPEL 248 (419)
T KOG0663|consen 175 LPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL------KPYTPLVVTLWYRAPEL 248 (419)
T ss_pred chHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc------ccCcceEEEeeecCHHH
Confidence 999998888876 699999999999999999999999999999999876631 22233446889999999
Q ss_pred ccccC-CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC---------------------------CC
Q 042809 144 LRNEG-LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP---------------------------HF 195 (241)
Q Consensus 144 ~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 195 (241)
+.|.+ |+.+.|+||+||++.|++++.+.|.+..+-+....+......... .+
T Consensus 249 LLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF 328 (419)
T KOG0663|consen 249 LLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKF 328 (419)
T ss_pred hcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhc
Confidence 98855 889999999999999999999999876544433333322211110 01
Q ss_pred Chh-hHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCccC
Q 042809 196 PTQ-FFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKN 237 (241)
Q Consensus 196 ~~~-~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~~ 237 (241)
+.. +++...+|+..+|..||.+|.|++++|.|.||++.+...
T Consensus 329 ~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~ 371 (419)
T KOG0663|consen 329 GALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI 371 (419)
T ss_pred cccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence 111 446788999999999999999999999999999865543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=277.37 Aligned_cols=221 Identities=29% Similarity=0.479 Sum_probs=179.7
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+++.||+|.+... .....+.+|+.++.+++||||++ ...+..|+||||+++|+|.+++.. ...+++
T Consensus 14 ~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~ 92 (312)
T cd05585 14 KRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR-EGRFDL 92 (312)
T ss_pred ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHh-cCCCCH
Confidence 5678999999998632 33456788999999999999988 567889999999999999999987 456777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.
T Consensus 93 ~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~gt~~y~aPE~~~ 166 (312)
T cd05585 93 SRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD------DKTNTFCGTPEYLAPELLL 166 (312)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC------CccccccCCcccCCHHHHc
Confidence 7777666544 799999999999999999999999999999986432211 1122345899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC---ChH
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW---SAE 222 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~ 222 (241)
+..++.++||||+|+++|++++|..||.+......... .......++...+..+.+++.+||..+|.+|| ++.
T Consensus 167 ~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~ 242 (312)
T cd05585 167 GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK----ILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQ 242 (312)
T ss_pred CCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHH----HHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHH
Confidence 98899999999999999999999999976543322221 12334556677888999999999999999997 579
Q ss_pred HHhcCCCCCCC
Q 042809 223 ELLNHTFISGN 233 (241)
Q Consensus 223 ~~l~~p~~~~~ 233 (241)
+++.||||+..
T Consensus 243 e~l~hp~~~~~ 253 (312)
T cd05585 243 EIKNHPFFSQL 253 (312)
T ss_pred HHHcCCCcCCC
Confidence 99999999874
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=275.33 Aligned_cols=227 Identities=28% Similarity=0.435 Sum_probs=194.6
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
+--||..||||++.+. .....+++|++-|+.++|||||+ ...-.+|+|+|.-++|+|++||-.+...+.+.
T Consensus 39 HVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~ 118 (864)
T KOG4717|consen 39 HVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNED 118 (864)
T ss_pred hhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHH
Confidence 3458999999998843 34566899999999999999999 56678999999999999999999999999999
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeec-CCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGS-HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
.++.++.|| +|+..+|||||||+|+++-. -|-+||+|||++..+.+ .......||+..|.|||++.
T Consensus 119 La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-------G~kL~TsCGSLAYSAPEILL 191 (864)
T KOG4717|consen 119 LAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-------GKKLTTSCGSLAYSAPEILL 191 (864)
T ss_pred HHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC-------cchhhcccchhhccCchhhh
Confidence 999999988 58899999999999997744 58899999999976544 34455678999999999999
Q ss_pred ccCCC-chhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 146 NEGLD-FATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 146 ~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
|..|+ ++.||||||+++|.++.|+.||....+......+. ...+..|..++.++++||..||..+|++|.|++++
T Consensus 192 GDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm----DCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI 267 (864)
T KOG4717|consen 192 GDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM----DCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEI 267 (864)
T ss_pred cCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh----cccccCchhhhHHHHHHHHHHHhcCchhhccHHHH
Confidence 98886 78999999999999999999998765444433333 56678889999999999999999999999999999
Q ss_pred hcCCCCCCCCccCCC
Q 042809 225 LNHTFISGNAKKNST 239 (241)
Q Consensus 225 l~~p~~~~~~~~~~~ 239 (241)
..++|++....-.++
T Consensus 268 ~s~~Wlq~~D~~~sT 282 (864)
T KOG4717|consen 268 VSTSWLQAGDRGLST 282 (864)
T ss_pred hccccccCCCCCccc
Confidence 999999876654443
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=276.80 Aligned_cols=221 Identities=27% Similarity=0.450 Sum_probs=179.5
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+... .....+.+|+++++.++||||++ ...+..|+||||+++++|..++.. ...+++
T Consensus 16 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~~~~ 94 (323)
T cd05595 16 EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTE 94 (323)
T ss_pred ECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHH-cCCCCH
Confidence 5678999999998743 23456778999999999999988 567789999999999999998876 456777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.++.++|+|||++...... ........|++.|+|||.+.
T Consensus 95 ~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~------~~~~~~~~gt~~y~aPE~~~ 168 (323)
T cd05595 95 ERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD------GATMKTFCGTPEYLAPEVLE 168 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC------CCccccccCCcCcCCccccc
Confidence 7777766654 79999999999999999999999999999988642111 11122345899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----C
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----S 220 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s 220 (241)
+..++.++|+||||+++|++++|..||............. .....++..+++.+.+++.+||+.+|.+|+ +
T Consensus 169 ~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~----~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 244 (323)
T cd05595 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL----MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 244 (323)
T ss_pred CCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh----cCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCC
Confidence 8889999999999999999999999997654433322221 233445667888999999999999999998 9
Q ss_pred hHHHhcCCCCCCC
Q 042809 221 AEELLNHTFISGN 233 (241)
Q Consensus 221 ~~~~l~~p~~~~~ 233 (241)
+.++++||||...
T Consensus 245 ~~~~l~h~~~~~~ 257 (323)
T cd05595 245 AKEVMEHRFFLSI 257 (323)
T ss_pred HHHHHcCCCcCCC
Confidence 9999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=277.86 Aligned_cols=221 Identities=27% Similarity=0.469 Sum_probs=179.8
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+... .....+.+|+.+++.++||||++ ..++..|+||||+++|+|.+++.. ...+++
T Consensus 16 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~l~~ 94 (328)
T cd05593 16 EKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR-ERVFSE 94 (328)
T ss_pred ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh-cCCCCH
Confidence 5678999999998743 33456789999999999999987 677889999999999999999876 456777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.++.+||+|||++...... ........|++.|+|||.+.
T Consensus 95 ~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~------~~~~~~~~gt~~y~aPE~~~ 168 (328)
T cd05593 95 DRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD------AATMKTFCGTPEYLAPEVLE 168 (328)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc------ccccccccCCcCccChhhhc
Confidence 7776666544 79999999999999999999999999999998642211 11122346899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----C
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----S 220 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s 220 (241)
+..++.++|+||||+++|++++|+.||............ ......++...+.++.+++++||..+|.+|+ +
T Consensus 169 ~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~----~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 244 (328)
T cd05593 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI----LMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDD 244 (328)
T ss_pred CCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh----ccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCC
Confidence 888999999999999999999999999765433322221 2233456677888999999999999999997 8
Q ss_pred hHHHhcCCCCCCC
Q 042809 221 AEELLNHTFISGN 233 (241)
Q Consensus 221 ~~~~l~~p~~~~~ 233 (241)
+.++++||||...
T Consensus 245 ~~~il~h~~~~~~ 257 (328)
T cd05593 245 AKEIMRHSFFTGV 257 (328)
T ss_pred HHHHhcCCCcCCC
Confidence 9999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=274.93 Aligned_cols=228 Identities=25% Similarity=0.450 Sum_probs=176.3
Q ss_pred CCCCCCcEEEEEeccchH----------------HHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCC
Q 042809 1 MNKGTGALFVVKSAESEA----------------GVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGS 57 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~~~----------------~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~ 57 (241)
+|..+|+.||||++.+.. ..+...+|+.+|+++.|||||+ .....+|+|+|||..|.
T Consensus 117 r~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~ 196 (576)
T KOG0585|consen 117 RDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGE 196 (576)
T ss_pred eecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCc
Confidence 366789999999977321 2357889999999999999998 56778999999999887
Q ss_pred HHHHHHHhCCC-CCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccc
Q 042809 58 LLDVAEKFGGT-LDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQ 130 (241)
Q Consensus 58 L~~~l~~~~~~-~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 130 (241)
+...-. ..+ +....++.+++ +|||.+|++||||||+|+|++.+|++||+|||.+...... ..........
T Consensus 197 v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~-~~~~~d~~L~ 273 (576)
T KOG0585|consen 197 VKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQG-SDEGSDDQLS 273 (576)
T ss_pred cccCCC--CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccC-CccccHHHHh
Confidence 643322 233 77777777766 6699999999999999999999999999999999755332 1112222333
Q ss_pred cccCcccccCcccccccC----CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC--hhhHHHHH
Q 042809 131 SIGGTQLWMAPEVLRNEG----LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP--TQFFKKVL 204 (241)
Q Consensus 131 ~~~~~~~~~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 204 (241)
...|||.|+|||.+.++. .+.+.||||+|++||-++.|+.||.+...-.....+ ...+..+| +.+.+.++
T Consensus 274 ~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI----vn~pL~fP~~pe~~e~~k 349 (576)
T KOG0585|consen 274 RTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI----VNDPLEFPENPEINEDLK 349 (576)
T ss_pred hcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH----hcCcccCCCcccccHHHH
Confidence 467999999999997732 347889999999999999999999875332222222 23333333 34678999
Q ss_pred HHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 205 DFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 205 ~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
+||++||.+||.+|+++.++..|||......
T Consensus 350 Dli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 350 DLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred HHHHHHhhcChhheeehhhheecceeccCCC
Confidence 9999999999999999999999999987643
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=252.90 Aligned_cols=228 Identities=25% Similarity=0.336 Sum_probs=183.8
Q ss_pred CCCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 1 MNKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
+|.+||+.||||.+.-. .......+|++.|+.++|+||+. ...+.+.+|+||++ .+|...+++....++.
T Consensus 22 ~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd~~i~l~p 100 (318)
T KOG0659|consen 22 RDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKDKNIILSP 100 (318)
T ss_pred EecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcccccccCH
Confidence 47899999999998732 22456889999999999999988 67889999999997 6999999998889999
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
+.++.++.+. ||++.+.||||||.|++++++|.+||+|||++..+....... ....-|+.|+|||.+.
T Consensus 101 a~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~------~~~V~TRWYRAPELLf 174 (318)
T KOG0659|consen 101 ADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ------THQVVTRWYRAPELLF 174 (318)
T ss_pred HHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc------ccceeeeeccChHHhc
Confidence 9998887754 799999999999999999999999999999998776522211 1224688999999998
Q ss_pred cc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCC------------------------CChhhH
Q 042809 146 NE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPH------------------------FPTQFF 200 (241)
Q Consensus 146 ~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~ 200 (241)
|. .|+...|+||+||++.|++-|.+-|.+..+-+-...+........++ .-...+
T Consensus 175 Gsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas 254 (318)
T KOG0659|consen 175 GSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAAS 254 (318)
T ss_pred cchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcccccccccc
Confidence 74 58899999999999999999988887765444433333332222211 112234
Q ss_pred HHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 201 KKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 201 ~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.++.+|+.+||..||.+|+|+.|++.|+||+..+.
T Consensus 255 ~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 255 SDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred HHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence 67899999999999999999999999999986543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=268.91 Aligned_cols=218 Identities=26% Similarity=0.450 Sum_probs=185.4
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
+...|+.||||.+++ +...-.+++|++||..|+||||+. ++.+.+.+||||..+|.|++|+.+ .+.+++
T Consensus 74 e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSe-r~~LsE 152 (668)
T KOG0611|consen 74 EHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISE-RGSLSE 152 (668)
T ss_pred hccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHH-hccccH
Confidence 346799999999774 344556899999999999999988 788999999999999999999998 578999
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..++.+++|| +|.++++|||||.+||++|.++.+||.|||++..+.+ ..-...+||++.|.+||++.
T Consensus 153 rEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~-------~kfLqTFCGSPLYASPEIvN 225 (668)
T KOG0611|consen 153 REARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD-------KKFLQTFCGSPLYASPEIVN 225 (668)
T ss_pred HHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc-------ccHHHHhcCCcccCCccccC
Confidence 9999999987 6999999999999999999999999999999987655 22345688999999999999
Q ss_pred ccCC-CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 146 NEGL-DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 146 ~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
|.+| .+..|.||||+++|.++.|..||.+.+.......+. .+. +. .+.-+.+..-||++||..||.+|.|++++
T Consensus 226 G~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs---~Ga-Yr-EP~~PSdA~gLIRwmLmVNP~RRATieDi 300 (668)
T KOG0611|consen 226 GTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS---RGA-YR-EPETPSDASGLIRWMLMVNPERRATIEDI 300 (668)
T ss_pred CCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh---ccc-cc-CCCCCchHHHHHHHHHhcCcccchhHHHH
Confidence 9998 589999999999999999999999875544433333 222 11 23345578899999999999999999999
Q ss_pred hcCCCCCC
Q 042809 225 LNHTFISG 232 (241)
Q Consensus 225 l~~p~~~~ 232 (241)
..|=|++-
T Consensus 301 AsHWWvNw 308 (668)
T KOG0611|consen 301 ASHWWVNW 308 (668)
T ss_pred hhhheeec
Confidence 99988854
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=269.30 Aligned_cols=226 Identities=28% Similarity=0.419 Sum_probs=178.8
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh---CCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF---GGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~ 68 (241)
++.+|+.||+|.+... ...+.+..|+.+++.+.|+||++ ..+...++||||+++|+|..++... ...
T Consensus 14 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~ 93 (280)
T cd05608 14 MRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG 93 (280)
T ss_pred EccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCC
Confidence 5678999999998643 23356788999999999999987 5667899999999999999887542 345
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
+++..+..++.|+ ||++|++||||+|+||+++.++.++|+|||.+........ ......|++.|+|||
T Consensus 94 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~------~~~~~~g~~~y~aPE 167 (280)
T cd05608 94 FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS------KTKGYAGTPGFMAPE 167 (280)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc------cccccCCCcCccCHH
Confidence 7777776666554 7999999999999999999999999999999865433111 112345789999999
Q ss_pred cccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC---
Q 042809 143 VLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW--- 219 (241)
Q Consensus 143 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp--- 219 (241)
.+.+..++.++|+||||+++|++++|+.||.......................+..++..+.+++.+||+.+|.+||
T Consensus 168 ~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 247 (280)
T cd05608 168 LLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFR 247 (280)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCC
Confidence 99999999999999999999999999999976433222222222222333445566788999999999999999999
Q ss_pred --ChHHHhcCCCCCCC
Q 042809 220 --SAEELLNHTFISGN 233 (241)
Q Consensus 220 --s~~~~l~~p~~~~~ 233 (241)
|++++++||||+..
T Consensus 248 ~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 248 DGNCDGLRTHPLFRDL 263 (280)
T ss_pred CCCHHHHhcChhhhcC
Confidence 88999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=271.76 Aligned_cols=225 Identities=24% Similarity=0.404 Sum_probs=179.1
Q ss_pred CCCCCcEEEEEeccchH-HHHH--HHHHHHHHhhcC-CCcccc------cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEA-GVQA--LRNEAEIRQSLN-SPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-~~~~--~~~e~~~l~~l~-h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
.+.+|..||||..+..- ..++ =.+|++.|++|. ||||++ +.+.++|+|||||+ .+|+.+++.++..+++
T Consensus 31 ~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~R~r~fse 109 (538)
T KOG0661|consen 31 SKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNLYQLMKDRNRLFSE 109 (538)
T ss_pred ecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh-hhHHHHHhhcCCcCCH
Confidence 46789999999877431 1222 358999999999 999988 44459999999996 6999999999999999
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..++.++.|+ +|.+|+.|||+||+|||++.+..+||+|||+|+.+..... ......|+.|+|||++.
T Consensus 110 ~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP-------YTeYVSTRWYRAPEvLL 182 (538)
T KOG0661|consen 110 SDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP-------YTEYVSTRWYRAPEVLL 182 (538)
T ss_pred HHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC-------cchhhhcccccchHHhh
Confidence 9999999988 5999999999999999999999999999999987655222 22344689999999985
Q ss_pred -ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC----------------------------CCC
Q 042809 146 -NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP----------------------------HFP 196 (241)
Q Consensus 146 -~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~ 196 (241)
.+.|+...|+||+||+++|+.+-++.|.+..+ ...+.+....-..| ..-
T Consensus 183 rs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE--~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~ 260 (538)
T KOG0661|consen 183 RSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE--IDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLL 260 (538)
T ss_pred hccccCCchHHHHHHHHHHHHHHhcccCCCCcH--HHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhC
Confidence 46689999999999999999999999976432 22222222111111 011
Q ss_pred hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 197 TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 197 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
+..+.++.++|.+|++.||++|||++++++||||.....-
T Consensus 261 p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 261 PNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred cccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 2256789999999999999999999999999999876553
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=274.89 Aligned_cols=226 Identities=29% Similarity=0.405 Sum_probs=189.5
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.||+.+|+|.+.+.. ..+.+.+|+.+|+++. ||||+. ++...+++|||+|.||.|.+.+... .++
T Consensus 56 ~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~s 133 (382)
T KOG0032|consen 56 EKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYS 133 (382)
T ss_pred ecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCC
Confidence 57889999999987543 3468999999999999 999988 7788999999999999999999986 388
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecC----CCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH----GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~----~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
+..+..++.|+ ||+.|++||||||+|+++... +.++++|||++..... .......+||+.|+|
T Consensus 134 E~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-------~~~~~~~~Gtp~y~A 206 (382)
T KOG0032|consen 134 ERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-------GERLHTIVGTPEYVA 206 (382)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-------CceEeeecCCccccC
Confidence 88887777765 799999999999999999654 4799999999986544 234456789999999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS 220 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 220 (241)
||.+.+..|+..+|+||+|+++|.|++|..||.+.+.......+..............++..+.++|+.|+..+|.+|+|
T Consensus 207 PEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~t 286 (382)
T KOG0032|consen 207 PEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLT 286 (382)
T ss_pred chhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCC
Confidence 99999999999999999999999999999999887655544433322223334445667899999999999999999999
Q ss_pred hHHHhcCCCCCCCCcc
Q 042809 221 AEELLNHTFISGNAKK 236 (241)
Q Consensus 221 ~~~~l~~p~~~~~~~~ 236 (241)
+.++|+|||++.....
T Consensus 287 a~~~L~HpWi~~~~~~ 302 (382)
T KOG0032|consen 287 AAQALQHPWIKSIGEA 302 (382)
T ss_pred HHHHhcCccccCCccc
Confidence 9999999999876443
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=276.91 Aligned_cols=222 Identities=30% Similarity=0.510 Sum_probs=178.0
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|++... .....+.+|+.++..++||||++ ...+..|+||||++|++|.+++.. ...+++
T Consensus 22 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~ 100 (333)
T cd05600 22 KKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN-LGVLSE 100 (333)
T ss_pred ECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHH-cCCCCH
Confidence 4678999999998743 23456889999999999999988 667889999999999999999986 456777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||+.|++||||+|+||+++.++.+||+|||++..... ......|++.|+|||.+.
T Consensus 101 ~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---------~~~~~~gt~~y~aPE~~~ 171 (333)
T cd05600 101 DHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---------YANSVVGSPDYMAPEVLR 171 (333)
T ss_pred HHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---------ccCCcccCccccChhHhc
Confidence 7766666554 7999999999999999999999999999999875432 112345899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhc-CCCCCCC---hhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACS-NEKPHFP---TQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
+..++.++||||||+++|+|++|..||................. ...+... ...+.++.+++.+||..+|.+|||+
T Consensus 172 ~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~ 251 (333)
T cd05600 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSL 251 (333)
T ss_pred CCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCH
Confidence 98999999999999999999999999977544333222221111 1111111 2457899999999999999999999
Q ss_pred HHHhcCCCCCCC
Q 042809 222 EELLNHTFISGN 233 (241)
Q Consensus 222 ~~~l~~p~~~~~ 233 (241)
++++.||||+..
T Consensus 252 ~~ll~h~~~~~~ 263 (333)
T cd05600 252 EDIKNHPFFKEV 263 (333)
T ss_pred HHHHhCcccCCC
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=272.48 Aligned_cols=226 Identities=28% Similarity=0.445 Sum_probs=176.3
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+|..||+|.+..+ ...+.+.+|++++++++||||++ ..++..++||||+++++|.+++... ..+++..
T Consensus 26 ~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~ 104 (331)
T cd06649 26 HKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA-KRIPEEI 104 (331)
T ss_pred ECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHc-CCCCHHH
Confidence 5678999999987743 34567999999999999999998 5667899999999999999999873 4577777
Q ss_pred HHHHHHHH------hhcC-CccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 74 IRLYTKEI------LHGN-GILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 74 ~~~~~~~~------Lh~~-~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
+..++.|+ ||+. +++||||||+||+++.++.++|+|||++...... ......|++.|+|||.+.+
T Consensus 105 ~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--------~~~~~~g~~~y~aPE~~~~ 176 (331)
T cd06649 105 LGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--------MANSFVGTRSYMSPERLQG 176 (331)
T ss_pred HHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--------ccccCCCCcCcCCHhHhcC
Confidence 66666544 7875 6999999999999999999999999998654331 1123458899999999999
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHH----------------------------------------
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKI---------------------------------------- 186 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------------------------------------- 186 (241)
..++.++|+||||+++|++++|+.||..............
T Consensus 177 ~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T cd06649 177 THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFEL 256 (331)
T ss_pred CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHH
Confidence 8899999999999999999999999965433222111110
Q ss_pred ---HhcCCCCCC-ChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 187 ---ACSNEKPHF-PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 187 ---~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
......+.. ....+.++.+|+.+||+.+|++|||++++++||||+....+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~ 310 (331)
T cd06649 257 LDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVE 310 (331)
T ss_pred HHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcccc
Confidence 000111111 12356789999999999999999999999999999866543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=275.83 Aligned_cols=211 Identities=27% Similarity=0.414 Sum_probs=176.1
Q ss_pred cEEEEEeccc-hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHH-hCCCCCHHHHHHHHH
Q 042809 7 ALFVVKSAES-EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEK-FGGTLDAGVIRLYTK 79 (241)
Q Consensus 7 ~~vaiK~~~~-~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~ 79 (241)
..||+|.+.. ....+.|.+|+.+|++|+|+|||+ ..++.+|||||||+.|+|.+||+. .+..+.......++.
T Consensus 231 ~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~ 310 (468)
T KOG0197|consen 231 TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAA 310 (468)
T ss_pred CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHH
Confidence 3788888775 334577889999999999999998 555689999999999999999997 567788888888888
Q ss_pred HH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchh
Q 042809 80 EI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT 153 (241)
Q Consensus 80 ~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 153 (241)
|+ |+++++|||||...||||+.+..+||+|||+++...+... .......-+..|.|||.+...+++.++
T Consensus 311 qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y-----~~~~~~kfPIkWtAPEa~~~~~FS~kS 385 (468)
T KOG0197|consen 311 QIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY-----TASEGGKFPIKWTAPEALNYGKFSSKS 385 (468)
T ss_pred HHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCce-----eecCCCCCCceecCHHHHhhCCccccc
Confidence 76 7899999999999999999999999999999985433111 111111235669999999999999999
Q ss_pred hHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 154 DIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 154 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
||||||++|||++| |+.||.+.+... .+.....+.+...|..+|+.+.++++.||..+|++|||++.+.
T Consensus 386 DVWSFGVlL~E~fT~G~~py~~msn~e---v~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 386 DVWSFGVLLWELFTYGRVPYPGMSNEE---VLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ceeehhhhHHHHhccCCCCCCCCCHHH---HHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 99999999999999 999998765544 4455556777778888999999999999999999999999764
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=276.77 Aligned_cols=223 Identities=34% Similarity=0.569 Sum_probs=183.8
Q ss_pred CCCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 1 MNKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
+|++|+++||+|++.- +...+.+.+|+..+.+++++||.+ ..+..+|++||||.||++.+.++.. ..+++.
T Consensus 33 ~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~-~~~~E~ 111 (467)
T KOG0201|consen 33 IDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSG-NILDEF 111 (467)
T ss_pred eeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccC-CCCccc
Confidence 4789999999999883 345678999999999999999977 6778899999999999999999973 333443
Q ss_pred HHH------HHHHHHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIR------LYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~------~~~~~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+. ..++.+||.++.+|||||+.||+++.+|.+||+|||.+....... .....+.||+.|||||++++
T Consensus 112 ~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~------~rr~tfvGTPfwMAPEVI~~ 185 (467)
T KOG0201|consen 112 EIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV------KRRKTFVGTPFWMAPEVIKQ 185 (467)
T ss_pred eeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh------hccccccccccccchhhhcc
Confidence 332 334567899999999999999999999999999999997654421 12256779999999999999
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
..|+.++||||||++.+||.+|.+|+.+...- ..+...-+..+|.+....++.+++|+..||.++|+.|||+.+++.
T Consensus 186 ~~Y~~KADIWSLGITaiEla~GePP~s~~hPm---rvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 186 SGYDTKADIWSLGITAIELAKGEPPHSKLHPM---RVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccchhhhhhhhHHHHHHhcCCCCCcccCcc---eEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 99999999999999999999999999775331 111222234555666678889999999999999999999999999
Q ss_pred CCCCCCC
Q 042809 227 HTFISGN 233 (241)
Q Consensus 227 ~p~~~~~ 233 (241)
|+|++.+
T Consensus 263 h~FIk~a 269 (467)
T KOG0201|consen 263 HKFIKRA 269 (467)
T ss_pred hHHHHhc
Confidence 9999983
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=273.36 Aligned_cols=221 Identities=28% Similarity=0.463 Sum_probs=178.0
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+++.||+|.+... ...+.+..|..++..+ .||||++ ...+.+|+||||+++|+|.+++.. ...++
T Consensus 16 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~-~~~l~ 94 (320)
T cd05590 16 LKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFD 94 (320)
T ss_pred EcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHH-cCCCC
Confidence 5678999999998743 2345677888888877 5999988 577889999999999999999887 35677
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||++|++||||||+||+++.++.++|+|||++...... ........|++.|+|||.+
T Consensus 95 ~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~------~~~~~~~~gt~~y~aPE~~ 168 (320)
T cd05590 95 EARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN------GKTTSTFCGTPDYIAPEIL 168 (320)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC------CCcccccccCccccCHHHH
Confidence 77777666554 79999999999999999999999999999998642210 0112234589999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh---
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA--- 221 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--- 221 (241)
.+..++.++|+||||+++|++++|+.||............. ......+...+.++.+++++||+.+|.+||++
T Consensus 169 ~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~ 244 (320)
T cd05590 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL----NDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTL 244 (320)
T ss_pred cCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh----cCCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 98889999999999999999999999997754433322222 23344566678899999999999999999998
Q ss_pred ---HHHhcCCCCCCC
Q 042809 222 ---EELLNHTFISGN 233 (241)
Q Consensus 222 ---~~~l~~p~~~~~ 233 (241)
++++.||||+..
T Consensus 245 ~~~~~~~~h~~f~~~ 259 (320)
T cd05590 245 GGEEAILRHPFFKEL 259 (320)
T ss_pred CCHHHHHcCCCcCCC
Confidence 999999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=275.58 Aligned_cols=214 Identities=25% Similarity=0.381 Sum_probs=175.4
Q ss_pred CcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 6 GALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 6 ~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
+..||+|.+... ...+.+.+|+.++..++||||++ ...+.+|+||||+.+|+|.+++.. ...+++..+.
T Consensus 56 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~ 134 (340)
T PTZ00426 56 FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGC 134 (340)
T ss_pred CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHH
Confidence 468999987632 33456889999999999999998 567789999999999999999987 4567777776
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCC
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL 149 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 149 (241)
.++.|+ ||++|++||||||+||+++.++.++|+|||++..... ......|++.|+|||.+.+..+
T Consensus 135 ~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~---------~~~~~~gt~~y~aPE~~~~~~~ 205 (340)
T PTZ00426 135 FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT---------RTYTLCGTPEYIAPEILLNVGH 205 (340)
T ss_pred HHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC---------CcceecCChhhcCHHHHhCCCC
Confidence 666654 7999999999999999999999999999999865422 1123468999999999998888
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----ChHHH
Q 042809 150 DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----SAEEL 224 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~ 224 (241)
+.++|+||||+++|+|++|..||.+.......... ......++...+..+.+++++||+.+|.+|+ |++++
T Consensus 206 ~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i----~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~ 281 (340)
T PTZ00426 206 GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI----LEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNV 281 (340)
T ss_pred CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH----hcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHH
Confidence 99999999999999999999999875432222221 1233345666788999999999999999995 89999
Q ss_pred hcCCCCCCC
Q 042809 225 LNHTFISGN 233 (241)
Q Consensus 225 l~~p~~~~~ 233 (241)
++||||++.
T Consensus 282 ~~hp~f~~~ 290 (340)
T PTZ00426 282 KEHPWFGNI 290 (340)
T ss_pred HcCCCcCCC
Confidence 999999864
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=268.56 Aligned_cols=222 Identities=25% Similarity=0.416 Sum_probs=170.3
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.++..||+|.+... .....+.+|+.++++++||||++ ..+...++||||++ ++|.+++...+..++...
T Consensus 26 ~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~ 104 (288)
T cd07871 26 SKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHN 104 (288)
T ss_pred ECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHhcCCCCCHHH
Confidence 4678999999987632 23456789999999999999988 56678999999997 599999987666677777
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc-
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN- 146 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~- 146 (241)
+..++.|+ ||++|++||||||+||+++.++.+||+|||++....... .......+++.|+|||.+.+
T Consensus 105 ~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~ 178 (288)
T cd07871 105 VKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT------KTYSNEVVTLWYRPPDVLLGS 178 (288)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC------ccccCceecccccChHHhcCC
Confidence 66665544 799999999999999999999999999999986432210 11123457889999999865
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCC------------------C--------CCChhhH
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK------------------P--------HFPTQFF 200 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------~--------~~~~~~~ 200 (241)
..++.++|+||+|+++|++++|+.||.+.................. + ......+
T Consensus 179 ~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (288)
T cd07871 179 TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLD 258 (288)
T ss_pred cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCC
Confidence 5578999999999999999999999976543332222211111000 0 0012345
Q ss_pred HHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 201 KKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 201 ~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
.++.+|+++||..+|.+|||++++++||||
T Consensus 259 ~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 259 TDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred HHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 688999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=268.32 Aligned_cols=223 Identities=23% Similarity=0.374 Sum_probs=170.3
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+++.||+|.+... ...+.+.+|+.+++.++||||++ ..++..++||||++++.+..+.. ....++..
T Consensus 22 ~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~ 100 (287)
T cd07848 22 HKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEE-MPNGVPPE 100 (287)
T ss_pred ECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHh-cCCCCCHH
Confidence 5678999999987632 33466889999999999999988 56778999999998876655443 34567777
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||+.|++||||+|+||+++.++.++|+|||++........ .......|++.|+|||.+.+
T Consensus 101 ~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~ 175 (287)
T cd07848 101 KVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-----ANYTEYVATRWYRSPELLLG 175 (287)
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-----ccccccccccccCCcHHHcC
Confidence 777666655 7999999999999999999999999999999976532111 11223457899999999998
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC------------------CC----------CCChh
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE------------------KP----------HFPTQ 198 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------~~----------~~~~~ 198 (241)
..++.++|+||+|+++|++++|+.||................... .+ .....
T Consensus 176 ~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T cd07848 176 APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGI 255 (287)
T ss_pred CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcc
Confidence 889999999999999999999999997643322211111100000 00 00112
Q ss_pred hHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 199 FFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 199 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
.+..+.+|+++||+.+|++|||++++++||||
T Consensus 256 ~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 256 LSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 56679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=275.93 Aligned_cols=221 Identities=27% Similarity=0.467 Sum_probs=179.2
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+... .....+.+|++++..++||||++ ...+..|+||||+++|+|..++.. ...+++
T Consensus 16 ~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~l~~ 94 (325)
T cd05594 16 EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSE 94 (325)
T ss_pred ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCH
Confidence 5678999999998743 23456788999999999999987 567889999999999999998876 456777
Q ss_pred HHHHHHHHHH------hhc-CCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 72 GVIRLYTKEI------LHG-NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~-~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
..+..++.|+ ||+ .|++||||||+||+++.++.+||+|||++...... ........|++.|+|||.+
T Consensus 95 ~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~------~~~~~~~~gt~~y~aPE~~ 168 (325)
T cd05594 95 DRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD------GATMKTFCGTPEYLAPEVL 168 (325)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC------CcccccccCCcccCCHHHH
Confidence 7777666654 797 89999999999999999999999999998642211 0111234589999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW----- 219 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----- 219 (241)
.+..++.++||||||+++|+|++|..||............. .....++...++++.+++++||+.+|++|+
T Consensus 169 ~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~----~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 244 (325)
T cd05594 169 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL----MEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPD 244 (325)
T ss_pred ccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh----cCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCC
Confidence 98889999999999999999999999997654433322222 233445667788999999999999999997
Q ss_pred ChHHHhcCCCCCCC
Q 042809 220 SAEELLNHTFISGN 233 (241)
Q Consensus 220 s~~~~l~~p~~~~~ 233 (241)
++.++++||||++.
T Consensus 245 ~~~~il~h~~~~~~ 258 (325)
T cd05594 245 DAKEIMQHKFFAGI 258 (325)
T ss_pred CHHHHhcCCCcCCC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=271.93 Aligned_cols=220 Identities=30% Similarity=0.477 Sum_probs=175.9
Q ss_pred CCCCcEEEEEeccch------HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 3 KGTGALFVVKSAESE------AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
..+|+.||+|.+... .....+.+|+.+++.++||||++ ..++..|+||||+.+++|.+++... ..+.+
T Consensus 21 ~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~ 99 (323)
T cd05584 21 ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE-GIFME 99 (323)
T ss_pred CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHc-CCCCH
Confidence 467899999998743 22345678999999999999988 5677899999999999999999873 55666
Q ss_pred HHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++. ++||++|++||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.
T Consensus 100 ~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~gt~~y~aPE~~~ 173 (323)
T cd05584 100 DTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG------TVTHTFCGTIEYMAPEILM 173 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC------CcccccCCCccccChhhcc
Confidence 66555554 44799999999999999999999999999999986322110 1112345899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----C
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----S 220 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s 220 (241)
+..++.++||||||+++|++++|..||............ .......+...+..+.+++++||+.+|.+|| +
T Consensus 174 ~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 249 (323)
T cd05584 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI----LKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGD 249 (323)
T ss_pred CCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH----HcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCC
Confidence 888899999999999999999999999765433222221 1233455667788999999999999999999 8
Q ss_pred hHHHhcCCCCCCC
Q 042809 221 AEELLNHTFISGN 233 (241)
Q Consensus 221 ~~~~l~~p~~~~~ 233 (241)
+++++.||||+..
T Consensus 250 ~~~l~~h~~~~~~ 262 (323)
T cd05584 250 AAEVQSHPFFRHV 262 (323)
T ss_pred HHHHhcCCCcCCC
Confidence 9999999999754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=273.03 Aligned_cols=224 Identities=31% Similarity=0.533 Sum_probs=172.0
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+|+.||||.+.. ......+.+|+++++.++|+||++ ...+.+++||||+++++|.+.. ...+..
T Consensus 95 ~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~ 169 (353)
T PLN00034 95 HRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-----IADEQF 169 (353)
T ss_pred ECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc-----cCCHHH
Confidence 467899999999753 234567899999999999999988 5677899999999999986532 223333
Q ss_pred HHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc-
Q 042809 74 IRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN- 146 (241)
Q Consensus 74 ~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~- 146 (241)
+..++. ++||++|++||||||+||+++.++.+||+|||++....... .......|+..|+|||.+..
T Consensus 170 ~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~ 243 (353)
T PLN00034 170 LADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM------DPCNSSVGTIAYMSPERINTD 243 (353)
T ss_pred HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc------ccccccccCccccCccccccc
Confidence 333333 55899999999999999999999999999999987543211 11123458999999998743
Q ss_pred ----cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 147 ----EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 147 ----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
...+.++||||||+++|++++|+.||....................+..+...+.++.+||.+||+.+|.+|||+.
T Consensus 244 ~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ 323 (353)
T PLN00034 244 LNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAM 323 (353)
T ss_pred cccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHH
Confidence 2335689999999999999999999974333333333333333444555667788999999999999999999999
Q ss_pred HHhcCCCCCCCCcc
Q 042809 223 ELLNHTFISGNAKK 236 (241)
Q Consensus 223 ~~l~~p~~~~~~~~ 236 (241)
++++||||......
T Consensus 324 ell~hp~~~~~~~~ 337 (353)
T PLN00034 324 QLLQHPFILRAQPG 337 (353)
T ss_pred HHhcCcccccCCcc
Confidence 99999999887543
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=272.94 Aligned_cols=225 Identities=29% Similarity=0.493 Sum_probs=177.2
Q ss_pred CCCCcEEEEEeccch------HHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 3 KGTGALFVVKSAESE------AGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
..+|+.||+|++... ...+.+.+|+.++..++ |+||+. ..++.+++||||+.+|+|.+++.. ...++
T Consensus 25 ~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~ 103 (332)
T cd05614 25 HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ-RDNFS 103 (332)
T ss_pred CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHH-cCCCC
Confidence 468999999998642 23456788999999995 899987 567789999999999999999987 35677
Q ss_pred HHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.| +||++|++||||||+||+++.++.++|+|||++........ .......|++.|+|||.+
T Consensus 104 ~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~ 178 (332)
T cd05614 104 EDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK-----ERTYSFCGTIEYMAPEII 178 (332)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC-----CccccccCCccccCHHHh
Confidence 7777666654 47999999999999999999999999999999875422111 111234689999999999
Q ss_pred ccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC----
Q 042809 145 RNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW---- 219 (241)
Q Consensus 145 ~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---- 219 (241)
.+. .++.++||||||+++|++++|..||....................+..+..++..+.+++.+||+.+|++||
T Consensus 179 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 258 (332)
T cd05614 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGP 258 (332)
T ss_pred cCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCC
Confidence 865 478899999999999999999999965432222222222223344556677888999999999999999999
Q ss_pred -ChHHHhcCCCCCCC
Q 042809 220 -SAEELLNHTFISGN 233 (241)
Q Consensus 220 -s~~~~l~~p~~~~~ 233 (241)
+++++++||||+..
T Consensus 259 ~~~~~~l~h~~~~~~ 273 (332)
T cd05614 259 QGASEIKEHPFFKGL 273 (332)
T ss_pred CCHHHHHcCCCcCCC
Confidence 88899999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=269.98 Aligned_cols=221 Identities=28% Similarity=0.491 Sum_probs=176.5
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+|+.||+|.+..+ .....+..|..++..+ .||||++ ...+.+|+||||+.+++|..++.. ...++
T Consensus 16 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~-~~~~~ 94 (316)
T cd05620 16 LKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD-KGRFD 94 (316)
T ss_pred ECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH-cCCCC
Confidence 5678999999998753 2345567788887754 7999987 567899999999999999999987 45677
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
...+..++.|+ ||++|++||||||+||+++.++.++|+|||++...... ........|++.|+|||.+
T Consensus 95 ~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~gt~~y~aPE~~ 168 (316)
T cd05620 95 LYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG------DNRASTFCGTPDYIAPEIL 168 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC------CCceeccCCCcCccCHHHH
Confidence 77766665544 79999999999999999999999999999988632110 0112235689999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh-HH
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA-EE 223 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~ 223 (241)
.+..++.++|+||+|+++|+|++|..||............. ...+..+...+.++.+++++||..+|.+||++ ++
T Consensus 169 ~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~ 244 (316)
T cd05620 169 QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR----VDTPHYPRWITKESKDILEKLFERDPTRRLGVVGN 244 (316)
T ss_pred cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHH
Confidence 99999999999999999999999999997654433322222 23455566788899999999999999999998 58
Q ss_pred HhcCCCCCCC
Q 042809 224 LLNHTFISGN 233 (241)
Q Consensus 224 ~l~~p~~~~~ 233 (241)
++.||||+..
T Consensus 245 ~~~h~~f~~~ 254 (316)
T cd05620 245 IRGHPFFKTI 254 (316)
T ss_pred HHcCCCcCCC
Confidence 8899999774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=272.05 Aligned_cols=229 Identities=24% Similarity=0.361 Sum_probs=171.4
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCccccc----------CCceeeeeecccCCCCHHHHHHHhCC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGRN----------GEKTVNIFMEYMAGGSLLDVAEKFGG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~----------~~~~~~lv~e~~~~~~L~~~l~~~~~ 67 (241)
|+.+|..||+|.+.. ......+.+|+.+++.++||||++. .....|+||||+. ++|.+++.. ..
T Consensus 21 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~ 98 (338)
T cd07859 21 DTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA-ND 98 (338)
T ss_pred ECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHh-cc
Confidence 577899999998763 2334568899999999999999871 1235899999995 699999886 45
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
.+++..+..++.|+ ||++|++||||||+||+++.++.+||+|||++.......... .......|++.|+||
T Consensus 99 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~---~~~~~~~~t~~y~aP 175 (338)
T cd07859 99 DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA---IFWTDYVATRWYRAP 175 (338)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc---ccccCCCCCCCcCCH
Confidence 67777777766654 799999999999999999999999999999987543211111 112234589999999
Q ss_pred ccccc--cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHH------------------------hcCCCCCC
Q 042809 142 EVLRN--EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIA------------------------CSNEKPHF 195 (241)
Q Consensus 142 E~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------------------~~~~~~~~ 195 (241)
|.+.+ ..++.++||||||+++|++++|+.||.+............. ........
T Consensus 176 E~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 255 (338)
T cd07859 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPF 255 (338)
T ss_pred HHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCch
Confidence 99876 56889999999999999999999999664322211111000 00000000
Q ss_pred ---ChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 196 ---PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 196 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.+..++.+.+++.+||+.+|.+|||++++++||||+....
T Consensus 256 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 256 SQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0124567899999999999999999999999999977555
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=271.30 Aligned_cols=224 Identities=27% Similarity=0.459 Sum_probs=177.8
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+++.||+|.+... .....+..|..++..+ +||||++ .....+|+||||+++|+|.+++.. ...++
T Consensus 16 ~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~-~~~l~ 94 (329)
T cd05588 16 LKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR-QRKLP 94 (329)
T ss_pred ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHH-cCCCC
Confidence 5678999999998743 2345678899999988 6999988 567889999999999999999876 45688
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||++|++||||||+||+++.++.++|+|||++...... ........|++.|+|||.+
T Consensus 95 ~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~------~~~~~~~~gt~~y~aPE~~ 168 (329)
T cd05588 95 EEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP------GDTTSTFCGTPNYIAPEIL 168 (329)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC------CCccccccCCccccCHHHH
Confidence 88877776655 79999999999999999999999999999998632110 1112234689999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchh-----chHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKIS-----NAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 219 (241)
.+..++.++|+||||+++|++++|+.||..... ..................|..++..+.+++++||+.+|.+|+
T Consensus 169 ~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 248 (329)
T cd05588 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERL 248 (329)
T ss_pred cCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcC
Confidence 998899999999999999999999999953211 111112222222344456677888999999999999999998
Q ss_pred C------hHHHhcCCCCCC
Q 042809 220 S------AEELLNHTFISG 232 (241)
Q Consensus 220 s------~~~~l~~p~~~~ 232 (241)
| +++++.||||..
T Consensus 249 ~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 249 GCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred CCCCCCCHHHHhcCCCCCC
Confidence 7 789999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=273.33 Aligned_cols=228 Identities=28% Similarity=0.427 Sum_probs=173.9
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|++... .....+.+|+.++.+++|+||++ .....+|+||||++||+|.+++.. ...+++
T Consensus 22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~ 100 (363)
T cd05628 22 KKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK-KDTLTE 100 (363)
T ss_pred ECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh-cCCCCH
Confidence 5678999999998743 23456788999999999999988 667789999999999999999987 456788
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCC----------------------
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG---------------------- 123 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---------------------- 123 (241)
..+..++.|+ ||++|++||||||+||+++.++.++|+|||++..........
T Consensus 101 ~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (363)
T cd05628 101 EETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180 (363)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccccccccccccccccccc
Confidence 7777776654 799999999999999999999999999999987543211000
Q ss_pred -------ccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC
Q 042809 124 -------NLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP 196 (241)
Q Consensus 124 -------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (241)
..........||+.|+|||.+.+..++.++|+|||||++|+|++|..||.+........... .......++
T Consensus 181 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~p 258 (363)
T cd05628 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVM--NWKETLIFP 258 (363)
T ss_pred ccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCcCcccCC
Confidence 00001123568999999999999889999999999999999999999997654333222221 111122222
Q ss_pred --hhhHHHHHHHHHHhhccCCC---CCCChHHHhcCCCCCCC
Q 042809 197 --TQFFKKVLDFLAKCLERKPE---KRWSAEELLNHTFISGN 233 (241)
Q Consensus 197 --~~~~~~~~~li~~~l~~~p~---~Rps~~~~l~~p~~~~~ 233 (241)
...++++.+++.+++. +|. .||+++++++||||++.
T Consensus 259 ~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 259 PEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 2356789999998664 344 46899999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=275.79 Aligned_cols=230 Identities=28% Similarity=0.478 Sum_probs=179.5
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+... .....+.+|+.++..+.||||++ ..++..|+||||+.+++|.+++... ..++.
T Consensus 22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~ 100 (350)
T cd05573 22 DKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPE 100 (350)
T ss_pred ECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCH
Confidence 4568999999998743 23456889999999999999988 5778899999999999999999874 66788
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhccccc-----------------------C
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKN-----------------------N 122 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-----------------------~ 122 (241)
..+..++.|+ ||+.|++||||||+||+++.++.++|+|||++........ .
T Consensus 101 ~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (350)
T cd05573 101 ETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180 (350)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccccccccccccccccc
Confidence 7777776654 7999999999999999999999999999999876543210 0
Q ss_pred CccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHH
Q 042809 123 GNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKK 202 (241)
Q Consensus 123 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (241)
...........|++.|+|||.+.+..++.++|||||||++|+|++|+.||..........................++++
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 260 (350)
T cd05573 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPE 260 (350)
T ss_pred ccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHH
Confidence 00011223455899999999999999999999999999999999999999775433222222211011111122235889
Q ss_pred HHHHHHHhhccCCCCCCC-hHHHhcCCCCCCC
Q 042809 203 VLDFLAKCLERKPEKRWS-AEELLNHTFISGN 233 (241)
Q Consensus 203 ~~~li~~~l~~~p~~Rps-~~~~l~~p~~~~~ 233 (241)
+.++|.+||. +|.+||+ ++++++||||+..
T Consensus 261 ~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 261 AIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 9999999997 9999999 9999999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=264.54 Aligned_cols=225 Identities=27% Similarity=0.454 Sum_probs=179.7
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCC
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~ 70 (241)
+..+++.||+|.+.... ....+.+|+.+++.++||||++ ..++.+++||||+++++|.+++.... ..++
T Consensus 21 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 100 (285)
T cd05605 21 VRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD 100 (285)
T ss_pred EcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCC
Confidence 45678999999886432 2345678999999999999987 56678999999999999999887643 4577
Q ss_pred HHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.| +||+.|++|+||+|+||+++.++.++|+|||++...... .......|++.|+|||.+
T Consensus 101 ~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~ 173 (285)
T cd05605 101 EERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-------ETIRGRVGTVGYMAPEVV 173 (285)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-------CccccccCCCCccCcHHh
Confidence 7777666554 479999999999999999999999999999998654321 111234578999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW----- 219 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----- 219 (241)
.+..++.++|+||+|+++|++++|..||.+.....................+..++..+.+++.+||+.||.+||
T Consensus 174 ~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 253 (285)
T cd05605 174 KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGE 253 (285)
T ss_pred cCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCC
Confidence 988899999999999999999999999987544333222222233344455667888999999999999999999
Q ss_pred ChHHHhcCCCCCCC
Q 042809 220 SAEELLNHTFISGN 233 (241)
Q Consensus 220 s~~~~l~~p~~~~~ 233 (241)
++++++.||||...
T Consensus 254 ~~~~l~~~~~~~~~ 267 (285)
T cd05605 254 GAEEVKAHPFFRTA 267 (285)
T ss_pred CHHHHhcCcCccCC
Confidence 89999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=276.36 Aligned_cols=228 Identities=27% Similarity=0.471 Sum_probs=176.5
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||||++... .....+.+|+.++..++||||++ ..+..+|+||||+.+|+|.+++.. ...+++
T Consensus 22 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~ 100 (364)
T cd05599 22 KKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK-KDTFTE 100 (364)
T ss_pred ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHH-cCCCCH
Confidence 5678999999998743 23455788999999999999988 678899999999999999999987 456788
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCcc--------------------
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNL-------------------- 125 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~-------------------- 125 (241)
..+..++.|+ ||++|++||||||+||+++.++.++|+|||++............
T Consensus 101 ~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (364)
T cd05599 101 EETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180 (364)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccccccccccccccccccc
Confidence 8777776655 79999999999999999999999999999998654221100000
Q ss_pred ------------ccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC
Q 042809 126 ------------KQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP 193 (241)
Q Consensus 126 ------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 193 (241)
........||+.|+|||++.+..++.++|||||||++|+|++|..||............ .......
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i--~~~~~~~ 258 (364)
T cd05599 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKI--INWKETL 258 (364)
T ss_pred ccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHH--HcCCCcc
Confidence 00111245899999999999888999999999999999999999999765432222111 1111111
Q ss_pred CCC--hhhHHHHHHHHHHhhccCCCCCCC---hHHHhcCCCCCCC
Q 042809 194 HFP--TQFFKKVLDFLAKCLERKPEKRWS---AEELLNHTFISGN 233 (241)
Q Consensus 194 ~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~~p~~~~~ 233 (241)
..+ ...++.+.++|++|+. +|.+|++ +++++.||||++.
T Consensus 259 ~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 259 QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 222 2457899999999996 8999997 9999999999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=275.99 Aligned_cols=229 Identities=24% Similarity=0.425 Sum_probs=173.5
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+++.||+|.+... .....+.+|+.+++.++||||++ ...+.+|+||||+++|+|.+++... ..+++
T Consensus 22 ~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e 100 (381)
T cd05626 22 KVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-EVFPE 100 (381)
T ss_pred ECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhc-CCCCH
Confidence 5678999999998743 23456889999999999999998 6678899999999999999999873 56777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCc---------------------
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGN--------------------- 124 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~--------------------- 124 (241)
..++.++.|+ ||+.|++||||||+||+++.++.++|+|||++...........
T Consensus 101 ~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (381)
T cd05626 101 VLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180 (381)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccc
Confidence 7766665544 7999999999999999999999999999998753211000000
Q ss_pred --------------------cccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHH
Q 042809 125 --------------------LKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLL 184 (241)
Q Consensus 125 --------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 184 (241)
.........||+.|+|||.+.+..++.++|||||||++|+|++|..||............
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i 260 (381)
T cd05626 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKV 260 (381)
T ss_pred cccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHH
Confidence 000012346899999999999888999999999999999999999999765433222111
Q ss_pred HHHhcCCCCCCC--hhhHHHHHHHHHHhh--ccCCCCCCChHHHhcCCCCCCC
Q 042809 185 KIACSNEKPHFP--TQFFKKVLDFLAKCL--ERKPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 185 ~~~~~~~~~~~~--~~~~~~~~~li~~~l--~~~p~~Rps~~~~l~~p~~~~~ 233 (241)
. ........+ ..+++++.+++.+|+ ..++..|+++++++.||||+..
T Consensus 261 ~--~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 261 I--NWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred H--ccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 1 111112222 346789999999954 5556669999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=258.69 Aligned_cols=228 Identities=29% Similarity=0.470 Sum_probs=184.3
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh-CCCCC
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~ 70 (241)
.++++..+|+|++.++. ...++..|-+||..++||-+.. +.+...|+|||||.||+|..+.+.+ +..++
T Consensus 98 l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fs 177 (459)
T KOG0610|consen 98 LRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFS 177 (459)
T ss_pred ecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccc
Confidence 35678999999988653 3456788999999999999977 7888999999999999999999986 45688
Q ss_pred HHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhccccc-----------------------
Q 042809 71 AGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKN----------------------- 121 (241)
Q Consensus 71 ~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~----------------------- 121 (241)
+..+++++. +|||-.|||+|||||+|||+-++|.+-|+||+++........
T Consensus 178 e~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~ 257 (459)
T KOG0610|consen 178 ESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSC 257 (459)
T ss_pred hhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccc
Confidence 888888765 568999999999999999999999999999998864311000
Q ss_pred -------C-C-------------------ccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCcc
Q 042809 122 -------N-G-------------------NLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGD 174 (241)
Q Consensus 122 -------~-~-------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 174 (241)
. . ........+.||-.|+|||++.|...+.++|.|+||+++|||+.|..||.+
T Consensus 258 f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG 337 (459)
T KOG0610|consen 258 FSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKG 337 (459)
T ss_pred cccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCC
Confidence 0 0 000122356789999999999999999999999999999999999999998
Q ss_pred chhchHHHHHHHHhcCCCCCCC--hhhHHHHHHHHHHhhccCCCCCCC----hHHHhcCCCCCCC
Q 042809 175 KISNAAATLLKIACSNEKPHFP--TQFFKKVLDFLAKCLERKPEKRWS----AEELLNHTFISGN 233 (241)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~~p~~~~~ 233 (241)
...+.....+- ...+.+| +.++..+++||+++|.+||.+|.. ++||.+||||++.
T Consensus 338 ~~~~~Tl~NIv----~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 338 SNNKETLRNIV----GQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGV 398 (459)
T ss_pred CCchhhHHHHh----cCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCC
Confidence 75544332222 2233333 356789999999999999999997 9999999999874
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=274.14 Aligned_cols=226 Identities=29% Similarity=0.428 Sum_probs=176.5
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+.... ..+.+.+|+.+++.+.|+||++ ..+...++||||+++++|.+++......+++
T Consensus 22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~ 101 (330)
T cd05601 22 EKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDE 101 (330)
T ss_pred ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCH
Confidence 56789999999987432 3456889999999999999988 5677899999999999999999986667888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||+.|++||||||+||+++.++.++|+|||++........ .......|++.|+|||.+.
T Consensus 102 ~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-----~~~~~~~gt~~y~aPE~~~ 176 (330)
T cd05601 102 DMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-----VNSKLPVGTPDYIAPEVLT 176 (330)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-----eeeecccCCccccCHHHhc
Confidence 8877666554 7999999999999999999999999999999875432111 1112345899999999986
Q ss_pred ------ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC
Q 042809 146 ------NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219 (241)
Q Consensus 146 ------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 219 (241)
+..++.++||||||+++|+|++|..||...........................+..+.+|+++||. +|.+||
T Consensus 177 ~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~ 255 (330)
T cd05601 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERL 255 (330)
T ss_pred cccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCC
Confidence 4456789999999999999999999997654333222111111111111223467889999999997 999999
Q ss_pred ChHHHhcCCCCCCC
Q 042809 220 SAEELLNHTFISGN 233 (241)
Q Consensus 220 s~~~~l~~p~~~~~ 233 (241)
|+++++.||||+..
T Consensus 256 t~~~l~~h~~~~~~ 269 (330)
T cd05601 256 GYEGLCCHPFFSKI 269 (330)
T ss_pred CHHHHhCCCCcCCC
Confidence 99999999999753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=269.65 Aligned_cols=225 Identities=29% Similarity=0.443 Sum_probs=190.0
Q ss_pred CCCCCCcEEEEEecc----chHHHHHHHHHHHHHhhcCCCcccc-----cCCce-eeeeecccCCCCHHHHHHHhC-CCC
Q 042809 1 MNKGTGALFVVKSAE----SEAGVQALRNEAEIRQSLNSPNIGR-----NGEKT-VNIFMEYMAGGSLLDVAEKFG-GTL 69 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~----~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~-~~lv~e~~~~~~L~~~l~~~~-~~~ 69 (241)
+++.+++.||+|.+. .+.......+|..++++++|||||. ..+++ ++|||+||+||+|.+.+.... .-+
T Consensus 24 rhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f 103 (426)
T KOG0589|consen 24 RHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLF 103 (426)
T ss_pred hhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccc
Confidence 467788999999977 3345567899999999999999998 44455 999999999999999998865 668
Q ss_pred CHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
++..+..++.|+ ||+++++|||||+.|||++.++.++|+|||+++...... .......||+.|+.||+
T Consensus 104 ~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~------~~a~tvvGTp~YmcPEi 177 (426)
T KOG0589|consen 104 PEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED------SLASTVVGTPYYMCPEI 177 (426)
T ss_pred cHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch------hhhheecCCCcccCHHH
Confidence 888877777665 799999999999999999999999999999999876521 12345779999999999
Q ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH
Q 042809 144 LRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 144 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
+.+.+|..++|||||||++||+++-+.+|...+.. .+..........+.|..++.+++.+|+.|+.++|..||++.+
T Consensus 178 l~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~ 254 (426)
T KOG0589|consen 178 LSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALE 254 (426)
T ss_pred hCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHH
Confidence 99999999999999999999999999999875433 333333344466778889999999999999999999999999
Q ss_pred HhcCCCCCCCC
Q 042809 224 LLNHTFISGNA 234 (241)
Q Consensus 224 ~l~~p~~~~~~ 234 (241)
+|.+|.+....
T Consensus 255 LL~~P~l~~~~ 265 (426)
T KOG0589|consen 255 LLRRPHLLRYL 265 (426)
T ss_pred HhhChhhhhHH
Confidence 99999876443
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=265.67 Aligned_cols=226 Identities=25% Similarity=0.412 Sum_probs=169.8
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+|+.||+|.+... .....+.+|+.+++.++||||++ ..+...++||||+. ++|.+++......++...
T Consensus 26 ~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~ 104 (303)
T cd07869 26 SKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPEN 104 (303)
T ss_pred ECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHH
Confidence 4568999999997732 22345778999999999999988 56778999999995 689888887666778877
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc-
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN- 146 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~- 146 (241)
+..++.|+ ||++|++||||||+||+++.++.+||+|||++...... ........+++.|+|||.+.+
T Consensus 105 ~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~ 178 (303)
T cd07869 105 VKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP------SHTYSNEVVTLWYRPPDVLLGS 178 (303)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC------CccCCCCcccCCCCChHHHcCC
Confidence 77776655 79999999999999999999999999999998643221 111223457889999999865
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchH--HHHHHHHhcCC-------------CC-----CCCh---------
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAA--ATLLKIACSNE-------------KP-----HFPT--------- 197 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~-------------~~-----~~~~--------- 197 (241)
..++.++|+||+|+++|+|++|..||.+...... ........... .+ ..+.
T Consensus 179 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (303)
T cd07869 179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKL 258 (303)
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhcc
Confidence 4578899999999999999999999976422111 11111000000 00 0000
Q ss_pred hhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 198 QFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 198 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
..+..+.+|+.+||+.+|++|||++++++||||+...
T Consensus 259 ~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 259 SYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred CCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 1235788999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=278.21 Aligned_cols=230 Identities=23% Similarity=0.412 Sum_probs=174.6
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+.... ....+.+|++++.+++|+||++ ..++.+|+||||+++|+|.+++... ..+++
T Consensus 22 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~ 100 (376)
T cd05598 22 KVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL-GIFEE 100 (376)
T ss_pred ECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCH
Confidence 56789999999987432 3456789999999999999988 6678999999999999999999873 56777
Q ss_pred HHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccC-----------------------
Q 042809 72 GVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNN----------------------- 122 (241)
Q Consensus 72 ~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~----------------------- 122 (241)
..+..++.| +||++|++||||||+||+++.++.++|+|||++.........
T Consensus 101 ~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (376)
T cd05598 101 DLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180 (376)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccccccccccccccccccc
Confidence 776666554 479999999999999999999999999999997532100000
Q ss_pred --------------CccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHh
Q 042809 123 --------------GNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIAC 188 (241)
Q Consensus 123 --------------~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 188 (241)
...........|++.|+|||.+.+..++.++|||||||++|+|++|..||.+..............
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 260 (376)
T cd05598 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWE 260 (376)
T ss_pred ccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccC
Confidence 000000113468999999999999889999999999999999999999997754333222211111
Q ss_pred cCCCCCCChhhHHHHHHHHHHhhccCCCCCC---ChHHHhcCCCCCCC
Q 042809 189 SNEKPHFPTQFFKKVLDFLAKCLERKPEKRW---SAEELLNHTFISGN 233 (241)
Q Consensus 189 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~~p~~~~~ 233 (241)
..........++..+.+++.+|+ .+|.+|+ |+.+++.||||++.
T Consensus 261 ~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 261 TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 11111122346788999999976 5999999 99999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=269.22 Aligned_cols=220 Identities=25% Similarity=0.460 Sum_probs=175.9
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+|+.||+|.+... .....+..|.+++..+ +||||++ ...+..|+||||+++++|..++.. ...++
T Consensus 16 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~~~ 94 (321)
T cd05591 16 LKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQR-SRKFD 94 (321)
T ss_pred ECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHH-cCCCC
Confidence 4678899999998743 2345577888888866 6999988 567789999999999999999986 35677
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||++|++||||||+||+++.++.++|+|||++....... .......|++.|+|||.+
T Consensus 95 ~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~------~~~~~~~gt~~y~aPE~~ 168 (321)
T cd05591 95 EPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG------VTTTTFCGTPDYIAPEIL 168 (321)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC------ccccccccCccccCHHHH
Confidence 77766665544 799999999999999999999999999999986432110 112234589999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW----- 219 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----- 219 (241)
.+..++.++|+||||+++|+|++|+.||............. ......+...+.++.+++.+||+.+|.+||
T Consensus 169 ~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~----~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~ 244 (321)
T cd05591 169 QELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL----HDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVAS 244 (321)
T ss_pred cCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH----cCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCC
Confidence 99889999999999999999999999997654433322221 233345566788999999999999999999
Q ss_pred --ChHHHhcCCCCCC
Q 042809 220 --SAEELLNHTFISG 232 (241)
Q Consensus 220 --s~~~~l~~p~~~~ 232 (241)
+++++++||||..
T Consensus 245 ~~~~~~~~~hp~~~~ 259 (321)
T cd05591 245 QGGEDAIKQHPFFKE 259 (321)
T ss_pred CCCHHHHhcCCccCC
Confidence 9999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=270.11 Aligned_cols=225 Identities=28% Similarity=0.462 Sum_probs=176.6
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+++.||+|.+... .....+.+|+.++.++ +||||++ ...+..++||||+++++|..++.. ...++
T Consensus 16 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~~l~ 94 (329)
T cd05618 16 LKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLP 94 (329)
T ss_pred ECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHH-cCCCC
Confidence 5678999999998743 3345677888888877 7999988 567789999999999999998876 45677
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||++|++||||||+||+++.++.++|+|||++...... ........|++.|+|||.+
T Consensus 95 ~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~------~~~~~~~~gt~~y~aPE~~ 168 (329)
T cd05618 95 EEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP------GDTTSTFCGTPNYIAPEIL 168 (329)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC------CCccccccCCccccCHHHH
Confidence 77777666544 79999999999999999999999999999998642211 0112234689999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccch-----hchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKI-----SNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 219 (241)
.+..++.++|+||||+++|++++|..||.... ..................+|...+..+.+++++||+.+|.+||
T Consensus 169 ~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~ 248 (329)
T cd05618 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERL 248 (329)
T ss_pred cCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcC
Confidence 99889999999999999999999999995211 1111111222222344456777888999999999999999999
Q ss_pred C------hHHHhcCCCCCCC
Q 042809 220 S------AEELLNHTFISGN 233 (241)
Q Consensus 220 s------~~~~l~~p~~~~~ 233 (241)
| ++++++||||+..
T Consensus 249 ~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 249 GCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred CCCCCCCHHHHhcCCCCCCC
Confidence 8 5899999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=267.05 Aligned_cols=221 Identities=26% Similarity=0.466 Sum_probs=175.7
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+++.||+|.+... .....+..|..++..+ .||||++ ...+.+++||||+++|+|.+++.. ...++
T Consensus 16 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~ 94 (316)
T cd05619 16 LKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS-CHKFD 94 (316)
T ss_pred ECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCC
Confidence 5678999999998753 2345566777887764 8999988 567789999999999999999987 35567
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
...+..++.|+ ||+.|++||||||+||+++.++.++|+|||++...... ........|++.|+|||.+
T Consensus 95 ~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~gt~~y~aPE~~ 168 (316)
T cd05619 95 LPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG------DAKTCTFCGTPDYIAPEIL 168 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC------CCceeeecCCccccCHHHH
Confidence 76666666544 79999999999999999999999999999998632110 0111234589999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH-H
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE-E 223 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~ 223 (241)
.+..++.++|+||+|+++|++++|..||............. ...+..+...+.++.+++.+||..+|.+||++. +
T Consensus 169 ~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 244 (316)
T cd05619 169 LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR----MDNPCYPRWLTREAKDILVKLFVREPERRLGVKGD 244 (316)
T ss_pred cCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHH
Confidence 98889999999999999999999999997654433222222 223445666788999999999999999999996 8
Q ss_pred HhcCCCCCCC
Q 042809 224 LLNHTFISGN 233 (241)
Q Consensus 224 ~l~~p~~~~~ 233 (241)
+++||||+..
T Consensus 245 l~~h~~~~~~ 254 (316)
T cd05619 245 IRQHPFFREI 254 (316)
T ss_pred HHcCcccCCC
Confidence 9999999774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=267.42 Aligned_cols=221 Identities=28% Similarity=0.474 Sum_probs=178.1
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+++.||+|.+... .....+.+|.+++..+ +||||++ ...+.+|+||||+++++|..++.. ...++
T Consensus 16 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~ 94 (318)
T cd05570 16 LKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFD 94 (318)
T ss_pred ECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH-cCCCC
Confidence 4678899999998743 2345677888998888 5999988 567789999999999999999887 35677
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||++|++||||+|+||+++.++.++|+|||++...... ........|++.|+|||.+
T Consensus 95 ~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~g~~~y~aPE~~ 168 (318)
T cd05570 95 EPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG------GVTTSTFCGTPDYIAPEIL 168 (318)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC------CCcccceecCccccCHHHh
Confidence 77777666554 79999999999999999999999999999988532110 0111234588999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh---
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA--- 221 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--- 221 (241)
.+..++.++|+||||+++|++++|+.||............ .......+...+..+.+++++||..+|.+|||+
T Consensus 169 ~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i----~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~ 244 (318)
T cd05570 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI----LEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPT 244 (318)
T ss_pred cCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH----HcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCC
Confidence 9999999999999999999999999999765433322221 123345566778899999999999999999999
Q ss_pred --HHHhcCCCCCCC
Q 042809 222 --EELLNHTFISGN 233 (241)
Q Consensus 222 --~~~l~~p~~~~~ 233 (241)
.+++.||||+..
T Consensus 245 ~~~~ll~~~~~~~~ 258 (318)
T cd05570 245 GEQDIKGHPFFREI 258 (318)
T ss_pred CHHHHhcCCCcCCC
Confidence 999999999774
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=274.02 Aligned_cols=223 Identities=24% Similarity=0.418 Sum_probs=173.4
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+... .....+.+|+.+++.++||||++ ..+..+|+||||++||+|.+++.. ..+++
T Consensus 64 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~l~~ 141 (370)
T cd05596 64 HKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN--YDIPE 141 (370)
T ss_pred ECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh--cCCCH
Confidence 5678999999998642 23345788999999999999988 677889999999999999999976 34666
Q ss_pred HHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++. .+||+.|++||||||+||+++.++.+||+|||++....... ........|++.|+|||.+.
T Consensus 142 ~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~ 216 (370)
T cd05596 142 KWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-----MVRCDTAVGTPDYISPEVLK 216 (370)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-----cccCCCCCCCcCeECHHHhc
Confidence 66665554 44899999999999999999999999999999987543211 01112346899999999986
Q ss_pred cc----CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC--hhhHHHHHHHHHHhhccCCCC--
Q 042809 146 NE----GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP--TQFFKKVLDFLAKCLERKPEK-- 217 (241)
Q Consensus 146 ~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~-- 217 (241)
+. .++.++|+|||||++|+|++|..||............ ........++ ..++.++.++|++||..+|.+
T Consensus 217 ~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~ 294 (370)
T cd05596 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI--MDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLG 294 (370)
T ss_pred cCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHH--HcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccC
Confidence 53 3678999999999999999999999875443222221 1111122223 246789999999999999988
Q ss_pred CCChHHHhcCCCCCCC
Q 042809 218 RWSAEELLNHTFISGN 233 (241)
Q Consensus 218 Rps~~~~l~~p~~~~~ 233 (241)
|+|+++++.||||+..
T Consensus 295 R~s~~ell~h~~~~~~ 310 (370)
T cd05596 295 RNGVDEIKSHPFFKND 310 (370)
T ss_pred CCCHHHHhcCcccCCC
Confidence 9999999999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=271.51 Aligned_cols=221 Identities=28% Similarity=0.474 Sum_probs=178.9
Q ss_pred CCCCCcEEEEEeccchH----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESEA----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+|+.||+|++.... ....+.+|++++.+++||||++ ..++..|+||||+++++|.+++.. ...+++.
T Consensus 20 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~ 98 (318)
T cd05582 20 GPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEE 98 (318)
T ss_pred cCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHH
Confidence 35689999999987432 3445778999999999999988 567889999999999999999976 4567887
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||+.|++||||+|+||+++.++.++|+|||++....... .......|++.|+|||.+.+
T Consensus 99 ~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~ 172 (318)
T cd05582 99 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE------KKAYSFCGTVEYMAPEVVNR 172 (318)
T ss_pred HHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC------CceecccCChhhcCHHHHcC
Confidence 777776654 799999999999999999999999999999986543210 11223468999999999998
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC-----h
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS-----A 221 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~ 221 (241)
..++.++|+||||+++|+|++|..||............. ......+...+..+.+++++||+.+|.+||| +
T Consensus 173 ~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~----~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~ 248 (318)
T cd05582 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL----KAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGV 248 (318)
T ss_pred CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH----cCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCH
Confidence 888999999999999999999999997654332222211 2334456667889999999999999999999 7
Q ss_pred HHHhcCCCCCCC
Q 042809 222 EELLNHTFISGN 233 (241)
Q Consensus 222 ~~~l~~p~~~~~ 233 (241)
++++.||||...
T Consensus 249 ~~~~~~~~~~~~ 260 (318)
T cd05582 249 EEIKRHPFFSTI 260 (318)
T ss_pred HHHhCCCCcCCC
Confidence 889999999753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=266.79 Aligned_cols=221 Identities=30% Similarity=0.542 Sum_probs=176.0
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+++.||+|.+..+ ...+.+..|..++..+ .||||++ .....+|+||||++||+|..++.. ...++
T Consensus 16 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~-~~~~~ 94 (316)
T cd05592 16 LKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFD 94 (316)
T ss_pred ECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCC
Confidence 4678999999998743 2334456677776654 7999988 567789999999999999999987 45677
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||+.|++||||||+||+++.++.++|+|||++....... .......|++.|+|||.+
T Consensus 95 ~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~------~~~~~~~gt~~y~aPE~~ 168 (316)
T cd05592 95 EARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE------GKASTFCGTPDYIAPEIL 168 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC------CccccccCCccccCHHHH
Confidence 77777766655 799999999999999999999999999999986432211 112334689999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH-H
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE-E 223 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~ 223 (241)
.+..++.++|+||||+++|+|++|..||.+.......... ....+.++...+.++.+++.+||+.+|.+||++. +
T Consensus 169 ~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i----~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~ 244 (316)
T cd05592 169 KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI----LNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGD 244 (316)
T ss_pred cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH----HcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHH
Confidence 9988999999999999999999999999875443322222 2344556777888999999999999999999875 8
Q ss_pred HhcCCCCCCC
Q 042809 224 LLNHTFISGN 233 (241)
Q Consensus 224 ~l~~p~~~~~ 233 (241)
++.||||+..
T Consensus 245 l~~h~~~~~~ 254 (316)
T cd05592 245 IRQHPFFRGI 254 (316)
T ss_pred HHcCcccCCC
Confidence 8899999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=268.05 Aligned_cols=220 Identities=28% Similarity=0.461 Sum_probs=174.9
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHH---hhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIR---QSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l---~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
++.+|+.||||.+... ...+.+.+|.+++ ..++||||++ ...+..|+||||+++++|..++.. ..
T Consensus 20 ~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~--~~ 97 (324)
T cd05589 20 YKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DV 97 (324)
T ss_pred ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc--CC
Confidence 4678999999998743 2345566676655 5667999988 567889999999999999988865 56
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
+++..+..++.|+ ||+.|++||||||+||+++.++.+||+|||++...... ........|++.|+|||
T Consensus 98 l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~------~~~~~~~~g~~~y~aPE 171 (324)
T cd05589 98 FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF------GDRTSTFCGTPEFLAPE 171 (324)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC------CCcccccccCccccCHh
Confidence 7777777666654 79999999999999999999999999999988642211 11123456899999999
Q ss_pred cccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC---
Q 042809 143 VLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW--- 219 (241)
Q Consensus 143 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp--- 219 (241)
.+.+..++.++|+||||+++|++++|..||.+........... ......+..++..+.+++.+||+.+|.+||
T Consensus 172 ~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~----~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 172 VLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV----NDEVRYPRFLSREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred HhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence 9999889999999999999999999999997754433322221 223445667788999999999999999999
Q ss_pred --ChHHHhcCCCCCCC
Q 042809 220 --SAEELLNHTFISGN 233 (241)
Q Consensus 220 --s~~~~l~~p~~~~~ 233 (241)
++.++++||||+..
T Consensus 248 ~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 248 EKDAEDVKKQPFFRDI 263 (324)
T ss_pred CCCHHHHhhCCCcCCC
Confidence 79999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=267.26 Aligned_cols=221 Identities=24% Similarity=0.453 Sum_probs=176.5
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCc-ccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPN-IGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~-i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+++.||+|++... ...+.+..|.+++..+.|++ |+. ...+.+|+||||+++|+|.+++.. ...++
T Consensus 21 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~-~~~~~ 99 (324)
T cd05587 21 RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFK 99 (324)
T ss_pred ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCC
Confidence 5678899999998743 34566788999999998765 544 567789999999999999999987 35677
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||++|++||||||+||+++.++.++|+|||++...... ........|++.|+|||.+
T Consensus 100 ~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~------~~~~~~~~gt~~y~aPE~~ 173 (324)
T cd05587 100 EPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG------GKTTRTFCGTPDYIAPEII 173 (324)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC------CCceeeecCCccccChhhh
Confidence 77776666544 79999999999999999999999999999998532110 1112345689999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh---
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA--- 221 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--- 221 (241)
.+..++.++|+||+|+++|+|++|+.||.+.......... ......++...+..+.+++++||..+|.+|++.
T Consensus 174 ~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i----~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 249 (324)
T cd05587 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI----MEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPT 249 (324)
T ss_pred cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH----HcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCC
Confidence 9988999999999999999999999999765443332222 233455667788899999999999999999976
Q ss_pred --HHHhcCCCCCCC
Q 042809 222 --EELLNHTFISGN 233 (241)
Q Consensus 222 --~~~l~~p~~~~~ 233 (241)
+++++||||+..
T Consensus 250 ~~~~~~~hp~~~~~ 263 (324)
T cd05587 250 GERDIREHAFFRRI 263 (324)
T ss_pred CHHHHhcCCCcCCC
Confidence 899999999763
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=268.35 Aligned_cols=221 Identities=27% Similarity=0.430 Sum_probs=173.6
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHH-HHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAE-IRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~-~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+|+.||+|.+.... ....+.+|.. +++.++||||++ ...+..|+||||+++|+|..++.. ...++
T Consensus 16 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~ 94 (323)
T cd05575 16 HKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR-ERSFP 94 (323)
T ss_pred ECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHh-cCCCC
Confidence 56789999999987432 2234445544 467899999998 567789999999999999999986 45677
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||++|++||||||+||+++.++.+||+|||++...... ........|++.|+|||.+
T Consensus 95 ~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~gt~~y~aPE~~ 168 (323)
T cd05575 95 EPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH------SKTTSTFCGTPEYLAPEVL 168 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC------CCccccccCChhhcChhhh
Confidence 77776666544 79999999999999999999999999999998643211 1112234589999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh---
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA--- 221 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--- 221 (241)
.+..++.++|+||||+++|+|++|..||............. ......+...+..+.+++++||+.+|.+||++
T Consensus 169 ~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (323)
T cd05575 169 RKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL----NKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDD 244 (323)
T ss_pred cCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH----cCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCC
Confidence 99889999999999999999999999997654332222211 23334555678899999999999999999987
Q ss_pred -HHHhcCCCCCCC
Q 042809 222 -EELLNHTFISGN 233 (241)
Q Consensus 222 -~~~l~~p~~~~~ 233 (241)
.+++.||||...
T Consensus 245 ~~~il~~~~~~~~ 257 (323)
T cd05575 245 FLEIKNHVFFSSI 257 (323)
T ss_pred HHHHHcCCCcCCC
Confidence 699999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=274.71 Aligned_cols=228 Identities=26% Similarity=0.454 Sum_probs=173.1
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+... ...+.+.+|++++.+++||||++ .....+|+||||+++|+|.+++.. ...+++
T Consensus 22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~ 100 (377)
T cd05629 22 KKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK-YDTFSE 100 (377)
T ss_pred ECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHh-cCCCCH
Confidence 5678999999987642 23466889999999999999998 677889999999999999999986 356777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCC---------ccc----------
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG---------NLK---------- 126 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---------~~~---------- 126 (241)
..++.++.|+ ||+.|++||||||+||+++.++.++|+|||++.......... ...
T Consensus 101 ~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (377)
T cd05629 101 DVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180 (377)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccc
Confidence 7776666544 799999999999999999999999999999986321100000 000
Q ss_pred ----------------------cccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHH
Q 042809 127 ----------------------QSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLL 184 (241)
Q Consensus 127 ----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 184 (241)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|..||............
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i 260 (377)
T cd05629 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKI 260 (377)
T ss_pred cccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHH
Confidence 0001245899999999999888999999999999999999999999765432222211
Q ss_pred HHHhcCCCCCCCh--hhHHHHHHHHHHhhccCCCCC---CChHHHhcCCCCCCC
Q 042809 185 KIACSNEKPHFPT--QFFKKVLDFLAKCLERKPEKR---WSAEELLNHTFISGN 233 (241)
Q Consensus 185 ~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R---ps~~~~l~~p~~~~~ 233 (241)
. .......++. .++.++.+++.+||. +|.+| +|+.+++.||||++.
T Consensus 261 ~--~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 261 I--NWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred H--ccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 1 1111122222 467889999999997 67765 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=274.74 Aligned_cols=230 Identities=24% Similarity=0.418 Sum_probs=174.5
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+++.||+|.+... .....+.+|+.+++++.||||++ ..++.+|+||||+++|+|.+++... ..+++
T Consensus 22 ~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e 100 (382)
T cd05625 22 KVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFPE 100 (382)
T ss_pred ECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCH
Confidence 5678999999998743 23456889999999999999998 6677899999999999999999874 56777
Q ss_pred HHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCC----------------------
Q 042809 72 GVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG---------------------- 123 (241)
Q Consensus 72 ~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---------------------- 123 (241)
..++.++.| +||++|++||||||+||+++.+|.++|+|||++..........
T Consensus 101 ~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (382)
T cd05625 101 DLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180 (382)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccccccccccccccccccc
Confidence 777666654 4799999999999999999999999999999975321100000
Q ss_pred -------------------ccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHH
Q 042809 124 -------------------NLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLL 184 (241)
Q Consensus 124 -------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 184 (241)
..........||+.|+|||.+.+..++.++||||+||++|+|++|+.||............
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i 260 (382)
T cd05625 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKV 260 (382)
T ss_pred ccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0000012346899999999999988999999999999999999999999765432222211
Q ss_pred HHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC---hHHHhcCCCCCCC
Q 042809 185 KIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS---AEELLNHTFISGN 233 (241)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~~p~~~~~ 233 (241)
..............+++++.+++.+|+ .+|.+|++ ++++++||||+..
T Consensus 261 ~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 261 INWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 111111111222356788999999976 59999997 9999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=265.50 Aligned_cols=226 Identities=29% Similarity=0.462 Sum_probs=174.5
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+|..+|+|.+.. ......+.+|+++++.++||||++ ..++..++||||+.+++|.+++.. ...++...
T Consensus 26 ~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~ 104 (333)
T cd06650 26 HKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQI 104 (333)
T ss_pred ECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHH-cCCCCHHH
Confidence 456889999998763 344567899999999999999998 567789999999999999999987 34566766
Q ss_pred HHHHHHH------HhhcC-CccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 74 IRLYTKE------ILHGN-GILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 74 ~~~~~~~------~Lh~~-~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
+..++.+ +||+. +++|+||||+||+++.++.++|+|||++...... ......++..|+|||.+.+
T Consensus 105 ~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--------~~~~~~~~~~y~aPE~~~~ 176 (333)
T cd06650 105 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--------MANSFVGTRSYMSPERLQG 176 (333)
T ss_pred HHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--------ccccCCCCccccCHHHhcC
Confidence 6655554 47974 7999999999999999999999999998654331 1122357889999999998
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHH-----------------------------------------
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLK----------------------------------------- 185 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----------------------------------------- 185 (241)
..++.++|+||||+++|++++|+.||.............
T Consensus 177 ~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (333)
T cd06650 177 THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLD 256 (333)
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHH
Confidence 889999999999999999999999997543322211110
Q ss_pred HHhcCCCCCCC-hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 186 IACSNEKPHFP-TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 186 ~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
.......+..+ ...+.++.+|+.+||+.+|.+|||+++++.||||+....+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~ 308 (333)
T cd06650 257 YIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAE 308 (333)
T ss_pred HHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCccc
Confidence 00011111111 1245688999999999999999999999999999876544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=244.71 Aligned_cols=220 Identities=26% Similarity=0.465 Sum_probs=185.0
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh-CCCCC
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~ 70 (241)
-++++-+||+|++.++. ...++.+|+++-..|+||||++ -+...+|+++||..+|+|...+.+. ...++
T Consensus 43 ekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~ 122 (281)
T KOG0580|consen 43 EKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFD 122 (281)
T ss_pred eccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhccccccc
Confidence 46788899999987654 3456899999999999999998 6788999999999999999999954 34577
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+.....++.|+ +|.++++||||||+|++++..|.+|++|||++..... ......+||..|+|||..
T Consensus 123 e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~--------~kR~tlcgt~dyl~pEmv 194 (281)
T KOG0580|consen 123 EQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--------NKRKTLCGTLDYLPPEMV 194 (281)
T ss_pred ccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC--------CCceeeecccccCCHhhc
Confidence 77666666654 7999999999999999999999999999999975433 233567899999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
.+..++...|+|++|++.||++.|.+||...........+. .....+|..++..+.++|.+|+.++|.+|.+..++
T Consensus 195 ~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~----k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v 270 (281)
T KOG0580|consen 195 EGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR----KVDLKFPSTISGGAADLISRLLVKNPIERLALTEV 270 (281)
T ss_pred CCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH----HccccCCcccChhHHHHHHHHhccCccccccHHHH
Confidence 99999999999999999999999999998765333322222 33445567888999999999999999999999999
Q ss_pred hcCCCCCCC
Q 042809 225 LNHTFISGN 233 (241)
Q Consensus 225 l~~p~~~~~ 233 (241)
+.|||+...
T Consensus 271 ~~hpwI~a~ 279 (281)
T KOG0580|consen 271 MDHPWIVAN 279 (281)
T ss_pred hhhHHHHhc
Confidence 999998654
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=271.03 Aligned_cols=223 Identities=25% Similarity=0.448 Sum_probs=172.3
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+++.||+|.+... .....+.+|+.+++.++||||++ ..+..+|+||||+++|+|.+++.. ..+++
T Consensus 64 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~~~~ 141 (370)
T cd05621 64 HKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPE 141 (370)
T ss_pred ECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCH
Confidence 4678999999997642 23445789999999999999998 677889999999999999999976 34677
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.++.+||+|||++....... ........|++.|+|||.+.
T Consensus 142 ~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-----~~~~~~~~gt~~Y~aPE~~~ 216 (370)
T cd05621 142 KWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-----MVRCDTAVGTPDYISPEVLK 216 (370)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-----ceecccCCCCcccCCHHHHh
Confidence 6666666544 799999999999999999999999999999987543211 11123456899999999997
Q ss_pred cc----CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC--hhhHHHHHHHHHHhhccCCCC--
Q 042809 146 NE----GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP--TQFFKKVLDFLAKCLERKPEK-- 217 (241)
Q Consensus 146 ~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~-- 217 (241)
+. .++.++|+||+|+++|+|++|..||............ .........+ ..++..+.+++.+||..++.+
T Consensus 217 ~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i--~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~ 294 (370)
T cd05621 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI--MDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLG 294 (370)
T ss_pred ccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHH--HhCCcccCCCCcccCCHHHHHHHHHHccCchhccC
Confidence 53 3678999999999999999999999765433222221 1112222233 345788999999999865543
Q ss_pred CCChHHHhcCCCCCCC
Q 042809 218 RWSAEELLNHTFISGN 233 (241)
Q Consensus 218 Rps~~~~l~~p~~~~~ 233 (241)
|+|++++++||||+..
T Consensus 295 R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 295 RNGVEEIKQHPFFKND 310 (370)
T ss_pred CCCHHHHhcCcccCCC
Confidence 8899999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=258.81 Aligned_cols=225 Identities=29% Similarity=0.453 Sum_probs=172.9
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCC
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~ 70 (241)
++.+|+.||+|.+.... ....+..|++++++++||||++ ..+...++||||++|++|.+++.... ..++
T Consensus 14 ~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~ 93 (277)
T cd05607 14 VKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLE 93 (277)
T ss_pred EccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCC
Confidence 46789999999886422 2344567999999999999988 56788999999999999999886533 3466
Q ss_pred HHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
...+..++. ++||+.|++||||+|+||+++.++.++|+|||++....... ......|+..|+|||.+
T Consensus 94 ~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~ 166 (277)
T cd05607 94 MERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-------TITQRAGTNGYMAPEIL 166 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-------eeeccCCCCCccCHHHH
Confidence 666655554 44799999999999999999999999999999986543311 11234578899999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchH-HHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh--
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAA-ATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA-- 221 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-- 221 (241)
.+..++.++|+||+|+++|++++|..||........ ..................++.++.+++++||+.+|.+||++
T Consensus 167 ~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~ 246 (277)
T cd05607 167 KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSRE 246 (277)
T ss_pred ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCcc
Confidence 888899999999999999999999999975432211 11222211112122223567889999999999999999999
Q ss_pred --HHHhcCCCCCCC
Q 042809 222 --EELLNHTFISGN 233 (241)
Q Consensus 222 --~~~l~~p~~~~~ 233 (241)
++++.||||+.-
T Consensus 247 ~~~~~~~h~~f~~~ 260 (277)
T cd05607 247 KNDDPRKHEFFKTI 260 (277)
T ss_pred chhhhhcChhhcCC
Confidence 678899999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=277.13 Aligned_cols=220 Identities=23% Similarity=0.340 Sum_probs=175.6
Q ss_pred CcEEEEEecc--chHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh---CCCCCHHHHH
Q 042809 6 GALFVVKSAE--SEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF---GGTLDAGVIR 75 (241)
Q Consensus 6 ~~~vaiK~~~--~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~ 75 (241)
+..||+|.+. .......+.+|+.+++.++||||++ ...+..|+||||+++|+|.+++... ..++++..+.
T Consensus 93 ~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~ 172 (478)
T PTZ00267 93 KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172 (478)
T ss_pred CeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHH
Confidence 6788888754 2334456788999999999999998 5678999999999999999988642 3457777776
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCC
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL 149 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 149 (241)
.++.|+ ||+.|++||||||+||+++.++.+||+|||++........ ........|++.|+|||.+.+..+
T Consensus 173 ~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~ 248 (478)
T PTZ00267 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS----LDVASSFCGTPYYLAPELWERKRY 248 (478)
T ss_pred HHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc----cccccccCCCccccCHhHhCCCCC
Confidence 666554 7999999999999999999999999999999975533111 111234568999999999999889
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCC
Q 042809 150 DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTF 229 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~ 229 (241)
+.++||||||+++|+|++|..||....... .......+.....+..++..+.++|.+||..+|.+|||+++++.|+|
T Consensus 249 ~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~ 325 (478)
T PTZ00267 249 SKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEF 325 (478)
T ss_pred CcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHH
Confidence 999999999999999999999997654322 22222223334455667889999999999999999999999999999
Q ss_pred CCC
Q 042809 230 ISG 232 (241)
Q Consensus 230 ~~~ 232 (241)
++.
T Consensus 326 ~~~ 328 (478)
T PTZ00267 326 LKY 328 (478)
T ss_pred HHH
Confidence 853
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=265.15 Aligned_cols=225 Identities=27% Similarity=0.454 Sum_probs=178.1
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+++.||+|++..+ ...+.+.+|+.++.++ .||||+. .....+|+||||+++++|..++.. ...++
T Consensus 16 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~ 94 (327)
T cd05617 16 LKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR-QRKLP 94 (327)
T ss_pred ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCC
Confidence 4678899999998743 3345678999999888 5999987 567889999999999999998876 35688
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||++|++||||||+||+++.++.++|+|||++...... ........|++.|+|||.+
T Consensus 95 ~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~gt~~y~aPE~~ 168 (327)
T cd05617 95 EEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP------GDTTSTFCGTPNYIAPEIL 168 (327)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC------CCceecccCCcccCCHHHH
Confidence 88777776654 79999999999999999999999999999998642110 1112235689999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhc---hHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC-
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISN---AAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS- 220 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps- 220 (241)
.+..++.++|+||||+++|+|++|..||...... .................|...+..+.+++++||+.+|.+|++
T Consensus 169 ~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 9989999999999999999999999999532111 111222222233444567778889999999999999999997
Q ss_pred -----hHHHhcCCCCCCC
Q 042809 221 -----AEELLNHTFISGN 233 (241)
Q Consensus 221 -----~~~~l~~p~~~~~ 233 (241)
+++++.||||+..
T Consensus 249 ~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 249 QPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred CCCCCHHHHHcCCCCCCC
Confidence 5799999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=260.37 Aligned_cols=225 Identities=28% Similarity=0.469 Sum_probs=176.0
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~ 70 (241)
++.+++.||+|.+... .....+.+|+.++++++|++++. ..++..++||||+.+++|.+++.... ..++
T Consensus 21 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~ 100 (285)
T cd05630 21 VRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE 100 (285)
T ss_pred EcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCC
Confidence 4678999999987642 22345778999999999999987 46678999999999999999986533 3577
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++...... .......|+..|+|||.+
T Consensus 101 ~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-------~~~~~~~g~~~y~aPE~~ 173 (285)
T cd05630 101 EGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-------QTIKGRVGTVGYMAPEVV 173 (285)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-------ccccCCCCCccccChHHH
Confidence 76666665544 79999999999999999999999999999988643321 111233588999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC----
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS---- 220 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---- 220 (241)
.+..++.++|+||+|+++|++++|..||.......................+...+.++.+|+.+||+.+|.+|||
T Consensus 174 ~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~ 253 (285)
T cd05630 174 KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGG 253 (285)
T ss_pred cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCC
Confidence 9888999999999999999999999999764332211111111112223345567788999999999999999999
Q ss_pred -hHHHhcCCCCCCC
Q 042809 221 -AEELLNHTFISGN 233 (241)
Q Consensus 221 -~~~~l~~p~~~~~ 233 (241)
+++++.||||+..
T Consensus 254 ~~~~~~~h~~~~~~ 267 (285)
T cd05630 254 GAREVKEHPLFKQI 267 (285)
T ss_pred chHHHHcChhhhcc
Confidence 8999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=252.57 Aligned_cols=224 Identities=29% Similarity=0.419 Sum_probs=179.4
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhc-CCCcccc---------cCCceeeeeecccCCCCHHHHHHHhC-CCCC
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSL-NSPNIGR---------NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~ 70 (241)
++.||..+|+|++.+. ...++|+++--.. .|||||. .+..++.+|||.|+||.|++.+++++ +.++
T Consensus 83 ~k~T~ekfALKvL~Ds---~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afT 159 (400)
T KOG0604|consen 83 HKRTQEKFALKVLLDS---PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFT 159 (400)
T ss_pred eccchhhhHHHHHhcC---HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccch
Confidence 5677888888877643 4467888875555 4999987 56778999999999999999999864 4688
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecC---CCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH---GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
+..+..+..|| ||+.+|.||||||+|+|++.+ ..+||+|||+++.... .......+-|+.|.||
T Consensus 160 Erea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~-------~~~L~TPc~TPyYvaP 232 (400)
T KOG0604|consen 160 EREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE-------PGDLMTPCFTPYYVAP 232 (400)
T ss_pred HHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC-------CccccCCcccccccCH
Confidence 88887777655 899999999999999999764 4599999999986543 2334456679999999
Q ss_pred ccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC----hhhHHHHHHHHHHhhccCCCC
Q 042809 142 EVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP----TQFFKKVLDFLAKCLERKPEK 217 (241)
Q Consensus 142 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~ 217 (241)
|++-..+|+..+|+||+|+++|-|+.|.+||...-......-.+.........+| ..+++...++|+.+|..+|.+
T Consensus 233 evlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~Pte 312 (400)
T KOG0604|consen 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTE 312 (400)
T ss_pred HHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchh
Confidence 9999899999999999999999999999999765443333333333333444444 457789999999999999999
Q ss_pred CCChHHHhcCCCCCCCCc
Q 042809 218 RWSAEELLNHTFISGNAK 235 (241)
Q Consensus 218 Rps~~~~l~~p~~~~~~~ 235 (241)
|.|+++++.|||+.....
T Consensus 313 RlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 313 RLTIEEVMDHPWINQYEA 330 (400)
T ss_pred heeHHHhhcCchhccccc
Confidence 999999999999977654
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=271.12 Aligned_cols=228 Identities=28% Similarity=0.473 Sum_probs=175.3
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+... .....+.+|+.++..++||||++ .....+|+||||++||+|.+++.. ...+++
T Consensus 22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~ 100 (360)
T cd05627 22 KKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK-KDTLSE 100 (360)
T ss_pred ECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHh-cCCCCH
Confidence 5678999999998742 23456788999999999999988 677889999999999999999986 456777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCC----------------------
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG---------------------- 123 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---------------------- 123 (241)
..+..++.|+ ||++|++||||||+||+++.+|.++|+|||++..........
T Consensus 101 ~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (360)
T cd05627 101 EATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180 (360)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCccccccccccccc
Confidence 7777766654 799999999999999999999999999999986442211000
Q ss_pred -------ccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC
Q 042809 124 -------NLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP 196 (241)
Q Consensus 124 -------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (241)
..........||+.|+|||++.+..++.++|+|||||++|+|++|..||.............. ......++
T Consensus 181 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~--~~~~~~~p 258 (360)
T cd05627 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMN--WKETLVFP 258 (360)
T ss_pred ccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHc--CCCceecC
Confidence 000011234689999999999999999999999999999999999999976544332222211 11112222
Q ss_pred h--hhHHHHHHHHHHhhccCCCCCC---ChHHHhcCCCCCCC
Q 042809 197 T--QFFKKVLDFLAKCLERKPEKRW---SAEELLNHTFISGN 233 (241)
Q Consensus 197 ~--~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~~p~~~~~ 233 (241)
. ..+.++.++|.+|+ .+|.+|+ +++++++||||++.
T Consensus 259 ~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 259 PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 2 35678999999977 4999998 58999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=267.08 Aligned_cols=222 Identities=25% Similarity=0.297 Sum_probs=167.7
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
|+.+++.||+|... ...+.+|+.++++++||||++ ......++|+|++. ++|..++... ..++...+..
T Consensus 113 d~~~~~~vaiK~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~ 186 (391)
T PHA03212 113 DNKTCEHVVIKAGQ----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAK-RNIAICDILA 186 (391)
T ss_pred ECCCCCEEEEechh----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhc-CCCCHHHHHH
Confidence 67889999999755 345679999999999999998 45678999999995 6899988763 4567776666
Q ss_pred HHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCC
Q 042809 77 YTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD 150 (241)
Q Consensus 77 ~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 150 (241)
++.|+ ||++|++||||||+||+++.++.++|+|||++........ .......||+.|+|||.+.+..++
T Consensus 187 i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~ 261 (391)
T PHA03212 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-----NKYYGWAGTIATNAPELLARDPYG 261 (391)
T ss_pred HHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-----cccccccCccCCCChhhhcCCCCC
Confidence 65544 7999999999999999999999999999999864322111 112234689999999999998899
Q ss_pred chhhHHHHHHHHHHHHhCCCCCccchh--------chHHHHHHH----------------------Hh---cCCCCCCC-
Q 042809 151 FATDIWSLGCMVIEMATGRPPWGDKIS--------NAAATLLKI----------------------AC---SNEKPHFP- 196 (241)
Q Consensus 151 ~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~----------------------~~---~~~~~~~~- 196 (241)
.++||||||+++|++++|..||..... .....+... .. .......+
T Consensus 262 ~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (391)
T PHA03212 262 PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPL 341 (391)
T ss_pred cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCC
Confidence 999999999999999999987643211 000000000 00 00000011
Q ss_pred ----hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 197 ----TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 197 ----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
...+.++.+|+.+||+.+|.+|||++++++||||+.-.
T Consensus 342 ~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 342 WTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred HHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 12456889999999999999999999999999997744
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=253.51 Aligned_cols=223 Identities=39% Similarity=0.686 Sum_probs=176.9
Q ss_pred CCCCCcEEEEEeccch-------HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCC
Q 042809 2 NKGTGALFVVKSAESE-------AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTL 69 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 69 (241)
++.+|+.||+|.+... .....+.+|+.++++++||||++ ......++|+||+++++|.+++... ..+
T Consensus 23 ~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~ 101 (263)
T cd06625 23 DVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GAL 101 (263)
T ss_pred EcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHh-CCC
Confidence 4678999999987632 12456889999999999999988 5667999999999999999999874 456
Q ss_pred CHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
+......++.|+ ||+.|++|+||+|+||+++.++.++|+|||++.......... .......++..|+|||.
T Consensus 102 ~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~ 178 (263)
T cd06625 102 TETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG---TGMKSVTGTPYWMSPEV 178 (263)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc---ccccCCCcCccccCcce
Confidence 666666555544 799999999999999999999999999999986543211100 11123446788999999
Q ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH
Q 042809 144 LRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 144 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
+.+..++.++|+||+|+++|++++|+.||..... .............+..+...+..+.+++.+||..+|.+|||+.+
T Consensus 179 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 256 (263)
T cd06625 179 ISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA--MAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEE 256 (263)
T ss_pred eccCCCCchhhhHHHHHHHHHHHhCCCCccccch--HHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 9988899999999999999999999999976422 22222333334445567778889999999999999999999999
Q ss_pred HhcCCCC
Q 042809 224 LLNHTFI 230 (241)
Q Consensus 224 ~l~~p~~ 230 (241)
++.||||
T Consensus 257 ll~~~~~ 263 (263)
T cd06625 257 LLRHFFV 263 (263)
T ss_pred HhhCCCC
Confidence 9999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=268.05 Aligned_cols=225 Identities=24% Similarity=0.394 Sum_probs=171.2
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+++.||+|.+... .....+.+|+.++..++||||++ ..+...|+||||+++|+|.+++.. ..++.
T Consensus 64 ~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~--~~~~~ 141 (371)
T cd05622 64 HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPE 141 (371)
T ss_pred ECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCH
Confidence 5678999999997632 23445788999999999999988 577889999999999999999976 34666
Q ss_pred HHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.| +||++|++||||||+||+++.++.+||+|||++....... ........||+.|+|||.+.
T Consensus 142 ~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-----~~~~~~~~gt~~y~aPE~l~ 216 (371)
T cd05622 142 KWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-----MVRCDTAVGTPDYISPEVLK 216 (371)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-----cccccCcccCccccCHHHHh
Confidence 666655554 4799999999999999999999999999999987543211 01122456899999999997
Q ss_pred ccC----CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCC--CC
Q 042809 146 NEG----LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEK--RW 219 (241)
Q Consensus 146 ~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rp 219 (241)
+.. ++.++|+||||+++|+|++|..||...........+..............++..+.++|.+||...+.+ |+
T Consensus 217 ~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~ 296 (371)
T cd05622 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRN 296 (371)
T ss_pred ccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCC
Confidence 533 678999999999999999999999765433222222111111111223457889999999999854443 78
Q ss_pred ChHHHhcCCCCCCC
Q 042809 220 SAEELLNHTFISGN 233 (241)
Q Consensus 220 s~~~~l~~p~~~~~ 233 (241)
+++++++||||++.
T Consensus 297 ~~~ei~~h~~~~~~ 310 (371)
T cd05622 297 GVEEIKRHLFFKND 310 (371)
T ss_pred CHHHHhcCcccCCC
Confidence 99999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=253.70 Aligned_cols=225 Identities=32% Similarity=0.616 Sum_probs=177.0
Q ss_pred CCCCCcEEEEEeccch-----------HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh
Q 042809 2 NKGTGALFVVKSAESE-----------AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF 65 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~ 65 (241)
++.+++.||+|.+... ...+.+.+|+.++++++||||++ ...+..++|+||+++++|.+++...
T Consensus 21 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 100 (267)
T cd06628 21 NASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY 100 (267)
T ss_pred ecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhc
Confidence 4567899999976521 22356889999999999999988 5677899999999999999999874
Q ss_pred CCCCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccccc
Q 042809 66 GGTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139 (241)
Q Consensus 66 ~~~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (241)
..++...+..++. ++||+.|++||||+|+||+++.++.++|+|||.+....................++..|+
T Consensus 101 -~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 179 (267)
T cd06628 101 -GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179 (267)
T ss_pred -cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCcc
Confidence 5566666655555 447999999999999999999999999999999876543211111111122345788899
Q ss_pred CcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC
Q 042809 140 APEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219 (241)
Q Consensus 140 aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 219 (241)
|||.+.+..++.++|+||+|+++|++++|..||....... .. ........+..+...+..+.+++++||+.+|.+||
T Consensus 180 ~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 256 (267)
T cd06628 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AI-FKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRP 256 (267)
T ss_pred ChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HH-HHHhccCCCcCCcccCHHHHHHHHHHccCCchhCc
Confidence 9999998888999999999999999999999997643322 11 12222344556677888999999999999999999
Q ss_pred ChHHHhcCCCC
Q 042809 220 SAEELLNHTFI 230 (241)
Q Consensus 220 s~~~~l~~p~~ 230 (241)
+++++++||||
T Consensus 257 ~~~~il~~~~~ 267 (267)
T cd06628 257 TAAELLKHPFL 267 (267)
T ss_pred CHHHHhhCCCC
Confidence 99999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=253.48 Aligned_cols=226 Identities=32% Similarity=0.551 Sum_probs=191.6
Q ss_pred CCCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
+++.+|.++|||.+.-+...+++..|+.+|.+.+.|++|+ .....+|+|||||..|+.++.++-++.++.+..+.
T Consensus 53 IH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs 132 (502)
T KOG0574|consen 53 IHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEIS 132 (502)
T ss_pred HHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHH
Confidence 4789999999999999888999999999999999999999 55678999999999999999999988999988877
Q ss_pred HHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCC
Q 042809 76 LYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL 149 (241)
Q Consensus 76 ~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 149 (241)
.+++ ||||...-+|||||..||+++.+|..||.|||.+....+-.. ....++||+.|+|||++..-.|
T Consensus 133 ~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA------KRNTVIGTPFWMAPEVI~EIGY 206 (502)
T KOG0574|consen 133 AVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA------KRNTVIGTPFWMAPEVIEEIGY 206 (502)
T ss_pred HHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH------hhCccccCcccccHHHHHHhcc
Confidence 6654 789999999999999999999999999999999987655222 2245779999999999999899
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCC--CChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 150 DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPH--FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
...+||||||++..||..|++||.+- +....+.... ...++. .|...+.++-+++++||.++|++|-|+.++++|
T Consensus 207 ~~~ADIWSLGITaIEMAEG~PPYsDI--HPMRAIFMIP-T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 207 DTKADIWSLGITAIEMAEGRPPYSDI--HPMRAIFMIP-TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred chhhhHhhhcchhhhhhcCCCCcccc--cccceeEecc-CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 99999999999999999999999762 2222222111 122222 345677899999999999999999999999999
Q ss_pred CCCCCCCc
Q 042809 228 TFISGNAK 235 (241)
Q Consensus 228 p~~~~~~~ 235 (241)
||++++..
T Consensus 284 ~FiknA~g 291 (502)
T KOG0574|consen 284 TFIKNAPG 291 (502)
T ss_pred hhhcCCCc
Confidence 99987653
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=255.53 Aligned_cols=227 Identities=30% Similarity=0.451 Sum_probs=180.5
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh--CCCCCH
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF--GGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~ 71 (241)
++.+|+.||+|.+.. +.....+.+|+.++++++||||++ ...+..++|+||+++++|..++... ...+++
T Consensus 22 ~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~ 101 (286)
T cd06622 22 HRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE 101 (286)
T ss_pred EcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCH
Confidence 456899999998763 334567899999999999999988 5678999999999999999998763 236778
Q ss_pred HHHHHHHHHH------hhc-CCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 72 GVIRLYTKEI------LHG-NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~-~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
..+..++.++ ||+ .|++|+||+|+||+++.++.++|+|||.+...... ......+++.|+|||.+
T Consensus 102 ~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--------~~~~~~~~~~y~aPE~~ 173 (286)
T cd06622 102 DVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--------LAKTNIGCQSYMAPERI 173 (286)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--------ccccCCCccCccCcchh
Confidence 7777766654 786 69999999999999999999999999998654321 11223467889999998
Q ss_pred cccC------CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCC
Q 042809 145 RNEG------LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218 (241)
Q Consensus 145 ~~~~------~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 218 (241)
.+.. ++.++|+||+|+++|++++|..||....................+..+..++.++.+++.+||..+|.+|
T Consensus 174 ~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 253 (286)
T cd06622 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRR 253 (286)
T ss_pred cCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccC
Confidence 6543 4788999999999999999999997644433333333333445556677788999999999999999999
Q ss_pred CChHHHhcCCCCCCCCcc
Q 042809 219 WSAEELLNHTFISGNAKK 236 (241)
Q Consensus 219 ps~~~~l~~p~~~~~~~~ 236 (241)
|++++++.||||......
T Consensus 254 p~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 254 PTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred CCHHHHhcChhhhhccCC
Confidence 999999999999776543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=251.67 Aligned_cols=221 Identities=34% Similarity=0.543 Sum_probs=178.6
Q ss_pred CCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHH
Q 042809 3 KGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLY 77 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 77 (241)
+.+++.+++|.+......+.+.+|++++++++|+||++ ......|+++||+.+++|.+++...+..+++..+..+
T Consensus 25 ~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~ 104 (256)
T cd06612 25 KETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI 104 (256)
T ss_pred cCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHH
Confidence 45689999999887666788999999999999999988 5668899999999999999999876677888887777
Q ss_pred HHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+.|+ ||+.+++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.
T Consensus 105 ~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~ 178 (256)
T cd06612 105 LYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA------KRNTVIGTPFWMAPEVIQEIGYNN 178 (256)
T ss_pred HHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc------ccccccCCccccCHHHHhcCCCCc
Confidence 6655 7999999999999999999999999999999876543111 112334688899999999888999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 152 ATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
++|+||+|+++|++++|..||............. .........+..++..+.+++.+||+.+|.+|||+.+++.||||
T Consensus 179 ~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP-NKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc-cCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997643322211111 01111122334566789999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=259.76 Aligned_cols=227 Identities=24% Similarity=0.409 Sum_probs=173.4
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+++.||+|.+... .....+.+|+.++++++||||++ ..++..++||||++ ++|.+++...+..++...
T Consensus 27 ~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~ 105 (309)
T cd07872 27 SKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMHN 105 (309)
T ss_pred ecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHhcCCCCCHHH
Confidence 5678899999987632 22345778999999999999988 56778999999997 589998887666677777
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc-
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN- 146 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~- 146 (241)
+..++.|+ ||++|++||||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.+
T Consensus 106 ~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~ 179 (309)
T cd07872 106 VKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT------KTYSNEVVTLWYRPPDVLLGS 179 (309)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc------cccccccccccccCCHHHhCC
Confidence 76666544 799999999999999999999999999999986432211 11122346889999999865
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC-------------------CC-------CCChhhH
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE-------------------KP-------HFPTQFF 200 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------~~-------~~~~~~~ 200 (241)
..++.++|+||+|+++|++++|+.||.+.+............... +. .....++
T Consensus 180 ~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (309)
T cd07872 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLD 259 (309)
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCC
Confidence 457889999999999999999999997654433322221111000 00 0112356
Q ss_pred HHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 201 KKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 201 ~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.++.+++.+||+.+|.+|||++++++||||+.-..
T Consensus 260 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 260 TEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred HHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 78899999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=264.19 Aligned_cols=221 Identities=24% Similarity=0.378 Sum_probs=173.2
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHH-HHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAE-IRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~-~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+|+.||+|++... .....+.+|.. +++.++||||++ ..++..|+||||+.+++|..++.. ...++
T Consensus 16 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~ 94 (325)
T cd05604 16 RKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR-ERSFP 94 (325)
T ss_pred ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHH-cCCCC
Confidence 5678999999998743 22344555554 467789999988 567889999999999999998876 45677
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||+.|++||||||+||+++.++.++|+|||++...... ........|++.|+|||.+
T Consensus 95 ~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~------~~~~~~~~gt~~y~aPE~~ 168 (325)
T cd05604 95 EPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ------SDTTTTFCGTPEYLAPEVI 168 (325)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC------CCCcccccCChhhCCHHHH
Confidence 77777766654 79999999999999999999999999999998642211 0111234589999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh---
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA--- 221 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--- 221 (241)
.+..++.++|+||||+++|+|++|..||...+......... ......+...+..+.+++++||..+|.+||++
T Consensus 169 ~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 169 RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL----HKPLVLRPGASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred cCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH----cCCccCCCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 99889999999999999999999999997654333222111 22233445577889999999999999999976
Q ss_pred -HHHhcCCCCCCC
Q 042809 222 -EELLNHTFISGN 233 (241)
Q Consensus 222 -~~~l~~p~~~~~ 233 (241)
.+++.||||...
T Consensus 245 ~~~i~~h~~f~~~ 257 (325)
T cd05604 245 FLEIQEHPFFESL 257 (325)
T ss_pred HHHHhcCCCcCCC
Confidence 589999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=260.26 Aligned_cols=221 Identities=24% Similarity=0.448 Sum_probs=175.3
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCC-Ccccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNS-PNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h-~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+|+.||+|.+... ...+.+..|..++..+.| ++|+. ...+.+|+||||+++|+|.+++.. ...++
T Consensus 21 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~-~~~l~ 99 (323)
T cd05615 21 RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ-VGKFK 99 (323)
T ss_pred ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHH-cCCCC
Confidence 5678999999998743 234557788899888875 55554 566789999999999999999987 35677
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||++|++||||||+||+++.++.++|+|||++....... .......|++.|+|||.+
T Consensus 100 ~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~------~~~~~~~gt~~y~aPE~~ 173 (323)
T cd05615 100 EPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG------VTTRTFCGTPDYIAPEII 173 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC------ccccCccCCccccCHHHH
Confidence 77777776654 799999999999999999999999999999986432110 112234589999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC----
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS---- 220 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---- 220 (241)
.+..++.++|+||+|+++|+|++|..||.+........... ......+...+.++.+++.+||+.+|.+|++
T Consensus 174 ~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~----~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~ 249 (323)
T cd05615 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM----EHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPE 249 (323)
T ss_pred cCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCCCCCccCCHHHHHHHHHHcccCHhhCCCCCCC
Confidence 98889999999999999999999999997754433222221 2334456677889999999999999999997
Q ss_pred -hHHHhcCCCCCCC
Q 042809 221 -AEELLNHTFISGN 233 (241)
Q Consensus 221 -~~~~l~~p~~~~~ 233 (241)
.+++++||||+..
T Consensus 250 ~~~~i~~h~~f~~~ 263 (323)
T cd05615 250 GERDIREHAFFRRI 263 (323)
T ss_pred CHHHHhcCcccCCC
Confidence 4789999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=261.57 Aligned_cols=221 Identities=24% Similarity=0.432 Sum_probs=175.0
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+++.||+|.+... .....+..|..++..+. |++|+. ...+.+|+||||+++|+|.+++... ..++
T Consensus 21 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~-~~~~ 99 (323)
T cd05616 21 RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQV-GRFK 99 (323)
T ss_pred ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHc-CCCC
Confidence 5678899999998743 22345677888887775 777765 5677899999999999999999863 5677
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||++|++||||||+||+++.++.++|+|||++...... ........|++.|+|||.+
T Consensus 100 ~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~------~~~~~~~~gt~~y~aPE~~ 173 (323)
T cd05616 100 EPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD------GVTTKTFCGTPDYIAPEII 173 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC------CCccccCCCChhhcCHHHh
Confidence 77777666544 79999999999999999999999999999998643210 0112234689999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh---
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA--- 221 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--- 221 (241)
.+..++.++|+||||+++|+|++|+.||.+........... .....++...+.++.+++.+||+.+|.+|++.
T Consensus 174 ~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~ 249 (323)
T cd05616 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM----EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPE 249 (323)
T ss_pred cCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCC
Confidence 99999999999999999999999999997754433322222 23345667788899999999999999999974
Q ss_pred --HHHhcCCCCCCC
Q 042809 222 --EELLNHTFISGN 233 (241)
Q Consensus 222 --~~~l~~p~~~~~ 233 (241)
+++++||||+..
T Consensus 250 ~~~~i~~h~~~~~~ 263 (323)
T cd05616 250 GERDIKEHAFFRYI 263 (323)
T ss_pred CHHHHhcCCCcCCC
Confidence 899999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=249.06 Aligned_cols=220 Identities=25% Similarity=0.408 Sum_probs=176.8
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh-CCCCCH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~ 71 (241)
++.+|+.|++|.+.. ......+.+|+++++.++|||+++ ...+..++|+||+++++|.+++... ...++.
T Consensus 21 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 100 (256)
T cd08529 21 RKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPE 100 (256)
T ss_pred EcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCH
Confidence 456889999998762 345677899999999999999988 5667899999999999999999875 455666
Q ss_pred HHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++. .+||+.|++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.
T Consensus 101 ~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~ 174 (256)
T cd08529 101 DQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT------NFANTIVGTPYYLSPELCE 174 (256)
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc------chhhccccCccccCHHHhc
Confidence 66555554 44899999999999999999999999999999987543311 1112345788899999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
+..++.++|+||||+++|++++|..||....... ..........+..+..++..+.+++.+||+.+|++||++.+++
T Consensus 175 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll 251 (256)
T cd08529 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLL 251 (256)
T ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHh
Confidence 8888999999999999999999999997654222 2222223344445556778999999999999999999999999
Q ss_pred cCCCC
Q 042809 226 NHTFI 230 (241)
Q Consensus 226 ~~p~~ 230 (241)
+|||+
T Consensus 252 ~~~~~ 256 (256)
T cd08529 252 RNPSL 256 (256)
T ss_pred hCCCC
Confidence 99996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=255.91 Aligned_cols=227 Identities=26% Similarity=0.433 Sum_probs=180.2
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~ 70 (241)
+..+|+.||+|.+... .....+.+|+.+++.++|+||+. ..++..++|+||+.+++|.+++...+ ..++
T Consensus 21 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 100 (285)
T cd05632 21 VRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE 100 (285)
T ss_pred ECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCC
Confidence 4568999999987643 22345788999999999999987 56778999999999999999887643 3577
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
...+..++.|+ ||+.|++||||+|+||+++.++.++|+|||++...... .......|+..|+|||.+
T Consensus 101 ~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~g~~~~~aPE~~ 173 (285)
T cd05632 101 EERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-------ESIRGRVGTVGYMAPEVL 173 (285)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-------CcccCCCCCcCccChHHh
Confidence 87777766654 79999999999999999999999999999988643221 111234588999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC----
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS---- 220 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---- 220 (241)
.+..++.++|+||+|+++|++++|..||.......................+...+..+.+|+.+||+.+|.+|||
T Consensus 174 ~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 253 (285)
T cd05632 174 NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEE 253 (285)
T ss_pred cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCccc
Confidence 9888999999999999999999999999765433222222222223333455667788999999999999999999
Q ss_pred -hHHHhcCCCCCCCCc
Q 042809 221 -AEELLNHTFISGNAK 235 (241)
Q Consensus 221 -~~~~l~~p~~~~~~~ 235 (241)
+.+++.|+||+....
T Consensus 254 ~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 254 GAGEVKRHPFFRNMNF 269 (285)
T ss_pred ChHHHHcChhhhcCCH
Confidence 889999999987644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=252.07 Aligned_cols=224 Identities=33% Similarity=0.550 Sum_probs=180.5
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+++.+|+|.+... ...+.+.+|+.+++.++||||++ ..+...++|+||+++++|.+++... ..++.
T Consensus 14 ~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~ 92 (262)
T cd05572 14 VKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR-GLFDE 92 (262)
T ss_pred ECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhc-CCCCH
Confidence 4567999999997632 34467899999999999999988 5677899999999999999999874 45676
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.
T Consensus 93 ~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~ 165 (262)
T cd05572 93 YTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-------KTWTFCGTPEYVAPEIIL 165 (262)
T ss_pred HHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------ccccccCCcCccChhHhc
Confidence 6666655544 799999999999999999999999999999987654321 112335788899999998
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC-----
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS----- 220 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----- 220 (241)
+..++.++|+||+|+++|++++|..||.....+.................+...+..+.+++.+||..+|.+|||
T Consensus 166 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~ 245 (262)
T cd05572 166 NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGG 245 (262)
T ss_pred CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccC
Confidence 888899999999999999999999999876532322222222223445556666889999999999999999999
Q ss_pred hHHHhcCCCCCCC
Q 042809 221 AEELLNHTFISGN 233 (241)
Q Consensus 221 ~~~~l~~p~~~~~ 233 (241)
++++++||||+.-
T Consensus 246 ~~~l~~~~~~~~~ 258 (262)
T cd05572 246 IKDIKKHKWFNGF 258 (262)
T ss_pred HHHHhcChhhhCC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=263.49 Aligned_cols=228 Identities=29% Similarity=0.471 Sum_probs=174.3
Q ss_pred CCCcEEEEEecc----chHHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 4 GTGALFVVKSAE----SEAGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 4 ~~~~~vaiK~~~----~~~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
..+..||+|.+. .+.....+.+|+.+|.+|+ |.+||. ..++.+|+||||-+ .+|...|+..........
T Consensus 383 s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~ 461 (677)
T KOG0596|consen 383 SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGD-IDLNKILKKKKSIDPDWF 461 (677)
T ss_pred CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeeccc-ccHHHHHHhccCCCchHH
Confidence 345667777644 4556778999999999998 999988 67899999999985 699999998766666567
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
++.+..|+ +|+.||||.||||.|+++ -+|.+||+|||++..+.....+. .....+||+.|++||.+...
T Consensus 462 lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI----~kdsQvGT~NYMsPEAl~~~ 536 (677)
T KOG0596|consen 462 LKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSI----VKDSQVGTVNYMSPEALTDM 536 (677)
T ss_pred HHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccce----eeccccCcccccCHHHHhhc
Confidence 77777776 499999999999999999 78999999999998776643333 33567899999999998643
Q ss_pred C-----------CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhH-HHHHHHHHHhhccCC
Q 042809 148 G-----------LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFF-KKVLDFLAKCLERKP 215 (241)
Q Consensus 148 ~-----------~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~~l~~~p 215 (241)
. .+.++|||||||+||+|+.|+.||..-.. ....+.......-.-++|..-+ .++.++++.||..||
T Consensus 537 ~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdP 615 (677)
T KOG0596|consen 537 SSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDP 615 (677)
T ss_pred cccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCc
Confidence 2 45789999999999999999999965321 1111111111111112332222 239999999999999
Q ss_pred CCCCChHHHhcCCCCCCCCccCC
Q 042809 216 EKRWSAEELLNHTFISGNAKKNS 238 (241)
Q Consensus 216 ~~Rps~~~~l~~p~~~~~~~~~~ 238 (241)
++|||+.++|+|||+.......+
T Consensus 616 kkR~si~eLLqhpFl~~~~i~~~ 638 (677)
T KOG0596|consen 616 KKRWSIPELLQHPFLQIQPIPVE 638 (677)
T ss_pred ccCCCcHHHhcCcccccccccch
Confidence 99999999999999988655443
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=272.41 Aligned_cols=224 Identities=21% Similarity=0.323 Sum_probs=178.0
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccccC-------------CceeeeeecccCCCCHHHHHHH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGRNG-------------EKTVNIFMEYMAGGSLLDVAEK 64 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~-------------~~~~~lv~e~~~~~~L~~~l~~ 64 (241)
++.+|+.||||.+.. +.....+.+|+..+..++|+|+++.. ...+++||||+++|+|.+++..
T Consensus 53 ~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~ 132 (496)
T PTZ00283 53 RVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKS 132 (496)
T ss_pred EcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHH
Confidence 467899999999763 34456788999999999999998711 1147899999999999999975
Q ss_pred h---CCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCc
Q 042809 65 F---GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGT 135 (241)
Q Consensus 65 ~---~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 135 (241)
. ...+++..+..++.|+ ||+.|++||||||+||+++.++.+||+|||++......... .......|+
T Consensus 133 ~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~----~~~~~~~Gt 208 (496)
T PTZ00283 133 RAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD----DVGRTFCGT 208 (496)
T ss_pred hhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccc----cccccccCC
Confidence 3 2457777766666544 79999999999999999999999999999998754331111 112235689
Q ss_pred ccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCC
Q 042809 136 QLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKP 215 (241)
Q Consensus 136 ~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 215 (241)
+.|+|||.+.+..++.++||||||+++|++++|..||...... ..............+...++++.+++.+||+.+|
T Consensus 209 ~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 285 (496)
T PTZ00283 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDP 285 (496)
T ss_pred cceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCh
Confidence 9999999999988999999999999999999999999764332 2223333344445667788899999999999999
Q ss_pred CCCCChHHHhcCCCCCC
Q 042809 216 EKRWSAEELLNHTFISG 232 (241)
Q Consensus 216 ~~Rps~~~~l~~p~~~~ 232 (241)
.+|||+.++++|||++.
T Consensus 286 ~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 286 KRRPSSSKLLNMPICKL 302 (496)
T ss_pred hhCcCHHHHHhCHHHHH
Confidence 99999999999999864
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=270.77 Aligned_cols=231 Identities=35% Similarity=0.593 Sum_probs=195.5
Q ss_pred CCCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCC--CH
Q 042809 1 MNKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTL--DA 71 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~ 71 (241)
+|..|...+|||.+.. ++..+-+..|+.+-+.|+|.|||+ ..++.+-++||-++||+|++++++..+++ .+
T Consensus 595 RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNE 674 (1226)
T KOG4279|consen 595 RDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNE 674 (1226)
T ss_pred ccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccch
Confidence 5889999999998774 344566999999999999999998 56778889999999999999999988887 77
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeec-CCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGS-HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
..+-.+..|| ||++.|||||||.+|++++. .|.+||+|||-++......+ ....+.||..|+|||++
T Consensus 675 stm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP------~TETFTGTLQYMAPEvI 748 (1226)
T KOG4279|consen 675 STMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP------CTETFTGTLQYMAPEVI 748 (1226)
T ss_pred hHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc------cccccccchhhhChHhh
Confidence 8888888887 69999999999999999954 78999999999987644222 22456799999999999
Q ss_pred cc--cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 145 RN--EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 145 ~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
.. +.|..++|||||||++.||.||++||....... ..+.+......-|++|..++.+++++|.+|+..+|.+||++.
T Consensus 749 DqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-AAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~ 827 (1226)
T KOG4279|consen 749 DQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-AAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAK 827 (1226)
T ss_pred ccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-HhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHH
Confidence 65 448899999999999999999999997654332 334455555667888999999999999999999999999999
Q ss_pred HHhcCCCCCCCCccCC
Q 042809 223 ELLNHTFISGNAKKNS 238 (241)
Q Consensus 223 ~~l~~p~~~~~~~~~~ 238 (241)
++|++||++...++.-
T Consensus 828 ~LL~DpFlq~~~kk~r 843 (1226)
T KOG4279|consen 828 DLLQDPFLQHNNKKPR 843 (1226)
T ss_pred HhccCcccccCCCCCC
Confidence 9999999988866543
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=248.64 Aligned_cols=220 Identities=29% Similarity=0.486 Sum_probs=175.5
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHh-CCCCC
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~ 70 (241)
++.+++.+|+|.+... ...+.+.+|++++++++|+|+++ ..+..+++|+||+++++|.+++... ...++
T Consensus 21 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~ 100 (257)
T cd08223 21 HRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLP 100 (257)
T ss_pred EcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCC
Confidence 4667899999997632 34566889999999999999987 2344689999999999999999864 34577
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.++ ||+.|++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+
T Consensus 101 ~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~y~aPE~~ 174 (257)
T cd08223 101 ENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC------DMASTLIGTPYYMSPELF 174 (257)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC------CccccccCCcCccChhHh
Confidence 77777666644 799999999999999999999999999999987543211 111234578899999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
.+..++.++|+||+|++++++++|..||...+.... ......+..+..+...+..+.+++.+||+.+|.+|||+.++
T Consensus 175 ~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~ 251 (257)
T cd08223 175 SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL---VYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSI 251 (257)
T ss_pred cCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHH
Confidence 988889999999999999999999999975433222 12222233445566778899999999999999999999999
Q ss_pred hcCCCC
Q 042809 225 LNHTFI 230 (241)
Q Consensus 225 l~~p~~ 230 (241)
+.||||
T Consensus 252 l~~~~~ 257 (257)
T cd08223 252 LRQPYI 257 (257)
T ss_pred hcCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=253.68 Aligned_cols=211 Identities=17% Similarity=0.185 Sum_probs=166.2
Q ss_pred CCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cC----CceeeeeecccCCCCHHHHHHHhCCCC
Q 042809 4 GTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NG----EKTVNIFMEYMAGGSLLDVAEKFGGTL 69 (241)
Q Consensus 4 ~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~ 69 (241)
.+|+.||+|.+... ...+.+.+|+.++.+++||||++ .. ...+++||||+++|+|.+++... ..+
T Consensus 41 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~ 119 (283)
T PHA02988 41 FNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDL 119 (283)
T ss_pred ECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC-CCC
Confidence 36889999998742 22467889999999999999998 11 34689999999999999999874 456
Q ss_pred CHHHHHHHHH------HHhhc-CCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 70 DAGVIRLYTK------EILHG-NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 70 ~~~~~~~~~~------~~Lh~-~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
+......++. .+||+ .+++||||+|+||+++.++.+||+|||++....... ....++..|+|||
T Consensus 120 ~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~y~aPE 190 (283)
T PHA02988 120 SFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---------FKNVNFMVYFSYK 190 (283)
T ss_pred ChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---------ccccCcccccCHH
Confidence 6655555544 34797 599999999999999999999999999987543211 1234788999999
Q ss_pred cccc--cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC
Q 042809 143 VLRN--EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS 220 (241)
Q Consensus 143 ~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 220 (241)
.+.+ ..++.++||||||+++|++++|..||.+.......... ......+..+...+..+.+++.+||+.+|.+|||
T Consensus 191 ~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 268 (283)
T PHA02988 191 MLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI--INKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPN 268 (283)
T ss_pred HhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH--HhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcC
Confidence 9976 67899999999999999999999999875433322221 1223344556567889999999999999999999
Q ss_pred hHHHhc
Q 042809 221 AEELLN 226 (241)
Q Consensus 221 ~~~~l~ 226 (241)
++++++
T Consensus 269 ~~ell~ 274 (283)
T PHA02988 269 IKEILY 274 (283)
T ss_pred HHHHHH
Confidence 999985
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=261.31 Aligned_cols=220 Identities=27% Similarity=0.428 Sum_probs=172.4
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHH-HHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAE-IRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~-~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+|+.||+|.+.... ....+.+|.. +++.++||||++ ...+..|+||||+++++|..++.. ...+.
T Consensus 16 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~ 94 (321)
T cd05603 16 RKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR-ERCFL 94 (321)
T ss_pred ECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH-cCCCC
Confidence 56789999999987432 2334455544 578899999998 567789999999999999998876 45667
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||+.|++||||||+||+++.+|.+||+|||++....... .......|++.|+|||.+
T Consensus 95 ~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~gt~~y~aPE~~ 168 (321)
T cd05603 95 EPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE------ETTSTFCGTPEYLAPEVL 168 (321)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC------CccccccCCcccCCHHHh
Confidence 77666666544 799999999999999999999999999999986422111 111234589999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh---
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA--- 221 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--- 221 (241)
.+..++.++|+||||+++|+|++|..||...+....... ........+...+..+.+++.+||+.+|.+||++
T Consensus 169 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (321)
T cd05603 169 RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDN----ILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKAD 244 (321)
T ss_pred cCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHH----HhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCC
Confidence 988899999999999999999999999977543222221 1233445566677899999999999999999975
Q ss_pred -HHHhcCCCCCC
Q 042809 222 -EELLNHTFISG 232 (241)
Q Consensus 222 -~~~l~~p~~~~ 232 (241)
.++++||||..
T Consensus 245 ~~~~~~~~~~~~ 256 (321)
T cd05603 245 FLEIKNHVFFSP 256 (321)
T ss_pred HHHHhCCCCcCC
Confidence 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=270.32 Aligned_cols=222 Identities=24% Similarity=0.329 Sum_probs=164.7
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCccccc-------------CCceeeeeecccCCCCHHHHHHH---h
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGRN-------------GEKTVNIFMEYMAGGSLLDVAEK---F 65 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-------------~~~~~~lv~e~~~~~~L~~~l~~---~ 65 (241)
++.+++.||||.+.... ....+|+.+++.++||||++. ....+++||||++ ++|.+++.. .
T Consensus 87 ~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~ 163 (440)
T PTZ00036 87 CIDTSEKVAIKKVLQDP--QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARN 163 (440)
T ss_pred ECCCCCEEEEEEEecCc--chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhc
Confidence 46789999999876432 234579999999999999871 1235779999997 588777754 2
Q ss_pred CCCCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCC-CeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 66 GGTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHG-DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 66 ~~~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
...++...+..++.| +||++|++||||||+||+++.++ .+||+|||++....... ......+++.|
T Consensus 164 ~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~-------~~~~~~~t~~y 236 (440)
T PTZ00036 164 NHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ-------RSVSYICSRFY 236 (440)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCC-------CcccCCCCcCc
Confidence 456777777666554 48999999999999999998665 69999999997543311 11234578999
Q ss_pred cCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC-----------------CC--------
Q 042809 139 MAPEVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN-----------------EK-------- 192 (241)
Q Consensus 139 ~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------~~-------- 192 (241)
+|||.+.+. .++.++|||||||++|+|++|.+||.+................ .+
T Consensus 237 ~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~ 316 (440)
T PTZ00036 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLK 316 (440)
T ss_pred cCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHH
Confidence 999998764 6899999999999999999999999765332221111111000 00
Q ss_pred CCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCC
Q 042809 193 PHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 193 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~ 233 (241)
..++...+.++.+|+.+||..+|.+|||+.++++||||+.-
T Consensus 317 ~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 317 KVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 01223356789999999999999999999999999999754
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=261.76 Aligned_cols=220 Identities=25% Similarity=0.418 Sum_probs=171.2
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHH-HHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEA-EIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~-~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+++.||+|++.... ....+..|. .+++.++||||++ ...+..|+||||+++++|.+++.. ...+.
T Consensus 16 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~ 94 (325)
T cd05602 16 HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFL 94 (325)
T ss_pred ECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHh-cCCCC
Confidence 56788999999987432 222344444 4567789999988 567889999999999999999987 34566
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||++|++||||||+||+++.++.++|+|||++...... ........|++.|+|||.+
T Consensus 95 ~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~------~~~~~~~~gt~~y~aPE~~ 168 (325)
T cd05602 95 EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH------NGTTSTFCGTPEYLAPEVL 168 (325)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC------CCCcccccCCccccCHHHH
Confidence 66666655544 79999999999999999999999999999998643221 1112344689999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH--
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE-- 222 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-- 222 (241)
.+..++.++||||||+++|+|++|..||............. ......+...+..+.+++++||+.+|.+|+++.
T Consensus 169 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 169 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL----NKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred cCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH----hCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 99889999999999999999999999997654333222221 223344556788999999999999999999876
Q ss_pred --HHhcCCCCCC
Q 042809 223 --ELLNHTFISG 232 (241)
Q Consensus 223 --~~l~~p~~~~ 232 (241)
++++|+||..
T Consensus 245 ~~~i~~~~~~~~ 256 (325)
T cd05602 245 FMEIKNHIFFSP 256 (325)
T ss_pred HHHHhcCcccCC
Confidence 8999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=250.97 Aligned_cols=224 Identities=33% Similarity=0.541 Sum_probs=179.5
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+++.+++|.+... .....+.+|+++++++.||||++ ......++|+||+.+++|.+++......++...
T Consensus 22 ~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 101 (265)
T cd06605 22 HRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERI 101 (265)
T ss_pred EcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHH
Confidence 4568999999987643 44567889999999999999987 567889999999999999999987556777777
Q ss_pred HHHHHHHH------hhc-CCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 74 IRLYTKEI------LHG-NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 74 ~~~~~~~~------Lh~-~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
+..++.|+ ||+ .|++|+||+|+||+++.++.++|+|||.+........ ....++..|+|||.+.+
T Consensus 102 ~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--------~~~~~~~~y~~PE~~~~ 173 (265)
T cd06605 102 LGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--------KTFVGTSSYMAPERIQG 173 (265)
T ss_pred HHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--------hcccCChhccCHHHHcC
Confidence 76665544 799 9999999999999999999999999999875533111 11457888999999998
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccch--hchHHHHHHHHhcCCCCCCChh-hHHHHHHHHHHhhccCCCCCCChHH
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKI--SNAAATLLKIACSNEKPHFPTQ-FFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
..++.++|+||||+++|++++|..||.... ................+..+.. ++..+.++|.+||..+|.+|||+.+
T Consensus 174 ~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 253 (265)
T cd06605 174 NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKE 253 (265)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHH
Confidence 889999999999999999999999996542 1222223333333334444444 7788999999999999999999999
Q ss_pred HhcCCCCCCC
Q 042809 224 LLNHTFISGN 233 (241)
Q Consensus 224 ~l~~p~~~~~ 233 (241)
++.||||+..
T Consensus 254 ll~~~~~~~~ 263 (265)
T cd06605 254 LLEHPFIKKY 263 (265)
T ss_pred HhhCchhhcc
Confidence 9999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=259.52 Aligned_cols=233 Identities=24% Similarity=0.349 Sum_probs=171.0
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh-CCCCCH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~ 71 (241)
++.+|+.||+|.+..+ ...+.+.+|+.+++.++||||++ ..++..++|+||+++++|.+++... ...+++
T Consensus 21 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~ 100 (327)
T cd08227 21 YKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSE 100 (327)
T ss_pred ecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCH
Confidence 5788999999998743 33456788999999999999988 5677899999999999999999764 344777
Q ss_pred HHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCcc-ccccccccCcccccCcccc
Q 042809 72 GVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNL-KQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 72 ~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~ 144 (241)
..+..++.| +||++|++||||||+||+++.++.++++||+.............. ........++..|+|||.+
T Consensus 101 ~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (327)
T cd08227 101 LAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVL 180 (327)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHh
Confidence 776666654 479999999999999999999999999999865443221110000 0001122456779999999
Q ss_pred cc--cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC--------------------------------
Q 042809 145 RN--EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN-------------------------------- 190 (241)
Q Consensus 145 ~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------------- 190 (241)
.+ ..++.++||||||+++|++++|..||..................
T Consensus 181 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T cd08227 181 QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTV 260 (327)
T ss_pred hcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCccccc
Confidence 76 45889999999999999999999999753322111110000000
Q ss_pred ----------CCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 191 ----------EKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 191 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
........+++.+.+++.+||+.||.+|||++++++||||+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 261 STPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred CCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 00011123456899999999999999999999999999997644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=263.05 Aligned_cols=225 Identities=23% Similarity=0.347 Sum_probs=170.3
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCc-----eeeeeecccCCCCHHHHHHHhCC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEK-----TVNIFMEYMAGGSLLDVAEKFGG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~-----~~~lv~e~~~~~~L~~~l~~~~~ 67 (241)
|+.+|+.||+|.+.. ....+.+.+|+++++.++|+||++ .... ..|+|+||+. ++|.+++.. ..
T Consensus 21 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~ 98 (372)
T cd07853 21 DPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVS-PQ 98 (372)
T ss_pred ECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhc-CC
Confidence 567899999998753 234567889999999999999988 2222 7899999996 688888875 45
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
.++...+..++.|+ ||+.|++||||||+||+++.++.++|+|||++....... ........+++.|+||
T Consensus 99 ~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~-----~~~~~~~~~~~~y~aP 173 (372)
T cd07853 99 PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE-----SKHMTQEVVTQYYRAP 173 (372)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc-----cccCCCCCcCCCcCCH
Confidence 67777777766654 799999999999999999999999999999987543211 1111223468889999
Q ss_pred cccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHH----------------------hcCCCC-----
Q 042809 142 EVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIA----------------------CSNEKP----- 193 (241)
Q Consensus 142 E~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------------------~~~~~~----- 193 (241)
|.+.+. .++.++||||+||++|+|++|+.||.+.........+... .....+
T Consensus 174 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (372)
T cd07853 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVL 253 (372)
T ss_pred HHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHh
Confidence 999874 4788999999999999999999999764332221111110 000011
Q ss_pred -CCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCC
Q 042809 194 -HFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 194 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~ 233 (241)
......++.+.+|+.+||+.||.+|||+.++++||||++.
T Consensus 254 ~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 254 YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 1223346789999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=255.24 Aligned_cols=224 Identities=29% Similarity=0.438 Sum_probs=173.1
Q ss_pred CCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc---------cC-CceeeeeecccCCCCHHHHHHHh---CCCC
Q 042809 3 KGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR---------NG-EKTVNIFMEYMAGGSLLDVAEKF---GGTL 69 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~---------~~-~~~~~lv~e~~~~~~L~~~l~~~---~~~~ 69 (241)
..+++.||||..-.+.. .-.+|+.+|+.+.|||||+ .. .-++.+|||||+ .+|..+++.. +..+
T Consensus 46 ~e~~~~vAIKKv~~d~r--~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~m 122 (364)
T KOG0658|consen 46 RETEEEVAIKKVLQDKR--YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRM 122 (364)
T ss_pred cCCCceeEEEEecCCCC--cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-HHHHHHHHHHhhcCCCC
Confidence 35688999998664331 2347899999999999998 22 336789999997 5999999853 5667
Q ss_pred CHHHHHHHHHHH------hhcCCccccCCCCCcEEeecC-CCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH-GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
+...++.+..|+ ||+.|++||||||.|+++|.+ |.+||||||.|+.......+ .+..-++.|+|||
T Consensus 123 p~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn-------iSYicSRyYRaPE 195 (364)
T KOG0658|consen 123 PLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN-------ISYICSRYYRAPE 195 (364)
T ss_pred ceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc-------eeEEEeccccCHH
Confidence 777777777665 799999999999999999986 89999999999977653322 2233588999999
Q ss_pred cccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCC----------------C---------CCC
Q 042809 143 VLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK----------------P---------HFP 196 (241)
Q Consensus 143 ~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------~---------~~~ 196 (241)
.+.| ..|+.+.||||.||++.||+-|++.|.+.........+....+... + -+.
T Consensus 196 Lifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~ 275 (364)
T KOG0658|consen 196 LIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFF 275 (364)
T ss_pred HHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecc
Confidence 9987 5589999999999999999999999988544433322222211100 0 123
Q ss_pred hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 197 TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 197 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
...+++..+|+.++|..+|.+|.++.+++.||||+.-...
T Consensus 276 ~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 276 KRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 4466899999999999999999999999999999876554
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=262.42 Aligned_cols=220 Identities=26% Similarity=0.329 Sum_probs=163.6
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----c------CCceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----N------GEKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~------~~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
|+.+|+.||+|.+.. ......+.+|+.+++.++||||++ . ....+|+||||+++ +|...+..
T Consensus 42 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-- 118 (359)
T cd07876 42 DTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM-- 118 (359)
T ss_pred EcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc--
Confidence 567899999999763 234567889999999999999987 1 11357999999964 67776643
Q ss_pred CCCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
.++...+..++.| +||++|++||||||+||+++.++.++|+|||++...... .......+++.|+|
T Consensus 119 -~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~~~t~~y~a 190 (359)
T cd07876 119 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN-------FMMTPYVVTRYYRA 190 (359)
T ss_pred -cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC-------ccCCCCcccCCCCC
Confidence 3566665555554 479999999999999999999999999999998643221 11122457889999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHH------------------hcCCCCC--------
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIA------------------CSNEKPH-------- 194 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------------~~~~~~~-------- 194 (241)
||.+.+..++.++||||||+++|+|++|+.||.+.+........... .....+.
T Consensus 191 PE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (359)
T cd07876 191 PEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEE 270 (359)
T ss_pred chhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhh
Confidence 99999989999999999999999999999999764322111000000 0000000
Q ss_pred ------------CChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 195 ------------FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 195 ------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
.....+..+.+|+.+||..+|++|||++++++||||+.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 271 LFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred hccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 11123467899999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=252.54 Aligned_cols=228 Identities=34% Similarity=0.555 Sum_probs=177.7
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.++..+++|.+.. ....+.+.+|+++++.++|||+++ ......++|+||+++++|..++.....++++..+
T Consensus 26 ~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~ 105 (282)
T cd06643 26 NKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQI 105 (282)
T ss_pred ECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHH
Confidence 456788999998763 345677889999999999999988 5667899999999999999988765567788877
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc---
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR--- 145 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--- 145 (241)
..++.|+ ||+.|++||||+|+||+++.++.++|+|||++....... .......++..|+|||.+.
T Consensus 106 ~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~ 179 (282)
T cd06643 106 RVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI------QRRDSFIGTPYWMAPEVVMCET 179 (282)
T ss_pred HHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc------cccccccccccccCHhhccccC
Confidence 7766654 799999999999999999999999999999986443211 1112345788999999984
Q ss_pred --ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH
Q 042809 146 --NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 146 --~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
+..++.++|+||+|+++|++++|..||............. .........+..++..+.+++.+||+.+|.+|||+++
T Consensus 180 ~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (282)
T cd06643 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQ 258 (282)
T ss_pred CCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHh-hcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 3456789999999999999999999997643222111111 1111122334557789999999999999999999999
Q ss_pred HhcCCCCCCCCcc
Q 042809 224 LLNHTFISGNAKK 236 (241)
Q Consensus 224 ~l~~p~~~~~~~~ 236 (241)
+++||||+.....
T Consensus 259 il~~~~~~~~~~~ 271 (282)
T cd06643 259 LLQHPFVTVNSNK 271 (282)
T ss_pred HhcCCCEeccCCC
Confidence 9999999876544
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=252.29 Aligned_cols=225 Identities=32% Similarity=0.528 Sum_probs=178.5
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.++..+|+|.+.. ....+.+.+|++++++++||||++ ..+...|+||||+++++|.+++...+..+++..+
T Consensus 26 ~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~ 105 (280)
T cd06611 26 HKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQI 105 (280)
T ss_pred EcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHH
Confidence 346789999999763 345567889999999999999988 5677899999999999999999886667888888
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc---
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR--- 145 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--- 145 (241)
..++.|+ ||+.|++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.
T Consensus 106 ~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~ 179 (280)
T cd06611 106 RYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL------QKRDTFIGTPYWMAPEVVACET 179 (280)
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc------cccceeecchhhcCHHHHhhcc
Confidence 8777654 799999999999999999999999999999876543211 1112345788899999974
Q ss_pred --ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC--CCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 146 --NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP--HFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 146 --~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
+..++.++|+||||+++|++++|..||......... ........+ ..+...+.++.+++.+||..+|.+|||+
T Consensus 180 ~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 256 (280)
T cd06611 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL---LKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTA 256 (280)
T ss_pred cCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH---HHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCH
Confidence 344677899999999999999999999765332221 111222222 2344567889999999999999999999
Q ss_pred HHHhcCCCCCCCCc
Q 042809 222 EELLNHTFISGNAK 235 (241)
Q Consensus 222 ~~~l~~p~~~~~~~ 235 (241)
+++++||||+....
T Consensus 257 ~~il~~~~~~~~~~ 270 (280)
T cd06611 257 AELLKHPFVSDQSD 270 (280)
T ss_pred HHHhcChhhcccch
Confidence 99999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=275.08 Aligned_cols=214 Identities=23% Similarity=0.395 Sum_probs=177.4
Q ss_pred CCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC---------
Q 042809 5 TGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG--------- 67 (241)
Q Consensus 5 ~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~--------- 67 (241)
....||||.+++. .....|++|++++..++|||||+ ..++.+|+|+|||.+|+|..||..+..
T Consensus 515 ~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~ 594 (774)
T KOG1026|consen 515 DEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQ 594 (774)
T ss_pred cceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCC
Confidence 4567999998853 35678999999999999999999 788899999999999999999987532
Q ss_pred C----CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccc
Q 042809 68 T----LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL 137 (241)
Q Consensus 68 ~----~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (241)
. ++......++.|| |-++.+|||||-.+||+|+.+-.|||+|||+++.+-. .+..+......-+.+
T Consensus 595 ~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYs----sDYYk~~~~t~lPIR 670 (774)
T KOG1026|consen 595 DTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYS----SDYYKVRGNTLLPIR 670 (774)
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhh----hhhhcccCCceeeee
Confidence 2 6677777777766 7899999999999999999999999999999975422 111111112234678
Q ss_pred ccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 138 WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 138 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
|||||.+..++|+.++||||+||++||+++ |..||.+...+...+.++ .+.....|...|..+++|+..||+.+|+
T Consensus 671 WMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~---~g~lL~~Pe~CP~~vY~LM~~CW~~~P~ 747 (774)
T KOG1026|consen 671 WMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR---AGQLLSCPENCPTEVYSLMLECWNENPK 747 (774)
T ss_pred cCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH---cCCcccCCCCCCHHHHHHHHHHhhcCcc
Confidence 999999999999999999999999999999 999998876665554444 3444777888999999999999999999
Q ss_pred CCCChHHHh
Q 042809 217 KRWSAEELL 225 (241)
Q Consensus 217 ~Rps~~~~l 225 (241)
+|||+++|-
T Consensus 748 ~RPsF~eI~ 756 (774)
T KOG1026|consen 748 RRPSFKEIH 756 (774)
T ss_pred cCCCHHHHH
Confidence 999999974
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=248.58 Aligned_cols=225 Identities=40% Similarity=0.663 Sum_probs=175.3
Q ss_pred CCCcEEEEEeccc--------hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 4 GTGALFVVKSAES--------EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 4 ~~~~~vaiK~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
.+|..+|+|.+.. ......+.+|++++++++|+||++ ...+..++|+||+++++|.+++... ..++
T Consensus 22 ~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~ 100 (265)
T cd06631 22 NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLP 100 (265)
T ss_pred cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhc-CCCC
Confidence 4678899997652 223456889999999999999988 5668899999999999999999874 4567
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
...+..++.|+ ||+.+++|+||+|+||+++.++.++|+|||.+....................++..|+|||.+
T Consensus 101 ~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 180 (265)
T cd06631 101 EPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180 (265)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhh
Confidence 77766665544 799999999999999999999999999999987543211111111122234578899999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
.+..++.++|+||||+++|++++|..||.......... .........+..+..++..+.+++++||..+|.+|||++++
T Consensus 181 ~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 259 (265)
T cd06631 181 NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-YIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQL 259 (265)
T ss_pred cCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH-HhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 98888999999999999999999999997543222111 11111123345666788899999999999999999999999
Q ss_pred hcCCCC
Q 042809 225 LNHTFI 230 (241)
Q Consensus 225 l~~p~~ 230 (241)
+.||||
T Consensus 260 l~~~~~ 265 (265)
T cd06631 260 LRHDFL 265 (265)
T ss_pred hcCCCC
Confidence 999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=251.59 Aligned_cols=224 Identities=36% Similarity=0.598 Sum_probs=179.6
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
+..+|..||+|.+... .....+.+|+.+++.++|+||++ ..+...|+|+||+.+++|.+++... +++...
T Consensus 22 ~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~ 99 (274)
T cd06609 22 DKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETY 99 (274)
T ss_pred ECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc--CCCHHH
Confidence 4568999999997632 33466889999999999999988 5667899999999999999999863 677777
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
+..++.|+ ||+.+++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+.
T Consensus 100 ~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~ 173 (274)
T cd06609 100 IAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM------SKRNTFVGTPFWMAPEVIKQS 173 (274)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc------cccccccCCccccChhhhccC
Confidence 77766655 799999999999999999999999999999987654321 111234477889999999988
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChh-hHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 148 GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQ-FFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
.++.++|+||||+++|++++|..||........ .........+..+.. .+..+.+++.+||..+|.+|||+++++.
T Consensus 174 ~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 174 GYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 899999999999999999999999975432221 111222333333333 7788999999999999999999999999
Q ss_pred CCCCCCCCcc
Q 042809 227 HTFISGNAKK 236 (241)
Q Consensus 227 ~p~~~~~~~~ 236 (241)
||||+....+
T Consensus 251 ~~~~~~~~~~ 260 (274)
T cd06609 251 HKFIKKAKKT 260 (274)
T ss_pred ChhhcCCCcc
Confidence 9999886554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=254.09 Aligned_cols=218 Identities=26% Similarity=0.372 Sum_probs=163.3
Q ss_pred CCcEEEEEeccch----HHHHHHHHHHHHHhhc---CCCcccc----------cCCceeeeeecccCCCCHHHHHHHhC-
Q 042809 5 TGALFVVKSAESE----AGVQALRNEAEIRQSL---NSPNIGR----------NGEKTVNIFMEYMAGGSLLDVAEKFG- 66 (241)
Q Consensus 5 ~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l---~h~~i~~----------~~~~~~~lv~e~~~~~~L~~~l~~~~- 66 (241)
+|..||+|.+... .....+.+|+.+++.+ .||||++ .....+++|+||+. ++|.+++....
T Consensus 26 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~ 104 (290)
T cd07862 26 GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE 104 (290)
T ss_pred CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCC
Confidence 4688999987632 1233456777777665 6999987 13456899999996 69999987642
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..+++..+..++.|+ ||++|++||||||+||+++.++.++|+|||++...... .......|++.|+|
T Consensus 105 ~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~~~~y~a 177 (290)
T cd07862 105 PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-------MALTSVVVTLWYRA 177 (290)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC-------cccccccccccccC
Confidence 346777776666654 79999999999999999999999999999998654321 11223457899999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC-CCC----------------------CCCh
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN-EKP----------------------HFPT 197 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~----------------------~~~~ 197 (241)
||.+.+..++.++|+||||+++|++++|..||.+................ ... ...+
T Consensus 178 PE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (290)
T cd07862 178 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT 257 (290)
T ss_pred hHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHcc
Confidence 99998888999999999999999999999999765433222221111100 000 0112
Q ss_pred hhHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 198 QFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 198 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
.++..+.+++.+||+.+|++|||+.++++||||
T Consensus 258 ~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 258 DIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred CCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 355678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=252.00 Aligned_cols=226 Identities=31% Similarity=0.465 Sum_probs=178.1
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~ 70 (241)
++.+|+.||+|.+... .....+.+|++++++++||||++ ...+..|+||||+++++|.+++.... ..++
T Consensus 14 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 93 (277)
T cd05577 14 VKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP 93 (277)
T ss_pred EcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCC
Confidence 4668999999987642 22445678999999999999988 56678999999999999999998743 3577
Q ss_pred HHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.| +||+.|++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+
T Consensus 94 ~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~~~~y~~PE~~ 166 (277)
T cd05577 94 EARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-------KKIKGRAGTPGYMAPEVL 166 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-------CccccccCCCCcCCHHHh
Confidence 7776666554 479999999999999999999999999999988754321 111223467889999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW----- 219 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----- 219 (241)
.+..++.++|+||+|+++|++++|..||.......................+...++.+.+++.+||+.+|.+||
T Consensus 167 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 246 (277)
T cd05577 167 QGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGG 246 (277)
T ss_pred cCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcc
Confidence 888889999999999999999999999976543222222222222334455566788999999999999999999
Q ss_pred ChHHHhcCCCCCCCC
Q 042809 220 SAEELLNHTFISGNA 234 (241)
Q Consensus 220 s~~~~l~~p~~~~~~ 234 (241)
++.+++.||||+...
T Consensus 247 ~~~~ll~h~~~~~~~ 261 (277)
T cd05577 247 SADEVREHPLFKDLN 261 (277)
T ss_pred cHHHHHhChhhhcCC
Confidence 888899999996543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=291.29 Aligned_cols=236 Identities=38% Similarity=0.665 Sum_probs=199.2
Q ss_pred CCCCCCcEEEEEecc----chHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 1 MNKGTGALFVVKSAE----SEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~----~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++..||...|+|-+. .....+...+|..++..+.|||+|+ ...+.++|+||||++|+|.+.+.. +...++
T Consensus 1255 vN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~-gri~dE 1333 (1509)
T KOG4645|consen 1255 VNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEH-GRIEDE 1333 (1509)
T ss_pred ecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHh-cchhhh
Confidence 477899999999765 2334566889999999999999998 678889999999999999999986 555666
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
...+.+..|+ ||+.|||||||||.||+++.+|.+|++|||.+..+.... ...+.......||+.|||||++.
T Consensus 1334 ~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~--~~~~~el~~~~GT~~YMAPEvit 1411 (1509)
T KOG4645|consen 1334 MVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA--QTMPGELQSMMGTPMYMAPEVIT 1411 (1509)
T ss_pred hHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch--hcCCHHHHhhcCCchhcCchhhc
Confidence 6666666655 799999999999999999999999999999998765532 12234455677999999999997
Q ss_pred ccC---CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 146 NEG---LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 146 ~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
+.. ...++||||||||+.||+||+.||... +....+......+..|.+|..++..-.+|+..||..||++|+++.
T Consensus 1412 ~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~--dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~ 1489 (1509)
T KOG4645|consen 1412 GTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL--DNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTAS 1489 (1509)
T ss_pred ccccCCCCcchhhhcccceEEEeecCCCchhhc--cchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHH
Confidence 754 457899999999999999999999875 334455566667888899999999999999999999999999999
Q ss_pred HHhcCCCCCCCCccCCCCC
Q 042809 223 ELLNHTFISGNAKKNSTEE 241 (241)
Q Consensus 223 ~~l~~p~~~~~~~~~~~~~ 241 (241)
|+++|-|-+....+.+.+|
T Consensus 1490 qlle~~f~~~~~d~~s~~~ 1508 (1509)
T KOG4645|consen 1490 QLLEHAFGKSCTDEDSSEQ 1508 (1509)
T ss_pred HHHHhhccccccccchhhc
Confidence 9999999999888887765
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=259.26 Aligned_cols=222 Identities=23% Similarity=0.357 Sum_probs=168.2
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCccccc-----------CCceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGRN-----------GEKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~-----------~~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
++.+++.||+|.+... .....+.+|+.+++.++||||++. .....|++++++ +++|.+++..
T Consensus 36 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-- 112 (343)
T cd07878 36 DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC-- 112 (343)
T ss_pred ECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc--
Confidence 5678999999998643 234567899999999999999871 124579999998 6799988864
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..++...+..++.|+ ||++|++||||||+||+++.++.+||+|||++...... .....+++.|+|
T Consensus 113 ~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~---------~~~~~~t~~y~a 183 (343)
T cd07878 113 QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE---------MTGYVATRWYRA 183 (343)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC---------cCCccccccccC
Confidence 467887777776655 79999999999999999999999999999998754321 122357899999
Q ss_pred cccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC-------------------CCCCCC----
Q 042809 141 PEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN-------------------EKPHFP---- 196 (241)
Q Consensus 141 PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------~~~~~~---- 196 (241)
||.+.+ ..++.++||||||+++|+|++|..||.+................ ..+..+
T Consensus 184 PE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (343)
T cd07878 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDL 263 (343)
T ss_pred chHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhH
Confidence 999976 56788999999999999999999999764322211111110000 000011
Q ss_pred ----hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 197 ----TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 197 ----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
...++.+.+|+.+||..+|.+|||+.++++||||.....
T Consensus 264 ~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 264 KKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred HHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 123456789999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=258.96 Aligned_cols=218 Identities=22% Similarity=0.317 Sum_probs=165.3
Q ss_pred CCCCcEEEEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc------cCCceeeeeecccCCCCHHHHHHHhC------
Q 042809 3 KGTGALFVVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFG------ 66 (241)
Q Consensus 3 ~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~------ 66 (241)
+.++..||+|.+.. ......+.+|+.++..+ +||||++ ...+.+++||||+++|+|.+++....
T Consensus 34 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~ 113 (338)
T cd05102 34 KSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPY 113 (338)
T ss_pred cccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccc
Confidence 34567899999864 23456789999999999 7999988 33456899999999999999997532
Q ss_pred -------------------------------------------------------CCCCHHHHHHHHH------HHhhcC
Q 042809 67 -------------------------------------------------------GTLDAGVIRLYTK------EILHGN 85 (241)
Q Consensus 67 -------------------------------------------------------~~~~~~~~~~~~~------~~Lh~~ 85 (241)
.+++...+..++. .+||++
T Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 193 (338)
T cd05102 114 REKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR 193 (338)
T ss_pred cccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1244444444444 448999
Q ss_pred CccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHH
Q 042809 86 GILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165 (241)
Q Consensus 86 ~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 165 (241)
|++||||||+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|++
T Consensus 194 ~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el 269 (338)
T cd05102 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269 (338)
T ss_pred CEECCCCccceEEEcCCCcEEEeecccccccccCcch----hcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHH
Confidence 9999999999999999999999999998754321110 111223356789999999988899999999999999999
Q ss_pred Hh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 166 AT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 166 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++ |..||.+...... .......+.....+...++.+.+++.+||+.+|.+|||+.++++
T Consensus 270 ~~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 270 FSLGASPYPGVQINEE--FCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred HhCCCCCCCCCCccHH--HHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 97 9999976433221 11222223334455667789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=254.54 Aligned_cols=226 Identities=30% Similarity=0.482 Sum_probs=174.7
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
+..+|..+|+|.+.. ......+.+|++++++++||||++ ..++.+++|+||+++++|.+++... ..++...
T Consensus 22 ~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~ 100 (308)
T cd06615 22 HRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPENI 100 (308)
T ss_pred EcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc-CCCCHHH
Confidence 456889999998763 334566889999999999999988 5678999999999999999999874 5677777
Q ss_pred HHHHHHHH------hhc-CCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 74 IRLYTKEI------LHG-NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 74 ~~~~~~~~------Lh~-~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
+..++.|+ ||+ .+++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+
T Consensus 101 ~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--------~~~~~~~~~~~~aPE~~~~ 172 (308)
T cd06615 101 LGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--------MANSFVGTRSYMSPERLQG 172 (308)
T ss_pred HHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--------ccccCCCCcCccChhHhcC
Confidence 76666654 797 69999999999999999999999999988643221 1123457889999999988
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHH---------------------------------hcCCCC
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIA---------------------------------CSNEKP 193 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------------------------------~~~~~~ 193 (241)
..++.++|+||||+++|++++|..||............... .....+
T Consensus 173 ~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (308)
T cd06615 173 THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPP 252 (308)
T ss_pred CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCc
Confidence 88899999999999999999999998654322211111100 001111
Q ss_pred CCCh-hhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 194 HFPT-QFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 194 ~~~~-~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
..+. .++.++.+++.+||..+|++|||+++++.||||.....+
T Consensus 253 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 296 (308)
T cd06615 253 KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE 296 (308)
T ss_pred cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence 1111 246679999999999999999999999999999875443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=260.38 Aligned_cols=224 Identities=30% Similarity=0.492 Sum_probs=193.9
Q ss_pred CCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCCH
Q 042809 3 KGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDA 71 (241)
Q Consensus 3 ~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~ 71 (241)
+.||+.||+|++.+ ..+.....+|-.+|.++..+.||. +..+.+|+|+..|+||+|.-+|...+ ..+++
T Consensus 207 raTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e 286 (591)
T KOG0986|consen 207 RATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDE 286 (591)
T ss_pred ecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCch
Confidence 46889999998764 345566789999999999999988 88999999999999999999888764 46999
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+.+++.++ ||..+||+||+||+||++|..|.++|+|+|+|..+.+.. ......||.+|||||++.
T Consensus 287 ~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~-------~~~~rvGT~GYMAPEvl~ 359 (591)
T KOG0986|consen 287 QRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK-------PIRGRVGTVGYMAPEVLQ 359 (591)
T ss_pred HHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC-------ccccccCcccccCHHHHc
Confidence 9999999877 699999999999999999999999999999998776522 223346999999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----C
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----S 220 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s 220 (241)
...|+...|.|||||++|+|+.|+.||.........+.+..........++...++++.+|.+.+|.+||.+|. .
T Consensus 360 ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~g 439 (591)
T KOG0986|consen 360 NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEG 439 (591)
T ss_pred CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcC
Confidence 99999999999999999999999999987665555555555666667778888999999999999999999998 7
Q ss_pred hHHHhcCCCCCCC
Q 042809 221 AEELLNHTFISGN 233 (241)
Q Consensus 221 ~~~~l~~p~~~~~ 233 (241)
++++.+||||+.-
T Consensus 440 a~evk~HpfFk~l 452 (591)
T KOG0986|consen 440 AQEVKEHPFFKDL 452 (591)
T ss_pred cchhhhCcccccC
Confidence 8899999999863
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=250.75 Aligned_cols=224 Identities=36% Similarity=0.542 Sum_probs=175.5
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.+++.|++|.+.. ....+.+.+|+.+++.++||||++ ..++..++||||+++++|..++......++...+
T Consensus 33 ~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~ 112 (292)
T cd06644 33 NKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI 112 (292)
T ss_pred ECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHH
Confidence 457889999999763 344677889999999999999988 5677899999999999999988765667788877
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc---
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR--- 145 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--- 145 (241)
..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++...... ........+++.|+|||.+.
T Consensus 113 ~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~ 186 (292)
T cd06644 113 QVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT------LQRRDSFIGTPYWMAPEVVMCET 186 (292)
T ss_pred HHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc------ccccceecCCccccCceeecccc
Confidence 7776655 79999999999999999999999999999987643221 11112345788899999984
Q ss_pred --ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCC--CCCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 146 --NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK--PHFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 146 --~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
...++.++|+||||+++|++++|..||........ .... ..... ...+..++.++.+++++||..+|.+||++
T Consensus 187 ~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 263 (292)
T cd06644 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKI-AKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSA 263 (292)
T ss_pred ccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHHH-hcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCH
Confidence 34467889999999999999999999976432221 1111 11111 22345567789999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q 042809 222 EELLNHTFISGNA 234 (241)
Q Consensus 222 ~~~l~~p~~~~~~ 234 (241)
+++++||||....
T Consensus 264 ~~il~~~~~~~~~ 276 (292)
T cd06644 264 AQLLEHPFVSSVT 276 (292)
T ss_pred HHHhcCccccccc
Confidence 9999999997544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=255.30 Aligned_cols=224 Identities=23% Similarity=0.365 Sum_probs=162.5
Q ss_pred CCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhC--------C
Q 042809 3 KGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFG--------G 67 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~--------~ 67 (241)
..+++.||+|.+........+.+|+.++++++||||++ ..+..+++|+||+. ++|.+++.... .
T Consensus 25 ~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~ 103 (317)
T cd07868 25 GKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPV 103 (317)
T ss_pred CCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcc
Confidence 35778999999886555566889999999999999987 34567899999995 58988876421 2
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEe----ecCCCeeecCCCcchhhcccccCCccccccccccCccc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLL----GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL 137 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (241)
.++...+..++.|+ ||++|++||||||+||++ +.++.+||+|||++........ .........+++.
T Consensus 104 ~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~~~t~~ 180 (317)
T cd07868 104 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK---PLADLDPVVVTFW 180 (317)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCc---cccccCCcccccc
Confidence 46677666666654 799999999999999999 4557899999999975432111 0111233457899
Q ss_pred ccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhch----------HHHHHHHHh------------------
Q 042809 138 WMAPEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNA----------AATLLKIAC------------------ 188 (241)
Q Consensus 138 ~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----------~~~~~~~~~------------------ 188 (241)
|+|||.+.+ ..++.++|+||+||++|++++|+.||....... ...+.....
T Consensus 181 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (317)
T cd07868 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHST 260 (317)
T ss_pred ccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhh
Confidence 999999977 457889999999999999999999996432210 000000000
Q ss_pred -----cCCCC----------CCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 189 -----SNEKP----------HFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 189 -----~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
..... ......+..+.+|+++||+.||.+|||++++++||||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 261 LMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00000 0000123468899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=260.94 Aligned_cols=220 Identities=25% Similarity=0.310 Sum_probs=164.5
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----------cCCceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----------NGEKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----------~~~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
|+.+++.||||.+.. ......+.+|+.+++.++||||+. .....+|+||||++ ++|..++..
T Consensus 45 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-- 121 (364)
T cd07875 45 DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM-- 121 (364)
T ss_pred ECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh--
Confidence 567889999999763 334567889999999999999987 12246899999996 578777754
Q ss_pred CCCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
.++...+..++. ++||++|++||||||+||+++.++.++|+|||++...... .......+++.|+|
T Consensus 122 -~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-------~~~~~~~~t~~y~a 193 (364)
T cd07875 122 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-------FMMTPYVVTRYYRA 193 (364)
T ss_pred -cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC-------CcccCCcccCCcCC
Confidence 355555555554 4479999999999999999999999999999999754321 11123457899999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC------------------CCC---------
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN------------------EKP--------- 193 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------~~~--------- 193 (241)
||.+.+..++.++||||||+++|+|++|+.||.+.+.............. ..+
T Consensus 194 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (364)
T cd07875 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK 273 (364)
T ss_pred HHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHh
Confidence 99999999999999999999999999999999764332211111100000 000
Q ss_pred -----------CCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 194 -----------HFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 194 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
......+..+.+|+.+||+.||.+|||++++++||||..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 274 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred hCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 001112357899999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=253.56 Aligned_cols=227 Identities=24% Similarity=0.404 Sum_probs=172.8
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.++..||+|.+... .....+.+|+.+++.++||||++ ......++|+||++ ++|.+++......++...
T Consensus 27 ~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~ 105 (301)
T cd07873 27 SKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHN 105 (301)
T ss_pred EcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHH
Confidence 4678899999987632 23456788999999999999988 56778999999997 599999887666677777
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc-
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN- 146 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~- 146 (241)
+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.+
T Consensus 106 ~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~ 179 (301)
T cd07873 106 VKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT------KTYSNEVVTLWYRPPDILLGS 179 (301)
T ss_pred HHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC------CcccccceeecccCcHHHhCC
Confidence 77666544 799999999999999999999999999999986432211 11122346788999999865
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC------------------CCCC--------CChhhH
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN------------------EKPH--------FPTQFF 200 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------~~~~--------~~~~~~ 200 (241)
..++.++|+||||+++|+|++|+.||...+.............. ..+. ....++
T Consensus 180 ~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (301)
T cd07873 180 TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLD 259 (301)
T ss_pred CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCC
Confidence 34788999999999999999999999765433222111111000 0000 112356
Q ss_pred HHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 201 KKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 201 ~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.++.+||.+||..+|.+|||++++++||||+.-.+
T Consensus 260 ~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 260 SDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 78899999999999999999999999999977654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=258.76 Aligned_cols=227 Identities=25% Similarity=0.376 Sum_probs=172.3
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+++.||+|++... ...+.+.+|..++..++|+||+. ..++++|+||||+.+++|.+++......+++
T Consensus 22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~ 101 (331)
T cd05597 22 MKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPE 101 (331)
T ss_pred ECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCH
Confidence 4678999999998742 23455889999999999999987 6778999999999999999999876667888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.++.++|+|||++........ .......|++.|+|||.+.
T Consensus 102 ~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05597 102 DMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-----VQSNVAVGTPDYISPEILQ 176 (331)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-----ccccceeccccccCHHHHh
Confidence 8777776654 7999999999999999999999999999999865432111 1112245899999999986
Q ss_pred c-----cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHH-HhcCCCCCCChhhHHHHHHHHHHhhccCCC--C
Q 042809 146 N-----EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKI-ACSNEKPHFPTQFFKKVLDFLAKCLERKPE--K 217 (241)
Q Consensus 146 ~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~--~ 217 (241)
. ..++.++|+||+|+++|+|++|+.||.............. ......+......+..+.+++++|+...++ .
T Consensus 177 ~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~ 256 (331)
T cd05597 177 AMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLG 256 (331)
T ss_pred hccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccC
Confidence 3 3467889999999999999999999976433222111111 011111222234678999999998865443 3
Q ss_pred CCChHHHhcCCCCCCC
Q 042809 218 RWSAEELLNHTFISGN 233 (241)
Q Consensus 218 Rps~~~~l~~p~~~~~ 233 (241)
|+++++++.||||.+.
T Consensus 257 r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 257 RNGLQDFKDHPFFEGI 272 (331)
T ss_pred CCCHHHHhcCCCCCCC
Confidence 7899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=253.02 Aligned_cols=224 Identities=35% Similarity=0.554 Sum_probs=176.9
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
|..+|+.|++|.+... ...+.+.+|+.+++.++|||+++ ......++|+||+.+++|..++.. ..+++..+
T Consensus 40 ~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~ 117 (296)
T cd06655 40 DVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQI 117 (296)
T ss_pred EcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh--cCCCHHHH
Confidence 5678999999987632 33567889999999999999988 567789999999999999999875 35677776
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..++.++ ||+.|++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..
T Consensus 118 ~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~ 191 (296)
T cd06655 118 AAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS------KRSTMVGTPYWMAPEVVTRKA 191 (296)
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc------cCCCcCCCccccCcchhcCCC
Confidence 6665544 7999999999999999999999999999998875433111 112235788999999999888
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCC
Q 042809 149 LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHT 228 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p 228 (241)
++.++|+||||+++|++++|..||............. .........+..++..+.++|++||..+|.+|||+.+++.||
T Consensus 192 ~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 8999999999999999999999997654322221111 111112233456778899999999999999999999999999
Q ss_pred CCCCCC
Q 042809 229 FISGNA 234 (241)
Q Consensus 229 ~~~~~~ 234 (241)
||+...
T Consensus 271 ~~~~~~ 276 (296)
T cd06655 271 FLKLAK 276 (296)
T ss_pred Hhhhcc
Confidence 998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=252.61 Aligned_cols=233 Identities=27% Similarity=0.362 Sum_probs=177.7
Q ss_pred CCCCCcEEEEEeccchH-------HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCC
Q 042809 2 NKGTGALFVVKSAESEA-------GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTL 69 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 69 (241)
++.+|+.||+|.+.... ....+.+|++++++++|+||++ ......++||||+ +++|.+++......+
T Consensus 21 ~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~ 99 (298)
T cd07841 21 DKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVL 99 (298)
T ss_pred ECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCC
Confidence 45678999999987432 2345778999999999999988 5567899999999 889999998744467
Q ss_pred CHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
++..+..++.|+ ||++|++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.
T Consensus 100 ~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~ 173 (298)
T cd07841 100 TPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN------RKMTHQVVTRWYRAPEL 173 (298)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC------ccccccccceeeeCHHH
Confidence 887777776654 799999999999999999999999999999987554311 11122235778999999
Q ss_pred ccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC-------------------CCCC-----CChh
Q 042809 144 LRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN-------------------EKPH-----FPTQ 198 (241)
Q Consensus 144 ~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------~~~~-----~~~~ 198 (241)
+.+ ..++.++|+||||+++|++++|..||.................. .... ....
T Consensus 174 ~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
T cd07841 174 LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPA 253 (298)
T ss_pred HhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhccc
Confidence 865 45688999999999999999998877654332211111100000 0000 1123
Q ss_pred hHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCccCCCCC
Q 042809 199 FFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKNSTEE 241 (241)
Q Consensus 199 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~~~~~~ 241 (241)
.+..+.+++.+||+.+|++|||+++++.||||++.+..+++.|
T Consensus 254 ~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~~~ 296 (298)
T cd07841 254 ASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPSQ 296 (298)
T ss_pred ccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCCCC
Confidence 4578899999999999999999999999999999999888765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=248.34 Aligned_cols=222 Identities=34% Similarity=0.578 Sum_probs=172.3
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCC--CHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTL--DAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~ 72 (241)
++.++..|++|.+.. ....+.+.+|+.++++++|+||++ ..++..++|+||+.+++|.+++......+ +..
T Consensus 29 ~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 108 (268)
T cd06624 29 DLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQ 108 (268)
T ss_pred ecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHH
Confidence 456788999998763 334567899999999999999988 56678999999999999999998754444 555
Q ss_pred HHHHHHHH------HhhcCCccccCCCCCcEEeec-CCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 73 VIRLYTKE------ILHGNGILHCDLKCNNVLLGS-HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 73 ~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
.+..++.| +||++|++|+||+|+||+++. ++.++|+|||.+........ ......++..|+|||.+.
T Consensus 109 ~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~aPE~~~ 182 (268)
T cd06624 109 TIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTETFTGTLQYMAPEVID 182 (268)
T ss_pred HHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC------ccccCCCCccccChhhhc
Confidence 55555444 479999999999999999976 67899999999865432111 111234688999999986
Q ss_pred ccC--CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH
Q 042809 146 NEG--LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 146 ~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
+.. ++.++|+||+|+++|++++|..||........ ...........+..+...++++.+++++||+.+|.+|||+++
T Consensus 183 ~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 261 (268)
T cd06624 183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-AMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHD 261 (268)
T ss_pred cccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-hHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHH
Confidence 543 67899999999999999999999975432221 112222223344566678889999999999999999999999
Q ss_pred HhcCCCC
Q 042809 224 LLNHTFI 230 (241)
Q Consensus 224 ~l~~p~~ 230 (241)
++.||||
T Consensus 262 ll~~~~~ 268 (268)
T cd06624 262 LLQDPFL 268 (268)
T ss_pred HHhCCCC
Confidence 9999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=252.21 Aligned_cols=219 Identities=31% Similarity=0.520 Sum_probs=179.4
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+++.+|+|.+... ...+.+.+|+++++++.||||++ ..+...++||||+++++|.+++... ..++.
T Consensus 22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~ 100 (290)
T cd05580 22 HKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPE 100 (290)
T ss_pred EcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc-CCCCH
Confidence 4568899999997642 33566889999999999999988 5678899999999999999999874 56777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++...... .....+++.|+|||.+.
T Consensus 101 ~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~y~aPE~~~ 171 (290)
T cd05580 101 PVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---------TYTLCGTPEYLAPEIIL 171 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---------CCCCCCCccccChhhhc
Confidence 7777666654 79999999999999999999999999999998755331 12345788999999998
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----C
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----S 220 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s 220 (241)
+...+.++|+||||+++|++++|..||............ .......+...+..+.+++++||..+|.+|+ +
T Consensus 172 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~ 247 (290)
T cd05580 172 SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI----LEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNG 247 (290)
T ss_pred CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----hcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCC
Confidence 888889999999999999999999999765422221111 1334456666788999999999999999999 9
Q ss_pred hHHHhcCCCCCCCC
Q 042809 221 AEELLNHTFISGNA 234 (241)
Q Consensus 221 ~~~~l~~p~~~~~~ 234 (241)
++++++||||+...
T Consensus 248 ~~~l~~~~~~~~~~ 261 (290)
T cd05580 248 VNDIKNHPWFAGID 261 (290)
T ss_pred HHHHHcCcccccCC
Confidence 99999999997644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=252.66 Aligned_cols=224 Identities=34% Similarity=0.542 Sum_probs=175.2
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.+++.|++|.+... ...+.+.+|+.+++.+.|+||++ ..+...|+|+||+++++|.+++.. ..++...+
T Consensus 41 ~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~ 118 (296)
T cd06654 41 DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQI 118 (296)
T ss_pred ECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh--cCCCHHHH
Confidence 4678899999987642 33567889999999999999988 456789999999999999999875 34666666
Q ss_pred HHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..++.| +||+.|++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..
T Consensus 119 ~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~ 192 (296)
T cd06654 119 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ------SKRSTMVGTPYWMAPEVVTRKA 192 (296)
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc------cccCcccCCccccCHHHHcCCC
Confidence 655544 4799999999999999999999999999999887543211 1112235788999999999888
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCC
Q 042809 149 LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHT 228 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p 228 (241)
++.++|+||||+++|++++|+.||........... ...........+..++..+.+++.+||..+|.+|||+++++.||
T Consensus 193 ~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~ 271 (296)
T cd06654 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (296)
T ss_pred CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH-HhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence 89999999999999999999999976543221111 11111112223456778899999999999999999999999999
Q ss_pred CCCCCC
Q 042809 229 FISGNA 234 (241)
Q Consensus 229 ~~~~~~ 234 (241)
||....
T Consensus 272 ~~~~~~ 277 (296)
T cd06654 272 FLKIAK 277 (296)
T ss_pred hhhccC
Confidence 997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=247.66 Aligned_cols=223 Identities=39% Similarity=0.687 Sum_probs=173.6
Q ss_pred CCCCCcEEEEEeccch-------HHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhCC
Q 042809 2 NKGTGALFVVKSAESE-------AGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~ 67 (241)
++.+|+.|++|.+... .....+.+|+.++++++||||++ ......++++||+++++|.+++... .
T Consensus 23 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~ 101 (266)
T cd06651 23 DVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-G 101 (266)
T ss_pred EcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHc-C
Confidence 4678999999987521 23456889999999999999987 2346789999999999999999863 4
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
.++......++.|+ ||+.+++|+||+|+||+++.++.++|+|||++......... ........++..|+||
T Consensus 102 ~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~~y~aP 178 (266)
T cd06651 102 ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS---GTGIRSVTGTPYWMSP 178 (266)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc---CCccccCCccccccCH
Confidence 56766666665544 79999999999999999999999999999998654321100 0111224478889999
Q ss_pred ccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 142 EVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 142 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
|.+.+..++.++|+||+|+++|++++|+.||..... .............+..+...++.+.+++ +||..+|++|||+
T Consensus 179 E~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~ 255 (266)
T cd06651 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--MAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSA 255 (266)
T ss_pred HHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--HHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCH
Confidence 999988889999999999999999999999976432 2222233333344566667788899998 6777899999999
Q ss_pred HHHhcCCCCC
Q 042809 222 EELLNHTFIS 231 (241)
Q Consensus 222 ~~~l~~p~~~ 231 (241)
++++.||||+
T Consensus 256 ~eil~hp~~~ 265 (266)
T cd06651 256 EELLRHPFAQ 265 (266)
T ss_pred HHHhcCcccc
Confidence 9999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=252.30 Aligned_cols=227 Identities=30% Similarity=0.465 Sum_probs=177.2
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.++..||||.+.. ....+.+.+|+..++.++|+||++ ...+..++||||+++++|.+++.. ..++...+
T Consensus 43 ~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~ 120 (292)
T cd06658 43 EKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQI 120 (292)
T ss_pred ECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc--CCCCHHHH
Confidence 456789999998763 334567889999999999999988 567889999999999999998864 45677777
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..++.|+ ||++|++||||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..
T Consensus 121 ~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~ 194 (292)
T cd06658 121 ATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV------PKRKSLVGTPYWMAPEVISRLP 194 (292)
T ss_pred HHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc------ccCceeecCccccCHHHHccCC
Confidence 6666654 799999999999999999999999999999986543211 1112345788999999998888
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCC
Q 042809 149 LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHT 228 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p 228 (241)
++.++|+||+|+++|++++|..||................ ..........+..+.+++.+||..+|.+|||++++++||
T Consensus 195 ~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 273 (292)
T cd06658 195 YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL-PPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHP 273 (292)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 8999999999999999999999997654332222222111 111112234567899999999999999999999999999
Q ss_pred CCCCCCccC
Q 042809 229 FISGNAKKN 237 (241)
Q Consensus 229 ~~~~~~~~~ 237 (241)
||+......
T Consensus 274 ~~~~~~~~~ 282 (292)
T cd06658 274 FLKLAGPPS 282 (292)
T ss_pred hhhccCCcc
Confidence 998765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=247.37 Aligned_cols=227 Identities=37% Similarity=0.636 Sum_probs=179.1
Q ss_pred CCCCCcEEEEEeccch--------HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAESE--------AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
++.+|+.||+|.+... ...+.+.+|+..+++++|+||++ ...+..++|+||+.+++|.+++... .+
T Consensus 21 ~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~ 99 (268)
T cd06630 21 DVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-GA 99 (268)
T ss_pred EcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHh-CC
Confidence 4678999999987632 24567899999999999999988 5677899999999999999999863 46
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCC-CeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG-DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
+++..+..++.|+ ||++|++|+||+|+||+++.++ .++|+|||.+........... .......++..|+||
T Consensus 100 ~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~~~~~~~P 177 (268)
T cd06630 100 FKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG--EFQGQLLGTIAFMAP 177 (268)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCC--ccccccccccceeCH
Confidence 6777766666654 7999999999999999998776 599999999876543211111 111234578899999
Q ss_pred ccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHH-HHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC
Q 042809 142 EVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAAT-LLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS 220 (241)
Q Consensus 142 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 220 (241)
|.+.+..++.++|+||+|++++++++|..||.......... ..........+..+...+.++.+++.+||..+|.+|||
T Consensus 178 E~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 257 (268)
T cd06630 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPP 257 (268)
T ss_pred hHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcC
Confidence 99988888999999999999999999999996543322222 22222234455667778889999999999999999999
Q ss_pred hHHHhcCCCCC
Q 042809 221 AEELLNHTFIS 231 (241)
Q Consensus 221 ~~~~l~~p~~~ 231 (241)
+.+++.||||+
T Consensus 258 ~~~ll~~~~~~ 268 (268)
T cd06630 258 SRELLKHPVFR 268 (268)
T ss_pred HHHHhcCcccC
Confidence 99999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=249.19 Aligned_cols=225 Identities=35% Similarity=0.580 Sum_probs=180.7
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.++..||+|.+.. ......+.+|+.+++.+.|+||++ ..+...++||||+++++|.+++.. .+++...
T Consensus 25 ~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~l~~~~ 102 (277)
T cd06640 25 DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQ 102 (277)
T ss_pred EccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc--CCCCHHH
Confidence 466889999998763 334567889999999999999988 567889999999999999999875 4566666
Q ss_pred HHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 74 IRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 74 ~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
+..++. ++||+.+++|+||+|+||+++.++.++++|||++....... .......++..|+|||.+.+.
T Consensus 103 ~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~y~apE~~~~~ 176 (277)
T cd06640 103 IATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ------IKRNTFVGTPFWMAPEVIQQS 176 (277)
T ss_pred HHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc------cccccccCcccccCHhHhccC
Confidence 555554 44799999999999999999999999999999986543311 111223467889999999888
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 148 GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
.++.++|+||||+++|++++|..||......... ........+..+...+..+.+++.+||..+|.+||++.+++.|
T Consensus 177 ~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 177 AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL---FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh---hhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 8999999999999999999999999764332221 1222233455666788899999999999999999999999999
Q ss_pred CCCCCCCccC
Q 042809 228 TFISGNAKKN 237 (241)
Q Consensus 228 p~~~~~~~~~ 237 (241)
|||.....+.
T Consensus 254 ~~~~~~~~~~ 263 (277)
T cd06640 254 KFIVKNAKKT 263 (277)
T ss_pred hHhhhcchhh
Confidence 9998877654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=260.88 Aligned_cols=221 Identities=29% Similarity=0.445 Sum_probs=170.6
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhc---CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSL---NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l---~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
++.+|+.||+|++.... ....+..|..++... .||||+. ......|+||||+.+|+|.+++.. ...
T Consensus 14 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~ 92 (330)
T cd05586 14 KKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK-EGR 92 (330)
T ss_pred ECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHh-cCC
Confidence 56789999999986432 223345666666655 6999987 567889999999999999999886 456
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
+++..+..++.|+ ||++|++||||||+||+++.++.++|+|||++....... .......|++.|+|||
T Consensus 93 ~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~gt~~y~aPE 166 (330)
T cd05586 93 FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN------KTTNTFCGTTEYLAPE 166 (330)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC------CCccCccCCccccCHH
Confidence 7887777766654 799999999999999999999999999999986432110 1122346899999999
Q ss_pred ccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC-hhhHHHHHHHHHHhhccCCCCCC-
Q 042809 143 VLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP-TQFFKKVLDFLAKCLERKPEKRW- 219 (241)
Q Consensus 143 ~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp- 219 (241)
.+.+. .++.++||||||+++|+|++|..||............ ... ...++ ..++.++.+++++||..+|.+||
T Consensus 167 ~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i---~~~-~~~~~~~~~~~~~~~li~~~L~~~P~~R~~ 242 (330)
T cd05586 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI---AFG-KVRFPKNVLSDEGRQFVKGLLNRNPQHRLG 242 (330)
T ss_pred HHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH---HcC-CCCCCCccCCHHHHHHHHHHcCCCHHHCCC
Confidence 98764 4788999999999999999999999765433322221 111 12222 24678899999999999999998
Q ss_pred ---ChHHHhcCCCCCCC
Q 042809 220 ---SAEELLNHTFISGN 233 (241)
Q Consensus 220 ---s~~~~l~~p~~~~~ 233 (241)
+++++++||||+..
T Consensus 243 ~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 243 AHRDAVELKEHPFFADI 259 (330)
T ss_pred CCCCHHHHhcCccccCC
Confidence 79999999999764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=264.85 Aligned_cols=209 Identities=30% Similarity=0.465 Sum_probs=171.8
Q ss_pred CCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHH
Q 042809 5 TGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTK 79 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 79 (241)
.+..||||+++. .-..+++-|++|+||||+. ....++|||||||..|.|...|+. +..+.......+..
T Consensus 146 ~netVAVKKV~e-----lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk 219 (904)
T KOG4721|consen 146 HNETVAVKKVRE-----LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSK 219 (904)
T ss_pred cCceehhHHHhh-----hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHH
Confidence 466788887662 2346788899999999988 667899999999999999999998 45666666655554
Q ss_pred ------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchh
Q 042809 80 ------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT 153 (241)
Q Consensus 80 ------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 153 (241)
+|||.++|+|||||.-|||++.+..+||+|||-++...+. .....++||..|||||.+...+.+.++
T Consensus 220 ~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-------STkMSFaGTVaWMAPEvIrnePcsEKV 292 (904)
T KOG4721|consen 220 GIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-------STKMSFAGTVAWMAPEVIRNEPCSEKV 292 (904)
T ss_pred HhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-------hhhhhhhhhHhhhCHHHhhcCCccccc
Confidence 5699999999999999999999999999999999876552 223457799999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCC
Q 042809 154 DIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHT 228 (241)
Q Consensus 154 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p 228 (241)
||||||+|||||+||..||.+-+. ...++...........|..+++.+.=|+++||+..|..|||+.+++.|-
T Consensus 293 DIwSfGVVLWEmLT~EiPYkdVds--sAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 293 DIWSFGVVLWEMLTGEIPYKDVDS--SAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred ceehhHHHHHHHHhcCCCccccch--heeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 999999999999999999987432 2222222222344566778889999999999999999999999999984
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=250.18 Aligned_cols=223 Identities=30% Similarity=0.448 Sum_probs=170.9
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
|..+++.||+|.+..+ .....+.+|+.++.++.||||++ ...+..++|+||+++++|..+. .+++..
T Consensus 22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~ 96 (279)
T cd06619 22 HLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR-----KIPEHV 96 (279)
T ss_pred EcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh-----cCCHHH
Confidence 5678999999987632 34567889999999999999998 5667899999999999996553 244554
Q ss_pred HHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 74 IRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 74 ~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
+..++. ++||+.|++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+.
T Consensus 97 ~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~ 168 (279)
T cd06619 97 LGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--------IAKTYVGTNAYMAPERISGE 168 (279)
T ss_pred HHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--------cccCCCCChhhcCceeecCC
Confidence 444444 4579999999999999999999999999999998754321 11234578899999999988
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccchhch----HHHHHHHHhcCCCCCC-ChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 148 GLDFATDIWSLGCMVIEMATGRPPWGDKISNA----AATLLKIACSNEKPHF-PTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
.++.++|+||||+++|++++|..||....... .............+.. ....+.++.+++.+||+.+|.+||+++
T Consensus 169 ~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~ 248 (279)
T cd06619 169 QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPE 248 (279)
T ss_pred CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHH
Confidence 89999999999999999999999996432111 1111111111112222 234667899999999999999999999
Q ss_pred HHhcCCCCCCCCccC
Q 042809 223 ELLNHTFISGNAKKN 237 (241)
Q Consensus 223 ~~l~~p~~~~~~~~~ 237 (241)
+++.||||......+
T Consensus 249 eil~~~~~~~~~~~~ 263 (279)
T cd06619 249 NLMDHPFIVQYNDGN 263 (279)
T ss_pred HHhcCcccccccCcc
Confidence 999999998775554
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=258.07 Aligned_cols=221 Identities=24% Similarity=0.300 Sum_probs=164.6
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----------cCCceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----------NGEKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----------~~~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
|..+++.||+|.+.. ......+.+|+.+++.++||||++ ......|+||||+++ +|...+..
T Consensus 38 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-- 114 (355)
T cd07874 38 DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM-- 114 (355)
T ss_pred ecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh--
Confidence 567899999998763 234567889999999999999987 122467999999964 77777654
Q ss_pred CCCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
.++...+..++. ++||++|++||||||+||+++.++.+||+|||++...... .......+++.|+|
T Consensus 115 -~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~t~~y~a 186 (355)
T cd07874 115 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-------FMMTPYVVTRYYRA 186 (355)
T ss_pred -cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc-------cccCCccccCCccC
Confidence 356655555554 4479999999999999999999999999999999754321 11123457899999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC------------------CC----------
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN------------------EK---------- 192 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------~~---------- 192 (241)
||.+.+..++.++|+||||+++|+|++|+.||.+................ ..
T Consensus 187 PE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (355)
T cd07874 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 266 (355)
T ss_pred HHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchh
Confidence 99999988999999999999999999999999764321111100000000 00
Q ss_pred ----------CCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCC
Q 042809 193 ----------PHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 193 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~ 233 (241)
...+...+..+.+++.+||..+|.+|||+.++++||||...
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 267 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred hccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 00111234578999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=245.48 Aligned_cols=220 Identities=31% Similarity=0.495 Sum_probs=178.2
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHh---CC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKF---GG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~---~~ 67 (241)
++.+|+.+|+|.+.. ....+.+.+|+.++++++|+||++ ......++++||+++++|.+++... ..
T Consensus 21 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~ 100 (265)
T cd08217 21 RKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK 100 (265)
T ss_pred ecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhccc
Confidence 567889999998752 344567889999999999999987 2456789999999999999999764 45
Q ss_pred CCCHHHHHHHHHHH------hh-----cCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcc
Q 042809 68 TLDAGVIRLYTKEI------LH-----GNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQ 136 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh-----~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (241)
.++...+..++.++ || +.+++|+||+|+||+++.++.++|+|||++........ ......+++
T Consensus 101 ~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~------~~~~~~~~~ 174 (265)
T cd08217 101 YIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS------FAKTYVGTP 174 (265)
T ss_pred CCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcc------cccccccCC
Confidence 67777766666544 79 89999999999999999999999999999986543211 012234788
Q ss_pred cccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 137 LWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 137 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
.|+|||.+.+..++.++|+||||++++++++|..||...... ...........+..+...+..+.+++.+||+.+|.
T Consensus 175 ~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~ 251 (265)
T cd08217 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPD 251 (265)
T ss_pred CccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcc
Confidence 999999998888899999999999999999999999875422 22233333444556677888999999999999999
Q ss_pred CCCChHHHhcCCCC
Q 042809 217 KRWSAEELLNHTFI 230 (241)
Q Consensus 217 ~Rps~~~~l~~p~~ 230 (241)
+|||++++++|||+
T Consensus 252 ~Rp~~~~il~~~~~ 265 (265)
T cd08217 252 KRPSTEELLQLPLI 265 (265)
T ss_pred cCCCHHHHhhCCCC
Confidence 99999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=247.73 Aligned_cols=220 Identities=29% Similarity=0.486 Sum_probs=180.6
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+++.||+|.+... ...+.+.+|++.+++++||||++ ......++|+||+.|++|.+++... ..++.
T Consensus 21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~ 99 (258)
T cd05578 21 KRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSE 99 (258)
T ss_pred EccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCH
Confidence 4678999999988743 34677899999999999999988 6778899999999999999999874 57777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.
T Consensus 100 ~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~ 172 (258)
T cd05578 100 EQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-------LTTSTSGTPGYMAPEVLC 172 (258)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-------cccccCCChhhcCHHHHc
Confidence 7777766655 799999999999999999999999999999987653311 112344778899999998
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh--HH
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA--EE 223 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--~~ 223 (241)
+..++.++|+||||+++|++++|..||............. .........+...+..+.+++++||..+|.+||++ .+
T Consensus 173 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~ 251 (258)
T cd05578 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA-KQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKD 251 (258)
T ss_pred ccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH-HhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHH
Confidence 8888999999999999999999999998765432222222 22224455667778899999999999999999999 99
Q ss_pred HhcCCCC
Q 042809 224 LLNHTFI 230 (241)
Q Consensus 224 ~l~~p~~ 230 (241)
++.||||
T Consensus 252 l~~~~~~ 258 (258)
T cd05578 252 LKNHPYF 258 (258)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=252.87 Aligned_cols=225 Identities=34% Similarity=0.540 Sum_probs=175.3
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.+|+.||+|.+.. ....+.+.+|+.+++.++|+||++ ..++..++||||+++++|.+++.. ..++...+
T Consensus 40 ~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~ 117 (297)
T cd06656 40 DIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQI 117 (297)
T ss_pred ECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh--CCCCHHHH
Confidence 467899999998763 233466889999999999999988 567789999999999999999975 34566666
Q ss_pred HHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..++.+ +||+.|++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..
T Consensus 118 ~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~ 191 (297)
T cd06656 118 AAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ------SKRSTMVGTPYWMAPEVVTRKA 191 (297)
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc------cCcCcccCCccccCHHHHcCCC
Confidence 555544 4799999999999999999999999999999986543211 1112335788899999999888
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCC
Q 042809 149 LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHT 228 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p 228 (241)
++.++|+||||+++|++++|..||........... ...........+...+..+.+++.+||..+|.+|||+++++.||
T Consensus 192 ~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (297)
T cd06656 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP 270 (297)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-eccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 89999999999999999999999976433221111 10111112223455677899999999999999999999999999
Q ss_pred CCCCCCc
Q 042809 229 FISGNAK 235 (241)
Q Consensus 229 ~~~~~~~ 235 (241)
||+....
T Consensus 271 ~~~~~~~ 277 (297)
T cd06656 271 FLKLAKP 277 (297)
T ss_pred hhccccc
Confidence 9976544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=250.91 Aligned_cols=222 Identities=32% Similarity=0.512 Sum_probs=173.1
Q ss_pred CCCCCcEEEEEeccchHH----HHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESEAG----VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+++.||+|.+..... .....+|+.++++++||||++ ......++||||+++++|.+++.. ...++..
T Consensus 20 ~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~-~~~~~~~ 98 (260)
T PF00069_consen 20 NKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQK-NKPLSEE 98 (260)
T ss_dssp ETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHH-HSSBBHH
T ss_pred ECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccccccccccc-ccccccc
Confidence 567889999999885432 223456999999999999988 567889999999999999999984 4677888
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc-
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR- 145 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~- 145 (241)
.+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||.+..... .........++..|+|||.+.
T Consensus 99 ~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~ 172 (260)
T PF00069_consen 99 EILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE------NNENFNPFVGTPEYMAPEVLQQ 172 (260)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS------TTSEBSSSSSSGGGSCHHHHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc------cccccccccccccccccccccc
Confidence 888777766 7999999999999999999999999999999864311 112233455788999999998
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC---CCCCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE---KPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
+...+.++|+||+|+++|+|++|..||................... ........+..+.+++.+||+.+|.+|||++
T Consensus 173 ~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~ 252 (260)
T PF00069_consen 173 GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAE 252 (260)
T ss_dssp TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHH
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHH
Confidence 7888999999999999999999999998752222222222111110 0011111237899999999999999999999
Q ss_pred HHhcCCCC
Q 042809 223 ELLNHTFI 230 (241)
Q Consensus 223 ~~l~~p~~ 230 (241)
++++||||
T Consensus 253 ~l~~~~~~ 260 (260)
T PF00069_consen 253 ELLKHPWF 260 (260)
T ss_dssp HHHTSGGG
T ss_pred HHhcCCCC
Confidence 99999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=251.25 Aligned_cols=221 Identities=27% Similarity=0.355 Sum_probs=165.3
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhc---CCCcccc----------cCCceeeeeecccCCCCHHHHHHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSL---NSPNIGR----------NGEKTVNIFMEYMAGGSLLDVAEK 64 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l---~h~~i~~----------~~~~~~~lv~e~~~~~~L~~~l~~ 64 (241)
++.+|+.||+|.+... .....+.+|+.+++.+ .||||++ ......++|+||+. ++|.+++..
T Consensus 21 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~ 99 (288)
T cd07863 21 DPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDK 99 (288)
T ss_pred ECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHh
Confidence 5778999999987632 1223456777777665 6999987 12456899999997 589998876
Q ss_pred hC-CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccc
Q 042809 65 FG-GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL 137 (241)
Q Consensus 65 ~~-~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (241)
.. ..++...+..++.|+ ||++|++|+||||+||+++.++.++|+|||++...... .......++..
T Consensus 100 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~~ 172 (288)
T cd07863 100 VPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ-------MALTPVVVTLW 172 (288)
T ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCc-------ccCCCcccccc
Confidence 43 347777777776654 79999999999999999999999999999998754321 11122347889
Q ss_pred ccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC-CC----------------------CC
Q 042809 138 WMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN-EK----------------------PH 194 (241)
Q Consensus 138 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~----------------------~~ 194 (241)
|+|||.+.+..++.++||||+|+++|++++|..||.................. .. ..
T Consensus 173 y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (288)
T cd07863 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQS 252 (288)
T ss_pred ccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHH
Confidence 99999999888999999999999999999999999664332222111111000 00 00
Q ss_pred CChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 195 FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 195 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
..+.++..+.+++.+||+.||.+|||+.+++.||||
T Consensus 253 ~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 253 VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred hCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 112355678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=261.56 Aligned_cols=223 Identities=28% Similarity=0.453 Sum_probs=174.0
Q ss_pred CCCCCcEEEEEeccchH-HHHHHHHHHHHHhhcC-C-----Ccccc-----cCCceeeeeecccCCCCHHHHHHHhC-CC
Q 042809 2 NKGTGALFVVKSAESEA-GVQALRNEAEIRQSLN-S-----PNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~-h-----~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~ 68 (241)
|.+|++.||||++++.. -..+...|+.+|..|+ | -|+|+ ...+++|||+|.+. .+|.++++... ..
T Consensus 207 d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f~G 285 (586)
T KOG0667|consen 207 DHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKFRG 285 (586)
T ss_pred ecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhh-hhHHHHHHhcCCCC
Confidence 78999999999999654 4577889999999997 3 35676 67899999999995 69999999753 45
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecC--CCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH--GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
++...++.++.|+ ||+.||||+||||+|||+..- ..+||+|||.+....+ ..+ ..+.++.|+|
T Consensus 286 lsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q--------~vy-tYiQSRfYRA 356 (586)
T KOG0667|consen 286 LSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ--------RVY-TYIQSRFYRA 356 (586)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC--------cce-eeeecccccc
Confidence 8899999988887 699999999999999999664 3699999999986544 111 4567899999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC------------------------------
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN------------------------------ 190 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------ 190 (241)
||++.|.+|+.+.|||||||++.||++|.+.|.+..+.+....+......
T Consensus 357 PEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~ 436 (586)
T KOG0667|consen 357 PEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETS 436 (586)
T ss_pred chhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeec
Confidence 99999999999999999999999999998888664322221111111000
Q ss_pred ------------------CCCCCC-----------hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 191 ------------------EKPHFP-----------TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 191 ------------------~~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
.....| ......+.+++++||..||.+|+|..++++||||++..
T Consensus 437 ~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 437 APRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred ccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccccc
Confidence 000001 11224689999999999999999999999999998443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=243.99 Aligned_cols=230 Identities=28% Similarity=0.408 Sum_probs=177.6
Q ss_pred CCCCCCcEEEEEeccchH----HHHHHHHHHHHHhhcCCCc-ccc------cC-----CceeeeeecccCCCCHHHHHHH
Q 042809 1 MNKGTGALFVVKSAESEA----GVQALRNEAEIRQSLNSPN-IGR------NG-----EKTVNIFMEYMAGGSLLDVAEK 64 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~-i~~------~~-----~~~~~lv~e~~~~~~L~~~l~~ 64 (241)
+++.+|+.||+|+++-+. ......+|+.+++.++|+| |+. .. ...+++|+||++ -+|..++..
T Consensus 31 r~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~ 109 (323)
T KOG0594|consen 31 RSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDS 109 (323)
T ss_pred EEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccHHHHHHh
Confidence 467899999999987332 3466799999999999999 877 22 238999999996 599999998
Q ss_pred hC---CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCc
Q 042809 65 FG---GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGT 135 (241)
Q Consensus 65 ~~---~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 135 (241)
.. ...+...++.+..|+ ||++||+||||||.||+++.+|.+||+|||++....-. ........+|
T Consensus 110 ~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip------~~~yt~evvT 183 (323)
T KOG0594|consen 110 LPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIP------MRTYTPEVVT 183 (323)
T ss_pred ccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCC------cccccccEEE
Confidence 65 357777777777776 69999999999999999999999999999999855421 1223445578
Q ss_pred ccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC--------------CCC----
Q 042809 136 QLWMAPEVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP--------------HFP---- 196 (241)
Q Consensus 136 ~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------~~~---- 196 (241)
..|+|||++.|. .|+...||||+||++.||++++..|.+..+......+......... .++
T Consensus 184 lWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~ 263 (323)
T KOG0594|consen 184 LWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPG 263 (323)
T ss_pred eeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCC
Confidence 889999999886 6899999999999999999999999775443322222222111000 111
Q ss_pred -hh-------hHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCccC
Q 042809 197 -TQ-------FFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKN 237 (241)
Q Consensus 197 -~~-------~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~~ 237 (241)
.. ..++..+++.+||+.+|.+|.|++.++.||||.......
T Consensus 264 ~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~ 312 (323)
T KOG0594|consen 264 PKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS 312 (323)
T ss_pred ccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence 11 113789999999999999999999999999998775543
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=262.10 Aligned_cols=224 Identities=22% Similarity=0.305 Sum_probs=170.4
Q ss_pred CCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHH
Q 042809 3 KGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLY 77 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 77 (241)
..+++.||+|.+... ....+|++++++++||||++ ......|+|||++. ++|.+++.. ...+++..+..+
T Consensus 116 ~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i 190 (392)
T PHA03207 116 DEQRKKVIVKAVTGG---KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDR-SGPLPLEQAITI 190 (392)
T ss_pred CccceeEEEEecccc---ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHh-cCCCCHHHHHHH
Confidence 456788999987754 23568999999999999998 45678999999995 689998854 567888887777
Q ss_pred HHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+.|+ ||++|++||||||+||+++.++.++|+|||++........ ........|++.|+|||.+.+..++.
T Consensus 191 ~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ 266 (392)
T PHA03207 191 QRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD----TPQCYGWSGTLETNSPELLALDPYCA 266 (392)
T ss_pred HHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc----cccccccccccCccCHhHhcCCCCCc
Confidence 6655 7999999999999999999999999999999875433211 11122356899999999999988999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCccchhch----HHHHHHHH----------------------hcCCCCC--CC-----hh
Q 042809 152 ATDIWSLGCMVIEMATGRPPWGDKISNA----AATLLKIA----------------------CSNEKPH--FP-----TQ 198 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~----------------------~~~~~~~--~~-----~~ 198 (241)
++|||||||++|+|++|+.||.+..... ...+.... .....+. .+ ..
T Consensus 267 ~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (392)
T PHA03207 267 KTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYG 346 (392)
T ss_pred hhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccC
Confidence 9999999999999999999996543221 11111100 0000000 01 12
Q ss_pred hHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 199 FFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 199 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.+.++.++|++||..+|.+|||+.+++.||||+....
T Consensus 347 ~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 347 MHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred cchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 3467889999999999999999999999999976544
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=247.44 Aligned_cols=221 Identities=31% Similarity=0.521 Sum_probs=169.4
Q ss_pred CCCCCcEEEEEeccch-HHHHHHHHHHHHHhhc-CCCcccc-----c------CCceeeeeecccCCCCHHHHHHHh-CC
Q 042809 2 NKGTGALFVVKSAESE-AGVQALRNEAEIRQSL-NSPNIGR-----N------GEKTVNIFMEYMAGGSLLDVAEKF-GG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~-----~------~~~~~~lv~e~~~~~~L~~~l~~~-~~ 67 (241)
++.+++.||+|.+... .....+.+|+.++.++ +|+||++ . .....|+|+||+.+++|.+++... ..
T Consensus 27 ~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~ 106 (272)
T cd06637 27 HVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN 106 (272)
T ss_pred EcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCC
Confidence 4568899999997643 3346688999999998 6999987 1 135689999999999999999874 34
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
.+++..+..++.|+ ||+.+++|+||+|+||+++.++.++|+|||++....... .......|+..|+||
T Consensus 107 ~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~------~~~~~~~g~~~y~aP 180 (272)
T cd06637 107 TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV------GRRNTFIGTPYWMAP 180 (272)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccccc------ccCCcccccccccCH
Confidence 57777666665544 899999999999999999999999999999987543211 112234578899999
Q ss_pred cccc-----ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 142 EVLR-----NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 142 E~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
|.+. +..++.++|+||+|+++|++++|..||........ .............+...+..+.+|+.+||..+|.
T Consensus 181 E~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 258 (272)
T cd06637 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHS 258 (272)
T ss_pred hHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH--HHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChh
Confidence 9986 34577899999999999999999999965432221 1111111222222345667899999999999999
Q ss_pred CCCChHHHhcCCCC
Q 042809 217 KRWSAEELLNHTFI 230 (241)
Q Consensus 217 ~Rps~~~~l~~p~~ 230 (241)
+|||+.+++.||||
T Consensus 259 ~Rpt~~~il~~~~~ 272 (272)
T cd06637 259 QRPTTEQLMKHPFI 272 (272)
T ss_pred hCCCHHHHhhCCCC
Confidence 99999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=251.16 Aligned_cols=223 Identities=35% Similarity=0.598 Sum_probs=177.0
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+|..||+|.+.. ....+.+.+|+.++++++||||++ ......++|+||+++++|.+++.. ..++...
T Consensus 25 ~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~ 102 (277)
T cd06642 25 DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETY 102 (277)
T ss_pred EcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc--CCCCHHH
Confidence 467789999998762 344567899999999999999988 567789999999999999999875 4566766
Q ss_pred HHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 74 IRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 74 ~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
+..++.+ +||++|++|+||+|+||+++.++.++++|||++....... .......++..|+|||.+.+.
T Consensus 103 ~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~ 176 (277)
T cd06642 103 IATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ------IKRNTFVGTPFWMAPEVIKQS 176 (277)
T ss_pred HHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc------hhhhcccCcccccCHHHhCcC
Confidence 6665554 4799999999999999999999999999999986543311 111223478889999999988
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 148 GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
.++.++|+||||+++|++++|..||.......... .......+..+...+..+.+++.+||+.+|.+|||+.+++.|
T Consensus 177 ~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 177 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---LIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh---hhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 89999999999999999999999986543322211 112223334445667889999999999999999999999999
Q ss_pred CCCCCCCc
Q 042809 228 TFISGNAK 235 (241)
Q Consensus 228 p~~~~~~~ 235 (241)
|||.....
T Consensus 254 ~~~~~~~~ 261 (277)
T cd06642 254 KFITRYTK 261 (277)
T ss_pred HHHHHHhh
Confidence 99975543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=253.09 Aligned_cols=230 Identities=29% Similarity=0.448 Sum_probs=176.6
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh-CCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~ 70 (241)
+..+|+.||+|.+..+ ...+.+.+|++.+..++|+||++ ......|+||||+.+++|.+++... +..++
T Consensus 22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~ 101 (316)
T cd05574 22 LKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLS 101 (316)
T ss_pred EcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccC
Confidence 3567899999987743 24567889999999999999988 5677899999999999999998864 35677
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCcc-------------------
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNL------------------- 125 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~------------------- 125 (241)
+.....++.|+ ||+.|++|+||+|+||+++.++.++|+|||++............
T Consensus 102 ~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (316)
T cd05574 102 EEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhh
Confidence 77776665544 79999999999999999999999999999998754321110000
Q ss_pred ----ccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHH
Q 042809 126 ----KQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFK 201 (241)
Q Consensus 126 ----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (241)
........|+..|+|||.+.+..++.++||||||+++|++++|..||.......... ...............+.
T Consensus 182 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 259 (316)
T cd05574 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFS--NILKKEVTFPGSPPVSS 259 (316)
T ss_pred cccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHH--HHhcCCccCCCccccCH
Confidence 001113357888999999998889999999999999999999999997654332221 11111111111222678
Q ss_pred HHHHHHHHhhccCCCCCCC----hHHHhcCCCCCCC
Q 042809 202 KVLDFLAKCLERKPEKRWS----AEELLNHTFISGN 233 (241)
Q Consensus 202 ~~~~li~~~l~~~p~~Rps----~~~~l~~p~~~~~ 233 (241)
.+.+++.+||..+|.+||| +++++.||||+..
T Consensus 260 ~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 260 SARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 9999999999999999999 9999999999764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=244.74 Aligned_cols=219 Identities=42% Similarity=0.755 Sum_probs=175.8
Q ss_pred CCCCCcEEEEEeccch-------HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCC
Q 042809 2 NKGTGALFVVKSAESE-------AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTL 69 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 69 (241)
++.++..|++|.+... ...+.+.+|+.+++.++|+||++ ..+...++|+||+++++|.+++... ..+
T Consensus 21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~ 99 (258)
T cd06632 21 NLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSF 99 (258)
T ss_pred EcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhc-CCC
Confidence 3568899999987632 25677999999999999999988 5667899999999999999999874 456
Q ss_pred CHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
+...+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.
T Consensus 100 ~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-------~~~~~~~~~~y~~pe~ 172 (258)
T cd06632 100 PEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-------FAKSFKGSPYWMAPEV 172 (258)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-------cccccCCCcceeCHHH
Confidence 676666655544 799999999999999999999999999999987543311 1123457888999999
Q ss_pred ccccC-CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 144 LRNEG-LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 144 ~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
+.... ++.++|+||||+++|++++|..||..... .............+..+..++..+.+++++||..+|.+|||+.
T Consensus 173 ~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 250 (258)
T cd06632 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--VAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAA 250 (258)
T ss_pred hcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--HHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHH
Confidence 87766 88999999999999999999999976542 2222222222344455667788999999999999999999999
Q ss_pred HHhcCCCC
Q 042809 223 ELLNHTFI 230 (241)
Q Consensus 223 ~~l~~p~~ 230 (241)
+++.|||+
T Consensus 251 ~~l~~~~~ 258 (258)
T cd06632 251 ELLEHPFV 258 (258)
T ss_pred HHhcCCCC
Confidence 99999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=245.33 Aligned_cols=220 Identities=25% Similarity=0.432 Sum_probs=176.2
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCCH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~ 71 (241)
++.+|+.||+|.+.. ....+.+.+|+.++++++||||++ ...+..++|+||+.+++|.+++.... ..++.
T Consensus 21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~ 100 (256)
T cd08218 21 SKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPE 100 (256)
T ss_pred EcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCH
Confidence 456789999998763 234567899999999999999988 66779999999999999999997643 34666
Q ss_pred HHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.| +||++|++|+||+|+||+++.++.++++|||++....... .......+++.|+|||.+.
T Consensus 101 ~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~ 174 (256)
T cd08218 101 DQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV------ELARTCIGTPYYLSPEICE 174 (256)
T ss_pred HHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch------hhhhhccCCccccCHHHhC
Confidence 666555554 4799999999999999999999999999999987543311 1112234788899999998
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
+..++.++|+||||++++++++|..||....... .......+..+..+...+.++.++|.+||+.+|.+||++.+++
T Consensus 175 ~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl 251 (256)
T cd08218 175 NRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN---LVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251 (256)
T ss_pred CCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH---HHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence 8888899999999999999999999997543322 2222233444555667788999999999999999999999999
Q ss_pred cCCCC
Q 042809 226 NHTFI 230 (241)
Q Consensus 226 ~~p~~ 230 (241)
+||||
T Consensus 252 ~~~~~ 256 (256)
T cd08218 252 EKNFI 256 (256)
T ss_pred hCcCC
Confidence 99997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=257.05 Aligned_cols=225 Identities=24% Similarity=0.380 Sum_probs=171.8
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+++.+|+|.+.+. .....+.+|..++..++|+||+. .....+|+||||+.+|+|.+++......+++
T Consensus 22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~ 101 (332)
T cd05623 22 LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPE 101 (332)
T ss_pred ECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCH
Confidence 4667899999998642 22345788999999999999987 6778899999999999999999876667787
Q ss_pred HHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.| +||+.|++||||||+||+++.++.++|+|||++....... ........|++.|+|||++.
T Consensus 102 ~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~ 176 (332)
T cd05623 102 DMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-----TVQSSVAVGTPDYISPEILQ 176 (332)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-----cceecccccCccccCHHHHh
Confidence 777666654 4799999999999999999999999999999986432211 01112345899999999986
Q ss_pred -----ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC---CCCCChhhHHHHHHHHHHhhccCCCC
Q 042809 146 -----NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE---KPHFPTQFFKKVLDFLAKCLERKPEK 217 (241)
Q Consensus 146 -----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~ 217 (241)
...++.++|+||||+++|+|++|..||........... ...... .+.....++.++.+++++|+..++.+
T Consensus 177 ~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~--i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r 254 (332)
T cd05623 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK--IMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHR 254 (332)
T ss_pred ccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHH--HhCCCccccCCCccccCCHHHHHHHHHHccChhhh
Confidence 34578899999999999999999999976433222211 111111 12222356789999999998664444
Q ss_pred --CCChHHHhcCCCCCCC
Q 042809 218 --RWSAEELLNHTFISGN 233 (241)
Q Consensus 218 --Rps~~~~l~~p~~~~~ 233 (241)
|++++++++||||.+.
T Consensus 255 ~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 255 LGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred cCCCCHHHHhCCCCcCCC
Confidence 6899999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=244.04 Aligned_cols=222 Identities=35% Similarity=0.510 Sum_probs=174.9
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.+++.+++|.+... ...+.+.+|+.++++++||||++ .....+|++|||+.+++|.+++......++...+
T Consensus 24 ~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~ 103 (262)
T cd06613 24 DIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQI 103 (262)
T ss_pred ecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHH
Confidence 4567889999987743 34678999999999999999988 5677899999999999999999876567888777
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc-
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE- 147 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~- 147 (241)
..++.|+ ||+.|++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+.
T Consensus 104 ~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~------~~~~~~~~~~~y~~Pe~~~~~~ 177 (262)
T cd06613 104 AYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI------AKRKSFIGTPYWMAPEVAAVER 177 (262)
T ss_pred HHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh------hccccccCCccccCchhhcccc
Confidence 7666654 799999999999999999999999999999987554311 011234578889999999776
Q ss_pred --CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHH-hcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 148 --GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIA-CSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 148 --~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
.++.++|+||||+++|+|++|..||............... ........+...+.++.+++++||..+|.+|||+.++
T Consensus 178 ~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 257 (262)
T cd06613 178 KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKL 257 (262)
T ss_pred cCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHH
Confidence 7888999999999999999999999764322222111111 0111112234567789999999999999999999999
Q ss_pred hcCCC
Q 042809 225 LNHTF 229 (241)
Q Consensus 225 l~~p~ 229 (241)
+.|+|
T Consensus 258 l~~~~ 262 (262)
T cd06613 258 LQHPF 262 (262)
T ss_pred hcCCC
Confidence 99998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=265.32 Aligned_cols=223 Identities=21% Similarity=0.315 Sum_probs=164.2
Q ss_pred CCCCCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCc------ccc------cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAESE-AGVQALRNEAEIRQSLNSPN------IGR------NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~------i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
+..+++.||||+++.. .....+..|+.++..++|.+ ++. ....++|+|||++ +++|.+++... ..
T Consensus 150 ~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~ 227 (467)
T PTZ00284 150 DRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-GP 227 (467)
T ss_pred EcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc-CC
Confidence 5678899999998742 33445677888888887655 433 3456899999999 67999988863 56
Q ss_pred CCHHHHHHHHHHH------hhc-CCccccCCCCCcEEeecCC----------------CeeecCCCcchhhcccccCCcc
Q 042809 69 LDAGVIRLYTKEI------LHG-NGILHCDLKCNNVLLGSHG----------------DVKLPDLGCARRVNDLKNNGNL 125 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~-~~~vH~dl~p~Nil~~~~~----------------~~kl~dfg~~~~~~~~~~~~~~ 125 (241)
++...+..++.|+ ||+ .|++||||||+||+++.++ .+||+|||.+.....
T Consensus 228 l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~------- 300 (467)
T PTZ00284 228 FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH------- 300 (467)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-------
Confidence 7777777666654 797 5999999999999998765 499999998753211
Q ss_pred ccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC--------------
Q 042809 126 KQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE-------------- 191 (241)
Q Consensus 126 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 191 (241)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.................
T Consensus 301 --~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~ 378 (467)
T PTZ00284 301 --SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEAR 378 (467)
T ss_pred --ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHH
Confidence 1223568999999999999999999999999999999999999997654332222211111000
Q ss_pred ---------CCCCC---------------hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 192 ---------KPHFP---------------TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 192 ---------~~~~~---------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.+... ....+.+.+||.+||..||.+|||++++++||||.....
T Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 379 LLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP 446 (467)
T ss_pred HHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence 00000 011345789999999999999999999999999987443
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=249.62 Aligned_cols=222 Identities=24% Similarity=0.372 Sum_probs=167.9
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+|+.||+|.+... .....+.+|+.++++++||||++ .+....++|+||+. ++|.+++......+++.
T Consensus 21 ~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~ 99 (284)
T cd07839 21 NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPE 99 (284)
T ss_pred ECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHH
Confidence 5678999999987632 22356788999999999999988 66778999999996 58988887766678888
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||++|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+
T Consensus 100 ~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~ 173 (284)
T cd07839 100 IVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV------RCYSAEVVTLWYRPPDVLFG 173 (284)
T ss_pred HHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC------CCcCCCccccCCcChHHHhC
Confidence 887777655 799999999999999999999999999999987543211 11122346788999999876
Q ss_pred cC-CCchhhHHHHHHHHHHHHhCCCCCccchh-chHHHHHHHHhc----------------CCCCC---------CChhh
Q 042809 147 EG-LDFATDIWSLGCMVIEMATGRPPWGDKIS-NAAATLLKIACS----------------NEKPH---------FPTQF 199 (241)
Q Consensus 147 ~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~----------------~~~~~---------~~~~~ 199 (241)
.. ++.++|+||||+++|+|++|..|+..... ............ ...+. ..+.+
T Consensus 174 ~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
T cd07839 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKL 253 (284)
T ss_pred CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccC
Confidence 44 68899999999999999998888643221 111111100000 00000 11235
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 200 FKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 200 ~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
+..+.+++++||+.+|.+|||+++++.||||
T Consensus 254 ~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 254 NSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 6788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=247.79 Aligned_cols=223 Identities=33% Similarity=0.533 Sum_probs=175.4
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.+++.+++|.+.. ....+.+.+|+.+++.+.||||++ ...+..++|+||+.+++|.+++.. ..++...+
T Consensus 40 ~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~ 117 (285)
T cd06648 40 DKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQI 117 (285)
T ss_pred ECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHH
Confidence 456789999998763 233556889999999999999988 466889999999999999999987 45676666
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..++.|+ ||++|++||||+|+||+++.++.++|+|||.+....... .......|++.|+|||.+.+..
T Consensus 118 ~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~ 191 (285)
T cd06648 118 ATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV------PRRKSLVGTPYWMAPEVISRLP 191 (285)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC------cccccccCCccccCHHHhcCCC
Confidence 6665544 799999999999999999999999999999876443211 1112345788999999998888
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCC--CChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 149 LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPH--FPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++.++|+||+|+++|++++|..||............. ....+. .+...+..+.+++.+||+.+|++|||+.++++
T Consensus 192 ~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 192 YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR---DNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH---hcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 8999999999999999999999997643322222211 111122 22336788999999999999999999999999
Q ss_pred CCCCCCCCc
Q 042809 227 HTFISGNAK 235 (241)
Q Consensus 227 ~p~~~~~~~ 235 (241)
||||+....
T Consensus 269 ~~~~~~~~~ 277 (285)
T cd06648 269 HPFLAKAGP 277 (285)
T ss_pred CcccccCCC
Confidence 999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=243.81 Aligned_cols=223 Identities=38% Similarity=0.638 Sum_probs=173.6
Q ss_pred CCCCCcEEEEEeccc-------hHHHHHHHHHHHHHhhcCCCcccc-----c--CCceeeeeecccCCCCHHHHHHHhCC
Q 042809 2 NKGTGALFVVKSAES-------EAGVQALRNEAEIRQSLNSPNIGR-----N--GEKTVNIFMEYMAGGSLLDVAEKFGG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~-----~--~~~~~~lv~e~~~~~~L~~~l~~~~~ 67 (241)
++.+|+.||+|.+.. ....+.+.+|+.++.++.||||++ . ....+++|+||+++++|.+++... .
T Consensus 23 ~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~ 101 (265)
T cd06652 23 DADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY-G 101 (265)
T ss_pred EcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHc-C
Confidence 567899999998642 123567889999999999999988 1 235688999999999999999864 4
Q ss_pred CCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 68 TLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 68 ~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
.++......++.+ +||+.+++|+||+|+||+++.++.++|+|||.+......... ........++..|+||
T Consensus 102 ~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~~~~y~aP 178 (265)
T cd06652 102 ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS---GTGMKSVTGTPYWMSP 178 (265)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccccc---ccccccCCCCccccCh
Confidence 5666666665554 479999999999999999999999999999988754321100 0111234578899999
Q ss_pred ccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 142 EVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 142 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
|.+.+..++.++|+||||+++|++++|..||...... ............+..+...+..+.+++++|+. +|++|||+
T Consensus 179 E~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~ 255 (265)
T cd06652 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--AAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSA 255 (265)
T ss_pred hhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH--HHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCH
Confidence 9998888899999999999999999999999764222 22223333333455667778889999999995 89999999
Q ss_pred HHHhcCCCCC
Q 042809 222 EELLNHTFIS 231 (241)
Q Consensus 222 ~~~l~~p~~~ 231 (241)
+++++|||++
T Consensus 256 ~~il~~~~~~ 265 (265)
T cd06652 256 DELLRHTFVH 265 (265)
T ss_pred HHHhcCcccC
Confidence 9999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=256.88 Aligned_cols=219 Identities=26% Similarity=0.314 Sum_probs=163.5
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
++.++..||+|...... ...|+.++++++||||++ ......++|+|++. ++|.+++......+++..+..
T Consensus 87 ~~~~~~~valK~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~ 161 (357)
T PHA03209 87 KPGQPDPVVLKIGQKGT----TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALI 161 (357)
T ss_pred ECCCCceEEEEeCCccc----cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHH
Confidence 45678899999865432 356899999999999998 55678999999995 699999887667788888777
Q ss_pred HHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCC
Q 042809 77 YTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD 150 (241)
Q Consensus 77 ~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 150 (241)
++.|+ ||++|++||||||+||+++.++.++|+|||.+...... .......|++.|+|||.+.+..++
T Consensus 162 i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~ 234 (357)
T PHA03209 162 IEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-------PAFLGLAGTVETNAPEVLARDKYN 234 (357)
T ss_pred HHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-------cccccccccccccCCeecCCCCCC
Confidence 76654 79999999999999999999999999999998642221 111234588999999999998899
Q ss_pred chhhHHHHHHHHHHHHhCCCC-Cccchhch-------HHHHHHH--HhcCCCCCCC------------------------
Q 042809 151 FATDIWSLGCMVIEMATGRPP-WGDKISNA-------AATLLKI--ACSNEKPHFP------------------------ 196 (241)
Q Consensus 151 ~~~Di~slG~~l~~l~~g~~p-~~~~~~~~-------~~~~~~~--~~~~~~~~~~------------------------ 196 (241)
.++|+||||+++|+++++..+ |....... ...+... .....+..++
T Consensus 235 ~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (357)
T PHA03209 235 SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTR 314 (357)
T ss_pred chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccc
Confidence 999999999999999985444 33211110 0000000 0000000111
Q ss_pred ------hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 197 ------TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 197 ------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
...+.++.+||.+||+.||.+|||++++++||||+.
T Consensus 315 ~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 315 YPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 123456778999999999999999999999999975
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=261.93 Aligned_cols=222 Identities=23% Similarity=0.264 Sum_probs=166.4
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
+..+++.||+|... ...+.+|++++++++|+||++ ..++..++|+|++. ++|.+++......+++..+..
T Consensus 190 ~~~~~~~vavK~~~----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~ 264 (461)
T PHA03211 190 HPDYPQRVVVKAGW----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTA 264 (461)
T ss_pred ECCCCCEEEEeccc----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHH
Confidence 45678899999644 234678999999999999998 45678999999995 699999887656788888877
Q ss_pred HHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCC
Q 042809 77 YTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD 150 (241)
Q Consensus 77 ~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 150 (241)
++.|+ ||++|++||||||+||+++.++.++|+|||++........ ........|++.|+|||.+.+..++
T Consensus 265 i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~----~~~~~~~~GT~~Y~APE~~~~~~~~ 340 (461)
T PHA03211 265 VARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS----TPFHYGIAGTVDTNAPEVLAGDPYT 340 (461)
T ss_pred HHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc----cccccccCCCcCCcCHHHHcCCCCC
Confidence 77755 7999999999999999999999999999999875432111 1111234589999999999999999
Q ss_pred chhhHHHHHHHHHHHHhCCCCCccch--------hchHHHHHHHHhcC--C---------------------CCCCC---
Q 042809 151 FATDIWSLGCMVIEMATGRPPWGDKI--------SNAAATLLKIACSN--E---------------------KPHFP--- 196 (241)
Q Consensus 151 ~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~--~---------------------~~~~~--- 196 (241)
.++|||||||++|++++|..++.... ......++...... . .+...
T Consensus 341 ~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 420 (461)
T PHA03211 341 PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPA 420 (461)
T ss_pred chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcc
Confidence 99999999999999999775542211 11111111111100 0 00000
Q ss_pred ----hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 197 ----TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 197 ----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
...+.++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 421 ~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 421 WTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred hhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 023357899999999999999999999999999964
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=244.94 Aligned_cols=225 Identities=33% Similarity=0.589 Sum_probs=182.6
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+|+.|++|.+... .....+.+|+..+.+++|+|+++ ......++|+||+++++|.+++... ..++...
T Consensus 22 ~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~ 100 (264)
T cd06623 22 HKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPV 100 (264)
T ss_pred EcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-CCCCHHH
Confidence 4568999999997754 34678999999999999999988 5678999999999999999999874 5677777
Q ss_pred HHHHHHHH------hhc-CCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 74 IRLYTKEI------LHG-NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 74 ~~~~~~~~------Lh~-~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
...++.|+ ||+ .|++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+
T Consensus 101 ~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~------~~~~~~~~~y~~pE~~~~ 174 (264)
T cd06623 101 LAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ------CNTFVGTVTYMSPERIQG 174 (264)
T ss_pred HHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc------ccceeecccccCHhhhCC
Confidence 66665544 799 99999999999999999999999999998755432111 112346788999999988
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChh-hHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQ-FFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
..++.++|+||||+++|++++|..||....................+..+.. .+..+.+++++||..+|.+|||+.+++
T Consensus 175 ~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll 254 (264)
T cd06623 175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELL 254 (264)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 8889999999999999999999999976542222333333334444555555 788999999999999999999999999
Q ss_pred cCCCCCCC
Q 042809 226 NHTFISGN 233 (241)
Q Consensus 226 ~~p~~~~~ 233 (241)
+|||++..
T Consensus 255 ~~~~~~~~ 262 (264)
T cd06623 255 QHPFIKKA 262 (264)
T ss_pred hCHHHHhc
Confidence 99999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=245.98 Aligned_cols=219 Identities=32% Similarity=0.494 Sum_probs=169.5
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
+..+++.||+|.+... .....+.+|+.+++.++||||++ ...+..++|+||+++++|.+++.. .+.+++..+
T Consensus 30 ~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~ 108 (267)
T cd06645 30 NVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV-TGPLSESQI 108 (267)
T ss_pred EcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHh-cCCCCHHHH
Confidence 4678999999987643 33456889999999999999988 567889999999999999999876 356777777
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc---
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR--- 145 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--- 145 (241)
..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++....... .......|+..|+|||.+.
T Consensus 109 ~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~ 182 (267)
T cd06645 109 AYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI------AKRKSFIGTPYWMAPEVAAVER 182 (267)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc------cccccccCcccccChhhhcccc
Confidence 7766654 799999999999999999999999999999986543211 1112345788999999974
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCC-CCC--ChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK-PHF--PTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
...++.++|+||+|+++|++++|..||.......... ........ +.. ...++..+.+++.+||..+|.+|||++
T Consensus 183 ~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 260 (267)
T cd06645 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAE 260 (267)
T ss_pred CCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH--hhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHH
Confidence 4457889999999999999999999986533222111 11111111 111 123567899999999999999999999
Q ss_pred HHhcCCC
Q 042809 223 ELLNHTF 229 (241)
Q Consensus 223 ~~l~~p~ 229 (241)
++++|||
T Consensus 261 ~ll~~~~ 267 (267)
T cd06645 261 KLLQHPF 267 (267)
T ss_pred HHhcCCC
Confidence 9999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=247.31 Aligned_cols=223 Identities=27% Similarity=0.447 Sum_probs=170.3
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhh---cCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQS---LNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~---l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
++.+|+.+|+|.+... .....+.+|..++.. ..||||+. ..++..++||||+++++|.+++... ..
T Consensus 15 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~-~~ 93 (279)
T cd05633 15 KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GV 93 (279)
T ss_pred ECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhc-CC
Confidence 4578999999987642 112234445444333 46999987 4567899999999999999998863 56
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
+++..+..++.|+ ||+.+++|+||+|+||+++.++.++|+|||++....... .....|+..|+|||
T Consensus 94 l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~y~aPE 165 (279)
T cd05633 94 FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--------PHASVGTHGYMAPE 165 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--------ccCcCCCcCccCHH
Confidence 7877777666544 799999999999999999999999999999986443211 11235789999999
Q ss_pred ccc-ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC--
Q 042809 143 VLR-NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-- 219 (241)
Q Consensus 143 ~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-- 219 (241)
.+. +..++.++|+||+|+++|++++|..||........... ...........+...+.++.+++++||..+|.+||
T Consensus 166 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 244 (279)
T cd05633 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGC 244 (279)
T ss_pred HhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH-HHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCC
Confidence 986 45678999999999999999999999975433322222 22222334455667888999999999999999999
Q ss_pred ---ChHHHhcCCCCCCCC
Q 042809 220 ---SAEELLNHTFISGNA 234 (241)
Q Consensus 220 ---s~~~~l~~p~~~~~~ 234 (241)
|++++++||||++..
T Consensus 245 ~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 245 LGRGAQEVKEHVFFKGID 262 (279)
T ss_pred CCCCHHHHHhCccccCCC
Confidence 699999999998854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=243.51 Aligned_cols=219 Identities=25% Similarity=0.388 Sum_probs=174.3
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCCH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~ 71 (241)
++.+++.+|+|.+.. ......+.+|+.++++++|||+++ ..++..++|+||+++++|.+++.... ..+++
T Consensus 21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 100 (256)
T cd08220 21 RKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDE 100 (256)
T ss_pred EcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCH
Confidence 456889999998763 234567899999999999999987 56778999999999999999998753 34677
Q ss_pred HHHHHHHHH------HhhcCCccccCCCCCcEEeecCC-CeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 72 GVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHG-DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 72 ~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
..+..++.+ +||++|++|+||+|+||+++.++ .++|+|||.+....... ......++..|+|||.+
T Consensus 101 ~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~ 173 (256)
T cd08220 101 DTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-------KAYTVVGTPCYISPELC 173 (256)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-------cccccccCCcccCchhc
Confidence 766665554 47999999999999999998654 57999999997654311 11223478899999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
.+..++.++|+||||+++|++++|..||......... ...........+...+.++.+++.+||..+|.+|||+.++
T Consensus 174 ~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l 250 (256)
T cd08220 174 EGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV---LKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQI 250 (256)
T ss_pred cCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH---HHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHH
Confidence 9888899999999999999999999999765433222 2222233344555678899999999999999999999999
Q ss_pred hcCCCC
Q 042809 225 LNHTFI 230 (241)
Q Consensus 225 l~~p~~ 230 (241)
++||||
T Consensus 251 l~~p~~ 256 (256)
T cd08220 251 MAQPIC 256 (256)
T ss_pred hhCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=241.46 Aligned_cols=220 Identities=26% Similarity=0.429 Sum_probs=176.0
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh-CCCCCH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~ 71 (241)
+..+|+.+++|.+.. ......+.+|+.++++++|+||++ ...+..++++||+++++|.+++... ...++.
T Consensus 21 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~ 100 (256)
T cd08221 21 RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE 100 (256)
T ss_pred EcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCH
Confidence 457889999998652 345567889999999999999988 6678899999999999999999874 345677
Q ss_pred HHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.| +||+.|++|+||+|+||+++.++.++|+|||.+........ ......+++.|.|||.+.
T Consensus 101 ~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~------~~~~~~~~~~y~ape~~~ 174 (256)
T cd08221 101 EMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS------MAETVVGTPYYMSPELCQ 174 (256)
T ss_pred HHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc------cccccCCCccccCHhhcC
Confidence 766665554 47999999999999999999999999999999875433211 112345788999999998
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
+..++.++|+||||+++|++++|..||.......... ....+.....+...+.++.+++.+||..+|.+|||+++++
T Consensus 175 ~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll 251 (256)
T cd08221 175 GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV---KIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251 (256)
T ss_pred CCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHh
Confidence 8888899999999999999999999997643322221 1122333334456778999999999999999999999999
Q ss_pred cCCCC
Q 042809 226 NHTFI 230 (241)
Q Consensus 226 ~~p~~ 230 (241)
+|||+
T Consensus 252 ~~~~l 256 (256)
T cd08221 252 DQPLL 256 (256)
T ss_pred hCcCC
Confidence 99996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=255.74 Aligned_cols=225 Identities=26% Similarity=0.419 Sum_probs=172.7
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+++.||+|.+... .....+.+|..++..+.|+||+. ...+..|+||||+.||+|.+++......+++
T Consensus 22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~ 101 (331)
T cd05624 22 MKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPE 101 (331)
T ss_pred ECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCH
Confidence 4678899999998642 22345788999999999999987 6778999999999999999999876667788
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.++.++|+|||++........ .......|++.|+|||.+.
T Consensus 102 ~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-----~~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05624 102 DMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-----VQSSVAVGTPDYISPEILQ 176 (331)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-----eeeccccCCcccCCHHHHh
Confidence 7777666654 7999999999999999999999999999999865432110 1112345899999999987
Q ss_pred c-----cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC---hhhHHHHHHHHHHhhccCCCC
Q 042809 146 N-----EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP---TQFFKKVLDFLAKCLERKPEK 217 (241)
Q Consensus 146 ~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~ 217 (241)
+ ..++.++|+||+|+++|+|++|+.||.......... ..........++ ..++..+.+++.+|+...+++
T Consensus 177 ~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~--~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~ 254 (331)
T cd05624 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG--KIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERR 254 (331)
T ss_pred ccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH--HHHcCCCcccCCCccccCCHHHHHHHHHHccCchhh
Confidence 5 457889999999999999999999997643322211 111111112222 345789999999999865544
Q ss_pred --CCChHHHhcCCCCCCC
Q 042809 218 --RWSAEELLNHTFISGN 233 (241)
Q Consensus 218 --Rps~~~~l~~p~~~~~ 233 (241)
|+++++++.||||+..
T Consensus 255 ~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 255 LGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred cCCCCHHHHhcCCCcCCC
Confidence 4699999999999763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=245.48 Aligned_cols=227 Identities=30% Similarity=0.529 Sum_probs=173.3
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHH---hCCC
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEK---FGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~---~~~~ 68 (241)
++.+++.+|+|.+... .....+.+|++++++++||||++ ...+.+++||||+++++|.+++.. ....
T Consensus 22 ~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 101 (287)
T cd06621 22 LKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR 101 (287)
T ss_pred ECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCC
Confidence 4568899999987732 34567899999999999999988 234578999999999999988764 2345
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
++...+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++....... .....++..|+|||
T Consensus 102 l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~y~~pE 173 (287)
T cd06621 102 IGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--------AGTFTGTSFYMAPE 173 (287)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc--------cccccCCccccCHH
Confidence 6666665555544 799999999999999999999999999999986443211 11234678899999
Q ss_pred cccccCCCchhhHHHHHHHHHHHHhCCCCCccchh--chHHHHHHHHhcCCCCCC------ChhhHHHHHHHHHHhhccC
Q 042809 143 VLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKIS--NAAATLLKIACSNEKPHF------PTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 143 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~ 214 (241)
.+.+..++.++|+||||+++|++++|..||..... ...............+.. ....++.+.+++.+||..+
T Consensus 174 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 253 (287)
T cd06621 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKD 253 (287)
T ss_pred HhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCC
Confidence 99988899999999999999999999999976421 111122221111111111 1234678999999999999
Q ss_pred CCCCCChHHHhcCCCCCCCCcc
Q 042809 215 PEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 215 p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
|.+|||+.+++.||||+....+
T Consensus 254 p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 254 PTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred cccCCCHHHHHhCccccccccc
Confidence 9999999999999999766554
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=248.36 Aligned_cols=231 Identities=25% Similarity=0.378 Sum_probs=173.8
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+++.|++|.+... .....+.+|+.+++.++||||++ ..++..++||||++|++|.+++... ..+++
T Consensus 22 ~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~ 100 (305)
T cd05609 22 HKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI-GALPV 100 (305)
T ss_pred ECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHc-CCCCH
Confidence 4567899999987743 23456889999999999999988 5677899999999999999999874 45677
Q ss_pred HHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccC---------CccccccccccCcc
Q 042809 72 GVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNN---------GNLKQSWQSIGGTQ 136 (241)
Q Consensus 72 ~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~~~~~ 136 (241)
..+..++. ++||+.|++|+||+|+||+++.++.++|+|||++......... ...........++.
T Consensus 101 ~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (305)
T cd05609 101 DMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180 (305)
T ss_pred HHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCc
Confidence 66665544 4579999999999999999999999999999987631100000 00000111234678
Q ss_pred cccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 137 LWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 137 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
.|+|||.+.+..++.++|+||||+++|++++|..||.+.............. ...+......+.++.+++++||+.+|.
T Consensus 181 ~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~ 259 (305)
T cd05609 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-IEWPEGDEALPADAQDLISRLLRQNPL 259 (305)
T ss_pred cccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCCCCccccCCHHHHHHHHHHhccChh
Confidence 8999999988888999999999999999999999997654333222221111 111222235678899999999999999
Q ss_pred CCCC---hHHHhcCCCCCCCC
Q 042809 217 KRWS---AEELLNHTFISGNA 234 (241)
Q Consensus 217 ~Rps---~~~~l~~p~~~~~~ 234 (241)
+||+ +.++++||||....
T Consensus 260 ~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 260 ERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred hccCccCHHHHHhCccccCCC
Confidence 9997 79999999996543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=253.62 Aligned_cols=224 Identities=23% Similarity=0.358 Sum_probs=161.6
Q ss_pred CCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHh--------CC
Q 042809 3 KGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKF--------GG 67 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~--------~~ 67 (241)
..++..||+|.+........+.+|+.+++.++||||++ ..+...++|+||+. ++|.+++... ..
T Consensus 25 ~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~ 103 (317)
T cd07867 25 GKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPM 103 (317)
T ss_pred CCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCc
Confidence 34678999999886655567889999999999999987 34668899999996 5888887532 12
Q ss_pred CCCHHHHHHHHHH------HhhcCCccccCCCCCcEEe----ecCCCeeecCCCcchhhcccccCCccccccccccCccc
Q 042809 68 TLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLL----GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL 137 (241)
Q Consensus 68 ~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (241)
.+++..+..++.| +||+.|++||||||+||++ +.++.++|+|||++......... ........+++.
T Consensus 104 ~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~~t~~ 180 (317)
T cd07867 104 QLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP---LADLDPVVVTFW 180 (317)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCccc---ccccCcceeccc
Confidence 3566666655554 4799999999999999999 45678999999999754331110 111223457889
Q ss_pred ccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchH----------HHHHHHH-------------------
Q 042809 138 WMAPEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAA----------ATLLKIA------------------- 187 (241)
Q Consensus 138 ~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----------~~~~~~~------------------- 187 (241)
|+|||.+.+ ..++.++||||+|+++|+++||..||.....+.. .......
T Consensus 181 y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (317)
T cd07867 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPT 260 (317)
T ss_pred ccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchh
Confidence 999999876 4578999999999999999999999965322100 0000000
Q ss_pred ----hcCCC----------CCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 188 ----CSNEK----------PHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 188 ----~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
..... ..........+.+|+.+||..||.+|||++++++||||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 261 LQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00000 00011123468899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=245.07 Aligned_cols=225 Identities=26% Similarity=0.434 Sum_probs=175.2
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
+..+|+.||+|.+.. +...+.+.+|+++++.++||||++ .....+++|+||+++++|.+++.. .+.++...
T Consensus 26 ~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~ 104 (284)
T cd06620 26 HIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK-GGPIPVEI 104 (284)
T ss_pred EcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHh-ccCCCHHH
Confidence 356789999998653 344677899999999999999988 566889999999999999999887 35677777
Q ss_pred HHHHHHHH------hhc-CCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 74 IRLYTKEI------LHG-NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 74 ~~~~~~~~------Lh~-~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
+..++.++ ||+ .+++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+
T Consensus 105 ~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--------~~~~~~~~~~~aPE~~~~ 176 (284)
T cd06620 105 LGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--------ADTFVGTSTYMSPERIQG 176 (284)
T ss_pred HHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--------cCccccCcccCCHHHHcc
Confidence 76666544 786 689999999999999999999999999886432211 112457889999999988
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhc--------hHHHHHHHHhcCCCCCCChh-hHHHHHHHHHHhhccCCCC
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISN--------AAATLLKIACSNEKPHFPTQ-FFKKVLDFLAKCLERKPEK 217 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~ 217 (241)
..++.++|+||||+++|++++|..||...... ..............+..+.. .+..+.+++.+||..+|.+
T Consensus 177 ~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 256 (284)
T cd06620 177 GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTE 256 (284)
T ss_pred CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCccc
Confidence 88899999999999999999999999754331 11112222222222333332 6678999999999999999
Q ss_pred CCChHHHhcCCCCCCCCc
Q 042809 218 RWSAEELLNHTFISGNAK 235 (241)
Q Consensus 218 Rps~~~~l~~p~~~~~~~ 235 (241)
|||++++++||||.....
T Consensus 257 Rpt~~e~~~~~~~~~~~~ 274 (284)
T cd06620 257 RPTPQQLCAMPPFIQALR 274 (284)
T ss_pred CcCHHHHhcCcccccccc
Confidence 999999999999976544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=247.04 Aligned_cols=222 Identities=28% Similarity=0.370 Sum_probs=167.2
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC--CCCC
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG--GTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~ 70 (241)
++.+|..||+|.+... .....+.+|+.++++++||||++ ..++..++||||+. ++|.+++.... ..++
T Consensus 21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~ 99 (285)
T cd07861 21 NKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMD 99 (285)
T ss_pred ECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCC
Confidence 4568999999987632 23466889999999999999988 56788999999997 68999887543 4577
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
...+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++...... ........+++.|+|||.+
T Consensus 100 ~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~~~~~y~aPE~~ 173 (285)
T cd07861 100 AELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP------VRVYTHEVVTLWYRAPEVL 173 (285)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC------cccccCCcccccccChHHh
Confidence 77766665544 79999999999999999999999999999998654321 1111223467889999998
Q ss_pred ccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC-------------------------CCCCCChh
Q 042809 145 RNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN-------------------------EKPHFPTQ 198 (241)
Q Consensus 145 ~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~ 198 (241)
.+. .++.++|+||||+++|++++|+.||.+................ ........
T Consensus 174 ~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (285)
T cd07861 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKN 253 (285)
T ss_pred cCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCC
Confidence 654 4688999999999999999999999754322111110000000 00001123
Q ss_pred hHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 199 FFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 199 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
++.++.++|++||..+|.+|||+.+++.||||
T Consensus 254 ~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 254 LDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 56788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=258.27 Aligned_cols=226 Identities=35% Similarity=0.584 Sum_probs=187.9
Q ss_pred CCCCCcEEEEEecc--chHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAE--SEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~--~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.++...|.|++. ++...+.+.-|++||..+.||+|++ ..++.+|++.|||.||-.+..+-+.+.++.+..+
T Consensus 53 nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QI 132 (1187)
T KOG0579|consen 53 NKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQI 132 (1187)
T ss_pred cccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHH
Confidence 56777778888866 4566788999999999999999998 6788999999999999999999998999999999
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc---
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR--- 145 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--- 145 (241)
..++.|. ||+++|+|||||..||+++-+|.++|.|||.+-.... .......++|||.|+|||+..
T Consensus 133 qvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~------t~qkRDsFIGTPYWMAPEVvmCET 206 (1187)
T KOG0579|consen 133 QVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS------TRQKRDSFIGTPYWMAPEVVMCET 206 (1187)
T ss_pred HHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh------HHhhhccccCCcccccchheeecc
Confidence 8887754 7999999999999999999999999999998853221 123446788999999999874
Q ss_pred --ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC--CCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 146 --NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP--HFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 146 --~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
..+|+.++||||||++|.+|..+.+|-... ..+..+++.. +..+| -.|...+..+.+|+++||.+||..||++
T Consensus 207 ~KD~PYDykaDiWSlGITLIEMAqiEPPHhel--npMRVllKia-KSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~a 283 (1187)
T KOG0579|consen 207 FKDQPYDYKADIWSLGITLIEMAQIEPPHHEL--NPMRVLLKIA-KSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPA 283 (1187)
T ss_pred ccCCCchhhhhHHhhhhHHHHHhccCCCcccc--chHHHHHHHh-hcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCH
Confidence 578999999999999999999999998653 2233333322 23333 3466678899999999999999999999
Q ss_pred HHHhcCCCCCCCCcc
Q 042809 222 EELLNHTFISGNAKK 236 (241)
Q Consensus 222 ~~~l~~p~~~~~~~~ 236 (241)
++++.|||+.....+
T Consensus 284 aqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 284 AQLLKHPFVQNAPSN 298 (1187)
T ss_pred HHHhhCcccccCCcc
Confidence 999999999866543
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=245.80 Aligned_cols=224 Identities=25% Similarity=0.394 Sum_probs=171.8
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+|..||+|.+... .....+.+|+.++++++|||+++ ..+...++|+||+ +++|.+++......+++.
T Consensus 21 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~ 99 (286)
T cd07832 21 DRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEA 99 (286)
T ss_pred ECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHH
Confidence 4568999999997632 23467889999999999999988 5678899999999 999999998766778888
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+
T Consensus 100 ~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~ 174 (286)
T cd07832 100 QVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-----RLYSHQVATRWYRAPELLYG 174 (286)
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-----CccccccCcccccCceeeec
Confidence 777776654 7999999999999999999999999999999876543211 11223457889999999865
Q ss_pred c-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC---------------------CC-----CCChhh
Q 042809 147 E-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE---------------------KP-----HFPTQF 199 (241)
Q Consensus 147 ~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------~~-----~~~~~~ 199 (241)
. .++.++||||+|+++|++++|.+||................... .. ......
T Consensus 175 ~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (286)
T cd07832 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDA 254 (286)
T ss_pred cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCc
Confidence 4 45889999999999999999988886543222111111100000 00 001234
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHHhcCCCCC
Q 042809 200 FKKVLDFLAKCLERKPEKRWSAEELLNHTFIS 231 (241)
Q Consensus 200 ~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~ 231 (241)
+..+.+++++||..+|.+|||+++++.||||.
T Consensus 255 ~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 255 SPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 57899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=240.20 Aligned_cols=218 Identities=22% Similarity=0.323 Sum_probs=170.7
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+|+.||+|.+.. ......+.+|++++++++||||++ ......++||||+.+++|.+++...+..+++..
T Consensus 16 ~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 95 (252)
T cd05084 16 LRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKE 95 (252)
T ss_pred EecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHH
Confidence 456899999998663 334567899999999999999988 567789999999999999999987666677777
Q ss_pred HHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 74 IRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 74 ~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
+..++.| +||+.|++|+||+|+||+++.++.++|+|||++........ .........+..|+|||.+.+.
T Consensus 96 ~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~ 171 (252)
T cd05084 96 LIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY----ASTGGMKQIPVKWTAPEALNYG 171 (252)
T ss_pred HHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc----cccCCCCCCceeecCchhhcCC
Confidence 7666654 47999999999999999999999999999999865432110 0001111234569999999988
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 148 GLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
.++.++|+||||+++|++++ |..||............ ........+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 172 ~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 172 RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI---EQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH---HcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 89999999999999999998 89998654433322222 223344555667789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=247.75 Aligned_cols=232 Identities=27% Similarity=0.402 Sum_probs=173.9
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh-CCCCCH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~ 71 (241)
++.+|+.||+|.+.. ....+.+.+|+.+++.++|+||++ ......+++|||+++++|.+++... ...+++
T Consensus 21 ~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~ 100 (314)
T cd08216 21 HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPE 100 (314)
T ss_pred ecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCH
Confidence 456899999999763 345577999999999999999988 5677899999999999999999864 345677
Q ss_pred HHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccC-CccccccccccCcccccCcccc
Q 042809 72 GVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNN-GNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 72 ~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
..+..++.| +||+++++|+||+|+||+++.++.++++|||.+......... ...........++..|+|||.+
T Consensus 101 ~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (314)
T cd08216 101 LAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180 (314)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHh
Confidence 766666554 479999999999999999999999999999988654321110 0011111233467789999998
Q ss_pred cc--cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC--------------------------------
Q 042809 145 RN--EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN-------------------------------- 190 (241)
Q Consensus 145 ~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------------- 190 (241)
.+ ..++.++|+||+|+++|++++|..||........ ........
T Consensus 181 ~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (314)
T cd08216 181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDS 258 (314)
T ss_pred cCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcCCcCcccccccccchhhh
Confidence 65 3478899999999999999999999976432211 11111000
Q ss_pred CCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 191 EKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 191 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
........++.++.+++.+||..+|.+|||++++++||||+.-..
T Consensus 259 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~ 303 (314)
T cd08216 259 VDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKR 303 (314)
T ss_pred hhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence 001112334568899999999999999999999999999987653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=244.01 Aligned_cols=221 Identities=28% Similarity=0.466 Sum_probs=187.8
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
.|.||+.||+|+++++. ...--..|-+.|...+||.+.. +..+++|+||||.+||.|+-++.. ...+++
T Consensus 189 EKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsr-er~FsE 267 (516)
T KOG0690|consen 189 EKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSR-ERVFSE 267 (516)
T ss_pred ecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhh-hhcccc
Confidence 47899999999988653 2333456788899999999865 788999999999999999999887 466788
Q ss_pred HHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
...+.+.. .|||++++|.||||.+|.++|.+|.+||+|||+++.-. ........+||||.|+|||++.
T Consensus 268 ~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I------~~g~t~kTFCGTPEYLAPEVle 341 (516)
T KOG0690|consen 268 DRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI------KYGDTTKTFCGTPEYLAPEVLE 341 (516)
T ss_pred hhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc------cccceeccccCChhhcCchhhc
Confidence 88777655 45899999999999999999999999999999997422 2234456789999999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----C
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----S 220 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s 220 (241)
...|..+.|.|.+|+++|||+.|+.||.+.+.+...+++- .....+|..++++...|+..+|.++|++|. .
T Consensus 342 DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl----~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdD 417 (516)
T KOG0690|consen 342 DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL----MEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDD 417 (516)
T ss_pred cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH----hhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchh
Confidence 9999999999999999999999999999887766665554 334567888999999999999999999997 7
Q ss_pred hHHHhcCCCCCCC
Q 042809 221 AEELLNHTFISGN 233 (241)
Q Consensus 221 ~~~~l~~p~~~~~ 233 (241)
+.++++|+||+.-
T Consensus 418 akEi~~h~FF~~v 430 (516)
T KOG0690|consen 418 AKEIMRHRFFASV 430 (516)
T ss_pred HHHHHhhhhhccC
Confidence 8999999999754
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=246.80 Aligned_cols=222 Identities=25% Similarity=0.451 Sum_probs=169.2
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+|+.||+|.+... ...+.+.+|+.++++++|+|+++ ......++||||+++++|..++.. ...+++.
T Consensus 22 ~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~ 100 (286)
T cd07847 22 NRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN-PRGVPEH 100 (286)
T ss_pred ECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhC-CCCCCHH
Confidence 4668999999987632 23356789999999999999988 567789999999998888877664 4457777
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+
T Consensus 101 ~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~ 174 (286)
T cd07847 101 LIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD------DYTDYVATRWYRAPELLVG 174 (286)
T ss_pred HHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc------cccCcccccccCCHHHHhC
Confidence 777766654 7999999999999999999999999999999976533111 1122346788999999876
Q ss_pred -cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC--------------------CCCC-------CChh
Q 042809 147 -EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN--------------------EKPH-------FPTQ 198 (241)
Q Consensus 147 -~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------------~~~~-------~~~~ 198 (241)
..++.++|+||||+++|++++|..||.+................ ..+. ....
T Consensus 175 ~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (286)
T cd07847 175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPN 254 (286)
T ss_pred CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhcc
Confidence 45788999999999999999999999765433222221111000 0000 0123
Q ss_pred hHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 199 FFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 199 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
.+..+.+++.+||+.+|.+|||+.+++.||||
T Consensus 255 ~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 255 ISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 46789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=242.18 Aligned_cols=215 Identities=20% Similarity=0.270 Sum_probs=170.4
Q ss_pred CCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 4 GTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 4 ~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
.++..||+|.+... .....+.+|+..+.+++||||++ ...+..++||||+++|+|.+++......+++..+.
T Consensus 31 ~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~ 110 (266)
T cd05064 31 KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLM 110 (266)
T ss_pred CceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHH
Confidence 56779999997743 33456889999999999999998 56778999999999999999998766677888777
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCC
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL 149 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 149 (241)
.++.|+ ||++|++||||+|+||+++.++.++++|||.+........ .......++..|+|||.+.+..+
T Consensus 111 ~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~ 185 (266)
T cd05064 111 GMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-----YTTMSGKSPVLWAAPEAIQYHHF 185 (266)
T ss_pred HHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccch-----hcccCCCCceeecCHHHHhhCCc
Confidence 776654 7999999999999999999999999999998754321100 01112224568999999999999
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 150 DFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
+.++||||||+++|++++ |..||.+.......... ........+...+..+.+++.+||+.+|.+|||++++++
T Consensus 186 ~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 186 SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV---EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH---HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999875 99999765443332222 223334456677889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=246.91 Aligned_cols=225 Identities=31% Similarity=0.503 Sum_probs=175.9
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.+++.||+|.+.. ....+.+.+|+.++..++|||+++ ..++..++|+||+++++|.+++.. ..++...+
T Consensus 42 ~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~ 119 (297)
T cd06659 42 EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQI 119 (297)
T ss_pred EcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh--cCCCHHHH
Confidence 456789999999763 233566889999999999999988 567889999999999999998865 45677777
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..
T Consensus 120 ~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~ 193 (297)
T cd06659 120 ATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV------PKRKSLVGTPYWMAPEVISRTP 193 (297)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc------ccccceecCccccCHHHHccCC
Confidence 6666654 799999999999999999999999999999986443211 1112345788999999999888
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCC
Q 042809 149 LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHT 228 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p 228 (241)
++.++|+||||+++|++++|..||.............. ........+...+..+.+++.+||+.+|.+|||++++++||
T Consensus 194 ~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 194 YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD-SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-cCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 99999999999999999999999975433222221111 11111222345667899999999999999999999999999
Q ss_pred CCCCCCc
Q 042809 229 FISGNAK 235 (241)
Q Consensus 229 ~~~~~~~ 235 (241)
||.....
T Consensus 273 ~~~~~~~ 279 (297)
T cd06659 273 FLLQTGL 279 (297)
T ss_pred hhccCCC
Confidence 9987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=244.54 Aligned_cols=225 Identities=36% Similarity=0.607 Sum_probs=179.2
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.++..||+|.... ......+.+|+..+.+++||||++ ..+...++|+||+++++|.+++.. ..++...
T Consensus 25 ~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~--~~~~~~~ 102 (277)
T cd06641 25 DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQ 102 (277)
T ss_pred ECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc--CCCCHHH
Confidence 456889999998663 234567889999999999999987 567789999999999999999875 4566776
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
+..++.++ ||+.|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+.
T Consensus 103 ~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~ 176 (277)
T cd06641 103 IATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ------IKRNTFVGTPFWMAPEVIKQS 176 (277)
T ss_pred HHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch------hhhccccCCccccChhhhccC
Confidence 66665544 799999999999999999999999999999886443211 111223578889999999888
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 148 GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
.++.++|+||+|+++|++++|..||........ .........+..+..++.++.+++.+||..+|.+||++.++++|
T Consensus 177 ~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 177 AYDSKADIWSLGITAIELAKGEPPHSELHPMKV---LFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhHHHHHHHHHHHHcCCCCCCccchHHH---HHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 889999999999999999999999976433222 12222233445566678899999999999999999999999999
Q ss_pred CCCCCCCccC
Q 042809 228 TFISGNAKKN 237 (241)
Q Consensus 228 p~~~~~~~~~ 237 (241)
|||.....+.
T Consensus 254 ~~~~~~~~~~ 263 (277)
T cd06641 254 KFIVRFAKKT 263 (277)
T ss_pred HHHhhhhhcc
Confidence 9998876553
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=244.20 Aligned_cols=221 Identities=31% Similarity=0.513 Sum_probs=168.8
Q ss_pred CCCCCcEEEEEeccch-HHHHHHHHHHHHHhhc-CCCcccc-----------cCCceeeeeecccCCCCHHHHHHHh-CC
Q 042809 2 NKGTGALFVVKSAESE-AGVQALRNEAEIRQSL-NSPNIGR-----------NGEKTVNIFMEYMAGGSLLDVAEKF-GG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~-----------~~~~~~~lv~e~~~~~~L~~~l~~~-~~ 67 (241)
++.+++.+|+|.+... .....+..|+.+++++ +|+||++ ......+++|||+.+++|.+++... ..
T Consensus 37 ~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~ 116 (282)
T cd06636 37 HVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN 116 (282)
T ss_pred EcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCC
Confidence 4568899999987643 3456788999999999 5999987 1246789999999999999999864 34
Q ss_pred CCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 68 TLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 68 ~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
.+++..+..++. .+||+.|++|+||+|+||+++.++.++|+|||++....... .......+++.|+||
T Consensus 117 ~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~y~aP 190 (282)
T cd06636 117 ALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV------GRRNTFIGTPYWMAP 190 (282)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc------cCCCcccccccccCH
Confidence 466666555554 44899999999999999999999999999999987543211 111234578899999
Q ss_pred cccc-----ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 142 EVLR-----NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 142 E~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
|.+. +..++.++|+||||+++|++++|..||........ ................++.++.++|.+||+.+|.
T Consensus 191 E~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 268 (282)
T cd06636 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYL 268 (282)
T ss_pred hhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--hhhHhhCCCCCCcccccCHHHHHHHHHHhCCChh
Confidence 9875 34577889999999999999999999965432211 1111111111222335678999999999999999
Q ss_pred CCCChHHHhcCCCC
Q 042809 217 KRWSAEELLNHTFI 230 (241)
Q Consensus 217 ~Rps~~~~l~~p~~ 230 (241)
+|||+.+++.||||
T Consensus 269 ~Rp~~~ell~~~~~ 282 (282)
T cd06636 269 SRPSTEQLLKHPFI 282 (282)
T ss_pred hCcCHHHHhcCCCC
Confidence 99999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=242.32 Aligned_cols=226 Identities=35% Similarity=0.604 Sum_probs=176.3
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
+..+|+.+++|.+... ...+.+.+|++++++++||||++ ..+...|+|+||+.+++|.+++...+ .+++
T Consensus 14 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~ 92 (265)
T cd05579 14 KKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG-SLDE 92 (265)
T ss_pred ECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC-CCCH
Confidence 4567999999997643 34567899999999999999988 56788999999999999999998743 6777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCC--ccccccccccCcccccCccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG--NLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~aPE~ 143 (241)
..+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++.......... ..........++..|+|||.
T Consensus 93 ~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~ 172 (265)
T cd05579 93 DVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172 (265)
T ss_pred HHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHH
Confidence 7777666654 799999999999999999999999999999987543211100 00011223446788999999
Q ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChh--hHHHHHHHHHHhhccCCCCCCCh
Q 042809 144 LRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQ--FFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 144 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
..+...+.++|+||||+++|++++|..||............. ......+.. .+..+.+++++||+.+|.+|||+
T Consensus 173 ~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~ 248 (265)
T cd05579 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL----NGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGA 248 (265)
T ss_pred hcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----cCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCC
Confidence 988888899999999999999999999997654333222211 112223333 37899999999999999999999
Q ss_pred ---HHHhcCCCCCC
Q 042809 222 ---EELLNHTFISG 232 (241)
Q Consensus 222 ---~~~l~~p~~~~ 232 (241)
.+++.||||+.
T Consensus 249 ~~~~~~l~~~~~~~ 262 (265)
T cd05579 249 KSIEEIKNHPFFKG 262 (265)
T ss_pred ccHHHHhcCccccC
Confidence 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=242.41 Aligned_cols=223 Identities=35% Similarity=0.616 Sum_probs=173.8
Q ss_pred CCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC--CCCCHH
Q 042809 3 KGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG--GTLDAG 72 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~ 72 (241)
+.++..+++|.+..+ .....+.+|++.++.++|+|+++ ..+...++|+|++++++|.+++.... ..+++.
T Consensus 23 ~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~ 102 (267)
T cd06610 23 LPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEA 102 (267)
T ss_pred cCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHH
Confidence 457889999987632 35677999999999999999988 56788999999999999999998642 356777
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++.......... ........++..|+|||.+..
T Consensus 103 ~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~y~~Pe~~~~ 180 (267)
T cd06610 103 IIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT--RKVRKTFVGTPCWMAPEVMEQ 180 (267)
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc--ccccccccCChhhcChHHHcc
Confidence 776666554 799999999999999999999999999999987654422111 011233457889999999876
Q ss_pred c-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC-----hhhHHHHHHHHHHhhccCCCCCCC
Q 042809 147 E-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP-----TQFFKKVLDFLAKCLERKPEKRWS 220 (241)
Q Consensus 147 ~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps 220 (241)
. .++.++|+||||+++|++++|..||........ ... ......+..+ ..++..+.+++.+||..+|.+|||
T Consensus 181 ~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 257 (267)
T cd06610 181 VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LML-TLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT 257 (267)
T ss_pred ccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHH-HhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcC
Confidence 6 678999999999999999999999976433221 111 1111222221 245688999999999999999999
Q ss_pred hHHHhcCCCC
Q 042809 221 AEELLNHTFI 230 (241)
Q Consensus 221 ~~~~l~~p~~ 230 (241)
+++++.||||
T Consensus 258 ~~~ll~~p~~ 267 (267)
T cd06610 258 AEELLKHKFF 267 (267)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=245.53 Aligned_cols=227 Identities=30% Similarity=0.482 Sum_probs=177.1
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.+|..||+|.+.. ......+.+|+.+++.++|+|+++ ...+..++||||+++++|.+++.. ..++...+
T Consensus 41 ~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~ 118 (292)
T cd06657 41 VKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQI 118 (292)
T ss_pred EcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc--CCCCHHHH
Confidence 356889999998753 334566889999999999999988 567889999999999999998764 45677666
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..++.|+ ||+.|++||||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.+..
T Consensus 119 ~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~y~~pE~~~~~~ 192 (292)
T cd06657 119 AAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV------PRRKSLVGTPYWMAPELISRLP 192 (292)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc------ccccccccCccccCHHHhcCCC
Confidence 6666544 799999999999999999999999999999876443211 1122345788899999998888
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCC
Q 042809 149 LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHT 228 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p 228 (241)
++.++|+||+|+++|++++|..||................. .........+..+.+++.+||..+|.+||++.+++.||
T Consensus 193 ~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~ 271 (292)
T cd06657 193 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 271 (292)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-cccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcCh
Confidence 89999999999999999999999976433332222221111 11112234677899999999999999999999999999
Q ss_pred CCCCCCccC
Q 042809 229 FISGNAKKN 237 (241)
Q Consensus 229 ~~~~~~~~~ 237 (241)
||......+
T Consensus 272 ~~~~~~~~~ 280 (292)
T cd06657 272 FLAKAGPPS 280 (292)
T ss_pred HHhccCCCc
Confidence 998877544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=242.33 Aligned_cols=217 Identities=23% Similarity=0.366 Sum_probs=168.3
Q ss_pred CCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC--------
Q 042809 3 KGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-------- 66 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-------- 66 (241)
..++..||+|.+... ...+.+.+|+++++.++|+||++ ......++||||+++++|.+++...+
T Consensus 32 ~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~ 111 (280)
T cd05049 32 ENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKS 111 (280)
T ss_pred cCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcc
Confidence 356789999998743 24577999999999999999988 56678999999999999999998643
Q ss_pred -----CCCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCc
Q 042809 67 -----GTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGT 135 (241)
Q Consensus 67 -----~~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 135 (241)
..+++..+..++. ++||++|++|+||+|+||+++.++.++|+|||++........ ........++
T Consensus 112 ~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~----~~~~~~~~~~ 187 (280)
T cd05049 112 PDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY----YRVGGHTMLP 187 (280)
T ss_pred cccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcc----eecCCCCccc
Confidence 2345555555544 447999999999999999999999999999999864322110 0111122346
Q ss_pred ccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccC
Q 042809 136 QLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 136 ~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 214 (241)
+.|+|||.+.+..++.++||||||+++|++++ |..||............. .+.....+...+..+.+++++||..+
T Consensus 188 ~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~ 264 (280)
T cd05049 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT---QGRLLQRPRTCPSEVYDIMLGCWKRD 264 (280)
T ss_pred ceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---cCCcCCCCCCCCHHHHHHHHHHcCCC
Confidence 78999999999999999999999999999998 999997654433322222 23333445567889999999999999
Q ss_pred CCCCCChHHHhc
Q 042809 215 PEKRWSAEELLN 226 (241)
Q Consensus 215 p~~Rps~~~~l~ 226 (241)
|.+|||++++++
T Consensus 265 p~~Rp~~~eil~ 276 (280)
T cd05049 265 PQQRINIKDIHE 276 (280)
T ss_pred cccCCCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=241.52 Aligned_cols=221 Identities=27% Similarity=0.467 Sum_probs=169.0
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHH-hhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIR-QSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l-~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+|+.||+|.+.... ....+..|..++ ....|+|+++ ..++..|+|+||+++++|.+++... ..++
T Consensus 17 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~ 95 (260)
T cd05611 17 KRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLP 95 (260)
T ss_pred ecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHc-CCCC
Confidence 45688999999986432 223344555444 4457999988 5667899999999999999999873 4567
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
...+..++.|+ ||+.+++|+||+|+||+++.++.++|+|||.+..... .....++..|+|||.+
T Consensus 96 ~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----------~~~~~~~~~y~~pe~~ 165 (260)
T cd05611 96 EDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----------NKKFVGTPDYLAPETI 165 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----------cccCCCCcCccChhhh
Confidence 77776666554 7999999999999999999999999999998864322 1123467889999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC---Ch
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW---SA 221 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~ 221 (241)
.+..++.++|+||+|+++|++++|..||..........................++..+.+++.+||+.+|.+|| ++
T Consensus 166 ~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 245 (260)
T cd05611 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGY 245 (260)
T ss_pred cCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcH
Confidence 888789999999999999999999999976544333222222111222233345678999999999999999999 55
Q ss_pred HHHhcCCCCCCC
Q 042809 222 EELLNHTFISGN 233 (241)
Q Consensus 222 ~~~l~~p~~~~~ 233 (241)
++++.||||+..
T Consensus 246 ~~~l~~~~~~~~ 257 (260)
T cd05611 246 QEIKSHPFFKSI 257 (260)
T ss_pred HHHHcChHhhcC
Confidence 899999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=240.75 Aligned_cols=217 Identities=24% Similarity=0.379 Sum_probs=171.5
Q ss_pred CCCCCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~ 74 (241)
++++++.||+|.+... .....+.+|++.+++++|+||++ ..++..++||||+++++|.+++.... ..++...+
T Consensus 27 ~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~ 106 (263)
T cd05052 27 WKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 106 (263)
T ss_pred EecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHH
Confidence 4567899999997743 33567899999999999999988 56778999999999999999997643 34677766
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..++.|+ ||++|++||||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+..
T Consensus 107 ~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~ 181 (263)
T cd05052 107 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-----TAHAGAKFPIKWTAPESLAYNK 181 (263)
T ss_pred HHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-----eccCCCCCccccCCHHHhccCC
Confidence 6665544 7999999999999999999999999999999875433111 1111122356799999999888
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 149 LDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++.++|+||||+++|++++ |..||.+...... ............+...+..+.+++.+||..+|.+|||+.++++
T Consensus 182 ~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 182 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 9999999999999999998 9999976543332 2222233445566778889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=239.72 Aligned_cols=224 Identities=38% Similarity=0.663 Sum_probs=174.5
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
+..+++.|++|.+... .....+.+|+.+++.++|+||++ ...+..++|+||+++++|.+++... ..++..
T Consensus 21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~ 99 (264)
T cd06626 21 NLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHG-RILDEH 99 (264)
T ss_pred ECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhc-CCCChH
Confidence 4567899999997732 34677999999999999999988 5677899999999999999999873 446666
Q ss_pred HHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.+ +||+.|++|+||+|+||+++.++.++|+|||.+........... .......++..|+|||.+.+
T Consensus 100 ~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~ 177 (264)
T cd06626 100 VIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG--EEVQSLAGTPAYMAPEVITG 177 (264)
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc--ccccCCcCCcCccChhhccC
Confidence 66665554 47999999999999999999999999999999876543221111 10123457889999999987
Q ss_pred cC---CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhh--HHHHHHHHHHhhccCCCCCCCh
Q 042809 147 EG---LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQF--FKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 147 ~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~l~~~p~~Rps~ 221 (241)
.. .+.++|+||||+++|++++|+.||........ ..........+..+... +..+.+++++||+.+|.+|||+
T Consensus 178 ~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 255 (264)
T cd06626 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTA 255 (264)
T ss_pred CCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCH
Confidence 65 78899999999999999999999965432221 11112223344444443 7889999999999999999999
Q ss_pred HHHhcCCCC
Q 042809 222 EELLNHTFI 230 (241)
Q Consensus 222 ~~~l~~p~~ 230 (241)
++++.|||+
T Consensus 256 ~~i~~~~~~ 264 (264)
T cd06626 256 SELLQHPFV 264 (264)
T ss_pred HHHhcCCCC
Confidence 999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=244.46 Aligned_cols=221 Identities=35% Similarity=0.549 Sum_probs=168.5
Q ss_pred CCCCCcEEEEEeccch-HHHHHHHHHHHHHhhc-CCCcccc------c----CCceeeeeecccCCCCHHHHHHH---hC
Q 042809 2 NKGTGALFVVKSAESE-AGVQALRNEAEIRQSL-NSPNIGR------N----GEKTVNIFMEYMAGGSLLDVAEK---FG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~------~----~~~~~~lv~e~~~~~~L~~~l~~---~~ 66 (241)
++.+++.+|+|.+... .....+.+|+.++.++ +|||+++ . ..+..++|+||+++++|.+++.. .+
T Consensus 43 ~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~ 122 (291)
T cd06639 43 NKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG 122 (291)
T ss_pred ECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcC
Confidence 4578999999998743 3346678899999999 7999988 1 23578999999999999998864 24
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..+++..++.++.|+ ||+.|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|
T Consensus 123 ~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~y~a 196 (291)
T cd06639 123 QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL------RRNTSVGTPFWMA 196 (291)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccc------cccCccCCccccC
Confidence 567777776666544 7999999999999999999999999999999875432111 1122347888999
Q ss_pred ccccccc-----CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC--CCChhhHHHHHHHHHHhhcc
Q 042809 141 PEVLRNE-----GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP--HFPTQFFKKVLDFLAKCLER 213 (241)
Q Consensus 141 PE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~ 213 (241)
||.+... .++.++|+||||+++|++++|+.||........ ..... ....+ ..+...+..+.++|.+||+.
T Consensus 197 PE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~ 273 (291)
T cd06639 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LFKIP-RNPPPTLLHPEKWCRSFNHFISQCLIK 273 (291)
T ss_pred hhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HHHHh-cCCCCCCCcccccCHHHHHHHHHHhhc
Confidence 9998543 257899999999999999999999976432222 11111 11111 22334567899999999999
Q ss_pred CCCCCCChHHHhcCCCCC
Q 042809 214 KPEKRWSAEELLNHTFIS 231 (241)
Q Consensus 214 ~p~~Rps~~~~l~~p~~~ 231 (241)
+|.+|||+.++++||||+
T Consensus 274 ~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 274 DFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ChhhCcCHHHHhcCcccC
Confidence 999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=242.02 Aligned_cols=216 Identities=25% Similarity=0.421 Sum_probs=167.0
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
++.+|..+|+|.+...... .. |+.....+ +|||+++ ...+..++||||+++++|.+++... ..+++..+.
T Consensus 37 ~~~~~~~~~~k~~~~~~~~-~~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~ 112 (267)
T PHA03390 37 HKPTQKLFVQKIIKAKNFN-AI--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVK 112 (267)
T ss_pred EcCCCcEEEEEEEehhhcc-hh--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHH
Confidence 4678899999998754311 11 22222222 6999988 5567899999999999999999874 478888888
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecCC-CeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHG-DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
.++.|+ ||+.|++|+||+|+||+++.++ .++|+|||.+...... ....++..|+|||.+.+..
T Consensus 113 ~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~----------~~~~~~~~y~aPE~~~~~~ 182 (267)
T PHA03390 113 KIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP----------SCYDGTLDYFSPEKIKGHN 182 (267)
T ss_pred HHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC----------ccCCCCCcccChhhhcCCC
Confidence 777655 7999999999999999999988 9999999988654321 1234788999999999888
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCccchhchHH-HHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC-hHHHhc
Q 042809 149 LDFATDIWSLGCMVIEMATGRPPWGDKISNAAA-TLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS-AEELLN 226 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~~l~ 226 (241)
++.++|+||+|+++|++++|..||......... ....... ......+...+..+.+++.+||+.+|.+||+ ++++++
T Consensus 183 ~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 183 YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 999999999999999999999999754333221 1111111 2333445568889999999999999999995 699999
Q ss_pred CCCCCC
Q 042809 227 HTFISG 232 (241)
Q Consensus 227 ~p~~~~ 232 (241)
||||+.
T Consensus 262 h~~~~~ 267 (267)
T PHA03390 262 HPFLKI 267 (267)
T ss_pred CCcccC
Confidence 999964
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=238.69 Aligned_cols=217 Identities=22% Similarity=0.302 Sum_probs=170.4
Q ss_pred CCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 3 KGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 3 ~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++++..+|+|.+.. ....+.+.+|+.+++.+.||||++ ......++||||+++++|.+++.. ...++...+
T Consensus 19 ~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~ 97 (257)
T cd05116 19 KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGPLNKFLQK-NKHVTEKNI 97 (257)
T ss_pred CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCcHHHHHHh-cCCCCHHHH
Confidence 56789999998763 234567899999999999999988 345678999999999999999986 356777777
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..++.|+ ||++|++||||+|+||+++.++.++|+|||++........ .........++..|+|||.+....
T Consensus 98 ~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05116 98 TELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN---YYKAKTHGKWPVKWYAPECMNYYK 174 (257)
T ss_pred HHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCC---eeeecCCCCCCccccCHhHhccCC
Confidence 7766654 7999999999999999999999999999999875432111 000111122357899999998888
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 149 LDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++.++|+||||+++|++++ |..||........... ......+..+...+.++.++|.+||+.+|.+|||++++..
T Consensus 175 ~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM---IESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 8999999999999999998 9999976543332222 2234455667778899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=239.88 Aligned_cols=223 Identities=51% Similarity=0.864 Sum_probs=179.6
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCC--ceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGE--KTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+++.|++|.+... ...+.+.+|+..+++++|+||++ ... ...++|+||+++++|.+++.... .++
T Consensus 21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~ 99 (260)
T cd06606 21 DKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLP 99 (260)
T ss_pred ECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC-CCC
Confidence 4568999999997743 34778999999999999999988 344 78999999999999999998753 677
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
...+..++.++ ||+.|++|+||+|+||+++.++.++|+|||.+......... .......++..|.|||.+
T Consensus 100 ~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~y~~pE~~ 175 (260)
T cd06606 100 EPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG----EGTGSVRGTPYWMAPEVI 175 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc----ccccCCCCCccccCHhhh
Confidence 77776666544 79999999999999999999999999999998765442210 012234578889999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
.+...+.++|+||||++++++++|..||.... ...............+..+...+..+.+++.+|+..+|.+||++.++
T Consensus 176 ~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~l 254 (260)
T cd06606 176 RGEEYGRAADIWSLGCTVIEMATGKPPWSELG-NPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADEL 254 (260)
T ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHH
Confidence 88888999999999999999999999997754 12222222222234455666778899999999999999999999999
Q ss_pred hcCCCC
Q 042809 225 LNHTFI 230 (241)
Q Consensus 225 l~~p~~ 230 (241)
+.||||
T Consensus 255 l~~~~~ 260 (260)
T cd06606 255 LQHPFL 260 (260)
T ss_pred hhCCCC
Confidence 999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=242.92 Aligned_cols=218 Identities=28% Similarity=0.415 Sum_probs=167.8
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh-CCCCCHH
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~ 72 (241)
+...+..|+||.+.. ....+.+.+|++.+++++||||++ ...+..++|+||+++|+|.+++... ...++..
T Consensus 24 ~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~ 103 (259)
T PF07714_consen 24 DNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQ 103 (259)
T ss_dssp TTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHH
T ss_pred cCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 456788999999863 344788999999999999999998 5556699999999999999999986 5678888
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
....++.|+ ||+++++|++|+++||+++.++.+||+|||++....... .............|+|||.+.+
T Consensus 104 ~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~ 179 (259)
T PF07714_consen 104 QRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS----KYKNDSSQQLPLRYLAPEVLKD 179 (259)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS----SEEESTTSESGGGGS-HHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc----cccccccccccccccccccccc
Confidence 877776655 799999999999999999999999999999997652210 0111222335678999999998
Q ss_pred cCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 147 EGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
..++.++||||||+++||+++ |+.||.+........ ..........+...+..+.+++.+||+.+|.+|||+.+++
T Consensus 180 ~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~ 256 (259)
T PF07714_consen 180 GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIE---KLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEIL 256 (259)
T ss_dssp SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHH---HHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccc---cccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 889999999999999999999 789987754433222 2233444555667788999999999999999999999997
Q ss_pred c
Q 042809 226 N 226 (241)
Q Consensus 226 ~ 226 (241)
+
T Consensus 257 ~ 257 (259)
T PF07714_consen 257 Q 257 (259)
T ss_dssp H
T ss_pred h
Confidence 5
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=243.41 Aligned_cols=219 Identities=35% Similarity=0.491 Sum_probs=167.9
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.+|+.||+|.+... .....+.+|+.++.+++||||++ ..+...++|+||+++++|.+++.. ...++...+
T Consensus 30 ~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~ 108 (267)
T cd06646 30 NLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV-TGPLSELQI 108 (267)
T ss_pred ECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHH
Confidence 4578899999997643 33456889999999999999988 567789999999999999999876 356777776
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc---
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR--- 145 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--- 145 (241)
..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.
T Consensus 109 ~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~ 182 (267)
T cd06646 109 AYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI------AKRKSFIGTPYWMAPEVAAVEK 182 (267)
T ss_pred HHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc------cccCccccCccccCHhHccccc
Confidence 6666544 799999999999999999999999999999987543211 1112334788899999884
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC---CCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP---HFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
...++.++|+||+|+++|++++|+.||......... .........+ .....++..+.+++++||..+|.+|||++
T Consensus 183 ~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~ 260 (267)
T cd06646 183 NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAE 260 (267)
T ss_pred CCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--eeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHH
Confidence 344678999999999999999999998654221111 1100111111 11234567899999999999999999999
Q ss_pred HHhcCCC
Q 042809 223 ELLNHTF 229 (241)
Q Consensus 223 ~~l~~p~ 229 (241)
++++|+|
T Consensus 261 ~il~~l~ 267 (267)
T cd06646 261 RLLTHLF 267 (267)
T ss_pred HHhcCCC
Confidence 9999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=270.08 Aligned_cols=213 Identities=25% Similarity=0.396 Sum_probs=176.3
Q ss_pred cEEEEEecc---chHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh------CCCCCHH
Q 042809 7 ALFVVKSAE---SEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF------GGTLDAG 72 (241)
Q Consensus 7 ~~vaiK~~~---~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~ 72 (241)
..||+|.+. +......|.+|+.+|+.++||||++ ......+|++|||+||+|..||++. ...+...
T Consensus 723 ~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~ 802 (1025)
T KOG1095|consen 723 IQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMR 802 (1025)
T ss_pred eEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHH
Confidence 458888876 4566788999999999999999998 5688999999999999999999986 5567788
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
....++.++ |+++++|||||..+|||++....+||+|||+|+-+-.. ...+......-...|+|||.+..
T Consensus 803 dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~----~yyr~~~~a~lPvkWm~PEsl~d 878 (1025)
T KOG1095|consen 803 DLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDK----DYYRKHGEAMLPVKWMPPESLKD 878 (1025)
T ss_pred HHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhc----hheeccCccccceecCCHHHHhh
Confidence 877777754 89999999999999999999999999999999843221 11111111223567999999999
Q ss_pred cCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 147 EGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
+.++.++||||||+++||++| |..||.+........ ....+.+.+.|..++..++++|.+||+.+|.+||++..++
T Consensus 879 ~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~---~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~ 955 (1025)
T KOG1095|consen 879 GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL---DVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIV 955 (1025)
T ss_pred cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH---HHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHH
Confidence 999999999999999999999 999998764444333 2233447777888999999999999999999999999998
Q ss_pred c
Q 042809 226 N 226 (241)
Q Consensus 226 ~ 226 (241)
+
T Consensus 956 ~ 956 (1025)
T KOG1095|consen 956 E 956 (1025)
T ss_pred h
Confidence 6
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=246.60 Aligned_cols=226 Identities=23% Similarity=0.325 Sum_probs=170.0
Q ss_pred CCCCCcEEEEEeccchH----HHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESEA----GVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+|..||+|.+..+. ....+.+|+.++++++|+||++ ...+..++||||+. ++|.+++......++
T Consensus 28 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~ 106 (309)
T cd07845 28 DTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFS 106 (309)
T ss_pred ECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCC
Confidence 56789999999976322 1234668999999999999987 22356899999996 589998887556677
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
...+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+
T Consensus 107 ~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~ 180 (309)
T cd07845 107 ESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA------KPMTPKVVTLWYRAPELL 180 (309)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc------CCCCcccccccccChhhh
Confidence 87777776655 799999999999999999999999999999987654311 111122346789999998
Q ss_pred cc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCC---------------CCC-----------Ch
Q 042809 145 RN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK---------------PHF-----------PT 197 (241)
Q Consensus 145 ~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------~~~-----------~~ 197 (241)
.+ ..++.++|+||+|+++|++++|..||...+................ ... ..
T Consensus 181 ~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (309)
T cd07845 181 LGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFP 260 (309)
T ss_pred cCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhcc
Confidence 75 4578899999999999999999999976544333222222111000 000 01
Q ss_pred hhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 198 QFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 198 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
..++.+.++|++||+.||.+|||++++++||||+..+
T Consensus 261 ~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 261 WLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred ccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 2467889999999999999999999999999998554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=271.94 Aligned_cols=224 Identities=32% Similarity=0.465 Sum_probs=181.8
Q ss_pred CCCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 1 MNKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
+++.|+++||+|++.+ ......|+.|-.+|.--..+=|+. +++.++|+||||++||+|-.++...+ +++
T Consensus 95 r~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~p 173 (1317)
T KOG0612|consen 95 RHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLP 173 (1317)
T ss_pred EeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CCh
Confidence 3578999999999886 344566888888888777777776 89999999999999999999999977 899
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+.++++|+..+ ||+.|+|||||||+|||+|..|.+||+|||.+....... .-......|||-|+|||++
T Consensus 174 E~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG-----~V~s~~aVGTPDYISPEvL 248 (1317)
T KOG0612|consen 174 EDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG-----TVRSSVAVGTPDYISPEVL 248 (1317)
T ss_pred HHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC-----cEEeccccCCCCccCHHHH
Confidence 99999998866 799999999999999999999999999999997665311 1233456799999999999
Q ss_pred c----c-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC--hhhHHHHHHHHHHhhccCCCC
Q 042809 145 R----N-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP--TQFFKKVLDFLAKCLERKPEK 217 (241)
Q Consensus 145 ~----~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~ 217 (241)
. + +.|++.+|.||+|+++|||+.|..||....-... +-+.........+| ..+++++.+||++++. +|..
T Consensus 249 qs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT--Y~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~ 325 (1317)
T KOG0612|consen 249 QSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET--YGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREV 325 (1317)
T ss_pred HhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH--HHHHhchhhhcCCCcccccCHHHHHHHHHHhc-Chhh
Confidence 5 3 5688999999999999999999999976432222 11222222233344 5689999999999875 6999
Q ss_pred CCC---hHHHhcCCCCCCC
Q 042809 218 RWS---AEELLNHTFISGN 233 (241)
Q Consensus 218 Rps---~~~~l~~p~~~~~ 233 (241)
|.. ++++..||||.+-
T Consensus 326 RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 326 RLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred hcccccHHHHHhCccccCC
Confidence 997 9999999999764
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=238.88 Aligned_cols=220 Identities=25% Similarity=0.423 Sum_probs=173.8
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCCH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~ 71 (241)
++.+|..+|+|.+... ...+.+.+|+.+++.++|+||++ ......++|+||+.+++|.+++.... ..+++
T Consensus 21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 100 (257)
T cd08225 21 AKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE 100 (257)
T ss_pred EcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCH
Confidence 4567899999998643 34567889999999999999988 66778999999999999999997643 34666
Q ss_pred HHHHHHHH------HHhhcCCccccCCCCCcEEeecCCC-eeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 72 GVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGD-VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 72 ~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
..+..++. ++||+.+++|+||+|+||+++.++. ++|+|||.+........ ......|++.|+|||.+
T Consensus 101 ~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~ape~~ 174 (257)
T cd08225 101 DQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME------LAYTCVGTPYYLSPEIC 174 (257)
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc------cccccCCCccccCHHHH
Confidence 66665554 4479999999999999999988865 69999998876543111 11223578889999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
.+..++.++|+||||++++++++|..||........ ................+.++.+++.+||..+|++|||+.++
T Consensus 175 ~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l 251 (257)
T cd08225 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL---VLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSI 251 (257)
T ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 888889999999999999999999999975433222 22222233334445667899999999999999999999999
Q ss_pred hcCCCC
Q 042809 225 LNHTFI 230 (241)
Q Consensus 225 l~~p~~ 230 (241)
+.||||
T Consensus 252 l~~~~~ 257 (257)
T cd08225 252 LKRPFL 257 (257)
T ss_pred hhCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=240.86 Aligned_cols=222 Identities=37% Similarity=0.694 Sum_probs=170.0
Q ss_pred CCCCCcEEEEEeccch------------HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHH
Q 042809 2 NKGTGALFVVKSAESE------------AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEK 64 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~ 64 (241)
++.+|+.||+|.+... ...+.+.+|+.+++.++|||+++ ......++|+||+.+++|.+++..
T Consensus 22 ~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 101 (272)
T cd06629 22 NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT 101 (272)
T ss_pred ecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhh
Confidence 4568999999986521 12346788999999999999987 667789999999999999999987
Q ss_pred hCCCCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 65 FGGTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 65 ~~~~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
. ..++...+..++.| +||+++++||||+|+||+++.++.++++|||++......... .......++..|
T Consensus 102 ~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~y 176 (272)
T cd06629 102 Y-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN----DQNMSMQGSVFW 176 (272)
T ss_pred c-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccccccc----cccccccCCccc
Confidence 5 56777776665554 479999999999999999999999999999998754321110 111233478889
Q ss_pred cCcccccccC--CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCC----CChhhHHHHHHHHHHhhc
Q 042809 139 MAPEVLRNEG--LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPH----FPTQFFKKVLDFLAKCLE 212 (241)
Q Consensus 139 ~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~ 212 (241)
+|||.+.... ++.++|+||||+++|++++|..||...... .............. ....++..+.+++.+||.
T Consensus 177 ~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 254 (272)
T cd06629 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFT 254 (272)
T ss_pred cCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHHHHhhccccCCcCCccccccCCHHHHHHHHHHhc
Confidence 9999987654 788999999999999999999999653221 11111111111222 223457899999999999
Q ss_pred cCCCCCCChHHHhcCCCC
Q 042809 213 RKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 213 ~~p~~Rps~~~~l~~p~~ 230 (241)
.+|.+|||++++++|||+
T Consensus 255 ~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 255 INPDNRPTARELLQHPFI 272 (272)
T ss_pred CChhhCCCHHHHhhCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=233.00 Aligned_cols=223 Identities=27% Similarity=0.453 Sum_probs=174.2
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
.+.+|.++|||..+. ....+++...+.++..-. +|+||+ ..+..+++.||.|. ..+..+++.-.+++++.
T Consensus 113 ~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C~ekLlkrik~piPE~ 191 (391)
T KOG0983|consen 113 FRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TCAEKLLKRIKGPIPER 191 (391)
T ss_pred EcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HHHHHHHHHhcCCchHH
Confidence 367899999998774 344666777777766554 999998 56777889999994 68888888767788887
Q ss_pred HHHHHHHH------Hh-hcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 73 VIRLYTKE------IL-HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 73 ~~~~~~~~------~L-h~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
.+-.+... || ..+|++|||+||+||++|..|.+|+||||++....+.. ......|.+.|+|||.+.
T Consensus 192 ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-------AhtrsAGC~~YMaPERid 264 (391)
T KOG0983|consen 192 ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-------AHTRSAGCAAYMAPERID 264 (391)
T ss_pred hhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc-------ccccccCCccccCccccC
Confidence 77665543 34 36889999999999999999999999999998766532 233345889999999995
Q ss_pred ---ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC--hhhHHHHHHHHHHhhccCCCCCCC
Q 042809 146 ---NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP--TQFFKKVLDFLAKCLERKPEKRWS 220 (241)
Q Consensus 146 ---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps 220 (241)
..+|+.++||||||++++|+.||+.||.+...+-.. +.......++.++ ...++++++|+..||.+|+.+||.
T Consensus 265 p~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~--ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~ 342 (391)
T KOG0983|consen 265 PPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV--LTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPK 342 (391)
T ss_pred CCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH--HHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcc
Confidence 356889999999999999999999999875433221 1111224444444 347899999999999999999999
Q ss_pred hHHHhcCCCCCCCC
Q 042809 221 AEELLNHTFISGNA 234 (241)
Q Consensus 221 ~~~~l~~p~~~~~~ 234 (241)
..++|+|||++...
T Consensus 343 Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 343 YNKLLEHPFIKRYE 356 (391)
T ss_pred hHHHhcCcceeecc
Confidence 99999999997654
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=242.68 Aligned_cols=222 Identities=27% Similarity=0.367 Sum_probs=166.6
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh-CCCCCH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~ 71 (241)
++.+|+.||+|.+... .....+.+|++++++++||||++ ..++..++||||+. ++|.+++... ...+++
T Consensus 21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~ 99 (284)
T cd07860 21 NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPL 99 (284)
T ss_pred ECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCH
Confidence 4678999999987632 22356889999999999999988 67788999999996 6899988764 345677
Q ss_pred HHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++. ++||+.|++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.
T Consensus 100 ~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~ 173 (284)
T cd07860 100 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV------RTYTHEVVTLWYRAPEILL 173 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc------cccccccccccccCCeEEe
Confidence 66665555 44899999999999999999999999999999986543211 1112233578899999887
Q ss_pred ccC-CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC---------------------CC----CCChhh
Q 042809 146 NEG-LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE---------------------KP----HFPTQF 199 (241)
Q Consensus 146 ~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------~~----~~~~~~ 199 (241)
+.. ++.++|+||||+++|+++||..||................... .. .....+
T Consensus 174 ~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
T cd07860 174 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPL 253 (284)
T ss_pred cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccC
Confidence 654 5788999999999999999999996643322111111100000 00 011234
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 200 FKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 200 ~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
+..+.++|.+||+.+|.+|||+++++.||||
T Consensus 254 ~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 254 DEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred CHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 5678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=244.28 Aligned_cols=219 Identities=20% Similarity=0.277 Sum_probs=161.9
Q ss_pred CCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC---------
Q 042809 4 GTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG--------- 66 (241)
Q Consensus 4 ~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 66 (241)
.++..||+|.+.. ......+.+|+.++.+++||||++ ...+..++||||+.+++|.+++....
T Consensus 44 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 123 (304)
T cd05096 44 GRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123 (304)
T ss_pred CcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccc
Confidence 3556899998774 334567899999999999999988 45677999999999999999987632
Q ss_pred ---------CCCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCcccccccc
Q 042809 67 ---------GTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQS 131 (241)
Q Consensus 67 ---------~~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 131 (241)
..++...+..++. .+||+.|++||||||+||+++.++.+||+|||++........ ......
T Consensus 124 ~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~----~~~~~~ 199 (304)
T cd05096 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY----YRIQGR 199 (304)
T ss_pred cccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCce----eEecCc
Confidence 1233444444444 448999999999999999999999999999999865422110 111122
Q ss_pred ccCcccccCcccccccCCCchhhHHHHHHHHHHHHh--CCCCCccchhchHHHHHHHHh----cCCCCCCChhhHHHHHH
Q 042809 132 IGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT--GRPPWGDKISNAAATLLKIAC----SNEKPHFPTQFFKKVLD 205 (241)
Q Consensus 132 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 205 (241)
..++..|+|||.+.+..++.++|+||||+++|++++ +..||................ .......+...+..+.+
T Consensus 200 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (304)
T cd05096 200 AVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYE 279 (304)
T ss_pred CCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHH
Confidence 335678999999988889999999999999999987 567886543333222211111 11112234456778999
Q ss_pred HHHHhhccCCCCCCChHHHhc
Q 042809 206 FLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 206 li~~~l~~~p~~Rps~~~~l~ 226 (241)
++.+||+.+|.+|||+.++.+
T Consensus 280 li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 280 LMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHHHccCCchhCcCHHHHHH
Confidence 999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=243.65 Aligned_cols=227 Identities=36% Similarity=0.579 Sum_probs=178.9
Q ss_pred CCCCCcEEEEEeccchH-HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 2 NKGTGALFVVKSAESEA-GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
++.++..+++|.+.... ..+.+.+|++.++.++|+|+++ ......++|+||+++++|.+++......++...+.
T Consensus 40 ~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~ 119 (286)
T cd06614 40 DRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA 119 (286)
T ss_pred EccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHH
Confidence 34578899999987433 3567889999999999999988 56688999999999999999999865467777777
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCC
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL 149 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 149 (241)
.++.++ ||+.|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..+
T Consensus 120 ~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~ 193 (286)
T cd06614 120 YVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS------KRNSVVGTPYWMAPEVIKRKDY 193 (286)
T ss_pred HHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh------hhccccCCcccCCHhHhcCCCC
Confidence 666644 7999999999999999999999999999998865432111 1122346788999999988888
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCC--ChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 150 DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHF--PTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
+.++|+||||+++|++++|..||............. ....+.. +..++..+.+++.+||+.+|.+|||+.+++.|
T Consensus 194 ~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 194 GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT---TKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 999999999999999999999997643322222111 1111221 22367889999999999999999999999999
Q ss_pred CCCCCCCccC
Q 042809 228 TFISGNAKKN 237 (241)
Q Consensus 228 p~~~~~~~~~ 237 (241)
|||+....+.
T Consensus 271 ~~~~~~~~~~ 280 (286)
T cd06614 271 PFLKKACPKE 280 (286)
T ss_pred hHhhccCchH
Confidence 9999865543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=238.13 Aligned_cols=218 Identities=39% Similarity=0.634 Sum_probs=175.7
Q ss_pred CCCCCcEEEEEeccchH--HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESEA--GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.+|+.+++|.+.... ....+.+|+..+..++|+|++. ..+...++++||+++++|.+++......++...+
T Consensus 21 ~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~ 100 (253)
T cd05122 21 HKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQI 100 (253)
T ss_pred ECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHH
Confidence 34578999999987554 5678999999999999999987 5567899999999999999999875456777777
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..++.++ ||+.|++||||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..
T Consensus 101 ~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~PE~~~~~~ 173 (253)
T cd05122 101 AYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-------RNTMVGTPYWMAPEVINGKP 173 (253)
T ss_pred HHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-------ccceecCCcccCHHHHcCCC
Confidence 7666544 7999999999999999999999999999999876544211 22345788899999998888
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChh--hHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 149 LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQ--FFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
.+.++|+||||+++|++++|..||...+.......... ...+..+.. ++..+.+++++||..+|.+|||+.+++.
T Consensus 174 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 89999999999999999999999976533222222221 222222222 3788999999999999999999999999
Q ss_pred CCC
Q 042809 227 HTF 229 (241)
Q Consensus 227 ~p~ 229 (241)
|||
T Consensus 251 ~~~ 253 (253)
T cd05122 251 HPF 253 (253)
T ss_pred CCC
Confidence 998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=251.97 Aligned_cols=217 Identities=23% Similarity=0.310 Sum_probs=165.1
Q ss_pred CCCcEEEEEeccch---HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC--------
Q 042809 4 GTGALFVVKSAESE---AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-------- 66 (241)
Q Consensus 4 ~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-------- 66 (241)
.++..||+|.+... .....+.+|+.+++.+ +|+||++ ...+..++||||+.+|+|.+++....
T Consensus 66 ~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~ 145 (374)
T cd05106 66 DNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVM 145 (374)
T ss_pred cccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccc
Confidence 45568999998742 3356688999999999 7999998 56678999999999999999986531
Q ss_pred -------------------------------------------------------------CCCCHHHHHHHHHH-----
Q 042809 67 -------------------------------------------------------------GTLDAGVIRLYTKE----- 80 (241)
Q Consensus 67 -------------------------------------------------------------~~~~~~~~~~~~~~----- 80 (241)
.+++...+..++.|
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL 225 (374)
T cd05106 146 ALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGM 225 (374)
T ss_pred cccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHH
Confidence 12455555555554
Q ss_pred -HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhhHHHHH
Q 042809 81 -ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159 (241)
Q Consensus 81 -~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG 159 (241)
+||++|++||||||+||+++.++.++|+|||++........ ........++..|+|||.+.+..++.++||||||
T Consensus 226 ~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG 301 (374)
T cd05106 226 DFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN----YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 301 (374)
T ss_pred HHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc----eeeccCCCCccceeCHHHhcCCCCCccccHHHHH
Confidence 48999999999999999999999999999999865432111 0111122345679999999888899999999999
Q ss_pred HHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 160 CMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 160 ~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
+++|++++ |..||........ .............+...+.++.+++.+||+.+|.+|||+.++++
T Consensus 302 vil~ellt~G~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 302 ILLWEIFSLGKSPYPGILVNSK--FYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHhCCCCCCccccccHH--HHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999997 9999976433221 22222223334445556789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=253.60 Aligned_cols=220 Identities=32% Similarity=0.467 Sum_probs=181.0
Q ss_pred CCCCCCcEEEEEecc-----chHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 1 MNKGTGALFVVKSAE-----SEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
+|..|+.+||||... +..-...+..|++.|.+++|||++. ..+...|+|||||- |+-++++.-...++.
T Consensus 46 rd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDlleVhkKplq 124 (948)
T KOG0577|consen 46 RDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ 124 (948)
T ss_pred eccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccHHHHHHHHhccch
Confidence 478899999999865 2344667999999999999999988 56678899999995 699999998888888
Q ss_pred HHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++. .|||+.+.+|||||..||+++..|.|||+|||.+....+ ...+.|||.|+|||++
T Consensus 125 EvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----------AnsFvGTPywMAPEVI 194 (948)
T KOG0577|consen 125 EVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----------ANSFVGTPYWMAPEVI 194 (948)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc----------hhcccCCccccchhHh
Confidence 888877765 568999999999999999999999999999999976544 2356799999999998
Q ss_pred c---ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCC-ChhhHHHHHHHHHHhhccCCCCCCC
Q 042809 145 R---NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHF-PTQFFKKVLDFLAKCLERKPEKRWS 220 (241)
Q Consensus 145 ~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps 220 (241)
. .+.|+-++||||||++..++...++|+.+.. .+. .+........|.+ ....+..+++|+..||++-|.+|||
T Consensus 195 LAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN--AMS-ALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRpt 271 (948)
T KOG0577|consen 195 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMS-ALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPT 271 (948)
T ss_pred eeccccccCCccceeeccchhhhhhhcCCCccCch--HHH-HHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCc
Confidence 5 4668999999999999999999999976532 222 2222222333433 3567789999999999999999999
Q ss_pred hHHHhcCCCCCCCC
Q 042809 221 AEELLNHTFISGNA 234 (241)
Q Consensus 221 ~~~~l~~p~~~~~~ 234 (241)
.++++.|+|+....
T Consensus 272 se~ll~H~fv~R~R 285 (948)
T KOG0577|consen 272 SEELLKHRFVLRER 285 (948)
T ss_pred HHHHhhcchhccCC
Confidence 99999999986543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=251.32 Aligned_cols=219 Identities=23% Similarity=0.323 Sum_probs=165.3
Q ss_pred CCCCcEEEEEeccch---HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC------
Q 042809 3 KGTGALFVVKSAESE---AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG------ 67 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~------ 67 (241)
.+++..||+|.+... ...+.+.+|+.++..+ +||||++ ...+..++||||+++|+|.+++.....
T Consensus 62 ~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~ 141 (375)
T cd05104 62 SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPK 141 (375)
T ss_pred CccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhccccccccc
Confidence 456778999998632 3456788999999999 7999998 567789999999999999999975321
Q ss_pred --------------------------------------------------------------------CCCHHHHHHHHH
Q 042809 68 --------------------------------------------------------------------TLDAGVIRLYTK 79 (241)
Q Consensus 68 --------------------------------------------------------------------~~~~~~~~~~~~ 79 (241)
.++...+..++.
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 221 (375)
T cd05104 142 HEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSY 221 (375)
T ss_pred ccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHH
Confidence 244444555544
Q ss_pred ------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchh
Q 042809 80 ------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT 153 (241)
Q Consensus 80 ------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 153 (241)
++||+.|++||||||+||+++.++.++|+|||++........ ........++..|+|||.+.+..++.++
T Consensus 222 qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~s 297 (375)
T cd05104 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN----YVVKGNARLPVKWMAPESIFNCVYTFES 297 (375)
T ss_pred HHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc----ccccCCCCCCcceeChhHhcCCCCCCCC
Confidence 447999999999999999999999999999999875432111 0111122345679999999998999999
Q ss_pred hHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 154 DIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 154 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
|+||||+++|++++ |..||........ .............+...+.++.+++.+||+.+|++|||+.++++.
T Consensus 298 Di~slG~~l~ellt~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 298 DVWSYGILLWEIFSLGSSPYPGMPVDSK--FYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CHHHHHHHHHHHHhcCCCCCCCCCchHH--HHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99999999999998 8999866432221 112222222333444567789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=241.49 Aligned_cols=216 Identities=22% Similarity=0.353 Sum_probs=168.4
Q ss_pred CCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC----------
Q 042809 5 TGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG---------- 66 (241)
Q Consensus 5 ~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 66 (241)
++..|++|.+.. ......+.+|+..+.+++||||++ ......++++||+++++|.+++....
T Consensus 34 ~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~ 113 (283)
T cd05048 34 SATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113 (283)
T ss_pred ceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccc
Confidence 447899998763 234566899999999999999988 56678999999999999999998642
Q ss_pred -----CCCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCc
Q 042809 67 -----GTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGT 135 (241)
Q Consensus 67 -----~~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 135 (241)
..++...+..++.| +||+.|++|+||+|+||+++.++.++|+|||++........ ........++
T Consensus 114 ~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~----~~~~~~~~~~ 189 (283)
T cd05048 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY----YRVQSKSLLP 189 (283)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeecccccc----ccccCCCccc
Confidence 23555555555544 47999999999999999999999999999999864422111 1111223457
Q ss_pred ccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccC
Q 042809 136 QLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 136 ~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 214 (241)
+.|+|||.+.+..++.++|+||||+++|++++ |..||.+......... ......+..+...+..+.+|+.+||+.+
T Consensus 190 ~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~l~~~c~~~~ 266 (283)
T cd05048 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM---IRSRQLLPCPEDCPARVYALMIECWNEI 266 (283)
T ss_pred ccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HHcCCcCCCcccCCHHHHHHHHHHccCC
Confidence 78999999988889999999999999999998 9999976544333222 2233444556778899999999999999
Q ss_pred CCCCCChHHHhcC
Q 042809 215 PEKRWSAEELLNH 227 (241)
Q Consensus 215 p~~Rps~~~~l~~ 227 (241)
|.+|||+.+++++
T Consensus 267 p~~Rp~~~~i~~~ 279 (283)
T cd05048 267 PARRPRFKDIHTR 279 (283)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=257.41 Aligned_cols=223 Identities=27% Similarity=0.412 Sum_probs=186.5
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
+.-||..||||.+.+. .....+.+|+++|+.++|||||+ .....+|+||||+.+|.+++|+...+ +..+.
T Consensus 77 ~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~g-r~~e~ 155 (596)
T KOG0586|consen 77 HILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHG-RMKEK 155 (596)
T ss_pred ecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcc-cchhh
Confidence 5678999999998843 33455899999999999999998 67889999999999999999999854 44446
Q ss_pred HHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.++.++. +|||++++||||||.+||+++.+..+||+|||++..+.. .......+|++.|.|||++.+
T Consensus 156 ~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-------~~~lqt~cgsppyAaPEl~~g 228 (596)
T KOG0586|consen 156 EARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY-------GLMLQTFCGSPPYAAPELFNG 228 (596)
T ss_pred hhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc-------cccccccCCCCCccChHhhcC
Confidence 5655554 568999999999999999999999999999999986643 233456789999999999999
Q ss_pred cCC-CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 147 EGL-DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 147 ~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
..| .+.+|+|++|+++|.++.|.+||.+..-... +.........++..++.++.++|+++|.++|.+|+++++++
T Consensus 229 ~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L----r~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim 304 (596)
T KOG0586|consen 229 KKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL----RPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIM 304 (596)
T ss_pred cccCCcceehhhhhhhheeeeecccccCCcccccc----cchheeeeecccceeechhHHHHHHhhccCccccCCHHHhh
Confidence 877 5899999999999999999999987543332 23333556677888889999999999999999999999999
Q ss_pred cCCCCCCCCcc
Q 042809 226 NHTFISGNAKK 236 (241)
Q Consensus 226 ~~p~~~~~~~~ 236 (241)
.|.|......+
T Consensus 305 ~~~W~n~~~~~ 315 (596)
T KOG0586|consen 305 KDRWRNDLLEA 315 (596)
T ss_pred hhcccchhhhh
Confidence 99999765543
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=237.91 Aligned_cols=220 Identities=30% Similarity=0.509 Sum_probs=179.5
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh---CCCC
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF---GGTL 69 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~ 69 (241)
+..++..+++|.+... .....+.+|++.++.++|+|+++ ......++|+||+++++|.+++... +..+
T Consensus 21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 100 (258)
T cd08215 21 RKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPF 100 (258)
T ss_pred EcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCc
Confidence 3567899999997743 45677899999999999999988 4568999999999999999999875 3667
Q ss_pred CHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
+...+..++.++ ||+.|++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.
T Consensus 101 ~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~~y~~pe~ 174 (258)
T cd08215 101 PEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV------DLAKTVVGTPYYLSPEL 174 (258)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc------ceecceeeeecccChhH
Confidence 777777666654 799999999999999999999999999999987554321 11123457888999999
Q ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH
Q 042809 144 LRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 144 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
+.+..++.++|+||+|++++++++|..||...... ..............+...+..+.+++.+||..+|.+|||+.+
T Consensus 175 ~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 251 (258)
T cd08215 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQ 251 (258)
T ss_pred hccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 98888899999999999999999999999664322 222333334455566677889999999999999999999999
Q ss_pred HhcCCCC
Q 042809 224 LLNHTFI 230 (241)
Q Consensus 224 ~l~~p~~ 230 (241)
++.||||
T Consensus 252 ll~~~~~ 258 (258)
T cd08215 252 ILQSPFI 258 (258)
T ss_pred HhcCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=238.72 Aligned_cols=217 Identities=25% Similarity=0.457 Sum_probs=173.5
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh-CCCCCHH
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~ 72 (241)
++.+++.+|+|.++. ....+.+.+|+.+++.++|+||++ ..++.+|+|+||+++++|.+++... +..++..
T Consensus 21 ~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~ 100 (255)
T cd08219 21 HVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPED 100 (255)
T ss_pred EcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHH
Confidence 467899999998752 344577889999999999999988 6778999999999999999998753 3456777
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||++|++|+||+|+||+++.++.++++|||.+........ ......+++.|+|||.+.+
T Consensus 101 ~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~ 174 (255)
T cd08219 101 TILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA------YACTYVGTPYYVPPEIWEN 174 (255)
T ss_pred HHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc------ccccccCCccccCHHHHcc
Confidence 766666654 7999999999999999999999999999999865433111 1123457888999999998
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
..++.++|+||||+++|++++|..||........ ............+..++..+.+++.+||+.+|.+|||+.+++.
T Consensus 175 ~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 175 MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---ILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred CCcCchhhhhhhchhheehhhccCCCCCCCHHHH---HHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 8899999999999999999999999976433222 2222233344456667788999999999999999999999986
Q ss_pred C
Q 042809 227 H 227 (241)
Q Consensus 227 ~ 227 (241)
.
T Consensus 252 ~ 252 (255)
T cd08219 252 R 252 (255)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=237.26 Aligned_cols=218 Identities=20% Similarity=0.301 Sum_probs=170.7
Q ss_pred CCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 4 GTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 4 ~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
+++..||+|..... ...+.+.+|+.++++++||||++ ......++||||+++++|.+++......+++..+..
T Consensus 20 ~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 99 (257)
T cd05115 20 KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVE 99 (257)
T ss_pred CCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHH
Confidence 44567999987643 33466899999999999999988 345578999999999999999987666778887777
Q ss_pred HHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCC
Q 042809 77 YTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD 150 (241)
Q Consensus 77 ~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 150 (241)
++.|+ ||++|++|+||+|+||+++.++.++|+|||++......... ........++..|+|||.+.+..++
T Consensus 100 ~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~ 176 (257)
T cd05115 100 LMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY---YKARSAGKWPLKWYAPECINFRKFS 176 (257)
T ss_pred HHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccc---eeccCCCCCCcccCCHHHHccCCCC
Confidence 76655 79999999999999999999999999999998744321110 0111111235679999999888889
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 151 FATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 151 ~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
.++|+||||+++|++++ |..||........ ......+.....+...++++.+++.+||..+|++||++.++.+.
T Consensus 177 ~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---MSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred chhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999996 9999976543332 23333444556667778899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=241.64 Aligned_cols=224 Identities=33% Similarity=0.577 Sum_probs=174.8
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcC---CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLN---SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~---h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+|+.||+|.+.. ....+.+.+|+.+++++. |||+++ ..+...++||||+++++|.+++.. ..++
T Consensus 22 ~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~ 99 (277)
T cd06917 22 HVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIA 99 (277)
T ss_pred EcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc--cCCC
Confidence 467899999998763 334567889999999997 999987 566789999999999999999875 3677
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.++ ||+.|++|+||+|+||+++.++.++|+|||.+....... .......|+..|+|||.+
T Consensus 100 ~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~ 173 (277)
T cd06917 100 EKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS------SKRSTFVGTPYWMAPEVI 173 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc------cccccccCCcceeCHHHh
Confidence 77666665544 799999999999999999999999999999987554311 111233578889999998
Q ss_pred cc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCCh-hhHHHHHHHHHHhhccCCCCCCChH
Q 042809 145 RN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPT-QFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 145 ~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
.+ ..++.++|+||||+++|++++|..||.......... .......+..+. ..+.++.+++.+||+.+|.+|||+.
T Consensus 174 ~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~ 250 (277)
T cd06917 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM---LIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAE 250 (277)
T ss_pred ccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh---ccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHH
Confidence 65 446889999999999999999999997643322211 111122233333 2677899999999999999999999
Q ss_pred HHhcCCCCCCCCcc
Q 042809 223 ELLNHTFISGNAKK 236 (241)
Q Consensus 223 ~~l~~p~~~~~~~~ 236 (241)
+++.||||+.....
T Consensus 251 ~il~~~~~~~~~~~ 264 (277)
T cd06917 251 ELLKSKWIKAHSKT 264 (277)
T ss_pred HHhhChHhhccccC
Confidence 99999999876643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=249.33 Aligned_cols=234 Identities=23% Similarity=0.345 Sum_probs=173.6
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc---------cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR---------NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
++.+|+.||+|.+... .....+.+|+.++++++||||++ ......++|+||+. ++|.+++.. ...
T Consensus 26 ~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~ 103 (334)
T cd07855 26 DTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHS-DQP 103 (334)
T ss_pred EcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhcc-CCC
Confidence 5678999999987643 33566788999999999999987 13467899999995 689998876 355
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
++...+..++.|+ ||+.|++||||+|+||+++.++.++|+|||++.......... ........++..|+|||
T Consensus 104 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~y~~PE 181 (334)
T cd07855 104 LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH--KYFMTEYVATRWYRAPE 181 (334)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCC--CcccccccccccccChH
Confidence 7777777776644 799999999999999999999999999999986543211110 11112235788899999
Q ss_pred cccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHh----------------------cCCCCCC----
Q 042809 143 VLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIAC----------------------SNEKPHF---- 195 (241)
Q Consensus 143 ~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------~~~~~~~---- 195 (241)
.+.+ ..++.++|+||||+++|++++|+.||.+.............. .......
T Consensus 182 ~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (334)
T cd07855 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSK 261 (334)
T ss_pred HhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHH
Confidence 9865 457889999999999999999999996543221111111000 0011111
Q ss_pred -ChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCccCCC
Q 042809 196 -PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKNST 239 (241)
Q Consensus 196 -~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~~~~ 239 (241)
....+.++.++|++||+.+|.+|||+++++.||||.......+.
T Consensus 262 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~ 306 (334)
T cd07855 262 IFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDE 306 (334)
T ss_pred HcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccc
Confidence 13356789999999999999999999999999999876665543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=250.61 Aligned_cols=220 Identities=26% Similarity=0.323 Sum_probs=164.5
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCccccc-----------CCceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGRN-----------GEKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~-----------~~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
++.+|+.||+|.+.. ......+.+|+.++++++||||++. .....|+||||+. ++|.+.+...
T Consensus 37 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~- 114 (353)
T cd07850 37 DTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD- 114 (353)
T ss_pred ECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc-
Confidence 567899999998753 3345678899999999999999871 2246799999996 5888888652
Q ss_pred CCCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
++...+..++.| +||+.|++||||+|+||+++.++.++|+|||++....... ......++..|+|
T Consensus 115 --l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-------~~~~~~~~~~y~a 185 (353)
T cd07850 115 --LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-------MMTPYVVTRYYRA 185 (353)
T ss_pred --CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC-------CCCCCcccccccC
Confidence 666666555554 4799999999999999999999999999999997543311 1122346888999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC------------------CCC---------
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN------------------EKP--------- 193 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------~~~--------- 193 (241)
||.+.+..++.++|+||||+++|+|++|..||...+.............. ..+
T Consensus 186 PE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (353)
T cd07850 186 PEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEE 265 (353)
T ss_pred HHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhh
Confidence 99999988999999999999999999999999654321111100000000 000
Q ss_pred ------------CCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 194 ------------HFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 194 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
..+...+..+.+++.+||+.+|.+|||+.+++.||||+.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 266 LFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 001124567899999999999999999999999998863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=236.64 Aligned_cols=219 Identities=36% Similarity=0.672 Sum_probs=178.4
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+++.|++|.+... ...+.+.+|++++.+++|+|+++ ......++|+||+++++|.+++... ..+++.
T Consensus 21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~ 99 (254)
T cd06627 21 NLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPES 99 (254)
T ss_pred EcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-cCCCHH
Confidence 4567899999997743 35677999999999999999987 5667899999999999999999874 567777
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||...+
T Consensus 100 ~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~------~~~~~~~~~y~~pe~~~~ 173 (254)
T cd06627 100 LVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD------DASVVGTPYWMAPEVIEM 173 (254)
T ss_pred HHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc------ccccccchhhcCHhhhcC
Confidence 777666654 79999999999999999999999999999999765442111 123457888999999988
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
...+.++|+|++|+++|++++|..||...... ... ........+..+...+..+.+++.+||..+|++|||+++++.
T Consensus 174 ~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 174 SGASTASDIWSLGCTVIELLTGNPPYYDLNPM--AAL-FRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCccHH--HHH-HHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 77889999999999999999999999764321 111 122234445566677889999999999999999999999999
Q ss_pred CCCC
Q 042809 227 HTFI 230 (241)
Q Consensus 227 ~p~~ 230 (241)
||||
T Consensus 251 ~~~~ 254 (254)
T cd06627 251 HPWI 254 (254)
T ss_pred CCCC
Confidence 9997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=242.90 Aligned_cols=223 Identities=26% Similarity=0.471 Sum_probs=169.7
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++++++.||+|.+.. ....+.+.+|++++++++|+||++ ..++..++|+||++++.+..+... ...++..
T Consensus 22 ~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~-~~~~~~~ 100 (288)
T cd07833 22 NKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEAS-PGGLPPD 100 (288)
T ss_pred eCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhc-CCCCCHH
Confidence 567899999998763 233567899999999999999988 566789999999988666665554 4557777
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.++ ||+.|++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+
T Consensus 101 ~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~ 175 (288)
T cd07833 101 AVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-----SPLTDYVATRWYRAPELLVG 175 (288)
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-----ccccCcccccCCcCCchhcC
Confidence 776666544 7999999999999999999999999999999876543211 11123456788999999988
Q ss_pred c-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCC--------------------C--------CCCh
Q 042809 147 E-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK--------------------P--------HFPT 197 (241)
Q Consensus 147 ~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------~--------~~~~ 197 (241)
. .++.++|+||||+++|++++|..||.+.................. . .++.
T Consensus 176 ~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (288)
T cd07833 176 DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPG 255 (288)
T ss_pred CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCC
Confidence 7 788999999999999999999999975433222111111000000 0 1122
Q ss_pred hhHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 198 QFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 198 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
.++..+.++|++||..+|++|||+++++.||||
T Consensus 256 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 256 KVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 347789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=240.40 Aligned_cols=223 Identities=26% Similarity=0.440 Sum_probs=171.4
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHH---HhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEI---RQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~---l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
++.+|+.||+|.+... .....+..|..+ +....||||+. ...+..++|+||+.|++|..++.. ...
T Consensus 15 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~-~~~ 93 (278)
T cd05606 15 KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGV 93 (278)
T ss_pred EecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHh-cCC
Confidence 4578899999987642 111223444433 44457999987 566789999999999999998876 456
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
+++..+..++.|+ ||+.+++|+||+|+||+++.++.++|+|||++...... ......|+..|+|||
T Consensus 94 l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~y~aPE 165 (278)
T cd05606 94 FSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------KPHASVGTHGYMAPE 165 (278)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--------CCcCcCCCcCCcCcH
Confidence 7888877777655 79999999999999999999999999999998644321 112335889999999
Q ss_pred ccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC--
Q 042809 143 VLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-- 219 (241)
Q Consensus 143 ~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-- 219 (241)
.+.+. .++.++|+||+|+++|++++|..||............. .........+...+..+.+++.+||..+|.+||
T Consensus 166 ~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~ 244 (278)
T cd05606 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGC 244 (278)
T ss_pred HhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-HhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCC
Confidence 99754 57889999999999999999999997653322222221 222334556666788999999999999999999
Q ss_pred ---ChHHHhcCCCCCCCC
Q 042809 220 ---SAEELLNHTFISGNA 234 (241)
Q Consensus 220 ---s~~~~l~~p~~~~~~ 234 (241)
++.++++||||+...
T Consensus 245 ~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 245 LGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred CCCCHHHHHhCccccCCC
Confidence 999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=236.33 Aligned_cols=214 Identities=25% Similarity=0.393 Sum_probs=167.0
Q ss_pred CCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 5 TGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 5 ~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
++..+|+|.+... .....+.+|+.++++++||||++ ......++||||+++|+|.+++......++...+..++
T Consensus 27 ~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 106 (256)
T cd05114 27 AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMC 106 (256)
T ss_pred cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHH
Confidence 4567999987643 33467889999999999999988 56678999999999999999998655567777666665
Q ss_pred HH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCch
Q 042809 79 KE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA 152 (241)
Q Consensus 79 ~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 152 (241)
.+ +||+.|++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+..++.+
T Consensus 107 ~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~ 181 (256)
T cd05114 107 QDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-----TSSSGAKFPVKWSPPEVFNFSKYSSK 181 (256)
T ss_pred HHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-----eccCCCCCchhhCChhhcccCccchh
Confidence 54 48999999999999999999999999999998875432111 01112224567999999988889999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 153 TDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 153 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
+|+||||+++|++++ |+.||............ ........+...+..+.+++.+||+.+|.+|||++++++
T Consensus 182 ~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 182 SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI---SRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999 99999765433332222 222233344556778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=233.11 Aligned_cols=234 Identities=26% Similarity=0.356 Sum_probs=183.2
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
+..||+.||||++.+. ..+.+..+|++++...+ |+||+. +++..+|+|||.|.||+|-+.|..+ ..+++..
T Consensus 99 ~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~-~~F~E~E 177 (463)
T KOG0607|consen 99 SIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKR-KHFNERE 177 (463)
T ss_pred eeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHh-hhccHHH
Confidence 5678999999999864 45788999999999998 999988 8889999999999999999999984 5567766
Q ss_pred HHHHHH------HHhhcCCccccCCCCCcEEeecCCC---eeecCCCcchhhccccc-CCccccccccccCcccccCccc
Q 042809 74 IRLYTK------EILHGNGILHCDLKCNNVLLGSHGD---VKLPDLGCARRVNDLKN-NGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 74 ~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~---~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
+..++. .+||.+||.||||||+||+-...+. +||+||++......... ...........+|+..|||||+
T Consensus 178 As~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEV 257 (463)
T KOG0607|consen 178 ASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEV 257 (463)
T ss_pred HHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhH
Confidence 665555 4589999999999999999966544 89999999865432111 1222344567789999999998
Q ss_pred cc-----ccCCCchhhHHHHHHHHHHHHhCCCCCccchhc-----------hHHHHHHHHhcCCCCCCCh----hhHHHH
Q 042809 144 LR-----NEGLDFATDIWSLGCMVIEMATGRPPWGDKISN-----------AAATLLKIACSNEKPHFPT----QFFKKV 203 (241)
Q Consensus 144 ~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~~~----~~~~~~ 203 (241)
.. ...|+.++|.||||+++|-|+.|.+||.+.-.. ...+.+........+++|. .++.+.
T Consensus 258 Vd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~ea 337 (463)
T KOG0607|consen 258 VDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEA 337 (463)
T ss_pred HhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHH
Confidence 74 355789999999999999999999999653211 1122222223344555553 467889
Q ss_pred HHHHHHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 204 LDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 204 ~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
.++++.++..++.+|.++.++++|||++.-+.+
T Consensus 338 kdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 338 KDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 999999999999999999999999999876654
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=238.24 Aligned_cols=220 Identities=25% Similarity=0.406 Sum_probs=167.9
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh---CCC
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF---GGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~ 68 (241)
++.+|+.||+|.+.. ......+.+|+++++.++||||++ ...+..++|+||+++++|.+++... ...
T Consensus 23 ~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~ 102 (267)
T cd08228 23 CLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL 102 (267)
T ss_pred EeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCC
Confidence 456889999997542 334566889999999999999988 4567899999999999999988642 334
Q ss_pred CCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
+++..+..++. .+||++|++|+||+|+||+++.++.++|+|||.+........ ......+++.|+|||
T Consensus 103 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~------~~~~~~~~~~~~aPE 176 (267)
T cd08228 103 IPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT------AAHSLVGTPYYMSPE 176 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH------HHhcCCCCccccChh
Confidence 66666555554 448999999999999999999999999999998875433111 112235788899999
Q ss_pred cccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 143 VLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 143 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
.+.+..++.++|+||+|+++|++++|..||...................++..+...+..+.+++.+||..+|.+|||++
T Consensus 177 ~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 256 (267)
T cd08228 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIG 256 (267)
T ss_pred hhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHH
Confidence 99888889999999999999999999999965433222222221222222222345678899999999999999999999
Q ss_pred HHhcC
Q 042809 223 ELLNH 227 (241)
Q Consensus 223 ~~l~~ 227 (241)
++++.
T Consensus 257 ~vl~~ 261 (267)
T cd08228 257 YVHQI 261 (267)
T ss_pred HHHHH
Confidence 99864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=267.72 Aligned_cols=222 Identities=24% Similarity=0.342 Sum_probs=169.6
Q ss_pred CCCCCcEEEEEecc----chHHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHh---CC
Q 042809 2 NKGTGALFVVKSAE----SEAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKF---GG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~----~~~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~---~~ 67 (241)
++.++..+|+|.+. .......+..|+.++.+++||||++ .....+|+||||+.+++|.+++... ..
T Consensus 34 dk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g 113 (1021)
T PTZ00266 34 HKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFG 113 (1021)
T ss_pred ECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccC
Confidence 56788899999876 2344677899999999999999988 2346799999999999999999763 34
Q ss_pred CCCHHHHHHHHHHH------hhcC-------CccccCCCCCcEEeecC-----------------CCeeecCCCcchhhc
Q 042809 68 TLDAGVIRLYTKEI------LHGN-------GILHCDLKCNNVLLGSH-----------------GDVKLPDLGCARRVN 117 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~-------~~vH~dl~p~Nil~~~~-----------------~~~kl~dfg~~~~~~ 117 (241)
.+++..++.++.|+ ||+. +|+|+||||+|||++.+ +.+||+|||++....
T Consensus 114 ~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~ 193 (1021)
T PTZ00266 114 KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG 193 (1021)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccc
Confidence 67887777766654 7984 59999999999999642 348999999997543
Q ss_pred ccccCCccccccccccCcccccCcccccc--cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCC
Q 042809 118 DLKNNGNLKQSWQSIGGTQLWMAPEVLRN--EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHF 195 (241)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 195 (241)
.. .......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||..... ........... +...
T Consensus 194 ~~-------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~--~~qli~~lk~~-p~lp 263 (1021)
T PTZ00266 194 IE-------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN--FSQLISELKRG-PDLP 263 (1021)
T ss_pred cc-------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc--HHHHHHHHhcC-CCCC
Confidence 21 11123458999999999864 4478899999999999999999999975432 11222221111 1111
Q ss_pred ChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCC
Q 042809 196 PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 196 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~ 233 (241)
....+.++.+||.+||..+|.+|||+.++|.|||++..
T Consensus 264 i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 264 IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 23457789999999999999999999999999999744
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=239.67 Aligned_cols=217 Identities=24% Similarity=0.390 Sum_probs=168.2
Q ss_pred CCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC---------
Q 042809 3 KGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG--------- 66 (241)
Q Consensus 3 ~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 66 (241)
..++..+|+|.+.. ....+.+.+|+.++++++||||++ ...+..++|+||+++++|.+++...+
T Consensus 32 ~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~ 111 (288)
T cd05093 32 EQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111 (288)
T ss_pred CCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCcccccccc
Confidence 34567799998774 344567999999999999999988 56778999999999999999998643
Q ss_pred ---CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccc
Q 042809 67 ---GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL 137 (241)
Q Consensus 67 ---~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (241)
..+++..+..++.|+ ||++|++||||+|+||+++.++.++|+|||++....... .........++..
T Consensus 112 ~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~~~ 187 (288)
T cd05093 112 NRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD----YYRVGGHTMLPIR 187 (288)
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCc----eeecCCCCCcccc
Confidence 236777766666544 799999999999999999999999999999987442211 0111122334678
Q ss_pred ccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 138 WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 138 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
|+|||.+.+..++.++|+||||+++|++++ |..||.......... ....+.....+...+..+.+++.+||+.+|.
T Consensus 188 y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~---~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 264 (288)
T cd05093 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE---CITQGRVLQRPRTCPKEVYDLMLGCWQREPH 264 (288)
T ss_pred ccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHcCCcCCCCCCCCHHHHHHHHHHccCChh
Confidence 999999998889999999999999999998 999986643332222 2222333344455678899999999999999
Q ss_pred CCCChHHHhc
Q 042809 217 KRWSAEELLN 226 (241)
Q Consensus 217 ~Rps~~~~l~ 226 (241)
+|||+.+++.
T Consensus 265 ~Rpt~~~v~~ 274 (288)
T cd05093 265 MRLNIKEIHS 274 (288)
T ss_pred hCCCHHHHHH
Confidence 9999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=243.22 Aligned_cols=226 Identities=27% Similarity=0.361 Sum_probs=166.3
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCccccc-------------CCceeeeeecccCCCCHHHHHHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGRN-------------GEKTVNIFMEYMAGGSLLDVAEK 64 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~-------------~~~~~~lv~e~~~~~~L~~~l~~ 64 (241)
++.+|+.||+|.+... .....+.+|+.++++++||||++. .....++|+||+. ++|.+++..
T Consensus 33 ~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~ 111 (310)
T cd07865 33 HKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSN 111 (310)
T ss_pred ECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHh
Confidence 4678999999987632 223346789999999999999871 1246799999996 589888877
Q ss_pred hCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 65 FGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 65 ~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
....++...+..++.|+ ||++|++|+||+|+||+++.++.++|+|||++.......... ........++..|
T Consensus 112 ~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~y 189 (310)
T cd07865 112 KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK--PNRYTNRVVTLWY 189 (310)
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccC--CCCccCcccCccc
Confidence 55567888777776655 799999999999999999999999999999987543311111 1111233467889
Q ss_pred cCcccccccC-CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCC---------------CC------
Q 042809 139 MAPEVLRNEG-LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPH---------------FP------ 196 (241)
Q Consensus 139 ~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~------ 196 (241)
+|||.+.+.. ++.++|+||||+++|++++|..||....................+. .+
T Consensus 190 ~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (310)
T cd07865 190 RPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRK 269 (310)
T ss_pred cCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchh
Confidence 9999987643 6789999999999999999999997654333222222211111100 00
Q ss_pred -------hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 197 -------TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 197 -------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
...+..+.++|.+||..+|.+|||++++++||||
T Consensus 270 ~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 270 VKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0123567899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=243.69 Aligned_cols=222 Identities=36% Similarity=0.573 Sum_probs=172.8
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
+..+++.|++|.+.. ....+.+.+|+.+++.++||||++ ......|+|+||+++++|.+++.. ..++...+
T Consensus 40 ~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~ 117 (293)
T cd06647 40 DVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQI 117 (293)
T ss_pred EcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh--cCCCHHHH
Confidence 456789999999763 234567889999999999999988 456789999999999999999986 34556665
Q ss_pred HHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..++.+ +||++|++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.+..
T Consensus 118 ~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~ 191 (293)
T cd06647 118 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ------SKRSTMVGTPYWMAPEVVTRKA 191 (293)
T ss_pred HHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc------cccccccCChhhcCchhhccCC
Confidence 555544 4799999999999999999999999999999886443211 1112335788899999998888
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCC--CChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 149 LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPH--FPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++.++|+||||+++|++++|..||........... ......+. .+..++..+.+++.+||..+|.+||++.+++.
T Consensus 192 ~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee---hhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 89999999999999999999999976433221111 11111121 23345678999999999999999999999999
Q ss_pred CCCCCCCC
Q 042809 227 HTFISGNA 234 (241)
Q Consensus 227 ~p~~~~~~ 234 (241)
||||+...
T Consensus 269 h~~~~~~~ 276 (293)
T cd06647 269 HPFLKIAK 276 (293)
T ss_pred CHHHhcCc
Confidence 99998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=239.14 Aligned_cols=224 Identities=30% Similarity=0.556 Sum_probs=179.3
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+|+.||+|++.. ......+.+|+.++.++. ||||++ ..++..++||||+.+++|.+++... ..++
T Consensus 22 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~ 100 (280)
T cd05581 22 EKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLD 100 (280)
T ss_pred EcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHc-CCCC
Confidence 456899999999764 233466889999999999 999988 6778899999999999999999874 4678
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCC--------------ccccccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG--------------NLKQSWQ 130 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--------------~~~~~~~ 130 (241)
...+..++.|+ ||+.|++|+||+|+||+++.++.++++|||++.......... .......
T Consensus 101 ~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (280)
T cd05581 101 EKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180 (280)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccc
Confidence 87777776655 799999999999999999999999999999987654322110 0012223
Q ss_pred cccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHh
Q 042809 131 SIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKC 210 (241)
Q Consensus 131 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 210 (241)
...++..|+|||...+..++.++|+||||++++++++|+.||............. ......+...++.+.+++++|
T Consensus 181 ~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~ 256 (280)
T cd05581 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL----KLEYSFPPNFPPDAKDLIEKL 256 (280)
T ss_pred cccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH----hcCCCCCCccCHHHHHHHHHH
Confidence 4457788999999988888999999999999999999999998654322221111 333455666788999999999
Q ss_pred hccCCCCCCCh----HHHhcCCCC
Q 042809 211 LERKPEKRWSA----EELLNHTFI 230 (241)
Q Consensus 211 l~~~p~~Rps~----~~~l~~p~~ 230 (241)
|+.+|.+|||+ ++++.||||
T Consensus 257 l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 257 LVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred hcCCHhhCCCcccCHHHHhcCCCC
Confidence 99999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=241.22 Aligned_cols=222 Identities=28% Similarity=0.425 Sum_probs=167.4
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+|+.||+|.+... ...+.+.+|++++..++||||++ ..+...++|+||+++++|..+... ...++..
T Consensus 22 ~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~ 100 (286)
T cd07846 22 HKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY-PNGLDES 100 (286)
T ss_pred ECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhc-cCCCCHH
Confidence 4567899999986532 23456889999999999999988 677889999999999888887665 3457777
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+
T Consensus 101 ~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~ 174 (286)
T cd07846 101 RVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG------EVYTDYVATRWYRAPELLVG 174 (286)
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc------cccCcccceeeccCcHHhcc
Confidence 777666544 799999999999999999999999999999987543311 11122346788999999875
Q ss_pred -cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC------------------CCC---------CCChh
Q 042809 147 -EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN------------------EKP---------HFPTQ 198 (241)
Q Consensus 147 -~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------~~~---------~~~~~ 198 (241)
..++.++|+||||+++|++++|..||.................. ..+ ...+.
T Consensus 175 ~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (286)
T cd07846 175 DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPK 254 (286)
T ss_pred ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCC
Confidence 34678899999999999999999998654321111110100000 000 01124
Q ss_pred hHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 199 FFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 199 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
.+..+.+++++||..+|.+|||++++++||||
T Consensus 255 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 255 LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 56789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=241.35 Aligned_cols=221 Identities=33% Similarity=0.545 Sum_probs=166.3
Q ss_pred CCCCCcEEEEEeccchH-HHHHHHHHHHHHhhc-CCCcccc----------cCCceeeeeecccCCCCHHHHHHHh---C
Q 042809 2 NKGTGALFVVKSAESEA-GVQALRNEAEIRQSL-NSPNIGR----------NGEKTVNIFMEYMAGGSLLDVAEKF---G 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~----------~~~~~~~lv~e~~~~~~L~~~l~~~---~ 66 (241)
++.+++.+|+|.+.... ....+.+|+.++..+ +||||++ ..+...++||||+++++|.+++... +
T Consensus 39 ~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 118 (286)
T cd06638 39 NKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG 118 (286)
T ss_pred ECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccC
Confidence 46788999999876432 245688899999999 6999988 1345799999999999999987642 3
Q ss_pred CCCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..+++..+..++.| +||+.+++||||+|+||+++.++.++|+|||.+....... .......|++.|+|
T Consensus 119 ~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~y~a 192 (286)
T cd06638 119 ERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR------LRRNTSVGTPFWMA 192 (286)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCC------CccccccCCCcccC
Confidence 45666665555544 4799999999999999999999999999999986543211 11123357889999
Q ss_pred cccccc-----cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC-CCCCCChhhHHHHHHHHHHhhccC
Q 042809 141 PEVLRN-----EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN-EKPHFPTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 141 PE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~ 214 (241)
||.+.. ..++.++|+||+|+++|++++|+.||........ ........ .....+...+..+.+++.+||+.+
T Consensus 193 PE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 270 (286)
T cd06638 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--LFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKD 270 (286)
T ss_pred hhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--HhhccccCCCcccCCCCcCHHHHHHHHHHccCC
Confidence 998753 4468899999999999999999999976432111 11111111 111123345678999999999999
Q ss_pred CCCCCChHHHhcCCCC
Q 042809 215 PEKRWSAEELLNHTFI 230 (241)
Q Consensus 215 p~~Rps~~~~l~~p~~ 230 (241)
|.+|||+.++++|+||
T Consensus 271 p~~Rps~~ell~~~~~ 286 (286)
T cd06638 271 YEKRPTVSDLLQHVFI 286 (286)
T ss_pred cccCCCHHHHhhcccC
Confidence 9999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=241.60 Aligned_cols=222 Identities=28% Similarity=0.422 Sum_probs=168.3
Q ss_pred CCCCCcEEEEEeccchH----HHHHHHHHHHHHhhcCCCcccc-----cCC--ceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESEA----GVQALRNEAEIRQSLNSPNIGR-----NGE--KTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~-----~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+++.+++|.++... ....+.+|+.++.+++||||++ ... ...|+|+||+. ++|.+++......++
T Consensus 26 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~ 104 (293)
T cd07843 26 DKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFL 104 (293)
T ss_pred ECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCC
Confidence 45678999999887322 2335678999999999999987 233 88999999997 599999987655678
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
...+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+
T Consensus 105 ~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~------~~~~~~~~~~~~~aPE~~ 178 (293)
T cd07843 105 QSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL------KPYTQLVVTLWYRAPELL 178 (293)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc------cccccccccccccCchhh
Confidence 87777666544 799999999999999999999999999999887554321 111223467889999998
Q ss_pred cccC-CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC---------------------------CCCCCC
Q 042809 145 RNEG-LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN---------------------------EKPHFP 196 (241)
Q Consensus 145 ~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~ 196 (241)
.+.. ++.++|+||+|+++|++++|..||.................. ....++
T Consensus 179 ~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (293)
T cd07843 179 LGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFP 258 (293)
T ss_pred cCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhcccc
Confidence 7644 588999999999999999999999765432222111111000 001122
Q ss_pred hh-hHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 197 TQ-FFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 197 ~~-~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
.. ++..+.++|++||+.+|++|||+++++.||||
T Consensus 259 ~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 259 ALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 22 46788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=235.04 Aligned_cols=218 Identities=32% Similarity=0.540 Sum_probs=176.4
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+++.+|+|.+.... ....+..|+.++++++|+|+++ ..+...++||||+++++|.+++... ..+++
T Consensus 14 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~ 92 (250)
T cd05123 14 KKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE-GRFSE 92 (250)
T ss_pred ECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhc-CCCCH
Confidence 35678999999977432 4557899999999999999987 6788899999999999999999874 45677
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
.....++.|+ ||+.+++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||...
T Consensus 93 ~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~~~~~Pe~~~ 166 (250)
T cd05123 93 ERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------SRTNTFCGTPEYLAPEVLL 166 (250)
T ss_pred HHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC------CcccCCcCCccccChHHhC
Confidence 7766665544 799999999999999999999999999999987543311 1122345788899999998
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh---H
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA---E 222 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---~ 222 (241)
+...+.++|+||||+++|++++|..||........ ..... ......+...+..+.+++++||..+|.+|||+ +
T Consensus 167 ~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~~~~-~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~ 242 (250)
T cd05123 167 GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI---YEKIL-KDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAE 242 (250)
T ss_pred CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHh-cCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHH
Confidence 88889999999999999999999999976543222 11111 24455666678899999999999999999999 9
Q ss_pred HHhcCCCC
Q 042809 223 ELLNHTFI 230 (241)
Q Consensus 223 ~~l~~p~~ 230 (241)
+++.||||
T Consensus 243 ~l~~~~~f 250 (250)
T cd05123 243 EIKAHPFF 250 (250)
T ss_pred HHHhCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=236.09 Aligned_cols=209 Identities=25% Similarity=0.361 Sum_probs=164.7
Q ss_pred CCCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
+|+.+|+.||+|.+..... ..+|...+....||||++ ......++||||+++++|.+++... ..+++..+.
T Consensus 13 ~~~~~~~~~~~K~i~~~~~---~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~ 88 (237)
T cd05576 13 MDTRTQQTFILKGLRKSSE---YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNIPEECVK 88 (237)
T ss_pred EEccCCcEEEEEeecchhh---hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh-cCCCHHHHH
Confidence 3678999999999886542 334555555667999988 5667899999999999999999874 457777777
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCC
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL 149 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 149 (241)
.++.|+ ||++|++|+||+|+||+++.++.++++|||.+...... .....++..|+|||.+.+..+
T Consensus 89 ~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~ 159 (237)
T cd05576 89 RWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---------CDGEAVENMYCAPEVGGISEE 159 (237)
T ss_pred HHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---------cccCCcCccccCCcccCCCCC
Confidence 666654 79999999999999999999999999999987544331 112234667999999988888
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh-----HHH
Q 042809 150 DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA-----EEL 224 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~~ 224 (241)
+.++|+||+|+++|++++|..|+....... ........+...+..+.+++.+||+.+|.+|||+ +++
T Consensus 160 ~~~~DvwslG~il~el~~g~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~ 231 (237)
T cd05576 160 TEACDWWSLGAILFELLTGKTLVECHPSGI--------NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDI 231 (237)
T ss_pred CchhhHHHHHHHHHHHHHCcchhhcCchhc--------ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHH
Confidence 999999999999999999998875432110 0111223456677889999999999999999985 999
Q ss_pred hcCCCC
Q 042809 225 LNHTFI 230 (241)
Q Consensus 225 l~~p~~ 230 (241)
+.||||
T Consensus 232 ~~h~~~ 237 (237)
T cd05576 232 KSHPFF 237 (237)
T ss_pred HcCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=233.25 Aligned_cols=218 Identities=28% Similarity=0.407 Sum_probs=176.2
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh---CCCC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF---GGTL 69 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~ 69 (241)
++.+|+.+|+|.+.. ......+.+|+++++.++|+||++ ......++|+||+++++|.+++... ...+
T Consensus 21 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~ 100 (256)
T cd08530 21 RLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLI 100 (256)
T ss_pred ECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCC
Confidence 467889999998763 233556789999999999999987 5668899999999999999998763 2456
Q ss_pred CHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 70 DAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 70 ~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
+...+..++. .+||+.|++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.
T Consensus 101 ~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--------~~~~~~~~~~~~~Pe~ 172 (256)
T cd08530 101 PEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--------MAKTQIGTPHYMAPEV 172 (256)
T ss_pred CHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--------CcccccCCccccCHHH
Confidence 6666555544 4489999999999999999999999999999999765442 1122346888999999
Q ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH
Q 042809 144 LRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 144 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
+.+..++.++|+||+|+++|++++|+.||...+.... .........+..+...+.++.+++.+||+.+|.+|||+.+
T Consensus 173 ~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08530 173 WKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---RYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDK 249 (256)
T ss_pred HCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHH
Confidence 9998899999999999999999999999977544322 2222334444555678889999999999999999999999
Q ss_pred HhcCCCC
Q 042809 224 LLNHTFI 230 (241)
Q Consensus 224 ~l~~p~~ 230 (241)
+++||++
T Consensus 250 ~l~~p~~ 256 (256)
T cd08530 250 ILASPAV 256 (256)
T ss_pred HhcCCCC
Confidence 9999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=246.13 Aligned_cols=228 Identities=29% Similarity=0.390 Sum_probs=168.9
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc----------cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR----------NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~----------~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
++.+|+.||+|.+.. ......+.+|+.++++++|+||++ ......++|+||+. ++|.+++.. ..
T Consensus 26 ~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~ 102 (336)
T cd07849 26 HKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT--QH 102 (336)
T ss_pred EcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhc--CC
Confidence 567899999998752 234566788999999999999987 12246899999996 588888864 56
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
+++..+..++.|+ ||+.|++||||+|+||+++.++.++|+|||++.......... .......+++.|+|||
T Consensus 103 l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~y~aPE 179 (336)
T cd07849 103 LSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT---GFLTEYVATRWYRAPE 179 (336)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccccc---CCcCCcCcCCCccChH
Confidence 7777777666544 799999999999999999999999999999987543321111 1122345788999999
Q ss_pred cccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHh----------------------cCCCCCC----
Q 042809 143 VLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIAC----------------------SNEKPHF---- 195 (241)
Q Consensus 143 ~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------~~~~~~~---- 195 (241)
.+.+ ..++.++|+||+|+++|++++|+.||.+.............. ....+..
T Consensus 180 ~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (336)
T cd07849 180 IMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNK 259 (336)
T ss_pred HhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHH
Confidence 8754 457889999999999999999999996543211111100000 0000010
Q ss_pred -ChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 196 -PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 196 -~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.+..+.++.+++.+||+.+|.+|||+.++++||||+....
T Consensus 260 ~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 260 LFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 1234567999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=235.85 Aligned_cols=210 Identities=26% Similarity=0.385 Sum_probs=167.5
Q ss_pred CCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHhCC-CCCHHHHHHH
Q 042809 5 TGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGG-TLDAGVIRLY 77 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~ 77 (241)
.|..+|+|........+.+.+|+.++++++|+|+++ ..++..++|+||+++++|.+++..... .+++..+..+
T Consensus 28 ~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 107 (256)
T cd05082 28 RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 107 (256)
T ss_pred cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHH
Confidence 577899999887666778999999999999999988 345678999999999999999987433 3566666555
Q ss_pred HH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+. ++||++|++|+||+|+||+++.++.++|+|||++....... .....+..|+|||.+.+..++.
T Consensus 108 ~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~ 178 (256)
T cd05082 108 SLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---------DTGKLPVKWTAPEALREKKFST 178 (256)
T ss_pred HHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC---------CCCccceeecCHHHHccCCCCc
Confidence 54 44799999999999999999999999999999886432211 1122356799999998888899
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++|+||||+++|++++ |..||......... ........+..+...+..+.+++.+||+.+|++|||+.++++
T Consensus 179 ~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred hhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999998 99999764333322 222233344555667889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=244.70 Aligned_cols=219 Identities=21% Similarity=0.300 Sum_probs=166.5
Q ss_pred CCCCcEEEEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc------cCCceeeeeecccCCCCHHHHHHHhC------
Q 042809 3 KGTGALFVVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFG------ 66 (241)
Q Consensus 3 ~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~------ 66 (241)
..+++.||+|.+.. ....+.+.+|+.++.++ .|+||++ ..+..+++++||+++++|.+++....
T Consensus 34 ~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~ 113 (337)
T cd05054 34 SASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPY 113 (337)
T ss_pred ccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhcccccccc
Confidence 35678999999873 23456688899999999 7999988 34567899999999999999986532
Q ss_pred ------------------------------------------------------CCCCHHHHHHHHHH------HhhcCC
Q 042809 67 ------------------------------------------------------GTLDAGVIRLYTKE------ILHGNG 86 (241)
Q Consensus 67 ------------------------------------------------------~~~~~~~~~~~~~~------~Lh~~~ 86 (241)
..++...+..++.| +||++|
T Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ 193 (337)
T cd05054 114 RNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK 193 (337)
T ss_pred ccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 14555555555554 479999
Q ss_pred ccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHH
Q 042809 87 ILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMA 166 (241)
Q Consensus 87 ~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 166 (241)
++||||||+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++|||||||++|+++
T Consensus 194 ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~ 269 (337)
T cd05054 194 CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF 269 (337)
T ss_pred eecCCCCcceEEEeCCCcEEEeccccchhcccCcch----hhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHH
Confidence 999999999999999999999999999764321110 1112233567799999999999999999999999999999
Q ss_pred h-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 167 T-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 167 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
+ |..||.+...... .............+...+.++.+++.+||+.+|.+|||+++++++
T Consensus 270 t~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 270 SLGASPYPGVQIDEE--FCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HcCCCCCCCCCccHH--HHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8 9999976332221 111112223334455667889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=240.82 Aligned_cols=222 Identities=27% Similarity=0.432 Sum_probs=165.0
Q ss_pred CCCCCcEEEEEeccchH---HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESEA---GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+|+.||+|.+..+. ....+.+|++++++++|+||++ ......++||||+. ++|.+++......++...
T Consensus 26 ~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~ 104 (291)
T cd07844 26 SKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHN 104 (291)
T ss_pred EcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhCCCCCCHHH
Confidence 45678999999976432 2245678999999999999988 66778999999997 499999987666777777
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc-
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN- 146 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~- 146 (241)
+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+
T Consensus 105 ~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~ 178 (291)
T cd07844 105 VRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS------KTYSNEVVTLWYRPPDVLLGS 178 (291)
T ss_pred HHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC------ccccccccccccCCcHHhhcC
Confidence 77666544 799999999999999999999999999999986432110 11112235778999999875
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhc-hHHHHHHHHhcCC------------------CCCC--------Chhh
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISN-AAATLLKIACSNE------------------KPHF--------PTQF 199 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~------------------~~~~--------~~~~ 199 (241)
..++.++|+||+|+++|++++|..||.+.... ............. .... ....
T Consensus 179 ~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (291)
T cd07844 179 TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRL 258 (291)
T ss_pred cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCC
Confidence 45788999999999999999999999654311 1111000000000 0000 0112
Q ss_pred H--HHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 200 F--KKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 200 ~--~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
. .++.+++.+||+.+|.+|||+.++++||||
T Consensus 259 ~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 259 DRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred CCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 2 678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=235.24 Aligned_cols=222 Identities=37% Similarity=0.650 Sum_probs=174.5
Q ss_pred CCCCCcEEEEEeccc-------hHHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhCC
Q 042809 2 NKGTGALFVVKSAES-------EAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~ 67 (241)
++.+|+.||+|.+.. ......+.+|+.++++++|+||++ .....+++|+||+++++|.+++... .
T Consensus 23 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~ 101 (264)
T cd06653 23 DADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY-G 101 (264)
T ss_pred EcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHc-C
Confidence 567899999998641 234567889999999999999987 2245688999999999999999874 4
Q ss_pred CCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 68 TLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 68 ~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
.++......++.| +||+.|++|+||+|+||+++.++.++|+|||++.......... .......++..|+||
T Consensus 102 ~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~~~y~aP 178 (264)
T cd06653 102 ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSG---TGIKSVTGTPYWMSP 178 (264)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccC---ccccccCCcccccCH
Confidence 4666666655554 4799999999999999999999999999999987543211100 111234578889999
Q ss_pred ccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 142 EVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 142 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
|.+.+..++.++|+||||+++|++++|..||..... .............+..+..++..+.+++++||. +|..|||+
T Consensus 179 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~ 255 (264)
T cd06653 179 EVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA--MAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTA 255 (264)
T ss_pred hhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH--HHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccH
Confidence 999888889999999999999999999999976432 222333333344566788888999999999999 57999999
Q ss_pred HHHhcCCCC
Q 042809 222 EELLNHTFI 230 (241)
Q Consensus 222 ~~~l~~p~~ 230 (241)
.+++.|||.
T Consensus 256 ~~~~~~~~~ 264 (264)
T cd06653 256 EFLLRHPFV 264 (264)
T ss_pred HHHhcCCCC
Confidence 999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=238.95 Aligned_cols=216 Identities=24% Similarity=0.395 Sum_probs=167.9
Q ss_pred CCCcEEEEEeccchH--HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC----------
Q 042809 4 GTGALFVVKSAESEA--GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG---------- 66 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 66 (241)
.++..+++|.+.... ..+.+.+|+.++.+++|+||++ ......++||||+++++|.+++....
T Consensus 33 ~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 112 (291)
T cd05094 33 KDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 112 (291)
T ss_pred CcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccc
Confidence 456778899877443 3467899999999999999988 66778999999999999999998642
Q ss_pred -----CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCc
Q 042809 67 -----GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGT 135 (241)
Q Consensus 67 -----~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 135 (241)
..++...+..++.|+ ||++|++||||+|+||+++.++.++|+|||++....... .........++
T Consensus 113 ~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~----~~~~~~~~~~~ 188 (291)
T cd05094 113 PRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD----YYRVGGHTMLP 188 (291)
T ss_pred cccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCc----eeecCCCCCcc
Confidence 235666666665544 799999999999999999999999999999986543211 01111223457
Q ss_pred ccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccC
Q 042809 136 QLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 136 ~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 214 (241)
..|+|||.+.+..++.++|+||||+++|++++ |..||.......... ..........+...+..+.+++.+||+.+
T Consensus 189 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 265 (291)
T cd05094 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE---CITQGRVLERPRVCPKEVYDIMLGCWQRE 265 (291)
T ss_pred eeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHhCCCCCCCCccCCHHHHHHHHHHcccC
Confidence 78999999998889999999999999999999 999986644333222 22223333445556788999999999999
Q ss_pred CCCCCChHHHhc
Q 042809 215 PEKRWSAEELLN 226 (241)
Q Consensus 215 p~~Rps~~~~l~ 226 (241)
|.+|||+.++++
T Consensus 266 P~~Rpt~~~v~~ 277 (291)
T cd05094 266 PQQRLNIKEIYK 277 (291)
T ss_pred hhhCcCHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=238.49 Aligned_cols=220 Identities=35% Similarity=0.570 Sum_probs=167.5
Q ss_pred CCCCCcEEEEEeccch-HHHHHHHHHHHHHhhc-CCCcccc-----c------CCceeeeeecccCCCCHHHHHHHh---
Q 042809 2 NKGTGALFVVKSAESE-AGVQALRNEAEIRQSL-NSPNIGR-----N------GEKTVNIFMEYMAGGSLLDVAEKF--- 65 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~-----~------~~~~~~lv~e~~~~~~L~~~l~~~--- 65 (241)
++.++..+++|.+... ...+.+.+|+.+++++ .|+||++ . ....+++||||+++++|.+++...
T Consensus 27 ~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 106 (275)
T cd06608 27 HKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK 106 (275)
T ss_pred ECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhc
Confidence 4567889999997743 3356789999999999 6999987 1 245689999999999999998763
Q ss_pred CCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccccc
Q 042809 66 GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139 (241)
Q Consensus 66 ~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (241)
+..++...+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||.+....... .......++..|+
T Consensus 107 ~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~~y~ 180 (275)
T cd06608 107 GKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL------GRRNTFIGTPYWM 180 (275)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccch------hhhcCcccccccc
Confidence 3567777766665544 799999999999999999999999999999886443211 1112345788899
Q ss_pred Ccccccc-----cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCC--CChhhHHHHHHHHHHhhc
Q 042809 140 APEVLRN-----EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPH--FPTQFFKKVLDFLAKCLE 212 (241)
Q Consensus 140 aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~ 212 (241)
|||.+.. ..++.++|+||||+++|++++|..||....... ..... .....+. .+...+..+.+++.+||.
T Consensus 181 aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~ 257 (275)
T cd06608 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALFKI-PRNPPPTLKSPENWSKKFNDFISECLI 257 (275)
T ss_pred CHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHHHh-hccCCCCCCchhhcCHHHHHHHHHHhh
Confidence 9998753 346778999999999999999999997532211 11111 1111111 123356789999999999
Q ss_pred cCCCCCCChHHHhcCCCC
Q 042809 213 RKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 213 ~~p~~Rps~~~~l~~p~~ 230 (241)
.+|.+|||+.+++.|||+
T Consensus 258 ~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 258 KNYEQRPFMEELLEHPFI 275 (275)
T ss_pred cChhhCcCHHHHhcCCCC
Confidence 999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=246.47 Aligned_cols=235 Identities=25% Similarity=0.377 Sum_probs=170.3
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCCH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~ 71 (241)
|+.+|+.||+|.... ....+.+.+|+.+++.++||||++ ..++..++|+||+.+++|.+++.... ..+++
T Consensus 21 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~ 100 (328)
T cd08226 21 HTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSE 100 (328)
T ss_pred EcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCH
Confidence 567899999999762 234577899999999999999988 56778999999999999999988642 34666
Q ss_pred HHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCc-cccccccccCcccccCcccc
Q 042809 72 GVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGN-LKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 72 ~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~ 144 (241)
..+..++. ++||+.|++||||||+||+++.++.++++||+.+........... .........++..|+|||.+
T Consensus 101 ~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (328)
T cd08226 101 ALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELL 180 (328)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhh
Confidence 66655554 448999999999999999999999999999986543322111000 00000112245679999999
Q ss_pred ccc--CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHh----------------------------------
Q 042809 145 RNE--GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIAC---------------------------------- 188 (241)
Q Consensus 145 ~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------------------- 188 (241)
.+. .++.++|+||+|+++|++++|..||................
T Consensus 181 ~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (328)
T cd08226 181 RQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVA 260 (328)
T ss_pred cCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhc
Confidence 763 46889999999999999999999997643222111100000
Q ss_pred ---------cCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 189 ---------SNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 189 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
.......+...+..+.+|+++||..+|.+|||++++++||||+...+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 261 AGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred cccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 000011123456789999999999999999999999999999776553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=237.20 Aligned_cols=217 Identities=19% Similarity=0.303 Sum_probs=165.3
Q ss_pred CCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC--------
Q 042809 4 GTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG-------- 67 (241)
Q Consensus 4 ~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~-------- 67 (241)
.++..||+|.+... .....+.+|+.+++.++||||++ ..+...++||||+.+++|.+++.....
T Consensus 34 ~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 113 (277)
T cd05062 34 EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQ 113 (277)
T ss_pred CceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccc
Confidence 35678999987632 33456889999999999999988 566789999999999999999976432
Q ss_pred -CCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 68 -TLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 68 -~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
.++...+..++. .+||+.|++|+||||+||+++.++.++|+|||++........ ........++..|+|
T Consensus 114 ~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~y~a 189 (277)
T cd05062 114 APPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY----YRKGGKGLLPVRWMS 189 (277)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcce----eecCCCCccCHhhcC
Confidence 133444443333 558999999999999999999999999999999864432111 011112234678999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 219 (241)
||.+.+..++.++|+||||+++|++++ |..||.+...... .........+..+...+..+.+++.+||+.+|.+||
T Consensus 190 PE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 266 (277)
T cd05062 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP 266 (277)
T ss_pred hhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 999998889999999999999999999 7889876543322 222223334455666778899999999999999999
Q ss_pred ChHHHhcC
Q 042809 220 SAEELLNH 227 (241)
Q Consensus 220 s~~~~l~~ 227 (241)
|+.+++..
T Consensus 267 s~~e~l~~ 274 (277)
T cd05062 267 SFLEIISS 274 (277)
T ss_pred CHHHHHHH
Confidence 99999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=238.32 Aligned_cols=219 Identities=26% Similarity=0.415 Sum_probs=165.9
Q ss_pred CCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 3 KGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
..++..||+|.+... .....+.+|+++++.++||||++ ......++||||+++++|.+++.. ..+++.
T Consensus 30 ~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~ 107 (283)
T cd05080 30 DGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLA 107 (283)
T ss_pred CCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH--cCCCHH
Confidence 457889999998743 34567889999999999999988 224568999999999999999986 357777
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||++|++|+||+|+||+++.++.++|+|||++......... ........++..|+|||.+.+
T Consensus 108 ~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~~PE~~~~ 184 (283)
T cd05080 108 QLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY---YRVREDGDSPVFWYAVECLKE 184 (283)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchh---hccCCCCCCCceeeCHhHhcc
Confidence 777766654 79999999999999999999999999999998754331110 000112234567999999988
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchH------------HHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccC
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAA------------ATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 214 (241)
..++.++|+||||+++|++++|..||........ ...............+...+..+.+++.+||+.+
T Consensus 185 ~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 264 (283)
T cd05080 185 NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETE 264 (283)
T ss_pred cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 8889999999999999999999999854321110 0011111112222334556789999999999999
Q ss_pred CCCCCChHHHhc
Q 042809 215 PEKRWSAEELLN 226 (241)
Q Consensus 215 p~~Rps~~~~l~ 226 (241)
|.+|||++++++
T Consensus 265 p~~Rps~~~i~~ 276 (283)
T cd05080 265 AKFRPTFRSLIP 276 (283)
T ss_pred hhhCCCHHHHHH
Confidence 999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=240.46 Aligned_cols=219 Identities=32% Similarity=0.475 Sum_probs=170.5
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+.. ....+.+.+|+.+++.++||||++ ...+..++|+||+. |+|.+++......+++
T Consensus 36 ~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~ 114 (307)
T cd06607 36 DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQE 114 (307)
T ss_pred EcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCH
Confidence 346789999998752 233456889999999999999988 56678999999997 5888887765566777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++...... ....++..|+|||.+.
T Consensus 115 ~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----------~~~~~~~~y~aPE~~~ 184 (307)
T cd06607 115 VEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----------NSFVGTPYWMAPEVIL 184 (307)
T ss_pred HHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----------CCccCCccccCceeee
Confidence 7776665544 79999999999999999999999999999988643221 1234678899999874
Q ss_pred ---ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCC-ChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 146 ---NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHF-PTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 146 ---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
...++.++|+||||+++|++++|..||......... .. ......+.. +...+..+.+++.+||+.+|.+|||+
T Consensus 185 ~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 261 (307)
T cd06607 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YH-IAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSS 261 (307)
T ss_pred ccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH--HH-HhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCH
Confidence 355788999999999999999999999764322211 11 111222222 23466789999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q 042809 222 EELLNHTFISGNA 234 (241)
Q Consensus 222 ~~~l~~p~~~~~~ 234 (241)
.+++.||||....
T Consensus 262 ~~il~~~~~~~~~ 274 (307)
T cd06607 262 EELLKHRFVLRER 274 (307)
T ss_pred HHHhcChhhcccC
Confidence 9999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=232.72 Aligned_cols=216 Identities=24% Similarity=0.356 Sum_probs=168.9
Q ss_pred CCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 4 GTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 4 ~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
.++..+|+|.+... .....+.+|+.+++.++||||++ ...+..++||||+++++|.+++......+++..+.
T Consensus 17 ~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 96 (250)
T cd05085 17 KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLV 96 (250)
T ss_pred cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHH
Confidence 35788999987632 33456889999999999999988 56678999999999999999998755667777776
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCC
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL 149 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 149 (241)
.++.++ ||+.|++|+||+|+||+++.++.++|+|||++........ .......++..|+|||.+.+..+
T Consensus 97 ~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~ 171 (250)
T cd05085 97 KFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-----SSSGLKQIPIKWTAPEALNYGRY 171 (250)
T ss_pred HHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc-----ccCCCCCCcccccCHHHhccCCC
Confidence 666544 7999999999999999999999999999999864322110 01111223567999999988888
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 150 DFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
+.++|+||||+++|++++ |..||........... .........+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus 172 ~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ---VEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH---HHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 999999999999999998 9999976543332222 22233344556678899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=238.86 Aligned_cols=220 Identities=23% Similarity=0.362 Sum_probs=164.6
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcC-CCcccc-----cCC--ceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLN-SPNIGR-----NGE--KTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~-----~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.++..||+|.+... .......+|+..+.++. |+|+++ ... +..++|+||+. ++|.+++......++
T Consensus 20 ~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~ 98 (282)
T cd07831 20 SRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLP 98 (282)
T ss_pred EcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCC
Confidence 4568899999987642 22234457888898886 999987 333 78999999997 588888887556778
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||+.|++|+||+|+||+++. +.++|+|||++....... ......++..|+|||.+
T Consensus 99 ~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~ 170 (282)
T cd07831 99 EKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-------PYTEYISTRWYRAPECL 170 (282)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC-------CcCCCCCCcccCChhHh
Confidence 88877776655 79999999999999999999 999999999987553311 11123467889999977
Q ss_pred cc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC--------------CCCCC-----------Chh
Q 042809 145 RN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN--------------EKPHF-----------PTQ 198 (241)
Q Consensus 145 ~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------~~~~~-----------~~~ 198 (241)
.. ..++.++|+||+|+++|++++|..||...+.............. ..... ...
T Consensus 171 ~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (282)
T cd07831 171 LTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPN 250 (282)
T ss_pred hcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHccc
Confidence 54 45688999999999999999999999764332221111110000 00011 123
Q ss_pred hHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 199 FFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 199 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
.+..+.++|.+||+.+|.+|||++++++||||
T Consensus 251 ~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 251 ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 56889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=239.66 Aligned_cols=227 Identities=32% Similarity=0.473 Sum_probs=170.0
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHH-HhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh---CCCC
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEI-RQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF---GGTL 69 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~-l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~ 69 (241)
++.+|+.||+|.+... .....+..|+.. ++.+.||||++ ..++..|+|+||++ ++|.+++... +..+
T Consensus 22 ~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~ 100 (283)
T cd06617 22 HVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTI 100 (283)
T ss_pred EcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCC
Confidence 5678999999987632 223445556665 56668999998 55678999999996 6898887652 3457
Q ss_pred CHHHHHHHHHHH------hhcC-CccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 70 DAGVIRLYTKEI------LHGN-GILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~-~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
++..+..++.|+ ||++ +++||||+|+||+++.++.++|+|||++....... ......++..|+|||
T Consensus 101 ~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE 173 (283)
T cd06617 101 PEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-------AKTIDAGCKPYMAPE 173 (283)
T ss_pred CHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-------ccccccCCccccChh
Confidence 787777666654 7987 99999999999999999999999999987543211 111234678899999
Q ss_pred cccc----cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC-hhhHHHHHHHHHHhhccCCCC
Q 042809 143 VLRN----EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP-TQFFKKVLDFLAKCLERKPEK 217 (241)
Q Consensus 143 ~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~ 217 (241)
.+.+ ..++.++|+||+|+++|++++|+.||...... ... .........+..+ ..++.++.+++.+||..+|.+
T Consensus 174 ~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 251 (283)
T cd06617 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQ-LKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKE 251 (283)
T ss_pred hcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHH-HHHHHhcCCCCCCccccCHHHHHHHHHHccCChhh
Confidence 8865 34578999999999999999999999653221 111 1111222223332 346788999999999999999
Q ss_pred CCChHHHhcCCCCCCCCccCC
Q 042809 218 RWSAEELLNHTFISGNAKKNS 238 (241)
Q Consensus 218 Rps~~~~l~~p~~~~~~~~~~ 238 (241)
|||+++++.||||.....+++
T Consensus 252 Rp~~~~il~~~~~~~~~~~~~ 272 (283)
T cd06617 252 RPNYPELLQHPFFELHLSKNT 272 (283)
T ss_pred CcCHHHHhcCchhhhcccccH
Confidence 999999999999998776543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=235.27 Aligned_cols=218 Identities=26% Similarity=0.429 Sum_probs=167.4
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh---CCC
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF---GGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~ 68 (241)
++.+|..+|+|.+.. ......+.+|+.+++.+.|+||++ ..++..++++||+++++|.+++... ...
T Consensus 23 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~ 102 (267)
T cd08229 23 CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL 102 (267)
T ss_pred ecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCC
Confidence 456899999997653 234467889999999999999988 4567899999999999999998742 345
Q ss_pred CCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
+++..+..++.+ +||+.|++|+||+|+||+++.++.++|+|||++........ ......++..|+|||
T Consensus 103 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~ape 176 (267)
T cd08229 103 IPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT------AAHSLVGTPYYMSPE 176 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc------ccccccCCcCccCHH
Confidence 676666655554 47999999999999999999999999999998865433111 112345788899999
Q ss_pred cccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCC-CChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 143 VLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPH-FPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 143 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
.+.+..++.++|+||||+++|++++|..||.+..... ............+. .+...+..+.+++.+||..+|.+|||+
T Consensus 177 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 255 (267)
T cd08229 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDI 255 (267)
T ss_pred HhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCH
Confidence 9988889999999999999999999999996543221 12212211122222 233577899999999999999999999
Q ss_pred HHHhc
Q 042809 222 EELLN 226 (241)
Q Consensus 222 ~~~l~ 226 (241)
+++++
T Consensus 256 ~~i~~ 260 (267)
T cd08229 256 TYVYD 260 (267)
T ss_pred HHHHH
Confidence 97764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=234.86 Aligned_cols=215 Identities=26% Similarity=0.394 Sum_probs=168.2
Q ss_pred CCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 5 TGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 5 ~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
++..+|+|.+... .....+.+|+.+++.++||||++ ...+..++|+||+++++|.+++......+++..+..++
T Consensus 27 ~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~ 106 (256)
T cd05059 27 GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC 106 (256)
T ss_pred CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHH
Confidence 4567899987643 23456888999999999999987 56678999999999999999998755667777776666
Q ss_pred HHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCch
Q 042809 79 KEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA 152 (241)
Q Consensus 79 ~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 152 (241)
.|+ ||+.|++|+||+|+||+++.++.++|+|||++....+... .......++..|+|||.+.+..++.+
T Consensus 107 ~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~y~~Pe~~~~~~~~~~ 181 (256)
T cd05059 107 SDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-----TSSQGTKFPVKWAPPEVFDYSRFSSK 181 (256)
T ss_pred HHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-----cccCCCCCCccccCHHHhccCCCCch
Confidence 544 7999999999999999999999999999999865432110 00111123457999999998889999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 153 TDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 153 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
+|+||||+++|++++ |..||......... ...........+...+..+.+++.+||..+|++|||+.++++.
T Consensus 182 ~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 182 SDVWSFGVLMWEVFSEGKMPYERFSNSEVV---ESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHH---HHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999 89999765433322 2222233344556678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=249.69 Aligned_cols=206 Identities=32% Similarity=0.533 Sum_probs=171.5
Q ss_pred chHHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHHH------h
Q 042809 16 SEAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------L 82 (241)
Q Consensus 16 ~~~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~------L 82 (241)
++...++|..|+.+|+.|+||||++ ....++.+|+|.|..|+|..|++++ .......++.|++|| |
T Consensus 81 ~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yL 159 (632)
T KOG0584|consen 81 SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYL 159 (632)
T ss_pred ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhh
Confidence 4556788999999999999999998 4456799999999999999999985 667888888888887 4
Q ss_pred hcC--CccccCCCCCcEEeec-CCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhhHHHHH
Q 042809 83 HGN--GILHCDLKCNNVLLGS-HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159 (241)
Q Consensus 83 h~~--~~vH~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG 159 (241)
|++ .|+|||||.+|||++. .|.|||+|+|+|..... ......+|||.|||||.+. ..|...+||||||
T Consensus 160 Hs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~--------s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFG 230 (632)
T KOG0584|consen 160 HSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK--------SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFG 230 (632)
T ss_pred hcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc--------cccceeccCccccChHHHh-hhcchhhhhhhhh
Confidence 665 4999999999999976 48999999999987655 2224478999999999997 6688999999999
Q ss_pred HHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCC-CChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 160 CMVIEMATGRPPWGDKISNAAATLLKIACSNEKPH-FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 160 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
+++.||+|+..||..... ...+.+....+.+|. +..--.+++++||.+||.. ...|+|+.++|.||||+...
T Consensus 231 MCmLEMvT~eYPYsEC~n--~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~ 303 (632)
T KOG0584|consen 231 MCMLEMVTSEYPYSECTN--PAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDG 303 (632)
T ss_pred HHHHHHHhccCChhhhCC--HHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcccc
Confidence 999999999999987633 334455555555443 3344457999999999999 99999999999999998863
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=238.51 Aligned_cols=222 Identities=29% Similarity=0.453 Sum_probs=167.4
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC--CCCCH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG--GTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~ 71 (241)
++.+|..||+|.+... .....+.+|+.++++++|+||++ ...+..++|+||+++ +|.+++.... ..+++
T Consensus 21 ~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~ 99 (284)
T cd07836 21 NRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDP 99 (284)
T ss_pred ECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCH
Confidence 4678999999987632 23456788999999999999988 566789999999974 8999887644 45777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.
T Consensus 100 ~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~~~~~y~~PE~~~ 173 (284)
T cd07836 100 NTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV------NTFSNEVVTLWYRAPDVLL 173 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc------cccccccccccccChHHhc
Confidence 7776666544 799999999999999999999999999999986543211 1112234578899999986
Q ss_pred cc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhc--------------CCCCC-----------CChhh
Q 042809 146 NE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACS--------------NEKPH-----------FPTQF 199 (241)
Q Consensus 146 ~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------~~~~~-----------~~~~~ 199 (241)
+. .++.++|+||||+++|++++|..||.+............... ..... ..+..
T Consensus 174 ~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
T cd07836 174 GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHA 253 (284)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhc
Confidence 64 468899999999999999999999976543322111111000 00000 01234
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 200 FKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 200 ~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
+..+.+++.+||+.+|.+||+++++++||||
T Consensus 254 ~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 254 DPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 5678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=236.82 Aligned_cols=218 Identities=21% Similarity=0.349 Sum_probs=167.4
Q ss_pred CCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC--------
Q 042809 3 KGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-------- 66 (241)
Q Consensus 3 ~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-------- 66 (241)
..++..|++|.+.. ......+.+|+.+++.++||||++ ......|+||||+++++|.+++....
T Consensus 31 ~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 110 (283)
T cd05090 31 MDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCS 110 (283)
T ss_pred CCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccc
Confidence 45678899999873 233467889999999999999988 56678999999999999999986432
Q ss_pred --------CCCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccc
Q 042809 67 --------GTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSI 132 (241)
Q Consensus 67 --------~~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 132 (241)
..++...+..++. ++||++|++|+||+|+||+++.++.++|+|||++........ .......
T Consensus 111 ~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~ 186 (283)
T cd05090 111 SDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADY----YRVQPKS 186 (283)
T ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcc----eecccCC
Confidence 1244444444444 458999999999999999999999999999999975432111 1111223
Q ss_pred cCcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhh
Q 042809 133 GGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCL 211 (241)
Q Consensus 133 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 211 (241)
.++..|+|||.+.+..++.++|+||||+++|++++ |..||.+...... ............+...+..+.+++.+||
T Consensus 187 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~cl 263 (283)
T cd05090 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV---IEMVRKRQLLPCSEDCPPRMYSLMTECW 263 (283)
T ss_pred CccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHcCCcCCCCCCCCHHHHHHHHHHc
Confidence 35677999999988889999999999999999998 9999976433222 2222223344456667889999999999
Q ss_pred ccCCCCCCChHHHhcC
Q 042809 212 ERKPEKRWSAEELLNH 227 (241)
Q Consensus 212 ~~~p~~Rps~~~~l~~ 227 (241)
+.+|.+||++.+++++
T Consensus 264 ~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 264 QEGPSRRPRFKDIHTR 279 (283)
T ss_pred ccCcccCcCHHHHHHH
Confidence 9999999999999765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=236.43 Aligned_cols=222 Identities=26% Similarity=0.400 Sum_probs=166.2
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
+..++..||+|.+.. ....+.+.+|++++.+++||||++ .....+++|+||+++++|.+++......++..
T Consensus 29 ~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~ 108 (284)
T cd05081 29 QDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR 108 (284)
T ss_pred cCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHH
Confidence 456889999999763 344567899999999999999987 23456899999999999999998755567777
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||++|++|+||+|+||+++.++.++|+|||++.......... .......++..|+|||.+.+
T Consensus 109 ~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~ 185 (284)
T cd05081 109 KLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYY---KVREPGESPIFWYAPESLTE 185 (284)
T ss_pred HHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcce---eecCCCCCceEeeCHHHhcc
Confidence 766666544 799999999999999999999999999999987553311100 00011123456999999988
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchH-------------HHHHHHHhcCCCCCCChhhHHHHHHHHHHhhcc
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAA-------------ATLLKIACSNEKPHFPTQFFKKVLDFLAKCLER 213 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 213 (241)
..++.++|+||||+++|++++|..++........ ...............+...+..+.+++.+||..
T Consensus 186 ~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 265 (284)
T cd05081 186 SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNN 265 (284)
T ss_pred CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccC
Confidence 8899999999999999999998766543211100 011111112223334456678899999999999
Q ss_pred CCCCCCChHHHhc
Q 042809 214 KPEKRWSAEELLN 226 (241)
Q Consensus 214 ~p~~Rps~~~~l~ 226 (241)
+|.+|||+.+++.
T Consensus 266 ~p~~Rpt~~ei~~ 278 (284)
T cd05081 266 DPSQRPSFSELAL 278 (284)
T ss_pred ChhhCCCHHHHHH
Confidence 9999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=237.92 Aligned_cols=222 Identities=27% Similarity=0.403 Sum_probs=167.1
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCCH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~ 71 (241)
++.+|+.||+|.+..+ .....+.+|++.++.++|||+++ ...+..++|+||++ ++|.+++.... ..+++
T Consensus 20 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~ 98 (283)
T cd07835 20 DKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDP 98 (283)
T ss_pred EcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCH
Confidence 4568999999987633 22356889999999999999998 66789999999995 69999988743 35677
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||+.+++||||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.
T Consensus 99 ~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~~~aPE~~~ 172 (283)
T cd07835 99 PLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV------RTYTHEVVTLWYRAPEILL 172 (283)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc------cccCccccccCCCCCceee
Confidence 7766665544 799999999999999999999999999999986442211 1112234578899999887
Q ss_pred cc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHh---------------------cC----CCCCCChhh
Q 042809 146 NE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIAC---------------------SN----EKPHFPTQF 199 (241)
Q Consensus 146 ~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------~~----~~~~~~~~~ 199 (241)
+. .++.++|+||||+++|++++|..||................ .. ........+
T Consensus 173 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (283)
T cd07835 173 GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNL 252 (283)
T ss_pred cCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCC
Confidence 64 46889999999999999999999996543221111100000 00 000112345
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 200 FKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 200 ~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
+..+.+++.+||+.+|.+|||+++++.||||
T Consensus 253 ~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 253 DEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 5789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=238.27 Aligned_cols=221 Identities=29% Similarity=0.395 Sum_probs=163.6
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+|+.||+|.+... .....+.+|+.+++.++|+||++ ..+...|+|+||+. ++|.+++......+....
T Consensus 26 ~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~ 104 (291)
T cd07870 26 SRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYN 104 (291)
T ss_pred EcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHH
Confidence 4567899999997643 22345778999999999999987 56678999999995 688887766445566666
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+.
T Consensus 105 ~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~ 178 (291)
T cd07870 105 VRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS------QTYSSEVVTLWYRPPDVLLGA 178 (291)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC------CCCCCccccccccCCceeecC
Confidence 66665544 799999999999999999999999999999986532211 111223468889999998763
Q ss_pred -CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHh-cCC--------------------CCCCC---------
Q 042809 148 -GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIAC-SNE--------------------KPHFP--------- 196 (241)
Q Consensus 148 -~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~--------------------~~~~~--------- 196 (241)
.++.++|+||||+++|++++|..||...... ......... .+. ....+
T Consensus 179 ~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd07870 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-FEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKR 257 (291)
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-HHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccc
Confidence 4788999999999999999999999654321 111111000 000 00000
Q ss_pred hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 197 TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 197 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
...+..+.+++.+|+..+|.+|||+.+++.||||
T Consensus 258 ~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 258 LSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0124578899999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=234.12 Aligned_cols=217 Identities=27% Similarity=0.416 Sum_probs=176.3
Q ss_pred CCCcEEEEEeccchH---HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh--------CC
Q 042809 4 GTGALFVVKSAESEA---GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF--------GG 67 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~--------~~ 67 (241)
.++..|++|.+.... ..+.+.+|++.+..++|+|+++ ......++||||+++++|.+++... ..
T Consensus 21 ~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 100 (262)
T cd00192 21 GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKS 100 (262)
T ss_pred CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccc
Confidence 348899999987432 2577899999999999999988 5678899999999999999999986 46
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
.+++..+..++.|+ ||++|++|+||+|+||+++.++.++|+|||.+........ ........++..|+||
T Consensus 101 ~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aP 176 (262)
T cd00192 101 TLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY----YRKKTGGKLPIRWMAP 176 (262)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc----cccccCCCcCccccCH
Confidence 78888888777765 7999999999999999999999999999999976544211 1112233467889999
Q ss_pred ccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC
Q 042809 142 EVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS 220 (241)
Q Consensus 142 E~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 220 (241)
|.+.+..++.++|+||+|+++|++++ |..||......... ...........+..++.++.+++.+||..+|.+|||
T Consensus 177 E~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 253 (262)
T cd00192 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL---EYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPT 253 (262)
T ss_pred HHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcC
Confidence 99988888999999999999999999 69999776433322 222224445566777899999999999999999999
Q ss_pred hHHHhcC
Q 042809 221 AEELLNH 227 (241)
Q Consensus 221 ~~~~l~~ 227 (241)
+++++.+
T Consensus 254 ~~~l~~~ 260 (262)
T cd00192 254 FSELVER 260 (262)
T ss_pred HHHHHHh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=235.91 Aligned_cols=217 Identities=24% Similarity=0.393 Sum_probs=167.7
Q ss_pred CCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC---------
Q 042809 3 KGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG--------- 66 (241)
Q Consensus 3 ~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 66 (241)
..++..+++|.+.. ......+.+|+++++.++|+||++ ...+..++|+||+.+++|.+++....
T Consensus 32 ~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~ 111 (280)
T cd05092 32 EQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111 (280)
T ss_pred CCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhccc
Confidence 34677899998763 344567999999999999999988 56678999999999999999998643
Q ss_pred -----CCCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCc
Q 042809 67 -----GTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGT 135 (241)
Q Consensus 67 -----~~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 135 (241)
..++...+..++.| +||+.|++|+||+|+||+++.++.++|+|||++....... .........++
T Consensus 112 ~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~----~~~~~~~~~~~ 187 (280)
T cd05092 112 EDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YYRVGGRTMLP 187 (280)
T ss_pred ccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCc----eeecCCCcccc
Confidence 23566666665554 4799999999999999999999999999999986432211 00111122346
Q ss_pred ccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccC
Q 042809 136 QLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 136 ~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 214 (241)
+.|+|||.+.+..++.++|+||||+++|++++ |..||......... ...........+...++.+.+++.+||..+
T Consensus 188 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 264 (280)
T cd05092 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI---ECITQGRELERPRTCPPEVYAIMQGCWQRE 264 (280)
T ss_pred ccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH---HHHHcCccCCCCCCCCHHHHHHHHHHccCC
Confidence 78999999998889999999999999999998 99999654333222 222223334455667889999999999999
Q ss_pred CCCCCChHHHhc
Q 042809 215 PEKRWSAEELLN 226 (241)
Q Consensus 215 p~~Rps~~~~l~ 226 (241)
|.+||++++++.
T Consensus 265 P~~Rp~~~~l~~ 276 (280)
T cd05092 265 PQQRMVIKDIHS 276 (280)
T ss_pred hhhCCCHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=238.67 Aligned_cols=220 Identities=32% Similarity=0.467 Sum_probs=170.4
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|..|++|.+.. ......+.+|+.++..++|||+++ ......|+||||+. ++|.+++.....+++.
T Consensus 42 ~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~ 120 (313)
T cd06633 42 NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQE 120 (313)
T ss_pred ECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCH
Confidence 456889999998762 233456889999999999999988 56678999999996 5888888766667777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++..... .....++..|+|||.+.
T Consensus 121 ~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----------~~~~~~~~~y~aPE~~~ 190 (313)
T cd06633 121 VEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----------ANSFVGTPYWMAPEVIL 190 (313)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----------CCCccccccccChhhcc
Confidence 7776665544 7999999999999999999999999999998854321 11234788899999984
Q ss_pred ---ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 146 ---NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 146 ---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
...++.++|+||||+++|++++|..||......... ................+..+.+++.+||+.+|.+||++.
T Consensus 191 ~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~ 268 (313)
T cd06633 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASA 268 (313)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHH
Confidence 355788999999999999999999998764322221 111111222222334566799999999999999999999
Q ss_pred HHhcCCCCCCCC
Q 042809 223 ELLNHTFISGNA 234 (241)
Q Consensus 223 ~~l~~p~~~~~~ 234 (241)
+++.||||+...
T Consensus 269 ~~l~~~~~~~~~ 280 (313)
T cd06633 269 ELLRHDFVRRDR 280 (313)
T ss_pred HHhcCcccCCCc
Confidence 999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=237.76 Aligned_cols=226 Identities=25% Similarity=0.477 Sum_probs=174.2
Q ss_pred CCCCcEEEEEeccch------HHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 3 KGTGALFVVKSAESE------AGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
..+|..||+|.+... ...+.+.+|+.++.++. |+||+. ..+...|+|+||+++++|.+++... ..++
T Consensus 25 ~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~ 103 (290)
T cd05613 25 HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR-ERFK 103 (290)
T ss_pred CCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHc-CCCC
Confidence 357899999998742 22456788999999995 899987 4567899999999999999999874 5566
Q ss_pred HHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
...+..++. .+||+.|++||||+|+||+++.++.++|+|||++........ .......++..|+|||.+
T Consensus 104 ~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~ 178 (290)
T cd05613 104 EQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-----ERAYSFCGTIEYMAPDIV 178 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc-----cccccccCCcccCChhhc
Confidence 666665554 448999999999999999999999999999999875432111 111234578899999998
Q ss_pred ccc--CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC---
Q 042809 145 RNE--GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW--- 219 (241)
Q Consensus 145 ~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp--- 219 (241)
.+. .++.++|+||||+++|++++|..||....................+..+...+..+.+++++||+.+|.+||
T Consensus 179 ~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~ 258 (290)
T cd05613 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCG 258 (290)
T ss_pred cCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCC
Confidence 753 357789999999999999999999964322222222222222334455666788999999999999999997
Q ss_pred --ChHHHhcCCCCCCCC
Q 042809 220 --SAEELLNHTFISGNA 234 (241)
Q Consensus 220 --s~~~~l~~p~~~~~~ 234 (241)
++++++.||||....
T Consensus 259 ~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 259 PSDADEIKKHPFFQKIN 275 (290)
T ss_pred CCCHHHHHcCcccccCC
Confidence 899999999998765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=235.26 Aligned_cols=222 Identities=20% Similarity=0.303 Sum_probs=167.9
Q ss_pred CCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC---------
Q 042809 5 TGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG--------- 67 (241)
Q Consensus 5 ~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~--------- 67 (241)
.+..||+|.+... .....+.+|+..++.++||||++ ......++||||+.+|+|.+++.....
T Consensus 35 ~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 114 (288)
T cd05061 35 AETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114 (288)
T ss_pred cceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCC
Confidence 3568999987632 23345788999999999999988 556689999999999999999976321
Q ss_pred CCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 68 TLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 68 ~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
..+...+..++. .+||+++++||||+|+||+++.++.++|+|||++........ ........++..|+||
T Consensus 115 ~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~~p 190 (288)
T cd05061 115 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY----YRKGGKGLLPVRWMAP 190 (288)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCcccccccccc----ccccCCCcccccccCH
Confidence 223333333333 558999999999999999999999999999999864322110 1111122346679999
Q ss_pred ccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC
Q 042809 142 EVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS 220 (241)
Q Consensus 142 E~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 220 (241)
|.+.+..++.++|+||||+++|++++ |..||........ ............+...+..+.+++.+||+.+|++|||
T Consensus 191 E~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 267 (288)
T cd05061 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV---LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPT 267 (288)
T ss_pred HHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcC
Confidence 99988889999999999999999998 7889976443332 2222223334455566789999999999999999999
Q ss_pred hHHHhc------CCCCCCC
Q 042809 221 AEELLN------HTFISGN 233 (241)
Q Consensus 221 ~~~~l~------~p~~~~~ 233 (241)
+.++++ ||||++.
T Consensus 268 ~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 268 FLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred HHHHHHHHHhhcCCCCCCC
Confidence 999987 9999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=232.51 Aligned_cols=216 Identities=25% Similarity=0.370 Sum_probs=168.0
Q ss_pred CcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhC-CCCCHHHHHHH
Q 042809 6 GALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDAGVIRLY 77 (241)
Q Consensus 6 ~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~ 77 (241)
...||+|.+... ...+.+.+|+..+++++||||++ ..+...++|+||+++++|.+++.... ..+++..+..+
T Consensus 23 ~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 102 (257)
T cd05040 23 VIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDY 102 (257)
T ss_pred ceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHH
Confidence 346999998854 34567899999999999999988 22278999999999999999998754 45677777666
Q ss_pred HHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+.| +||++|++|+||+|+||+++.++.++|+|||++......... ........++..|+|||.+.+..++.
T Consensus 103 ~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~~y~~pE~~~~~~~~~ 179 (257)
T cd05040 103 AVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH---YVMEEHLKVPFAWCAPESLRTRTFSH 179 (257)
T ss_pred HHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc---eecccCCCCCceecCHHHhcccCcCc
Confidence 554 479999999999999999999999999999998765331110 01111234577899999999888999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++|+||||+++|++++ |..||.............. .......+...+..+.+++.+||+.+|++|||+.++++
T Consensus 180 ~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 180 ASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK--EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred hhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh--cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 9999999999999999 9999965433332222221 23333445567789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=257.34 Aligned_cols=217 Identities=26% Similarity=0.382 Sum_probs=170.4
Q ss_pred CCCCcEEEEEecc--chHHHHHHHHHHHHHhhcC-CCcccc-----------cC-CceeeeeecccCCCCHHHHHHHh-C
Q 042809 3 KGTGALFVVKSAE--SEAGVQALRNEAEIRQSLN-SPNIGR-----------NG-EKTVNIFMEYMAGGSLLDVAEKF-G 66 (241)
Q Consensus 3 ~~~~~~vaiK~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~-----------~~-~~~~~lv~e~~~~~~L~~~l~~~-~ 66 (241)
...|..||+|+.- ++...+.+.+|+.+|++|. |+|||. .+ ...+.|+||||.||.|-+++..+ .
T Consensus 59 ~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq 138 (738)
T KOG1989|consen 59 VKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ 138 (738)
T ss_pred cCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHh
Confidence 4455899999744 5667888999999999998 999987 22 35788999999999999999865 4
Q ss_pred CCCCHHHHHHHHHHH------hhcCC--ccccCCCCCcEEeecCCCeeecCCCcchhhcccccCC---ccccccccccCc
Q 042809 67 GTLDAGVIRLYTKEI------LHGNG--ILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG---NLKQSWQSIGGT 135 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~--~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~~ 135 (241)
..+++..++.++.++ ||..+ |+|||||-+|||++.+|.+||||||.++......... .....--...-|
T Consensus 139 ~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TT 218 (738)
T KOG1989|consen 139 TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTT 218 (738)
T ss_pred ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCC
Confidence 569999999888866 79888 9999999999999999999999999997543211100 000111122358
Q ss_pred ccccCcccc---cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC--hhhHHHHHHHHHHh
Q 042809 136 QLWMAPEVL---RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP--TQFFKKVLDFLAKC 210 (241)
Q Consensus 136 ~~~~aPE~~---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~ 210 (241)
+.|+|||.+ .+...+.++|||||||+||.|+....||.....-.+. ...+.+| +.++..+.+||+.|
T Consensus 219 p~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl--------ng~Y~~P~~p~ys~~l~~LI~~m 290 (738)
T KOG1989|consen 219 PQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL--------NGNYSFPPFPNYSDRLKDLIRTM 290 (738)
T ss_pred ccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE--------eccccCCCCccHHHHHHHHHHHH
Confidence 999999987 4566789999999999999999999999765332221 2223333 46889999999999
Q ss_pred hccCCCCCCChHHHhcC
Q 042809 211 LERKPEKRWSAEELLNH 227 (241)
Q Consensus 211 l~~~p~~Rps~~~~l~~ 227 (241)
|+.+|.+||++.+++.+
T Consensus 291 L~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 291 LQPNPDERPNIYQVLEE 307 (738)
T ss_pred hccCcccCCCHHHHHHH
Confidence 99999999999998865
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=237.67 Aligned_cols=225 Identities=27% Similarity=0.405 Sum_probs=169.0
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHH---H-hCCC
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAE---K-FGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~---~-~~~~ 68 (241)
++.+|+.+|+|.+... .....+.+|+.++.++. |+||++ ..+...+++|||+. ++|.++.. . ....
T Consensus 25 ~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~ 103 (288)
T cd06616 25 HKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSV 103 (288)
T ss_pred ECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCC
Confidence 5678999999987632 34567889999999997 999998 55677899999996 46655432 2 2356
Q ss_pred CCHHHHHHHHHH------Hhhc-CCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 69 LDAGVIRLYTKE------ILHG-NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 69 ~~~~~~~~~~~~------~Lh~-~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
+++..+..++.+ +||+ .+++||||+|+||+++.++.++|+|||++....... ......+++.|+||
T Consensus 104 l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aP 176 (288)
T cd06616 104 IPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI-------AKTRDAGCRPYMAP 176 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC-------ccccccCccCccCH
Confidence 777776666554 4686 599999999999999999999999999987543311 11123478889999
Q ss_pred cccccc---CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCC----ChhhHHHHHHHHHHhhccC
Q 042809 142 EVLRNE---GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHF----PTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 142 E~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~ 214 (241)
|.+.+. .++.++|+||+|+++|++++|..||.... ..............+.. +..++..+.+|+.+||+.+
T Consensus 177 E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 254 (288)
T cd06616 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKD 254 (288)
T ss_pred HHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCC
Confidence 999766 67899999999999999999999997543 12222222222222222 2346788999999999999
Q ss_pred CCCCCChHHHhcCCCCCCCCcc
Q 042809 215 PEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 215 p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
|.+|||+++++.||||+....+
T Consensus 255 p~~Rpt~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 255 ESKRPKYKELLEHPFIKDYEER 276 (288)
T ss_pred hhhCcCHHHHhcChhhhchhhc
Confidence 9999999999999999775543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=232.82 Aligned_cols=216 Identities=22% Similarity=0.347 Sum_probs=169.6
Q ss_pred CCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 5 TGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 5 ~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
+...||+|.+.. ......+.+|+.++++++||||++ ...+..++||||+++++|.+++....+.++...+..
T Consensus 31 ~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 110 (266)
T cd05033 31 KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVG 110 (266)
T ss_pred CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHH
Confidence 456899998763 234566889999999999999988 566789999999999999999987666777877776
Q ss_pred HHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCC
Q 042809 77 YTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD 150 (241)
Q Consensus 77 ~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 150 (241)
++. ++||+.+++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+..++
T Consensus 111 ~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~y~~Pe~~~~~~~~ 186 (266)
T cd05033 111 MLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT----YTTKGGKIPIRWTAPEAIAYRKFT 186 (266)
T ss_pred HHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc----eeccCCCCCccccChhhhccCCCc
Confidence 665 4489999999999999999999999999999999866421110 001112245679999999988899
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 151 FATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 151 ~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
.++|+||||+++|++++ |..||............ ........+...+..+.+++.+||+.+|++||++++++++
T Consensus 187 ~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 187 SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV---EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH---HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999999999998 99999765433332222 2222334455677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=251.79 Aligned_cols=213 Identities=27% Similarity=0.378 Sum_probs=168.4
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH---
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG--- 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~--- 72 (241)
++.+++..++|++.++ .....+|+.++...+ ||||++ .+..+.|+|||.++|+-|.+.+..........
T Consensus 343 ~~~t~~~~~vkii~~~--~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~~e~~~w 420 (612)
T KOG0603|consen 343 SSPTDQEPAVKIISKR--ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFCSEASQW 420 (612)
T ss_pred ccccccchhheecccc--ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhHHHHHHH
Confidence 5667788888888765 234557777776665 999988 67889999999999988888777633222111
Q ss_pred -HHHHHHHHHhhcCCccccCCCCCcEEe-ecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCC
Q 042809 73 -VIRLYTKEILHGNGILHCDLKCNNVLL-GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD 150 (241)
Q Consensus 73 -~~~~~~~~~Lh~~~~vH~dl~p~Nil~-~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 150 (241)
..+..+..+||++|+|||||||+||++ ++.|+++|+|||.+...... ....+-|..|.|||.+....++
T Consensus 421 ~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---------~~tp~~t~~y~APEvl~~~~yt 491 (612)
T KOG0603|consen 421 AAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---------CDTPALTLQYVAPEVLAIQEYT 491 (612)
T ss_pred HHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---------hcccchhhcccChhhhccCCCC
Confidence 122233466999999999999999999 68899999999999865542 3334568889999999999999
Q ss_pred chhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 151 FATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 151 ~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
.++|+||||++||+|++|+.||...... ..+. .....+.+...++..+++|+++||+.+|.+|+++.++..||||
T Consensus 492 ~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~---~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 492 EACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIH---TRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cchhhHHHHHHHHHHHhCCCccccCCch--HHHH---HhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 9999999999999999999999876554 1111 1233344557889999999999999999999999999999999
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=235.07 Aligned_cols=216 Identities=23% Similarity=0.333 Sum_probs=166.8
Q ss_pred CCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC------CCC
Q 042809 5 TGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG------TLD 70 (241)
Q Consensus 5 ~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~ 70 (241)
++..|++|.+.. ......+.+|+.+++.++|+||++ ......++||||+.+++|.+++...+. .++
T Consensus 35 ~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~ 114 (277)
T cd05036 35 VELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLT 114 (277)
T ss_pred CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCC
Confidence 678899998762 233456889999999999999988 556678999999999999999987432 466
Q ss_pred HHHHHHHHHH------HhhcCCccccCCCCCcEEeecCC---CeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 71 AGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHG---DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 71 ~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
+..+..++.| +||+++++|+||+|+||+++.++ .++|+|||++........ .........+..|+||
T Consensus 115 ~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aP 190 (277)
T cd05036 115 MKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY----YRKGGRAMLPIKWMPP 190 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccc----eecCCCCCccHhhCCH
Confidence 6666665554 47999999999999999998765 589999999875522110 0111112234679999
Q ss_pred ccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC
Q 042809 142 EVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS 220 (241)
Q Consensus 142 E~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 220 (241)
|.+.+..++.++||||||+++|++++ |..||...+...... ..........+...+..+.+++.+||+.+|++|||
T Consensus 191 E~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps 267 (277)
T cd05036 191 EAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME---FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPN 267 (277)
T ss_pred HHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcC
Confidence 99998889999999999999999997 999997654433322 22233444556677889999999999999999999
Q ss_pred hHHHhcC
Q 042809 221 AEELLNH 227 (241)
Q Consensus 221 ~~~~l~~ 227 (241)
++++++|
T Consensus 268 ~~~vl~~ 274 (277)
T cd05036 268 FATILER 274 (277)
T ss_pred HHHHHHH
Confidence 9999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=232.88 Aligned_cols=214 Identities=22% Similarity=0.357 Sum_probs=167.2
Q ss_pred CcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHH
Q 042809 6 GALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTK 79 (241)
Q Consensus 6 ~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 79 (241)
+..+|+|.+... ...+.+.+|+.++++++||||++ ......++||||+.+++|.+++......+++..+..++.
T Consensus 28 ~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 107 (256)
T cd05113 28 QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK 107 (256)
T ss_pred CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHH
Confidence 446999987743 23467899999999999999988 455678999999999999999987555678777777766
Q ss_pred HH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchh
Q 042809 80 EI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT 153 (241)
Q Consensus 80 ~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 153 (241)
|+ ||+.|++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+..++.++
T Consensus 108 ~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-----~~~~~~~~~~~y~~pe~~~~~~~~~~~ 182 (256)
T cd05113 108 DVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-----TSSVGSKFPVRWSPPEVLLYSKFSSKS 182 (256)
T ss_pred HHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-----eecCCCccChhhCCHHHHhcCcccchh
Confidence 54 7999999999999999999999999999998865432111 111122345679999999888899999
Q ss_pred hHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 154 DIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 154 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
|+||||+++|++++ |..||............ ........+...+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 183 Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 183 DVWAFGVLMWEVYSLGKMPYERFNNSETVEKV---SQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH---hcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999999998 99999764433222222 2223333445567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=239.98 Aligned_cols=214 Identities=21% Similarity=0.312 Sum_probs=166.5
Q ss_pred cEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHH
Q 042809 7 ALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTK 79 (241)
Q Consensus 7 ~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 79 (241)
..||+|.+.. ....+.+.+|+.+++.++||||++ ......++|+||+.+|+|.+++......++......++.
T Consensus 37 ~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~ 116 (316)
T cd05108 37 IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 116 (316)
T ss_pred eeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHH
Confidence 3489999763 344567889999999999999998 234567899999999999999998655677766666555
Q ss_pred H------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchh
Q 042809 80 E------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT 153 (241)
Q Consensus 80 ~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 153 (241)
| +||++|++||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..++.++
T Consensus 117 qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~ 192 (316)
T cd05108 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE----YHAEGGKVPIKWMALESILHRIYTHQS 192 (316)
T ss_pred HHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcc----eeccCCccceeecChHHhccCCCCchh
Confidence 4 479999999999999999999999999999999765431111 011112235679999999988899999
Q ss_pred hHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 154 DIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 154 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
||||||+++|++++ |..||.+......... .........+...+.++.+++.+||..+|.+|||+.+++.+
T Consensus 193 Di~slGv~l~el~t~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 193 DVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred hhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999998 9999976543333222 22233334455667889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=237.09 Aligned_cols=225 Identities=29% Similarity=0.506 Sum_probs=171.6
Q ss_pred CCCCcEEEEEeccch------HHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 3 KGTGALFVVKSAESE------AGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
..+++.||+|.+... ...+.+.+|+.++.+++ ||||++ ..+...++||||+.+++|.+++... ..++
T Consensus 25 ~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~ 103 (288)
T cd05583 25 HDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-EHFT 103 (288)
T ss_pred ccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhc-CCcC
Confidence 457889999987642 23456789999999995 999988 5667899999999999999998863 4566
Q ss_pred HHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
...+..++.| +||+.|++|+||+|+||+++.++.++|+|||++........ .......++..|+|||.+
T Consensus 104 ~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~ 178 (288)
T cd05583 104 ESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE-----ERAYSFCGTIEYMAPEVI 178 (288)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc-----cccccccCCccccCHHHh
Confidence 7666655554 47999999999999999999999999999998865432111 011123478899999998
Q ss_pred cccC--CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC--
Q 042809 145 RNEG--LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS-- 220 (241)
Q Consensus 145 ~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-- 220 (241)
.+.. .+.++|+||||+++|++++|..||....................+..+...+..+.+++.+||+.+|++|||
T Consensus 179 ~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~ 258 (288)
T cd05583 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGAN 258 (288)
T ss_pred cCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcc
Confidence 7655 678999999999999999999999643222211122222223334556667789999999999999999998
Q ss_pred -hHHHhcCCCCCCC
Q 042809 221 -AEELLNHTFISGN 233 (241)
Q Consensus 221 -~~~~l~~p~~~~~ 233 (241)
+.++++||||+..
T Consensus 259 ~~~~~l~~~~~~~~ 272 (288)
T cd05583 259 GADEIKNHPFFQGI 272 (288)
T ss_pred hHHHHhcCcccccC
Confidence 5677999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=224.30 Aligned_cols=224 Identities=27% Similarity=0.424 Sum_probs=169.1
Q ss_pred CCCCcEEEEEecc--chHHHHHHHHHHHHHhhcCCCcccc----------cCCceeeeeecccCCCCHHHHHHHh---CC
Q 042809 3 KGTGALFVVKSAE--SEAGVQALRNEAEIRQSLNSPNIGR----------NGEKTVNIFMEYMAGGSLLDVAEKF---GG 67 (241)
Q Consensus 3 ~~~~~~vaiK~~~--~~~~~~~~~~e~~~l~~l~h~~i~~----------~~~~~~~lv~e~~~~~~L~~~l~~~---~~ 67 (241)
..|++.||+|++. +....+...+|++..++++|||+++ +.....|++++|...|+|.+.+... +.
T Consensus 43 ~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~ 122 (302)
T KOG2345|consen 43 LSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGN 122 (302)
T ss_pred cCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCC
Confidence 4678999999866 3456788999999999999999987 4566799999999999999988764 45
Q ss_pred CCCHHHHHHHHHHH------hhcCC--ccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccc---cccccccCcc
Q 042809 68 TLDAGVIRLYTKEI------LHGNG--ILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLK---QSWQSIGGTQ 136 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~--~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~---~~~~~~~~~~ 136 (241)
.++++.+..++.++ ||+.. +.||||||.||+++..+.+++.|||.+....-...+.... .......-|.
T Consensus 123 ~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~ 202 (302)
T KOG2345|consen 123 FVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTI 202 (302)
T ss_pred ccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCC
Confidence 78999998888765 79988 9999999999999999999999999997653211111111 1222333578
Q ss_pred cccCcccccc---cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHH-HHhcCCCCCCChhhHHHHHHHHHHhhc
Q 042809 137 LWMAPEVLRN---EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLK-IACSNEKPHFPTQFFKKVLDFLAKCLE 212 (241)
Q Consensus 137 ~~~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~ 212 (241)
.|+|||.+.- ...+.++|||||||++|.|+.|..||...........+. .......|. ...+++.+.++|+.||+
T Consensus 203 pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~-~~~yse~l~~lik~mlq 281 (302)
T KOG2345|consen 203 PYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPN-SSRYSEALHQLIKSMLQ 281 (302)
T ss_pred cccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCC-CCCccHHHHHHHHHHhc
Confidence 8999999964 345689999999999999999999995422211110000 000011111 22378899999999999
Q ss_pred cCCCCCCChHHHhcC
Q 042809 213 RKPEKRWSAEELLNH 227 (241)
Q Consensus 213 ~~p~~Rps~~~~l~~ 227 (241)
.||.+||++.+++.+
T Consensus 282 vdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 282 VDPNQRPTIPELLSK 296 (302)
T ss_pred CCcccCCCHHHHHHH
Confidence 999999999999864
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=232.74 Aligned_cols=214 Identities=23% Similarity=0.349 Sum_probs=167.3
Q ss_pred CCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCCHHHHHHH
Q 042809 5 TGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDAGVIRLY 77 (241)
Q Consensus 5 ~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~ 77 (241)
+++.||+|.+... ...+.+.+|+.++++++||||++ ...+..++||||+.+++|.+++.... ..++...+..+
T Consensus 29 ~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 108 (261)
T cd05068 29 NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM 108 (261)
T ss_pred CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHH
Confidence 4567999988743 33567889999999999999987 56678999999999999999998643 45777777666
Q ss_pred HHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+.++ ||+.|++|+||+|+||+++.++.++|+|||++......... .......+..|+|||.+.+..++.
T Consensus 109 ~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~ 183 (261)
T cd05068 109 AAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-----AREGAKFPIKWTAPEAALYNRFSI 183 (261)
T ss_pred HHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-----ccCCCcCceeccCccccccCCCCc
Confidence 6554 79999999999999999999999999999998765421110 011112245799999999888999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++|+||||+++|++++ |+.||.+........ ..........+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 184 ~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 184 KSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ---QVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred hhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 9999999999999999 999997654333222 22222333445667789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=241.60 Aligned_cols=233 Identities=24% Similarity=0.326 Sum_probs=171.8
Q ss_pred CCCCCcEEEEEeccchHHH----------------HHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHH
Q 042809 2 NKGTGALFVVKSAESEAGV----------------QALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLD 60 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~----------------~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~ 60 (241)
|+.+|+.||+|.+...... ..+.+|+++++.++|+||++ ...+..++||||+. ++|.+
T Consensus 30 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~ 108 (335)
T PTZ00024 30 DTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKK 108 (335)
T ss_pred ECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHH
Confidence 5678999999987643211 14778999999999999988 56778999999996 69999
Q ss_pred HHHHhCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCC--------ccc
Q 042809 61 VAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG--------NLK 126 (241)
Q Consensus 61 ~l~~~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--------~~~ 126 (241)
++.. ...++......++.|+ ||+.|++|+||+|+||+++.++.++|+|||++.......... ...
T Consensus 109 ~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 187 (335)
T PTZ00024 109 VVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187 (335)
T ss_pred HHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeeccccccccccccccccccc
Confidence 9876 4557777776666654 799999999999999999999999999999987654211000 001
Q ss_pred cccccccCcccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC------------
Q 042809 127 QSWQSIGGTQLWMAPEVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP------------ 193 (241)
Q Consensus 127 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 193 (241)
.......+++.|+|||.+.+. .++.++|+||||+++|++++|..||.....................
T Consensus 188 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 267 (335)
T PTZ00024 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLY 267 (335)
T ss_pred ccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccc
Confidence 111223457789999998764 3688999999999999999999999765433222211111100000
Q ss_pred ------------CCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 194 ------------HFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 194 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
......+..+.+++.+||+.+|.+|||+++++.||||+.....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 268 TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred cccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 0012235678999999999999999999999999999876553
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=243.24 Aligned_cols=229 Identities=27% Similarity=0.366 Sum_probs=173.1
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCC-----ceeeeeecccCCCCHHHHHHHhCC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGE-----KTVNIFMEYMAGGSLLDVAEKFGG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~-----~~~~lv~e~~~~~~L~~~l~~~~~ 67 (241)
+..+|+.+|+|.+.. ....+.+.+|+.+++.++|+||++ ... ...|+||||+. ++|.+++... .
T Consensus 21 ~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~ 98 (330)
T cd07834 21 DKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSP-Q 98 (330)
T ss_pred eCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCC-C
Confidence 456789999998764 334567899999999999999987 222 37899999997 5899988763 4
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
.+++..+..++.++ ||+.|++|+||+|+||+++.++.++|+|||.+......... ........++..|+||
T Consensus 99 ~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~---~~~~~~~~~~~~y~aP 175 (330)
T cd07834 99 PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE---KGFLTEYVVTRWYRAP 175 (330)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc---cccccccccccCcCCc
Confidence 77777777666654 79999999999999999999999999999999865442211 0112233468889999
Q ss_pred cccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC---------------------------
Q 042809 142 EVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP--------------------------- 193 (241)
Q Consensus 142 E~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------- 193 (241)
|.+.+. .++.++|+||+|+++|++++|..||....................+
T Consensus 176 E~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (330)
T cd07834 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLS 255 (330)
T ss_pred eeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhH
Confidence 999887 7889999999999999999999999765432222111111100000
Q ss_pred CCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 194 HFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 194 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
......+..+.+++++||+.+|.+|||++++++||||+....
T Consensus 256 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 256 KLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred HhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 011224678999999999999999999999999999976544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=235.71 Aligned_cols=223 Identities=24% Similarity=0.400 Sum_probs=166.9
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.++..||+|.+.. ......+.+|+.+++.++|||+++ .+....++||||++|++|.+++......++.
T Consensus 29 ~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~ 108 (284)
T cd05079 29 GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL 108 (284)
T ss_pred CCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCH
Confidence 356789999999773 334567899999999999999987 2246789999999999999999875555677
Q ss_pred HHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.+ +||++|++||||+|+||+++.++.++|+|||++......... ........++..|+|||.+.
T Consensus 109 ~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~~y~apE~~~ 185 (284)
T cd05079 109 KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY---YTVKDDLDSPVFWYAPECLI 185 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccc---eeecCCCCCCccccCHHHhc
Confidence 766666554 479999999999999999999999999999998755331111 01112344667899999998
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchh------------chHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhcc
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKIS------------NAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLER 213 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 213 (241)
+..++.++|+||||+++|+++++..|...... ..................+...+..+.+|+.+||+.
T Consensus 186 ~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 265 (284)
T cd05079 186 QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEF 265 (284)
T ss_pred cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccC
Confidence 88889999999999999999997765422110 011111111112223334556778999999999999
Q ss_pred CCCCCCChHHHhcC
Q 042809 214 KPEKRWSAEELLNH 227 (241)
Q Consensus 214 ~p~~Rps~~~~l~~ 227 (241)
+|.+|||+++++..
T Consensus 266 ~p~~Rpt~~~il~~ 279 (284)
T cd05079 266 QPSKRTTFQNLIEG 279 (284)
T ss_pred CcccCcCHHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=236.44 Aligned_cols=222 Identities=27% Similarity=0.447 Sum_probs=171.0
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+|+.+++|.+... .....+.+|+.++++++|+||++ ..+...++|+||+.+ +|.+++......++..
T Consensus 20 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~ 98 (283)
T cd05118 20 DKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPES 98 (283)
T ss_pred cCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHH
Confidence 5678999999987633 23467889999999999999988 567889999999974 8998888755677777
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.++ ||+.+++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+
T Consensus 99 ~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~~~~PE~~~~ 172 (283)
T cd05118 99 LIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV------RPYTHYVVTRWYRAPELLLG 172 (283)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc------ccccCccCcccccCcHHHhc
Confidence 777666654 799999999999999999999999999999987554321 11122346788999999877
Q ss_pred c-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCC--------------------------CCCChhh
Q 042809 147 E-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK--------------------------PHFPTQF 199 (241)
Q Consensus 147 ~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~ 199 (241)
. ..+.++|+||+|+++|++++|+.||.................... .......
T Consensus 173 ~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (283)
T cd05118 173 DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNA 252 (283)
T ss_pred CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhh
Confidence 6 678999999999999999999999965433221111111000000 0112245
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 200 FKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 200 ~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
+..+.++|.+||+.+|.+||++.+++.||||
T Consensus 253 ~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 253 SPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred CHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 6789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=236.47 Aligned_cols=218 Identities=24% Similarity=0.329 Sum_probs=167.8
Q ss_pred CCCCcEEEEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCCHH
Q 042809 3 KGTGALFVVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDAG 72 (241)
Q Consensus 3 ~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~ 72 (241)
..++..+|+|.+.. ....+.+.+|+.+++++ +||||++ ...+..++|+||+.+++|.+++.... ..++..
T Consensus 62 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~ 141 (302)
T cd05055 62 SDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLE 141 (302)
T ss_pred CCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHH
Confidence 34567899998763 33456789999999999 7999998 56678999999999999999998643 236777
Q ss_pred HHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
....++.+ +||+++++|+||+|+||+++.++.++++|||++........ ........++..|+|||.+.+
T Consensus 142 ~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~ 217 (302)
T cd05055 142 DLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN----YVVKGNARLPVKWMAPESIFN 217 (302)
T ss_pred HHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCc----eeecCCCCcccccCCHhhhcc
Confidence 76666554 47999999999999999999999999999999875433111 001112335678999999988
Q ss_pred cCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 147 EGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
..++.++||||+|+++|++++ |..||........ .............+...+..+.+++.+||+.+|.+|||+.+++
T Consensus 218 ~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell 295 (302)
T cd05055 218 CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIV 295 (302)
T ss_pred CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 889999999999999999998 9999876433222 1122222333344455678999999999999999999999997
Q ss_pred c
Q 042809 226 N 226 (241)
Q Consensus 226 ~ 226 (241)
.
T Consensus 296 ~ 296 (302)
T cd05055 296 Q 296 (302)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=238.37 Aligned_cols=227 Identities=23% Similarity=0.329 Sum_probs=166.3
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC-CCCH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG-TLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~ 71 (241)
++.+|+.||+|.+... ...+.+.+|++++++++||||++ ......++||||++ ++|.+++..... .++.
T Consensus 23 ~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~ 101 (294)
T PLN00009 23 DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNP 101 (294)
T ss_pred ecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCH
Confidence 4678999999987632 23456889999999999999988 66789999999996 588888765432 2455
Q ss_pred HHHHHHHH------HHhhcCCccccCCCCCcEEeec-CCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 72 GVIRLYTK------EILHGNGILHCDLKCNNVLLGS-HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 72 ~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
..+..++. ++||+++++|+||+|+||+++. ++.+||+|||++....... .......+++.|+|||.+
T Consensus 102 ~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~y~~PE~~ 175 (294)
T PLN00009 102 RLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV------RTFTHEVVTLWYRAPEIL 175 (294)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc------cccccCceeecccCHHHH
Confidence 55544444 4589999999999999999985 4579999999986543211 111223467889999998
Q ss_pred ccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC-----------------CCC--------CChh
Q 042809 145 RNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE-----------------KPH--------FPTQ 198 (241)
Q Consensus 145 ~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------~~~--------~~~~ 198 (241)
.+. .++.++|+||+|+++|++++|..||...+............... .+. ..+.
T Consensus 176 ~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (294)
T PLN00009 176 LGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPT 255 (294)
T ss_pred hCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcC
Confidence 664 46889999999999999999999997643322211111000000 000 1133
Q ss_pred hHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 199 FFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 199 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.+..+.+++.+||+.+|.+||++.++++||||.+-..
T Consensus 256 ~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 256 LEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred CChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 5678899999999999999999999999999987543
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=234.89 Aligned_cols=217 Identities=21% Similarity=0.314 Sum_probs=166.7
Q ss_pred CCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh----------
Q 042809 4 GTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF---------- 65 (241)
Q Consensus 4 ~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---------- 65 (241)
.+++.||+|.+... .....+.+|+.++..++||||++ ......++++||+.+++|.+++...
T Consensus 33 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~ 112 (283)
T cd05091 33 EQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTD 112 (283)
T ss_pred CceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccc
Confidence 35688999998743 23466889999999999999988 5567799999999999999998642
Q ss_pred -----CCCCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccC
Q 042809 66 -----GGTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGG 134 (241)
Q Consensus 66 -----~~~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 134 (241)
...++...+..++. ++||+.|++||||||+||+++.++.+||+|||++........ ........+
T Consensus 113 ~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~ 188 (283)
T cd05091 113 DDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY----YKLMGNSLL 188 (283)
T ss_pred cccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchh----eeeccCccC
Confidence 12355555554444 458999999999999999999999999999999875432111 111122335
Q ss_pred cccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhcc
Q 042809 135 TQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLER 213 (241)
Q Consensus 135 ~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 213 (241)
++.|+|||.+.+..++.++|+||||+++|++++ |..||.+....... ...........+...+..+.+++.+||+.
T Consensus 189 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~li~~cl~~ 265 (283)
T cd05091 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI---EMIRNRQVLPCPDDCPAWVYTLMLECWNE 265 (283)
T ss_pred CccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHHcCCcCCCCCCCCHHHHHHHHHHhCC
Confidence 678999999988889999999999999999998 88898765443322 22222333445667888999999999999
Q ss_pred CCCCCCChHHHhcC
Q 042809 214 KPEKRWSAEELLNH 227 (241)
Q Consensus 214 ~p~~Rps~~~~l~~ 227 (241)
+|.+||++++++..
T Consensus 266 ~p~~RP~~~~i~~~ 279 (283)
T cd05091 266 FPSRRPRFKDIHSR 279 (283)
T ss_pred CcccCCCHHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=231.44 Aligned_cols=215 Identities=23% Similarity=0.361 Sum_probs=168.0
Q ss_pred CCcEEEEEeccchH---HHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHH
Q 042809 5 TGALFVVKSAESEA---GVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLY 77 (241)
Q Consensus 5 ~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 77 (241)
++..+|+|.+..+. ..+.+.+|+.+++.+.|+||++ ......++||||+++++|.+++... ..+++..+..+
T Consensus 22 ~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~ 100 (257)
T cd05060 22 KEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKKR-REIPVSDLKEL 100 (257)
T ss_pred CcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCCcHHHHHHhC-CCCCHHHHHHH
Confidence 44789999977433 4567899999999999999988 4455789999999999999999874 36777777666
Q ss_pred HHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+.|+ ||..+++|+||+|+||+++.++.++|+|||.+........ .........++..|+|||.+.+..++.
T Consensus 101 ~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~ 177 (257)
T cd05060 101 AHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD---YYRATTAGRWPLKWYAPECINYGKFSS 177 (257)
T ss_pred HHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc---ccccccCccccccccCHHHhcCCCCCc
Confidence 6654 7999999999999999999999999999999875533111 111111112345799999999888999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++|+||||+++|++++ |..||......... ...........+...+..+.+++.+||..+|++|||+.++++
T Consensus 178 ~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 178 KSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI---AMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred cchHHHHHHHHHHHHcCCCCCcccCCHHHHH---HHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999998 99999765433322 222233344556667789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=233.07 Aligned_cols=212 Identities=22% Similarity=0.310 Sum_probs=168.4
Q ss_pred CcEEEEEeccchH--HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh-CCCCCHHHHHHH
Q 042809 6 GALFVVKSAESEA--GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDAGVIRLY 77 (241)
Q Consensus 6 ~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~ 77 (241)
+..+++|.+.... ....+.+|+.+++.++|+||++ ......++||||+++++|.+++... +..++...+..+
T Consensus 30 ~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 109 (261)
T cd05148 30 RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDM 109 (261)
T ss_pred CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHH
Confidence 7889999987543 3567899999999999999988 5667899999999999999999864 345676666665
Q ss_pred HH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+. ++||+.|++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.
T Consensus 110 ~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~------~~~~~~~~~~~~PE~~~~~~~~~ 183 (261)
T cd05148 110 ACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL------SSDKKIPYKWTAPEAASHGTFST 183 (261)
T ss_pred HHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc------ccCCCCceEecCHHHHccCCCCc
Confidence 54 4479999999999999999999999999999999765331111 11223466799999998888899
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++|+||||+++|++++ |..||........... .........+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 184 ~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 184 KSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ---ITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH---HHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999998 8999976543322222 2233444556677889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=242.16 Aligned_cols=225 Identities=24% Similarity=0.340 Sum_probs=168.9
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCccccc----------CCceeeeeecccCCCCHHHHHHHhCC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGRN----------GEKTVNIFMEYMAGGSLLDVAEKFGG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~----------~~~~~~lv~e~~~~~~L~~~l~~~~~ 67 (241)
++.+|+.||+|.+.. ......+.+|+.+++.++|+||++. .....|+|+||+. ++|.+++.. ..
T Consensus 26 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~ 103 (337)
T cd07858 26 NSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRS-SQ 103 (337)
T ss_pred ecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhc-CC
Confidence 567899999998763 2334567889999999999999871 1145899999995 699998876 45
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
.+++..+..++.|+ ||+++++|+||+|+||+++.++.++|+|||++....... .......++..|+||
T Consensus 104 ~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~------~~~~~~~~~~~y~aP 177 (337)
T cd07858 104 TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG------DFMTEYVVTRWYRAP 177 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc------ccccccccccCccCh
Confidence 67887777776655 799999999999999999999999999999987543311 111223467889999
Q ss_pred ccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhc----------------------CCC--C---
Q 042809 142 EVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACS----------------------NEK--P--- 193 (241)
Q Consensus 142 E~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------------~~~--~--- 193 (241)
|.+.. ..++.++|+||||+++|++++|..||.+............... ... .
T Consensus 178 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (337)
T cd07858 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFA 257 (337)
T ss_pred HHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHH
Confidence 98864 4578899999999999999999999965432111111110000 000 0
Q ss_pred CCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 194 HFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 194 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
......+.++.+++++||+.+|.+|||++++++||||....
T Consensus 258 ~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 258 RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 01234567899999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=249.66 Aligned_cols=214 Identities=25% Similarity=0.381 Sum_probs=171.5
Q ss_pred cEEEEEecc----chHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 7 ALFVVKSAE----SEAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 7 ~~vaiK~~~----~~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
..||||+++ .+...+.|.+|+..+++-+|.||+- -....+.||+-||+|.+|+.++......++......++
T Consensus 415 GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIA 494 (678)
T KOG0193|consen 415 GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIA 494 (678)
T ss_pred cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCceeeeehhccCchhhhhccchhhhhhHHHHHHHH
Confidence 358999977 3456888999999999999999986 34444599999999999999999877888888888888
Q ss_pred HHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc---ccCC
Q 042809 79 KEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR---NEGL 149 (241)
Q Consensus 79 ~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~ 149 (241)
+|+ ||.++|+|+|||..|||+.++++|||+|||++.....+... .......|+..|+|||++. ..+|
T Consensus 495 qQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~----~q~~qp~gsilwmAPEvIRmqd~nPf 570 (678)
T KOG0193|consen 495 QQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE----QQLEQPHGSLLWMAPEVIRMQDDNPF 570 (678)
T ss_pred HHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc----cccCCCccchhhhcHHHHhhcccCCC
Confidence 866 89999999999999999999999999999999876554222 2234456889999999985 4678
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCC---ChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 150 DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHF---PTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++.+||||||+++|||++|..||.....+.+ +.........++. ....+.++.+|+..||.+++++||++.+++.
T Consensus 571 S~qSDVYaFGiV~YELltg~lPysi~~~dqI--ifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 571 SFQSDVYAFGIVWYELLTGELPYSIQNRDQI--IFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred CcccchhhhhHHHHHHHhCcCCcCCCChhhe--EEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 9999999999999999999999985322221 1111111112222 2345678999999999999999999999886
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=231.87 Aligned_cols=218 Identities=28% Similarity=0.484 Sum_probs=168.6
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh---CCC
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF---GGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~ 68 (241)
++.+|+.||+|.+.. ....+.+.+|++++++++|+|+++ ..++..++||||+++++|.+++... +..
T Consensus 23 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 102 (267)
T cd08224 23 CLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL 102 (267)
T ss_pred EcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCC
Confidence 346899999998652 233567899999999999999987 5667899999999999999998753 344
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
++...+..++.++ ||+.|++|+||+|+||+++.++.++|+|||++........ ......++..|.|||
T Consensus 103 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~y~apE 176 (267)
T cd08224 103 IPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT------AAHSLVGTPYYMSPE 176 (267)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc------ccceecCCccccCHH
Confidence 6666666655544 7999999999999999999999999999999865432111 112234788899999
Q ss_pred cccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCCh-hhHHHHHHHHHHhhccCCCCCCCh
Q 042809 143 VLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPT-QFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 143 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
.+.+..++.++|+||||+++|++++|..||...... .............+..+. ..+..+.+++.+||..+|.+|||+
T Consensus 177 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~ 255 (267)
T cd08224 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDI 255 (267)
T ss_pred HhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCH
Confidence 999888999999999999999999999999654322 112222222223333444 677789999999999999999999
Q ss_pred HHHhc
Q 042809 222 EELLN 226 (241)
Q Consensus 222 ~~~l~ 226 (241)
.++++
T Consensus 256 ~~il~ 260 (267)
T cd08224 256 SYVLQ 260 (267)
T ss_pred HHHHH
Confidence 99874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=236.74 Aligned_cols=222 Identities=31% Similarity=0.446 Sum_probs=172.3
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|..+|+|.+.. ......+.+|++++++++|||+++ ..+...++|+||+. |+|.+++.....++++
T Consensus 46 ~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~ 124 (317)
T cd06635 46 DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE 124 (317)
T ss_pred EcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhcCCCCH
Confidence 456789999998762 233457889999999999999988 56678999999997 5888888766667777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.++ ||+.|++|+||+|+||+++.++.++|+|||++..... .....++..|+|||.+.
T Consensus 125 ~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----------~~~~~~~~~y~aPE~~~ 194 (317)
T cd06635 125 VEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----------ANSFVGTPYWMAPEVIL 194 (317)
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC----------cccccCCccccChhhhh
Confidence 7776665544 7999999999999999999999999999998864322 11234788899999974
Q ss_pred ---ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 146 ---NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 146 ---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
...++.++|+||||+++|++++|..||.......... ...............+..+.+++.+||+.+|.+||++.
T Consensus 195 ~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 272 (317)
T cd06635 195 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSE 272 (317)
T ss_pred cCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH--HHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHH
Confidence 4557889999999999999999999987643222211 11111222223345667899999999999999999999
Q ss_pred HHhcCCCCCCCCcc
Q 042809 223 ELLNHTFISGNAKK 236 (241)
Q Consensus 223 ~~l~~p~~~~~~~~ 236 (241)
++++|+|+.....+
T Consensus 273 ~il~~~~~~~~~~~ 286 (317)
T cd06635 273 ELLKHMFVLRERPE 286 (317)
T ss_pred HHHhChhhhccCcc
Confidence 99999998665543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=247.34 Aligned_cols=210 Identities=25% Similarity=0.393 Sum_probs=171.3
Q ss_pred EEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 9 FVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 9 vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
||+|.... ......+.+|+++|++++|||||+ .....+++|||+|+||+|.++|+..+..++......++
T Consensus 189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~ 268 (474)
T KOG0194|consen 189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFC 268 (474)
T ss_pred eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHH
Confidence 89998773 456788999999999999999998 67889999999999999999999976667777776666
Q ss_pred H------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCch
Q 042809 79 K------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA 152 (241)
Q Consensus 79 ~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 152 (241)
. +|||+++++||||-.+|||++.++.+||+|||++.......... ....-+..|+|||.+..+.|+.+
T Consensus 269 ~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~------~~~klPirWLAPEtl~~~~~s~k 342 (474)
T KOG0194|consen 269 YDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKK------FLKKLPIRWLAPETLNTGIFSFK 342 (474)
T ss_pred HHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeecc------ccccCcceecChhhhccCccccc
Confidence 5 56999999999999999999999999999999986443111000 01124678999999999999999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 153 TDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 153 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
+||||||+++||+++ |..||.+.........+ ...+.+...+...+..+..++.+||..+|.+|||+.++.+
T Consensus 343 TDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI--~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 343 TDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI--VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred cchhheeeeEEeeeccCCCCCCCCCHHHHHHHH--HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 999999999999999 88999876544332222 2334455566678889999999999999999999998764
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=236.74 Aligned_cols=223 Identities=28% Similarity=0.386 Sum_probs=162.9
Q ss_pred CCCCCcEEEEEeccchH----HHHHHHHHHHHHhhcC-CCcccc-----cC-----CceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAESEA----GVQALRNEAEIRQSLN-SPNIGR-----NG-----EKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~-----~~-----~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
++.+|+.||+|...... ....+.+|+.+++.+. ||||++ .. ....|+||||+++ +|.+++....
T Consensus 22 ~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~ 100 (295)
T cd07837 22 DKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNG 100 (295)
T ss_pred ECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhc
Confidence 46789999999876432 2356888999999996 699987 12 2238999999975 8988886532
Q ss_pred ----CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeec-CCCeeecCCCcchhhcccccCCccccccccccCc
Q 042809 67 ----GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS-HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGT 135 (241)
Q Consensus 67 ----~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 135 (241)
..+++..+..++.|+ ||++|++||||+|+||+++. ++.++|+|||++....... .......++
T Consensus 101 ~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~ 174 (295)
T cd07837 101 RGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV------KSYTHEIVT 174 (295)
T ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCc------cccCCcccc
Confidence 346777777666644 79999999999999999998 8899999999986442210 111122457
Q ss_pred ccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC-C---------------CC-----
Q 042809 136 QLWMAPEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN-E---------------KP----- 193 (241)
Q Consensus 136 ~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~---------------~~----- 193 (241)
+.|+|||.+.+ ..++.++|+||||+++|++++|..||.+................ . .+
T Consensus 175 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (295)
T cd07837 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQ 254 (295)
T ss_pred cCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccch
Confidence 78999998865 45688999999999999999999999764322211111100000 0 00
Q ss_pred ---CCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCC
Q 042809 194 ---HFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFIS 231 (241)
Q Consensus 194 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~ 231 (241)
...+..+..+.++|.+||..+|.+|||+++++.||||+
T Consensus 255 ~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 255 DLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00123567899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=231.41 Aligned_cols=214 Identities=25% Similarity=0.390 Sum_probs=165.9
Q ss_pred CCcEEEEEeccc-hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh-CCCCCHHHHHHH
Q 042809 5 TGALFVVKSAES-EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDAGVIRLY 77 (241)
Q Consensus 5 ~~~~vaiK~~~~-~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~ 77 (241)
++..||+|.+.. ....+.+.+|+.+++.++|+||++ ...+..++|+||+.+++|.+++... ...++......+
T Consensus 29 ~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 108 (261)
T cd05072 29 NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF 108 (261)
T ss_pred CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHH
Confidence 456789998764 334578899999999999999988 5667899999999999999999764 345666555555
Q ss_pred HH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+. ++||+.+++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+..++.
T Consensus 109 ~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~ 183 (261)
T cd05072 109 SAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-----TAREGAKFPIKWTAPEAINFGSFTI 183 (261)
T ss_pred HHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce-----eccCCCccceecCCHHHhccCCCCh
Confidence 44 448999999999999999999999999999999976543111 1111223466799999998888899
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++|+||||+++|++++ |..||............ ............+..+.+++.+||..+|++|||++++.+
T Consensus 184 ~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 184 KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL---QRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred hhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH---HcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999998 99999765433322222 222233344457789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=230.47 Aligned_cols=212 Identities=24% Similarity=0.360 Sum_probs=167.6
Q ss_pred CCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhC-CCCCHHHHHHH
Q 042809 3 KGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDAGVIRLY 77 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~ 77 (241)
+.+++.||+|.+..+.....+.+|+.++++++|||+++ ...+..++||||+.+++|.+++.... ..++......+
T Consensus 26 ~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 105 (254)
T cd05083 26 EYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQF 105 (254)
T ss_pred ccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHH
Confidence 34788899999887666678999999999999999988 33445799999999999999998653 34666666555
Q ss_pred HHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+.| +||+.|++||||+|+||+++.++.++|+|||.+...... ......+..|+|||.+.+..++.
T Consensus 106 ~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---------~~~~~~~~~y~~pe~~~~~~~~~ 176 (254)
T cd05083 106 SLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---------VDNSKLPVKWTAPEALKHKKFSS 176 (254)
T ss_pred HHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---------CCCCCCCceecCHHHhccCCcCc
Confidence 554 479999999999999999999999999999988643221 01122356799999998888999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++|+||||+++|++++ |..||........... .........+...+..+.+++++||+.+|.+|||+++++.
T Consensus 177 ~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 177 KSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC---VEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH---HhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999998 9999976544333222 2223333445567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=233.68 Aligned_cols=222 Identities=28% Similarity=0.417 Sum_probs=169.6
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+++.+|+|.+... ...+.+.+|+.++++++|+|+++ ...+..++|+||++ ++|.+++......++..
T Consensus 20 ~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~ 98 (282)
T cd07829 20 DKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPN 98 (282)
T ss_pred ecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHH
Confidence 4567999999987743 33466789999999999999988 56688999999997 59999998854567777
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.++ ||+.|++||||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+
T Consensus 99 ~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~ 172 (282)
T cd07829 99 LIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR------TYTHEVVTLWYRAPEILLG 172 (282)
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc------ccCccccCcCcCChHHhcC
Confidence 777666644 7999999999999999999999999999999875433111 1122335677999999876
Q ss_pred c-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhc-----------------CCCC--------CCChhhH
Q 042809 147 E-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACS-----------------NEKP--------HFPTQFF 200 (241)
Q Consensus 147 ~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------~~~~--------~~~~~~~ 200 (241)
. .++.++|+||||+++|++++|..||................. ...+ ...+..+
T Consensus 173 ~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (282)
T cd07829 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLD 252 (282)
T ss_pred CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhccccc
Confidence 6 788999999999999999999999976543222111111000 0000 0011235
Q ss_pred HHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 201 KKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 201 ~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
..+.+++.+||..+|.+||++++++.||||
T Consensus 253 ~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 253 PEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 689999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=229.88 Aligned_cols=218 Identities=23% Similarity=0.325 Sum_probs=163.6
Q ss_pred CCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 5 TGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 5 ~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
++..+|+|.+.. ....+.+.+|+.+++.++||||++ ..++..++|+||+.+++|.+++...........+.
T Consensus 22 ~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 101 (262)
T cd05058 22 QKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLI 101 (262)
T ss_pred ceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHH
Confidence 456899998753 234567889999999999999987 34556899999999999999998755555555544
Q ss_pred HHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCC
Q 042809 76 LYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL 149 (241)
Q Consensus 76 ~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 149 (241)
.++. .+||+.+++|+||+|+||+++.++.++|+|||++.......... ........++..|+|||.+.+..+
T Consensus 102 ~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~ 179 (262)
T cd05058 102 GFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS--VHNHTGAKLPVKWMALESLQTQKF 179 (262)
T ss_pred HHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee--ecccccCcCCccccChhHhccCcc
Confidence 4444 44899999999999999999999999999999987543211000 011112335678999999988889
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 150 DFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
+.++||||||+++|++++ |.+||...... ...........+..+...+..+.+++.+||..+|.+||++.+++..
T Consensus 180 ~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 180 TTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred chHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999 55666543222 2223333334444455567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=232.63 Aligned_cols=216 Identities=20% Similarity=0.305 Sum_probs=167.9
Q ss_pred CCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC--------
Q 042809 4 GTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG-------- 67 (241)
Q Consensus 4 ~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~-------- 67 (241)
.++..||+|.+... .....+.+|+.+++.++||||++ ......++||||+++++|.+++.....
T Consensus 34 ~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~ 113 (277)
T cd05032 34 EPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGL 113 (277)
T ss_pred CcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCC
Confidence 45688999997633 33456889999999999999988 566789999999999999999976321
Q ss_pred -CCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 68 -TLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 68 -~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
.+++..+..++. .+||+.+++|+||+|+||+++.++.++|+|||++........ ........++..|+|
T Consensus 114 ~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~a 189 (277)
T cd05032 114 GPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY----YRKGGKGLLPVRWMA 189 (277)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcc----cccCCCCCccccccC
Confidence 244455554444 447999999999999999999999999999999875433111 111122335678999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 219 (241)
||.+.+..++.++|+||||+++|++++ |..||.......... ..........+...+..+.+++.+||+.+|.+||
T Consensus 190 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 266 (277)
T cd05032 190 PESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK---FVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRP 266 (277)
T ss_pred HHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH---HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCC
Confidence 999988888999999999999999998 999997654433332 2223444555666788999999999999999999
Q ss_pred ChHHHhc
Q 042809 220 SAEELLN 226 (241)
Q Consensus 220 s~~~~l~ 226 (241)
|+.++++
T Consensus 267 t~~~l~~ 273 (277)
T cd05032 267 TFLEIVS 273 (277)
T ss_pred CHHHHHH
Confidence 9999976
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=235.92 Aligned_cols=220 Identities=30% Similarity=0.423 Sum_probs=170.5
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.++..+|+|.+.. ......+.+|+++++.++|+|+++ ......++|+||+. |+|.+++......++.
T Consensus 36 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~ 114 (308)
T cd06634 36 DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE 114 (308)
T ss_pred EcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCH
Confidence 456789999998752 233456889999999999999988 46678999999996 6888888765666777
Q ss_pred HHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.+ +||+.+++||||+|+||+++.++.++|+|||++..... .....++..|+|||.+.
T Consensus 115 ~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----------~~~~~~~~~y~aPE~~~ 184 (308)
T cd06634 115 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----------ANXFVGTPYWMAPEVIL 184 (308)
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----------cccccCCccccCHHHHh
Confidence 777666554 47999999999999999999999999999998864432 11234678899999975
Q ss_pred ---ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 146 ---NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 146 ---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
...++.++||||||+++|++++|..||............ .............+..+.++|.+||..+|.+||+++
T Consensus 185 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~ 262 (308)
T cd06634 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 262 (308)
T ss_pred hcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH--hhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHH
Confidence 345678999999999999999999998664322221111 111112222345677899999999999999999999
Q ss_pred HHhcCCCCCCCC
Q 042809 223 ELLNHTFISGNA 234 (241)
Q Consensus 223 ~~l~~p~~~~~~ 234 (241)
+++.|||+....
T Consensus 263 ~ll~~~~~~~~~ 274 (308)
T cd06634 263 VLLKHRFVLRER 274 (308)
T ss_pred HHhhCccccccC
Confidence 999999997754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=241.52 Aligned_cols=224 Identities=23% Similarity=0.369 Sum_probs=168.6
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCC------ceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGE------KTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~------~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
++.+++.||+|.+.. ......+.+|+.++++++|||+++ ... ...++|+||+ +++|.+++..
T Consensus 36 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-- 112 (343)
T cd07851 36 DTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-- 112 (343)
T ss_pred ECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc--
Confidence 456789999998763 233466788999999999999987 222 2489999999 5799999875
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..+++..+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++...... .....++..|+|
T Consensus 113 ~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---------~~~~~~~~~y~a 183 (343)
T cd07851 113 QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---------MTGYVATRWYRA 183 (343)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc---------ccCCcccccccC
Confidence 467777766666544 79999999999999999999999999999998754321 122346788999
Q ss_pred cccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC------------------------CCC-
Q 042809 141 PEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE------------------------KPH- 194 (241)
Q Consensus 141 PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------~~~- 194 (241)
||.+.+ ..++.++|+||||+++|++++|+.||.+................. ...
T Consensus 184 PE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (343)
T cd07851 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDF 263 (343)
T ss_pred HHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCH
Confidence 999865 457889999999999999999999997643322211111110000 000
Q ss_pred --CChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCccC
Q 042809 195 --FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKN 237 (241)
Q Consensus 195 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~~ 237 (241)
.....+..+.+++.+||+.+|.+|||+.+++.||||+......
T Consensus 264 ~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~ 308 (343)
T cd07851 264 KEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE 308 (343)
T ss_pred HHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence 0112467899999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=229.18 Aligned_cols=214 Identities=25% Similarity=0.355 Sum_probs=167.2
Q ss_pred CcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHH
Q 042809 6 GALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLY 77 (241)
Q Consensus 6 ~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 77 (241)
++.|++|.+... .....+.+|+++++++.|+||++ ......++|+||+++++|.+++......++...+..+
T Consensus 19 ~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~ 98 (251)
T cd05041 19 NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQM 98 (251)
T ss_pred CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHH
Confidence 889999987743 24567899999999999999987 6677899999999999999999875556677666555
Q ss_pred HH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+. ++||+++++|+||+|+||+++.++.++|+|||.+........ .........+..|+|||.+.+..++.
T Consensus 99 ~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~ 174 (251)
T cd05041 99 SLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY----TVSDGLKQIPIKWTAPEALNYGRYTS 174 (251)
T ss_pred HHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc----eeccccCcceeccCChHhhccCCCCc
Confidence 44 448999999999999999999999999999999875432110 00001122356699999998888999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++|+||||+++|++++ |..||............. .......+...+..+.+++.+||..+|.+|||+.++++
T Consensus 175 ~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE---SGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred chhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh---cCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 9999999999999999 889987654433322222 22233445567789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=232.11 Aligned_cols=212 Identities=24% Similarity=0.315 Sum_probs=165.5
Q ss_pred EEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHH
Q 042809 8 LFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKE 80 (241)
Q Consensus 8 ~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 80 (241)
.+++|..... .....+.+|+..+.++.||||++ ......++++||+.+|+|.+++......+++..+..++.|
T Consensus 38 ~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~q 117 (279)
T cd05111 38 PVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ 117 (279)
T ss_pred EEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHH
Confidence 4788887632 23466788888999999999998 3455678999999999999999876667788777777665
Q ss_pred H------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhh
Q 042809 81 I------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATD 154 (241)
Q Consensus 81 ~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 154 (241)
+ ||++|++|+||+|+||+++.++.++|+|||.+........ ........++..|+|||.+.+..++.++|
T Consensus 118 i~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~~pE~~~~~~~~~~~D 193 (279)
T cd05111 118 IAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK----KYFYSEHKTPIKWMALESILFGRYTHQSD 193 (279)
T ss_pred HHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc----ccccCCCCCcccccCHHHhccCCcCchhh
Confidence 5 7999999999999999999999999999999875432111 11122334667899999999888999999
Q ss_pred HHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 155 IWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 155 i~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
+||||+++|++++ |..||.+.......... ..+.....+...+.++.+++.+||..+|.+|||+.+++.
T Consensus 194 v~slG~il~el~t~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 194 VWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL---EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999998 99999765433332222 223333344456678899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=234.66 Aligned_cols=223 Identities=29% Similarity=0.461 Sum_probs=168.8
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCC--ceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGE--KTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+|+.+|+|.+... .....+.+|+.+++.++|+|+++ ... +..++|+||++ ++|.+++......++
T Consensus 20 ~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~ 98 (287)
T cd07840 20 NKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFT 98 (287)
T ss_pred ECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccCCCCC
Confidence 4567899999998743 23456889999999999999987 333 78999999997 499999887555778
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+
T Consensus 99 ~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~ 173 (287)
T cd07840 99 ESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-----ADYTNRVITLWYRPPELL 173 (287)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-----ccccccccccccCCceee
Confidence 87777666654 7999999999999999999999999999999976544211 111223457789999987
Q ss_pred cc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC-------------------CCCC--------C
Q 042809 145 RN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE-------------------KPHF--------P 196 (241)
Q Consensus 145 ~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------~~~~--------~ 196 (241)
.+ ..++.++|+||||+++|++++|..||................... .... .
T Consensus 174 ~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T cd07840 174 LGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFK 253 (287)
T ss_pred EccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhc
Confidence 65 457889999999999999999999997654332222211111000 0000 0
Q ss_pred hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 197 TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 197 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
..++..+.+++++||..+|.+|||+++++.||||
T Consensus 254 ~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 254 HLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 1126788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=236.11 Aligned_cols=227 Identities=29% Similarity=0.455 Sum_probs=169.5
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+|+.||+|.+... .....+..|+.++.+.. ||||++ ......|+||||+. ++|.+++......+++.
T Consensus 36 ~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~ 114 (296)
T cd06618 36 FKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPED 114 (296)
T ss_pred ECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcCCCCHH
Confidence 3456899999998642 33455667777666665 999988 56778999999995 58888887756677777
Q ss_pred HHHHHHHHH------hhc-CCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 73 VIRLYTKEI------LHG-NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 73 ~~~~~~~~~------Lh~-~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
.+..++.++ ||+ .|++||||+|+||+++.++.++|+|||++........ .....++..|+|||.+.
T Consensus 115 ~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~-------~~~~~~~~~y~aPE~~~ 187 (296)
T cd06618 115 ILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-------KTRSAGCAAYMAPERID 187 (296)
T ss_pred HHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-------ccCCCCCccccCHhhcC
Confidence 766666544 797 6999999999999999999999999999865432111 11223677899999987
Q ss_pred ccC----CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC--hhhHHHHHHHHHHhhccCCCCCC
Q 042809 146 NEG----LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP--TQFFKKVLDFLAKCLERKPEKRW 219 (241)
Q Consensus 146 ~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp 219 (241)
+.. ++.++|+||||+++|++++|..||...... ............+..+ ...+..+.+++.+||..+|.+||
T Consensus 188 ~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 265 (296)
T cd06618 188 PPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRP 265 (296)
T ss_pred CCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCC
Confidence 553 678999999999999999999999653221 1112222222222222 23577899999999999999999
Q ss_pred ChHHHhcCCCCCCCCccCC
Q 042809 220 SAEELLNHTFISGNAKKNS 238 (241)
Q Consensus 220 s~~~~l~~p~~~~~~~~~~ 238 (241)
|++++++||||.....+.+
T Consensus 266 ~~~~il~~~~~~~~~~~~~ 284 (296)
T cd06618 266 KYRELLQHPFIRRYETAEV 284 (296)
T ss_pred CHHHHhcChhhhccchhHH
Confidence 9999999999987655443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=238.27 Aligned_cols=222 Identities=26% Similarity=0.390 Sum_probs=163.5
Q ss_pred CCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCC--ceeeeeecccCCCCHHHHHHHhC----CC
Q 042809 5 TGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGE--KTVNIFMEYMAGGSLLDVAEKFG----GT 68 (241)
Q Consensus 5 ~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~--~~~~lv~e~~~~~~L~~~l~~~~----~~ 68 (241)
+|..||+|.+.. ....+.+.+|+.+++.++||||++ ... ..+++|+||+++ +|.+++.... ..
T Consensus 26 ~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~ 104 (316)
T cd07842 26 DGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVS 104 (316)
T ss_pred CCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcC
Confidence 789999999875 334567889999999999999988 333 789999999974 7777765432 25
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeec----CCCeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS----HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~----~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
+++..+..++.|+ ||+.+++|+||+|+||+++. ++.+||+|||++......... ........++..|
T Consensus 105 ~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~~y 181 (316)
T cd07842 105 IPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP---LADLDPVVVTIWY 181 (316)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCccc---ccccCCccccccc
Confidence 6777766665544 79999999999999999999 899999999998755332111 1111234568889
Q ss_pred cCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhch----------HHHHHHHH--------------------
Q 042809 139 MAPEVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNA----------AATLLKIA-------------------- 187 (241)
Q Consensus 139 ~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----------~~~~~~~~-------------------- 187 (241)
+|||.+.+. .++.++|+||||++++++++|+.||.+..... ........
T Consensus 182 ~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (316)
T cd07842 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTL 261 (316)
T ss_pred cCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhh
Confidence 999988764 57889999999999999999999997543322 00000000
Q ss_pred -hcCCCCCCC-----------hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 188 -CSNEKPHFP-----------TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 188 -~~~~~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
........+ ...+..+.+++.+||+.+|++|||+.++++||||
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 262 MKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 000001111 0344578999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=228.56 Aligned_cols=210 Identities=26% Similarity=0.390 Sum_probs=169.2
Q ss_pred CCcEEEEEeccchHH-HHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC-CCCHHHHHHH
Q 042809 5 TGALFVVKSAESEAG-VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG-TLDAGVIRLY 77 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~ 77 (241)
.|+.||+|.+..... .+.+.+|+.+++.++|+||++ ......++||||+++++|.+++..... .+++..+..+
T Consensus 28 ~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 107 (256)
T cd05039 28 RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGF 107 (256)
T ss_pred cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHH
Confidence 478899999886654 678999999999999999988 557889999999999999999987432 5677777766
Q ss_pred HHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+.|+ ||+.|++|+||+|+||+++.++.++|+|||.+........ ....+..|+|||.+.+..++.
T Consensus 108 ~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---------~~~~~~~~~ape~~~~~~~~~ 178 (256)
T cd05039 108 ALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---------SGKLPVKWTAPEALREKKFST 178 (256)
T ss_pred HHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc---------cCCCcccccCchhhcCCcCCc
Confidence 6654 7999999999999999999999999999999976532111 122356799999998888899
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++|+||||+++|++++ |..||............ ........+...++.+.+++.+||..+|.+|||+.+++.
T Consensus 179 ~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV---EKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---hcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 9999999999999997 99999765433332222 222333445567789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=229.81 Aligned_cols=212 Identities=25% Similarity=0.393 Sum_probs=164.4
Q ss_pred cEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHh-CCCCCHHHHHHHHHH
Q 042809 7 ALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDAGVIRLYTKE 80 (241)
Q Consensus 7 ~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~ 80 (241)
..||+|.+... ...+.+.+|+.++++++||||++ ......++||||+.+++|.+++... +..+++..+..++.+
T Consensus 31 ~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~ 110 (262)
T cd05071 31 TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 110 (262)
T ss_pred ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHH
Confidence 46899998753 33567899999999999999987 4456689999999999999999864 334666666665554
Q ss_pred H------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhh
Q 042809 81 I------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATD 154 (241)
Q Consensus 81 ~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 154 (241)
+ ||+.+++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||...+..++.++|
T Consensus 111 l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~D 185 (262)
T cd05071 111 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-----TARQGAKFPIKWTAPEAALYGRFTIKSD 185 (262)
T ss_pred HHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc-----ccccCCcccceecCHhHhccCCCCchhh
Confidence 4 7999999999999999999999999999999865433111 1111223567799999998888999999
Q ss_pred HHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 155 IWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 155 i~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
+||||+++|++++ |..||.+....... ...........+...+..+.+++.+||+.+|.+|||++++++
T Consensus 186 vwslG~~l~ellt~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 186 VWSFGILLTELTTKGRVPYPGMVNREVL---DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCChHHHH---HHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 9999999999999 88899765433222 222223333445667889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=230.55 Aligned_cols=217 Identities=21% Similarity=0.322 Sum_probs=167.2
Q ss_pred CcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHH
Q 042809 6 GALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLY 77 (241)
Q Consensus 6 ~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 77 (241)
+..||+|.+.. +.....+..|+.+++.++||||++ ..+...++||||+++++|.+++....+.++...+..+
T Consensus 32 ~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i 111 (269)
T cd05065 32 EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGM 111 (269)
T ss_pred ceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHH
Confidence 34799999773 344678999999999999999988 5677899999999999999999876666777777766
Q ss_pred HHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+.|+ ||++|++|+||+|+||+++.++.++|+|||.+............... .....+..|+|||.+.+..++.
T Consensus 112 ~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~ 190 (269)
T cd05065 112 LRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS-LGGKIPIRWTAPEAIAYRKFTS 190 (269)
T ss_pred HHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccc-cCCCcceeecCHhHhccCcccc
Confidence 6544 79999999999999999999999999999988654331111110000 0011235799999999888999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++|+||||+++|++++ |..||............ ........+...+..+.+++.+||..+|.+||++++++.
T Consensus 191 ~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 191 ASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI---EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred hhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH---HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999887 99999765433322222 222333444566788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=236.40 Aligned_cols=228 Identities=28% Similarity=0.421 Sum_probs=167.2
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-------------cCCceeeeeecccCCCCHHHHHHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-------------NGEKTVNIFMEYMAGGSLLDVAEK 64 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-------------~~~~~~~lv~e~~~~~~L~~~l~~ 64 (241)
++.+|+.+|+|.+... .....+.+|+++++.++||||++ .....+++|+||+. ++|...+..
T Consensus 29 ~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~ 107 (311)
T cd07866 29 QIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLEN 107 (311)
T ss_pred ECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhc
Confidence 4678899999987532 22345778999999999999987 11345799999996 478887776
Q ss_pred hCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCc-----ccccccccc
Q 042809 65 FGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGN-----LKQSWQSIG 133 (241)
Q Consensus 65 ~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~-----~~~~~~~~~ 133 (241)
....+++..+..++.|+ ||++|++|+||+|+||+++.++.++|+|||++........... .........
T Consensus 108 ~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (311)
T cd07866 108 PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187 (311)
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccce
Confidence 55678888877776655 7999999999999999999999999999999975533211111 111222345
Q ss_pred CcccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCC-------------------C
Q 042809 134 GTQLWMAPEVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK-------------------P 193 (241)
Q Consensus 134 ~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------~ 193 (241)
+++.|+|||.+.+. .++.++|+||+|+++|++++|..||.+.................. .
T Consensus 188 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (311)
T cd07866 188 VTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFT 267 (311)
T ss_pred eccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCC
Confidence 67889999988654 478899999999999999999999976544332222211111000 0
Q ss_pred CCC-------hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 194 HFP-------TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 194 ~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
..+ ......+.+++.+||+.+|.+|||+.+++.||||
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 268 NYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 001 1233578899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=237.91 Aligned_cols=227 Identities=24% Similarity=0.359 Sum_probs=169.4
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+.. ....+.+.+|++++..++||||++ ......++|+||+ +++|.+++.. ..++.
T Consensus 31 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~ 107 (328)
T cd07856 31 DQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS--RPLEK 107 (328)
T ss_pred ECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc--CCCCH
Confidence 567899999998653 234567889999999999999988 3355789999999 5699988874 34566
Q ss_pred HHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++. ++||+.|++|+||+|+||+++.++.++|+|||.+..... ......++..|+|||.+.
T Consensus 108 ~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---------~~~~~~~~~~y~aPE~~~ 178 (328)
T cd07856 108 QFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---------QMTGYVSTRYYRAPEIML 178 (328)
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---------CcCCCcccccccCceeee
Confidence 55555544 448999999999999999999999999999999864322 111234677899999886
Q ss_pred c-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHh----------------------cCCCCCC-----Ch
Q 042809 146 N-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIAC----------------------SNEKPHF-----PT 197 (241)
Q Consensus 146 ~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------~~~~~~~-----~~ 197 (241)
+ ..++.++|+||||+++|++++|..||................ ....... ..
T Consensus 179 ~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (328)
T cd07856 179 TWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFK 258 (328)
T ss_pred ccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcC
Confidence 5 567899999999999999999999996543221111111000 0000111 12
Q ss_pred hhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCccCCCC
Q 042809 198 QFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKNSTE 240 (241)
Q Consensus 198 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~~~~~ 240 (241)
..+..+.++|++||+.+|.+|||+++++.||||.....+.+.+
T Consensus 259 ~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~ 301 (328)
T cd07856 259 NADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEP 301 (328)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcccc
Confidence 3467899999999999999999999999999998776665543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=235.19 Aligned_cols=217 Identities=22% Similarity=0.346 Sum_probs=167.0
Q ss_pred CCCcEEEEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHh---------
Q 042809 4 GTGALFVVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF--------- 65 (241)
Q Consensus 4 ~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~--------- 65 (241)
..+..+|+|.+.. +.....+.+|+.++.++ +|+||++ ..++.+++||||+.+++|.+++...
T Consensus 40 ~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~ 119 (293)
T cd05053 40 NETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASP 119 (293)
T ss_pred CCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCcccccc
Confidence 3457899998764 23446688999999999 7999988 5667899999999999999999753
Q ss_pred ------CCCCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCcccccccccc
Q 042809 66 ------GGTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIG 133 (241)
Q Consensus 66 ------~~~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 133 (241)
...++...+..++.| +||+.|++||||+|+||+++.++.++|+|||.+........ ........
T Consensus 120 ~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~ 195 (293)
T cd05053 120 DDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY----YRKTTNGR 195 (293)
T ss_pred ccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccc----eeccCCCC
Confidence 234566655555554 48999999999999999999999999999999875433111 11111122
Q ss_pred CcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhc
Q 042809 134 GTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLE 212 (241)
Q Consensus 134 ~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 212 (241)
++..|+|||.+.+..++.++||||||+++|++++ |..||.......... ..........+...+..+.+++.+||.
T Consensus 196 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~ 272 (293)
T cd05053 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK---LLKEGYRMEKPQNCTQELYHLMRDCWH 272 (293)
T ss_pred CCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH---HHHcCCcCCCCCCCCHHHHHHHHHHcc
Confidence 4567999999988889999999999999999998 999997654333222 222333444556677899999999999
Q ss_pred cCCCCCCChHHHhcC
Q 042809 213 RKPEKRWSAEELLNH 227 (241)
Q Consensus 213 ~~p~~Rps~~~~l~~ 227 (241)
.+|++|||+.+++++
T Consensus 273 ~~p~~Rps~~eil~~ 287 (293)
T cd05053 273 EVPSQRPTFKQLVED 287 (293)
T ss_pred cCcccCcCHHHHHHH
Confidence 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=241.94 Aligned_cols=216 Identities=28% Similarity=0.322 Sum_probs=162.9
Q ss_pred CCcEEEEEeccc---hHHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhC---------
Q 042809 5 TGALFVVKSAES---EAGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG--------- 66 (241)
Q Consensus 5 ~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 66 (241)
++..||+|++.. ....+.+.+|+.++.++. ||||++ ...+..|+|||||++|+|.+++....
T Consensus 66 ~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~ 145 (400)
T cd05105 66 PVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPE 145 (400)
T ss_pred CceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccc
Confidence 345799999863 233567899999999996 999998 56778999999999999999886531
Q ss_pred --------------------------------------------------------------------------------
Q 042809 67 -------------------------------------------------------------------------------- 66 (241)
Q Consensus 67 -------------------------------------------------------------------------------- 66 (241)
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 225 (400)
T cd05105 146 KPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNL 225 (400)
T ss_pred cccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHH
Confidence
Q ss_pred ------CCCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccC
Q 042809 67 ------GTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGG 134 (241)
Q Consensus 67 ------~~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 134 (241)
..++...+..++. .+||+.+++|+||+|+||+++.++.++|+|||++........ ........+
T Consensus 226 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~----~~~~~~~~~ 301 (400)
T cd05105 226 LSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSN----YVSKGSTFL 301 (400)
T ss_pred HHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceecccccc----ccccCCcCC
Confidence 1233333344443 458999999999999999999999999999999875432111 111122335
Q ss_pred cccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhcc
Q 042809 135 TQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLER 213 (241)
Q Consensus 135 ~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 213 (241)
+..|+|||.+.+..++.++||||||+++|++++ |..||......... ............+...+..+.+++.+||+.
T Consensus 302 ~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 379 (400)
T cd05105 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--YNKIKSGYRMAKPDHATQEVYDIMVKCWNS 379 (400)
T ss_pred CcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--HHHHhcCCCCCCCccCCHHHHHHHHHHCcc
Confidence 678999999988889999999999999999997 99998654322211 111222233445566788999999999999
Q ss_pred CCCCCCChHHHhc
Q 042809 214 KPEKRWSAEELLN 226 (241)
Q Consensus 214 ~p~~Rps~~~~l~ 226 (241)
+|++|||+.++.+
T Consensus 380 dP~~RPt~~~l~~ 392 (400)
T cd05105 380 EPEKRPSFLHLSD 392 (400)
T ss_pred CHhHCcCHHHHHH
Confidence 9999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=233.76 Aligned_cols=219 Identities=21% Similarity=0.313 Sum_probs=166.0
Q ss_pred CCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC---------
Q 042809 4 GTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG--------- 66 (241)
Q Consensus 4 ~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 66 (241)
..+..||+|.+... ...+.+.+|++++.+++||||++ ..++..++|+||+.+++|.+++....
T Consensus 44 ~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 123 (296)
T cd05051 44 DAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123 (296)
T ss_pred CCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhccccccccccc
Confidence 35577999997743 34667899999999999999988 55688999999999999999998743
Q ss_pred -CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccccc
Q 042809 67 -GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139 (241)
Q Consensus 67 -~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (241)
..++...+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++....... .........++..|+
T Consensus 124 ~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~y~ 199 (296)
T cd05051 124 SKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD----YYRVQGRAPLPIRWM 199 (296)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCc----ceeecCcCCCCceec
Confidence 156777776666544 799999999999999999999999999999986543211 011112334567899
Q ss_pred CcccccccCCCchhhHHHHHHHHHHHHh--CCCCCccchhchHHHHHHHH----hcCCCCCCChhhHHHHHHHHHHhhcc
Q 042809 140 APEVLRNEGLDFATDIWSLGCMVIEMAT--GRPPWGDKISNAAATLLKIA----CSNEKPHFPTQFFKKVLDFLAKCLER 213 (241)
Q Consensus 140 aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~ 213 (241)
|||.+.+..++.++||||||+++|++++ +..||............... ........+...+.++.+++.+||+.
T Consensus 200 aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 279 (296)
T cd05051 200 AWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRR 279 (296)
T ss_pred CHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhcc
Confidence 9999988889999999999999999998 77888654332222111111 01111223445668999999999999
Q ss_pred CCCCCCChHHHhc
Q 042809 214 KPEKRWSAEELLN 226 (241)
Q Consensus 214 ~p~~Rps~~~~l~ 226 (241)
+|.+|||+.++++
T Consensus 280 ~p~~Rpt~~el~~ 292 (296)
T cd05051 280 DEEDRPTFREIHL 292 (296)
T ss_pred ChhcCCCHHHHHH
Confidence 9999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=229.82 Aligned_cols=214 Identities=24% Similarity=0.378 Sum_probs=165.7
Q ss_pred CCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHh-CCCCCHHHHHHHH
Q 042809 5 TGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDAGVIRLYT 78 (241)
Q Consensus 5 ~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ 78 (241)
++..+|+|.+... ...+.+.+|+.++++++|+|+++ ......++||||+++++|.+++... ...++...+..++
T Consensus 29 ~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ 108 (260)
T cd05070 29 GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA 108 (260)
T ss_pred CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHH
Confidence 4567899987742 33467899999999999999988 4455689999999999999999764 2346766666655
Q ss_pred HH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCch
Q 042809 79 KE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA 152 (241)
Q Consensus 79 ~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 152 (241)
.+ +||+.|++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||...+..++.+
T Consensus 109 ~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~ 183 (260)
T cd05070 109 AQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-----TARQGAKFPIKWTAPEAALYGRFTIK 183 (260)
T ss_pred HHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-----ccccCCCCCccccChHHHhcCCCcch
Confidence 54 47999999999999999999999999999999975433110 01111224567999999988888999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 153 TDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 153 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
+|+||||+++|++++ |..||.+..... .............+...+..+.+++.+||..+|.+|||++++.+
T Consensus 184 ~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 184 SDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred hhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 999999999999999 899997643322 22222233344556677889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=239.28 Aligned_cols=225 Identities=23% Similarity=0.343 Sum_probs=168.9
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCC------ceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGE------KTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~------~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
+..+|+.||+|.+.. ......+.+|+.++++++||||++ ..+ ...++|+||+ +++|.+++..
T Consensus 36 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-- 112 (343)
T cd07880 36 DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-- 112 (343)
T ss_pred ECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc--
Confidence 567899999998753 233456889999999999999987 111 2468999999 6799988875
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..+++..+..++.|+ ||+.|++||||+|+||+++.++.++|+|||++...... .....+++.|+|
T Consensus 113 ~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~y~a 183 (343)
T cd07880 113 EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE---------MTGYVVTRWYRA 183 (343)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC---------ccccccCCcccC
Confidence 467777777766654 79999999999999999999999999999998754321 112346788999
Q ss_pred cccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC-----------------------CC----
Q 042809 141 PEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN-----------------------EK---- 192 (241)
Q Consensus 141 PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------~~---- 192 (241)
||.+.+ ..++.++|+||+|+++|++++|..||.+................ ..
T Consensus 184 PE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (343)
T cd07880 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDF 263 (343)
T ss_pred HHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchH
Confidence 999876 45788999999999999999999999764322111110000000 00
Q ss_pred CCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCccCC
Q 042809 193 PHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKNS 238 (241)
Q Consensus 193 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~~~ 238 (241)
.......+..+.+++.+|++.+|.+|||+.+++.||||+......+
T Consensus 264 ~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~ 309 (343)
T cd07880 264 RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPED 309 (343)
T ss_pred HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccc
Confidence 0011235567899999999999999999999999999987655433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=246.46 Aligned_cols=215 Identities=24% Similarity=0.357 Sum_probs=180.6
Q ss_pred CCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 4 GTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 4 ~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
+.+--||||..+. ....+.|.+|+-+|+.++||||++ -.+...|+|||.+..|.|.+|++.....++......
T Consensus 416 ge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~l 495 (974)
T KOG4257|consen 416 GERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVMELAPLGELREYLQQNKDSLPLRTLTL 495 (974)
T ss_pred CcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEecccchhHHHHHHhccccchHHHHHH
Confidence 3445588888663 355788999999999999999999 567889999999999999999999888899999888
Q ss_pred HHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCC
Q 042809 77 YTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD 150 (241)
Q Consensus 77 ~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 150 (241)
++.|+ ||++++|||||...||++++...+||+|||++...++...... . ...-+.-|+|||.+..+.++
T Consensus 496 y~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka----S-~~kLPIKWmaPESINfRrFT 570 (974)
T KOG4257|consen 496 YCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA----S-RGKLPIKWMAPESINFRRFT 570 (974)
T ss_pred HHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhc----c-ccccceeecCccccchhccc
Confidence 88876 7999999999999999999999999999999998766322111 1 11124569999999999999
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 151 FATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 151 ~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
.++|||.||+++||++. |..||.+-...+. +.....+.+.+.|+.+|+.++.|+.+||+.+|.+||++.++..
T Consensus 571 tASDVWMFgVCmWEIl~lGvkPfqgvkNsDV---I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 571 TASDVWMFGVCMWEILSLGVKPFQGVKNSDV---IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred chhhHHHHHHHHHHHHHhcCCccccccccce---EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 99999999999999998 9999987544332 2233457788899999999999999999999999999988753
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=229.13 Aligned_cols=214 Identities=22% Similarity=0.325 Sum_probs=165.7
Q ss_pred cEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 7 ALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 7 ~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
..+++|.+.. ....+.+.+|++++++++|||+++ ...+..++||||+++++|.+++......++...+..++
T Consensus 34 ~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 113 (268)
T cd05063 34 VAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGML 113 (268)
T ss_pred eEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHH
Confidence 4799998763 334567899999999999999988 66678999999999999999998765667777766655
Q ss_pred H------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCch
Q 042809 79 K------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA 152 (241)
Q Consensus 79 ~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 152 (241)
. ++||+.|++|+||+|+||+++.++.++++|||++.......... ........+..|+|||.+.+..++.+
T Consensus 114 ~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~ 190 (268)
T cd05063 114 RGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT---YTTSGGKIPIRWTAPEAIAYRKFTSA 190 (268)
T ss_pred HHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccc---eeccCCCcCceecCHHHhhcCCcChH
Confidence 5 44899999999999999999999999999999986543211110 00111123457999999988888999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 153 TDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 153 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
+|+||||+++|++++ |..||............ ........+...+..+.+++.+||+.+|.+||++.++++
T Consensus 191 ~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 191 SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI---NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred hHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH---hcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 999999999999998 99999764433322222 222333344556788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=234.43 Aligned_cols=215 Identities=23% Similarity=0.343 Sum_probs=163.7
Q ss_pred CCcEEEEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC---------
Q 042809 5 TGALFVVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG--------- 66 (241)
Q Consensus 5 ~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 66 (241)
++..+|+|.+.. ......+.+|+.+++++ +||||++ ...+..++|+||+.+|+|.+++....
T Consensus 43 ~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~ 122 (314)
T cd05099 43 QTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD 122 (314)
T ss_pred cceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCccccccc
Confidence 456799998773 33456788999999999 5999988 45677999999999999999998642
Q ss_pred ------CCCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccC
Q 042809 67 ------GTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGG 134 (241)
Q Consensus 67 ------~~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 134 (241)
..++...+..++. ++||++|++|+||+|+||+++.++.++|+|||.+.......... ......+
T Consensus 123 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~ 198 (314)
T cd05099 123 ITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK----KTSNGRL 198 (314)
T ss_pred ccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEcccccccccccccccc----ccccCCC
Confidence 2355554444443 45899999999999999999999999999999997553311111 0111123
Q ss_pred cccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhcc
Q 042809 135 TQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLER 213 (241)
Q Consensus 135 ~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 213 (241)
+..|+|||.+.+..++.++|+||||+++|++++ |..||............ ........+...+.++.+++.+||+.
T Consensus 199 ~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~ 275 (314)
T cd05099 199 PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL---REGHRMDKPSNCTHELYMLMRECWHA 275 (314)
T ss_pred CccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 457999999988889999999999999999999 89999765433333222 22333344566778899999999999
Q ss_pred CCCCCCChHHHhc
Q 042809 214 KPEKRWSAEELLN 226 (241)
Q Consensus 214 ~p~~Rps~~~~l~ 226 (241)
+|.+|||+.++++
T Consensus 276 ~p~~Rps~~~ll~ 288 (314)
T cd05099 276 VPTQRPTFKQLVE 288 (314)
T ss_pred CcccCcCHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=228.78 Aligned_cols=212 Identities=22% Similarity=0.352 Sum_probs=163.9
Q ss_pred cEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhC-CCCCHHHHHHHHHH
Q 042809 7 ALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDAGVIRLYTKE 80 (241)
Q Consensus 7 ~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~ 80 (241)
..+|+|.+... ...+.+.+|+.++++++|+|+++ ...+..++||||+.+++|.+++.... ..++...+..++.+
T Consensus 31 ~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~ 110 (260)
T cd05069 31 TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQ 110 (260)
T ss_pred ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHH
Confidence 46889987643 33467889999999999999988 44566899999999999999998643 34666666555554
Q ss_pred ------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhh
Q 042809 81 ------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATD 154 (241)
Q Consensus 81 ------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 154 (241)
+||+.|++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||...+...+.++|
T Consensus 111 l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~y~~Pe~~~~~~~~~~~D 185 (260)
T cd05069 111 IADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-----TARQGAKFPIKWTAPEAALYGRFTIKSD 185 (260)
T ss_pred HHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-----cccCCCccchhhCCHHHhccCCcChHHH
Confidence 47999999999999999999999999999999865432110 1111223466799999998888999999
Q ss_pred HHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 155 IWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 155 i~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
+||||+++|++++ |..||.+........ ..........+...+..+.+++++||..+|.+|||++++++
T Consensus 186 i~slG~~l~el~t~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 186 VWSFGILLTELVTKGRVPYPGMVNREVLE---QVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999 999997654333222 22223334455667889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=234.53 Aligned_cols=216 Identities=22% Similarity=0.325 Sum_probs=165.7
Q ss_pred CCcEEEEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC---------
Q 042809 5 TGALFVVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG--------- 66 (241)
Q Consensus 5 ~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 66 (241)
++..+|+|.+.. +.....+.+|+.++..+ +||||++ ...+..|+||||+.+++|.+++....
T Consensus 49 ~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~ 128 (307)
T cd05098 49 RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYN 128 (307)
T ss_pred ccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccc
Confidence 446799999874 33456788999999999 6999988 56678999999999999999998642
Q ss_pred ------CCCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccC
Q 042809 67 ------GTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGG 134 (241)
Q Consensus 67 ------~~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 134 (241)
..++...+..++. ++||+.|++|+||+|+||+++.++.++|+|||.+......... .......+
T Consensus 129 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~----~~~~~~~~ 204 (307)
T cd05098 129 PTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----KKTTNGRL 204 (307)
T ss_pred cccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchh----hccccCCC
Confidence 1355555555544 4589999999999999999999999999999998654321100 00111223
Q ss_pred cccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhcc
Q 042809 135 TQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLER 213 (241)
Q Consensus 135 ~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 213 (241)
+..|+|||.+.+..++.++|+||||+++|++++ |..||........... .........+...+.++.+++.+||..
T Consensus 205 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~ 281 (307)
T cd05098 205 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL---LKEGHRMDKPSNCTNELYMMMRDCWHA 281 (307)
T ss_pred ccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH---HHcCCCCCCCCcCCHHHHHHHHHHccc
Confidence 467999999988889999999999999999998 8899876543332222 222333455666788999999999999
Q ss_pred CCCCCCChHHHhcC
Q 042809 214 KPEKRWSAEELLNH 227 (241)
Q Consensus 214 ~p~~Rps~~~~l~~ 227 (241)
+|.+|||+.+++++
T Consensus 282 ~p~~Rps~~evl~~ 295 (307)
T cd05098 282 VPSQRPTFKQLVED 295 (307)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=235.01 Aligned_cols=223 Identities=29% Similarity=0.434 Sum_probs=166.6
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cC----------CceeeeeecccCCCCHHHHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NG----------EKTVNIFMEYMAGGSLLDVA 62 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~----------~~~~~lv~e~~~~~~L~~~l 62 (241)
++.+|+.||+|.++.. .....+.+|+.++++++||||++ .. ...+++|+||+++ +|.+++
T Consensus 28 ~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l 106 (302)
T cd07864 28 DKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLL 106 (302)
T ss_pred ECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHH
Confidence 4567899999998632 22346778999999999999988 11 2379999999975 788877
Q ss_pred HHhCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcc
Q 042809 63 EKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQ 136 (241)
Q Consensus 63 ~~~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (241)
......++...+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||.+........ .......++.
T Consensus 107 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~ 181 (302)
T cd07864 107 ESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-----RPYTNKVITL 181 (302)
T ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcc-----cccccceecc
Confidence 7655567777777766654 7999999999999999999999999999999875433111 1111223567
Q ss_pred cccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCC---------------------
Q 042809 137 LWMAPEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPH--------------------- 194 (241)
Q Consensus 137 ~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------- 194 (241)
.|+|||.+.+ ..++.++|+||||+++|++++|+.||....................+.
T Consensus 182 ~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (302)
T cd07864 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYR 261 (302)
T ss_pred CccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccc
Confidence 8999998865 446889999999999999999999997644332222222221111100
Q ss_pred -----CChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 195 -----FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 195 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
.....+..+.+++.+||+.+|.+|||+++++.||||
T Consensus 262 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 262 RRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 011346789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=233.52 Aligned_cols=216 Identities=23% Similarity=0.342 Sum_probs=165.3
Q ss_pred CCcEEEEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC--------
Q 042809 5 TGALFVVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG-------- 67 (241)
Q Consensus 5 ~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~-------- 67 (241)
++..||+|.... ......+.+|+.+++.+ +||||++ ......++||||+.+++|.+++.....
T Consensus 46 ~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 125 (304)
T cd05101 46 EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125 (304)
T ss_pred cceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccc
Confidence 456899998764 23456789999999999 7999988 566789999999999999999987421
Q ss_pred -------CCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccC
Q 042809 68 -------TLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGG 134 (241)
Q Consensus 68 -------~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 134 (241)
.++...+..++. ++||++|++|+||||+||+++.++.++|+|||.+......... .......+
T Consensus 126 ~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~----~~~~~~~~ 201 (304)
T cd05101 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYY----KKTTNGRL 201 (304)
T ss_pred cccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceeccccccc----ccccCCCC
Confidence 234444444443 5589999999999999999999999999999998755331111 11112234
Q ss_pred cccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhcc
Q 042809 135 TQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLER 213 (241)
Q Consensus 135 ~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 213 (241)
++.|+|||.+.+..++.++||||||+++|++++ |..||...+........ ........+...+..+.+++.+||..
T Consensus 202 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~ 278 (304)
T cd05101 202 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL---KEGHRMDKPANCTNELYMMMRDCWHA 278 (304)
T ss_pred CceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH---HcCCcCCCCCCCCHHHHHHHHHHccc
Confidence 678999999988889999999999999999998 88888765443332222 22233344556778999999999999
Q ss_pred CCCCCCChHHHhcC
Q 042809 214 KPEKRWSAEELLNH 227 (241)
Q Consensus 214 ~p~~Rps~~~~l~~ 227 (241)
+|.+|||+.++++.
T Consensus 279 ~p~~Rps~~e~l~~ 292 (304)
T cd05101 279 IPSHRPTFKQLVED 292 (304)
T ss_pred ChhhCCCHHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=229.12 Aligned_cols=215 Identities=23% Similarity=0.338 Sum_probs=167.2
Q ss_pred CcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHH
Q 042809 6 GALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLY 77 (241)
Q Consensus 6 ~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 77 (241)
+..+|+|.+.. ....+.+.+|+.++++++||||++ ..++..++||||+++++|.+++......++......+
T Consensus 32 ~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i 111 (267)
T cd05066 32 EIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGM 111 (267)
T ss_pred ceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHH
Confidence 45799998763 334567899999999999999998 5677899999999999999999876666777776666
Q ss_pred HHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+.|+ ||++|++|+||+|+||+++.++.++|+|||++.......... .......++..|+|||.+.+..++.
T Consensus 112 ~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~ 188 (267)
T cd05066 112 LRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA---YTTRGGKIPIRWTAPEAIAYRKFTS 188 (267)
T ss_pred HHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccccee---eecCCCccceeecCHhHhccCccCc
Confidence 5544 799999999999999999999999999999987553311111 0011112346799999999888999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++|+||||+++|++++ |..||............ ........+...++.+.+++.+||+.+|.+|||+.++++
T Consensus 189 ~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 189 ASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI---EEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred hhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH---hCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999887 99999765433322222 222233444566788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=229.02 Aligned_cols=207 Identities=20% Similarity=0.294 Sum_probs=159.6
Q ss_pred CcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 6 GALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 6 ~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
...+++|.+... .....+.+|+.++..++||||++ ..+...++||||+++++|..++......++...+..++
T Consensus 32 ~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~ 111 (262)
T cd05077 32 EIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVA 111 (262)
T ss_pred ceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHH
Confidence 446889987643 33456888999999999999998 45667899999999999999988766678888777776
Q ss_pred HHH------hhcCCccccCCCCCcEEeecCCC-------eeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 79 KEI------LHGNGILHCDLKCNNVLLGSHGD-------VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 79 ~~~------Lh~~~~vH~dl~p~Nil~~~~~~-------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
.|+ ||++|++||||+|+||+++.++. ++++|||.+..... .....++..|+|||.+.
T Consensus 112 ~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~----------~~~~~~~~~y~aPE~~~ 181 (262)
T cd05077 112 KQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS----------RQECVERIPWIAPECVE 181 (262)
T ss_pred HHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC----------cccccccccccChhhhc
Confidence 655 79999999999999999987664 89999998864322 11234678899999986
Q ss_pred -ccCCCchhhHHHHHHHHHHHH-hCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH
Q 042809 146 -NEGLDFATDIWSLGCMVIEMA-TGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 146 -~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
+..++.++||||||+++|+++ +|..||............. .........+.++.+++.+||+.+|.+||++.+
T Consensus 182 ~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~ 256 (262)
T cd05077 182 DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE-----GQCMLVTPSCKELADLMTHCMNYDPNQRPFFRA 256 (262)
T ss_pred CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHh-----cCccCCCCChHHHHHHHHHHcCCChhhCcCHHH
Confidence 466888999999999999998 5888887643322221111 111222334568999999999999999999999
Q ss_pred HhcC
Q 042809 224 LLNH 227 (241)
Q Consensus 224 ~l~~ 227 (241)
++++
T Consensus 257 il~~ 260 (262)
T cd05077 257 IMRD 260 (262)
T ss_pred HHHh
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=238.05 Aligned_cols=230 Identities=27% Similarity=0.400 Sum_probs=167.9
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhc-CCCcccc-------cCCceeeeeecccCCCCHHHHHHHhCCCC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSL-NSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGGTL 69 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 69 (241)
++.+|+.+|+|.+.. ......+.+|+.++.++ +||||++ .+....++|+||+. ++|..++... .+
T Consensus 28 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~ 104 (337)
T cd07852 28 DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN--IL 104 (337)
T ss_pred EcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC--CC
Confidence 466889999998642 33456678899999999 9999988 23446899999997 5999998763 55
Q ss_pred CHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 70 DAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 70 ~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
+......++. ++||+.|++|+||+|+||+++.++.++|+|||++.......... .........++..|+|||.
T Consensus 105 ~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~ 183 (337)
T cd07852 105 EDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP-ENPVLTDYVATRWYRAPEI 183 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc-cCcchhcccccccccCcee
Confidence 6665555444 44899999999999999999999999999999987553321110 0112223457888999998
Q ss_pred ccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhc------------------------CCC---CCC
Q 042809 144 LRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACS------------------------NEK---PHF 195 (241)
Q Consensus 144 ~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------------~~~---~~~ 195 (241)
+.+ ..++.++|+||||+++|++++|+.||.+............... ... ...
T Consensus 184 ~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (337)
T cd07852 184 LLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDEL 263 (337)
T ss_pred eeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhh
Confidence 865 4568899999999999999999999965432221111100000 000 011
Q ss_pred ChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 196 PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 196 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.+..+..+.+++.+||+.+|.+|||+.++++|||++.-..
T Consensus 264 ~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 264 LPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred ccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 1225678999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=230.17 Aligned_cols=217 Identities=18% Similarity=0.295 Sum_probs=166.3
Q ss_pred CCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cC------CceeeeeecccCCCCHHHHHHHhC--
Q 042809 4 GTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NG------EKTVNIFMEYMAGGSLLDVAEKFG-- 66 (241)
Q Consensus 4 ~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~------~~~~~lv~e~~~~~~L~~~l~~~~-- 66 (241)
.++..||+|.+.. ......+.+|+..++.++||||++ .. ....++|+||+++++|..++....
T Consensus 25 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~ 104 (273)
T cd05035 25 GSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG 104 (273)
T ss_pred CCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhcc
Confidence 3568899998763 234567899999999999999987 11 124799999999999999986531
Q ss_pred ---CCCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccc
Q 042809 67 ---GTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL 137 (241)
Q Consensus 67 ---~~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (241)
..++...+..++.| +||+.+++|+||+|+||+++.++.++|+|||++......... .......++..
T Consensus 105 ~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~ 180 (273)
T cd05035 105 GLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYY----RQGRIAKMPVK 180 (273)
T ss_pred CCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccc----cccccccCCcc
Confidence 24666666655554 479999999999999999999999999999998754331111 11112234567
Q ss_pred ccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 138 WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 138 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
|+|||.+.+..++.++|+||||+++|++++ |..||.+...... ............+...+..+.+++.+||+.+|.
T Consensus 181 ~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 257 (273)
T cd05035 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI---YDYLRHGNRLKQPEDCLDELYDLMYSCWRADPK 257 (273)
T ss_pred ccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChh
Confidence 999999988889999999999999999999 8999976443322 222233444556677888999999999999999
Q ss_pred CCCChHHHhcC
Q 042809 217 KRWSAEELLNH 227 (241)
Q Consensus 217 ~Rps~~~~l~~ 227 (241)
+|||+.+++.+
T Consensus 258 ~Rp~~~e~~~~ 268 (273)
T cd05035 258 DRPTFTKLREV 268 (273)
T ss_pred hCcCHHHHHHH
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=229.89 Aligned_cols=208 Identities=20% Similarity=0.319 Sum_probs=159.8
Q ss_pred CCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHH
Q 042809 5 TGALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLY 77 (241)
Q Consensus 5 ~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 77 (241)
....|++|.+... .....+.+|+.+++.++||||++ ......++||||+++++|..++....+.++...+..+
T Consensus 43 ~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i 122 (274)
T cd05076 43 RELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV 122 (274)
T ss_pred eeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHH
Confidence 3457899988743 23456888999999999999998 4567889999999999999999876667777777766
Q ss_pred HHHH------hhcCCccccCCCCCcEEeecCC-------CeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 78 TKEI------LHGNGILHCDLKCNNVLLGSHG-------DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 78 ~~~~------Lh~~~~vH~dl~p~Nil~~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+.|+ ||++|++||||+|+||+++..+ .++++|||.+...... ....++..|+|||.+
T Consensus 123 ~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~----------~~~~~~~~~~aPe~~ 192 (274)
T cd05076 123 AQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR----------EERVERIPWIAPECV 192 (274)
T ss_pred HHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc----------cccccCCcccCchhh
Confidence 6654 7999999999999999997654 3799999987533221 112367789999988
Q ss_pred cc-cCCCchhhHHHHHHHHHHHH-hCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 145 RN-EGLDFATDIWSLGCMVIEMA-TGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 145 ~~-~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
.+ ..++.++|+||||+++|+++ +|..||............. .....+......+.+++.+||+.+|.+|||++
T Consensus 193 ~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~ 267 (274)
T cd05076 193 PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE-----KKHRLPEPSCKELATLISQCLTYEPTQRPSFR 267 (274)
T ss_pred cCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHH-----hccCCCCCCChHHHHHHHHHcccChhhCcCHH
Confidence 65 55789999999999999985 6999997654333222211 12223333456799999999999999999999
Q ss_pred HHhcC
Q 042809 223 ELLNH 227 (241)
Q Consensus 223 ~~l~~ 227 (241)
+++++
T Consensus 268 ~il~~ 272 (274)
T cd05076 268 TILRD 272 (274)
T ss_pred HHHHh
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=234.90 Aligned_cols=214 Identities=23% Similarity=0.320 Sum_probs=162.5
Q ss_pred CCCc--EEEEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC------
Q 042809 4 GTGA--LFVVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG------ 66 (241)
Q Consensus 4 ~~~~--~vaiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~------ 66 (241)
.+|. .+++|.... ......+.+|+.++.++ +|+||++ ..++..|+|+||+++++|.+++...+
T Consensus 30 ~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 109 (303)
T cd05088 30 KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 109 (303)
T ss_pred cCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccc
Confidence 4454 457776552 33456788999999999 7999988 56778999999999999999997632
Q ss_pred ---------CCCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCcccccccc
Q 042809 67 ---------GTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQS 131 (241)
Q Consensus 67 ---------~~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 131 (241)
..++...+..++.| +||++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 110 ~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-------~~~~ 182 (303)
T cd05088 110 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-------KKTM 182 (303)
T ss_pred cccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchhh-------hccc
Confidence 23566666666554 4799999999999999999999999999999985322100 0111
Q ss_pred ccCcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHh
Q 042809 132 IGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKC 210 (241)
Q Consensus 132 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 210 (241)
...+..|+|||.+.+..++.++||||||+++|+++| |..||.......... ..........+...+..+.+++.+|
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~ 259 (303)
T cd05088 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE---KLPQGYRLEKPLNCDDEVYDLMRQC 259 (303)
T ss_pred CCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH---HHhcCCcCCCCCCCCHHHHHHHHHH
Confidence 123567999999988888999999999999999998 999997644332222 2222223334455678899999999
Q ss_pred hccCCCCCCChHHHhcC
Q 042809 211 LERKPEKRWSAEELLNH 227 (241)
Q Consensus 211 l~~~p~~Rps~~~~l~~ 227 (241)
|+.+|.+|||+++++..
T Consensus 260 l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 260 WREKPYERPSFAQILVS 276 (303)
T ss_pred cCCChhhCcCHHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=230.39 Aligned_cols=214 Identities=23% Similarity=0.328 Sum_probs=162.0
Q ss_pred CCCCc--EEEEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-----
Q 042809 3 KGTGA--LFVVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG----- 66 (241)
Q Consensus 3 ~~~~~--~vaiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~----- 66 (241)
+++|. .+++|.... ....+.+.+|+.++.++ .||||++ ...+..++||||+++++|.+++....
T Consensus 17 ~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~ 96 (270)
T cd05047 17 KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 96 (270)
T ss_pred cCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccc
Confidence 34454 468887763 34456788999999999 6999988 55677999999999999999997632
Q ss_pred ----------CCCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccc
Q 042809 67 ----------GTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQ 130 (241)
Q Consensus 67 ----------~~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 130 (241)
..++...+..++. ++||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 97 ~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~-------~~~ 169 (270)
T cd05047 97 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-------KKT 169 (270)
T ss_pred cccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhh-------hcc
Confidence 1355565555544 44899999999999999999999999999999985322110 011
Q ss_pred cccCcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHH
Q 042809 131 SIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAK 209 (241)
Q Consensus 131 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 209 (241)
....+..|+|||.+.+..++.++|+||||+++|++++ |..||......... ...........+...+.++.+++.+
T Consensus 170 ~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~ 246 (270)
T cd05047 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---EKLPQGYRLEKPLNCDDEVYDLMRQ 246 (270)
T ss_pred CCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH---HHHhCCCCCCCCCcCCHHHHHHHHH
Confidence 1223567999999988889999999999999999997 99999664333222 2222223334455567789999999
Q ss_pred hhccCCCCCCChHHHhc
Q 042809 210 CLERKPEKRWSAEELLN 226 (241)
Q Consensus 210 ~l~~~p~~Rps~~~~l~ 226 (241)
||..+|.+|||+++++.
T Consensus 247 ~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 247 CWREKPYERPSFAQILV 263 (270)
T ss_pred HcccChhhCCCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=230.33 Aligned_cols=214 Identities=23% Similarity=0.338 Sum_probs=164.9
Q ss_pred CcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC------CCCCH
Q 042809 6 GALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG------GTLDA 71 (241)
Q Consensus 6 ~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~ 71 (241)
++.+++|.+... .....+.+|+.+++.++||||++ ......++|+||+++++|.+++.... ..++.
T Consensus 26 ~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 105 (269)
T cd05044 26 PIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTL 105 (269)
T ss_pred ceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccH
Confidence 468899987643 34667889999999999999988 56678999999999999999997531 23555
Q ss_pred HHHHHHHH------HHhhcCCccccCCCCCcEEeecCC-----CeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 72 GVIRLYTK------EILHGNGILHCDLKCNNVLLGSHG-----DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 72 ~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~-----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..+..++. .+||+.+++|+||+|+||+++.++ .++++|||++........ ........++..|+|
T Consensus 106 ~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~y~a 181 (269)
T cd05044 106 KELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY----YRKEGEGLLPVRWMA 181 (269)
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccc----cccCcccCCCccccC
Confidence 65555554 458999999999999999999887 899999999875432111 011112234678999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 219 (241)
||.+.+..++.++|+||||+++|++++ |..||........ ............+...+..+.+++.+||..+|.+||
T Consensus 182 PE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 258 (269)
T cd05044 182 PESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERP 258 (269)
T ss_pred HHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCC
Confidence 999998889999999999999999998 9999975433222 222222333445566788999999999999999999
Q ss_pred ChHHHhc
Q 042809 220 SAEELLN 226 (241)
Q Consensus 220 s~~~~l~ 226 (241)
|++++++
T Consensus 259 ~~~~i~~ 265 (269)
T cd05044 259 TFDRIQE 265 (269)
T ss_pred CHHHHHH
Confidence 9999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=230.12 Aligned_cols=212 Identities=25% Similarity=0.319 Sum_probs=165.3
Q ss_pred EEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHH
Q 042809 8 LFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKE 80 (241)
Q Consensus 8 ~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 80 (241)
.||+|.+.. ......+.+|+.++..+.||||++ ......++++||+++|+|.+++......++...+..++.|
T Consensus 38 ~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~q 117 (279)
T cd05109 38 PVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ 117 (279)
T ss_pred EEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHH
Confidence 589998763 334567889999999999999987 3345678999999999999999876566777777766665
Q ss_pred H------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhh
Q 042809 81 I------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATD 154 (241)
Q Consensus 81 ~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 154 (241)
+ ||++|++||||+|+||+++.++.++|+|||++......... .......++..|+|||...+..++.++|
T Consensus 118 i~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~D 193 (279)
T cd05109 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE----YHADGGKVPIKWMALESILHRRFTHQSD 193 (279)
T ss_pred HHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccce----eecCCCccchhhCCHHHhccCCCCchhH
Confidence 4 79999999999999999999999999999998755321110 0011122456799999998888999999
Q ss_pred HHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 155 IWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 155 i~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
|||||+++|++++ |..||............ ........+...+.++.+++.+||..+|.+|||+.+++.
T Consensus 194 i~slG~~l~el~t~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 194 VWSYGVTVWELMTFGAKPYDGIPAREIPDLL---EKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999998 99999765433332222 223334445567789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=231.85 Aligned_cols=210 Identities=22% Similarity=0.314 Sum_probs=160.7
Q ss_pred EEEEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC------------
Q 042809 8 LFVVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG------------ 66 (241)
Q Consensus 8 ~vaiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 66 (241)
.+++|.+.. ....+.+.+|+.++.++ .||||++ ...+..++|+||+++++|.+++....
T Consensus 31 ~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 110 (297)
T cd05089 31 NAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEH 110 (297)
T ss_pred eeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhcccccccccccccc
Confidence 467777652 33456789999999999 6999988 45677999999999999999997632
Q ss_pred ---CCCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccc
Q 042809 67 ---GTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL 137 (241)
Q Consensus 67 ---~~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (241)
..++...+..++.| +||+.|++||||||+||+++.++.++|+|||++....... .......+..
T Consensus 111 ~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~ 183 (297)
T cd05089 111 GTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV-------KKTMGRLPVR 183 (297)
T ss_pred CccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCcccccee-------ccCCCCcCcc
Confidence 23556666655554 4799999999999999999999999999999985322110 0111123456
Q ss_pred ccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 138 WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 138 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
|+|||.+.+..++.++||||||+++|+|++ |..||.......... ..........+..++..+.+++.+||+.+|.
T Consensus 184 y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 260 (297)
T cd05089 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE---KLPQGYRMEKPRNCDDEVYELMRQCWRDRPY 260 (297)
T ss_pred ccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HHhcCCCCCCCCCCCHHHHHHHHHHcCCChh
Confidence 999999988889999999999999999997 999997654433222 2222333444556778999999999999999
Q ss_pred CCCChHHHhcC
Q 042809 217 KRWSAEELLNH 227 (241)
Q Consensus 217 ~Rps~~~~l~~ 227 (241)
+|||++++++.
T Consensus 261 ~Rp~~~~i~~~ 271 (297)
T cd05089 261 ERPPFAQISVQ 271 (297)
T ss_pred hCcCHHHHHHH
Confidence 99999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=227.60 Aligned_cols=215 Identities=21% Similarity=0.361 Sum_probs=167.2
Q ss_pred CCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 5 TGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 5 ~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
++..+|+|.+... .....+.+|+++++++.|||+++ ......++|+||+++++|.+++......++...+..++
T Consensus 27 ~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 106 (256)
T cd05112 27 EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106 (256)
T ss_pred CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHH
Confidence 4678999987743 23457889999999999999988 56678999999999999999998765667777766665
Q ss_pred HH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCch
Q 042809 79 KE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA 152 (241)
Q Consensus 79 ~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 152 (241)
.+ +||+.+++|+||+|+||+++.++.++|+|||.+....... ........++..|+|||.+.+..++.+
T Consensus 107 ~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~~~aPe~~~~~~~~~~ 181 (256)
T cd05112 107 LDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-----YTSSTGTKFPVKWSSPEVFSFSKYSSK 181 (256)
T ss_pred HHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc-----ccccCCCccchhhcCHhHhccCCcChH
Confidence 54 4799999999999999999999999999999886443211 011112224567999999988889999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 153 TDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 153 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
+|+||||+++|++++ |..||........... .........+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 182 ~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 182 SDVWSFGVLMWEVFSEGKTPYENRSNSEVVET---INAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH---HhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 999999999999998 9999976443332222 22222333344467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=231.16 Aligned_cols=214 Identities=21% Similarity=0.328 Sum_probs=164.8
Q ss_pred CcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-----------
Q 042809 6 GALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG----------- 66 (241)
Q Consensus 6 ~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~----------- 66 (241)
...+++|.+..+ .....+.+|+.++..++||||++ ..++..++|+||+.+++|.+++....
T Consensus 30 ~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 109 (290)
T cd05045 30 YTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDG 109 (290)
T ss_pred ceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCcccccccccc
Confidence 457888887632 33567889999999999999998 56677999999999999999987531
Q ss_pred ------------CCCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccc
Q 042809 67 ------------GTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQS 128 (241)
Q Consensus 67 ------------~~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 128 (241)
..++...+..++.| +||+.|++||||+|+||+++.++.++|+|||++........ ...
T Consensus 110 ~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~----~~~ 185 (290)
T cd05045 110 NRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS----YVK 185 (290)
T ss_pred ccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccc----hhc
Confidence 23455555555554 47999999999999999999999999999999875432111 011
Q ss_pred cccccCcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHH
Q 042809 129 WQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFL 207 (241)
Q Consensus 129 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 207 (241)
.....++..|+|||.+.+..++.++||||||+++|++++ |..||.+......... .........+...+..+.+++
T Consensus 186 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i 262 (290)
T cd05045 186 RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL---LKTGYRMERPENCSEEMYNLM 262 (290)
T ss_pred ccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH---HhCCCCCCCCCCCCHHHHHHH
Confidence 112234678999999988889999999999999999998 9999976544333332 222333445566778999999
Q ss_pred HHhhccCCCCCCChHHHhc
Q 042809 208 AKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 208 ~~~l~~~p~~Rps~~~~l~ 226 (241)
.+||+.+|.+||++++++.
T Consensus 263 ~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 263 LTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHccCCcccCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=227.52 Aligned_cols=201 Identities=27% Similarity=0.460 Sum_probs=160.0
Q ss_pred HHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh---CCCCCHHHHHHHHHHH------hhcC
Q 042809 20 VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF---GGTLDAGVIRLYTKEI------LHGN 85 (241)
Q Consensus 20 ~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~------Lh~~ 85 (241)
...+.+|+.+++.++||||++ ......++|+||+++++|.+++... +..+++..+..++.|+ ||+.
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 125 (260)
T cd08222 46 TVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125 (260)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc
Confidence 345678899999999999988 5667899999999999999988642 3457777666665544 7999
Q ss_pred CccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHH
Q 042809 86 GILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165 (241)
Q Consensus 86 ~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 165 (241)
|++|+||+|+||+++. +.++|+|||.+....... .......+++.|+|||.+.+..++.++|+||+|+++|++
T Consensus 126 ~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l 198 (260)
T cd08222 126 RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198 (260)
T ss_pred CccccCCChhheEeec-CCEeecccCceeecCCCc------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 9999999999999964 679999999886543211 111234468889999999888888999999999999999
Q ss_pred HhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 166 ATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 166 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
++|..||..... ............+..+...+.++.+++.+||..+|.+||+++++++||||
T Consensus 199 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 199 CCLAHAFEGQNF---LSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HhCCCCCCCccH---HHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999965432 22222233345556677788899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=228.47 Aligned_cols=215 Identities=23% Similarity=0.370 Sum_probs=166.7
Q ss_pred CCCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHh-CCCCCHHHHHHH
Q 042809 4 GTGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDAGVIRLY 77 (241)
Q Consensus 4 ~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~ 77 (241)
.+++.||+|.+... .....+.+|+.++++++|+||++ ...+..++|+||+.+++|.+++... +..++......+
T Consensus 28 ~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i 107 (260)
T cd05067 28 NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDM 107 (260)
T ss_pred CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHH
Confidence 45788999987743 33567889999999999999988 4456789999999999999998753 345666665555
Q ss_pred HH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+. .+||+.|++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+..++.
T Consensus 108 ~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~y~~pe~~~~~~~~~ 182 (260)
T cd05067 108 AAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-----TAREGAKFPIKWTAPEAINYGTFTI 182 (260)
T ss_pred HHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-----ccccCCcccccccCHHHhccCCcCc
Confidence 44 447999999999999999999999999999999865432110 0111223467899999998888899
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++|+||||+++|++++ |..||.+......... .........+...+..+.+++.+||+.+|++|||+++++.
T Consensus 183 ~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 183 KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN---LERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH---HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999 9999976543332222 2223334455567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=239.02 Aligned_cols=221 Identities=25% Similarity=0.384 Sum_probs=163.3
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----c------CCceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----N------GEKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~------~~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
++.+|+.||+|.+... .....+.+|+.+++.++||||++ . .....++|+||+. .+|.+++.
T Consensus 36 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--- 111 (342)
T cd07879 36 DKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG--- 111 (342)
T ss_pred eCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc---
Confidence 4678999999987632 23456789999999999999987 1 1235799999996 47776653
Q ss_pred CCCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..++...+..++.| +||+.|++||||+|+||+++.++.++|+|||++..... ......++..|+|
T Consensus 112 ~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~---------~~~~~~~~~~y~a 182 (342)
T cd07879 112 HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA---------EMTGYVVTRWYRA 182 (342)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC---------CCCCceeeecccC
Confidence 34666666665554 47999999999999999999999999999999864322 1112346788999
Q ss_pred cccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhc-------------------CCCCCCC----
Q 042809 141 PEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACS-------------------NEKPHFP---- 196 (241)
Q Consensus 141 PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------~~~~~~~---- 196 (241)
||.+.+ ..++.++|+||||+++|++++|+.||.+............... ...+..+
T Consensus 183 PE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (342)
T cd07879 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDF 262 (342)
T ss_pred hhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchH
Confidence 999876 4578899999999999999999999976432221111111000 0001111
Q ss_pred ----hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 197 ----TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 197 ----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
+..+..+.+++.+||+.+|.+|||+++++.||||.....
T Consensus 263 ~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 263 STLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 124567899999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=228.12 Aligned_cols=213 Identities=20% Similarity=0.318 Sum_probs=162.4
Q ss_pred EEEEEeccc----hHHHHHHHHHHHHHhhcCCCccccc-----------CCceeeeeecccCCCCHHHHHHHh-----CC
Q 042809 8 LFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGRN-----------GEKTVNIFMEYMAGGSLLDVAEKF-----GG 67 (241)
Q Consensus 8 ~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~-----------~~~~~~lv~e~~~~~~L~~~l~~~-----~~ 67 (241)
.+|+|.+.. ....+.+.+|+..++.++|+||++. .....++|+||+.+|+|.+++... ..
T Consensus 28 ~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 107 (272)
T cd05075 28 KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ 107 (272)
T ss_pred eEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcc
Confidence 689998652 3456778999999999999999871 123578999999999999988542 12
Q ss_pred CCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 68 TLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 68 ~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
.++...+..++. ++||++|++||||||+||+++.++.++|+|||++........ ........+++.|+||
T Consensus 108 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~~~~p 183 (272)
T cd05075 108 YLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY----YRQGRIAKMPVKWIAI 183 (272)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccc----eecCCcccCCcccCCH
Confidence 356666655554 458999999999999999999999999999999875433111 0111223356789999
Q ss_pred ccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC
Q 042809 142 EVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS 220 (241)
Q Consensus 142 E~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 220 (241)
|...+..++.++|+||||+++|++++ |..||........ ............+...+..+.+++.+||+.+|.+|||
T Consensus 184 e~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 260 (272)
T cd05075 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI---YDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPS 260 (272)
T ss_pred HHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcC
Confidence 99998889999999999999999999 8999976433322 2222233333445567788999999999999999999
Q ss_pred hHHHhcC
Q 042809 221 AEELLNH 227 (241)
Q Consensus 221 ~~~~l~~ 227 (241)
+.++++.
T Consensus 261 ~~~l~~~ 267 (272)
T cd05075 261 FETLRCE 267 (272)
T ss_pred HHHHHHH
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=230.41 Aligned_cols=217 Identities=20% Similarity=0.297 Sum_probs=164.6
Q ss_pred CCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC-------
Q 042809 3 KGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG------- 67 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~------- 67 (241)
..++..||+|.+... .....+.+|+.++.++.||||++ ..+...++|+||+++++|.+++.....
T Consensus 32 ~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 111 (288)
T cd05050 32 YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLS 111 (288)
T ss_pred CCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCcccccccc
Confidence 347889999987643 33566889999999999999988 566789999999999999999985321
Q ss_pred --------------CCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCcccc
Q 042809 68 --------------TLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQ 127 (241)
Q Consensus 68 --------------~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 127 (241)
.++...+..++.| +||+++++||||+|+||+++.++.++|+|||.+........ ..
T Consensus 112 ~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----~~ 187 (288)
T cd05050 112 HSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY----YK 187 (288)
T ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCcc----cc
Confidence 2444445555554 47999999999999999999999999999999864322110 00
Q ss_pred ccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHH
Q 042809 128 SWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDF 206 (241)
Q Consensus 128 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 206 (241)
.......+..|+|||.+.+..++.++|+||||+++|++++ |..||.+....... ...........+...+..+.++
T Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~l 264 (288)
T cd05050 188 ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI---YYVRDGNVLSCPDNCPLELYNL 264 (288)
T ss_pred ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHhcCCCCCCCCCCCHHHHHH
Confidence 1111223567999999988889999999999999999998 88888654333222 2222233334455677899999
Q ss_pred HHHhhccCCCCCCChHHHhc
Q 042809 207 LAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 207 i~~~l~~~p~~Rps~~~~l~ 226 (241)
+.+||+.+|.+|||++++++
T Consensus 265 i~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 265 MRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=238.78 Aligned_cols=218 Identities=27% Similarity=0.366 Sum_probs=164.6
Q ss_pred CCCcEEEEEeccchHH--HHHHHHHHHHHhhcCCCcccc-----cCCc-eeeeeecccCCCCHHHHHHHhCC-CCCHHHH
Q 042809 4 GTGALFVVKSAESEAG--VQALRNEAEIRQSLNSPNIGR-----NGEK-TVNIFMEYMAGGSLLDVAEKFGG-TLDAGVI 74 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~i~~-----~~~~-~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~ 74 (241)
.+|..||||.+..... ..+|.+|+.++.+++|||+++ ...+ +.+||+|||++|+|.+++..... ++++...
T Consensus 97 ~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R 176 (361)
T KOG1187|consen 97 SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETR 176 (361)
T ss_pred CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHH
Confidence 3458999998876543 466999999999999999999 3444 69999999999999999998655 7888877
Q ss_pred HHHHH------HHhhcCC---ccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccc-cCcccccCcccc
Q 042809 75 RLYTK------EILHGNG---ILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSI-GGTQLWMAPEVL 144 (241)
Q Consensus 75 ~~~~~------~~Lh~~~---~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~aPE~~ 144 (241)
..++. +|||+.. ++|||||++|||+|.+..+||+|||++...... ....... .||.+|++||+.
T Consensus 177 ~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~------~~~~~~~~~gt~gY~~PEy~ 250 (361)
T KOG1187|consen 177 LKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG------DTSVSTTVMGTFGYLAPEYA 250 (361)
T ss_pred HHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc------ccceeeecCCCCccCChhhh
Confidence 77765 4589744 999999999999999999999999999543320 0011111 689999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccch---hchHHHHHHHH----------hcCCC-CCCCh-hhHHHHHHHHHH
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKI---SNAAATLLKIA----------CSNEK-PHFPT-QFFKKVLDFLAK 209 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~----------~~~~~-~~~~~-~~~~~~~~li~~ 209 (241)
..+..+.++||||||+++.|++||+.+..... ........... ..... ...+. ..-..+..+..+
T Consensus 251 ~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~ 330 (361)
T KOG1187|consen 251 STGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALR 330 (361)
T ss_pred ccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHH
Confidence 99889999999999999999999998875421 11111111001 11111 12222 344568889999
Q ss_pred hhccCCCCCCChHHHhcC
Q 042809 210 CLERKPEKRWSAEELLNH 227 (241)
Q Consensus 210 ~l~~~p~~Rps~~~~l~~ 227 (241)
|++.+|.+||++.+++..
T Consensus 331 C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 331 CLRPDPKERPTMSQVVKE 348 (361)
T ss_pred HcCcCCCcCcCHHHHHHH
Confidence 999999999999997643
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=228.31 Aligned_cols=214 Identities=25% Similarity=0.336 Sum_probs=167.3
Q ss_pred CcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 6 GALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 6 ~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
...|++|..... ...+.+.+|+.++++++||||++ ..+...++||||+++++|.+++......++...+..++
T Consensus 34 ~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 113 (270)
T cd05056 34 KIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYS 113 (270)
T ss_pred CcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHH
Confidence 457899987643 34567899999999999999998 34566889999999999999998755567777777666
Q ss_pred HHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCch
Q 042809 79 KEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA 152 (241)
Q Consensus 79 ~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 152 (241)
.++ ||+.|++|+||+|+||+++.++.++|+|||.+......... . .....++..|+|||.+.+..++.+
T Consensus 114 ~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~----~-~~~~~~~~~y~aPE~~~~~~~~~~ 188 (270)
T cd05056 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY----K-ASKGKLPIKWMAPESINFRRFTSA 188 (270)
T ss_pred HHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccce----e-cCCCCccccccChhhhccCCCCch
Confidence 544 79999999999999999999999999999998654331110 0 011223567999999988888999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 153 TDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 153 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
+|+||||+++|++++ |..||......... ...........+...+..+.+++.+||..+|.+|||+.+++..
T Consensus 189 ~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 189 SDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999996 99999765433222 2222233444566778899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=231.88 Aligned_cols=221 Identities=27% Similarity=0.429 Sum_probs=168.3
Q ss_pred CCCCcEEEEEeccchH---HHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 3 KGTGALFVVKSAESEA---GVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
.++++.+|+|.+.... ....+.+|+++++.+.|+||++ ......++|+||+++++|.+++......++..
T Consensus 30 ~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~ 109 (284)
T cd05038 30 DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK 109 (284)
T ss_pred CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHH
Confidence 4568899999987443 3677999999999999999988 23557999999999999999998765567777
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||.+......... ........++..|+|||.+.+
T Consensus 110 ~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~~Pe~~~~ 186 (284)
T cd05038 110 RLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY---YYVKEPGESPIFWYAPECLRT 186 (284)
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcc---eeccCCCCCcccccCcHHHcc
Confidence 766665544 79999999999999999999999999999999765421110 011111224556999999988
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhch------------HHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccC
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNA------------AATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 214 (241)
..++.++|+||||+++|++++|..|+....... ................+...+..+.+++.+||+.+
T Consensus 187 ~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 266 (284)
T cd05038 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAE 266 (284)
T ss_pred CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccC
Confidence 888999999999999999999999986532221 11111222222233334556678999999999999
Q ss_pred CCCCCChHHHhc
Q 042809 215 PEKRWSAEELLN 226 (241)
Q Consensus 215 p~~Rps~~~~l~ 226 (241)
|.+|||+.++++
T Consensus 267 p~~Rpt~~ei~~ 278 (284)
T cd05038 267 PQDRPSFADLIL 278 (284)
T ss_pred hhhCCCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=255.69 Aligned_cols=221 Identities=24% Similarity=0.255 Sum_probs=162.7
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-----
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG----- 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~----- 66 (241)
|+.+|+.||+|.+.. +...+.+.+|++++.+++||||++ ..++..++||||++|++|.+++....
T Consensus 23 d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l 102 (932)
T PRK13184 23 DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL 102 (932)
T ss_pred ECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhcccc
Confidence 567899999999763 234567899999999999999998 56778999999999999999987521
Q ss_pred -----CCCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCC------------
Q 042809 67 -----GTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG------------ 123 (241)
Q Consensus 67 -----~~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~------------ 123 (241)
...+...+..++. ++||++|++||||||+||+++.++.++|+|||++..........
T Consensus 103 ~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~ 182 (932)
T PRK13184 103 SKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182 (932)
T ss_pred chhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccc
Confidence 1223333333333 55899999999999999999999999999999997552110000
Q ss_pred ccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCC--ChhhHH
Q 042809 124 NLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHF--PTQFFK 201 (241)
Q Consensus 124 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 201 (241)
..........||+.|+|||.+.+..++.++||||+|+++|+|++|..||.......... . .....+... ...+++
T Consensus 183 s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~--~-~~i~~P~~~~p~~~iP~ 259 (932)
T PRK13184 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY--R-DVILSPIEVAPYREIPP 259 (932)
T ss_pred cccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh--h-hhccChhhccccccCCH
Confidence 00011123458999999999999999999999999999999999999997643322111 1 111111111 134667
Q ss_pred HHHHHHHHhhccCCCCCCChHHHh
Q 042809 202 KVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 202 ~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
.+.+++.+||+.+|++|++..+.+
T Consensus 260 ~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 260 FLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred HHHHHHHHHccCChhhCcCHHHHH
Confidence 899999999999999998765544
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=245.06 Aligned_cols=224 Identities=30% Similarity=0.461 Sum_probs=185.5
Q ss_pred CCCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 1 MNKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++++||+.||||++.+. .....+++|+.||..+.||.||. +..+.+++|||.+.|.-|.=.+.+..+++++
T Consensus 584 ~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~e 663 (888)
T KOG4236|consen 584 KHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPE 663 (888)
T ss_pred eecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchH
Confidence 36899999999998742 34578999999999999999998 8899999999999654444455566788888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCC---CeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG---DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
..-++++.|| ||-++|+|+||||+||++.+.. .+||||||.+..+++... .....||+.|+|||
T Consensus 664 r~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-------RrsVVGTPAYLaPE 736 (888)
T KOG4236|consen 664 RITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-------RRSVVGTPAYLAPE 736 (888)
T ss_pred HHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-------hhhhcCCccccCHH
Confidence 8877777766 6999999999999999997653 599999999998877321 23567999999999
Q ss_pred cccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 143 VLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 143 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
++....|...-|+||+|+++|--++|..||... +++...+.+..-..++.-...+++...+||..+|+..-.+|.|++
T Consensus 737 VLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvd 814 (888)
T KOG4236|consen 737 VLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVD 814 (888)
T ss_pred HHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchH
Confidence 999999999999999999999999999999764 344444444444444544567889999999999999999999999
Q ss_pred HHhcCCCCCCC
Q 042809 223 ELLNHTFISGN 233 (241)
Q Consensus 223 ~~l~~p~~~~~ 233 (241)
..+.|||+++.
T Consensus 815 k~lsh~Wlq~y 825 (888)
T KOG4236|consen 815 KSLSHPWLQDY 825 (888)
T ss_pred hhccchhhhcc
Confidence 99999999764
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=235.82 Aligned_cols=219 Identities=21% Similarity=0.317 Sum_probs=162.9
Q ss_pred CCCCcEEEEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc------cCCceeeeeecccCCCCHHHHHHHhCC-----
Q 042809 3 KGTGALFVVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGG----- 67 (241)
Q Consensus 3 ~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~----- 67 (241)
..+++.||||.++. ......+.+|+.++.++ +||||++ ..+...++||||+++|+|.+++.....
T Consensus 34 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~ 113 (343)
T cd05103 34 TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPY 113 (343)
T ss_pred cccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccc
Confidence 35688999999874 23456788999999999 5899987 334568999999999999999875321
Q ss_pred -------------------------------------------------------------CCCHHHHHHHHH------H
Q 042809 68 -------------------------------------------------------------TLDAGVIRLYTK------E 80 (241)
Q Consensus 68 -------------------------------------------------------------~~~~~~~~~~~~------~ 80 (241)
.++......++. +
T Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~ 193 (343)
T cd05103 114 KTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGME 193 (343)
T ss_pred cccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHH
Confidence 133333344444 4
Q ss_pred HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhhHHHHHH
Q 042809 81 ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGC 160 (241)
Q Consensus 81 ~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~ 160 (241)
+||++|++||||||+||+++.++.++|+|||++........ ........++..|+|||.+.+..++.++|+||||+
T Consensus 194 ~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 269 (343)
T cd05103 194 FLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 269 (343)
T ss_pred HHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc----hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHH
Confidence 48999999999999999999999999999999875422111 01111223456799999998888999999999999
Q ss_pred HHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 161 MVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 161 ~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
++|++++ |..||........ .............+...++.+.+++.+||+.+|.+|||+.++++|
T Consensus 270 ~l~el~~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 270 LLWEIFSLGASPYPGVKIDEE--FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHHHCCCCCCCCccccHH--HHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999997 9999865432211 112222233334445566789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=237.06 Aligned_cols=225 Identities=28% Similarity=0.392 Sum_probs=163.9
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cC--------------CceeeeeecccCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NG--------------EKTVNIFMEYMAGGSLLD 60 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~--------------~~~~~lv~e~~~~~~L~~ 60 (241)
++.+|+.||+|.+... ...+.+.+|++++++++||||++ .. ....|+|+||+. ++|.+
T Consensus 26 ~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~ 104 (342)
T cd07854 26 DSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLAN 104 (342)
T ss_pred ECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHH
Confidence 5678999999987632 34567889999999999999987 11 135799999997 59998
Q ss_pred HHHHhCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeec-CCCeeecCCCcchhhcccccCCcccccccccc
Q 042809 61 VAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS-HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIG 133 (241)
Q Consensus 61 ~l~~~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 133 (241)
++.. ..+++..+..++.|+ ||+.|++||||+|+||+++. ++.++++|||.+.......... .......
T Consensus 105 ~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~ 179 (342)
T cd07854 105 VLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK---GYLSEGL 179 (342)
T ss_pred HHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccc---ccccccc
Confidence 8874 457777777666655 79999999999999999975 4578999999986543211111 0111234
Q ss_pred CcccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHH-------------------h--cCC
Q 042809 134 GTQLWMAPEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIA-------------------C--SNE 191 (241)
Q Consensus 134 ~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~--~~~ 191 (241)
++..|+|||.+.+ ..++.++|+||||+++|++++|+.||............... . ...
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (342)
T cd07854 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGG 259 (342)
T ss_pred ccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhccc
Confidence 6788999998754 55788999999999999999999999654321111110000 0 001
Q ss_pred CCCC-----ChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 192 KPHF-----PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 192 ~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
.... ....+.++.+++.+||+.+|.+|||+.+++.||||+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 260 EPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred ccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 1111 1235578899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=230.17 Aligned_cols=217 Identities=20% Similarity=0.262 Sum_probs=160.7
Q ss_pred CcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-----------
Q 042809 6 GALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG----------- 66 (241)
Q Consensus 6 ~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~----------- 66 (241)
...||+|.+.. ......+.+|++++++++|+|+++ ...+..++||||+.+++|.+++....
T Consensus 44 ~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 123 (295)
T cd05097 44 PVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123 (295)
T ss_pred ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccC
Confidence 34689998763 334567899999999999999988 56778999999999999999996532
Q ss_pred CCCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..++...+..++. ++||+.|++|+||+|+||+++.++.++|+|||++....... .........++..|+|
T Consensus 124 ~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~~~y~a 199 (295)
T cd05097 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD----YYRIQGRAVLPIRWMA 199 (295)
T ss_pred CcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCc----ceeccCcCcCceeecC
Confidence 1244444444444 45899999999999999999999999999999986543211 0111122334678999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHh--CCCCCccchhchHHHHHHH----HhcCCCCCCChhhHHHHHHHHHHhhccC
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMAT--GRPPWGDKISNAAATLLKI----ACSNEKPHFPTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~--g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~ 214 (241)
||.+.+..++.++|+||||+++|++++ +..||.............. .........+...+..+.+++.+||+.+
T Consensus 200 PE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 279 (295)
T cd05097 200 WESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRD 279 (295)
T ss_pred hhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCC
Confidence 999988889999999999999999998 6678865433222211111 1111122234456789999999999999
Q ss_pred CCCCCChHHHhc
Q 042809 215 PEKRWSAEELLN 226 (241)
Q Consensus 215 p~~Rps~~~~l~ 226 (241)
|.+|||++++++
T Consensus 280 p~~RPs~~~i~~ 291 (295)
T cd05097 280 IKDRPTFNKIHH 291 (295)
T ss_pred chhCcCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=236.70 Aligned_cols=222 Identities=23% Similarity=0.341 Sum_probs=165.1
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCccccc-----------CCceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGRN-----------GEKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~-----------~~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
++.+|+.||+|.+... ...+.+.+|+.++++++||||++. .....+++++++ +++|.+++..
T Consensus 38 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-- 114 (345)
T cd07877 38 DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-- 114 (345)
T ss_pred EcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc--
Confidence 4678999999987632 234567889999999999999871 124578899888 6899888875
Q ss_pred CCCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..+++..+..++.| +||+.|++|+||+|+||+++.++.++|+|||++..... ......++..|+|
T Consensus 115 ~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~---------~~~~~~~~~~y~a 185 (345)
T cd07877 115 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---------EMTGYVATRWYRA 185 (345)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc---------cccccccCCCccC
Confidence 35777776666554 47999999999999999999999999999999865432 1122346788999
Q ss_pred cccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhc----------------------CCCCC---
Q 042809 141 PEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACS----------------------NEKPH--- 194 (241)
Q Consensus 141 PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------------~~~~~--- 194 (241)
||.+.+ ..++.++|+||+|+++|++++|..||................. ...+.
T Consensus 186 PE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (345)
T cd07877 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF 265 (345)
T ss_pred HHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcch
Confidence 999866 4578899999999999999999999965432221111100000 00000
Q ss_pred --CChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 195 --FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 195 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.....++.+.++|.+||+.+|.+|||+.++++||||+....
T Consensus 266 ~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 266 ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 01124567899999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=226.62 Aligned_cols=214 Identities=24% Similarity=0.377 Sum_probs=166.7
Q ss_pred CCcEEEEEeccc-hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCCHHHHHHH
Q 042809 5 TGALFVVKSAES-EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDAGVIRLY 77 (241)
Q Consensus 5 ~~~~vaiK~~~~-~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~ 77 (241)
+++.+|+|.+.. ....+.+.+|+.++++++|+||++ ..+...++||||+++++|.+++.... ..++...+..+
T Consensus 29 ~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~ 108 (261)
T cd05034 29 GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM 108 (261)
T ss_pred CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHH
Confidence 456789998774 344577899999999999999988 45578999999999999999998643 45677766666
Q ss_pred HHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+.+ +||++|++|+||+|+||+++.++.++|+|||.+....... ........++..|+|||.+.+...+.
T Consensus 109 ~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~ 183 (261)
T cd05034 109 AAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-----YTAREGAKFPIKWTAPEAANYGRFTI 183 (261)
T ss_pred HHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh-----hhhhhccCCCccccCHHHhccCCcCc
Confidence 554 4799999999999999999999999999999987554311 01111122356799999999888999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++|+||+|+++|++++ |+.||.+........ ..........+...+..+.+++.+||..+|.+||+++++.+
T Consensus 184 ~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 184 KSDVWSFGILLTEIVTYGRVPYPGMTNREVLE---QVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 9999999999999998 999997654332222 22223333445556789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=234.40 Aligned_cols=225 Identities=22% Similarity=0.316 Sum_probs=165.3
Q ss_pred CcEEEEEeccch----HHHHHHHHHHHHHhhcC-CCccccc---------CCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 6 GALFVVKSAESE----AGVQALRNEAEIRQSLN-SPNIGRN---------GEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 6 ~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~---------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
+..||+|.+... ...+.+.+|+.+++++. ||||++. ....++++++|+. ++|.+++.. ...+++
T Consensus 27 ~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~-~~~~~~ 104 (332)
T cd07857 27 EETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRS-GQPLTD 104 (332)
T ss_pred CceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhc-CCCCCH
Confidence 889999987632 23456788999999995 9999881 1245789999995 699999876 456777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||++.......... ........|+..|+|||.+.
T Consensus 105 ~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~ 182 (332)
T cd07857 105 AHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN--AGFMTEYVATRWYRAPEIML 182 (332)
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccc--cccccCcccCccccCcHHHh
Confidence 7777766655 799999999999999999999999999999997543321111 11112345788999999876
Q ss_pred c-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHH------------------------hcCCCCC---CCh
Q 042809 146 N-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIA------------------------CSNEKPH---FPT 197 (241)
Q Consensus 146 ~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------------------~~~~~~~---~~~ 197 (241)
+ ..++.++|+||+|+++|++++|..||............... ....... ...
T Consensus 183 ~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (332)
T cd07857 183 SFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFP 262 (332)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCC
Confidence 5 45789999999999999999999999654322111110000 0000011 112
Q ss_pred hhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 198 QFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 198 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
..+..+.+++.+||+.+|.+|||+.+++.|||++.-.
T Consensus 263 ~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 263 NANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 2457899999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=229.02 Aligned_cols=207 Identities=20% Similarity=0.322 Sum_probs=159.9
Q ss_pred CcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 6 GALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 6 ~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
...+++|.+... ...+.+.+|+.+++.+.||||++ ..+...++||||+++|+|.+++...+..++......++
T Consensus 27 ~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 106 (258)
T cd05078 27 KTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVA 106 (258)
T ss_pred cchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHH
Confidence 345888887643 33467889999999999999998 45577899999999999999998766667777776666
Q ss_pred HHH------hhcCCccccCCCCCcEEeecCCC--------eeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 79 KEI------LHGNGILHCDLKCNNVLLGSHGD--------VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 79 ~~~------Lh~~~~vH~dl~p~Nil~~~~~~--------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
.|+ ||++|++||||+|+||+++.++. ++++|||.+..... .....++..|+|||.+
T Consensus 107 ~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~----------~~~~~~~~~y~aPE~~ 176 (258)
T cd05078 107 KQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP----------KEILLERIPWVPPECI 176 (258)
T ss_pred HHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC----------chhccccCCccCchhc
Confidence 544 79999999999999999988765 58999998764322 1123467889999999
Q ss_pred ccc-CCCchhhHHHHHHHHHHHHhC-CCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 145 RNE-GLDFATDIWSLGCMVIEMATG-RPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 145 ~~~-~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
.+. .++.++|+||||+++|++++| ..|+............ ......+...+.++.+++.+||+.+|++|||++
T Consensus 177 ~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 251 (258)
T cd05078 177 ENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-----EDRHQLPAPKWTELANLINQCMDYEPDFRPSFR 251 (258)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-----HccccCCCCCcHHHHHHHHHHhccChhhCCCHH
Confidence 864 478899999999999999998 4666543332221111 123345555667899999999999999999999
Q ss_pred HHhcC
Q 042809 223 ELLNH 227 (241)
Q Consensus 223 ~~l~~ 227 (241)
++++.
T Consensus 252 ~il~~ 256 (258)
T cd05078 252 AIIRD 256 (258)
T ss_pred HHHHh
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=225.37 Aligned_cols=214 Identities=28% Similarity=0.449 Sum_probs=170.6
Q ss_pred CCcEEEEEeccchH---HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCC-CCHHHHH
Q 042809 5 TGALFVVKSAESEA---GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGT-LDAGVIR 75 (241)
Q Consensus 5 ~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~ 75 (241)
++..||+|.+.... ..+.+.+|+..+..+.|+||++ ...+..+++|||+++++|.+++...... +++..+.
T Consensus 27 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~ 106 (258)
T smart00219 27 KEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLL 106 (258)
T ss_pred CCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHH
Confidence 35899999987443 5678999999999999999988 5567899999999999999999874433 7787777
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCC
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL 149 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 149 (241)
.++.|+ ||+.|++|+||+|+||+++.++.++|+|||++........... ....++..|+|||.+.+..+
T Consensus 107 ~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-----~~~~~~~~y~~Pe~~~~~~~ 181 (258)
T smart00219 107 SFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKK-----KGGKLPIRWMAPESLKDGKF 181 (258)
T ss_pred HHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccccc-----ccCCCcccccChHHhccCCC
Confidence 776655 7999999999999999999999999999999976544211110 01225678999999988888
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 150 DFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
+.++|+||+|++++++++ |..||........ ............+...+..+.+++.+||..+|.+|||+.++++
T Consensus 182 ~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 182 TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---LEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 999999999999999998 8898876433222 2222233444555667889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=204.40 Aligned_cols=226 Identities=26% Similarity=0.413 Sum_probs=181.0
Q ss_pred CCCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 1 MNKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
+++.|+++||+|.++- +.......+|+-+++.++|.||++ ..+..+.+|+|||. .+|..|..+..+.++.
T Consensus 22 rn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfdslng~~d~ 100 (292)
T KOG0662|consen 22 RNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSLNGDLDP 100 (292)
T ss_pred ccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHHhcCCcCCH
Confidence 4678999999999772 233566889999999999999999 67889999999995 6999999999999999
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
+.++.+..|+ +|++++.|||+||.|.+++.+|.+|+.|||++..++-. .+.+....-|..|.+|.++.
T Consensus 101 ~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip------vrcysaevvtlwyrppdvlf 174 (292)
T KOG0662|consen 101 EIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP------VRCYSAEVVTLWYRPPDVLF 174 (292)
T ss_pred HHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc------eEeeeceeeeeeccCcceee
Confidence 9999998887 49999999999999999999999999999999866541 12233445688899999998
Q ss_pred ccC-CCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCC----------------CCC---------hh
Q 042809 146 NEG-LDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKP----------------HFP---------TQ 198 (241)
Q Consensus 146 ~~~-~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~----------------~~~---------~~ 198 (241)
|.+ |+...|+||.||++.|+.. |++.|.+.+.......+......... .++ +.
T Consensus 175 gakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~ 254 (292)
T KOG0662|consen 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPK 254 (292)
T ss_pred eeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhh
Confidence 865 7889999999999999998 88888776554443333322221111 111 11
Q ss_pred hHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCC
Q 042809 199 FFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 199 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~ 233 (241)
....-++++++++.-+|.+|++++.+++||||.+.
T Consensus 255 lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 255 LNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred hcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 22356899999999999999999999999999764
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=249.43 Aligned_cols=212 Identities=25% Similarity=0.257 Sum_probs=152.2
Q ss_pred HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC----CCCCHHHHHHHHH------HHhh
Q 042809 19 GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG----GTLDAGVIRLYTK------EILH 83 (241)
Q Consensus 19 ~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~------~~Lh 83 (241)
....+.+|+.++.+++||||++ ...+..|+|++++. ++|..++.... .......+..++. ++||
T Consensus 206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH 284 (501)
T PHA03210 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284 (501)
T ss_pred HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 4566889999999999999998 56678899999995 58888776422 1122333333333 5589
Q ss_pred cCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhhHHHHHHHHH
Q 042809 84 GNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163 (241)
Q Consensus 84 ~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 163 (241)
++|++||||||+||+++.++.+||+|||++........ .......|+..|+|||.+.+..++.++|||||||++|
T Consensus 285 ~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 359 (501)
T PHA03210 285 DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-----AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILL 359 (501)
T ss_pred hCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccc-----cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHH
Confidence 99999999999999999999999999999975533111 1112346899999999999999999999999999999
Q ss_pred HHHhCCC-CCccchhchHHHHHHHHhc--CCCCCC----------------------------ChhhHHHHHHHHHHhhc
Q 042809 164 EMATGRP-PWGDKISNAAATLLKIACS--NEKPHF----------------------------PTQFFKKVLDFLAKCLE 212 (241)
Q Consensus 164 ~l~~g~~-p~~~~~~~~~~~~~~~~~~--~~~~~~----------------------------~~~~~~~~~~li~~~l~ 212 (241)
+|++|.. |+..........+...... .....+ ....+.++.+++.+||+
T Consensus 360 ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~ 439 (501)
T PHA03210 360 DMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLT 439 (501)
T ss_pred HHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhc
Confidence 9999775 4433222211111111100 000000 01234567888999999
Q ss_pred cCCCCCCChHHHhcCCCCCCCCcc
Q 042809 213 RKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 213 ~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
.||.+|||+.+++.||||.....+
T Consensus 440 ~DP~~Rpsa~elL~hp~f~~~~~~ 463 (501)
T PHA03210 440 FDWHLRPGAAELLALPLFSAEEEE 463 (501)
T ss_pred cCcccCcCHHHHhhChhhhcCCch
Confidence 999999999999999999876543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=223.40 Aligned_cols=219 Identities=38% Similarity=0.613 Sum_probs=172.3
Q ss_pred CCCCCcEEEEEeccchHH---HHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESEAG---VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
+.++|..+|+|.+..... .+.+.+|++.+++++|+|+++ ......++++||+.+++|.+++.... .++...
T Consensus 10 ~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~ 88 (244)
T smart00220 10 DKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG-RLSEDE 88 (244)
T ss_pred ECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc-CCCHHH
Confidence 356789999999885433 678999999999999999987 45578999999999899999998743 266666
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
...++.++ ||+.+++|+||+|+||+++.++.++++|||.+....... ......++..|+|||...+.
T Consensus 89 ~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~~pE~~~~~ 161 (244)
T smart00220 89 ARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-------LLTTFVGTPEYMAPEVLLGK 161 (244)
T ss_pred HHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-------ccccccCCcCCCCHHHHccC
Confidence 66555544 799999999999999999999999999999997654421 22334578889999999888
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChh--hHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 148 GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQ--FFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
.++.++|+|++|++++++++|..||...... .................. ++..+.+++.+||..+|.+||++.+++
T Consensus 162 ~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~ 239 (244)
T smart00220 162 GYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEAL 239 (244)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHh
Confidence 8899999999999999999999999662111 112222211211111111 678899999999999999999999999
Q ss_pred cCCCC
Q 042809 226 NHTFI 230 (241)
Q Consensus 226 ~~p~~ 230 (241)
+||||
T Consensus 240 ~~~~~ 244 (244)
T smart00220 240 QHPFF 244 (244)
T ss_pred hCCCC
Confidence 99997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=228.19 Aligned_cols=221 Identities=26% Similarity=0.406 Sum_probs=164.4
Q ss_pred CCCCCcEEEEEeccchH---HHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCCH
Q 042809 2 NKGTGALFVVKSAESEA---GVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~ 71 (241)
+..+++.|+||.+.... ......+|+..+.+++ |+|+++ ..++..++||||+ +++|.+++.... ..++.
T Consensus 20 ~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~ 98 (283)
T cd07830 20 NKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSE 98 (283)
T ss_pred ECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCH
Confidence 34678999999876432 2234567899999999 999988 5688999999999 789999888753 45677
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.
T Consensus 99 ~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~ 171 (283)
T cd07830 99 SVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-------PYTDYVSTRWYRAPEILL 171 (283)
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-------CcCCCCCcccccCceeee
Confidence 7766666544 799999999999999999999999999999987543311 112234678899999885
Q ss_pred c-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC---------------CC-----------CCCChh
Q 042809 146 N-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN---------------EK-----------PHFPTQ 198 (241)
Q Consensus 146 ~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~-----------~~~~~~ 198 (241)
+ ..++.++|+||||++++++++|..||.................. .. ......
T Consensus 172 ~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (283)
T cd07830 172 RSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPN 251 (283)
T ss_pred cCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHccc
Confidence 4 45788999999999999999999999654322211110000000 00 000112
Q ss_pred hHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 199 FFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 199 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
.+..+.+++++||+.+|.+|||+++++.||||
T Consensus 252 ~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 252 ASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred CCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 24679999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=229.03 Aligned_cols=218 Identities=20% Similarity=0.273 Sum_probs=161.4
Q ss_pred CCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC---------
Q 042809 5 TGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG--------- 67 (241)
Q Consensus 5 ~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~--------- 67 (241)
++..+|+|.+.. ......+.+|+.+++.++|+||++ ...+..++||||+.+++|.+++.....
T Consensus 45 ~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 124 (296)
T cd05095 45 QPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124 (296)
T ss_pred ceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccc
Confidence 456799999873 334567899999999999999988 566789999999999999999986421
Q ss_pred -CCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 68 -TLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 68 -~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
.++...+..++. ++||+.|++|+||||+||+++.++.++|+|||++........ ........++..|++
T Consensus 125 ~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~~~~ 200 (296)
T cd05095 125 VTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY----YRIQGRAVLPIRWMS 200 (296)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcc----eeccCcCcCccccCC
Confidence 233444555444 448999999999999999999999999999999875422110 011112234567999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHh--CCCCCccchhchHHHHHHH----HhcCCCCCCChhhHHHHHHHHHHhhccC
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMAT--GRPPWGDKISNAAATLLKI----ACSNEKPHFPTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~--g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~ 214 (241)
||...+..++.++|+||||+++|++++ |..||.............. .........+...+..+.+++.+||+.+
T Consensus 201 pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 280 (296)
T cd05095 201 WESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRN 280 (296)
T ss_pred HHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCC
Confidence 999888889999999999999999998 7788865433222211111 0111112233456688999999999999
Q ss_pred CCCCCChHHHhc
Q 042809 215 PEKRWSAEELLN 226 (241)
Q Consensus 215 p~~Rps~~~~l~ 226 (241)
|.+|||+.++++
T Consensus 281 p~~Rp~~~~i~~ 292 (296)
T cd05095 281 AKERPSFQEIHA 292 (296)
T ss_pred cccCCCHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=228.87 Aligned_cols=221 Identities=28% Similarity=0.383 Sum_probs=163.5
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhc---CCCcccc-----cCCc-----eeeeeecccCCCCHHHHHHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSL---NSPNIGR-----NGEK-----TVNIFMEYMAGGSLLDVAEK 64 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l---~h~~i~~-----~~~~-----~~~lv~e~~~~~~L~~~l~~ 64 (241)
++.+++.||+|.+... .....+.+|+.+++++ .|+|+++ .... ..++++||+. ++|.+++..
T Consensus 20 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~ 98 (287)
T cd07838 20 DLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSK 98 (287)
T ss_pred ECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHH
Confidence 3457899999998632 2234566788777766 5999988 2223 4999999997 589998876
Q ss_pred hC-CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccc
Q 042809 65 FG-GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL 137 (241)
Q Consensus 65 ~~-~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (241)
.. ..+++..+..++.|+ ||+.+++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 99 ~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~-------~~~~~~~~~~ 171 (287)
T cd07838 99 CPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM-------ALTSVVVTLW 171 (287)
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCc-------cccccccccc
Confidence 43 357777777666544 799999999999999999999999999999987653311 1112236788
Q ss_pred ccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC-------------------CC----CC
Q 042809 138 WMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN-------------------EK----PH 194 (241)
Q Consensus 138 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------~~----~~ 194 (241)
|+|||.+.+..++.++|+||+|+++|+|++|..||.................. .. ..
T Consensus 172 ~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T cd07838 172 YRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKS 251 (287)
T ss_pred ccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhh
Confidence 99999999888999999999999999999999999765433222211111000 00 00
Q ss_pred CChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 195 FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 195 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
.....+..+.+++++||+.+|.+||++++++.||||
T Consensus 252 ~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 252 FVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 112345778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=225.73 Aligned_cols=219 Identities=23% Similarity=0.276 Sum_probs=157.4
Q ss_pred CCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC----CCC
Q 042809 3 KGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG----TLD 70 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~ 70 (241)
..++..+|+|.++.. .....+.+|+.++++++||||++ ......++||||+++|+|.+++..... ..+
T Consensus 19 ~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 98 (269)
T cd05087 19 GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPD 98 (269)
T ss_pred CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhccccccc
Confidence 345678999987643 23356888999999999999988 456678999999999999999976321 234
Q ss_pred HHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
...+..++. .+||+.+++|+||||+||+++.++.++|+|||.+....... .........++..|+|||.+
T Consensus 99 ~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~ 174 (269)
T cd05087 99 PTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED----YYVTPDQLWVPLRWIAPELV 174 (269)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc----eeecCCCcCCcccccCHhHh
Confidence 444433333 45899999999999999999999999999999986432211 01111223467789999998
Q ss_pred ccc-------CCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHH--hcCCCCCCChhhHHHHHHHHHHhhccC
Q 042809 145 RNE-------GLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIA--CSNEKPHFPTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 145 ~~~-------~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~ 214 (241)
.+. .++.++|+||||+++|++++ |..||............... .....+......+..+.+++++|| .+
T Consensus 175 ~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~ 253 (269)
T cd05087 175 DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQ 253 (269)
T ss_pred ccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cC
Confidence 642 35779999999999999997 99999765433322111111 111122223345678899999999 68
Q ss_pred CCCCCChHHHhc
Q 042809 215 PEKRWSAEELLN 226 (241)
Q Consensus 215 p~~Rps~~~~l~ 226 (241)
|.+|||+++++.
T Consensus 254 P~~Rpt~~~l~~ 265 (269)
T cd05087 254 PEQRPSAEEVHL 265 (269)
T ss_pred cccCCCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=236.57 Aligned_cols=219 Identities=26% Similarity=0.302 Sum_probs=164.9
Q ss_pred CCCCcEEEEEeccch---HHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC------
Q 042809 3 KGTGALFVVKSAESE---AGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG------ 67 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~------ 67 (241)
..+++.||+|++... ...+.+.+|+.++.++. ||||++ ...+..++|+||+.+|+|.+++...+.
T Consensus 64 ~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~ 143 (401)
T cd05107 64 SQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYY 143 (401)
T ss_pred CCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhh
Confidence 456678999998743 23456889999999998 999988 556789999999999999999975321
Q ss_pred --------------------------------------------------------------------------------
Q 042809 68 -------------------------------------------------------------------------------- 67 (241)
Q Consensus 68 -------------------------------------------------------------------------------- 67 (241)
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (401)
T cd05107 144 LDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPER 223 (401)
T ss_pred cccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCC
Confidence
Q ss_pred -----------CCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccc
Q 042809 68 -----------TLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQ 130 (241)
Q Consensus 68 -----------~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 130 (241)
.++......++. ++||+.+++||||+|+||+++.++.++|+|||++......... ....
T Consensus 224 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~----~~~~ 299 (401)
T cd05107 224 TRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY----ISKG 299 (401)
T ss_pred cchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceeccccccc----ccCC
Confidence 123333333333 5589999999999999999999999999999998754221110 1111
Q ss_pred cccCcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHH
Q 042809 131 SIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAK 209 (241)
Q Consensus 131 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 209 (241)
...++..|+|||.+.+..++.++|+||||+++|++++ |..||........ .......+.....+...+..+.+++.+
T Consensus 300 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~--~~~~~~~~~~~~~p~~~~~~l~~li~~ 377 (401)
T cd05107 300 STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ--FYNAIKRGYRMAKPAHASDEIYEIMQK 377 (401)
T ss_pred CcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH--HHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 2345778999999988888999999999999999998 8999865432221 112222233444556678899999999
Q ss_pred hhccCCCCCCChHHHhcC
Q 042809 210 CLERKPEKRWSAEELLNH 227 (241)
Q Consensus 210 ~l~~~p~~Rps~~~~l~~ 227 (241)
||..+|.+||+++++++.
T Consensus 378 cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 378 CWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HcCCChhHCcCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=250.53 Aligned_cols=214 Identities=23% Similarity=0.379 Sum_probs=180.4
Q ss_pred CcEEEEEecc---chHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHH
Q 042809 6 GALFVVKSAE---SEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLY 77 (241)
Q Consensus 6 ~~~vaiK~~~---~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 77 (241)
-..||||.++ .+.....|..|+.||-++.||||++ .....+.||+|||++|+|++||+...+.+....+.-+
T Consensus 657 e~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgM 736 (996)
T KOG0196|consen 657 EITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGM 736 (996)
T ss_pred ceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHH
Confidence 3679999988 3566778999999999999999998 5677899999999999999999998888888777766
Q ss_pred HH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccC--cccccCcccccccCC
Q 042809 78 TK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGG--TQLWMAPEVLRNEGL 149 (241)
Q Consensus 78 ~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~--~~~~~aPE~~~~~~~ 149 (241)
++ .||-+.++|||||..+|||++++-..|++|||++...++..+... ....| +.+|.|||.+..+++
T Consensus 737 LrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~y-----tt~GGKIPiRWTAPEAIa~RKF 811 (996)
T KOG0196|consen 737 LRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY-----TTLGGKIPIRWTAPEAIAYRKF 811 (996)
T ss_pred HHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccc-----cccCCccceeecChhHhhhccc
Confidence 66 558999999999999999999999999999999998766442222 12222 467999999999999
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 150 DFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
+.++||||+|+++||.++ |..||.+..+.+..+.++ .+.+.+-|.++|..+..|+..||++|-..||++++++..
T Consensus 812 TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe---~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 812 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE---QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CchhhccccceEEEEecccCCCcccccchHHHHHHHH---hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 999999999999999988 999999877655544444 345555677889999999999999999999999998753
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=226.66 Aligned_cols=215 Identities=23% Similarity=0.308 Sum_probs=166.2
Q ss_pred CCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHhC-------CC
Q 042809 5 TGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFG-------GT 68 (241)
Q Consensus 5 ~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~ 68 (241)
++..|++|.+.. ......+.+|+.+++++.|+||++ ..+...+++++|+.+++|.+++.... ..
T Consensus 34 ~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~ 113 (280)
T cd05043 34 KEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA 113 (280)
T ss_pred ceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccC
Confidence 478899998763 344567889999999999999988 33577899999999999999997642 34
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
++...+..++.++ ||+.+++|+||+|+||+++.++.++|+|||++......... .......++..|+|||
T Consensus 114 l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~----~~~~~~~~~~~y~apE 189 (280)
T cd05043 114 LSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH----CLGDNENRPVKWMALE 189 (280)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceE----EeCCCCCcchhccCHH
Confidence 6777666666544 79999999999999999999999999999999754321110 0111223567799999
Q ss_pred cccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 143 VLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 143 ~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
.+.+..++.++||||||+++|++++ |..||......... ...........+...+..+.+++.+||..+|++|||+
T Consensus 190 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 266 (280)
T cd05043 190 SLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA---AYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSF 266 (280)
T ss_pred HHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH---HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCH
Confidence 9988889999999999999999999 99999764332222 2222233333445567889999999999999999999
Q ss_pred HHHhc
Q 042809 222 EELLN 226 (241)
Q Consensus 222 ~~~l~ 226 (241)
.++++
T Consensus 267 ~~~~~ 271 (280)
T cd05043 267 SQLVQ 271 (280)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=218.28 Aligned_cols=231 Identities=27% Similarity=0.347 Sum_probs=185.4
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-------------cCCceeeeeecccCCCCHHHHHHH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-------------NGEKTVNIFMEYMAGGSLLDVAEK 64 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-------------~~~~~~~lv~e~~~~~~L~~~l~~ 64 (241)
.+.+|+.||+|..-- +.-.....+|+++|..++|+|++. .....+|+|+.+|++ +|+-++..
T Consensus 38 ~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn 116 (376)
T KOG0669|consen 38 SKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSN 116 (376)
T ss_pred hcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcC
Confidence 467888899987542 222355789999999999999865 345579999999986 99999988
Q ss_pred hCCCCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 65 FGGTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 65 ~~~~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
...+++...+..+.. +++|...|+|||+|+.|++++.+|.++|+|||++..+....... ........-|..|
T Consensus 117 ~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~--kprytnrvvTLwY 194 (376)
T KOG0669|consen 117 RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVV--KPRYTNRVVTLWY 194 (376)
T ss_pred ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccC--CCCcccceeeeec
Confidence 778899988887766 45799999999999999999999999999999997654432222 1223334458899
Q ss_pred cCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhh------------------
Q 042809 139 MAPEVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQF------------------ 199 (241)
Q Consensus 139 ~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------ 199 (241)
++||.+.|. .|++..|+|+.||++.+|+|+.+.++++++......+...+....++..+.+
T Consensus 195 rppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~ 274 (376)
T KOG0669|consen 195 RPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQ 274 (376)
T ss_pred CCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcch
Confidence 999999874 5889999999999999999999999998888888888877765544322111
Q ss_pred -------------HHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 200 -------------FKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 200 -------------~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.++..+|+.+++..||.+|+++++++.|.||...+.
T Consensus 275 ~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 275 KRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred hhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 136789999999999999999999999999976654
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=231.25 Aligned_cols=216 Identities=22% Similarity=0.334 Sum_probs=164.9
Q ss_pred CcEEEEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC----------
Q 042809 6 GALFVVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG---------- 66 (241)
Q Consensus 6 ~~~vaiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 66 (241)
+..||+|.+.. ....+.+.+|+.+++++ +||||++ ...+..++++||+.+|+|.+++....
T Consensus 44 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 123 (334)
T cd05100 44 PVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDT 123 (334)
T ss_pred ceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCccccccccc
Confidence 34789998774 33457789999999999 7999988 55668999999999999999998632
Q ss_pred -----CCCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCc
Q 042809 67 -----GTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGT 135 (241)
Q Consensus 67 -----~~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 135 (241)
..++...+..++. .+||++|++||||+|+||+++.++.++|+|||++......... .......++
T Consensus 124 ~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~ 199 (334)
T cd05100 124 CKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY----KKTTNGRLP 199 (334)
T ss_pred ccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceeccccccc----ccccCCCcC
Confidence 1244444444444 4489999999999999999999999999999998754331110 011112234
Q ss_pred ccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccC
Q 042809 136 QLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 136 ~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 214 (241)
..|+|||.+.+..++.++|+||||+++|++++ |..||............ ........+...+..+.+++.+||+.+
T Consensus 200 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~ 276 (334)
T cd05100 200 VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL---KEGHRMDKPANCTHELYMIMRECWHAV 276 (334)
T ss_pred ceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---HcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 67999999998889999999999999999998 88999765443332222 223334455567788999999999999
Q ss_pred CCCCCChHHHhcCC
Q 042809 215 PEKRWSAEELLNHT 228 (241)
Q Consensus 215 p~~Rps~~~~l~~p 228 (241)
|.+|||+.+++.+.
T Consensus 277 p~~Rps~~ell~~l 290 (334)
T cd05100 277 PSQRPTFKQLVEDL 290 (334)
T ss_pred hhhCcCHHHHHHHH
Confidence 99999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=228.21 Aligned_cols=213 Identities=23% Similarity=0.342 Sum_probs=163.6
Q ss_pred EEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHH
Q 042809 8 LFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKE 80 (241)
Q Consensus 8 ~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 80 (241)
.+|+|.+... .....+.+|+.+++.+.||||++ ......++++||+++|+|.+++......++...+..++.|
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~q 117 (303)
T cd05110 38 PVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ 117 (303)
T ss_pred eEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHH
Confidence 5788887643 23446889999999999999998 2334577999999999999999876556777776666654
Q ss_pred H------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhh
Q 042809 81 I------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATD 154 (241)
Q Consensus 81 ~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 154 (241)
+ ||++|++|+||+|+||+++.++.+||+|||++......... .......++..|+|||.+.+..++.++|
T Consensus 118 i~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~D 193 (303)
T cd05110 118 IAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE----YNADGGKMPIKWMALECIHYRKFTHQSD 193 (303)
T ss_pred HHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccc----cccCCCccccccCCHHHhccCCCChHHH
Confidence 4 79999999999999999999999999999999755321110 1111223467899999999888999999
Q ss_pred HHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 155 IWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 155 i~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
|||||+++|++++ |..||.+.......... ........+...+.++.+++.+||..+|.+||+++++++.
T Consensus 194 iwslG~~l~el~t~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 194 VWSYGVTIWELMTFGGKPYDGIPTREIPDLL---EKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999998 99999764333332222 2233333445566789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=222.90 Aligned_cols=214 Identities=22% Similarity=0.389 Sum_probs=163.5
Q ss_pred CCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHh-CCCCCHHHHHHHH
Q 042809 5 TGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDAGVIRLYT 78 (241)
Q Consensus 5 ~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ 78 (241)
.+..+++|.+... ...+.+.+|+.++++++|+||++ ......+++|||+++++|.+++... +...+...+..++
T Consensus 29 ~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ 108 (260)
T cd05073 29 KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 108 (260)
T ss_pred CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHH
Confidence 4566889987643 34567899999999999999988 3336789999999999999999864 3345555554444
Q ss_pred H------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCch
Q 042809 79 K------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA 152 (241)
Q Consensus 79 ~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 152 (241)
. ++||+.|++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+..++.+
T Consensus 109 ~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~ 183 (260)
T cd05073 109 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-----TAREGAKFPIKWTAPEAINFGSFTIK 183 (260)
T ss_pred HHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-----ccccCCcccccccCHhHhccCCcCcc
Confidence 4 448999999999999999999999999999999875433111 11111234567999999988888999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 153 TDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 153 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
+|+||||+++|++++ |..||............ ........+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 184 ~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 184 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---hCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 999999999999999 99999765433322222 223333445567788999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=223.15 Aligned_cols=204 Identities=22% Similarity=0.322 Sum_probs=158.5
Q ss_pred cEEEEEeccchHH-HHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHH
Q 042809 7 ALFVVKSAESEAG-VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKE 80 (241)
Q Consensus 7 ~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 80 (241)
..+++|.+..... ...+.+|+.++++++||||++ .. ...++|+||+++++|.+++......++...+..++.|
T Consensus 31 ~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 109 (259)
T cd05037 31 VSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQ 109 (259)
T ss_pred eeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHH
Confidence 4678887764433 677899999999999999988 23 6789999999999999999876556777777766665
Q ss_pred H------hhcCCccccCCCCCcEEeecCC-------CeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 81 I------LHGNGILHCDLKCNNVLLGSHG-------DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 81 ~------Lh~~~~vH~dl~p~Nil~~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
+ ||++|++|+||+|+||+++.++ .++|+|||++..... .....++..|+|||.+.+.
T Consensus 110 i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~~~~y~aPE~~~~~ 179 (259)
T cd05037 110 LASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS----------REERVERIPWIAPECIRNG 179 (259)
T ss_pred HHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc----------ccccccCCCccChhhhcCC
Confidence 4 7999999999999999999887 799999999875432 1122356779999999876
Q ss_pred --CCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 148 --GLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 148 --~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
.++.++|+||||+++|++++ |..||............. .....+......+.+++.+||..+|.+|||+.++
T Consensus 180 ~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 254 (259)
T cd05037 180 QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-----DQHRLPMPDCAELANLINQCWTYDPTKRPSFRAI 254 (259)
T ss_pred CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-----cCCCCCCCCchHHHHHHHHHhccChhhCCCHHHH
Confidence 78899999999999999999 688886653222222111 1111222223789999999999999999999999
Q ss_pred hc
Q 042809 225 LN 226 (241)
Q Consensus 225 l~ 226 (241)
++
T Consensus 255 l~ 256 (259)
T cd05037 255 LR 256 (259)
T ss_pred HH
Confidence 86
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=230.77 Aligned_cols=220 Identities=25% Similarity=0.462 Sum_probs=178.0
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCC-cccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSP-NIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~-~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
.+.|...||||+++++. ..+--..|-++|.....| .++. +.-+.+|.||||++||+|--.++.. +.+.
T Consensus 370 rkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~-GkFK 448 (683)
T KOG0696|consen 370 RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GKFK 448 (683)
T ss_pred ccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHh-cccC
Confidence 36778899999988542 234455676777755544 4444 7888999999999999999999874 5677
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.++ ||++||++||||.+||+++.+|.+||.|||+++.- .........++|||.|+|||++
T Consensus 449 Ep~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn------i~~~~TTkTFCGTPdYiAPEIi 522 (683)
T KOG0696|consen 449 EPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN------IFDGVTTKTFCGTPDYIAPEII 522 (683)
T ss_pred CchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc------ccCCcceeeecCCCcccccceE
Confidence 77777777655 89999999999999999999999999999999631 1112334578899999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW----- 219 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----- 219 (241)
...+|+.++|.||+|++||||+.|+.||.+.+++.....+. ...-.+|..++.++.++.+..|.+.|.+|.
T Consensus 523 ~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~----ehnvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ 598 (683)
T KOG0696|consen 523 AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM----EHNVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPE 598 (683)
T ss_pred EecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH----HccCcCcccccHHHHHHHHHHhhcCCccccCCCCc
Confidence 99999999999999999999999999999876655443333 344567889999999999999999999997
Q ss_pred ChHHHhcCCCCCC
Q 042809 220 SAEELLNHTFISG 232 (241)
Q Consensus 220 s~~~~l~~p~~~~ 232 (241)
.-.++-.||||+.
T Consensus 599 ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 599 GERDIREHPFFRR 611 (683)
T ss_pred cccchhhCcchhh
Confidence 3467899999975
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=223.17 Aligned_cols=218 Identities=22% Similarity=0.281 Sum_probs=155.9
Q ss_pred CCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCC----CCHH
Q 042809 5 TGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGT----LDAG 72 (241)
Q Consensus 5 ~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~ 72 (241)
....+++|.+... .....+.+|+..++.++|+||++ ......++||||+++|+|.+++...... .+..
T Consensus 21 ~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 100 (269)
T cd05042 21 SKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD 100 (269)
T ss_pred CCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHH
Confidence 4567888876532 33456789999999999999988 5667899999999999999999874321 2344
Q ss_pred HHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++. ++||++|++||||||+||+++.++.++|+|||++....... .........++..|+|||.+..
T Consensus 101 ~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~ 176 (269)
T cd05042 101 VLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED----YYITKDCHAVPLRWLAPELVEI 176 (269)
T ss_pred HHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch----heeccCCCCCcccccCHHHHhh
Confidence 4444443 55899999999999999999999999999999885432110 0001122234677999998743
Q ss_pred -------cCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHh--cCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 147 -------EGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIAC--SNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 147 -------~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
..++.++|+||||+++|++++ |..||................ ....+..+...+..+.+++..|| .+|.
T Consensus 177 ~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~ 255 (269)
T cd05042 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPE 255 (269)
T ss_pred ccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcc
Confidence 346789999999999999999 888987653322211111111 11122334456778889999998 5999
Q ss_pred CCCChHHHhcC
Q 042809 217 KRWSAEELLNH 227 (241)
Q Consensus 217 ~Rps~~~~l~~ 227 (241)
+|||++++++-
T Consensus 256 ~Rpt~~~v~~~ 266 (269)
T cd05042 256 TRPTAEEVHEL 266 (269)
T ss_pred cccCHHHHHHH
Confidence 99999999763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=224.24 Aligned_cols=217 Identities=21% Similarity=0.333 Sum_probs=167.2
Q ss_pred CCCcEEEEEeccchH---HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC--------
Q 042809 4 GTGALFVVKSAESEA---GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG-------- 67 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~-------- 67 (241)
.+.+.+++|.+.... ..+.+.+|++++.+++|+||++ ......++||||+++++|.+++.....
T Consensus 33 ~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~ 112 (275)
T cd05046 33 GGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPP 112 (275)
T ss_pred CCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhccccccccccc
Confidence 356789999876432 3577999999999999999988 556789999999999999999986431
Q ss_pred CCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 68 TLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 68 ~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
.++...+..++.| +||+.+++|+||+|+||+++.++.++++|||++....... ........++..|+||
T Consensus 113 ~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~y~~P 187 (275)
T cd05046 113 PLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE-----YYKLRNALIPLRWLAP 187 (275)
T ss_pred CCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCccc-----ccccCCceeEEeecCh
Confidence 4677777766654 4899999999999999999999999999999886432211 1111223356779999
Q ss_pred ccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC
Q 042809 142 EVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS 220 (241)
Q Consensus 142 E~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 220 (241)
|.+.+...+.++|+||||+++|++++ |..||............. ........+...+..+.+++.+||+.+|.+|||
T Consensus 188 E~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~ 265 (275)
T cd05046 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ--AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPS 265 (275)
T ss_pred hhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH--cCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCC
Confidence 99988888899999999999999998 888996643333222211 112222334557789999999999999999999
Q ss_pred hHHHhcC
Q 042809 221 AEELLNH 227 (241)
Q Consensus 221 ~~~~l~~ 227 (241)
+.+++..
T Consensus 266 ~~~~l~~ 272 (275)
T cd05046 266 FSELVSA 272 (275)
T ss_pred HHHHHHH
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=241.38 Aligned_cols=229 Identities=24% Similarity=0.431 Sum_probs=179.2
Q ss_pred CCCCcEEEEEeccchHHH-----HHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 3 KGTGALFVVKSAESEAGV-----QALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
.+|.+.||+|.+++.+.. .-...|-.||.....+-||+ ++.+++|+||+|++||++-++|... +.|++.
T Consensus 651 vDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrm-gIFeE~ 729 (1034)
T KOG0608|consen 651 VDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFEED 729 (1034)
T ss_pred cchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHh-ccCHHH
Confidence 456888899988865433 23678999999999999998 8899999999999999999999874 678899
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCC-----------------------
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG----------------------- 123 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~----------------------- 123 (241)
.+++++.++ +|..|++||||||+|||+|.+|.+||+|||+++.+..-....
T Consensus 730 LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~ 809 (1034)
T KOG0608|consen 730 LARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADIS 809 (1034)
T ss_pred HHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhcccc
Confidence 999888755 799999999999999999999999999999998542210000
Q ss_pred -------------ccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC
Q 042809 124 -------------NLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN 190 (241)
Q Consensus 124 -------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 190 (241)
..........||+.|+|||++....++..+|.|+.|++||+|+.|++||...+.......+.+....
T Consensus 810 ~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~ 889 (1034)
T KOG0608|consen 810 KCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNF 889 (1034)
T ss_pred ccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhc
Confidence 0000112456899999999999999999999999999999999999999876655444333333333
Q ss_pred CCCCCChhhHHHHHHHHHHhhccCCCCCC---ChHHHhcCCCCCCC
Q 042809 191 EKPHFPTQFFKKVLDFLAKCLERKPEKRW---SAEELLNHTFISGN 233 (241)
Q Consensus 191 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~~p~~~~~ 233 (241)
........++.++.++|.++.. +++.|. ..+++..||||++-
T Consensus 890 l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 890 LHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred cccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCcccccc
Confidence 3333445678899999988653 577787 56679999999763
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=223.24 Aligned_cols=213 Identities=24% Similarity=0.321 Sum_probs=166.6
Q ss_pred cEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHH
Q 042809 7 ALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTK 79 (241)
Q Consensus 7 ~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 79 (241)
..+|+|..... .....+.+|+.++.+++||||++ ......++|+||+.+|+|.+++......+++..+..++.
T Consensus 37 ~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 116 (279)
T cd05057 37 IPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV 116 (279)
T ss_pred eEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHH
Confidence 36899987643 34567889999999999999988 233789999999999999999988666788888777766
Q ss_pred HH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchh
Q 042809 80 EI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT 153 (241)
Q Consensus 80 ~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 153 (241)
|+ ||+.|++|+||+|+||+++.++.++|+|||.+.......... ......++..|+|||.+....++.++
T Consensus 117 qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~ 192 (279)
T cd05057 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY----HAEGGKVPIKWMALESILHRIYTHKS 192 (279)
T ss_pred HHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccce----ecCCCcccccccCHHHhhcCCcCchh
Confidence 55 799999999999999999999999999999997553211100 01112235679999999888889999
Q ss_pred hHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 154 DIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 154 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
|+||||+++|++++ |..||........... .........+...+..+.+++.+||..+|.+|||+.+++.
T Consensus 193 Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 193 DVWSYGVTVWELMTFGAKPYEGIPAVEIPDL---LEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred hHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH---HhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999998 9999976543333222 2223334445556778999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=228.99 Aligned_cols=223 Identities=24% Similarity=0.338 Sum_probs=172.0
Q ss_pred CCCCCcEEEEEeccc-hHHHHHHHHHHHHHhhcC--CCcc----cc-----cCCceeeeeecccCCCCHHHHHHHh-CCC
Q 042809 2 NKGTGALFVVKSAES-EAGVQALRNEAEIRQSLN--SPNI----GR-----NGEKTVNIFMEYMAGGSLLDVAEKF-GGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-~~~~~~~~~e~~~l~~l~--h~~i----~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~ 68 (241)
|.+++..||+|++++ ....+...-|++.+.++. -|+= +. +..++.|+|+|.+ |.++++++... -.+
T Consensus 110 D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~ 188 (415)
T KOG0671|consen 110 DRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIP 188 (415)
T ss_pred ecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccc
Confidence 667799999999885 344566778899999884 2221 11 7889999999999 67999999984 357
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecC--------------------CCeeecCCCcchhhcccccC
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH--------------------GDVKLPDLGCARRVNDLKNN 122 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~--------------------~~~kl~dfg~~~~~~~~~~~ 122 (241)
++...++.++.|+ ||+.+++|.||||+||++.+. ..++++|||.++...+
T Consensus 189 fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e---- 264 (415)
T KOG0671|consen 189 FPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE---- 264 (415)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceecc----
Confidence 8999999999887 699999999999999999532 1288999999975443
Q ss_pred CccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCC-------
Q 042809 123 GNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHF------- 195 (241)
Q Consensus 123 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 195 (241)
.......|..|+|||++.+-.++..+||||+||+|+|++||...|+..++.....+.+......+..+
T Consensus 265 -----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~ 339 (415)
T KOG0671|consen 265 -----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKE 339 (415)
T ss_pred -----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhH
Confidence 12345579999999999999999999999999999999999999987654443323222221111100
Q ss_pred -------------------------C----------hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 196 -------------------------P----------TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 196 -------------------------~----------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
+ .....++.+|+++||..||.+|+|+.|++.||||+...
T Consensus 340 Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 340 KYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred hhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 0 01123689999999999999999999999999998754
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=236.54 Aligned_cols=215 Identities=23% Similarity=0.367 Sum_probs=174.8
Q ss_pred CCCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCC-CCHHHHHH
Q 042809 4 GTGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGT-LDAGVIRL 76 (241)
Q Consensus 4 ~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~ 76 (241)
+....||||.++.+ -..++|..|+.+|+.++|||+|+ ..+..+|||+|||..|+|.+|++++... ++...+..
T Consensus 290 kyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLly 369 (1157)
T KOG4278|consen 290 KYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLY 369 (1157)
T ss_pred ccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHH
Confidence 44567899988844 45788999999999999999988 6778899999999999999999997543 44444445
Q ss_pred HHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCC
Q 042809 77 YTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD 150 (241)
Q Consensus 77 ~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 150 (241)
++.| ||..++++||||...|||+..+..+|+.|||++....... ...+....-.+-|.|||.+....++
T Consensus 370 MAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-----YTAHAGAKFPIKWTAPEsLAyNtFS 444 (1157)
T KOG4278|consen 370 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-----YTAHAGAKFPIKWTAPESLAYNTFS 444 (1157)
T ss_pred HHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc-----eecccCccCcccccCcccccccccc
Confidence 5544 4899999999999999999999999999999998665422 2222223345679999999999999
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 151 FATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 151 ~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
.++|||+||++||||.| |..||.+-+. .........+.+-..|..+++.+++|+++||+.+|.+||+++++-+
T Consensus 445 iKSDVWAFGVLLWEIATYGMsPYPGidl---SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 445 IKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred cchhhHHHHHHHHHHHhcCCCCCCCccH---HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 99999999999999999 9999987433 3344444556666677889999999999999999999999998743
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=235.29 Aligned_cols=217 Identities=19% Similarity=0.238 Sum_probs=171.2
Q ss_pred CcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCC-CHHHHHH
Q 042809 6 GALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTL-DAGVIRL 76 (241)
Q Consensus 6 ~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~ 76 (241)
+..||+|.++. ......|.+|+++|.+++||||+. ..++.+++|+|||+.|+|..|+.....+. +.+....
T Consensus 562 ~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vs 641 (807)
T KOG1094|consen 562 PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVS 641 (807)
T ss_pred ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHH
Confidence 47899999884 345678999999999999999998 67889999999999999999999863332 2222223
Q ss_pred HHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCC
Q 042809 77 YTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD 150 (241)
Q Consensus 77 ~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 150 (241)
++. .||.+.++|||||.+.||+++.++++||+|||++...-.. ...+.-....-+.+|+|+|.+.-++++
T Consensus 642 i~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg----~yy~vqgr~vlpiRwmawEsillgkFt 717 (807)
T KOG1094|consen 642 ICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG----DYYRVQGRAVLPIRWMAWESILLGKFT 717 (807)
T ss_pred HHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC----CceeeecceeeeeeehhHHHHHhcccc
Confidence 333 5589999999999999999999999999999999854221 111222223346889999999999999
Q ss_pred chhhHHHHHHHHHHHHh--CCCCCccchhchHHHHHHHHhcCC----CCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 151 FATDIWSLGCMVIEMAT--GRPPWGDKISNAAATLLKIACSNE----KPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 151 ~~~Di~slG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
.++|+|+||+++||+++ ...||...+++...+......... .+..|..++..+.+++.+||+.+..+|||++++
T Consensus 718 taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l 797 (807)
T KOG1094|consen 718 TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL 797 (807)
T ss_pred chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence 99999999999999887 789998876666554444333222 224567788899999999999999999999998
Q ss_pred hc
Q 042809 225 LN 226 (241)
Q Consensus 225 l~ 226 (241)
..
T Consensus 798 h~ 799 (807)
T KOG1094|consen 798 HL 799 (807)
T ss_pred HH
Confidence 64
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=217.06 Aligned_cols=226 Identities=29% Similarity=0.387 Sum_probs=174.4
Q ss_pred CCCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHH----hCC
Q 042809 1 MNKGTGALFVVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEK----FGG 67 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~----~~~ 67 (241)
+++.+|+.+|||.++. +...+++..|.+...+- ++||||+ ..++.-|+.||.|+ .+|+.+.+. ...
T Consensus 84 ~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~ 162 (361)
T KOG1006|consen 84 LHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKS 162 (361)
T ss_pred hcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhc
Confidence 4789999999999884 34567788888776555 5999999 78889999999995 577665432 234
Q ss_pred CCCHHHHHHHH------HHHh-hcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 68 TLDAGVIRLYT------KEIL-HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 68 ~~~~~~~~~~~------~~~L-h~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
.+++..+..++ +.+| ...+++|||+||+||+++..|.+||||||++....+.- ......|...|+|
T Consensus 163 ~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si-------AkT~daGCrpYmA 235 (361)
T KOG1006|consen 163 RIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI-------AKTVDAGCRPYMA 235 (361)
T ss_pred cCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHH-------HhhhccCCccccC
Confidence 56666655443 3445 46789999999999999999999999999998665521 2223457889999
Q ss_pred cccccc--cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC-----hhhHHHHHHHHHHhhcc
Q 042809 141 PEVLRN--EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP-----TQFFKKVLDFLAKCLER 213 (241)
Q Consensus 141 PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~ 213 (241)
||.+.. ..|+.++|+||||+++||+.||..|+..... ..+.+.+...+.++.+. ...+..+..+|.-|+.+
T Consensus 236 PERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~K 313 (361)
T KOG1006|consen 236 PERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIK 313 (361)
T ss_pred hhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhc
Confidence 999953 4588999999999999999999999977643 33444444445544332 23678899999999999
Q ss_pred CCCCCCChHHHhcCCCCCCCCcc
Q 042809 214 KPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 214 ~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
+-..||+..+++.+||++..+..
T Consensus 314 d~~~Rpky~~Lk~~~fyr~y~~~ 336 (361)
T KOG1006|consen 314 DRSDRPKYDDLKKFPFYRMYAVE 336 (361)
T ss_pred ccccCcchhhhhcCchhhhhhhc
Confidence 99999999999999999877654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=236.33 Aligned_cols=214 Identities=30% Similarity=0.484 Sum_probs=182.1
Q ss_pred EEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 9 FVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 9 vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
+|+|++++. ...+-+..|-.+|...+.|.||+ .+...+|++||-|-||.|.+.++.+ +.++...+++++
T Consensus 448 fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~ 526 (732)
T KOG0614|consen 448 FALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDR-GSFDDYTARFYV 526 (732)
T ss_pred HHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhc-CCcccchhhhhH
Confidence 566665533 33455788999999999999998 7888999999999999999999984 667776666665
Q ss_pred H------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCch
Q 042809 79 K------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA 152 (241)
Q Consensus 79 ~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 152 (241)
. +|||++||++|||||+|++++.+|-+||.|||.++.+.. ....+.++|||.|.|||++.....+.+
T Consensus 527 acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~-------g~KTwTFcGTpEYVAPEIILnKGHD~a 599 (732)
T KOG0614|consen 527 ACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS-------GRKTWTFCGTPEYVAPEIILNKGHDRA 599 (732)
T ss_pred HHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc-------CCceeeecCCcccccchhhhccCcchh
Confidence 4 679999999999999999999999999999999998766 345678999999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----ChHHHhcC
Q 042809 153 TDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----SAEELLNH 227 (241)
Q Consensus 153 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~~ 227 (241)
+|.||||+++||+++|.+||++.+ .+..............+|..+.....+||+++...+|.+|. .+.++-.|
T Consensus 600 vDyWaLGIli~ELL~G~pPFs~~d--pmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 600 VDYWALGILIYELLTGSPPFSGVD--PMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred hHHHHHHHHHHHHHcCCCCCCCCc--hHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 999999999999999999998853 34444444444556678888999999999999999999998 49999999
Q ss_pred CCCCC
Q 042809 228 TFISG 232 (241)
Q Consensus 228 p~~~~ 232 (241)
.||.+
T Consensus 678 ~Wf~g 682 (732)
T KOG0614|consen 678 RWFEG 682 (732)
T ss_pred hhhhc
Confidence 99965
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=220.86 Aligned_cols=214 Identities=25% Similarity=0.386 Sum_probs=163.8
Q ss_pred CCcEEEEEeccc------------hHHHHHHHHHHHHHhh-cCCCcccc-----cCCceeeeeecccCCCCHHHHHHH--
Q 042809 5 TGALFVVKSAES------------EAGVQALRNEAEIRQS-LNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEK-- 64 (241)
Q Consensus 5 ~~~~vaiK~~~~------------~~~~~~~~~e~~~l~~-l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~-- 64 (241)
+++.+|+|.+.. ......+.+|+.++.+ ++||||++ ..++..++|+||+++++|.+++..
T Consensus 25 ~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~ 104 (269)
T cd08528 25 GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLK 104 (269)
T ss_pred CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHH
Confidence 678999997642 2234567788888865 78999988 567899999999999999998854
Q ss_pred -hCCCCCHHHHHHHHHHH------hhc-CCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcc
Q 042809 65 -FGGTLDAGVIRLYTKEI------LHG-NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQ 136 (241)
Q Consensus 65 -~~~~~~~~~~~~~~~~~------Lh~-~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (241)
....++...++.++.|+ ||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus 105 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-------~~~~~~~~~ 177 (269)
T cd08528 105 EKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES-------KLTSVVGTI 177 (269)
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccccc-------ccccccCcc
Confidence 34567777666665544 785 789999999999999999999999999997543311 123345788
Q ss_pred cccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 137 LWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 137 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
.|+|||.+.+..++.++|+||||+++|++++|..||............. .....+......+..+.+++.+||+.+|+
T Consensus 178 ~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 255 (269)
T cd08528 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV--EAVYEPLPEGMYSEDVTDVITSCLTPDAE 255 (269)
T ss_pred cCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHh--hccCCcCCcccCCHHHHHHHHHHCCCCCc
Confidence 8999999998889999999999999999999999997643322222211 11111212224678899999999999999
Q ss_pred CCCChHHHhcC
Q 042809 217 KRWSAEELLNH 227 (241)
Q Consensus 217 ~Rps~~~~l~~ 227 (241)
+|||+.++.++
T Consensus 256 ~Rp~~~e~~~~ 266 (269)
T cd08528 256 ARPDIIQVSAM 266 (269)
T ss_pred cCCCHHHHHHH
Confidence 99999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=239.66 Aligned_cols=219 Identities=24% Similarity=0.330 Sum_probs=178.5
Q ss_pred CcEEEEEeccchH---HHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHH-hCCCCCHHHHHHH
Q 042809 6 GALFVVKSAESEA---GVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEK-FGGTLDAGVIRLY 77 (241)
Q Consensus 6 ~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~ 77 (241)
-..||||+++... ....|.+|+.+|.+|+|+|+++ .-+....+|+|.+..|+|.+.|.. ....+-....-.|
T Consensus 138 ~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdy 217 (1039)
T KOG0199|consen 138 HVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDY 217 (1039)
T ss_pred EEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhcccchHHHHHhhccccceeHHHHHHH
Confidence 3578999988542 4577999999999999999999 344788999999999999999988 3455666666555
Q ss_pred HH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+. +||.++++|||||-..|+++-....+||+|||+...++.....-. -.....-...|.|||.+...+++.
T Consensus 218 a~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv---m~p~rkvPfAWCaPEsLrh~kFSh 294 (1039)
T KOG0199|consen 218 AMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV---MAPQRKVPFAWCAPESLRHRKFSH 294 (1039)
T ss_pred HHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE---ecCCCcCcccccCHhHhccccccc
Confidence 55 458999999999999999999999999999999987765322111 111122356799999999999999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
++|+|++|+++|||+| |+.||.+.. ...+++....+.....|+.++++++++++.||..+|.+|||+..+.+.-+.
T Consensus 295 aSDvWmyGVTiWEMFtyGEePW~G~~---g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 295 ASDVWMYGVTIWEMFTYGEEPWVGCR---GIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred cchhhhhhhhHHhhhccCCCCCCCCC---HHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 9999999999999999 999998753 344455555777888889999999999999999999999999998765444
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=219.08 Aligned_cols=216 Identities=20% Similarity=0.269 Sum_probs=154.2
Q ss_pred CcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC---CCCCHHHH
Q 042809 6 GALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG---GTLDAGVI 74 (241)
Q Consensus 6 ~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~ 74 (241)
...+++|.... ....+.+.+|+..+..++||||++ ......++||||+++|+|.+++.... ...+...+
T Consensus 22 ~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 101 (268)
T cd05086 22 VARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLL 101 (268)
T ss_pred cceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHH
Confidence 44567776553 234567999999999999999998 55678899999999999999998642 22344333
Q ss_pred HHHH------HHHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc--
Q 042809 75 RLYT------KEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN-- 146 (241)
Q Consensus 75 ~~~~------~~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-- 146 (241)
..++ .++||+.+++|+||+|+||+++.++.++|+|||++...... ..........++..|+|||.+..
T Consensus 102 ~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~ 177 (268)
T cd05086 102 QRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE----DYIETEDDKCVPLRWLAPELVGEFH 177 (268)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc----hhhhcccCCcCcccccCchhccccc
Confidence 3333 35589999999999999999999999999999987532110 00011123446788999998743
Q ss_pred -----cCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHH--hcCCCCCCChhhHHHHHHHHHHhhccCCCCC
Q 042809 147 -----EGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIA--CSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218 (241)
Q Consensus 147 -----~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 218 (241)
..++.++|+||||+++|++++ |..||............... .....+..+...++.+.+++..|| .+|.+|
T Consensus 178 ~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~R 256 (268)
T cd05086 178 GGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKR 256 (268)
T ss_pred CccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccC
Confidence 235678999999999999997 67788654332222211111 111223344556788999999999 679999
Q ss_pred CChHHHhc
Q 042809 219 WSAEELLN 226 (241)
Q Consensus 219 ps~~~~l~ 226 (241)
||++++++
T Consensus 257 p~~~~i~~ 264 (268)
T cd05086 257 ATAEEVHR 264 (268)
T ss_pred CCHHHHHH
Confidence 99999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=231.31 Aligned_cols=222 Identities=25% Similarity=0.410 Sum_probs=172.5
Q ss_pred CCCCCcEEEEEeccchHH-HHHHHHHHHHHhhcC------CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC--
Q 042809 2 NKGTGALFVVKSAESEAG-VQALRNEAEIRQSLN------SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG-- 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~------h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~-- 67 (241)
|..-|.-||||+++++.. .+.=.+|+++|++|. .-|.++ ...+++|+|+|-+. -+|.+.++..+.
T Consensus 453 D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nv 531 (752)
T KOG0670|consen 453 DQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNV 531 (752)
T ss_pred ccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCccc
Confidence 566778999999997654 355689999999995 234444 78899999999994 699999998754
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecC-CCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH-GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
.+....++.|++|+ |...|++|.||||+|||++.. ..+||||||.|....+... ....-+..|.|
T Consensus 532 GL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei--------tPYLVSRFYRa 603 (752)
T KOG0670|consen 532 GLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEI--------TPYLVSRFYRA 603 (752)
T ss_pred ceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccccccc--------cHHHHHHhccC
Confidence 46666666666665 678999999999999999875 5689999999976655211 11224678999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC---------------------------
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP--------------------------- 193 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------- 193 (241)
||++.|.+|+...|+||+||+|||++||+..|.+.+...+..+........+.
T Consensus 604 PEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~v 683 (752)
T KOG0670|consen 604 PEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKV 683 (752)
T ss_pred cceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEecccc
Confidence 99999999999999999999999999999999988777665544322111000
Q ss_pred --------------------------CCC---hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 194 --------------------------HFP---TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 194 --------------------------~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
.++ +.....+.+|+.+||.+||.+|.|+.++|.||||.+
T Consensus 684 T~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 684 TEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred ccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 011 112246899999999999999999999999999975
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=218.00 Aligned_cols=218 Identities=18% Similarity=0.306 Sum_probs=162.5
Q ss_pred CCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCccccc-----C---C---ceeeeeecccCCCCHHHHHHHhC-
Q 042809 3 KGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGRN-----G---E---KTVNIFMEYMAGGSLLDVAEKFG- 66 (241)
Q Consensus 3 ~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~-----~---~---~~~~lv~e~~~~~~L~~~l~~~~- 66 (241)
..++..||+|.+.. ....+.+.+|+.++++++||||++. . . ...+++++|+.+|+|..++....
T Consensus 24 ~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 103 (273)
T cd05074 24 DGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRI 103 (273)
T ss_pred CCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcc
Confidence 45788999998763 3446678899999999999999881 1 1 13478899999999998875421
Q ss_pred ----CCCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcc
Q 042809 67 ----GTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQ 136 (241)
Q Consensus 67 ----~~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (241)
..++...+..++.| +||+.|++|+||+|+||+++.++.++|+|||.+........ ........++.
T Consensus 104 ~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~ 179 (273)
T cd05074 104 GEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY----YRQGCASKLPV 179 (273)
T ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcc----eecCCCccCch
Confidence 13566655555554 47999999999999999999999999999999875432110 01111223456
Q ss_pred cccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCC
Q 042809 137 LWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKP 215 (241)
Q Consensus 137 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 215 (241)
.|++||.+.+..++.++|+||||+++|++++ |..||........ ............+...+..+.+++.+||+.+|
T Consensus 180 ~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p 256 (273)
T cd05074 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNYLIKGNRLKQPPDCLEDVYELMCQCWSPEP 256 (273)
T ss_pred hhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCh
Confidence 7999999988888999999999999999999 8899876433222 22222233333445567899999999999999
Q ss_pred CCCCChHHHhcC
Q 042809 216 EKRWSAEELLNH 227 (241)
Q Consensus 216 ~~Rps~~~~l~~ 227 (241)
.+|||+.+++..
T Consensus 257 ~~Rps~~~~~~~ 268 (273)
T cd05074 257 KCRPSFQHLRDQ 268 (273)
T ss_pred hhCcCHHHHHHH
Confidence 999999999763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=243.86 Aligned_cols=112 Identities=30% Similarity=0.529 Sum_probs=94.6
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
+..+++.||||++... .....+.+|+.++..++||||++ .....+|+||||+.|++|.+++... ..+.+
T Consensus 25 ~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~-~~l~~ 103 (669)
T cd05610 25 KKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY-GYFDE 103 (669)
T ss_pred ECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhc-CCCCH
Confidence 4567899999998743 23467889999999999999988 5667899999999999999999863 45667
Q ss_pred HHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcch
Q 042809 72 GVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 72 ~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
..++.++.| +||++|++||||||+||+++.++.++|+|||++.
T Consensus 104 ~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 104 EMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 666666554 4799999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=218.28 Aligned_cols=219 Identities=26% Similarity=0.322 Sum_probs=165.0
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----------cCCceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----------NGEKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----------~~~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
|.-++++||+|....+ ...++..+|...+..+.|+||++ ..-...|+|||+|. .+|...+.-
T Consensus 37 D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~-- 113 (369)
T KOG0665|consen 37 DQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVILM-- 113 (369)
T ss_pred hhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHHH--
Confidence 4567889999986643 34567889999999999999988 34457899999996 699998884
Q ss_pred CCCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
.++-..+..+..| .||+.|++||||||+||++..++.+||.|||++...... -.......++.|.|
T Consensus 114 -elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-------~~mtpyVvtRyyra 185 (369)
T KOG0665|consen 114 -ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-------FMMTPYVVTRYYRA 185 (369)
T ss_pred -hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc-------cccCchhheeeccC
Confidence 3556666666554 479999999999999999999999999999999754331 12233456888999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC------------------------------
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN------------------------------ 190 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------ 190 (241)
||++.+..+...+||||+||++.||++|..-|.+.+.-+--.........
T Consensus 186 pevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~ 265 (369)
T KOG0665|consen 186 PEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSE 265 (369)
T ss_pred chheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhh
Confidence 99999988999999999999999999999888653211110000000000
Q ss_pred CCC--------CCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCC
Q 042809 191 EKP--------HFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFIS 231 (241)
Q Consensus 191 ~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~ 231 (241)
..+ ..++.-...+++++.+||..+|++|.|+.++|+|||++
T Consensus 266 ~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 266 LFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 000 00111234689999999999999999999999999996
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=236.12 Aligned_cols=168 Identities=33% Similarity=0.460 Sum_probs=140.8
Q ss_pred CCCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-------cC----CceeeeeecccCCCCHHHHHHHh-
Q 042809 1 MNKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-------NG----EKTVNIFMEYMAGGSLLDVAEKF- 65 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-------~~----~~~~~lv~e~~~~~~L~~~l~~~- 65 (241)
+++.||..||||.++. ....+.-.+|+++|++++|+|||+ .. .....+|||||.||+|...+.+.
T Consensus 33 rnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PE 112 (732)
T KOG4250|consen 33 RNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPE 112 (732)
T ss_pred cccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcc
Confidence 4789999999999885 455677889999999999999998 12 44578999999999999999864
Q ss_pred -CCCCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeec--CCC--eeecCCCcchhhcccccCCccccccccccC
Q 042809 66 -GGTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGS--HGD--VKLPDLGCARRVNDLKNNGNLKQSWQSIGG 134 (241)
Q Consensus 66 -~~~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~--~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 134 (241)
...+++.....++. .+||++||+||||||.||++-. +|+ .||+|||.|+...+ ...+.+..|
T Consensus 113 N~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d-------~s~~~S~vG 185 (732)
T KOG4250|consen 113 NAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDD-------NSLFTSLVG 185 (732)
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCC-------CCeeeeecC
Confidence 34577777766655 4589999999999999999833 344 79999999987766 235667889
Q ss_pred cccccCccccc-ccCCCchhhHHHHHHHHHHHHhCCCCCccc
Q 042809 135 TQLWMAPEVLR-NEGLDFATDIWSLGCMVIEMATGRPPWGDK 175 (241)
Q Consensus 135 ~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 175 (241)
|+.|++||.+. ...|+..+|.|||||++|+++||..||-..
T Consensus 186 T~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 186 TEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred chhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 99999999998 488899999999999999999999999543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=235.98 Aligned_cols=224 Identities=34% Similarity=0.565 Sum_probs=177.4
Q ss_pred CCCCCcEEEEEeccc-hHHHHHHHHHHHHHhhcC-CCcccc----------cCCceeeeeecccCCCCHHHHHHHh-CCC
Q 042809 2 NKGTGALFVVKSAES-EAGVQALRNEAEIRQSLN-SPNIGR----------NGEKTVNIFMEYMAGGSLLDVAEKF-GGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~----------~~~~~~~lv~e~~~~~~L~~~l~~~-~~~ 68 (241)
++++|+.+|+|+..- ...-+++..|..+++.+. |||++. -.++.+|||||||.|||.-++.+.. +.+
T Consensus 40 ~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~r 119 (953)
T KOG0587|consen 40 HVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNR 119 (953)
T ss_pred eeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccc
Confidence 567888888888663 344567888899999886 999976 6788999999999999999998865 567
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
+.+..+..++..+ ||...++|||||..||+++.+|.|||.|||.+..... ........+||+.|+|||
T Consensus 120 l~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds------T~grRnT~iGtP~WMAPE 193 (953)
T KOG0587|consen 120 LKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS------TVGRRNTFIGTPYWMAPE 193 (953)
T ss_pred hhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec------ccccccCcCCCcccccce
Confidence 8888877776644 7999999999999999999999999999999865433 122334677999999999
Q ss_pred cccc-----cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHh-cCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 143 VLRN-----EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIAC-SNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 143 ~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
++.. ..|+.++|+||||++..||..|.+|+.+. .....+....- .......|...+..+.++|..||.++..
T Consensus 194 Viac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm--HPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e 271 (953)
T KOG0587|consen 194 VIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM--HPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYE 271 (953)
T ss_pred eeecccCCCCCcccccchhhccceeehhcCCCCCccCc--chhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccc
Confidence 9964 44678999999999999999999999763 33333322111 1111123566778999999999999999
Q ss_pred CCCChHHHhcCCCCCCC
Q 042809 217 KRWSAEELLNHTFISGN 233 (241)
Q Consensus 217 ~Rps~~~~l~~p~~~~~ 233 (241)
+||++.+++.|||++..
T Consensus 272 ~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 272 QRPSTEELLKHPFITEQ 288 (953)
T ss_pred cCcchhhhccCCccccc
Confidence 99999999999999843
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=240.79 Aligned_cols=220 Identities=29% Similarity=0.406 Sum_probs=162.1
Q ss_pred CcEEEEEeccchHHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCC------CC-HH
Q 042809 6 GALFVVKSAESEAGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGT------LD-AG 72 (241)
Q Consensus 6 ~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~-~~ 72 (241)
|+.||||.+-.+- ...+.+|+..+..-+ |||||+ .+....|+..|.|. .+|.+++...+.. .. ..
T Consensus 533 ~R~VAVKrll~e~-~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~ 610 (903)
T KOG1027|consen 533 GREVAVKRLLEEF-FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPIS 610 (903)
T ss_pred CceehHHHHhhHh-HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccccHHH
Confidence 5677888766443 566789999998876 999999 78889999999996 7999999873110 11 11
Q ss_pred HHH--HHHHHHhhcCCccccCCCCCcEEeec---CC--CeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 73 VIR--LYTKEILHGNGILHCDLKCNNVLLGS---HG--DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 73 ~~~--~~~~~~Lh~~~~vH~dl~p~Nil~~~---~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
... ....+.||+.+||||||||.||+++. ++ +++|+|||+++........- .......||.+|.|||.+.
T Consensus 611 ~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~---~r~s~~sGt~GW~APE~L~ 687 (903)
T KOG1027|consen 611 VLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF---SRLSGGSGTSGWQAPEQLR 687 (903)
T ss_pred HHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh---hcccCCCCcccccCHHHHh
Confidence 111 22335599999999999999999977 34 58999999999765432222 2245567999999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 146 NEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
....+.++||||+||++|+.++ |..||.+.-... .+++..........-.... ++.+||.+|++.+|..|||+.++
T Consensus 688 ~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~V 764 (903)
T KOG1027|consen 688 EDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANILTGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDV 764 (903)
T ss_pred ccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhhcCccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHH
Confidence 8888889999999999999999 599998754332 2222211111111111111 78999999999999999999999
Q ss_pred hcCCCCCCC
Q 042809 225 LNHTFISGN 233 (241)
Q Consensus 225 l~~p~~~~~ 233 (241)
|.||||=..
T Consensus 765 L~HPlFW~~ 773 (903)
T KOG1027|consen 765 LNHPLFWDS 773 (903)
T ss_pred hCCCccCCh
Confidence 999998443
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=212.34 Aligned_cols=224 Identities=27% Similarity=0.386 Sum_probs=166.0
Q ss_pred cEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHhC----CCCCHH
Q 042809 7 ALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFG----GTLDAG 72 (241)
Q Consensus 7 ~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~ 72 (241)
+.+|||.++.+ -......+|+.+++.++|||++. ..+..+++++||.++ +|...|+-++ ..++..
T Consensus 54 k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~ 132 (438)
T KOG0666|consen 54 KEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRS 132 (438)
T ss_pred hhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHH
Confidence 47888988755 23356889999999999999987 458999999999987 9999887542 346777
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecC----CCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSH----GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~----~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
.++.++-|+ ||++=+.||||||.||++..+ |.+||+|+|++..+.+.-.. ......+.-|..|+|||
T Consensus 133 mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkp---l~s~d~VVVTiWYRAPE 209 (438)
T KOG0666|consen 133 MVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKP---LASLDPVVVTIWYRAPE 209 (438)
T ss_pred HHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccc---cccCCceEEEEEecChH
Confidence 777776666 699999999999999999888 89999999999876552111 11223345688899999
Q ss_pred cccccC-CCchhhHHHHHHHHHHHHhCCCCCccchhchH-------HHHHHHHhcCCCC------------CC-------
Q 042809 143 VLRNEG-LDFATDIWSLGCMVIEMATGRPPWGDKISNAA-------ATLLKIACSNEKP------------HF------- 195 (241)
Q Consensus 143 ~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~------------~~------- 195 (241)
.+.|.. |+++.|+|+.||++.|++|-.+.|.+...... ..+.+.......| +.
T Consensus 210 LLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f 289 (438)
T KOG0666|consen 210 LLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDF 289 (438)
T ss_pred HhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHh
Confidence 999855 79999999999999999998887765322111 0111111000000 00
Q ss_pred ------C----------hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 196 ------P----------TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 196 ------~----------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
+ ..-++...+|+.++|..||.+|+|++++++|+||+...
T Consensus 290 ~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 290 RRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP 344 (438)
T ss_pred HHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence 0 00113478999999999999999999999999998763
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=212.49 Aligned_cols=224 Identities=26% Similarity=0.468 Sum_probs=180.8
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
.++|.++||+|+++++ ...+-...|-....+.. ||.+|. +.+..+++|.||++||+|--.++. ...++
T Consensus 271 ~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqr-qrklp 349 (593)
T KOG0695|consen 271 LKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLP 349 (593)
T ss_pred hcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhh-hhcCc
Confidence 5789999999998754 23444566666666664 888876 788999999999999999888887 46688
Q ss_pred HHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
++.++.+.. .+||++||+.||||.+|++++..|.+||+|+|+++.--. .......++|||.|.|||++
T Consensus 350 eeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~------~gd~tstfcgtpnyiapeil 423 (593)
T KOG0695|consen 350 EEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG------PGDTTSTFCGTPNYIAPEIL 423 (593)
T ss_pred HHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC------CCcccccccCCCcccchhhh
Confidence 888877654 458999999999999999999999999999999973211 12334578899999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCc----cchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWG----DKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW- 219 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp- 219 (241)
.|..|....|.|+||++++||+.|+.||. ++.+.+....+.+......-.+|..++-....+++..|++||++|.
T Consensus 424 rgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 424 RGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred cccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 99999999999999999999999999994 2333333444444444455567788888889999999999999996
Q ss_pred -----ChHHHhcCCCCCC
Q 042809 220 -----SAEELLNHTFISG 232 (241)
Q Consensus 220 -----s~~~~l~~p~~~~ 232 (241)
.+.++-.|+||+.
T Consensus 504 c~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 504 CRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred CCcccchhhhhcchhhhh
Confidence 5789999999974
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=237.58 Aligned_cols=184 Identities=29% Similarity=0.428 Sum_probs=134.3
Q ss_pred ceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhc
Q 042809 44 KTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVN 117 (241)
Q Consensus 44 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 117 (241)
..+||=||||+..+|.+++......-.....+.++++| +|++|++||||||.|||+++++.+||+|||+++...
T Consensus 669 ~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~ 748 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLK 748 (1351)
T ss_pred eEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhh
Confidence 35788899999877777777633222567777777766 699999999999999999999999999999998732
Q ss_pred c-----------ccc-CCccccccccccCcccccCcccccccC---CCchhhHHHHHHHHHHHHhCCCCCccchhchHHH
Q 042809 118 D-----------LKN-NGNLKQSWQSIGGTQLWMAPEVLRNEG---LDFATDIWSLGCMVIEMATGRPPWGDKISNAAAT 182 (241)
Q Consensus 118 ~-----------~~~-~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 182 (241)
. +.. ............||..|+|||.+.+.. |+.++|+||||++++||+. ||....+.. ..
T Consensus 749 ~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa-~i 824 (1351)
T KOG1035|consen 749 ENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA-SI 824 (1351)
T ss_pred hhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHH-HH
Confidence 1 000 111111334567999999999997644 8999999999999999987 576543322 22
Q ss_pred HHHHHhcCCCCC---CChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 183 LLKIACSNEKPH---FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 183 ~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
+.... .+..|. +....-+.-..+|++|++.||.+|||+.++|.+.||-.
T Consensus 825 L~~LR-~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 825 LTNLR-KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred HHhcc-cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 22222 222221 22333356678999999999999999999999999975
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=228.65 Aligned_cols=189 Identities=21% Similarity=0.208 Sum_probs=125.8
Q ss_pred cCCceeeeeecccCCCCHHHHHHHhCCCCC-------------------HHHHHHHH------HHHhhcCCccccCCCCC
Q 042809 41 NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD-------------------AGVIRLYT------KEILHGNGILHCDLKCN 95 (241)
Q Consensus 41 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------------------~~~~~~~~------~~~Lh~~~~vH~dl~p~ 95 (241)
..+...++|+||+.+++|.+++........ ...+..++ +++||+++++||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 456789999999999999999876432111 11122232 35589999999999999
Q ss_pred cEEeec-CCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC----------------------CCch
Q 042809 96 NVLLGS-HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG----------------------LDFA 152 (241)
Q Consensus 96 Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----------------------~~~~ 152 (241)
||+++. ++.+||+|||++........ .......+++.|+|||.+.... +..+
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~-----~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGIN-----YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccc-----cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 999986 57899999999975432111 1112356789999999764221 2345
Q ss_pred hhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHh-------cCCCCCCChh----------hHHHHHHHHHHhhccCC
Q 042809 153 TDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIAC-------SNEKPHFPTQ----------FFKKVLDFLAKCLERKP 215 (241)
Q Consensus 153 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~----------~~~~~~~li~~~l~~~p 215 (241)
+||||+||++|+|+++..++......- ........ .......... .....++|+.+||+.||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNLIQF-NRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHHHHH-HHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 699999999999999877754321110 00000000 0000001111 12245689999999999
Q ss_pred CCCCChHHHhcCCCCCCCCc
Q 042809 216 EKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 216 ~~Rps~~~~l~~p~~~~~~~ 235 (241)
.+|||++++++||||++...
T Consensus 439 ~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 439 RQRISAKAALAHPYFDREGL 458 (566)
T ss_pred ccCCCHHHHhCCcCcCCCCc
Confidence 99999999999999987654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=225.77 Aligned_cols=216 Identities=24% Similarity=0.363 Sum_probs=171.6
Q ss_pred CcEEEEEeccc---hHHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhC----------
Q 042809 6 GALFVVKSAES---EAGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG---------- 66 (241)
Q Consensus 6 ~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 66 (241)
...||||.... ....+.+..|+++|+.+. |+||+. ...+.+++|+||+.+|+|.++++..+
T Consensus 328 ~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~ 407 (609)
T KOG0200|consen 328 YVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGV 407 (609)
T ss_pred eEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCC
Confidence 56899999773 345688999999999997 999988 45788999999999999999999865
Q ss_pred -----CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCc
Q 042809 67 -----GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGT 135 (241)
Q Consensus 67 -----~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 135 (241)
..+.......++.|+ |++.+++||||-.+||+++.+..+||+|||+++.......... ......-.
T Consensus 408 ~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~---~~~~~~LP 484 (609)
T KOG0200|consen 408 FPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRT---KSSAGTLP 484 (609)
T ss_pred CccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEe---cCCCCccc
Confidence 236667777777765 7999999999999999999999999999999974333111110 00000023
Q ss_pred ccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccC
Q 042809 136 QLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 136 ~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 214 (241)
..|+|||.+....|+.++||||+|+++||++| |..||.+-.. ...+.+....+.+...|...+.+++++++.||+.+
T Consensus 485 ~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~ 562 (609)
T KOG0200|consen 485 VKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNAD 562 (609)
T ss_pred eeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCC
Confidence 45999999999999999999999999999999 9999976321 12223344556666778888899999999999999
Q ss_pred CCCCCChHHHhc
Q 042809 215 PEKRWSAEELLN 226 (241)
Q Consensus 215 p~~Rps~~~~l~ 226 (241)
|.+||++.++.+
T Consensus 563 p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 563 PEDRPTFSECVE 574 (609)
T ss_pred cccCCCHHHHHH
Confidence 999999999864
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=204.00 Aligned_cols=197 Identities=16% Similarity=0.150 Sum_probs=137.4
Q ss_pred HHHHhhcCCCcccccC---------CceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHH------HhhcCCccccC
Q 042809 27 AEIRQSLNSPNIGRNG---------EKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKE------ILHGNGILHCD 91 (241)
Q Consensus 27 ~~~l~~l~h~~i~~~~---------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~------~Lh~~~~vH~d 91 (241)
...+..+.|+|++... ....+++++++. .++.+.+... ...++..+..++.| +||+++++|||
T Consensus 74 ~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrD 151 (294)
T PHA02882 74 WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGD 151 (294)
T ss_pred HHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 3445567899987711 124467888874 5777776652 33455555555544 48999999999
Q ss_pred CCCCcEEeecCCCeeecCCCcchhhcccccCCc-cccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCC
Q 042809 92 LKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGN-LKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRP 170 (241)
Q Consensus 92 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 170 (241)
|||+||+++.++.++|+|||++........... .........||+.|+|||.+.+..++.++||||||+++|++++|+.
T Consensus 152 iKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~ 231 (294)
T PHA02882 152 IKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKL 231 (294)
T ss_pred CCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999976532111111 0111123458999999999999999999999999999999999999
Q ss_pred CCccchhch-HHHHHHH----HhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 171 PWGDKISNA-AATLLKI----ACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 171 p~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
||....... ....... ..... .......+..+.++++.|+..+|.+||+++++++
T Consensus 232 P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 232 PWKGFGHNGNLIHAAKCDFIKRLHEG-KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred CCCccccchHHHHHhHHHHHHHhhhh-hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 997653221 1111110 00111 1112344678999999999999999999999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=188.92 Aligned_cols=224 Identities=25% Similarity=0.402 Sum_probs=162.6
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcC-CCcccc-------cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLN-SPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
+..++..++||+++ +...+.+.+|+++|..|. ||||++ .......+|+||+++.+...+... ++.-.
T Consensus 59 ~~~~~eK~ViKiLK-PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t----l~d~d 133 (338)
T KOG0668|consen 59 NITNNEKCVIKILK-PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT----LTDYD 133 (338)
T ss_pred ccCCCceEEEeeec-hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh----hchhh
Confidence 44678889999987 333577999999999998 999987 456678899999998887766654 33334
Q ss_pred HHHHH------HHHhhcCCccccCCCCCcEEeecCC-CeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 74 IRLYT------KEILHGNGILHCDLKCNNVLLGSHG-DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 74 ~~~~~------~~~Lh~~~~vH~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
++.+. +.++|+.||.|||+||.|++++... .++|+|+|++.-..+.. .......++.|.-||.+..
T Consensus 134 IryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~-------eYnVRVASRyfKGPELLVd 206 (338)
T KOG0668|consen 134 IRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-------EYNVRVASRYFKGPELLVD 206 (338)
T ss_pred HHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc-------eeeeeeehhhcCCchheee
Confidence 44443 4557999999999999999998864 59999999997654422 2223345677889999865
Q ss_pred -cCCCchhhHHHHHHHHHHHHhCCCCCccchhc--hHHHHHHHH------------hcCCCCCC----------------
Q 042809 147 -EGLDFATDIWSLGCMVIEMATGRPPWGDKISN--AAATLLKIA------------CSNEKPHF---------------- 195 (241)
Q Consensus 147 -~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~------------~~~~~~~~---------------- 195 (241)
..|+.+-|+|||||++..|+..+.||....+. ....+.+.. .....+.+
T Consensus 207 y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi 286 (338)
T KOG0668|consen 207 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFI 286 (338)
T ss_pred chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhC
Confidence 44788899999999999999988887432111 111111100 00011100
Q ss_pred ----ChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCccC
Q 042809 196 ----PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKN 237 (241)
Q Consensus 196 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~~ 237 (241)
..-.++++.+|+.++|..|..+|+|+.|++.||||....+..
T Consensus 287 ~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~ 332 (338)
T KOG0668|consen 287 NSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAE 332 (338)
T ss_pred CccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHh
Confidence 011347899999999999999999999999999997765543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=210.93 Aligned_cols=223 Identities=20% Similarity=0.172 Sum_probs=148.0
Q ss_pred CCCcEEEEEeccchH--HHHH--------------HHHHHHHHhhcCCCcccc------------------cCCceeeee
Q 042809 4 GTGALFVVKSAESEA--GVQA--------------LRNEAEIRQSLNSPNIGR------------------NGEKTVNIF 49 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~--~~~~--------------~~~e~~~l~~l~h~~i~~------------------~~~~~~~lv 49 (241)
..++.||||.+.... ..+. ...|+.++.+++|.+++. ...+..++|
T Consensus 184 ~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV 263 (507)
T PLN03224 184 QKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLV 263 (507)
T ss_pred ccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEE
Confidence 456789999976321 1222 334667777777766522 124578999
Q ss_pred ecccCCCCHHHHHHHhCCC-----------------------CCHHHHHHHHH------HHhhcCCccccCCCCCcEEee
Q 042809 50 MEYMAGGSLLDVAEKFGGT-----------------------LDAGVIRLYTK------EILHGNGILHCDLKCNNVLLG 100 (241)
Q Consensus 50 ~e~~~~~~L~~~l~~~~~~-----------------------~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~ 100 (241)
+||+.+++|.+++...... ++...+..++. .+||+.+++||||||+||+++
T Consensus 264 ~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~ 343 (507)
T PLN03224 264 WKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT 343 (507)
T ss_pred EEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC
Confidence 9999999999998753211 22334444444 447999999999999999999
Q ss_pred cCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCC----------------------CchhhHHHH
Q 042809 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL----------------------DFATDIWSL 158 (241)
Q Consensus 101 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~----------------------~~~~Di~sl 158 (241)
.++.++|+|||++........ .......+++.|+|||.+..... ....|+||+
T Consensus 344 ~~~~~kL~DFGla~~~~~~~~-----~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSl 418 (507)
T PLN03224 344 VDGQVKIIDFGAAVDMCTGIN-----FNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTA 418 (507)
T ss_pred CCCcEEEEeCcCccccccCCc-----cCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhH
Confidence 999999999999864322110 11112234789999998753221 124699999
Q ss_pred HHHHHHHHhCCC-CCccchhc--------hHHHHHHHHhcCCCCCC--ChhhHHHHHHHHHHhhccCC---CCCCChHHH
Q 042809 159 GCMVIEMATGRP-PWGDKISN--------AAATLLKIACSNEKPHF--PTQFFKKVLDFLAKCLERKP---EKRWSAEEL 224 (241)
Q Consensus 159 G~~l~~l~~g~~-p~~~~~~~--------~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p---~~Rps~~~~ 224 (241)
||++++|++|.. ||.+...- ......+. .......+ ....++..++|+.+||..+| .+|+|++++
T Consensus 419 Gvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~ea 497 (507)
T PLN03224 419 GVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQA 497 (507)
T ss_pred HHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHH
Confidence 999999999875 66431100 00011111 11112222 23466889999999999866 689999999
Q ss_pred hcCCCCCC
Q 042809 225 LNHTFISG 232 (241)
Q Consensus 225 l~~p~~~~ 232 (241)
|+||||..
T Consensus 498 L~Hp~f~~ 505 (507)
T PLN03224 498 LSHRFFLP 505 (507)
T ss_pred hCCCCcCC
Confidence 99999975
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=218.35 Aligned_cols=213 Identities=25% Similarity=0.324 Sum_probs=175.8
Q ss_pred CcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 6 GALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 6 ~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
+.+||||++.+ .....++..|+-.|.+|+|||+++ --...+.||++|+++|+|.+|++.++..+.......+.
T Consensus 725 KipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~ 804 (1177)
T KOG1025|consen 725 KIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWC 804 (1177)
T ss_pred cceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhcccchHHHHHHHhhccccHHHHHHHH
Confidence 56899998774 345678999999999999999998 23334899999999999999999988887777777666
Q ss_pred HHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCch
Q 042809 79 KEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA 152 (241)
Q Consensus 79 ~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 152 (241)
.|| ||++++|||||-.+||||.+...+|+.|||+++....... ......-.-.+-|+|-|.+....|+++
T Consensus 805 ~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~----ey~~~~gK~pikwmale~i~~~~~thq 880 (1177)
T KOG1025|consen 805 YQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK----EYSAPGGKVPIKWMALESIRIRKYTHQ 880 (1177)
T ss_pred HHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc----cccccccccCcHHHHHHHhhccCCCch
Confidence 654 8999999999999999999999999999999987654211 111111223567999999999999999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 153 TDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 153 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
+||||||+++||++| |..|+.+...+.+...++ .+.+...|+..+-+++-++.+||..|+..||+++++.
T Consensus 881 SDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle---~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 881 SDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE---KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred hhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh---ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 999999999999999 999998865555544444 4566778888999999999999999999999998875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=200.52 Aligned_cols=226 Identities=24% Similarity=0.355 Sum_probs=171.8
Q ss_pred CCCCCCcEEEEEecc----chHHHHHHHHHHHHHhhcCCCcccc----------cCCceeeeeecccCCCCHHHHHHHhC
Q 042809 1 MNKGTGALFVVKSAE----SEAGVQALRNEAEIRQSLNSPNIGR----------NGEKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~----~~~~~~~~~~e~~~l~~l~h~~i~~----------~~~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
.|..+|+.|++|++. +-...+++++|++++..++|.|++. ..=..+|+|+|.|. .+|...+-+ .
T Consensus 73 TDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIVS-P 150 (449)
T KOG0664|consen 73 TDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIVS-P 150 (449)
T ss_pred cCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheecc-C
Confidence 378899999999866 3345688999999999999999977 12246889999996 599988887 5
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
+.++...++.++.|| ||+.+|.||||||.|.+++++..+||||||++..-+.... .......-|..|+|
T Consensus 151 Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~-----~hMTqEVVTQYYRA 225 (449)
T KOG0664|consen 151 QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR-----LNMTHEVVTQYYRA 225 (449)
T ss_pred CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh-----hhhHHHHHHHHhcc
Confidence 788888888888877 6999999999999999999999999999999986544221 11222334778999
Q ss_pred ccccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHH------------hcC----------CCCCC--
Q 042809 141 PEVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIA------------CSN----------EKPHF-- 195 (241)
Q Consensus 141 PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------~~~----------~~~~~-- 195 (241)
||++.|. .|+.+.||||+||++.|++..+..|.....-....++... +.+ ..+.+
T Consensus 226 PEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~v 305 (449)
T KOG0664|consen 226 PELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQR 305 (449)
T ss_pred HHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccc
Confidence 9999884 5899999999999999999988888654332222222111 111 11111
Q ss_pred ------ChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCC
Q 042809 196 ------PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 196 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~ 233 (241)
+..-..+...+...++..+|++|.+.++++.|++....
T Consensus 306 LYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 306 LYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred eeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 11222467788999999999999999999999998543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=204.84 Aligned_cols=233 Identities=21% Similarity=0.329 Sum_probs=177.0
Q ss_pred CCCCCcEEEEEecc---------chHHHHHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAE---------SEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
|...++.||+|+-. ++.-.+-..+|.+|-+.|.||.||+ .+.+.+|-|+|||+|.+|+-|++. .
T Consensus 484 Dl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQ-h 562 (775)
T KOG1151|consen 484 DLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQ-H 562 (775)
T ss_pred ccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHh-h
Confidence 45567899999844 1122344789999999999999998 678899999999999999999987 4
Q ss_pred CCCCHHHHHHHHHHHh------h--cCCccccCCCCCcEEeec---CCCeeecCCCcchhhcccccCCccccc-cccccC
Q 042809 67 GTLDAGVIRLYTKEIL------H--GNGILHCDLKCNNVLLGS---HGDVKLPDLGCARRVNDLKNNGNLKQS-WQSIGG 134 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~L------h--~~~~vH~dl~p~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~-~~~~~~ 134 (241)
..+++..++.++.|++ . +-.|+|-||||.||++-. .|.+||+|||+++...+...+...... .....|
T Consensus 563 klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAG 642 (775)
T KOG1151|consen 563 KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAG 642 (775)
T ss_pred hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCc
Confidence 6678888888888774 3 345999999999999943 477999999999988764444333222 234568
Q ss_pred cccccCcccccc----cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHh-cCCCCCC--ChhhHHHHHHHH
Q 042809 135 TQLWMAPEVLRN----EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIAC-SNEKPHF--PTQFFKKVLDFL 207 (241)
Q Consensus 135 ~~~~~aPE~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~li 207 (241)
|..|+|||++.- .+.+.++||||+|+++|.++.|+.||......... +..+.. ....-.+ -+.++.+..+||
T Consensus 643 TYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI-LqeNTIlkAtEVqFP~KPvVsseAkaFI 721 (775)
T KOG1151|consen 643 TYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI-LQENTILKATEVQFPPKPVVSSEAKAFI 721 (775)
T ss_pred eeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH-HhhhchhcceeccCCCCCccCHHHHHHH
Confidence 999999999853 34678999999999999999999999764332211 111111 1111122 245778999999
Q ss_pred HHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 208 AKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 208 ~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
++||+.--++|..+.++..||+|.+....
T Consensus 722 RRCLaYRKeDR~DV~qLA~dpyllPh~rr 750 (775)
T KOG1151|consen 722 RRCLAYRKEDRIDVQQLACDPYLLPHIRR 750 (775)
T ss_pred HHHHHhhhhhhhhHHHHccCccccchhhh
Confidence 99999999999999999999999876543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=233.85 Aligned_cols=209 Identities=20% Similarity=0.297 Sum_probs=151.5
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
++.+|..||+|.+..... ....|++.+++++||||++ ......++||||+++|+|.+++.. +++.....
T Consensus 711 ~~~~~~~vavK~~~~~~~--~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~ 784 (968)
T PLN00113 711 SIKNGMQFVVKEINDVNS--IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRK 784 (968)
T ss_pred ECCCCcEEEEEEccCCcc--ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHH
Confidence 356889999998874332 2235688999999999998 566788999999999999999974 45555554
Q ss_pred HHH------HHhh---cCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 77 YTK------EILH---GNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 77 ~~~------~~Lh---~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
++. ++|| +.+++||||||+||+++.++..++. |+....... .....+++.|+|||++.+.
T Consensus 785 i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----------~~~~~~t~~y~aPE~~~~~ 853 (968)
T PLN00113 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----------DTKCFISSAYVAPETRETK 853 (968)
T ss_pred HHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----------CCCccccccccCcccccCC
Confidence 444 4589 6799999999999999988887765 444322111 0112468899999999998
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccchhc--hHHHHHHHHhc------------CCCCCCChhhHHHHHHHHHHhhcc
Q 042809 148 GLDFATDIWSLGCMVIEMATGRPPWGDKISN--AAATLLKIACS------------NEKPHFPTQFFKKVLDFLAKCLER 213 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~------------~~~~~~~~~~~~~~~~li~~~l~~ 213 (241)
.++.++||||||+++||++||+.||...... ........... ......+.....++.+++.+||+.
T Consensus 854 ~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~ 933 (968)
T PLN00113 854 DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTAT 933 (968)
T ss_pred CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcC
Confidence 9999999999999999999999998532111 11111111000 001122334445788999999999
Q ss_pred CCCCCCChHHHhcC
Q 042809 214 KPEKRWSAEELLNH 227 (241)
Q Consensus 214 ~p~~Rps~~~~l~~ 227 (241)
+|.+|||+.++++.
T Consensus 934 ~P~~RPt~~evl~~ 947 (968)
T PLN00113 934 DPTARPCANDVLKT 947 (968)
T ss_pred CchhCcCHHHHHHH
Confidence 99999999999865
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=196.72 Aligned_cols=98 Identities=23% Similarity=0.324 Sum_probs=79.4
Q ss_pred CCCCCcEEEEEeccchH-HHHHHHHHHHHHhhcC-----C---Ccccc---------cCCceeeeeecccCCCCHHHHHH
Q 042809 2 NKGTGALFVVKSAESEA-GVQALRNEAEIRQSLN-----S---PNIGR---------NGEKTVNIFMEYMAGGSLLDVAE 63 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~-----h---~~i~~---------~~~~~~~lv~e~~~~~~L~~~l~ 63 (241)
|..+.+.||+|+.++-. -.+....|+++|++++ | .+||+ .++.++|+|+|++ |.+|-.+|.
T Consensus 99 Dtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~ 177 (590)
T KOG1290|consen 99 DTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIK 177 (590)
T ss_pred eccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHH
Confidence 66788999999999754 4567899999999995 2 23554 7788999999999 679988887
Q ss_pred Hh-CCCCCHHHHHHHHHHH------hh-cCCccccCCCCCcEEee
Q 042809 64 KF-GGTLDAGVIRLYTKEI------LH-GNGILHCDLKCNNVLLG 100 (241)
Q Consensus 64 ~~-~~~~~~~~~~~~~~~~------Lh-~~~~vH~dl~p~Nil~~ 100 (241)
.. -..++...++.+++|+ || +.||+|.||||+|||+.
T Consensus 178 ~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 178 YSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred HhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 64 3568888888888776 56 47999999999999996
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=224.60 Aligned_cols=185 Identities=19% Similarity=0.211 Sum_probs=130.0
Q ss_pred CceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCC------------
Q 042809 43 EKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGD------------ 104 (241)
Q Consensus 43 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~------------ 104 (241)
...++.++||+ +++|.+++......++...+..++.|+ ||++||+||||||+|||++..|.
T Consensus 52 ~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~ 130 (793)
T PLN00181 52 DDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDS 130 (793)
T ss_pred cchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcc
Confidence 35678889998 569999998655668888888888766 79999999999999999965444
Q ss_pred -------eeecCCCcchhhcccccC----------CccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHh
Q 042809 105 -------VKLPDLGCARRVNDLKNN----------GNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT 167 (241)
Q Consensus 105 -------~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 167 (241)
+|++|||++......... ...........||+.|+|||.+.+..++.++|||||||++|||++
T Consensus 131 ~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~ 210 (793)
T PLN00181 131 GSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFC 210 (793)
T ss_pred cccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhh
Confidence 555555555432110000 000001112357888999999999999999999999999999999
Q ss_pred CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCC
Q 042809 168 GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 168 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~ 233 (241)
|..|+..... ..... ... .. +...........+++.+||..+|.+|||+.++++||||...
T Consensus 211 ~~~~~~~~~~-~~~~~-~~~--~~-~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 211 PVSSREEKSR-TMSSL-RHR--VL-PPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred CCCchhhHHH-HHHHH-HHh--hc-ChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 9888754211 11111 111 11 11111123456789999999999999999999999999764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=196.56 Aligned_cols=226 Identities=30% Similarity=0.409 Sum_probs=167.2
Q ss_pred CCcEEEEEeccchHHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 5 TGALFVVKSAESEAGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
.+..||+|.+..-+...++.+|+++|..+. +.||++ ..++.+.+|+||+++.+..++... ++...++.++
T Consensus 63 ~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl 138 (418)
T KOG1167|consen 63 KRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYL 138 (418)
T ss_pred ccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc----CCHHHHHHHH
Confidence 578899999987777788999999999997 889987 788999999999999999999887 4455555555
Q ss_pred H------HHhhcCCccccCCCCCcEEeec-CCCeeecCCCcchhhcccc------c------------------------
Q 042809 79 K------EILHGNGILHCDLKCNNVLLGS-HGDVKLPDLGCARRVNDLK------N------------------------ 121 (241)
Q Consensus 79 ~------~~Lh~~~~vH~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~------~------------------------ 121 (241)
. ..+|.+|||||||||+|++++. .+...|.|||++....... .
T Consensus 139 ~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~ 218 (418)
T KOG1167|consen 139 RNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASK 218 (418)
T ss_pred HHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccC
Confidence 4 4479999999999999999976 4779999999998211100 0
Q ss_pred --------CCccccccccccCcccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchH--HHHHH-----
Q 042809 122 --------NGNLKQSWQSIGGTQLWMAPEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAA--ATLLK----- 185 (241)
Q Consensus 122 --------~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~----- 185 (241)
+...........||++|.|||++.. ...++++||||.|+++..+++++.||.....+.. .++..
T Consensus 219 p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~ 298 (418)
T KOG1167|consen 219 PAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSA 298 (418)
T ss_pred CCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChH
Confidence 1111223345669999999999865 5578899999999999999999999843222111 00000
Q ss_pred ----HHhc-CC----------------------------C--------CCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 186 ----IACS-NE----------------------------K--------PHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 186 ----~~~~-~~----------------------------~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
.... +. . .......+..+.+|+.+|+..||.+|.|++++
T Consensus 299 ~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeA 378 (418)
T KOG1167|consen 299 EMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDA 378 (418)
T ss_pred HHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHH
Confidence 0000 00 0 00011123478999999999999999999999
Q ss_pred hcCCCCCCCC
Q 042809 225 LNHTFISGNA 234 (241)
Q Consensus 225 l~~p~~~~~~ 234 (241)
|.||||....
T Consensus 379 LkHpFF~~~~ 388 (418)
T KOG1167|consen 379 LKHPFFDEAD 388 (418)
T ss_pred hcCcCCcchh
Confidence 9999998543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=176.02 Aligned_cols=167 Identities=29% Similarity=0.405 Sum_probs=133.7
Q ss_pred CCCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHH---hCCC
Q 042809 1 MNKGTGALFVVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEK---FGGT 68 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~---~~~~ 68 (241)
++..+|.++|+|.+.. ....+++.+|+.+..+. .+|.+|. ...+.+|+.||.|+ .+|+.+.+. .++.
T Consensus 66 rh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ 144 (282)
T KOG0984|consen 66 RHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGT 144 (282)
T ss_pred eeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCc
Confidence 3678999999999773 44567788888886655 5999988 67889999999995 688876654 3667
Q ss_pred CCHHHHHHHHHHH------hhc-CCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 69 LDAGVIRLYTKEI------LHG-NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~-~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
.++..+-.++..+ ||+ ..++|||+||+||+++.+|++|+||||.+....+. .......|...|+||
T Consensus 145 ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS-------iAkt~daGCkpYmaP 217 (282)
T KOG0984|consen 145 IPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS-------IAKTMDAGCKPYMAP 217 (282)
T ss_pred CchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhh-------hHHHHhcCCCccCCh
Confidence 7777776666544 564 67999999999999999999999999999876552 122234578899999
Q ss_pred ccccc----cCCCchhhHHHHHHHHHHHHhCCCCCccc
Q 042809 142 EVLRN----EGLDFATDIWSLGCMVIEMATGRPPWGDK 175 (241)
Q Consensus 142 E~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 175 (241)
|.+.. ..|+.++||||||++++||.+++.||...
T Consensus 218 Eri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 218 ERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 99853 46889999999999999999999999654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=180.35 Aligned_cols=184 Identities=40% Similarity=0.600 Sum_probs=153.1
Q ss_pred CCCcEEEEEeccchHH---HHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 4 GTGALFVVKSAESEAG---VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
.+|+.+++|.+..... .+.+.+|+..++.+.|+++++ ......++++||+.+++|.+++......++.....
T Consensus 16 ~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~ 95 (215)
T cd00180 16 KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEIL 95 (215)
T ss_pred CCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHH
Confidence 4689999999886654 478999999999999999987 44578999999999899999998753456666665
Q ss_pred HHHH------HHhhcCCccccCCCCCcEEeec-CCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc-
Q 042809 76 LYTK------EILHGNGILHCDLKCNNVLLGS-HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE- 147 (241)
Q Consensus 76 ~~~~------~~Lh~~~~vH~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~- 147 (241)
.++. +.||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+...|.+||.....
T Consensus 96 ~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~ 169 (215)
T cd00180 96 RILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------LLKTIVGTPAYMAPEVLLGKG 169 (215)
T ss_pred HHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc------hhhcccCCCCccChhHhcccC
Confidence 5554 3489999999999999999999 89999999999975543211 12234467889999999877
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 148 GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
..+.++|+|++|++++++ ..+.+++.+|+..+|.+||++++++.+
T Consensus 170 ~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 170 YYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred CCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 778899999999999998 578899999999999999999999987
Q ss_pred C
Q 042809 228 T 228 (241)
Q Consensus 228 p 228 (241)
+
T Consensus 215 ~ 215 (215)
T cd00180 215 L 215 (215)
T ss_pred C
Confidence 5
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=207.82 Aligned_cols=224 Identities=33% Similarity=0.508 Sum_probs=178.6
Q ss_pred CCCCCCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 1 MNKGTGALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
+|+.+++..|+|+++-+ ...+.+.+|+-+++..+||||+. ...+.+|++||||.||+|.+.-.- .+++++..
T Consensus 35 Rd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~-Tgplselq 113 (829)
T KOG0576|consen 35 RDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHV-TGPLSELQ 113 (829)
T ss_pred cccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeee-cccchhHH
Confidence 58899999999998743 45778899999999999999998 678899999999999999887665 46788877
Q ss_pred HHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc--
Q 042809 74 IRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR-- 145 (241)
Q Consensus 74 ~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-- 145 (241)
+....+ .+||+.|=+|||||..||+++..|.+|+.|||.+-.+.- +-.....++||+.|+|||...
T Consensus 114 iayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita------ti~KrksfiGtpywmapEvaave 187 (829)
T KOG0576|consen 114 IAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA------TIAKRKSFIGTPYWMAPEVAAVE 187 (829)
T ss_pred HHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh------hhhhhhcccCCccccchhHHHHH
Confidence 777666 458999999999999999999999999999999865543 123346788999999999873
Q ss_pred -ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC---CCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 146 -NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP---HFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 146 -~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
.+.|...+|+|++|+...|+-.-++|..+. .......-....+..+ .-....++.+-+|++.++.++|++|||+
T Consensus 188 rkggynqlcdiwa~gitAiel~eLqpplfdl--hpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRpta 265 (829)
T KOG0576|consen 188 RKGGYNQLCDIWALGITAIELGELQPPLFDL--HPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTA 265 (829)
T ss_pred hcccccccccccccccchhhhhhcCCccccc--chHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCCh
Confidence 455788999999999999998888886542 2222222222222222 1223456789999999999999999999
Q ss_pred HHHhcCCCCCCC
Q 042809 222 EELLNHTFISGN 233 (241)
Q Consensus 222 ~~~l~~p~~~~~ 233 (241)
+.+|.|||....
T Consensus 266 eklL~h~fvs~~ 277 (829)
T KOG0576|consen 266 EKLLQHPFVSQT 277 (829)
T ss_pred hhheeceeeccc
Confidence 999999998765
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=188.68 Aligned_cols=211 Identities=25% Similarity=0.333 Sum_probs=151.7
Q ss_pred CCCcEEEEEeccchHHHHHHHHHHHHHh--hcCCCcccc---------cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 4 GTGALFVVKSAESEAGVQALRNEAEIRQ--SLNSPNIGR---------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~~~~~~~~e~~~l~--~l~h~~i~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
-+++.||||++.... .+.+.+|-+|++ .++|+||++ .....++||++|.+.|+|.+||.. ...++.
T Consensus 231 L~~~~VAVKifp~~~-kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~--ntisw~ 307 (534)
T KOG3653|consen 231 LDNRLVAVKIFPEQE-KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA--NTISWN 307 (534)
T ss_pred ccCceeEEEecCHHH-HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHh--ccccHH
Confidence 357899999998554 567878877766 457999987 235589999999999999999997 345565
Q ss_pred HHHHHHH------HHhhc---------CCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccc
Q 042809 73 VIRLYTK------EILHG---------NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL 137 (241)
Q Consensus 73 ~~~~~~~------~~Lh~---------~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (241)
....++. ++||+ ..|+|||||..|||+.+|++..|+|||++..+....... ......||.+
T Consensus 308 ~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~----d~~~qVGT~R 383 (534)
T KOG3653|consen 308 SLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQG----DTHGQVGTRR 383 (534)
T ss_pred HHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCc----chhhhhhhhh
Confidence 5544443 55764 569999999999999999999999999998876533322 2233779999
Q ss_pred ccCcccccccC-CC-----chhhHHHHHHHHHHHHhCC------------CCCcc-----chhchHHHHHHHHhcCCCCC
Q 042809 138 WMAPEVLRNEG-LD-----FATDIWSLGCMVIEMATGR------------PPWGD-----KISNAAATLLKIACSNEKPH 194 (241)
Q Consensus 138 ~~aPE~~~~~~-~~-----~~~Di~slG~~l~~l~~g~------------~p~~~-----~~~~~~~~~~~~~~~~~~~~ 194 (241)
|||||.+.|.- +. .+.||||+|.++||+++.- .||.. .+.+.+....- ....+|.
T Consensus 384 YMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV--~kK~RP~ 461 (534)
T KOG3653|consen 384 YMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVV--RKKQRPK 461 (534)
T ss_pred hcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHH--hhccCCC
Confidence 99999997633 12 4689999999999999732 23321 11111111111 1233444
Q ss_pred CChh-----hHHHHHHHHHHhhccCCCCCCChHH
Q 042809 195 FPTQ-----FFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 195 ~~~~-----~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
++.. ....+++.+..||..|++.|.|+.=
T Consensus 462 ~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 462 IPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred ChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 4432 2356899999999999999998754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=180.22 Aligned_cols=164 Identities=26% Similarity=0.281 Sum_probs=125.2
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCc
Q 042809 56 GSLLDVAEKFGGTLDAGVIRLYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGT 135 (241)
Q Consensus 56 ~~L~~~l~~~~~~~~~~~~~~~~~~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 135 (241)
|+|.+++...+..+++..+..++.|+++...++|..-||+||+++.++.+++ ||.+...... ...|+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~kp~Nil~~~~~~~~~--fG~~~~~~~~-----------~~~g~ 67 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQAKSGNILLTWDGLLKL--DGSVAFKTPE-----------QSRVD 67 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccEeEcCccceee--ccceEeeccc-----------cCCCc
Confidence 6899999987778999999999998866666666666999999999999999 9988654331 12478
Q ss_pred ccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhc-hHHHHHHHHhcCCCC---CCChhhHH--HHHHHHHH
Q 042809 136 QLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISN-AAATLLKIACSNEKP---HFPTQFFK--KVLDFLAK 209 (241)
Q Consensus 136 ~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~--~~~~li~~ 209 (241)
+.|+|||.+.+..++.++||||||+++|++++|+.||...... ..............+ ..+...+. .+.+++.+
T Consensus 68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 9999999999999999999999999999999999999654221 111111111111111 11223333 69999999
Q ss_pred hhccCCCCCCChHHHhcCCCCCC
Q 042809 210 CLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 210 ~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
||..+|.+|||+.++++|+|+..
T Consensus 148 cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 148 CASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=187.49 Aligned_cols=215 Identities=26% Similarity=0.370 Sum_probs=152.8
Q ss_pred CCcEEEEEeccchHHHHHHHHHHHHHh--hcCCCcccc-------c--CCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 5 TGALFVVKSAESEAGVQALRNEAEIRQ--SLNSPNIGR-------N--GEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~~~~~~e~~~l~--~l~h~~i~~-------~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
.|..||||++.+.+ ....++|.+++. .|+|+||+. . .--++|||++|-++|||+|||.. ..++...
T Consensus 233 rGe~VAVKiF~srd-E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ 309 (513)
T KOG2052|consen 233 RGEDVAVKIFSSRD-ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEG 309 (513)
T ss_pred cCCceEEEEecccc-hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHH
Confidence 47899999999765 355666777655 569999976 1 12379999999999999999997 5677777
Q ss_pred HHHHHHHH------hhc--------CCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccccc
Q 042809 74 IRLYTKEI------LHG--------NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139 (241)
Q Consensus 74 ~~~~~~~~------Lh~--------~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (241)
...+++.+ ||. -.|.|||||..||+|..+|+..|+|+|++........ ..........||.+|+
T Consensus 310 ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~--~idi~~N~rVGTKRYM 387 (513)
T KOG2052|consen 310 MLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTD--TIDIPPNPRVGTKRYM 387 (513)
T ss_pred HHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCC--cccCCCCCccceeecc
Confidence 66666543 552 2499999999999999999999999999986655332 2223334567999999
Q ss_pred CcccccccC------CCchhhHHHHHHHHHHHHh----------CCCCCccchhch--HHHHHHHHh-cCCCCCCCh---
Q 042809 140 APEVLRNEG------LDFATDIWSLGCMVIEMAT----------GRPPWGDKISNA--AATLLKIAC-SNEKPHFPT--- 197 (241)
Q Consensus 140 aPE~~~~~~------~~~~~Di~slG~~l~~l~~----------g~~p~~~~~~~~--~~~~~~~~~-~~~~~~~~~--- 197 (241)
|||++...- .-..+||||||.++||+.- -++||.+-...+ ...+.+..+ ...+|..|.
T Consensus 388 APEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~ 467 (513)
T KOG2052|consen 388 APEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWK 467 (513)
T ss_pred ChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccc
Confidence 999996421 2257899999999999884 247876533222 122222111 123333332
Q ss_pred --hhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 198 --QFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 198 --~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
.....+..+++.||..+|.-|.|+-.+
T Consensus 468 s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 468 SDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred cCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 233567889999999999999987554
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=186.29 Aligned_cols=203 Identities=22% Similarity=0.295 Sum_probs=159.7
Q ss_pred hHHHHHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHhCC-------CCCHHHHHHHH-----
Q 042809 17 EAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGG-------TLDAGVIRLYT----- 78 (241)
Q Consensus 17 ~~~~~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~----- 78 (241)
+.....+..|.-++..+.|||+.. +.....++++.++.-|+|..++..+++ .++.-....++
T Consensus 328 ~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~ 407 (563)
T KOG1024|consen 328 QIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAM 407 (563)
T ss_pred HHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHH
Confidence 445567888999999999999977 677788999999999999999995432 12222223333
Q ss_pred -HHHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhhHHH
Q 042809 79 -KEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWS 157 (241)
Q Consensus 79 -~~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 157 (241)
..+||+.|++|.||..+|++++..-++||+|=.+++-..+. ...........+..|++||.+....|+.++|+||
T Consensus 408 am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~----DYhcLGDnEnRPvkWMslEal~n~~yssasDvWs 483 (563)
T KOG1024|consen 408 AMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPG----DYHCLGDNENRPVKWMSLEALQNSHYSSASDVWS 483 (563)
T ss_pred HHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcc----cccccCCCCCCcccccCHHHHhhhhhcchhhhHH
Confidence 34589999999999999999999999999998888754331 1111112222466799999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 158 LGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 158 lG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
||+++||++| |+.|+.+-+.... ......+.+...|..+|+++..++.-||+..|++|||.+++..
T Consensus 484 fGVllWELmtlg~~PyaeIDPfEm---~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 484 FGVLLWELMTLGKLPYAEIDPFEM---EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHHHHHHHhcCCCCccccCHHHH---HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 9999999999 9999987544444 3444456777788899999999999999999999999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=194.09 Aligned_cols=165 Identities=30% Similarity=0.406 Sum_probs=142.5
Q ss_pred CCCCCCcEEEEEeccchHHHHH----------HHHHHHHHhhcC---CCcccc-----cCCceeeeeeccc-CCCCHHHH
Q 042809 1 MNKGTGALFVVKSAESEAGVQA----------LRNEAEIRQSLN---SPNIGR-----NGEKTVNIFMEYM-AGGSLLDV 61 (241)
Q Consensus 1 ~~~~~~~~vaiK~~~~~~~~~~----------~~~e~~~l~~l~---h~~i~~-----~~~~~~~lv~e~~-~~~~L~~~ 61 (241)
+||+++..|+||.+.+++.... .--|+.||..++ |+||++ ++++.+|++||-- +|-+|+++
T Consensus 581 i~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~ 660 (772)
T KOG1152|consen 581 IHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDF 660 (772)
T ss_pred eecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhh
Confidence 4788899999999887654332 346999999998 999999 8899999999987 45699999
Q ss_pred HHHhCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCc
Q 042809 62 AEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGT 135 (241)
Q Consensus 62 l~~~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 135 (241)
+.- ...+++..+..++.|+ ||++||||||||-+|+.++.+|-+||+|||.+..... ..+..+.||
T Consensus 661 IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ks--------gpfd~f~gt 731 (772)
T KOG1152|consen 661 IEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKS--------GPFDVFVGT 731 (772)
T ss_pred hhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhcC--------CCcceeeee
Confidence 986 6788898999999887 7999999999999999999999999999999976544 345667899
Q ss_pred ccccCcccccccCC-CchhhHHHHHHHHHHHHhCCCCCcc
Q 042809 136 QLWMAPEVLRNEGL-DFATDIWSLGCMVIEMATGRPPWGD 174 (241)
Q Consensus 136 ~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~ 174 (241)
..|.|||.+.|.+| ....|||++|+++|.++....||.+
T Consensus 732 v~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 732 VDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999999999887 5678999999999999999998853
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-25 Score=164.65 Aligned_cols=167 Identities=39% Similarity=0.630 Sum_probs=135.1
Q ss_pred CCCCcEEEEEeccchH---HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 3 KGTGALFVVKSAESEA---GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
.++++.+++|.+.... ..+.+.+|++.+.+++|+|+++ ......++++|++.+++|.+++......++....
T Consensus 21 ~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~ 100 (225)
T smart00221 21 KGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEA 100 (225)
T ss_pred cCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHH
Confidence 3468899999988542 4678999999999999999988 4557899999999999999999875432566665
Q ss_pred HHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc-ccc
Q 042809 75 RLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL-RNE 147 (241)
Q Consensus 75 ~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~ 147 (241)
..++.+ +||+.+++|+||+|.||+++.++.++|+|||.+........ .......++..|++||.+ ...
T Consensus 101 ~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~ 175 (225)
T smart00221 101 RFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-----ALLKTVKGTPFYLAPEVLLGGK 175 (225)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-----ccccceeccCCcCCHhHhcCCC
Confidence 555554 47999999999999999999999999999998876544210 012234467789999998 667
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCcc
Q 042809 148 GLDFATDIWSLGCMVIEMATGRPPWGD 174 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~g~~p~~~ 174 (241)
.++.++|+|+||++++++++|+.||..
T Consensus 176 ~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 176 GYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 778899999999999999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=168.07 Aligned_cols=218 Identities=21% Similarity=0.315 Sum_probs=156.3
Q ss_pred CCCCCcEEEEEeccchH-HHHHHHHHHHHHhhcC-CCcccc------cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESEA-GVQALRNEAEIRQSLN-SPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
|+.++..+|+|.+..+. ....|.+|...--.|. |.||+. +..+.+.+++||++.|+|.+-+.. ..+-+..
T Consensus 45 Hr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~--~GigE~~ 122 (378)
T KOG1345|consen 45 HRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA--AGIGEAN 122 (378)
T ss_pred ccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc--ccccHHH
Confidence 67899999999988764 4577899988877776 899987 677788899999999999888775 3344444
Q ss_pred HHHHHH------HHhhcCCccccCCCCCcEEee-cC-CCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 74 IRLYTK------EILHGNGILHCDLKCNNVLLG-SH-GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 74 ~~~~~~------~~Lh~~~~vH~dl~p~Nil~~-~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
...++. .++|++++||||||.+||++- .+ .++||||||.....+..... ..-+..|.+||.+.
T Consensus 123 ~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~---------~~~~~~y~~pe~~~ 193 (378)
T KOG1345|consen 123 TKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY---------LEYVNNYHAPELCD 193 (378)
T ss_pred HHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehh---------hhhhcccCCcHHHh
Confidence 444433 558999999999999999993 33 46999999998755431111 11245678888774
Q ss_pred c-----cCCCchhhHHHHHHHHHHHHhCCCCCccchhchH-HHHHHHHhcCCCCCCC---hhhHHHHHHHHHHhhccCCC
Q 042809 146 N-----EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAA-ATLLKIACSNEKPHFP---TQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 146 ~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~ 216 (241)
. ....+.+|+|.||+++|.++||..||+.....+. .-.......+..+..| ...++.+..++++-|...++
T Consensus 194 ~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~ 273 (378)
T KOG1345|consen 194 TVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFK 273 (378)
T ss_pred hccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCccc
Confidence 3 2245789999999999999999999974322221 1122223333344444 34567888999999999999
Q ss_pred CC---CChHHHhcCCCC
Q 042809 217 KR---WSAEELLNHTFI 230 (241)
Q Consensus 217 ~R---ps~~~~l~~p~~ 230 (241)
+| .+++......|.
T Consensus 274 drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 274 DRCKIWTAKKMRKCLWK 290 (378)
T ss_pred ccchhHHHHHHHHHHHH
Confidence 99 566665555554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-26 Score=192.25 Aligned_cols=208 Identities=27% Similarity=0.360 Sum_probs=155.0
Q ss_pred HHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHHH------hhcCCccccC
Q 042809 23 LRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCD 91 (241)
Q Consensus 23 ~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~------Lh~~~~vH~d 91 (241)
+..|.-+-..+.|+|++. .......-+||||++ +|+.++... ..+....+..++.|+ +|+.|+.|||
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrd 445 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRD 445 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceecc
Confidence 455666677789999876 333333334999998 999999973 456666666666655 7999999999
Q ss_pred CCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc-hhhHHHHHHHHHHHHhCCC
Q 042809 92 LKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF-ATDIWSLGCMVIEMATGRP 170 (241)
Q Consensus 92 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~ 170 (241)
+|++|++++.+|.+||+|||.+.......... ........|+..|+|||.+.+..|.+ ..||||.|+++.-|.+|+.
T Consensus 446 lK~enll~~~~g~lki~Dfg~~~vf~~~~e~~--~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~ 523 (601)
T KOG0590|consen 446 LKLENLLVTENGILKIIDFGAASVFRYPWEKN--IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRF 523 (601)
T ss_pred CccccEEEecCCceEEeecCcceeeccCcchh--hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCC
Confidence 99999999999999999999998664422211 12334567899999999999998875 5799999999999999999
Q ss_pred CCccchhchHH--HHH---HHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 171 PWGDKISNAAA--TLL---KIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 171 p~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
||......... ... .......+......++...+.+|.+||+.+|.+|.|++++++.+||+.-.
T Consensus 524 ~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 524 PWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred ccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 99654333221 000 00111122233345677899999999999999999999999999998654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7e-22 Score=148.64 Aligned_cols=175 Identities=20% Similarity=0.322 Sum_probs=149.2
Q ss_pred CCCCcEEEEEeccchHHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 3 KGTGALFVVKSAESEAGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
.-+|.+||||.-...+...++..|.+..+.|. .++|-. ..+.+-.+|+|.+ |.+|.+++.-++..++...+..
T Consensus 50 l~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~m 128 (449)
T KOG1165|consen 50 LYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAM 128 (449)
T ss_pred cccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHH
Confidence 44789999999887777889999999999986 566644 5666777999999 7899999999999999999988
Q ss_pred HHHHH------hhcCCccccCCCCCcEEeecCCC-----eeecCCCcchhhcccccCC-ccccccccccCcccccCcccc
Q 042809 77 YTKEI------LHGNGILHCDLKCNNVLLGSHGD-----VKLPDLGCARRVNDLKNNG-NLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 77 ~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~-----~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~aPE~~ 144 (241)
++.|. +|++.+|.|||||+|+|+...++ +.++|||+++...+..... .+.+...+..||.+||+-...
T Consensus 129 iA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTH 208 (449)
T KOG1165|consen 129 IAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTH 208 (449)
T ss_pred HHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeecc
Confidence 88866 69999999999999999976554 8899999999876654433 334566788899999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhc
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISN 178 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 178 (241)
.|...+.+.|+-|||=++++++-|.+||.+....
T Consensus 209 lGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 209 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred ccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 9999999999999999999999999999875443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-23 Score=175.87 Aligned_cols=212 Identities=23% Similarity=0.293 Sum_probs=146.4
Q ss_pred CCcEEEEEeccch------HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 5 TGALFVVKSAESE------AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 5 ~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
....|+||++-+. +...+...|++ ...+++||.++ ..+..-|+|-+|..+ +|+|.+.. +..+....
T Consensus 45 ~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlST-RPFL~~iE 121 (1431)
T KOG1240|consen 45 REGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLST-RPFLVLIE 121 (1431)
T ss_pred CCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhcc-chHHHHHH
Confidence 3445889986643 23344445555 55678999987 677889999999975 99999987 45566666
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCC-ccccccccccCcccccCcccccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG-NLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+.++-|+ +|..|++|||||.+||++++=+.+.|+||..-+..--...+. .+.--+.....-..|+|||.+..
T Consensus 122 KkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~ 201 (1431)
T KOG1240|consen 122 KKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVS 201 (1431)
T ss_pred HHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhc
Confidence 66666666 599999999999999999999999999998765321111111 01111122223345999999843
Q ss_pred c----------C-CCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCC-----hhhHHHHHHHHHH
Q 042809 147 E----------G-LDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFP-----TQFFKKVLDFLAK 209 (241)
Q Consensus 147 ~----------~-~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~ 209 (241)
. . .+++.||||+||++.|+++ |+++|.-. .+....... ...+ .-....+++++..
T Consensus 202 ~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~~~--~~~~e~~Le~Ied~~~Rnlil~ 273 (1431)
T KOG1240|consen 202 ALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRSGN--ADDPEQLLEKIEDVSLRNLILS 273 (1431)
T ss_pred cccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhccC--ccCHHHHHHhCcCccHHHHHHH
Confidence 1 1 4678999999999999999 89998532 111111111 1111 1112368999999
Q ss_pred hhccCCCCCCChHHHhcC
Q 042809 210 CLERKPEKRWSAEELLNH 227 (241)
Q Consensus 210 ~l~~~p~~Rps~~~~l~~ 227 (241)
|++.+|.+|.|+++.|+.
T Consensus 274 Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 274 MIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHccCchhccCHHHHHHh
Confidence 999999999999999975
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.3e-23 Score=165.32 Aligned_cols=210 Identities=25% Similarity=0.426 Sum_probs=164.5
Q ss_pred CCCcEEEEEeccchH----HHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 4 GTGALFVVKSAESEA----GVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
+.|..|++|+..+.. .......|..++..++ ||.+++ +.+..+++++++..||.|...+... ..+....
T Consensus 20 da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~-~~f~~~~ 98 (612)
T KOG0603|consen 20 DAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKE-VMFDELD 98 (612)
T ss_pred cccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccC-CchHHHH
Confidence 456777888766321 1124556777888887 999887 8889999999999999999988863 3444444
Q ss_pred HHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 74 IRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 74 ~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
...+.. +.+|+.+++|+|+|++||+++.+|.+++.|||.++..-+.+ ..+|+..|+|||++.
T Consensus 99 ~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----------~~cgt~eymApEI~~-- 166 (612)
T KOG0603|consen 99 VAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----------IACGTYEYRAPEIIN-- 166 (612)
T ss_pred HHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh----------hcccchhhhhhHhhh--
Confidence 443333 44799999999999999999999999999999998654411 127899999999998
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----ChH
Q 042809 148 GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----SAE 222 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ 222 (241)
....++|.||+|++.++++||..||... -.. ........+|...+..+++++.+++..+|..|. -+.
T Consensus 167 gh~~a~D~ws~gvl~felltg~~pf~~~---~~~-----~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~ 238 (612)
T KOG0603|consen 167 GHLSAADWWSFGVLAFELLTGTLPFGGD---TMK-----RILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVD 238 (612)
T ss_pred ccCCcccchhhhhhHHHHhhCCCCCchH---HHH-----HHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhH
Confidence 4677899999999999999999999871 111 122345677888999999999999999999997 457
Q ss_pred HHhcCCCCCCCC
Q 042809 223 ELLNHTFISGNA 234 (241)
Q Consensus 223 ~~l~~p~~~~~~ 234 (241)
++++|+||....
T Consensus 239 eik~h~f~~~i~ 250 (612)
T KOG0603|consen 239 EIKQHEFFQSID 250 (612)
T ss_pred HHhccchheeee
Confidence 899999996543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=141.65 Aligned_cols=174 Identities=20% Similarity=0.317 Sum_probs=144.0
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCC----Ccccc--cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNS----PNIGR--NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h----~~i~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
...+|..||||+-.+...-..+.-|.++...|++ |+|-. .....-.+||+.. |.+|.+++.-+...++...+.
T Consensus 36 ~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvL 114 (341)
T KOG1163|consen 36 SITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVL 114 (341)
T ss_pred eccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHH
Confidence 3568999999998887777888999999999984 44433 5667788999999 799999999988889998888
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecC---CCeeecCCCcchhhcccccCCcc-ccccccccCcccccCccccc
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSH---GDVKLPDLGCARRVNDLKNNGNL-KQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~ 145 (241)
.++-|+ +|.++++||||||+|++..-+ ..+.++|||+++...+....... .+.-....||.+|.+-....
T Consensus 115 MLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~ 194 (341)
T KOG1163|consen 115 MLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHL 194 (341)
T ss_pred HHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhh
Confidence 887765 699999999999999999543 56899999999987664443322 23345567999999999998
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccch
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKI 176 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 176 (241)
+-..+.+.|+-|+|.++.++--|..||++-.
T Consensus 195 g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 195 GIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred hhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 8888999999999999999999999998753
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=146.21 Aligned_cols=199 Identities=26% Similarity=0.322 Sum_probs=121.0
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCC---Cc-------c-c-----c-----------cCCc-----
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNS---PN-------I-G-----R-----------NGEK----- 44 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h---~~-------i-~-----~-----------~~~~----- 44 (241)
|..||+.+|+|.+.. ....+.+.+|.-....+.+ |. + + + .+..
T Consensus 33 d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~ 112 (288)
T PF14531_consen 33 DVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVL 112 (288)
T ss_dssp ETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETTEEEEEE
T ss_pred EccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCccceee
Confidence 678999999998652 2345667777655554332 11 1 1 1 1112
Q ss_pred eeeeeecccCCCCHHHHHHH---hCCC---CCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCc
Q 042809 45 TVNIFMEYMAGGSLLDVAEK---FGGT---LDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGC 112 (241)
Q Consensus 45 ~~~lv~e~~~~~~L~~~l~~---~~~~---~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~ 112 (241)
..+++|+-+. ++|.+++.. .... +.......+.. +.||..|++|+||+|+|++++.+|.+.|+||+.
T Consensus 113 n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~ 191 (288)
T PF14531_consen 113 NRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSS 191 (288)
T ss_dssp SEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGG
T ss_pred hhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHH
Confidence 3467788885 688887543 2222 11111122222 348999999999999999999999999999988
Q ss_pred chhhcccccCCccccccccccCcccccCcccccc--------cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHH
Q 042809 113 ARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN--------EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLL 184 (241)
Q Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 184 (241)
....+..... ...+..|.|||.... ..++.+.|.|+||+++|.++++..||...........
T Consensus 192 ~~r~g~~~~~---------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~- 261 (288)
T PF14531_consen 192 LVRAGTRYRC---------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW- 261 (288)
T ss_dssp EEETTEEEEG---------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-
T ss_pred HeecCceeec---------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-
Confidence 8765542111 223567899997744 2467899999999999999999999976543332211
Q ss_pred HHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCC
Q 042809 185 KIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218 (241)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 218 (241)
....+. .+|+.++.||.++|+.+|.+|
T Consensus 262 ------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 ------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 111223 788899999999999999987
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.7e-20 Score=144.67 Aligned_cols=229 Identities=31% Similarity=0.457 Sum_probs=165.0
Q ss_pred cEEEEEeccchH-----HHHHHHHHHHHHhhcCCC-cccc-----cCCceeeeeecccCCCCHHHHHHHhC--CCCCHHH
Q 042809 7 ALFVVKSAESEA-----GVQALRNEAEIRQSLNSP-NIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG--GTLDAGV 73 (241)
Q Consensus 7 ~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~-~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~ 73 (241)
..+++|.+.... ....+.+|+.++..+.|+ ++++ ......+++++++.+++|.+++.... ..+....
T Consensus 23 ~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 102 (384)
T COG0515 23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE 102 (384)
T ss_pred cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHH
Confidence 356777766332 356789999999999988 6877 44555899999999999997777643 2567777
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCC-CeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHG-DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
...+..|+ +|+.+++|||+||+||+++..+ .++++|||.+....................++..|.+||.+.+
T Consensus 103 ~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~ 182 (384)
T COG0515 103 ALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182 (384)
T ss_pred HHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcC
Confidence 66666654 7999999999999999999988 6999999998744332111100012345668999999999987
Q ss_pred ---cCCCchhhHHHHHHHHHHHHhCCCCCccchh----chHHHHHHHHhcC-CCCCCChhh----HHHHHHHHHHhhccC
Q 042809 147 ---EGLDFATDIWSLGCMVIEMATGRPPWGDKIS----NAAATLLKIACSN-EKPHFPTQF----FKKVLDFLAKCLERK 214 (241)
Q Consensus 147 ---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~li~~~l~~~ 214 (241)
...+...|+|++|++++++++|..||..... ............. ......... ...+.+++..++..+
T Consensus 183 ~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (384)
T COG0515 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKD 262 (384)
T ss_pred CCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcC
Confidence 5678899999999999999999999766542 1222222211111 111222221 257899999999999
Q ss_pred CCCCCChHHHhcCCCCCCCCc
Q 042809 215 PEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 215 p~~Rps~~~~l~~p~~~~~~~ 235 (241)
|..|.+..+...+++......
T Consensus 263 ~~~r~~~~~~~~~~~~~~~~~ 283 (384)
T COG0515 263 PKNRLSSSSDLSHDLLAHLKL 283 (384)
T ss_pred chhcCCHHHHhhchHhhCccc
Confidence 999999999888876655443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-19 Score=143.64 Aligned_cols=220 Identities=20% Similarity=0.240 Sum_probs=153.6
Q ss_pred CcEEEEEeccchHHH--HHHHHHHHHHhhcCC----Ccccc------cCCceeeeeecccCCCCHHHHHHHhC-CCCCHH
Q 042809 6 GALFVVKSAESEAGV--QALRNEAEIRQSLNS----PNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDAG 72 (241)
Q Consensus 6 ~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~h----~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~ 72 (241)
+..+|+|........ ..+..|..++..+.. +++.. .....-++||+.+ |.+|.++..... ..++..
T Consensus 44 ~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~ 122 (322)
T KOG1164|consen 44 NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRK 122 (322)
T ss_pred CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHh
Confidence 367888887654222 267888888888873 34433 2456789999999 789999887654 678888
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCC-----CeeecCCCcchhhcccccCC---ccccc-cccccCccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG-----DVKLPDLGCARRVNDLKNNG---NLKQS-WQSIGGTQL 137 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~-----~~kl~dfg~~~~~~~~~~~~---~~~~~-~~~~~~~~~ 137 (241)
.+..++.|. ||+.|++||||||.|+.+.... .+.|.|||++.......... ...+. .....||..
T Consensus 123 T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~r 202 (322)
T KOG1164|consen 123 TVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLR 202 (322)
T ss_pred HHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccc
Confidence 877777665 6999999999999999997653 58999999998332111111 11111 234559999
Q ss_pred ccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCC-CChhhHHHHHHHHHHhhccCCC
Q 042809 138 WMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPH-FPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 138 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~ 216 (241)
|.++....+...+.+.|+||+++++.++..|..||...................... .....+..+..+...+-..+..
T Consensus 203 y~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (322)
T KOG1164|consen 203 YASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYE 282 (322)
T ss_pred cccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCc
Confidence 999999999999999999999999999999999996654322222222221111111 2333445666777766668888
Q ss_pred CCCChHHHhc
Q 042809 217 KRWSAEELLN 226 (241)
Q Consensus 217 ~Rps~~~~l~ 226 (241)
.+|....+..
T Consensus 283 ~~Pdy~~~~~ 292 (322)
T KOG1164|consen 283 DKPDYEKLAE 292 (322)
T ss_pred CCCCHHHHHH
Confidence 8887666543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=149.18 Aligned_cols=140 Identities=17% Similarity=0.116 Sum_probs=98.1
Q ss_pred CCcEEEEEeccc-------hHHHHHHHHHHHHHhhcCCCcccc--cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 5 TGALFVVKSAES-------EAGVQALRNEAEIRQSLNSPNIGR--NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 5 ~~~~vaiK~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
++..||||.... ......+.+|++++++++|+|++. ...+..|+||||++|++|... .. ..........
T Consensus 43 ~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~~LVmE~~~G~~L~~~-~~-~~~~~~~~~i 120 (365)
T PRK09188 43 PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKDGLVRGWTEGVPLHLA-RP-HGDPAWFRSA 120 (365)
T ss_pred CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCcEEEEEccCCCCHHHh-Cc-cchHHHHHHH
Confidence 678889998542 234567999999999999999986 334568999999999999632 11 1111111222
Q ss_pred HHHHHHhhcCCccccCC-CCCcEEeecCCCeeecCCCcchhhcccccCCcc--ccccccccCcccccCcccccc
Q 042809 76 LYTKEILHGNGILHCDL-KCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNL--KQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 76 ~~~~~~Lh~~~~vH~dl-~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.-+..+||+.|++|||| ||+||+++.++.++|+|||++............ ........+++.|.+||.+..
T Consensus 121 ~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 121 HRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred HHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 23345689999999999 999999999999999999999866442111110 011124557788999998853
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.5e-21 Score=162.30 Aligned_cols=174 Identities=24% Similarity=0.336 Sum_probs=133.8
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCC---------ccc
Q 042809 56 GSLLDVAEKFGGTLDAGVIRLYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG---------NLK 126 (241)
Q Consensus 56 ~~L~~~l~~~~~~~~~~~~~~~~~~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---------~~~ 126 (241)
|+=.+.++. -+.++... .++.+|||+.|++|+|+||+|.+++.-|.+|++|||+.+..-...... ...
T Consensus 136 gDc~tllk~-~g~lPvdm--vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~E 212 (1205)
T KOG0606|consen 136 GDCATLLKN-IGPLPVDM--VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHE 212 (1205)
T ss_pred chhhhhccc-CCCCcchh--hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHH
Confidence 344444443 23344333 567799999999999999999999999999999999987542211100 000
Q ss_pred cccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHH
Q 042809 127 QSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDF 206 (241)
Q Consensus 127 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 206 (241)
-.-...+||+.|.|||++....|...+|.|++|+++|+++.|..||.+.+.+.............+.. ...++++++++
T Consensus 213 f~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~-dea~p~Ea~dl 291 (1205)
T KOG0606|consen 213 FQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE-DEALPPEAQDL 291 (1205)
T ss_pred hhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc-CcCCCHHHHHH
Confidence 11235689999999999999999999999999999999999999999987777665555444444444 56678899999
Q ss_pred HHHhhccCCCCCC---ChHHHhcCCCCCCC
Q 042809 207 LAKCLERKPEKRW---SAEELLNHTFISGN 233 (241)
Q Consensus 207 i~~~l~~~p~~Rp---s~~~~l~~p~~~~~ 233 (241)
+.++|+.+|..|. .+-++.+|+||+.-
T Consensus 292 i~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 292 IEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred HHHHHHhChHhhcccchhhhhhhccceeec
Confidence 9999999999996 67788999999653
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-20 Score=141.93 Aligned_cols=177 Identities=21% Similarity=0.284 Sum_probs=122.8
Q ss_pred CCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecC--C--CeeecCCC
Q 042809 42 GEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH--G--DVKLPDLG 111 (241)
Q Consensus 42 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~--~--~~kl~dfg 111 (241)
....+|+||.-.+ .+|..|+-.+. .+......++.|+ ||.+|+.|||+|.+||++.-+ + .+.++|||
T Consensus 314 ~~~tlylvMkrY~-~tLr~yl~~~~--~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFG 390 (598)
T KOG4158|consen 314 EPKTLYLVMKRYR-QTLREYLWTRH--RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFG 390 (598)
T ss_pred CCceEEEehhcch-hhHHHHHhcCC--CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccc
Confidence 3467999998885 59999998732 3334444444444 799999999999999999543 3 37899999
Q ss_pred cchhhcccccCCccccccccccCcccccCcccccccC------CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHH
Q 042809 112 CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG------LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLK 185 (241)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~------~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 185 (241)
.+.--....-........-...|.-..+|||+....+ -..++|.|+.|.+.||+++...||....+ ..... +
T Consensus 391 CcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~-r 468 (598)
T KOG4158|consen 391 CCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDT-R 468 (598)
T ss_pred eeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heech-h
Confidence 8853322111111111222345677789999986432 12589999999999999999999976322 11111 1
Q ss_pred HHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH
Q 042809 186 IACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
.-.....|.+|..+++.+++++..+|+.||.+|+|..-
T Consensus 469 ~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 469 TYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred hhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence 12224567788889999999999999999999997543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.2e-21 Score=153.08 Aligned_cols=182 Identities=25% Similarity=0.322 Sum_probs=131.7
Q ss_pred CceeeeeecccCCCCHHHHHHHh--CCCCCHHHHHHHHHHHh---hcCCccccCCCCCcEEeecCCCeeecCCCcchhhc
Q 042809 43 EKTVNIFMEYMAGGSLLDVAEKF--GGTLDAGVIRLYTKEIL---HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVN 117 (241)
Q Consensus 43 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~L---h~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 117 (241)
..++|+.|++|.-.+|.+++... ....+......++.|+- .-+|.+|+|++|.||+...++.+||+|||+.+...
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~yk~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~ 407 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEYKGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQD 407 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhhccchhhhccccccccccchhhhhhhhhheeecc
Confidence 34789999999999999999743 23345555555666553 23899999999999999999999999999998765
Q ss_pred ccccCCccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCC
Q 042809 118 DLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFP 196 (241)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (241)
................||..|++||.+.+..|+.++||||||++++|++. -..++ +.............++.+-
T Consensus 408 ~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~-----er~~t~~d~r~g~ip~~~~ 482 (516)
T KOG1033|consen 408 KDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF-----ERIATLTDIRDGIIPPEFL 482 (516)
T ss_pred cCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH-----HHHHhhhhhhcCCCChHHh
Confidence 54322222334456679999999999999999999999999999999998 22222 1111111111112222222
Q ss_pred hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 197 TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 197 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
. -.+.-..|+++++...|.+||++.+.-.|+|.
T Consensus 483 ~-d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 483 Q-DYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred h-cCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 2 22456689999999999999988888887775
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-20 Score=137.84 Aligned_cols=207 Identities=21% Similarity=0.320 Sum_probs=149.6
Q ss_pred CcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC-CCCHHHHH
Q 042809 6 GALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG-TLDAGVIR 75 (241)
Q Consensus 6 ~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~ 75 (241)
|-.++.|++.-. +....|..|.-.++.+.||||+. ....++.++..||+.|+|+..+.+... ..+...+.
T Consensus 213 gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav 292 (448)
T KOG0195|consen 213 GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAV 292 (448)
T ss_pred CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHH
Confidence 344556665522 22345778888899889999987 667889999999999999999987532 24444444
Q ss_pred HHHH------HHhhcCC--ccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 76 LYTK------EILHGNG--ILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 76 ~~~~------~~Lh~~~--~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
.+++ .+||+.. +.---|+...+++|.+-+.+|+--+.-..+.+ ....-.|.|++||.++..
T Consensus 293 ~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe-----------~gr~y~pawmspealqrk 361 (448)
T KOG0195|consen 293 RFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-----------VGRAYSPAWMSPEALQRK 361 (448)
T ss_pred HHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec-----------cccccCcccCCHHHHhcC
Confidence 4444 4478754 33335888999999988877743222111111 111236789999999876
Q ss_pred CCC---chhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 148 GLD---FATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 148 ~~~---~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
+.+ .++|+|||++++||+.|...||.+... ..--.+....+....+|+..+..+..|+.-|++.||.+||.++.+
T Consensus 362 ped~n~raadmwsfaillwel~trevpfadlsp--mecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 362 PEDLNIRAADMWSFAILLWELNTREVPFADLSP--MECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred chhcchhhhhHHHHHHHHHHhhccccccccCCc--hhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 543 578999999999999999999977532 222234455578888999999999999999999999999998876
Q ss_pred h
Q 042809 225 L 225 (241)
Q Consensus 225 l 225 (241)
+
T Consensus 440 v 440 (448)
T KOG0195|consen 440 V 440 (448)
T ss_pred h
Confidence 5
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-19 Score=144.56 Aligned_cols=193 Identities=26% Similarity=0.384 Sum_probs=137.2
Q ss_pred HhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHH------HHhhcCCc-cccCCCCCcE
Q 042809 30 RQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTK------EILHGNGI-LHCDLKCNNV 97 (241)
Q Consensus 30 l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~------~~Lh~~~~-vH~dl~p~Ni 97 (241)
|+.+.|.|+.+ .++...++|.+||..|+|.+.+......++.-....+.+ ++||.-.+ .|+.+++.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 46788999987 566899999999999999999998655555555544444 45786554 9999999999
Q ss_pred EeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC-------CCchhhHHHHHHHHHHHHhCCC
Q 042809 98 LLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG-------LDFATDIWSLGCMVIEMATGRP 170 (241)
Q Consensus 98 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-------~~~~~Di~slG~~l~~l~~g~~ 170 (241)
+++..+.+|++|||+...... ...............|.|||.+.+.. .+.++|+||+|++++|+++...
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~----~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEE----TAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred eeeeeEEEEechhhhcccccc----cccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999876543 00011111122356699999997632 3567899999999999999999
Q ss_pred CCccchhchH-HHHHHHHhc-CC---CCCCC-h-hhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 171 PWGDKISNAA-ATLLKIACS-NE---KPHFP-T-QFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 171 p~~~~~~~~~-~~~~~~~~~-~~---~~~~~-~-~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
||........ .++...... .. .|... . ..++++..++.+||..+|.+||+++++-.
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 9966322111 222222222 22 22222 1 34457999999999999999999998743
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.5e-20 Score=135.01 Aligned_cols=138 Identities=18% Similarity=0.254 Sum_probs=97.7
Q ss_pred CCcEEEEEeccch-----HHHHH------HHHHHHHHhhcCCCcccc-----c--------CCceeeeeecccCCCCHHH
Q 042809 5 TGALFVVKSAESE-----AGVQA------LRNEAEIRQSLNSPNIGR-----N--------GEKTVNIFMEYMAGGSLLD 60 (241)
Q Consensus 5 ~~~~vaiK~~~~~-----~~~~~------~~~e~~~l~~l~h~~i~~-----~--------~~~~~~lv~e~~~~~~L~~ 60 (241)
++..+|+|.+..+ ..... +.+|+..+.++.|++|.. . ..+..++||||++|.+|.+
T Consensus 53 ~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~ 132 (232)
T PRK10359 53 DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELND 132 (232)
T ss_pred CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHH
Confidence 4667999998732 22223 579999999999999866 1 1246899999999999988
Q ss_pred HHHHhCCCCCHHHHHHH--HHHHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 61 VAEKFGGTLDAGVIRLY--TKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 61 ~l~~~~~~~~~~~~~~~--~~~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
+.. ++......+ +...+|+.|++|||++|+||+++.+| ++|+|||......+.. .
T Consensus 133 ~~~-----~~~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~-------a---------- 189 (232)
T PRK10359 133 MPE-----ISEDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRK-------A---------- 189 (232)
T ss_pred hhh-----ccHHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchh-------h----------
Confidence 743 223322222 33458999999999999999999988 9999999886543210 0
Q ss_pred cCcccccccCCCchhhHHHHHHHHHHHH
Q 042809 139 MAPEVLRNEGLDFATDIWSLGCMVIEMA 166 (241)
Q Consensus 139 ~aPE~~~~~~~~~~~Di~slG~~l~~l~ 166 (241)
...+.....+..++|+|+||+++..+.
T Consensus 190 -~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 190 -KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -HHHHHHHhHhcccccccceeEeehHHH
Confidence 011333444567899999999986553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-18 Score=125.11 Aligned_cols=168 Identities=20% Similarity=0.143 Sum_probs=107.8
Q ss_pred CCcEEEEEeccchH------HHHHHHHHHHHHhhcCC-Ccccc-cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 5 TGALFVVKSAESEA------GVQALRNEAEIRQSLNS-PNIGR-NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 5 ~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h-~~i~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
.+..++.+.+.... ....+.+|+++|++|.| +++.. ..-+..+++|||+.|.+|...+.. ..........
T Consensus 24 ~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~~L~~~~~~--~~~~~~~qi~ 101 (218)
T PRK12274 24 GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGAAMYQRPPR--GDLAYFRAAR 101 (218)
T ss_pred CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCccHHhhhhh--hhHHHHHHHH
Confidence 34555555544221 12357899999999964 55555 223557999999999999765432 1122122223
Q ss_pred HHHHHhhcCCccccCC-CCCcEEeecCCCeeecCCCcchhhcccccC------Cccccc-cccccCcccccCcccccc-c
Q 042809 77 YTKEILHGNGILHCDL-KCNNVLLGSHGDVKLPDLGCARRVNDLKNN------GNLKQS-WQSIGGTQLWMAPEVLRN-E 147 (241)
Q Consensus 77 ~~~~~Lh~~~~vH~dl-~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~-~~~~~~~~~~~aPE~~~~-~ 147 (241)
-+.+.+|++|++|||| +|.||+++.+|.++|+|||++......... ...... ......++.+++|+...- .
T Consensus 102 ~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~ 181 (218)
T PRK12274 102 RLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLK 181 (218)
T ss_pred HHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc
Confidence 3445689999999999 799999999999999999999754331110 000000 001224556666665432 1
Q ss_pred CCC-chhhHHHHHHHHHHHHhCCCCCcc
Q 042809 148 GLD-FATDIWSLGCMVIEMATGRPPWGD 174 (241)
Q Consensus 148 ~~~-~~~Di~slG~~l~~l~~g~~p~~~ 174 (241)
..+ .+.+.++.|.-+|.++|+..++..
T Consensus 182 ~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 182 RTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred cchhHHHHHHHhcchHHHHHhccCCccc
Confidence 233 567888999999999998888654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.9e-18 Score=125.88 Aligned_cols=110 Identities=18% Similarity=0.146 Sum_probs=80.4
Q ss_pred CCcEEEEEeccchHH----------------------------HHHHHHHHHHHhhcCCCcccc---cCCceeeeeeccc
Q 042809 5 TGALFVVKSAESEAG----------------------------VQALRNEAEIRQSLNSPNIGR---NGEKTVNIFMEYM 53 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~----------------------------~~~~~~e~~~l~~l~h~~i~~---~~~~~~~lv~e~~ 53 (241)
+|+.||+|+++.... .....+|++.+.++.++++.. ......++||||+
T Consensus 20 ~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~~~~~iVmE~i 99 (190)
T cd05147 20 NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILLKSHVLVMEFI 99 (190)
T ss_pred CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEecCCEEEEEEe
Confidence 799999999864310 012235999999998776633 1112338999999
Q ss_pred CCCCHHHHHHHhCCCCCHHHHHHHHHH------Hh-hcCCccccCCCCCcEEeecCCCeeecCCCcchhh
Q 042809 54 AGGSLLDVAEKFGGTLDAGVIRLYTKE------IL-HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRV 116 (241)
Q Consensus 54 ~~~~L~~~l~~~~~~~~~~~~~~~~~~------~L-h~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~ 116 (241)
+|++|...... ...++...+..++.| .+ |+.|++||||||+||+++ ++.++|+|||++...
T Consensus 100 ~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 100 GDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 98777655433 356777776666654 36 799999999999999998 588999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.9e-17 Score=120.05 Aligned_cols=109 Identities=17% Similarity=0.153 Sum_probs=80.0
Q ss_pred CCcEEEEEeccchHH----------------------------HHHHHHHHHHHhhcCCCcccc---cCCceeeeeeccc
Q 042809 5 TGALFVVKSAESEAG----------------------------VQALRNEAEIRQSLNSPNIGR---NGEKTVNIFMEYM 53 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~----------------------------~~~~~~e~~~l~~l~h~~i~~---~~~~~~~lv~e~~ 53 (241)
+|+.||||+++.... ...+.+|...+.++.|+++.. ......++||||+
T Consensus 20 ~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~lVmE~~ 99 (190)
T cd05145 20 DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLKKNVLVMEFI 99 (190)
T ss_pred CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEecCCEEEEEEe
Confidence 799999999774210 122467899999999988743 1112348999999
Q ss_pred CCCCHHHH-HHHhCCCCCHHHHHHHHHHH------hhc-CCccccCCCCCcEEeecCCCeeecCCCcchhh
Q 042809 54 AGGSLLDV-AEKFGGTLDAGVIRLYTKEI------LHG-NGILHCDLKCNNVLLGSHGDVKLPDLGCARRV 116 (241)
Q Consensus 54 ~~~~L~~~-l~~~~~~~~~~~~~~~~~~~------Lh~-~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~ 116 (241)
+|+++... +.. ..++......++.++ +|+ .|++||||||+||+++ ++.++|+|||++...
T Consensus 100 ~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 100 GDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred cCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceec
Confidence 88755443 433 455555555555544 688 9999999999999998 899999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.8e-17 Score=138.17 Aligned_cols=210 Identities=25% Similarity=0.360 Sum_probs=156.7
Q ss_pred HHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHH-HHhCCCCCHHHHHHHHHHH------hh-cC
Q 042809 20 VQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVA-EKFGGTLDAGVIRLYTKEI------LH-GN 85 (241)
Q Consensus 20 ~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~~~~------Lh-~~ 85 (241)
......|..+=+.+. |+|++. ......+++++|..|+++++.+ .......+...+..++.|+ +| ..
T Consensus 64 ~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~ 143 (601)
T KOG0590|consen 64 SEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN 143 (601)
T ss_pred hhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc
Confidence 444556777777777 999987 6777899999999999999988 4432244445555555554 79 99
Q ss_pred CccccCCCCCcEEeecCC-CeeecCCCcchhhcccccCCccccccccccC-cccccCcccccccC-CCchhhHHHHHHHH
Q 042809 86 GILHCDLKCNNVLLGSHG-DVKLPDLGCARRVNDLKNNGNLKQSWQSIGG-TQLWMAPEVLRNEG-LDFATDIWSLGCMV 162 (241)
Q Consensus 86 ~~vH~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~-~~~~~aPE~~~~~~-~~~~~Di~slG~~l 162 (241)
++.|+|++|+|.+++..+ ..++.|||++...... ..........+| ++.|.|||...+.. ..+..|+||.|+++
T Consensus 144 ~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~---~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l 220 (601)
T KOG0590|consen 144 GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK---NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVL 220 (601)
T ss_pred ccccCCCCCccchhccCCCcccCCCchhhcccccc---CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccc
Confidence 999999999999999999 9999999999876552 122233344556 99999999998853 46788999999999
Q ss_pred HHHHhCCCCCccchhchHHHHHHHHhc-CCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 163 IEMATGRPPWGDKISNAAATLLKIACS-NEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 163 ~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
..+++|..||................. ...............+++.+++..+|..|.+++++..+||+..
T Consensus 221 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 221 SAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 999999999866433332111111111 1122334456678889999999999999999999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.4e-16 Score=133.82 Aligned_cols=159 Identities=21% Similarity=0.319 Sum_probs=123.0
Q ss_pred CCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc---------cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 5 TGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR---------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
+|+.||+|+-.-.. .-+|.-..+++.+|+ +-+.. ...+.-++|+||.+.|+|-+++.. ....++....
T Consensus 721 ~~~~~alK~e~P~~-~WEfYI~~q~~~RLk-~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~-~~~m~e~lv~ 797 (974)
T KOG1166|consen 721 NGKLVALKVEKPPN-PWEFYICLQVMERLK-PQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINT-NKVMDEYLVM 797 (974)
T ss_pred CCcEEEEEeecCCC-ceeeeehHHHHHhhc-hhhhcchHHHHHHHccCCcceeeeeccccccHHHhhcc-CCCCCchhhh
Confidence 38999999866333 344555556666666 32222 666778899999999999999995 5667777777
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeec-------CCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGS-------HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~-------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
++..|+ ||..+||||||||+|+++.. ...++|+|||.+.-..-.... ..+....+|..+--+|
T Consensus 798 ~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~----~~F~~~~~td~f~C~E 873 (974)
T KOG1166|consen 798 FFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDG----TKFKAVWHTDLFDCIE 873 (974)
T ss_pred HHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCC----cEEeeeeccccchhHH
Confidence 777666 69999999999999999943 234899999999755443332 3455667788899999
Q ss_pred cccccCCCchhhHHHHHHHHHHHHhCCC
Q 042809 143 VLRNEGLDFATDIWSLGCMVIEMATGRP 170 (241)
Q Consensus 143 ~~~~~~~~~~~Di~slG~~l~~l~~g~~ 170 (241)
...|.+|++.+|.|+++.+++-|+.|+.
T Consensus 874 M~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 874 MREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred HhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.8e-15 Score=110.37 Aligned_cols=109 Identities=19% Similarity=0.175 Sum_probs=77.2
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhc-----CCCcccc-----cCC---ceee-eeecc--cCCCCHHHHHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSL-----NSPNIGR-----NGE---KTVN-IFMEY--MAGGSLLDVAE 63 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l-----~h~~i~~-----~~~---~~~~-lv~e~--~~~~~L~~~l~ 63 (241)
++.++.. +||+.... ...+.+.+|+.+++.+ .||||++ +++ +.++ +|+|| +.+++|.+++.
T Consensus 21 hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~ 99 (210)
T PRK10345 21 HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAE 99 (210)
T ss_pred CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHH
Confidence 3455555 68886632 2356799999999999 5799988 222 3433 78999 44789999997
Q ss_pred HhCCCCCHHH--H---HHHHHHHhhcCCccccCCCCCcEEeecC----CCeeecCCCcc
Q 042809 64 KFGGTLDAGV--I---RLYTKEILHGNGILHCDLKCNNVLLGSH----GDVKLPDLGCA 113 (241)
Q Consensus 64 ~~~~~~~~~~--~---~~~~~~~Lh~~~~vH~dl~p~Nil~~~~----~~~kl~dfg~~ 113 (241)
.. .+++.. . ..-+.++||+++++||||||+||+++.. +.++|+||+.+
T Consensus 100 ~~--~~~e~~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 100 QC--RYEEDVAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred cc--cccHhHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 62 344432 1 1122367899999999999999999743 37999995444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.8e-15 Score=112.85 Aligned_cols=113 Identities=19% Similarity=0.167 Sum_probs=79.9
Q ss_pred CCCCCcEEEEEeccchH--------------------------HHHHHHHHHHHHhhcCCCccc--c-cCCceeeeeecc
Q 042809 2 NKGTGALFVVKSAESEA--------------------------GVQALRNEAEIRQSLNSPNIG--R-NGEKTVNIFMEY 52 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~--------------------------~~~~~~~e~~~l~~l~h~~i~--~-~~~~~~~lv~e~ 52 (241)
+..+|+.||+|.++... ....+.+|+..+.++.+.++. . ......++||||
T Consensus 50 ~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~~~~~lV~E~ 129 (237)
T smart00090 50 FDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAWRRNVLVMEF 129 (237)
T ss_pred cCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEecCceEEEEE
Confidence 45789999999876321 112356899999999764432 1 122345899999
Q ss_pred cCCCCHHHHHHHhCCCCCHHHHHHHHHH------HhhcCC-ccccCCCCCcEEeecCCCeeecCCCcchhh
Q 042809 53 MAGGSLLDVAEKFGGTLDAGVIRLYTKE------ILHGNG-ILHCDLKCNNVLLGSHGDVKLPDLGCARRV 116 (241)
Q Consensus 53 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~------~Lh~~~-~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~ 116 (241)
++|++|...... ...........++.| .||+.| ++|+||||+||+++ ++.++|+|||.+...
T Consensus 130 ~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 130 IGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred ecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 998888766533 233444333344443 379999 99999999999998 889999999998643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=107.25 Aligned_cols=108 Identities=25% Similarity=0.298 Sum_probs=80.5
Q ss_pred CCcEEEEEeccch----------HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCC
Q 042809 5 TGALFVVKSAESE----------AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTL 69 (241)
Q Consensus 5 ~~~~vaiK~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 69 (241)
+|..+++|..... ....++.+|++++..+.|+++.. ......++||||++|++|.+++.....
T Consensus 16 ~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~-- 93 (199)
T TIGR03724 16 LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND-- 93 (199)
T ss_pred CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH--
Confidence 5678899974321 12356789999999998877533 455567899999999999998875321
Q ss_pred CHHHHHHHHHHHhhcCCccccCCCCCcEEeecCCCeeecCCCcchh
Q 042809 70 DAGVIRLYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115 (241)
Q Consensus 70 ~~~~~~~~~~~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~ 115 (241)
........+...||+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus 94 ~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 94 ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 1222222333558999999999999999998 89999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.4e-14 Score=107.24 Aligned_cols=108 Identities=19% Similarity=0.306 Sum_probs=80.0
Q ss_pred CcEEEEEeccch---------------HHHHHHHHHHHHHhhcCCCccc--c------cCCc---eeeeeecccCC-CCH
Q 042809 6 GALFVVKSAESE---------------AGVQALRNEAEIRQSLNSPNIG--R------NGEK---TVNIFMEYMAG-GSL 58 (241)
Q Consensus 6 ~~~vaiK~~~~~---------------~~~~~~~~e~~~l~~l~h~~i~--~------~~~~---~~~lv~e~~~~-~~L 58 (241)
+..+|+|.+... .....+.+|+.++..|.|+++. . .... ..++|+|+++| .+|
T Consensus 55 ~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L 134 (239)
T PRK01723 55 GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDL 134 (239)
T ss_pred CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCH
Confidence 567788876421 1234578899999999988862 1 1112 23599999997 699
Q ss_pred HHHHHHhCCCCCHHHHHHHHH--HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchh
Q 042809 59 LDVAEKFGGTLDAGVIRLYTK--EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115 (241)
Q Consensus 59 ~~~l~~~~~~~~~~~~~~~~~--~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~ 115 (241)
.+++.. ..++......++. ..||+.|++|+||||.||+++.++.++|+|||.+..
T Consensus 135 ~~~l~~--~~l~~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 135 VALLQE--APLSEEQWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 998875 3455555444444 348999999999999999999999999999998853
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.5e-14 Score=105.07 Aligned_cols=109 Identities=28% Similarity=0.339 Sum_probs=80.1
Q ss_pred CCcEEEEEeccch----------HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCC
Q 042809 5 TGALFVVKSAESE----------AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTL 69 (241)
Q Consensus 5 ~~~~vaiK~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 69 (241)
+|..+++|..... .....+.+|+.++..+.|+++.. ......++||||++|++|.+++..... .
T Consensus 18 ~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~-~ 96 (211)
T PRK14879 18 LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM-E 96 (211)
T ss_pred CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccH-H
Confidence 5677888874421 12345788999999999888754 356678999999999999999876321 0
Q ss_pred CHHHHHH--HHHHHhhcCCccccCCCCCcEEeecCCCeeecCCCcchh
Q 042809 70 DAGVIRL--YTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115 (241)
Q Consensus 70 ~~~~~~~--~~~~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~ 115 (241)
....+.. .+...+|+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus 97 ~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 97 ELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 0111111 122448999999999999999998 88999999998854
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.1e-14 Score=105.71 Aligned_cols=110 Identities=18% Similarity=0.143 Sum_probs=78.2
Q ss_pred CCCcEEEEEeccchH------------------------HHHHHHHHHHHHhhcCCCcc--cc-cCCceeeeeecccCCC
Q 042809 4 GTGALFVVKSAESEA------------------------GVQALRNEAEIRQSLNSPNI--GR-NGEKTVNIFMEYMAGG 56 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~------------------------~~~~~~~e~~~l~~l~h~~i--~~-~~~~~~~lv~e~~~~~ 56 (241)
.+|+.||||+++.+. ....+..|..++..+.++++ .. ......++||||++|+
T Consensus 37 ~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~~~~~~lv~e~~~g~ 116 (198)
T cd05144 37 PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPIDWNRHAVVMEYIDGV 116 (198)
T ss_pred CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceeecCCceEEEEEeCCc
Confidence 479999999855221 11235678888988887753 22 2344568999999999
Q ss_pred CHHHHHHHhCCCCCHHHHHHHHH--HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhh
Q 042809 57 SLLDVAEKFGGTLDAGVIRLYTK--EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRV 116 (241)
Q Consensus 57 ~L~~~l~~~~~~~~~~~~~~~~~--~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~ 116 (241)
+|...... ......+..++. ..+|+.|++|+||+|.||+++.++.++|+|||++...
T Consensus 117 ~L~~~~~~---~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 117 ELYRVRVL---EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred chhhcccc---ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 99776431 112222233333 3379999999999999999999999999999999644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.6e-13 Score=93.32 Aligned_cols=91 Identities=27% Similarity=0.376 Sum_probs=72.1
Q ss_pred HHHHHHHHHHHhhcC-----CCcccccCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHHH--hhcCCccccCC
Q 042809 20 VQALRNEAEIRQSLN-----SPNIGRNGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI--LHGNGILHCDL 92 (241)
Q Consensus 20 ~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~--Lh~~~~vH~dl 92 (241)
..+..+|++++.+++ .|-+...+.+...++|||++|..|.+++.+. .......+..++ ||..|++||||
T Consensus 43 r~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~----~~~~~r~vG~~vg~lH~~givHGDL 118 (204)
T COG3642 43 RERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA----RPDLLREVGRLVGKLHKAGIVHGDL 118 (204)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc----chHHHHHHHHHHHHHHhcCeecCCC
Confidence 455678999998886 3444447888889999999999999999873 344455555544 99999999999
Q ss_pred CCCcEEeecCCCeeecCCCcchh
Q 042809 93 KCNNVLLGSHGDVKLPDLGCARR 115 (241)
Q Consensus 93 ~p~Nil~~~~~~~kl~dfg~~~~ 115 (241)
+++||+++.++ +.++|||++..
T Consensus 119 TtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 119 TTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ccceEEEeCCc-EEEEECCcccc
Confidence 99999996544 99999999964
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.5e-13 Score=115.77 Aligned_cols=92 Identities=25% Similarity=0.299 Sum_probs=72.3
Q ss_pred HHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHHHhhcCCccccCCCC
Q 042809 20 VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHGNGILHCDLKC 94 (241)
Q Consensus 20 ~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~Lh~~~~vH~dl~p 94 (241)
.+.+.+|++++..++|+++.. ......++||||++|++|.+++... ........-....||+.|++||||||
T Consensus 380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~~~---~~~~~~i~~~L~~lH~~giiHrDlkp 456 (535)
T PRK09605 380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLEGN---PELVRKVGEIVAKLHKAGIVHGDLTT 456 (535)
T ss_pred HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHHHH---HHHHHHHHHHHHHHHhCCCccCCCCh
Confidence 356889999999999999865 3455678999999999999988631 11112222233568999999999999
Q ss_pred CcEEeecCCCeeecCCCcchh
Q 042809 95 NNVLLGSHGDVKLPDLGCARR 115 (241)
Q Consensus 95 ~Nil~~~~~~~kl~dfg~~~~ 115 (241)
+||++ .++.++|+|||++..
T Consensus 457 ~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 457 SNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred HHEEE-ECCcEEEEeCccccc
Confidence 99999 678999999999864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1e-12 Score=99.71 Aligned_cols=194 Identities=21% Similarity=0.253 Sum_probs=126.7
Q ss_pred HhhcCCCcccc----------cCCceeeeeecccCCCCHHHHHHHh---CCCCCHHHHHHHHHHH------hhcC--Ccc
Q 042809 30 RQSLNSPNIGR----------NGEKTVNIFMEYMAGGSLLDVAEKF---GGTLDAGVIRLYTKEI------LHGN--GIL 88 (241)
Q Consensus 30 l~~l~h~~i~~----------~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~------Lh~~--~~v 88 (241)
+.++.|.|+++ .+.....+++|||..|+|..+|++. +..+.......++-|+ ||+. .++
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 44556777776 3566788999999999999999874 3445555556666665 6764 499
Q ss_pred ccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhC
Q 042809 89 HCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATG 168 (241)
Q Consensus 89 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 168 (241)
|++++.+.|++..+|-+|++.-.....-... ............+-++|.+||.=.....+.++|||+||+...++..+
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~--~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSV--NSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhh--hhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999998888887542211110000 01111111223356778888887666677889999999999999887
Q ss_pred CCCCccchhchHH-HHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 169 RPPWGDKISNAAA-TLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 169 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
..-..+....... ........+... ..-+.++.+|++-+|..||++.+++.||.+-+
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~len-------~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIGLEN-------GLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred eeccCCCcceeehhhhhhhheeeccC-------ccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 7654332221111 111111111111 12346889999999999999999999996543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.9e-13 Score=109.22 Aligned_cols=223 Identities=22% Similarity=0.237 Sum_probs=157.1
Q ss_pred CCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 3 KGTGALFVVKSAES----EAGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 3 ~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
..++..+|+|.-.. +.....=.+|+...+++. |++.++ ...+..++=+|+|. .+|.++-......++..
T Consensus 140 ~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~ 218 (524)
T KOG0601|consen 140 SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDN 218 (524)
T ss_pred ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhhcccccCCch
Confidence 34667778887331 222233456777777776 888887 77889999999995 78888877655545555
Q ss_pred HHHHHHHH----------HhhcCCccccCCCCCcEEeecC-CCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 73 VIRLYTKE----------ILHGNGILHCDLKCNNVLLGSH-GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 73 ~~~~~~~~----------~Lh~~~~vH~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
.++..+.+ .+|+.+++|-|++|.||+...+ ...+++|||++..+.+.......... ....|...|++|
T Consensus 219 ~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~-~r~~~~~~Y~~k 297 (524)
T KOG0601|consen 219 LLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVS-KRPEGDCIYAAK 297 (524)
T ss_pred hhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCccccceeee-ecCCCCceEeCh
Confidence 55544443 3699999999999999999999 77899999999988775444433332 223467779999
Q ss_pred ccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 142 EVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 142 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
|..++. ++..+|+|++|.++.+..++..+............ +. ...+.++....+..+...+..|+..+|..|++.
T Consensus 298 e~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~-r~--~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~ 373 (524)
T KOG0601|consen 298 ELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL-RQ--GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTA 373 (524)
T ss_pred hhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccc-cc--ccCchhhhcCcchhhhhHHHHhcCcchhhhhHH
Confidence 998765 57789999999999999887765533211111111 00 012233344445566679999999999999999
Q ss_pred HHHhcCCCCC
Q 042809 222 EELLNHTFIS 231 (241)
Q Consensus 222 ~~~l~~p~~~ 231 (241)
+.++.++++.
T Consensus 374 q~~~~l~~i~ 383 (524)
T KOG0601|consen 374 QILTALNVIH 383 (524)
T ss_pred HHHhcccccc
Confidence 9999999875
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.9e-12 Score=104.82 Aligned_cols=156 Identities=20% Similarity=0.319 Sum_probs=109.5
Q ss_pred CCCCcEEEEEeccchHH--HHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH-
Q 042809 3 KGTGALFVVKSAESEAG--VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI- 74 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~- 74 (241)
+.++.+|.+..+..+.. .....+-++.|+.++||||++ +.++++|+|+|-+ ..|..+++..+ .+....-
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-~~~v~~Gl 110 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-KEEVCLGL 110 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-HHHHHHHH
Confidence 56788888888775544 566788889999999999998 6778999999999 48999998854 1111111
Q ss_pred HHH--HHHHhh-cCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 75 RLY--TKEILH-GNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 75 ~~~--~~~~Lh-~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
..+ ++-+|| ..+++|++|.-+.|+++..|..||++|.++........ ... ...-.-.|..|+.+.... -
T Consensus 111 ~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~----~~~--~~~~~~s~~~P~~~~~s~--~ 182 (690)
T KOG1243|consen 111 FQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA----PAK--SLYLIESFDDPEEIDPSE--W 182 (690)
T ss_pred HHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----ccc--cchhhhcccChhhcCccc--c
Confidence 111 123365 78899999999999999999999999998865433211 000 001112245555443322 3
Q ss_pred hhhHHHHHHHHHHHHhCC
Q 042809 152 ATDIWSLGCMVIEMATGR 169 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~g~ 169 (241)
..|.|.||+++++++.|.
T Consensus 183 s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNGS 200 (690)
T ss_pred chhhhhHHHHHHHHhCcc
Confidence 469999999999999983
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.8e-13 Score=114.84 Aligned_cols=196 Identities=25% Similarity=0.345 Sum_probs=142.0
Q ss_pred CCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH------HHHHHhhcCCccccCCCCCcEEeecCCCeeecCCCcchh
Q 042809 42 GEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL------YTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115 (241)
Q Consensus 42 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~------~~~~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~ 115 (241)
-....+||++|.++++|.+.+..-+ ..+.+..+. ...+.||+..+.|+|++|.|.+...+|..++.+|+....
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccc
Confidence 4567999999999999999988743 333333322 233668998899999999999999999999999984432
Q ss_pred hccccc---------------------CCccc----cccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCC
Q 042809 116 VNDLKN---------------------NGNLK----QSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRP 170 (241)
Q Consensus 116 ~~~~~~---------------------~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 170 (241)
.+.... ..... .......+++.|.+||...+......+|.|++|+++++.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 211100 00000 11234568899999999999999999999999999999999999
Q ss_pred CCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH---HHhcCCCCCCCCccCCC
Q 042809 171 PWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE---ELLNHTFISGNAKKNST 239 (241)
Q Consensus 171 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~---~~l~~p~~~~~~~~~~~ 239 (241)
||...........+.... ..-+.-+...+....+++...+..+|.+|..+. +.-.|+||+..+-++=+
T Consensus 1034 p~na~tpq~~f~ni~~~~-~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1034 PFNAETPQQIFENILNRD-IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLA 1104 (1205)
T ss_pred CCCCcchhhhhhccccCC-CCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccc
Confidence 998765544332211111 111223345667899999999999999999888 89999999887665543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.9e-12 Score=103.02 Aligned_cols=78 Identities=22% Similarity=0.330 Sum_probs=57.5
Q ss_pred cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH-HHH---HHHHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhh
Q 042809 41 NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI-RLY---TKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRV 116 (241)
Q Consensus 41 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~-~~~---~~~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~ 116 (241)
......++||||++|++|.++........+...+ ... +...+|..|++|+|++|.||+++.+|.++++|||++...
T Consensus 228 ~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 228 DRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 3445678999999999999887643222232222 222 223468999999999999999999999999999999765
Q ss_pred cc
Q 042809 117 ND 118 (241)
Q Consensus 117 ~~ 118 (241)
.+
T Consensus 308 ~~ 309 (437)
T TIGR01982 308 SE 309 (437)
T ss_pred CH
Confidence 43
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.9e-13 Score=111.69 Aligned_cols=157 Identities=17% Similarity=0.194 Sum_probs=113.7
Q ss_pred HHHhh-cCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCC---ccccccccccCcccccCcccccccCCCchhh
Q 042809 79 KEILH-GNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG---NLKQSWQSIGGTQLWMAPEVLRNEGLDFATD 154 (241)
Q Consensus 79 ~~~Lh-~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 154 (241)
++++| +.++||++|.|++|+++.+|.+||+.|+.+........-. ..............|.|||++.+...++++|
T Consensus 112 l~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~~sd 191 (700)
T KOG2137|consen 112 LAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTPASD 191 (700)
T ss_pred hhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccccccccc
Confidence 35677 5789999999999999999999999999987654421100 0011111222356699999999988889999
Q ss_pred HHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCC
Q 042809 155 IWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 155 i~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~ 233 (241)
+||+|+++|.+.. |+.-+......................+...++.++++=+.+++..++.-||++..+...|||.+.
T Consensus 192 ~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 192 VFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP 271 (700)
T ss_pred ceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence 9999999999994 555554432222222222222233334456788899999999999999999999999999999876
Q ss_pred Cc
Q 042809 234 AK 235 (241)
Q Consensus 234 ~~ 235 (241)
..
T Consensus 272 ~~ 273 (700)
T KOG2137|consen 272 GL 273 (700)
T ss_pred hh
Confidence 54
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.8e-12 Score=92.87 Aligned_cols=90 Identities=22% Similarity=0.202 Sum_probs=55.5
Q ss_pred HHHHHHhhcCCCcc-cc--cCCceeeeeecccCCC-----CHHHHHHHhCCCCCHHHHHHHHHHHhhc-CCccccCCCCC
Q 042809 25 NEAEIRQSLNSPNI-GR--NGEKTVNIFMEYMAGG-----SLLDVAEKFGGTLDAGVIRLYTKEILHG-NGILHCDLKCN 95 (241)
Q Consensus 25 ~e~~~l~~l~h~~i-~~--~~~~~~~lv~e~~~~~-----~L~~~l~~~~~~~~~~~~~~~~~~~Lh~-~~~vH~dl~p~ 95 (241)
.|...+..+.+..+ +. ......++||||++++ .|.+.... ............+...+|. .|++|+||+|+
T Consensus 66 ~e~~~l~~l~~~~~~~~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~ 144 (187)
T cd05119 66 KEFRNLKRLYEAGVPVPKPIDLNRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEY 144 (187)
T ss_pred HHHHHHHHHHHcCCCCCceEecCCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChh
Confidence 45555555554332 11 2224568999999984 33333221 0000111111122244798 99999999999
Q ss_pred cEEeecCCCeeecCCCcchhh
Q 042809 96 NVLLGSHGDVKLPDLGCARRV 116 (241)
Q Consensus 96 Nil~~~~~~~kl~dfg~~~~~ 116 (241)
||+++ ++.++++|||.+...
T Consensus 145 Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 145 NILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred hEEEE-CCcEEEEECcccccc
Confidence 99999 899999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.4e-11 Score=85.35 Aligned_cols=113 Identities=24% Similarity=0.297 Sum_probs=79.2
Q ss_pred CCCcEEEEEe-----ccc-----hHHHHHHHHHHHHHhhcC-----CCcccccCCceeeeeecccCC-CCHHHHHHHhCC
Q 042809 4 GTGALFVVKS-----AES-----EAGVQALRNEAEIRQSLN-----SPNIGRNGEKTVNIFMEYMAG-GSLLDVAEKFGG 67 (241)
Q Consensus 4 ~~~~~vaiK~-----~~~-----~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~ 67 (241)
-.|+.++||. ++- .-...+..+|++++.+++ .|-++..+...-+++|||++| .++.+++.+...
T Consensus 28 ~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~ 107 (229)
T KOG3087|consen 28 FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTME 107 (229)
T ss_pred cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHcc
Confidence 3577778885 221 223456789999998886 444444677778899999976 588999887633
Q ss_pred CCCHHH-----HHHHHHHH--hhcCCccccCCCCCcEEeecCCC---eeecCCCcchhh
Q 042809 68 TLDAGV-----IRLYTKEI--LHGNGILHCDLKCNNVLLGSHGD---VKLPDLGCARRV 116 (241)
Q Consensus 68 ~~~~~~-----~~~~~~~~--Lh~~~~vH~dl~p~Nil~~~~~~---~kl~dfg~~~~~ 116 (241)
...... ++.+..++ ||..+++||||+.+||++.+++. +.++|||++...
T Consensus 108 ~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 108 DESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred CcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 322222 22333333 89999999999999999977654 589999998643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=9.4e-12 Score=89.30 Aligned_cols=104 Identities=25% Similarity=0.271 Sum_probs=73.1
Q ss_pred CCcEEEEEeccchH-HHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH-
Q 042809 5 TGALFVVKSAESEA-GVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT- 78 (241)
Q Consensus 5 ~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~- 78 (241)
.|+.|++|...... ....+.+|+..+..+.+.++++ ......++||||++|.++.+. . .........++
T Consensus 20 ~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~--~---~~~~~~~~~l~~ 94 (170)
T cd05151 20 ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTE--D---FSDPENLEKIAK 94 (170)
T ss_pred CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccccc--c---ccCHHHHHHHHH
Confidence 36789999976543 2345688999999887655544 333346899999999888653 1 11222222222
Q ss_pred -HHHhhcCCc-----cccCCCCCcEEeecCCCeeecCCCcch
Q 042809 79 -KEILHGNGI-----LHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 79 -~~~Lh~~~~-----vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
...||+.++ +|||++|.||+++ ++.++++||+.+.
T Consensus 95 ~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 95 LLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred HHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 344898875 9999999999998 7789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.5e-11 Score=100.75 Aligned_cols=77 Identities=21% Similarity=0.321 Sum_probs=56.9
Q ss_pred cCCceeeeeecccCCCCHHHHH--HHhCC---CCCHHHHHHHHHHHhhcCCccccCCCCCcEEeecCC----CeeecCCC
Q 042809 41 NGEKTVNIFMEYMAGGSLLDVA--EKFGG---TLDAGVIRLYTKEILHGNGILHCDLKCNNVLLGSHG----DVKLPDLG 111 (241)
Q Consensus 41 ~~~~~~~lv~e~~~~~~L~~~l--~~~~~---~~~~~~~~~~~~~~Lh~~~~vH~dl~p~Nil~~~~~----~~kl~dfg 111 (241)
+.....++||||++|+++.++- ...+. .+....+..++.|++ ..|++|+|++|.||+++.+| .++++|||
T Consensus 231 d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-~~GffHaDpHPGNIlv~~~g~~~~~i~llDFG 309 (537)
T PRK04750 231 DYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-RDGFFHADMHPGNIFVSYDPPENPRYIALDFG 309 (537)
T ss_pred ccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-hCCeeeCCCChHHeEEecCCCCCCeEEEEecc
Confidence 4456678999999999998753 32211 233333444555554 68999999999999999988 89999999
Q ss_pred cchhhcc
Q 042809 112 CARRVND 118 (241)
Q Consensus 112 ~~~~~~~ 118 (241)
++....+
T Consensus 310 ivg~l~~ 316 (537)
T PRK04750 310 IVGSLNK 316 (537)
T ss_pred eEEECCH
Confidence 9976544
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.7e-12 Score=88.44 Aligned_cols=107 Identities=21% Similarity=0.182 Sum_probs=74.4
Q ss_pred CcEEEEEeccchHHHHHHHHHHHHHhhcCCC--cccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 6 GALFVVKSAESEAGVQALRNEAEIRQSLNSP--NIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 6 ~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~--~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
+..+++|..........+.+|+.++..+++. ++.+ ...+..++++||+.++++..+ .. ...........-+
T Consensus 21 ~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-~~-~~~~~~~~~~~~~ 98 (155)
T cd05120 21 DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-SE-EEKEDIAEQLAEL 98 (155)
T ss_pred CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-CH-HHHHHHHHHHHHH
Confidence 3678999887554356788999999999764 4433 444679999999998877644 00 0000011111112
Q ss_pred HHHhhc---CCccccCCCCCcEEeecCCCeeecCCCcch
Q 042809 79 KEILHG---NGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 79 ~~~Lh~---~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
...||. .+++|+|++|.||+++..+.++++|||.+.
T Consensus 99 l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 99 LAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred HHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 344676 479999999999999998999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.4e-10 Score=84.14 Aligned_cols=89 Identities=15% Similarity=0.183 Sum_probs=58.2
Q ss_pred HHHHHHhhcCCCccc-c--cCCceeeeeecccCCCCHHH-HHHHhCCCCCHHHHHHH----HH---HHhhcCCccccCCC
Q 042809 25 NEAEIRQSLNSPNIG-R--NGEKTVNIFMEYMAGGSLLD-VAEKFGGTLDAGVIRLY----TK---EILHGNGILHCDLK 93 (241)
Q Consensus 25 ~e~~~l~~l~h~~i~-~--~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~----~~---~~Lh~~~~vH~dl~ 93 (241)
+|.+.|.++...++- + ..-..-++||||+.++.+.. .++. ..++......+ +. .++|..|++||||+
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 899999988644431 1 23356788999997643422 2322 22322222111 11 22399999999999
Q ss_pred CCcEEeecCCCeeecCCCcchhh
Q 042809 94 CNNVLLGSHGDVKLPDLGCARRV 116 (241)
Q Consensus 94 p~Nil~~~~~~~kl~dfg~~~~~ 116 (241)
+.||+++ ++.+.|+|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999996 578999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.5e-10 Score=83.70 Aligned_cols=95 Identities=22% Similarity=0.234 Sum_probs=58.3
Q ss_pred HHHHHHHHHHhhcCCCcc-cc--cCCceeeeeecccC--CCCHHHHHHHhCCCCCHHH-HHHH---HHHHhhcCCccccC
Q 042809 21 QALRNEAEIRQSLNSPNI-GR--NGEKTVNIFMEYMA--GGSLLDVAEKFGGTLDAGV-IRLY---TKEILHGNGILHCD 91 (241)
Q Consensus 21 ~~~~~e~~~l~~l~h~~i-~~--~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~-~~~~---~~~~Lh~~~~vH~d 91 (241)
....+|.+.|.++...++ ++ ..-..-++||||++ |..+..+....-....... ...+ +...+|..|++|||
T Consensus 53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGD 132 (188)
T PF01163_consen 53 EWAKKEFRNLKRLYEAGVPVPKPYDYNRNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGD 132 (188)
T ss_dssp HHHHHHHHHHHHCCCTT-SS--EEEEETTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS
T ss_pred HHHHHHHHHHHHHHHCCccCCcEEEEeCCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecC
Confidence 346789999999987665 33 22334579999998 6555544433101122222 2222 22347999999999
Q ss_pred CCCCcEEeecCCCeeecCCCcchhh
Q 042809 92 LKCNNVLLGSHGDVKLPDLGCARRV 116 (241)
Q Consensus 92 l~p~Nil~~~~~~~kl~dfg~~~~~ 116 (241)
|++.||+++.+ .+.++|||.+...
T Consensus 133 Ls~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 133 LSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp -STTSEEEETT-CEEE--GTTEEET
T ss_pred CChhhEEeecc-eEEEEecCcceec
Confidence 99999999776 9999999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-09 Score=83.35 Aligned_cols=110 Identities=22% Similarity=0.234 Sum_probs=74.3
Q ss_pred CCcEEEEEeccchH---HHH----------HHHHHHHHHhhcCCCcc-----cc--c--C---CceeeeeecccCCC-CH
Q 042809 5 TGALFVVKSAESEA---GVQ----------ALRNEAEIRQSLNSPNI-----GR--N--G---EKTVNIFMEYMAGG-SL 58 (241)
Q Consensus 5 ~~~~vaiK~~~~~~---~~~----------~~~~e~~~l~~l~h~~i-----~~--~--~---~~~~~lv~e~~~~~-~L 58 (241)
.|+.|.||...... ..+ .+.+|...+.++...+| +- . . ...-++|||++++. +|
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL 123 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL 123 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence 46789999764221 112 37788888887753333 32 1 1 34578999999875 89
Q ss_pred HHHHHHh-CCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeec-------CCCeeecCCCcch
Q 042809 59 LDVAEKF-GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS-------HGDVKLPDLGCAR 114 (241)
Q Consensus 59 ~~~l~~~-~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~-------~~~~kl~dfg~~~ 114 (241)
.+++... ....+......++.++ ||..|++|+|++++||+++. ++.+.++||+.+.
T Consensus 124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9998643 2233333333333332 89999999999999999975 3578999999874
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.4e-09 Score=83.74 Aligned_cols=174 Identities=13% Similarity=0.144 Sum_probs=109.0
Q ss_pred eeeeeecccCCC-CHHHHHHHh--CC---CCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCc
Q 042809 45 TVNIFMEYMAGG-SLLDVAEKF--GG---TLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGC 112 (241)
Q Consensus 45 ~~~lv~e~~~~~-~L~~~l~~~--~~---~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~ 112 (241)
...++|..+.|. ....+.... ++ ...+..+...++. -||+.|.+-||++++|++++.++.+.|.|-+.
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 377888888764 333333221 11 1333333333332 28999999999999999999999999988554
Q ss_pred chhhcccccCCccccccccccCcccccCccccc-----ccCCCchhhHHHHHHHHHHHHhC-CCCCccchh----chHHH
Q 042809 113 ARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR-----NEGLDFATDIWSLGCMVIEMATG-RPPWGDKIS----NAAAT 182 (241)
Q Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~----~~~~~ 182 (241)
...-. ....+.+..|...|++||... +..-+...|.|.||+++++++.| +.||.+-.. ....+
T Consensus 164 fqi~~-------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E 236 (637)
T COG4248 164 FQINA-------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE 236 (637)
T ss_pred eeecc-------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch
Confidence 32211 123455677899999999875 33345678999999999999984 999965110 00000
Q ss_pred --HH-------HHHhcC---CCCCCCh-hhHHHHHHHHHHhhcc--CCCCCCChHHHh
Q 042809 183 --LL-------KIACSN---EKPHFPT-QFFKKVLDFLAKCLER--KPEKRWSAEELL 225 (241)
Q Consensus 183 --~~-------~~~~~~---~~~~~~~-~~~~~~~~li~~~l~~--~p~~Rps~~~~l 225 (241)
+. .....+ .+...|. -+++++..++.+|+.. ++.-|||++..+
T Consensus 237 ~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~ 294 (637)
T COG4248 237 TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWV 294 (637)
T ss_pred hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHH
Confidence 00 000001 1111222 2557899999999985 356899987643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.9e-09 Score=88.07 Aligned_cols=212 Identities=23% Similarity=0.205 Sum_probs=135.4
Q ss_pred CCCcEEEEEeccchH----HHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 4 GTGALFVVKSAESEA----GVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
.++.+|++|...+.. ....-..|+.+...+. |.|++. ....+.|+=.|||+++++...+.. ...+++..
T Consensus 289 ~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~-~~~~d~~~ 367 (524)
T KOG0601|consen 289 EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT-SQMLDEDP 367 (524)
T ss_pred CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHH-HHhcCcch
Confidence 567788888655321 1111234444444444 666655 455667788999999888776633 34455555
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecC-CCeeecCCCcchhhcccccCCccccccccccCcccc-cCccccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSH-GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW-MAPEVLR 145 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~-~aPE~~~ 145 (241)
.+....|+ +|+..++|+|++|+||++..+ +..+++||+.+..+.-. .. .....+..| .++....
T Consensus 368 ~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~--~~------~~~~~~r~~p~~~~~~e 439 (524)
T KOG0601|consen 368 RLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS--SG------VFHHIDRLYPIAEILLE 439 (524)
T ss_pred hhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee--cc------cccccccccccchhhcc
Confidence 55555554 699999999999999999886 77889999988642110 00 011123334 3555556
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
...+..++|+++||..+.+.+++..--..... ...+. .+..+.. +....++..+.+.++..++..|+++-++.
T Consensus 440 ~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--~~~i~----~~~~p~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~ 512 (524)
T KOG0601|consen 440 DYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--SLTIR----SGDTPNL-PGLKLQLQVLLKVMINPDRKRRPSAVELS 512 (524)
T ss_pred ccccccccccccccccccccccCcccCccccc--ceeee----cccccCC-CchHHhhhhhhhhhcCCccccchhhhhhc
Confidence 67778899999999999999987644322111 11111 1122222 23337788899999999999999999988
Q ss_pred cCCCCC
Q 042809 226 NHTFIS 231 (241)
Q Consensus 226 ~~p~~~ 231 (241)
.|.-|.
T Consensus 513 ~~~~~~ 518 (524)
T KOG0601|consen 513 LHSEFY 518 (524)
T ss_pred ccchhh
Confidence 887543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.6e-08 Score=73.99 Aligned_cols=67 Identities=24% Similarity=0.400 Sum_probs=48.0
Q ss_pred CCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH--HHHhhcCCccccCCCCCcEEeecCCCeeecCCCcch
Q 042809 42 GEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT--KEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 42 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~--~~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
.....++||||++|..|.++.. +++.....+. ..-||+.|++|||.+|.|++++ ++.++++||+...
T Consensus 114 ~~~~~~ll~EYIeG~~l~d~~~-----i~e~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~-~~~i~iID~~~k~ 182 (229)
T PF06176_consen 114 YTSSYVLLMEYIEGVELNDIED-----IDEDLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS-NNGIRIIDTQGKR 182 (229)
T ss_pred ceeEEEEEEEEecCeecccchh-----cCHHHHHHHHHHHHHHHHcCCccCCCCcCcEEEE-CCcEEEEECcccc
Confidence 3456678999999988876543 2222211222 2348999999999999999997 4559999997664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.87 E-value=9.7e-08 Score=77.43 Aligned_cols=192 Identities=16% Similarity=0.234 Sum_probs=134.3
Q ss_pred CCCCcEEEEEeccchH--HHHHHHHHHHHHhhcCCCcccc---------cCCceeeeeecccCC-CCHHHHHHH------
Q 042809 3 KGTGALFVVKSAESEA--GVQALRNEAEIRQSLNSPNIGR---------NGEKTVNIFMEYMAG-GSLLDVAEK------ 64 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~---------~~~~~~~lv~e~~~~-~~L~~~l~~------ 64 (241)
+-+|..|++|++...+ ....--.-+++++++.|+|+|+ ..+..+++|++|.++ ++|.++-..
T Consensus 298 ~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~ 377 (655)
T KOG3741|consen 298 NVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTK 377 (655)
T ss_pred ccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCcccc
Confidence 4578899999984322 1122334578899999999988 577889999999975 678775432
Q ss_pred --------hCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccc
Q 042809 65 --------FGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQ 130 (241)
Q Consensus 65 --------~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 130 (241)
.+....+..++.++.|+ +|+.|+.-+-|.|.+|+++.+.+++|+..|......+..
T Consensus 378 ~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~---------- 447 (655)
T KOG3741|consen 378 RTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP---------- 447 (655)
T ss_pred ccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC----------
Confidence 12346678888888776 799999999999999999998899998888775443310
Q ss_pred cccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHh
Q 042809 131 SIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKC 210 (241)
Q Consensus 131 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 210 (241)
. +.+.+ ..+-|.-.||.++..+.||..-....+......+ . ..-..++.++++++.-+
T Consensus 448 --------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~-~--------~I~~~yS~D~rn~v~yl 505 (655)
T KOG3741|consen 448 --------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHL-T--------RITTTYSTDLRNVVEYL 505 (655)
T ss_pred --------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHH-H--------HhhhhhhHHHHHHHHHH
Confidence 0 11111 2356999999999999998655322211111111 1 22345778899999999
Q ss_pred hccCCCCCCChHHHhcC
Q 042809 211 LERKPEKRWSAEELLNH 227 (241)
Q Consensus 211 l~~~p~~Rps~~~~l~~ 227 (241)
...++++ -++.+++.+
T Consensus 506 ~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 506 ESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HhcCccc-ccHHHHHHH
Confidence 9988887 588887754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.6e-08 Score=74.81 Aligned_cols=94 Identities=27% Similarity=0.344 Sum_probs=66.6
Q ss_pred HHHHHHHHHHHhhcCCCcc-----cc------cCCceeeeeecccCC-CCHHHHHHHhCCCCCHHHHHHHHHHH------
Q 042809 20 VQALRNEAEIRQSLNSPNI-----GR------NGEKTVNIFMEYMAG-GSLLDVAEKFGGTLDAGVIRLYTKEI------ 81 (241)
Q Consensus 20 ~~~~~~e~~~l~~l~h~~i-----~~------~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~------ 81 (241)
.....+|...+..|....| +. ......++|+|++++ .+|.+++..... .+......++.++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 3457788888887764444 22 122456899999987 489999986322 2222223333322
Q ss_pred hhcCCccccCCCCCcEEeecCC---CeeecCCCcch
Q 042809 82 LHGNGILHCDLKCNNVLLGSHG---DVKLPDLGCAR 114 (241)
Q Consensus 82 Lh~~~~vH~dl~p~Nil~~~~~---~~kl~dfg~~~ 114 (241)
||..|++|+|+++.|||++.++ .+.++||+-+.
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 8999999999999999998887 79999998775
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.58 E-value=9.7e-08 Score=71.42 Aligned_cols=55 Identities=20% Similarity=0.251 Sum_probs=39.6
Q ss_pred CcEEEEEeccchH---HHHHHHHHHHHHhhcCCCcc-----cc--cCC---ceeeeeecccCCCCHHH
Q 042809 6 GALFVVKSAESEA---GVQALRNEAEIRQSLNSPNI-----GR--NGE---KTVNIFMEYMAGGSLLD 60 (241)
Q Consensus 6 ~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i-----~~--~~~---~~~~lv~e~~~~~~L~~ 60 (241)
|+.+++|...... ....+.+|++++..+.+.++ +. ... +..++||||++|.++.+
T Consensus 22 g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~ 89 (223)
T cd05154 22 GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRD 89 (223)
T ss_pred CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCC
Confidence 5789999977543 35678999999999875443 22 221 36789999999887754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.1e-07 Score=69.92 Aligned_cols=92 Identities=25% Similarity=0.243 Sum_probs=63.7
Q ss_pred HHHHHHHHHHHhhcCCC--cccc-cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHH-HH--hhcCCccccCCC
Q 042809 20 VQALRNEAEIRQSLNSP--NIGR-NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTK-EI--LHGNGILHCDLK 93 (241)
Q Consensus 20 ~~~~~~e~~~l~~l~h~--~i~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~-~~--Lh~~~~vH~dl~ 93 (241)
.....+|.++|.+|... .|-+ ..-+.-.+|||+++|-.|...--. .-....+...++ .+ +-..|+||||++
T Consensus 153 Rl~A~rEf~~L~~L~~~G~~VP~P~~~nRHaVvMe~ieG~eL~~~r~~---~en~~~il~~il~~~~~~~~~GiVHGDlS 229 (304)
T COG0478 153 RLAAEREFEALQRLYPEGVKVPKPIAWNRHAVVMEYIEGVELYRLRLD---VENPDEILDKILEEVRKAYRRGIVHGDLS 229 (304)
T ss_pred HHHHHHHHHHHHHhhhcCCCCCCccccccceeeeehcccceeecccCc---ccCHHHHHHHHHHHHHHHHHcCccccCCc
Confidence 34467899999998755 3333 566677899999998777544311 122222222222 22 237999999999
Q ss_pred CCcEEeecCCCeeecCCCcch
Q 042809 94 CNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 94 p~Nil~~~~~~~kl~dfg~~~ 114 (241)
+.||+++.+|.+.++||-.+.
T Consensus 230 efNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 230 EFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred hheEEEecCCCEEEEeCcccc
Confidence 999999999999999996654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.4e-07 Score=76.90 Aligned_cols=95 Identities=24% Similarity=0.430 Sum_probs=69.3
Q ss_pred HHHHHHHHhhcC-----CCc-----ccccCCceeeeeecccCCCCHHHHHHHhCCCCCH-----HHHHHHHHHHhhcCCc
Q 042809 23 LRNEAEIRQSLN-----SPN-----IGRNGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA-----GVIRLYTKEILHGNGI 87 (241)
Q Consensus 23 ~~~e~~~l~~l~-----h~~-----i~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----~~~~~~~~~~Lh~~~~ 87 (241)
+.+|+..+.+++ .++ |..+....-.++|||++|..+.+...-.....+. .....++.|+++ .|+
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~-dgf 286 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLR-DGF 286 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHh-cCc
Confidence 446666666663 233 2336778889999999999998885433344442 223444556666 999
Q ss_pred cccCCCCCcEEeecCCCeeecCCCcchhhcc
Q 042809 88 LHCDLKCNNVLLGSHGDVKLPDLGCARRVND 118 (241)
Q Consensus 88 vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 118 (241)
+|+|.+|.||+++.+|++.+.|||++....+
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 9999999999999999999999999976544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.2e-06 Score=64.06 Aligned_cols=108 Identities=19% Similarity=0.209 Sum_probs=74.4
Q ss_pred cEEEEEecc--------chHHHHHHHHHHHHHhhcCCCccc-c----------cCCceeeeeecccCC-CCHHHHHHHhC
Q 042809 7 ALFVVKSAE--------SEAGVQALRNEAEIRQSLNSPNIG-R----------NGEKTVNIFMEYMAG-GSLLDVAEKFG 66 (241)
Q Consensus 7 ~~vaiK~~~--------~~~~~~~~~~e~~~l~~l~h~~i~-~----------~~~~~~~lv~e~~~~-~~L~~~l~~~~ 66 (241)
+.+-+|... -+.+...|.+|...+.+|..-+|- + .....-.||+|-++| .+|.+++....
T Consensus 42 ~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~ 121 (216)
T PRK09902 42 KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHA 121 (216)
T ss_pred cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCC
Confidence 456677643 134678899999999999754442 1 223457899997754 69999987632
Q ss_pred -CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCC--eeecCCCcch
Q 042809 67 -GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGD--VKLPDLGCAR 114 (241)
Q Consensus 67 -~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~--~kl~dfg~~~ 114 (241)
.+.+......++.++ ||..|+.|+|+.+.||+++.+|. +.++||.-+.
T Consensus 122 ~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 122 VSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 123333222333222 89999999999999999987777 8999997654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.20 E-value=9.1e-06 Score=72.22 Aligned_cols=200 Identities=22% Similarity=0.329 Sum_probs=125.4
Q ss_pred HHHHHHHHHHHHhhcCCCcccc--------cCCc-eeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHHH------hh
Q 042809 19 GVQALRNEAEIRQSLNSPNIGR--------NGEK-TVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LH 83 (241)
Q Consensus 19 ~~~~~~~e~~~l~~l~h~~i~~--------~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~------Lh 83 (241)
.......|...+.++.|+|++. ...+ ...+..++|...++.+.++. -+..+....+.+..++ +|
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHH
Confidence 3445567777888889999977 2222 34456789988899999887 4667777777776665 46
Q ss_pred cCCccccCCCCC---cEEeecCCCeeec--CCCcchhhcccccCCccccccccccCcccccCcccccccCCC--chhhHH
Q 042809 84 GNGILHCDLKCN---NVLLGSHGDVKLP--DLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD--FATDIW 156 (241)
Q Consensus 84 ~~~~vH~dl~p~---Nil~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~--~~~Di~ 156 (241)
+..+.|.-+..+ +--.+..+.+.++ ||+......+..... ...-+..+.++|........ ...|+|
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~-------~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF-------SDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCcccch-------hhcCccccccccccccccchhhhhhHHH
Confidence 554444433333 1122233445555 777776554421111 11224456677777655544 346999
Q ss_pred HHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 157 SLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 157 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
++|.+...+..|..+-... ...... .+........+...+|+.-++++|+++.+++.|+|.+.....
T Consensus 377 ~lgll~~~~~~~~~i~~~~--~~~~~~-----------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~ 443 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKS--AVPVSL-----------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDN 443 (1351)
T ss_pred HHHHHHhhhhhcCcccccc--cchhhh-----------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccc
Confidence 9999999998866553221 000000 111111156788899999999999999999999999877665
Q ss_pred CCC
Q 042809 237 NST 239 (241)
Q Consensus 237 ~~~ 239 (241)
.+.
T Consensus 444 ~~~ 446 (1351)
T KOG1035|consen 444 ESS 446 (1351)
T ss_pred ccc
Confidence 543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.3e-05 Score=66.77 Aligned_cols=77 Identities=21% Similarity=0.288 Sum_probs=54.4
Q ss_pred cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH-----HHHHHHhhcCCccccCCCCCcEEeec----CCCeeecCCC
Q 042809 41 NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR-----LYTKEILHGNGILHCDLKCNNVLLGS----HGDVKLPDLG 111 (241)
Q Consensus 41 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~-----~~~~~~Lh~~~~vH~dl~p~Nil~~~----~~~~kl~dfg 111 (241)
.......|+||||+|..+.+.-.-....++...+. .++.|++ ..|++|+|-+|.||+++. ++.+.+.|||
T Consensus 272 ~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf-~~GffHaDPHPGNilv~~~~~~~~~ivllDhG 350 (538)
T KOG1235|consen 272 DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIF-KTGFFHADPHPGNILVRPNPEGDEEIVLLDHG 350 (538)
T ss_pred hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHH-hcCCccCCCCCCcEEEecCCCCCccEEEEccc
Confidence 56668899999999987766543323334443332 2223444 467999999999999984 5679999999
Q ss_pred cchhhcc
Q 042809 112 CARRVND 118 (241)
Q Consensus 112 ~~~~~~~ 118 (241)
+.....+
T Consensus 351 l~~~is~ 357 (538)
T KOG1235|consen 351 LYAVISH 357 (538)
T ss_pred ccccccH
Confidence 9976544
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.3e-05 Score=56.60 Aligned_cols=105 Identities=25% Similarity=0.222 Sum_probs=76.1
Q ss_pred CCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc--cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHH--H
Q 042809 5 TGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR--NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTK--E 80 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~--~ 80 (241)
.|..+|+|+-+.++....+..|++++..+.-.++.+ ..-+.-.+.|||+.|.+|.+.-... +...+...+- -
T Consensus 44 ~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~~~~~~~----~rk~l~~vlE~a~ 119 (201)
T COG2112 44 RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLGKLEIGG----DRKHLLRVLEKAY 119 (201)
T ss_pred cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchhhhhhcc----cHHHHHHHHHHHH
Confidence 466899999998888899999999999999888776 2333344559999998998776641 2222222222 2
Q ss_pred HhhcCCccccCCCC--CcEEeecCCCeeecCCCcch
Q 042809 81 ILHGNGILHCDLKC--NNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 81 ~Lh~~~~vH~dl~p--~Nil~~~~~~~kl~dfg~~~ 114 (241)
.|-..||-|+.|.- .||++ .++.+.|+||+.++
T Consensus 120 ~LD~~GI~H~El~~~~k~vlv-~~~~~~iIDFd~At 154 (201)
T COG2112 120 KLDRLGIEHGELSRPWKNVLV-NDRDVYIIDFDSAT 154 (201)
T ss_pred HHHHhccchhhhcCCceeEEe-cCCcEEEEEccchh
Confidence 26788999998864 45555 55699999999886
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.9e-05 Score=58.32 Aligned_cols=108 Identities=14% Similarity=0.203 Sum_probs=66.2
Q ss_pred CcEEEEEeccchHHHHHHHHHHHHHhhcCC-----Ccccc--cCCceeeeeecccCCCC-HH--------------HHHH
Q 042809 6 GALFVVKSAESEAGVQALRNEAEIRQSLNS-----PNIGR--NGEKTVNIFMEYMAGGS-LL--------------DVAE 63 (241)
Q Consensus 6 ~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h-----~~i~~--~~~~~~~lv~e~~~~~~-L~--------------~~l~ 63 (241)
|..+++|............+|.+.+..+.. |.++. ...+..++|||+++|.+ +. ..+.
T Consensus 22 ~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la 101 (226)
T TIGR02172 22 TGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFA 101 (226)
T ss_pred CCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHH
Confidence 446778887754445667899999988753 33333 45666789999999863 11 1111
Q ss_pred H-----hCC---CCC------------------HHHHHHHHHHHhh----cCCccccCCCCCcEEeecCCCeeecCCCcc
Q 042809 64 K-----FGG---TLD------------------AGVIRLYTKEILH----GNGILHCDLKCNNVLLGSHGDVKLPDLGCA 113 (241)
Q Consensus 64 ~-----~~~---~~~------------------~~~~~~~~~~~Lh----~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~ 113 (241)
. +.. ... .......+..+|. ...++|+|++|.||+++.++ +.++||+.+
T Consensus 102 ~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a 180 (226)
T TIGR02172 102 EMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDF 180 (226)
T ss_pred HHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhc
Confidence 1 010 000 0011111222222 23478999999999998877 999999877
Q ss_pred h
Q 042809 114 R 114 (241)
Q Consensus 114 ~ 114 (241)
.
T Consensus 181 ~ 181 (226)
T TIGR02172 181 G 181 (226)
T ss_pred C
Confidence 4
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.03 E-value=2e-05 Score=58.79 Aligned_cols=93 Identities=16% Similarity=0.170 Sum_probs=56.4
Q ss_pred HHHHHHHhhcCCCcc-cc--cCCceeeeeecccCCC-CHHHHHHHhCCCC-CHHHHHHHHH----HHhhcCCccccCCCC
Q 042809 24 RNEAEIRQSLNSPNI-GR--NGEKTVNIFMEYMAGG-SLLDVAEKFGGTL-DAGVIRLYTK----EILHGNGILHCDLKC 94 (241)
Q Consensus 24 ~~e~~~l~~l~h~~i-~~--~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~-~~~~~~~~~~----~~Lh~~~~vH~dl~p 94 (241)
.+|..-|+++.-.+| ++ ..-..-.|||||+... .=.-.|+.-+... ....+...+. .+++..++||+||+.
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSE 195 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSE 195 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeecCCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchh
Confidence 356666777654443 11 3444667899999543 1111223211111 1111222222 225779999999999
Q ss_pred CcEEeecCCCeeecCCCcchhhc
Q 042809 95 NNVLLGSHGDVKLPDLGCARRVN 117 (241)
Q Consensus 95 ~Nil~~~~~~~kl~dfg~~~~~~ 117 (241)
.||++. ++.+.++|++.+....
T Consensus 196 yNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 196 YNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hheEEE-CCeEEEEECccccccC
Confidence 999998 8999999999886543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.81 E-value=8.2e-05 Score=56.60 Aligned_cols=54 Identities=19% Similarity=0.157 Sum_probs=36.6
Q ss_pred CcEEEEEeccchHHHHHHHHHHHHHhhcCC----Ccccc--cCCceeeeeecccCCCCHHH
Q 042809 6 GALFVVKSAESEAGVQALRNEAEIRQSLNS----PNIGR--NGEKTVNIFMEYMAGGSLLD 60 (241)
Q Consensus 6 ~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h----~~i~~--~~~~~~~lv~e~~~~~~L~~ 60 (241)
+..+++|...... ...+.+|+++++.+.. |.++. ..++..++|||+++|.+|..
T Consensus 22 ~~~~~vk~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 22 NPGLYLKIAPSGP-TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred CCcEEEEecCCCc-ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 3578888877543 4457788888888752 22222 33356789999999887764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00049 Score=52.04 Aligned_cols=30 Identities=27% Similarity=0.340 Sum_probs=25.1
Q ss_pred CCccccCCCCCcEEeecCCCeeecCCCcch
Q 042809 85 NGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
.+++|||+++.||+++.++...|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 458999999999999866556799998774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00014 Score=56.98 Aligned_cols=30 Identities=30% Similarity=0.370 Sum_probs=26.6
Q ss_pred CCccccCCCCCcEEeecCCCeeecCCCcch
Q 042809 85 NGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
.+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 579999999999999887777899998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00048 Score=50.43 Aligned_cols=89 Identities=20% Similarity=0.211 Sum_probs=61.5
Q ss_pred HHHHHHHHHHHHhhcC-CC-----cccc-----cCCceeeeeecccCC------CCHHHHHHHhCCCCCH--HHHHHHHH
Q 042809 19 GVQALRNEAEIRQSLN-SP-----NIGR-----NGEKTVNIFMEYMAG------GSLLDVAEKFGGTLDA--GVIRLYTK 79 (241)
Q Consensus 19 ~~~~~~~e~~~l~~l~-h~-----~i~~-----~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~--~~~~~~~~ 79 (241)
...+..+|+.....+. .. +|.+ +++.-..+|+|.+.. .||.+++.. ..++. ..+..-+.
T Consensus 54 ~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~~~~~~L~~f~ 131 (199)
T PF10707_consen 54 RYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTEELRQALDEFK 131 (199)
T ss_pred hhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccHHHHHHHHHHH
Confidence 4567788888887777 43 3433 666677888887742 378999975 33444 22333345
Q ss_pred HHhhcCCccccCCCCCcEEeecCC----CeeecC
Q 042809 80 EILHGNGILHCDLKCNNVLLGSHG----DVKLPD 109 (241)
Q Consensus 80 ~~Lh~~~~vH~dl~p~Nil~~~~~----~~kl~d 109 (241)
++|-+.+|+.+|++|.||++...+ .+.|+|
T Consensus 132 ~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 132 RYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 668899999999999999996543 366666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00023 Score=54.60 Aligned_cols=108 Identities=20% Similarity=0.265 Sum_probs=62.9
Q ss_pred CCcEEEEEeccchHHH--HHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHH--------------HHHH
Q 042809 5 TGALFVVKSAESEAGV--QALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLD--------------VAEK 64 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~--------------~l~~ 64 (241)
+|+.+++|........ -...+|.++++.+....+++ ... -++|+||++|.++.. .+..
T Consensus 18 ~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~--~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~ 95 (256)
T TIGR02721 18 PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE--HWLLVEWLEGEVITLDQFVALDLLLELAALLHQ 95 (256)
T ss_pred CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC--CEEEEEeccCcccccccccCchhHHHHHHHHHH
Confidence 4567888876543211 13578888888886433433 322 478999999866532 1111
Q ss_pred h-CC-----CCCHH-HHHHHHH----------------HHhh-------cCCccccCCCCCcEEeecCCCeeecCCCcch
Q 042809 65 F-GG-----TLDAG-VIRLYTK----------------EILH-------GNGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 65 ~-~~-----~~~~~-~~~~~~~----------------~~Lh-------~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
- .. +++.. .+..+.. .+.. ...++|+|+.|.||+++.++ +.++||+.+.
T Consensus 96 lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 96 LHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred HhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 1 11 11111 1111111 1111 13589999999999998877 7899998875
Q ss_pred h
Q 042809 115 R 115 (241)
Q Consensus 115 ~ 115 (241)
.
T Consensus 175 ~ 175 (256)
T TIGR02721 175 D 175 (256)
T ss_pred c
Confidence 3
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00053 Score=54.12 Aligned_cols=31 Identities=29% Similarity=0.349 Sum_probs=27.5
Q ss_pred cCCccccCCCCCcEEeecCCCeeecCCCcch
Q 042809 84 GNGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 84 ~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
..+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3789999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00028 Score=53.07 Aligned_cols=54 Identities=24% Similarity=0.319 Sum_probs=39.8
Q ss_pred cEEEEEeccchHHHHHHHHHHHHHhhcCCCc-----ccc-----cCCceeeeeecccCCCCHHH
Q 042809 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPN-----IGR-----NGEKTVNIFMEYMAGGSLLD 60 (241)
Q Consensus 7 ~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~-----i~~-----~~~~~~~lv~e~~~~~~L~~ 60 (241)
..+++|..........+.+|..++..+.... ++. ......+++|++++|.++..
T Consensus 21 ~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 21 GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence 5889999887756778889999988886333 332 23335789999999987776
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00014 Score=56.60 Aligned_cols=90 Identities=16% Similarity=0.137 Sum_probs=63.8
Q ss_pred HHHHHHHHhhcC-CCcccc--cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHHH---hhcCCccccCCCCCc
Q 042809 23 LRNEAEIRQSLN-SPNIGR--NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI---LHGNGILHCDLKCNN 96 (241)
Q Consensus 23 ~~~e~~~l~~l~-h~~i~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~---Lh~~~~vH~dl~p~N 96 (241)
..+|...|+.|. |---|+ .+-+.-++|||++.|-+|...-.- .+...+-.-+..+ |-..|++|||.+--|
T Consensus 157 a~kEfafmkaL~e~gfpVPkpiD~~RH~Vvmelv~g~Pl~~v~~v----~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFN 232 (465)
T KOG2268|consen 157 ATKEFAFMKALYERGFPVPKPIDHNRHCVVMELVDGYPLRQVRHV----EDPPTLYDDLMGLIVRLANHGLIHGDFNEFN 232 (465)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccccceeeHHHhhcccceeeeeec----CChHHHHHHHHHHHHHHHHcCceecccchhe
Confidence 457888888886 333344 667778999999998887654332 2222222222222 678999999999999
Q ss_pred EEeecCCCeeecCCCcchhh
Q 042809 97 VLLGSHGDVKLPDLGCARRV 116 (241)
Q Consensus 97 il~~~~~~~kl~dfg~~~~~ 116 (241)
|+++.++.++++||--+...
T Consensus 233 imv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 233 IMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred eEEecCCCEEEeechHhhcc
Confidence 99999999999999766543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00038 Score=54.77 Aligned_cols=30 Identities=30% Similarity=0.275 Sum_probs=26.4
Q ss_pred CCccccCCCCCcEEeecC----CCeeecCCCcch
Q 042809 85 NGILHCDLKCNNVLLGSH----GDVKLPDLGCAR 114 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~~----~~~kl~dfg~~~ 114 (241)
.+++|+|+.+.||+++.+ +.+.++||+.+.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 357999999999999875 889999998884
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.47 E-value=6.4e-05 Score=69.16 Aligned_cols=204 Identities=13% Similarity=-0.011 Sum_probs=126.9
Q ss_pred HHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhC---CCCCHHHHHHHHHH-H-----hh
Q 042809 20 VQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFG---GTLDAGVIRLYTKE-I-----LH 83 (241)
Q Consensus 20 ~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~-~-----Lh 83 (241)
.+....|...++...|+++.. ......|..++|+.+|.+++.+-+.- ..+...-+...-.+ + +|
T Consensus 1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 444556666666778888755 55667899999999999999887632 22222222211112 1 12
Q ss_pred c-----CCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhhHHHH
Q 042809 84 G-----NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSL 158 (241)
Q Consensus 84 ~-----~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl 158 (241)
+ .--+|+++++.|.++..+..++++++|+.+...+. ....+...+++-|+++++...-.++.++|+|..
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~------~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~ 1426 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV------LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRR 1426 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCch------HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHH
Confidence 1 22589999999999999999999999999732221 122234456777888998888888888999999
Q ss_pred HHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 159 GCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 159 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
|+.+|....|..+|-............. +.....+.-.|.+.-.+...++-.....||.-...+..+.+..
T Consensus 1427 s~~ly~rs~~n~~fi~flq~~Lkgiidn---~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYFIFFLQPALKGIIDN---HTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred HHHHHHHhcccHHHHHHHHHHHcCcccc---cccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 9999998888777643211111111111 1111222222333434444444555667777777666665543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.40 E-value=1.9e-05 Score=66.19 Aligned_cols=187 Identities=26% Similarity=0.272 Sum_probs=112.7
Q ss_pred HHHHHHHHHhhcCCCc-ccc-----cCCceeeeeecccCCC-CHHHHHHHhCCCCCHHHHHHHHH-----------HHhh
Q 042809 22 ALRNEAEIRQSLNSPN-IGR-----NGEKTVNIFMEYMAGG-SLLDVAEKFGGTLDAGVIRLYTK-----------EILH 83 (241)
Q Consensus 22 ~~~~e~~~l~~l~h~~-i~~-----~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~-----------~~Lh 83 (241)
..+-++++|.+++||| .+. +.+...+++++++.++ +...-+. .++.....+.. ..+|
T Consensus 279 ~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~-----~se~~~~~~~~~~~~r~et~~l~~l~ 353 (829)
T KOG0576|consen 279 SRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMT-----VSEIALEQYQFAYPLRKETRPLAELH 353 (829)
T ss_pred hhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCC-----hhhHhhhhhhhhhhhhhhcccccccc
Confidence 3556789999999999 554 6677899999999776 2111110 11111111111 2245
Q ss_pred cCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhhHHHHHHHHH
Q 042809 84 GNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163 (241)
Q Consensus 84 ~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 163 (241)
+.--+|+| ||+. ..+..+..+|+......... ......+++.++|||......+....|.|++|.-..
T Consensus 354 ~~~~~~~d----~~l~-s~~~~~~~~~~v~~~L~~~~-------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~ 421 (829)
T KOG0576|consen 354 SSYKVHRD----NILG-SEEEVKLLDFAVPPQLTRTM-------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAI 421 (829)
T ss_pred cccccCcc----cccc-cccccccccccCCcccCccc-------ccccCCCCCCCCCchhhcccccccCCCccCCCcchh
Confidence 55456776 6666 44788999999886554421 223456899999999999888888999999998766
Q ss_pred HHHhCCCCCccchhchHHHHHHHHhcCCCCCCCh------hhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 164 EMATGRPPWGDKISNAAATLLKIACSNEKPHFPT------QFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 164 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
++.-|-+|-......- ...+..+..+. +.+..-.++...|+...|..|+....++-|.+|.+
T Consensus 422 ~~ap~~pPr~~P~~~~-------~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 422 QMAPGLPPRSSPPAVL-------PMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred hcCCCCCCCCCCcccc-------CCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 6666666643210000 00000000000 00011123566688888888888888887777755
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.008 Score=43.76 Aligned_cols=92 Identities=21% Similarity=0.168 Sum_probs=62.6
Q ss_pred HHHHHHHhhcCC-Ccccc-cCCceeeeeecccCCCCHHHH---HHHhCCCCCHHHHHHHHHHHh------hc---CCccc
Q 042809 24 RNEAEIRQSLNS-PNIGR-NGEKTVNIFMEYMAGGSLLDV---AEKFGGTLDAGVIRLYTKEIL------HG---NGILH 89 (241)
Q Consensus 24 ~~e~~~l~~l~h-~~i~~-~~~~~~~lv~e~~~~~~L~~~---l~~~~~~~~~~~~~~~~~~~L------h~---~~~vH 89 (241)
.+|.-++..+++ +++.+ .+.....+|+||...+++... +.. -...++.....++.++| +. ..+.-
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~l 85 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGRFYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLGFFYL 85 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCCEEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEE
Confidence 457788888886 45655 444456678899987655321 111 11245666666666664 11 33778
Q ss_pred cCCCCCcEEeecCCCeeecCCCcchhh
Q 042809 90 CDLKCNNVLLGSHGDVKLPDLGCARRV 116 (241)
Q Consensus 90 ~dl~p~Nil~~~~~~~kl~dfg~~~~~ 116 (241)
.|++++|+-++.+|++|++|.+.+...
T Consensus 86 cDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 86 CDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred eecchHHeEEeCCCcEEEEechhcchh
Confidence 899999999999999999999988654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0024 Score=52.95 Aligned_cols=160 Identities=23% Similarity=0.272 Sum_probs=94.3
Q ss_pred HHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHHHhhcCCccccCCCC
Q 042809 21 QALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHGNGILHCDLKC 94 (241)
Q Consensus 21 ~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~Lh~~~~vH~dl~p 94 (241)
..+.-...+++.+.|+|... ..-....+|+|+++ .+|.+++..+. +.... ++ ..++.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~--l~~~s-------~~-~~~~~~----- 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN--LKDES-------LL-AHGVLH----- 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc--cchhh-------hc-ccccce-----
Confidence 44556678889999999854 33345889999994 69999998732 11111 11 222222
Q ss_pred CcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCcc
Q 042809 95 NNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGD 174 (241)
Q Consensus 95 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 174 (241)
-|++ +.+| .++... ... ..+++|||++|.++.++.-|..-+..
T Consensus 91 ~~~~-------~~td-~~~t~~-------------~~~----------------~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 91 LNII-------YITD-HFLTKY-------------PSP----------------IGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred ehhh-------hccc-cccccC-------------CCC----------------CCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 2222 2233 111100 001 11489999999999999988776654
Q ss_pred chhchHHHHHHHHhcCCCC--------CCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCC
Q 042809 175 KISNAAATLLKIACSNEKP--------HFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~ 233 (241)
.........+......... .+-...+..+..+...|+-..|..||...++..++-|...
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 3332222221111110000 1112344567889999999999999999999998877543
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.002 Score=51.28 Aligned_cols=88 Identities=18% Similarity=0.217 Sum_probs=57.0
Q ss_pred HHHHHHHhhcCCCcccc---cCCceeeeeecccCCCC-HHHHHHHhCCCCCHHHHHHHHHH-------HhhcCCccccCC
Q 042809 24 RNEAEIRQSLNSPNIGR---NGEKTVNIFMEYMAGGS-LLDVAEKFGGTLDAGVIRLYTKE-------ILHGNGILHCDL 92 (241)
Q Consensus 24 ~~e~~~l~~l~h~~i~~---~~~~~~~lv~e~~~~~~-L~~~l~~~~~~~~~~~~~~~~~~-------~Lh~~~~vH~dl 92 (241)
..|.+-|++|....|-. ..-..-.|||+++.+.. -.-.|+. ..++...+..+-++ +-+..++||.||
T Consensus 214 EKE~RNLkRl~~aGIP~PePIlLk~hVLVM~FlGrdgw~aPkLKd--~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADL 291 (520)
T KOG2270|consen 214 EKEMRNLKRLNNAGIPCPEPILLKNHVLVMEFLGRDGWAAPKLKD--ASLSTSKARELYQQCVRIMRRLYQKCRLVHADL 291 (520)
T ss_pred HHHHHHHHHHHhcCCCCCCceeeecceEeeeeccCCCCcCccccc--ccCChHHHHHHHHHHHHHHHHHHHHhceeccch
Confidence 46777788887666432 22234568999995322 1222332 33444444433332 238899999999
Q ss_pred CCCcEEeecCCCeeecCCCcch
Q 042809 93 KCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 93 ~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
.-.|+++ .+|.+.++|.+-+.
T Consensus 292 SEfN~Ly-hdG~lyiIDVSQSV 312 (520)
T KOG2270|consen 292 SEFNLLY-HDGKLYIIDVSQSV 312 (520)
T ss_pred hhhhheE-ECCEEEEEEccccc
Confidence 9999999 88999999987765
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0062 Score=47.25 Aligned_cols=30 Identities=10% Similarity=0.144 Sum_probs=24.9
Q ss_pred CCcEEEEEeccchHHHHHHHHHHHHHhhcC
Q 042809 5 TGALFVVKSAESEAGVQALRNEAEIRQSLN 34 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~ 34 (241)
.|..+++|..........+.+|++++..+.
T Consensus 34 ~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~ 63 (276)
T cd05152 34 DGVPWVLRIPRRPDVSERAAAEKRVLALVR 63 (276)
T ss_pred CCCeEEEEecCCHHHHHHHHHHHHHHHHHH
Confidence 477888998887666778899999999886
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.011 Score=54.25 Aligned_cols=31 Identities=26% Similarity=0.400 Sum_probs=26.0
Q ss_pred CCccccCCCCCcEEeecCC--Ce-eecCCCcchh
Q 042809 85 NGILHCDLKCNNVLLGSHG--DV-KLPDLGCARR 115 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~~~--~~-kl~dfg~~~~ 115 (241)
.+++|+|+++.||+++.++ .+ -|+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5699999999999998875 44 4999998764
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.013 Score=46.55 Aligned_cols=28 Identities=36% Similarity=0.469 Sum_probs=25.2
Q ss_pred ccccCCCCCcEEeecCCC-eeecCCCcch
Q 042809 87 ILHCDLKCNNVLLGSHGD-VKLPDLGCAR 114 (241)
Q Consensus 87 ~vH~dl~p~Nil~~~~~~-~kl~dfg~~~ 114 (241)
++|+|+.|.||+++.+.. ..++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999988875 8899998774
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.039 Score=41.29 Aligned_cols=52 Identities=23% Similarity=0.324 Sum_probs=38.4
Q ss_pred cEEEEEeccchHHHHHHHHHHHHHhhcCCCc------ccc--cCCceeeeeecccCCCCHH
Q 042809 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPN------IGR--NGEKTVNIFMEYMAGGSLL 59 (241)
Q Consensus 7 ~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~------i~~--~~~~~~~lv~e~~~~~~L~ 59 (241)
..+.+|+-..+. ...|..|+.-|..|.-.| ++. ....+.|+|+||++-+.+.
T Consensus 40 ~~~FvK~n~~~~-~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 40 DPFFVKCNQREQ-LSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cceEEEecchhh-HHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 567788766554 577888988888776444 333 7788999999999877664
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.004 Score=49.38 Aligned_cols=30 Identities=30% Similarity=0.360 Sum_probs=25.8
Q ss_pred CCccccCCCCCcEEeecCCCeeecCCCcch
Q 042809 85 NGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
.+++|+|++|.||+++.+....|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 479999999999999866556899999885
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.0045 Score=44.74 Aligned_cols=29 Identities=28% Similarity=0.439 Sum_probs=25.1
Q ss_pred CccccCCCCCcEEeecCCCeeecCCCcchh
Q 042809 86 GILHCDLKCNNVLLGSHGDVKLPDLGCARR 115 (241)
Q Consensus 86 ~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~ 115 (241)
..+|+|+.|.|++++.+| ++++||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 468999999999997776 89999998853
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.0037 Score=47.20 Aligned_cols=30 Identities=27% Similarity=0.305 Sum_probs=26.4
Q ss_pred CCccccCCCCCcEEeec-CCCeeecCCCcch
Q 042809 85 NGILHCDLKCNNVLLGS-HGDVKLPDLGCAR 114 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~-~~~~kl~dfg~~~ 114 (241)
.+++|+|+.+.||+++. ++.+.++||..+.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 46899999999999997 5789999998774
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.054 Score=42.56 Aligned_cols=51 Identities=18% Similarity=0.056 Sum_probs=34.4
Q ss_pred EEEEEeccchHHHHHHHHHHHHHhhcCC------Ccccc-----cCCceeeeeecccCCCCH
Q 042809 8 LFVVKSAESEAGVQALRNEAEIRQSLNS------PNIGR-----NGEKTVNIFMEYMAGGSL 58 (241)
Q Consensus 8 ~vaiK~~~~~~~~~~~~~e~~~l~~l~h------~~i~~-----~~~~~~~lv~e~~~~~~L 58 (241)
.+++|..+.......+.+|++.++.|.- |.++. ...+..++|||+++|+++
T Consensus 39 ~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 39 NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 4667775542244688999999987753 33332 224668999999998754
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.033 Score=43.48 Aligned_cols=52 Identities=23% Similarity=0.351 Sum_probs=32.3
Q ss_pred CCCcEEEEEeccchHHHHHHHHHHHHHhhcC--CCcccc------cCCceeeeeecccCCC
Q 042809 4 GTGALFVVKSAESEAGVQALRNEAEIRQSLN--SPNIGR------NGEKTVNIFMEYMAGG 56 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~--h~~i~~------~~~~~~~lv~e~~~~~ 56 (241)
.+++.+.+|.-. ......|..|++-|+.|. .+-.++ ...+.-++|+||++.+
T Consensus 38 ~~~~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 38 TDGGSYFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp TTS-EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred CCCccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 467889999887 545678999999999884 333232 3445569999999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.083 Score=47.70 Aligned_cols=32 Identities=19% Similarity=0.365 Sum_probs=25.5
Q ss_pred CCccccCCCCCcEEeecC-CC-eeecCCCcchhh
Q 042809 85 NGILHCDLKCNNVLLGSH-GD-VKLPDLGCARRV 116 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~~-~~-~kl~dfg~~~~~ 116 (241)
..++|+|+++.||+++.+ +. .-|.||+++..-
T Consensus 225 ~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 225 TGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred cceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 359999999999999863 33 579999988643
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.0054 Score=45.53 Aligned_cols=30 Identities=37% Similarity=0.478 Sum_probs=21.3
Q ss_pred CCccccCCCCCcEEe-ecCCCeeecCCCcch
Q 042809 85 NGILHCDLKCNNVLL-GSHGDVKLPDLGCAR 114 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~-~~~~~~kl~dfg~~~ 114 (241)
..++|+|+.+.||++ +.++.++++||..+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 357899999999999 888999999999885
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.061 Score=43.81 Aligned_cols=61 Identities=23% Similarity=0.235 Sum_probs=41.7
Q ss_pred CCceeeeeecccCCCCHHHHHHHhCCC--CCHHHHHHHHHHH---hhcCCccccCCCCCcEEeecC
Q 042809 42 GEKTVNIFMEYMAGGSLLDVAEKFGGT--LDAGVIRLYTKEI---LHGNGILHCDLKCNNVLLGSH 102 (241)
Q Consensus 42 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~---Lh~~~~vH~dl~p~Nil~~~~ 102 (241)
......++-+|..|-++..+++..+++ +....+...+.++ |--.+++|.|++|.||++-.+
T Consensus 316 ~~~~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 316 LHTDLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ccccceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 344556778899999999999875444 2222333333333 456889999999999999544
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.0089 Score=46.14 Aligned_cols=31 Identities=32% Similarity=0.246 Sum_probs=27.9
Q ss_pred CCccccCCCCCcEEeecCCCeeecCCCcchh
Q 042809 85 NGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~ 115 (241)
.-++|+|+.|.|++.+..|.++|+||..|..
T Consensus 153 ~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 153 LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred eeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 3589999999999999999999999998863
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.017 Score=45.66 Aligned_cols=29 Identities=28% Similarity=0.455 Sum_probs=25.4
Q ss_pred CCccccCCCCCcEEeecCCCeeecCCCcch
Q 042809 85 NGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
.+++|||+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57899999999999987 678999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.029 Score=44.86 Aligned_cols=74 Identities=16% Similarity=0.194 Sum_probs=49.4
Q ss_pred CCcccc-cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHH---HHhh----cCCccccCCCCCcEEeecCCCee
Q 042809 35 SPNIGR-NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTK---EILH----GNGILHCDLKCNNVLLGSHGDVK 106 (241)
Q Consensus 35 h~~i~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~---~~Lh----~~~~vH~dl~p~Nil~~~~~~~k 106 (241)
.+.+++ ......|++|++- |++|...-.. ..+.+..++. .++| ...+-|||++..||+++ +|.+-
T Consensus 289 ~~~vv~~de~~y~yl~~kdh-gt~is~ik~~-----~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gnvt 361 (488)
T COG5072 289 TLKVVSLDETLYLYLHFKDH-GTPISIIKAD-----RSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVT 361 (488)
T ss_pred cceEEecCCceEEEEEEecC-Cceeeeeecc-----cHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceE
Confidence 344555 5666788888887 5566433222 2333333332 3344 34578999999999998 99999
Q ss_pred ecCCCcchh
Q 042809 107 LPDLGCARR 115 (241)
Q Consensus 107 l~dfg~~~~ 115 (241)
|+||.++..
T Consensus 362 LIDfklsRl 370 (488)
T COG5072 362 LIDFKLSRL 370 (488)
T ss_pred EEEeeeeec
Confidence 999999873
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.83 E-value=0.013 Score=46.34 Aligned_cols=30 Identities=13% Similarity=0.124 Sum_probs=27.3
Q ss_pred CCccccCCCCCcEEeecCCCeeecCCCcch
Q 042809 85 NGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
.+++|+|+.++|++++.++.+.++||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 369999999999999999999999998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.12 Score=38.57 Aligned_cols=81 Identities=19% Similarity=0.181 Sum_probs=54.4
Q ss_pred HHHHHHHHHHhhcCCCcccc---cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH--HHHHHhh--cCCccccCCC
Q 042809 21 QALRNEAEIRQSLNSPNIGR---NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL--YTKEILH--GNGILHCDLK 93 (241)
Q Consensus 21 ~~~~~e~~~l~~l~h~~i~~---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~--~~~~~Lh--~~~~vH~dl~ 93 (241)
..+.++.+++.++. .|++ .+...+.++.|.|--... .....+.. -.+...| ..+.+|||-+
T Consensus 103 ~~y~nky~v~Armh--GilrL~NDn~~~yGvIlE~Cy~~~i----------~~~N~i~agi~~L~~fH~~~~~~lHGD~n 170 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKNDNNYKYGVILERCYKIKI----------NFSNFITAGIKDLMDFHSENQHCLHGDCN 170 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecCCCceeEEEEeeccCccc----------chhHHHHHhHHHHHHhhccCCCeecCCCC
Confidence 45677888877764 3444 566678899999953211 11111111 1223357 3679999999
Q ss_pred CCcEEeecCCCeeecCCCcc
Q 042809 94 CNNVLLGSHGDVKLPDLGCA 113 (241)
Q Consensus 94 p~Nil~~~~~~~kl~dfg~~ 113 (241)
|+||+-|..|-+||.|-+..
T Consensus 171 p~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 171 PDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred hhheeecCCCCEEecChhhh
Confidence 99999999999999997644
|
The function of this family is unknown. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.43 E-value=0.026 Score=45.31 Aligned_cols=31 Identities=23% Similarity=0.388 Sum_probs=26.5
Q ss_pred CCccccCCCCCcEEeec-CCCeeecCCCcchh
Q 042809 85 NGILHCDLKCNNVLLGS-HGDVKLPDLGCARR 115 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~-~~~~kl~dfg~~~~ 115 (241)
..++|+|+++.||+++. ++.+.++||+.+..
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 46899999999999986 46799999998853
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=94.33 E-value=0.029 Score=41.17 Aligned_cols=31 Identities=32% Similarity=0.354 Sum_probs=25.5
Q ss_pred cCCccccCCCCCcEEeecCC-----CeeecCCCcch
Q 042809 84 GNGILHCDLKCNNVLLGSHG-----DVKLPDLGCAR 114 (241)
Q Consensus 84 ~~~~vH~dl~p~Nil~~~~~-----~~kl~dfg~~~ 114 (241)
...++|||+.+.||++..++ .+.++||..+.
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 35689999999999997654 58999998774
|
subfamily of choline kinases |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=93.95 E-value=0.042 Score=43.89 Aligned_cols=29 Identities=24% Similarity=0.399 Sum_probs=25.4
Q ss_pred ccccCCCCCcEEeec-CCCeeecCCCcchh
Q 042809 87 ILHCDLKCNNVLLGS-HGDVKLPDLGCARR 115 (241)
Q Consensus 87 ~vH~dl~p~Nil~~~-~~~~kl~dfg~~~~ 115 (241)
++|+|+.+.||+++. ++.++++||+.+..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 789999999999975 47899999998853
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.46 E-value=0.057 Score=42.62 Aligned_cols=32 Identities=16% Similarity=0.153 Sum_probs=28.5
Q ss_pred CCccccCCCCCcEEeecCCCeeecCCCcchhh
Q 042809 85 NGILHCDLKCNNVLLGSHGDVKLPDLGCARRV 116 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~ 116 (241)
-.++|||+++.|++++..+.+-++||+++..-
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 45899999999999999988999999998743
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=92.96 E-value=0.14 Score=40.80 Aligned_cols=46 Identities=22% Similarity=0.288 Sum_probs=30.8
Q ss_pred HHHHHHHHHHHh----------hcCCccccCCCCCcEEeecCC------------------CeeecCCCcchhh
Q 042809 71 AGVIRLYTKEIL----------HGNGILHCDLKCNNVLLGSHG------------------DVKLPDLGCARRV 116 (241)
Q Consensus 71 ~~~~~~~~~~~L----------h~~~~vH~dl~p~Nil~~~~~------------------~~kl~dfg~~~~~ 116 (241)
..-++.+++|+. .-...+|.||||+|||+=+.. ..+|.||+.+...
T Consensus 274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 344566667661 235689999999999993322 1567788777643
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.89 E-value=0.12 Score=41.01 Aligned_cols=32 Identities=28% Similarity=0.342 Sum_probs=22.6
Q ss_pred CHHHHHHHHHHHh----------hcCCccccCCCCCcEEeec
Q 042809 70 DAGVIRLYTKEIL----------HGNGILHCDLKCNNVLLGS 101 (241)
Q Consensus 70 ~~~~~~~~~~~~L----------h~~~~vH~dl~p~Nil~~~ 101 (241)
-..-++.+++|++ .-..++|.||||+||++=+
T Consensus 277 ~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd 318 (444)
T PHA03111 277 LVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFD 318 (444)
T ss_pred HHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEec
Confidence 3444666677762 1356899999999999943
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.59 E-value=0.064 Score=42.77 Aligned_cols=28 Identities=32% Similarity=0.248 Sum_probs=23.8
Q ss_pred CCccccCCCCCcEEeecCCCeeecCCCcch
Q 042809 85 NGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
.+++|+|+.+.||+++ + .+.++||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4689999999999994 4 57899998874
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=92.38 E-value=0.09 Score=42.28 Aligned_cols=31 Identities=26% Similarity=0.433 Sum_probs=25.1
Q ss_pred hcCCccccCCCCCcEEeecCCCeeecCCCcch
Q 042809 83 HGNGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 83 h~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
+...++|||+.+.||+++.+ .++++|+..+.
T Consensus 190 ~~~~llHGDl~~gNi~~~~~-~~~~iD~e~~~ 220 (370)
T TIGR01767 190 SAETLLHGDLHSGSIFVSEH-ETKVIDPEFAF 220 (370)
T ss_pred CcceeeeccCCcccEEEcCC-CCEEEcCcccc
Confidence 34678999999999999665 47799998664
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 241 | ||||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-30 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-30 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-30 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-30 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-29 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-29 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-29 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-28 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-28 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-28 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-28 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-27 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-27 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-27 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-27 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-27 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-27 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-25 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-24 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-24 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-24 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-23 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-23 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-22 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-21 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-21 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-21 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-20 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-20 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-20 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-18 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-18 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-18 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-18 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-18 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-18 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-18 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-18 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-18 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-17 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-17 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-17 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-17 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-17 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-17 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-17 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-17 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-17 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-17 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-17 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-17 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-17 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-17 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-17 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-17 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-17 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-17 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-17 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-17 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-17 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-17 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-17 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-16 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-16 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-16 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-16 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-16 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-16 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-16 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-16 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-16 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-16 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-16 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-15 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-15 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-15 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-13 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-11 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-11 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-11 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 9e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-08 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-08 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-08 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-08 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-08 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-08 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-08 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-08 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-08 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-08 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-08 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-08 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-08 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-08 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 7e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 7e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 7e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 8e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 8e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-06 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 8e-06 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 8e-06 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 8e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-06 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-06 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 9e-06 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 9e-06 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-05 |
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 9e-87
Identities = 78/258 (30%), Positives = 119/258 (46%), Gaps = 25/258 (9%)
Query: 1 MNKGTGALFVVK--SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYM 53
+ +K Q L E + + L NI + + + IFME +
Sbjct: 42 RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101
Query: 54 AGGSLLDVAEKFGGTLDAG--VIRLYTKEI------LHGNGILHCDLKCNNVLLGSH-GD 104
GGSL + G L I YTK+I LH N I+H D+K +NVL+ ++ G
Sbjct: 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV 161
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR--NEGLDFATDIWSLGCMV 162
+K+ D G ++R+ + + GT +MAPE++ G A DIWSLGC +
Sbjct: 162 LKISDFGTSKRLAGINPCTE------TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTI 215
Query: 163 IEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222
IEMATG+PP+ + + A + K+ P P + F+ KC E P+KR A
Sbjct: 216 IEMATGKPPFYE-LGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACAN 274
Query: 223 ELLNHTFISGNAKKNSTE 240
+LL F+ ++KK T+
Sbjct: 275 DLLVDEFLKVSSKKKKTQ 292
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 3e-77
Identities = 75/245 (30%), Positives = 96/245 (39%), Gaps = 22/245 (8%)
Query: 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAG 55
+K TG VK E E L+SP I VNIFME + G
Sbjct: 78 KDKQTGFQCAVKKVRLE---VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134
Query: 56 GSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG-DVKLP 108
GSL + ++ G L Y + LH ILH D+K +NVLL S G L
Sbjct: 135 GSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALC 193
Query: 109 DLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATG 168
D G A + +L I GT+ MAPEV+ + D DIWS CM++ M G
Sbjct: 194 DFGHALCLQPDGLGKSLLTG-DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252
Query: 169 RPPWGDKISNAAATLLKIACSNEKPHF--PTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226
PW LKIA S P P + + L ++P R SA EL
Sbjct: 253 CHPWTQY--FRGPLCLKIA-SEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRR 309
Query: 227 HTFIS 231
+
Sbjct: 310 KVGKA 314
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 1e-70
Identities = 64/252 (25%), Positives = 114/252 (45%), Gaps = 33/252 (13%)
Query: 1 MNKGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNI---------GRNGEKTVN 47
++ T +++ Q + EAE+ + L PNI G+K +
Sbjct: 46 LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105
Query: 48 IFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHG--------NGILHCDLKCNNVLL 99
+ E M G+L ++F + V+R + ++IL G I+H DLKC+N+ +
Sbjct: 106 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 164
Query: 100 -GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSL 158
G G VK+ DLG A +++ GT +MAPE+ E D + D+++
Sbjct: 165 TGPTGSVKIGDLGLATLKRASFA--------KAVIGTPEFMAPEMY-EEKYDESVDVYAF 215
Query: 159 GCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
G ++EMAT P+ + NAA ++ + F +V + + C+ + ++R
Sbjct: 216 GMCMLEMATSEYPYSE-CQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 274
Query: 219 WSAEELLNHTFI 230
+S ++LLNH F
Sbjct: 275 YSIKDLLNHAFF 286
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 6e-61
Identities = 60/261 (22%), Positives = 101/261 (38%), Gaps = 27/261 (10%)
Query: 1 MNKGTGALFVVK-----SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFM 50
G +K E ++ + LN PN+ + + +NI +
Sbjct: 52 ACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111
Query: 51 EYMAGGSLLDVAEKF---GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS 101
E G L + + F + + Y ++ +H ++H D+K NV + +
Sbjct: 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA 171
Query: 102 HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCM 161
G VKL DLG R + S GT +M+PE + G +F +DIWSLGC+
Sbjct: 172 TGVVKLGDLGLGRF---FSSKTTAAHSLV---GTPYYMSPERIHENGYNFKSDIWSLGCL 225
Query: 162 VIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVL-DFLAKCLERKPEKRWS 220
+ EMA + P+ N + KI + P P+ + + L + C+ PEKR
Sbjct: 226 LYEMAALQSPFYGDKMNLYSLCKKI-EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPD 284
Query: 221 AEELLNHTFISGNAKKNSTEE 241
+ + +S E
Sbjct: 285 VTYVYDVAKRMHACTASSLEH 305
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 7e-61
Identities = 54/246 (21%), Positives = 87/246 (35%), Gaps = 30/246 (12%)
Query: 1 MNKGTGALFVVK----SAESEAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFM 50
+K G L+ VK E + + P R + +
Sbjct: 77 RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136
Query: 51 EYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGD 104
E G SL E +G +L + Y ++ LH G++H D+K N+ LG G
Sbjct: 137 EL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR 195
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIE 164
KL D G + + + G +MAPE+L A D++SLG ++E
Sbjct: 196 CKLGDFGLLVELGT-------AGAGEVQEGDPRYMAPELL-QGSYGTAADVFSLGLTILE 247
Query: 165 MATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
+A + ++ P F ++ L LE P+ R +AE L
Sbjct: 248 VACNMELP-----HGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302
Query: 225 LNHTFI 230
L +
Sbjct: 303 LALPVL 308
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 6e-60
Identities = 81/259 (31%), Positives = 119/259 (45%), Gaps = 37/259 (14%)
Query: 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGRNGEKTVN------------I 48
++K TG + +K E+ +Q + E I Q +SP++ V I
Sbjct: 49 IHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHV-------VKYYGSYFKNTDLWI 101
Query: 49 FMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH 102
MEY GS+ D+ TL I + LH +H D+K N+LL +
Sbjct: 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE 161
Query: 103 GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMV 162
G KL D G A ++ D N ++ GT WMAPEV++ G + DIWSLG
Sbjct: 162 GHAKLADFGVAGQLTDTMAKRN------TVIGTPFWMAPEVIQEIGYNCVADIWSLGITA 215
Query: 163 IEMATGRPPWGDKISNAAATLLKIACSNEKPHF--PTQFFKKVLDFLAKCLERKPEKRWS 220
IEMA G+PP+ D + + I +N P F P + DF+ +CL + PE+R +
Sbjct: 216 IEMAEGKPPYADI--HPMRAIFMIP-TNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRAT 272
Query: 221 AEELLNHTFISGNAKKNST 239
A +LL H F+ +AK S
Sbjct: 273 ATQLLQHPFVR-SAKGVSI 290
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 9e-60
Identities = 86/253 (33%), Positives = 123/253 (48%), Gaps = 27/253 (10%)
Query: 1 MNKGTGALFVVKS---AESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFME 51
++ T + +K E+E ++ ++ E + +SP + + K + I ME
Sbjct: 42 IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK-LWIIME 100
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDV 105
Y+ GGS LD+ E G LD I +EIL H +H D+K NVLL HG+V
Sbjct: 101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEV 158
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
KL D G A ++ D + N + GT WMAPEV++ D DIWSLG IE+
Sbjct: 159 KLADFGVAGQLTDTQIKRN------TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 212
Query: 166 ATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
A G PP + + L I N P + K + +F+ CL ++P R +A+ELL
Sbjct: 213 ARGEPPHSEL--HPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELL 269
Query: 226 NHTFISGNAKKNS 238
H FI NAKK S
Sbjct: 270 KHKFILRNAKKTS 282
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 8e-59
Identities = 67/263 (25%), Positives = 107/263 (40%), Gaps = 38/263 (14%)
Query: 9 FVVKSAESEAGVQALRNEAEIRQSLNSPNIG-------RNGEKTVNIFMEYMAGGSLLDV 61
+V + + RNE L + ++ + + ME L
Sbjct: 59 YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSW 117
Query: 62 AEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115
+K ++D + Y K +L H +GI+H DLK N L+ G +KL D G A +
Sbjct: 118 LKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQ 175
Query: 116 VNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG-----------LDFATDIWSLGCMVIE 164
+ + S GT +M PE +++ + +D+WSLGC++
Sbjct: 176 MQPDTTSVVKD----SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231
Query: 165 MATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
M G+ P+ I N + L I N + FP K + D L CL+R P++R S EL
Sbjct: 232 MTYGKTPFQQ-IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
Query: 225 LNHTFISGNAK------KNSTEE 241
L H ++ K +TEE
Sbjct: 291 LAHPYVQIQTHPVNQMAKGTTEE 313
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 9e-59
Identities = 49/275 (17%), Positives = 90/275 (32%), Gaps = 55/275 (20%)
Query: 1 MNKGTGALFVVK----SAESEAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFM 50
+ + G ++ +K Q E L ++ R + + I
Sbjct: 31 VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90
Query: 51 EYMAGGSLLDV---AEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS 101
EY GGSL D + ++ ++ +H ++H D+K +N+ +
Sbjct: 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISR 150
Query: 102 HGD-------------------VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142
K+ DLG R++ Q G ++A E
Sbjct: 151 TSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----------QVEEGDSRFLANE 200
Query: 143 VLR-NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFK 201
VL+ N DI++L V+ A P +I P P +
Sbjct: 201 VLQENYTHLPKADIFALALTVVCAAGAEPLP-----RNGDQWHEI-RQGRLPRIPQVLSQ 254
Query: 202 KVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236
+ + L + PE+R SA L+ H+ + ++K
Sbjct: 255 EFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-58
Identities = 63/254 (24%), Positives = 103/254 (40%), Gaps = 32/254 (12%)
Query: 9 FVVKSAESEAGVQALRNEAEIRQSLNSPNIG-------RNGEKTVNIFMEYMAGGSLLDV 61
+V + + RNE L + ++ + + ME L
Sbjct: 40 YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSW 98
Query: 62 AEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115
+K ++D + Y K +L H +GI+H DLK N L+ G +KL D G A +
Sbjct: 99 LKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQ 156
Query: 116 VNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG-----------LDFATDIWSLGCMVIE 164
+ + S GT +M PE +++ + +D+WSLGC++
Sbjct: 157 MQPDTTSVVKD----SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 212
Query: 165 MATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
M G+ P+ I N + L I N + FP K + D L CL+R P++R S EL
Sbjct: 213 MTYGKTPFQQ-IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
Query: 225 LNHTFISGNAKKNS 238
L H ++ +
Sbjct: 272 LAHPYVQIQTHPVN 285
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-58
Identities = 62/254 (24%), Positives = 102/254 (40%), Gaps = 32/254 (12%)
Query: 9 FVVKSAESEAGVQALRNEAEIRQSLNSPNIG-------RNGEKTVNIFMEYMAGGSLLDV 61
+V + + RNE L + ++ + + ME L
Sbjct: 87 YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSW 145
Query: 62 AEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115
+K ++D + Y K +L H +GI+H DLK N L+ G +KL D G A +
Sbjct: 146 LKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQ 203
Query: 116 VNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG-----------LDFATDIWSLGCMVIE 164
+ + S G +M PE +++ + +D+WSLGC++
Sbjct: 204 MQPDTTSVVKD----SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 259
Query: 165 MATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
M G+ P+ I N + L I N + FP K + D L CL+R P++R S EL
Sbjct: 260 MTYGKTPFQQ-IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
Query: 225 LNHTFISGNAKKNS 238
L H ++ +
Sbjct: 319 LAHPYVQIQTHPVN 332
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 4e-58
Identities = 87/261 (33%), Positives = 126/261 (48%), Gaps = 41/261 (15%)
Query: 1 MNKGTGALFVVK--SAESEAGVQALRNEAEIRQSLNSPNIGRNGEKTVN----------- 47
M+ TG ++ + + + + + NE + + +PNI VN
Sbjct: 40 MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI-------VNYLDSYLVGDEL 92
Query: 48 -IFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
+ MEY+AGGSL DV + +D G I +E LH N ++H D+K +N+LLG
Sbjct: 93 WVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGC 160
G VKL D G ++ ++ + ++ GT WMAPEV+ + DIWSLG
Sbjct: 151 MDGSVKLTDFGFCAQITPEQSKRS------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 161 MVIEMATGRPPWGDKISNAAATLLKIACSNEKPHF--PTQFFKKVLDFLAKCLERKPEKR 218
M IEM G PP+ ++ N L IA +N P P + DFL +CLE EKR
Sbjct: 205 MAIEMIEGEPPYLNE--NPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 261
Query: 219 WSAEELLNHTFISGNAKKNST 239
SA+ELL H F+ AK S+
Sbjct: 262 GSAKELLQHQFLK-IAKPLSS 281
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 9e-58
Identities = 62/256 (24%), Positives = 108/256 (42%), Gaps = 25/256 (9%)
Query: 2 NKGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEY 52
+ G +V+K S S + R E + ++ PNI + ++ I M+Y
Sbjct: 45 STEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104
Query: 53 MAGGSLLDVAEKFGGT-LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDV 105
GG L G I + +I +H ILH D+K N+ L G V
Sbjct: 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTV 164
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
+L D G AR L + L ++ GT +++PE+ N+ + +DIW+LGC++ E+
Sbjct: 165 QLGDFGIARV---LNSTVELARACI---GTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218
Query: 166 ATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
T + + + +LKI S P + + +++ +R P R S +L
Sbjct: 219 CTLKHAFEAG--SMKNLVLKI-ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSIL 275
Query: 226 NHTFISGNAKKNSTEE 241
FI+ +K + +
Sbjct: 276 EKGFIAKRIEKFLSPQ 291
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-57
Identities = 69/261 (26%), Positives = 109/261 (41%), Gaps = 41/261 (15%)
Query: 1 MNKGTGALFVVK--SAESEAGVQALRNEAEIRQSLNSPNIGRNGEKTVN----------- 47
K +G VK + + L NE I + N+ V
Sbjct: 65 REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV-------VEMYKSYLVGEEL 117
Query: 48 -IFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
+ ME++ GG+L D+ + L+ I + + LH G++H D+K +++LL
Sbjct: 118 WVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT 175
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGC 160
G VKL D G +++ S+ GT WMAPEV+ DIWSLG
Sbjct: 176 LDGRVKLSDFGFCAQISKDVPKRK------SLVGTPYWMAPEVISRSLYATEVDIWSLGI 229
Query: 161 MVIEMATGRPPWGDKISNAAATLLKIACSNEKPHF--PTQFFKKVLDFLAKCLERKPEKR 218
MVIEM G PP+ + + ++ + P + + DFL + L R P++R
Sbjct: 230 MVIEMVDGEPPYFSD--SPVQAMKRLR-DSPPPKLKNSHKVSPVLRDFLERMLVRDPQER 286
Query: 219 WSAEELLNHTFISGNAKKNST 239
+A+ELL+H F+
Sbjct: 287 ATAQELLDHPFLL-QTGLPEC 306
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 4e-57
Identities = 81/266 (30%), Positives = 121/266 (45%), Gaps = 44/266 (16%)
Query: 1 MNKGTGALFVVK--SAESEAGVQALRNEAEIRQSLNSPNIGRNGEKTVN----------- 47
NK TGAL K +SE ++ E EI + + P I V
Sbjct: 39 KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI-------VKLLGAYYHDGKL 91
Query: 48 -IFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
I +E+ GG++ + + L I++ +++ LH I+H DLK NVL+
Sbjct: 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT 151
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV-----LRNEGLDFATDI 155
GD++L D G + + + S GT WMAPEV +++ D+ DI
Sbjct: 152 LEGDIRLADFGVSAKNLKTLQKRD------SFIGTPYWMAPEVVMCETMKDTPYDYKADI 205
Query: 156 WSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHF--PTQFFKKVLDFLAKCLER 213
WSLG +IEMA PP + N LLKIA ++ P P+++ + DFL L++
Sbjct: 206 WSLGITLIEMAQIEPPHHE--LNPMRVLLKIA-KSDPPTLLTPSKWSVEFRDFLKIALDK 262
Query: 214 KPEKRWSAEELLNHTFISGNAKKNST 239
PE R SA +LL H F+S + N
Sbjct: 263 NPETRPSAAQLLEHPFVS-SITSNKA 287
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 5e-56
Identities = 73/271 (26%), Positives = 114/271 (42%), Gaps = 38/271 (14%)
Query: 1 MNKGTGALFVVKS---AESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFME 51
+K + + + L E + + PNI ++ + + M+
Sbjct: 35 YCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE-LWLVMK 93
Query: 52 YMAGGSLLDV-------AEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVL 98
++GGS+LD+ E G LD I +E+L H NG +H D+K N+L
Sbjct: 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNIL 153
Query: 99 LGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL-RNEGLDFATDIWS 157
LG G V++ D G + + + + ++ GT WMAPEV+ + G DF DIWS
Sbjct: 154 LGEDGSVQIADFGVSAFLAT-GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWS 212
Query: 158 LGCMVIEMATGRPPWGDK---------ISNAAATLLKIACSNEKPHFPTQFFKKVLDFLA 208
G IE+ATG P+ + N +L E + F+ ++
Sbjct: 213 FGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFR---KMIS 269
Query: 209 KCLERKPEKRWSAEELLNHTFISGNAKKNST 239
CL++ PEKR +A ELL H F AK
Sbjct: 270 LCLQKDPEKRPTAAELLRHKFFQ-KAKNKEF 299
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-54
Identities = 65/302 (21%), Positives = 110/302 (36%), Gaps = 64/302 (21%)
Query: 1 MNKGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFM 50
K TG V+ A S V L+ E + + N PNI + + +
Sbjct: 47 RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE-LWVVT 105
Query: 51 EYMAGGSLLD-VAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHG 103
+MA GS D + F ++ I + +L H G +H +K +++L+ G
Sbjct: 106 SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG 165
Query: 104 DVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR--NEGLDFATDIWSLGC 160
V L L ++ + + + W++PEVL+ +G D +DI+S+G
Sbjct: 166 KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 225
Query: 161 MVIEMATGRPPWGD---------KISNAAATLL--------------------------- 184
E+A G P+ D K++ LL
Sbjct: 226 TACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSL 285
Query: 185 ------KIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKNS 238
+ + F F+ +CL+R P+ R SA LLNH+F K+ +
Sbjct: 286 TTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK-QIKRRA 344
Query: 239 TE 240
+E
Sbjct: 345 SE 346
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-52
Identities = 72/266 (27%), Positives = 105/266 (39%), Gaps = 49/266 (18%)
Query: 1 MNKGTGALFVVK-----SAESEAGVQALRNEAEIRQSLNSPNIGRNGEKTVN-------- 47
+ + +K +S Q + E Q L PN +
Sbjct: 74 RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT-------IQYRGCYLRE 126
Query: 48 ----IFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNV 97
+ MEY GS D+ E L I T LH + ++H D+K N+
Sbjct: 127 HTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 185
Query: 98 LLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE---GLDFATD 154
LL G VKL D G A + N S GT WMAPEV+ D D
Sbjct: 186 LLSEPGLVKLGDFGSASIMA--PAN--------SFVGTPYWMAPEVILAMDEGQYDGKVD 235
Query: 155 IWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVL-DFLAKCLER 213
+WSLG IE+A +PP + NA + L IA NE P + + + +F+ CL++
Sbjct: 236 VWSLGITCIELAERKPPLFNM--NAMSALYHIA-QNESPALQSGHWSEYFRNFVDSCLQK 292
Query: 214 KPEKRWSAEELLNHTFISGNAKKNST 239
P+ R ++E LL H F+ + +
Sbjct: 293 IPQDRPTSEVLLKHRFVL-RERPPTV 317
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-52
Identities = 53/263 (20%), Positives = 97/263 (36%), Gaps = 45/263 (17%)
Query: 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNI---------------------GR 40
++ G +V+K + + E + L+ NI R
Sbjct: 32 HRIDGKTYVIKRVKYNN--EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR 89
Query: 41 NGEKTVNIFMEYMAGGSLLDV-AEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLK 93
+ K + I ME+ G+L ++ G LD + ++I +H +++ DLK
Sbjct: 90 SKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLK 149
Query: 94 CNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT 153
+N+ L VK+ D G LKN+G GT +M+PE + ++
Sbjct: 150 PSNIFLVDTKQVKIGDFGLVTS---LKNDGKRT----RSKGTLRYMSPEQISSQDYGKEV 202
Query: 154 DIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLER 213
D+++LG ++ E+ + + F KK L K L +
Sbjct: 203 DLYALGLILAELLHVCDTA----FETSKFFTDL----RDGIISDIFDKKEKTLLQKLLSK 254
Query: 214 KPEKRWSAEELLNHTFISGNAKK 236
KPE R + E+L + + +
Sbjct: 255 KPEDRPNTSEILRTLTVWKKSPE 277
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-51
Identities = 71/265 (26%), Positives = 114/265 (43%), Gaps = 36/265 (13%)
Query: 1 MNKGTGALFVVKSAESEAG-VQALRNEAEI-RQSLNSPNI-----------GRNGEKTVN 47
+ TG L +K + + ++ E + ++ + NI + +
Sbjct: 44 RHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103
Query: 48 IFMEYMAGGSLLDVAEKF-GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
+ ME+ GS+ D+ + G TL I +EI LH + ++H D+K NVLL
Sbjct: 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 163
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE-----GLDFATDI 155
+ +VKL D G + +++ N + GT WMAPEV+ + DF +D+
Sbjct: 164 ENAEVKLVDFGVSAQLDRTVGRRN------TFIGTPYWMAPEVIACDENPDATYDFKSDL 217
Query: 156 WSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHF-PTQFFKKVLDFLAKCLERK 214
WSLG IEMA G PP D + L I N P ++ KK F+ CL +
Sbjct: 218 WSLGITAIEMAEGAPPLCDM--HPMRALFLIP-RNPAPRLKSKKWSKKFQSFIESCLVKN 274
Query: 215 PEKRWSAEELLNHTFISGNAKKNST 239
+R + E+L+ H FI +
Sbjct: 275 HSQRPATEQLMKHPFIR-DQPNERQ 298
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-50
Identities = 70/260 (26%), Positives = 110/260 (42%), Gaps = 34/260 (13%)
Query: 2 NKGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFM 50
K G + V K + +EA Q L +E + + L PNI R T+ I M
Sbjct: 27 RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86
Query: 51 EYMAGGSLLDV---AEKFGGTLDAGVIRLYTKEI------LH-----GNGILHCDLKCNN 96
EY GG L V K LD + ++ H G+ +LH DLK N
Sbjct: 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 146
Query: 97 VLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIW 156
V L +VKL D G AR L ++ + +++ GT +M+PE + + +DIW
Sbjct: 147 VFLDGKQNVKLGDFGLARI---LNHDTSFAKTFV---GTPYYMSPEQMNRMSYNEKSDIW 200
Query: 157 SLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216
SLGC++ E+ PP+ + KI + P ++ ++ + + + L K
Sbjct: 201 SLGCLLYELCALMPPFTAF--SQKELAGKI-REGKFRRIPYRYSDELNEIITRMLNLKDY 257
Query: 217 KRWSAEELLNHTFISGNAKK 236
R S EE+L + I +
Sbjct: 258 HRPSVEEILENPLILEHHHH 277
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 6e-50
Identities = 58/276 (21%), Positives = 97/276 (35%), Gaps = 40/276 (14%)
Query: 2 NKGTGALFVVKS-AESEAGVQALRNEAEIRQSLNSPNI------------------GRNG 42
N + +K +E + + +E + SLN +
Sbjct: 27 NALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKK 86
Query: 43 EKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNN 96
+ T+ I MEY G+L D+ ++IL H GI+H DLK N
Sbjct: 87 KSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMN 146
Query: 97 VLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIG--------GTQLWMAPEVLRNEG 148
+ + +VK+ D G A+ V+ + L GT +++A EVL G
Sbjct: 147 IFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG 206
Query: 149 L-DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK--PHFPTQFFKKVLD 205
+ D++SLG + EM L K+ + + P F K
Sbjct: 207 HYNEKIDMYSLGIIFFEMIYPFSTG----MERVNILKKLRSVSIEFPPDFDDNKMKVEKK 262
Query: 206 FLAKCLERKPEKRWSAEELLNHTFISGNAKKNSTEE 241
+ ++ P KR A LLN ++ + +E
Sbjct: 263 IIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKE 298
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-49
Identities = 48/263 (18%), Positives = 86/263 (32%), Gaps = 39/263 (14%)
Query: 2 NKGTGALFVVKS---AESEAGVQALRNEAEIRQSLNSPNIGR-----------------N 41
NK + +K E + + E + L P I R +
Sbjct: 26 NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85
Query: 42 GEKTVNIFMEYMAGGSLLDV--AEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLK 93
+ + I M+ +L D + V +I LH G++H DLK
Sbjct: 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLK 145
Query: 94 CNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIG------GTQLWMAPEVLRNE 147
+N+ VK+ D G ++ + + + GT+L+M+PE +
Sbjct: 146 PSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN 205
Query: 148 GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFL 207
DI+SLG ++ E+ P L + + P TQ + +
Sbjct: 206 SYSHKVDIFSLGLILFELLY--PFSTQ---MERVRTLTDVRNLKFPPLFTQKYPCEYVMV 260
Query: 208 AKCLERKPEKRWSAEELLNHTFI 230
L P +R A ++ +
Sbjct: 261 QDMLSPSPMERPEAINIIENAVF 283
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 8e-48
Identities = 71/294 (24%), Positives = 118/294 (40%), Gaps = 68/294 (23%)
Query: 1 MNKGTGALFVVK---SAESEAGVQALRNEAEIRQSLNSPNI----G---RNGEKTVNIFM 50
+K +G + K A + E ++ NSP I G +GE ++I M
Sbjct: 53 SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE--ISICM 110
Query: 51 EYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHG-------NGILHCDLKCNNVLLGSHG 103
E+M GGSL V K G + ++ + ++ G + I+H D+K +N+L+ S G
Sbjct: 111 EHMDGGSLDQVL-KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG 169
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163
++KL D G + ++ D N + GT+ +M+PE L+ +DIWS+G ++
Sbjct: 170 EIKLCDFGVSGQLIDSMANSFV--------GTRSYMSPERLQGTHYSVQSDIWSMGLSLV 221
Query: 164 EMATGRPPWGDKISNAAAT---------------------------------------LL 184
EMA GR P + LL
Sbjct: 222 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELL 281
Query: 185 KIACSNEKPHFPTQFFKKVL-DFLAKCLERKPEKRWSAEELLNHTFISGNAKKN 237
+ P P+ F DF+ KCL + P +R ++L+ H FI + +
Sbjct: 282 DYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-47
Identities = 64/263 (24%), Positives = 108/263 (41%), Gaps = 39/263 (14%)
Query: 1 MNKGTGALFVVK---SAESEAGVQALRNEAEI-RQSLNSPNI----G---RNGEKTVNIF 49
+ TG + VK + ++ + + + ++ +S + P I G N + V I
Sbjct: 45 RFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD--VFIA 102
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHG-------NGILHCDLKCNNVLLGSH 102
ME M G + ++ G + ++ T I+ +G++H D+K +N+LL
Sbjct: 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER 161
Query: 103 GDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL-----RNEGLDFATDIW 156
G +KL D G R V+D + + G +MAPE + D D+W
Sbjct: 162 GQIKLCDFGISGRLVDDKAKDRSA--------GCAAYMAPERIDPPDPTKPDYDIRADVW 213
Query: 157 SLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP--TQFFKKVLDFLAKCLERK 214
SLG ++E+ATG+ P+ + +L E P P F F+ CL +
Sbjct: 214 SLGISLVELATGQFPYKN--CKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKD 271
Query: 215 PEKRWSAEELLNHTFISGNAKKN 237
KR +LL H+FI
Sbjct: 272 HRKRPKYNKLLEHSFIKRYETLE 294
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-47
Identities = 61/263 (23%), Positives = 108/263 (41%), Gaps = 38/263 (14%)
Query: 1 MNKGTGALFVVK---SAESEAGVQALRNEAEI-RQSLNSPNI----G---RNGEKTVNIF 49
+ +G + VK + + + L + +I ++++ P G R G+ V I
Sbjct: 27 RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD--VWIC 84
Query: 50 MEYMAGG--SLLDVAEKFGGTLDAGVIRLYTKEILHG-------NGILHCDLKCNNVLLG 100
ME M G T+ ++ I+ ++H D+K +NVL+
Sbjct: 85 MELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN 144
Query: 101 SHGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL----DFATDI 155
+ G VK+ D G V+D+ + + G + +MAPE + E +DI
Sbjct: 145 ALGQVKMCDFGISGYLVDDVAKDIDA--------GCKPYMAPERINPELNQKGYSVKSDI 196
Query: 156 WSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVL-DFLAKCLERK 214
WSLG +IE+A R P+ L ++ P P F DF ++CL++
Sbjct: 197 WSLGITMIELAILRFPYDS-WGTPFQQLKQV-VEEPSPQLPADKFSAEFVDFTSQCLKKN 254
Query: 215 PEKRWSAEELLNHTFISGNAKKN 237
++R + EL+ H F + + K
Sbjct: 255 SKERPTYPELMQHPFFTLHESKG 277
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-47
Identities = 64/267 (23%), Positives = 112/267 (41%), Gaps = 42/267 (15%)
Query: 1 MNKGTGALFVVK---SAESEAGVQALRNEAEI-RQSLNSPNI----G---RNGEKTVNIF 49
++K +G + VK S E + L + ++ +S + P I G R G+ I
Sbjct: 42 VHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD--CWIC 99
Query: 50 MEYMAGGS---LLDVAEKFGGTLDAGVIRLYTKEILHG-------NGILHCDLKCNNVLL 99
ME M+ V + ++ T + I+H D+K +N+LL
Sbjct: 100 MELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL 159
Query: 100 GSHGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL----RNEGLDFATD 154
G++KL D G + V+ + + G + +MAPE + +G D +D
Sbjct: 160 DRSGNIKLCDFGISGQLVDSIAKTRDA--------GCRPYMAPERIDPSASRQGYDVRSD 211
Query: 155 IWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPT----QFFKKVLDFLAKC 210
+WSLG + E+ATGR P+ ++ L ++ + P +F ++F+ C
Sbjct: 212 VWSLGITLYELATGRFPYPK-WNSVFDQLTQV-VKGDPPQLSNSEEREFSPSFINFVNLC 269
Query: 211 LERKPEKRWSAEELLNHTFISGNAKKN 237
L + KR +ELL H FI ++
Sbjct: 270 LTKDESKRPKYKELLKHPFILMYEERA 296
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-46
Identities = 57/257 (22%), Positives = 95/257 (36%), Gaps = 27/257 (10%)
Query: 3 KGTGALFVVKSAESEAGVQALRNEAEI-RQSLNSPNIGR-----NGEKTVNIFMEYMAGG 56
VK E E ++ R+S PN+ R + I +E
Sbjct: 45 MFDNRDVAVKRILPEC-FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AA 102
Query: 57 SLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGD-----V 105
+L + E+ ++ LH I+H DLK +N+L+
Sbjct: 103 TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKA 162
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR---NEGLDFATDIWSLGCMV 162
+ D G ++ L + + GT+ W+APE+L E + DI+S GC+
Sbjct: 163 MISDFGLCKK---LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVF 219
Query: 163 IEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221
+ + G P+G A +L ACS + H + + K + P+KR SA
Sbjct: 220 YYVISEGSHPFGKS-LQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSA 278
Query: 222 EELLNHTFISGNAKKNS 238
+ +L H F K+
Sbjct: 279 KHVLKHPFFWSLEKQLQ 295
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-44
Identities = 54/252 (21%), Positives = 90/252 (35%), Gaps = 27/252 (10%)
Query: 2 NKGTGALFVVK--SAESEAGVQALRNEAEIRQSLNSPNI---------GRNGEKTVNIFM 50
G + +K + + + EA++ + N PNI R + + +
Sbjct: 50 GLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109
Query: 51 EYMAGGSLLDVAEKF---GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS 101
+ G+L + E+ G L I I +H G H DLK N+LLG
Sbjct: 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGD 169
Query: 102 HGDVKLPDLGCARRVNDLKNN---GNLKQSWQSIGGTQLWMAPEVL---RNEGLDFATDI 155
G L DLG + Q W + T + APE+ + +D TD+
Sbjct: 170 EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDV 229
Query: 156 WSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKP 215
WSLGC++ M G P+ D + ++ + + + L + P
Sbjct: 230 WSLGCVLYAMMFGEGPY-DMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDP 288
Query: 216 EKRWSAEELLNH 227
+R LL+
Sbjct: 289 HQRPHIPLLLSQ 300
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-41
Identities = 40/237 (16%), Positives = 85/237 (35%), Gaps = 24/237 (10%)
Query: 13 SAESEAGVQALRNEAEIRQSLNSPNI-----GRNGEKTVNIFMEYMAGGSLLDV--AEKF 65
S + + A + ++ N + + + I M+ +L D
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 66 GGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDL 119
+ GV +I H G++H DLK +N+ VK+ D G ++
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 120 KNNGNLKQSWQSIG------GTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWG 173
+ + + GT+L+M+PE + DI+SLG ++ E+
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277
Query: 174 DKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
+++ ++ + + P TQ + + + L P +R A +++ +
Sbjct: 278 ERVR-----IITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-40
Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 24/233 (10%)
Query: 20 VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74
LR E EI+ L PNI R + V + +EY G++ +K D
Sbjct: 53 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRT 111
Query: 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQS 128
Y E+ H ++H D+K N+LLGS G++K+ D G + +
Sbjct: 112 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-------- 163
Query: 129 WQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIAC 188
+ GT ++ PE++ D D+WSLG + E G+PP+ T +I
Sbjct: 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--TYQETYKRI-- 219
Query: 189 SNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKNSTEE 241
S + FP + D +++ L+ P +R E+L H +I+ N+ K S +
Sbjct: 220 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQ 272
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-40
Identities = 66/271 (24%), Positives = 112/271 (41%), Gaps = 49/271 (18%)
Query: 3 KGTGALFVVKS--------AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIF 49
KGTG + K + + + E I + + PNI + V +
Sbjct: 27 KGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLI 86
Query: 50 MEYMAGGSLLD--VAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGS 101
+E ++GG L D ++ +A + K+IL H I H DLK N++L
Sbjct: 87 LELVSGGELFDFLAEKESLTEDEA---TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLD 143
Query: 102 H----GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWS 157
+KL D G A ++ +++I GT ++APE++ E L D+WS
Sbjct: 144 KNVPNPRIKLIDFGIAHKIEA-------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 196
Query: 158 LGCMVIE--MATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKC 210
+G VI + +G P G+ TL I S F ++F DF+ +
Sbjct: 197 IG--VITYILLSGASPFLGE---TKQETLTNI--SAVNYDFDEEYFSNTSELAKDFIRRL 249
Query: 211 LERKPEKRWSAEELLNHTFISGNAKKNSTEE 241
L + P++R + + L H++I ++N E
Sbjct: 250 LVKDPKRRMTIAQSLEHSWIKAIRRRNVRGE 280
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-39
Identities = 37/285 (12%), Positives = 72/285 (25%), Gaps = 67/285 (23%)
Query: 2 NKGTGALFVVK-----SAESEAGVQALRNEAEIRQSLNSPNI------------------ 38
+ F +K + S + ++ L L +
Sbjct: 83 DVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142
Query: 39 -----------GRNGEKTVNIF--MEYMAG-----GSLLDVAEKFGGTLDAGVIRLYTKE 80
G++ N M + S LD F G + + T +
Sbjct: 143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQ 202
Query: 81 I------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGG 134
+ L G++H +N+ + G + L D+ +V +
Sbjct: 203 LIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---------PASSV 253
Query: 135 TQLWMAPEVLRNEGL--DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK 192
+ E L A + W LG + + P+G + + S
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRP--SLRV 311
Query: 193 PHFPTQFFKK-------VLDFLAKCLERKPEKRWSAEELLNHTFI 230
P + F V + + L +R E +
Sbjct: 312 PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-39
Identities = 58/262 (22%), Positives = 110/262 (41%), Gaps = 38/262 (14%)
Query: 2 NKGTGALFVVKS--AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMA 54
K TG +FV K ++NE I L+ P + + + + +E+++
Sbjct: 72 EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131
Query: 55 GGSLLD--VAEKFGGT-LDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD- 104
GG L D AE + + + Y ++ H + I+H D+K N++ +
Sbjct: 132 GGELFDRIAAEDYKMSEAEV---INYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKAS 188
Query: 105 -VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163
VK+ D G A ++N + + T + APE++ E + F TD+W++G +
Sbjct: 189 SVKIIDFGLATKLNP-------DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGY 241
Query: 164 EMATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEKR 218
+ +G P G+ + TL + F F V DF+ L+++P KR
Sbjct: 242 VLLSGLSPFAGE---DDLETLQNV--KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKR 296
Query: 219 WSAEELLNHTFISGNAKKNSTE 240
+ + L H ++ G+ ++
Sbjct: 297 LTVHDALEHPWLKGDHSNLTSR 318
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-39
Identities = 73/262 (27%), Positives = 114/262 (43%), Gaps = 42/262 (16%)
Query: 2 NKGTGALFVVKS--AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMA 54
TG K + ++NE + L+ N+ + + + + MEY+
Sbjct: 110 ETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169
Query: 55 GGSLLD--VAEKFGGT-LDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD- 104
GG L D + E + T LD L+ K+I H ILH DLK N+L +
Sbjct: 170 GGELFDRIIDESYNLTELDT---ILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK 226
Query: 105 -VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163
+K+ D G ARR K LK GT ++APEV+ + + F TD+WS+G VI
Sbjct: 227 QIKIIDFGLARR---YKPREKLKV----NFGTPEFLAPEVVNYDFVSFPTDMWSVG--VI 277
Query: 164 E--MATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPE 216
+ +G P GD N A TL I + + F+ + +F++K L ++
Sbjct: 278 AYMLLSGLSPFLGD---NDAETLNNI--LACRWDLEDEEFQDISEEAKEFISKLLIKEKS 332
Query: 217 KRWSAEELLNHTFISGNAKKNS 238
R SA E L H ++S + +
Sbjct: 333 WRISASEALKHPWLSDHKLHSR 354
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-39
Identities = 66/264 (25%), Positives = 112/264 (42%), Gaps = 41/264 (15%)
Query: 2 NKGTGALFVVKS----AESEAGVQALRNEAEIRQSLNS-PNIGR-----NGEKTVNIFME 51
+K TG + K + + +E + + S P + + + +E
Sbjct: 50 SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILE 109
Query: 52 YMAGGSLLD-VAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGS--- 101
Y AGG + + + + K+IL H N I+H DLK N+LL S
Sbjct: 110 YAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYP 169
Query: 102 HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCM 161
GD+K+ D G +R++ + I GT ++APE+L + + ATD+W++G
Sbjct: 170 LGDIKIVDFGMSRKIGH-------ACELREIMGTPEYLAPEILNYDPITTATDMWNIG-- 220
Query: 162 VIE--MATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERK 214
+I + T P G+ + T L I S + + F V DF+ L +
Sbjct: 221 IIAYMLLTHTSPFVGE---DNQETYLNI--SQVNVDYSEETFSSVSQLATDFIQSLLVKN 275
Query: 215 PEKRWSAEELLNHTFISGNAKKNS 238
PEKR +AE L+H+++ +N
Sbjct: 276 PEKRPTAEICLSHSWLQQWDFENL 299
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-39
Identities = 47/260 (18%), Positives = 105/260 (40%), Gaps = 37/260 (14%)
Query: 3 KGTGALFVVKS-AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGG 56
+ ++ K ++ E I NI + + + E+++G
Sbjct: 27 TSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86
Query: 57 SLLD--VAEKFGGT-LDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD--V 105
+ + F + Y ++ H + I H D++ N++ + +
Sbjct: 87 DIFERINTSAFELNEREI---VSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTI 143
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
K+ + G AR++ +++ + + APEV +++ + ATD+WSLG +V +
Sbjct: 144 KIIEFGQARQLKP-------GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVL 196
Query: 166 ATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEKRWS 220
+G P + + I N + F + FK++ +DF+ + L ++ + R +
Sbjct: 197 LSGINPFLAE---TNQQIIENI--MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT 251
Query: 221 AEELLNHTFISGNAKKNSTE 240
A E L H ++ ++ ST+
Sbjct: 252 ASEALQHPWLKQKIERVSTK 271
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 5e-39
Identities = 57/260 (21%), Positives = 102/260 (39%), Gaps = 38/260 (14%)
Query: 3 KGTGALFVVKS--AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAG 55
+ TG F K E+ + +R E + L P + + + + E+M+G
Sbjct: 179 RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238
Query: 56 GSLLD--VAEKFGGT-LDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD-- 104
G L + E + +A Y +++ H N +H DLK N++ +
Sbjct: 239 GELFEKVADEHNKMSEDEA---VEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE 295
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIE 164
+KL D G ++ KQS + GT + APEV + + + TD+WS+G +
Sbjct: 296 LKLIDFGLTAHLDP-------KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 348
Query: 165 MATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEKRW 219
+ +G P G+ N TL + + + F + DF+ K L P R
Sbjct: 349 LLSGLSPFGGE---NDDETLRNV--KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM 403
Query: 220 SAEELLNHTFISGNAKKNST 239
+ + L H +++
Sbjct: 404 TIHQALEHPWLTPGNAPGRD 423
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-38
Identities = 67/269 (24%), Positives = 110/269 (40%), Gaps = 47/269 (17%)
Query: 2 NKGTGALFVVKS--------AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNI 48
K TG + K + + + E I + + N+ V +
Sbjct: 33 EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92
Query: 49 FMEYMAGGSLLD-VAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGS 101
+E ++GG L D +A+K +L + K+IL H I H DLK N++L
Sbjct: 93 ILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD 150
Query: 102 H----GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWS 157
+KL D G A + D +++I GT ++APE++ E L D+WS
Sbjct: 151 KNIPIPHIKLIDFGLAHEIED-------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 203
Query: 158 LGCMVIE--MATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKC 210
+G VI + +G P GD TL I ++ F +FF DF+ K
Sbjct: 204 IG--VITYILLSGASPFLGD---TKQETLANI--TSVSYDFDEEFFSHTSELAKDFIRKL 256
Query: 211 LERKPEKRWSAEELLNHTFISGNAKKNST 239
L ++ KR + +E L H +I+ + +
Sbjct: 257 LVKETRKRLTIQEALRHPWITPVDNQQAM 285
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-38
Identities = 63/269 (23%), Positives = 110/269 (40%), Gaps = 49/269 (18%)
Query: 2 NKGTGALFVVKS--------AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNI 48
K TG + K + + + E I + + PN+ + V +
Sbjct: 32 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91
Query: 49 FMEYMAGGSLLD--VAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLG 100
+E +AGG L D ++ +A + K+IL H I H DLK N++L
Sbjct: 92 ILELVAGGELFDFLAEKESLTEEEA---TEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 148
Query: 101 SH----GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIW 156
+K+ D G A +++ +++I GT ++APE++ E L D+W
Sbjct: 149 DRNVPKPRIKIIDFGLAHKIDF-------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMW 201
Query: 157 SLGCMVIE--MATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAK 209
S+G VI + +G P GD TL + S F ++F DF+ +
Sbjct: 202 SIG--VITYILLSGASPFLGD---TKQETLANV--SAVNYEFEDEYFSNTSALAKDFIRR 254
Query: 210 CLERKPEKRWSAEELLNHTFISGNAKKNS 238
L + P+KR + ++ L H +I + +
Sbjct: 255 LLVKDPKKRMTIQDSLQHPWIKPKDTQQA 283
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-38
Identities = 67/270 (24%), Positives = 109/270 (40%), Gaps = 49/270 (18%)
Query: 2 NKGTGALFVVKS--------AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNI 48
K TG + K + + + E I + + PNI V +
Sbjct: 33 EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92
Query: 49 FMEYMAGGSLLD--VAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLG 100
+E ++GG L D ++ +A + K+IL H I H DLK N++L
Sbjct: 93 ILELVSGGELFDFLAQKESLSEEEA---TSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149
Query: 101 SH----GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIW 156
+KL D G A + D +++I GT ++APE++ E L D+W
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIED-------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMW 202
Query: 157 SLGCMVIE--MATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAK 209
S+G VI + +G P GD TL I + F +FF + DF+ K
Sbjct: 203 SIG--VITYILLSGASPFLGD---TKQETLANI--TAVSYDFDEEFFSQTSELAKDFIRK 255
Query: 210 CLERKPEKRWSAEELLNHTFISGNAKKNST 239
L ++ KR + +E L H +I+ + +
Sbjct: 256 LLVKETRKRLTIQEALRHPWITPVDTQQAM 285
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-37
Identities = 63/270 (23%), Positives = 103/270 (38%), Gaps = 47/270 (17%)
Query: 2 NKGTGALFVVKS-------AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIF 49
N+ TG F VK + + L+ EA I L P+I + + + +
Sbjct: 45 NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104
Query: 50 MEYMAGGSLLD--VAEKFGGTL----DAGVIRLYTKEIL------HGNGILHCDLKCNNV 97
E+M G L V G + A Y ++IL H N I+H D+K + V
Sbjct: 105 FEFMDGADLCFEIVKRADAGFVYSEAVA---SHYMRQILEALRYCHDNNIIHRDVKPHCV 161
Query: 98 LLGSHGD---VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATD 154
LL S + VKL G A ++ + GT +MAPEV++ E D
Sbjct: 162 LLASKENSAPVKLGGFGVAIQLGESG------LVAGGRVGTPHFMAPEVVKREPYGKPVD 215
Query: 155 IWSLGCMVIEMATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAK 209
+W G ++ + +G P +G K L + K + + + D + +
Sbjct: 216 VWGCGVILFILLSGCLPFYGTK-----ERLFEGIIKG-KYKMNPRQWSHISESAKDLVRR 269
Query: 210 CLERKPEKRWSAEELLNHTFISGNAKKNST 239
L P +R + E LNH ++ +
Sbjct: 270 MLMLDPAERITVYEALNHPWLKERDRYAYK 299
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-37
Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 21/230 (9%)
Query: 23 LRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLY 77
++NE +I L P+I V + +E G + + R +
Sbjct: 58 VQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF 117
Query: 78 TKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQS 131
+I LH +GILH DL +N+LL + ++K+ D G A LK +
Sbjct: 118 MHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA---TQLKMPHEKHYT--- 171
Query: 132 IGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE 191
+ GT +++PE+ +D+WSLGCM + GRPP+ TL K+
Sbjct: 172 LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD--TVKNTLNKV--VLA 227
Query: 192 KPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKNSTEE 241
P+ + D + + L R P R S +L+H F+S N+ S +E
Sbjct: 228 DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-36
Identities = 54/225 (24%), Positives = 97/225 (43%), Gaps = 24/225 (10%)
Query: 23 LRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLY 77
LR E EI+ L PNI R + K + + +E+ G L +K G D +
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATF 119
Query: 78 TKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQS 131
+E+ H ++H D+K N+L+G G++K+ D G + L+ +
Sbjct: 120 MEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--------T 171
Query: 132 IGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE 191
+ GT ++ PE++ + D D+W G + E G PP+ + T +I N
Sbjct: 172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP--SHTETHRRI--VNV 227
Query: 192 KPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236
FP D ++K L P +R + ++ H ++ N+++
Sbjct: 228 DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-36
Identities = 73/262 (27%), Positives = 109/262 (41%), Gaps = 40/262 (15%)
Query: 2 NKGTGALFVVKS----AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEY 52
+K TG F K S Q L EA I + L PNI R E + +
Sbjct: 27 HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86
Query: 53 MAGGSLLD--VAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD 104
+ GG L + VA +F DA ++IL H NGI+H +LK N+LL S
Sbjct: 87 VTGGELFEDIVAREFYSEADA---SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK 143
Query: 105 ---VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCM 161
VKL D G A VND ++W GT +++PEVL+ + DIW+ G +
Sbjct: 144 GAAVKLADFGLAIEVND-------SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 196
Query: 162 VIEMATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPE 216
+ + G PP W + + +I +P+ + V + L P+
Sbjct: 197 LYILLVGYPPFWDE---DQHRLYAQIKAG--AYDYPSPEWDTVTPEAKSLIDSMLTVNPK 251
Query: 217 KRWSAEELLNHTFISGNAKKNS 238
KR +A++ L +I + S
Sbjct: 252 KRITADQALKVPWICNRERVAS 273
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-36
Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 21/229 (9%)
Query: 15 ESEAGVQALRNEAEIRQSLNSPNI----GRNGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70
+ +QA +NE + + NI G + + I ++ G SL +
Sbjct: 59 PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFE 118
Query: 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGN 124
+ ++ LH I+H DLK NN+ L VK+ D G A K+ +
Sbjct: 119 MKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT----EKSRWS 174
Query: 125 LKQSWQSIGGTQLWMAPEVLRNEGL---DFATDIWSLGCMVIEMATGRPPWGDKISNAAA 181
++ + G+ LWMAPEV+R + F +D+++ G ++ E+ TG+ P+ + I+N
Sbjct: 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN-INNRDQ 233
Query: 182 TLLKIACSNEKPH---FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
+ + + P + K++ +A+CL++K ++R S +L
Sbjct: 234 IIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 7e-36
Identities = 67/301 (22%), Positives = 105/301 (34%), Gaps = 73/301 (24%)
Query: 2 NKGTGALFVVKS-------AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIF 49
T A+ +K + V+ ++ E + + L+ PNI R E+ + +
Sbjct: 47 ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV 106
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVI----------------------------------- 74
ME GG LLD F
Sbjct: 107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQR 166
Query: 75 ----RLYTKEIL------HGNGILHCDLKCNNVLLGSHGD--VKLPDLGCARRVNDLKNN 122
++I H GI H D+K N L ++ +KL D G ++ L N
Sbjct: 167 EKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG 226
Query: 123 GNLKQSWQSIGGTQLWMAPEVLR--NEGLDFATDIWSLGCMVIEMATGRPP-WGDKISNA 179
+ GT ++APEVL NE D WS G ++ + G P G N
Sbjct: 227 EY--YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGV---ND 281
Query: 180 AATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235
A T+ ++ N+K F + + D L+ L R ++R+ A L H +IS +
Sbjct: 282 ADTISQV--LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339
Query: 236 K 236
K
Sbjct: 340 K 340
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-36
Identities = 62/248 (25%), Positives = 103/248 (41%), Gaps = 27/248 (10%)
Query: 2 NKGTGALFVVK-----SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFME 51
+ T +F K + + E I +SL ++ V + +E
Sbjct: 62 DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDV 105
SLL++ ++ L R Y ++I LH N ++H DLK N+ L +V
Sbjct: 122 LCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEV 180
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
K+ D G A ++ +G K+ + GT ++APEVL +G F D+WS+GC++ +
Sbjct: 181 KIGDFGLA---TKVEYDGERKKV---LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 234
Query: 166 ATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
G+PP+ T L+I + P + K L+ P R + ELL
Sbjct: 235 LVGKPPFETS--CLKETYLRI--KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 290
Query: 226 NHTFISGN 233
N F +
Sbjct: 291 NDEFFTSG 298
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-36
Identities = 62/248 (25%), Positives = 103/248 (41%), Gaps = 27/248 (10%)
Query: 2 NKGTGALFVVK-----SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFME 51
+ T +F K + + E I +SL ++ V + +E
Sbjct: 36 DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDV 105
SLL++ ++ L R Y ++I LH N ++H DLK N+ L +V
Sbjct: 96 LCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEV 154
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
K+ D G A ++ +G K+ + GT ++APEVL +G F D+WS+GC++ +
Sbjct: 155 KIGDFGLA---TKVEYDGERKKV---LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 208
Query: 166 ATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
G+PP+ T L+I + P + K L+ P R + ELL
Sbjct: 209 LVGKPPFETS--CLKETYLRI--KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 264
Query: 226 NHTFISGN 233
N F +
Sbjct: 265 NDEFFTSG 272
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 66/259 (25%), Positives = 113/259 (43%), Gaps = 33/259 (12%)
Query: 2 NKGTGALFVVKS----AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEY 52
+K T +K + S + L E + + L+ PNI + ++ + ME
Sbjct: 58 DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117
Query: 53 MAGGSLLD--VAEKFGGTLDA-GVIR--LYTKEILHGNGILHCDLKCNNVLLGSHGD--- 104
GG L D + +DA +I+ L LH + I+H DLK N+LL S
Sbjct: 118 YKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDAL 177
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIE 164
+K+ D G + + ++ + GT ++APEVLR + D D+WS+G ++
Sbjct: 178 IKIVDFGLSAVFEN-------QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFI 229
Query: 165 MATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEKRWS 220
+ G PP+G + L K+ K F + +K V D + + L+ ++R S
Sbjct: 230 LLAGYPPFGGQ--TDQEILRKVE--KGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRIS 285
Query: 221 AEELLNHTFISGNAKKNST 239
A++ L H +I K +
Sbjct: 286 AQQALEHPWIKEMCSKKES 304
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-35
Identities = 73/263 (27%), Positives = 109/263 (41%), Gaps = 40/263 (15%)
Query: 2 NKGTGALFVVKS----AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEY 52
+K TG F K S Q L EA I + L PNI R E + +
Sbjct: 50 HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109
Query: 53 MAGGSLLD--VAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD 104
+ GG L + VA +F DA ++IL H NGI+H +LK N+LL S
Sbjct: 110 VTGGELFEDIVAREFYSEADA---SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK 166
Query: 105 ---VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCM 161
VKL D G A VND ++W GT +++PEVL+ + DIW+ G +
Sbjct: 167 GAAVKLADFGLAIEVND-------SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 219
Query: 162 VIEMATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPE 216
+ + G PP W + + +I +P+ + V + L P+
Sbjct: 220 LYILLVGYPPFWDE---DQHRLYAQIKAG--AYDYPSPEWDTVTPEAKSLIDSMLTVNPK 274
Query: 217 KRWSAEELLNHTFISGNAKKNST 239
KR +A++ L +I + S
Sbjct: 275 KRITADQALKVPWICNRERVASA 297
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 70/259 (27%), Positives = 109/259 (42%), Gaps = 36/259 (13%)
Query: 2 NKGTGALFVVKS-----AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFME 51
+K TG VK + + ++L E ++ + L+ PNI + + + E
Sbjct: 47 DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106
Query: 52 YMAGGSLLD--VAEKFGGTLDA-GVIR--LYTKEILHGNGILHCDLKCNNVLLGSHGD-- 104
GG L D ++ K +DA +IR L +H N I+H DLK N+LL S
Sbjct: 107 VYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDA 166
Query: 105 -VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163
+++ D G + + + GT ++APEVL D D+WS G ++
Sbjct: 167 NIRIIDFGLSTHFEA-------SKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILY 218
Query: 164 EMATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEKR 218
+ +G PP G N L K+ K F +KKV D + K L P R
Sbjct: 219 ILLSGCPPFNGA---NEYDILKKV--EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMR 273
Query: 219 WSAEELLNHTFISGNAKKN 237
SA + L+H +I K+
Sbjct: 274 ISARDALDHEWIQTYTKEQ 292
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-35
Identities = 61/289 (21%), Positives = 99/289 (34%), Gaps = 62/289 (21%)
Query: 2 NKGTGALFVVKS---AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIF--ME 51
+K TG LF +K V E E+ + LN NI + T + ME
Sbjct: 30 HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89
Query: 52 YMAGGSLLDVAEKFG--GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
+ GSL V E+ L + +++ L NGI+H ++K N++
Sbjct: 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE 149
Query: 104 D----VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL--------DF 151
D KL D G AR L+++ S+ GT+ ++ P++ L
Sbjct: 150 DGQSVYKLTDFGAARE---LEDDEQFV----SLYGTEEYLHPDMYERAVLRKDHQKKYGA 202
Query: 152 ATDIWSLGCMVIEMATGRPPWGDKIS--NAAATLLKI---------ACSNEKPHFPTQFF 200
D+WS+G ATG P+ + KI + + + P +
Sbjct: 203 TVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWS 262
Query: 201 KK--------------VLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235
+ LA LE EK W ++ T +
Sbjct: 263 GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRG 311
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-35
Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 23/231 (9%)
Query: 12 KSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDV--AEK 64
+ V E I + L PNI ++I EY++ GSL +
Sbjct: 70 EQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG 129
Query: 65 FGGTLDAGVIRLYTKEI------LHGNG--ILHCDLKCNNVLLGSHGDVKLPDLGCARRV 116
LD ++ LH I+H +LK N+L+ VK+ D G +R
Sbjct: 130 AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR-- 187
Query: 117 NDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKI 176
LK + L +S GT WMAPEVLR+E + +D++S G ++ E+AT + PWG+
Sbjct: 188 --LKASTFLSS--KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL- 242
Query: 177 SNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
N A + + ++ P +V + C +P KR S +++
Sbjct: 243 -NPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-35
Identities = 66/256 (25%), Positives = 103/256 (40%), Gaps = 45/256 (17%)
Query: 3 KGTGALFVVKSAE-----SEAGVQALRNEAEIRQSLNSPNIGRNGEKTVNIF-------- 49
T + +K E E V + E ++ L+ P V ++
Sbjct: 52 LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF-------VKLYFTFQDDEK 104
Query: 50 ----MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLL 99
+ Y G LL K G + D R YT EI LHG GI+H DLK N+LL
Sbjct: 105 LYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL 163
Query: 100 GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
+++ D G A+ ++ ++ S GT +++PE+L + ++D+W+LG
Sbjct: 164 NEDMHIQITDFGTAKVLSPESKQA---RAN-SFVGTAQYVSPELLTEKSACKSSDLWALG 219
Query: 160 CMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219
C++ ++ G PP+ N KI + FP +FF K D + K L KR
Sbjct: 220 CIIYQLVAGLPPFRAG--NEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRL 275
Query: 220 ------SAEELLNHTF 229
L H F
Sbjct: 276 GCEEMEGYGPLKAHPF 291
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-35
Identities = 60/254 (23%), Positives = 111/254 (43%), Gaps = 29/254 (11%)
Query: 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGG 56
KGT + +K + + +R E + L+ PNI + +++ +E + GG
Sbjct: 74 QKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG 133
Query: 57 SLLD--VAEKFGGTLDA-GVIR--LYTKEILHGNGILHCDLKCNNVLLGSHGD---VKLP 108
L D V + + DA ++ L LH NGI+H DLK N+L + +K+
Sbjct: 134 ELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIA 193
Query: 109 DLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATG 168
D G ++ V + +++ GT + APE+LR D+WS+G + + G
Sbjct: 194 DFGLSKIVEH-------QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
Query: 169 RPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEKRWSAEE 223
P + + +I N + +F + ++ +V D + K + P+KR + +
Sbjct: 247 FEPFYDE--RGDQFMFRRI--LNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQ 302
Query: 224 LLNHTFISGNAKKN 237
L H +++G A
Sbjct: 303 ALQHPWVTGKAANF 316
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-35
Identities = 55/278 (19%), Positives = 103/278 (37%), Gaps = 46/278 (16%)
Query: 2 NKGTGALFVVKSAESEAGVQALRNEAEI-RQSLNSPNIGR-----NGEKTVNIFMEYMAG 55
G VK + E ++ +S + PN+ R ++ + I +E
Sbjct: 35 GSFQGRPVAVKRMLIDF-CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-N 92
Query: 56 GSLLDVAEKFGGTLDAGVIRLYTKEI-------------LHGNGILHCDLKCNNVLLGSH 102
+L D+ E D + LH I+H DLK N+L+ +
Sbjct: 93 LNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTS 151
Query: 103 GD-------------VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN--- 146
+ + D G ++++ + + + + GT W APE+L
Sbjct: 152 SRFTADQQTGAENLRILISDFGLCKKLDS--GQSSFRTNLNNPSGTSGWRAPELLEESNN 209
Query: 147 ----EGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIAC-SNEKPHFPTQFF 200
L + DI+S+GC+ + + G+ P+GDK S + + I K
Sbjct: 210 LQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLI 269
Query: 201 KKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKNS 238
+ D +++ ++ P KR +A ++L H +KK
Sbjct: 270 AEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLE 307
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 35/249 (14%), Positives = 66/249 (26%), Gaps = 47/249 (18%)
Query: 8 LFVVKSAESEAGVQALRNEAEIRQSLNSPNIGRNGEKT-----VNIFMEYM-AGGSLLDV 61
L +K+ + ++ + + R ++ F Y +L
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189
Query: 62 AE------KFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPD 109
E +L T ++ LH G++H L+ +++L G V L
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
Query: 110 LGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL-----------DFATDIWSL 158
R ++ + PE+ F+ D W+L
Sbjct: 250 FEHLVRDGAR----------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299
Query: 159 GCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
G ++ + P A I + P V L L E R
Sbjct: 300 GLVIYWIWCADLPITK--DAALGGSEWI--FRSCKNIPQP----VRALLEGFLRYPKEDR 351
Query: 219 WSAEELLNH 227
+ +
Sbjct: 352 LLPLQAMET 360
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 71/263 (26%), Positives = 106/263 (40%), Gaps = 39/263 (14%)
Query: 2 NKGTGALFVVKS----AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEY 52
G + S Q L EA I + L PNI R + E + +
Sbjct: 32 KVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL 91
Query: 53 MAGGSLLD--VAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD 104
+ GG L + VA ++ DA ++IL H G++H +LK N+LL S
Sbjct: 92 VTGGELFEDIVAREYYSEADA---SHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLK 148
Query: 105 ---VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCM 161
VKL D G A V + Q+W GT +++PEVLR + D+W+ G +
Sbjct: 149 GAAVKLADFGLAIEV---EGEQ---QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVI 202
Query: 162 VIEMATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPE 216
+ + G PP W + + +I FP+ + V D + K L P
Sbjct: 203 LYILLVGYPPFWDE---DQHRLYQQIKAG--AYDFPSPEWDTVTPEAKDLINKMLTINPS 257
Query: 217 KRWSAEELLNHTFISGNAKKNST 239
KR +A E L H +IS + S
Sbjct: 258 KRITAAEALKHPWISHRSTVASC 280
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-34
Identities = 62/260 (23%), Positives = 101/260 (38%), Gaps = 41/260 (15%)
Query: 2 NKGTGALFVVKS----AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEY 52
++ T + VK + + E E+ + L+ PNI + + I E
Sbjct: 43 DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102
Query: 53 MAGGSLLD--VAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD 104
GG L D + K DA K++ H + I+H DLK N+LL S
Sbjct: 103 YTGGELFDEIIKRKRFSEHDA---ARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159
Query: 105 ---VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCM 161
+K+ D G + + GT ++APEVLR D D+WS G +
Sbjct: 160 DCDIKIIDFGLSTCFQQ-------NTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVI 211
Query: 162 VIEMATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPE 216
+ + +G PP +G N L ++ K F ++ + D + K L P
Sbjct: 212 LYILLSGTPPFYGK---NEYDILKRVETG--KYAFDLPQWRTISDDAKDLIRKMLTFHPS 266
Query: 217 KRWSAEELLNHTFISGNAKK 236
R +A + L H +I + +
Sbjct: 267 LRITATQCLEHPWIQKYSSE 286
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-34
Identities = 57/270 (21%), Positives = 101/270 (37%), Gaps = 46/270 (17%)
Query: 2 NKGTGALFVVKS---------------AESEAGVQALRNEAEIRQSLNSPNIGR-----N 41
K + +K E + + NE + +SL+ PNI +
Sbjct: 57 EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116
Query: 42 GEKTVNIFMEYMAGGSLLDVAEKFGG---TLDAGVIR--LYTKEILHGNGILHCDLKCNN 96
+K + E+ GG L + A +++ L LH + I+H D+K N
Sbjct: 117 DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPEN 176
Query: 97 VLLGSHGD---VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT 153
+LL + +K+ D G + + + GT ++APEVL+ + +
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSFFSK-------DYKLRDRLGTAYYIAPEVLK-KKYNEKC 228
Query: 154 DIWSLGCMVIEMATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLA 208
D+WS G ++ + G PP G + + K +F +K + + +
Sbjct: 229 DVWSCGVIMYILLCGYPPFGGQNDQD-----IIKKVEKGKYYFDFNDWKNISDEAKELIK 283
Query: 209 KCLERKPEKRWSAEELLNHTFISGNAKKNS 238
L KR +AEE LN +I A +
Sbjct: 284 LMLTYDYNKRCTAEEALNSRWIKKYANNIN 313
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-34
Identities = 60/232 (25%), Positives = 95/232 (40%), Gaps = 25/232 (10%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNSPNIGR---NGEKTVNIFMEYMAGGSLLDV--AEKF 65
+K ESE+ +A E +N PNI + V + MEY GGSL +V +
Sbjct: 36 IKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEP 95
Query: 66 GGTLDAGVIRLYTKEI------LHG---NGILHCDLKCNNVLLGSHGDV-KLPDLGCARR 115
A + + LH ++H DLK N+LL + G V K+ D G A
Sbjct: 96 LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155
Query: 116 VNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDK 175
+ N G+ WMAPEV D++S G ++ E+ T R P+ +
Sbjct: 156 IQTHMTNNK---------GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE- 205
Query: 176 ISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
I A ++ + +P K + + +C + P +R S EE++
Sbjct: 206 IGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-34
Identities = 70/272 (25%), Positives = 115/272 (42%), Gaps = 45/272 (16%)
Query: 2 NKGTGALFVVKS----------AESEAGVQALRNEAEIRQSLNSPNIGRNGE----KTVN 47
+ T ++ A + E EI + LN P I + +
Sbjct: 156 ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY 215
Query: 48 IFMEYMAGGSLLD-VAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
I +E M GG L D V L +LY ++ LH NGI+H DLK NVLL
Sbjct: 216 IVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 273
Query: 101 SHGD---VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN---EGLDFATD 154
S + +K+ D G ++ + + +++ GT ++APEVL + G + A D
Sbjct: 274 SQEEDCLIKITDFGHSKILGE-------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVD 326
Query: 155 IWSLGCMVIEMATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAK 209
WSLG ++ +G PP + + LK ++ K +F + + +V LD + K
Sbjct: 327 CWSLGVILFICLSGYPPFSEHRTQVS----LKDQITSGKYNFIPEVWAEVSEKALDLVKK 382
Query: 210 CLERKPEKRWSAEELLNHTFISGNAKKNSTEE 241
L P+ R++ EE L H ++ K ++
Sbjct: 383 LLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 414
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-34
Identities = 63/260 (24%), Positives = 103/260 (39%), Gaps = 35/260 (13%)
Query: 2 NKGTGALFVVKS----AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEY 52
++ T + VK + + E E+ + L+ PNI + + I E
Sbjct: 43 DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102
Query: 53 MAGGSLLD--VAEKFGGTLDA-GVIR--LYTKEILHGNGILHCDLKCNNVLLGSHGD--- 104
GG L D + K DA +I+ +H + I+H DLK N+LL S
Sbjct: 103 YTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCD 162
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIE 164
+K+ D G + + GT ++APEVLR D D+WS G ++
Sbjct: 163 IKIIDFGLSTCFQQ-------NTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYI 214
Query: 165 MATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEKRW 219
+ +G PP +G N L ++ K F ++ + D + K L P R
Sbjct: 215 LLSGTPPFYGK---NEYDILKRV--ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI 269
Query: 220 SAEELLNHTFISGNAKKNST 239
+A + L H +I + + T
Sbjct: 270 TATQCLEHPWIQKYSSETPT 289
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-33
Identities = 64/257 (24%), Positives = 108/257 (42%), Gaps = 33/257 (12%)
Query: 2 NKGTGALFVVKSAE--SEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMA 54
+ TG LF +K + +L NE + + + NI + M+ ++
Sbjct: 30 QRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS 89
Query: 55 GGSLLD--VAEKFGGTLDA-GVIR--LYTKEILHGNGILHCDLKCNNVLLGSHGD---VK 106
GG L D + DA VI+ L + LH NGI+H DLK N+L + + +
Sbjct: 90 GGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIM 149
Query: 107 LPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMA 166
+ D G ++ + + GT ++APEVL + A D WS+G + +
Sbjct: 150 ITDFGLSKMEQN--------GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201
Query: 167 TGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEKRWSA 221
G PP + + S L F + F+ + DF+ LE+ P +R++
Sbjct: 202 CGYPPFYEETESK-----LFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTC 256
Query: 222 EELLNHTFISGNAKKNS 238
E+ L+H +I GN +
Sbjct: 257 EKALSHPWIDGNTALHR 273
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-33
Identities = 64/251 (25%), Positives = 111/251 (44%), Gaps = 37/251 (14%)
Query: 1 MNKGTGALFVVKS---AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEY 52
+ +G V+K+ S+ ++ + E E+ +SL+ PNI + + I ME
Sbjct: 42 EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101
Query: 53 MAGGSLLD---VAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHG 103
GG LL+ A+ G L G + K+++ H ++H DLK N+L
Sbjct: 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS 161
Query: 104 D---VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGC 160
+K+ D G A + + GT L+MAPEV + + F DIWS G
Sbjct: 162 PHSPIKIIDFGLAELFKS-------DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGV 213
Query: 161 MVIEMATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFF---KKVLDFLAKCLERKPE 216
++ + TG P G + K + ++P++ + + +D L + L + PE
Sbjct: 214 VMYFLLTGCLPFTGT---SLEEVQQKA--TYKEPNYAVECRPLTPQAVDLLKQMLTKDPE 268
Query: 217 KRWSAEELLNH 227
+R SA ++L+H
Sbjct: 269 RRPSAAQVLHH 279
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 66/258 (25%), Positives = 99/258 (38%), Gaps = 44/258 (17%)
Query: 3 KGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGRNGEKTVNIF-------- 49
K TG L+ K + G Q E +I ++S I V++
Sbjct: 207 KATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI-------VSLAYAFETKTD 259
Query: 50 ----MEYMAGGSL---LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNN 96
M M GG + + ++ YT +I LH I++ DLK N
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPEN 319
Query: 97 VLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIW 156
VLL G+V++ DLG A + + GT +MAPE+L E DF+ D +
Sbjct: 320 VLLDDDGNVRISDLGLA------VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYF 373
Query: 157 SLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216
+LG + EM R P+ + LK + +P +F DF L++ PE
Sbjct: 374 ALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPE 433
Query: 217 KR-----WSAEELLNHTF 229
KR S + L H
Sbjct: 434 KRLGFRDGSCDGLRTHPL 451
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-33
Identities = 61/259 (23%), Positives = 97/259 (37%), Gaps = 39/259 (15%)
Query: 2 NKGTGALFVVKS--AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMA 54
KGT K V + E EI +SL+ PNI R + + ME
Sbjct: 30 QKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT 89
Query: 55 GGSLLD--VAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD-- 104
GG L + V ++ DA K++L H + H DLK N L +
Sbjct: 90 GGELFERVVHKRVFRESDA---ARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS 146
Query: 105 -VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163
+KL D G A R + ++ GT +++P+VL D WS G M+
Sbjct: 147 PLKLIDFGLAARFKP-------GKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMY 198
Query: 164 EMATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEKR 218
+ G PP + +LKI FP + + V + + L + P++R
Sbjct: 199 VLLCGYPPFSAP---TDSEVMLKI--REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQR 253
Query: 219 WSAEELLNHTFISGNAKKN 237
++ + L H + +
Sbjct: 254 ITSLQALEHEWFEKQLSSS 272
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-33
Identities = 62/262 (23%), Positives = 106/262 (40%), Gaps = 35/262 (13%)
Query: 2 NKGTGALFVVKSAESEAGVQALRNEAEI-RQSLNSPNI---------GRNGEKTVNIFME 51
++ TG +K R E + Q+ P+I +G++ + I ME
Sbjct: 50 HRRTGQKCALKLLYDSPKA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME 106
Query: 52 YMAGGSLLD-VAEKFGGTLD----AGVIR--LYTKEILHGNGILHCDLKCNNVLLGSHGD 104
M GG L + E+ A ++R + LH + I H D+K N+L S
Sbjct: 107 CMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEK 166
Query: 105 ---VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCM 161
+KL D G A+ + Q+ T ++APEVL E D + D+WSLG +
Sbjct: 167 DAVLKLTDFGFAKETTQ--------NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
Query: 162 VIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEK 217
+ + G PP+ A + +K + FP + +V + L+ P +
Sbjct: 219 MYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 278
Query: 218 RWSAEELLNHTFISGNAKKNST 239
R + + +NH +I+ + T
Sbjct: 279 RLTITQFMNHPWINQSMVVPQT 300
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-33
Identities = 60/289 (20%), Positives = 95/289 (32%), Gaps = 62/289 (21%)
Query: 2 NKGTGALFVVKS---AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIF--ME 51
+K TG LF +K V E E+ + LN NI + T + ME
Sbjct: 30 HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89
Query: 52 YMAGGSLLDVAEKFG--GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
+ GSL V E+ L + +++ L NGI+H ++K N++
Sbjct: 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE 149
Query: 104 D----VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL--------DF 151
D KL D G AR L+++ S+ GT+ ++ P++ L
Sbjct: 150 DGQSVYKLTDFGAARE---LEDDEQFV----SLYGTEEYLHPDMYERAVLRKDHQKKYGA 202
Query: 152 ATDIWSLGCMVIEMATGRPPWGD------------KISNAAATLLKIACSNEK------- 192
D+WS+G ATG P+ KI + +
Sbjct: 203 TVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWS 262
Query: 193 ------PHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235
+ LA LE EK W ++ T +
Sbjct: 263 GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 46/197 (23%), Positives = 86/197 (43%), Gaps = 27/197 (13%)
Query: 50 MEYMAGGSL---LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
++ + GG L L F ++L+ E+ L I+H D+K +N+LL
Sbjct: 94 VDLLLGGDLRYHLQQNVHF----KEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD 149
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE---GLDFATDIWS 157
HG V + D A + + ++ GT+ +MAPE+ + G FA D WS
Sbjct: 150 EHGHVHITDFNIAAMLPR-------ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWS 202
Query: 158 LGCMVIEMATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216
LG E+ GR P +++ + +P+ + ++++ L K LE P+
Sbjct: 203 LGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYPSAWSQEMVSLLKKLLEPNPD 260
Query: 217 KRW-SAEELLNHTFISG 232
+R+ ++ N +++
Sbjct: 261 QRFSQLSDVQNFPYMND 277
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-32
Identities = 58/259 (22%), Positives = 101/259 (38%), Gaps = 28/259 (10%)
Query: 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNS-PNIGR-----NGEKTVNIFMEYMAG 55
+K + F VK + E + PNI + + + + ME + G
Sbjct: 32 HKKSNQAFAVKIISKRM-EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90
Query: 56 GSLLD--VAEKFGGTLDA-GVIR--LYTKEILHGNGILHCDLKCNNVLLGSHGD---VKL 107
G L + +K +A ++R + +H G++H DLK N+L D +K+
Sbjct: 91 GELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKI 150
Query: 108 PDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT 167
D G AR Q ++ T + APE+L G D + D+WSLG ++ M +
Sbjct: 151 IDFGFARLKPPDN------QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLS 204
Query: 168 GRPP-WGDKISNAAATLLKIACS--NEKPHFPTQFFKKV----LDFLAKCLERKPEKRWS 220
G+ P S + ++I F + +K V D + L P KR
Sbjct: 205 GQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK 264
Query: 221 AEELLNHTFISGNAKKNST 239
L + ++ ++ +S
Sbjct: 265 MSGLRYNEWLQDGSQLSSN 283
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-32
Identities = 46/233 (19%), Positives = 81/233 (34%), Gaps = 27/233 (11%)
Query: 13 SAESEAGVQALRNEAEIRQSLNSPNIGR-NG--EKTVNIFMEYMAGGSLLDVAEKFGGTL 69
E Q + E I +LN PNI + G + ME++ G L +
Sbjct: 60 ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPI 119
Query: 70 DAGVIRLYTKEI------LHGNG--ILHCDLKCNNVLLGSHGD-----VKLPDLGCARRV 116
V +I + I+H DL+ N+ L S + K+ D G +++
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS 179
Query: 117 NDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT--DIWSLGCMVIEMATGRPPWGD 174
S + G WMAPE + E + D +S ++ + TG P+ +
Sbjct: 180 V---------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
Query: 175 KISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
+ I +P P ++ + + C P+KR ++
Sbjct: 231 YSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-32
Identities = 54/245 (22%), Positives = 96/245 (39%), Gaps = 22/245 (8%)
Query: 3 KGTGALFVVKS--AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAG 55
+ TG + V+K E + E ++ + L PN+ + +K +N EY+ G
Sbjct: 32 RETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG 91
Query: 56 GSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPD 109
G+L + + + K+I LH I+H DL +N L+ + +V + D
Sbjct: 92 GTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVAD 151
Query: 110 LGCARRVNDLKNN--------GNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCM 161
G AR + D K ++ ++ G WMAPE++ D D++S G +
Sbjct: 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIV 211
Query: 162 VIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221
+ E+ D + L + + P +C + PEKR S
Sbjct: 212 LCEIIGRVNADPDYLPRTMDFGLNVR-GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSF 270
Query: 222 EELLN 226
+L +
Sbjct: 271 VKLEH 275
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-32
Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 41/227 (18%)
Query: 24 RNEAEIRQSLNSPNIGRNGEKTVNIF------------MEYMAGGSLLDVAEKFGGTLDA 71
E L+ NI V++ MEY+ G +L + E G L
Sbjct: 59 EREVHNSSQLSHQNI-------VSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSV 110
Query: 72 GVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNL 125
+T +IL H I+H D+K N+L+ S+ +K+ D G A+ +++ +L
Sbjct: 111 DTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE----TSL 166
Query: 126 KQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPW-GDKISNAAATLL 184
Q+ + GT + +PE + E D TDI+S+G ++ EM G PP+ G+ A + +
Sbjct: 167 TQT-NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE---TAVSIAI 222
Query: 185 KIACSNEKPHFPTQFFKKV---LDFL-AKCLERKPEKRW-SAEELLN 226
K + P+ T K + L + + E+ R+ + +E+ +
Sbjct: 223 K-HIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKD 268
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-32
Identities = 63/265 (23%), Positives = 104/265 (39%), Gaps = 40/265 (15%)
Query: 2 NKGTGALFVVKSAESEAGVQALRNEAEI-RQSLNSPNI---------GRNGEKTVNIFME 51
NK T F +K + R E E+ ++ P+I G K + I ME
Sbjct: 83 NKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139
Query: 52 YMAGGSLLD-VAEKFGGTLD----AGVIR--LYTKEILHGNGILHCDLKCNNVLLGSHGD 104
+ GG L + ++ + +++ + LH I H D+K N+L S
Sbjct: 140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP 199
Query: 105 ---VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCM 161
+KL D G A+ S + T ++APEVL E D + D+WSLG
Sbjct: 200 NAILKLTDFGFAKETTS-------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG-- 250
Query: 162 VIE--MATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKVL----DFLAKCLERK 214
VI + G PP + + + + + FP + +V + L+ +
Sbjct: 251 VIMYILLCGYPPFYSNHGLAISPGMKT-RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 309
Query: 215 PEKRWSAEELLNHTFISGNAKKNST 239
P +R + E +NH +I + K T
Sbjct: 310 PTQRMTITEFMNHPWIMQSTKVPQT 334
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 9e-32
Identities = 63/256 (24%), Positives = 103/256 (40%), Gaps = 43/256 (16%)
Query: 3 KGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGRNGEKTVNIF-------- 49
+ TG ++ K E + G NE +I + +NS + V++
Sbjct: 206 RATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV-------VSLAYAYETKDA 258
Query: 50 ----MEYMAGGSLLDVAEKFG-GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVL 98
+ M GG L G Y EI LH I++ DLK N+L
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENIL 318
Query: 99 LGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSL 158
L HG +++ DLG A V + Q+ + GT +MAPEV++NE F+ D W+L
Sbjct: 319 LDDHGHIRISDLGLAVHVPE-------GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWAL 371
Query: 159 GCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
GC++ EM G+ P+ + ++ + +F + ++ L + P +R
Sbjct: 372 GCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431
Query: 219 -----WSAEELLNHTF 229
SA E+ H
Sbjct: 432 LGCRGGSAREVKEHPL 447
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-31
Identities = 71/272 (26%), Positives = 115/272 (42%), Gaps = 45/272 (16%)
Query: 2 NKGTGALFVVKS----------AESEAGVQALRNEAEIRQSLNSPNIGRNGE----KTVN 47
+ T +K A + E EI + LN P I + +
Sbjct: 31 ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY 90
Query: 48 IFMEYMAGGSLLD-VAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
I +E M GG L D V L +LY ++ LH NGI+H DLK NVLL
Sbjct: 91 IVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 148
Query: 101 SHGD---VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN---EGLDFATD 154
S + +K+ D G ++ + + +++ GT ++APEVL + G + A D
Sbjct: 149 SQEEDCLIKITDFGHSKILGE-------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVD 201
Query: 155 IWSLGCMVIEMATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAK 209
WSLG ++ +G PP + + LK ++ K +F + + +V LD + K
Sbjct: 202 CWSLGVILFICLSGYPPFSEHRTQVS----LKDQITSGKYNFIPEVWAEVSEKALDLVKK 257
Query: 210 CLERKPEKRWSAEELLNHTFISGNAKKNSTEE 241
L P+ R++ EE L H ++ K ++
Sbjct: 258 LLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 289
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-31
Identities = 56/265 (21%), Positives = 99/265 (37%), Gaps = 46/265 (17%)
Query: 2 NKGTGALFVVK--SAESEAGVQALRNEAEIRQSL-NSPNI-------------GRNGEKT 45
+ G+G + +K + E +A+ E + L PNI G+
Sbjct: 49 DVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108
Query: 46 VNIFMEYMAGGSLLDVAEKF--GGTLDAGVIRLYTKEI------LHGNG--ILHCDLKCN 95
+ E G L++ +K G L + + +H I+H DLK
Sbjct: 109 FLLLTEL-CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVE 167
Query: 96 NVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIG------GTQLWMAPEVL---RN 146
N+LL + G +KL D G A ++ + Q + T ++ PE++ N
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227
Query: 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPT--QFFKKVL 204
+ DIW+LGC++ + + P+ D L+I N K P +
Sbjct: 228 FPIGEKQDIWALGCILYLLCFRQHPFED------GAKLRIV--NGKYSIPPHDTQYTVFH 279
Query: 205 DFLAKCLERKPEKRWSAEELLNHTF 229
+ L+ PE+R S E+++
Sbjct: 280 SLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 60/275 (21%), Positives = 85/275 (30%), Gaps = 56/275 (20%)
Query: 2 NKGTGALFVVK---SAESEAGVQALRNEAEIRQSLNSPNI-----------GRNGEKTVN 47
++ TG +K S + E +I + LN PN+
Sbjct: 35 HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL 94
Query: 48 IFMEYMAGGSLLDVAEKFG--GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLL 99
+ MEY GG L +F L G IR +I LH N I+H DLK N++L
Sbjct: 95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVL 154
Query: 100 GSHGD---VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIW 156
K+ DLG A +L GT ++APE+L + D W
Sbjct: 155 QPGPQRLIHKIIDLGYA---KELDQGELCT----EFVGTLQYLAPELLEQKKYTVTVDYW 207
Query: 157 SLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQF-------FKKVL----- 204
S G + E TG P+ H F VL
Sbjct: 208 SFGTLAFECITGFRPFLPN--WQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNH 265
Query: 205 ----------DFLAKCLERKPEKRWSAEELLNHTF 229
+L L +R + + N
Sbjct: 266 LSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-31
Identities = 52/226 (23%), Positives = 88/226 (38%), Gaps = 43/226 (19%)
Query: 24 RNEAEIRQSLNSPNIGRNGEKTVNIF------------MEYMAGGSLLDVAEKFGGTLDA 71
+ EA L P++ V I M + G L + + G
Sbjct: 82 QREARTAGRLQEPHV-------VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPP 134
Query: 72 GVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNL 125
+ + ++I H G H D+K N+L+ + L D G A D L
Sbjct: 135 RAVAI-VRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD----EKL 189
Query: 126 KQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPW-GDKISNAAATLL 184
Q ++G T +MAPE + DI++L C++ E TG PP+ GD++S A +
Sbjct: 190 TQLGNTVG-TLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI- 247
Query: 185 KIACSNEKPHFPTQFFKKV---LD-FLAKCLERKPEKRW-SAEELL 225
N+ P+ + D +A+ + + PE R+ + +L
Sbjct: 248 -----NQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLS 288
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-31
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 32/225 (14%)
Query: 24 RNEAEIRQSLNSPNI---------GRNGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74
R EA+ +LN P I I MEY+ G +L D+ G +
Sbjct: 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRA 118
Query: 75 RLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQS 128
+ H NGI+H D+K N+++ + VK+ D G AR + D + ++ Q+
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD--SGNSVTQT 176
Query: 129 WQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPW-GDKISNAAATLLK-I 186
IG Q +++PE R + +D +D++SLGC++ E+ TG PP+ GD + + + +
Sbjct: 177 AAVIGTAQ-YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD---SPVSVAYQHV 232
Query: 187 ACSNEKPHFPTQFFKKV---LDFL-AKCLERKPEKRW-SAEELLN 226
E P P+ + + LD + K L + PE R+ +A E+
Sbjct: 233 ---REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-31
Identities = 45/224 (20%), Positives = 76/224 (33%), Gaps = 36/224 (16%)
Query: 16 SEAGVQALRNEAEIRQSLNSPNI----G---RNGEKTVNIFMEYMAGGSLLDV-AEKFGG 67
S + E + + PN+ G + +M GSL +V E
Sbjct: 47 STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF 106
Query: 68 TLDAGVIRLYTKEI------LH--GNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDL 119
+D + ++ LH I L +V++ ++
Sbjct: 107 VVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF----- 161
Query: 120 KNNGNLKQSWQSIG--GTQLWMAPEVLRNEGLDFAT---DIWSLGCMVIEMATGRPPWGD 174
S+QS G W+APE L+ + D D+WS ++ E+ T P+ D
Sbjct: 162 --------SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
Query: 175 KISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
+SN +K+A +P P V + C+ P KR
Sbjct: 214 -LSNMEI-GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-31
Identities = 62/271 (22%), Positives = 108/271 (39%), Gaps = 49/271 (18%)
Query: 2 NKGTGALFVVKS-----------AESEAGVQALRNEAEIRQSLNS-PNIGR-----NGEK 44
+K T + VK E + +A E +I + ++ PNI +
Sbjct: 38 HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97
Query: 45 TVNIFMEYMAGGSLLD-VAEKFGGTLD----AGVIR--LYTKEILHGNGILHCDLKCNNV 97
+ + M G L D + EK TL ++R L LH I+H DLK N+
Sbjct: 98 FFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENI 155
Query: 98 LLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR------NEGLDF 151
LL ++KL D G + +++ + + + GT ++APE++ + G
Sbjct: 156 LLDDDMNIKLTDFGFSCQLDP-------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGK 208
Query: 152 ATDIWSLGCMVIEMATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDF 206
D+WS G ++ + G PP W K ++ F + + D
Sbjct: 209 EVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS-----GNYQFGSPEWDDYSDTVKDL 263
Query: 207 LAKCLERKPEKRWSAEELLNHTFISGNAKKN 237
+++ L +P+KR++AEE L H F +
Sbjct: 264 VSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-31
Identities = 50/234 (21%), Positives = 91/234 (38%), Gaps = 26/234 (11%)
Query: 15 ESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTL 69
++E ++A + E + N+ + I G +L V L
Sbjct: 68 DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVL 127
Query: 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG 123
D R +EI LH GILH DLK NV +G V + D G ++ + G
Sbjct: 128 DVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF-SISGVLQAG 185
Query: 124 NLKQSWQSIGGTQLWMAPEVLRNEGL---------DFATDIWSLGCMVIEMATGRPPWGD 174
+ + G +APE++R +D+++LG + E+ P+
Sbjct: 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
Query: 175 KISNAAATLLKIACSNEKPHFPTQFF-KKVLDFLAKCLERKPEKRWSAEELLNH 227
+ A A + ++ + KP+ K++ D L C + E+R + +L++
Sbjct: 246 Q--PAEAIIWQMG-TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 6e-31
Identities = 36/200 (18%), Positives = 54/200 (27%), Gaps = 37/200 (18%)
Query: 48 IFMEYMAG-----GSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNN 96
M G +L +L T ++ LH G++H L+ +
Sbjct: 182 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVD 241
Query: 97 VLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL----WMAPEVLRNEG---- 148
++L G V L R S S G A +L
Sbjct: 242 IVLDQRGGVFLTGFEHLVRDGA---------SAVSPIGRGFAPPETTAERMLPFGQHHPT 292
Query: 149 -LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFL 207
+ FA D W+LG + + P D A I + P V L
Sbjct: 293 LMTFAFDTWTLGLAIYWIWCADLPNTD--DAALGGSEWI--FRSCKNIPQP----VRALL 344
Query: 208 AKCLERKPEKRWSAEELLNH 227
L E R + +
Sbjct: 345 EGFLRYPKEDRLLPLQAMET 364
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-31
Identities = 52/236 (22%), Positives = 88/236 (37%), Gaps = 42/236 (17%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNI----------GRNGEKTVNIFMEYMAGG 56
L + + E + + P+I R+G+ I MEY+ G
Sbjct: 110 VLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQ 169
Query: 57 SLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDL 110
SL G L Y EIL H G+++ DLK N++L + +KL DL
Sbjct: 170 SL---KRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML-TEEQLKLIDL 225
Query: 111 GCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRP 170
G R+N + GT + APE++R G ATDI+++G + + P
Sbjct: 226 GAVSRINSF----------GYLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLP 274
Query: 171 PWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-SAEELL 225
+ + + + L + ++ P +R+ +AEE+
Sbjct: 275 TR------NGRYVDGLPEDDPVLKTYDSYG----RLLRRAIDPDPRQRFTTAEEMS 320
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-30
Identities = 64/277 (23%), Positives = 107/277 (38%), Gaps = 43/277 (15%)
Query: 2 NKGTGALFVVKSAE--SEAGVQALRNEAEI-RQSLNSPNIGR-----NGEKTVNIFMEYM 53
N T + VK E + E E+ Q N+ E + E M
Sbjct: 34 NLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM 93
Query: 54 AGGSLLD--VAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGD- 104
GGS+L + L+A V+ +++ LH GI H DLK N+L
Sbjct: 94 RGGSILSHIHKRRHFNELEASVV---VQDVASALDFLHNKGIAHRDLKPENILCEHPNQV 150
Query: 105 --VKLPDLGCARRVNDLKNNGNLK-QSWQSIGGTQLWMAPEVLRNEGL-----DFATDIW 156
VK+ D + + + + G+ +MAPEV+ D D+W
Sbjct: 151 SPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLW 210
Query: 157 SLGCMVIEMATGRPP-WGDKISNAAATLLKIACSNE----------KPHFPTQFFKKVL- 204
SLG ++ + +G PP G S+ + + + K FP + + +
Sbjct: 211 SLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISC 270
Query: 205 ---DFLAKCLERKPEKRWSAEELLNHTFISGNAKKNS 238
D ++K L R ++R SA ++L H ++ G A +N+
Sbjct: 271 AAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-30
Identities = 29/236 (12%), Positives = 62/236 (26%), Gaps = 38/236 (16%)
Query: 20 VQALRNEAEIRQSLNSPNIGRNGE-----KTVNIFMEYMAGGSLLDVAEKFG----GTLD 70
E + + + E + G+LL+ + +
Sbjct: 111 FYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMP 170
Query: 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS-----------HGDVKLPDLGCA 113
G++ + + +H I+H D+K +N +LG+ + L DLG +
Sbjct: 171 QGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 114 RRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWG 173
+ T + E+L N+ ++ D + + V M G
Sbjct: 231 IDMKLFPKGTIFTAKC----ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286
Query: 174 DKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTF 229
+ + + L + +LL
Sbjct: 287 KNEGGE-----CKPEGLFRRLPHLDMWNEFFH---VMLNIPDCHHLPSLDLLRQKL 334
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-30
Identities = 70/279 (25%), Positives = 108/279 (38%), Gaps = 66/279 (23%)
Query: 2 NKGTG---ALFVVKSAESEAGV--QALRNEAEIR--QSLNSPNIGR-----NGEKTVNIF 49
NK TG A+ ++ + V A+R EI+ + L N+ +K +
Sbjct: 46 NKDTGRIVAIKKFLESDDDKMVKKIAMR---EIKLLKQLRHENLVNLLEVCKKKKRWYLV 102
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHG 103
E++ ++LD E F LD V++ Y +I+ H + I+H D+K N+L+ G
Sbjct: 103 FEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG 161
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQ----LWM-APEVL-RNEGLDFATDIWS 157
VKL D G AR + W APE+L + A D+W+
Sbjct: 162 VVKLCDFGFARTLAAPGEV-----------YDDEVATRWYRAPELLVGDVKYGKAVDVWA 210
Query: 158 LGCMVIEMATGRPPW-GD-------KISNAAATL----------LKIACSNEKPHF-PTQ 198
+GC+V EM G P + GD I L + P +
Sbjct: 211 IGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKERE 270
Query: 199 FFKKV--------LDFLAKCLERKPEKRWSAEELLNHTF 229
++ +D KCL P+KR ELL+H F
Sbjct: 271 PLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-30
Identities = 73/258 (28%), Positives = 109/258 (42%), Gaps = 30/258 (11%)
Query: 2 NKGTGALFVVKSAESEAGVQALRNEAEI-RQSLNSPNIGR-----NGEKTVNIFMEYMAG 55
+K T F VK + + E EI + PNI + K V + E M G
Sbjct: 43 HKATNMEFAVKIIDKSK--RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100
Query: 56 GSLLD--VAEKFGGTLDA-GVIR--LYTKEILHGNGILHCDLKCNNVLLGSHGD----VK 106
G LLD + +KF +A V+ T E LH G++H DLK +N+L ++
Sbjct: 101 GELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIR 160
Query: 107 LPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMA 166
+ D G A+++ NG L T ++APEVL +G D A DIWSLG ++ M
Sbjct: 161 ICDFGFAKQLRA--ENGLLMT----PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTML 214
Query: 167 TGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEKRWSA 221
TG P L +I + K ++ V D ++K L P +R +A
Sbjct: 215 TGYTPFANGPDDTPEEILARI--GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTA 272
Query: 222 EELLNHTFISGNAKKNST 239
+L H +I +
Sbjct: 273 ALVLRHPWIVHWDQLPQY 290
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-30
Identities = 52/196 (26%), Positives = 79/196 (40%), Gaps = 30/196 (15%)
Query: 50 MEYMAGGSL---LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
++ M GG L L F +R Y EI +H +++ DLK N+LL
Sbjct: 271 LDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD 326
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL-RNEGLDFATDIWSLG 159
HG V++ DLG A + K + + GT +MAPEVL + D + D +SLG
Sbjct: 327 EHGHVRISDLGLACDFSKKKPH--------ASVGTHGYMAPEVLQKGVAYDSSADWFSLG 378
Query: 160 CMVIEMATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
CM+ ++ G P K + P F ++ L L+R +R
Sbjct: 379 CMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMAVELPDSFSPELRSLLEGLLQRDVNRR 436
Query: 219 -----WSAEELLNHTF 229
A+E+ F
Sbjct: 437 LGCLGRGAQEVKESPF 452
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-29
Identities = 56/243 (23%), Positives = 93/243 (38%), Gaps = 34/243 (13%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDV 61
A + ++ +R EA++ L PNI E + + ME+ GG L V
Sbjct: 37 AARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRV 96
Query: 62 AEKFGGTLDAGVIRLYTKEI------LHGNG---ILHCDLKCNNVLLG--------SHGD 104
+ ++ + +I LH I+H DLK +N+L+ S+
Sbjct: 97 LSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIE 164
+K+ D G AR + S G WMAPEV+R +D+WS G ++ E
Sbjct: 155 LKITDFGLAR----EWHRTTKM----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWE 206
Query: 165 MATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
+ TG P+ + A +A + P+ + + C P R S +
Sbjct: 207 LLTGEVPFRGI--DGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNI 264
Query: 225 LNH 227
L+
Sbjct: 265 LDQ 267
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-29
Identities = 57/255 (22%), Positives = 91/255 (35%), Gaps = 51/255 (20%)
Query: 23 LRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-------GTLD 70
+NE +I + + V I EYM S+L E F +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 71 AGVIRLYTKEILHG-------NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG 123
VI+ K +L+ I H D+K +N+L+ +G VKL D G + + D K
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK--- 206
Query: 124 NLKQSWQSIGGTQLWMAPEVLRNEGL--DFATDIWSLGCMVIEMATGRPPWGDKISNAAA 181
+ GT +M PE NE DIWSLG + M P+ K +
Sbjct: 207 -----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK-ISLVE 260
Query: 182 TLLKIACSNEKPHFPTQFFKKVL-------------------DFLAKCLERKPEKRWSAE 222
I + +P + DFL L + P +R ++E
Sbjct: 261 LFNNI--RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318
Query: 223 ELLNHTFISGNAKKN 237
+ L H +++ ++
Sbjct: 319 DALKHEWLADTNIED 333
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-29
Identities = 59/290 (20%), Positives = 104/290 (35%), Gaps = 88/290 (30%)
Query: 2 NKGTG---ALFVVKSAESEAGV--QALRNEAEIR--QSLNSPNIGR-----NGEKTVNIF 49
N+ TG A+ +E + + ALR EIR + L PN+ ++ +++
Sbjct: 24 NRDTGQIVAIKKFLESEDDPVIKKIALR---EIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHG 103
EY ++L +++ + +++ T + L H + +H D+K N+L+ H
Sbjct: 81 FEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS 139
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGG-----TQ----LWM-APEVL-RNEGLDFA 152
+KL D G AR + G W +PE+L +
Sbjct: 140 VIKLCDFGFAR----------------LLTGPSDYYDDEVATRWYRSPELLVGDTQYGPP 183
Query: 153 TDIWSLGCMVIEMATGRPPW-GD-------KISNAAATLLKIACSNEK--------PHFP 196
D+W++GC+ E+ +G P W G I L + +F
Sbjct: 184 VDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDL------IPRHQQVFSTNQYFS 237
Query: 197 TQFFKKV-----------------LDFLAKCLERKPEKRWSAEELLNHTF 229
L L CL P +R + E+LL+H +
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 7e-29
Identities = 58/194 (29%), Positives = 93/194 (47%), Gaps = 31/194 (15%)
Query: 50 MEYMAGG---SLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
M+Y+ GG SLL +++F V + Y E+ LH I++ DLK N+LL
Sbjct: 85 MDYIEGGELFSLLRKSQRF----PNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD 140
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGC 160
+G +K+ D G A+ V D+ ++ GT ++APEV+ + + + D WS G
Sbjct: 141 KNGHIKITDFGFAKYVPDVTY---------TLCGTPDYIAPEVVSTKPYNKSIDWWSFGI 191
Query: 161 MVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW- 219
++ EM G P+ D N T KI N + FP F + V D L++ + R +R
Sbjct: 192 LIYEMLAGYTPFYDS--NTMKTYEKIL--NAELRFPPFFNEDVKDLLSRLITRDLSQRLG 247
Query: 220 ----SAEELLNHTF 229
E++ NH +
Sbjct: 248 NLQNGTEDVKNHPW 261
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-29
Identities = 55/194 (28%), Positives = 87/194 (44%), Gaps = 31/194 (15%)
Query: 50 MEYMAGG---SLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
MEY+AGG S L +F R Y +I LH +++ DLK N+L+
Sbjct: 120 MEYVAGGEMFSHLRRIGRF----SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGC 160
G +++ D G A+RV ++ GT +APE++ ++G + A D W+LG
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW---------TLCGTPEALAPEIILSKGYNKAVDWWALGV 226
Query: 161 MVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW- 219
++ EMA G PP+ KI + K FP+ F + D L L+ KR+
Sbjct: 227 LIYEMAAGYPPFFAD--QPIQIYEKIV--SGKVRFPSHFSSDLKDLLRNLLQVDLTKRFG 282
Query: 220 ----SAEELLNHTF 229
++ NH +
Sbjct: 283 NLKNGVNDIKNHKW 296
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-28
Identities = 62/195 (31%), Positives = 87/195 (44%), Gaps = 30/195 (15%)
Query: 50 MEYMAGGSL---LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
+EY++GG L L+ F Y EI LH GI++ DLK N++L
Sbjct: 100 LEYLSGGELFMQLEREGIF----MEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN 155
Query: 101 SHGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
G VKL D G C K + + + GT +MAPE+L G + A D WSLG
Sbjct: 156 HQGHVKLTDFGLC-------KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLG 208
Query: 160 CMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR- 218
++ +M TG PP+ + N T+ KI K + P ++ D L K L+R R
Sbjct: 209 ALMYDMLTGAPPFTGE--NRKKTIDKIL--KCKLNLPPYLTQEARDLLKKLLKRNAASRL 264
Query: 219 ----WSAEELLNHTF 229
A E+ H F
Sbjct: 265 GAGPGDAGEVQAHPF 279
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-28
Identities = 54/195 (27%), Positives = 81/195 (41%), Gaps = 30/195 (15%)
Query: 50 MEYMAGGSL---LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
++++ GG L L F ++ Y E+ LH GI++ DLK N+LL
Sbjct: 105 LDFLRGGDLFTRLSKEVMF----TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD 160
Query: 101 SHGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
G +KL D G K + + ++ S GT +MAPEV+ G + D WS G
Sbjct: 161 EEGHIKLTDFGLS-------KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFG 213
Query: 160 CMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR- 218
++ EM TG P+ K + T+ I K P + L +R P R
Sbjct: 214 VLMFEMLTGTLPFQGK--DRKETMTMIL--KAKLGMPQFLSPEAQSLLRMLFKRNPANRL 269
Query: 219 ----WSAEELLNHTF 229
EE+ H+F
Sbjct: 270 GAGPDGVEEIKRHSF 284
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-28
Identities = 56/191 (29%), Positives = 83/191 (43%), Gaps = 26/191 (13%)
Query: 50 MEYMAGGSL---LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
MEY+ GG L + KF D Y EI LH GI++ DLK +N+LL
Sbjct: 97 MEYLNGGDLMYHIQSCHKF----DLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD 152
Query: 101 SHGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
G +K+ D G C K N + GT ++APE+L + + + D WS G
Sbjct: 153 KDGHIKIADFGMC-------KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFG 205
Query: 160 CMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219
++ EM G+ P+ + + I + P +P K+ D L K R+PEKR
Sbjct: 206 VLLYEMLIGQSPFHGQ--DEEELFHSIR--MDNPFYPRWLEKEAKDLLVKLFVREPEKRL 261
Query: 220 -SAEELLNHTF 229
++ H
Sbjct: 262 GVRGDIRQHPL 272
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-28
Identities = 55/194 (28%), Positives = 76/194 (39%), Gaps = 29/194 (14%)
Query: 50 MEYMAGGSL---LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
++Y+ GG L L F R Y EI LH I++ DLK N+LL
Sbjct: 118 LDYINGGELFYHLQRERCF----LEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD 173
Query: 101 SHGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
S G + L D G C K N + + GT ++APEVL + D D W LG
Sbjct: 174 SQGHIVLTDFGLC-------KENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLG 226
Query: 160 CMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR- 218
++ EM G PP+ + N A I N+ L L++ KR
Sbjct: 227 AVLYEMLYGLPPFYSR--NTAEMYDNIL--NKPLQLKPNITNSARHLLEGLLQKDRTKRL 282
Query: 219 ---WSAEELLNHTF 229
E+ +H F
Sbjct: 283 GAKDDFMEIKSHVF 296
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-28
Identities = 60/263 (22%), Positives = 106/263 (40%), Gaps = 48/263 (18%)
Query: 2 NKGTGALFVVKS----------AESEAGVQALRNEAEIRQSLNS-PNIGR-----NGEKT 45
++ TG F VK + E +A R E I + + P+I
Sbjct: 115 HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174
Query: 46 VNIFMEYMAGGSLLD-VAEKFGGTLD----AGVIR--LYTKEILHGNGILHCDLKCNNVL 98
+ + + M G L D + EK L ++R L LH N I+H DLK N+L
Sbjct: 175 MFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENIL 232
Query: 99 LGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR------NEGLDFA 152
L + ++L D G + + + + + GT ++APE+L+ + G
Sbjct: 233 LDDNMQIRLSDFGFSCHLEP-------GEKLRELCGTPGYLAPEILKCSMDETHPGYGKE 285
Query: 153 TDIWSLGCMVIEMATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFL 207
D+W+ G ++ + G PP W + +++ + F + + D +
Sbjct: 286 VDLWACGVILFTLLAGSPPFWHRRQILMLRMIME-----GQYQFSSPEWDDRSSTVKDLI 340
Query: 208 AKCLERKPEKRWSAEELLNHTFI 230
++ L+ PE R +AE+ L H F
Sbjct: 341 SRLLQVDPEARLTAEQALQHPFF 363
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-27
Identities = 54/195 (27%), Positives = 84/195 (43%), Gaps = 30/195 (15%)
Query: 50 MEYMAGGSL---LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
MEY GG L L F R Y EI LH +++ D+K N++L
Sbjct: 84 MEYANGGELFFHLSRERVF----TEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139
Query: 101 SHGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
G +K+ D G C K + + ++ GT ++APEVL + A D W LG
Sbjct: 140 KDGHIKITDFGLC-------KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 192
Query: 160 CMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR- 218
++ EM GR P+ ++ + I E+ FP + LA L++ P++R
Sbjct: 193 VVMYEMMCGRLPFYNQ--DHERLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 248
Query: 219 ----WSAEELLNHTF 229
A+E++ H F
Sbjct: 249 GGGPSDAKEVMEHRF 263
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 47/195 (24%), Positives = 79/195 (40%), Gaps = 30/195 (15%)
Query: 50 MEYMAGGSL---LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
MEY+ GG L + +F Y EI L GI++ DLK +NV+L
Sbjct: 100 MEYVNGGDLMYHIQQVGRF----KEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 155
Query: 101 SHGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
S G +K+ D G C K N + ++ GT ++APE++ + + D W+ G
Sbjct: 156 SEGHIKIADFGMC-------KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFG 208
Query: 160 CMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR- 218
++ EM G+ P+ + + I +P K+ + + + P KR
Sbjct: 209 VLLYEMLAGQAPFEGE--DEDELFQSIM--EHNVAYPKSMSKEAVAICKGLMTKHPGKRL 264
Query: 219 ----WSAEELLNHTF 229
++ H F
Sbjct: 265 GCGPEGERDIKEHAF 279
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-27
Identities = 56/254 (22%), Positives = 99/254 (38%), Gaps = 63/254 (24%)
Query: 22 ALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76
+R E I + L NI + + +K + + E++ L + + G L++ +
Sbjct: 47 TIR-EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKS 104
Query: 77 YTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVND-LKNNGNLKQSW 129
+ ++L H +LH DLK N+L+ G++K+ D G AR ++
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY------- 157
Query: 130 QSIGGTQ----LWM-APEVLRNEGL-DFATDIWSLGCMVIEMATGRPPW-GDKISNAAAT 182
T LW AP+VL DIWS+GC+ EM G P + G + A
Sbjct: 158 -----THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV---SEADQ 209
Query: 183 LLKI-------------------ACSNEKPHFPTQFFKKV--------LDFLAKCLERKP 215
L++I + ++ +D L+K L+ P
Sbjct: 210 LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269
Query: 216 EKRWSAEELLNHTF 229
+R +A++ L H +
Sbjct: 270 NQRITAKQALEHAY 283
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-27
Identities = 54/196 (27%), Positives = 81/196 (41%), Gaps = 31/196 (15%)
Query: 50 MEYMAGGSL---LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
ME++ GG L + + +F D R Y EI LH GI++ DLK +NVLL
Sbjct: 103 MEFVNGGDLMFHIQKSRRF----DEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD 158
Query: 101 SHGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
G KL D G C K + + GT ++APE+L+ A D W++G
Sbjct: 159 HEGHCKLADFGMC-------KEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMG 211
Query: 160 CMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR- 218
++ EM G P+ + N I N++ +PT + L + + P R
Sbjct: 212 VLLYEMLCGHAPFEAE--NEDDLFEAIL--NDEVVYPTWLHEDATGILKSFMTKNPTMRL 267
Query: 219 -----WSAEELLNHTF 229
+L H F
Sbjct: 268 GSLTQGGEHAILRHPF 283
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-27
Identities = 52/200 (26%), Positives = 83/200 (41%), Gaps = 25/200 (12%)
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
M+Y GG LL + KF L + R Y E+ +H +H D+K +N+L+ +G
Sbjct: 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG 212
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR-----NEGLDFATDIWSL 158
++L D G ++ + QS GT +++PE+L+ D WSL
Sbjct: 213 HIRLADFGSCLKLME----DGTVQSS-VAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267
Query: 159 GCMVIEMATGRPPWGDKISNAAATLLKIACSNEK---PHFPTQFFKKVLDFLAKCLERKP 215
G + EM G P+ + + T KI E+ P T + D + + +
Sbjct: 268 GVCMYEMLYGETPFYAE--SLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLI-CSR 324
Query: 216 EKR---WSAEELLNHTFISG 232
E R E+ H F SG
Sbjct: 325 EHRLGQNGIEDFKKHPFFSG 344
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-27
Identities = 57/199 (28%), Positives = 86/199 (43%), Gaps = 27/199 (13%)
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
MEY GG LL + KFG + A + R Y EI +H G +H D+K +N+LL G
Sbjct: 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG 199
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF-------ATDIW 156
++L D G ++ +G ++ GT +++PE+L+ G D W
Sbjct: 200 HIRLADFGSCLKLRA---DGTVRSL--VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWW 254
Query: 157 SLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK---PHFPTQFFKKVLDFLAKCLER 213
+LG EM G+ P+ + A T KI E P ++ DF+ + L
Sbjct: 255 ALGVFAYEMFYGQTPFYAD--STAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQR-LLC 311
Query: 214 KPEKR---WSAEELLNHTF 229
PE R A + H F
Sbjct: 312 PPETRLGRGGAGDFRTHPF 330
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 31/199 (15%)
Query: 50 MEYMAGGSL---LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
++Y+ GG L L E+F +++Y EI LH GI++ D+K N+LL
Sbjct: 138 LDYINGGELFTHLSQRERF----TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD 193
Query: 101 SHGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE--GLDFATDIWS 157
S+G V L D G V D GT +MAP+++R G D A D WS
Sbjct: 194 SNGHVVLTDFGLSKEFVADETERAY------DFCGTIEYMAPDIVRGGDSGHDKAVDWWS 247
Query: 158 LGCMVIEMATGRPPW--GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKP 215
LG ++ E+ TG P+ + ++ A +I +P +P + D + + L + P
Sbjct: 248 LGVLMYELLTGASPFTVDGEKNSQAEISRRIL--KSEPPYPQEMSALAKDLIQRLLMKDP 305
Query: 216 EKR-----WSAEELLNHTF 229
+KR A+E+ H F
Sbjct: 306 KKRLGCGPRDADEIKEHLF 324
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 47/195 (24%), Positives = 79/195 (40%), Gaps = 30/195 (15%)
Query: 50 MEYMAGGSL---LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
MEY+ GG L + +F Y EI L GI++ DLK +NV+L
Sbjct: 421 MEYVNGGDLMYHIQQVGRF----KEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 476
Query: 101 SHGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
S G +K+ D G C K N + ++ GT ++APE++ + + D W+ G
Sbjct: 477 SEGHIKIADFGMC-------KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFG 529
Query: 160 CMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR- 218
++ EM G+ P+ + + I +P K+ + + + P KR
Sbjct: 530 VLLYEMLAGQAPFEGE--DEDELFQSIM--EHNVAYPKSMSKEAVAICKGLMTKHPGKRL 585
Query: 219 ----WSAEELLNHTF 229
++ H F
Sbjct: 586 GCGPEGERDIKEHAF 600
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-26
Identities = 57/203 (28%), Positives = 83/203 (40%), Gaps = 36/203 (17%)
Query: 50 MEYMAGGSL---LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
+EY+ GG L + K R Y+ EI LH GI++ DLK +NVLL
Sbjct: 89 IEYVNGGDLMFHMQRQRKL----PEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD 144
Query: 101 SHGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
S G +KL D G C K + + GT ++APE+LR E F+ D W+LG
Sbjct: 145 SEGHIKLTDYGMC-------KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALG 197
Query: 160 CMVIEMATGRPPWGDKISNAAA-------TLLKIACSNEKPHFPTQFFKKVLDFLAKCLE 212
++ EM GR P+ S+ I ++ P K L L
Sbjct: 198 VLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--EKQIRIPRSLSVKAASVLKSFLN 255
Query: 213 RKPEKR------WSAEELLNHTF 229
+ P++R ++ H F
Sbjct: 256 KDPKERLGCHPQTGFADIQGHPF 278
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 54/195 (27%), Positives = 85/195 (43%), Gaps = 25/195 (12%)
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG 103
MEYM GG L+++ + + R YT E+ +H G +H D+K +N+LL G
Sbjct: 148 MEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 205
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF----ATDIWSLG 159
+KL D G ++N + + + GT +++PEVL+++G D D WS+G
Sbjct: 206 HLKLADFGTCMKMNK----EGMVRCD-TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 260
Query: 160 CMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFF--KKVLDFLAKCLERKPEK 217
+ EM G P+ + T KI FP K+ + + L E
Sbjct: 261 VFLYEMLVGDTPFYAD--SLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREV 317
Query: 218 R---WSAEELLNHTF 229
R EE+ H F
Sbjct: 318 RLGRNGVEEIKRHLF 332
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 71/291 (24%), Positives = 111/291 (38%), Gaps = 83/291 (28%)
Query: 2 NKGTGALFVVK--SAESEAGV--QALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEY 52
NK TG +K +SE G A+R E + + L NI R + E + + E+
Sbjct: 26 NKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKELKHENIVRLYDVIHTENKLTLVFEF 84
Query: 53 MAG--GSLLD--VAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSH 102
M +D L+ +++ + ++L H N ILH DLK N+L+
Sbjct: 85 MDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR 144
Query: 103 GDVKLPDLGCARRVND-LKNNGNLKQSWQSIGGTQ----LWM-APEVLRNEGL-----DF 151
G +KL D G AR + + LW AP+VL +
Sbjct: 145 GQLKLGDFGLARAFGIPVNTF------------SSEVVTLWYRAPDVL----MGSRTYST 188
Query: 152 ATDIWSLGCMVIEMATGRPPW-GDKISNAAATLLKI--AC-----------------SNE 191
+ DIWS GC++ EM TG+P + G N L I +
Sbjct: 189 SIDIWSCGCILAEMITGKPLFPGT---NDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPN 245
Query: 192 KPHFPTQFFKKV-------------LDFLAKCLERKPEKRWSAEELLNHTF 229
P + ++V +DFL L+ P+ R SA++ L+H +
Sbjct: 246 IQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-26
Identities = 66/252 (26%), Positives = 104/252 (41%), Gaps = 58/252 (23%)
Query: 22 ALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76
A+R E + + L+ PNI + E+ + + E+M L V ++ L I++
Sbjct: 66 AIR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKI 123
Query: 77 YTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVND-LKNNGNLKQSW 129
Y ++L H + ILH DLK N+L+ S G +KL D G AR +++
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY------- 176
Query: 130 QSIGGTQ----LWM-APEVLRNEGL-DFATDIWSLGCMVIEMATGRPPW-GD-------K 175
T LW AP+VL + DIWS+GC+ EM TG+P + G K
Sbjct: 177 -----THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK 231
Query: 176 ISNA----------AATLLKIACSNEKPHFPTQFFKKV--------LDFLAKCLERKPEK 217
I + L + F + + + +D L+ L P K
Sbjct: 232 IFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNK 291
Query: 218 RWSAEELLNHTF 229
R SA + +NH +
Sbjct: 292 RISARDAMNHPY 303
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-26
Identities = 57/203 (28%), Positives = 83/203 (40%), Gaps = 36/203 (17%)
Query: 50 MEYMAGGSL---LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
+EY+ GG L + K R Y+ EI LH GI++ DLK +NVLL
Sbjct: 132 IEYVNGGDLMFHMQRQRKL----PEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD 187
Query: 101 SHGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
S G +KL D G C K + + GT ++APE+LR E F+ D W+LG
Sbjct: 188 SEGHIKLTDYGMC-------KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALG 240
Query: 160 CMVIEMATGRPPWGDKISNAAA-------TLLKIACSNEKPHFPTQFFKKVLDFLAKCLE 212
++ EM GR P+ S+ I ++ P K L L
Sbjct: 241 VLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--EKQIRIPRSLSVKAASVLKSFLN 298
Query: 213 RKPEKR------WSAEELLNHTF 229
+ P++R ++ H F
Sbjct: 299 KDPKERLGCHPQTGFADIQGHPF 321
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 61/263 (23%), Positives = 98/263 (37%), Gaps = 64/263 (24%)
Query: 15 ESEAGV--QALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG 67
E E G A+R E + + L NI + EK++ + EY+ L + G
Sbjct: 38 EHEEGAPCTAIR-EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGN 95
Query: 68 TLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVND-LK 120
++ ++L+ ++L H +LH DLK N+L+ G++KL D G AR + K
Sbjct: 96 IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155
Query: 121 NNGNLKQSWQSIGGTQ----LWM-APEVL---RNEGLDFATDIWSLGCMVIEMATGRPPW 172
LW P++L + D+W +GC+ EMATGRP +
Sbjct: 156 TY------------DNEVVTLWYRPPDILLGSTDYST--QIDMWGVGCIFYEMATGRPLF 201
Query: 173 -GD-------KISNA----------AATLLKIACSNEKPHFPTQFFKKV--------LDF 206
G I + + P + + D
Sbjct: 202 PGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADL 261
Query: 207 LAKCLERKPEKRWSAEELLNHTF 229
L K L+ + R SAE+ + H F
Sbjct: 262 LTKLLQFEGRNRISAEDAMKHPF 284
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 54/196 (27%), Positives = 83/196 (42%), Gaps = 31/196 (15%)
Query: 50 MEYMAGGSL---LDVAEKFGGTLDAGVIRLYTKEI------LHG-NGILHCDLKCNNVLL 99
MEY GG L L F R Y EI LH +++ DLK N++L
Sbjct: 227 MEYANGGELFFHLSRERVF----SEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 282
Query: 100 GSHGDVKLPDLG-CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSL 158
G +K+ D G C K + ++ GT ++APEVL + A D W L
Sbjct: 283 DKDGHIKITDFGLC-------KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 335
Query: 159 GCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
G ++ EM GR P+ ++ + I E+ FP + L+ L++ P++R
Sbjct: 336 GVVMYEMMCGRLPFYNQ--DHEKLFELIL--MEEIRFPRTLGPEAKSLLSGLLKKDPKQR 391
Query: 219 -----WSAEELLNHTF 229
A+E++ H F
Sbjct: 392 LGGGSEDAKEIMQHRF 407
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-25
Identities = 55/263 (20%), Positives = 94/263 (35%), Gaps = 57/263 (21%)
Query: 2 NKGTGALFVVKSAESEAGVQALRNEAEI-RQSLNSPNI---------GRNGEKTVNIFME 51
NK T F +K + R E E+ ++ P+I G K + I ME
Sbjct: 39 NKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 95
Query: 52 YMAGGSLLD-VAEKFGGTLD----AGVIR--LYTKEILHGNGILHCDLKCNNVLLGSHGD 104
+ GG L + ++ + +++ + LH I H D+K N+L S
Sbjct: 96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP 155
Query: 105 ---VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCM 161
+KL D G A E E D + D+WSLG +
Sbjct: 156 NAILKLTDFG---------------------------FAKETTG-EKYDKSCDMWSLGVI 187
Query: 162 VIEMATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPE 216
+ + G PP + + + + + FP + +V + L+ +P
Sbjct: 188 MYILLCGYPPFYSNHGLAISPGMKT-RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 246
Query: 217 KRWSAEELLNHTFISGNAKKNST 239
+R + E +NH +I + K T
Sbjct: 247 QRMTITEFMNHPWIMQSTKVPQT 269
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 3e-25
Identities = 67/277 (24%), Positives = 106/277 (38%), Gaps = 63/277 (22%)
Query: 2 NKGTG---ALFVVKSAESEAGV--QALRNEAEIRQSLNSPNIGR-----NGEKTVNIFME 51
N+ T AL V+ + + GV ALR E + + L NI R + +K + + E
Sbjct: 23 NRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDV 105
+ L + G LD +++ + ++L H +LH DLK N+L+ +G++
Sbjct: 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGEL 140
Query: 106 KLPDLGCARRVND-LKNNGNLKQSWQSIGGTQ----LWM-APEVLRNEGL-DFATDIWSL 158
KL + G AR ++ + LW P+VL L + D+WS
Sbjct: 141 KLANFGLARAFGIPVRCY------------SAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188
Query: 159 GCMVIEMATGRPPW--GD-------KISNA----------AATLLKIACSNEKPHFPTQF 199
GC+ E+A P G+ +I + T L T
Sbjct: 189 GCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSL 248
Query: 200 FKKV-------LDFLAKCLERKPEKRWSAEELLNHTF 229
V D L L+ P +R SAEE L H +
Sbjct: 249 VNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-25
Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 26/229 (11%)
Query: 12 KSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLD-VAEKF 65
K+ + +Q L E I + LN PNI + EKT+ + MEY +GG + D +
Sbjct: 50 KTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH- 108
Query: 66 GGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDL 119
G + R ++I+ H I+H DLK N+LL + ++K+ D G + N+
Sbjct: 109 -GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS---NEF 164
Query: 120 KNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD-FATDIWSLGCMVIEMATGRPPWGDKISN 178
G L G + APE+ + + D D+WSLG ++ + +G P+ N
Sbjct: 165 TVGGKLDAF----CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QN 218
Query: 179 AAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
++ K P + L + L P KR + E+++
Sbjct: 219 LKELRERV--LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-24
Identities = 60/257 (23%), Positives = 94/257 (36%), Gaps = 64/257 (24%)
Query: 22 ALRNEAEIRQSLNS---PNI--------GRNGEKTVNIF--MEYMAG--GSLLDVAEKFG 66
+R E + + L + PN+ ++ + E++ + LD + G
Sbjct: 58 TIR-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG 116
Query: 67 GTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLK 120
+ I+ ++L H + ++H DLK N+L+ S G +KL D G AR +
Sbjct: 117 --VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-- 172
Query: 121 NNGNLKQSWQSIGGTQLWM-APEVLRNEGLDFATDIWSLGCMVIEMATGRP--PWGDKIS 177
+ + + T LW APEVL D+WS+GC+ EM +P G
Sbjct: 173 ---QMALTSVVV--T-LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR-GS--- 222
Query: 178 NAAATLLKI--AC---------------SNEKPHFPTQFFKKV--------LDFLAKCLE 212
+ L KI Q +K D L KCL
Sbjct: 223 SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLT 282
Query: 213 RKPEKRWSAEELLNHTF 229
P KR SA L+H +
Sbjct: 283 FNPAKRISAYSALSHPY 299
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-24
Identities = 65/287 (22%), Positives = 98/287 (34%), Gaps = 79/287 (27%)
Query: 2 NKGTG---ALFVVKSAESEAGV--QALRNEAEIRQSLNSPNIGR-----NGEKTVNIFME 51
+ T A+ ++ E GV A+R E + + L NI + +++ E
Sbjct: 55 DTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113
Query: 52 YMAG--GSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLL---- 99
Y +D + VI+ + +++ H LH DLK N+LL
Sbjct: 114 YAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSD 169
Query: 100 -GSHGDVKLPDLGCARRVND-LKNNGNLKQSWQSIGGTQ----LWM-APEVLRNEGL-DF 151
+K+ D G AR ++ T LW PE+L
Sbjct: 170 ASETPVLKIGDFGLARAFGIPIRQF------------THEIITLWYRPPEILLGSRHYST 217
Query: 152 ATDIWSLGCMVIEMATGRPPW-GDKISNAAATLLKI-------------------ACSNE 191
+ DIWS+ C+ EM P + GD + L KI
Sbjct: 218 SVDIWSIACIWAEMLMKTPLFPGD---SEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQS 274
Query: 192 KPHFPTQFFKKV---------LDFLAKCLERKPEKRWSAEELLNHTF 229
P F + K+V LD L LE P KR SA+ L H +
Sbjct: 275 FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 2e-24
Identities = 69/285 (24%), Positives = 105/285 (36%), Gaps = 72/285 (25%)
Query: 2 NKGTG---ALFVVKSAESEAGVQ-----ALRNEAEIRQSLNS---PNI--------GRNG 42
+ +G AL V+ G +R E + + L + PN+
Sbjct: 30 DPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPNVVRLMDVCATSRT 88
Query: 43 EKTVNIF--MEYMAG--GSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDL 92
++ + + E++ + LD A G L A I+ ++ L H N I+H DL
Sbjct: 89 DREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLDFLHANCIVHRDL 146
Query: 93 KCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM-APEVLRNEGLDF 151
K N+L+ S G VKL D G AR + + + + T LW APEVL
Sbjct: 147 KPENILVTSGGTVKLADFGLARIYSY-----QMALTPVVV--T-LWYRAPEVLLQSTYAT 198
Query: 152 ATDIWSLGCMVIEMATGRP--PWGDKISNAAATLLKI--AC---------------SNEK 192
D+WS+GC+ EM +P G+ + A L KI
Sbjct: 199 PVDMWSVGCIFAEMFRRKPLFC-GN---SEADQLGKIFDLIGLPPEDDWPRDVSLPRGAF 254
Query: 193 PHFPTQFFKKV--------LDFLAKCLERKPEKRWSAEELLNHTF 229
P + + V L + L P KR SA L H++
Sbjct: 255 PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-24
Identities = 56/250 (22%), Positives = 95/250 (38%), Gaps = 51/250 (20%)
Query: 24 RNEAEIRQ--SLNSPNI---------GRNGEKTVNIFMEYMAGGSL--------LDVAEK 64
E E+ L NI R+ + + Y GSL LD
Sbjct: 48 FRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC 107
Query: 65 FGGTLDA--GVIRLYTKEILHG--NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLK 120
L G+ L+ + I H DLK N+L+ +G + DLG A +
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167
Query: 121 NNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT------DIWSLGCMVI-EMATG----- 168
N ++ + + GT+ +MAPEVL DIW+ G +V+ E+A
Sbjct: 168 NQLDVGNNPRV--GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG-LVLWEVARRMVSNG 224
Query: 169 -----RPPWGDKISNAAAT--LLKIACS-NEKPHFPTQFF-----KKVLDFLAKCLERKP 215
+PP+ D + N + + K+ C ++P+ P ++F + + +C + P
Sbjct: 225 IVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNP 284
Query: 216 EKRWSAEELL 225
R +A +
Sbjct: 285 SARLTALRIK 294
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 9e-24
Identities = 50/250 (20%), Positives = 92/250 (36%), Gaps = 51/250 (20%)
Query: 24 RNEAEIRQ--SLNSPNI---------GRNGEKTVNIFMEYMAGGSL--------LDVAEK 64
E EI Q + NI G + + +Y GSL LD
Sbjct: 77 FRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSM 136
Query: 65 FGGTLDA--GVIRLYTKEILHG--NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLK 120
+ G+ L+T+ I H DLK N+L+ +G + DLG A +
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196
Query: 121 NNGNLKQSWQSIGGTQLWMAPEVL------RNEGLDFATDIWSLGCMVI-EMATG----- 168
N ++ + + GT+ +M PEVL + D++S G +++ E+A
Sbjct: 197 NEVDIPPNTRV--GTKRYMPPEVLDESLNRNHFQSYIMADMYSFG-LILWEVARRCVSGG 253
Query: 169 -----RPPWGDKISNAAAT---LLKIACSNEKPHFPTQFF-----KKVLDFLAKCLERKP 215
+ P+ D + + + + +P FP ++ +++ + +C P
Sbjct: 254 IVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNP 313
Query: 216 EKRWSAEELL 225
R +A +
Sbjct: 314 ASRLTALRVK 323
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-23
Identities = 51/229 (22%), Positives = 98/229 (42%), Gaps = 30/229 (13%)
Query: 20 VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIF--MEYMAGGSLLDVAEKFGGTLDAG 72
++ + E I + L+ PN+ + + +++ E + G +++V L
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSED 137
Query: 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLK 126
R Y +++ LH I+H D+K +N+L+G G +K+ D G + ++ L
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG--SDALLS 195
Query: 127 QSWQSIGGTQLWMAPEVLRNEGLDF---ATDIWSLGCMVIEMATGRPPWGDKISNAAATL 183
+ GT +MAPE L F A D+W++G + G+ P+ D
Sbjct: 196 NT----VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD--ERIMCLH 249
Query: 184 LKIACSNEKPHFP--TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
KI ++ FP + + D + + L++ PE R E+ H ++
Sbjct: 250 SKI--KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-23
Identities = 55/231 (23%), Positives = 92/231 (39%), Gaps = 24/231 (10%)
Query: 23 LRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLY 77
++ E I + LN N+ + +F+EY +GG L D E G + + +
Sbjct: 52 IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRF 110
Query: 78 TKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQS 131
++ LHG GI H D+K N+LL ++K+ D G A L +
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-- 168
Query: 132 IGGTQLWMAPEVLRNEGLD-FATDIWSLGCMVI--EMATGRPPWGDKISNAAATLLKIAC 188
GT ++APE+L+ D+WS G ++ M G PW D+ S++
Sbjct: 169 --GTLPYVAPELLKRREFHAEPVDVWSCG--IVLTAMLAGELPW-DQPSDSCQEYSDW-K 222
Query: 189 SNEKPHFPTQFF-KKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKNS 238
+ P + L L K L P R + ++ + + KK +
Sbjct: 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-23
Identities = 52/236 (22%), Positives = 88/236 (37%), Gaps = 67/236 (28%)
Query: 55 GGSLLDVAEKFG-GTLDAGVIRLYTKEILHG-------NGILHCDLKCNNVLL------G 100
G +LL + +K+ + ++ +K++L G GI+H D+K NVL+
Sbjct: 113 GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGC 160
+ +K+ DLG A ++ + S Q+ + + +PEVL DIWS C
Sbjct: 173 NLIQIKIADLGNACWYDE-----HYTNSIQT----REYRSPEVLLGAPWGCGADIWSTAC 223
Query: 161 MVIEMATGR----PPWGDKISNAAATLLKIA----------------------------- 187
++ E+ TG P G + + +I
Sbjct: 224 LIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRN 283
Query: 188 -----------CSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232
EK F K++ DFL+ L+ P KR A L+NH ++
Sbjct: 284 ISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-23
Identities = 65/266 (24%), Positives = 98/266 (36%), Gaps = 72/266 (27%)
Query: 22 ALRNEAEIR--QSLNSPNI-----------GRNGEKTVNIFM--EYM----AGGSLLDVA 62
ALR EI+ Q L N+ +I++ ++ AG LL
Sbjct: 63 ALR---EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV 117
Query: 63 EKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRV 116
I+ + +L H N ILH D+K NVL+ G +KL D G AR
Sbjct: 118 ---LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174
Query: 117 NDLKNNGNLKQSWQSIGGTQLWM-APEVL---RNEGLDFATDIWSLGCMVIEMATGRP-- 170
+ KN+ + + + + T LW PE+L R+ G D+W GC++ EM T P
Sbjct: 175 SLAKNSQPNRYTNRVV--T-LWYRPPELLLGERDYGP--PIDLWGAGCIMAEMWTRSPIM 229
Query: 171 PWGD-------KISNA----------AATLLKIACSNEKPHFPTQFFKKV---------- 203
G+ IS ++ E + K
Sbjct: 230 Q-GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA 288
Query: 204 LDFLAKCLERKPEKRWSAEELLNHTF 229
LD + K L P +R +++ LNH F
Sbjct: 289 LDLIDKLLVLDPAQRIDSDDALNHDF 314
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-23
Identities = 63/286 (22%), Positives = 103/286 (36%), Gaps = 80/286 (27%)
Query: 2 NKGTGALFVVK------SAESEAGV--QALRNEAEIRQSLNSPNIGR-----NGEKTVNI 48
+K T + +K +E++ G+ ALR E ++ Q L+ PNI + +++
Sbjct: 31 DKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIGLLDAFGHKSNISL 89
Query: 49 FMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSH 102
++M L + + L I+ Y L H + ILH DLK NN+LL +
Sbjct: 90 VFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN 148
Query: 103 GDVKLPDLGCARRVND-LKNNGNLKQSWQSIGGTQ----LWM-APEVLRNEGL-----DF 151
G +KL D G A+ + T W APE+L
Sbjct: 149 GVLKLADFGLAKSFGSPNRAY------------THQVVTRWYRAPELL----FGARMYGV 192
Query: 152 ATDIWSLGCMVIEMATGRP--PWGDKISNAAATLLKI--ACS--NEK------------- 192
D+W++GC++ E+ P P GD + L +I E+
Sbjct: 193 GVDMWAVGCILAELLLRVPFLP-GD---SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 248
Query: 193 -PHFPTQFFKKV--------LDFLAKCLERKPEKRWSAEELLNHTF 229
FP + LD + P R +A + L +
Sbjct: 249 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-22
Identities = 54/234 (23%), Positives = 92/234 (39%), Gaps = 24/234 (10%)
Query: 23 LRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLY 77
++ E I + LN N+ + +F+EY +GG L D E G + + +
Sbjct: 52 IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRF 110
Query: 78 TKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQS 131
+++ HG GI H D+K N+LL ++K+ D G A L +
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-- 168
Query: 132 IGGTQLWMAPEVLRNEGLD-FATDIWSLGCMVI--EMATGRPPWGDKISNAAATLLKIAC 188
GT ++APE+L+ D+WS G ++ M G PW D+ S++
Sbjct: 169 --GTLPYVAPELLKRREFHAEPVDVWSCG--IVLTAMLAGELPW-DQPSDSCQEYSDW-K 222
Query: 189 SNEKPHFPTQFF-KKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKNSTEE 241
+ P + L L K L P R + ++ + + KK +
Sbjct: 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 5e-22
Identities = 51/254 (20%), Positives = 95/254 (37%), Gaps = 51/254 (20%)
Query: 21 QALRNEAEIRQ--SLNSPNI---------GRNGEKTVNIFMEYMAGGSL--------LDV 61
++ EAEI Q L NI + + +Y GSL + V
Sbjct: 79 RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV 138
Query: 62 AEKFGGTLDA--GV--IRLYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVN 117
L G+ + + I H DLK N+L+ +G + DLG A R +
Sbjct: 139 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 198
Query: 118 DLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL------DFATDIWSLGCMVI-EMATG-- 168
+ ++ + + GT+ +MAPEVL + DI+++G +V E+A
Sbjct: 199 SATDTIDIAPNHRV--GTKRYMAPEVLDDSINMKHFESFKRADIYAMG-LVFWEIARRCS 255
Query: 169 --------RPPWGDKISNAAAT--LLKIACSNEK-PHFPTQF-----FKKVLDFLAKCLE 212
+ P+ D + + + + K+ C + P+ P ++ + + + +C
Sbjct: 256 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 315
Query: 213 RKPEKRWSAEELLN 226
R +A +
Sbjct: 316 ANGAARLTALRIKK 329
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-21
Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 26/221 (11%)
Query: 23 LRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLD-VAEKFGGTLDAGVIRL 76
++ E + + P+I + + + MEY++GG L D + + G ++ R
Sbjct: 58 IKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARR 115
Query: 77 YTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQ 130
++IL H + ++H DLK NVLL +H + K+ D G + N + + L+ S
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS---NMMSDGEFLRTSC- 171
Query: 131 SIGGTQLWMAPEVLRNEGLD-FATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACS 189
G+ + APEV+ DIWS G ++ + G P+ D + KI
Sbjct: 172 ---GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD--EHVPTLFKKI--R 224
Query: 190 NEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
+ P + V L L+ P KR + +++ H +
Sbjct: 225 GGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 5e-21
Identities = 63/301 (20%), Positives = 101/301 (33%), Gaps = 81/301 (26%)
Query: 2 NKGTGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNI-------GRNGEKTVNIFMEYM 53
+ + +K E + A R E + + L PN+ + ++ V + +Y
Sbjct: 44 DGKDDKDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 102
Query: 54 AG--GSLLD-----VAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLG 100
++ A K L G+++ +IL H N +LH DLK N+L+
Sbjct: 103 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVM 162
Query: 101 S----HGDVKLPDLGCARRVND-LKNNGNLKQSWQSIGGTQLWM-APEVL---RNEGLDF 151
G VK+ D+G AR N LK +L + T W APE+L R+
Sbjct: 163 GEGPERGRVKIADMGFARLFNSPLKPLADLDP--VVV--T-FWYRAPELLLGARHYTK-- 215
Query: 152 ATDIWSLGCMVIEMATGRP-------PWGDKISNAAATLLKI------------------ 186
A DIW++GC+ E+ T P L +I
Sbjct: 216 AIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKM 275
Query: 187 -ACSNEKPHFPTQFFKKV-----------------LDFLAKCLERKPEKRWSAEELLNHT 228
S F + L K L P KR ++E+ +
Sbjct: 276 PEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335
Query: 229 F 229
+
Sbjct: 336 Y 336
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 6e-21
Identities = 30/228 (13%), Positives = 63/228 (27%), Gaps = 56/228 (24%)
Query: 14 AESEAGVQALRNEAEIRQSLNSPNI------GRNGEKTVNIFMEYMAGGSLLDVAEKFGG 67
+ +Q + ++ P + + + E++ GGSL +VA+
Sbjct: 69 VLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL-VVAEWIRGGSLQEVAD--TS 125
Query: 68 TLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKN 121
G IR + + H G+ + V + GDV L
Sbjct: 126 PSPVGAIRA-MQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA----- 179
Query: 122 NGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPW-GDKISNAA 180
+ DI +G + + R P + +
Sbjct: 180 ----------------------------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGL 211
Query: 181 ATLLKIACSNEKPHFPTQFFKKV---LD-FLAKCLERKPEKRWSAEEL 224
A + +P P + + + A+ ++ R ++ L
Sbjct: 212 APAERDT--AGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 1e-20
Identities = 62/244 (25%), Positives = 104/244 (42%), Gaps = 31/244 (12%)
Query: 2 NKGTGALFVVK-----SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFME 51
++ TG VK S V +R E + + P+I + + + + ME
Sbjct: 37 HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96
Query: 52 YMAGGSLLD-VAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD 104
Y++GG L D + + G LD R ++IL H + ++H DLK NVLL +H +
Sbjct: 97 YVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN 154
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD-FATDIWSLGCMVI 163
K+ D G + N + + L+ S G+ + APEV+ DIWS G ++
Sbjct: 155 AKIADFGLS---NMMSDGEFLRTSC----GSPNYAAPEVISGRLYAGPEVDIWSSGVILY 207
Query: 164 EMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223
+ G P+ D + KI + + P V+ L L+ P KR + ++
Sbjct: 208 ALLCGTLPFDD--DHVPTLFKKI--CDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKD 263
Query: 224 LLNH 227
+ H
Sbjct: 264 IREH 267
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 1e-20
Identities = 65/343 (18%), Positives = 101/343 (29%), Gaps = 130/343 (37%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGRNGEKTV----NIF------------- 49
A+ VVKSAE + +E + +S+ + + + V + F
Sbjct: 66 AMKVVKSAEHYT--ETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMV 123
Query: 50 MEYMAGGSLLDVAEKF-GGTLDAGVIRLYTKEILHG-------NGILHCDLKCNNVLLG- 100
E + G LL K L ++ +++L G I+H D+K N+LL
Sbjct: 124 FEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSV 182
Query: 101 ------------------------------------------------SHGDVKLPDLGC 112
VK+ DLG
Sbjct: 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGN 242
Query: 113 ARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPP- 171
A V+ + + T+ + + EVL G + DIWS CM E+ATG
Sbjct: 243 ACWVH---------KHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLF 293
Query: 172 ----------------------------------WGDKISNAAATLLKIA---------C 188
+ + L I
Sbjct: 294 EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353
Query: 189 SNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFIS 231
EK + + DFL LE PEKR +A E L H +++
Sbjct: 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-20
Identities = 49/232 (21%), Positives = 79/232 (34%), Gaps = 25/232 (10%)
Query: 10 VVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEK 64
+ EA I + + PNI R ++ + I ME + GG L
Sbjct: 146 SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT 205
Query: 65 FGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVND 118
G L + + L +H DL N L+ +K+ D G +R D
Sbjct: 206 EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265
Query: 119 LKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGD 174
S G Q+ W APE L +D+WS G ++ E + G P+ +
Sbjct: 266 -------GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN 318
Query: 175 KISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226
+SN + + P V + +C +P +R S +
Sbjct: 319 -LSNQQT--REFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-20
Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 27/221 (12%)
Query: 23 LRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLD-VAEKFGGTLDAGVIRL 76
+ E + L P+I + + + +EY AGG L D + EK + R
Sbjct: 56 VEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEK--KRMTEDEGRR 112
Query: 77 YTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQ 130
+ ++I+ H + I+H DLK N+LL + +VK+ D G + N + + LK S
Sbjct: 113 FFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS---NIMTDGNFLKTSC- 168
Query: 131 SIGGTQLWMAPEVLRNEGLD-FATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACS 189
G+ + APEV+ + D+WS G ++ M GR P+ D K+ +
Sbjct: 169 ---GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD--EFIPNLFKKV--N 221
Query: 190 NEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
+ P + + + P +R + +E+ +
Sbjct: 222 SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-20
Identities = 54/238 (22%), Positives = 90/238 (37%), Gaps = 31/238 (13%)
Query: 12 KSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIF--MEYMAGGS--LLDVA 62
K G ++ E ++ + L N+ + E+ ++ MEY G +LD
Sbjct: 42 KLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV 101
Query: 63 EKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRV 116
+ Y ++ LH GI+H D+K N+LL + G +K+ LG A +
Sbjct: 102 PE--KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
Query: 117 NDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL--DFATDIWSLGCMVI--EMATGRPPW 172
+ + + S G+ + PE+ F DIWS G V + TG P+
Sbjct: 160 HPFAADDTCRTSQ----GSPAFQPPEIANGLDTFSGFKVDIWSAG--VTLYNITTGLYPF 213
Query: 173 GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230
N I P + D L LE +P KR+S ++ H++
Sbjct: 214 EG--DNIYKLFENI--GKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-20
Identities = 48/194 (24%), Positives = 74/194 (38%), Gaps = 55/194 (28%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
LH GI+H DLK +N+++ S +K+ D G AR + + T+ + AP
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYV----VTRYYRAP 195
Query: 142 EVLRNEGLDFATDIWSLGCMVIEMATGRP--PWGD---------------------KISN 178
EV+ G DIWS+GC++ EM G P D K+
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255
Query: 179 AAATLLKIACSNEKPHFPTQFFKKV--------------------LDFLAKCLERKPEKR 218
T ++ +P + F+K+ D L+K L KR
Sbjct: 256 TVRTYVE-----NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 310
Query: 219 WSAEELLNHTFISG 232
S +E L H +I+
Sbjct: 311 ISVDEALQHPYINV 324
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 3e-20
Identities = 46/194 (23%), Positives = 73/194 (37%), Gaps = 55/194 (28%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
LH GI+H DLK +N+++ S +K+ D G AR + + T+ + AP
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYV----VTRYYRAP 232
Query: 142 EVLRNEGLDFATDIWSLGCMVIEMATGRP--PWGD---------------------KISN 178
EV+ G DIWS+GC++ EM + P D K+
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292
Query: 179 AAATLLKIACSNEKPHFPTQFFKKV--------------------LDFLAKCLERKPEKR 218
++ +P + F K+ D L+K L P KR
Sbjct: 293 TVRNYVE-----NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 347
Query: 219 WSAEELLNHTFISG 232
S ++ L H +I+
Sbjct: 348 ISVDDALQHPYINV 361
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-20
Identities = 49/218 (22%), Positives = 82/218 (37%), Gaps = 43/218 (19%)
Query: 29 IRQSLNSPNIGR-----NGEKTVNIFMEY-MAGGSLLD-VAEKFGGTLDAGVIRLYTKEI 81
+ P + R ++ + +E + L D + EK G L G R + ++
Sbjct: 91 VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQV 148
Query: 82 L------HGNGILHCDLKCNNVLL-GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGG 134
+ H G++H D+K N+L+ G KL D G L ++ G
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG----ALLHDEPYTDF----DG 200
Query: 135 TQLWMAPEVLRNEGLD-FATDIWSLGCMVI--EMATGRPPWGD--KISNAAATLLKIACS 189
T+++ PE + +WSLG ++ +M G P+ +I A
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLG--ILLYDMVCGDIPFERDQEILEA---------- 248
Query: 190 NEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
+ HFP + +CL KP R S EE+L
Sbjct: 249 --ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-20
Identities = 44/179 (24%), Positives = 71/179 (39%), Gaps = 37/179 (20%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
+H GI+H DLK N+ + ++K+ D G AR+ + T+ + AP
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---------EMTGYVVTRWYRAP 194
Query: 142 EVLRN-EGLDFATDIWSLGCMVIEMATGRP--PWGD------KISN-----AAATLLKIA 187
EV+ N DIWS+GC++ EM TG+ D +I A + ++
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254
Query: 188 CSNEK------PHFPTQFFKKV--------LDFLAKCLERKPEKRWSAEELLNHTFISG 232
K P + F + ++ L K L E+R +A E L H +
Sbjct: 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-20
Identities = 41/180 (22%), Positives = 70/180 (38%), Gaps = 36/180 (20%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
LH G++H DL N+LL + D+ + D AR + N + + AP
Sbjct: 150 LHEAGVVHRDLHPGNILLADNNDITICDFNLAREDT---ADANKTHYVT----HRWYRAP 202
Query: 142 EVLRN-EGLDFATDIWSLGCMVIEMATGRP--PWGD------KISN-----AAATLLKIA 187
E++ +G D+WS GC++ EM + KI ++ +
Sbjct: 203 ELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFS 262
Query: 188 CSNEK-------PHFPTQFFKKV--------LDFLAKCLERKPEKRWSAEELLNHTFISG 232
+ + + P + + V LD +AK LE P++R S E+ L H +
Sbjct: 263 SPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-19
Identities = 49/191 (25%), Positives = 80/191 (41%), Gaps = 25/191 (13%)
Query: 1 MNKGTGALFVVKS--AESEAGVQALRNEAEIRQSLNSPNI-------GRNGEKTVNIFME 51
+ TGAL VK + + E +I ++L+S I G +++ + ME
Sbjct: 47 LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVME 106
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDV 105
Y+ G L D ++ LDA + LY+ +I L +H DL N+L+ S V
Sbjct: 107 YLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHV 166
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMV 162
K+ D G A+ + K+ + Q W APE L + +D+WS G ++
Sbjct: 167 KIADFGLAKLLPLDKD------YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220
Query: 163 IEMAT-GRPPW 172
E+ T
Sbjct: 221 YELFTYCDKSC 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-19
Identities = 47/178 (26%), Positives = 73/178 (41%), Gaps = 37/178 (20%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
+H I+H DLK +N+ + ++K+ D G AR D T+ + AP
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---------EMTGYVATRWYRAP 198
Query: 142 EVLRN-EGLDFATDIWSLGCMVIEMATGRP--PWGD------KISN-----AAATLLKIA 187
E++ N + DIWS+GC++ E+ TGR P D I A L KI+
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 188 CSNEK------PHFPTQFFKKV--------LDFLAKCLERKPEKRWSAEELLNHTFIS 231
+ + P F V +D L K L +KR +A + L H + +
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-19
Identities = 61/259 (23%), Positives = 96/259 (37%), Gaps = 71/259 (27%)
Query: 26 EAEIRQSLNSPNI-----------GRNGEKTVNIFMEYMAG--GSLLDVAEKFGGTLDAG 72
E +I + + PN+ + E +N+ +EY+ K T+
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML 141
Query: 73 VIRLYTKEIL------HGNGILHCDLKCNNVLL-GSHGDVKLPDLGCARRVNDLKNNGNL 125
+I+LY ++L H GI H D+K N+LL G +KL D G A+ + + N
Sbjct: 142 LIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN--- 198
Query: 126 KQSWQSIGGTQ----LWM-APEV-LRNEGLDFATDIWSLGCMVIEMATGRP--PWGDKIS 177
+ APE+ DIWS GC++ E+ G+P P G+
Sbjct: 199 ---------VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP-GE--- 245
Query: 178 NAAATLLKI------------ACSNEK------PHFPTQFFKKV---------LDFLAKC 210
+ L++I N P F KV +D +++
Sbjct: 246 SGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRL 305
Query: 211 LERKPEKRWSAEELLNHTF 229
LE P R +A E L H F
Sbjct: 306 LEYTPSARLTAIEALCHPF 324
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-19
Identities = 37/184 (20%), Positives = 71/184 (38%), Gaps = 41/184 (22%)
Query: 82 LHGNGILHCDLKCNNVLLGSHG-DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140
+H +LH DLK N+ + + +K+ D G AR ++ ++ T+ + +
Sbjct: 136 IHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV---TKWYRS 192
Query: 141 PEVLRN-EGLDFATDIWSLGCMVIEMATGRP--PWGD---------------------KI 176
P +L + A D+W+ GC+ EM TG+ ++
Sbjct: 193 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQEL 252
Query: 177 SNAAATLLKIACSNEKPHFPTQFFKKV--------LDFLAKCLERKPEKRWSAEELLNHT 228
+ ++ P + ++ +DFL + L P R +AEE L+H
Sbjct: 253 LSVIPVYIR-----NDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307
Query: 229 FISG 232
++S
Sbjct: 308 YMSI 311
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-19
Identities = 49/185 (26%), Positives = 79/185 (42%), Gaps = 35/185 (18%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIG----GTQL 137
LHG+ ++H DLK +N+L+ S+ D+K+ D G AR +++ + + QS T+
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187
Query: 138 WMAPEVLRN-EGLDFATDIWSLGCMVIEMATGRP--------------------PWGDKI 176
+ APEV+ A D+WS GC++ E+ RP P D
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247
Query: 177 -----SNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEKRWSAEELLNH 227
S A +K + F +V +D L + L P KR +A+E L H
Sbjct: 248 LRCIESPRAREYIKSLPMYPAAPL-EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 228 TFISG 232
++
Sbjct: 307 PYLQT 311
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-19
Identities = 45/179 (25%), Positives = 73/179 (40%), Gaps = 37/179 (20%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
+H G++H DLK N+ + ++K+ D G AR + + T+ + AP
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVV----TRWYRAP 192
Query: 142 EVLRN-EGLDFATDIWSLGCMVIEMATGRP--PWGD------KISN-----AAATLLKIA 187
EV+ + + DIWS+GC++ EM TG+ D +I + K+
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252
Query: 188 CSNEK------PHFPTQFFKKV--------LDFLAKCLERKPEKRWSAEELLNHTFISG 232
K P P + F ++ D L K LE +KR +A + L H F
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-19
Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 31/179 (17%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141
+H +LH DLK +N+LL + D+K+ D G AR + + + T+ + AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP---DHDHTGFLTEYVATRWYRAP 200
Query: 142 EVLRN-EGLDFATDIWSLGCMVIEMATGRP--PWGD------KISN-----AAATLLKIA 187
E++ N +G + DIWS+GC++ EM + RP P I + L I
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 188 CSNEK------PHFPTQFFKKV--------LDFLAKCLERKPEKRWSAEELLNHTFISG 232
+ PH + ++ LD L K L P KR E+ L H ++
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 3e-19
Identities = 49/261 (18%), Positives = 90/261 (34%), Gaps = 56/261 (21%)
Query: 21 QALRNEAEIRQ--SLNSPNI----------GRNGEKTVNIFMEYMAGGSLLDVAEKFGGT 68
Q NE I + + NI +G + MEY GSL
Sbjct: 50 QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD 109
Query: 69 LDA----------GVIRLYTKEILHGNG---ILHCDLKCNNVLLGSHGDVKLPDLGCARR 115
+ G+ L+T+ + I H DL NVL+ + G + D G + R
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 116 VNDLKNNGNLKQSWQSIG--GTQLWMAPEVLRN-------EGLDFATDIWSLGCMVIEMA 166
+ + ++ +I GT +MAPEVL E D+++LG + E+
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 167 TG-------------RPPWGDKISN--AAATLLKIACS-NEKPHFP------TQFFKKVL 204
+ + ++ N + + ++P FP + + +
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289
Query: 205 DFLAKCLERKPEKRWSAEELL 225
+ + C ++ E R +A+
Sbjct: 290 ETIEDCWDQDAEARLTAQXAE 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-19
Identities = 46/259 (17%), Positives = 88/259 (33%), Gaps = 53/259 (20%)
Query: 16 SEAGVQALRNEAEIRQ--SLNSPNI---------GRNGEKTVNIFMEYMAGGSL------ 58
Q+ +NE E+ + NI G + + + + + GSL
Sbjct: 56 PIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA 115
Query: 59 --LDVAEKFGGTLDA--GVIRLYTKEILHGNG----ILHCDLKCNNVLLGSHGDVKLPDL 110
+ E G+ L+ +G I H D+K NVLL ++ + D
Sbjct: 116 NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175
Query: 111 GCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR-----NEGLDFATDIWSLGCMVIEM 165
G A + K+ G+ GT+ +MAPEVL D++++G ++ E+
Sbjct: 176 GLALKFEAGKSAGDTH----GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231
Query: 166 ATGRPPWGDKISN-------------AAATLLKIACSNEK-PHFP-----TQFFKKVLDF 206
A+ + + + ++ +K P + +
Sbjct: 232 ASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCET 291
Query: 207 LAKCLERKPEKRWSAEELL 225
+ +C + E R SA +
Sbjct: 292 IEECWDHDAEARLSAGCVG 310
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-19
Identities = 62/287 (21%), Positives = 105/287 (36%), Gaps = 82/287 (28%)
Query: 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSL-NSPNIGR-------NGEKTVNIFMEY 52
+N VVK + + R E +I ++L PNI +T + E+
Sbjct: 56 INITNNEKVVVKILKPVKKKKIKR-EIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114
Query: 53 MAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLL-GSHGDV 105
+ ++ TL IR Y EIL H GI+H D+K +NV++ H +
Sbjct: 115 VNNTDF----KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKL 170
Query: 106 KLPDLGCAR----------RVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN-EGLDFATD 154
+L D G A RV ++ + PE+L + + D++ D
Sbjct: 171 RLIDWGLAEFYHPGQEYNVRV-----------------ASRYFKGPELLVDYQMYDYSLD 213
Query: 155 IWSLGCMVIEMATGRPPW--GD-------KIS------NAAATLLKIACSNEK------P 193
+WSLGCM+ M + P+ G +I+ + + K +
Sbjct: 214 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILG 273
Query: 194 HFPTQFFKKV-------------LDFLAKCLERKPEKRWSAEELLNH 227
+ +++ LDFL K L + R +A E + H
Sbjct: 274 RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 7e-19
Identities = 44/194 (22%), Positives = 78/194 (40%), Gaps = 38/194 (19%)
Query: 48 IFMEYMAG-GSLLD-VAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLL 99
+ +E L D + E+ G L + R + ++L H G+LH D+K N+L+
Sbjct: 125 LILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 182
Query: 100 -GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD-FATDIWS 157
+ G++KL D G L + GT+++ PE +R + +WS
Sbjct: 183 DLNRGELKLIDFGSG----ALLKDTVYTDF----DGTRVYSPPEWIRYHRYHGRSAAVWS 234
Query: 158 LGCMVI--EMATGRPPWGD--KISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLER 213
LG ++ +M G P+ +I + F + + + CL
Sbjct: 235 LG--ILLYDMVCGDIPFEHDEEIIRG------------QVFFRQRVSSECQHLIRWCLAL 280
Query: 214 KPEKRWSAEELLNH 227
+P R + EE+ NH
Sbjct: 281 RPSDRPTFEEIQNH 294
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 8e-19
Identities = 48/185 (25%), Positives = 77/185 (41%), Gaps = 24/185 (12%)
Query: 1 MNKGTGALFVVKS--AESEAGVQALRNEAEIRQSLNSPNI-------GRNGEKTVNIFME 51
+ TG + VK +E ++ E EI +SL NI G + + + ME
Sbjct: 34 LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDV 105
Y+ GSL D +K +D + YT +I L +H DL N+L+ + V
Sbjct: 94 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMV 162
K+ D G + + K ++ + W APE L A+D+WS G ++
Sbjct: 154 KIGDFGLTKVLPQDKE------FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 207
Query: 163 IEMAT 167
E+ T
Sbjct: 208 YELFT 212
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-19
Identities = 38/225 (16%), Positives = 70/225 (31%), Gaps = 58/225 (25%)
Query: 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLK- 126
+R ++ LH N + H DLK N+L + L + + +KN ++
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS-IRV 183
Query: 127 ----------QSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRP------ 170
+ +I T+ + PEV+ G D+WS+GC++ E G
Sbjct: 184 ADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243
Query: 171 ----------------------------------PWGDKISNAAATLLKIACSNEKPHFP 196
W + S+
Sbjct: 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 303
Query: 197 TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKNSTEE 241
+ ++ D + + LE P +R + E L H F +G + +
Sbjct: 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFH 348
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 9e-19
Identities = 48/252 (19%), Positives = 88/252 (34%), Gaps = 47/252 (18%)
Query: 2 NKGTGALFVVK----------SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTV 46
+K VVK + + + E I + NI + +
Sbjct: 45 DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF 104
Query: 47 NIFME-YMAGGSLLD-VAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVL 98
+ ME + +G L + LD + +++ L I+H D+K N++
Sbjct: 105 QLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIV 162
Query: 99 LGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD-FATDIWS 157
+ +KL D G A L+ GT + APEVL ++WS
Sbjct: 163 IAEDFTIKLIDFGSA---AYLERGKLFYTFC----GTIEYCAPEVLMGNPYRGPELEMWS 215
Query: 158 LGCMVIEMATGRPPWGD--KISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKP 215
LG + + P+ + + A H P K+++ ++ L+ P
Sbjct: 216 LGVTLYTLVFEENPFCELEETVEA------------AIHPPYLVSKELMSLVSGLLQPVP 263
Query: 216 EKRWSAEELLNH 227
E+R + E+L+
Sbjct: 264 ERRTTLEKLVTD 275
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 9e-19
Identities = 49/185 (26%), Positives = 79/185 (42%), Gaps = 24/185 (12%)
Query: 1 MNKGTGALFVVKS--AESEAGVQALRNEAEIRQSLNSPNI-------GRNGEKTVNIFME 51
+ TG + VK +E ++ E EI +SL NI G + + + ME
Sbjct: 65 LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDV 105
Y+ GSL D +K +D + YT +I L +H DL N+L+ + V
Sbjct: 125 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 184
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMV 162
K+ D G + L + K+ ++ + W APE L A+D+WS G ++
Sbjct: 185 KIGDFGLTK---VLPQD---KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238
Query: 163 IEMAT 167
E+ T
Sbjct: 239 YELFT 243
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-18
Identities = 56/259 (21%), Positives = 94/259 (36%), Gaps = 66/259 (25%)
Query: 23 LRNEAEIRQSLNSPNI-----------GRNGEKTVNIFMEYMAG--GSLLDVAEKFGGTL 69
R E +I + L+ NI + E +N+ ++Y+ + + TL
Sbjct: 95 NR-ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 153
Query: 70 DAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSH-GDVKLPDLGCARRVNDLKNN 122
++LY ++ H GI H D+K N+LL +KL D G A+++ + N
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 123 GNLKQSWQSIGGTQ----LWM-APEV-LRNEGLDFATDIWSLGCMVIEMATGRP--PWGD 174
+ APE+ + D+WS GC++ E+ G+P P GD
Sbjct: 214 ------------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP-GD 260
Query: 175 -------KISNAAATLLK--IACSNEK------PHFPTQFFKKV---------LDFLAKC 210
+I T + I N P + KV + ++
Sbjct: 261 SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRL 320
Query: 211 LERKPEKRWSAEELLNHTF 229
LE P R + E H+F
Sbjct: 321 LEYTPTARLTPLEACAHSF 339
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 2e-18
Identities = 46/183 (25%), Positives = 75/183 (40%), Gaps = 23/183 (12%)
Query: 10 VVKSAESEAGVQALRNEAEIRQSLNSPNIGR-NG---EKTVNIFMEYMAGGSLLDVAEKF 65
K+ S++ + EA + + P+I + G E V I ME G L +
Sbjct: 425 TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVR 484
Query: 66 GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDL 119
+LD + LY ++ L +H D+ NVL+ S+ VKL D G +R + D
Sbjct: 485 KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED- 543
Query: 120 KNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDK 175
++ +L WMAPE + A+D+W G + E+ G P+
Sbjct: 544 -------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG- 595
Query: 176 ISN 178
+ N
Sbjct: 596 VKN 598
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-18
Identities = 48/222 (21%), Positives = 72/222 (32%), Gaps = 70/222 (31%)
Query: 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLK- 126
IR +I LH N + H DLK N+L + + R L N +K
Sbjct: 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD-IKV 178
Query: 127 ----------QSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRP------ 170
+ ++ T+ + APEV+ G D+WS+GC++IE G
Sbjct: 179 VDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238
Query: 171 ----------------------------------PW------GDKISNAAATLLKIACSN 190
W G +S A L + S
Sbjct: 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ 298
Query: 191 EKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232
+ H +++ D + K LE P KR + E L H F
Sbjct: 299 DVEH------ERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-18
Identities = 45/184 (24%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 10 VVKSAESEAGVQALRNEAEIRQSLNSPNIGR-NG---EKTVNIFMEYMAGGSLLDVAEKF 65
K + + +EA I ++L+ P+I + G E+ I ME G L E+
Sbjct: 47 TCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERN 106
Query: 66 GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDL 119
+L + LY+ +I L +H D+ N+L+ S VKL D G +R + D
Sbjct: 107 KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED- 165
Query: 120 KNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDK 175
+ + T+L WM+PE + A+D+W + E+ + G+ P+
Sbjct: 166 -------EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW- 217
Query: 176 ISNA 179
+ N
Sbjct: 218 LENK 221
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-18
Identities = 49/266 (18%), Positives = 99/266 (37%), Gaps = 54/266 (20%)
Query: 5 TGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGRNGEKTVNIFMEYMAG--GSLLDVA 62
TG + + + S + + K +N+ MEY+ +L
Sbjct: 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSF 131
Query: 63 EKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSH-GDVKLPDLGCARR 115
+ G ++ +I +Y ++ H GI H D+K N+L+ S +KL D G A++
Sbjct: 132 IRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKK 191
Query: 116 VNDLKNNGNLKQSWQSIGGTQ----LWM-APEVLRN-EGLDFATDIWSLGCMVIEMATGR 169
+ + + + APE++ + D+WS+GC+ E+ G+
Sbjct: 192 LIPSEPS------------VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 170 P--PWGDKISNAAATLLK---------IACSNEK------PHFPTQFFKKV--------- 203
P G+ + +++ + N P + ++K+
Sbjct: 240 PLFS-GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298
Query: 204 LDFLAKCLERKPEKRWSAEELLNHTF 229
+D L + L +P+ R + E + H F
Sbjct: 299 IDLLEQILRYEPDLRINPYEAMAHPF 324
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 6e-18
Identities = 65/260 (25%), Positives = 97/260 (37%), Gaps = 31/260 (11%)
Query: 2 NKGTGALFVVKSAESEAGVQA-LRNEAEIRQSLNSPNIGRNGE-----KTVNIFMEYMAG 55
+K T L VK E A + ++ E +SL PNI R E + I MEY +G
Sbjct: 41 DKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100
Query: 56 GSLLD-VAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSH--GDVK 106
G L + + G R + +++L H I H DLK N LL +K
Sbjct: 101 GELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLK 158
Query: 107 LPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD-FATDIWSLGCMVIEM 165
+ D G + + K S GT ++APEVL + D D+WS G + M
Sbjct: 159 ICDFGYS---KSSVLHSQPK----STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVM 211
Query: 166 ATGRPPWGDKISNAAATLLKIAC--SNEKPHFPTQFF--KKVLDFLAKCLERKPEKRWSA 221
G P+ D K + K P + +++ P R S
Sbjct: 212 LVGAYPFED--PEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISI 269
Query: 222 EELLNHTFISGNAKKNSTEE 241
E+ H++ N + E
Sbjct: 270 PEIKTHSWFLKNLPADLMNE 289
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-17
Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 23/183 (12%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNSPNI----GRNGEKTVNIFMEYMAGGSLLDVAEKFG 66
K+ S++ + EA + + P+I G E V I ME G L +
Sbjct: 51 CKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRK 110
Query: 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLK 120
+LD + LY ++ L +H D+ NVL+ S+ VKL D G +R + D
Sbjct: 111 YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-- 168
Query: 121 NNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKI 176
++ +L WMAPE + A+D+W G + E+ G P+ +
Sbjct: 169 ------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-V 221
Query: 177 SNA 179
N
Sbjct: 222 KNN 224
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-17
Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 22/184 (11%)
Query: 10 VVKSAESEAGVQALRNEAEIRQSLNSPNIGR-NG---EKTVNIFMEYMAGGSLLDVAEKF 65
++ A S + + +EA + S+++P++ R G TV + + M G LLD +
Sbjct: 51 ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH 110
Query: 66 GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDL 119
+ + + + +I L ++H DL NVL+ + VK+ D G A+ +
Sbjct: 111 KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA- 169
Query: 120 KNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDK 175
++ G ++ WMA E + + +D+WS G V E+ T G P+
Sbjct: 170 ------EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG- 222
Query: 176 ISNA 179
I +
Sbjct: 223 IPAS 226
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-17
Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 22/207 (10%)
Query: 26 EAEIRQSLNSPNIGR-NG---EKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI 81
E SL+ N+ R G + + E GSLLD K G G + Y ++
Sbjct: 71 EVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 82 ------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGT 135
L +H DL N+LL + VK+ D G R + + +
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD------HYVMQEHR 184
Query: 136 QL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNE 191
++ W APE L+ A+D W G + EM T G+ PW ++ + L KI E
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQI-LHKIDKEGE 242
Query: 192 KPHFPTQFFKKVLDFLAKCLERKPEKR 218
+ P + + + + +C KPE R
Sbjct: 243 RLPRPEDCPQDIYNVMVQCWAHKPEDR 269
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-17
Identities = 48/210 (22%), Positives = 73/210 (34%), Gaps = 59/210 (28%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM-- 139
LH G+LH D+K +N+LL + VK+ D G +R +++ N +
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 140 -------------APEV-LRNEGLDFATDIWSLGCMVIEMATGRP--PWGD------KIS 177
APE+ L + D+WSLGC++ E+ G+P P +I
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244
Query: 178 NA-----AATLLKIACSN---------EKPHFPTQFFKKV-------------------- 203
+ I EK + +
Sbjct: 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEE 304
Query: 204 -LDFLAKCLERKPEKRWSAEELLNHTFISG 232
LD L K L+ P KR SA + L H F+S
Sbjct: 305 ALDLLDKLLQFNPNKRISANDALKHPFVSI 334
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-17
Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 28/222 (12%)
Query: 21 QALRNEAEIRQSLNSPNI----GRNGEKTVNIFMEYMAGGSLLD-VAEKFGGTLDAGVIR 75
+A EA++ + L + E+ + I EYM+ GSLLD + + G L +
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV 283
Query: 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSW 129
+I + +H DL+ N+L+G + K+ D G AR + D +
Sbjct: 284 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--------NEY 335
Query: 130 QSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLK 185
+ G + W APE +D+WS G ++ E+ T GR P+ ++ ++
Sbjct: 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
Query: 186 IACSNEKPHF-PTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226
P P + C ++PE+R + E L
Sbjct: 396 RGYRMPCPPECPESLHDLMCQ----CWRKEPEERPTFEYLQA 433
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 3e-17
Identities = 41/174 (23%), Positives = 71/174 (40%), Gaps = 24/174 (13%)
Query: 21 QALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75
EA+ L+ P + + + E + I EY++ G LL+ G L+ +
Sbjct: 48 DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL 107
Query: 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSW 129
++ L + +H DL N L+ VK+ D G R V D +
Sbjct: 108 EMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD--------DQY 159
Query: 130 QSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNA 179
S GT+ W APEV +D+W+ G ++ E+ + G+ P+ +N+
Sbjct: 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL-YTNS 212
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-17
Identities = 43/170 (25%), Positives = 68/170 (40%), Gaps = 22/170 (12%)
Query: 25 NEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTK 79
EA I + NI R + K + I EYM G+L + G + +
Sbjct: 95 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 154
Query: 80 EI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIG 133
I L +H DL N+L+ S+ K+ D G +R + D
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS------ 208
Query: 134 GTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNA 179
G ++ W APE + A+D+WS G ++ E+ T G P+ + +SN
Sbjct: 209 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNH 257
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-17
Identities = 51/250 (20%), Positives = 80/250 (32%), Gaps = 76/250 (30%)
Query: 48 IFMEYMAGGSLLDV--AEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLL 99
+ E + +L ++ KF G ++R + I LH N I+HCDLK N+LL
Sbjct: 176 MTFELL-SMNLYELIKKNKFQG-FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL 233
Query: 100 GSHG--DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWS 157
G +K+ D G + + + QS + + APEV+ D+WS
Sbjct: 234 KQQGRSGIKVIDFGSSCYEHQ-----RVYTYIQS----RFYRAPEVILGARYGMPIDMWS 284
Query: 158 LGCMV---------------------IEMATGRPPW----------------GDKISNAA 180
LGC++ + G P G
Sbjct: 285 LGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTV 344
Query: 181 ATLLKIACSNEKPHFPTQFFKKV------------------LDFLAKCLERKPEKRWSAE 222
TL + + LDFL +CLE P R +
Sbjct: 345 TTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404
Query: 223 ELLNHTFISG 232
+ L H ++
Sbjct: 405 QALRHPWLRR 414
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 3e-17
Identities = 44/173 (25%), Positives = 74/173 (42%), Gaps = 24/173 (13%)
Query: 21 QALRNEAEIRQSLNSPNI----GRNGEKTVNIFMEYMAGGSLLD-VAEKFGGTLDAGVIR 75
+A EA++ + L + E+ + I EYM+ GSLLD + + G L +
Sbjct: 307 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV 366
Query: 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSW 129
+I + +H DL+ N+L+G + K+ D G AR + D +
Sbjct: 367 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--------NEY 418
Query: 130 QSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISN 178
+ G + W APE +D+WS G ++ E+ T GR P+ + N
Sbjct: 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVN 470
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 3e-17
Identities = 35/182 (19%), Positives = 67/182 (36%), Gaps = 21/182 (11%)
Query: 12 KSAESEAGVQALRNEAEIRQSLNSPNI----GRNGEKTVNIFMEYMAGGSLLDVAEKFGG 67
K +A + + EA+I L++P I G + + + ME GG L
Sbjct: 372 KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKRE 431
Query: 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKN 121
+ + ++ L +H +L NVLL + K+ D G ++ + +
Sbjct: 432 EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491
Query: 122 NGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKIS 177
+ + + W APE + +D+WS G + E + G+ P+ +
Sbjct: 492 ------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK-MK 544
Query: 178 NA 179
Sbjct: 545 GP 546
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 5e-17
Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 29/225 (12%)
Query: 20 VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLD-VAEKFGGTLDAGV 73
V+ EA + + + PN+ + E I E+M G+LLD + E + A V
Sbjct: 260 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 319
Query: 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQ 127
+ +I L +H +L N L+G + VK+ D G +R +
Sbjct: 320 LLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG--------D 371
Query: 128 SWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATL 183
++ + G + W APE L +D+W+ G ++ E+AT G P+ + L
Sbjct: 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 431
Query: 184 LKIACSNEKP-HFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
L+ E+P P + ++ + C + P R S E+
Sbjct: 432 LEKDYRMERPEGCPEKVYELMRA----CWQWNPSDRPSFAEIHQA 472
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-17
Identities = 42/172 (24%), Positives = 68/172 (39%), Gaps = 22/172 (12%)
Query: 12 KSAESEAGVQALRNEAEIRQSLNSPNI-------GRNGEKTVNIFMEYMAGGSLLDVAEK 64
K + L+ E EI ++L NI +G + + ME++ GSL + K
Sbjct: 59 KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK 118
Query: 65 FGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVND 118
++ Y +I L +H DL NVL+ S VK+ D G +
Sbjct: 119 NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK---A 175
Query: 119 LKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT 167
++ + K+ + W APE L A+D+WS G + E+ T
Sbjct: 176 IETD---KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-17
Identities = 44/184 (23%), Positives = 74/184 (40%), Gaps = 22/184 (11%)
Query: 10 VVKSAESEAGVQALRNEAEIRQSLNSPNIGR-NG---EKTVNIFMEYMAGGSLLDVAEKF 65
V++ QA+ + SL+ +I R G ++ + +Y+ GSLLD +
Sbjct: 49 VIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQH 108
Query: 66 GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDL 119
G L ++ + +I L +G++H +L NVLL S V++ D G A +
Sbjct: 109 RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP- 167
Query: 120 KNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDK 175
+ WMA E + +D+WS G V E+ T G P+
Sbjct: 168 ------DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG- 220
Query: 176 ISNA 179
+ A
Sbjct: 221 LRLA 224
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 9e-17
Identities = 45/169 (26%), Positives = 70/169 (41%), Gaps = 22/169 (13%)
Query: 26 EAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKE 80
EA I + PNI R K V I EYM GSL K + +
Sbjct: 96 EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 81 I------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGG 134
I L G +H DL N+L+ S+ K+ D G R + D ++ + G
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED------DPEAAYTTRG 209
Query: 135 TQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNA 179
++ W +PE + A+D+WS G ++ E+ + G P+ + +SN
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-MSNQ 257
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 9e-17
Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 30/186 (16%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLD-VAE 63
VK +++A QA EA + L N+ + + + I EYMA GSL+D +
Sbjct: 221 VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 280
Query: 64 KFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVN 117
+ L + ++ ++ L GN +H DL NVL+ K+ D G + +
Sbjct: 281 RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340
Query: 118 DLKNNGNL--KQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPP-WG 173
++ G L K W APE LR + +D+WS G ++ E+ + GR P
Sbjct: 341 STQDTGKLPVK-----------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 389
Query: 174 DKISNA 179
I
Sbjct: 390 --IPLK 393
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-16
Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 22/184 (11%)
Query: 10 VVKSAESEAGVQALRNEAEIRQSLNSPNIGR-NG---EKTVNIFMEYMAGGSLLDVAEKF 65
++ A S + + +EA + S+++P++ R G TV + + M G LLD +
Sbjct: 51 ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH 110
Query: 66 GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDL 119
+ + + + +I L ++H DL NVL+ + VK+ D G A+ +
Sbjct: 111 KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA- 169
Query: 120 KNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDK 175
++ G ++ WMA E + + +D+WS G V E+ T G P+
Sbjct: 170 ------EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG- 222
Query: 176 ISNA 179
I +
Sbjct: 223 IPAS 226
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-16
Identities = 36/182 (19%), Positives = 67/182 (36%), Gaps = 21/182 (11%)
Query: 12 KSAESEAGVQALRNEAEIRQSLNSPNI----GRNGEKTVNIFMEYMAGGSLLDVAEKFGG 67
K +A + + EA+I L++P I G + + + ME GG L
Sbjct: 46 KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKRE 105
Query: 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKN 121
+ + ++ L +H DL NVLL + K+ D G ++ + +
Sbjct: 106 EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165
Query: 122 NGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKIS 177
+ + + W APE + +D+WS G + E + G+ P+ +
Sbjct: 166 ------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK-MK 218
Query: 178 NA 179
Sbjct: 219 GP 220
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 26/175 (14%)
Query: 21 QALRNEAEIRQSLNSPNI----GRNGEKTVNIFMEYMAGGSLLD-VAEKFGGTLDAGVIR 75
+A EA + ++L + ++ + I E+MA GSLLD + G +
Sbjct: 228 EAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI 287
Query: 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSW 129
++ +I + +H DL+ N+L+ + K+ D G AR + D +
Sbjct: 288 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--------NEY 339
Query: 130 QSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPP-WGDKISNA 179
+ G + W APE + +D+WS G +++E+ T GR P G +SN
Sbjct: 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG--MSNP 392
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-16
Identities = 54/244 (22%), Positives = 75/244 (30%), Gaps = 71/244 (29%)
Query: 55 GGSLLDVAEK--FGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVK 106
G SL ++ + + G I+LY EI L + H DLK N+LL K
Sbjct: 119 GPSLYEIITRNNYNG-FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177
Query: 107 LPDLGCARRVNDLKNNGNLKQSWQSI-----GG-------------TQLWMAPEVLRNEG 148
K + I G T+ + APEV+ N G
Sbjct: 178 SLITVRRVTDGKKIQIYRTKST--GIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLG 235
Query: 149 LDFATDIWSLGCMVIEMAT---------------------GRPP----------WGDKIS 177
D ++D+WS GC++ E+ T P G K
Sbjct: 236 WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYV 295
Query: 178 NAAATLLKIACSNEKPHFPTQFFK-----------KVLDFLAKCLERKPEKRWSAEELLN 226
N L + + K DFL L+ P R S ELL
Sbjct: 296 NKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355
Query: 227 HTFI 230
H F+
Sbjct: 356 HKFL 359
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-16
Identities = 43/169 (25%), Positives = 68/169 (40%), Gaps = 22/169 (13%)
Query: 26 EAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKE 80
EA I + PNI R + I EYM GSL G + +
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159
Query: 81 I------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGG 134
+ L G +H DL NVL+ S+ K+ D G +R + D + + G
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAYTTT-----G 213
Query: 135 TQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNA 179
++ W APE + A+D+WS G ++ E+ G P+ + ++N
Sbjct: 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN-MTNR 261
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-16
Identities = 42/174 (24%), Positives = 72/174 (41%), Gaps = 24/174 (13%)
Query: 21 QALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75
EA++ +L+ + + ++ + I EYMA G LL+ + +
Sbjct: 64 DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL 123
Query: 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSW 129
K++ L LH DL N L+ G VK+ D G +R V D +
Sbjct: 124 EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--------DEY 175
Query: 130 QSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNA 179
S G++ W PEVL +DIW+ G ++ E+ + G+ P+ +N+
Sbjct: 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNS 228
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 4e-16
Identities = 41/174 (23%), Positives = 72/174 (41%), Gaps = 24/174 (13%)
Query: 21 QALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75
+ EAE+ L+ P + + + + + E+M G L D G A +
Sbjct: 48 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLL 107
Query: 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSW 129
++ L ++H DL N L+G + +K+ D G R V D +
Sbjct: 108 GMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--------DQY 159
Query: 130 QSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNA 179
S GT+ W +PEV +D+WS G ++ E+ + G+ P+ + SN+
Sbjct: 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNS 212
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-16
Identities = 41/185 (22%), Positives = 67/185 (36%), Gaps = 22/185 (11%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEK 64
+ V+A E + + LN PN+ E ++ + YM G LL
Sbjct: 57 LSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS 116
Query: 65 FGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVND 118
+ + ++ L +H DL N +L VK+ D G AR + D
Sbjct: 117 PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176
Query: 119 LKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGD 174
+ + +L W A E L+ +D+WS G ++ E+ T G PP+
Sbjct: 177 REYYSVQQH-----RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH 231
Query: 175 KISNA 179
I
Sbjct: 232 -IDPF 235
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 8e-16
Identities = 40/185 (21%), Positives = 71/185 (38%), Gaps = 22/185 (11%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEK 64
+ V E I + + PN+ E + + + YM G L +
Sbjct: 125 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 184
Query: 65 FGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVND 118
+ + ++ L +H DL N +L VK+ D G AR + D
Sbjct: 185 ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244
Query: 119 LKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGD 174
+ + ++ G +L WMA E L+ + +D+WS G ++ E+ T G PP+ D
Sbjct: 245 KEFDSVHNKT-----GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 299
Query: 175 KISNA 179
++
Sbjct: 300 -VNTF 303
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 8e-16
Identities = 39/188 (20%), Positives = 68/188 (36%), Gaps = 28/188 (14%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEK 64
+ V E I + + PN+ E + + + YM G L +
Sbjct: 61 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 120
Query: 65 FGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVND 118
+ + ++ L +H DL N +L VK+ D G AR + D
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180
Query: 119 LKNNGNLKQSWQSIGGTQL------WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPP 171
+ + S+ WMA E L+ + +D+WS G ++ E+ T G PP
Sbjct: 181 --------KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
Query: 172 WGDKISNA 179
+ D ++
Sbjct: 233 YPD-VNTF 239
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-15
Identities = 50/191 (26%), Positives = 84/191 (43%), Gaps = 28/191 (14%)
Query: 2 NKGTGALFVVKSAESEAGVQALRN---EAEIRQSLNSPNIGR-------NGEKTVNIFME 51
N GTG + VK+ +++AG Q E +I ++L +I + G ++ + ME
Sbjct: 56 NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME 115
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDV 105
Y+ GSL D + ++ + L+ ++I LH +H DL NVLL + V
Sbjct: 116 YVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLV 173
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMV 162
K+ D G A+ V + ++ W APE L+ +A+D+WS G +
Sbjct: 174 KIGDFGLAKAVPEGHE------YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 227
Query: 163 IEMAT-GRPPW 172
E+ T
Sbjct: 228 YELLTHCDSSQ 238
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-15
Identities = 45/247 (18%), Positives = 86/247 (34%), Gaps = 57/247 (23%)
Query: 28 EIRQSLNSPNIGRNGEKTVNIFMEYMAG--GSLLDVAEKFGGTLDAGVIRLYTKEILHG- 84
+++ + + +N+ MEY+ + +I+++ +++
Sbjct: 83 QLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSI 142
Query: 85 -------NGILHCDLKCNNVLL-GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQ 136
+ H D+K +NVL+ + G +KL D G A++++ + N
Sbjct: 143 GCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN------------VA 190
Query: 137 ----LWM-APEVLRN-EGLDFATDIWSLGCMVIEMATGRP-------------------- 170
+ APE++ + A DIWS+GC+ EM G P
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250
Query: 171 PWGDKIS-----NAAATLLKIACSNEKPHFPTQFFK---KVLDFLAKCLERKPEKRWSAE 222
P + + + L F K + D L+ L+ PE+R
Sbjct: 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY 310
Query: 223 ELLNHTF 229
E L H +
Sbjct: 311 EALCHPY 317
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-15
Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 30/186 (16%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLD-VAE 63
VK +++A QA EA + L N+ + + + I EYMA GSL+D +
Sbjct: 49 VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 108
Query: 64 KFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVN 117
+ L + ++ ++ L GN +H DL NVL+ K+ D G + +
Sbjct: 109 RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168
Query: 118 DLKNNGNL--KQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPP-WG 173
++ G L K W APE LR + +D+WS G ++ E+ + GR P
Sbjct: 169 STQDTGKLPVK-----------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217
Query: 174 DKISNA 179
I
Sbjct: 218 --IPLK 221
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 6e-15
Identities = 42/176 (23%), Positives = 70/176 (39%), Gaps = 26/176 (14%)
Query: 20 VQALRNEAEIRQSLNSPNI----GRNGEKTVNIFMEYMAGGSLLD-VAEKFGGTLDAGVI 74
A EA + + L + ++ + I EYM GSL+D + G L +
Sbjct: 52 PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQS 128
+I + +H DL+ N+L+ K+ D G AR + D
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED--------NE 163
Query: 129 WQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPP-WGDKISNA 179
+ + G + W APE + +D+WS G ++ E+ T GR P G ++N
Sbjct: 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--MTNP 217
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-14
Identities = 43/223 (19%), Positives = 69/223 (30%), Gaps = 72/223 (32%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM-- 139
+H +GI+H DLK N LL VK+ D G AR +N K+ + ++
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 140 --------------APEV-LRNEGLDFATDIWSLGCMVIEMATGRPPW------------ 172
APE+ L E + DIWS GC+ E+
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
Query: 173 GDKISNAAAT--------------LLKI-------------ACSNEK--------PHFPT 197
G + L I + + PH
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324
Query: 198 QFFKKV--------LDFLAKCLERKPEKRWSAEELLNHTFISG 232
K+ ++ L L+ P KR + ++ L+H ++
Sbjct: 325 INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-14
Identities = 35/117 (29%), Positives = 56/117 (47%), Gaps = 20/117 (17%)
Query: 64 KFGGTLDAGVIRLYTKEILHG--------NGILHCDLKCNNVLL--GSHGDVKLPDLGCA 113
F G + + R + +++ I+HCDLK N+LL +K+ D G +
Sbjct: 150 NFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
Query: 114 RRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRP 170
++ + Q QS + + +PEVL D A D+WSLGC+++EM TG P
Sbjct: 209 CQLGQ-----RIYQYIQS----RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 8e-06
Identities = 8/31 (25%), Positives = 13/31 (41%)
Query: 204 LDFLAKCLERKPEKRWSAEELLNHTFISGNA 234
D + + L+ P+ R L H+F A
Sbjct: 350 KDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-14
Identities = 45/177 (25%), Positives = 74/177 (41%), Gaps = 27/177 (15%)
Query: 20 VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLD-VAEKFGGTLDAGV 73
V+ EA + + + PN+ + E I E+M G+LLD + E + A V
Sbjct: 53 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 112
Query: 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQ 127
+ +I L +H DL N L+G + VK+ D G +R +
Sbjct: 113 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--------D 164
Query: 128 SWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPP-WGDKISNA 179
++ + G + W APE L +D+W+ G ++ E+AT G P G I +
Sbjct: 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG--IDLS 219
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-14
Identities = 38/243 (15%), Positives = 82/243 (33%), Gaps = 38/243 (15%)
Query: 12 KSAESEAGVQALRNEAEIRQSLNSPNI-----------GRNGEKTVNIFMEYMAGGSLLD 60
+ + ++ EA + + P++ + + + +M G L
Sbjct: 61 ADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHA 120
Query: 61 V-----AEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPD 109
+ L + + +I L +H DL N +L V + D
Sbjct: 121 FLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD 180
Query: 110 LGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMA 166
G +R++ ++ ++L W+A E L + +D+W+ G + E+
Sbjct: 181 FGLSRKIYS-------GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
Query: 167 T-GRPPWGDKISNAAATLLKIACSNEKPHF-PTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
T G+ P+ + L ++P + + D + +C P++R S L
Sbjct: 234 TRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVY----DLMYQCWSADPKQRPSFTCL 289
Query: 225 LNH 227
Sbjct: 290 RME 292
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 3e-14
Identities = 48/231 (20%), Positives = 64/231 (27%), Gaps = 80/231 (34%)
Query: 82 LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM-- 139
+H GILH DLK N L+ VK+ D G AR V+ +N + L
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 140 -------------------APEV-LRNEGLDFATDIWSLGCMVIEM-----------ATG 168
APE+ L E A D+WS+GC+ E+ A
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291
Query: 169 RP--PWGDKISNAAAT----------------LLKI-------------ACSNEK----- 192
P P + L I A E
Sbjct: 292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYI 351
Query: 193 ---PHFPTQFFKKV--------LDFLAKCLERKPEKRWSAEELLNHTFISG 232
P + + L + L P KR + E L H F
Sbjct: 352 RIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 5e-14
Identities = 35/168 (20%), Positives = 68/168 (40%), Gaps = 22/168 (13%)
Query: 26 EAEIRQSLNSPNI----GRNGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI 81
EA + Q L++P I G ++ + ME G L ++ + I ++
Sbjct: 68 EANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQV 126
Query: 82 ------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGT 135
L + +H DL NVLL + K+ D G ++ + +N +++
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN------YYKAQTHG 180
Query: 136 QL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNA 179
+ W APE + +D+WS G ++ E + G+ P+ + +
Sbjct: 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGS 227
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-13
Identities = 55/244 (22%), Positives = 90/244 (36%), Gaps = 40/244 (16%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLD---- 60
V A S NEA + + N ++ R G+ T+ + ME M G L
Sbjct: 63 VNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL-VIMELMTRGDLKSYLRS 121
Query: 61 -----VAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPD 109
+ EI L+ N +H DL N ++ VK+ D
Sbjct: 122 LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 181
Query: 110 LGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMA 166
G R D+ ++ G L WM+PE L++ +D+WS G ++ E+A
Sbjct: 182 FGMTR---DIYETDYYRKG----GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
Query: 167 T-GRPPWGDKISNA-AATLLKIACSNEKPHF-PTQFFKKVLDFLAKCLERKPEKRWSAEE 223
T P+ +SN + +KP P F + + C + P+ R S E
Sbjct: 235 TLAEQPYQG-LSNEQVLRFVMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRPSFLE 289
Query: 224 LLNH 227
+++
Sbjct: 290 IISS 293
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-13
Identities = 40/239 (16%), Positives = 80/239 (33%), Gaps = 39/239 (16%)
Query: 16 SEAGVQALRNEAEIRQSLNSPNI----------GRNGEKTVNIFMEYMAGGSLLDV---- 61
S+ ++ +EA + + PN+ G + + +M G L
Sbjct: 76 SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS 135
Query: 62 -AEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114
E + + + +I L LH DL N +L V + D G ++
Sbjct: 136 RLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
Query: 115 RVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRP 170
++ ++ ++ W+A E L + +D+W+ G + E+AT G
Sbjct: 196 KIYS-------GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMT 248
Query: 171 PWGDKISNA-AATLLKIACSNEKPHF-PTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
P+ + N L ++P + + + + C P R + L
Sbjct: 249 PYPG-VQNHEMYDYLLHGHRLKQPEDCLDELY----EIMYSCWRTDPLDRPTFSVLRLQ 302
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-13
Identities = 35/179 (19%), Positives = 62/179 (34%), Gaps = 40/179 (22%)
Query: 26 EAEIRQSLNSPNIGRN-----GEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKE 80
A + L+ ++ N + E++ GSL +K ++ K+
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121
Query: 81 I------LHGNGILHCDLKCNNVLLGSHGD--------VKLPDLGCARRVNDLKNNGNLK 126
+ L N ++H ++ N+LL D +KL D G + V
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-------- 173
Query: 127 QSWQSIGGTQL---WMAPEVLRNEGLDF--ATDIWSLGCMVIEMAT-GRPPWGDKISNA 179
Q W+ PE + N + ATD WS G + E+ + G P + +
Sbjct: 174 -----KDILQERIPWVPPECIEN-PKNLNLATDKWSFGTTLWEICSGGDKPLSA-LDSQ 225
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 8e-13
Identities = 56/255 (21%), Positives = 95/255 (37%), Gaps = 56/255 (21%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNS-PNIGRNGEKTVN------------IFMEYMAGGS 57
+KS +AL +E +I L NI VN + EY G
Sbjct: 84 LKSTAHADEKEALMSELKIMSHLGQHENI-------VNLLGACTHGGPVLVITEYCCYGD 136
Query: 58 LLD------VAEKFGGTLDAGVIRLYTKEILH-------------GNGILHCDLKCNNVL 98
LL+ + T+++LH +H D+ NVL
Sbjct: 137 LLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196
Query: 99 LGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDI 155
L + K+ D G AR D+ N+ N G +L WMAPE + + +D+
Sbjct: 197 LTNGHVAKIGDFGLAR---DIMNDSNYIVK----GNARLPVKWMAPESIFDCVYTVQSDV 249
Query: 156 WSLGCMVIEMAT-GRPPW-GDKISNAAATLLKIACSNEKPHF-PTQFFKKVLDFLAKCLE 212
WS G ++ E+ + G P+ G +++ L+K +P F P + + C
Sbjct: 250 WSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIY----SIMQACWA 305
Query: 213 RKPEKRWSAEELLNH 227
+P R + +++ +
Sbjct: 306 LEPTHRPTFQQICSF 320
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 64.3 bits (156), Expect = 4e-12
Identities = 50/226 (22%), Positives = 85/226 (37%), Gaps = 27/226 (11%)
Query: 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSLNS----PNI---GRNGEKTVNIFMEYM 53
N T +K + L E++I + L PN+ G G+ V + M+ +
Sbjct: 27 TNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV-LVMDLL 85
Query: 54 AGGSLLDVAEKFGG------TLDAGVIRLYTKEILHGNGILHCDLKCNNVLLGSHGD--- 104
G SL D+ L + E +H LH D+K +N L+G
Sbjct: 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSW-QSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163
V + D G A++ D + ++ +++ GT + + D+ SLG +++
Sbjct: 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLM 204
Query: 164 EMATGRPPW-GDKISNAAA-----TLLKIACSNEK--PHFPTQFFK 201
G PW G K + K+A S E +PT+F
Sbjct: 205 YFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFAS 250
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-12
Identities = 56/253 (22%), Positives = 99/253 (39%), Gaps = 48/253 (18%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNS-PNIGR------NGEKTVNIFMEYMAGGSLLD--- 60
+K + +AL +E ++ L + NI G T+ I EY G LL+
Sbjct: 61 LKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI-TEYCCYGDLLNFLR 119
Query: 61 -------VAEKFGGTLDAGVIRLYTKEILH-------------GNGILHCDLKCNNVLLG 100
++ ++ + L +++L +H DL N+LL
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWS 157
K+ D G AR D+KN+ N G +L WMAPE + N F +D+WS
Sbjct: 180 HGRITKICDFGLAR---DIKNDSNYVVK----GNARLPVKWMAPESIFNCVYTFESDVWS 232
Query: 158 LGCMVIEMAT-GRPPWGDKISNA-AATLLKIACSNEKPHF-PTQFFKKVLDFLAKCLERK 214
G + E+ + G P+ ++ ++K P P + + D + C +
Sbjct: 233 YGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY----DIMKTCWDAD 288
Query: 215 PEKRWSAEELLNH 227
P KR + ++++
Sbjct: 289 PLKRPTFKQIVQL 301
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-12
Identities = 46/205 (22%), Positives = 76/205 (37%), Gaps = 40/205 (19%)
Query: 1 MNKGTGALFV-VKS--AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEY 52
++ + V VK+ + A + + EAE+ +L +I + + + EY
Sbjct: 39 LSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEY 98
Query: 53 MAGGSLLD--------VAEKFGGTLDAGVIRLYTKEILH-------------GNGILHCD 91
M G L G L ++LH +H D
Sbjct: 99 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRD 158
Query: 92 LKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEG 148
L N L+G++ VK+ D G +R V ++ G T L WM PE +
Sbjct: 159 LATRNCLVGANLLVKIGDFGMSRDVYS-------TDYYRVGGHTMLPIRWMPPESIMYRK 211
Query: 149 LDFATDIWSLGCMVIEMAT-GRPPW 172
+D+WS G ++ E+ T G+ PW
Sbjct: 212 FTTESDVWSFGVILWEIFTYGKQPW 236
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-12
Identities = 50/251 (19%), Positives = 91/251 (36%), Gaps = 45/251 (17%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNS-PNIGR------NGEKTVNIFMEYMAGGSLLD--- 60
+K + + +AL +E +I + N+ + + +E+ G+L
Sbjct: 65 LKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR 124
Query: 61 -----VAEKFGGTLDAGVIRLYTKEILH-------------GNGILHCDLKCNNVLLGSH 102
D L + ++ +H DL N+LL
Sbjct: 125 SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 103 GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLG 159
VK+ D G AR D+ + + + G +L WMAPE + + +D+WS G
Sbjct: 185 NVVKICDFGLAR---DIYKDPDYVRK----GDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 160 CMVIEMAT-GRPPW-GDKISNAAATLLKIACSNEKPHF-PTQFFKKVLDFLAKCLERKPE 216
++ E+ + G P+ G KI LK P + + + + C +P
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY----QTMLDCWHGEPS 293
Query: 217 KRWSAEELLNH 227
+R + EL+ H
Sbjct: 294 QRPTFSELVEH 304
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-12
Identities = 51/197 (25%), Positives = 77/197 (39%), Gaps = 38/197 (19%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLD----- 60
+K A SE+ Q + EAE+ L +I R + + + EYM G L
Sbjct: 79 LKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH 137
Query: 61 --VAEKFGGTLDAGVIRLYTKEILH-------------GNGILHCDLKCNNVLLGSHGDV 105
A+ G D L ++L G +H DL N L+G V
Sbjct: 138 GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMV 162
K+ D G +R + ++ G T L WM PE + +D+WS G ++
Sbjct: 198 KIGDFGMSRDIYS-------TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 250
Query: 163 IEMAT-GRPPWGDKISN 178
E+ T G+ PW +SN
Sbjct: 251 WEIFTYGKQPWYQ-LSN 266
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-12
Identities = 43/194 (22%), Positives = 76/194 (39%), Gaps = 40/194 (20%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNS-PNIGR------NGEKTVNIFMEYMAGGSLLD--- 60
+KS +E + L +E E+ + + NI + +EY + G+L +
Sbjct: 109 LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY-VIVEYASKGNLREYLQ 167
Query: 61 -----VAEKFGGTLDAGVIRLYTKEILH-------------GNGILHCDLKCNNVLLGSH 102
E +L +K+++ +H DL NVL+
Sbjct: 168 ARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 227
Query: 103 GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLG 159
+K+ D G AR D+ + K++ +L WMAPE L + +D+WS G
Sbjct: 228 NVMKIADFGLAR---DIHHIDYYKKT----TNGRLPVKWMAPEALFDRIYTHQSDVWSFG 280
Query: 160 CMVIEMAT-GRPPW 172
++ E+ T G P+
Sbjct: 281 VLLWEIFTLGGSPY 294
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-11
Identities = 44/198 (22%), Positives = 75/198 (37%), Gaps = 38/198 (19%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLD----- 60
+K + R+EA +R L PN+ ++ +++ Y + G L +
Sbjct: 47 LKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMR 106
Query: 61 ----------VAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGD 104
L+ +I L + ++H DL NVL+ +
Sbjct: 107 SPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN 166
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCM 161
VK+ DLG R V ++ +G + L WMAPE + +DIWS G +
Sbjct: 167 VKISDLGLFREVYA-------ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVV 219
Query: 162 VIEMAT-GRPPWGDKISN 178
+ E+ + G P+ SN
Sbjct: 220 LWEVFSYGLQPYCG-YSN 236
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-11
Identities = 44/224 (19%), Positives = 85/224 (37%), Gaps = 27/224 (12%)
Query: 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSLNS----PNI---GRNGEKTVNIFMEYM 53
+ G +K + L E++I + + P I G G+ V + ME +
Sbjct: 29 TDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV-MVMELL 87
Query: 54 AGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD--- 104
G SL D+ + L +++ H +H D+K +N L+G
Sbjct: 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL 146
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSW-QSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163
V + D G A++ D + + ++ +++ GT + + D+ SLG +++
Sbjct: 147 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLM 206
Query: 164 EMATGRPPW-GDKISNAAATL-----LKIACSNEK--PHFPTQF 199
G PW G K + K++ E +P++F
Sbjct: 207 YFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEF 250
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-11
Identities = 45/264 (17%), Positives = 92/264 (34%), Gaps = 66/264 (25%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNSPNIGRNGEKTVN------------IFMEYMAGGSL 58
+K S + ++ L +E + + +N P++ + + +EY GSL
Sbjct: 61 LKENASPSELRDLLSEFNVLKQVNHPHV-------IKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 59 LD----------------VAEKFGGTLDAGVIRLYTKEILH-------------GNGILH 89
+ L +++ ++H
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173
Query: 90 CDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRN 146
DL N+L+ +K+ D G +R D+ + + ++ WMA E L +
Sbjct: 174 RDLAARNILVAEGRKMKISDFGLSR---DVYEEDSYVKR----SQGRIPVKWMAIESLFD 226
Query: 147 EGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNA-AATLLKIACSNEKPHF-PTQFFKKV 203
+D+WS G ++ E+ T G P+ I LLK E+P + +
Sbjct: 227 HIYTTQSDVWSFGVLLWEIVTLGGNPYPG-IPPERLFNLLKTGHRMERPDNCSEEMY--- 282
Query: 204 LDFLAKCLERKPEKRWSAEELLNH 227
+ +C +++P+KR ++
Sbjct: 283 -RLMLQCWKQEPDKRPVFADISKD 305
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-11
Identities = 52/256 (20%), Positives = 95/256 (37%), Gaps = 57/256 (22%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNS-PNIGRNGEKTVN------------IFMEYMAGGS 57
+K +E + L +E E+ + + NI +N + +EY + G+
Sbjct: 121 LKDDATEKDLSDLVSEMEMMKMIGKHKNI-------INLLGACTQDGPLYVIVEYASKGN 173
Query: 58 LLD--------VAEKFGGTLDAGVIRLYTKEILH-------------GNGILHCDLKCNN 96
L + E ++ K+++ +H DL N
Sbjct: 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233
Query: 97 VLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFAT 153
VL+ + +K+ D G AR D+ N K++ +L WMAPE L + +
Sbjct: 234 VLVTENNVMKIADFGLAR---DINNIDYYKKT----TNGRLPVKWMAPEALFDRVYTHQS 286
Query: 154 DIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHF-PTQFFKKVLDFLAKCL 211
D+WS G ++ E+ T G P+ LLK +KP + + + C
Sbjct: 287 DVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY----MMMRDCW 342
Query: 212 ERKPEKRWSAEELLNH 227
P +R + ++L+
Sbjct: 343 HAVPSQRPTFKQLVED 358
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-11
Identities = 47/186 (25%), Positives = 64/186 (34%), Gaps = 31/186 (16%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLD----- 60
+ SE EA I N NI R I +E MAGG L
Sbjct: 109 LPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET 168
Query: 61 -VAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGD---VKLPDL 110
+L + ++I L N +H D+ N LL G K+ D
Sbjct: 169 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 228
Query: 111 GCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT 167
G AR D+ G ++ G L WM PE TD WS G ++ E+ +
Sbjct: 229 GMAR---DIYRAGYYRKG----GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
Query: 168 -GRPPW 172
G P+
Sbjct: 282 LGYMPY 287
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-11
Identities = 47/186 (25%), Positives = 63/186 (33%), Gaps = 31/186 (16%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDV---- 61
+ SE EA I N NI R I ME MAGG L
Sbjct: 68 LPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET 127
Query: 62 --AEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGD---VKLPDL 110
+L + ++I L N +H D+ N LL G K+ D
Sbjct: 128 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187
Query: 111 GCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLGCMVIEMAT 167
G AR D+ ++ G L WM PE TD WS G ++ E+ +
Sbjct: 188 GMAR---DIYRASYYRKG----GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
Query: 168 -GRPPW 172
G P+
Sbjct: 241 LGYMPY 246
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-11
Identities = 52/251 (20%), Positives = 94/251 (37%), Gaps = 47/251 (18%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNS-PNIGR------NGEKTVNIFMEYMAGGSLLD--- 60
+K +E + L +E E+ + + NI + +EY + G+L +
Sbjct: 75 LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY-VIVEYASKGNLREYLR 133
Query: 61 -----VAEKFGGTLDAGVIRLYTKEILH-------------GNGILHCDLKCNNVLLGSH 102
E ++ K+++ +H DL NVL+ +
Sbjct: 134 ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 193
Query: 103 GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFATDIWSLG 159
+K+ D G AR D+ N K++ +L WMAPE L + +D+WS G
Sbjct: 194 NVMKIADFGLAR---DINNIDYYKKT----TNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 160 CMVIEMAT-GRPPWGDKISNA-AATLLKIACSNEKPHF-PTQFFKKVLDFLAKCLERKPE 216
++ E+ T G P+ I LLK +KP + + + C P
Sbjct: 247 VLMWEIFTLGGSPYPG-IPVEELFKLLKEGHRMDKPANCTNELY----MMMRDCWHAVPS 301
Query: 217 KRWSAEELLNH 227
+R + ++L+
Sbjct: 302 QRPTFKQLVED 312
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-11
Identities = 46/207 (22%), Positives = 74/207 (35%), Gaps = 59/207 (28%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNS-PNIGRNGEKTVN------------IFMEYMAGGS 57
+K + +AL +E ++ L S NI VN + EY G
Sbjct: 83 LKEKADSSEREALMSELKMMTQLGSHENI-------VNLLGACTLSGPIYLIFEYCCYGD 135
Query: 58 LLD---------------VAEKFGGTLDAGVIRLYTKEILH-------------GNGILH 89
LL+ + + + L +++L +H
Sbjct: 136 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 195
Query: 90 CDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRN 146
DL NVL+ VK+ D G AR D+ ++ N G +L WMAPE L
Sbjct: 196 RDLAARNVLVTHGKVVKICDFGLAR---DIMSDSNYVVR----GNARLPVKWMAPESLFE 248
Query: 147 EGLDFATDIWSLGCMVIEMAT-GRPPW 172
+D+WS G ++ E+ + G P+
Sbjct: 249 GIYTIKSDVWSYGILLWEIFSLGVNPY 275
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-10
Identities = 41/207 (19%), Positives = 66/207 (31%), Gaps = 59/207 (28%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNSPNIGRNGEKTVN------------IFMEYMAGGSL 58
+K S + EA + ++PNI V + EYMA G L
Sbjct: 85 LKEEASADMQADFQREAALMAEFDNPNI-------VKLLGVCAVGKPMCLLFEYMAYGDL 137
Query: 59 LD----------------VAEKFGGTLDAGVIRLYTKEILH-------------GNGILH 89
+ G L E L +H
Sbjct: 138 NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 197
Query: 90 CDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRN 146
DL N L+G + VK+ D G +R ++ + K G + WM PE +
Sbjct: 198 RDLATRNCLVGENMVVKIADFGLSR---NIYSADYYKAD----GNDAIPIRWMPPESIFY 250
Query: 147 EGLDFATDIWSLGCMVIEMAT-GRPPW 172
+D+W+ G ++ E+ + G P+
Sbjct: 251 NRYTTESDVWAYGVVLWEIFSYGLQPY 277
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 3e-10
Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 15/153 (9%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL-- 137
E L +H DL N+LL VK+ D G AR + + + G +L
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-------YVRKGDARLPL 259
Query: 138 -WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPW-GDKISNAAATLLKIACSNEKPH 194
WMAPE + + +D+WS G ++ E+ + G P+ G KI LK P
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 319
Query: 195 FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
+ T ++ + C +P +R + EL+ H
Sbjct: 320 YTTP---EMYQTMLDCWHGEPSQRPTFSELVEH 349
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-10
Identities = 43/228 (18%), Positives = 84/228 (36%), Gaps = 29/228 (12%)
Query: 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSLNS----PNI---GRNGEKTVNIFMEYM 53
N +K + LR+E + L PN+ G+ G V + ++ +
Sbjct: 30 TNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV-LVIDLL 88
Query: 54 AGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD--- 104
G SL D+ + G + + K++L H +++ D+K +N L+G
Sbjct: 89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNA 147
Query: 105 --VKLPDLGCARRVNDLKNNGNLKQSW-QSIGGTQLWMAPEVLRNEGLDFATDIWSLGCM 161
+ + D G + D ++ +++ GT +M+ D+ +LG +
Sbjct: 148 NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHV 207
Query: 162 VIEMATGRPPW-GDKISNAAATL-----LKIACSNEK--PHFPTQFFK 201
+ G PW G K + K + + FP +F+K
Sbjct: 208 FMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYK 255
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-09
Identities = 43/208 (20%), Positives = 73/208 (35%), Gaps = 58/208 (27%)
Query: 11 VKSAESEAGVQALRNEAEIRQSLNS-PNIGRNGEKTVN------------IFMEYMAGGS 57
+K S+ + E E+ L PNI +N + +EY G+
Sbjct: 60 MKEYASKDDHRDFAGELEVLCKLGHHPNI-------INLLGACEHRGYLYLAIEYAPHGN 112
Query: 58 LLD--------VAEKFGGTLDAGVIRLYTKEILH-------------GNGILHCDLKCNN 96
LLD + ++ L ++++LH +H DL N
Sbjct: 113 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 172
Query: 97 VLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL---WMAPEVLRNEGLDFAT 153
+L+G + K+ D G +R +L WMA E L +
Sbjct: 173 ILVGENYVAKIADFGLSRGQEVYVKK----------TMGRLPVRWMAIESLNYSVYTTNS 222
Query: 154 DIWSLGCMVIEMAT--GRPPWGDKISNA 179
D+WS G ++ E+ + G P G ++ A
Sbjct: 223 DVWSYGVLLWEIVSLGGTPYCG--MTCA 248
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-08
Identities = 46/197 (23%), Positives = 75/197 (38%), Gaps = 40/197 (20%)
Query: 51 EYMAGGSL---LDVAEKFGGTLDAGVIRLYTKEI----------LHGNGILHCDLKCNNV 97
+YM G+L L ++ ++ RL EI LH I+H D+K N+
Sbjct: 115 KYMENGNLKRHLYGSDLPTMSMSWE-QRL---EICIGAARGLHYLHTRAIIHRDVKSINI 170
Query: 98 LLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQS--IGGTQLWMAPEVLRNEGLDFATDI 155
LL + K+ D G +++ + L Q+ S + GT ++ PE L +D+
Sbjct: 171 LLDENFVPKITDFGISKKGTE------LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDV 224
Query: 156 WSLGCMVIEMATGRPP--------------WGDKISNAAATLLKIACSNEKPHFPTQFFK 201
+S G ++ E+ R W S+ L +I N + +
Sbjct: 225 YSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-VESHNNGQLEQIVDPNLADKIRPESLR 283
Query: 202 KVLDFLAKCLERKPEKR 218
K D KCL E R
Sbjct: 284 KFGDTAVKCLALSSEDR 300
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-08
Identities = 41/206 (19%), Positives = 77/206 (37%), Gaps = 22/206 (10%)
Query: 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNS----PNI---GRNGEKTVNIFMEYMA 54
N T +K ++ L E + L S P + G G+ + +E +
Sbjct: 30 NLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA-MVLELL- 87
Query: 55 GGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD---- 104
G SL D+ + T + + +++ H +++ D+K N L+G G+
Sbjct: 88 GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQ 147
Query: 105 -VKLPDLGCARRVNDLKNNGNLKQSW-QSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMV 162
+ + D A+ D + ++ +S+ GT +M+ + D+ +LG M
Sbjct: 148 VIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMF 207
Query: 163 IEMATGRPPW-GDKISNAAATLLKIA 187
+ G PW G K KI
Sbjct: 208 MYFLRGSLPWQGLKADTLKERYQKIG 233
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-07
Identities = 41/135 (30%), Positives = 58/135 (42%), Gaps = 25/135 (18%)
Query: 51 EYMAGGSLLDV--AEKFGGTLD--------AGVIR--LYTKEILHGNGILHCDLKCNNVL 98
YM GSLLD L G + LH N +H D+K N+L
Sbjct: 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINF----LHENHHIHRDIKSANIL 165
Query: 99 LGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQS--IGGTQLWMAPEVLRNEGLDFATDIW 156
L K+ D G A + + Q+ + I GT +MAPE LR E + +DI+
Sbjct: 166 LDEAFTAKISDFGLA------RASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIY 218
Query: 157 SLGCMVIEMATGRPP 171
S G +++E+ TG P
Sbjct: 219 SFGVVLLEIITGLPA 233
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-05
Identities = 28/136 (20%), Positives = 53/136 (38%), Gaps = 14/136 (10%)
Query: 80 EILHGNGILHCDLKCNNVLLG--SHGDVKLPDLGCARRVNDLKNNGNLKQSWQ-SIGGTQ 136
E +H N +H D+K N+LLG + V L D G + R N+ +++ + GT
Sbjct: 165 EYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTI 224
Query: 137 LWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATL---------LKIA 187
+ + + + L +D+ LG ++ G+ PW + + A L +
Sbjct: 225 EFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQS 284
Query: 188 CSNEKPH--FPTQFFK 201
P + +
Sbjct: 285 VLKWAPSGSSCCEIAQ 300
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 2e-05
Identities = 24/87 (27%), Positives = 42/87 (48%), Gaps = 9/87 (10%)
Query: 87 ILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQS--IGGTQLWMAPEVL 144
I+H D+K N+LL + + D G A+ ++ K + + + GT +APE L
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-------KDTHVTTAVRGTIGHIAPEYL 207
Query: 145 RNEGLDFATDIWSLGCMVIEMATGRPP 171
TD++ G M++E+ TG+
Sbjct: 208 STGKSSEKTDVFGYGVMLLELITGQRA 234
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-05
Identities = 29/137 (21%), Positives = 46/137 (33%), Gaps = 16/137 (11%)
Query: 80 EILHGNGILHCDLKCNNVLLGSHGD--VKLPDLGCARRVNDLKNNGNLKQSW-QSIGGTQ 136
E +H + +H D+K +N+LL V L D G A R + + GT
Sbjct: 166 EYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTI 225
Query: 137 LWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPW-GDKISNAAATLLKIA-------- 187
+ + + D+ LG +I+ TG PW + KI
Sbjct: 226 EFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASL 285
Query: 188 ---CSNEKPHFPTQFFK 201
C + P + K
Sbjct: 286 MDKCFPAA-NAPGEIAK 301
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 7e-05
Identities = 18/116 (15%), Positives = 34/116 (29%), Gaps = 10/116 (8%)
Query: 9 FVVKSAESEAGVQALRNEAEIRQSLNSPNIGRNGEKTVNIFMEYMAGGSLLDVAEKFGGT 68
V+ + ++A + + S N + + I +E+ GG L+ +
Sbjct: 101 HCVQGSYPPLLLKAWDHYNSTKGSAN-DRPDFFKDDQLFIVLEFEFGGIDLE--QMRTKL 157
Query: 69 LDAGVIRLYTKEILHG-------NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVN 117
+ ++ H DL NVLL KL +
Sbjct: 158 SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 8e-05
Identities = 22/111 (19%), Positives = 40/111 (36%), Gaps = 4/111 (3%)
Query: 80 EILHGNGILHCDLKCNNVLLG--SHGDVKLPDLGCARRVNDLKNNGNLK-QSWQSIGGTQ 136
E LH N +H ++ N+ + V L G A R + S G
Sbjct: 173 EFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDL 232
Query: 137 LWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPW-GDKISNAAATLLKI 186
+++ ++ + G +D+ SLG +++ G PW + K
Sbjct: 233 EFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQ 283
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 9e-05
Identities = 36/234 (15%), Positives = 69/234 (29%), Gaps = 83/234 (35%)
Query: 20 VQALRNEAEIRQSL----NSPNIGRNGEKTVNIFMEYMAGGSLLDVAEKFGGT-LDAGVI 74
V L+ ++RQ+L + N+ +G + G G T + V
Sbjct: 131 VSRLQPYLKLRQALLELRPAKNVLIDG----------VLG---------SGKTWVALDVC 171
Query: 75 RLYTKEILHGNGI--------------------LHCDLKCNNVLLGSHGDVKLPDLGCAR 114
Y + I L + N H +
Sbjct: 172 LSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSS-NIK-----L 225
Query: 115 RVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWS--------LGCMVIEMA 166
R++ ++ L++ +S L L ++ + L C + +
Sbjct: 226 RIHSIQAE--LRRLLKS------KPYENCLLV--LL---NVQNAKAWNAFNLSCKI--LL 270
Query: 167 TGRPPWGDK-ISNA--AATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEK 217
T R K +++ AAT I+ + T +V L K L+ +P+
Sbjct: 271 TTR----FKQVTDFLSAATTTHISLDHHSMTL-TP--DEVKSLLLKYLDCRPQD 317
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 241 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.6 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.35 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.01 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.77 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.59 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.52 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.34 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.32 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.13 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.81 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.66 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.59 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.48 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.01 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.99 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.06 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.87 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.31 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 94.99 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 94.65 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 94.23 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.17 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.15 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 93.77 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.64 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 93.51 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 93.45 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.19 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.07 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.94 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 90.54 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-58 Score=354.03 Aligned_cols=223 Identities=28% Similarity=0.505 Sum_probs=188.4
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.||+.||||++.+. ...+.+.+|+++|++++||||++ .+++.+|+|||||+||+|.+++... +.+++
T Consensus 53 ~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~-~~l~e 131 (311)
T 4aw0_A 53 ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDE 131 (311)
T ss_dssp ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCH
T ss_pred ECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc-CCCCH
Confidence 6789999999998743 33567899999999999999998 7888999999999999999999874 67899
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..++.++.|+ ||++|++||||||+|||++.+|.+||+|||++....... ........+||+.|+|||++.
T Consensus 132 ~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~----~~~~~~~~~GTp~YmAPEvl~ 207 (311)
T 4aw0_A 132 TCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES----KQARANSFVGTAQYVSPELLT 207 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT----TCCCBCCCCSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC----CcccccCcccCcccCCHHHHc
Confidence 9988887766 799999999999999999999999999999998653311 112234567999999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH--
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE-- 223 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-- 223 (241)
+..|+.++||||+||++|+|++|+.||.+.........+. .....+|..+++++.+||++||..||.+|||++|
T Consensus 208 ~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~----~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII----KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----cCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 9999999999999999999999999998754433322222 2345667788999999999999999999999988
Q ss_pred ----HhcCCCCCCC
Q 042809 224 ----LLNHTFISGN 233 (241)
Q Consensus 224 ----~l~~p~~~~~ 233 (241)
+++||||++-
T Consensus 284 ~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 284 GYGPLKAHPFFESV 297 (311)
T ss_dssp CHHHHHTSGGGTTC
T ss_pred CCHHHHCCCCcCCC
Confidence 5899999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-58 Score=359.97 Aligned_cols=226 Identities=24% Similarity=0.419 Sum_probs=189.6
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCCH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~ 71 (241)
|+.+|+.||||++.. ....+.+.+|+.++++++|||||+ .+++.+|+|||||+||+|.+++...+ ..+++
T Consensus 45 ~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e 124 (350)
T 4b9d_A 45 STEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE 124 (350)
T ss_dssp ETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCH
T ss_pred ECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCH
Confidence 678999999999863 345678999999999999999998 67789999999999999999998653 45788
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..++.++.|+ ||++||+||||||+|||++.+|.+||+|||++....... ......+||+.|+|||++.
T Consensus 125 ~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~------~~~~~~~GT~~YmAPE~l~ 198 (350)
T 4b9d_A 125 DQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV------ELARACIGTPYYLSPEICE 198 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH------HHHHHHHSCCTTCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc------ccccccCCCccccCHHHHC
Confidence 7877776655 799999999999999999999999999999997654311 1123457999999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
+..|+.++|||||||++|+|++|+.||.+...... .........+..+..++.++.+||.+||+.||.+|||+++++
T Consensus 199 ~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l 275 (350)
T 4b9d_A 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL---VLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSIL 275 (350)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 99999999999999999999999999987543332 222233445566778899999999999999999999999999
Q ss_pred cCCCCCCCCcc
Q 042809 226 NHTFISGNAKK 236 (241)
Q Consensus 226 ~~p~~~~~~~~ 236 (241)
+||||+....+
T Consensus 276 ~hp~~~~~~~~ 286 (350)
T 4b9d_A 276 EKGFIAKRIEK 286 (350)
T ss_dssp TSHHHHTTGGG
T ss_pred cCHHhhcCCCc
Confidence 99999876543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-57 Score=355.85 Aligned_cols=225 Identities=29% Similarity=0.479 Sum_probs=186.8
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.||+.||||++... ...+.+.+|+.+|++++|||||+ ..++.+|+|||||+||+|.+++.. ..+++..+
T Consensus 95 ~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~ 172 (346)
T 4fih_A 95 VRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQI 172 (346)
T ss_dssp ETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH--SCCCHHHH
T ss_pred ECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHH
Confidence 6789999999998633 33466889999999999999998 677899999999999999999986 56889888
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..++.|+ ||++||+||||||+|||++.+|.+||+|||++....... ......+||+.|+|||++.+..
T Consensus 173 ~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~------~~~~~~~GTp~YmAPEvl~~~~ 246 (346)
T 4fih_A 173 AAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV------PRRKSLVGTPYWMAPELISRLP 246 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS------CCBCCCCSCGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC------CcccccccCcCcCCHHHHCCCC
Confidence 8887765 799999999999999999999999999999997653311 1224567999999999999999
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCC
Q 042809 149 LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHT 228 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p 228 (241)
|+.++|||||||++|+|++|..||.+.........+... .......+..+++++.+||.+||..||.+|||++|+++||
T Consensus 247 y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp 325 (346)
T 4fih_A 247 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 325 (346)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 999999999999999999999999875443333322221 1122233456789999999999999999999999999999
Q ss_pred CCCCCCc
Q 042809 229 FISGNAK 235 (241)
Q Consensus 229 ~~~~~~~ 235 (241)
||+....
T Consensus 326 ~~~~~~~ 332 (346)
T 4fih_A 326 FLAKAGP 332 (346)
T ss_dssp GGGGCCC
T ss_pred hhcCCCC
Confidence 9986543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=344.41 Aligned_cols=220 Identities=28% Similarity=0.506 Sum_probs=177.6
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc---------cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR---------NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
|+.+|..||+|.+.. ....+.+.+|++++++++|||||+ ..+..+|+|||||+||+|.+++... ..
T Consensus 47 ~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~-~~ 125 (290)
T 3fpq_A 47 DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KV 125 (290)
T ss_dssp ETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHH-SS
T ss_pred ECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhc-CC
Confidence 678999999999763 344677999999999999999998 1346789999999999999999874 67
Q ss_pred CCHHHHHHHHHHH------hhcCC--ccccCCCCCcEEeec-CCCeeecCCCcchhhcccccCCccccccccccCccccc
Q 042809 69 LDAGVIRLYTKEI------LHGNG--ILHCDLKCNNVLLGS-HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~--~vH~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (241)
+++..+..++.|+ ||++| ++||||||+|||++. +|.+||+|||++..... ......+||+.|+
T Consensus 126 l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--------~~~~~~~GTp~Ym 197 (290)
T 3fpq_A 126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--------SFAKAVIGTPEFM 197 (290)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--------TSBEESCSSCCCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--------CccCCcccCcccc
Confidence 8888887777655 79998 999999999999975 78999999999974322 1223567999999
Q ss_pred CcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC-CCCCCChhhHHHHHHHHHHhhccCCCCC
Q 042809 140 APEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN-EKPHFPTQFFKKVLDFLAKCLERKPEKR 218 (241)
Q Consensus 140 aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R 218 (241)
|||++.+ +++.++|||||||++|+|+||+.||.+.... ..+....... .+...+...++++.+||.+||+.||.+|
T Consensus 198 APE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 274 (290)
T 3fpq_A 198 APEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 274 (290)
T ss_dssp CGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGS
T ss_pred CHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHC
Confidence 9999875 5899999999999999999999999764322 2222222222 2233455567899999999999999999
Q ss_pred CChHHHhcCCCCCCC
Q 042809 219 WSAEELLNHTFISGN 233 (241)
Q Consensus 219 ps~~~~l~~p~~~~~ 233 (241)
||++++++||||++.
T Consensus 275 ~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 275 YSIKDLLNHAFFQEE 289 (290)
T ss_dssp CCHHHHHTSGGGC--
T ss_pred cCHHHHhcCccccCC
Confidence 999999999999753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-57 Score=343.06 Aligned_cols=219 Identities=22% Similarity=0.345 Sum_probs=176.9
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
|+.+|+.||||++.. ....+.+.+|+.++++++||||++ .+++.+|+||||| +|+|.+++.. .+.+++
T Consensus 34 ~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~-~~~l~e 111 (275)
T 3hyh_A 34 HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQ-RDKMSE 111 (275)
T ss_dssp CTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHH-SCSCCH
T ss_pred ECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHH-cCCCCH
Confidence 678999999999863 233567899999999999999998 7788999999999 6799999987 467999
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..++.++.|+ ||++|++||||||+||+++.++.+||+|||++....+. ......+||+.|+|||++.
T Consensus 112 ~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-------~~~~~~~GT~~Y~APE~~~ 184 (275)
T 3hyh_A 112 QEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-------NFLKTSCGSPNYAAPEVIS 184 (275)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------------------CTTSCHHHHS
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-------CccCCeeECcccCChhhhc
Confidence 9998888766 79999999999999999999999999999999765431 1223467999999999999
Q ss_pred ccCC-CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 146 NEGL-DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 146 ~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
+..+ +.++||||+||++|+|++|+.||.+........... ...+.+|..+++++.+||++||+.||.+|||++++
T Consensus 185 ~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~ei 260 (275)
T 3hyh_A 185 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS----NGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEI 260 (275)
T ss_dssp SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH----cCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 8876 579999999999999999999998754433322222 23455677889999999999999999999999999
Q ss_pred hcCCCCCCC
Q 042809 225 LNHTFISGN 233 (241)
Q Consensus 225 l~~p~~~~~ 233 (241)
++||||+..
T Consensus 261 l~hpw~k~~ 269 (275)
T 3hyh_A 261 MQDDWFKVD 269 (275)
T ss_dssp HHCHHHHTT
T ss_pred HcCcccccC
Confidence 999999754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-56 Score=356.56 Aligned_cols=224 Identities=29% Similarity=0.483 Sum_probs=186.2
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.||+.||||.+... ...+.+.+|+.+|+.++|||||+ ..++.+|+|||||+||+|.+++.. ..+++..+
T Consensus 172 ~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~--~~l~e~~~ 249 (423)
T 4fie_A 172 VRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQI 249 (423)
T ss_dssp ETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--SCCCHHHH
T ss_pred ECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc--cCCCHHHH
Confidence 6789999999998632 33466899999999999999998 677899999999999999999986 56888888
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..++.|+ ||++||+||||||+|||++.+|.+||+|||++....... ......+||+.|+|||++.+..
T Consensus 250 ~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~------~~~~~~~GTp~YmAPEvl~~~~ 323 (423)
T 4fie_A 250 AAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV------PRRKSLVGTPYWMAPELISRLP 323 (423)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC------CCBCCCEECTTTCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC------ccccccccCcCcCCHHHHCCCC
Confidence 8887765 799999999999999999999999999999997653311 1224567999999999999999
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCC
Q 042809 149 LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHT 228 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p 228 (241)
|+.++|||||||++|+|++|..||.+.........+.... ......+..+++++.+||.+||..||.+|||++|+++||
T Consensus 324 y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp 402 (423)
T 4fie_A 324 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 402 (423)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 9999999999999999999999998754433333322211 122233456789999999999999999999999999999
Q ss_pred CCCCCC
Q 042809 229 FISGNA 234 (241)
Q Consensus 229 ~~~~~~ 234 (241)
||+...
T Consensus 403 ~~~~~~ 408 (423)
T 4fie_A 403 FLAKAG 408 (423)
T ss_dssp GGGGCC
T ss_pred HhcCCC
Confidence 998654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=347.30 Aligned_cols=221 Identities=28% Similarity=0.455 Sum_probs=178.6
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+++.||+|++... .....+.+|+.++++++||||++ .+++.+|+|||||+||+|.+++... +.+++.
T Consensus 48 ~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~ 126 (304)
T 3ubd_A 48 GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-VMFTEE 126 (304)
T ss_dssp STTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHH-CCCCHH
T ss_pred CCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhc-CCCCHH
Confidence 3568899999998632 22346889999999999999998 6778999999999999999999874 578898
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.++.++.|+ ||++|++||||||+|||++.+|.+||+|||++....... ......+||+.|+|||++.+
T Consensus 127 ~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~------~~~~~~~GT~~YmAPE~~~~ 200 (304)
T 3ubd_A 127 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE------KKAYSFCGTVEYMAPEVVNR 200 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----------CCCCSCCCCGGGCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC------ccccccccCcccCCHHHhcc
Confidence 888887765 799999999999999999999999999999997543311 12234679999999999999
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC-----h
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS-----A 221 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~ 221 (241)
..++.++||||+||++|+|++|+.||.+.+.......+. ...+.+|..+++++.+||++||+.||.+||| +
T Consensus 201 ~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~ 276 (304)
T 3ubd_A 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL----KAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGV 276 (304)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTH
T ss_pred CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH----cCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCH
Confidence 999999999999999999999999998754433332222 2345567788999999999999999999998 5
Q ss_pred HHHhcCCCCCCC
Q 042809 222 EELLNHTFISGN 233 (241)
Q Consensus 222 ~~~l~~p~~~~~ 233 (241)
+++++||||++-
T Consensus 277 ~eil~Hp~f~~i 288 (304)
T 3ubd_A 277 EEIKRHSFFSTI 288 (304)
T ss_dssp HHHHTSGGGTTC
T ss_pred HHHHcCccccCC
Confidence 899999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-55 Score=341.11 Aligned_cols=228 Identities=30% Similarity=0.382 Sum_probs=182.2
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
|+.||+.||||+++.+.. ..+|+.++++++|||||+ .+++.+|+|||||+||+|.+++... +.+++..+..
T Consensus 79 ~~~~g~~vAiK~i~~~~~---~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~ 154 (336)
T 4g3f_A 79 DKQTGFQCAVKKVRLEVF---RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALY 154 (336)
T ss_dssp ETTTCCEEEEEEEETTTC---CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHH
T ss_pred ECCCCCEEEEEEECHHHh---HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHc-CCCCHHHHHH
Confidence 678999999999985432 357999999999999998 6778899999999999999999874 5789988888
Q ss_pred HHHHH------hhcCCccccCCCCCcEEeecCC-CeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCC
Q 042809 77 YTKEI------LHGNGILHCDLKCNNVLLGSHG-DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL 149 (241)
Q Consensus 77 ~~~~~------Lh~~~~vH~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 149 (241)
++.|+ ||++||+||||||+|||++.+| .+||+|||++........... .......+||+.|+|||++.+..+
T Consensus 155 ~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~-~~~~~~~~GT~~YmAPE~~~~~~y 233 (336)
T 4g3f_A 155 YLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS-LLTGDYIPGTETHMAPEVVMGKPC 233 (336)
T ss_dssp HHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------------CCCCCCGGGCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc-eecCCccccCccccCHHHHCCCCC
Confidence 87765 7999999999999999999988 599999999986543211111 111234579999999999999999
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH-----
Q 042809 150 DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL----- 224 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~----- 224 (241)
+.++|||||||++|+|++|+.||.+.........+... .......+..+++.+.+||.+||++||.+|||++|+
T Consensus 234 ~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~ 312 (336)
T 4g3f_A 234 DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE-PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312 (336)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS-CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC-CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 99999999999999999999999775444333222211 111224567788999999999999999999999997
Q ss_pred --------hcCCCCCCCCc
Q 042809 225 --------LNHTFISGNAK 235 (241)
Q Consensus 225 --------l~~p~~~~~~~ 235 (241)
++|||+....+
T Consensus 313 ~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 313 KALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp HHHHHTTSSCSCSSSSCCC
T ss_pred HHHhhhhhccCCCcCCCCC
Confidence 67999977654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-53 Score=326.84 Aligned_cols=216 Identities=23% Similarity=0.377 Sum_probs=178.1
Q ss_pred CCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC---------
Q 042809 3 KGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG--------- 66 (241)
Q Consensus 3 ~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 66 (241)
+.+|..||||.++. ....+.|.+|+++|++++|||||+ ..++.+|+|||||++|+|.+++...+
T Consensus 40 ~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~ 119 (299)
T 4asz_A 40 EQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 119 (299)
T ss_dssp ---CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC---
T ss_pred CCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCccccccccc
Confidence 45789999999873 445678999999999999999999 66788999999999999999998642
Q ss_pred ---CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccc
Q 042809 67 ---GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL 137 (241)
Q Consensus 67 ---~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (241)
..+++..+..++.|+ ||+++++||||||+||+++.++.+||+|||++........ ........||+.
T Consensus 120 ~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~----~~~~~~~~gt~~ 195 (299)
T 4asz_A 120 NPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY----YRVGGHTMLPIR 195 (299)
T ss_dssp -CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC----EEETTTEEECGG
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCc----eeecCceecChh
Confidence 468888888777655 8999999999999999999999999999999976533111 112223458999
Q ss_pred ccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 138 WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 138 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
|+|||.+.+..++.++|||||||++|||+| |+.||.+...... ......+..+..|..+++++.+|+.+||+.+|.
T Consensus 196 ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~ 272 (299)
T 4asz_A 196 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IECITQGRVLQRPRTCPQEVYELMLGCWQREPH 272 (299)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred hcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHcCCCCCCCccchHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999999 9999987544333 233333555667788899999999999999999
Q ss_pred CCCChHHHh
Q 042809 217 KRWSAEELL 225 (241)
Q Consensus 217 ~Rps~~~~l 225 (241)
+|||+++++
T Consensus 273 ~RPs~~~i~ 281 (299)
T 4asz_A 273 MRKNIKGIH 281 (299)
T ss_dssp GSCCHHHHH
T ss_pred HCcCHHHHH
Confidence 999999984
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=328.33 Aligned_cols=219 Identities=25% Similarity=0.400 Sum_probs=173.0
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC--------
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-------- 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-------- 66 (241)
+..+++.||||.++. ....+.|.+|+++|++++|||||+ ...+.+|+|||||++|+|.+++....
T Consensus 67 ~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~ 146 (329)
T 4aoj_A 67 PEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAG 146 (329)
T ss_dssp C---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC------
T ss_pred cCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccc
Confidence 456789999999873 445678999999999999999998 66778999999999999999997642
Q ss_pred ------CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccC
Q 042809 67 ------GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGG 134 (241)
Q Consensus 67 ------~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 134 (241)
.++++..+..++.|+ ||+++++||||||+|||++.++.+||+|||++........ ........|
T Consensus 147 ~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~----~~~~~~~~g 222 (329)
T 4aoj_A 147 GEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY----YRVGGRTML 222 (329)
T ss_dssp -----CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------------------CCC
T ss_pred cccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCc----ceecCcccc
Confidence 357787777777654 8999999999999999999999999999999975533111 112234568
Q ss_pred cccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhcc
Q 042809 135 TQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLER 213 (241)
Q Consensus 135 ~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 213 (241)
|+.|+|||++.+..++.++|||||||++|||+| |+.||.+....... .....+..+..|..+++++.+|+.+||+.
T Consensus 223 t~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~---~~i~~g~~~~~p~~~~~~~~~li~~cl~~ 299 (329)
T 4aoj_A 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI---DCITQGRELERPRACPPEVYAIMRGCWQR 299 (329)
T ss_dssp CGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH---HHHHHTCCCCCCTTCCHHHHHHHHHHCCS
T ss_pred cccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH---HHHHcCCCCCCcccccHHHHHHHHHHcCc
Confidence 999999999999999999999999999999999 89999875443332 22333456677888899999999999999
Q ss_pred CCCCCCChHHHhcC
Q 042809 214 KPEKRWSAEELLNH 227 (241)
Q Consensus 214 ~p~~Rps~~~~l~~ 227 (241)
||++|||+++++++
T Consensus 300 dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 300 EPQQRHSIKDVHAR 313 (329)
T ss_dssp STTTSCCHHHHHHH
T ss_pred ChhHCcCHHHHHHH
Confidence 99999999999764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=324.38 Aligned_cols=227 Identities=21% Similarity=0.275 Sum_probs=165.7
Q ss_pred CCCCCcEEEEEecc---chHHHHHHHHHHHHHhhcCCCccccc-----------------CCceeeeeecccCCCCHHHH
Q 042809 2 NKGTGALFVVKSAE---SEAGVQALRNEAEIRQSLNSPNIGRN-----------------GEKTVNIFMEYMAGGSLLDV 61 (241)
Q Consensus 2 ~~~~~~~vaiK~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-----------------~~~~~~lv~e~~~~~~L~~~ 61 (241)
++.+|+.||||.+. .+...+.+.+|+.+|++++|||||+. ....+|+|||||+||+|.++
T Consensus 26 ~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~ 105 (299)
T 4g31_A 26 NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDW 105 (299)
T ss_dssp ETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHH
T ss_pred ECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHH
Confidence 67899999999876 33455779999999999999999981 12358999999999999999
Q ss_pred HHHhCC--CCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCc------ccc
Q 042809 62 AEKFGG--TLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGN------LKQ 127 (241)
Q Consensus 62 l~~~~~--~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~------~~~ 127 (241)
+..... ..+...+..++. ++||++|++||||||+|||++.+|.+||+|||++........... ...
T Consensus 106 l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~ 185 (299)
T 4g31_A 106 MNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185 (299)
T ss_dssp HHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------
T ss_pred HHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCcccccccccccccc
Confidence 987432 233444454544 458999999999999999999999999999999986644222111 011
Q ss_pred ccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHH
Q 042809 128 SWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFL 207 (241)
Q Consensus 128 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 207 (241)
.....+||+.|+|||.+.+..|+.++|||||||++|+|++ ||..... .............+......++.+.+||
T Consensus 186 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~li 260 (299)
T 4g31_A 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--RVRTLTDVRNLKFPPLFTQKYPCEYVMV 260 (299)
T ss_dssp ------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHH
T ss_pred ccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--HHHHHHHHhcCCCCCCCcccCHHHHHHH
Confidence 2234579999999999999999999999999999999996 7765322 1122222222222323334556788999
Q ss_pred HHhhccCCCCCCChHHHhcCCCCCCC
Q 042809 208 AKCLERKPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 208 ~~~l~~~p~~Rps~~~~l~~p~~~~~ 233 (241)
++||+.||.+|||++++++||||++-
T Consensus 261 ~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 261 QDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-52 Score=320.54 Aligned_cols=221 Identities=24% Similarity=0.339 Sum_probs=171.0
Q ss_pred cEEEEEecc----chHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 7 ALFVVKSAE----SEAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 7 ~~vaiK~~~----~~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
..||||+++ +....+.|.+|+.++++++|||||+ ..++.+|+|||||+||+|.+++......+++..+..++
T Consensus 59 ~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~ 138 (307)
T 3omv_A 59 GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIA 138 (307)
T ss_dssp SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHH
T ss_pred CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHH
Confidence 358999876 3455678999999999999999998 45567899999999999999998877789998888777
Q ss_pred HHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc---cCC
Q 042809 79 KEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN---EGL 149 (241)
Q Consensus 79 ~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~ 149 (241)
.|+ ||+++++||||||+|||++.++.+||+|||++........ ........||+.|+|||++.+ .++
T Consensus 139 ~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~----~~~~~~~~GT~~ymAPE~l~~~~~~~y 214 (307)
T 3omv_A 139 RQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG----SQQVEQPTGSVLWMAPEVIRMQDNNPF 214 (307)
T ss_dssp HHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----------------CCCCTTSCCHHHHHCCSSCCC
T ss_pred HHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc----ceeecccccCCCccCHHHhhccCCCCC
Confidence 655 8999999999999999999999999999999975433111 112234579999999999964 458
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhc--CCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH---
Q 042809 150 DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACS--NEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL--- 224 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~--- 224 (241)
+.++|||||||++|||+||+.||.+............... ...+..+..+++.+.+|+.+||+.+|.+|||++++
T Consensus 215 ~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 215 SFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred CcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999976433222211111111 11223456788999999999999999999999986
Q ss_pred ---hcCCCCC
Q 042809 225 ---LNHTFIS 231 (241)
Q Consensus 225 ---l~~p~~~ 231 (241)
++|++.+
T Consensus 295 Le~l~~~lpk 304 (307)
T 3omv_A 295 IELLQHSLPK 304 (307)
T ss_dssp HHHHHTTCCC
T ss_pred HHHHhccCCC
Confidence 4666643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=323.65 Aligned_cols=219 Identities=20% Similarity=0.314 Sum_probs=177.5
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-------
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG------- 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~------- 66 (241)
+..+++.||||.++.. ...+.|.+|+.++++++|||||+ ..++.+++|||||++|+|.+++....
T Consensus 52 ~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~ 131 (308)
T 4gt4_A 52 PGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGS 131 (308)
T ss_dssp ----CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-
T ss_pred cCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccc
Confidence 3467889999998743 34578999999999999999998 66778999999999999999997532
Q ss_pred --------CCCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccc
Q 042809 67 --------GTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSI 132 (241)
Q Consensus 67 --------~~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 132 (241)
..+++..+..++.| +||+++++||||||+|||++.++.+||+|||++........ .......
T Consensus 132 ~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~----~~~~~~~ 207 (308)
T 4gt4_A 132 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY----YKLLGNS 207 (308)
T ss_dssp ----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGC----BCSSSSS
T ss_pred cccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCc----eeEeccc
Confidence 34777777666654 48999999999999999999999999999999976543211 1122345
Q ss_pred cCcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhh
Q 042809 133 GGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCL 211 (241)
Q Consensus 133 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 211 (241)
.||+.|+|||.+.+..++.++|||||||++|||+| |..||.+....... .....+..++.|..++.++.+|+.+||
T Consensus 208 ~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~---~~i~~~~~~~~p~~~~~~~~~li~~C~ 284 (308)
T 4gt4_A 208 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV---EMIRNRQVLPCPDDCPAWVYALMIECW 284 (308)
T ss_dssp CBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH---HHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCCCCCCcccchHHHHHHHHHHc
Confidence 68999999999999999999999999999999999 89999876544333 333345556678888999999999999
Q ss_pred ccCCCCCCChHHHhcC
Q 042809 212 ERKPEKRWSAEELLNH 227 (241)
Q Consensus 212 ~~~p~~Rps~~~~l~~ 227 (241)
+.+|.+|||+++++++
T Consensus 285 ~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 285 NEFPSRRPRFKDIHSR 300 (308)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred CCChhHCcCHHHHHHH
Confidence 9999999999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-52 Score=332.61 Aligned_cols=230 Identities=22% Similarity=0.334 Sum_probs=180.6
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----------cCCceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----------NGEKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----------~~~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
|+.||+.||||++.. ....+.+.+|+.+|+.++|||||+ ...+++|+|||||+ |+|.+++.. .
T Consensus 75 ~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~-~ 152 (398)
T 4b99_A 75 RRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHS-S 152 (398)
T ss_dssp ETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTS-S
T ss_pred ECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHh-c
Confidence 678999999999863 334567889999999999999988 13468999999996 689999986 5
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
+.+++..++.++.|+ ||++|++||||||+||+++.+|.+||+|||++.......... .......+||+.|+|
T Consensus 153 ~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~--~~~~~~~~GT~~Y~A 230 (398)
T 4b99_A 153 QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH--QYFMTEYVATRWYRA 230 (398)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---------CCCCCSSCCCCTTCC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCcccc--ccccccceeChHhcC
Confidence 689999998888866 799999999999999999999999999999997653311111 122345679999999
Q ss_pred ccccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCC--------------------CCC----
Q 042809 141 PEVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK--------------------PHF---- 195 (241)
Q Consensus 141 PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------~~~---- 195 (241)
||++.+. .++.++||||+||++|+|++|+.||.+.........+........ +..
T Consensus 231 PEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
T 4b99_A 231 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPW 310 (398)
T ss_dssp HHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCH
T ss_pred HHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCH
Confidence 9998875 468999999999999999999999987654443333322221111 000
Q ss_pred ---ChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 196 ---PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 196 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.+..++++.+||++||..||.+|||++++|+||||+....
T Consensus 311 ~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 311 ETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp HHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred HHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 1234678999999999999999999999999999987543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=345.16 Aligned_cols=227 Identities=23% Similarity=0.415 Sum_probs=188.5
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.||+.||+|.+.. ....+.+.+|+.+|+.++||||++ ..+..+|+|||||+||+|.+++......+++..+
T Consensus 178 ~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~ 257 (573)
T 3uto_A 178 ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA 257 (573)
T ss_dssp ETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHH
T ss_pred ECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHH
Confidence 678999999998764 344577899999999999999998 7888999999999999999999876678999988
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecC--CCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSH--GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
..++.|+ ||++|++||||||+||+++.+ +.+||+|||++..... .......+||+.|+|||++.+
T Consensus 258 ~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~-------~~~~~~~~GT~~y~APEv~~~ 330 (573)
T 3uto_A 258 VEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-------KQSVKVTTGTAEFAAPEVAEG 330 (573)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT-------TSEEEEECSSGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC-------CCceeeeEECccccCHHHhCC
Confidence 8887765 799999999999999999865 8899999999986543 122345679999999999999
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
..|+.++||||+||++|+|++|..||.+.........+..............+++++.+||++||..||.+|||++++++
T Consensus 331 ~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 331 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999999999999999999999999876544333332222112222233467889999999999999999999999999
Q ss_pred CCCCCCCCc
Q 042809 227 HTFISGNAK 235 (241)
Q Consensus 227 ~p~~~~~~~ 235 (241)
||||+....
T Consensus 411 Hpw~~~~~~ 419 (573)
T 3uto_A 411 HPWLTPGNA 419 (573)
T ss_dssp STTTSCCCC
T ss_pred CcCcCCCCC
Confidence 999986543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=339.21 Aligned_cols=222 Identities=25% Similarity=0.423 Sum_probs=182.7
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHH---HHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALR---NEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~---~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
++.||+.||||++.+.. ....+. +++.+++.++|||||+ .+.+.+|+|||||+||+|.+++... +.
T Consensus 210 ~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~-~~ 288 (689)
T 3v5w_A 210 KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GV 288 (689)
T ss_dssp ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-CC
T ss_pred ECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhc-CC
Confidence 67899999999987432 122233 4466677789999998 7888999999999999999999874 67
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
+++..++.++.|+ ||++||+||||||+|||++.+|.+||+|||++...... .....+||+.|+|||
T Consensus 289 l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~--------~~~t~~GTp~YmAPE 360 (689)
T 3v5w_A 289 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------KPHASVGTHGYMAPE 360 (689)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--------CCCSCCSCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC--------CCCCccCCcCccCHH
Confidence 8999998888765 79999999999999999999999999999999765431 123467999999999
Q ss_pred ccc-ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC-
Q 042809 143 VLR-NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS- 220 (241)
Q Consensus 143 ~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps- 220 (241)
++. +..|+.++|+|||||++|+|++|..||.+........+.... ......+|..+++++.+||.+||..||.+|++
T Consensus 361 vl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i-~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~ 439 (689)
T 3v5w_A 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGC 439 (689)
T ss_dssp HHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH-HHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred HHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh-cCCCCCCCccCCHHHHHHHHHHccCCHhHCCCC
Confidence 996 467999999999999999999999999775444333333222 23445677889999999999999999999998
Q ss_pred ----hHHHhcCCCCCCC
Q 042809 221 ----AEELLNHTFISGN 233 (241)
Q Consensus 221 ----~~~~l~~p~~~~~ 233 (241)
++++++||||++-
T Consensus 440 ~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 440 LGRGAQEVKESPFFRSL 456 (689)
T ss_dssp SSSTHHHHTTSGGGTTC
T ss_pred CCCCHHHHhcCccccCC
Confidence 7999999999863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=320.66 Aligned_cols=227 Identities=26% Similarity=0.337 Sum_probs=172.1
Q ss_pred CCCCcEEEEEeccchHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 3 KGTGALFVVKSAESEAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
..+++.||+|.+........+.+|+++++.+ .||||++ ...+++|+|||||+||+|.+++. .+++..++.
T Consensus 46 ~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~ 121 (361)
T 4f9c_A 46 VGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVRE 121 (361)
T ss_dssp TSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHH
T ss_pred CCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHH
Confidence 4678999999987666667789999999998 5999998 67789999999999999999985 378888888
Q ss_pred HHHHH------hhcCCccccCCCCCcEEeecC-CCeeecCCCcchhhcccccCC----------------------cccc
Q 042809 77 YTKEI------LHGNGILHCDLKCNNVLLGSH-GDVKLPDLGCARRVNDLKNNG----------------------NLKQ 127 (241)
Q Consensus 77 ~~~~~------Lh~~~~vH~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~----------------------~~~~ 127 (241)
++.|+ ||++|++||||||+|||++.+ +.+||+|||+|....+..... ....
T Consensus 122 ~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (361)
T 4f9c_A 122 YMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQ 201 (361)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC----------------------
T ss_pred HHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccc
Confidence 87766 799999999999999999887 799999999997543211100 0011
Q ss_pred ccccccCcccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchH--HHHHHHH-----------------
Q 042809 128 SWQSIGGTQLWMAPEVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAA--ATLLKIA----------------- 187 (241)
Q Consensus 128 ~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~----------------- 187 (241)
.....+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.....+.. ..+....
T Consensus 202 ~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~ 281 (361)
T 4f9c_A 202 QVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSIL 281 (361)
T ss_dssp ----CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEE
T ss_pred cccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhcccccc
Confidence 22345799999999999875 488999999999999999999999954322111 0000000
Q ss_pred ----------------hcC----------------CCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCC
Q 042809 188 ----------------CSN----------------EKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 188 ----------------~~~----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~ 233 (241)
... ........+++++.+|+++||..||.+|||++|+|+||||++-
T Consensus 282 ~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 282 CSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp ESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred ccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 000 0001123456789999999999999999999999999999863
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=317.42 Aligned_cols=218 Identities=21% Similarity=0.292 Sum_probs=176.2
Q ss_pred CCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCC-Ccccc------cCCceeeeeecccCCCCHHHHHHHhC-------
Q 042809 4 GTGALFVVKSAES---EAGVQALRNEAEIRQSLNS-PNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFG------- 66 (241)
Q Consensus 4 ~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h-~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~------- 66 (241)
.+++.||||.+.. ....+.+.+|+++|.++.| ||||+ ..++.+++|||||++|+|.++|+...
T Consensus 92 ~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~ 171 (353)
T 4ase_A 92 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 171 (353)
T ss_dssp TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-
T ss_pred cCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhccccccccc
Confidence 4567899999874 3445779999999999975 89998 33567999999999999999998632
Q ss_pred --------CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccc
Q 042809 67 --------GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSI 132 (241)
Q Consensus 67 --------~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 132 (241)
..+++..+..++.|+ ||+++++||||||+||+++.++.+||+|||+++...... ........
T Consensus 172 ~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~----~~~~~~~~ 247 (353)
T 4ase_A 172 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP----DYVRKGDA 247 (353)
T ss_dssp ------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCT----TSEEETTE
T ss_pred ccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCC----Cceeeccc
Confidence 346777777666654 899999999999999999999999999999997553311 11122345
Q ss_pred cCcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhh
Q 042809 133 GGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCL 211 (241)
Q Consensus 133 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 211 (241)
.||+.|+|||++.+..++.++|||||||++|||+| |..||.+..... ........+..+..|...++++.+++.+||
T Consensus 248 ~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~--~~~~~i~~g~~~~~p~~~~~~~~~li~~c~ 325 (353)
T 4ase_A 248 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTRMRAPDYTTPEMYQTMLDCW 325 (353)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHHHTCCCCCCTTCCHHHHHHHHHHT
T ss_pred cccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--HHHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence 68999999999999999999999999999999998 999997753322 122223335566777788899999999999
Q ss_pred ccCCCCCCChHHHhcC
Q 042809 212 ERKPEKRWSAEELLNH 227 (241)
Q Consensus 212 ~~~p~~Rps~~~~l~~ 227 (241)
+.||.+|||++++++|
T Consensus 326 ~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 326 HGEPSQRPTFSELVEH 341 (353)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred CcChhHCcCHHHHHHH
Confidence 9999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=303.92 Aligned_cols=222 Identities=26% Similarity=0.420 Sum_probs=185.7
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
|+.+|+.||+|++.. ....+.+.+|+++++.++||||++ ...+..|+||||+++++|.+++... +.+++.
T Consensus 36 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~ 114 (328)
T 3fe3_A 36 HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEK 114 (328)
T ss_dssp ETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-CCCCHH
T ss_pred ECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHc-CCCCHH
Confidence 567899999999763 345677899999999999999998 6778999999999999999999874 568888
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||++|++||||||+||+++.++.+||+|||++...... ......+|++.|+|||.+.+
T Consensus 115 ~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~ 187 (328)
T 3fe3_A 115 EARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-------GKLDAFCGAPPYAAPELFQG 187 (328)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-------CGGGTTSSSGGGCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-------CccccccCCcceeCcccccC
Confidence 887777655 79999999999999999999999999999999754331 12334568999999999988
Q ss_pred cCCC-chhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 147 EGLD-FATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 147 ~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
..++ .++||||+|+++|+|++|..||.+........... ......|...++++.+|+++||..||.+|||+++++
T Consensus 188 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil 263 (328)
T 3fe3_A 188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL----RGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIM 263 (328)
T ss_dssp CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHT
T ss_pred CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 7765 79999999999999999999998765443333222 234456667888999999999999999999999999
Q ss_pred cCCCCCCCCc
Q 042809 226 NHTFISGNAK 235 (241)
Q Consensus 226 ~~p~~~~~~~ 235 (241)
+||||+....
T Consensus 264 ~h~~~~~~~~ 273 (328)
T 3fe3_A 264 KDRWINAGHE 273 (328)
T ss_dssp TCTTTTTTCT
T ss_pred cCHhhcCCCc
Confidence 9999987554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=303.40 Aligned_cols=221 Identities=27% Similarity=0.435 Sum_probs=182.1
Q ss_pred CCCCCcEEEEEeccchH--------HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAESEA--------GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
++.+|+.||+|.+.... ..+.+.+|+.++++++||||++ .....+++||||++||+|.+++.. ...
T Consensus 33 ~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~ 111 (361)
T 2yab_A 33 EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ-KES 111 (361)
T ss_dssp ETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT-CSC
T ss_pred ECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHh-cCC
Confidence 56789999999987432 2467899999999999999998 677899999999999999999976 467
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCC----CeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG----DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
+++..+..++.|+ ||++|++||||||+||+++.++ .+||+|||++...... .......||+.|
T Consensus 112 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~-------~~~~~~~gt~~y 184 (361)
T 2yab_A 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-------VEFKNIFGTPEF 184 (361)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT-------CCCCCCCSCGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC-------CccccCCCCccE
Confidence 8888888887765 7999999999999999998877 7999999999765431 122345689999
Q ss_pred cCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC----hhhHHHHHHHHHHhhccC
Q 042809 139 MAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP----TQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 139 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~ 214 (241)
+|||.+.+..++.++|+||||+++|+|++|..||.+.........+. .....++ ..++..+.+||++||..+
T Consensus 185 ~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~s~~~~~li~~~L~~d 260 (361)
T 2yab_A 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT----AVSYDFDEEFFSQTSELAKDFIRKLLVKE 260 (361)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH----TTCCCCCHHHHTTSCHHHHHHHHHHSCSS
T ss_pred ECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hcCCCCCchhccCCCHHHHHHHHHHCCCC
Confidence 99999999899999999999999999999999998754433322222 2222333 346788999999999999
Q ss_pred CCCCCChHHHhcCCCCCCCC
Q 042809 215 PEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 215 p~~Rps~~~~l~~p~~~~~~ 234 (241)
|.+|||++++++||||+...
T Consensus 261 P~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 261 TRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp TTTSCCHHHHHTSTTTSCSS
T ss_pred hhHCcCHHHHhcCcCcCCCc
Confidence 99999999999999998643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=301.45 Aligned_cols=228 Identities=19% Similarity=0.324 Sum_probs=184.5
Q ss_pred CCCCCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 2 NKGTGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
++.+|+.||+|.+... .....+.+|+.+++.++||||++ ...+..++||||++|++|.+++......+++..+.
T Consensus 26 ~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~ 105 (321)
T 1tki_A 26 ETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV 105 (321)
T ss_dssp ETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHH
T ss_pred ECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHH
Confidence 5678999999997743 34567889999999999999998 56778999999999999999998766678888888
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeec--CCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGS--HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
.++.|+ ||++|++||||||+||+++. ++.+||+|||++...... .......|++.|+|||.+.+.
T Consensus 106 ~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~ 178 (321)
T 1tki_A 106 SYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-------DNFRLLFTAPEYYAPEVHQHD 178 (321)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-------CEEEEEESCGGGSCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-------CccccccCChhhcCcHHhcCC
Confidence 777765 79999999999999999987 789999999999755331 122345689999999999988
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 148 GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
.++.++||||||+++|+|++|..||.+........................++.++.+++.+||..+|.+|||+.++++|
T Consensus 179 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 88999999999999999999999998765443333322221111111113467899999999999999999999999999
Q ss_pred CCCCCCCcc
Q 042809 228 TFISGNAKK 236 (241)
Q Consensus 228 p~~~~~~~~ 236 (241)
|||+.....
T Consensus 259 p~~~~~~~~ 267 (321)
T 1tki_A 259 PWLKQKIER 267 (321)
T ss_dssp HHHHSCGGG
T ss_pred hhhccCccc
Confidence 999876554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=293.25 Aligned_cols=219 Identities=22% Similarity=0.254 Sum_probs=158.1
Q ss_pred CCcEEEEEeccchHHHH-HHHHHHHHHhhcCCCcccc------c---CCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 5 TGALFVVKSAESEAGVQ-ALRNEAEIRQSLNSPNIGR------N---GEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~~-~~~~e~~~l~~l~h~~i~~------~---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
+|+.||||++....... ...+|+..+.+++||||++ . ....+|+|||||++|+|.+++.. ..+++..+
T Consensus 25 ~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~ 102 (303)
T 3hmm_A 25 RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGM 102 (303)
T ss_dssp TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHH
T ss_pred CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh--CCCCHHHH
Confidence 68899999998654332 2345666677899999998 1 12368999999999999999986 45777776
Q ss_pred HHHHHH------HhhcC--------CccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 75 RLYTKE------ILHGN--------GILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 75 ~~~~~~------~Lh~~--------~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..++.| +||++ +++||||||+|||++.++.+||+|||++.......... ........||+.|+|
T Consensus 103 ~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~--~~~~~~~~GT~~ymA 180 (303)
T 3hmm_A 103 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI--DIAPNHRVGTKRYMA 180 (303)
T ss_dssp HHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEE--SCC-----CCGGGCC
T ss_pred HHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCce--eeecccccccccccC
Confidence 666654 47876 99999999999999999999999999997553321111 112234569999999
Q ss_pred ccccccc------CCCchhhHHHHHHHHHHHHhCCCCCccchh------------chHHHHHHHH-hcCCCCCCCh----
Q 042809 141 PEVLRNE------GLDFATDIWSLGCMVIEMATGRPPWGDKIS------------NAAATLLKIA-CSNEKPHFPT---- 197 (241)
Q Consensus 141 PE~~~~~------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------~~~~~~~~~~-~~~~~~~~~~---- 197 (241)
||++.+. .++.++|||||||++|||+||..||..... .......... .....+..|.
T Consensus 181 PE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~ 260 (303)
T 3hmm_A 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS 260 (303)
T ss_dssp HHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGS
T ss_pred HHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccc
Confidence 9999754 367799999999999999999776532111 1111222221 2233444443
Q ss_pred -hhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 198 -QFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 198 -~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
..+..+.+|+.+||+.||.+|||+.++++.
T Consensus 261 ~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 261 CEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 345678999999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=296.19 Aligned_cols=221 Identities=27% Similarity=0.446 Sum_probs=183.6
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+.+.. ....+.+|+.++..++||||++ ...+.+|+||||++||+|.+++... ..+++
T Consensus 26 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~ 104 (337)
T 1o6l_A 26 EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTE 104 (337)
T ss_dssp ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCH
T ss_pred ECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCH
Confidence 56789999999987542 3566889999999999999988 6778999999999999999999874 56788
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.+|.+||+|||++...... .......+||+.|+|||.+.
T Consensus 105 ~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~------~~~~~~~~gt~~y~aPE~~~ 178 (337)
T 1o6l_A 105 ERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD------GATMKTFCGTPEYLAPEVLE 178 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT------TCCBCCCEECGGGCCGGGGS
T ss_pred HHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC------CCcccccccChhhCChhhhc
Confidence 8877776654 79999999999999999999999999999998743221 11223456899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----C
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----S 220 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s 220 (241)
+..++.++|+||||+++|+|++|..||.+........... .....++..+++++.++|++||+.+|.+|| +
T Consensus 179 ~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~ 254 (337)
T 1o6l_A 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL----MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254 (337)
T ss_dssp SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTT
T ss_pred CCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH----cCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCC
Confidence 9999999999999999999999999997754433332222 233456677889999999999999999999 9
Q ss_pred hHHHhcCCCCCCC
Q 042809 221 AEELLNHTFISGN 233 (241)
Q Consensus 221 ~~~~l~~p~~~~~ 233 (241)
++++++||||+.-
T Consensus 255 ~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 255 AKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHTSGGGTTC
T ss_pred HHHHHcCCCcCCC
Confidence 9999999999764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=291.42 Aligned_cols=225 Identities=34% Similarity=0.545 Sum_probs=183.7
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
|+.+|+.||+|.+... ...+.+.+|+.+++.++||||++ ...+..++||||+++++|.+++.. ..+++..+
T Consensus 41 ~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~ 118 (297)
T 3fxz_A 41 DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQI 118 (297)
T ss_dssp BTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHH
T ss_pred ECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh--cCCCHHHH
Confidence 6788999999997632 34567899999999999999998 567789999999999999999987 35777777
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..++.|+ ||++|++||||||+||+++.++.+||+|||++....... .......|++.|+|||.+.+..
T Consensus 119 ~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~ 192 (297)
T 3fxz_A 119 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ------SKRSTMVGTPYWMAPEVVTRKA 192 (297)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT------CCBCCCCSCGGGCCHHHHHCSC
T ss_pred HHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc------cccCCccCCcCccChhhhcCCC
Confidence 7776654 799999999999999999999999999999987543311 1123456899999999999999
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCC
Q 042809 149 LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHT 228 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p 228 (241)
++.++||||||+++|+|++|..||.+........... .........+..++..+.+++.+||+.+|.+|||++++++||
T Consensus 193 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 9999999999999999999999997654333222222 122233344667888999999999999999999999999999
Q ss_pred CCCCCCc
Q 042809 229 FISGNAK 235 (241)
Q Consensus 229 ~~~~~~~ 235 (241)
||+....
T Consensus 272 ~~~~~~~ 278 (297)
T 3fxz_A 272 FLKIAKP 278 (297)
T ss_dssp GGGGCCC
T ss_pred hhcccCc
Confidence 9986543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=302.98 Aligned_cols=225 Identities=27% Similarity=0.396 Sum_probs=184.9
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+|+.||+|.+.. ....+.+.+|+.+++.++||||++ ..++..|+||||+.||+|.+++.. ...+++.
T Consensus 32 ~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~~e~ 110 (444)
T 3soa_A 32 KVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA-REYYSEA 110 (444)
T ss_dssp ETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHH-CSCCCHH
T ss_pred ECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHH-cCCCCHH
Confidence 577899999998763 234567899999999999999998 678899999999999999999987 4668888
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeec---CCCeeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGS---HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
.+..++.|+ ||++|++||||||+||+++. ++.+||+|||++....... .......|++.|+|||.
T Consensus 111 ~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~------~~~~~~~gt~~Y~APE~ 184 (444)
T 3soa_A 111 DASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ------QAWFGFAGTPGYLSPEV 184 (444)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC------CBCCCSCSCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC------ceeecccCCcccCCHHH
Confidence 888777765 79999999999999999984 5789999999997543311 11234568999999999
Q ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH
Q 042809 144 LRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 144 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
+.+..++.++||||+|+++|+|++|..||.+........................+++.+.+||.+||+.||.+|||+++
T Consensus 185 l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e 264 (444)
T 3soa_A 185 LRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAE 264 (444)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 99989999999999999999999999999876554444443333222233333467889999999999999999999999
Q ss_pred HhcCCCCCCC
Q 042809 224 LLNHTFISGN 233 (241)
Q Consensus 224 ~l~~p~~~~~ 233 (241)
+++||||+..
T Consensus 265 ~L~hp~~~~~ 274 (444)
T 3soa_A 265 ALKHPWISHR 274 (444)
T ss_dssp HHHSCTTHHH
T ss_pred HhcCccccCC
Confidence 9999999754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=292.04 Aligned_cols=218 Identities=28% Similarity=0.493 Sum_probs=182.6
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|++.... ..+.+.+|..+++.++||||++ .....+|+||||++||+|.+++.. ...+++
T Consensus 27 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~ 105 (318)
T 1fot_A 27 SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPN 105 (318)
T ss_dssp ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-TSSCCH
T ss_pred ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH-cCCCCH
Confidence 46789999999987542 3466889999999999999998 677899999999999999999987 456888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.+|.+||+|||++..... .....+||+.|+|||.+.
T Consensus 106 ~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---------~~~~~~gt~~y~aPE~~~ 176 (318)
T 1fot_A 106 PVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---------VTYTLCGTPDYIAPEVVS 176 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---------CBCCCCSCTTTCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC---------ccccccCCccccCHhHhc
Confidence 8877776654 7999999999999999999999999999999975432 112356899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----C
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----S 220 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s 220 (241)
+..++.++|+||||+++|+|++|..||.+........... .....++...+.++.+++++||..+|.+|| +
T Consensus 177 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~----~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 252 (318)
T 1fot_A 177 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL----NAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNG 252 (318)
T ss_dssp TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----HCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTT
T ss_pred CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCC
Confidence 9999999999999999999999999997654333222222 123456677888999999999999999999 9
Q ss_pred hHHHhcCCCCCCC
Q 042809 221 AEELLNHTFISGN 233 (241)
Q Consensus 221 ~~~~l~~p~~~~~ 233 (241)
++++++||||++.
T Consensus 253 ~~~i~~hp~f~~~ 265 (318)
T 1fot_A 253 TEDVKNHPWFKEV 265 (318)
T ss_dssp THHHHTSGGGSSC
T ss_pred HHHHhcCccccCC
Confidence 9999999999763
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=298.24 Aligned_cols=221 Identities=28% Similarity=0.448 Sum_probs=180.7
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+|+.||+|++... ...+.+.+|..++..+ .||||++ ...+.+|+||||++||+|.+++... ..++
T Consensus 44 ~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~ 122 (353)
T 3txo_A 44 VKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFD 122 (353)
T ss_dssp ETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCC
T ss_pred EcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCC
Confidence 5678999999998743 2346688999999988 5999998 6778999999999999999999874 5688
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..++.++.|+ ||++|++||||||+||+++.+|.+||+|||++...... .......+||+.|+|||++
T Consensus 123 ~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~------~~~~~~~~gt~~y~aPE~~ 196 (353)
T 3txo_A 123 EARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN------GVTTATFCGTPDYIAPEIL 196 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------------CCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC------CccccccCCCcCeEChhhc
Confidence 88888777655 79999999999999999999999999999998643221 1122345699999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh---
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA--- 221 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--- 221 (241)
.+..++.++|+||||+++|+|++|..||.+.........+. .....++..++.++.+++++||..+|.+||++
T Consensus 197 ~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~----~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~ 272 (353)
T 3txo_A 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL----NDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQ 272 (353)
T ss_dssp HHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGG
T ss_pred CCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH----cCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCccc
Confidence 99889999999999999999999999998765444333322 23445667788899999999999999999998
Q ss_pred ---HHHhcCCCCCCC
Q 042809 222 ---EELLNHTFISGN 233 (241)
Q Consensus 222 ---~~~l~~p~~~~~ 233 (241)
+++++||||++-
T Consensus 273 ~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 273 GGEHAILRHPFFKEI 287 (353)
T ss_dssp TCTHHHHTSGGGTTC
T ss_pred CCHHHHhhCCcccCC
Confidence 899999999863
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=295.73 Aligned_cols=225 Identities=24% Similarity=0.419 Sum_probs=181.3
Q ss_pred CCCCCcEEEEEeccchH--------HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAESEA--------GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
++.+|+.||+|.+.... ..+.+.+|+.++++++||||++ ......++||||+++++|.+++.. ...
T Consensus 32 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~ 110 (326)
T 2y0a_A 32 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KES 110 (326)
T ss_dssp ETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT-SSC
T ss_pred ECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHh-cCC
Confidence 56789999999876421 3577999999999999999998 677889999999999999999976 467
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCC----CeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG----DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
+++..+..++.|+ ||++|++||||||+||+++.++ .+||+|||++...... .......|++.|
T Consensus 111 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~~gt~~y 183 (326)
T 2y0a_A 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-------NEFKNIFGTPEF 183 (326)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTT-------SCCCCCCSCTTT
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCC-------CccccccCCcCc
Confidence 8888888777655 7999999999999999998887 7999999999755331 112334689999
Q ss_pred cCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCC
Q 042809 139 MAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218 (241)
Q Consensus 139 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 218 (241)
+|||.+.+..++.++||||||+++|+|++|..||.+.........................+..+.+|+++||..+|.+|
T Consensus 184 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 263 (326)
T 2y0a_A 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263 (326)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGS
T ss_pred CCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhC
Confidence 99999999899999999999999999999999997754433332222211111111123456789999999999999999
Q ss_pred CChHHHhcCCCCCCCC
Q 042809 219 WSAEELLNHTFISGNA 234 (241)
Q Consensus 219 ps~~~~l~~p~~~~~~ 234 (241)
||++++++||||+...
T Consensus 264 pt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 264 MTIQDSLQHPWIKPKD 279 (326)
T ss_dssp CCHHHHHHSTTTSCCS
T ss_pred CCHHHHhcCCCccCCc
Confidence 9999999999998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=298.66 Aligned_cols=227 Identities=22% Similarity=0.405 Sum_probs=185.4
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.+|+.||+|.+... .....+.+|+.+++.++||||++ ......++||||+.+++|.+++......+++..+
T Consensus 72 ~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~ 151 (387)
T 1kob_A 72 EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV 151 (387)
T ss_dssp ETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHH
T ss_pred ECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHH
Confidence 5678999999998743 34567899999999999999998 6778999999999999999999876667888888
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeec--CCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGS--HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
..++.|+ ||++|++||||||+||+++. ++.+||+|||++...... .......||+.|+|||.+.+
T Consensus 152 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~ 224 (387)
T 1kob_A 152 INYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-------EIVKVTTATAEFAAPEIVDR 224 (387)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-------SCEEEECSSGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-------cceeeeccCCCccCchhccC
Confidence 8777755 79999999999999999975 467999999999754331 11233468999999999999
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
..++.++||||||+++|+|++|..||.+........................++.++.+||++||..+|.+|||++++++
T Consensus 225 ~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 225 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 88999999999999999999999999875443333333222222233334567889999999999999999999999999
Q ss_pred CCCCCCCCc
Q 042809 227 HTFISGNAK 235 (241)
Q Consensus 227 ~p~~~~~~~ 235 (241)
||||+....
T Consensus 305 hp~~~~~~~ 313 (387)
T 1kob_A 305 HPWLKGDHS 313 (387)
T ss_dssp STTTSSCCT
T ss_pred CccccCCcc
Confidence 999987644
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=296.85 Aligned_cols=224 Identities=28% Similarity=0.436 Sum_probs=181.4
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+|+.||+|.+.. ....+.+.+|+.+++.++||||++ ...+..|+||||+.+|+|.+++.. ...+++.
T Consensus 50 ~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~ 128 (362)
T 2bdw_A 50 HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEA 128 (362)
T ss_dssp ETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT-CSCCCHH
T ss_pred ECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH-cCCCCHH
Confidence 567899999999863 344677899999999999999998 677889999999999999999986 4567888
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCC---CeeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG---DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
.+..++.|+ ||++|++||||||+||+++.++ .+||+|||++...... .......|++.|+|||.
T Consensus 129 ~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-------~~~~~~~gt~~y~aPE~ 201 (362)
T 2bdw_A 129 DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-------EAWHGFAGTPGYLSPEV 201 (362)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-------CSCCCSCSCTTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-------cccccCCCCccccCHHH
Confidence 877777655 7999999999999999998654 5999999999755431 11233568999999999
Q ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH
Q 042809 144 LRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 144 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
+.+..++.++||||||+++|+|++|..||.+........................+++++.+||.+||..+|.+|||+++
T Consensus 202 ~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 281 (362)
T 2bdw_A 202 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQ 281 (362)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 99988999999999999999999999999876544333333222211122222456889999999999999999999999
Q ss_pred HhcCCCCCCC
Q 042809 224 LLNHTFISGN 233 (241)
Q Consensus 224 ~l~~p~~~~~ 233 (241)
+++||||...
T Consensus 282 ~l~hp~~~~~ 291 (362)
T 2bdw_A 282 ALKVPWICNR 291 (362)
T ss_dssp HTTSHHHHTH
T ss_pred HhcCcccCCC
Confidence 9999999754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=294.95 Aligned_cols=221 Identities=26% Similarity=0.462 Sum_probs=183.4
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+|+.||+|.+... .....+.+|..++..+ +||||++ .....+|+||||++||+|.+++... ..++
T Consensus 38 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~ 116 (345)
T 1xjd_A 38 FKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFD 116 (345)
T ss_dssp ETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCC
T ss_pred ECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCC
Confidence 5678999999998754 2345678899999877 8999998 6778999999999999999999874 5688
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||++|++||||||+||+++.+|.+||+|||++...... .......+||+.|+|||.+
T Consensus 117 ~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~------~~~~~~~~gt~~y~aPE~~ 190 (345)
T 1xjd_A 117 LSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG------DAKTNTFCGTPDYIAPEIL 190 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT------TCCBCCCCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC------CCcccCCCCCcccCChhhh
Confidence 88887777655 79999999999999999999999999999998643211 1122345689999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH-H
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE-E 223 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~ 223 (241)
.+..++.++|+||||+++|+|++|..||.+.........+. ...+.++..++.++.++|.+||..+|.+||++. +
T Consensus 191 ~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~ 266 (345)
T 1xjd_A 191 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR----MDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGD 266 (345)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSC
T ss_pred cCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH----hCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHH
Confidence 99999999999999999999999999998754443332222 233456677889999999999999999999998 9
Q ss_pred HhcCCCCCCC
Q 042809 224 LLNHTFISGN 233 (241)
Q Consensus 224 ~l~~p~~~~~ 233 (241)
+++||||+.-
T Consensus 267 i~~hp~f~~~ 276 (345)
T 1xjd_A 267 IRQHPLFREI 276 (345)
T ss_dssp GGGSGGGTTC
T ss_pred HHcCccccCC
Confidence 9999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=298.80 Aligned_cols=225 Identities=28% Similarity=0.467 Sum_probs=181.3
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+|+.||+|++.+. ...+.+.+|..++.++ +||||++ .....+|+||||++||+|..++... ..++
T Consensus 73 ~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~ 151 (396)
T 4dc2_A 73 LKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLP 151 (396)
T ss_dssp ETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCC
T ss_pred ECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHc-CCCC
Confidence 5678999999998743 2234578999999887 7999998 6788999999999999999999874 5688
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..++.++.|+ ||++|++||||||+||+++.+|.+||+|||++...... .......+||+.|+|||++
T Consensus 152 ~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~------~~~~~~~~gt~~Y~aPE~l 225 (396)
T 4dc2_A 152 EEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP------GDTTSTFCGTPNYIAPEIL 225 (396)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT------TCCBCCCCBCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC------CCccccccCCcccCCchhh
Confidence 88888777655 79999999999999999999999999999999642211 1123446799999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhc-----hHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISN-----AAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 219 (241)
.+..++.++|+||||+++|+|++|+.||...... ................+|..++.++.+||++||+.+|.+||
T Consensus 226 ~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~ 305 (396)
T 4dc2_A 226 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERL 305 (396)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTST
T ss_pred cCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcC
Confidence 9999999999999999999999999999532111 11111222222345567778889999999999999999999
Q ss_pred Ch------HHHhcCCCCCCC
Q 042809 220 SA------EELLNHTFISGN 233 (241)
Q Consensus 220 s~------~~~l~~p~~~~~ 233 (241)
++ +++++||||++-
T Consensus 306 ~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 306 GCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp TCSTTTHHHHHHHSTTTTTC
T ss_pred CCCCCCCHHHHhcCccccCC
Confidence 85 899999999764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=294.75 Aligned_cols=228 Identities=25% Similarity=0.372 Sum_probs=168.5
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
++.+++.||+|.+......+.+.+|+.++++++||||++ ......++||||+++++|.+++.. ...+++..+..
T Consensus 74 ~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~ 152 (349)
T 2w4o_A 74 QKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE-KGYYSERDAAD 152 (349)
T ss_dssp ETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT-CSSCCHHHHHH
T ss_pred ECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHH
Confidence 467889999999987766778899999999999999998 667889999999999999999986 45678887777
Q ss_pred HHHHH------hhcCCccccCCCCCcEEeec---CCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 77 YTKEI------LHGNGILHCDLKCNNVLLGS---HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 77 ~~~~~------Lh~~~~vH~dl~p~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
++.|+ ||+.|++||||||+||+++. ++.+||+|||++...... .......|++.|+|||.+.+.
T Consensus 153 i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~ 225 (349)
T 2w4o_A 153 AVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-------VLMKTVCGTPGYCAPEILRGC 225 (349)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------------------CGGGSCHHHHTTC
T ss_pred HHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-------cccccccCCCCccCHHHhcCC
Confidence 77655 79999999999999999975 789999999999755331 112335689999999999998
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccchhchHH-HHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 148 GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAA-TLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
.++.++||||||+++|+|++|..||......... .................++..+.+|+++||..+|.+|||+.++++
T Consensus 226 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 226 AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 8999999999999999999999999765433211 111111111112233567789999999999999999999999999
Q ss_pred CCCCCCCCccC
Q 042809 227 HTFISGNAKKN 237 (241)
Q Consensus 227 ~p~~~~~~~~~ 237 (241)
||||.+...+.
T Consensus 306 hp~~~~~~~~~ 316 (349)
T 2w4o_A 306 HPWVTGKAANF 316 (349)
T ss_dssp STTTTSTTCCC
T ss_pred CcccCCCccch
Confidence 99998876543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=293.25 Aligned_cols=218 Identities=28% Similarity=0.504 Sum_probs=183.1
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|++.... ..+.+.+|+.++..++||||++ .....+|+||||++||+|.+++... ..+++
T Consensus 62 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~ 140 (350)
T 1rdq_E 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSE 140 (350)
T ss_dssp ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CCCCH
T ss_pred ECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCH
Confidence 56789999999987442 3467889999999999999998 6778999999999999999999874 56888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.+|.+||+|||++...... ....+||+.|+|||.+.
T Consensus 141 ~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---------~~~~~gt~~y~aPE~~~ 211 (350)
T 1rdq_E 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---------TWTLCGTPEALAPEIIL 211 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---------BCCCEECGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC---------cccccCCccccCHHHhc
Confidence 8887777655 79999999999999999999999999999999754331 12346899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC-----
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS----- 220 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----- 220 (241)
+..++.++|+||||+++|+|++|..||.+.........+. .....++..++.++.++|.+||+.+|.+||+
T Consensus 212 ~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~----~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 287 (350)
T 1rdq_E 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV----SGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNG 287 (350)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTT
T ss_pred CCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH----cCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCC
Confidence 9999999999999999999999999998754433322222 2234566778899999999999999999998
Q ss_pred hHHHhcCCCCCCC
Q 042809 221 AEELLNHTFISGN 233 (241)
Q Consensus 221 ~~~~l~~p~~~~~ 233 (241)
++++++||||+..
T Consensus 288 ~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 288 VNDIKNHKWFATT 300 (350)
T ss_dssp THHHHTSGGGTTC
T ss_pred HHHHHhCcCcCCC
Confidence 9999999999763
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=299.26 Aligned_cols=225 Identities=24% Similarity=0.393 Sum_probs=179.8
Q ss_pred CCCCCcEEEEEeccchHH-----HHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEAG-----VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|++.+... ...+.+|+.++..++||||++ .....+|+||||++||+|.+++.. ..+++
T Consensus 90 ~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~e 167 (410)
T 3v8s_A 90 HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPE 167 (410)
T ss_dssp ETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH--CCCCH
T ss_pred ECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCH
Confidence 567899999999875432 234789999999999999998 678899999999999999999986 45788
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..++.++.|+ ||++|++||||||+||+++.+|.+||+|||++....... .......+||+.|+|||++.
T Consensus 168 ~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-----~~~~~~~~gt~~Y~APE~l~ 242 (410)
T 3v8s_A 168 KWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-----MVRCDTAVGTPDYISPEVLK 242 (410)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-----EEECCSCCSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-----cccccCCcCCccccCHHHhh
Confidence 8877776655 799999999999999999999999999999997543311 11223457999999999997
Q ss_pred ccC----CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCC--CC
Q 042809 146 NEG----LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEK--RW 219 (241)
Q Consensus 146 ~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rp 219 (241)
+.. ++.++|+||||+++|+|++|..||.+.........+..............++.++.+||++||..+|.+ ||
T Consensus 243 ~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~ 322 (410)
T 3v8s_A 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRN 322 (410)
T ss_dssp TTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSS
T ss_pred ccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCC
Confidence 655 788999999999999999999999875443333222211111122223457889999999999999988 99
Q ss_pred ChHHHhcCCCCCCC
Q 042809 220 SAEELLNHTFISGN 233 (241)
Q Consensus 220 s~~~~l~~p~~~~~ 233 (241)
+++++++||||++-
T Consensus 323 ~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 323 GVEEIKRHLFFKND 336 (410)
T ss_dssp CHHHHHTSGGGCCS
T ss_pred CHHHHhcCccccCC
Confidence 99999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=290.52 Aligned_cols=225 Identities=28% Similarity=0.468 Sum_probs=181.2
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+|+.||+|++... ...+.+.+|..++.++ +||||++ .....+|+||||++||+|.+++... ..++
T Consensus 30 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~ 108 (345)
T 3a8x_A 30 LKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLP 108 (345)
T ss_dssp ETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCC
T ss_pred ECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCC
Confidence 5678999999998742 3456788999999988 7999998 6778999999999999999999874 5688
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..++.++.|+ ||++|++||||||+||+++.+|.+||+|||++...... .......+||+.|+|||.+
T Consensus 109 ~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~------~~~~~~~~gt~~y~aPE~~ 182 (345)
T 3a8x_A 109 EEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP------GDTTSTFCGTPNYIAPEIL 182 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT------TCCBCCCCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC------CCcccccCCCccccCcccc
Confidence 88887776655 79999999999999999999999999999998643211 1122345689999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhc-----hHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISN-----AAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 219 (241)
.+..++.++|+||||+++|+|++|..||...... ................++...+..+.++|++||+.+|.+||
T Consensus 183 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~ 262 (345)
T 3a8x_A 183 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERL 262 (345)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTST
T ss_pred CCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCC
Confidence 9999999999999999999999999999642110 11111111122234556777889999999999999999999
Q ss_pred Ch------HHHhcCCCCCCC
Q 042809 220 SA------EELLNHTFISGN 233 (241)
Q Consensus 220 s~------~~~l~~p~~~~~ 233 (241)
++ +++++||||++-
T Consensus 263 ~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 263 GCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp TCCTTTHHHHHHTSGGGTTC
T ss_pred CCCCcCCHHHHhcCCccCCC
Confidence 85 899999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=294.21 Aligned_cols=220 Identities=21% Similarity=0.309 Sum_probs=180.1
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+.... ....+.+|+.+++.++||||++ ......++||||+ +|+|.+++... ..+++
T Consensus 30 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~-~~l~~ 107 (336)
T 3h4j_B 30 HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK-KRMTE 107 (336)
T ss_dssp ETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHH-CSCCH
T ss_pred ECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHc-CCCCH
Confidence 56789999999987432 2346889999999999999998 6778899999999 68999998874 56888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.++.+||+|||++...... ......+|++.|+|||.+.
T Consensus 108 ~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-------~~~~~~~gt~~y~aPE~~~ 180 (336)
T 3h4j_B 108 DEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-------NFLKTSCGSPNYAAPEVIN 180 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-------BTTCCCTTSTTTSCGGGSC
T ss_pred HHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-------cccccccCCcCcCCHHHHc
Confidence 8887777765 79999999999999999999999999999999755431 1223456899999999998
Q ss_pred ccCC-CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 146 NEGL-DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 146 ~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
+..+ +.++||||||+++|++++|..||.+....... ..........+...++.+.+|+++||+.||.+|||++++
T Consensus 181 ~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~ei 256 (336)
T 3h4j_B 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEI 256 (336)
T ss_dssp CSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----CCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred CCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----HHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 8776 68999999999999999999999764332211 111123345566788899999999999999999999999
Q ss_pred hcCCCCCCCC
Q 042809 225 LNHTFISGNA 234 (241)
Q Consensus 225 l~~p~~~~~~ 234 (241)
++||||+...
T Consensus 257 l~hp~~~~~~ 266 (336)
T 3h4j_B 257 RRDPWFNVNL 266 (336)
T ss_dssp TTCHHHHTTC
T ss_pred HhChhhccCC
Confidence 9999998653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=282.42 Aligned_cols=227 Identities=28% Similarity=0.430 Sum_probs=185.0
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+|+.||+|.+.. ....+.+.+|+.++++++||||++ ......++||||+++++|.+++... ..++..
T Consensus 27 ~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~ 105 (284)
T 3kk8_A 27 HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEA 105 (284)
T ss_dssp ETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHH
T ss_pred EcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhc-CCCCHH
Confidence 567899999999763 334577889999999999999988 6778899999999999999998874 567887
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCC---eeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGD---VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
.+..++.|+ ||++|++||||+|+||+++.++. ++|+|||.+...... .......|++.|+|||.
T Consensus 106 ~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~ 178 (284)
T 3kk8_A 106 DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-------EAWHGFAGTPGYLSPEV 178 (284)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-------CBCCCSCSCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-------ccccCCCCCcCCcCchh
Confidence 777776655 79999999999999999987665 999999999654431 11233568999999999
Q ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH
Q 042809 144 LRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 144 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
+.+..++.++||||||+++|++++|..||.+........................+++.+.+++.+||+.+|.+|||+++
T Consensus 179 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 258 (284)
T 3kk8_A 179 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQ 258 (284)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHH
Confidence 99999999999999999999999999999876554444444333333333333567889999999999999999999999
Q ss_pred HhcCCCCCCCCcc
Q 042809 224 LLNHTFISGNAKK 236 (241)
Q Consensus 224 ~l~~p~~~~~~~~ 236 (241)
+++||||+.....
T Consensus 259 ~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 259 ALKVPWICNRERV 271 (284)
T ss_dssp HTTSHHHHSCCCG
T ss_pred HhcCccccCChhH
Confidence 9999999876553
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=296.90 Aligned_cols=225 Identities=25% Similarity=0.370 Sum_probs=181.3
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.+|+.||+|++... ...+.+.+|+.++.+++||||++ ...+..++||||+++++|.+++......+++..+
T Consensus 110 ~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~ 189 (373)
T 2x4f_A 110 ETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189 (373)
T ss_dssp ETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHH
T ss_pred EcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHH
Confidence 4678999999998743 44677999999999999999998 6678899999999999999999876667888777
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEee--cCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLG--SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
..++.|+ ||+.|++||||||+||+++ .++.+||+|||++....... ......|++.|+|||.+.+
T Consensus 190 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 262 (373)
T 2x4f_A 190 ILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-------KLKVNFGTPEFLAPEVVNY 262 (373)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-------BCCCCCSSCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-------ccccccCCCcEeChhhccC
Confidence 7776654 7999999999999999994 56789999999997654311 1223458999999999998
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
..++.++||||||+++|+|++|..||.+........................+++.+.+||.+||+.+|.+|||++++++
T Consensus 263 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 263 DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 88999999999999999999999999875443333222222111122222456789999999999999999999999999
Q ss_pred CCCCCCC
Q 042809 227 HTFISGN 233 (241)
Q Consensus 227 ~p~~~~~ 233 (241)
||||+..
T Consensus 343 hp~~~~~ 349 (373)
T 2x4f_A 343 HPWLSDH 349 (373)
T ss_dssp SHHHHCH
T ss_pred CcCcCCC
Confidence 9999764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=292.58 Aligned_cols=223 Identities=25% Similarity=0.483 Sum_probs=184.1
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+.... ....+.+|+.++..++||||++ .....+|+||||+.||+|.+++.. ...+++
T Consensus 36 ~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~ 114 (384)
T 4fr4_A 36 KNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKE 114 (384)
T ss_dssp ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT-TCCCCH
T ss_pred ECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh-cCCCCH
Confidence 56789999999987432 3467889999999999999998 677899999999999999999987 467888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.+|.++|+|||++...... ......+||+.|+|||++.
T Consensus 115 ~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-------~~~~~~~gt~~Y~aPE~~~ 187 (384)
T 4fr4_A 115 ETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-------TQITTMAGTKPYMAPEMFS 187 (384)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-------CCBCCCCSCGGGCCGGGTC
T ss_pred HHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-------CceeccCCCccccCCeeec
Confidence 8888777655 79999999999999999999999999999999754331 2223456999999999996
Q ss_pred c---cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC-h
Q 042809 146 N---EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS-A 221 (241)
Q Consensus 146 ~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~ 221 (241)
+ ..++.++|+||||+++|+|++|..||............... ......++..++..+.+||.+||+.+|.+||+ +
T Consensus 188 ~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~ 266 (384)
T 4fr4_A 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF-ETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQL 266 (384)
T ss_dssp CCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH-HHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSH
T ss_pred cCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH-hhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccH
Confidence 4 45889999999999999999999999765443333333222 23345567778899999999999999999998 9
Q ss_pred HHHhcCCCCCCC
Q 042809 222 EELLNHTFISGN 233 (241)
Q Consensus 222 ~~~l~~p~~~~~ 233 (241)
+++++||||++-
T Consensus 267 ~~l~~hp~f~~~ 278 (384)
T 4fr4_A 267 SDVQNFPYMNDI 278 (384)
T ss_dssp HHHHTSGGGTTC
T ss_pred HHHHcChhhhcC
Confidence 999999999764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=291.20 Aligned_cols=221 Identities=24% Similarity=0.423 Sum_probs=182.1
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+|+.||+|++... ...+.+.+|..++..+ .||||++ ...+.+|+||||++||+|.+++... ..++
T Consensus 41 ~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~ 119 (353)
T 2i0e_A 41 RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFK 119 (353)
T ss_dssp ETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCC
T ss_pred ECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCC
Confidence 4678999999998754 2346688999999988 6999988 6778999999999999999999874 5688
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||++|++||||||+||+++.+|.+||+|||++...... .......+||+.|+|||.+
T Consensus 120 ~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~------~~~~~~~~gt~~y~aPE~~ 193 (353)
T 2i0e_A 120 EPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD------GVTTKTFCGTPDYIAPEII 193 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT------TCCBCCCCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC------CcccccccCCccccChhhh
Confidence 88887777655 79999999999999999999999999999998743211 1122345789999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC----
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS---- 220 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---- 220 (241)
.+..++.++|+||||+++|+|++|..||.+.........+. .....++..++.++.+||++||..+|.+||+
T Consensus 194 ~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~ 269 (353)
T 2i0e_A 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM----EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPE 269 (353)
T ss_dssp TTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTT
T ss_pred cCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH----hCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCC
Confidence 99999999999999999999999999998754433322222 2344567778899999999999999999994
Q ss_pred -hHHHhcCCCCCCC
Q 042809 221 -AEELLNHTFISGN 233 (241)
Q Consensus 221 -~~~~l~~p~~~~~ 233 (241)
++++++||||+.-
T Consensus 270 ~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 270 GERDIKEHAFFRYI 283 (353)
T ss_dssp HHHHHHTSGGGTTC
T ss_pred CHHHHhcCccccCC
Confidence 6999999999753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=283.14 Aligned_cols=224 Identities=27% Similarity=0.438 Sum_probs=177.0
Q ss_pred CCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 4 GTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 4 ~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
.+|+.||+|.+... .....+.+|+.++++++||||++ ..+...++||||++ ++|.+++......+++..+
T Consensus 43 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~ 121 (311)
T 3niz_A 43 SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQI 121 (311)
T ss_dssp TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHTCTTCCCHHHH
T ss_pred CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHhccCCCCHHHH
Confidence 35899999998733 23467889999999999999998 67788999999997 5899998876677888888
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc-c
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN-E 147 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~ 147 (241)
..++.|+ ||++|++||||||+||+++.++.+||+|||++....... .......+++.|+|||.+.+ .
T Consensus 122 ~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~ 195 (311)
T 3niz_A 122 KIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV------RSYTHEVVTLWYRAPDVLMGSK 195 (311)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC------C---CCCCCCTTCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc------ccccCCcccCCcCCHHHhcCCC
Confidence 8777655 799999999999999999999999999999997553211 12233457999999999976 5
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCC--------------------------CChhhHH
Q 042809 148 GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPH--------------------------FPTQFFK 201 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~ 201 (241)
.++.++||||||+++|++++|..||.+..................+. ....++.
T Consensus 196 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (311)
T 3niz_A 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQ 275 (311)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCH
T ss_pred CCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCH
Confidence 57999999999999999999999997765554443333322221111 0122456
Q ss_pred HHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 202 KVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 202 ~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
++.+|+++||+.||.+|||++++++||||++-.
T Consensus 276 ~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 276 EGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 889999999999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=289.33 Aligned_cols=229 Identities=24% Similarity=0.368 Sum_probs=180.7
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+|+.||+|.+... ...+.+.+|+.+++.++||||++ ..++..|+||||+++++|.+++.. ...+++..
T Consensus 28 ~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~ 106 (323)
T 3tki_A 28 NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPD 106 (323)
T ss_dssp ETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBT-TTBCCHHH
T ss_pred ECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhh-cCCCCHHH
Confidence 5678999999997633 23466899999999999999998 677889999999999999999976 45688888
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
+..++.|+ ||++|++||||||+||+++.++.+||+|||++........ ........|++.|+|||.+.+.
T Consensus 107 ~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~ 182 (323)
T 3tki_A 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR----ERLLNKMCGTLPYVAPELLKRR 182 (323)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE----ECCBCSCCSCGGGSCHHHHHCS
T ss_pred HHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc----ccccCCCccCcCccCcHHhccC
Confidence 87777655 7999999999999999999999999999999975433111 1122345689999999999887
Q ss_pred CC-CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 148 GL-DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 148 ~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
.+ +.++||||||+++|+|++|..||......... ................++..+.+|+.+||..+|.+|||++++++
T Consensus 183 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 65 77899999999999999999999765443222 12222222222233567889999999999999999999999999
Q ss_pred CCCCCCCCcc
Q 042809 227 HTFISGNAKK 236 (241)
Q Consensus 227 ~p~~~~~~~~ 236 (241)
||||+....+
T Consensus 262 h~~~~~~~~~ 271 (323)
T 3tki_A 262 DRWYNKPLKK 271 (323)
T ss_dssp CTTTTCCCCC
T ss_pred Chhhcccccc
Confidence 9999876543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=289.34 Aligned_cols=226 Identities=23% Similarity=0.373 Sum_probs=163.8
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
++.+|+.||+|.+.... ...+.+|+.+++.+. ||||++ ......|+||||+++++|.+++.. ...+++..+.
T Consensus 32 ~~~~~~~vavK~~~~~~-~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~ 109 (325)
T 3kn6_A 32 HKKSNQAFAVKIISKRM-EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK-KKHFSETEAS 109 (325)
T ss_dssp ETTTCCEEEEEEEEGGG-HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-CSCCCHHHHH
T ss_pred ECCCCCEEEEEEEChhh-hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh-cCCCCHHHHH
Confidence 56789999999997553 567889999999998 999998 677889999999999999999987 4678888888
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecCC---CeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHG---DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.++.|+ ||++|++||||||+||+++.++ .+||+|||++....... .......|++.|+|||.+.+
T Consensus 110 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~~t~~y~aPE~~~~ 183 (325)
T 3kn6_A 110 YIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN------QPLKTPCFTLHYAAPELLNQ 183 (325)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------------
T ss_pred HHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC------CcccccCCCcCccCHHHhcC
Confidence 777755 7999999999999999998766 79999999997543211 11234457999999999999
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhc----hHHHHHHHHhcCCCCCCC----hhhHHHHHHHHHHhhccCCCCC
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISN----AAATLLKIACSNEKPHFP----TQFFKKVLDFLAKCLERKPEKR 218 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R 218 (241)
..++.++||||||+++|++++|..||...... ............ ....+ ..+++++.+||.+||..+|.+|
T Consensus 184 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 262 (325)
T 3kn6_A 184 NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKR 262 (325)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT-CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTC
T ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC-CCCCCcccccCCCHHHHHHHHHHCCCChhHC
Confidence 99999999999999999999999999764321 112222222222 22222 2467899999999999999999
Q ss_pred CChHHHhcCCCCCCCCcc
Q 042809 219 WSAEELLNHTFISGNAKK 236 (241)
Q Consensus 219 ps~~~~l~~p~~~~~~~~ 236 (241)
||++++++||||+.....
T Consensus 263 pt~~ell~h~w~~~~~~~ 280 (325)
T 3kn6_A 263 LKMSGLRYNEWLQDGSQL 280 (325)
T ss_dssp CCTTTSTTCGGGCTTCCC
T ss_pred CCHHHHhcChhhccCccC
Confidence 999999999999876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=297.83 Aligned_cols=227 Identities=22% Similarity=0.363 Sum_probs=182.4
Q ss_pred CCCCCcEEEEEeccchHHH-----HHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEAGV-----QALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|++...... ..+.+|..++..++||||++ .....+|+||||++||+|.+++......+++
T Consensus 95 ~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e 174 (437)
T 4aw2_A 95 LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPE 174 (437)
T ss_dssp ETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCH
T ss_pred EcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCH
Confidence 4678999999998754322 23889999999999999998 6788999999999999999999976678899
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..++.++.|+ ||++|++||||||+||+++.+|.+||+|||++....... .......+||+.|+|||++.
T Consensus 175 ~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-----~~~~~~~~GT~~Y~APE~l~ 249 (437)
T 4aw2_A 175 EMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-----TVQSSVAVGTPDYISPEILQ 249 (437)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-----CEECCSCCSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC-----CcccccccCCcCeeChHHHh
Confidence 8888877655 799999999999999999999999999999996543311 11123356999999999997
Q ss_pred -----ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHH-HHhcCCCCCCChhhHHHHHHHHHHhhccCCCC--
Q 042809 146 -----NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLK-IACSNEKPHFPTQFFKKVLDFLAKCLERKPEK-- 217 (241)
Q Consensus 146 -----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~-- 217 (241)
...++.++|+||||+++|+|++|+.||.+.........+. .......+.....+++++.+||++||..+|++
T Consensus 250 ~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~ 329 (437)
T 4aw2_A 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLG 329 (437)
T ss_dssp HHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTT
T ss_pred hcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccC
Confidence 4568899999999999999999999998754433322221 11122333333457889999999999988888
Q ss_pred CCChHHHhcCCCCCCC
Q 042809 218 RWSAEELLNHTFISGN 233 (241)
Q Consensus 218 Rps~~~~l~~p~~~~~ 233 (241)
|++++++++||||++-
T Consensus 330 r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 330 QNGIEDFKKHPFFSGI 345 (437)
T ss_dssp TTTTHHHHTSGGGTTC
T ss_pred CCCHHHHhCCCccCCC
Confidence 9999999999999764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=306.26 Aligned_cols=225 Identities=28% Similarity=0.459 Sum_probs=184.6
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCC
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~ 70 (241)
++.+|+.||+|.+.... ....+.+|+.++..++||||++ ...+.+|+||||++||+|.+++...+ ..++
T Consensus 205 ~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~ 284 (576)
T 2acx_A 205 VRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP 284 (576)
T ss_dssp ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCC
T ss_pred ECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCC
Confidence 46789999999987432 3456889999999999999998 67789999999999999999998643 3488
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||++|++||||||+||+++.+|.+||+|||++...... .......||+.|+|||++
T Consensus 285 e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~-------~~~~~~~GT~~Y~APEvl 357 (576)
T 2acx_A 285 EARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-------QTIKGRVGTVGYMAPEVV 357 (576)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT-------CCEECCCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC-------ccccccCCCccccCHHHH
Confidence 88888777655 79999999999999999999999999999999754331 112334689999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW----- 219 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----- 219 (241)
.+..++.++|+||||+++|+|++|..||......................++..++.++.+||++||..+|.+||
T Consensus 358 ~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~ 437 (576)
T 2acx_A 358 KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGG 437 (576)
T ss_dssp TTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSS
T ss_pred cCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCC
Confidence 998899999999999999999999999976543222222222222344556777889999999999999999999
Q ss_pred ChHHHhcCCCCCCC
Q 042809 220 SAEELLNHTFISGN 233 (241)
Q Consensus 220 s~~~~l~~p~~~~~ 233 (241)
+++++++||||+.-
T Consensus 438 sa~eil~HpfF~~i 451 (576)
T 2acx_A 438 SAREVKEHPLFKKL 451 (576)
T ss_dssp HHHHHHTSGGGTTC
T ss_pred CHHHHHhChhhccC
Confidence 89999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=282.69 Aligned_cols=225 Identities=27% Similarity=0.462 Sum_probs=183.1
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.++..||+|.+.... ....+.+|+.++++++||||++ ......++||||+++++|.+++... ..++.
T Consensus 30 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~ 108 (279)
T 3fdn_A 30 EKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDE 108 (279)
T ss_dssp ETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCH
T ss_pred EccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhc-CCCCH
Confidence 56788999999986432 2456889999999999999988 6778899999999999999999874 56777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||+.|++||||+|+||+++.++.++|+|||++...... ......|++.|+|||.+.
T Consensus 109 ~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--------~~~~~~~~~~y~aPE~~~ 180 (279)
T 3fdn_A 109 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--------RRTDLCGTLDYLPPEMIE 180 (279)
T ss_dssp HHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----------------CCCCTTCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc--------cccccCCCCCccCHhHhc
Confidence 7777766654 79999999999999999999999999999988644331 112345899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
+..++.++||||||+++|++++|..||............. ......+...+..+.+|+.+||+.+|.+|||+++++
T Consensus 181 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 256 (279)
T 3fdn_A 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 256 (279)
T ss_dssp TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----HTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred cCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH----hCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHh
Confidence 9989999999999999999999999998765444333322 233445666788999999999999999999999999
Q ss_pred cCCCCCCCCccCCC
Q 042809 226 NHTFISGNAKKNST 239 (241)
Q Consensus 226 ~~p~~~~~~~~~~~ 239 (241)
+||||+....+.+.
T Consensus 257 ~h~~~~~~~~~~~~ 270 (279)
T 3fdn_A 257 EHPWITANSSKPSN 270 (279)
T ss_dssp HCHHHHHHCSSCCC
T ss_pred hCccccCCccCccc
Confidence 99999887765543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=292.68 Aligned_cols=224 Identities=26% Similarity=0.337 Sum_probs=169.2
Q ss_pred CCCCCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 2 NKGTGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
++.+|+.||+|.+... ...+.+.+|+.+++.++||||++ ......++||||+++|+|.+++... ..+++..+.
T Consensus 41 ~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~ 119 (361)
T 3uc3_A 41 DKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA-GRFSEDEAR 119 (361)
T ss_dssp ETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHH
T ss_pred ECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhc-CCCCHHHHH
Confidence 5678999999998743 33466889999999999999998 6778899999999999999999874 568888888
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecCCC--eeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGD--VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
.++.|+ ||++|++||||||+||+++.++. +||+|||++...... .......|++.|+|||.+.+.
T Consensus 120 ~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~ 192 (361)
T 3uc3_A 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-------SQPKSTVGTPAYIAPEVLLRQ 192 (361)
T ss_dssp HHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------------------CTTSCHHHHHCS
T ss_pred HHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-------CCCCCCcCCCCcCChhhhcCC
Confidence 777765 79999999999999999987765 999999998643221 112334589999999999888
Q ss_pred CCCch-hhHHHHHHHHHHHHhCCCCCccchhchH-HHHHHHH-hcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 148 GLDFA-TDIWSLGCMVIEMATGRPPWGDKISNAA-ATLLKIA-CSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 148 ~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
.++.+ +||||||+++|+|++|+.||.+...... ....... ...........+++.+.+||++||+.+|.+|||++++
T Consensus 193 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el 272 (361)
T 3uc3_A 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEI 272 (361)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 77655 8999999999999999999976543222 2222211 1122222223567899999999999999999999999
Q ss_pred hcCCCCCCC
Q 042809 225 LNHTFISGN 233 (241)
Q Consensus 225 l~~p~~~~~ 233 (241)
++||||...
T Consensus 273 l~hp~f~~~ 281 (361)
T 3uc3_A 273 KTHSWFLKN 281 (361)
T ss_dssp HTSHHHHTT
T ss_pred HhCcchhcC
Confidence 999999654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=287.03 Aligned_cols=221 Identities=29% Similarity=0.467 Sum_probs=172.9
Q ss_pred CCCCCcEEEEEeccch------HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE------AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+|+.||+|++... .....+.+|+.+++.++||||++ ...+..|+||||+++++|.+++... ..++
T Consensus 41 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~ 119 (327)
T 3a62_A 41 GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE-GIFM 119 (327)
T ss_dssp STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHH-SSCC
T ss_pred cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhC-CCCC
Confidence 3578999999998743 23456789999999999999998 6778899999999999999999874 5677
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||++|++||||||+||+++.++.+||+|||++....... .......|++.|+|||.+
T Consensus 120 ~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~gt~~y~aPE~~ 193 (327)
T 3a62_A 120 EDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG------TVTHTFCGTIEYMAPEIL 193 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----------------CTTSSCCTTSCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC------ccccccCCCcCccCHhhC
Confidence 77777666554 799999999999999999999999999999987533211 112335689999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW----- 219 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----- 219 (241)
.+..++.++|+||||+++|+|++|..||.+........... ......+..++..+.+++++||..+|.+||
T Consensus 194 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~----~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~ 269 (327)
T 3a62_A 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL----KCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPG 269 (327)
T ss_dssp TTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH----HTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTT
T ss_pred cCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH----hCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCC
Confidence 99889999999999999999999999998754433322222 123455667888999999999999999999
Q ss_pred ChHHHhcCCCCCCC
Q 042809 220 SAEELLNHTFISGN 233 (241)
Q Consensus 220 s~~~~l~~p~~~~~ 233 (241)
+++++++||||+..
T Consensus 270 ~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 270 DAGEVQAHPFFRHI 283 (327)
T ss_dssp THHHHHHSGGGSSC
T ss_pred CHHHHHcCCcccCC
Confidence 88999999999754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=299.74 Aligned_cols=221 Identities=26% Similarity=0.383 Sum_probs=183.1
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||||.+.... ....+.+|+.+++.++||||++ ......|+||||++||+|.+++.. .+.+++
T Consensus 37 ~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~ 115 (476)
T 2y94_A 37 HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK-NGRLDE 115 (476)
T ss_dssp ETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS-SSSCCH
T ss_pred ECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh-cCCCCH
Confidence 56789999999987442 3467899999999999999998 667889999999999999999986 467888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.++.+||+|||++...... ......+|++.|+|||.+.
T Consensus 116 ~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-------~~~~~~~gt~~y~aPE~~~ 188 (476)
T 2y94_A 116 KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-------EFLRTSCGSPNYAAPEVIS 188 (476)
T ss_dssp HHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-------CCBCCCCSCSTTCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-------ccccccCCCcCeEChhhcc
Confidence 8888777765 79999999999999999999999999999999754331 1123456899999999998
Q ss_pred ccCC-CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 146 NEGL-DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 146 ~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
+..+ +.++||||||+++|+|++|..||.+........... ......+..+++.+.+||++||..||.+|||++++
T Consensus 189 ~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~ei 264 (476)
T 2y94_A 189 GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC----DGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDI 264 (476)
T ss_dssp TCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH----TTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh----cCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 8765 689999999999999999999998754433222221 23344566678899999999999999999999999
Q ss_pred hcCCCCCCCC
Q 042809 225 LNHTFISGNA 234 (241)
Q Consensus 225 l~~p~~~~~~ 234 (241)
++||||+...
T Consensus 265 l~hp~~~~~~ 274 (476)
T 2y94_A 265 REHEWFKQDL 274 (476)
T ss_dssp HTCHHHHTTC
T ss_pred HhCHHhhhcC
Confidence 9999997653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=293.48 Aligned_cols=234 Identities=24% Similarity=0.357 Sum_probs=177.2
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh-CCCCCH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~ 71 (241)
++.+|+.||+|.+.. ....+.+.+|+.+++.++||||++ ..++.+|+||||+++++|.+++... ...+++
T Consensus 48 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 127 (389)
T 3gni_B 48 YKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE 127 (389)
T ss_dssp ETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCH
T ss_pred EcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCH
Confidence 567899999999873 344577889999999999999998 5677899999999999999999874 356888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCC-ccccccccccCcccccCcccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG-NLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~aPE~~ 144 (241)
..+..++.|+ ||++|++||||||+||+++.++.+||+|||.+.......... ..........|++.|+|||.+
T Consensus 128 ~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 207 (389)
T 3gni_B 128 LAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207 (389)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHH
Confidence 8877777655 799999999999999999999999999999886543211111 111112234688999999999
Q ss_pred cc--cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHh----------------------------------
Q 042809 145 RN--EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIAC---------------------------------- 188 (241)
Q Consensus 145 ~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------------------- 188 (241)
.+ ..++.++||||||+++|+|++|+.||.+..............
T Consensus 208 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (389)
T 3gni_B 208 QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTT 287 (389)
T ss_dssp STTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------------------------------
T ss_pred hccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccccccccccccccccc
Confidence 87 578999999999999999999999997643322211100000
Q ss_pred --------cCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 189 --------SNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 189 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.......+..+++.+.+||++||+.||.+|||++++++||||+....
T Consensus 288 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~ 342 (389)
T 3gni_B 288 STPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 342 (389)
T ss_dssp ------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred CccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence 00001133456678999999999999999999999999999986543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=294.65 Aligned_cols=226 Identities=27% Similarity=0.417 Sum_probs=179.3
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|++.+.. ..+.+.+|..++..++||||++ ...+.+|+||||++||+|.+++...+..+++
T Consensus 82 ~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~ 161 (412)
T 2vd5_A 82 MKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA 161 (412)
T ss_dssp ETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCH
T ss_pred ECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCH
Confidence 46789999999987532 2344889999999999999998 6788999999999999999999987668888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..++.++.|+ ||++|++||||||+||+++.+|.+||+|||++....... .......+||+.|+|||++.
T Consensus 162 ~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~-----~~~~~~~~Gt~~Y~APE~l~ 236 (412)
T 2vd5_A 162 EMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-----TVRSLVAVGTPDYLSPEILQ 236 (412)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-----CEECSSCCSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC-----ccccceeccccCcCCHHHHh
Confidence 8888777655 799999999999999999999999999999997543311 11122356999999999997
Q ss_pred -------ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHH-HHhcCCCCCCChhhHHHHHHHHHHhhccCCCC
Q 042809 146 -------NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLK-IACSNEKPHFPTQFFKKVLDFLAKCLERKPEK 217 (241)
Q Consensus 146 -------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 217 (241)
+..++.++|+||||+++|+|++|+.||...........+. .......+..+..++.++.+||++||. +|.+
T Consensus 237 ~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~ 315 (412)
T 2vd5_A 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPET 315 (412)
T ss_dssp HHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGG
T ss_pred hcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-Chhh
Confidence 3568899999999999999999999997754433322221 111122333345678899999999999 9999
Q ss_pred C---CChHHHhcCCCCCCC
Q 042809 218 R---WSAEELLNHTFISGN 233 (241)
Q Consensus 218 R---ps~~~~l~~p~~~~~ 233 (241)
| |+++++++||||++-
T Consensus 316 Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 316 RLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp CTTTTTHHHHHTSGGGTTC
T ss_pred cCCCCCHHHHhcCCCcCCC
Confidence 8 599999999999764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=292.99 Aligned_cols=221 Identities=27% Similarity=0.409 Sum_probs=177.1
Q ss_pred CCCCCcEEEEEeccchH-------HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh---C
Q 042809 2 NKGTGALFVVKSAESEA-------GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF---G 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~ 66 (241)
++.+|+.||+|.+.... ..+.+.+|+.+++.++||||++ ..++..|+||||++|++|.+++... +
T Consensus 45 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~ 124 (351)
T 3c0i_A 45 NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG 124 (351)
T ss_dssp ETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTT
T ss_pred ECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccC
Confidence 56789999999986432 3577899999999999999998 5678899999999999999888653 3
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCC---eeecCCCcchhhcccccCCccccccccccCccc
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGD---VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL 137 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (241)
..+++..+..++.|+ ||++|++||||||+||+++.++. +||+|||++....... .......||+.
T Consensus 125 ~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~------~~~~~~~gt~~ 198 (351)
T 3c0i_A 125 FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG------LVAGGRVGTPH 198 (351)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS------CBCCCCCSCGG
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC------eeecCCcCCcC
Confidence 357888777776654 79999999999999999987655 9999999997654311 11223468999
Q ss_pred ccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC----hhhHHHHHHHHHHhhcc
Q 042809 138 WMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP----TQFFKKVLDFLAKCLER 213 (241)
Q Consensus 138 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~ 213 (241)
|+|||.+.+..++.++||||||+++|+|++|..||.+........... .. ...+ ..++..+.+||++||..
T Consensus 199 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~----~~-~~~~~~~~~~~s~~~~~li~~~L~~ 273 (351)
T 3c0i_A 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK----GK-YKMNPRQWSHISESAKDLVRRMLML 273 (351)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHH----TC-CCCCHHHHTTSCHHHHHHHHHHTCS
T ss_pred ccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHc----CC-CCCCccccccCCHHHHHHHHHHCCC
Confidence 999999999889999999999999999999999998753322211111 11 1122 34578899999999999
Q ss_pred CCCCCCChHHHhcCCCCCCC
Q 042809 214 KPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 214 ~p~~Rps~~~~l~~p~~~~~ 233 (241)
||.+|||+.++++||||+..
T Consensus 274 dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 274 DPAERITVYEALNHPWLKER 293 (351)
T ss_dssp STTTSCCHHHHHTSHHHHTH
T ss_pred ChhHCcCHHHHhcChhhcCC
Confidence 99999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=285.74 Aligned_cols=224 Identities=31% Similarity=0.492 Sum_probs=180.5
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.+|+.||||.+.. ....+.+.+|+.++++++||||++ ......++||||+++++|.+++.. ..+++..+
T Consensus 66 ~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~ 143 (321)
T 2c30_A 66 EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQI 143 (321)
T ss_dssp ETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHH
T ss_pred ECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHH
Confidence 456899999999763 334577899999999999999998 566789999999999999999875 56788887
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..++.|+ ||+.|++||||||+||+++.++.+||+|||++....... .......|++.|+|||.+.+..
T Consensus 144 ~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~ 217 (321)
T 2c30_A 144 ATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV------PKRKSLVGTPYWMAPEVISRSL 217 (321)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS------CCBCCCCSCGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc------cccccccCCccccCHhhhcCCC
Confidence 7777654 799999999999999999999999999999987543311 1123456899999999999988
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCC
Q 042809 149 LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHT 228 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p 228 (241)
++.++||||||+++|+|++|..||............... .......+..+++.+.+++.+||+.+|.+|||++++++||
T Consensus 218 ~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 218 YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-SCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 999999999999999999999999765433322222211 1111223345778999999999999999999999999999
Q ss_pred CCCCCC
Q 042809 229 FISGNA 234 (241)
Q Consensus 229 ~~~~~~ 234 (241)
||....
T Consensus 297 ~~~~~~ 302 (321)
T 2c30_A 297 FLLQTG 302 (321)
T ss_dssp GGGGCC
T ss_pred hhccCC
Confidence 997654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=288.10 Aligned_cols=221 Identities=25% Similarity=0.424 Sum_probs=180.7
Q ss_pred CCCCCcEEEEEeccchH--------HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAESEA--------GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
++.+|+.||+|.+.... ..+.+.+|+.++++++||||++ ......++||||+++++|.+++.. ...
T Consensus 33 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~ 111 (321)
T 2a2a_A 33 EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ-KES 111 (321)
T ss_dssp ETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSC
T ss_pred ECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh-cCC
Confidence 56789999999976421 3577999999999999999988 677889999999999999999986 466
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCC----CeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG----DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
+++..+..++.|+ ||++|++||||+|+||+++.++ .++|+|||++...... .......|++.|
T Consensus 112 ~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~gt~~y 184 (321)
T 2a2a_A 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-------VEFKNIFGTPEF 184 (321)
T ss_dssp EEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTT-------CCCCCCCSCGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCcc-------ccccccCCCCCc
Confidence 7888877776655 7999999999999999999887 7999999999755431 112334589999
Q ss_pred cCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC----hhhHHHHHHHHHHhhccC
Q 042809 139 MAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP----TQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 139 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~ 214 (241)
+|||.+.+..++.++|+||||+++|++++|..||.+........... ......+ ...+..+.+++.+||..+
T Consensus 185 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~~~~~li~~~l~~d 260 (321)
T 2a2a_A 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT----SVSYDFDEEFFSHTSELAKDFIRKLLVKE 260 (321)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH----TTCCCCCHHHHTTCCHHHHHHHHTTSCSS
T ss_pred cCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH----hcccccChhhhcccCHHHHHHHHHHcCCC
Confidence 99999999999999999999999999999999997754433322222 1222222 345678999999999999
Q ss_pred CCCCCChHHHhcCCCCCCCC
Q 042809 215 PEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 215 p~~Rps~~~~l~~p~~~~~~ 234 (241)
|.+|||++++++||||+...
T Consensus 261 p~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 261 TRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp TTTSCCHHHHHHSTTTSCSS
T ss_pred hhhCcCHHHHhcCccccCCC
Confidence 99999999999999998654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=299.31 Aligned_cols=221 Identities=27% Similarity=0.459 Sum_probs=174.8
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|++... .....+.+|+.++..++||||++ ...+.+|+||||+++|+|.+++... ..+++
T Consensus 169 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~ 247 (446)
T 4ejn_A 169 EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSE 247 (446)
T ss_dssp ETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHH-SCCCH
T ss_pred EcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhc-CCCCH
Confidence 5678999999998743 23456789999999999999988 5667899999999999999999874 56788
Q ss_pred HHHHHHHHHH------hhc-CCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 72 GVIRLYTKEI------LHG-NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~-~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
..+..++.|+ ||+ .|++||||||+||+++.++.+||+|||++...... ........||+.|+|||.+
T Consensus 248 ~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~------~~~~~~~~gt~~y~aPE~~ 321 (446)
T 4ejn_A 248 DRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD------GATMKTFCGTPEYLAPEVL 321 (446)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----------CCSSSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC------CcccccccCCccccCHhhc
Confidence 8877776654 798 99999999999999999999999999998753221 1122345689999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW----- 219 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----- 219 (241)
.+..++.++||||||+++|+|++|+.||.+........... .....++..+++.+.+||.+||+.||.+||
T Consensus 322 ~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~----~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 397 (446)
T 4ejn_A 322 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL----MEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSE 397 (446)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTT
T ss_pred CCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH----hCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCC
Confidence 99999999999999999999999999998765444333332 233456677888999999999999999999
Q ss_pred ChHHHhcCCCCCCC
Q 042809 220 SAEELLNHTFISGN 233 (241)
Q Consensus 220 s~~~~l~~p~~~~~ 233 (241)
|++++++||||++-
T Consensus 398 t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 398 DAKEIMQHRFFAGI 411 (446)
T ss_dssp THHHHHTSGGGTTC
T ss_pred CHHHHHhCccccCC
Confidence 99999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=283.22 Aligned_cols=227 Identities=27% Similarity=0.420 Sum_probs=177.7
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-----CC
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-----GT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~ 68 (241)
++.+|+.||+|.+... ...+.+.+|+.++++++||||++ ..++..++||||++ ++|.+++.... ..
T Consensus 26 ~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~ 104 (317)
T 2pmi_A 26 NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRG 104 (317)
T ss_dssp CSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCC
T ss_pred ECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccC
Confidence 5778999999987632 23467889999999999999998 67789999999997 59999998642 35
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
++...+..++.|+ ||++|++||||||+||+++.++.+||+|||++....... .......+++.|+|||
T Consensus 105 ~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~t~~y~aPE 178 (317)
T 2pmi_A 105 LELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV------NTFSSEVVTLWYRAPD 178 (317)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC------CCCCCCCSCCTTCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc------ccCCCCcccccccCch
Confidence 7777777666544 799999999999999999999999999999997543211 1122345799999999
Q ss_pred cccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC----------------------------
Q 042809 143 VLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP---------------------------- 193 (241)
Q Consensus 143 ~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------- 193 (241)
.+.+ ..++.++||||||+++|+|++|..||.+...................
T Consensus 179 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (317)
T 2pmi_A 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVL 258 (317)
T ss_dssp HHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHH
T ss_pred HhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhh
Confidence 9976 45899999999999999999999999776544433333222111100
Q ss_pred --CCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 194 --HFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 194 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
..+...+.++.+|+.+||+.||.+|||++++++||||+....
T Consensus 259 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 259 QPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred cccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 011235678999999999999999999999999999986544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=301.37 Aligned_cols=225 Identities=28% Similarity=0.419 Sum_probs=182.9
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC---CC
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG---GT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~---~~ 68 (241)
++.+|+.||+|++.... ....+.+|+.++.+++||||++ .....+|+||||++||+|.+++.... ..
T Consensus 206 ~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~ 285 (543)
T 3c4z_A 206 MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG 285 (543)
T ss_dssp ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCS
T ss_pred ECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhccccc
Confidence 46789999999987542 3456889999999999999998 67788999999999999999998642 46
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
+++..+..++.|+ ||++|++||||||+||+++.+|.+||+|||++....... ......+||+.|+|||
T Consensus 286 l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~------~~~~~~~GT~~Y~APE 359 (543)
T 3c4z_A 286 FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ------TKTKGYAGTPGFMAPE 359 (543)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC------CCBCCCCSCTTTSCHH
T ss_pred ccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC------cccccccCCccccChh
Confidence 8888877776655 799999999999999999999999999999997543311 1122346899999999
Q ss_pred cccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC--
Q 042809 143 VLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS-- 220 (241)
Q Consensus 143 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-- 220 (241)
++.+..++.++|+||||+++|+|++|..||......................++..++..+.+||++||+.+|.+||+
T Consensus 360 ~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred hhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 999999999999999999999999999999765322111112222222344567778899999999999999999996
Q ss_pred ---hHHHhcCCCCCC
Q 042809 221 ---AEELLNHTFISG 232 (241)
Q Consensus 221 ---~~~~l~~p~~~~ 232 (241)
++++++||||+.
T Consensus 440 ~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 440 DGSCDGLRTHPLFRD 454 (543)
T ss_dssp TTBSHHHHTSGGGTT
T ss_pred ccCHHHHHcCccccC
Confidence 589999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=280.28 Aligned_cols=227 Identities=26% Similarity=0.459 Sum_probs=161.4
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+.... ..+.+.+|+.++++++||||++ ...+..++||||+++++|.+++......++.
T Consensus 32 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 111 (278)
T 3cok_A 32 SIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE 111 (278)
T ss_dssp ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCH
T ss_pred EccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCH
Confidence 45789999999987442 2467899999999999999988 6778899999999999999999986677888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++|+||+|+||+++.++.++|+|||.+....... .......|++.|+|||.+.
T Consensus 112 ~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~ 185 (278)
T 3cok_A 112 NEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH------EKHYTLCGTPNYISPEIAT 185 (278)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----------------------------
T ss_pred HHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC------CcceeccCCCCcCCcchhc
Confidence 8888777765 799999999999999999999999999999987543211 1112345889999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
+..++.++|+||||+++|++++|..||.......... .........+..++.++.+++.+||+.+|.+|||+++++
T Consensus 186 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 261 (278)
T 3cok_A 186 RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----KVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVL 261 (278)
T ss_dssp ------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH----HHhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 8889999999999999999999999997654332211 111223345666788999999999999999999999999
Q ss_pred cCCCCCCCCccCC
Q 042809 226 NHTFISGNAKKNS 238 (241)
Q Consensus 226 ~~p~~~~~~~~~~ 238 (241)
+||||.......+
T Consensus 262 ~h~~~~~~~~~~~ 274 (278)
T 3cok_A 262 DHPFMSRNSSTKS 274 (278)
T ss_dssp TSTTTC-------
T ss_pred cCccccCCCCccc
Confidence 9999987765543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=278.48 Aligned_cols=225 Identities=24% Similarity=0.361 Sum_probs=175.8
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+|+.||+|.+.. ......+.+|+.++++++||||++ ..+...++||||+++ +|.+++......+++.
T Consensus 23 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~ 101 (292)
T 3o0g_A 23 NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPE 101 (292)
T ss_dssp ETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHH
T ss_pred ECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHH
Confidence 567899999999762 334577889999999999999998 567889999999975 7777777767788998
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||++|++||||||+||+++.++.+||+|||++...... ........+++.|+|||.+.+
T Consensus 102 ~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~ 175 (292)
T 3o0g_A 102 IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP------VRCYSAEVVTLWYRPPDVLFG 175 (292)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC------CSCCCSCCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc------cccccCCccccCCcChHHHcC
Confidence 888877765 79999999999999999999999999999999754321 112233457999999999987
Q ss_pred cC-CCchhhHHHHHHHHHHHHhCCCCC-ccchhchHHHHHHHHhcCCC-------------------------CCCChhh
Q 042809 147 EG-LDFATDIWSLGCMVIEMATGRPPW-GDKISNAAATLLKIACSNEK-------------------------PHFPTQF 199 (241)
Q Consensus 147 ~~-~~~~~Di~slG~~l~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~ 199 (241)
.. ++.++||||+|+++|+|++|..|| .+.................. .......
T Consensus 176 ~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (292)
T 3o0g_A 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKL 255 (292)
T ss_dssp CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTC
T ss_pred CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhccccc
Confidence 65 799999999999999999988775 33322222222221111100 0112346
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCC
Q 042809 200 FKKVLDFLAKCLERKPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 200 ~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~ 233 (241)
+..+.+|+++||+.||.+|||++++++||||++-
T Consensus 256 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 256 NATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 7889999999999999999999999999999863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=280.04 Aligned_cols=224 Identities=24% Similarity=0.458 Sum_probs=183.7
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.++..||+|.+.... ....+.+|+.+++.++||||++ ...+..++||||+++++|.+++... ..++.
T Consensus 35 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~ 113 (284)
T 2vgo_A 35 EKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-GRFDE 113 (284)
T ss_dssp ETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCH
T ss_pred EcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhc-CCCCH
Confidence 46788999999986432 2467899999999999999988 5678899999999999999999874 46778
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++|+||+|+||+++.++.++|+|||++...... ......|++.|+|||.+.
T Consensus 114 ~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~~~y~aPE~~~ 185 (284)
T 2vgo_A 114 QRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--------RRRTMCGTLDYLPPEMIE 185 (284)
T ss_dssp HHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--------CBCCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc--------ccccccCCCCcCCHHHhc
Confidence 7777776655 79999999999999999999999999999998644321 112345899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
+..++.++|+||||+++|++++|..||............. .....++..++..+.+++.+||+.+|.+|||+++++
T Consensus 186 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll 261 (284)
T 2vgo_A 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV----NVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVM 261 (284)
T ss_dssp TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----TTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh----ccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHh
Confidence 9889999999999999999999999997654333222221 233456677888999999999999999999999999
Q ss_pred cCCCCCCCCccCC
Q 042809 226 NHTFISGNAKKNS 238 (241)
Q Consensus 226 ~~p~~~~~~~~~~ 238 (241)
+||||+....+..
T Consensus 262 ~h~~~~~~~~~~~ 274 (284)
T 2vgo_A 262 EHPWVKANSRRVL 274 (284)
T ss_dssp TCHHHHHHCCCCC
T ss_pred hCHHHHhhccccC
Confidence 9999987655443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=280.61 Aligned_cols=225 Identities=26% Similarity=0.442 Sum_probs=181.0
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.+|+.||+|.+... ...+.+.+|+.++++++||||++ ......++||||+++++|.+++... ..+++..+
T Consensus 30 ~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~ 108 (304)
T 2jam_A 30 QRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER-GVYTEKDA 108 (304)
T ss_dssp ETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SCCCHHHH
T ss_pred ECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHc-CCCCHHHH
Confidence 4678999999998743 23456889999999999999988 6778899999999999999999874 56777777
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEe---ecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLL---GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..++.|+ ||++|++|+||+|+||++ +.++.++|+|||++..... .......|++.|+|||.+.
T Consensus 109 ~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~--------~~~~~~~~~~~y~aPE~~~ 180 (304)
T 2jam_A 109 SLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--------GIMSTACGTPGYVAPEVLA 180 (304)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--------BTTHHHHSCCCBCCTTTBS
T ss_pred HHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--------CccccccCCCCccChHHhc
Confidence 7776654 799999999999999999 6788999999999864322 1122345899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
+..++.++||||||+++|++++|..||..........................++..+.+++.+||..+|.+|||+++++
T Consensus 181 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 260 (304)
T 2jam_A 181 QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKAL 260 (304)
T ss_dssp SCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 99999999999999999999999999977654443333332222223334456788999999999999999999999999
Q ss_pred cCCCCCCCCc
Q 042809 226 NHTFISGNAK 235 (241)
Q Consensus 226 ~~p~~~~~~~ 235 (241)
+||||+....
T Consensus 261 ~h~~~~~~~~ 270 (304)
T 2jam_A 261 SHPWIDGNTA 270 (304)
T ss_dssp TSHHHHSSCS
T ss_pred cCccccCCCc
Confidence 9999987543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=298.54 Aligned_cols=226 Identities=25% Similarity=0.353 Sum_probs=180.8
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+|+.||+|++... .....+.+|+.++++++||||++ ......|+||||+.+++|.+++... ..+++.
T Consensus 43 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~ 121 (486)
T 3mwu_A 43 DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEH 121 (486)
T ss_dssp ETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHH
T ss_pred ECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc-CCCCHH
Confidence 5678999999998632 34577899999999999999998 6778999999999999999999874 568888
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeec---CCCeeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGS---HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
.+..++.|+ ||++|++||||||+||+++. ++.+||+|||++...... .......|++.|+|||+
T Consensus 122 ~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~ 194 (486)
T 3mwu_A 122 DAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-------TKMKDRIGTAYYIAPEV 194 (486)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-----------CCTTGGGGCCGGG
T ss_pred HHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-------CccCCCcCCCCCCCHHH
Confidence 887777655 79999999999999999954 557999999999755431 12234468999999999
Q ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH
Q 042809 144 LRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 144 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
+.+ .++.++||||+|+++|+|++|..||.+........................+++.+.+||.+||..+|.+|||+.+
T Consensus 195 ~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~ 273 (486)
T 3mwu_A 195 LRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQ 273 (486)
T ss_dssp GGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 976 4899999999999999999999999876544433333322222222223457889999999999999999999999
Q ss_pred HhcCCCCCCCCcc
Q 042809 224 LLNHTFISGNAKK 236 (241)
Q Consensus 224 ~l~~p~~~~~~~~ 236 (241)
+++||||+.....
T Consensus 274 ~l~hp~~~~~~~~ 286 (486)
T 3mwu_A 274 CLEHPWIQKYSSE 286 (486)
T ss_dssp HHHCHHHHHTCCC
T ss_pred HhcCHhhccCccc
Confidence 9999999866543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=277.55 Aligned_cols=223 Identities=24% Similarity=0.378 Sum_probs=173.1
Q ss_pred CCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 4 GTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 4 ~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
.+|+.||+|.+... ...+.+.+|+.++++++||||++ ...+..++||||+++ +|.+++......++...+
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~ 102 (288)
T 1ob3_A 24 NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTA 102 (288)
T ss_dssp TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHH
T ss_pred CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHH
Confidence 56899999987632 22467889999999999999998 567889999999975 999999876677888888
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc-
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE- 147 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~- 147 (241)
..++.|+ ||++|++||||||+||+++.++.+||+|||++....... .......+++.|+|||.+.+.
T Consensus 103 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~ 176 (288)
T 1ob3_A 103 KSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV------RKYTHEIVTLWYRAPDVLMGSK 176 (288)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------------CCCTTCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc------cccccccccccccCchheeCCC
Confidence 7777655 799999999999999999999999999999997653311 112234579999999999764
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCC-C------------------------CCChhhHHH
Q 042809 148 GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK-P------------------------HFPTQFFKK 202 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~------------------------~~~~~~~~~ 202 (241)
.++.++||||||+++|+|++|..||.+.................. . .....++..
T Consensus 177 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (288)
T 1ob3_A 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDES 256 (288)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHH
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHH
Confidence 589999999999999999999999977544333222221111100 0 011346788
Q ss_pred HHHHHHHhhccCCCCCCChHHHhcCCCCCCC
Q 042809 203 VLDFLAKCLERKPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 203 ~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~ 233 (241)
+.+|+++||+.||.+|||++++++||||+..
T Consensus 257 ~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 257 GIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 9999999999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=291.54 Aligned_cols=224 Identities=29% Similarity=0.395 Sum_probs=170.6
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHh-hcCCCcccc---------cCCceeeeeecccCCCCHHHHHHHhC-CCCC
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQ-SLNSPNIGR---------NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~-~l~h~~i~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~ 70 (241)
++.+|+.||||++... ..+.+|+.++. ..+||||++ ....++|+||||++||+|.+++...+ ..++
T Consensus 83 ~~~~~~~vAiK~~~~~---~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~ 159 (400)
T 1nxk_A 83 NKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT 159 (400)
T ss_dssp ETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCB
T ss_pred ECCCCCEEEEEEeCcc---hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCC
Confidence 5788999999998743 34678888874 457999988 23667999999999999999998743 3588
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeec---CCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS---HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
+..+..++.|+ ||++|++||||||+||+++. ++.+||+|||++...... ......+||+.|+||
T Consensus 160 ~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~-------~~~~~~~gt~~y~aP 232 (400)
T 1nxk_A 160 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-------NSLTTPCYTPYYVAP 232 (400)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC------------------CTTCCG
T ss_pred HHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC-------CccccCCCCCCccCH
Confidence 88888777655 79999999999999999987 788999999999754321 122345689999999
Q ss_pred ccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhch----HHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCC
Q 042809 142 EVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNA----AATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEK 217 (241)
Q Consensus 142 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 217 (241)
|++.+..++.++||||||+++|+|++|..||.+..... ...................++.++.+||++||..+|.+
T Consensus 233 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 312 (400)
T 1nxk_A 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 312 (400)
T ss_dssp GGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGG
T ss_pred hhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhH
Confidence 99999999999999999999999999999997643321 12222211111111222457889999999999999999
Q ss_pred CCChHHHhcCCCCCCCCc
Q 042809 218 RWSAEELLNHTFISGNAK 235 (241)
Q Consensus 218 Rps~~~~l~~p~~~~~~~ 235 (241)
|||++++++||||.....
T Consensus 313 Rpt~~eil~hp~~~~~~~ 330 (400)
T 1nxk_A 313 RMTITEFMNHPWIMQSTK 330 (400)
T ss_dssp SCCHHHHHHSHHHHTTTT
T ss_pred CcCHHHHhcCccccCCCC
Confidence 999999999999976544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=275.73 Aligned_cols=223 Identities=27% Similarity=0.443 Sum_probs=173.3
Q ss_pred CCCCCcEEEEEeccchH---HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh---CCCCC
Q 042809 2 NKGTGALFVVKSAESEA---GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF---GGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~ 70 (241)
++.+|..+|+|.+.... ..+.+.+|++++++++||||++ ......++||||+++++|.+++... +..++
T Consensus 43 ~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 122 (285)
T 3is5_A 43 ERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALS 122 (285)
T ss_dssp ETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCC
T ss_pred EccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCC
Confidence 46789999999977442 4578999999999999999998 6778899999999999999998653 46788
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEe---ecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLL---GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
+..+..++.|+ ||++|++||||+|+||++ +.++.++|+|||++...... .......|++.|+||
T Consensus 123 ~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~~~t~~y~aP 195 (285)
T 3is5_A 123 EGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-------EHSTNAAGTALYMAP 195 (285)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----------------CTTGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc-------ccCcCcccccCcCCh
Confidence 88877776654 799999999999999999 44678999999999754431 112334589999999
Q ss_pred ccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 142 EVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 142 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
|.+. ..++.++||||||+++|++++|..||.+............... .........++.+.+++.+||+.+|.+|||+
T Consensus 196 E~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 273 (285)
T 3is5_A 196 EVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP-NYAVECRPLTPQAVDLLKQMLTKDPERRPSA 273 (285)
T ss_dssp HHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCC--CCCCHHHHHHHHHHTCSCTTTSCCH
T ss_pred HHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc-ccccccCcCCHHHHHHHHHHccCChhhCcCH
Confidence 9986 4578999999999999999999999987654433332222111 1111223367889999999999999999999
Q ss_pred HHHhcCCCCCCC
Q 042809 222 EELLNHTFISGN 233 (241)
Q Consensus 222 ~~~l~~p~~~~~ 233 (241)
+++++||||+++
T Consensus 274 ~e~l~hp~f~~a 285 (285)
T 3is5_A 274 AQVLHHEWFKQA 285 (285)
T ss_dssp HHHHTSGGGGC-
T ss_pred HHHhcCHHhhcC
Confidence 999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=289.26 Aligned_cols=231 Identities=26% Similarity=0.383 Sum_probs=174.3
Q ss_pred CCCCCcEEEEEecc----chHHHHHHHHHHHHHhhcC-CCcccc-------cCCceeeeeecccCCCCHHHHHHHhCCCC
Q 042809 2 NKGTGALFVVKSAE----SEAGVQALRNEAEIRQSLN-SPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGGTL 69 (241)
Q Consensus 2 ~~~~~~~vaiK~~~----~~~~~~~~~~e~~~l~~l~-h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 69 (241)
|+.+|+.||+|.+. .......+.+|+.++..+. ||||++ .+...+|+||||++ ++|.+++.. ..+
T Consensus 30 ~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~ 106 (388)
T 3oz6_A 30 DRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA--NIL 106 (388)
T ss_dssp ETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH--TCC
T ss_pred ECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc--CCC
Confidence 67899999999875 3455677889999999998 999988 24457999999997 699999987 467
Q ss_pred CHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCC---------------ccccc
Q 042809 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG---------------NLKQS 128 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---------------~~~~~ 128 (241)
+...+..++.|+ ||+.|++||||||+||+++.++.+||+|||++.......... .....
T Consensus 107 ~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (388)
T 3oz6_A 107 EPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186 (388)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC------------
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccccccccccccccccccccc
Confidence 777777666544 799999999999999999999999999999997543211000 01112
Q ss_pred cccccCcccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCC---------------
Q 042809 129 WQSIGGTQLWMAPEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK--------------- 192 (241)
Q Consensus 129 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------- 192 (241)
.....||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+........
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~ 266 (388)
T 3oz6_A 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTM 266 (388)
T ss_dssp ---CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHH
T ss_pred ccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHH
Confidence 234578999999999986 6689999999999999999999999977544333322221111000
Q ss_pred ------------CC----------------CChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 193 ------------PH----------------FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 193 ------------~~----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.. .+...++++.+|+.+||..||.+|||++++++||||+.-..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~ 337 (388)
T 3oz6_A 267 IESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHN 337 (388)
T ss_dssp HHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCC
T ss_pred HHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcC
Confidence 00 01134678999999999999999999999999999876443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=282.41 Aligned_cols=220 Identities=22% Similarity=0.415 Sum_probs=173.3
Q ss_pred CCCCCcEEEEEeccchH----------------------------HHHHHHHHHHHHhhcCCCcccc-------cCCcee
Q 042809 2 NKGTGALFVVKSAESEA----------------------------GVQALRNEAEIRQSLNSPNIGR-------NGEKTV 46 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~----------------------------~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~ 46 (241)
++.+|+.||+|.+.... ..+.+.+|+.++++++||||++ ......
T Consensus 34 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (298)
T 2zv2_A 34 NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL 113 (298)
T ss_dssp ETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEE
T ss_pred ECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEE
Confidence 56789999999976432 1356889999999999999988 236789
Q ss_pred eeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccc
Q 042809 47 NIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLK 120 (241)
Q Consensus 47 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 120 (241)
++||||+++++|.+++. ...+++..+..++.|+ ||++|++||||||+||+++.++.+||+|||++.......
T Consensus 114 ~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 191 (298)
T 2zv2_A 114 YMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191 (298)
T ss_dssp EEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSS
T ss_pred EEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCcccccccc
Confidence 99999999999988654 3568888877776655 799999999999999999999999999999997543311
Q ss_pred cCCccccccccccCcccccCcccccccC---CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCCh
Q 042809 121 NNGNLKQSWQSIGGTQLWMAPEVLRNEG---LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPT 197 (241)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (241)
.......|++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+........... ..........
T Consensus 192 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~ 263 (298)
T 2zv2_A 192 ------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIK--SQALEFPDQP 263 (298)
T ss_dssp ------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCSSS
T ss_pred ------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHh--cccCCCCCcc
Confidence 1123346899999999997755 3778999999999999999999997654333222222 1222222334
Q ss_pred hhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCC
Q 042809 198 QFFKKVLDFLAKCLERKPEKRWSAEELLNHTFIS 231 (241)
Q Consensus 198 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~ 231 (241)
.++.++.+++.+||+.+|.+|||++++++||||+
T Consensus 264 ~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 264 DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred ccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 5778999999999999999999999999999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=275.63 Aligned_cols=220 Identities=28% Similarity=0.502 Sum_probs=174.4
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc---------cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR---------NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
++.++..||+|.+.. ....+.+.+|+.++++++||||++ .....+++||||+++++|.+++... ..
T Consensus 47 ~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~ 125 (290)
T 1t4h_A 47 DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KV 125 (290)
T ss_dssp ETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SS
T ss_pred ecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc-cC
Confidence 567899999998763 345677999999999999999987 2356799999999999999999874 56
Q ss_pred CCHHHHHHHHHHH------hhcCC--ccccCCCCCcEEee-cCCCeeecCCCcchhhcccccCCccccccccccCccccc
Q 042809 69 LDAGVIRLYTKEI------LHGNG--ILHCDLKCNNVLLG-SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~--~vH~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (241)
++...+..++.|+ ||+.| ++|+||+|+||+++ .++.++|+|||++..... .......|++.|+
T Consensus 126 ~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~--------~~~~~~~~t~~y~ 197 (290)
T 1t4h_A 126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--------SFAKAVIGTPEFM 197 (290)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--------TSBEESCSSCCCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc--------cccccccCCcCcC
Confidence 7777777666654 79999 99999999999997 789999999999964332 1122345899999
Q ss_pred CcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhc-CCCCCCChhhHHHHHHHHHHhhccCCCCC
Q 042809 140 APEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACS-NEKPHFPTQFFKKVLDFLAKCLERKPEKR 218 (241)
Q Consensus 140 aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R 218 (241)
|||.+.+ .++.++||||||+++|++++|..||....... ........ ......+...++.+.+++.+||+.+|.+|
T Consensus 198 aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 274 (290)
T 1t4h_A 198 APEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 274 (290)
T ss_dssp CGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGS
T ss_pred CHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhC
Confidence 9998875 48899999999999999999999997643222 22222222 22233445566789999999999999999
Q ss_pred CChHHHhcCCCCCCC
Q 042809 219 WSAEELLNHTFISGN 233 (241)
Q Consensus 219 ps~~~~l~~p~~~~~ 233 (241)
||++++++||||++.
T Consensus 275 ps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 275 YSIKDLLNHAFFQEE 289 (290)
T ss_dssp CCHHHHHTSGGGC--
T ss_pred CCHHHHhhCcccccC
Confidence 999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=287.79 Aligned_cols=221 Identities=25% Similarity=0.402 Sum_probs=173.0
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHH-HhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEI-RQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~-l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+++.||+|++.+.. ....+.+|..+ ++.++||||++ ...+.+|+||||++||+|.+++... ..++
T Consensus 59 ~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~ 137 (373)
T 2r5t_A 59 HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFL 137 (373)
T ss_dssp ETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCC
T ss_pred EcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCC
Confidence 56789999999987432 34456677776 57789999998 6778999999999999999999874 5677
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..++.++.|+ ||++|++||||||+||+++.+|.+||+|||++...... .......+||+.|+|||++
T Consensus 138 ~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~------~~~~~~~~gt~~y~aPE~~ 211 (373)
T 2r5t_A 138 EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH------NSTTSTFCGTPEYLAPEVL 211 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC------CCCCCSBSCCCCCCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC------CCccccccCCccccCHHHh
Confidence 77777776654 79999999999999999999999999999999753221 1122345789999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh---
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA--- 221 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--- 221 (241)
.+..++.++|+||||+++|+|++|..||.+.........+. .....++..++..+.+||++||+.+|.+||++
T Consensus 212 ~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL----NKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH----HSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred CCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH----hcccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 99999999999999999999999999997754433322222 12344566788899999999999999999986
Q ss_pred -HHHhcCCCCCCC
Q 042809 222 -EELLNHTFISGN 233 (241)
Q Consensus 222 -~~~l~~p~~~~~ 233 (241)
+++++||||+.-
T Consensus 288 ~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 288 FMEIKSHVFFSLI 300 (373)
T ss_dssp HHHHHTSGGGTTC
T ss_pred HHHHhCCccccCC
Confidence 699999999763
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=279.92 Aligned_cols=222 Identities=24% Similarity=0.374 Sum_probs=179.5
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.++..||+|.+... ...+.+.+|++++++++||||++ ......++||||+++++|.+++... ..+++..+
T Consensus 30 ~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~ 108 (277)
T 3f3z_A 30 QKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK-RVFRESDA 108 (277)
T ss_dssp ETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHH
T ss_pred eCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHc-CCCCHHHH
Confidence 5678899999997743 34678999999999999999998 6778899999999999999999874 56788777
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEe---ecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLL---GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..++.|+ ||++|++|+||+|+||++ +.++.++|+|||++...... .......+++.|+|||.+.
T Consensus 109 ~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-------~~~~~~~~t~~y~aPE~~~ 181 (277)
T 3f3z_A 109 ARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-------KMMRTKVGTPYYVSPQVLE 181 (277)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-------SCBCCCCSCTTTCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-------cchhccCCCCCccChHHhc
Confidence 7776655 799999999999999999 77889999999998754331 1223345899999999987
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCCh----hhHHHHHHHHHHhhccCCCCCCCh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPT----QFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
+. ++.++||||||+++|++++|..||.............. .....+. .+++.+.+++.+||+.+|.+|||+
T Consensus 182 ~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~ 256 (277)
T 3f3z_A 182 GL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE----GTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITS 256 (277)
T ss_dssp TC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred cc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh----CCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCH
Confidence 65 88999999999999999999999987544333322221 1222232 467899999999999999999999
Q ss_pred HHHhcCCCCCCCCcc
Q 042809 222 EELLNHTFISGNAKK 236 (241)
Q Consensus 222 ~~~l~~p~~~~~~~~ 236 (241)
.++++||||+.....
T Consensus 257 ~~~l~h~~~~~~~~~ 271 (277)
T 3f3z_A 257 LQALEHEWFEKQLSS 271 (277)
T ss_dssp HHHTTSHHHHHHHCC
T ss_pred HHHhcCHHHhccccc
Confidence 999999999765443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=295.09 Aligned_cols=220 Identities=25% Similarity=0.346 Sum_probs=167.0
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----------cCCceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----------NGEKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----------~~~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
|+.+|+.||||++.. ....+.+.+|+.+++.++||||++ .....+|+||||+++ +|.+.+..
T Consensus 83 ~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~-- 159 (464)
T 3ttj_A 83 DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM-- 159 (464)
T ss_dssp ETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS--
T ss_pred ECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh--
Confidence 577899999999863 345677899999999999999988 122568999999975 67776653
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
.++...+..++.|+ ||++|++||||||+||+++.++.+||+|||++...... .......||+.|+|
T Consensus 160 -~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-------~~~~~~~gt~~y~a 231 (464)
T 3ttj_A 160 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-------FMMTPYVVTRYYRA 231 (464)
T ss_dssp -CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C-------CCC----CCCTTCC
T ss_pred -cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC-------cccCCCcccccccC
Confidence 47777777776655 79999999999999999999999999999999765431 12234568999999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC------------------CCC--------
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE------------------KPH-------- 194 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------~~~-------- 194 (241)
||.+.+..++.++|||||||++|+|++|+.||.+.........+....... .+.
T Consensus 232 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (464)
T 3ttj_A 232 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 311 (464)
T ss_dssp HHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHH
T ss_pred HHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHH
Confidence 999999999999999999999999999999998754333222221111100 000
Q ss_pred -CC-----------hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 195 -FP-----------TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 195 -~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
++ ...++++.+|+.+||..||.+|||++++++||||+.
T Consensus 312 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 312 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 00 012567999999999999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=288.52 Aligned_cols=221 Identities=25% Similarity=0.411 Sum_probs=174.8
Q ss_pred CCCCCcEEEEEeccch----------HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHh
Q 042809 2 NKGTGALFVVKSAESE----------AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF 65 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----------~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~ 65 (241)
++.+|+.||||++... ...+.+.+|+.++.++ .||||++ ......++||||++|++|.+++...
T Consensus 115 ~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~ 194 (365)
T 2y7j_A 115 HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK 194 (365)
T ss_dssp ETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH
T ss_pred ECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc
Confidence 4578999999987532 2246688999999999 7999988 5678899999999999999999874
Q ss_pred CCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccccc
Q 042809 66 GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139 (241)
Q Consensus 66 ~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (241)
..++...+..++.|+ ||+.|++|+||+|+||+++.+|.++|+|||++...... .......|++.|+
T Consensus 195 -~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~-------~~~~~~~gt~~y~ 266 (365)
T 2y7j_A 195 -VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-------EKLRELCGTPGYL 266 (365)
T ss_dssp -SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT-------CCBCCCCSCGGGC
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC-------cccccCCCCCCcc
Confidence 567887777776655 79999999999999999999999999999998755431 1123456899999
Q ss_pred Ccccccc------cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCC--ChhhHHHHHHHHHHhh
Q 042809 140 APEVLRN------EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHF--PTQFFKKVLDFLAKCL 211 (241)
Q Consensus 140 aPE~~~~------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l 211 (241)
|||.+.+ ..++.++||||||+++|+|++|..||.............. ....... ....+..+.+++++||
T Consensus 267 aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~li~~~L 344 (365)
T 2y7j_A 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME--GQYQFSSPEWDDRSSTVKDLISRLL 344 (365)
T ss_dssp CHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCHHHHSSSCHHHHHHHHHHS
T ss_pred ChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--CCCCCCCcccccCCHHHHHHHHHHc
Confidence 9999864 3578899999999999999999999976543332222221 1111111 1235678999999999
Q ss_pred ccCCCCCCChHHHhcCCCCCC
Q 042809 212 ERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 212 ~~~p~~Rps~~~~l~~p~~~~ 232 (241)
+.+|.+|||++++++||||+.
T Consensus 345 ~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 345 QVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp CSSTTTSCCHHHHHHSGGGCC
T ss_pred CCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999963
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=279.01 Aligned_cols=227 Identities=26% Similarity=0.331 Sum_probs=171.4
Q ss_pred CCCCCcEEEEEeccchH-------HHHHHHHHHHHHhhcC---CCcccc------cC----CceeeeeecccCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESEA-------GVQALRNEAEIRQSLN---SPNIGR------NG----EKTVNIFMEYMAGGSLLDV 61 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~---h~~i~~------~~----~~~~~lv~e~~~~~~L~~~ 61 (241)
|+.+|+.||+|.+.... ....+.+|+.++++++ ||||++ .. ....++||||+. ++|.++
T Consensus 30 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~ 108 (308)
T 3g33_A 30 DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTY 108 (308)
T ss_dssp CTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHH
T ss_pred ECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHH
Confidence 67899999999976321 1245667777776665 999988 11 226899999996 699999
Q ss_pred HHHhCC-CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccC
Q 042809 62 AEKFGG-TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGG 134 (241)
Q Consensus 62 l~~~~~-~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 134 (241)
+..... .+++..+..++.|+ ||++|++||||||+||+++.++.+||+|||++...... .......|
T Consensus 109 ~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~~g 181 (308)
T 3g33_A 109 LDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-------MALTPVVV 181 (308)
T ss_dssp HHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTC-------CCSGGGGC
T ss_pred HhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCC-------cccCCccc
Confidence 987532 38888888777755 79999999999999999999999999999999755331 12234568
Q ss_pred cccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCC--------------------
Q 042809 135 TQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPH-------------------- 194 (241)
Q Consensus 135 ~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------- 194 (241)
|+.|+|||.+.+..++.++||||||+++|+|++|..||.+....................
T Consensus 182 t~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (308)
T 3g33_A 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRP 261 (308)
T ss_dssp CCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCC
T ss_pred cccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCc
Confidence 999999999999999999999999999999999999997765444433332222111100
Q ss_pred ---CChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 195 ---FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 195 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
....++..+.+||.+||+.||.+|||++++++||||+.....
T Consensus 262 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~~ 306 (308)
T 3g33_A 262 VQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGN 306 (308)
T ss_dssp HHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC------
T ss_pred HHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCCC
Confidence 012456789999999999999999999999999999876543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=299.54 Aligned_cols=225 Identities=24% Similarity=0.351 Sum_probs=182.0
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|++.. ....+.+.+|+.++++++||||++ ...+..++||||+.+++|.+++.. ...+++
T Consensus 47 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~ 125 (484)
T 3nyv_A 47 DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSE 125 (484)
T ss_dssp ETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCCBH
T ss_pred ECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHh-cCCCCH
Confidence 567899999999753 234677999999999999999998 677899999999999999999987 466888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEe---ecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLL---GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
..+..++.|+ ||++|++||||||+||++ +.++.+||+|||++...... .......|++.|+|||
T Consensus 126 ~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE 198 (484)
T 3nyv_A 126 VDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-------KKMKDKIGTAYYIAPE 198 (484)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC-------CSHHHHTTGGGTCCHH
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc-------cccccCCCCccccCce
Confidence 8877777655 799999999999999999 45788999999999765431 1223456899999999
Q ss_pred cccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 143 VLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 143 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
.+.+ .++.++||||+|+++|+|++|..||.+........................+++.+.+||++||+.+|.+|||++
T Consensus 199 ~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ 277 (484)
T 3nyv_A 199 VLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISAR 277 (484)
T ss_dssp HHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred eecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHH
Confidence 9976 589999999999999999999999987654443333332211112222345788999999999999999999999
Q ss_pred HHhcCCCCCCCCc
Q 042809 223 ELLNHTFISGNAK 235 (241)
Q Consensus 223 ~~l~~p~~~~~~~ 235 (241)
++++||||+....
T Consensus 278 e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 278 DALDHEWIQTYTK 290 (484)
T ss_dssp HHHTSHHHHHHTC
T ss_pred HHhhChhhccccc
Confidence 9999999976543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=284.50 Aligned_cols=222 Identities=24% Similarity=0.342 Sum_probs=175.4
Q ss_pred CCCCCcEEEEEecc----chHHHHHHHHHHHHHhhcCCCcccc-----cC------CceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAE----SEAGVQALRNEAEIRQSLNSPNIGR-----NG------EKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~----~~~~~~~~~~e~~~l~~l~h~~i~~-----~~------~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
|+.+|+.||||.+. .....+.+.+|+.+++.++||||++ .. ...+|+||||+ +++|.+++..
T Consensus 46 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-- 122 (367)
T 1cm8_A 46 DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-- 122 (367)
T ss_dssp ETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH--
T ss_pred ECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc--
Confidence 56889999999975 3344677899999999999999987 11 14579999999 7899999987
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..++...+..++.|+ ||++|++||||||+||+++.++.+||+|||++..... ......+|+.|+|
T Consensus 123 ~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~---------~~~~~~~t~~y~a 193 (367)
T 1cm8_A 123 EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---------EMTGYVVTRWYRA 193 (367)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS---------SCCSSCSCGGGCC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc---------ccCcCcCCCCcCC
Confidence 567888877777655 7999999999999999999999999999999975432 1123457999999
Q ss_pred cccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC------------------------C---
Q 042809 141 PEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE------------------------K--- 192 (241)
Q Consensus 141 PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------~--- 192 (241)
||.+.+ ..++.++||||+||++|+|++|+.||.+.........+....... .
T Consensus 194 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (367)
T 1cm8_A 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF 273 (367)
T ss_dssp THHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG
T ss_pred HHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCH
Confidence 999987 678999999999999999999999997754433222221111100 0
Q ss_pred CCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 193 PHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 193 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.......++.+.+|+.+||..||.+|||++++++||||+....
T Consensus 274 ~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 274 ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 0122345788999999999999999999999999999987554
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=280.30 Aligned_cols=226 Identities=32% Similarity=0.537 Sum_probs=185.5
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
++.+|+.||+|.+..+...+.+.+|+.++..++||||++ ...+..++||||+++++|.+++......++...+..
T Consensus 50 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 129 (314)
T 3com_A 50 HKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT 129 (314)
T ss_dssp ETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHH
T ss_pred ECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHH
Confidence 467899999999987766788999999999999999988 456789999999999999999987677888888887
Q ss_pred HHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCC
Q 042809 77 YTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD 150 (241)
Q Consensus 77 ~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 150 (241)
++.++ ||+.|++|+||+|+||+++.++.++|+|||.+....... .......|++.|+|||.+.+..++
T Consensus 130 i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~ 203 (314)
T 3com_A 130 ILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM------AKRNTVIGTPFWMAPEVIQEIGYN 203 (314)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB------SCBCCCCSCGGGCCHHHHSSSCBC
T ss_pred HHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc------cccCccCCCCCccChhhcCCCCCC
Confidence 77655 799999999999999999999999999999997554311 112234589999999999998899
Q ss_pred chhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCC
Q 042809 151 FATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFI 230 (241)
Q Consensus 151 ~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~ 230 (241)
.++||||||+++|+|++|..||............. .........+..++..+.+++.+||..+|.+|||++++++||||
T Consensus 204 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~ 282 (314)
T 3com_A 204 CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP-TNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282 (314)
T ss_dssp TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh-cCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 99999999999999999999997653322221111 11112223345567899999999999999999999999999999
Q ss_pred CCCC
Q 042809 231 SGNA 234 (241)
Q Consensus 231 ~~~~ 234 (241)
+...
T Consensus 283 ~~~~ 286 (314)
T 3com_A 283 RSAK 286 (314)
T ss_dssp HTCC
T ss_pred hcCC
Confidence 8764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=282.71 Aligned_cols=228 Identities=24% Similarity=0.398 Sum_probs=174.8
Q ss_pred CCCCCcEEEEEeccchHHH---HHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESEAGV---QALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+|+.||+|.+...... ..+.+|+.+++.++||||++ ...+..++||||++ ++|.+++...+..++...
T Consensus 23 ~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~ 101 (324)
T 3mtl_A 23 SKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHN 101 (324)
T ss_dssp ETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHH
T ss_pred ECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHH
Confidence 4678999999998744321 24568999999999999998 67788999999997 599999998777788888
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc-
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN- 146 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~- 146 (241)
+..++.|+ ||++|++||||||+||+++.++.+||+|||++....... .......+++.|+|||.+.+
T Consensus 102 ~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~~t~~y~aPE~~~~~ 175 (324)
T 3mtl_A 102 VKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT------KTYDNEVVTLWYRPPDILLGS 175 (324)
T ss_dssp HHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------------------CGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc------cccccccCcccccChhhhcCC
Confidence 77776655 799999999999999999999999999999987543211 11223457999999999976
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCC-C-------------------------ChhhH
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPH-F-------------------------PTQFF 200 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~-------------------------~~~~~ 200 (241)
..++.++||||||+++|+|++|..||.+.................... . ...++
T Consensus 176 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (324)
T 3mtl_A 176 TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLD 255 (324)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSC
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCC
Confidence 567999999999999999999999998765544443333322211111 0 12346
Q ss_pred HHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 201 KKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 201 ~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
.++.+|+.+||+.||.+|||++++++||||.....+
T Consensus 256 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 256 SDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred HHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 788999999999999999999999999999766543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=276.06 Aligned_cols=228 Identities=25% Similarity=0.385 Sum_probs=180.3
Q ss_pred CCCCCcEEEEEeccch-----------HHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHH
Q 042809 2 NKGTGALFVVKSAESE-----------AGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEK 64 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----------~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~ 64 (241)
++.+|+.||+|.+... ...+.+.+|+.+++++. ||||++ ......++||||+++++|.+++..
T Consensus 38 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 117 (298)
T 1phk_A 38 HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE 117 (298)
T ss_dssp ETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred EcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhc
Confidence 5678999999997532 23566889999999996 999998 677889999999999999999987
Q ss_pred hCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 65 FGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 65 ~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
. ..++...+..++.|+ ||++|++|+||+|+||+++.++.++|+|||.+...... .......+++.|
T Consensus 118 ~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~~y 189 (298)
T 1phk_A 118 K-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-------EKLREVCGTPSY 189 (298)
T ss_dssp H-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT-------CCBCCCCSCGGG
T ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCC-------cccccccCCccc
Confidence 4 567887777776655 79999999999999999999999999999998754331 112334589999
Q ss_pred cCccccc------ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhc
Q 042809 139 MAPEVLR------NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLE 212 (241)
Q Consensus 139 ~aPE~~~------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 212 (241)
+|||.+. ...++.++||||||+++|++++|..||..........................++..+.+++.+||+
T Consensus 190 ~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 269 (298)
T 1phk_A 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLV 269 (298)
T ss_dssp CCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCC
T ss_pred cCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHcc
Confidence 9999985 3457889999999999999999999997754433333222222222222234678899999999999
Q ss_pred cCCCCCCChHHHhcCCCCCCCCccC
Q 042809 213 RKPEKRWSAEELLNHTFISGNAKKN 237 (241)
Q Consensus 213 ~~p~~Rps~~~~l~~p~~~~~~~~~ 237 (241)
.+|.+|||++++++||||+....++
T Consensus 270 ~dp~~Rps~~~ll~h~~~~~~~~~~ 294 (298)
T 1phk_A 270 VQPQKRYTAEEALAHPFFQQYVVEE 294 (298)
T ss_dssp SSGGGSCCHHHHTTSGGGCTTC---
T ss_pred CCcccCCCHHHHHhChHhhhccchh
Confidence 9999999999999999998776554
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=287.35 Aligned_cols=233 Identities=26% Similarity=0.377 Sum_probs=174.8
Q ss_pred CCCCCcEEEEEeccch-------HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh----
Q 042809 2 NKGTGALFVVKSAESE-------AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF---- 65 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---- 65 (241)
++.+++.||+|.+... ...+.+.+|+.++++++||||++ ...+..++||||+++|+|.+++...
T Consensus 47 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~ 126 (345)
T 3hko_A 47 ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDS 126 (345)
T ss_dssp ETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETT
T ss_pred ECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccc
Confidence 5678999999997643 34577999999999999999998 6778899999999999999988521
Q ss_pred -----------------------------------CCCCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCC-
Q 042809 66 -----------------------------------GGTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHG- 103 (241)
Q Consensus 66 -----------------------------------~~~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~- 103 (241)
...+++..+..++. ++||++|++||||+|+||+++.++
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~ 206 (345)
T 3hko_A 127 TGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206 (345)
T ss_dssp TTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCC
Confidence 00123344444444 458999999999999999998776
Q ss_pred -CeeecCCCcchhhcccccCCccccccccccCcccccCcccccc--cCCCchhhHHHHHHHHHHHHhCCCCCccchhchH
Q 042809 104 -DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN--EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAA 180 (241)
Q Consensus 104 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 180 (241)
.+||+|||++.......... ........|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+......
T Consensus 207 ~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 284 (345)
T 3hko_A 207 FEIKLVDFGLSKEFYKLNNGE--YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT 284 (345)
T ss_dssp CCEEECCCTTCEEGGGTTCC----------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ceEEEeeccccccccccCccc--cccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH
Confidence 89999999997654322111 112234568999999999975 6688999999999999999999999977544433
Q ss_pred HHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 181 ATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
..................+++.+.++|.+||+.+|.+|||+.++++||||+....+
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 285 ISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDK 340 (345)
T ss_dssp HHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred HHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHh
Confidence 32222221111112223467899999999999999999999999999999886654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=282.46 Aligned_cols=232 Identities=24% Similarity=0.337 Sum_probs=181.4
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cC--------CceeeeeecccCCCCHHHHHHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NG--------EKTVNIFMEYMAGGSLLDVAEK 64 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~--------~~~~~lv~e~~~~~~L~~~l~~ 64 (241)
++.+|+.||+|.+... .....+.+|+.+++.++||||++ .. .+..++||||++ ++|.+.+..
T Consensus 38 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~ 116 (351)
T 3mi9_A 38 HRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSN 116 (351)
T ss_dssp ETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCS-EEHHHHHHC
T ss_pred ECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccC-CCHHHHHhh
Confidence 5678999999987532 22456789999999999999987 11 457899999997 488888887
Q ss_pred hCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 65 FGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 65 ~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
....++...+..++.|+ ||++|++||||||+||+++.++.+||+|||++.......... ........|++.|
T Consensus 117 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~gt~~y 194 (351)
T 3mi9_A 117 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ--PNRYTNRVVTLWY 194 (351)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSS--CCCCCSSCSCGGG
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccccccccc--ccccCCcccccCc
Confidence 66778888888877765 799999999999999999999999999999997654321111 1222345689999
Q ss_pred cCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChh-------------------
Q 042809 139 MAPEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQ------------------- 198 (241)
Q Consensus 139 ~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------- 198 (241)
+|||.+.+ ..++.++||||||+++|+|++|..||.+..................+.....
T Consensus 195 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
T 3mi9_A 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRK 274 (351)
T ss_dssp CCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCC
T ss_pred cCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccC
Confidence 99999976 4579999999999999999999999988665555544444433333322111
Q ss_pred ---------hHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 199 ---------FFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 199 ---------~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
.++.+.+||.+||+.||.+|||++++++||||......
T Consensus 275 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 275 VKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp HHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred HHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 14678999999999999999999999999999875543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=284.31 Aligned_cols=215 Identities=22% Similarity=0.340 Sum_probs=178.1
Q ss_pred CCCCCcEEEEEeccchH----------HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCC-CHHHHHHHh
Q 042809 2 NKGTGALFVVKSAESEA----------GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGG-SLLDVAEKF 65 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~-~L~~~l~~~ 65 (241)
|+.+|+.||+|.+.... ....+.+|+.++++++||||++ ...+..++||||+.+| +|.+++..
T Consensus 45 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~- 123 (335)
T 3dls_A 45 DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR- 123 (335)
T ss_dssp ETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHT-
T ss_pred ECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHh-
Confidence 57889999999987442 3446788999999999999998 6778899999999666 99999987
Q ss_pred CCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccccc
Q 042809 66 GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139 (241)
Q Consensus 66 ~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (241)
...+++..+..++.|+ ||++|++||||||+||+++.++.+||+|||++...... .......|++.|+
T Consensus 124 ~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~-------~~~~~~~gt~~y~ 196 (335)
T 3dls_A 124 HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-------KLFYTFCGTIEYC 196 (335)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT-------CCBCEECSCGGGC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC-------CceeccCCCcccc
Confidence 4568888887777655 79999999999999999999999999999999755431 1223456899999
Q ss_pred CcccccccCC-CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCC
Q 042809 140 APEVLRNEGL-DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218 (241)
Q Consensus 140 aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 218 (241)
|||.+.+..+ +.++||||||+++|++++|..||...... .......+..++..+.+|+.+||+.+|.+|
T Consensus 197 aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 266 (335)
T 3dls_A 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------VEAAIHPPYLVSKELMSLVSGLLQPVPERR 266 (335)
T ss_dssp CHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------TTTCCCCSSCCCHHHHHHHHHHTCSSGGGS
T ss_pred ChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------HhhccCCCcccCHHHHHHHHHHccCChhhC
Confidence 9999988776 78999999999999999999999763221 122233445577899999999999999999
Q ss_pred CChHHHhcCCCCCCCC
Q 042809 219 WSAEELLNHTFISGNA 234 (241)
Q Consensus 219 ps~~~~l~~p~~~~~~ 234 (241)
||++++++||||+...
T Consensus 267 ps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 267 TTLEKLVTDPWVTQPV 282 (335)
T ss_dssp CCHHHHHHCTTTTCCC
T ss_pred cCHHHHhcCccccCCc
Confidence 9999999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=282.71 Aligned_cols=235 Identities=26% Similarity=0.362 Sum_probs=171.0
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+|+.||||.+... .....+.+|+.++.++ +||||++ ...+..++||||+++++|.+++... ..+++..
T Consensus 34 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~ 112 (316)
T 2ac3_A 34 NLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELE 112 (316)
T ss_dssp CSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH-SSCCHHH
T ss_pred EcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHH
Confidence 5678999999998643 3457789999999985 6999998 5677899999999999999999874 5678877
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCC---eeecCCCcchhhcccccCC-ccccccccccCcccccCccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGD---VKLPDLGCARRVNDLKNNG-NLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~---~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~aPE~ 143 (241)
+..++.|+ ||++|++||||||+||+++.++. +||+|||++.......... ..........|++.|+|||.
T Consensus 113 ~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 192 (316)
T 2ac3_A 113 ASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192 (316)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHH
Confidence 77776655 79999999999999999988776 9999999987543211100 01112234458999999999
Q ss_pred ccc-----cCCCchhhHHHHHHHHHHHHhCCCCCccchhch------------HHHHHHHHhcCCCCCCCh----hhHHH
Q 042809 144 LRN-----EGLDFATDIWSLGCMVIEMATGRPPWGDKISNA------------AATLLKIACSNEKPHFPT----QFFKK 202 (241)
Q Consensus 144 ~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------------~~~~~~~~~~~~~~~~~~----~~~~~ 202 (241)
+.+ ..++.++||||||+++|+|++|..||....... ........ .......+. .++..
T Consensus 193 ~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~ 271 (316)
T 2ac3_A 193 VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI-QEGKYEFPDKDWAHISCA 271 (316)
T ss_dssp HHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHH-HHCCCCCCHHHHTTSCHH
T ss_pred hhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHH-hccCcccCchhcccCCHH
Confidence 975 557889999999999999999999997643211 11111111 112223332 36778
Q ss_pred HHHHHHHhhccCCCCCCChHHHhcCCCCCCCCccCC
Q 042809 203 VLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKNS 238 (241)
Q Consensus 203 ~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~~~ 238 (241)
+.+|+++||+.||.+|||++++++||||++...++.
T Consensus 272 ~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~ 307 (316)
T 2ac3_A 272 AKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307 (316)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSTTCC-------
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCccc
Confidence 999999999999999999999999999987655443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=286.06 Aligned_cols=223 Identities=29% Similarity=0.404 Sum_probs=176.3
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
++.+|+.||+|.+.... ....+|++++.++ +||||++ ......|+||||++||+|.+++.. ...+++..+.
T Consensus 43 ~~~~~~~~avK~~~~~~--~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~ 119 (342)
T 2qr7_A 43 HKATNMEFAVKIIDKSK--RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR-QKFFSEREAS 119 (342)
T ss_dssp ETTTTEEEEEEEEETTT--CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CTTCCHHHHH
T ss_pred ECCCCCEEEEEEEEccc--CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHH
Confidence 56789999999987543 2355788888888 6999998 677899999999999999999987 4568888887
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecC-C---CeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSH-G---DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~-~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
.++.|+ ||++|++||||||+||++..+ + .+||+|||++....... ......+|++.|+|||.+.
T Consensus 120 ~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~gt~~y~aPE~~~ 193 (342)
T 2qr7_A 120 AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN------GLLMTPCYTANFVAPEVLE 193 (342)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT------CCBCCSSCCSSCCCHHHHH
T ss_pred HHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC------CceeccCCCccccCHHHhc
Confidence 777655 799999999999999998543 3 49999999997543311 1123456899999999998
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC---CCCCCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN---EKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
+..++.++|+||||+++|+|++|..||..........+....... .....+..++..+.+||++||..||.+|||++
T Consensus 194 ~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 273 (342)
T 2qr7_A 194 RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAA 273 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHH
Confidence 888899999999999999999999999764333332332222211 12223456788999999999999999999999
Q ss_pred HHhcCCCCCCC
Q 042809 223 ELLNHTFISGN 233 (241)
Q Consensus 223 ~~l~~p~~~~~ 233 (241)
++++||||...
T Consensus 274 ~il~hp~~~~~ 284 (342)
T 2qr7_A 274 LVLRHPWIVHW 284 (342)
T ss_dssp HHTTSHHHHTG
T ss_pred HHhcCCeecCc
Confidence 99999999653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=281.49 Aligned_cols=221 Identities=31% Similarity=0.442 Sum_probs=179.5
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||||.+.. ....+.+.+|++++.+++||||++ ..++..++||||+. |+|.+++......+++
T Consensus 75 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~ 153 (348)
T 1u5q_A 75 DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE 153 (348)
T ss_dssp ETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCH
T ss_pred EccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCH
Confidence 467899999998752 334567899999999999999998 56778999999997 6899988776778888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.++.+||+|||++...... ....|++.|+|||.+.
T Consensus 154 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----------~~~~gt~~y~aPE~~~ 223 (348)
T 1u5q_A 154 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----------NSFVGTPYWMAPEVIL 223 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----------CCCCSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----------CcccCCcceeCHhhhc
Confidence 8887777655 79999999999999999999999999999998654321 2345899999999985
Q ss_pred ---ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 146 ---NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 146 ---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
+..++.++||||||+++|+|++|..||.+...... .........+...+...+..+.++|.+||+.+|.+|||++
T Consensus 224 ~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 301 (348)
T 1u5q_A 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 301 (348)
T ss_dssp TTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHH
Confidence 46688999999999999999999999976533222 2222222333333456788999999999999999999999
Q ss_pred HHhcCCCCCCCCc
Q 042809 223 ELLNHTFISGNAK 235 (241)
Q Consensus 223 ~~l~~p~~~~~~~ 235 (241)
++++||||.....
T Consensus 302 ~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 302 VLLKHRFVLRERP 314 (348)
T ss_dssp HHTTCHHHHSCCC
T ss_pred HHhhChhhhccCC
Confidence 9999999976543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=282.63 Aligned_cols=227 Identities=25% Similarity=0.391 Sum_probs=182.6
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHHh-CCCCC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~ 70 (241)
++.+|+.||+|.+.. ......+.+|+.++..+. ||||++ ......++||||+.+++|.+++... ...++
T Consensus 50 ~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 129 (327)
T 3lm5_A 50 SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS 129 (327)
T ss_dssp ETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCC
T ss_pred ECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCC
Confidence 567899999999773 233577899999999996 699988 6778899999999999999998643 35688
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeec---CCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS---HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
+..+..++.|+ ||++|++||||||+||+++. ++.+||+|||++...... .......|++.|+||
T Consensus 130 ~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~-------~~~~~~~gt~~y~aP 202 (327)
T 3lm5_A 130 ENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-------CELREIMGTPEYLAP 202 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----------------CCCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc-------cccccccCCcCccCC
Confidence 88877777655 79999999999999999987 789999999999765431 112335689999999
Q ss_pred ccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 142 EVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 142 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
|.+.+..++.++||||||+++|+|++|..||..........................++..+.+++.+||+.+|.+|||+
T Consensus 203 E~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 282 (327)
T 3lm5_A 203 EILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTA 282 (327)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred eeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCH
Confidence 99999999999999999999999999999998765544444444333344444456678899999999999999999999
Q ss_pred HHHhcCCCCCCCCc
Q 042809 222 EELLNHTFISGNAK 235 (241)
Q Consensus 222 ~~~l~~p~~~~~~~ 235 (241)
+++++||||+...-
T Consensus 283 ~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 283 EICLSHSWLQQWDF 296 (327)
T ss_dssp HHHTTCGGGCCCCT
T ss_pred HHHhCCHhhccccc
Confidence 99999999987543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=282.78 Aligned_cols=226 Identities=21% Similarity=0.293 Sum_probs=170.2
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCccccc------C------------------------------
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGRN------G------------------------------ 42 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~------~------------------------------ 42 (241)
++.+|+.||||++.. +...+.+.+|+.++++++||||++. .
T Consensus 27 ~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (332)
T 3qd2_B 27 NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMD 106 (332)
T ss_dssp ETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-------------------
T ss_pred EcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCccc
Confidence 567899999999762 3456789999999999999999871 1
Q ss_pred --------------------------CceeeeeecccCCCCHHHHHHHhCC--CCCHHHHHHHHH------HHhhcCCcc
Q 042809 43 --------------------------EKTVNIFMEYMAGGSLLDVAEKFGG--TLDAGVIRLYTK------EILHGNGIL 88 (241)
Q Consensus 43 --------------------------~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~------~~Lh~~~~v 88 (241)
....++||||+++++|.+++..... ..+...+..++. ++||++|++
T Consensus 107 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 186 (332)
T 3qd2_B 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186 (332)
T ss_dssp -------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred ccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCee
Confidence 1238999999999999999987432 233333444444 458999999
Q ss_pred ccCCCCCcEEeecCCCeeecCCCcchhhcccccCCcc------ccccccccCcccccCcccccccCCCchhhHHHHHHHH
Q 042809 89 HCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNL------KQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMV 162 (241)
Q Consensus 89 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l 162 (241)
||||||+||+++.++.+||+|||++............ ........|++.|+|||.+.+..++.++||||||+++
T Consensus 187 H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 266 (332)
T 3qd2_B 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLIL 266 (332)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHH
T ss_pred ecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHH
Confidence 9999999999999999999999999765442211110 1122335689999999999999999999999999999
Q ss_pred HHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 163 IEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 163 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
|++++|..|+... ............+......++.+.+++.+||+.+|.+|||++++++||||++
T Consensus 267 ~el~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 267 FELLYSFSTQMER-----VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHSCCCCHHHH-----HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HHHHHcCCChhHH-----HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 9999988775332 1222222223333333456678899999999999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=280.36 Aligned_cols=225 Identities=24% Similarity=0.298 Sum_probs=169.2
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
|+.+|+.||+|.+... .....+.+|+.++++++||||++ ..+...++||||++ ++|.+++.. ...+++.
T Consensus 55 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~ 132 (329)
T 3gbz_A 55 DTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDK-NPDVSMR 132 (329)
T ss_dssp ETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH-CTTCCHH
T ss_pred ECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhh-cCCCCHH
Confidence 5778999999998632 23456789999999999999998 66788999999997 599999987 4568888
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeec-----CCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGS-----HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~-----~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
.+..++.|+ ||++|++||||||+||+++. ++.+||+|||++....... .......+++.|+||
T Consensus 133 ~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~~t~~y~aP 206 (329)
T 3gbz_A 133 VIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI------RQFTHEIITLWYRPP 206 (329)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------------CCTTCCH
T ss_pred HHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc------cccCCCcCCccccCH
Confidence 877777655 79999999999999999954 4459999999997654311 112334579999999
Q ss_pred cccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCC-C------------------------
Q 042809 142 EVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPH-F------------------------ 195 (241)
Q Consensus 142 E~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~------------------------ 195 (241)
|.+.+. .++.++||||||+++|++++|..||.+.................... .
T Consensus 207 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
T 3gbz_A 207 EILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRV 286 (329)
T ss_dssp HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHH
T ss_pred HHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhh
Confidence 999874 47999999999999999999999997754433332222221111100 0
Q ss_pred -ChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 196 -PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 196 -~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
+..++.++.+||.+||+.||.+|||++++++||||+...
T Consensus 287 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 287 LGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp HGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 011567899999999999999999999999999998764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=285.41 Aligned_cols=225 Identities=29% Similarity=0.455 Sum_probs=178.3
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+|+.||+|.+.. ....+.+.+|+.+++.++||||++ ..++..++||||+++++|.+++... ..++...
T Consensus 54 ~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~ 132 (360)
T 3eqc_A 54 HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQI 132 (360)
T ss_dssp ETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-SSCCHHH
T ss_pred ECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHc-CCCCHHH
Confidence 567899999999773 345677999999999999999998 5677899999999999999999874 4577777
Q ss_pred HHHHHHHH------hhcC-CccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 74 IRLYTKEI------LHGN-GILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 74 ~~~~~~~~------Lh~~-~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
+..++.++ ||+. |++||||||+||+++.++.++|+|||++...... ......|++.|+|||.+.+
T Consensus 133 ~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--------~~~~~~gt~~y~aPE~~~~ 204 (360)
T 3eqc_A 133 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--------MANSFVGTRSYMSPERLQG 204 (360)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--------C----CCCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--------cccCCCCCCCeECHHHHcC
Confidence 76666654 7986 9999999999999999999999999999765431 1123458999999999999
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHH---------------------------------------HHH
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLL---------------------------------------KIA 187 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---------------------------------------~~~ 187 (241)
..++.++||||||+++|+|++|..||............ ...
T Consensus 205 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (360)
T 3eqc_A 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYI 284 (360)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHH
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHH
Confidence 99999999999999999999999999764433221111 111
Q ss_pred hcCCCCCC-ChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 188 CSNEKPHF-PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 188 ~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.....+.. +..++.++.+|+.+||+.+|.+|||++++++||||+....
T Consensus 285 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 285 VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp HHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred hccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 11111222 2346778999999999999999999999999999976543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=280.62 Aligned_cols=228 Identities=22% Similarity=0.308 Sum_probs=175.3
Q ss_pred CCCCCcEEEEEeccchH-------HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCC
Q 042809 2 NKGTGALFVVKSAESEA-------GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTL 69 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 69 (241)
++.+|+.||+|.+.... ....+.+|+.+++.++||||++ ...+..++||||+++ +|.+++......+
T Consensus 31 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~ 109 (346)
T 1ua2_A 31 DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVL 109 (346)
T ss_dssp CSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSC
T ss_pred ECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCC
Confidence 56789999999987321 1246789999999999999998 567889999999975 8999998766667
Q ss_pred CHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
++..+..++.|+ ||++|++||||||+||+++.++.+||+|||++....... .......+++.|+|||.
T Consensus 110 ~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~~t~~y~aPE~ 183 (346)
T 1ua2_A 110 TPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN------RAYTHQVVTRWYRAPEL 183 (346)
T ss_dssp CSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC------CCCCCSCCCCTTCCHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc------ccCCcccccccccCchH
Confidence 776666666544 799999999999999999999999999999997653311 11233468999999999
Q ss_pred cccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC-------------------CC-----Chh
Q 042809 144 LRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP-------------------HF-----PTQ 198 (241)
Q Consensus 144 ~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------~~-----~~~ 198 (241)
+.+. .++.++||||||+++|+|++|..||.+................... .. ...
T Consensus 184 ~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (346)
T 1ua2_A 184 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA 263 (346)
T ss_dssp HTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTT
T ss_pred hhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhcc
Confidence 9764 4789999999999999999999999775443333222222111100 00 133
Q ss_pred hHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 199 FFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 199 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
.+.++.+||++||..+|.+|||++++++||||+.....
T Consensus 264 ~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 264 AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp CCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred CCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 45789999999999999999999999999999876543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=296.13 Aligned_cols=223 Identities=25% Similarity=0.368 Sum_probs=178.8
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+|..||+|++... .....+.+|+.+++.++||||++ ......|+||||+.+|+|.+++... ..+++.
T Consensus 58 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~ 136 (494)
T 3lij_A 58 DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-MKFNEV 136 (494)
T ss_dssp ETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHH
T ss_pred ECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc-CCCCHH
Confidence 5678999999998743 23567899999999999999998 6778899999999999999998874 567777
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecC---CCeeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSH---GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
.+..++.|+ ||++|++||||||+||+++.. +.+||+|||++...... .......|++.|+|||.
T Consensus 137 ~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-------~~~~~~~gt~~y~aPE~ 209 (494)
T 3lij_A 137 DAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-------KKMKERLGTAYYIAPEV 209 (494)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-------BCBCCCCSCTTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-------ccccccCCCcCeeCHHH
Confidence 777776655 799999999999999999764 45999999999765431 12234568999999999
Q ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH
Q 042809 144 LRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 144 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
+.+ .++.++||||+|+++|+|++|..||.+........................++..+.+||++||+.+|.+|||+++
T Consensus 210 l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 288 (494)
T 3lij_A 210 LRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQ 288 (494)
T ss_dssp HTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred Hcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHH
Confidence 864 5899999999999999999999999876554443333322222222222457789999999999999999999999
Q ss_pred HhcCCCCCCC
Q 042809 224 LLNHTFISGN 233 (241)
Q Consensus 224 ~l~~p~~~~~ 233 (241)
+++||||+..
T Consensus 289 ~l~hp~~~~~ 298 (494)
T 3lij_A 289 ALEHPWIKEM 298 (494)
T ss_dssp HHTCHHHHHH
T ss_pred HhcCcccccC
Confidence 9999999753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=283.63 Aligned_cols=220 Identities=28% Similarity=0.409 Sum_probs=173.6
Q ss_pred CCCCCcEEEEEeccc-hHHHHHHHHHHHHHhhcC-----CCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCC
Q 042809 2 NKGTGALFVVKSAES-EAGVQALRNEAEIRQSLN-----SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTL 69 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-~~~~~~~~~e~~~l~~l~-----h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~ 69 (241)
++.+|+.||+|++.. ......+..|+.+++.+. ||||++ ...+..++||||+ +++|.+++.... ..+
T Consensus 56 ~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~ 134 (360)
T 3llt_A 56 HIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGF 134 (360)
T ss_dssp ETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCC
T ss_pred ECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCC
Confidence 467899999999874 444567888999999997 999998 5567899999999 889999998753 357
Q ss_pred CHHHHHHHHHHH------hhcCCccccCCCCCcEEeec-------------------------CCCeeecCCCcchhhcc
Q 042809 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS-------------------------HGDVKLPDLGCARRVND 118 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~-------------------------~~~~kl~dfg~~~~~~~ 118 (241)
+...+..++.|+ ||++|++||||||+||+++. ++.+||+|||++.....
T Consensus 135 ~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~ 214 (360)
T 3llt_A 135 HIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214 (360)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence 888777776655 79999999999999999975 78899999999975333
Q ss_pred cccCCccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC-----
Q 042809 119 LKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP----- 193 (241)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 193 (241)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...................+.
T Consensus 215 ~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 285 (360)
T 3llt_A 215 Y---------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYE 285 (360)
T ss_dssp C---------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHH
T ss_pred C---------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhh
Confidence 1 12345899999999999999999999999999999999999999775444333332222111100
Q ss_pred -----------------CC--------------------ChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCC
Q 042809 194 -----------------HF--------------------PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFIS 231 (241)
Q Consensus 194 -----------------~~--------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~ 231 (241)
.. +...++.+.+|+.+||+.||.+|||++++++||||+
T Consensus 286 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 286 ATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred hhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 00 001125678999999999999999999999999995
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=279.53 Aligned_cols=227 Identities=22% Similarity=0.381 Sum_probs=173.8
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+|+.||+|.+.. ....+.+.+|+.++++++||||++ ...+..++||||+++++|.+++.. ...++..
T Consensus 24 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~ 102 (311)
T 4agu_A 24 NRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY-QRGVPEH 102 (311)
T ss_dssp ETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT-SSCCCHH
T ss_pred eCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhh-hcCCCHH
Confidence 567899999998753 233567889999999999999998 567789999999999999988876 4567887
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||++|++||||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+
T Consensus 103 ~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~ 176 (311)
T 4agu_A 103 LVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS------DYYDDEVATRWYRSPELLVG 176 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------------------GGGCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc------cccCCCcCCccccChHHHhc
Confidence 777776654 799999999999999999999999999999997543311 11223457899999999976
Q ss_pred -cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC-----------------CCCC----------Chh
Q 042809 147 -EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE-----------------KPHF----------PTQ 198 (241)
Q Consensus 147 -~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------~~~~----------~~~ 198 (241)
..++.++||||+|+++|++++|..||.+................. .... ...
T Consensus 177 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T 4agu_A 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPN 256 (311)
T ss_dssp CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTT
T ss_pred CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhccc
Confidence 567999999999999999999999997765444333322221110 0000 024
Q ss_pred hHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 199 FFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 199 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
++..+.+|+++||+.+|.+|||++++++||||++...
T Consensus 257 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 257 ISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp CCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred ccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 5678999999999999999999999999999987654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=273.54 Aligned_cols=225 Identities=26% Similarity=0.439 Sum_probs=184.6
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+.. ....+.+.+|+.+++.++||||++ ...+..++||||+++++|.+++... ..++.
T Consensus 36 ~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~ 114 (294)
T 2rku_A 36 DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTE 114 (294)
T ss_dssp ETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CSCCH
T ss_pred ECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhc-CCCCH
Confidence 567899999998763 245677899999999999999998 6678899999999999999998874 56788
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||+|+||+++.++.++|+|||.+....... .......|++.|+|||.+.
T Consensus 115 ~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~ 188 (294)
T 2rku_A 115 PEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG------ERKKVLCGTPNYIAPEVLS 188 (294)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT------CCBCCCCSCCSSCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc------cccccccCCCCcCCcchhc
Confidence 7777776655 799999999999999999999999999999987543211 1122345899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
+..++.++|+||||+++|++++|..||............. ......+...+..+.+++.+||+.+|.+|||+++++
T Consensus 189 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll 264 (294)
T 2rku_A 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK----KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 264 (294)
T ss_dssp TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----TTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGG
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----hccCCCccccCHHHHHHHHHHcccChhhCcCHHHHh
Confidence 9889999999999999999999999997754433222221 233455667788999999999999999999999999
Q ss_pred cCCCCCCCCccC
Q 042809 226 NHTFISGNAKKN 237 (241)
Q Consensus 226 ~~p~~~~~~~~~ 237 (241)
+||||+.....+
T Consensus 265 ~~~~~~~~~~~~ 276 (294)
T 2rku_A 265 NDEFFTSGYIPA 276 (294)
T ss_dssp GSHHHHTSCCCS
T ss_pred hChheecCCcCC
Confidence 999998765543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=302.00 Aligned_cols=221 Identities=24% Similarity=0.423 Sum_probs=183.9
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.+|+.||||++... ...+.+.+|..++..+ .||+|+. ...+.+|+||||++||+|.+++... ..++
T Consensus 362 ~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~ 440 (674)
T 3pfq_A 362 RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFK 440 (674)
T ss_dssp ESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHH-SSCC
T ss_pred ECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhc-CCCC
Confidence 5678999999998743 2345678899999988 5999987 6778999999999999999999974 5688
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..+..++.|+ ||++|++||||||+||+++.+|.+||+|||++...... .......+||+.|+|||++
T Consensus 441 ~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~------~~~~~~~~GT~~Y~APE~l 514 (674)
T 3pfq_A 441 EPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD------GVTTKTFCGTPDYIAPEII 514 (674)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT------TCCBCCCCSCSSSCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC------CcccccccCCCcccCHhhh
Confidence 88888777655 79999999999999999999999999999999743221 1123346799999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh---
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA--- 221 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--- 221 (241)
.+..++.++|+||||+++|+|++|+.||.+.........+. .....+|..++.++.+||++||+.+|.+||++
T Consensus 515 ~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~ 590 (674)
T 3pfq_A 515 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM----EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPE 590 (674)
T ss_dssp TCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----SSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTT
T ss_pred cCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH----hCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCC
Confidence 99999999999999999999999999998754433322222 34556778889999999999999999999998
Q ss_pred --HHHhcCCCCCCC
Q 042809 222 --EELLNHTFISGN 233 (241)
Q Consensus 222 --~~~l~~p~~~~~ 233 (241)
+++++||||+.-
T Consensus 591 ~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 591 GERDIKEHAFFRYI 604 (674)
T ss_dssp HHHHHHSSGGGSSC
T ss_pred cHHHHhcCccccCC
Confidence 999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=273.42 Aligned_cols=230 Identities=23% Similarity=0.367 Sum_probs=180.7
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+|+.||+|.+... ...+.+.+|+.+++.++||||++ ...+..++||||+++++|.+++.. ...++...
T Consensus 28 ~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~ 106 (276)
T 2yex_A 28 NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPD 106 (276)
T ss_dssp ETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHH
T ss_pred ECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhh-ccCCCHHH
Confidence 4678999999997633 34577899999999999999988 566789999999999999999875 45677877
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
+..++.|+ ||++|++|+||+|+||+++.++.++|+|||.+........ ........|++.|+|||.+.+.
T Consensus 107 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~ 182 (276)
T 2yex_A 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR----ERLLNKMCGTLPYVAPELLKRR 182 (276)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE----ECCBCCCCSCGGGCCGGGGTCS
T ss_pred HHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc----hhcccCCccccCccChHHHhcC
Confidence 77776655 7999999999999999999999999999999975433111 1112345689999999999876
Q ss_pred CC-CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 148 GL-DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 148 ~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
.+ +.++|+||||+++|++++|..||......... ................++..+.+++.+||+.+|.+|||++++++
T Consensus 183 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 65 77899999999999999999999765433221 11111112222223467789999999999999999999999999
Q ss_pred CCCCCCCCccC
Q 042809 227 HTFISGNAKKN 237 (241)
Q Consensus 227 ~p~~~~~~~~~ 237 (241)
||||+....+.
T Consensus 262 ~~~~~~~~~~~ 272 (276)
T 2yex_A 262 DRWYNKPLKKG 272 (276)
T ss_dssp CTTTTCCCC--
T ss_pred CccccChhhcc
Confidence 99998876654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=279.65 Aligned_cols=228 Identities=25% Similarity=0.453 Sum_probs=178.4
Q ss_pred CCCCCcEEEEEeccch--------HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAESE--------AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
++.+|+.||+|.+... ...+.+.+|+.++++++||||++ ......++||||+++++|.+++... ..
T Consensus 26 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~ 104 (283)
T 3bhy_A 26 QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK-ES 104 (283)
T ss_dssp ETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SS
T ss_pred EcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhc-CC
Confidence 4678999999987632 13677999999999999999988 5678899999999999999999873 56
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCC----CeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG----DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
++...+..++.|+ ||++|++|+||+|+||+++.++ .++|+|||.+....... ......+++.|
T Consensus 105 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~y 177 (283)
T 3bhy_A 105 LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-------EFKNIFGTPEF 177 (283)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---------------CCCGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC-------cccccCCCcCc
Confidence 7888877777655 7999999999999999998877 79999999997543311 12234589999
Q ss_pred cCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCC
Q 042809 139 MAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218 (241)
Q Consensus 139 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 218 (241)
+|||.+.+..++.++|+||||+++|++++|..||...........................+..+.+++++||..+|.+|
T Consensus 178 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 257 (283)
T 3bhy_A 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRR 257 (283)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGS
T ss_pred cCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHC
Confidence 99999998889999999999999999999999997754433322222111111111123456789999999999999999
Q ss_pred CChHHHhcCCCCCCCCccC
Q 042809 219 WSAEELLNHTFISGNAKKN 237 (241)
Q Consensus 219 ps~~~~l~~p~~~~~~~~~ 237 (241)
||+.++++||||+....++
T Consensus 258 ps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 258 MTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp CCHHHHHHCHHHHHHHHCC
T ss_pred cCHHHHHhCHHHHHHHHHh
Confidence 9999999999997654443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=277.14 Aligned_cols=217 Identities=25% Similarity=0.355 Sum_probs=169.0
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||||++.. ........+|+..+.++ +||||++ ..++..++||||+ +++|.+++...+..+++
T Consensus 78 ~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~ 156 (311)
T 3p1a_A 78 SKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPE 156 (311)
T ss_dssp ETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCH
T ss_pred ECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCH
Confidence 567899999998653 33344555666666555 8999998 5678899999999 67999999887778999
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.++.+||+|||++...... .......||+.|+|||.+.
T Consensus 157 ~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-------~~~~~~~gt~~y~aPE~~~ 229 (311)
T 3p1a_A 157 AQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-------GAGEVQEGDPRYMAPELLQ 229 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------------CCCCCGGGCCGGGGG
T ss_pred HHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-------CCCcccCCCccccCHhHhc
Confidence 8888777755 79999999999999999999999999999998654331 1122345899999999987
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
+ .++.++||||||+++|++++|..|+..... . .........+..+..++..+.+++.+||+.+|.+|||+++++
T Consensus 230 ~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell 303 (311)
T 3p1a_A 230 G-SYGTAADVFSLGLTILEVACNMELPHGGEG--W---QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALL 303 (311)
T ss_dssp T-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--H---HHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred C-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--H---HHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 6 689999999999999999999766654321 1 111111222223345678999999999999999999999999
Q ss_pred cCCCCCC
Q 042809 226 NHTFISG 232 (241)
Q Consensus 226 ~~p~~~~ 232 (241)
+||||+.
T Consensus 304 ~hp~~~~ 310 (311)
T 3p1a_A 304 ALPVLRQ 310 (311)
T ss_dssp TSGGGSC
T ss_pred hCccccC
Confidence 9999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=278.77 Aligned_cols=223 Identities=26% Similarity=0.445 Sum_probs=183.6
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+++.||+|.+... ...+.+.+|+.+++.++||||++ ...+..++||||+++++|.+++... ..++.
T Consensus 62 ~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~ 140 (335)
T 2owb_A 62 DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTE 140 (335)
T ss_dssp ETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-CSCCH
T ss_pred ECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhcc-CCCCH
Confidence 5678999999997633 45677899999999999999998 6678899999999999999998874 56788
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||+|+||+++.++.++|+|||++....... .......|++.|+|||.+.
T Consensus 141 ~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~gt~~y~aPE~~~ 214 (335)
T 2owb_A 141 PEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG------ERKKVLCGTPNYIAPEVLS 214 (335)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT------CCBCCCCSCCSSCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc------ccccccCCCccccCHHHhc
Confidence 7777777655 799999999999999999999999999999997543211 1123345899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
+..++.++||||||+++|+|++|..||............. ......+..++..+.+++++||+.+|.+|||+++++
T Consensus 215 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell 290 (335)
T 2owb_A 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK----KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 290 (335)
T ss_dssp TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----HTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGG
T ss_pred cCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh----cCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 9889999999999999999999999997654333322222 123345667788999999999999999999999999
Q ss_pred cCCCCCCCCc
Q 042809 226 NHTFISGNAK 235 (241)
Q Consensus 226 ~~p~~~~~~~ 235 (241)
+||||+....
T Consensus 291 ~~~~~~~~~~ 300 (335)
T 2owb_A 291 NDEFFTSGYI 300 (335)
T ss_dssp GSHHHHTSCC
T ss_pred cCccccCCCc
Confidence 9999987654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=273.48 Aligned_cols=230 Identities=32% Similarity=0.551 Sum_probs=177.6
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC--CCCHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG--TLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~ 72 (241)
++.+++.||+|.+.. ....+.+.+|+.+++.++||||++ ...+..++||||+++++|.+++..... .++..
T Consensus 43 ~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 122 (295)
T 2clq_A 43 DLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ 122 (295)
T ss_dssp ETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHH
T ss_pred ECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHH
Confidence 467899999998764 334577999999999999999998 566789999999999999999987533 34566
Q ss_pred HHHHHHHH------HhhcCCccccCCCCCcEEeec-CCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 73 VIRLYTKE------ILHGNGILHCDLKCNNVLLGS-HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 73 ~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
.+..++.| +||++|++|+||+|+||+++. ++.++|+|||.+....... .......|++.|+|||.+.
T Consensus 123 ~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~ 196 (295)
T 2clq_A 123 TIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN------PCTETFTGTLQYMAPEIID 196 (295)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----------CCCCCCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC------CcccccCCCccccChhhhc
Confidence 66555544 489999999999999999988 8999999999987543311 1112345899999999997
Q ss_pred ccC--CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH
Q 042809 146 NEG--LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 146 ~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
+.. ++.++||||||+++|+|++|..||........ ...........+..+..++..+.+++.+||+.+|.+|||+++
T Consensus 197 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 275 (295)
T 2clq_A 197 KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACAND 275 (295)
T ss_dssp HGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-HHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHH
T ss_pred CCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-HHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 643 78999999999999999999999976433222 222223334555667788899999999999999999999999
Q ss_pred HhcCCCCCCCCccCC
Q 042809 224 LLNHTFISGNAKKNS 238 (241)
Q Consensus 224 ~l~~p~~~~~~~~~~ 238 (241)
+++||||+...++..
T Consensus 276 ll~~~~~~~~~~~~~ 290 (295)
T 2clq_A 276 LLVDEFLKVSSKKKK 290 (295)
T ss_dssp HHTSGGGCC------
T ss_pred HhcChhhhhccccCC
Confidence 999999988776543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=297.04 Aligned_cols=226 Identities=24% Similarity=0.332 Sum_probs=180.0
Q ss_pred CCCCCcEEEEEeccch---------------HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE---------------AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDV 61 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---------------~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~ 61 (241)
++.+++.||+|++... ...+.+.+|+.++++++||||++ ......|+|||||++|+|.++
T Consensus 57 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~ 136 (504)
T 3q5i_A 57 EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQ 136 (504)
T ss_dssp ETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHH
T ss_pred ECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHH
Confidence 5678999999997743 23467899999999999999998 678899999999999999999
Q ss_pred HHHhCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCC---CeeecCCCcchhhcccccCCccccccccc
Q 042809 62 AEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG---DVKLPDLGCARRVNDLKNNGNLKQSWQSI 132 (241)
Q Consensus 62 l~~~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 132 (241)
+... ..+++..+..++.|+ ||++|++||||||+||+++.++ .+||+|||++...... ......
T Consensus 137 l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~ 208 (504)
T 3q5i_A 137 IINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-------YKLRDR 208 (504)
T ss_dssp HHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT-------SCBCCC
T ss_pred HHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC-------Cccccc
Confidence 9874 568888877777655 7999999999999999998876 6999999999755431 122345
Q ss_pred cCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhc
Q 042809 133 GGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLE 212 (241)
Q Consensus 133 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 212 (241)
.|++.|+|||.+.+ .++.++||||+|+++|+|++|..||.+........................++..+.+||++||.
T Consensus 209 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 287 (504)
T 3q5i_A 209 LGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLT 287 (504)
T ss_dssp CSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTC
T ss_pred cCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcC
Confidence 68999999999874 58999999999999999999999998765544333332211111111113467899999999999
Q ss_pred cCCCCCCChHHHhcCCCCCCCCcc
Q 042809 213 RKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 213 ~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
.+|.+|||++++++||||+....+
T Consensus 288 ~dp~~R~t~~e~l~h~~~~~~~~~ 311 (504)
T 3q5i_A 288 YDYNKRCTAEEALNSRWIKKYANN 311 (504)
T ss_dssp SSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred CChhHCCCHHHHhcCHhhhhchhc
Confidence 999999999999999999766543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=272.26 Aligned_cols=221 Identities=24% Similarity=0.376 Sum_probs=173.5
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+.... ..+.+.+|+.+++.++||||++ ...+..++||||+++++|.+++... ..++.
T Consensus 32 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~ 110 (276)
T 2h6d_A 32 HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-GRVEE 110 (276)
T ss_dssp ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCH
T ss_pred ECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhcc-CCCCH
Confidence 45689999999987432 3457899999999999999988 5678899999999999999999874 46777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++|+||+|+||+++.++.++|+|||.+...... .......+++.|+|||.+.
T Consensus 111 ~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~ 183 (276)
T 2h6d_A 111 MEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-------EFLRTSCGSPNYAAPEVIS 183 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--------------------CCTGGGT
T ss_pred HHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC-------cceecccCCccccCHHHHc
Confidence 7777776655 79999999999999999999999999999998755331 1122345789999999998
Q ss_pred ccCC-CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 146 NEGL-DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 146 ~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
+..+ +.++|+||||+++|++++|..||............. ......+...+..+.+++.+||+.+|.+|||++++
T Consensus 184 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~ 259 (276)
T 2h6d_A 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR----GGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDI 259 (276)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh----cCcccCchhcCHHHHHHHHHHccCChhhCCCHHHH
Confidence 8765 689999999999999999999997654433322222 22334556677899999999999999999999999
Q ss_pred hcCCCCCCCC
Q 042809 225 LNHTFISGNA 234 (241)
Q Consensus 225 l~~p~~~~~~ 234 (241)
++||||+...
T Consensus 260 l~h~~~~~~~ 269 (276)
T 2h6d_A 260 REHEWFKQDL 269 (276)
T ss_dssp HHSHHHHTTC
T ss_pred HhChhhccCc
Confidence 9999998654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=283.97 Aligned_cols=225 Identities=27% Similarity=0.483 Sum_probs=178.2
Q ss_pred CCCCcEEEEEeccch------HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 3 KGTGALFVVKSAESE------AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
+.+|+.||||++... ...+.+.+|+.++..+ .||||++ ......++||||+++++|.+++... ..++
T Consensus 79 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~ 157 (355)
T 1vzo_A 79 HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFT 157 (355)
T ss_dssp TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH-SCCC
T ss_pred CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHc-CCCC
Confidence 468999999997632 2345678899999999 5999988 5667899999999999999999874 5678
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
...+..++.|+ ||++|++||||||+||+++.++.+||+|||++........ .......||+.|+|||.+
T Consensus 158 ~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-----~~~~~~~gt~~y~aPE~~ 232 (355)
T 1vzo_A 158 EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-----ERAYDFCGTIEYMAPDIV 232 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-----GGGCGGGSCCTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC-----CcccCcccCcCccChhhh
Confidence 87777776654 7999999999999999999999999999999975432111 112235689999999999
Q ss_pred cc--cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC---
Q 042809 145 RN--EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW--- 219 (241)
Q Consensus 145 ~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp--- 219 (241)
.+ ..++.++||||||+++|+|++|..||....................+..+..++..+.+||.+||..+|.+||
T Consensus 233 ~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~ 312 (355)
T 1vzo_A 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 312 (355)
T ss_dssp TTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSS
T ss_pred cCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCC
Confidence 86 3468899999999999999999999975433222222222222344566777888999999999999999999
Q ss_pred --ChHHHhcCCCCCCC
Q 042809 220 --SAEELLNHTFISGN 233 (241)
Q Consensus 220 --s~~~~l~~p~~~~~ 233 (241)
|++++++||||+..
T Consensus 313 ~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 313 PRDADEIKEHLFFQKI 328 (355)
T ss_dssp TTTHHHHHTSGGGTTC
T ss_pred CCCHHHHHcCcchhcC
Confidence 99999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=273.14 Aligned_cols=227 Identities=33% Similarity=0.508 Sum_probs=179.2
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.+|+.||+|.+... ...+.+.+|+.+++.++||||++ ..++..++||||+++++|.+++......++...+
T Consensus 40 ~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~ 119 (302)
T 2j7t_A 40 NKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI 119 (302)
T ss_dssp ETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHH
T ss_pred EcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHH
Confidence 4678999999997643 34677899999999999999988 5677899999999999999999887778888888
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc---
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR--- 145 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--- 145 (241)
..++.|+ ||++|++||||+|+||+++.++.++|+|||++........ ......|++.|+|||.+.
T Consensus 120 ~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~ 193 (302)
T 2j7t_A 120 QVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ------KRDSFIGTPYWMAPEVVMCET 193 (302)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH------C-----CCGGGCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc------ccccccCChhhcCCeeecccc
Confidence 8777655 7999999999999999999999999999998764332111 112345899999999983
Q ss_pred --ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC-CCCCCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 146 --NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN-EKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 146 --~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
+..++.++||||||+++|++++|..||.......... ...... .....+..++..+.+++.+||+.+|.+|||++
T Consensus 194 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 271 (302)
T 2j7t_A 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAA 271 (302)
T ss_dssp TTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred CCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH--HHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHH
Confidence 5668899999999999999999999997654332221 111111 11223556788999999999999999999999
Q ss_pred HHhcCCCCCCCCcc
Q 042809 223 ELLNHTFISGNAKK 236 (241)
Q Consensus 223 ~~l~~p~~~~~~~~ 236 (241)
++++||||+....+
T Consensus 272 ~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 272 QLLEHPFVSSITSN 285 (302)
T ss_dssp HHTTSTTTTTCCCC
T ss_pred HHhcChHHhhhccc
Confidence 99999999876543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=282.04 Aligned_cols=227 Identities=25% Similarity=0.367 Sum_probs=171.6
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc---------cCCceeeeeecccCCCCHHHHHHHhCC
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR---------NGEKTVNIFMEYMAGGSLLDVAEKFGG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~~ 67 (241)
|+.+|+.||+|++.. ......+.+|+.++.+++||||++ ......|+||||++|++|.+++... .
T Consensus 33 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~ 111 (311)
T 3ork_A 33 DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-G 111 (311)
T ss_dssp ETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHH-C
T ss_pred ECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhc-C
Confidence 567899999999763 244567899999999999999988 1223459999999999999999874 5
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
.+++..+..++.|+ ||++|++||||||+||+++.++.+||+|||++......... ........|++.|+||
T Consensus 112 ~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~gt~~y~aP 188 (311)
T 3ork_A 112 PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS---VTQTAAVIGTAQYLSP 188 (311)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---------------------CCTTCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccc---cccccccCcCcccCCH
Confidence 67888777776655 79999999999999999999999999999999765442111 1122334589999999
Q ss_pred ccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC--CCChhhHHHHHHHHHHhhccCCCCCC
Q 042809 142 EVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP--HFPTQFFKKVLDFLAKCLERKPEKRW 219 (241)
Q Consensus 142 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp 219 (241)
|.+.+..++.++||||||+++|+|++|..||.+........... .....+ .....++.++.+++.+||+.+|.+||
T Consensus 189 E~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~ 266 (311)
T 3ork_A 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV--REDPIPPSARHEGLSADLDAVVLKALAKNPENRY 266 (311)
T ss_dssp HHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh--cCCCCCcccccCCCCHHHHHHHHHHHhcCHhhCh
Confidence 99999999999999999999999999999997754433222111 111111 11234678899999999999999999
Q ss_pred ChHHHhcCCCCCCCC
Q 042809 220 SAEELLNHTFISGNA 234 (241)
Q Consensus 220 s~~~~l~~p~~~~~~ 234 (241)
+..+++.|+|++...
T Consensus 267 ~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 267 QTAAEMRADLVRVHN 281 (311)
T ss_dssp SSHHHHHHHHHHHHT
T ss_pred hhHHHHHHHHHHHhc
Confidence 999999999997543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=286.46 Aligned_cols=232 Identities=22% Similarity=0.278 Sum_probs=167.6
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc----------cCCceeeeeecccCCCCHHHHHHHhCC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR----------NGEKTVNIFMEYMAGGSLLDVAEKFGG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~----------~~~~~~~lv~e~~~~~~L~~~l~~~~~ 67 (241)
|+.+|+.||||++.. ....+.+.+|+.+++.++||||++ .....+|+||||+. ++|.+++.. ..
T Consensus 74 ~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~ 151 (458)
T 3rp9_A 74 DKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRT-PV 151 (458)
T ss_dssp ECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHS-SC
T ss_pred ECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhccc-CC
Confidence 577899999998753 345678999999999999999988 22357999999994 799999986 46
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCc-----------------
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGN----------------- 124 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~----------------- 124 (241)
.+++..+..++.|+ ||++|++||||||+||+++.++.+||+|||++...........
T Consensus 152 ~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (458)
T 3rp9_A 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231 (458)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC--------------
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCcccccccccccc
Confidence 78888888777765 7999999999999999999999999999999986543211100
Q ss_pred ----cccccccccCcccccCcccc-cccCCCchhhHHHHHHHHHHHHh-----------CCCCCccchh-----------
Q 042809 125 ----LKQSWQSIGGTQLWMAPEVL-RNEGLDFATDIWSLGCMVIEMAT-----------GRPPWGDKIS----------- 177 (241)
Q Consensus 125 ----~~~~~~~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~~-----------g~~p~~~~~~----------- 177 (241)
.........||+.|+|||++ .+..++.++|||||||++|+|++ |.++|.+...
T Consensus 232 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~ 311 (458)
T 3rp9_A 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGN 311 (458)
T ss_dssp -------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC---------------
T ss_pred ccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccc
Confidence 01123345689999999986 56678999999999999999998 6666644321
Q ss_pred ---------chHHHHHHHHhc--------------------CCCC-------CCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 178 ---------NAAATLLKIACS--------------------NEKP-------HFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 178 ---------~~~~~~~~~~~~--------------------~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
......+..... .... ...+..++++.+||++||..||.+|||+
T Consensus 312 ~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~ 391 (458)
T 3rp9_A 312 DFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITI 391 (458)
T ss_dssp -----CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred cccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCH
Confidence 000000000000 0000 0112346789999999999999999999
Q ss_pred HHHhcCCCCCCCCc
Q 042809 222 EELLNHTFISGNAK 235 (241)
Q Consensus 222 ~~~l~~p~~~~~~~ 235 (241)
+++++||||+....
T Consensus 392 ~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 392 NECLAHPFFKEVRI 405 (458)
T ss_dssp HHHHHSGGGTTTCC
T ss_pred HHHhcCHhhhhcCC
Confidence 99999999987643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=291.29 Aligned_cols=226 Identities=29% Similarity=0.464 Sum_probs=168.5
Q ss_pred CCCCCcEEEEEeccchH----------HHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCC
Q 042809 2 NKGTGALFVVKSAESEA----------GVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~ 67 (241)
++.+|+.||+|.+.... ....+.+|+.++++++||||++ ......++||||+++++|.+++.. ..
T Consensus 156 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~ 234 (419)
T 3i6u_A 156 ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG-NK 234 (419)
T ss_dssp ETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSEEEEEEECCTTCBGGGGTSS-SC
T ss_pred ECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCceEEEEEcCCCCcHHHHHhc-cC
Confidence 56789999999976431 1235789999999999999998 345568999999999999998876 46
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCC---CeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG---DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
.+++..+..++.|+ ||++|++||||||+||+++.++ .+||+|||++...... .......|++.|
T Consensus 235 ~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-------~~~~~~~gt~~y 307 (419)
T 3i6u_A 235 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-------SLMRTLCGTPTY 307 (419)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC------------------CTT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCC-------ccccccCCCCCc
Confidence 68888877776655 7999999999999999997654 4999999999765431 122345689999
Q ss_pred cCcccccc---cCCCchhhHHHHHHHHHHHHhCCCCCccchhch-HHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccC
Q 042809 139 MAPEVLRN---EGLDFATDIWSLGCMVIEMATGRPPWGDKISNA-AATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 139 ~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 214 (241)
+|||.+.+ ..++.++||||||+++|+|++|..||....... .............+.....++..+.+|+++||+.+
T Consensus 308 ~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 387 (419)
T 3i6u_A 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVD 387 (419)
T ss_dssp CCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSS
T ss_pred cCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCC
Confidence 99999853 567889999999999999999999997643322 22222211111111111345788999999999999
Q ss_pred CCCCCChHHHhcCCCCCCCCc
Q 042809 215 PEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 215 p~~Rps~~~~l~~p~~~~~~~ 235 (241)
|.+|||++++++||||++...
T Consensus 388 P~~Rps~~e~l~hp~~~~~~~ 408 (419)
T 3i6u_A 388 PKARFTTEEALRHPWLQDEDM 408 (419)
T ss_dssp TTTSCCHHHHHHSGGGCCHHH
T ss_pred hhHCcCHHHHhCCcccCChhH
Confidence 999999999999999986543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=275.96 Aligned_cols=226 Identities=36% Similarity=0.609 Sum_probs=185.6
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+|+.||+|.+... ...+.+.+|+.+++.++||||++ ..+...++||||+++++|.+++.. ..++...
T Consensus 43 ~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~ 120 (303)
T 3a7i_A 43 DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQ 120 (303)
T ss_dssp ETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT--SCCCHHH
T ss_pred ECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc--CCCCHHH
Confidence 5678999999998632 34678999999999999999988 556789999999999999999875 5678888
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
+..++.|+ ||+.|++|+||+|+||+++.++.++|+|||.+....... .......|++.|+|||.+.+.
T Consensus 121 ~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~ 194 (303)
T 3a7i_A 121 IATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ------IKRNTFVGTPFWMAPEVIKQS 194 (303)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB------CCBCCCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc------cccCccCCCcCccCHHHHhcC
Confidence 77776655 799999999999999999999999999999997554311 112334589999999999998
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 148 GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
.++.++|+||||+++|++++|..||.......... .......+..+..++..+.+++.+||..+|.+|||+.++++|
T Consensus 195 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 195 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLF---LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH---HhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 89999999999999999999999997653332222 222234455666788899999999999999999999999999
Q ss_pred CCCCCCCccCC
Q 042809 228 TFISGNAKKNS 238 (241)
Q Consensus 228 p~~~~~~~~~~ 238 (241)
|||.....+.+
T Consensus 272 ~~~~~~~~~~~ 282 (303)
T 3a7i_A 272 KFILRNAKKTS 282 (303)
T ss_dssp HHHHHHCCCGG
T ss_pred hhhhcCCCccH
Confidence 99977665544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=284.31 Aligned_cols=229 Identities=23% Similarity=0.339 Sum_probs=166.4
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhC--------
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFG-------- 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~-------- 66 (241)
+..+++.||+|.+........+.+|+.++++++||||++ ..+..+++||||+. ++|.+++....
T Consensus 44 ~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~ 122 (405)
T 3rgf_A 44 DGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKP 122 (405)
T ss_dssp SSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-----
T ss_pred cCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccc
Confidence 346789999999987655667889999999999999987 35678999999996 58888876421
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEe----ecCCCeeecCCCcchhhcccccCCccccccccccCcc
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLL----GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQ 136 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (241)
..+++..++.++.|+ ||++|++||||||+||++ +.++.+||+|||++........ .........||+
T Consensus 123 ~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~gt~ 199 (405)
T 3rgf_A 123 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK---PLADLDPVVVTF 199 (405)
T ss_dssp --CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-------------------CCC
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCc---ccccCCCceecC
Confidence 247777777776655 799999999999999999 6678999999999976543111 111223456899
Q ss_pred cccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhc----------hHHHHHHHHhcCCCCCCC---------
Q 042809 137 LWMAPEVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISN----------AAATLLKIACSNEKPHFP--------- 196 (241)
Q Consensus 137 ~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------~~~~~~~~~~~~~~~~~~--------- 196 (241)
.|+|||.+.+. .++.++|||||||++|+|++|..||.+.... ....+.. ..........
T Consensus 200 ~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~-~~g~p~~~~~~~~~~~~~~ 278 (405)
T 3rgf_A 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN-VMGFPADKDWEDIKKMPEH 278 (405)
T ss_dssp TTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH-HHCCCCTTTCGGGGGSTTH
T ss_pred cccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH-hhCCCChhhcchhhcCcch
Confidence 99999999874 4899999999999999999999999654321 1111111 1111000000
Q ss_pred -------------------------hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 197 -------------------------TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 197 -------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
...+..+.+||.+||..||.+|||++++++||||+....
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 279 STLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp HHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred hhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence 011457889999999999999999999999999987543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=277.17 Aligned_cols=228 Identities=26% Similarity=0.347 Sum_probs=176.2
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc----------cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR----------NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~----------~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
|+.+|+.||+|.+.. ....+.+.+|++++.+++||||++ ......++||||+. ++|.+++.. ..
T Consensus 48 ~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~--~~ 124 (364)
T 3qyz_A 48 DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT--QH 124 (364)
T ss_dssp ETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH--CC
T ss_pred ECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh--CC
Confidence 567899999999863 344577899999999999999987 12257899999997 599999986 45
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
++...+..++.|+ ||++|++||||||+||+++.++.++|+|||++.......... .......|++.|+|||
T Consensus 125 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~gt~~y~aPE 201 (364)
T 3qyz_A 125 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT---GFLTEYVATRWYRAPE 201 (364)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC---CTTCCCCSCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCcc---ccccccccccCCCCCH
Confidence 7887777776655 799999999999999999999999999999997654322111 1123346899999999
Q ss_pred cccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC----------------------CCC-----
Q 042809 143 VLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE----------------------KPH----- 194 (241)
Q Consensus 143 ~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------~~~----- 194 (241)
.+.+ ..++.++||||||+++|+|++|..||.+................. ...
T Consensus 202 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (364)
T 3qyz_A 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 281 (364)
T ss_dssp HHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH
T ss_pred HhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHH
Confidence 8754 458999999999999999999999997755443333222111110 001
Q ss_pred CChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 195 FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 195 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.....+.++.+|+.+||+.||.+|||++++++||||+....
T Consensus 282 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 282 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp HCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 11335678999999999999999999999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=279.05 Aligned_cols=225 Identities=28% Similarity=0.411 Sum_probs=172.3
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+|+.||+|.+.. ....+.+.+|+.++++++||||++ ......++||||+++++|.+++.. ...++..
T Consensus 46 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~ 124 (331)
T 4aaa_A 46 NKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF-PNGLDYQ 124 (331)
T ss_dssp ETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHS-TTCCCHH
T ss_pred ECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhh-ccCCCHH
Confidence 567899999998752 334566889999999999999998 567789999999999888887665 4568888
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||++|++||||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.+
T Consensus 125 ~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~ 198 (331)
T 4aaa_A 125 VVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG------EVYDDEVATRWYRAPELLVG 198 (331)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------------CCCCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc------cccCCCcCCccccCcccccC
Confidence 877777655 799999999999999999999999999999997543311 11223458999999999987
Q ss_pred c-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC------------------CCC---------CChh
Q 042809 147 E-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE------------------KPH---------FPTQ 198 (241)
Q Consensus 147 ~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------~~~---------~~~~ 198 (241)
. .++.++||||||+++|++++|..||.+................. .+. ....
T Consensus 199 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (331)
T 4aaa_A 199 DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPK 278 (331)
T ss_dssp CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTT
T ss_pred CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccc
Confidence 5 68899999999999999999999997754433222221111100 000 0124
Q ss_pred hHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCC
Q 042809 199 FFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 199 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~ 233 (241)
++..+.+|+.+||+.+|.+|||++++++||||+..
T Consensus 279 ~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 279 LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred hhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 56789999999999999999999999999999764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=269.27 Aligned_cols=218 Identities=21% Similarity=0.310 Sum_probs=172.7
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHh---CCC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF---GGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~ 68 (241)
++.+|+.||+|.+.. ......+.+|+..+..+ +||||++ ...+..++||||+++++|.+++... ...
T Consensus 32 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 111 (289)
T 1x8b_A 32 KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSY 111 (289)
T ss_dssp ETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCC
T ss_pred EcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccC
Confidence 567899999999763 33456788999999999 8999998 5677899999999999999999864 256
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCC-------------------CeeecCCCcchhhcccccCC
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG-------------------DVKLPDLGCARRVNDLKNNG 123 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~-------------------~~kl~dfg~~~~~~~~~~~~ 123 (241)
+++..+..++.|+ ||++|++||||||+||+++.++ .++|+|||.+......
T Consensus 112 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---- 187 (289)
T 1x8b_A 112 FKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---- 187 (289)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS----
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc----
Confidence 7888887777655 7999999999999999998544 7999999998755431
Q ss_pred ccccccccccCcccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHH
Q 042809 124 NLKQSWQSIGGTQLWMAPEVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKK 202 (241)
Q Consensus 124 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (241)
....|++.|+|||.+.+. .++.++||||||+++|++++|..++..... . ........+..+..++..
T Consensus 188 ------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~ 255 (289)
T 1x8b_A 188 ------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--W----HEIRQGRLPRIPQVLSQE 255 (289)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--H----HHHHTTCCCCCSSCCCHH
T ss_pred ------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--H----HHHHcCCCCCCCcccCHH
Confidence 123489999999999775 566899999999999999999887754321 1 112224445667778899
Q ss_pred HHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 203 VLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 203 ~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
+.+++.+||+.+|.+|||+.++++||||+....
T Consensus 256 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 288 (289)
T 1x8b_A 256 FTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288 (289)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTCTTC-----
T ss_pred HHHHHHHHhCCCcccCCCHHHHhhChHhhhhcc
Confidence 999999999999999999999999999987654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=270.40 Aligned_cols=225 Identities=30% Similarity=0.439 Sum_probs=181.0
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHh---CC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKF---GG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~---~~ 67 (241)
++.+|+.||+|.+.. ....+.+.+|+.++++++||||++ ......++||||+++++|.+++... ..
T Consensus 27 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 106 (279)
T 2w5a_A 27 RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ 106 (279)
T ss_dssp ETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTC
T ss_pred ECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCC
Confidence 467899999999763 345677999999999999999988 3456899999999999999999764 33
Q ss_pred CCCHHHHHHHHHHH------hhcCC-----ccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcc
Q 042809 68 TLDAGVIRLYTKEI------LHGNG-----ILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQ 136 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~-----~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (241)
.+++..+..++.|+ ||+.| ++|+||+|+||+++.++.++|+|||.+....... .......|++
T Consensus 107 ~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~ 180 (279)
T 2w5a_A 107 YLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT------SFAKTFVGTP 180 (279)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C------HHHHHHHSCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc------ccccccCCCc
Confidence 47888777777655 79998 9999999999999999999999999997654311 1112345789
Q ss_pred cccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 137 LWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 137 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
.|+|||.+.+..++.++||||||+++|++++|..||.......... .......+..+..++..+.+++.+||+.+|.
T Consensus 181 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 257 (279)
T 2w5a_A 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG---KIREGKFRRIPYRYSDELNEIITRMLNLKDY 257 (279)
T ss_dssp TTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred cccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHH---HHhhcccccCCcccCHHHHHHHHHHcCCCcc
Confidence 9999999999889999999999999999999999998754433222 2222344456677889999999999999999
Q ss_pred CCCChHHHhcCCCCCCCCc
Q 042809 217 KRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 217 ~Rps~~~~l~~p~~~~~~~ 235 (241)
+|||++++++|+|+.+...
T Consensus 258 ~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 258 HRPSVEEILENPLILEHHH 276 (279)
T ss_dssp GSCCHHHHHTSTTCCGGGS
T ss_pred cCCCHHHHHhChhhhhhcc
Confidence 9999999999999987653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=270.68 Aligned_cols=232 Identities=24% Similarity=0.337 Sum_probs=172.9
Q ss_pred CCCCCcEEEEEeccc-hHHHHHHHHHHHHHhhcCCCccccc------------------CCceeeeeecccCCCCHHHHH
Q 042809 2 NKGTGALFVVKSAES-EAGVQALRNEAEIRQSLNSPNIGRN------------------GEKTVNIFMEYMAGGSLLDVA 62 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~------------------~~~~~~lv~e~~~~~~L~~~l 62 (241)
++.+|+.||+|.+.. ....+.+.+|+.++++++||||++. .....++||||+++++|.+++
T Consensus 27 ~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 106 (303)
T 1zy4_A 27 NALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106 (303)
T ss_dssp ETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHH
T ss_pred EcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhh
Confidence 467899999999874 3456789999999999999999871 257899999999999999999
Q ss_pred HHhCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCC--------ccccc
Q 042809 63 EKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG--------NLKQS 128 (241)
Q Consensus 63 ~~~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--------~~~~~ 128 (241)
......++...+..++.|+ ||++|++||||+|+||+++.++.++|+|||++.......... .....
T Consensus 107 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (303)
T 1zy4_A 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186 (303)
T ss_dssp HHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC------------------
T ss_pred hccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccc
Confidence 9766667777666665544 799999999999999999999999999999997654311100 00112
Q ss_pred cccccCcccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchh-chHHHHHHHHhcCCCCCCChhhHHHHHHH
Q 042809 129 WQSIGGTQLWMAPEVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKIS-NAAATLLKIACSNEKPHFPTQFFKKVLDF 206 (241)
Q Consensus 129 ~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 206 (241)
.....|++.|+|||.+.+. .++.++||||||+++|++++ ||..... ..............++.++...+..+.++
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 263 (303)
T 1zy4_A 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKI 263 (303)
T ss_dssp -------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHH
T ss_pred cccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHH
Confidence 2345688999999999864 68899999999999999998 5543221 11112222122233444556677889999
Q ss_pred HHHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 207 LAKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 207 i~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
+++||+.||.+|||++++++||||+....+
T Consensus 264 i~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (303)
T 1zy4_A 264 IRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293 (303)
T ss_dssp HHHHTCSSGGGSCCHHHHHHSSCSCCCCHH
T ss_pred HHHHHhcCcccCcCHHHHhCCCCcCCCChH
Confidence 999999999999999999999999876543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=283.43 Aligned_cols=226 Identities=24% Similarity=0.370 Sum_probs=172.4
Q ss_pred CCCCCcEEEEEeccchH-HHHHHHHHHHHHhhc------CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CC
Q 042809 2 NKGTGALFVVKSAESEA-GVQALRNEAEIRQSL------NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l------~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~ 68 (241)
|+.+|+.||||++.... ....+.+|+.++..+ .|+||+. .....+++||||+. ++|.+++.... ..
T Consensus 118 ~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~ 196 (429)
T 3kvw_A 118 DHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQG 196 (429)
T ss_dssp ETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCC
T ss_pred ECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCC
Confidence 56789999999987543 356678888888887 4668887 45678999999996 69999998754 34
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCC--eeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGD--VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
+++..+..++.|+ ||++|++||||||+||+++.++. +||+|||++..... ......|++.|+|
T Consensus 197 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~---------~~~~~~gt~~y~a 267 (429)
T 3kvw_A 197 FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---------RVYTYIQSRFYRA 267 (429)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC---------CCCSSCSCGGGCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC---------cccccCCCCCccC
Confidence 7888777777655 79999999999999999999887 99999999864332 1123468999999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC---------------------------
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP--------------------------- 193 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------- 193 (241)
||.+.+..++.++|||||||++|+|++|..||.+...................
T Consensus 268 PE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (429)
T 3kvw_A 268 PEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTL 347 (429)
T ss_dssp HHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECC
T ss_pred hHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCccccccccc
Confidence 99999999999999999999999999999999776543332222211110000
Q ss_pred ---------------------C-------CChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCccC
Q 042809 194 ---------------------H-------FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKN 237 (241)
Q Consensus 194 ---------------------~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~~ 237 (241)
. ++...++.+.+||++||+.||.+|||++++++||||+....+.
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~~~ 419 (429)
T 3kvw_A 348 SDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKP 419 (429)
T ss_dssp CC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC------
T ss_pred ccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCCCC
Confidence 0 0011256789999999999999999999999999998765543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=275.58 Aligned_cols=223 Identities=28% Similarity=0.440 Sum_probs=172.5
Q ss_pred CCCcEEEEEecc----chHHHHHHHHHHHHHhhcCC--Ccccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 4 GTGALFVVKSAE----SEAGVQALRNEAEIRQSLNS--PNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 4 ~~~~~vaiK~~~----~~~~~~~~~~e~~~l~~l~h--~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
.+++.||+|.+. .....+.+.+|+.++.+++| |||++ ..+...++|||+. +++|.+++.. ...+++.
T Consensus 31 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~-~~~~~~~ 108 (343)
T 3dbq_A 31 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK-KKSIDPW 108 (343)
T ss_dssp TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH-SCCCCHH
T ss_pred CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeCC-CCCHHHHHHh-cCCCCHH
Confidence 468899999876 23445778999999999986 89988 6778999999955 7899999997 4677887
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||++|++||||||+||+++ ++.+||+|||++........ ........|++.|+|||.+.+
T Consensus 109 ~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~ 183 (343)
T 3dbq_A 109 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT----SVVKDSQVGTVNYMPPEAIKD 183 (343)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----------------CCCCSSCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc----cccCCCCcCCcCcCCHHHHhh
Confidence 777776655 7999999999999999996 68899999999976543211 111224568999999999865
Q ss_pred -----------cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCC
Q 042809 147 -----------EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKP 215 (241)
Q Consensus 147 -----------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 215 (241)
..++.++||||||+++|+|++|+.||..... .................+...+..+.+++.+||+.+|
T Consensus 184 ~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp 262 (343)
T 3dbq_A 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDP 262 (343)
T ss_dssp CC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSST
T ss_pred ccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-HHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCCh
Confidence 6688999999999999999999999975432 2222333333344455666677889999999999999
Q ss_pred CCCCChHHHhcCCCCCCCC
Q 042809 216 EKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 216 ~~Rps~~~~l~~p~~~~~~ 234 (241)
.+|||++++++||||+...
T Consensus 263 ~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 263 KQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp TTSCCHHHHHTSHHHHSCC
T ss_pred hHCCCHHHHHhCccccccC
Confidence 9999999999999997543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=273.77 Aligned_cols=235 Identities=30% Similarity=0.490 Sum_probs=161.3
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHH-------hC
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEK-------FG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~-------~~ 66 (241)
++.+|+.||+|.+... ...+.+.+|+.++++++||||++ ...+..++||||+++++|.+++.. ..
T Consensus 36 ~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 115 (303)
T 2vwi_A 36 CAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKS 115 (303)
T ss_dssp C----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTT
T ss_pred ECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhcccccc
Confidence 4568999999998743 34567889999999999999998 566789999999999999999975 24
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..++...+..++.|+ ||++|++||||+|+||+++.++.++|+|||++.......... .........|++.|+|
T Consensus 116 ~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~y~a 194 (303)
T 2vwi_A 116 GVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT-RNKVRKTFVGTPCWMA 194 (303)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC----------------CCCTTCC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCcc-chhhhcccCCCccccC
Confidence 557888887777655 799999999999999999999999999999987553321100 0111233468999999
Q ss_pred cccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC------CCCCChhhHHHHHHHHHHhhcc
Q 042809 141 PEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE------KPHFPTQFFKKVLDFLAKCLER 213 (241)
Q Consensus 141 PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~ 213 (241)
||.+.+ ..++.++||||||+++|++++|..||................... .......++..+.+++.+||+.
T Consensus 195 PE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 274 (303)
T 2vwi_A 195 PEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQK 274 (303)
T ss_dssp HHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCS
T ss_pred HHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccC
Confidence 999976 568899999999999999999999997754433322211111000 0122245667899999999999
Q ss_pred CCCCCCChHHHhcCCCCCCCCccC
Q 042809 214 KPEKRWSAEELLNHTFISGNAKKN 237 (241)
Q Consensus 214 ~p~~Rps~~~~l~~p~~~~~~~~~ 237 (241)
+|.+|||++++++||||+....++
T Consensus 275 dp~~Rps~~~ll~h~~~~~~~~~~ 298 (303)
T 2vwi_A 275 DPEKRPTAAELLRHKFFQKAKNKE 298 (303)
T ss_dssp SGGGSCCHHHHHTSTTC-------
T ss_pred ChhhCcCHHHHhhChhhhcCCCCc
Confidence 999999999999999998765543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=281.16 Aligned_cols=233 Identities=24% Similarity=0.326 Sum_probs=170.1
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCC-----ceeeeeecccCCCCHHHHHHHhCC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGE-----KTVNIFMEYMAGGSLLDVAEKFGG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~-----~~~~lv~e~~~~~~L~~~l~~~~~ 67 (241)
|+.+|+.||||++.. ....+.+.+|+.+++.++||||++ ... ..+|+||||++ ++|.+++.. ..
T Consensus 47 ~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~ 124 (432)
T 3n9x_A 47 DKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKT-PI 124 (432)
T ss_dssp ETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHS-SC
T ss_pred ECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhc-cC
Confidence 578899999999863 345678999999999999999988 122 67999999996 699999986 46
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCC----------------cc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG----------------NL 125 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~----------------~~ 125 (241)
.+++..+..++.|+ ||++|++||||||+||+++.++.+||+|||++.......... ..
T Consensus 125 ~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (432)
T 3n9x_A 125 FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204 (432)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccch
Confidence 68888888887765 799999999999999999999999999999998654321110 00
Q ss_pred ccccccccCcccccCcccc-cccCCCchhhHHHHHHHHHHHHhCCCCC-----------ccchh----------------
Q 042809 126 KQSWQSIGGTQLWMAPEVL-RNEGLDFATDIWSLGCMVIEMATGRPPW-----------GDKIS---------------- 177 (241)
Q Consensus 126 ~~~~~~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~-----------~~~~~---------------- 177 (241)
........||+.|+|||.+ .+..++.++|||||||++|+|++|..|| .+...
T Consensus 205 ~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~ 284 (432)
T 3n9x_A 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKS 284 (432)
T ss_dssp ------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHH
T ss_pred hccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccc
Confidence 0123456789999999986 5566899999999999999999854443 22110
Q ss_pred -chHHHHHHHH----------------------hcCCCCCC-----ChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCC
Q 042809 178 -NAAATLLKIA----------------------CSNEKPHF-----PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTF 229 (241)
Q Consensus 178 -~~~~~~~~~~----------------------~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~ 229 (241)
......+... ........ .+..++++.+|+++||..||.+|||++++++|||
T Consensus 285 ~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 364 (432)
T 3n9x_A 285 NRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPY 364 (432)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGG
T ss_pred hHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChh
Confidence 0000000000 00000111 1346788999999999999999999999999999
Q ss_pred CCCCCcc
Q 042809 230 ISGNAKK 236 (241)
Q Consensus 230 ~~~~~~~ 236 (241)
|+....+
T Consensus 365 f~~~~~~ 371 (432)
T 3n9x_A 365 LKDVRKK 371 (432)
T ss_dssp GTTTCCT
T ss_pred hhhccCc
Confidence 9876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=275.44 Aligned_cols=220 Identities=25% Similarity=0.395 Sum_probs=171.6
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhCC--CC
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGG--TL 69 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~ 69 (241)
++.+|+.||+|++... ...+.+.+|++++++++||||++ ......++||||+++++|.+++..... .+
T Consensus 30 ~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 109 (319)
T 4euu_A 30 HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL 109 (319)
T ss_dssp ETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCC
T ss_pred ECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCC
Confidence 5678999999998743 33567889999999999999988 234488999999999999999987432 37
Q ss_pred CHHHHHHHHHHH------hhcCCccccCCCCCcEEe----ecCCCeeecCCCcchhhcccccCCccccccccccCccccc
Q 042809 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLL----GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (241)
++..+..++.|+ ||++|++||||||+||++ +.++.+||+|||++...... .......|++.|+
T Consensus 110 ~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~-------~~~~~~~gt~~y~ 182 (319)
T 4euu_A 110 PESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-------EQFVSLYGTEEYL 182 (319)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT-------CCBCCCCSCGGGC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC-------CceeecccCCCcc
Confidence 888877777655 799999999999999999 66777999999999755431 1122345899999
Q ss_pred Cccccc--------ccCCCchhhHHHHHHHHHHHHhCCCCCccchhch-HHHHHHHHhcCC-------------------
Q 042809 140 APEVLR--------NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNA-AATLLKIACSNE------------------- 191 (241)
Q Consensus 140 aPE~~~--------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~------------------- 191 (241)
|||.+. +..++.++||||||+++|+|++|..||....... ............
T Consensus 183 aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 262 (319)
T 4euu_A 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWS 262 (319)
T ss_dssp CHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEE
T ss_pred CHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccC
Confidence 999986 4678899999999999999999999996432211 111111111111
Q ss_pred -----CCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCC
Q 042809 192 -----KPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHT 228 (241)
Q Consensus 192 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p 228 (241)
....+..++..+.+++++||+.||.+|||++++++||
T Consensus 263 ~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 263 GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred ccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 1134467788999999999999999999999999987
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=269.68 Aligned_cols=222 Identities=25% Similarity=0.371 Sum_probs=173.9
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
+..+|+.||+|.+.. ....+.+.+|+.++++++||||++ ......++||||+++++|.+++......++..
T Consensus 35 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 114 (295)
T 3ugc_A 35 QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 114 (295)
T ss_dssp CSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHH
T ss_pred cCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHH
Confidence 567899999999774 344577999999999999999988 22346899999999999999999866668888
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||+.|++||||||+||+++.++.+||+|||++......... ........++..|+|||.+.+
T Consensus 115 ~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~ 191 (295)
T 3ugc_A 115 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF---FKVKEPGESPIFWYAPESLTE 191 (295)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----------------CTTCGGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcce---eeeccCCCCccceeCcHHhcC
Confidence 777776655 79999999999999999999999999999999765432111 111223346778999999999
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhch-------------HHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhcc
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNA-------------AATLLKIACSNEKPHFPTQFFKKVLDFLAKCLER 213 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 213 (241)
..++.++||||||+++|++++|..|+....... ................+..+++.+.+++.+||+.
T Consensus 192 ~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 271 (295)
T 3ugc_A 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNN 271 (295)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCS
T ss_pred CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCC
Confidence 999999999999999999999999986543221 1122233334445566778889999999999999
Q ss_pred CCCCCCChHHHhc
Q 042809 214 KPEKRWSAEELLN 226 (241)
Q Consensus 214 ~p~~Rps~~~~l~ 226 (241)
+|.+|||++++++
T Consensus 272 dp~~Rps~~el~~ 284 (295)
T 3ugc_A 272 NVNQRPSFRDLAL 284 (295)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCCCHHHHHH
Confidence 9999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=273.91 Aligned_cols=223 Identities=26% Similarity=0.367 Sum_probs=171.0
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcC-CCcccc-------cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLN-SPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+|+.||+|.+.... .+.+.+|+.++++++ ||||++ ......++||||+++++|.+++.. ++...
T Consensus 57 ~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~ 131 (330)
T 3nsz_A 57 NITNNEKVVVKILKPVK-KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYD 131 (330)
T ss_dssp ETTTCCEEEEEEECSCC-HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG----CCHHH
T ss_pred ECCCCcEEEEEEecccc-hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh----CCHHH
Confidence 56789999999987543 577899999999998 999988 236778999999999999998864 66666
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCC-CeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHG-DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
+..++.|+ ||++|++||||||+||+++.++ .++|+|||++...... .......+++.|+|||.+.+
T Consensus 132 ~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~~~~~~y~aPE~~~~ 204 (330)
T 3nsz_A 132 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-------QEYNVRVASRYFKGPELLVD 204 (330)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT-------CCCCSCCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC-------CccccccccccccChhhhcC
Confidence 66666544 7999999999999999999777 7999999999754331 11233468899999999977
Q ss_pred -cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHH--HHHH---------HHhcC-----------------------C
Q 042809 147 -EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAA--TLLK---------IACSN-----------------------E 191 (241)
Q Consensus 147 -~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~---------~~~~~-----------------------~ 191 (241)
..++.++||||||+++|+|++|..||......... .... ..... .
T Consensus 205 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (330)
T 3nsz_A 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 284 (330)
T ss_dssp CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGC
T ss_pred CCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhc
Confidence 66899999999999999999999999442211110 0000 00000 0
Q ss_pred CCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 192 KPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 192 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
....+..++..+.+||.+||+.||.+|||++++++||||+...++
T Consensus 285 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 285 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 329 (330)
T ss_dssp CTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred cccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence 011122367899999999999999999999999999999876543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=270.69 Aligned_cols=226 Identities=26% Similarity=0.379 Sum_probs=165.7
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHH---hCCCC
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEK---FGGTL 69 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~ 69 (241)
++.+|+.||+|.+... .....+.++...++.++||||++ ...+..++||||++ ++|.+++.. .+..+
T Consensus 28 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~ 106 (290)
T 3fme_A 28 HVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTI 106 (290)
T ss_dssp ETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCC
T ss_pred ecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCC
Confidence 4678999999998632 22334555566688889999998 56778999999997 588887764 35678
Q ss_pred CHHHHHHHHHHH------hhcC-CccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 70 DAGVIRLYTKEI------LHGN-GILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~-~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
++..+..++.|+ ||++ |++||||||+||+++.++.++|+|||++...... .......|++.|+|||
T Consensus 107 ~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~t~~y~aPE 179 (290)
T 3fme_A 107 PEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-------VAKDIDAGCKPYMAPE 179 (290)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC----------------------CCCCCCSCHH
T ss_pred CHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc-------ccccccCCCccccChh
Confidence 888887777655 7998 9999999999999999999999999999765431 1112335899999999
Q ss_pred cc----cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCC
Q 042809 143 VL----RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218 (241)
Q Consensus 143 ~~----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 218 (241)
.+ .+..++.++||||+|+++|++++|..||...... ................+..++..+.+++.+||+.+|.+|
T Consensus 180 ~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 258 (290)
T 3fme_A 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-FQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKER 258 (290)
T ss_dssp HHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-HHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGS
T ss_pred hcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-HHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhC
Confidence 96 4567889999999999999999999999753222 222222222233333345678899999999999999999
Q ss_pred CChHHHhcCCCCCCCCcc
Q 042809 219 WSAEELLNHTFISGNAKK 236 (241)
Q Consensus 219 ps~~~~l~~p~~~~~~~~ 236 (241)
||++++++||||+....+
T Consensus 259 pt~~e~l~hp~f~~~~~~ 276 (290)
T 3fme_A 259 PTYPELMQHPFFTLHESK 276 (290)
T ss_dssp CCHHHHTTSHHHHHHHHS
T ss_pred cCHHHHHhCcccccCccc
Confidence 999999999999765443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=279.83 Aligned_cols=222 Identities=23% Similarity=0.344 Sum_probs=162.9
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----c------CCceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----N------GEKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~------~~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
|+.+|+.||||.+.. ....+.+.+|+.+++.++||||++ . .....|+|+|++ +++|.+++..
T Consensus 50 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-- 126 (367)
T 2fst_X 50 DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-- 126 (367)
T ss_dssp ETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-------
T ss_pred ECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc--
Confidence 578899999999753 345677889999999999999988 1 125689999999 6899999886
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..++...+..++.|+ ||++|++||||||+||+++.++.+||+|||++...... .....|++.|+|
T Consensus 127 ~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~t~~y~a 197 (367)
T 2fst_X 127 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---------MTGYVATRWYRA 197 (367)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------------------------CCCTTCC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc---------CCCcCcCcCccC
Confidence 568888877777655 79999999999999999999999999999999754331 223458999999
Q ss_pred cccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC----------------------CCCCC--
Q 042809 141 PEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN----------------------EKPHF-- 195 (241)
Q Consensus 141 PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------------~~~~~-- 195 (241)
||.+.+ ..++.++|||||||++|+|++|+.||.+.........+...... ..+..
T Consensus 198 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (367)
T 2fst_X 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF 277 (367)
T ss_dssp HHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCH
T ss_pred hHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCH
Confidence 999987 67899999999999999999999999775443332222211110 00111
Q ss_pred ---ChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 196 ---PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 196 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
....++.+.+|+.+||..||.+|||++++++||||+....
T Consensus 278 ~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 278 ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp HHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 1234578999999999999999999999999999987544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=274.63 Aligned_cols=217 Identities=21% Similarity=0.330 Sum_probs=175.6
Q ss_pred CCCcEEEEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC--------
Q 042809 4 GTGALFVVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-------- 66 (241)
Q Consensus 4 ~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-------- 66 (241)
.++..||+|.+.. ....+.+.+|+.+++++ +||||++ ...+.+|+||||+++|+|.+++....
T Consensus 111 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 190 (370)
T 2psq_A 111 KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190 (370)
T ss_dssp TCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC------
T ss_pred CcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccc
Confidence 4667899999874 34567799999999999 8999998 66778999999999999999998753
Q ss_pred -------CCCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCcccccccccc
Q 042809 67 -------GTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIG 133 (241)
Q Consensus 67 -------~~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 133 (241)
..++...+..++.| +||++|++||||||+||+++.++.+||+|||++........ ........
T Consensus 191 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~----~~~~~~~~ 266 (370)
T 2psq_A 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY----YKKTTNGR 266 (370)
T ss_dssp -----CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCT----TCTTTTTT
T ss_pred cccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccc----eecccCCC
Confidence 23666666666554 48999999999999999999999999999999975543211 11122334
Q ss_pred CcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhc
Q 042809 134 GTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLE 212 (241)
Q Consensus 134 ~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 212 (241)
+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+......... ......+..+..++.++.+++.+||+
T Consensus 267 ~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~ 343 (370)
T 2psq_A 267 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL---LKEGHRMDKPANCTNELYMMMRDCWH 343 (370)
T ss_dssp SCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---HHTTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred cccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HhcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 6788999999999999999999999999999999 9999987654443332 23344556677788999999999999
Q ss_pred cCCCCCCChHHHhcC
Q 042809 213 RKPEKRWSAEELLNH 227 (241)
Q Consensus 213 ~~p~~Rps~~~~l~~ 227 (241)
.+|.+|||+.+++++
T Consensus 344 ~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 344 AVPSQRPTFKQLVED 358 (370)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=270.98 Aligned_cols=221 Identities=23% Similarity=0.378 Sum_probs=171.7
Q ss_pred CCCCCcEEEEEecc-----chHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAE-----SEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
|+.+|+.||+|.+. .....+.+.+|+.++.+++||||++ ..++..++||||++|++|.+++... .+++.
T Consensus 32 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~ 110 (294)
T 4eqm_A 32 DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSV 110 (294)
T ss_dssp ETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCH
T ss_pred ECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhc-CCCCH
Confidence 56789999999864 3445678999999999999999998 6778899999999999999999874 56888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.++.+||+|||++........ .......|++.|+|||.+.
T Consensus 111 ~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~ 185 (294)
T 4eqm_A 111 DTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-----TQTNHVLGTVQYFSPEQAK 185 (294)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------------------CCSSCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc-----cccCccccCccccCHhHhc
Confidence 8877777655 7999999999999999999999999999999976543111 1123345899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC----CCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP----HFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
+..++.++||||||+++|++++|+.||.+....... .... ....+ ..+..++..+.+++.+||+.+|.+||+.
T Consensus 186 ~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~ 262 (294)
T 4eqm_A 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA--IKHI-QDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKT 262 (294)
T ss_dssp TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH--HHHH-SSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSS
T ss_pred CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHh-hccCCCcchhcccCCCHHHHHHHHHHhcCCHhHcccc
Confidence 999999999999999999999999999775432221 1111 12222 2345577899999999999999999966
Q ss_pred HHHhcCCCCC
Q 042809 222 EELLNHTFIS 231 (241)
Q Consensus 222 ~~~l~~p~~~ 231 (241)
.+.+.+.|..
T Consensus 263 ~~~l~~~l~~ 272 (294)
T 4eqm_A 263 IQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHHH
Confidence 6666655543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=278.02 Aligned_cols=222 Identities=25% Similarity=0.317 Sum_probs=177.2
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC------C
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG------G 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~------~ 67 (241)
+..+++.||||.+.. ......+.+|+.++++++||||++ ......++||||+++|+|.+++.... .
T Consensus 97 ~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 176 (367)
T 3l9p_A 97 NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 176 (367)
T ss_dssp ---CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCC
T ss_pred CCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccc
Confidence 346788999999863 445567889999999999999998 56778899999999999999998754 3
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCC---CeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG---DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
.++...+..++.|+ ||++|++||||||+||+++.+| .+||+|||++........ ........+++.|
T Consensus 177 ~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~----~~~~~~~~~t~~y 252 (367)
T 3l9p_A 177 SLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY----YRKGGCAMLPVKW 252 (367)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSS----CTTCCGGGSCGGG
T ss_pred cccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccc----cccCCCcCCcccE
Confidence 47777766666544 8999999999999999998655 499999999976543211 1122334578899
Q ss_pred cCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCC
Q 042809 139 MAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEK 217 (241)
Q Consensus 139 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 217 (241)
+|||.+.+..++.++||||||+++|+|++ |..||........ ............+..++..+.+|+.+||+.+|.+
T Consensus 253 ~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 329 (367)
T 3l9p_A 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPED 329 (367)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred ECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhH
Confidence 99999999999999999999999999998 9999987544333 3333344455566778889999999999999999
Q ss_pred CCChHHHhcCCCC
Q 042809 218 RWSAEELLNHTFI 230 (241)
Q Consensus 218 Rps~~~~l~~p~~ 230 (241)
|||+++++++.++
T Consensus 330 Rps~~eil~~l~~ 342 (367)
T 3l9p_A 330 RPNFAIILERIEY 342 (367)
T ss_dssp SCCHHHHHHHHHH
T ss_pred CcCHHHHHHHHHH
Confidence 9999999998755
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=277.89 Aligned_cols=222 Identities=28% Similarity=0.443 Sum_probs=170.8
Q ss_pred CCcEEEEEeccc----hHHHHHHHHHHHHHhhcC--CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 5 TGALFVVKSAES----EAGVQALRNEAEIRQSLN--SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 5 ~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~--h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
+|+.||||.+.. ....+.+.+|+.++.+++ ||||++ ..++.+|+|||+ .+++|.+++... ..+++..
T Consensus 79 ~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~-~~~~L~~~l~~~-~~~~~~~ 156 (390)
T 2zmd_A 79 KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK-KSIDPWE 156 (390)
T ss_dssp TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC-CSEEHHHHHHHC-SSCCHHH
T ss_pred CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEec-CCCCHHHHHHhc-CCCCHHH
Confidence 488999998763 345678999999999997 599988 567789999995 578999999874 5677777
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc-
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN- 146 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~- 146 (241)
+..++.|+ ||++|++||||||+||+++ ++.+||+|||++........ ........||+.|+|||++.+
T Consensus 157 ~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~ 231 (390)
T 2zmd_A 157 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT----SVVKDSQVGAVNYMPPEAIKDM 231 (390)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------------CCSCCCGGGCCHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc----cccCCCCCcCCCccChHHhhhc
Confidence 76666654 7999999999999999994 68999999999976543111 111234568999999999865
Q ss_pred ----------cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 147 ----------EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 147 ----------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
..++.++||||||+++|+|++|..||...... ...............++...+..+.+||.+||..+|.
T Consensus 232 ~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 310 (390)
T 2zmd_A 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK 310 (390)
T ss_dssp ------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTT
T ss_pred cccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChh
Confidence 36889999999999999999999999764322 1222222223333445556678899999999999999
Q ss_pred CCCChHHHhcCCCCCCCC
Q 042809 217 KRWSAEELLNHTFISGNA 234 (241)
Q Consensus 217 ~Rps~~~~l~~p~~~~~~ 234 (241)
+|||++++++||||+...
T Consensus 311 ~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 311 QRISIPELLAHPYVQIQT 328 (390)
T ss_dssp TSCCHHHHHTSHHHHSCC
T ss_pred hCCCHHHHhhCcCccccC
Confidence 999999999999997654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=272.53 Aligned_cols=232 Identities=26% Similarity=0.370 Sum_probs=175.1
Q ss_pred CCCCCcEEEEEecc---chHHHHHHHHHHHHHhhcCCCcccc----------cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAE---SEAGVQALRNEAEIRQSLNSPNIGR----------NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~---~~~~~~~~~~e~~~l~~l~h~~i~~----------~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
++.+|+.||||.+. .......+.+|+.++++++||||++ ......++||||+. ++|.+++.. ..
T Consensus 32 ~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~ 108 (353)
T 2b9h_A 32 HKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST--QM 108 (353)
T ss_dssp ETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH--CC
T ss_pred ECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh--cC
Confidence 46789999999976 2344567889999999999999987 12367999999997 699999987 46
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCc----cccccccccCcccc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGN----LKQSWQSIGGTQLW 138 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 138 (241)
++...+..++.|+ ||++|++||||||+||+++.++.++|+|||++........... .........|++.|
T Consensus 109 ~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 188 (353)
T 2b9h_A 109 LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccc
Confidence 7888777776655 7999999999999999999999999999999976543211111 01112234689999
Q ss_pred cCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCC-----------------------CC
Q 042809 139 MAPEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK-----------------------PH 194 (241)
Q Consensus 139 ~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------~~ 194 (241)
+|||.+.+ ..++.++||||||+++|+|++|..||.+.................. +.
T Consensus 189 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (353)
T 2b9h_A 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPA 268 (353)
T ss_dssp CCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCC
T ss_pred cCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCC
Confidence 99998764 6789999999999999999999999987654332222221111100 00
Q ss_pred -----CChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 195 -----FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 195 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
....++.++.+|+.+||+.||.+|||++++++||||+.....
T Consensus 269 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 315 (353)
T 2b9h_A 269 APLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP 315 (353)
T ss_dssp CCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred cchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence 113466789999999999999999999999999999876543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=277.11 Aligned_cols=225 Identities=29% Similarity=0.480 Sum_probs=171.7
Q ss_pred CCCCCcEEEEEeccchH----------HHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCC
Q 042809 2 NKGTGALFVVKSAESEA----------GVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~ 67 (241)
++.+|+.||||.+.... ....+.+|+.++++++||||++ ......++||||+++++|.+++.. ..
T Consensus 31 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~ 109 (322)
T 2ycf_A 31 ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG-NK 109 (322)
T ss_dssp ETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEETHHHHST-TC
T ss_pred EcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCceEEEEecCCCCcHHHHHhc-cC
Confidence 56789999999976431 2345889999999999999998 233458999999999999999876 45
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCC---eeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGD---VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
.++...+..++.|+ ||++|++||||+|+||+++.++. +||+|||++...... .......|++.|
T Consensus 110 ~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~gt~~y 182 (322)
T 2ycf_A 110 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-------SLMRTLCGTPTY 182 (322)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCC-------HHHHHHHSCCTT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccc-------cccccccCCcCc
Confidence 67887777766655 79999999999999999987665 999999999754331 112234589999
Q ss_pred cCccccc---ccCCCchhhHHHHHHHHHHHHhCCCCCccchhc-hHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccC
Q 042809 139 MAPEVLR---NEGLDFATDIWSLGCMVIEMATGRPPWGDKISN-AAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 139 ~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 214 (241)
+|||.+. +..++.++||||||+++|++++|..||...... ..............+.....++..+.+++.+||..+
T Consensus 183 ~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 262 (322)
T 2ycf_A 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVD 262 (322)
T ss_dssp CCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSS
T ss_pred cCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccC
Confidence 9999974 456789999999999999999999999764332 222222211111111112345788999999999999
Q ss_pred CCCCCChHHHhcCCCCCCCC
Q 042809 215 PEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 215 p~~Rps~~~~l~~p~~~~~~ 234 (241)
|.+|||++++++||||+...
T Consensus 263 P~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 263 PKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp TTTSCCHHHHHTSGGGCCHH
T ss_pred HhhCCCHHHHhhCcCcCCHH
Confidence 99999999999999997643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=271.00 Aligned_cols=218 Identities=21% Similarity=0.306 Sum_probs=175.6
Q ss_pred CCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 4 GTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 4 ~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
..+..||||.+.. ....+.+.+|+.++++++||||++ ......++||||+++++|.+++......++...+.
T Consensus 75 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 154 (325)
T 3kul_A 75 QRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV 154 (325)
T ss_dssp SCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHH
T ss_pred CCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHH
Confidence 3456699999873 345677999999999999999998 56778999999999999999998766788888888
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCC
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL 149 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 149 (241)
.++.|+ ||++|++||||||+||+++.++.++|+|||++.......... .......+++.|+|||.+.+..+
T Consensus 155 ~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~ 231 (325)
T 3kul_A 155 GMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA---YTTTGGKIPIRWTAPEAIAFRTF 231 (325)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CC---EECC---CCGGGSCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccce---eeccCCCCcccccCHhHhcCCCC
Confidence 777655 799999999999999999999999999999997654321111 11122335778999999998889
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 150 DFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
+.++||||||+++|++++ |..||.+....... ...........+..++..+.+++.+||..+|.+|||+.++++.
T Consensus 232 ~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 232 SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI---SSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH---HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH---HHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999 99999775443332 2233344555677788999999999999999999999998853
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=270.74 Aligned_cols=225 Identities=25% Similarity=0.357 Sum_probs=177.0
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+|+.||+|.+... ...+.+.+|+.++++++||||++ ......++|+||+.+++|.+++... ..++..
T Consensus 43 ~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~ 121 (287)
T 2wei_A 43 DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEH 121 (287)
T ss_dssp ETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHH
T ss_pred EcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc-CCCCHH
Confidence 4668999999997632 34677999999999999999988 5678899999999999999998874 467888
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCC---CeeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG---DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
.+..++.|+ ||++|++|+||+|+||+++.++ .++|+|||++....... ......+++.|+|||.
T Consensus 122 ~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~ 194 (287)
T 2wei_A 122 DAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-------KMKDRIGTAYYIAPEV 194 (287)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS-------SCSCHHHHHTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC-------ccccccCcccccChHH
Confidence 777776655 7999999999999999997644 69999999987654311 1122347889999999
Q ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH
Q 042809 144 LRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 144 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
+.+. ++.++|+||||+++|++++|..||.+........................++..+.+++.+||..+|.+|||+++
T Consensus 195 ~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 273 (287)
T 2wei_A 195 LRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQ 273 (287)
T ss_dssp HTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHH
Confidence 8764 889999999999999999999999875444333222221111111112456789999999999999999999999
Q ss_pred HhcCCCCCCCCc
Q 042809 224 LLNHTFISGNAK 235 (241)
Q Consensus 224 ~l~~p~~~~~~~ 235 (241)
+++||||+....
T Consensus 274 ll~hp~~~~~~~ 285 (287)
T 2wei_A 274 CLEHPWIQKYSS 285 (287)
T ss_dssp HHHSHHHHHHCC
T ss_pred HhcCHHHhcccc
Confidence 999999976543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=279.86 Aligned_cols=220 Identities=25% Similarity=0.324 Sum_probs=162.7
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cC------CceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NG------EKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~------~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
|+.+|+.||||.+.. ....+.+.+|+.+++.++||||++ .. ....|+||||++ ++|.+++..
T Consensus 46 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-- 122 (371)
T 2xrw_A 46 DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM-- 122 (371)
T ss_dssp ETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHHS--
T ss_pred ECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHhh--
Confidence 567899999999763 344677889999999999999987 11 237899999997 588888863
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
.++...+..++.|+ ||++|++||||||+||+++.++.+||+|||++...... .......|++.|+|
T Consensus 123 -~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~~gt~~y~a 194 (371)
T 2xrw_A 123 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-------FMMTPYVVTRYYRA 194 (371)
T ss_dssp -CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----------------------CTTCC
T ss_pred -ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc-------cccCCceecCCccC
Confidence 47777776666654 79999999999999999999999999999999755331 11223468999999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC------------------CCCCC-------
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN------------------EKPHF------- 195 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------~~~~~------- 195 (241)
||.+.+..++.++||||||+++|+|++|..||.+................ ..+.+
T Consensus 195 PE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (371)
T 2xrw_A 195 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK 274 (371)
T ss_dssp HHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHH
T ss_pred HHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhh
Confidence 99999988999999999999999999999999775432221111100000 00000
Q ss_pred -------------ChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 196 -------------PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 196 -------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
+...+..+.+|+++||..||.+|||++++++||||+.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 275 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0123678999999999999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=268.71 Aligned_cols=226 Identities=22% Similarity=0.362 Sum_probs=177.4
Q ss_pred CCCCCcEEEEEeccch------HHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHh-CC
Q 042809 2 NKGTGALFVVKSAESE------AGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKF-GG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~-~~ 67 (241)
++.+|+.||+|.+... .....+.+|+.++++++||||++ ......++||||+.++ |.+++... ..
T Consensus 26 ~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~ 104 (305)
T 2wtk_C 26 DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEK 104 (305)
T ss_dssp BTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTC
T ss_pred ECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCccc
Confidence 5678999999998743 23567899999999999999988 3456789999999865 87877763 45
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
.++...+..++.|+ ||++|++||||+|+||+++.++.++|+|||.+........ ........|++.|+||
T Consensus 105 ~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aP 180 (305)
T 2wtk_C 105 RFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA----DDTCRTSQGSPAFQPP 180 (305)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCS----SCEECCCCSCGGGCCH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcccc----ccccccCCCCCCCcCh
Confidence 67887777776655 7999999999999999999999999999999975533111 1122344589999999
Q ss_pred ccccccC--CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC
Q 042809 142 EVLRNEG--LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219 (241)
Q Consensus 142 E~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 219 (241)
|.+.+.. ++.++||||||+++|++++|..||.+........... ......+...+..+.+++.+||..+|.+||
T Consensus 181 E~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 256 (305)
T 2wtk_C 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG----KGSYAIPGDCGPPLSDLLKGMLEYEPAKRF 256 (305)
T ss_dssp HHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH----HCCCCCCSSSCHHHHHHHHHHTCSSTTTSC
T ss_pred hhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh----cCCCCCCCccCHHHHHHHHHHccCChhhCC
Confidence 9997644 3779999999999999999999998754333322222 223445667788999999999999999999
Q ss_pred ChHHHhcCCCCCCCCcc
Q 042809 220 SAEELLNHTFISGNAKK 236 (241)
Q Consensus 220 s~~~~l~~p~~~~~~~~ 236 (241)
|++++++||||+.....
T Consensus 257 s~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 257 SIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp CHHHHHHSHHHHSCCCC
T ss_pred CHHHHhcCcccccCCCC
Confidence 99999999999766543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=285.92 Aligned_cols=222 Identities=14% Similarity=0.099 Sum_probs=158.2
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhc--CCCcccc----c----------C---------------Cce
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSL--NSPNIGR----N----------G---------------EKT 45 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l--~h~~i~~----~----------~---------------~~~ 45 (241)
++.+|+.||+|++.. ....+.+.+|+.++..+ +||||++ . . ...
T Consensus 83 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~ 162 (371)
T 3q60_A 83 DVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162 (371)
T ss_dssp ETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEE
T ss_pred ECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeee
Confidence 567899999999874 23456678886555555 5999765 1 0 145
Q ss_pred eeeeecccCCCCHHHHHHHhCCCCCHHHH------HHH------HHHHhhcCCccccCCCCCcEEeecCCCeeecCCCcc
Q 042809 46 VNIFMEYMAGGSLLDVAEKFGGTLDAGVI------RLY------TKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCA 113 (241)
Q Consensus 46 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~------~~~------~~~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~ 113 (241)
.|+||||++ ++|.+++...+..+..... ..+ +.++||++|++||||||+||+++.++.+||+|||++
T Consensus 163 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a 241 (371)
T 3q60_A 163 YLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241 (371)
T ss_dssp EEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGE
T ss_pred EEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEeccee
Confidence 899999998 8999999875333333222 222 235589999999999999999999999999999999
Q ss_pred hhhcccccCCccccccccccCcccccCcccccc--cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHH---HHh
Q 042809 114 RRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN--EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLK---IAC 188 (241)
Q Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~ 188 (241)
....... ....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+........... ...
T Consensus 242 ~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 312 (371)
T 3q60_A 242 WKVGTRG---------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVP 312 (371)
T ss_dssp EETTCEE---------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSC
T ss_pred eecCCCc---------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhc
Confidence 7554311 12345699999999987 678999999999999999999999997753221110000 000
Q ss_pred --cCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCC
Q 042809 189 --SNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 189 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~ 233 (241)
.......+..+++.+.+||.+||+.+|.+|||++++++||||+..
T Consensus 313 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 313 GTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp CCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred cccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 011112224678899999999999999999999999999999754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=275.88 Aligned_cols=221 Identities=23% Similarity=0.340 Sum_probs=169.0
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCc------eeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEK------TVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~------~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
|+.+|+.||+|.+.. +...+.+.+|+.+++.++||||++ ...+ ..++||||+. ++|.+++.
T Consensus 63 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--- 138 (371)
T 4exu_A 63 DKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--- 138 (371)
T ss_dssp ETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT---
T ss_pred ECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh---
Confidence 577899999999863 344677899999999999999988 2222 2499999997 68888774
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..+++..+..++.|+ ||++|++||||||+||+++.++.+||+|||++...... .....+++.|+|
T Consensus 139 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---------~~~~~~t~~y~a 209 (371)
T 4exu_A 139 MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---------MTGYVVTRWYRA 209 (371)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----------------CTTCCCTTSC
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC---------cCCcccCccccC
Confidence 347888877777655 79999999999999999999999999999999754331 123457999999
Q ss_pred cccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC----------------------CCCC---
Q 042809 141 PEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN----------------------EKPH--- 194 (241)
Q Consensus 141 PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------------~~~~--- 194 (241)
||.+.+ ..++.++||||||+++|++++|..||.+................ ..+.
T Consensus 210 PE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (371)
T 4exu_A 210 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF 289 (371)
T ss_dssp HHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCH
T ss_pred HHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhH
Confidence 999987 67899999999999999999999999775433322222111100 0000
Q ss_pred --CChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 195 --FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 195 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.....++.+.+||.+||+.+|.+|||++++++||||+....
T Consensus 290 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 332 (371)
T 4exu_A 290 TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 332 (371)
T ss_dssp HHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence 11235678999999999999999999999999999986543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=272.23 Aligned_cols=226 Identities=30% Similarity=0.509 Sum_probs=172.7
Q ss_pred CCCCCcEEEEEeccch-HHHHHHHHHHHHHhhc-CCCcccc------c-----CCceeeeeecccCCCCHHHHHHHh-CC
Q 042809 2 NKGTGALFVVKSAESE-AGVQALRNEAEIRQSL-NSPNIGR------N-----GEKTVNIFMEYMAGGSLLDVAEKF-GG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~------~-----~~~~~~lv~e~~~~~~L~~~l~~~-~~ 67 (241)
++.+|+.||+|.+... ...+.+.+|+.+++++ +||||++ . .....++||||+++++|.+++... ..
T Consensus 45 ~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 124 (326)
T 2x7f_A 45 HVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN 124 (326)
T ss_dssp ETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGG
T ss_pred ECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccC
Confidence 4578999999997632 3456789999999999 7999988 1 156899999999999999999874 24
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
.++...+..++.|+ ||++|++|+||+|+||+++.++.++|+|||++....... .......|++.|+||
T Consensus 125 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~y~aP 198 (326)
T 2x7f_A 125 TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV------GRRNTFIGTPYWMAP 198 (326)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------------------CCGGGCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc------cccccccCCccccCh
Confidence 67777777666554 799999999999999999999999999999987553311 112234589999999
Q ss_pred cccc-----ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 142 EVLR-----NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 142 E~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
|.+. +..++.++||||||+++|++++|..||.+....... ............+..++..+.++|.+||..+|.
T Consensus 199 E~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 276 (326)
T 2x7f_A 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL--FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHS 276 (326)
T ss_dssp HHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGG
T ss_pred hhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH--HHhhcCccccCCccccCHHHHHHHHHHhccChh
Confidence 9997 566889999999999999999999999765332222 222222223333456778999999999999999
Q ss_pred CCCChHHHhcCCCCCCCCc
Q 042809 217 KRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 217 ~Rps~~~~l~~p~~~~~~~ 235 (241)
+|||++++++||||+....
T Consensus 277 ~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 277 QRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp GSCCHHHHHTSHHHHCCTT
T ss_pred hCCCHHHHhhChHHhhCcc
Confidence 9999999999999987654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=267.27 Aligned_cols=221 Identities=29% Similarity=0.431 Sum_probs=170.6
Q ss_pred CCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC--CCCHHH
Q 042809 5 TGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG--TLDAGV 73 (241)
Q Consensus 5 ~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~ 73 (241)
+|+.||+|.+.. ....+.+.+|+.++++++||||++ ......++||||+++++|.+++...+. .+++..
T Consensus 59 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 138 (309)
T 3p86_A 59 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138 (309)
T ss_dssp TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHH
T ss_pred CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHH
Confidence 578899999763 344567899999999999999998 667789999999999999999986432 277777
Q ss_pred HHHHHHHH------hhcCC--ccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 74 IRLYTKEI------LHGNG--ILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~--~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
+..++.|+ ||++| ++||||||+||+++.++.+||+|||++....... .......|++.|+|||.+.
T Consensus 139 ~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~------~~~~~~~gt~~y~aPE~~~ 212 (309)
T 3p86_A 139 RLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF------LSSKSAAGTPEWMAPEVLR 212 (309)
T ss_dssp HHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------------------CCTTSCHHHHT
T ss_pred HHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc------cccccCCCCccccChhhhc
Confidence 76666554 79999 9999999999999999999999999997543311 1123456899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
+..++.++||||||+++|++++|..||......... ............+..+++.+.++|.+||+.+|.+|||+++++
T Consensus 213 ~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll 290 (309)
T 3p86_A 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV--AAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIM 290 (309)
T ss_dssp TCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH--HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999999999999999999999875443332 222334555667788889999999999999999999999998
Q ss_pred c--CCCCCCC
Q 042809 226 N--HTFISGN 233 (241)
Q Consensus 226 ~--~p~~~~~ 233 (241)
+ .++++..
T Consensus 291 ~~L~~~~~~~ 300 (309)
T 3p86_A 291 DLLRPLIKSA 300 (309)
T ss_dssp HHHHHHHC--
T ss_pred HHHHHHHHhC
Confidence 7 4555443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=263.27 Aligned_cols=215 Identities=22% Similarity=0.362 Sum_probs=176.7
Q ss_pred CCcEEEEEeccchH-HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 5 TGALFVVKSAESEA-GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 5 ~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
++..||+|.+.... ..+.+.+|+.++++++||||++ ......++||||+++++|.+++......++...+..++
T Consensus 33 ~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~ 112 (269)
T 4hcu_A 33 NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 112 (269)
T ss_dssp TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHH
T ss_pred CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHH
Confidence 57789999987532 3567999999999999999998 56778999999999999999998877778888887776
Q ss_pred HHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCch
Q 042809 79 KEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA 152 (241)
Q Consensus 79 ~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 152 (241)
.|+ ||++|++||||||+||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.+
T Consensus 113 ~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~ 187 (269)
T 4hcu_A 113 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-----TSSTGTKFPVKWASPEVFSFSRYSSK 187 (269)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-----HSTTSTTCCGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc-----ccccCcccccccCCHHHhcCCCCCch
Confidence 655 7999999999999999999999999999999975433211 11123345778999999999999999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 153 TDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 153 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
+|+||+|+++|++++ |..||........ ............+...+..+.+++.+||+.+|.+|||+++++++
T Consensus 188 ~Di~slG~~l~~ll~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 188 SDVWSFGVLMWEVFSEGKIPYENRSNSEV---VEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999 9999987544333 22333344555566778899999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=278.71 Aligned_cols=218 Identities=22% Similarity=0.340 Sum_probs=176.0
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+|+.||+|.+... ...+.+.+|+.++++++||||++ ...+..++||||+++|+|.+++...+..++...
T Consensus 135 ~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 214 (377)
T 3cbl_A 135 LRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKT 214 (377)
T ss_dssp ETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHH
T ss_pred EecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHH
Confidence 3568999999997743 34467889999999999999998 566789999999999999999998766788888
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
+..++.|+ ||++|++||||+|+||+++.++.+||+|||++........ ........+++.|+|||.+.+.
T Consensus 215 ~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~ 290 (377)
T 3cbl_A 215 LLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY----AASGGLRQVPVKWTAPEALNYG 290 (377)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE----ECCSSCCEEEGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce----eecCCCCCCCcCcCCHhHhccC
Confidence 77776654 7999999999999999999999999999999875332110 0111112246779999999988
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 148 GLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
.++.++||||||+++|++++ |..||.+....... ...........+...+..+.+++.+||+.+|.+|||++++++
T Consensus 291 ~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 291 RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR---EFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH---HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 89999999999999999998 99999775443332 223334455567778889999999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=279.21 Aligned_cols=221 Identities=24% Similarity=0.410 Sum_probs=169.9
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCccccc----------------------------------------
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGRN---------------------------------------- 41 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~---------------------------------------- 41 (241)
|+.+|+.||+|.+.... ....+|+.+++.++||||++.
T Consensus 28 ~~~~~~~vAiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (383)
T 3eb0_A 28 DIESGKRFALKKVLQDP--RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIV 105 (383)
T ss_dssp ETTTCCEEEEEEEECCT--TSCCHHHHHHTTCCCTTBCCEEEEEEEC---------------------------------
T ss_pred ECCCCCEEEEEEEecCc--chHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccc
Confidence 56899999999887442 234589999999999999871
Q ss_pred ---CCceeeeeecccCCCCHHHHHHH---hCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEee-cCCCeeec
Q 042809 42 ---GEKTVNIFMEYMAGGSLLDVAEK---FGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG-SHGDVKLP 108 (241)
Q Consensus 42 ---~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~-~~~~~kl~ 108 (241)
....+++||||++ ++|.+.+.. .+..+++..+..++.|+ ||++|++||||||+||+++ .++.+||+
T Consensus 106 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~ 184 (383)
T 3eb0_A 106 NPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLC 184 (383)
T ss_dssp ----CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEEC
T ss_pred cCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEE
Confidence 1234889999997 588877764 35678888888777655 7999999999999999998 57899999
Q ss_pred CCCcchhhcccccCCccccccccccCcccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHH
Q 042809 109 DLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIA 187 (241)
Q Consensus 109 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 187 (241)
|||++....... ......+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||.+.............
T Consensus 185 Dfg~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 257 (383)
T 3eb0_A 185 DFGSAKKLIPSE-------PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQI 257 (383)
T ss_dssp CCTTCEECCTTS-------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred ECCCCcccCCCC-------CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999997543311 12234578999999998875 4899999999999999999999999875443332222211
Q ss_pred hcCC----------------CC---------CCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 188 CSNE----------------KP---------HFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 188 ~~~~----------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
.... .+ .++...+.++.+|+.+||..+|.+|||+.++++||||+.
T Consensus 258 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 258 MGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp HCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred hCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 1100 00 123446778999999999999999999999999999965
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=277.87 Aligned_cols=221 Identities=26% Similarity=0.342 Sum_probs=171.9
Q ss_pred CCCCCcEEEEEeccch-HHHHHHHHHHHHHhhcC--------CCcccc---------cCCceeeeeecccCCCCHHHHHH
Q 042809 2 NKGTGALFVVKSAESE-AGVQALRNEAEIRQSLN--------SPNIGR---------NGEKTVNIFMEYMAGGSLLDVAE 63 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~--------h~~i~~---------~~~~~~~lv~e~~~~~~L~~~l~ 63 (241)
|+.+|+.||+|++... ...+.+.+|+.+++.++ |+||++ ......++||||+ +++|.+++.
T Consensus 58 ~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~ 136 (397)
T 1wak_A 58 DIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWII 136 (397)
T ss_dssp ETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHH
T ss_pred ecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHH
Confidence 5678999999998853 44677899999999996 677877 1567899999999 567766666
Q ss_pred Hh-CCCCCHHHHHHHHHHH------hhcC-CccccCCCCCcEEeecCC--------------------------------
Q 042809 64 KF-GGTLDAGVIRLYTKEI------LHGN-GILHCDLKCNNVLLGSHG-------------------------------- 103 (241)
Q Consensus 64 ~~-~~~~~~~~~~~~~~~~------Lh~~-~~vH~dl~p~Nil~~~~~-------------------------------- 103 (241)
.. ...++...+..++.|+ ||++ |++||||||+||+++.++
T Consensus 137 ~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (397)
T 1wak_A 137 KSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216 (397)
T ss_dssp HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------
T ss_pred hcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcc
Confidence 53 3568888888777765 7998 999999999999998765
Q ss_pred -----------------CeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHH
Q 042809 104 -----------------DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMA 166 (241)
Q Consensus 104 -----------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 166 (241)
.+||+|||.+...... .....||+.|+|||.+.+..++.++||||||+++|+|+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 287 (397)
T 1wak_A 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---------FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELA 287 (397)
T ss_dssp CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---------SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccceEecccccccccccc---------CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHh
Confidence 7999999999755331 12345899999999999998999999999999999999
Q ss_pred hCCCCCccchhch------HHHHHHHHhcC--------------------------------------CCCCCChhhHHH
Q 042809 167 TGRPPWGDKISNA------AATLLKIACSN--------------------------------------EKPHFPTQFFKK 202 (241)
Q Consensus 167 ~g~~p~~~~~~~~------~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~ 202 (241)
+|..||....... ........... .....+...+..
T Consensus 288 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (397)
T 1wak_A 288 TGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 367 (397)
T ss_dssp HSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHH
T ss_pred hCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHH
Confidence 9999996533211 11111111000 011234566788
Q ss_pred HHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 203 VLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 203 ~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
+.+||.+||+.||.+|||++++++||||+.
T Consensus 368 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 368 FTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 999999999999999999999999999963
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=275.35 Aligned_cols=220 Identities=27% Similarity=0.409 Sum_probs=176.5
Q ss_pred CCcEEEEEeccchHHH-------------------HHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHH
Q 042809 5 TGALFVVKSAESEAGV-------------------QALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLD 60 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~-------------------~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~ 60 (241)
+|+.||+|.+...... +.+.+|+.++.+++||||++ ...+..++||||+++++|.+
T Consensus 53 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 132 (348)
T 2pml_X 53 DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILK 132 (348)
T ss_dssp TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSE
T ss_pred CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHH
Confidence 7899999998754322 78999999999999999988 56789999999999999999
Q ss_pred H------HHHh-CCCCCHHHHHHHHHHH------hhc-CCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccc
Q 042809 61 V------AEKF-GGTLDAGVIRLYTKEI------LHG-NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLK 126 (241)
Q Consensus 61 ~------l~~~-~~~~~~~~~~~~~~~~------Lh~-~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 126 (241)
+ +... ...++...+..++.|+ ||+ .|++||||+|+||+++.++.++|+|||.+......
T Consensus 133 ~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~------- 205 (348)
T 2pml_X 133 FDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK------- 205 (348)
T ss_dssp ESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT-------
T ss_pred HHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccc-------
Confidence 8 5542 4668888877777655 798 99999999999999999999999999999754331
Q ss_pred cccccccCcccccCccccccc-CCCc-hhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC--------
Q 042809 127 QSWQSIGGTQLWMAPEVLRNE-GLDF-ATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP-------- 196 (241)
Q Consensus 127 ~~~~~~~~~~~~~aPE~~~~~-~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 196 (241)
......+++.|+|||.+.+. .++. ++||||||+++|++++|..||....... ....... ......+
T Consensus 206 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~i~-~~~~~~~~~~~~~~~ 281 (348)
T 2pml_X 206 -KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--ELFNNIR-TKNIEYPLDRNHFLY 281 (348)
T ss_dssp -EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--HHHHHHT-SCCCCCCCSSSSSTT
T ss_pred -cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHh-ccCcCCccchhhhhc
Confidence 22344589999999999877 5665 9999999999999999999997654411 1111111 1222223
Q ss_pred -----------hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 197 -----------TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 197 -----------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
..++..+.+++.+||+.+|.+|||++++++||||+....
T Consensus 282 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 282 PLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp TTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred cccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 457789999999999999999999999999999987653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=274.73 Aligned_cols=224 Identities=25% Similarity=0.360 Sum_probs=151.2
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc---------cCCceeeeeecccCCCCHHHHHHHhC-CCCCH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR---------NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~ 71 (241)
++.+|+.||+|++..... ........+..+.||||++ ......++||||+++|+|.+++.... ..+++
T Consensus 50 ~~~~~~~vavK~~~~~~~--~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~ 127 (336)
T 3fhr_A 50 HRRTGQKCALKLLYDSPK--ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE 127 (336)
T ss_dssp ETTTCCEEEEEEEESSHH--HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBH
T ss_pred ECCCCCEEEEEEecCcHH--HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCH
Confidence 567899999999875432 2223334466678999987 23566899999999999999998753 36888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecC---CCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH---GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
..+..++.|+ ||++|++||||||+||+++.+ +.++|+|||++..... .......+++.|+|||
T Consensus 128 ~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~--------~~~~~~~~t~~y~aPE 199 (336)
T 3fhr_A 128 REAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--------NALQTPCYTPYYVAPE 199 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc--------cccccCCCCcCccChh
Confidence 8888877765 799999999999999999764 4599999999975433 1122345799999999
Q ss_pred cccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHH----HhcCCCCCCChhhHHHHHHHHHHhhccCCCCC
Q 042809 143 VLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKI----ACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218 (241)
Q Consensus 143 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 218 (241)
.+.+..++.++||||||+++|++++|..||.............. ............++..+.+|+.+||+.+|.+|
T Consensus 200 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 279 (336)
T 3fhr_A 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTER 279 (336)
T ss_dssp ----CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGS
T ss_pred hhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHC
Confidence 99888889999999999999999999999976544332111111 11111222234678899999999999999999
Q ss_pred CChHHHhcCCCCCCCCc
Q 042809 219 WSAEELLNHTFISGNAK 235 (241)
Q Consensus 219 ps~~~~l~~p~~~~~~~ 235 (241)
||++++++||||+....
T Consensus 280 pt~~ell~hp~~~~~~~ 296 (336)
T 3fhr_A 280 LTITQFMNHPWINQSMV 296 (336)
T ss_dssp CCHHHHHHSHHHHTGGG
T ss_pred cCHHHHhcCcccccccc
Confidence 99999999999987654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=271.97 Aligned_cols=222 Identities=22% Similarity=0.310 Sum_probs=167.2
Q ss_pred CCcEEEEEeccc-------------hHHHHHHHHHHHHHhhcCCCcccc----------cCCceeeeeecccCCCCHHHH
Q 042809 5 TGALFVVKSAES-------------EAGVQALRNEAEIRQSLNSPNIGR----------NGEKTVNIFMEYMAGGSLLDV 61 (241)
Q Consensus 5 ~~~~vaiK~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~----------~~~~~~~lv~e~~~~~~L~~~ 61 (241)
+|+.||||.+.. ....+.+.+|+.++++++||||++ ......|+||||++ |+|.++
T Consensus 45 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~ 123 (362)
T 3pg1_A 45 EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQV 123 (362)
T ss_dssp TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHH
T ss_pred CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHH
Confidence 489999998752 223477999999999999999987 22347899999997 699999
Q ss_pred HHHhCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCc
Q 042809 62 AEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGT 135 (241)
Q Consensus 62 l~~~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 135 (241)
+......++...+..++.|+ ||++|++||||||+||+++.++.++|+|||++...... .......++
T Consensus 124 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~t 196 (362)
T 3pg1_A 124 IHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD-------ANKTHYVTH 196 (362)
T ss_dssp HHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC----------------------C
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccc-------cccceeccc
Confidence 98766678888888777655 79999999999999999999999999999999744331 112234578
Q ss_pred ccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC--------------------CCCC
Q 042809 136 QLWMAPEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN--------------------EKPH 194 (241)
Q Consensus 136 ~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------------~~~~ 194 (241)
+.|+|||.+.+ ..++.++||||||+++|++++|..||.+................ ....
T Consensus 197 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (362)
T 3pg1_A 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSN 276 (362)
T ss_dssp GGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCC
T ss_pred ceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhccc
Confidence 99999999977 66899999999999999999999999875443332222111110 0000
Q ss_pred --------CChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 195 --------FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 195 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
.....++.+.+|+.+||+.+|.+|||++++++||||+...
T Consensus 277 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 277 VPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp CCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 1123467899999999999999999999999999998753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=269.05 Aligned_cols=217 Identities=19% Similarity=0.294 Sum_probs=176.2
Q ss_pred CCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC---------
Q 042809 4 GTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG--------- 66 (241)
Q Consensus 4 ~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 66 (241)
.+++.||+|.+.. ....+.+.+|+.++++++||||++ ...+..++||||+++++|.+++....
T Consensus 75 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 154 (343)
T 1luf_A 75 EPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 154 (343)
T ss_dssp SSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC--------
T ss_pred CCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCccccccccc
Confidence 5679999999874 334577999999999999999998 56788999999999999999998742
Q ss_pred --------------CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccc
Q 042809 67 --------------GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLK 126 (241)
Q Consensus 67 --------------~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 126 (241)
..++...+..++.|+ ||++|++||||||+||+++.++.+||+|||++........ .
T Consensus 155 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~----~ 230 (343)
T 1luf_A 155 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY----Y 230 (343)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC----B
T ss_pred ccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCcc----c
Confidence 467777777776655 7999999999999999999999999999999976543211 1
Q ss_pred cccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHH
Q 042809 127 QSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLD 205 (241)
Q Consensus 127 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (241)
.......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....... ...........+..++..+.+
T Consensus 231 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~ 307 (343)
T 1luf_A 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI---YYVRDGNILACPENCPLELYN 307 (343)
T ss_dssp C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---HHHHTTCCCCCCTTCCHHHHH
T ss_pred cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHH---HHHhCCCcCCCCCCCCHHHHH
Confidence 11223457889999999999889999999999999999999 99999775443332 223334445567778889999
Q ss_pred HHHHhhccCCCCCCChHHHhcC
Q 042809 206 FLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 206 li~~~l~~~p~~Rps~~~~l~~ 227 (241)
++++||+.+|.+|||+.+++++
T Consensus 308 li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 308 LMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcccCcccCCCHHHHHHH
Confidence 9999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=263.93 Aligned_cols=216 Identities=21% Similarity=0.317 Sum_probs=176.0
Q ss_pred CCCCCcEEEEEeccchH---------HHHHHHHHHHHHhhcCCCcccc---cCCceeeeeecccCCCCHHHHHHHhCCCC
Q 042809 2 NKGTGALFVVKSAESEA---------GVQALRNEAEIRQSLNSPNIGR---NGEKTVNIFMEYMAGGSLLDVAEKFGGTL 69 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 69 (241)
++.+++.||+|.+.... ..+.+.+|+.++++++||||++ ......++||||+++++|.+++......+
T Consensus 40 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 119 (287)
T 4f0f_A 40 LVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPI 119 (287)
T ss_dssp ETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTEEEEECCTTCBHHHHHHCTTSCC
T ss_pred EcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCeEEEEecCCCCHHHHHhcccCCc
Confidence 46789999999975211 1167899999999999999998 22223379999999999999998777788
Q ss_pred CHHHHHHHHHHH------hhcCC--ccccCCCCCcEEeecCCC-----eeecCCCcchhhcccccCCccccccccccCcc
Q 042809 70 DAGVIRLYTKEI------LHGNG--ILHCDLKCNNVLLGSHGD-----VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQ 136 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~~--~vH~dl~p~Nil~~~~~~-----~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (241)
+...+..++.|+ ||++| ++||||||+||+++.++. ++|+|||++..... ......|++
T Consensus 120 ~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~---------~~~~~~g~~ 190 (287)
T 4f0f_A 120 KWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---------SVSGLLGNF 190 (287)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS---------CEECCCCCC
T ss_pred cHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc---------cccccCCCc
Confidence 888887777655 79999 999999999999988776 99999999864322 123356899
Q ss_pred cccCccccc--ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccC
Q 042809 137 LWMAPEVLR--NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 137 ~~~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 214 (241)
.|+|||.+. ...++.++||||||+++|++++|..||....................+..+..+++.+.+++.+||+.+
T Consensus 191 ~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 270 (287)
T 4f0f_A 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGD 270 (287)
T ss_dssp TTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred cccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCC
Confidence 999999984 455788999999999999999999999876555544444445556667778888999999999999999
Q ss_pred CCCCCChHHHhc
Q 042809 215 PEKRWSAEELLN 226 (241)
Q Consensus 215 p~~Rps~~~~l~ 226 (241)
|.+|||++++++
T Consensus 271 p~~Rps~~~ll~ 282 (287)
T 4f0f_A 271 PKKRPHFSYIVK 282 (287)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCcCHHHHHH
Confidence 999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=268.62 Aligned_cols=222 Identities=18% Similarity=0.332 Sum_probs=163.4
Q ss_pred cEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCce------eeeeecccCCCCHHHHHHHhC-----
Q 042809 7 ALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKT------VNIFMEYMAGGSLLDVAEKFG----- 66 (241)
Q Consensus 7 ~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~------~~lv~e~~~~~~L~~~l~~~~----- 66 (241)
..||+|.+.. ....+.+.+|+.++++++||||++ ..... .++||||+.+++|.+++....
T Consensus 52 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~ 131 (323)
T 3qup_A 52 VKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131 (323)
T ss_dssp CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---C
T ss_pred eeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccc
Confidence 3899999873 344678999999999999999988 22222 399999999999999997542
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..++...+..++.|+ ||++|++||||||+||+++.++.+||+|||++........ ........+++.|+|
T Consensus 132 ~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~~~~~~y~a 207 (323)
T 3qup_A 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY----YRQGCASKLPVKWLA 207 (323)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------------------CCGGGCC
T ss_pred cccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecccccccccccc----ccccccccCcccccC
Confidence 257777777776654 7999999999999999999999999999999976533211 111123346778999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 219 (241)
||.+.+..++.++||||||+++|++++ |..||.+........ ..........+..++..+.+++.+||+.+|.+||
T Consensus 208 PE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 284 (323)
T 3qup_A 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN---YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRP 284 (323)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSC
T ss_pred chhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH---HHhcCCCCCCCCccCHHHHHHHHHHccCChhhCc
Confidence 999999999999999999999999999 999998765444332 2233445566677888999999999999999999
Q ss_pred C-------hHHHhcCCCCCCCCc
Q 042809 220 S-------AEELLNHTFISGNAK 235 (241)
Q Consensus 220 s-------~~~~l~~p~~~~~~~ 235 (241)
| +++++.|||+.....
T Consensus 285 s~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 285 SFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp CHHHHHHHHHHHHHC--------
T ss_pred CHHHHHHHHHHHHHHhhhcCCCC
Confidence 9 888999999987654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=272.75 Aligned_cols=220 Identities=20% Similarity=0.294 Sum_probs=174.8
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhc-CCCcccc------cCCceeeeeecccCCCCHHHHHHHhCC----
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSL-NSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGG---- 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~---- 67 (241)
+..+++.||||.+... ...+.+.+|++++.++ .||||++ ..+...++||||+++|+|.+++.....
T Consensus 48 ~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~ 127 (359)
T 3vhe_A 48 KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127 (359)
T ss_dssp STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCS
T ss_pred ccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccc
Confidence 5678899999998742 3456799999999999 6999998 345569999999999999999986432
Q ss_pred -------------------------------------------------------------CCCHHHHHHHHHHH-----
Q 042809 68 -------------------------------------------------------------TLDAGVIRLYTKEI----- 81 (241)
Q Consensus 68 -------------------------------------------------------------~~~~~~~~~~~~~~----- 81 (241)
.+++..+..++.|+
T Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~ 207 (359)
T 3vhe_A 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207 (359)
T ss_dssp CC------------------------------------------------------CTTTTCBCHHHHHHHHHHHHHHHH
T ss_pred cccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHH
Confidence 16666666666654
Q ss_pred -hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhhHHHHHH
Q 042809 82 -LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGC 160 (241)
Q Consensus 82 -Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~ 160 (241)
||++|++||||||+||+++.++.++|+|||++........ ........+++.|+|||.+.+..++.++||||||+
T Consensus 208 ~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 283 (359)
T 3vhe_A 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 283 (359)
T ss_dssp HHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT----CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc----chhccccCCCceeEChhhhcCCCCCchhhhhhHHH
Confidence 7999999999999999999999999999999975433111 11223345788999999999999999999999999
Q ss_pred HHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 161 MVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 161 ~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
++|+|++ |..||.+....... ............+...++.+.+++.+||+.+|.+|||++++++|
T Consensus 284 il~ellt~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 284 LLWEIFSLGASPYPGVKIDEEF--CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHTTTSCCSSTTCCCSHHH--HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCccchhHHH--HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 9999998 99999775433322 22222344555667788899999999999999999999999976
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=269.62 Aligned_cols=222 Identities=26% Similarity=0.376 Sum_probs=174.8
Q ss_pred CCCCcEEEEEeccc-hHHHHHHHHHHHHHhhcCCCc------ccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCC
Q 042809 3 KGTGALFVVKSAES-EAGVQALRNEAEIRQSLNSPN------IGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTL 69 (241)
Q Consensus 3 ~~~~~~vaiK~~~~-~~~~~~~~~e~~~l~~l~h~~------i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~ 69 (241)
+.+|+.||+|++.. ....+.+.+|+.++..++|++ +++ ...+..++||||+ +++|.+++...+ ..+
T Consensus 37 ~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~ 115 (339)
T 1z57_A 37 KAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPF 115 (339)
T ss_dssp TTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCC
T ss_pred CCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCC
Confidence 45789999999874 344677899999999998765 555 5667899999999 789999998754 357
Q ss_pred CHHHHHHHHHHH------hhcCCccccCCCCCcEEeec-------------------CCCeeecCCCcchhhcccccCCc
Q 042809 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS-------------------HGDVKLPDLGCARRVNDLKNNGN 124 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~-------------------~~~~kl~dfg~~~~~~~~~~~~~ 124 (241)
+...+..++.|+ ||++|++||||||+||+++. ++.++|+|||.+.....
T Consensus 116 ~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~------ 189 (339)
T 1z57_A 116 RLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE------ 189 (339)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS------
T ss_pred cHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc------
Confidence 787777776655 79999999999999999987 66899999999875432
Q ss_pred cccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCC------------
Q 042809 125 LKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK------------ 192 (241)
Q Consensus 125 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 192 (241)
......|++.|+|||.+.+..++.++||||||+++|++++|..||...................+
T Consensus 190 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 266 (339)
T 1z57_A 190 ---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKY 266 (339)
T ss_dssp ---CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGG
T ss_pred ---ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhH
Confidence 11234589999999999999999999999999999999999999977554433333222211110
Q ss_pred ----------------------------CCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 193 ----------------------------PHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 193 ----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
...+...++.+.+|+.+||..||.+|||++++++||||+.-.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 267 FHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp EETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred HhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence 011234567899999999999999999999999999998644
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=262.35 Aligned_cols=216 Identities=24% Similarity=0.346 Sum_probs=166.8
Q ss_pred CCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 4 GTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 4 ~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
.++..||+|.... ....+.+.+|+.++++++||||++ ..++..++||||+++++|.+++......++...+..
T Consensus 41 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 120 (281)
T 1mp8_A 41 NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL 120 (281)
T ss_dssp -CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHH
T ss_pred CCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHH
Confidence 3467899999763 345677999999999999999998 456678999999999999999998666788888777
Q ss_pred HHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCC
Q 042809 77 YTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD 150 (241)
Q Consensus 77 ~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 150 (241)
++.|+ ||++|++||||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+..++
T Consensus 121 ~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~ 195 (281)
T 1mp8_A 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-----YKASKGKLPIKWMAPESINFRRFT 195 (281)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------------------CCGGGCCHHHHHHCCCS
T ss_pred HHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccc-----cccccCCCcccccChhhcccCCCC
Confidence 76655 7999999999999999999999999999999976543211 111223467789999999988999
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 151 FATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 151 ~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
.++||||||+++|++++ |..||.+.......... ........+..+++.+.+++.+||+.+|.+|||+.+++++
T Consensus 196 ~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 196 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH---HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999997 99999876544433222 2334455677788999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=267.09 Aligned_cols=225 Identities=15% Similarity=0.207 Sum_probs=176.8
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
++.+|+.||+|.+......+.+.+|+.++..+ .|+|++. ......++||||+ +++|.+++...+..++...+.
T Consensus 31 ~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~ 109 (298)
T 1csn_A 31 NLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVA 109 (298)
T ss_dssp ETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHH
T ss_pred ECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHH
Confidence 46789999999988666667789999999999 6888877 5677899999999 899999999876778988888
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecCCC-----eeecCCCcchhhcccccCCcc-ccccccccCcccccCccc
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGD-----VKLPDLGCARRVNDLKNNGNL-KQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~-----~kl~dfg~~~~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~ 143 (241)
.++.|+ ||++|++||||||+||+++.++. ++|+|||++............ ........|++.|+|||.
T Consensus 110 ~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 189 (298)
T 1csn_A 110 MAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 189 (298)
T ss_dssp HHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred HHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchh
Confidence 887765 79999999999999999988776 999999999865442221111 112344568999999999
Q ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHH----HHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC
Q 042809 144 LRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATL----LKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219 (241)
Q Consensus 144 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 219 (241)
+.+..++.++||||||+++|++++|+.||........... .........+.....+++.+.+++.+||+.+|.+||
T Consensus 190 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP 269 (298)
T 1csn_A 190 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATP 269 (298)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC
T ss_pred hcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCC
Confidence 9999999999999999999999999999976432222111 111111111222335678999999999999999999
Q ss_pred ChHHHhcC
Q 042809 220 SAEELLNH 227 (241)
Q Consensus 220 s~~~~l~~ 227 (241)
|++++++.
T Consensus 270 ~~~~l~~~ 277 (298)
T 1csn_A 270 DYDYLQGL 277 (298)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=261.12 Aligned_cols=216 Identities=22% Similarity=0.324 Sum_probs=176.5
Q ss_pred CCCcEEEEEeccchH-HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHH
Q 042809 4 GTGALFVVKSAESEA-GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLY 77 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 77 (241)
.++..||+|.+.... ..+.+.+|+.++.+++||||++ ..+...++||||+++++|.+++...+..+++..+..+
T Consensus 30 ~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i 109 (268)
T 3sxs_A 30 KGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM 109 (268)
T ss_dssp TTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHH
T ss_pred cCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHH
Confidence 356789999987543 4567899999999999999998 6777899999999999999999987667888888877
Q ss_pred HHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+.|+ ||+.|++||||||+||+++.++.++|+|||.+....... ........+++.|+|||.+.+..++.
T Consensus 110 ~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~ 184 (268)
T 3sxs_A 110 CYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-----YVSSVGTKFPVKWSAPEVFHYFKYSS 184 (268)
T ss_dssp HHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-----EEECCSCCCCGGGCCHHHHHHSEEET
T ss_pred HHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh-----hhcccCCCcCcccCCHHHHhccCCch
Confidence 7755 799999999999999999999999999999997543311 11122334567899999999888999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
++|+||||+++|++++ |..||......... ...........+...++.+.+++.+||+.+|.+|||+++++++
T Consensus 185 ~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVV---LKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp THHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---HHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred hhhhHHHHHHHHHHHcCCCCCccccChHHHH---HHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999 99999765443332 2223344445566678899999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=271.80 Aligned_cols=221 Identities=24% Similarity=0.389 Sum_probs=172.3
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.+|+.||+|.+.. ....+.+.+|+.++++++||||++ ..+...++||||+++++|.+++......+++..+
T Consensus 31 ~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 110 (310)
T 3s95_A 31 HRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQR 110 (310)
T ss_dssp ETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHH
T ss_pred ECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHH
Confidence 567899999998653 455678999999999999999998 5678899999999999999999987778888887
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCc--------cccccccccCcccccC
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGN--------LKQSWQSIGGTQLWMA 140 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~a 140 (241)
..++.|+ ||++|++||||||+||+++.++.+||+|||++........... .........||+.|+|
T Consensus 111 ~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 190 (310)
T 3s95_A 111 VSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190 (310)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCC
T ss_pred HHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeC
Confidence 7776655 7999999999999999999999999999999976543221110 0011124568999999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHH---HHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCC
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAA---TLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEK 217 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 217 (241)
||.+.+..++.++||||||+++|++++|..||......... ....... ...+..+++.+.+++.+||+.+|.+
T Consensus 191 PE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~ 266 (310)
T 3s95_A 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD----RYCPPNCPPSFFPITVRCCDLDPEK 266 (310)
T ss_dssp HHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGG
T ss_pred HHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc----ccCCCCCCHHHHHHHHHHccCChhh
Confidence 99999999999999999999999999999998653221110 0001011 1123455667999999999999999
Q ss_pred CCChHHHhc
Q 042809 218 RWSAEELLN 226 (241)
Q Consensus 218 Rps~~~~l~ 226 (241)
|||++++++
T Consensus 267 Rps~~~l~~ 275 (310)
T 3s95_A 267 RPSFVKLEH 275 (310)
T ss_dssp SCCHHHHHH
T ss_pred CcCHHHHHH
Confidence 999999876
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=269.67 Aligned_cols=221 Identities=23% Similarity=0.326 Sum_probs=170.1
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCC------ceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGE------KTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~------~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
|+.+|+.||||.+.. +...+.+.+|+.+++.++||||++ ... ...|+||||+. ++|.+++.
T Consensus 45 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--- 120 (353)
T 3coi_A 45 DKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--- 120 (353)
T ss_dssp ETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT---
T ss_pred ECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc---
Confidence 567899999999763 344677899999999999999988 222 24599999997 68888774
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..+++..+..++.|+ ||++|++||||+|+||+++.++.+||+|||++...... .....+++.|+|
T Consensus 121 ~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~---------~~~~~~t~~y~a 191 (353)
T 3coi_A 121 LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---------MTGYVVTRWYRA 191 (353)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----------------CCSBCCSC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC---------ccccccCcCcCC
Confidence 347787777776655 79999999999999999999999999999999754321 123457999999
Q ss_pred cccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhc---------------------------CCC
Q 042809 141 PEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACS---------------------------NEK 192 (241)
Q Consensus 141 PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------------------~~~ 192 (241)
||.+.+ ..++.++||||||+++|+|++|..||.+............... ...
T Consensus 192 PE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (353)
T 3coi_A 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF 271 (353)
T ss_dssp HHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCT
T ss_pred HHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccH
Confidence 999977 6788999999999999999999999977543322222111100 001
Q ss_pred CCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 193 PHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 193 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.......+..+.+|+.+||..+|.+|||++++++||||+....
T Consensus 272 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 272 TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence 1223456789999999999999999999999999999986544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=279.28 Aligned_cols=223 Identities=23% Similarity=0.353 Sum_probs=167.7
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc-----------cCCceeeeeecccCCCCHHHHHHH---hCC
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----------NGEKTVNIFMEYMAGGSLLDVAEK---FGG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~-----------~~~~~~~lv~e~~~~~~L~~~l~~---~~~ 67 (241)
++.+|+.||||.+.... ....+|+++++.++||||++ .....+++||||+++ +|.+.+.. ...
T Consensus 75 ~~~~~~~vaiK~~~~~~--~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~ 151 (420)
T 1j1b_A 75 LCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 151 (420)
T ss_dssp ETTTCCEEEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTC
T ss_pred ECCCCcEEEEEEecccc--hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccC
Confidence 46789999999987542 23457999999999999987 123357899999975 77666553 356
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecC-CCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH-GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
.++...+..++.|+ ||++|++||||||+||+++.+ +.+||+|||++....... ......+++.|+|
T Consensus 152 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~-------~~~~~~~t~~y~a 224 (420)
T 1j1b_A 152 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-------PNVSYICSRYYRA 224 (420)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-------CCCSCCSCTTSCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC-------CceeeeeCCCcCC
Confidence 78888777776655 799999999999999999965 568999999997543311 1123457999999
Q ss_pred ccccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhc-----------C--CCCC------------
Q 042809 141 PEVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACS-----------N--EKPH------------ 194 (241)
Q Consensus 141 PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------~--~~~~------------ 194 (241)
||.+.+. .++.++|||||||++|+|++|+.||.+.........+..... . ....
T Consensus 225 PE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 304 (420)
T 1j1b_A 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 304 (420)
T ss_dssp HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHH
T ss_pred HHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHh
Confidence 9999764 689999999999999999999999977543322211111100 0 0000
Q ss_pred CChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 195 FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 195 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
++...+.++.+||++||..+|.+|||+.++++||||+...
T Consensus 305 ~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 305 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred cCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 2234578999999999999999999999999999997543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=268.12 Aligned_cols=223 Identities=26% Similarity=0.394 Sum_probs=180.7
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
+..+|+.||+|.+.. ....+.+.+|++++++++||||++ ......++||||+++++|.+++......++..
T Consensus 48 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 127 (327)
T 3lxl_A 48 GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS 127 (327)
T ss_dssp SSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHH
T ss_pred CCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHH
Confidence 577899999999874 344567999999999999999988 35677999999999999999998866678888
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||+.|++||||||+||+++.++.++|+|||++........ .........+++.|+|||.+.+
T Consensus 128 ~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~ 204 (327)
T 3lxl_A 128 RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD---YYVVREPGQSPIFWYAPESLSD 204 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCS---EEECSSCCCSCGGGSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCc---cceeeccCCccccccCHHHhcc
Confidence 888777655 7999999999999999999999999999999976533111 1111223457888999999999
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhc------------hHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccC
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISN------------AAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 214 (241)
..++.++||||||+++|++++|..||...... .................+..+++.+.+++.+||+.+
T Consensus 205 ~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 284 (327)
T 3lxl_A 205 NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPS 284 (327)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCC
Confidence 88999999999999999999999998654332 112233334445556667788899999999999999
Q ss_pred CCCCCChHHHhcC
Q 042809 215 PEKRWSAEELLNH 227 (241)
Q Consensus 215 p~~Rps~~~~l~~ 227 (241)
|.+|||+++++++
T Consensus 285 P~~Rps~~ell~~ 297 (327)
T 3lxl_A 285 PQDRPSFSALGPQ 297 (327)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=282.51 Aligned_cols=213 Identities=16% Similarity=0.174 Sum_probs=159.6
Q ss_pred CCCCCcEEEEEecc-----chHHHHHHHHHH---HHHhhcCCCccccc------------------------CCc-----
Q 042809 2 NKGTGALFVVKSAE-----SEAGVQALRNEA---EIRQSLNSPNIGRN------------------------GEK----- 44 (241)
Q Consensus 2 ~~~~~~~vaiK~~~-----~~~~~~~~~~e~---~~l~~l~h~~i~~~------------------------~~~----- 44 (241)
++.+|+.||||++. .....+.+.+|+ .++++++||||++. .++
T Consensus 94 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 173 (377)
T 3byv_A 94 DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 173 (377)
T ss_dssp C-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEE
T ss_pred ECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEE
Confidence 56789999999975 334567899999 55556679999761 111
Q ss_pred eeeeeecccCCCCHHHHHHHhCCCCC------HHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCc
Q 042809 45 TVNIFMEYMAGGSLLDVAEKFGGTLD------AGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGC 112 (241)
Q Consensus 45 ~~~lv~e~~~~~~L~~~l~~~~~~~~------~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~ 112 (241)
..|+||||+ +|+|.+++...+.... ...+..++. ++||++|++||||||+||+++.++.+||+|||+
T Consensus 174 ~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~ 252 (377)
T 3byv_A 174 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 252 (377)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGG
T ss_pred EEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechh
Confidence 388999999 5799999987422111 244444444 448999999999999999999999999999999
Q ss_pred chhhcccccCCccccccccccCcccccCccccccc-----------CCCchhhHHHHHHHHHHHHhCCCCCccchhchHH
Q 042809 113 ARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE-----------GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAA 181 (241)
Q Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 181 (241)
+..... ......| +.|+|||.+.+. .++.++||||||+++|+|++|..||.+.......
T Consensus 253 a~~~~~---------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~ 322 (377)
T 3byv_A 253 LVRDGA---------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS 322 (377)
T ss_dssp CEETTC---------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCS
T ss_pred heecCC---------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccch
Confidence 974322 1223457 899999999887 8999999999999999999999999664322111
Q ss_pred HHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCC
Q 042809 182 TLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~ 233 (241)
.. .......+++++.+||.+||+.+|.+|||+.++++||||+..
T Consensus 323 ~~--------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 323 EW--------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp GG--------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred hh--------hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 10 011124567789999999999999999999999999999753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=271.38 Aligned_cols=217 Identities=21% Similarity=0.343 Sum_probs=177.5
Q ss_pred CCCcEEEEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC--------
Q 042809 4 GTGALFVVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-------- 66 (241)
Q Consensus 4 ~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-------- 66 (241)
.++..||+|.+.. ......+.+|+++++++ +||||++ ..++..++||||+++|+|.+++....
T Consensus 99 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 178 (382)
T 3tt0_A 99 NRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 178 (382)
T ss_dssp TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCC
T ss_pred ccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhccccccccc
Confidence 4557899999874 34457789999999999 8999998 66778999999999999999999854
Q ss_pred -------CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCcccccccccc
Q 042809 67 -------GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIG 133 (241)
Q Consensus 67 -------~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 133 (241)
..+++..+..++.|+ ||++|++||||||+||+++.++.+||+|||++........ ........
T Consensus 179 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~----~~~~~~~~ 254 (382)
T 3tt0_A 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY----YKKTTNGR 254 (382)
T ss_dssp CCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCT----TCCCTTCC
T ss_pred ccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccc----cccccCCC
Confidence 347888887777655 7999999999999999999999999999999975543211 11122344
Q ss_pred CcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhc
Q 042809 134 GTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLE 212 (241)
Q Consensus 134 ~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 212 (241)
+++.|+|||.+.+..++.++||||||+++|++++ |..||.+...... ............+..++.++.+++.+||+
T Consensus 255 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 331 (382)
T 3tt0_A 255 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL---FKLLKEGHRMDKPSNCTNELYMMMRDCWH 331 (382)
T ss_dssp CGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHHHTTCCCCCCSSCCHHHHHHHHHHTC
T ss_pred CCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCCCCCCccCCHHHHHHHHHHcC
Confidence 6788999999999999999999999999999999 9999987544333 33333444556667788899999999999
Q ss_pred cCCCCCCChHHHhcC
Q 042809 213 RKPEKRWSAEELLNH 227 (241)
Q Consensus 213 ~~p~~Rps~~~~l~~ 227 (241)
.+|.+|||+++++++
T Consensus 332 ~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 332 AVPSQRPTFKQLVED 346 (382)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=274.45 Aligned_cols=224 Identities=21% Similarity=0.357 Sum_probs=170.5
Q ss_pred CCCCCcEEEEEeccch-HHHHHHHHHHHHHhhcC-CCc-----ccc-----cCCceeeeeecccCCCCHHHHHHHhC-CC
Q 042809 2 NKGTGALFVVKSAESE-AGVQALRNEAEIRQSLN-SPN-----IGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~-h~~-----i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~ 68 (241)
++.+|+.||||++... .....+.+|+.++..+. |++ |+. ...+..++||||+. ++|.+++.... ..
T Consensus 75 ~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~ 153 (382)
T 2vx3_A 75 DRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRG 153 (382)
T ss_dssp ETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSC
T ss_pred EcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCC
Confidence 5678999999998754 34567888999999886 665 554 45678999999996 59999998753 45
Q ss_pred CCHHHHHHHHHHH------hh--cCCccccCCCCCcEEeec--CCCeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 69 LDAGVIRLYTKEI------LH--GNGILHCDLKCNNVLLGS--HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh--~~~~vH~dl~p~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
++...+..++.|+ || +.|++||||||+||+++. ++.+||+|||++...... .....|++.|
T Consensus 154 ~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~---------~~~~~~t~~y 224 (382)
T 2vx3_A 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR---------IYQYIQSRFY 224 (382)
T ss_dssp CCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC---------CCSSCSCGGG
T ss_pred CCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc---------cccccCCccc
Confidence 7888877777655 67 579999999999999954 678999999999765331 1234689999
Q ss_pred cCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC-------------------------
Q 042809 139 MAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP------------------------- 193 (241)
Q Consensus 139 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------------- 193 (241)
+|||.+.+..++.++||||||+++|+|++|+.||.+...................
T Consensus 225 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (382)
T 2vx3_A 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKK 304 (382)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECC
T ss_pred cChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhcccccccccc
Confidence 9999999999999999999999999999999999875443332222211110000
Q ss_pred -----------------------------------CCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 194 -----------------------------------HFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 194 -----------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.......+.+.+||++||+.||.+|||++++|+||||+....
T Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 305 TKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381 (382)
T ss_dssp CCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC---
T ss_pred ccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccCCC
Confidence 000112247899999999999999999999999999987653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=271.34 Aligned_cols=217 Identities=22% Similarity=0.322 Sum_probs=165.3
Q ss_pred CCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 4 GTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 4 ~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
+++..||||.+.. +...+.+.+|+.++.+++||||++ ......++||||+++++|.+++...+..++...+.
T Consensus 71 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 150 (373)
T 2qol_A 71 KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150 (373)
T ss_dssp SCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHH
T ss_pred CCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHH
Confidence 5688899999863 445677999999999999999998 56778999999999999999999866678888877
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCC
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL 149 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 149 (241)
.++.|+ ||++|++||||||+||+++.++.+||+|||++.......... .......+++.|+|||.+.+..+
T Consensus 151 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~ 227 (373)
T 2qol_A 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA---YTTRGGKIPIRWTSPEAIAYRKF 227 (373)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------------------CTTSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccc---eeccCCCcCCCccChhhhccCCc
Confidence 776654 799999999999999999999999999999997654321111 11112234678999999999999
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 150 DFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
+.++||||||+++|++++ |..||........... .........+..++..+.+++.+||+.+|.+|||++++++
T Consensus 228 ~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~---i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 228 TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA---VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH---HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 999999999999999998 9999977544333222 2223334445667889999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=263.96 Aligned_cols=222 Identities=26% Similarity=0.400 Sum_probs=176.7
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
+..+|+.||+|.+... ...+.+.+|+.+++.++||||++ ......++||||+++++|.+++......++.
T Consensus 46 ~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 125 (302)
T 4e5w_A 46 GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL 125 (302)
T ss_dssp SSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCH
T ss_pred cCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCH
Confidence 5678999999998743 23577899999999999999988 2336789999999999999999877778888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.++.++|+|||++........ .........++..|+|||.+.
T Consensus 126 ~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~ 202 (302)
T 4e5w_A 126 KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE---YYTVKDDRDSPVFWYAPECLM 202 (302)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCC---EEECCCCTTCCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCc---ceeccCCCCCCccccCCeeec
Confidence 8887777655 7999999999999999999999999999999976543211 111223345788899999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccch------------hchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhcc
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKI------------SNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLER 213 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 213 (241)
+..++.++|+||||+++|++++|..|+.... ...................+..+++.+.+++.+||+.
T Consensus 203 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 282 (302)
T 4e5w_A 203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEF 282 (302)
T ss_dssp HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred CCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCC
Confidence 9889999999999999999999998864321 1122233333444555666778889999999999999
Q ss_pred CCCCCCChHHHhc
Q 042809 214 KPEKRWSAEELLN 226 (241)
Q Consensus 214 ~p~~Rps~~~~l~ 226 (241)
+|.+|||++++++
T Consensus 283 dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 283 QPSNRTSFQNLIE 295 (302)
T ss_dssp SGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHH
Confidence 9999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=260.13 Aligned_cols=217 Identities=24% Similarity=0.344 Sum_probs=174.1
Q ss_pred CCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 3 KGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
..++..||+|.+... ...+.+.+|+.++++++||||++ ..++..++||||+.+++|.+++......++...+.
T Consensus 37 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~ 116 (281)
T 3cc6_A 37 KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLV 116 (281)
T ss_dssp TCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHHTTTCCHHHHH
T ss_pred CCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEEEecCCCCCHHHHHHhccccCCHHHHH
Confidence 345667999998743 45677999999999999999998 44566799999999999999998877778888877
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCC
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL 149 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 149 (241)
.++.|+ ||++|++|+||+|+||+++.++.++|+|||++........ .......+++.|+|||.+.+..+
T Consensus 117 ~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~ 191 (281)
T 3cc6_A 117 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-----YKASVTRLPIKWMSPESINFRRF 191 (281)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--------------CCCCCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccc-----cccccCCCCcceeCchhhccCCC
Confidence 776654 7999999999999999999999999999999976543211 11123346788999999998889
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 150 DFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
+.++||||||+++|++++ |..||............. .......+..+++.+.+++.+||+.+|.+|||+++++++
T Consensus 192 ~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 192 TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE---KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH---HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh---cCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 999999999999999998 999997654444433332 233444566678899999999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=268.25 Aligned_cols=226 Identities=23% Similarity=0.322 Sum_probs=168.9
Q ss_pred CCCCCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCccccc------------CCceeeeeecccCCCCHHHHHHH---h
Q 042809 2 NKGTGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGRN------------GEKTVNIFMEYMAGGSLLDVAEK---F 65 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~------------~~~~~~lv~e~~~~~~L~~~l~~---~ 65 (241)
++.+|+.||||.+... .......+++..+..++||||++. .....++||||+++ +|...+.. .
T Consensus 44 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~ 122 (360)
T 3e3p_A 44 EKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR 122 (360)
T ss_dssp ETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTT
T ss_pred ECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhc
Confidence 5678999999987643 334557788888899999999881 12238899999975 66555443 2
Q ss_pred CCCCCHHHHHHHHHHH------hh--cCCccccCCCCCcEEeec-CCCeeecCCCcchhhcccccCCccccccccccCcc
Q 042809 66 GGTLDAGVIRLYTKEI------LH--GNGILHCDLKCNNVLLGS-HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQ 136 (241)
Q Consensus 66 ~~~~~~~~~~~~~~~~------Lh--~~~~vH~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (241)
...++...+..++.|+ || +.|++||||||+||+++. ++.+||+|||++....... ......|++
T Consensus 123 ~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~gt~ 195 (360)
T 3e3p_A 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE-------PNVAYICSR 195 (360)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS-------CCCSTTSCG
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC-------CcccccCCc
Confidence 4567777766666544 78 999999999999999997 8999999999997654311 122345799
Q ss_pred cccCcccccccC-CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC------------------------
Q 042809 137 LWMAPEVLRNEG-LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE------------------------ 191 (241)
Q Consensus 137 ~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------ 191 (241)
.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.................
T Consensus 196 ~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
T 3e3p_A 196 YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIP 275 (360)
T ss_dssp GGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCC
T ss_pred ceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCC
Confidence 999999997654 7999999999999999999999998754433332222111100
Q ss_pred ----CCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 192 ----KPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 192 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
....+...+..+.+|+.+||+.||.+|||+.++++||||+....
T Consensus 276 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 276 WSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred cccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 01122235678999999999999999999999999999987654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=263.98 Aligned_cols=220 Identities=19% Similarity=0.281 Sum_probs=178.7
Q ss_pred CCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 3 KGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 3 ~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
..++..||+|.+.. ....+.+.+|+.++++++||||++ ...+..++||||+++++|.+++......++...+.
T Consensus 34 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 113 (287)
T 1u59_A 34 RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA 113 (287)
T ss_dssp --CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHH
T ss_pred CCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHH
Confidence 45788999999874 345678999999999999999998 34556999999999999999998766778888888
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCC
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL 149 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 149 (241)
.++.|+ ||+.|++||||+|+||+++.++.++|+|||++........ .........+++.|+|||.+.+..+
T Consensus 114 ~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~ 190 (287)
T 1u59_A 114 ELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS---YYTARSAGKWPLKWYAPECINFRKF 190 (287)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC---EECCCCSSCCCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc---eeeccccccccccccCHHHhccCCC
Confidence 877765 7999999999999999999999999999999976533111 0111223346788999999998889
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCC
Q 042809 150 DFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHT 228 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p 228 (241)
+.++|+||||+++|++++ |..||......... ........+..+..+++.+.+++.+||+.+|.+|||+.+++++.
T Consensus 191 ~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH---HHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 999999999999999998 99999775443332 22333445566778889999999999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=270.97 Aligned_cols=226 Identities=25% Similarity=0.390 Sum_probs=173.0
Q ss_pred CCCCCcEEEEEeccch-HHHHHHHHHHHHHhhcC-----------CCcccc---------cCCceeeeeecccCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE-AGVQALRNEAEIRQSLN-----------SPNIGR---------NGEKTVNIFMEYMAGGSLLD 60 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~-----------h~~i~~---------~~~~~~~lv~e~~~~~~L~~ 60 (241)
|+.+|+.||+|.+... ...+.+.+|+.++.++. ||||++ ......++||||+ +++|.+
T Consensus 40 ~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~ 118 (373)
T 1q8y_A 40 DMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLA 118 (373)
T ss_dssp ETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHH
T ss_pred ecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHH
Confidence 5678999999998844 34567889999999887 789987 1334899999999 889999
Q ss_pred HHHHh-CCCCCHHHHHHHHHHH------hhcC-CccccCCCCCcEEeecC------CCeeecCCCcchhhcccccCCccc
Q 042809 61 VAEKF-GGTLDAGVIRLYTKEI------LHGN-GILHCDLKCNNVLLGSH------GDVKLPDLGCARRVNDLKNNGNLK 126 (241)
Q Consensus 61 ~l~~~-~~~~~~~~~~~~~~~~------Lh~~-~~vH~dl~p~Nil~~~~------~~~kl~dfg~~~~~~~~~~~~~~~ 126 (241)
++... ...++...+..++.|+ ||++ |++||||||+||+++.+ +.+||+|||++......
T Consensus 119 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~------- 191 (373)
T 1q8y_A 119 LIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH------- 191 (373)
T ss_dssp HHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-------
T ss_pred HHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-------
Confidence 99874 3457887777776655 7998 99999999999999644 36999999999755431
Q ss_pred cccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhc-------hHHHHHHHHh-----------
Q 042809 127 QSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISN-------AAATLLKIAC----------- 188 (241)
Q Consensus 127 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~----------- 188 (241)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ....+.....
T Consensus 192 --~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 269 (373)
T 1q8y_A 192 --YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGK 269 (373)
T ss_dssp --CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCT
T ss_pred --CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccc
Confidence 12345899999999999999999999999999999999999999754321 1111111000
Q ss_pred --------------------------cCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCccC
Q 042809 189 --------------------------SNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKN 237 (241)
Q Consensus 189 --------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~~ 237 (241)
......++...+..+.+||.+||+.||.+|||++++++||||+.....+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 344 (373)
T 1q8y_A 270 YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 344 (373)
T ss_dssp THHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCT
T ss_pred hhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccCcc
Confidence 0011234567788999999999999999999999999999999875543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=261.34 Aligned_cols=216 Identities=23% Similarity=0.344 Sum_probs=176.8
Q ss_pred CCCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHH
Q 042809 4 GTGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLY 77 (241)
Q Consensus 4 ~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 77 (241)
.++..||+|.+... ...+.+.+|++++++++||||++ ......++||||+++++|.+++......++...+..+
T Consensus 46 ~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i 125 (283)
T 3gen_A 46 RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM 125 (283)
T ss_dssp TTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHH
T ss_pred cCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHH
Confidence 35678999998743 23567899999999999999998 6677899999999999999999876667888888877
Q ss_pred HHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+.|+ ||++|++||||||+||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.
T Consensus 126 ~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~ 200 (283)
T 3gen_A 126 CKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-----TSSVGSKFPVRWSPPEVLMYSKFSS 200 (283)
T ss_dssp HHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-----HSTTSTTSCGGGCCHHHHHHCCCSH
T ss_pred HHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc-----ccccCCccCcccCCHHHhccCCCCc
Confidence 7655 7999999999999999999999999999999975533211 1112234677899999999989999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
++|+||||+++|++++ |..||.......... ..........+...++.+.+++.+||+.+|.+|||+++++++
T Consensus 201 ~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAE---HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH---HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCccccChhHHHH---HHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 9999999999999998 999998754433332 223334445566678899999999999999999999999876
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=276.42 Aligned_cols=210 Identities=26% Similarity=0.396 Sum_probs=173.1
Q ss_pred CCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHhCCC-CCHHHHHHH
Q 042809 5 TGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGGT-LDAGVIRLY 77 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~ 77 (241)
+|+.||||.+......+.+.+|+.++++++||||++ ......++||||+++|+|.+++...+.. ++...+..+
T Consensus 215 ~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 294 (450)
T 1k9a_A 215 RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 294 (450)
T ss_dssp TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHH
T ss_pred cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHH
Confidence 477999999987767788999999999999999988 3445799999999999999999986543 577776666
Q ss_pred HHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+.|+ ||++|++||||+|+||+++.++.+||+|||++...... .....+++.|+|||.+.+..++.
T Consensus 295 ~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~ 365 (450)
T 1k9a_A 295 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---------QDTGKLPVKWTAPEALREKKFST 365 (450)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---------------CCCTTTSCHHHHHSSCCCH
T ss_pred HHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---------ccCCCCCcceeCHHHhcCCCCCc
Confidence 6544 89999999999999999999999999999998743221 11224678899999999999999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++||||||+++|+|++ |..||........... ...+.....+..+++.+.++|.+||+.+|.+|||+.++++
T Consensus 366 ~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~---i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 366 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH---HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999998 9999987654443332 2234455667788899999999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=268.44 Aligned_cols=232 Identities=25% Similarity=0.372 Sum_probs=172.8
Q ss_pred CCCCCcEEEEEecc--chHHHHHHHHHHHHHhhcCCCccccc-------------------CCceeeeeecccCCCCHHH
Q 042809 2 NKGTGALFVVKSAE--SEAGVQALRNEAEIRQSLNSPNIGRN-------------------GEKTVNIFMEYMAGGSLLD 60 (241)
Q Consensus 2 ~~~~~~~vaiK~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-------------------~~~~~~lv~e~~~~~~L~~ 60 (241)
++.+|+.||+|.+. .....+.+.+|+.++++++||||++. .....++||||++ |+|.+
T Consensus 32 ~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~ 110 (320)
T 2i6l_A 32 DNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLAN 110 (320)
T ss_dssp ETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHH
T ss_pred ECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHH
Confidence 56789999999876 34456789999999999999999871 2367899999997 69999
Q ss_pred HHHHhCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEee-cCCCeeecCCCcchhhcccccCCcccccccccc
Q 042809 61 VAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG-SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIG 133 (241)
Q Consensus 61 ~l~~~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 133 (241)
++.. ..++...+..++.|+ ||++|++||||||+||+++ .++.+||+|||++......... ........
T Consensus 111 ~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~ 185 (320)
T 2i6l_A 111 VLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH---KGHLSEGL 185 (320)
T ss_dssp HHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC-----------CCCGGG
T ss_pred Hhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCccc---cccccccc
Confidence 9874 567787777776655 7999999999999999997 4668999999999765331111 11122345
Q ss_pred CcccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhc---------------------CC
Q 042809 134 GTQLWMAPEVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACS---------------------NE 191 (241)
Q Consensus 134 ~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------------~~ 191 (241)
+++.|+|||.+.+ ..++.++||||||+++|++++|..||.+............... ..
T Consensus 186 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (320)
T 2i6l_A 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMT 265 (320)
T ss_dssp SCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTT
T ss_pred ccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCccccccccc
Confidence 6889999998865 6789999999999999999999999976543322221111100 00
Q ss_pred CCC-----CChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCccCCC
Q 042809 192 KPH-----FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKNST 239 (241)
Q Consensus 192 ~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~~~~ 239 (241)
.+. ....++..+.+++++||+.+|.+|||++++++||||+...-..++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~~ 318 (320)
T 2i6l_A 266 EPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDE 318 (320)
T ss_dssp SCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC----
T ss_pred CCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccCC
Confidence 011 113467889999999999999999999999999999876655443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=264.00 Aligned_cols=218 Identities=21% Similarity=0.335 Sum_probs=176.2
Q ss_pred CCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC-------
Q 042809 3 KGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG------- 67 (241)
Q Consensus 3 ~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~------- 67 (241)
+.+++.||+|.+.. ....+.+.+|+.++++++||||++ ...+..++||||+++++|.+++.....
T Consensus 50 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 129 (314)
T 2ivs_A 50 RAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129 (314)
T ss_dssp CSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC-
T ss_pred ccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCccc
Confidence 35678999999874 345677899999999999999998 567789999999999999999987432
Q ss_pred ----------------CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCcc
Q 042809 68 ----------------TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNL 125 (241)
Q Consensus 68 ----------------~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 125 (241)
.++...+..++.|+ ||++|++||||||+||+++.++.++|+|||++........
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~---- 205 (314)
T 2ivs_A 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS---- 205 (314)
T ss_dssp ---------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSC----
T ss_pred ccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEcccccccccccccc----
Confidence 36777776666654 7999999999999999999999999999999875433111
Q ss_pred ccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHH
Q 042809 126 KQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVL 204 (241)
Q Consensus 126 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (241)
........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.......... ........+..+++.+.
T Consensus 206 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 282 (314)
T 2ivs_A 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL---KTGHRMERPDNCSEEMY 282 (314)
T ss_dssp EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---HTTCCCCCCTTCCHHHH
T ss_pred ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHh---hcCCcCCCCccCCHHHH
Confidence 111223346788999999999889999999999999999999 99999876554443332 23344556677889999
Q ss_pred HHHHHhhccCCCCCCChHHHhcC
Q 042809 205 DFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 205 ~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
+++.+||+.+|.+|||+++++++
T Consensus 283 ~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 283 RLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999865
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=263.66 Aligned_cols=224 Identities=25% Similarity=0.356 Sum_probs=173.9
Q ss_pred CCCcEEEEEeccchH----HHHHHHHHHHHHhhc---CCCcccc-----c-----CCceeeeeecccCCCCHHHHHHHhC
Q 042809 4 GTGALFVVKSAESEA----GVQALRNEAEIRQSL---NSPNIGR-----N-----GEKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l---~h~~i~~-----~-----~~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
.+|+.||+|.+.... ....+.+|+.+++.+ .||||++ . .....++||||+. ++|.+++....
T Consensus 35 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~ 113 (326)
T 1blx_A 35 NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP 113 (326)
T ss_dssp TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSC
T ss_pred CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcc
Confidence 578999999876321 123566787777766 8999988 1 5678999999997 69999998753
Q ss_pred -CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccccc
Q 042809 67 -GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139 (241)
Q Consensus 67 -~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (241)
..++...+..++.|+ ||++|++|+||+|+||+++.++.++|+|||++...... .......+++.|+
T Consensus 114 ~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~~~~y~ 186 (326)
T 1blx_A 114 EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-------MALTSVVVTLWYR 186 (326)
T ss_dssp TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG-------GGGCCCCCCCTTC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCC-------CCcccccccccee
Confidence 347888877777655 79999999999999999999999999999999754331 1223456899999
Q ss_pred CcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC-----------------------CCCCC
Q 042809 140 APEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE-----------------------KPHFP 196 (241)
Q Consensus 140 aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~ 196 (241)
|||.+.+..++.++||||||+++|++++|..||.+................. .....
T Consensus 187 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (326)
T 1blx_A 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV 266 (326)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTC
T ss_pred CHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhcc
Confidence 9999999889999999999999999999999998755433322222111100 00122
Q ss_pred hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 197 TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 197 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
..++..+.+|+.+||..+|.+|||+.++++||||+....
T Consensus 267 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 267 TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp CSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 456788999999999999999999999999999986543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=268.06 Aligned_cols=224 Identities=20% Similarity=0.311 Sum_probs=173.0
Q ss_pred CCCCC-cEEEEEeccch-HHHHHHHHHHHHHhhcCCCc------ccc-----cCCceeeeeecccCCCCHHHHHHHhC-C
Q 042809 2 NKGTG-ALFVVKSAESE-AGVQALRNEAEIRQSLNSPN------IGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-G 67 (241)
Q Consensus 2 ~~~~~-~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~------i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~ 67 (241)
++.++ ..||+|++... ...+.+.+|+.+++.++|++ ++. ...+..++||||+ +++|.+++.... .
T Consensus 40 ~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~ 118 (355)
T 2eu9_A 40 DHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQ 118 (355)
T ss_dssp ETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTC
T ss_pred ecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCC
Confidence 34555 79999998753 44577889999999998766 444 4567899999999 567777777643 5
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEe-------------------ecCCCeeecCCCcchhhcccccC
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLL-------------------GSHGDVKLPDLGCARRVNDLKNN 122 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~-------------------~~~~~~kl~dfg~~~~~~~~~~~ 122 (241)
.++...+..++.|+ ||++|++||||||+||++ +.++.+||+|||++.....
T Consensus 119 ~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---- 194 (355)
T 2eu9_A 119 PYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE---- 194 (355)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS----
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc----
Confidence 68888887777665 799999999999999999 5678899999999975332
Q ss_pred CccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCC----------
Q 042809 123 GNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK---------- 192 (241)
Q Consensus 123 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 192 (241)
......|++.|+|||.+.+..++.++||||||+++|+|++|..||...................+
T Consensus 195 -----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 269 (355)
T 2eu9_A 195 -----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQ 269 (355)
T ss_dssp -----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCG
T ss_pred -----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccch
Confidence 11234689999999999999999999999999999999999999987554433333222211110
Q ss_pred ------------------------------CCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 193 ------------------------------PHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 193 ------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.......+..+.+|+++||+.||.+|||++++++||||++...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 270 KYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTP 342 (355)
T ss_dssp GGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCH
T ss_pred hhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCCh
Confidence 0112234568999999999999999999999999999987543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=268.52 Aligned_cols=220 Identities=23% Similarity=0.277 Sum_probs=175.1
Q ss_pred CCCCcEEEEEeccch---HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCC-----
Q 042809 3 KGTGALFVVKSAESE---AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGT----- 68 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~----- 68 (241)
..++..||+|.+... ...+.+.+|+.++.++ .||||++ ...+..++||||+++|+|.+++......
T Consensus 72 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 151 (344)
T 1rjb_A 72 TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 151 (344)
T ss_dssp SSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC----
T ss_pred CCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccc
Confidence 456788999998743 3456789999999999 8999998 5677899999999999999999875432
Q ss_pred -----------------CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCcc
Q 042809 69 -----------------LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNL 125 (241)
Q Consensus 69 -----------------~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 125 (241)
++...+..++.|+ ||++|++||||||+||+++.++.++|+|||++........
T Consensus 152 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---- 227 (344)
T 1rjb_A 152 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN---- 227 (344)
T ss_dssp -----------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT----
T ss_pred cchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCcc----
Confidence 5666666666554 7999999999999999999999999999999976543211
Q ss_pred ccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHH
Q 042809 126 KQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVL 204 (241)
Q Consensus 126 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (241)
........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....... ............+...++.+.
T Consensus 228 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~ 305 (344)
T 1rjb_A 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF--YKLIQNGFKMDQPFYATEEIY 305 (344)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHHHHTTCCCCCCTTCCHHHH
T ss_pred ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHH--HHHHhcCCCCCCCCCCCHHHH
Confidence 111223446788999999999899999999999999999998 99999775433322 222233445556677889999
Q ss_pred HHHHHhhccCCCCCCChHHHhcCC
Q 042809 205 DFLAKCLERKPEKRWSAEELLNHT 228 (241)
Q Consensus 205 ~li~~~l~~~p~~Rps~~~~l~~p 228 (241)
+++.+||..+|.+|||+.+++++.
T Consensus 306 ~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 306 IIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHcCCCchhCcCHHHHHHHH
Confidence 999999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=275.97 Aligned_cols=226 Identities=23% Similarity=0.322 Sum_probs=162.4
Q ss_pred CCCCcEEEEEeccchHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC------
Q 042809 3 KGTGALFVVKSAESEAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD------ 70 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~------ 70 (241)
..+|+.||||.+..+. .+.+.+|+.++.++ +||||++ ......|+||||++ |+|.+++........
T Consensus 36 ~~~g~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~ 113 (434)
T 2rio_A 36 SFQGRPVAVKRMLIDF-CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQK 113 (434)
T ss_dssp ESSSSEEEEEEEEGGG-HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC-----------
T ss_pred EECCeEEEEEEEcHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhcc
Confidence 4578999999987543 46678999999887 7999998 67788999999996 699999986422111
Q ss_pred ------HHHHHHHHHHHhhcCCccccCCCCCcEEeecC-------------CCeeecCCCcchhhcccccCCcccccccc
Q 042809 71 ------AGVIRLYTKEILHGNGILHCDLKCNNVLLGSH-------------GDVKLPDLGCARRVNDLKNNGNLKQSWQS 131 (241)
Q Consensus 71 ------~~~~~~~~~~~Lh~~~~vH~dl~p~Nil~~~~-------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 131 (241)
.......+.++||++|++||||||+||+++.+ +.+||+|||++.......... ......
T Consensus 114 ~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~--~~~~~~ 191 (434)
T 2rio_A 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF--RTNLNN 191 (434)
T ss_dssp -CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC-------------
T ss_pred chhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccc--eeeecC
Confidence 11122223456899999999999999999764 379999999997654321110 111234
Q ss_pred ccCcccccCcccccc-------cCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcC--CCCCCChhhHH
Q 042809 132 IGGTQLWMAPEVLRN-------EGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSN--EKPHFPTQFFK 201 (241)
Q Consensus 132 ~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 201 (241)
..||+.|+|||.+.+ ..++.++||||||+++|+|++ |..||.+..... .......... .....+..++.
T Consensus 192 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~ 270 (434)
T 2rio_A 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-SNIIRGIFSLDEMKCLHDRSLIA 270 (434)
T ss_dssp ---CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-HHHHHTCCCCCCCTTCCCHHHHH
T ss_pred CCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-HHHhcCCCCcccccccccccchH
Confidence 568999999999976 568899999999999999999 999997643322 2222211111 11112346778
Q ss_pred HHHHHHHHhhccCCCCCCChHHHhcCCCCCCC
Q 042809 202 KVLDFLAKCLERKPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 202 ~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~ 233 (241)
++.+++.+||+.+|.+|||+.++++||||...
T Consensus 271 ~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 271 EATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred HHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 99999999999999999999999999999754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=269.76 Aligned_cols=223 Identities=17% Similarity=0.215 Sum_probs=175.3
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
++.+|+.||||.+......+.+.+|+.+++++ .||||++ ......++||||+ +++|.+++......+++..+.
T Consensus 30 ~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~ 108 (330)
T 2izr_A 30 NLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVL 108 (330)
T ss_dssp ETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHH
T ss_pred ECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHH
Confidence 46789999999988665566799999999999 8999988 5677899999999 899999999876788998888
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecCCC-----eeecCCCcchhhcccccCCc-cccccccccCcccccCccc
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGD-----VKLPDLGCARRVNDLKNNGN-LKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~-----~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~ 143 (241)
.++.|+ ||++|++||||||+||+++.++. ++|+|||++........... .........||+.|+|||.
T Consensus 109 ~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 188 (330)
T 2izr_A 109 MIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINT 188 (330)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred HHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHH
Confidence 887765 79999999999999999998887 99999999986543221111 1112245678999999999
Q ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHH----hcCCCCCCChhhHHHHHHHHHHhhccCCCCCC
Q 042809 144 LRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIA----CSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219 (241)
Q Consensus 144 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 219 (241)
+.+..++.++||||||+++|+|++|..||.+............. ............+ .+.+++.+||+.+|.+||
T Consensus 189 ~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP 267 (330)
T 2izr_A 189 HLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKP 267 (330)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCC
T ss_pred HcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999999999875433332222111 1111001112234 899999999999999999
Q ss_pred ChHHHhc
Q 042809 220 SAEELLN 226 (241)
Q Consensus 220 s~~~~l~ 226 (241)
+++++++
T Consensus 268 ~~~~l~~ 274 (330)
T 2izr_A 268 DYDYLRK 274 (330)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9998875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=273.36 Aligned_cols=222 Identities=24% Similarity=0.387 Sum_probs=163.3
Q ss_pred CCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc-----------cCCceeeeeecccCCCCHHHHHH---HhCCC
Q 042809 3 KGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----------NGEKTVNIFMEYMAGGSLLDVAE---KFGGT 68 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~-----------~~~~~~~lv~e~~~~~~L~~~l~---~~~~~ 68 (241)
+.++. +|+|.+.... ....+|+.+++.++||||++ .....+++||||+++ ++...+. .....
T Consensus 62 ~~~~~-~aikk~~~~~--~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~ 137 (394)
T 4e7w_A 62 VESDE-VAIKKVLQDK--RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQT 137 (394)
T ss_dssp TTTEE-EEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSC
T ss_pred CCCCe-EEEEEEecCc--chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCC
Confidence 34455 7777665332 22347999999999999988 223348899999976 4444333 22567
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEee-cCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG-SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
++...+..++.|+ ||++|++||||||+||+++ .++.+||+|||++....... ......+++.|+||
T Consensus 138 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~-------~~~~~~~t~~y~aP 210 (394)
T 4e7w_A 138 MPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE-------PNVSYICSRYYRAP 210 (394)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-------CCCSSCSCGGGCCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC-------CCcccccCcCccCH
Confidence 8888877777655 7999999999999999999 78999999999997543311 11234579999999
Q ss_pred cccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC----------------CCC---------CC
Q 042809 142 EVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN----------------EKP---------HF 195 (241)
Q Consensus 142 E~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------~~~---------~~ 195 (241)
|.+.+. .++.++||||+||++|+|++|+.||.+................ ..+ .+
T Consensus 211 E~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (394)
T 4e7w_A 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVF 290 (394)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHS
T ss_pred HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhc
Confidence 999764 5899999999999999999999999875433322222111100 000 02
Q ss_pred ChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 196 PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 196 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
+...++++.+|+.+||..+|.+|||+.++++||||+.-..
T Consensus 291 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 291 RPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred cccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 2346679999999999999999999999999999986544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=262.21 Aligned_cols=220 Identities=22% Similarity=0.308 Sum_probs=176.5
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC-----
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG----- 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~----- 67 (241)
+..+++.||+|.+... ...+.+.+|+.+++++ +||||++ ...+..++||||+++|+|.+++.....
T Consensus 49 ~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 128 (313)
T 1t46_A 49 KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128 (313)
T ss_dssp STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC---
T ss_pred ccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccc
Confidence 4678899999998743 3457799999999999 8999998 567789999999999999999987543
Q ss_pred ------------CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCcccccc
Q 042809 68 ------------TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSW 129 (241)
Q Consensus 68 ------------~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 129 (241)
.+++..+..++.|+ ||++|++||||||+||+++.++.++|+|||++........ ....
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~ 204 (313)
T 1t46_A 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN----YVVK 204 (313)
T ss_dssp -----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTT----SEEC
T ss_pred cccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEcccccccccccccc----ceec
Confidence 37777777776655 7999999999999999999999999999999976543211 1111
Q ss_pred ccccCcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHH
Q 042809 130 QSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLA 208 (241)
Q Consensus 130 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 208 (241)
....+++.|+|||.+.+..++.++||||||+++|+|++ |..||........... ..........+...+..+.+++.
T Consensus 205 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~ 282 (313)
T 1t46_A 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK--MIKEGFRMLSPEHAPAEMYDIMK 282 (313)
T ss_dssp SSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH--HHHHTCCCCCCTTSCHHHHHHHH
T ss_pred cCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH--HhccCCCCCCcccCCHHHHHHHH
Confidence 23346788999999999899999999999999999999 9999976543332222 22223334455667889999999
Q ss_pred HhhccCCCCCCChHHHhcC
Q 042809 209 KCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 209 ~~l~~~p~~Rps~~~~l~~ 227 (241)
+||+.+|.+|||+++++++
T Consensus 283 ~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 283 TCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCchhCcCHHHHHHH
Confidence 9999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=265.31 Aligned_cols=213 Identities=23% Similarity=0.340 Sum_probs=170.2
Q ss_pred EEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHH
Q 042809 8 LFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKE 80 (241)
Q Consensus 8 ~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 80 (241)
.||+|.+.. ....+.+.+|+.++++++||||++ ...+..++|+||+.+|+|.+++......++...+..++.|
T Consensus 46 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~q 125 (327)
T 3poz_A 46 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125 (327)
T ss_dssp EEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHH
T ss_pred EEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHH
Confidence 358887653 234577999999999999999998 2344588999999999999999987778888888777765
Q ss_pred H------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhh
Q 042809 81 I------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATD 154 (241)
Q Consensus 81 ~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 154 (241)
+ ||++|++||||||+||+++.++.+||+|||++........ ........+++.|+|||.+.+..++.++|
T Consensus 126 i~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 201 (327)
T 3poz_A 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK----EYHAEGGKVPIKWMALESILHRIYTHQSD 201 (327)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-----------CCCGGGSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc----cccccCCCccccccChHHhccCCCCchhh
Confidence 5 7999999999999999999999999999999986543211 11112334678899999999999999999
Q ss_pred HHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 155 IWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 155 i~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
|||||+++|++++ |..||.+........... .......+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 202 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 202 VWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred hhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH---cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999 999998765544433332 344455667788899999999999999999999999865
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=263.13 Aligned_cols=220 Identities=25% Similarity=0.422 Sum_probs=174.6
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
+..+|+.||+|.+... ...+.+.+|++++++++||||++ .....+++||||+++++|.+++.. ..++.
T Consensus 56 ~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~ 133 (318)
T 3lxp_A 56 NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR--HSIGL 133 (318)
T ss_dssp C--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG--SCCCH
T ss_pred CCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh--CCCCH
Confidence 5668999999998743 44677999999999999999988 335789999999999999999986 34777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||+.|++|+||||+||+++.++.++|+|||++........ .........++..|+|||.+.
T Consensus 134 ~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~ 210 (318)
T 3lxp_A 134 AQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE---YYRVREDGDSPVFWYAPECLK 210 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS---EEEC---CCCCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccc---ccccccCCCCCceeeChHHhc
Confidence 7777776655 7999999999999999999999999999999976543111 111123345788899999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhc------------hHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhcc
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISN------------AAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLER 213 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 213 (241)
+..++.++||||||+++|++++|..||...... .................+..++..+.+++++||+.
T Consensus 211 ~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 290 (318)
T 3lxp_A 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWET 290 (318)
T ss_dssp HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCC
Confidence 988999999999999999999999999754322 11122333344555666778889999999999999
Q ss_pred CCCCCCChHHHhc
Q 042809 214 KPEKRWSAEELLN 226 (241)
Q Consensus 214 ~p~~Rps~~~~l~ 226 (241)
+|.+|||++++++
T Consensus 291 dP~~Rps~~ell~ 303 (318)
T 3lxp_A 291 EASFRPTFENLIP 303 (318)
T ss_dssp SGGGSCCHHHHHH
T ss_pred CcccCcCHHHHHH
Confidence 9999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=262.99 Aligned_cols=222 Identities=29% Similarity=0.470 Sum_probs=163.6
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
++.+|+.||+|.+... ...+.+..+..+++.++||||++ ...+..++||||+ ++.+..+.......++..
T Consensus 46 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~ 124 (318)
T 2dyl_A 46 FRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPER 124 (318)
T ss_dssp ETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHH
T ss_pred EecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHH
Confidence 4678999999998632 22334455556788889999998 5678899999999 567777776656778888
Q ss_pred HHHHHHHHH------hhcC-CccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 73 VIRLYTKEI------LHGN-GILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~-~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
.+..++.|+ ||++ |++|+||+|+||+++.++.++|+|||++....... ......+++.|+|||.+.
T Consensus 125 ~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~ 197 (318)
T 2dyl_A 125 ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-------AKDRSAGCAAYMAPERID 197 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---------------------CCTTCCHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-------cccccCCCccccChhhcc
Confidence 887777655 7985 99999999999999999999999999987543311 112345899999999994
Q ss_pred -----ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC--hhhHHHHHHHHHHhhccCCCCC
Q 042809 146 -----NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP--TQFFKKVLDFLAKCLERKPEKR 218 (241)
Q Consensus 146 -----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R 218 (241)
+..++.++||||||+++|+|++|..||....... ...........+..+ ..++..+.+++.+||+.+|.+|
T Consensus 198 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 275 (318)
T 2dyl_A 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKR 275 (318)
T ss_dssp --------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTS
T ss_pred cccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHC
Confidence 4567889999999999999999999997632221 112222222223222 3467899999999999999999
Q ss_pred CChHHHhcCCCCCCC
Q 042809 219 WSAEELLNHTFISGN 233 (241)
Q Consensus 219 ps~~~~l~~p~~~~~ 233 (241)
||++++++||||+..
T Consensus 276 ps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 276 PKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCHHHHTTSHHHHHH
T ss_pred cCHHHHhhCHHHHhc
Confidence 999999999999754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=261.99 Aligned_cols=227 Identities=28% Similarity=0.438 Sum_probs=170.1
Q ss_pred CCCcEEEEEeccc----hHHHHHHHHHHHHHhhcC--CCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 4 GTGALFVVKSAES----EAGVQALRNEAEIRQSLN--SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 4 ~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~--h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
.+|+.||+|.+.. ....+.+.+|+.++.+++ ||||++ ...+..++|||+ .+++|.+++.. ...++..
T Consensus 50 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~-~~~~~~~ 127 (313)
T 3cek_A 50 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPW 127 (313)
T ss_dssp TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHH-CSSCCHH
T ss_pred CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEec-CCCcHHHHHHh-cCCCCHH
Confidence 3588999999752 345678999999999998 599988 567789999995 47899999987 4567777
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||++|++||||+|+||+++ ++.+||+|||++......... .......|++.|+|||.+.+
T Consensus 128 ~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 128 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS----VVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC------------------CCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcccc----ccccCCCCCCCcCCHHHHhh
Confidence 777766655 7999999999999999995 589999999999765432111 11123458999999999875
Q ss_pred -----------cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCC
Q 042809 147 -----------EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKP 215 (241)
Q Consensus 147 -----------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 215 (241)
..++.++||||||+++|+|++|..||...... ................+...+..+.+++.+||+.+|
T Consensus 203 ~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 281 (313)
T 3cek_A 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDP 281 (313)
T ss_dssp CC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSST
T ss_pred cccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-HHHHHHHHhcccccCCcccchHHHHHHHHHHccCCc
Confidence 46788999999999999999999999764322 222222233333445556667899999999999999
Q ss_pred CCCCChHHHhcCCCCCCCCccCC
Q 042809 216 EKRWSAEELLNHTFISGNAKKNS 238 (241)
Q Consensus 216 ~~Rps~~~~l~~p~~~~~~~~~~ 238 (241)
.+|||++++++||||+......+
T Consensus 282 ~~Rps~~ell~h~~~~~~~~~~~ 304 (313)
T 3cek_A 282 KQRISIPELLAHPYVQIQTHPVN 304 (313)
T ss_dssp TTSCCHHHHHTSHHHHCC-----
T ss_pred ccCcCHHHHhcCccccCCCCchh
Confidence 99999999999999987765443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=256.06 Aligned_cols=215 Identities=22% Similarity=0.356 Sum_probs=175.4
Q ss_pred CCcEEEEEeccchH-HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 5 TGALFVVKSAESEA-GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 5 ~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
++..||+|.+.... ..+.+.+|+.++++++||||++ ...+..++||||+++++|.+++......++...+..++
T Consensus 31 ~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 110 (267)
T 3t9t_A 31 NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMC 110 (267)
T ss_dssp TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHH
T ss_pred CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHH
Confidence 57789999987542 3567899999999999999988 56778999999999999999999876778888877776
Q ss_pred HHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCch
Q 042809 79 KEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA 152 (241)
Q Consensus 79 ~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 152 (241)
.|+ ||++|++|+||+|+||+++.++.++|+|||.+........ .......+++.|+|||.+.+..++.+
T Consensus 111 ~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~ 185 (267)
T 3t9t_A 111 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-----TSSTGTKFPVKWASPEVFSFSRYSSK 185 (267)
T ss_dssp HHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-----HSTTSTTCCGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc-----cccccccccccccChhhhcCCCccch
Confidence 655 7999999999999999999999999999999875433111 11122346778999999998889999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 153 TDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 153 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
+|+||||+++|++++ |..||......... ...........+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 186 ~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEVV---EDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hchhhhHHHHHHHhccCCCCCCCCCHHHHH---HHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999 89999765433322 2223334445566678899999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=264.89 Aligned_cols=222 Identities=25% Similarity=0.313 Sum_probs=174.0
Q ss_pred CCCCCcEEEEEecc---chHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC------C
Q 042809 2 NKGTGALFVVKSAE---SEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG------G 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~---~~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~------~ 67 (241)
+..++..||+|.+. .......+.+|+.++++++||||++ ......++||||+++++|.+++.... .
T Consensus 56 ~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 135 (327)
T 2yfx_A 56 NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS 135 (327)
T ss_dssp ----CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTT
T ss_pred CCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccc
Confidence 45678899999975 3345667899999999999999998 56678899999999999999999754 3
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecC---CCeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH---GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
.++...+..++.|+ ||++|++||||+|+||+++.+ ..++|+|||++........ ........+++.|
T Consensus 136 ~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y 211 (327)
T 2yfx_A 136 SLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY----YRKGGCAMLPVKW 211 (327)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC----------CCGGGSCGGG
T ss_pred cccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccc----cccCCCcCCCcce
Confidence 47777666666554 799999999999999999854 4599999999975533211 1112234578899
Q ss_pred cCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCC
Q 042809 139 MAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEK 217 (241)
Q Consensus 139 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 217 (241)
+|||.+.+..++.++||||||+++|+|++ |..||........ ............+..++..+.+++.+||+.+|.+
T Consensus 212 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 288 (327)
T 2yfx_A 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPED 288 (327)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred eCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---HHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhh
Confidence 99999999889999999999999999998 9999976543332 2333334455566778889999999999999999
Q ss_pred CCChHHHhcCCCC
Q 042809 218 RWSAEELLNHTFI 230 (241)
Q Consensus 218 Rps~~~~l~~p~~ 230 (241)
|||++++++++|+
T Consensus 289 Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 289 RPNFAIILERIEY 301 (327)
T ss_dssp SCCHHHHHHHHHH
T ss_pred CcCHHHHHHHHHH
Confidence 9999999998765
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=262.27 Aligned_cols=217 Identities=20% Similarity=0.320 Sum_probs=174.0
Q ss_pred CCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC---------
Q 042809 4 GTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG--------- 66 (241)
Q Consensus 4 ~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 66 (241)
.+++.||+|.+... .....+.+|+.+++.++||||++ ......++||||+++++|.+++...+
T Consensus 53 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 132 (322)
T 1p4o_A 53 EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132 (322)
T ss_dssp EEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTC
T ss_pred CCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCC
Confidence 46788999998743 34567899999999999999988 56778999999999999999998642
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..++...+..++.|+ ||++|++||||||+||+++.++.+||+|||++........ ........+++.|+|
T Consensus 133 ~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~a 208 (322)
T 1p4o_A 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY----YRKGGKGLLPVRWMS 208 (322)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGC----EEGGGSSEECGGGCC
T ss_pred CCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccc----cccccCCCCCCCccC
Confidence 345677766666544 7999999999999999999999999999999975543211 111223346788999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 219 (241)
||.+.+..++.++||||||+++|++++ |..||........ ............+..++..+.+++.+||+.+|.+||
T Consensus 209 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 285 (322)
T 1p4o_A 209 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP 285 (322)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred hhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH---HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCc
Confidence 999999889999999999999999999 8999977544332 222333444556677888999999999999999999
Q ss_pred ChHHHhcC
Q 042809 220 SAEELLNH 227 (241)
Q Consensus 220 s~~~~l~~ 227 (241)
|+.+++++
T Consensus 286 s~~e~l~~ 293 (322)
T 1p4o_A 286 SFLEIISS 293 (322)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999976
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=259.58 Aligned_cols=213 Identities=27% Similarity=0.398 Sum_probs=167.5
Q ss_pred CCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc---cCCceeeeeecccCCCCHHHHHHHhCC--CCCHHHHHHHHH
Q 042809 5 TGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR---NGEKTVNIFMEYMAGGSLLDVAEKFGG--TLDAGVIRLYTK 79 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~---~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~ 79 (241)
+++.||+|.+..+...+.+.+|+.++++++||||++ ...+..++||||+++++|.+++..... .++...+..++.
T Consensus 30 ~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 109 (307)
T 2eva_A 30 RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109 (307)
T ss_dssp TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHH
T ss_pred CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHH
Confidence 478899999988777888999999999999999998 334568999999999999999986432 356666655544
Q ss_pred ------HHhhc---CCccccCCCCCcEEeecCCC-eeecCCCcchhhcccccCCccccccccccCcccccCcccccccCC
Q 042809 80 ------EILHG---NGILHCDLKCNNVLLGSHGD-VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL 149 (241)
Q Consensus 80 ------~~Lh~---~~~vH~dl~p~Nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 149 (241)
++||+ +|++||||||+||+++.++. +||+|||++...... .....|++.|+|||.+.+..+
T Consensus 110 qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~ 180 (307)
T 2eva_A 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---------MTNNKGSAAWMAPEVFEGSNY 180 (307)
T ss_dssp HHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------------------CCTTSSCHHHHTCCCC
T ss_pred HHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---------cccCCCCCceEChhhhCCCCC
Confidence 44898 89999999999999998887 799999999754321 122348999999999999999
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 150 DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
+.++||||||+++|++++|+.||......... ..........+..+..++..+.+++.+||+.+|.+|||+++++++
T Consensus 181 ~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999999999999764333322 222233344556667788899999999999999999999999873
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=261.59 Aligned_cols=224 Identities=16% Similarity=0.192 Sum_probs=173.9
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
|+.+|+.||+|..........+.+|+.+++.++|++++. ......++||||+ +++|.+++......++...+.
T Consensus 30 ~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~ 108 (296)
T 4hgt_A 30 DIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVL 108 (296)
T ss_dssp ETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHH
T ss_pred EcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHH
Confidence 567899999999876666677999999999999888766 5667889999999 899999999767788988888
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEe---ecCCCeeecCCCcchhhcccccCCc-cccccccccCcccccCccccc
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLL---GSHGDVKLPDLGCARRVNDLKNNGN-LKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~ 145 (241)
.++.|+ ||++|++||||||+||++ +.++.+||+|||++........... .........|++.|+|||.+.
T Consensus 109 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 188 (296)
T 4hgt_A 109 LLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 188 (296)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhc
Confidence 877765 799999999999999999 7889999999999976544222111 111223456899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhc----hHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISN----AAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
+..++.++||||||+++|++++|..||.+.... ....................+++.+.+++.+||+.+|.+|||+
T Consensus 189 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 268 (296)
T 4hgt_A 189 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDY 268 (296)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCH
T ss_pred CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCH
Confidence 999999999999999999999999999763222 1111112111111111223457789999999999999999999
Q ss_pred HHHhc
Q 042809 222 EELLN 226 (241)
Q Consensus 222 ~~~l~ 226 (241)
+++++
T Consensus 269 ~~l~~ 273 (296)
T 4hgt_A 269 SYLRQ 273 (296)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=258.95 Aligned_cols=217 Identities=25% Similarity=0.390 Sum_probs=177.5
Q ss_pred CCCCCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh-CCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~ 74 (241)
++.++..||+|.+... ...+.+.+|+.++++++||||++ ......++||||+++++|.+++... ...++...+
T Consensus 34 ~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~ 113 (288)
T 3kfa_A 34 WKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 113 (288)
T ss_dssp EGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHH
T ss_pred ecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHH
Confidence 4567899999998743 34678999999999999999988 6677899999999999999999874 345777777
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..++.|+ ||++|++|+||+|+||+++.++.++|+|||.+....... ........+++.|+|||.+.+..
T Consensus 114 ~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~ 188 (288)
T 3kfa_A 114 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-----YTAHAGAKFPIKWTAPESLAYNK 188 (288)
T ss_dssp HHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-----SEEETTEEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-----cccccCCccccCcCChhhhccCC
Confidence 7666544 799999999999999999999999999999997554311 11222344677899999999999
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 149 LDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++.++||||||+++|++++ |..||............. .......+..+++.+.+++.+||..+|.+|||++++++
T Consensus 189 ~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 189 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 9999999999999999999 999998765544433332 33445556778889999999999999999999999976
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=277.68 Aligned_cols=218 Identities=24% Similarity=0.379 Sum_probs=177.0
Q ss_pred CCCCCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-CCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~ 74 (241)
++.++..||||.+... ...+.+.+|+.++++++||||++ ......++||||+++|+|.+++.... ..++...+
T Consensus 241 ~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~ 320 (495)
T 1opk_A 241 WKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 320 (495)
T ss_dssp EGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHH
T ss_pred EcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHH
Confidence 3567899999998743 34678999999999999999998 56778999999999999999998743 45777777
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..++.|+ ||++|++||||||+||+++.++.+||+|||++....... ........++..|+|||.+.+..
T Consensus 321 ~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~ 395 (495)
T 1opk_A 321 LYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-----YTAHAGAKFPIKWTAPESLAYNK 395 (495)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-----EECCTTCCCCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-----eeecCCCcCCcceeCHhHHhcCC
Confidence 6666544 899999999999999999999999999999997543211 11112234577899999999888
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 149 LDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
++.++||||||+++|+|++ |..||.+.......... ........+..++..+.+||.+||+.+|.+|||++++++.
T Consensus 396 ~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~ 472 (495)
T 1opk_A 396 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 472 (495)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9999999999999999999 99999876544433332 3344455667788999999999999999999999999763
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=258.72 Aligned_cols=218 Identities=22% Similarity=0.284 Sum_probs=174.4
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+++.||+|.+... ...+.+.+|+.+++.++||||++ ...+..++||||+++++|.+++.. ...++...
T Consensus 40 ~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~ 118 (291)
T 1xbb_A 40 MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ-NRHVKDKN 118 (291)
T ss_dssp CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHH-CTTCCHHH
T ss_pred CCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEEEEEeCCCCCHHHHHHh-CcCCCHHH
Confidence 3567899999998743 23577999999999999999998 445678999999999999999987 45678887
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
+..++.|+ ||++|++||||+|+||+++.++.++|+|||++........ .........+++.|+|||.+.+.
T Consensus 119 ~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~ 195 (291)
T 1xbb_A 119 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN---YYKAQTHGKWPVKWYAPECINYY 195 (291)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS---EEEC----CCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC---cccccccCCCCceeeChHHhccC
Confidence 77776655 7999999999999999999999999999999975433111 11111223357889999999988
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 148 GLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
.++.++||||||+++|++++ |..||.+...... .........+..+..++..+.+++.+||+.+|.+|||+.++++
T Consensus 196 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 196 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 89999999999999999999 9999987544333 2333334455667788899999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=261.30 Aligned_cols=224 Identities=17% Similarity=0.211 Sum_probs=174.8
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
++.+|+.||+|.+......+.+.+|+.+++.++|++++. ......++||||+ +++|.+++......++...+.
T Consensus 30 ~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~ 108 (296)
T 3uzp_A 30 DIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVL 108 (296)
T ss_dssp ETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHH
T ss_pred EcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHH
Confidence 567899999999876555567899999999999988765 5567889999999 899999998767788988888
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEee---cCCCeeecCCCcchhhcccccCCcc-ccccccccCcccccCccccc
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLG---SHGDVKLPDLGCARRVNDLKNNGNL-KQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~ 145 (241)
.++.|+ ||++|++||||||+||+++ .++.+||+|||++............ ........|++.|+|||.+.
T Consensus 109 ~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 188 (296)
T 3uzp_A 109 LLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 188 (296)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHT
T ss_pred HHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhc
Confidence 877765 7999999999999999994 7889999999999765442221110 11223456899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhc----hHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISN----AAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
+..++.++||||||+++|++++|+.||...... .................+..+++.+.+++.+||+.+|.+|||+
T Consensus 189 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 268 (296)
T 3uzp_A 189 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDY 268 (296)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCH
T ss_pred CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCH
Confidence 999999999999999999999999999763221 1112222121111112234567889999999999999999999
Q ss_pred HHHhc
Q 042809 222 EELLN 226 (241)
Q Consensus 222 ~~~l~ 226 (241)
+++++
T Consensus 269 ~~l~~ 273 (296)
T 3uzp_A 269 SYLRQ 273 (296)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=260.82 Aligned_cols=216 Identities=21% Similarity=0.301 Sum_probs=169.1
Q ss_pred CcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHH
Q 042809 6 GALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLY 77 (241)
Q Consensus 6 ~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 77 (241)
+..||+|.+.. ......+.+|+.++++++||||++ ...+..++||||+++++|.+++......++...+..+
T Consensus 73 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i 152 (333)
T 1mqb_A 73 EVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM 152 (333)
T ss_dssp EEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHH
T ss_pred cccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHH
Confidence 45699999873 344567899999999999999998 5677899999999999999999987677888888777
Q ss_pred HHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+.|+ ||++|++||||||+||+++.++.+||+|||++.......... .......+++.|+|||.+.+..++.
T Consensus 153 ~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~ 229 (333)
T 1mqb_A 153 LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT---YTTSGGKIPIRWTAPEAISYRKFTS 229 (333)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------------------CCCGGGSCHHHHHSCCCCH
T ss_pred HHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccc---cccCCCCccccccCchhcccCCCCc
Confidence 7655 799999999999999999999999999999997654321111 1112233577899999999889999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
++||||||+++|++++ |..||......... ...........+..++..+.+++.+||+.+|.+|||+++++++
T Consensus 230 ~~Di~slG~il~ellt~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 230 ASDVWSFGIVMWEVMTYGERPYWELSNHEVM---KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hhhhHHHHHHHHHHHcCCCCCcccCCHHHHH---HHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999 99999765443322 2223334445566788899999999999999999999998764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=261.94 Aligned_cols=222 Identities=25% Similarity=0.377 Sum_probs=174.2
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
+..+|+.||+|.+.. ....+.+.+|+.++++++||||++ ......++||||+++++|.+++......++..
T Consensus 66 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 145 (326)
T 2w1i_A 66 QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 145 (326)
T ss_dssp SSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHH
T ss_pred cCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHH
Confidence 567899999999763 345678999999999999999988 22347899999999999999999876678888
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.+..++.|+ ||++|++||||+|+||+++.++.++|+|||++........ .........++..|+|||.+.+
T Consensus 146 ~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~ 222 (326)
T 2w1i_A 146 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE---YYKVKEPGESPIFWYAPESLTE 222 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCS---EEECSSCCSCCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcccccc---ccccccCCCCceeEECchhhcC
Confidence 877776655 7999999999999999999999999999999976543211 0011122346778999999998
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhch-------------HHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhcc
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNA-------------AATLLKIACSNEKPHFPTQFFKKVLDFLAKCLER 213 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 213 (241)
..++.++||||||+++|++++|..||....... ................+..++..+.+++++||+.
T Consensus 223 ~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 302 (326)
T 2w1i_A 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNN 302 (326)
T ss_dssp CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCS
T ss_pred CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCC
Confidence 889999999999999999999999986432111 0112222233344556677889999999999999
Q ss_pred CCCCCCChHHHhc
Q 042809 214 KPEKRWSAEELLN 226 (241)
Q Consensus 214 ~p~~Rps~~~~l~ 226 (241)
+|.+|||+.++++
T Consensus 303 dP~~Rps~~el~~ 315 (326)
T 2w1i_A 303 NVNQRPSFRDLAL 315 (326)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=275.48 Aligned_cols=224 Identities=25% Similarity=0.342 Sum_probs=161.2
Q ss_pred CCCCcEEEEEeccchHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 3 KGTGALFVVKSAESEAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
..+|+.||||.+..+. ...+.+|+.+++.+ +||||++ ......|+||||+. |+|.+++...........+..
T Consensus 45 ~~~~~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~ 122 (432)
T 3p23_A 45 MFDNRDVAVKRILPEC-FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPIT 122 (432)
T ss_dssp ESSSSEEEEEEECTTT-EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHH
T ss_pred EeCCeEEEEEEECHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHH
Confidence 4578999999987433 24467899999999 7999998 56778999999996 699999987544333222222
Q ss_pred H------HHHHhhcCCccccCCCCCcEEeec---CC--CeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 77 Y------TKEILHGNGILHCDLKCNNVLLGS---HG--DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 77 ~------~~~~Lh~~~~vH~dl~p~Nil~~~---~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
+ +.++||++|++||||||+||+++. ++ .++|+|||++......... ........||+.|+|||.+.
T Consensus 123 i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~---~~~~~~~~gt~~y~APE~l~ 199 (432)
T 3p23_A 123 LLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS---FSRRSGVPGTEGWIAPEMLS 199 (432)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---------------CCSCTTSCCGGGTS
T ss_pred HHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc---eeeccccCCCcCccChhhhh
Confidence 3 335589999999999999999953 23 4789999999765432111 11223456899999999997
Q ss_pred ---ccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 146 ---NEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 146 ---~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
+..++.++|||||||++|++++ |..||......... .............+...+..+.+||.+||+.+|.+|||+
T Consensus 200 ~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 278 (432)
T 3p23_A 200 EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSA 278 (432)
T ss_dssp CC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred cccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCH
Confidence 4567789999999999999999 99999654332221 111111111112234556778999999999999999999
Q ss_pred HHHhcCCCCCC
Q 042809 222 EELLNHTFISG 232 (241)
Q Consensus 222 ~~~l~~p~~~~ 232 (241)
+++++||||..
T Consensus 279 ~evl~hp~f~~ 289 (432)
T 3p23_A 279 KHVLKHPFFWS 289 (432)
T ss_dssp HHHHTSTTTCC
T ss_pred HHHHhCccccC
Confidence 99999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=262.67 Aligned_cols=220 Identities=20% Similarity=0.303 Sum_probs=174.5
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhc-CCCcccc------cCCceeeeeecccCCCCHHHHHHHhCCC---
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSL-NSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGGT--- 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~--- 68 (241)
+..+++.||+|.+... .....+.+|+.++.++ +||||++ ..+...++||||+++++|.+++......
T Consensus 53 ~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 132 (316)
T 2xir_A 53 KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132 (316)
T ss_dssp STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEEC
T ss_pred ccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhccccccc
Confidence 3567899999998743 3456789999999999 6999988 3345699999999999999999875332
Q ss_pred ------------CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccc
Q 042809 69 ------------LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQ 130 (241)
Q Consensus 69 ------------~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 130 (241)
++...+..++.|+ ||++|++||||||+||+++.++.++|+|||++........ .....
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~ 208 (316)
T 2xir_A 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD----YVRKG 208 (316)
T ss_dssp C-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT----SEEET
T ss_pred ccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCcc----ceecc
Confidence 6777777666654 7999999999999999999999999999999975433111 11122
Q ss_pred cccCcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHH
Q 042809 131 SIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAK 209 (241)
Q Consensus 131 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 209 (241)
...+++.|+|||.+.+..++.++||||||+++|++++ |..||.+...... .............+...++.+.+++.+
T Consensus 209 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~ 286 (316)
T 2xir_A 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLKEGTRMRAPDYTTPEMYQTMLD 286 (316)
T ss_dssp TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--HHHHHHHTCCCCCCTTCCHHHHHHHHH
T ss_pred CCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH--HHHHhccCccCCCCCCCCHHHHHHHHH
Confidence 3446888999999999999999999999999999998 9999976543322 222222234455566778899999999
Q ss_pred hhccCCCCCCChHHHhcC
Q 042809 210 CLERKPEKRWSAEELLNH 227 (241)
Q Consensus 210 ~l~~~p~~Rps~~~~l~~ 227 (241)
||+.+|.+|||++++++|
T Consensus 287 ~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 287 CWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcCCChhhCcCHHHHHHH
Confidence 999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=267.60 Aligned_cols=217 Identities=24% Similarity=0.332 Sum_probs=164.1
Q ss_pred CcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 6 GALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 6 ~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
+..||+|.+.. ....+.+.+|+.++++++||||++ ..++..++||||+++|+|.+++......++...+..
T Consensus 117 ~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 196 (373)
T 3c1x_A 117 KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 196 (373)
T ss_dssp EEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHH
T ss_pred EEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHH
Confidence 45789998763 345678999999999999999988 345678999999999999999987666788777776
Q ss_pred HHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCC
Q 042809 77 YTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD 150 (241)
Q Consensus 77 ~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 150 (241)
++.|+ ||++|++||||||+||+++.++.+||+|||++.......... ........+++.|+|||.+.+..++
T Consensus 197 i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~ 274 (373)
T 3c1x_A 197 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS--VHNKTGAKLPVKWMALESLQTQKFT 274 (373)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CCGGGSCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccccc--ccccCCCCCcccccChHHhcCCCCC
Confidence 66544 799999999999999999999999999999997553321111 1111233467889999999999999
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 151 FATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 151 ~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
.++||||||+++|++++ |.+||.+.......... ........+..++..+.+++.+||+.+|.+|||+++++++
T Consensus 275 ~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~---~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 275 TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH---HcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999 78888765443333222 2233445566778899999999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=257.51 Aligned_cols=220 Identities=25% Similarity=0.414 Sum_probs=164.9
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHH---hCCC
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEK---FGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~---~~~~ 68 (241)
++.+|+.||+|.+.. ......+.+|+.++++++||||++ ...+..++||||+++++|.+++.. ....
T Consensus 53 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 132 (310)
T 2wqm_A 53 CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL 132 (310)
T ss_dssp ETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCC
T ss_pred EcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccC
Confidence 457899999998763 445677899999999999999998 566789999999999999999875 2456
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
++...+..++.|+ ||++|++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||
T Consensus 133 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~y~aPE 206 (310)
T 2wqm_A 133 IPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT------TAAHSLVGTPYYMSPE 206 (310)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------------------------CCSSCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC------ccccccCCCeeEeChH
Confidence 7887777766654 799999999999999999999999999999987543311 1112345789999999
Q ss_pred cccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 143 VLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 143 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
.+.+..++.++||||||+++|++++|..||.+..................+..+..++..+.+++.+||..+|.+|||++
T Consensus 207 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 286 (310)
T 2wqm_A 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVT 286 (310)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHH
Confidence 99998899999999999999999999999976433322222222222222223356788999999999999999999999
Q ss_pred HHhcC
Q 042809 223 ELLNH 227 (241)
Q Consensus 223 ~~l~~ 227 (241)
+++++
T Consensus 287 ~il~~ 291 (310)
T 2wqm_A 287 YVYDV 291 (310)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=264.29 Aligned_cols=221 Identities=20% Similarity=0.273 Sum_probs=172.4
Q ss_pred CCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC---CCCCHHH
Q 042809 4 GTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG---GTLDAGV 73 (241)
Q Consensus 4 ~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~ 73 (241)
.+|+.||+|.... ....+.+.+|+.+++.++||||++ ...+..++||||+++++|.+++.... ..+++..
T Consensus 61 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 140 (321)
T 2qkw_B 61 RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140 (321)
T ss_dssp TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHH
T ss_pred CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHH
Confidence 3688999998763 345678999999999999999998 56778999999999999999987542 2477777
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
+..++.|+ ||++|++||||||+||+++.++.+||+|||++........ ........|++.|+|||.+.+.
T Consensus 141 ~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~ 216 (321)
T 2qkw_B 141 RLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ----THLSTVVKGTLGYIDPEYFIKG 216 (321)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC----CCCBCCCEEETTTCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccc----cccccccCCCccccCHHHhcCC
Confidence 77666544 7999999999999999999999999999999875432111 1112234578999999999988
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHH----HHh---------cCCCCCCChhhHHHHHHHHHHhhccC
Q 042809 148 GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLK----IAC---------SNEKPHFPTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~ 214 (241)
.++.++||||||+++|++++|+.||............. ... .......+...+..+.+++.+||+.+
T Consensus 217 ~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 296 (321)
T 2qkw_B 217 RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALS 296 (321)
T ss_dssp BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSS
T ss_pred CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCC
Confidence 89999999999999999999999996543222111110 000 11122345677889999999999999
Q ss_pred CCCCCChHHHhcCC
Q 042809 215 PEKRWSAEELLNHT 228 (241)
Q Consensus 215 p~~Rps~~~~l~~p 228 (241)
|.+|||+++++++.
T Consensus 297 P~~Rps~~ell~~L 310 (321)
T 2qkw_B 297 SEDRPSMGDVLWKL 310 (321)
T ss_dssp GGGSCCHHHHHHHH
T ss_pred cccCcCHHHHHHHH
Confidence 99999999999764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=257.68 Aligned_cols=218 Identities=23% Similarity=0.320 Sum_probs=170.8
Q ss_pred CCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 5 TGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 5 ~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
++..+|+|.+.. ....+.+.+|+.++++++||||++ ..++..++||||+++++|.+++......++...+.
T Consensus 52 ~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~ 131 (298)
T 3f66_A 52 KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 131 (298)
T ss_dssp -CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHH
T ss_pred ceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHH
Confidence 445689998763 345677999999999999999988 45668899999999999999998766778888777
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCC
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL 149 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 149 (241)
.++.|+ ||++|++||||||+||+++.++.++|+|||++.......... ........+++.|+|||.+.+..+
T Consensus 132 ~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~ 209 (298)
T 3f66_A 132 GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS--VHNKTGAKLPVKWMALESLQTQKF 209 (298)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCB--C-----CCBCGGGSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhc--cccccCCCCCccccChHHhcCCCC
Confidence 766554 799999999999999999999999999999997654322111 112233456788999999999999
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 150 DFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
+.++|+||||+++|++++ |.+||........... .........+..++..+.+++.+||+.+|.+|||++++++.
T Consensus 210 ~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 210 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH---HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH---HhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999 6667765443333222 22334445566678899999999999999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=274.45 Aligned_cols=215 Identities=22% Similarity=0.376 Sum_probs=171.8
Q ss_pred CCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhC-CCCCHHHHHHHH
Q 042809 5 TGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDAGVIRLYT 78 (241)
Q Consensus 5 ~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 78 (241)
++..||||.+... ...+.+.+|+.++++++||||++ ......++||||+.+|+|.+++.... ..++...+..++
T Consensus 211 ~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 290 (454)
T 1qcf_A 211 KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 290 (454)
T ss_dssp TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHH
T ss_pred CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHH
Confidence 4678999998743 34678999999999999999998 44677999999999999999998532 356666666555
Q ss_pred HH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCch
Q 042809 79 KE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA 152 (241)
Q Consensus 79 ~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 152 (241)
.| +||++|++||||||+||+++.++.+||+|||++........ .......++..|+|||.+.+..++.+
T Consensus 291 ~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~ 365 (454)
T 1qcf_A 291 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-----TAREGAKFPIKWTAPEAINFGSFTIK 365 (454)
T ss_dssp HHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-----HTTCSSSSCGGGSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-----eccCCCcccccccCHHHhccCCCCcH
Confidence 54 48999999999999999999999999999999976533111 11122335778999999998899999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 153 TDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 153 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
+||||||+++|+|++ |+.||.+.......... ........+..++..+.++|.+||+.+|.+|||+++++..
T Consensus 366 ~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~ 438 (454)
T 1qcf_A 366 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSV 438 (454)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999999 99999875443333322 2334445567788999999999999999999999998753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=254.93 Aligned_cols=211 Identities=27% Similarity=0.449 Sum_probs=164.1
Q ss_pred CCcEEEEEeccch------HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 5 TGALFVVKSAESE------AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 5 ~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
+|..||+|.+... ...+.+.+|+++++.++||||++ ...+..++||||+++++|.+++.. ..+++..
T Consensus 29 ~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~ 106 (271)
T 3dtc_A 29 IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDI 106 (271)
T ss_dssp TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS--SCCCHHH
T ss_pred cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc--CCCCHHH
Confidence 4788999997632 23467899999999999999998 667789999999999999999864 5788887
Q ss_pred HHHHHHHH------hhcCC---ccccCCCCCcEEeec--------CCCeeecCCCcchhhcccccCCccccccccccCcc
Q 042809 74 IRLYTKEI------LHGNG---ILHCDLKCNNVLLGS--------HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQ 136 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~---~vH~dl~p~Nil~~~--------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (241)
+..++.|+ ||++| ++||||||+||+++. ++.++|+|||++....... .....|++
T Consensus 107 ~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~~ 178 (271)
T 3dtc_A 107 LVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT--------KMSAAGAY 178 (271)
T ss_dssp HHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---------------------CCG
T ss_pred HHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc--------ccCCCCcc
Confidence 77776655 79999 889999999999986 6789999999997554311 12345899
Q ss_pred cccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 137 LWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 137 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
.|+|||.+.+..++.++|+||||+++|++++|+.||.+...... .............+..++..+.+++.+||+.+|.
T Consensus 179 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 256 (271)
T 3dtc_A 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV--AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPH 256 (271)
T ss_dssp GGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred ceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcc
Confidence 99999999999999999999999999999999999977543322 2233333445556777889999999999999999
Q ss_pred CCCChHHHhcC
Q 042809 217 KRWSAEELLNH 227 (241)
Q Consensus 217 ~Rps~~~~l~~ 227 (241)
+|||+.+++++
T Consensus 257 ~Rps~~e~l~~ 267 (271)
T 3dtc_A 257 SRPSFTNILDQ 267 (271)
T ss_dssp GSCCHHHHHHH
T ss_pred cCcCHHHHHHH
Confidence 99999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=259.88 Aligned_cols=217 Identities=19% Similarity=0.253 Sum_probs=163.6
Q ss_pred CCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc---------cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 5 TGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR---------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 5 ~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
+|+.||||++... .......+|+.++.+++||||++ .....+++||||+++|+|.+++.. ..+++..+
T Consensus 46 ~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~ 123 (322)
T 3soc_A 46 LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNEL 123 (322)
T ss_dssp TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHH
T ss_pred CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHH
Confidence 4789999998743 33455677999999999999998 114568999999999999999987 45788777
Q ss_pred HHHHHHH------hhcC----------CccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 75 RLYTKEI------LHGN----------GILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 75 ~~~~~~~------Lh~~----------~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
..++.|+ ||+. |++||||||+||+++.++.+||+|||++........ ........|++.|
T Consensus 124 ~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~----~~~~~~~~gt~~y 199 (322)
T 3soc_A 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS----AGDTHGQVGTRRY 199 (322)
T ss_dssp HHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSC----CCCCTTCCCCGGG
T ss_pred HHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccC----ccccccCccCccc
Confidence 7776654 7998 999999999999999999999999999975543211 1112335689999
Q ss_pred cCcccccc-----cCCCchhhHHHHHHHHHHHHhCCCCCccchhc-------------hHHHHHHHH-hcCCCCCCCh--
Q 042809 139 MAPEVLRN-----EGLDFATDIWSLGCMVIEMATGRPPWGDKISN-------------AAATLLKIA-CSNEKPHFPT-- 197 (241)
Q Consensus 139 ~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------------~~~~~~~~~-~~~~~~~~~~-- 197 (241)
+|||.+.+ ..++.++||||||+++|+|++|..||.+.... ......... .....+..+.
T Consensus 200 ~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (322)
T 3soc_A 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYW 279 (322)
T ss_dssp CCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGG
T ss_pred cCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccc
Confidence 99999986 34567889999999999999999998653221 111111111 1222222222
Q ss_pred ---hhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 198 ---QFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 198 ---~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
..+..+.+|+.+||+.+|.+|||+.++++.
T Consensus 280 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 280 QKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 345679999999999999999999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=258.65 Aligned_cols=210 Identities=26% Similarity=0.383 Sum_probs=165.4
Q ss_pred CCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHhCC-CCCHHHHHHH
Q 042809 5 TGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGG-TLDAGVIRLY 77 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~ 77 (241)
+|+.||+|.+..+...+.+.+|+.++++++||||++ ...+..++||||+++++|.+++...+. .++...+..+
T Consensus 43 ~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 122 (278)
T 1byg_A 43 RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122 (278)
T ss_dssp TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHH
T ss_pred cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHH
Confidence 578999999987777788999999999999999988 344579999999999999999986432 2666666666
Q ss_pred HHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+.| +||++|++|+||+|+||+++.++.++|+|||++...... .....+++.|+|||.+.+..++.
T Consensus 123 ~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~ 193 (278)
T 1byg_A 123 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---------QDTGKLPVKWTAPEALREKKFST 193 (278)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------------------CCTTTSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc---------ccCCCccccccCHHHhCCCCCCc
Confidence 554 479999999999999999999999999999998754331 11234678899999999988999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++|+||||+++|++++ |..||.......... ..........+..+++.+.+++.+||+.+|.+|||+.++++
T Consensus 194 ~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 194 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH---HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 9999999999999998 999997754443322 22234445666778899999999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=281.66 Aligned_cols=218 Identities=22% Similarity=0.282 Sum_probs=174.1
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.+++.||||++... ...+.+.+|+.++++++||||++ ......++||||+++|+|.+++.. ...+++..
T Consensus 392 ~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~ 470 (635)
T 4fl3_A 392 MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ-NRHVKDKN 470 (635)
T ss_dssp CSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHH-CTTCCHHH
T ss_pred CCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCCCHHHHHhh-CCCCCHHH
Confidence 3567889999998743 33578999999999999999998 334568999999999999999986 46678877
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
+..++.|+ ||++|++||||||+||+++.++.+||+|||++......... ........+++.|+|||++.+.
T Consensus 471 ~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~---~~~~~~~~~t~~y~APE~~~~~ 547 (635)
T 4fl3_A 471 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY---YKAQTHGKWPVKWYAPECINYY 547 (635)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------------CGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc---cccccCCCCceeeeChhhhcCC
Confidence 77776654 79999999999999999999999999999999865432111 1111223457889999999999
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 148 GLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
.++.++||||||+++|+|++ |+.||.+...... ............+..++.++.+||.+||+.+|.+|||++++++
T Consensus 548 ~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 548 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999998 9999987654433 3333345556677788899999999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=261.69 Aligned_cols=217 Identities=21% Similarity=0.334 Sum_probs=172.3
Q ss_pred CCCcEEEEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC-------
Q 042809 4 GTGALFVVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG------- 67 (241)
Q Consensus 4 ~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~------- 67 (241)
.++..||+|.+.. ....+.+.+|+.+++++ +||||++ ...+..++||||+++++|.+++.....
T Consensus 65 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 144 (334)
T 2pvf_A 65 KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144 (334)
T ss_dssp ---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC
T ss_pred ccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccc
Confidence 5678999999874 34567789999999999 8999998 567789999999999999999987432
Q ss_pred --------CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCcccccccccc
Q 042809 68 --------TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIG 133 (241)
Q Consensus 68 --------~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 133 (241)
.++...+..++.|+ ||++|++||||||+||+++.++.+||+|||++........ ........
T Consensus 145 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~ 220 (334)
T 2pvf_A 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY----YKKTTNGR 220 (334)
T ss_dssp --------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSS----EECCSCCC
T ss_pred cccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEcccccccccccccc----ccccCCCC
Confidence 36776666666554 7999999999999999999999999999999975433111 11112234
Q ss_pred CcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhc
Q 042809 134 GTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLE 212 (241)
Q Consensus 134 ~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 212 (241)
+++.|+|||.+.+..++.++||||||+++|++++ |..||.+......... .........+..++..+.+++.+||+
T Consensus 221 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~ 297 (334)
T 2pvf_A 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL---LKEGHRMDKPANCTNELYMMMRDCWH 297 (334)
T ss_dssp CCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH---HHHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred cccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH---HhcCCCCCCCccCCHHHHHHHHHHcc
Confidence 6788999999998889999999999999999999 9999977544433322 22334455667788899999999999
Q ss_pred cCCCCCCChHHHhcC
Q 042809 213 RKPEKRWSAEELLNH 227 (241)
Q Consensus 213 ~~p~~Rps~~~~l~~ 227 (241)
.+|.+|||+.+++++
T Consensus 298 ~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 298 AVPSQRPTFKQLVED 312 (334)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999865
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=266.91 Aligned_cols=215 Identities=21% Similarity=0.398 Sum_probs=174.6
Q ss_pred CCCCCcEEEEEeccchH--------HHHHHHHHHHHHhhcC--CCcccc-----cCCceeeeeecccCC-CCHHHHHHHh
Q 042809 2 NKGTGALFVVKSAESEA--------GVQALRNEAEIRQSLN--SPNIGR-----NGEKTVNIFMEYMAG-GSLLDVAEKF 65 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~--h~~i~~-----~~~~~~~lv~e~~~~-~~L~~~l~~~ 65 (241)
++.+|+.||+|.+.... ....+.+|+.+++++. |+||++ ...+..++|+|++.+ ++|.+++...
T Consensus 64 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~ 143 (320)
T 3a99_A 64 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 143 (320)
T ss_dssp ETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH
T ss_pred ECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc
Confidence 56789999999987542 2345778999999997 599988 667889999999976 8999999874
Q ss_pred CCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEee-cCCCeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 66 GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG-SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 66 ~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
..++...+..++.|+ ||++|++||||+|+||+++ .++.+||+|||++...... ......|++.|
T Consensus 144 -~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~--------~~~~~~gt~~y 214 (320)
T 3a99_A 144 -GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--------VYTDFDGTRVY 214 (320)
T ss_dssp -CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS--------CBCCCCSCGGG
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc--------cccCCCCCccC
Confidence 567777777666654 7999999999999999999 6789999999998755431 12234589999
Q ss_pred cCcccccccCC-CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCC
Q 042809 139 MAPEVLRNEGL-DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEK 217 (241)
Q Consensus 139 ~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 217 (241)
+|||.+.+..+ +.++||||||+++|++++|..||..... .. ......+..++..+.+++.+||+.+|.+
T Consensus 215 ~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~-----~~~~~~~~~~~~~~~~li~~~l~~dp~~ 284 (320)
T 3a99_A 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----II-----RGQVFFRQRVSSECQHLIRWCLALRPSD 284 (320)
T ss_dssp SCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HH-----HCCCCCSSCCCHHHHHHHHHHTCSSGGG
T ss_pred CChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----hh-----cccccccccCCHHHHHHHHHHccCChhh
Confidence 99999987665 6789999999999999999999965321 11 1223345567789999999999999999
Q ss_pred CCChHHHhcCCCCCCCCc
Q 042809 218 RWSAEELLNHTFISGNAK 235 (241)
Q Consensus 218 Rps~~~~l~~p~~~~~~~ 235 (241)
|||++++++||||+....
T Consensus 285 Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 285 RPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp SCCHHHHHTSGGGSSCCC
T ss_pred CcCHHHHhcCHhhcCccC
Confidence 999999999999987654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=255.23 Aligned_cols=219 Identities=21% Similarity=0.304 Sum_probs=171.5
Q ss_pred CCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 4 GTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 4 ~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
.++..||+|.+.. ....+.+.+|+.++++++||||++ ..+...++|+||+.+++|.+++......++...+
T Consensus 47 ~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~ 126 (298)
T 3pls_A 47 QNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL 126 (298)
T ss_dssp SCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHH
T ss_pred CceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHH
Confidence 3455899998763 344677899999999999999998 2344459999999999999999886677888877
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..++.|+ ||++|++||||||+||+++.++.++|+|||++.......... ........+++.|+|||.+.+..
T Consensus 127 ~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~ 204 (298)
T 3pls_A 127 ISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS--VQQHRHARLPVKWTALESLQTYR 204 (298)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC--SCCSSCTTCGGGGSCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc--cccCcCCCCCccccChhhhccCC
Confidence 7776654 799999999999999999999999999999997554321111 11223345788999999999999
Q ss_pred CCchhhHHHHHHHHHHHHhCC-CCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 149 LDFATDIWSLGCMVIEMATGR-PPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
++.++||||||+++|++++|. +||.......... ..........+...+..+.+++.+||+.+|.+|||++++++.
T Consensus 205 ~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 205 FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH---FLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH---HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH---HhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999955 5554443333222 222334455566788899999999999999999999998753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=263.63 Aligned_cols=216 Identities=23% Similarity=0.431 Sum_probs=169.5
Q ss_pred CCCCCcEEEEEeccchH--------HHHHHHHHHHHHhhc----CCCcccc-----cCCceeeeeecc-cCCCCHHHHHH
Q 042809 2 NKGTGALFVVKSAESEA--------GVQALRNEAEIRQSL----NSPNIGR-----NGEKTVNIFMEY-MAGGSLLDVAE 63 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l----~h~~i~~-----~~~~~~~lv~e~-~~~~~L~~~l~ 63 (241)
++.+|+.||+|.+.... ....+.+|+.++.++ +||||++ ...+..++|+|+ +.+++|.+++.
T Consensus 52 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~ 131 (312)
T 2iwi_A 52 RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT 131 (312)
T ss_dssp CTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHH
T ss_pred EccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHH
Confidence 56789999999987432 234466899999999 8999998 566789999999 78899999998
Q ss_pred HhCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEee-cCCCeeecCCCcchhhcccccCCccccccccccCcc
Q 042809 64 KFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG-SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQ 136 (241)
Q Consensus 64 ~~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (241)
.. ..+++..+..++.|+ ||++|++||||+|+||+++ .++.++|+|||++...... ......|++
T Consensus 132 ~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~ 202 (312)
T 2iwi_A 132 EK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--------PYTDFDGTR 202 (312)
T ss_dssp HH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS--------CBCCCCSCT
T ss_pred hc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC--------cccccCCcc
Confidence 74 567888777777655 7999999999999999999 7899999999998755431 122345899
Q ss_pred cccCcccccccCCC-chhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCC
Q 042809 137 LWMAPEVLRNEGLD-FATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKP 215 (241)
Q Consensus 137 ~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 215 (241)
.|+|||.+.+..+. .++||||||+++|++++|..||..... .. .....++..++..+.+++.+||+.+|
T Consensus 203 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~-----~~~~~~~~~~~~~~~~li~~~l~~~p 272 (312)
T 2iwi_A 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----IL-----EAELHFPAHVSPDCCALIRRCLAPKP 272 (312)
T ss_dssp TTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HH-----HTCCCCCTTSCHHHHHHHHHHTCSST
T ss_pred cccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----Hh-----hhccCCcccCCHHHHHHHHHHccCCh
Confidence 99999999876664 589999999999999999999965321 11 12334556678899999999999999
Q ss_pred CCCCChHHHhcCCCCCCCCcc
Q 042809 216 EKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 216 ~~Rps~~~~l~~p~~~~~~~~ 236 (241)
.+|||++++++||||+.....
T Consensus 273 ~~Rps~~e~l~~~~~~~~~~~ 293 (312)
T 2iwi_A 273 SSRPSLEEILLDPWMQTPAED 293 (312)
T ss_dssp TTSCCHHHHHHSTTTCC----
T ss_pred hhCcCHHHHhcChhhcCchhc
Confidence 999999999999999876653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=281.05 Aligned_cols=217 Identities=18% Similarity=0.275 Sum_probs=173.0
Q ss_pred CCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 4 GTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 4 ~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
+++..||||.+.. ....+.+.+|+.++++++||||++ ...+.+++||||+.+|+|.+++......++...+..
T Consensus 361 ~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~ 440 (613)
T 2ozo_A 361 KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 440 (613)
T ss_dssp SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHH
T ss_pred CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHH
Confidence 4667899999874 235678999999999999999998 234569999999999999999987667788888887
Q ss_pred HHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCC
Q 042809 77 YTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD 150 (241)
Q Consensus 77 ~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 150 (241)
++.|+ ||++|++||||||+||+++.++.+||+|||++......... ........+++.|+|||.+.+..++
T Consensus 441 i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~---~~~~~~~~~~~~y~APE~~~~~~~~ 517 (613)
T 2ozo_A 441 LLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY---YTARSAGKWPLKWYAPECINFRKFS 517 (613)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------------CCTTSCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce---eeeccCCCCccceeCHhhhcCCCCC
Confidence 77655 79999999999999999999999999999999765331111 1111223356789999999999999
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 151 FATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 151 ~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
.++||||||+++|+|++ |..||.+....... .....+.....+..+++.+.++|.+||..+|.+|||++++++
T Consensus 518 ~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~---~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 518 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH---HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999998 99999876544332 233334555667788899999999999999999999999853
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=259.05 Aligned_cols=219 Identities=20% Similarity=0.304 Sum_probs=164.1
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.+|+.||+|.+... ...+.+.+|+.++++++||||++ ..++..++|+||+++++|.+++... ..++.
T Consensus 55 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~ 133 (309)
T 2h34_A 55 DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAP 133 (309)
T ss_dssp ETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHH-CSCCH
T ss_pred EcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc-CCCCH
Confidence 4678999999997632 33577899999999999999988 5677899999999999999999874 56788
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++|+||+|+||+++.++.++|+|||++....... ........+++.|+|||.+.
T Consensus 134 ~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~ 208 (309)
T 2h34_A 134 PRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK-----LTQLGNTVGTLYYMAPERFS 208 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------------------CCGGGCCGGGTC
T ss_pred HHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc-----cccccccCCCcCccCHHHHc
Confidence 7777776655 799999999999999999999999999999987554311 11122345899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-ChHHH
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-SAEEL 224 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~~ 224 (241)
+..++.++||||||+++|++++|..||............. .........+..++..+.+++.+||+.+|.+|| |++++
T Consensus 209 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l 287 (309)
T 2h34_A 209 ESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-QAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDL 287 (309)
T ss_dssp C----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-SCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred CCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-cCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHH
Confidence 9889999999999999999999999998754432222111 111112234556778899999999999999999 78887
Q ss_pred hcC
Q 042809 225 LNH 227 (241)
Q Consensus 225 l~~ 227 (241)
++.
T Consensus 288 ~~~ 290 (309)
T 2h34_A 288 SAA 290 (309)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=260.51 Aligned_cols=218 Identities=23% Similarity=0.333 Sum_probs=169.3
Q ss_pred CCCCcE----EEEEecc---chHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 3 KGTGAL----FVVKSAE---SEAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 3 ~~~~~~----vaiK~~~---~~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
+.+|+. ||+|.+. .....+.+.+|+.++++++||||++ ......++|++|+.+|+|.+++......++.
T Consensus 37 ~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~ 116 (327)
T 3lzb_A 37 IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGS 116 (327)
T ss_dssp CCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEEEECCCSSCBHHHHHHHTTTCCCH
T ss_pred cCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceEEEEecCCCcHHHHHHhcCCCCCH
Confidence 345554 4677654 2335678999999999999999998 2344588999999999999999987778888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.++.+||+|||++........ ........+++.|+|||.+.
T Consensus 117 ~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~----~~~~~~~~~t~~y~aPE~~~ 192 (327)
T 3lzb_A 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK----EYHAEGGKVPIKWMALESIL 192 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--------------------CCCGGGSCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc----cccccCCCccccccCHHHHc
Confidence 8887777655 7999999999999999999999999999999976543211 11112334677899999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 146 NEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
+..++.++||||||+++|++++ |..||.+.......... ........+...+.++.+++++||..+|.+|||+.++
T Consensus 193 ~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 269 (327)
T 3lzb_A 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFREL 269 (327)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH---HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9999999999999999999999 99999876555543333 2344555677788899999999999999999999999
Q ss_pred hcC
Q 042809 225 LNH 227 (241)
Q Consensus 225 l~~ 227 (241)
++.
T Consensus 270 l~~ 272 (327)
T 3lzb_A 270 IIE 272 (327)
T ss_dssp HHH
T ss_pred HHH
Confidence 863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=264.92 Aligned_cols=224 Identities=29% Similarity=0.436 Sum_probs=153.6
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHH-HHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHH----hCCC
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAE-IRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEK----FGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~ 68 (241)
++.+|+.||+|.+.. ......+..|+. +++.++||||++ ...+..++||||+++ +|.+++.. ....
T Consensus 43 ~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~ 121 (327)
T 3aln_A 43 HKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDV 121 (327)
T ss_dssp ETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCC
T ss_pred EcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhccc
Confidence 467899999999864 233445556665 777889999998 567889999999974 88888764 2466
Q ss_pred CCHHHHHHHHHHH------hhcC-CccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 69 LDAGVIRLYTKEI------LHGN-GILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~-~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
++...+..++.|+ ||+. |++||||+|+||+++.++.+||+|||++....... ......|++.|+||
T Consensus 122 ~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~gt~~y~aP 194 (327)
T 3aln_A 122 IPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI-------AKTRDAGCRPYMAP 194 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--------------------------
T ss_pred CcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc-------ccccCCCCccccCc
Confidence 7787777776654 7998 99999999999999999999999999997554311 11223588999999
Q ss_pred ccc----cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCC----ChhhHHHHHHHHHHhhcc
Q 042809 142 EVL----RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHF----PTQFFKKVLDFLAKCLER 213 (241)
Q Consensus 142 E~~----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~ 213 (241)
|.+ .+..++.++||||||+++|+|++|..||...... ............+.. ...++..+.+++.+||+.
T Consensus 195 E~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 272 (327)
T 3aln_A 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTK 272 (327)
T ss_dssp -----------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCS
T ss_pred eeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhC
Confidence 998 4566889999999999999999999999753221 111111111222222 235678999999999999
Q ss_pred CCCCCCChHHHhcCCCCCCCCc
Q 042809 214 KPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 214 ~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
+|.+|||+.++++||||.....
T Consensus 273 dp~~Rps~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 273 DESKRPKYKELLKHPFILMYEE 294 (327)
T ss_dssp SGGGSCCHHHHTTSHHHHHHHH
T ss_pred ChhhCcCHHHHHhChHHHHhHh
Confidence 9999999999999999976543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=255.39 Aligned_cols=216 Identities=24% Similarity=0.423 Sum_probs=160.0
Q ss_pred cEEEEEecc----chHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 7 ALFVVKSAE----SEAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 7 ~~vaiK~~~----~~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
..||+|.+. .....+.+.+|+.++++++||||+. ......++||||+++++|.+++......++...+..++
T Consensus 47 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~ 126 (289)
T 3og7_A 47 GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 126 (289)
T ss_dssp SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHH
T ss_pred CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHH
Confidence 358999876 3445678999999999999999998 56677899999999999999997766778888877776
Q ss_pred HHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc---ccCC
Q 042809 79 KEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR---NEGL 149 (241)
Q Consensus 79 ~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~ 149 (241)
.|+ ||++|++||||||+||+++.++.++|+|||++........ ........|++.|+|||.+. +..+
T Consensus 127 ~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~ 202 (289)
T 3og7_A 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG----SHQFEQLSGSILWMAPEVIRMQDSNPY 202 (289)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------------CCCTTCCHHHHC----CCS
T ss_pred HHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc----cccccccCCCccccCchhhcccCCCCC
Confidence 655 7999999999999999999999999999999975433111 11223455899999999986 5668
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCccchhchHH-HHHHHHh-cCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 150 DFATDIWSLGCMVIEMATGRPPWGDKISNAAA-TLLKIAC-SNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
+.++||||||+++|++++|..||.+....... ....... ..........++..+.+++.+||+.+|.+|||++++++
T Consensus 203 ~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 88999999999999999999999764433222 1211111 11122334567889999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=257.50 Aligned_cols=218 Identities=18% Similarity=0.279 Sum_probs=167.4
Q ss_pred CCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cC-----CceeeeeecccCCCCHHHHHHHh---
Q 042809 3 KGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NG-----EKTVNIFMEYMAGGSLLDVAEKF--- 65 (241)
Q Consensus 3 ~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~-----~~~~~lv~e~~~~~~L~~~l~~~--- 65 (241)
..++..||+|.+.. ....+.+.+|+.++++++||||++ .. ....++||||+++++|.+++...
T Consensus 59 ~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~ 138 (313)
T 3brb_A 59 DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE 138 (313)
T ss_dssp TSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBT
T ss_pred CCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhh
Confidence 34677999999763 345677999999999999999988 11 12469999999999999999642
Q ss_pred --CCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccc
Q 042809 66 --GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL 137 (241)
Q Consensus 66 --~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (241)
...++...+..++.|+ ||++|++||||||+||+++.++.+||+|||++........ ........+++.
T Consensus 139 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~ 214 (313)
T 3brb_A 139 TGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY----YRQGRIAKMPVK 214 (313)
T ss_dssp TSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC--------------------CCGG
T ss_pred cCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccc----cCcccccCCCcc
Confidence 3568888877777655 7999999999999999999999999999999976533111 111223446788
Q ss_pred ccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 138 WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 138 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
|+|||.+.+..++.++||||||+++|+|++ |..||........... ......+..+..++..+.+++.+||..+|.
T Consensus 215 y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 291 (313)
T 3brb_A 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY---LLHGHRLKQPEDCLDELYEIMYSCWRTDPL 291 (313)
T ss_dssp GSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---HHTTCCCCCBTTCCHHHHHHHHHTTCSSGG
T ss_pred ccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH---HHcCCCCCCCccccHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999999 9999977654443322 223445566677888999999999999999
Q ss_pred CCCChHHHhcC
Q 042809 217 KRWSAEELLNH 227 (241)
Q Consensus 217 ~Rps~~~~l~~ 227 (241)
+|||+.+++++
T Consensus 292 ~Rps~~~l~~~ 302 (313)
T 3brb_A 292 DRPTFSVLRLQ 302 (313)
T ss_dssp GSCCHHHHHHH
T ss_pred hCcCHHHHHHH
Confidence 99999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=270.90 Aligned_cols=220 Identities=24% Similarity=0.397 Sum_probs=171.6
Q ss_pred CcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHh-CCCCCHHHHHHHHH
Q 042809 6 GALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDAGVIRLYTK 79 (241)
Q Consensus 6 ~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~ 79 (241)
+..||||.+... ...+.+.+|+.++++++||||++ ..+...++||||+++|+|.+++... +..++...+..++.
T Consensus 208 ~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~ 287 (452)
T 1fmk_A 208 TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287 (452)
T ss_dssp TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHH
T ss_pred CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHH
Confidence 467999998743 23577999999999999999998 3447799999999999999999753 34577777776666
Q ss_pred HH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchh
Q 042809 80 EI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT 153 (241)
Q Consensus 80 ~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 153 (241)
|+ ||++|++||||+|+||+++.++.+||+|||++....... ........++..|+|||.+.+..++.++
T Consensus 288 qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~s 362 (452)
T 1fmk_A 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-----YTARQGAKFPIKWTAPEAALYGRFTIKS 362 (452)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------------CCGGGSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-----eecccCCcccccccCHhHHhcCCCCccc
Confidence 54 799999999999999999999999999999997654311 1111223467889999999999999999
Q ss_pred hHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC--CCC
Q 042809 154 DIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH--TFI 230 (241)
Q Consensus 154 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~--p~~ 230 (241)
||||||+++|+|++ |..||.+...... ......+.....+..++..+.++|.+||+.+|.+|||++++++. .++
T Consensus 363 DvwslG~~l~el~t~g~~P~~~~~~~~~---~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 363 DVWSFGILLTELTTKGRVPYPGMVNREV---LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred cHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 99999999999999 9999977544332 22233344555677788999999999999999999999999864 455
Q ss_pred CCC
Q 042809 231 SGN 233 (241)
Q Consensus 231 ~~~ 233 (241)
...
T Consensus 440 ~~~ 442 (452)
T 1fmk_A 440 TST 442 (452)
T ss_dssp SCS
T ss_pred ccC
Confidence 443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=261.87 Aligned_cols=215 Identities=24% Similarity=0.352 Sum_probs=170.1
Q ss_pred CCCCcEE--EEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC-----
Q 042809 3 KGTGALF--VVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG----- 66 (241)
Q Consensus 3 ~~~~~~v--aiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~----- 66 (241)
+.+|..+ |+|.+.. ....+.+.+|+.++.++ +||||++ ...+..++||||+++++|.+++....
T Consensus 47 ~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 126 (327)
T 1fvr_A 47 KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 126 (327)
T ss_dssp EETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHC
T ss_pred ccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhccccccc
Confidence 4556644 8888763 33456789999999999 8999998 56778999999999999999998643
Q ss_pred ----------CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccc
Q 042809 67 ----------GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQ 130 (241)
Q Consensus 67 ----------~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 130 (241)
..++...+..++.|+ ||++|++||||||+||+++.++.+||+|||++...... ....
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~-------~~~~ 199 (327)
T 1fvr_A 127 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-------VKKT 199 (327)
T ss_dssp HHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE-------CCC-
T ss_pred ccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCcccccc-------cccc
Confidence 367888877777655 79999999999999999999999999999998643321 1112
Q ss_pred cccCcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHH
Q 042809 131 SIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAK 209 (241)
Q Consensus 131 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 209 (241)
...+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+..... .............+..++..+.+++.+
T Consensus 200 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~ 276 (327)
T 1fvr_A 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLPQGYRLEKPLNCDDEVYDLMRQ 276 (327)
T ss_dssp ---CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHGGGTCCCCCCTTBCHHHHHHHHH
T ss_pred CCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH---HHHHhhcCCCCCCCCCCCHHHHHHHHH
Confidence 2346788999999998889999999999999999998 999997754333 223333344455667788999999999
Q ss_pred hhccCCCCCCChHHHhcC
Q 042809 210 CLERKPEKRWSAEELLNH 227 (241)
Q Consensus 210 ~l~~~p~~Rps~~~~l~~ 227 (241)
||..+|.+|||+++++++
T Consensus 277 ~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 277 CWREKPYERPSFAQILVS 294 (327)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCChhhCcCHHHHHHH
Confidence 999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=266.61 Aligned_cols=218 Identities=25% Similarity=0.357 Sum_probs=170.8
Q ss_pred CCCCcE----EEEEeccch---HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 3 KGTGAL----FVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 3 ~~~~~~----vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
+.+|.. ||+|.+... .....+.+|+.++.+++||||++ ..+...++|+||+.+|+|.+++......+++
T Consensus 35 ~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~ 114 (325)
T 3kex_A 35 IPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGP 114 (325)
T ss_dssp CCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEEEECCTTCBSHHHHHSSGGGSCT
T ss_pred cCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEEEEeCCCCCHHHHHHHccccCCH
Confidence 345554 777876533 22356789999999999999998 4567799999999999999999875556777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.++.+||+|||++........ ........++..|+|||.+.
T Consensus 115 ~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~~~~~~y~aPE~~~ 190 (325)
T 3kex_A 115 QLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK----QLLYSEAKTPIKWMALESIH 190 (325)
T ss_dssp THHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT----CCC-----CCTTTSCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccc----cccccCCCCcccccChHHhc
Confidence 7666666544 7999999999999999999999999999999986543211 11223345778999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 146 NEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
+..++.++||||||+++|++++ |..||.+.......... ........+...+.++.+++.+||..+|.+|||+.++
T Consensus 191 ~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 267 (325)
T 3kex_A 191 FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL---EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKEL 267 (325)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH---HTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHH
T ss_pred cCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH---HcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9999999999999999999999 99999876544433332 2334455566677889999999999999999999999
Q ss_pred hcC
Q 042809 225 LNH 227 (241)
Q Consensus 225 l~~ 227 (241)
+++
T Consensus 268 ~~~ 270 (325)
T 3kex_A 268 ANE 270 (325)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=258.02 Aligned_cols=206 Identities=20% Similarity=0.325 Sum_probs=164.9
Q ss_pred cEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHH
Q 042809 7 ALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTK 79 (241)
Q Consensus 7 ~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 79 (241)
..||+|.+.. ....+.+.+|+.++++++||||++ ..++..++||||+++++|.+++......++...+..++.
T Consensus 41 ~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ 120 (289)
T 4fvq_A 41 TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120 (289)
T ss_dssp EEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHH
T ss_pred hhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHH
Confidence 5799999763 344678999999999999999998 567788999999999999999998665588887777766
Q ss_pred HH------hhcCCccccCCCCCcEEeecCCC--------eeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 80 EI------LHGNGILHCDLKCNNVLLGSHGD--------VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 80 ~~------Lh~~~~vH~dl~p~Nil~~~~~~--------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
|+ ||++|++||||||+||+++.++. ++|+|||.+...... ....+++.|+|||.+.
T Consensus 121 qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~~~~y~aPE~~~ 190 (289)
T 4fvq_A 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----------DILQERIPWVPPECIE 190 (289)
T ss_dssp HHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH----------HHHHHTTTTSCHHHHH
T ss_pred HHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc----------cccCCcCcccCHHHhC
Confidence 54 79999999999999999999887 999999998654321 1234688899999998
Q ss_pred c-cCCCchhhHHHHHHHHHHHHhC-CCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH
Q 042809 146 N-EGLDFATDIWSLGCMVIEMATG-RPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 146 ~-~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
+ ..++.++||||||+++|++++| ..||............. .....+...+.++.+++.+||+.+|.+|||+++
T Consensus 191 ~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 265 (289)
T 4fvq_A 191 NPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-----DRHQLPAPKAAELANLINNCMDYEPDHRPSFRA 265 (289)
T ss_dssp CGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-----TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh-----ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 7 6789999999999999999995 55554433222222111 233344555678999999999999999999999
Q ss_pred HhcC
Q 042809 224 LLNH 227 (241)
Q Consensus 224 ~l~~ 227 (241)
++++
T Consensus 266 ll~~ 269 (289)
T 4fvq_A 266 IIRD 269 (289)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=251.13 Aligned_cols=209 Identities=19% Similarity=0.310 Sum_probs=169.8
Q ss_pred CCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cC--CceeeeeecccCCCCHHHHHHHhCC-CCCHH
Q 042809 5 TGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NG--EKTVNIFMEYMAGGSLLDVAEKFGG-TLDAG 72 (241)
Q Consensus 5 ~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~--~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~ 72 (241)
+|+.||+|.+.. ....+.+.+|+.++++++||||++ .. ....++||||+++|+|.+++..... .+++.
T Consensus 32 ~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 111 (271)
T 3kmu_A 32 QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQS 111 (271)
T ss_dssp TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHH
T ss_pred CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHH
Confidence 478899999773 344677999999999999999998 23 3788999999999999999987533 47888
Q ss_pred HHHHHHHHH------hhcCC--ccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 73 VIRLYTKEI------LHGNG--ILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~--~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
.+..++.|+ ||++| ++||||+|+||+++.++.++|+|||++..... ....+++.|+|||.+
T Consensus 112 ~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-----------~~~~~t~~y~aPE~~ 180 (271)
T 3kmu_A 112 QAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----------PGRMYAPAWVAPEAL 180 (271)
T ss_dssp HHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-----------TTCBSCGGGSCHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-----------cCccCCccccChhhh
Confidence 877777655 79999 99999999999999999999998887653222 223578999999999
Q ss_pred cccCCC---chhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 145 RNEGLD---FATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 145 ~~~~~~---~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
.+..++ .++||||||+++|++++|+.||.+...... ..........+..+..++..+.+++.+||+.+|.+|||+
T Consensus 181 ~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 258 (271)
T 3kmu_A 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI--GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKF 258 (271)
T ss_dssp HSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH--HHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred ccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH--HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 875544 379999999999999999999976543332 233334455667778889999999999999999999999
Q ss_pred HHHhc
Q 042809 222 EELLN 226 (241)
Q Consensus 222 ~~~l~ 226 (241)
+++++
T Consensus 259 ~~il~ 263 (271)
T 3kmu_A 259 DMIVP 263 (271)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=254.61 Aligned_cols=217 Identities=27% Similarity=0.391 Sum_probs=163.2
Q ss_pred CCcEEEEEeccchHHHHHHHHHHHHHhh--cCCCcccc---------cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 5 TGALFVVKSAESEAGVQALRNEAEIRQS--LNSPNIGR---------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~~~~~~e~~~l~~--l~h~~i~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
+|+.||+|.+.... ...+.+|.+++.. ++||||++ ......++||||+++|+|.+++.. ..++...
T Consensus 30 ~~~~vavK~~~~~~-~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~ 106 (301)
T 3q4u_A 30 QGENVAVKIFSSRD-EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVS 106 (301)
T ss_dssp TTEEEEEEEECGGG-HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHH
T ss_pred CCEEEEEEEecccc-chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh--cccCHHH
Confidence 68899999987554 4556667777766 78999988 235678999999999999999964 5688887
Q ss_pred HHHHHHHH------hh--------cCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccccc
Q 042809 74 IRLYTKEI------LH--------GNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139 (241)
Q Consensus 74 ~~~~~~~~------Lh--------~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (241)
+..++.|+ || +.|++||||||+||+++.++.+||+|||++.......... ........||+.|+
T Consensus 107 ~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~gt~~y~ 184 (301)
T 3q4u_A 107 CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL--DVGNNPRVGTKRYM 184 (301)
T ss_dssp HHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEE--ECCCCCCCCCGGGC
T ss_pred HHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccc--ccccccccccccee
Confidence 77776654 79 9999999999999999999999999999996543311111 11122346899999
Q ss_pred Cccccccc------CCCchhhHHHHHHHHHHHHhC----------CCCCccchhc--hHHHHHHHH-hcCCCCCCC----
Q 042809 140 APEVLRNE------GLDFATDIWSLGCMVIEMATG----------RPPWGDKISN--AAATLLKIA-CSNEKPHFP---- 196 (241)
Q Consensus 140 aPE~~~~~------~~~~~~Di~slG~~l~~l~~g----------~~p~~~~~~~--~~~~~~~~~-~~~~~~~~~---- 196 (241)
|||.+.+. .++.++||||||+++|+|++| ..||...... ......... .....+..+
T Consensus 185 aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (301)
T 3q4u_A 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWF 264 (301)
T ss_dssp CHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGG
T ss_pred ChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhc
Confidence 99999876 455789999999999999999 8888553211 111122211 222333333
Q ss_pred -hhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 197 -TQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 197 -~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
...+..+.+++.+||+.+|.+|||++++++
T Consensus 265 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 265 SDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp GSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 236688999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=258.40 Aligned_cols=221 Identities=21% Similarity=0.244 Sum_probs=170.6
Q ss_pred CCCcEEEEEeccchHH---HHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC---CCCCHH
Q 042809 4 GTGALFVVKSAESEAG---VQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG---GTLDAG 72 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~ 72 (241)
.+|+.||+|.+..... ...+.+|+.+++.++||||++ ......++||||+.+++|.+++.... ..+++.
T Consensus 52 ~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 131 (326)
T 3uim_A 52 ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 131 (326)
T ss_dssp SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHH
T ss_pred cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHH
Confidence 4689999999875432 236899999999999999998 56778899999999999999998643 247777
Q ss_pred HHHHHHHHH------hhcC---CccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 73 VIRLYTKEI------LHGN---GILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~---~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
.+..++.|+ ||++ |++||||||+||+++.++.++|+|||++....... ........|++.|+|||.
T Consensus 132 ~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~gt~~y~aPE~ 206 (326)
T 3uim_A 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-----THVTTAVRGTIGHIAPEY 206 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSS-----SCEECCCCSCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccc-----ccccccccCCcCccCHHH
Confidence 777666544 7999 99999999999999999999999999997543211 112233458999999999
Q ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCccchh-----chHHHHHHHH----------hcCCCCCCChhhHHHHHHHHH
Q 042809 144 LRNEGLDFATDIWSLGCMVIEMATGRPPWGDKIS-----NAAATLLKIA----------CSNEKPHFPTQFFKKVLDFLA 208 (241)
Q Consensus 144 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~li~ 208 (241)
+.+..++.++||||||+++|++++|..||..... .......... ........+...+..+.+++.
T Consensus 207 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 286 (326)
T 3uim_A 207 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVAL 286 (326)
T ss_dssp HHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHH
T ss_pred hccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHH
Confidence 9988899999999999999999999999953211 0111111100 011122345667789999999
Q ss_pred HhhccCCCCCCChHHHhcCCC
Q 042809 209 KCLERKPEKRWSAEELLNHTF 229 (241)
Q Consensus 209 ~~l~~~p~~Rps~~~~l~~p~ 229 (241)
+||+.+|.+|||+.+++++..
T Consensus 287 ~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 287 LCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp HHTCSCGGGSCCHHHHHHHHH
T ss_pred HHhCcCCccCCCHHHHHHHhc
Confidence 999999999999999998854
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=257.98 Aligned_cols=226 Identities=24% Similarity=0.389 Sum_probs=172.0
Q ss_pred CCCCCcEEEEEecc--chHHHHHHHHHHHHHhhcCCCcccc---------cCCceeeeeecccCCCCHHHHHHHh---CC
Q 042809 2 NKGTGALFVVKSAE--SEAGVQALRNEAEIRQSLNSPNIGR---------NGEKTVNIFMEYMAGGSLLDVAEKF---GG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~--~~~~~~~~~~e~~~l~~l~h~~i~~---------~~~~~~~lv~e~~~~~~L~~~l~~~---~~ 67 (241)
++.+|+.||+|.+. .....+.+.+|+.+++.++||||++ ......++|+||+.+++|.+++... +.
T Consensus 50 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 129 (317)
T 2buj_A 50 GLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN 129 (317)
T ss_dssp ETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTC
T ss_pred ecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCC
Confidence 46789999999875 3455678999999999999999988 1455889999999999999999873 56
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCc---cccccccccCcccc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGN---LKQSWQSIGGTQLW 138 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 138 (241)
.+++..+..++.|+ ||++|++||||+|+||+++.++.++|+|||.+........... .........|++.|
T Consensus 130 ~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 209 (317)
T 2buj_A 130 FLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209 (317)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCccc
Confidence 78888887777655 7999999999999999999999999999998865432111000 00111234478999
Q ss_pred cCcccccccC---CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCC
Q 042809 139 MAPEVLRNEG---LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKP 215 (241)
Q Consensus 139 ~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 215 (241)
+|||.+.+.. ++.++||||||+++|++++|..||............ ..........+...+..+.+++.+||+.+|
T Consensus 210 ~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 288 (317)
T 2buj_A 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL-AVQNQLSIPQSPRHSSALWQLLNSMMTVDP 288 (317)
T ss_dssp CCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH-HHHCC--CCCCTTSCHHHHHHHHHHTCSSG
T ss_pred CCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH-HhhccCCCCccccCCHHHHHHHHHHhhcCh
Confidence 9999987543 688999999999999999999999653221111111 111122333345678899999999999999
Q ss_pred CCCCChHHHhcCC
Q 042809 216 EKRWSAEELLNHT 228 (241)
Q Consensus 216 ~~Rps~~~~l~~p 228 (241)
.+|||+++++++-
T Consensus 289 ~~Rps~~~ll~~L 301 (317)
T 2buj_A 289 HQRPHIPLLLSQL 301 (317)
T ss_dssp GGSCCHHHHHHHH
T ss_pred hhCCCHHHHHHHh
Confidence 9999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=258.66 Aligned_cols=216 Identities=23% Similarity=0.306 Sum_probs=171.1
Q ss_pred CcEEEEEeccch---HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHh-----------
Q 042809 6 GALFVVKSAESE---AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF----------- 65 (241)
Q Consensus 6 ~~~vaiK~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~----------- 65 (241)
++.||+|.+... ...+.+.+|+.++.++ +||||++ ...+..++||||+++|+|.+++...
T Consensus 76 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 155 (333)
T 2i1m_A 76 VLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155 (333)
T ss_dssp CCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC----
T ss_pred hhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhccccccccccc
Confidence 358999998743 4567799999999999 8999998 5677899999999999999999864
Q ss_pred --CCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccc
Q 042809 66 --GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL 137 (241)
Q Consensus 66 --~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (241)
...++...+..++.|+ ||++|++||||||+||+++.++.++|+|||++........ ........+++.
T Consensus 156 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~ 231 (333)
T 2i1m_A 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN----YIVKGNARLPVK 231 (333)
T ss_dssp ---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTT----SEECSSCEECGG
T ss_pred ccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccc----eeecCCCCCCcc
Confidence 2346777777666654 7999999999999999999999999999999975543211 111223346788
Q ss_pred ccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 138 WMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 138 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
|+|||.+.+..++.++||||||+++|+|++ |..||.+........ ...........+...+..+.+++.+||+.+|.
T Consensus 232 y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 309 (333)
T 2i1m_A 232 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY--KLVKDGYQMAQPAFAPKNIYSIMQACWALEPT 309 (333)
T ss_dssp GSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH--HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred ccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH--HHHhcCCCCCCCCCCCHHHHHHHHHHhccChh
Confidence 999999999889999999999999999998 999997654333222 22222334445566788999999999999999
Q ss_pred CCCChHHHhcC
Q 042809 217 KRWSAEELLNH 227 (241)
Q Consensus 217 ~Rps~~~~l~~ 227 (241)
+|||+++++++
T Consensus 310 ~Rps~~~l~~~ 320 (333)
T 2i1m_A 310 HRPTFQQICSF 320 (333)
T ss_dssp GSCCHHHHHHH
T ss_pred hCcCHHHHHHH
Confidence 99999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=280.03 Aligned_cols=224 Identities=25% Similarity=0.333 Sum_probs=171.1
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----c------CCceeeeeecccCCCCHHHHHHHhCC
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----N------GEKTVNIFMEYMAGGSLLDVAEKFGG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~------~~~~~~lv~e~~~~~~L~~~l~~~~~ 67 (241)
++.+|+.||+|.+.. ....+.+.+|+.++++++||||++ . ..+..++||||++||+|.+++.....
T Consensus 35 ~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~ 114 (676)
T 3qa8_A 35 HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN 114 (676)
T ss_dssp CTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSC
T ss_pred ECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhccc
Confidence 677899999998763 345677999999999999999987 1 26778999999999999999987432
Q ss_pred --CCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCC---eeecCCCcchhhcccccCCccccccccccCcc
Q 042809 68 --TLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGD---VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQ 136 (241)
Q Consensus 68 --~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (241)
.+++..+..++.+ +||+.|++||||+|+||+++.++. ++|+|||.+....... ......|++
T Consensus 115 ~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~-------~~~~~~gt~ 187 (676)
T 3qa8_A 115 CCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-------LCTEFVGTL 187 (676)
T ss_dssp TTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC-------CCCCCCSCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccccccc-------ccccccCCc
Confidence 4666666665554 489999999999999999997765 8999999997654311 123356899
Q ss_pred cccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHH------HHHHHHh--------------cCCCCCCC
Q 042809 137 LWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAA------TLLKIAC--------------SNEKPHFP 196 (241)
Q Consensus 137 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~~--------------~~~~~~~~ 196 (241)
.|+|||.+.+..++.++||||||+++|++++|..||......... ....... ...+....
T Consensus 188 ~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~ 267 (676)
T 3qa8_A 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLS 267 (676)
T ss_dssp TTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCC
T ss_pred ccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhc
Confidence 999999999999999999999999999999999999653111000 0000000 00111234
Q ss_pred hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 197 TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 197 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
..++..+.+++.+||..||.+|||++++++||||+.
T Consensus 268 ~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 268 GILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp GGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 567889999999999999999999999999999854
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=253.00 Aligned_cols=217 Identities=25% Similarity=0.369 Sum_probs=169.4
Q ss_pred CcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 6 GALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 6 ~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
+..||+|.+.. ....+.+.+|+.++++++||||++ ......++|+||+.+++|.+++......++...+..
T Consensus 46 ~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~ 125 (291)
T 1u46_A 46 TVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 125 (291)
T ss_dssp EEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHH
T ss_pred eeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCceeeEecccCCCHHHHHHhccCCcCHHHHHH
Confidence 34789998763 245678999999999999999998 334458999999999999999988666788888777
Q ss_pred HHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCC
Q 042809 77 YTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD 150 (241)
Q Consensus 77 ~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 150 (241)
++.|+ ||++|++|+||+|+||+++.++.++|+|||++........ .........++..|+|||.+.+..++
T Consensus 126 ~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~ 202 (291)
T 1u46_A 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD---HYVMQEHRKVPFAWCAPESLKTRTFS 202 (291)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC---EEEC-----CCGGGCCHHHHHHCEEE
T ss_pred HHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccccc---chhhhccCCCCceeeCchhhcCCCCC
Confidence 77655 7999999999999999999999999999999876533111 01112234467789999999988889
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 151 FATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 151 ~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
.++|+||||+++|++++ |..||.......... ...........+..++..+.+++.+||+.+|.+|||+.+++++
T Consensus 203 ~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 203 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH--KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH--HHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999999 999997754433222 2222333445566788999999999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=256.67 Aligned_cols=215 Identities=23% Similarity=0.295 Sum_probs=171.8
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCccccc---------------------CCceeeeeecccCCCCHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGRN---------------------GEKTVNIFMEYMAGGSLLD 60 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~---------------------~~~~~~lv~e~~~~~~L~~ 60 (241)
++.+|+.||+|.+.... +.+.+|+.++++++||||++. .....++||||+++++|.+
T Consensus 32 ~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 109 (284)
T 2a19_B 32 HRIDGKTYVIKRVKYNN--EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ 109 (284)
T ss_dssp ETTTCCEEEEEEEECCS--GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHH
T ss_pred EcCCCeEEEEEEecccc--HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHH
Confidence 45689999999987543 457799999999999999871 1456899999999999999
Q ss_pred HHHHh-CCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCcccccccccc
Q 042809 61 VAEKF-GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIG 133 (241)
Q Consensus 61 ~l~~~-~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 133 (241)
++... ...++...+..++.|+ ||++|++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 110 ~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~ 182 (284)
T 2a19_B 110 WIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG-------KRTRSK 182 (284)
T ss_dssp HHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS-------CCCCCC
T ss_pred HHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccc-------cccccC
Confidence 99864 3567887777776654 799999999999999999999999999999987554311 112345
Q ss_pred CcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhcc
Q 042809 134 GTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLER 213 (241)
Q Consensus 134 ~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 213 (241)
+++.|+|||.+.+..++.++||||||+++|+|++|..|+..... ....... ...+..++..+.+++.+||+.
T Consensus 183 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~~~li~~~l~~ 254 (284)
T 2a19_B 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----FFTDLRD---GIISDIFDKKEKTLLQKLLSK 254 (284)
T ss_dssp SCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-----HHHHHHT---TCCCTTSCHHHHHHHHHHTCS
T ss_pred CcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-----HHHHhhc---ccccccCCHHHHHHHHHHccC
Confidence 89999999999998899999999999999999999998754211 1111111 123455677899999999999
Q ss_pred CCCCCCChHHHhcCCCCCCC
Q 042809 214 KPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 214 ~p~~Rps~~~~l~~p~~~~~ 233 (241)
+|.+|||+.+++++++.-..
T Consensus 255 dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 255 KPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp SGGGSCCHHHHHHHHHHHTC
T ss_pred ChhhCcCHHHHHHHHHHHhh
Confidence 99999999999999865433
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=253.17 Aligned_cols=214 Identities=22% Similarity=0.358 Sum_probs=171.3
Q ss_pred CCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhC-CCCCHHHHHHHH
Q 042809 5 TGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDAGVIRLYT 78 (241)
Q Consensus 5 ~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 78 (241)
++..||+|.+... ...+.+.+|++++++++||||++ ...+..++||||+++++|.+++.... ..++...+..++
T Consensus 36 ~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~ 115 (279)
T 1qpc_A 36 GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115 (279)
T ss_dssp TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHH
T ss_pred CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHH
Confidence 4678999988743 34677999999999999999988 44567899999999999999997532 257777777666
Q ss_pred HHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCch
Q 042809 79 KEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA 152 (241)
Q Consensus 79 ~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 152 (241)
.|+ ||++|++||||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+..++.+
T Consensus 116 ~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~ 190 (279)
T 1qpc_A 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-----TAREGAKFPIKWTAPEAINYGTFTIK 190 (279)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-----ECCTTCCCCTTTSCHHHHHHCEECHH
T ss_pred HHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-----ccccCCCCccCccChhhhccCCCCch
Confidence 654 7999999999999999999999999999999975543111 11123346778999999998889999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 153 TDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 153 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
+||||||+++|++++ |..||.+....... ...........+..++..+.+++.+||+.+|.+|||++++++
T Consensus 191 ~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVI---QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhHHHHHHHHHHHhCCCCCCcccCHHHHH---HHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 999999999999999 99999765443322 222333445556678889999999999999999999999876
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=262.35 Aligned_cols=219 Identities=18% Similarity=0.207 Sum_probs=167.7
Q ss_pred CCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc---------------------cCCceeeeeecccCCCCHHHHHH
Q 042809 5 TGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR---------------------NGEKTVNIFMEYMAGGSLLDVAE 63 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~---------------------~~~~~~~lv~e~~~~~~L~~~l~ 63 (241)
+++.||+|.+... +.+.+|+.++++++||||++ ..+...++||||+ +++|.+++.
T Consensus 74 ~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~ 149 (352)
T 2jii_A 74 QKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALD 149 (352)
T ss_dssp ---CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHH
T ss_pred cCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHH
Confidence 5899999998855 46889999999999999976 2367899999999 899999999
Q ss_pred Hh-CCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCC--CeeecCCCcchhhcccccCCc-ccccccccc
Q 042809 64 KF-GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG--DVKLPDLGCARRVNDLKNNGN-LKQSWQSIG 133 (241)
Q Consensus 64 ~~-~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~ 133 (241)
.. ...+++..+..++.|+ ||++|++||||||+||+++.++ .++|+|||++........... .........
T Consensus 150 ~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~ 229 (352)
T 2jii_A 150 VSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHE 229 (352)
T ss_dssp HSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTC
T ss_pred hCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCcccccccccccccc
Confidence 74 3678888888777765 7999999999999999999988 899999999976544222111 111123346
Q ss_pred CcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhch-HHHHHHHHhcCCCCCCC------hhhHHHHHHH
Q 042809 134 GTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNA-AATLLKIACSNEKPHFP------TQFFKKVLDF 206 (241)
Q Consensus 134 ~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~~l 206 (241)
|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ...............+. ..++..+.++
T Consensus 230 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 309 (352)
T 2jii_A 230 GDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKY 309 (352)
T ss_dssp SCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHH
T ss_pred CCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHH
Confidence 8999999999999899999999999999999999999998753221 11111111111112111 2357899999
Q ss_pred HHHhhccCCCCCCChHHHhcC
Q 042809 207 LAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 207 i~~~l~~~p~~Rps~~~~l~~ 227 (241)
+.+||..+|.+|||++++++.
T Consensus 310 i~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 310 LKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp HHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHhCChhhCCCHHHHHHH
Confidence 999999999999999998753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=267.77 Aligned_cols=219 Identities=25% Similarity=0.384 Sum_probs=168.7
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHHhC--CCC
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFG--GTL 69 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~ 69 (241)
++.+|+.||+|.+... ...+.+.+|++++++++||||++ ......++||||+++|+|.+++.... ..+
T Consensus 30 ~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l 109 (396)
T 4eut_A 30 HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL 109 (396)
T ss_dssp ETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCC
T ss_pred ECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCC
Confidence 5678999999998743 33567889999999999999988 23447899999999999999998643 237
Q ss_pred CHHHHHHHHHHH------hhcCCccccCCCCCcEEe----ecCCCeeecCCCcchhhcccccCCccccccccccCccccc
Q 042809 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLL----GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (241)
++..+..++.|+ ||++|++||||||+||++ +.++.+||+|||++...... .......|++.|+
T Consensus 110 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~-------~~~~~~~gt~~y~ 182 (396)
T 4eut_A 110 PESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-------EQFVSLYGTEEYL 182 (396)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG-------GGSSCSSSCCTTC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC-------CccccccCCcccc
Confidence 888877777655 799999999999999999 66677999999999755431 1223355899999
Q ss_pred Ccccccc--------cCCCchhhHHHHHHHHHHHHhCCCCCccchhc-hHHHHHHHHhcCCC------------------
Q 042809 140 APEVLRN--------EGLDFATDIWSLGCMVIEMATGRPPWGDKISN-AAATLLKIACSNEK------------------ 192 (241)
Q Consensus 140 aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~------------------ 192 (241)
|||.+.+ ..++.++||||||+++|++++|..||...... .............+
T Consensus 183 aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 262 (396)
T 4eut_A 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWS 262 (396)
T ss_dssp CHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEE
T ss_pred CHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccC
Confidence 9999865 55778999999999999999999999643221 11122222211111
Q ss_pred ------CCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 193 ------PHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 193 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
...+...+..+.+++++||..||.+|||+++++++
T Consensus 263 ~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 263 GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred ccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 12335677899999999999999999999998643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=255.40 Aligned_cols=206 Identities=29% Similarity=0.433 Sum_probs=157.6
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHH-hhcCCCcccc---------cCCceeeeeecccCCCCHHHHHHHhC-CCCC
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIR-QSLNSPNIGR---------NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l-~~l~h~~i~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~ 70 (241)
++.+|+.||+|.+... ..+.+|+.++ +.++||||++ ......++||||+++++|.+++.... ..++
T Consensus 39 ~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 115 (299)
T 3m2w_A 39 NKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT 115 (299)
T ss_dssp ETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCB
T ss_pred EcCCCcEEEEEEeccc---HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCC
Confidence 5678999999998753 3466888887 5568999988 23678999999999999999999753 3688
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeec---CCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS---HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
+..+..++.|+ ||++|++||||||+||+++. ++.++|+|||++....
T Consensus 116 ~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------ 171 (299)
T 3m2w_A 116 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------------ 171 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------------
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc------------------------
Confidence 88888777755 79999999999999999988 7889999999885321
Q ss_pred ccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC----hhhHHHHHHHHHHhhccCCCC
Q 042809 142 EVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP----TQFFKKVLDFLAKCLERKPEK 217 (241)
Q Consensus 142 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~ 217 (241)
+..++.++||||||+++|+|++|..||.......................+ ..++.++.+++.+||+.+|.+
T Consensus 172 ----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 247 (299)
T 3m2w_A 172 ----GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 247 (299)
T ss_dssp ----TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTT
T ss_pred ----cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhh
Confidence 134678999999999999999999999764322211000001111112222 346789999999999999999
Q ss_pred CCChHHHhcCCCCCCCCccCC
Q 042809 218 RWSAEELLNHTFISGNAKKNS 238 (241)
Q Consensus 218 Rps~~~~l~~p~~~~~~~~~~ 238 (241)
|||++++++||||+.......
T Consensus 248 Rps~~e~l~hp~~~~~~~~~~ 268 (299)
T 3m2w_A 248 RMTITEFMNHPWIMQSTKVPQ 268 (299)
T ss_dssp SCCHHHHHTSHHHHTGGGSCC
T ss_pred CCCHHHHhcChhhcccccCCC
Confidence 999999999999988765444
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=273.81 Aligned_cols=216 Identities=24% Similarity=0.339 Sum_probs=172.9
Q ss_pred CCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 4 GTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 4 ~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
..+..||+|.... ....+.+.+|+.++++++||||++ ..++..++||||+++|+|.+++...+..++...+..
T Consensus 416 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~ 495 (656)
T 2j0j_A 416 NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLIL 495 (656)
T ss_dssp SCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHH
T ss_pred CccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHH
Confidence 3467899998763 344577999999999999999998 455678999999999999999998666788887777
Q ss_pred HHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCC
Q 042809 77 YTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD 150 (241)
Q Consensus 77 ~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 150 (241)
++.|+ ||++|++||||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+..++
T Consensus 496 i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~ 570 (656)
T 2j0j_A 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-----YKASKGKLPIKWMAPESINFRRFT 570 (656)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---------------CCGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc-----eeccCCCCCcceeCHHHhcCCCCC
Confidence 66654 7999999999999999999999999999999976543211 111223467889999999998999
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 151 FATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 151 ~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
.++||||||+++|+|++ |..||.+......... .........+..+++.+.+++.+||+.+|.+|||+.++++.
T Consensus 571 ~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 571 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999997 9999987544333222 22344555677888999999999999999999999999863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=250.70 Aligned_cols=218 Identities=23% Similarity=0.311 Sum_probs=169.9
Q ss_pred CCcEEEEEeccc------hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh--CCCCCH
Q 042809 5 TGALFVVKSAES------EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF--GGTLDA 71 (241)
Q Consensus 5 ~~~~vaiK~~~~------~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~ 71 (241)
+|+.||+|.+.. +...+.+.+|+.++++++||||++ ...+..++||||+++++|.+++... ...++.
T Consensus 53 ~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 132 (307)
T 2nru_A 53 NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132 (307)
T ss_dssp SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCH
T ss_pred CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCH
Confidence 678999998753 334678999999999999999988 5677899999999999999999753 345787
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||+|+||+++.++.++|+|||++........ ........|++.|+|||.+.
T Consensus 133 ~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~ 208 (307)
T 2nru_A 133 HMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ----TVMTSRIVGTTAYMAPEALR 208 (307)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS----CEECSSCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc----cccccccCCCcCcCChHHhc
Confidence 7777666544 7999999999999999999999999999999875433111 11122345899999999987
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHH-H----------HHhcCCCCCCChhhHHHHHHHHHHhhccC
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLL-K----------IACSNEKPHFPTQFFKKVLDFLAKCLERK 214 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 214 (241)
+. ++.++|+||||+++|++++|..||............ . ..........+...+..+.+++.+||+.+
T Consensus 209 ~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 287 (307)
T 2nru_A 209 GE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEK 287 (307)
T ss_dssp TE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSS
T ss_pred CC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCC
Confidence 64 788999999999999999999999764332211111 1 11112233456677889999999999999
Q ss_pred CCCCCChHHHhcC
Q 042809 215 PEKRWSAEELLNH 227 (241)
Q Consensus 215 p~~Rps~~~~l~~ 227 (241)
|.+|||+++++++
T Consensus 288 p~~Rps~~~l~~~ 300 (307)
T 2nru_A 288 KNKRPDIKKVQQL 300 (307)
T ss_dssp TTTSCCHHHHHHH
T ss_pred cccCcCHHHHHHH
Confidence 9999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=260.24 Aligned_cols=221 Identities=19% Similarity=0.211 Sum_probs=164.0
Q ss_pred CCcEEEEEeccchHH-------------HHHHHHHHHHHhhcCCCcccc---------cCCceeeeeecccCCCCHHHHH
Q 042809 5 TGALFVVKSAESEAG-------------VQALRNEAEIRQSLNSPNIGR---------NGEKTVNIFMEYMAGGSLLDVA 62 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~-------------~~~~~~e~~~l~~l~h~~i~~---------~~~~~~~lv~e~~~~~~L~~~l 62 (241)
+++.||+|.+..... ...+.+|+..+..++||||++ ......++||||+ +++|.+++
T Consensus 64 ~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~ 142 (364)
T 3op5_A 64 SDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIY 142 (364)
T ss_dssp TTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHH
T ss_pred cccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHH
Confidence 468999999764321 012334556677788999988 1235689999999 89999999
Q ss_pred HHhCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEee--cCCCeeecCCCcchhhcccccCCcc-cccccccc
Q 042809 63 EKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG--SHGDVKLPDLGCARRVNDLKNNGNL-KQSWQSIG 133 (241)
Q Consensus 63 ~~~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~--~~~~~kl~dfg~~~~~~~~~~~~~~-~~~~~~~~ 133 (241)
......+++..+..++.|+ ||++|++||||||+||+++ .++.+||+|||++............ ........
T Consensus 143 ~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~ 222 (364)
T 3op5_A 143 EANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHD 222 (364)
T ss_dssp HHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCC
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccC
Confidence 9876789998888887765 7999999999999999999 8899999999999765442221111 11123455
Q ss_pred CcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHH-HHHHhcCCCCC------CChhhHHHHHHH
Q 042809 134 GTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATL-LKIACSNEKPH------FPTQFFKKVLDF 206 (241)
Q Consensus 134 ~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~~~l 206 (241)
||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+......... ........... .....+.++.++
T Consensus 223 gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 302 (364)
T 3op5_A 223 GTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKY 302 (364)
T ss_dssp CCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHH
T ss_pred CCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHH
Confidence 89999999999999999999999999999999999999986433222111 11110000000 013346789999
Q ss_pred HHHhhccCCCCCCChHHHhc
Q 042809 207 LAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 207 i~~~l~~~p~~Rps~~~~l~ 226 (241)
+..||+.+|.+|||++++++
T Consensus 303 i~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 303 METVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhcCCCCCCCCHHHHHH
Confidence 99999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=271.61 Aligned_cols=219 Identities=24% Similarity=0.391 Sum_probs=174.4
Q ss_pred CcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHh-CCCCCHHHHHHHHH
Q 042809 6 GALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDAGVIRLYTK 79 (241)
Q Consensus 6 ~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~ 79 (241)
+..||||.+... ...+.+.+|+.+|++++||||++ ..+...++||||+.+|+|.+++... +..++...+..++.
T Consensus 291 ~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ 370 (535)
T 2h8h_A 291 TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370 (535)
T ss_dssp TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHH
T ss_pred CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHH
Confidence 467999998743 33577999999999999999998 3447799999999999999999753 34577777776666
Q ss_pred HH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchh
Q 042809 80 EI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT 153 (241)
Q Consensus 80 ~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 153 (241)
|+ ||++|++||||+|+||+++.++.+||+|||++........ .......++..|+|||.+.+..++.++
T Consensus 371 qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~s 445 (535)
T 2h8h_A 371 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-----TARQGAKFPIKWTAPEAALYGRFTIKS 445 (535)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-----HTTCSTTSCGGGSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-----ecccCCcCcccccCHHHhccCCCCchh
Confidence 54 7999999999999999999999999999999976533110 111223357789999999999999999
Q ss_pred hHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC--CCC
Q 042809 154 DIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH--TFI 230 (241)
Q Consensus 154 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~--p~~ 230 (241)
||||||+++|+|++ |..||.+....... .....+.....+..++..+.+||.+||+.+|.+|||++++++. .++
T Consensus 446 DvwSlGv~l~el~t~g~~P~~~~~~~~~~---~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 446 DVWSFGILLTELTTKGRVPYPGMVNREVL---DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp HHHHHHHHHHHHTTTTCCSSTTCCHHHHH---HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 99999999999999 99999775443332 2223344455667788899999999999999999999999864 455
Q ss_pred CC
Q 042809 231 SG 232 (241)
Q Consensus 231 ~~ 232 (241)
..
T Consensus 523 ~~ 524 (535)
T 2h8h_A 523 TS 524 (535)
T ss_dssp CC
T ss_pred hc
Confidence 43
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=254.08 Aligned_cols=232 Identities=23% Similarity=0.279 Sum_probs=158.6
Q ss_pred CCCcEEEEEeccchHHHHHHHHHHHH--HhhcCCCcccc----------cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 4 GTGALFVVKSAESEAGVQALRNEAEI--RQSLNSPNIGR----------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~~~~~~~~e~~~--l~~l~h~~i~~----------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
.+|+.||+|++.... ...+..|.++ +..++||||++ .....+++||||+++|+|.+++... ..+.
T Consensus 34 ~~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~ 110 (336)
T 3g2f_A 34 LDERPVAVKVFSFAN-RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDW 110 (336)
T ss_dssp ETTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC--CBCH
T ss_pred ECCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc--ccch
Confidence 368899999987543 3334444444 55689999987 3345789999999999999999873 3466
Q ss_pred HHHHHHHHH------HhhcC---------CccccCCCCCcEEeecCCCeeecCCCcchhhcccccCC--ccccccccccC
Q 042809 72 GVIRLYTKE------ILHGN---------GILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG--NLKQSWQSIGG 134 (241)
Q Consensus 72 ~~~~~~~~~------~Lh~~---------~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~ 134 (241)
..+..++.| +||+. |++||||||+||+++.++.+||+|||++.......... ..........|
T Consensus 111 ~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~g 190 (336)
T 3g2f_A 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTS
T ss_pred hHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCC
Confidence 655555554 47999 99999999999999999999999999997553311100 11112234468
Q ss_pred cccccCcccccc-------cCCCchhhHHHHHHHHHHHHhCCCCCccchhc---------------hHHHH-HHHHhcCC
Q 042809 135 TQLWMAPEVLRN-------EGLDFATDIWSLGCMVIEMATGRPPWGDKISN---------------AAATL-LKIACSNE 191 (241)
Q Consensus 135 ~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------------~~~~~-~~~~~~~~ 191 (241)
|+.|+|||.+.+ ..++.++||||||+++|+|++|..||...... ..... ........
T Consensus 191 t~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (336)
T 3g2f_A 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQ 270 (336)
T ss_dssp CGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC
T ss_pred ccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhccccc
Confidence 999999999976 45667899999999999999997665321110 00011 11111222
Q ss_pred CCCCCh------hhHHHHHHHHHHhhccCCCCCCChHHH------hcCCCCCCCCccCC
Q 042809 192 KPHFPT------QFFKKVLDFLAKCLERKPEKRWSAEEL------LNHTFISGNAKKNS 238 (241)
Q Consensus 192 ~~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~~------l~~p~~~~~~~~~~ 238 (241)
.+.++. ..+..+.+||.+||+.+|.+|||++++ +.++|-++.....+
T Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~~~~ 329 (336)
T 3g2f_A 271 RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPT 329 (336)
T ss_dssp CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-------
T ss_pred CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcccCCCc
Confidence 233332 356789999999999999999999999 55788877665444
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=266.73 Aligned_cols=224 Identities=16% Similarity=0.198 Sum_probs=174.1
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
++.+|+.||||++........+.+|+++++.+.|++.+. ......++||||+ +++|.+++......+++..+.
T Consensus 28 ~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~ 106 (483)
T 3sv0_A 28 NIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVL 106 (483)
T ss_dssp ETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHH
T ss_pred ECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHH
Confidence 467899999999876655567899999999999766544 5677889999999 899999999777789998888
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEe---ecCCCeeecCCCcchhhcccccCCc-cccccccccCcccccCccccc
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLL---GSHGDVKLPDLGCARRVNDLKNNGN-LKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~ 145 (241)
.++.|+ ||++|++||||||+||++ +.++.+||+|||++........... .........|++.|+|||.+.
T Consensus 107 ~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 186 (483)
T 3sv0_A 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHL 186 (483)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT
T ss_pred HHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhc
Confidence 887765 799999999999999999 5789999999999986544222111 111223566899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHH----HHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATL----LKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
+..++.++||||||+++|+|++|..||.+......... ............+..++.++.+++.+||+.+|.+||++
T Consensus 187 ~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~ 266 (483)
T 3sv0_A 187 GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 266 (483)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCH
T ss_pred CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCH
Confidence 99999999999999999999999999976433222111 11111111112223456789999999999999999999
Q ss_pred HHHhc
Q 042809 222 EELLN 226 (241)
Q Consensus 222 ~~~l~ 226 (241)
+++++
T Consensus 267 ~el~~ 271 (483)
T 3sv0_A 267 SYLKR 271 (483)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=257.60 Aligned_cols=222 Identities=20% Similarity=0.250 Sum_probs=166.3
Q ss_pred CCCcEEEEEeccchH-------------HHHHHHHHHHHHhhcCCCcccc---------cCCceeeeeecccCCCCHHHH
Q 042809 4 GTGALFVVKSAESEA-------------GVQALRNEAEIRQSLNSPNIGR---------NGEKTVNIFMEYMAGGSLLDV 61 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~-------------~~~~~~~e~~~l~~l~h~~i~~---------~~~~~~~lv~e~~~~~~L~~~ 61 (241)
.++..+|+|...... ....+.+|+..+..++||||++ ......|+||||+ +++|.++
T Consensus 63 ~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~ 141 (345)
T 2v62_A 63 EKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKI 141 (345)
T ss_dssp GGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHH
T ss_pred CccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHH
Confidence 378999999876421 1123567888899999999988 1267899999999 8999999
Q ss_pred HHHhCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCC--CeeecCCCcchhhcccccCCc-cccccccc
Q 042809 62 AEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG--DVKLPDLGCARRVNDLKNNGN-LKQSWQSI 132 (241)
Q Consensus 62 l~~~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~ 132 (241)
+...+ .+++..+..++.|+ ||++|++||||||+||+++.++ .+||+|||++........... ........
T Consensus 142 l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~ 220 (345)
T 2v62_A 142 SGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220 (345)
T ss_dssp CBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCS
T ss_pred HHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhcccccc
Confidence 98743 78888887777655 7999999999999999999887 999999999976543222111 11122345
Q ss_pred cCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchH-HHHHHHHhcCCCCC------CChhhHHHHHH
Q 042809 133 GGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAA-ATLLKIACSNEKPH------FPTQFFKKVLD 205 (241)
Q Consensus 133 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~~~ 205 (241)
.|++.|+|||.+.+..++.++||||||+++|+|++|..||........ ............+. ....++..+.+
T Consensus 221 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 300 (345)
T 2v62_A 221 NGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQ 300 (345)
T ss_dssp CSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHH
T ss_pred CCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHH
Confidence 689999999999999899999999999999999999999965322221 11111111111110 01146678999
Q ss_pred HHHHhhccCCCCCCChHHHhcC
Q 042809 206 FLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 206 li~~~l~~~p~~Rps~~~~l~~ 227 (241)
++.+||..+|.+|||++++++.
T Consensus 301 li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 301 FLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHhhcCcccCCCHHHHHHH
Confidence 9999999999999999998753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=248.37 Aligned_cols=218 Identities=25% Similarity=0.367 Sum_probs=158.8
Q ss_pred CCcEEEEEeccchHHHHHHHHHHHHHhh--cCCCcccc-----cCC----ceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 5 TGALFVVKSAESEAGVQALRNEAEIRQS--LNSPNIGR-----NGE----KTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~~~~~~e~~~l~~--l~h~~i~~-----~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
+|+.||+|.+.... .....+|.+++.. ++||||++ ... ...++||||+++|+|.+++.. ..++...
T Consensus 59 ~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~ 135 (337)
T 3mdy_A 59 RGEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKS 135 (337)
T ss_dssp TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHH
T ss_pred CCceEEEEEEeccc-cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc--cCCCHHH
Confidence 48899999987544 3344455555554 48999988 122 689999999999999999986 4678877
Q ss_pred HHHHHHHH------hhcC--------CccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccccc
Q 042809 74 IRLYTKEI------LHGN--------GILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139 (241)
Q Consensus 74 ~~~~~~~~------Lh~~--------~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (241)
+..++.|+ ||++ |++||||||+||+++.++.+||+|||++........... .......|++.|+
T Consensus 136 ~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~~~~~gt~~y~ 213 (337)
T 3mdy_A 136 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD--IPPNTRVGTKRYM 213 (337)
T ss_dssp HHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCSSCSCGGGC
T ss_pred HHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeecccccccc--CCCCCCccCccee
Confidence 77776654 7988 999999999999999999999999999965433211111 1112346899999
Q ss_pred CcccccccCCCch------hhHHHHHHHHHHHHhC----------CCCCccchhc--hHHHHHH-HHhcCCCCCCCh---
Q 042809 140 APEVLRNEGLDFA------TDIWSLGCMVIEMATG----------RPPWGDKISN--AAATLLK-IACSNEKPHFPT--- 197 (241)
Q Consensus 140 aPE~~~~~~~~~~------~Di~slG~~l~~l~~g----------~~p~~~~~~~--~~~~~~~-~~~~~~~~~~~~--- 197 (241)
|||.+.+...+.. +||||||+++|+|++| +.||...... ....... .......+..+.
T Consensus 214 aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (337)
T 3mdy_A 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWS 293 (337)
T ss_dssp CHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGG
T ss_pred ChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccch
Confidence 9999987665544 9999999999999999 7777543211 1111111 122233344443
Q ss_pred --hhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 198 --QFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 198 --~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
.++..+.+++.+||+.+|.+|||+++++++
T Consensus 294 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 294 SDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp GSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 567889999999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=249.20 Aligned_cols=218 Identities=25% Similarity=0.357 Sum_probs=165.0
Q ss_pred CCcEEEEEeccchHHHHHHHHHHHHHhh--cCCCcccc-----cCC----ceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 5 TGALFVVKSAESEAGVQALRNEAEIRQS--LNSPNIGR-----NGE----KTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~~~~~~e~~~l~~--l~h~~i~~-----~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
+|+.||+|.+.... ...+.+|++++.. ++||||++ ... ...++||||+++|+|.+++.. ..++...
T Consensus 64 ~~~~vavK~~~~~~-~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~ 140 (342)
T 1b6c_B 64 RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEG 140 (342)
T ss_dssp TTEEEEEEEECGGG-HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHH
T ss_pred cCccEEEEEeCchh-HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHH
Confidence 58899999987554 4667888899887 78999988 222 279999999999999999986 4577777
Q ss_pred HHHHHHHH------hh--------cCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccccc
Q 042809 74 IRLYTKEI------LH--------GNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139 (241)
Q Consensus 74 ~~~~~~~~------Lh--------~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (241)
+..++.|+ || +.|++||||||+||+++.++.+||+|||++......... .........|++.|+
T Consensus 141 ~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~gt~~y~ 218 (342)
T 1b6c_B 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT--IDIAPNHRVGTKRYM 218 (342)
T ss_dssp HHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTE--EEECCCSCCCCGGGC
T ss_pred HHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccc--cccccccCCcCcccC
Confidence 77776655 79 899999999999999999999999999999754432110 001123346899999
Q ss_pred Cccccccc------CCCchhhHHHHHHHHHHHHhC----------CCCCccchhc--hHHHHHHHH-hcCCCCCCCh---
Q 042809 140 APEVLRNE------GLDFATDIWSLGCMVIEMATG----------RPPWGDKISN--AAATLLKIA-CSNEKPHFPT--- 197 (241)
Q Consensus 140 aPE~~~~~------~~~~~~Di~slG~~l~~l~~g----------~~p~~~~~~~--~~~~~~~~~-~~~~~~~~~~--- 197 (241)
|||.+.+. .++.++||||||+++|+|++| ..||...... ......... .....+..+.
T Consensus 219 aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (342)
T 1b6c_B 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQ 298 (342)
T ss_dssp CHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGG
T ss_pred CHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCccccc
Confidence 99999765 234689999999999999999 7888654221 112222222 2233344443
Q ss_pred --hhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 198 --QFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 198 --~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
..+..+.+++.+||+.+|.+|||+++++++
T Consensus 299 ~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 299 SCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 456789999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=253.84 Aligned_cols=212 Identities=16% Similarity=0.192 Sum_probs=164.2
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcC---CCcccc-----cCCceeeeeecccCCCCHHHHHHHh----CCCC
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLN---SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF----GGTL 69 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~---h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~ 69 (241)
+..+++.||+|.+.... ...+.+|+.++..+. |+||+. ...+..|+||||+++|+|.+++... ...+
T Consensus 91 ~~~~~~~vavK~~~~~~-~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l 169 (365)
T 3e7e_A 91 DAKNKQKFVLKVQKPAN-PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVM 169 (365)
T ss_dssp ---CCCCEEEEEESSCC-HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSC
T ss_pred ccccCcEEEEEEeCCCC-hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCC
Confidence 46789999999988543 556788888888887 899987 5678899999999999999999862 4568
Q ss_pred CHHHHHHHHHHH------hhcCCccccCCCCCcEEeec-----------CCCeeecCCCcchhhcccccCCccccccccc
Q 042809 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS-----------HGDVKLPDLGCARRVNDLKNNGNLKQSWQSI 132 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~-----------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 132 (241)
++..+..++.|+ ||++|++||||||+||+++. ++.+||+|||++........ .......
T Consensus 170 ~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~----~~~~~~~ 245 (365)
T 3e7e_A 170 PQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK----GTIFTAK 245 (365)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCT----TEEECCS
T ss_pred CHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCC----Cceeeee
Confidence 888888877755 79999999999999999998 89999999999965432111 1223445
Q ss_pred cCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhc
Q 042809 133 GGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLE 212 (241)
Q Consensus 133 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 212 (241)
.||+.|+|||.+.+..++.++||||||+++|+|++|+.||......... ........ ..++.+.+++..|++
T Consensus 246 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~~~~~~~--~~~~~~~~~~~~~l~ 317 (365)
T 3e7e_A 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK------PEGLFRRL--PHLDMWNEFFHVMLN 317 (365)
T ss_dssp SCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE------ECSCCTTC--SSHHHHHHHHHHHHC
T ss_pred cCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee------echhcccc--CcHHHHHHHHHHHcC
Confidence 6899999999999999999999999999999999999999654332110 00111111 246678899999999
Q ss_pred cCCCCCCChHHHhc
Q 042809 213 RKPEKRWSAEELLN 226 (241)
Q Consensus 213 ~~p~~Rps~~~~l~ 226 (241)
.+|.+|++..+.+.
T Consensus 318 ~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 318 IPDCHHLPSLDLLR 331 (365)
T ss_dssp CCCTTCCCCHHHHH
T ss_pred CCCCCcchHHHHHH
Confidence 99999975544443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=250.90 Aligned_cols=220 Identities=24% Similarity=0.395 Sum_probs=152.1
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcC-CCcccc-------------cCCceeeeeecccCCCCHHHHHHH-
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLN-SPNIGR-------------NGEKTVNIFMEYMAGGSLLDVAEK- 64 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~-------------~~~~~~~lv~e~~~~~~L~~~l~~- 64 (241)
++.+|+.||+|.+.. ......+.+|+.++.++. ||||++ ......++||||+. |+|.+++..
T Consensus 49 ~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~ 127 (337)
T 3ll6_A 49 DVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKM 127 (337)
T ss_dssp ETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHH
T ss_pred ECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHh
Confidence 467899999998753 344677899999999996 999987 23456899999996 699998875
Q ss_pred -hCCCCCHHHHHHHHHHH------hhcCC--ccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCc------ccccc
Q 042809 65 -FGGTLDAGVIRLYTKEI------LHGNG--ILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGN------LKQSW 129 (241)
Q Consensus 65 -~~~~~~~~~~~~~~~~~------Lh~~~--~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~------~~~~~ 129 (241)
....+++..+..++.|+ ||++| ++||||||+||+++.++.+||+|||++........... .....
T Consensus 128 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~ 207 (337)
T 3ll6_A 128 ESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207 (337)
T ss_dssp HTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC---------------
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhh
Confidence 34568888887777655 79999 99999999999999999999999999976543211110 00111
Q ss_pred ccccCcccccCcccc---cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHH
Q 042809 130 QSIGGTQLWMAPEVL---RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDF 206 (241)
Q Consensus 130 ~~~~~~~~~~aPE~~---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 206 (241)
....+++.|+|||.+ .+..++.++||||||+++|++++|..||....... ... .......+...+..+.+|
T Consensus 208 ~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~---~~~~~~~~~~~~~~~~~l 281 (337)
T 3ll6_A 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---IVN---GKYSIPPHDTQYTVFHSL 281 (337)
T ss_dssp ----------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------------CCCCTTCCSSGGGHHH
T ss_pred ccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---hhc---CcccCCcccccchHHHHH
Confidence 234589999999998 56678899999999999999999999997643221 111 111222234455678999
Q ss_pred HHHhhccCCCCCCChHHHhcCC
Q 042809 207 LAKCLERKPEKRWSAEELLNHT 228 (241)
Q Consensus 207 i~~~l~~~p~~Rps~~~~l~~p 228 (241)
+.+||+.+|.+|||+++++++.
T Consensus 282 i~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 282 IRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp HHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHHH
Confidence 9999999999999999999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=249.23 Aligned_cols=216 Identities=22% Similarity=0.290 Sum_probs=161.5
Q ss_pred EEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 8 LFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 8 ~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
.+|+|.+.. ....+.+.+|+.++++++||||++ ......++||||+++++|.+++...+..++...+..++
T Consensus 57 ~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~ 136 (319)
T 2y4i_B 57 EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIA 136 (319)
T ss_dssp SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHH
T ss_pred eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHH
Confidence 478888763 223456789999999999999988 56678999999999999999998766678877777776
Q ss_pred HHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc------
Q 042809 79 KEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN------ 146 (241)
Q Consensus 79 ~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------ 146 (241)
.|+ ||++|++||||+|+||+++ ++.++|+|||++.......... .........|++.|+|||.+.+
T Consensus 137 ~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 214 (319)
T 2y4i_B 137 QEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR-REDKLRIQNGWLCHLAPEIIRQLSPDTE 214 (319)
T ss_dssp HHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----------CCSCBCCSGGGGTSCHHHHSCBSCC--
T ss_pred HHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccc-cccccccCCCcccccChHHhhhcccccc
Confidence 655 7999999999999999997 7899999999987543221111 1122233458899999999874
Q ss_pred ---cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH
Q 042809 147 ---EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 147 ---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
..++.++||||||+++|++++|..||............ .........+..++..+.+++.+||..+|.+|||+.+
T Consensus 215 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 292 (319)
T 2y4i_B 215 EDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM--GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTK 292 (319)
T ss_dssp CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH--HTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHH
T ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh--ccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 34788999999999999999999999775443332222 1222222223356778999999999999999999999
Q ss_pred HhcC
Q 042809 224 LLNH 227 (241)
Q Consensus 224 ~l~~ 227 (241)
+++.
T Consensus 293 l~~~ 296 (319)
T 2y4i_B 293 LMDM 296 (319)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9864
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=258.85 Aligned_cols=212 Identities=18% Similarity=0.156 Sum_probs=158.2
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCC-Ccccc-------------------------------cCCc
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNS-PNIGR-------------------------------NGEK 44 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h-~~i~~-------------------------------~~~~ 44 (241)
|+.+|+.||||++.. ....+.+.+|+.++..+.| +|... ....
T Consensus 99 ~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (413)
T 3dzo_A 99 DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 178 (413)
T ss_dssp ETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CC
T ss_pred ecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCcccccc
Confidence 567899999999772 2235678999999999987 32210 0123
Q ss_pred eeeeeecccCCCCHHHHHHHh------CCCCCHHHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCc
Q 042809 45 TVNIFMEYMAGGSLLDVAEKF------GGTLDAGVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGC 112 (241)
Q Consensus 45 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~ 112 (241)
..+++|+++ +++|.+++... +..+++..+..++. ++||++|++||||||+||+++.++.+||+|||+
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~ 257 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGG
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccc
Confidence 467777777 57999988532 23344555555544 448999999999999999999999999999999
Q ss_pred chhhcccccCCccccccccccCcccccCcccc----------cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHH
Q 042809 113 ARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL----------RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAAT 182 (241)
Q Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 182 (241)
+...... .....| +.|+|||.+ .+..++.++||||||+++|+|++|+.||..........
T Consensus 258 a~~~~~~---------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~ 327 (413)
T 3dzo_A 258 LVRDGAS---------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE 327 (413)
T ss_dssp CEETTEE---------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG
T ss_pred eeecCCc---------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH
Confidence 8755442 233457 899999999 55567889999999999999999999997653322111
Q ss_pred HHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 183 LLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
. .. . ....++..+.+||.+||+.+|.+|||+.++++||||+.
T Consensus 328 ~---~~-~----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 328 W---IF-R----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp G---GG-S----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred H---HH-h----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 1 01 1 11245678999999999999999999999999999964
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=246.43 Aligned_cols=208 Identities=19% Similarity=0.214 Sum_probs=156.8
Q ss_pred CCcEEEEEeccchH----------HHHHHHHHHHHHhhcC--------------------------CCcccc-----c--
Q 042809 5 TGALFVVKSAESEA----------GVQALRNEAEIRQSLN--------------------------SPNIGR-----N-- 41 (241)
Q Consensus 5 ~~~~vaiK~~~~~~----------~~~~~~~e~~~l~~l~--------------------------h~~i~~-----~-- 41 (241)
+|+.||||.+.... ..+.+.+|+.+++.++ ||||++ .
T Consensus 42 ~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~ 121 (336)
T 2vuw_A 42 DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST 121 (336)
T ss_dssp TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHH
T ss_pred CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhh
Confidence 68999999987432 2377889999999886 455544 1
Q ss_pred -----------CCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHHH------hh-cCCccccCCCCCcEEeecCC
Q 042809 42 -----------GEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LH-GNGILHCDLKCNNVLLGSHG 103 (241)
Q Consensus 42 -----------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~------Lh-~~~~vH~dl~p~Nil~~~~~ 103 (241)
....+|+||||+++|++.+.+.. ..+++..++.++.|+ || ++|++||||||+||+++.++
T Consensus 122 ~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~ 199 (336)
T 2vuw_A 122 KGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTS 199 (336)
T ss_dssp TCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECS
T ss_pred ccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccC
Confidence 27899999999999977666643 567888888887766 79 99999999999999999987
Q ss_pred --------------------CeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhhHHHHHHH-H
Q 042809 104 --------------------DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCM-V 162 (241)
Q Consensus 104 --------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~-l 162 (241)
.+||+|||++..... ....||+.|+|||.+.+.. +.++||||++++ .
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----------~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~ 267 (336)
T 2vuw_A 200 LKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----------GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKEN 267 (336)
T ss_dssp CSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----------TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHH
T ss_pred CcceeeeccCccccccCCCceEEEeeccccEecCC-----------CcEEEeecccChhhhcCCC-ccceehhhhhCCCC
Confidence 899999999975543 1346899999999998776 889999998777 7
Q ss_pred HHHHhCCCCCccchhch-HHHHHHHHhcCCC---CCCChhhHHHHHHHHHHhhccCCCCCCChHHHh-cCCCCC
Q 042809 163 IEMATGRPPWGDKISNA-AATLLKIACSNEK---PHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL-NHTFIS 231 (241)
Q Consensus 163 ~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l-~~p~~~ 231 (241)
+++++|..||.+..... ............. ...+..+++++.+||++||+.+ |+++++ +||||+
T Consensus 268 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 268 NNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp TTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred cccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 77888999986531101 1111111111111 1123457889999999999976 999999 999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=260.50 Aligned_cols=202 Identities=24% Similarity=0.362 Sum_probs=157.3
Q ss_pred CCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCC-----ceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 5 TGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGE-----KTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 5 ~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
+|+.||||.+.. ......+.+|+.++.+++||||++ ... ...|+||||++|++|.+++.. .+++
T Consensus 105 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~ 181 (681)
T 2pzi_A 105 NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPV 181 (681)
T ss_dssp TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C---CCCH
T ss_pred CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCH
Confidence 689999998753 344567899999999999999988 111 127999999999999988764 6788
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.+ .+||+|||++...... ....||+.|+|||.+.
T Consensus 182 ~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~----------~~~~gt~~y~aPE~~~ 250 (681)
T 2pzi_A 182 AEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF----------GYLYGTPGFQAPEIVR 250 (681)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC----------SCCCCCTTTSCTTHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC----------CccCCCccccCHHHHc
Confidence 8877777655 799999999999999999874 9999999999755331 2345899999999997
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
+.. +.++||||||+++|+|++|..||.+...... .........++.+.++|.+||+.+|.+||+..+.+
T Consensus 251 ~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l 319 (681)
T 2pzi_A 251 TGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEM 319 (681)
T ss_dssp HCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred CCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------cccccccccCHHHHHHHhhhccCChhhCCCHHHHH
Confidence 654 8899999999999999999988865322110 00011123457899999999999999999999988
Q ss_pred cCCCCC
Q 042809 226 NHTFIS 231 (241)
Q Consensus 226 ~~p~~~ 231 (241)
.|+|+.
T Consensus 320 ~~~l~~ 325 (681)
T 2pzi_A 320 SAQLTG 325 (681)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 888763
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=226.90 Aligned_cols=189 Identities=16% Similarity=0.169 Sum_probs=143.3
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
|+.+|+.||+|.+.. ....+.+.+|+.++.+++||||++ ...+..|+||||++|++|.+++.. +. ..
T Consensus 52 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~-~~ 128 (286)
T 3uqc_A 52 DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT--SP-SP 128 (286)
T ss_dssp ETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT--CC-CH
T ss_pred ecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc--CC-Ch
Confidence 567899999999874 334578999999999999999988 566789999999999999999964 33 33
Q ss_pred HHHHHHHH------HHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTK------EILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~------~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++. ++||++|++||||||+||+++.+|.++|++++. ++
T Consensus 129 ~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~--------------------------~~----- 177 (286)
T 3uqc_A 129 VGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT--------------------------MP----- 177 (286)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC--------------------------CT-----
T ss_pred HHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc--------------------------cC-----
Confidence 34444454 448999999999999999999999999985432 22
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC---CCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP---HFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
.++.++||||||+++|+|++|+.||.+................... ..+..++..+.+++.+||+.||.+| |++
T Consensus 178 --~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~ 254 (286)
T 3uqc_A 178 --DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SAS 254 (286)
T ss_dssp --TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHH
T ss_pred --CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHH
Confidence 2688999999999999999999999765432110000000000000 1224567889999999999999999 999
Q ss_pred HHhcC
Q 042809 223 ELLNH 227 (241)
Q Consensus 223 ~~l~~ 227 (241)
++++.
T Consensus 255 el~~~ 259 (286)
T 3uqc_A 255 TLLNL 259 (286)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-33 Score=233.41 Aligned_cols=157 Identities=16% Similarity=0.120 Sum_probs=111.3
Q ss_pred CCcEEEEEeccc------------hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC
Q 042809 5 TGALFVVKSAES------------EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 5 ~~~~vaiK~~~~------------~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
+|..|++|.+.. +...+.+.+|+++|+++ .|+||++ ++++..||||||++|++|.+++.. +
T Consensus 258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~-~ 336 (569)
T 4azs_A 258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA-G 336 (569)
T ss_dssp ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT-T
T ss_pred ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh-C
Confidence 688999998752 34557799999999999 5999988 788999999999999999999987 4
Q ss_pred CCCCHHHHHHH---HHHHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 67 GTLDAGVIRLY---TKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 67 ~~~~~~~~~~~---~~~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
+++++..+..- +++++|++||+||||||+|||++.+|.+||+|||++....... ......+||+.|+|||.
T Consensus 337 ~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~------~~~~t~vGTp~YmAPE~ 410 (569)
T 4azs_A 337 EEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC------SWPTNLVQSFFVFVNEL 410 (569)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---------CCSHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC------ccccCceechhhccHHH
Confidence 56666543221 2255899999999999999999999999999999997553311 12234679999999999
Q ss_pred ccccCCCchhhHHHHHHHHHHHHhCC
Q 042809 144 LRNEGLDFATDIWSLGCMVIEMATGR 169 (241)
Q Consensus 144 ~~~~~~~~~~Di~slG~~l~~l~~g~ 169 (241)
+.+. +...+|+|++|++++.+.++.
T Consensus 411 l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 411 FAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp C------------------CCCCTTH
T ss_pred hCCC-CCCcccccccccchhhhcccc
Confidence 9765 566899999999887665543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-24 Score=179.44 Aligned_cols=163 Identities=20% Similarity=0.202 Sum_probs=122.4
Q ss_pred CCcEEEEEeccc----------hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCC
Q 042809 5 TGALFVVKSAES----------EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTL 69 (241)
Q Consensus 5 ~~~~vaiK~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 69 (241)
.+..+++|.... ....+.+.+|++++++++||||+. ......|+||||++|++|.+++.. ..
T Consensus 358 ~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---~~ 434 (540)
T 3en9_A 358 LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---NL 434 (540)
T ss_dssp SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---CT
T ss_pred CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---HH
Confidence 466778887431 112456899999999999999994 455667999999999999999886 33
Q ss_pred CHHHHHHHHHHHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCC-ccccccccccCcccccCcccccc--
Q 042809 70 DAGVIRLYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNG-NLKQSWQSIGGTQLWMAPEVLRN-- 146 (241)
Q Consensus 70 ~~~~~~~~~~~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~-- 146 (241)
........+.++||++|++||||||+||+++. .+||+|||++.......... ..........||+.|+|||++.+
T Consensus 435 ~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~ 512 (540)
T 3en9_A 435 DIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFL 512 (540)
T ss_dssp HHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHH
Confidence 44444445567799999999999999999988 99999999998654421100 00001235668999999999987
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCC
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPW 172 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~ 172 (241)
..|+...|+|+..+-..+-+.++.+|
T Consensus 513 ~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 513 EGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred HHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 55777889999988887777766665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-20 Score=145.14 Aligned_cols=108 Identities=19% Similarity=0.159 Sum_probs=80.9
Q ss_pred CCCcEEEEEeccchH--------------------HHHHHHHHHHHHhhcCCCcccc-cCCceeeeeecccCCCCHHHHH
Q 042809 4 GTGALFVVKSAESEA--------------------GVQALRNEAEIRQSLNSPNIGR-NGEKTVNIFMEYMAGGSLLDVA 62 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~--------------------~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~lv~e~~~~~~L~~~l 62 (241)
.+|+.||+|.++... ....+.+|+.++++++|+++.. ...+..|+||||++|++|.+ +
T Consensus 112 ~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~~~~~~~~~lvmE~~~g~~L~~-l 190 (282)
T 1zar_A 112 EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYR-V 190 (282)
T ss_dssp TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEETTEEEEECCCCEEGGG-C
T ss_pred CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCeEEeccceEEEEEecCCCcHHH-c
Confidence 578999999986321 3566899999999999544444 34466799999999999988 4
Q ss_pred HHhCCCCCHHHHHHHHHHHhhcCCccccCCCCCcEEeecCCCeeecCCCcch
Q 042809 63 EKFGGTLDAGVIRLYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 63 ~~~~~~~~~~~~~~~~~~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
.. ...........-+.++||++|++||||||+||+++ ++.++|+|||++.
T Consensus 191 ~~-~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 191 RV-ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp CC-SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred ch-hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence 21 11111222223334668999999999999999999 9999999999986
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=4.4e-16 Score=118.33 Aligned_cols=93 Identities=14% Similarity=0.122 Sum_probs=65.0
Q ss_pred HHHHHHHHHhhcCCCcccc---cCCceeeeeecccCC-C----CHHHHHHHhCCC--CCHHHHHHHHHHHhh-cCCcccc
Q 042809 22 ALRNEAEIRQSLNSPNIGR---NGEKTVNIFMEYMAG-G----SLLDVAEKFGGT--LDAGVIRLYTKEILH-GNGILHC 90 (241)
Q Consensus 22 ~~~~e~~~l~~l~h~~i~~---~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~--~~~~~~~~~~~~~Lh-~~~~vH~ 90 (241)
.+.+|+.++.++.|+++.. ......++||||+.+ | +|.++....... ........-+..+|| +.|++||
T Consensus 116 ~~~~E~~~l~~l~~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHr 195 (258)
T 1zth_A 116 WTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHA 195 (258)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred HHHHHHHHHHHHHhCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 5789999999998876522 223467899999942 3 777765431111 111111222335589 9999999
Q ss_pred CCCCCcEEeecCCCeeecCCCcchhh
Q 042809 91 DLKCNNVLLGSHGDVKLPDLGCARRV 116 (241)
Q Consensus 91 dl~p~Nil~~~~~~~kl~dfg~~~~~ 116 (241)
||||+||+++. .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999987 9999999999643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.35 E-value=2.6e-13 Score=107.64 Aligned_cols=89 Identities=15% Similarity=0.100 Sum_probs=58.7
Q ss_pred HHHHHHHhhcCCCcccc---cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHH--HHHHhhcCCccccCCCCCcEE
Q 042809 24 RNEAEIRQSLNSPNIGR---NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLY--TKEILHGNGILHCDLKCNNVL 98 (241)
Q Consensus 24 ~~e~~~l~~l~h~~i~~---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~--~~~~Lh~~~~vH~dl~p~Nil 98 (241)
.+|...|.++.+.++.. ......++||||++|++|..+... .........+ +...||+.|+|||||||.|||
T Consensus 161 ~kE~~nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~---~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NIL 237 (397)
T 4gyi_A 161 IKEFAFMKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSV---PDPASLYADLIALILRLAKHGLIHGDFNEFNIL 237 (397)
T ss_dssp HHHHHHHHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCC---SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred HHHHHHHHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhccc---HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEE
Confidence 35667777775544422 122234799999999888654321 1111221222 224489999999999999999
Q ss_pred eecCCC----------eeecCCCcchh
Q 042809 99 LGSHGD----------VKLPDLGCARR 115 (241)
Q Consensus 99 ~~~~~~----------~kl~dfg~~~~ 115 (241)
++.+|. +.|+||+-+..
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EeCCCCcccccccccceEEEEeCCccc
Confidence 988773 88999997754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.05 E-value=1.9e-10 Score=87.04 Aligned_cols=55 Identities=18% Similarity=0.212 Sum_probs=40.7
Q ss_pred CCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcc-cc------cCCceeeeeecccCCCCHH
Q 042809 4 GTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNI-GR------NGEKTVNIFMEYMAGGSLL 59 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i-~~------~~~~~~~lv~e~~~~~~L~ 59 (241)
.+|..+++|..... ....+.+|+.+++.+.+.++ ++ ..++..++||||++|.+|.
T Consensus 42 ~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 42 QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 45678999987754 33568899999998865454 33 4456789999999998874
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=2.3e-10 Score=86.84 Aligned_cols=107 Identities=18% Similarity=0.192 Sum_probs=71.4
Q ss_pred CCcEEEEEeccch--HHHHHHHHHHHHHhhcCC-Ccc---cc--cCCceeeeeecccCCCCHHHHHHHhCCCCCH-HHHH
Q 042809 5 TGALFVVKSAESE--AGVQALRNEAEIRQSLNS-PNI---GR--NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA-GVIR 75 (241)
Q Consensus 5 ~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h-~~i---~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-~~~~ 75 (241)
.|..+++|..... .....+.+|+.+++.+.. ..+ +. ...+..|+||||++|.+|.+.+.. .... ....
T Consensus 36 ~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~---~~~~~~~~~ 112 (263)
T 3tm0_A 36 ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED---EQSPEKIIE 112 (263)
T ss_dssp SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT---TTCHHHHHH
T ss_pred CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCC---cccHHHHHH
Confidence 3678999997742 223468899999998863 222 22 456788999999999999775321 1111 1111
Q ss_pred HHH--HHHhhc-----------------------------------------------------------CCccccCCCC
Q 042809 76 LYT--KEILHG-----------------------------------------------------------NGILHCDLKC 94 (241)
Q Consensus 76 ~~~--~~~Lh~-----------------------------------------------------------~~~vH~dl~p 94 (241)
.++ ...||+ ..++|||++|
T Consensus 113 ~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~ 192 (263)
T 3tm0_A 113 LYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGD 192 (263)
T ss_dssp HHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCT
T ss_pred HHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCc
Confidence 111 122555 4589999999
Q ss_pred CcEEeecCCCeeecCCCcch
Q 042809 95 NNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 95 ~Nil~~~~~~~kl~dfg~~~ 114 (241)
.||+++.++.+.|+||+.+.
T Consensus 193 ~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 193 SNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TSEEEETTEEEEECCCTTCE
T ss_pred CcEEEECCcEEEEEEchhcc
Confidence 99999765556799998774
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.77 E-value=5.9e-09 Score=80.84 Aligned_cols=161 Identities=16% Similarity=0.187 Sum_probs=90.2
Q ss_pred cEEEEEeccchHHHHHHHHHHHHHhhcC-CCcc-----ccc--CC---ceeeeeecccCCCCHHHHHHH-----------
Q 042809 7 ALFVVKSAESEAGVQALRNEAEIRQSLN-SPNI-----GRN--GE---KTVNIFMEYMAGGSLLDVAEK----------- 64 (241)
Q Consensus 7 ~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~i-----~~~--~~---~~~~lv~e~~~~~~L~~~l~~----------- 64 (241)
..+++|..........+.+|++++..+. +..+ +.. .. ...|+||++++|.+|.+....
T Consensus 41 ~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~~l~~~~~~~~~ 120 (304)
T 3sg8_A 41 RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLNNLPKQSQNQAA 120 (304)
T ss_dssp TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHHTSCHHHHHHHH
T ss_pred CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccccCCHHHHHHHH
Confidence 4578998876666788999999998884 3333 111 12 245889999999877642111
Q ss_pred ---------h---CC-------CCCHH------------------------HHHHHHHHHhh-------cCCccccCCCC
Q 042809 65 ---------F---GG-------TLDAG------------------------VIRLYTKEILH-------GNGILHCDLKC 94 (241)
Q Consensus 65 ---------~---~~-------~~~~~------------------------~~~~~~~~~Lh-------~~~~vH~dl~p 94 (241)
- .. ..... .+.....++|. ...++|||++|
T Consensus 121 ~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~ 200 (304)
T 3sg8_A 121 KDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSS 200 (304)
T ss_dssp HHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCG
T ss_pred HHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCc
Confidence 0 00 00000 00011111121 14589999999
Q ss_pred CcEEeec--CCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc----cccC----------CCchhhHHHH
Q 042809 95 NNVLLGS--HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL----RNEG----------LDFATDIWSL 158 (241)
Q Consensus 95 ~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~----------~~~~~Di~sl 158 (241)
.||+++. .+.+.++||+.+....... ..........-.+|+.. .+.. .....+.|++
T Consensus 201 ~N~l~~~~~~~~~~~iD~~~~~~~~~~~-------Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l 273 (304)
T 3sg8_A 201 DHILFDTEKNTICGIIDFGDAAISDPDN-------DFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSF 273 (304)
T ss_dssp GGEEEETTTTEEEEECCCTTCEEECTTH-------HHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHH
T ss_pred ccEEEeCCCCCEEEEEeCCCCccCChHH-------HHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHH
Confidence 9999988 4557899999886422100 00000000000112211 1110 1123689999
Q ss_pred HHHHHHHHhCCCCCcc
Q 042809 159 GCMVIEMATGRPPWGD 174 (241)
Q Consensus 159 G~~l~~l~~g~~p~~~ 174 (241)
+.++|.+.+|..+|-.
T Consensus 274 ~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 274 EKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHHHHHHHTTCHHHHH
T ss_pred HHHHHHHHcCCHHHHH
Confidence 9999999999888743
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.59 E-value=1.3e-07 Score=74.91 Aligned_cols=31 Identities=16% Similarity=0.299 Sum_probs=26.6
Q ss_pred CCccccCCCCCcEEeecCCC--eeecCCCcchh
Q 042809 85 NGILHCDLKCNNVLLGSHGD--VKLPDLGCARR 115 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~~~~--~kl~dfg~~~~ 115 (241)
.+++|||+++.||+++.++. +.|+||+.+..
T Consensus 216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 56999999999999987764 68999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=3.5e-06 Score=65.25 Aligned_cols=55 Identities=15% Similarity=0.145 Sum_probs=40.4
Q ss_pred CcEEEEEeccchHHHHHHHHHHHHHhhcCCC-cc-cc-------cCCceeeeeecccCCCCHHH
Q 042809 6 GALFVVKSAESEAGVQALRNEAEIRQSLNSP-NI-GR-------NGEKTVNIFMEYMAGGSLLD 60 (241)
Q Consensus 6 ~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~-~i-~~-------~~~~~~~lv~e~~~~~~L~~ 60 (241)
|..+++|..........+.+|+++|..+.+. .+ ++ ...+..++||||++|.+|.+
T Consensus 39 g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~ 102 (306)
T 3tdw_A 39 NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGE 102 (306)
T ss_dssp TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHH
T ss_pred CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECch
Confidence 4567889877666677899999999999753 11 11 23456789999999987765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=4.1e-06 Score=63.55 Aligned_cols=58 Identities=12% Similarity=0.190 Sum_probs=41.5
Q ss_pred CCCcEEEEEeccchHHHHHHHHHHHHHhhcCC----Ccccc--cCCceeeeeecccCCCCHHHHH
Q 042809 4 GTGALFVVKSAESEAGVQALRNEAEIRQSLNS----PNIGR--NGEKTVNIFMEYMAGGSLLDVA 62 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h----~~i~~--~~~~~~~lv~e~~~~~~L~~~l 62 (241)
..+..+++|...... ...+.+|...|+.+.- |.++. ...+..++|||+++|.++.+..
T Consensus 48 ~~~~~~~lk~~~~~~-~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~ 111 (272)
T 4gkh_A 48 PNAPELFLKHGKGSV-ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVL 111 (272)
T ss_dssp TTCCCEEEEEEETHH-HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHH
T ss_pred CCCeEEEEEECCCCC-HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccc
Confidence 345678899876543 5678899999988852 33332 4567889999999998876654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.13 E-value=5.1e-05 Score=54.93 Aligned_cols=117 Identities=11% Similarity=0.026 Sum_probs=77.2
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHH---hhcC----CccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccc
Q 042809 56 GSLLDVAEKFGGTLDAGVIRLYTKEI---LHGN----GILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQS 128 (241)
Q Consensus 56 ~~L~~~l~~~~~~~~~~~~~~~~~~~---Lh~~----~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 128 (241)
-+|.+.|..++.++++..++.++.|. |++. .-...=+.|..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 38999999999999999999998877 3332 112223456899999999988864 1110
Q ss_pred cccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHH
Q 042809 129 WQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLA 208 (241)
Q Consensus 129 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 208 (241)
.....+.|||... ...+.+.-|||||+++|.-+....| +..+..+++++..||.
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~ 151 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLID 151 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHH
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHH
Confidence 0123456787763 3446788999999999998874443 2334556778888888
Q ss_pred Hhhcc
Q 042809 209 KCLER 213 (241)
Q Consensus 209 ~~l~~ 213 (241)
.|...
T Consensus 152 ~Mt~~ 156 (229)
T 2yle_A 152 HMANT 156 (229)
T ss_dssp HHTTC
T ss_pred HHHhc
Confidence 88755
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00026 Score=55.29 Aligned_cols=31 Identities=26% Similarity=0.380 Sum_probs=27.8
Q ss_pred cCCccccCCCCCcEEeecCCCeeecCCCcch
Q 042809 84 GNGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 84 ~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
..+++|||+++.||+++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 3679999999999999888899999999774
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00016 Score=57.92 Aligned_cols=30 Identities=23% Similarity=0.397 Sum_probs=25.5
Q ss_pred cCCccccCCCCCcEEeecCCCeeecCCCcch
Q 042809 84 GNGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 84 ~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
...++|||+.+.||+++.+ .++++||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 4679999999999999765 48999998765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.00094 Score=51.33 Aligned_cols=30 Identities=23% Similarity=0.364 Sum_probs=25.4
Q ss_pred CCccccCCCCCcEEeecCCCeeecCCCcchh
Q 042809 85 NGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~ 115 (241)
..++|+|+.+.||+ ..++.+.++||+.+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 34899999999999 5677899999988753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.005 Score=47.61 Aligned_cols=53 Identities=19% Similarity=0.130 Sum_probs=37.5
Q ss_pred CCcEEEEEeccchHHHHHHHHHHHHHhhcCC------Ccccc--cCCceeeeeecccCCCCH
Q 042809 5 TGALFVVKSAESEAGVQALRNEAEIRQSLNS------PNIGR--NGEKTVNIFMEYMAGGSL 58 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h------~~i~~--~~~~~~~lv~e~~~~~~L 58 (241)
++..+++|..... ....+..|+..|+.|.. |.++. ...+..++||||++|.++
T Consensus 58 ~~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 58 EVQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp SSCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred CCCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 3567889987644 36778899998888752 22222 445689999999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.06 E-value=0.0068 Score=46.16 Aligned_cols=56 Identities=20% Similarity=0.089 Sum_probs=36.0
Q ss_pred CCCCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCc-c-cc--cCCceeeeeecccCCCCH
Q 042809 3 KGTGALFVVKSAESE--AGVQALRNEAEIRQSLNSPN-I-GR--NGEKTVNIFMEYMAGGSL 58 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~-i-~~--~~~~~~~lv~e~~~~~~L 58 (241)
..+|+.|++|..... .....+..|+..|+.|.-.. + ++ ...+.-++||||+.++..
T Consensus 36 l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 36 LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDDRTLAMEWVDERPP 97 (288)
T ss_dssp ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEETTEEEEECCCCCCC
T ss_pred ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccCceEEEEeecccCC
Confidence 357899999986643 22356889999998885221 1 22 222345789999976543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.87 E-value=0.0032 Score=50.83 Aligned_cols=32 Identities=16% Similarity=0.288 Sum_probs=28.0
Q ss_pred hcCCccccCCCCCcEEeecCCCeeecCCCcchh
Q 042809 83 HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115 (241)
Q Consensus 83 h~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~ 115 (241)
+...++|||+++.||+++.++ ++++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 467899999999999998776 99999988864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.31 E-value=0.005 Score=47.61 Aligned_cols=30 Identities=30% Similarity=0.314 Sum_probs=25.8
Q ss_pred CCccccCCCCCcEEeecCCCeeecCCCcch
Q 042809 85 NGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 468999999999999876656899998775
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=94.99 E-value=0.0082 Score=46.70 Aligned_cols=32 Identities=22% Similarity=0.232 Sum_probs=27.3
Q ss_pred cCCccccCCCCCcEEeecC----CCeeecCCCcchh
Q 042809 84 GNGILHCDLKCNNVLLGSH----GDVKLPDLGCARR 115 (241)
Q Consensus 84 ~~~~vH~dl~p~Nil~~~~----~~~kl~dfg~~~~ 115 (241)
...++|||+++.||+++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4579999999999999874 6789999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=94.65 E-value=0.0098 Score=46.70 Aligned_cols=31 Identities=23% Similarity=0.204 Sum_probs=25.8
Q ss_pred cCCccccCCCCCcEEeecCCCeeecCCCcch
Q 042809 84 GNGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 84 ~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
...++|+|+++.||+++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 4579999999999999854447899998875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=94.23 E-value=0.017 Score=45.62 Aligned_cols=30 Identities=23% Similarity=0.232 Sum_probs=24.5
Q ss_pred CCccccCCCCCcEEeecCCCeeecCCCcchh
Q 042809 85 NGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~ 115 (241)
.+++|+|+++.||+++.+ .+.++||+.+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~-~~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNK-CLRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC--CEEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCC-cEEEEEecCCCC
Confidence 358999999999999754 489999988753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.17 E-value=0.019 Score=44.82 Aligned_cols=31 Identities=23% Similarity=0.335 Sum_probs=27.4
Q ss_pred CCccccCCCCCcEEeecCCCeeecCCCcchh
Q 042809 85 NGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~ 115 (241)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 5689999999999999888899999987753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.15 E-value=0.02 Score=44.29 Aligned_cols=29 Identities=31% Similarity=0.255 Sum_probs=25.0
Q ss_pred cCCccccCCCCCcEEeecCCCeeecCCCcch
Q 042809 84 GNGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 84 ~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
...++|||+++.||+++ + .+.++||+.+.
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 35589999999999998 4 89999998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=93.77 E-value=0.026 Score=45.67 Aligned_cols=51 Identities=14% Similarity=0.082 Sum_probs=31.8
Q ss_pred CCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCC
Q 042809 5 TGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGS 57 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~ 57 (241)
++..+++|+.........+.+|..++..+...++.+ ...+ .+|+||++|.+
T Consensus 104 ~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~--g~v~e~l~G~~ 158 (429)
T 1nw1_A 104 EPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEYIPSRP 158 (429)
T ss_dssp CCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECCCCEEE
T ss_pred CCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC--CEEEEEeCCcc
Confidence 357889998854221245668999888886444433 1111 37899998643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.64 E-value=0.45 Score=34.32 Aligned_cols=108 Identities=12% Similarity=0.056 Sum_probs=68.3
Q ss_pred cCCCcccc----cCCceeeeeecccCC-CCHHHHHHHhCCCCCHHHHHHHHHHHh----hcCCccccCCCCCcEEeecCC
Q 042809 33 LNSPNIGR----NGEKTVNIFMEYMAG-GSLLDVAEKFGGTLDAGVIRLYTKEIL----HGNGILHCDLKCNNVLLGSHG 103 (241)
Q Consensus 33 l~h~~i~~----~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~L----h~~~~vH~dl~p~Nil~~~~~ 103 (241)
..||+.+. ..++.+.+-++.-++ -++.. ++. .+......++.+++ |...-+|--|+|+|++++.++
T Consensus 42 ~~~~~Fl~~~I~e~eD~v~~~y~~~~~~~~f~~-ik~----~~~~eKlr~l~ni~~l~~~~~~r~tf~L~P~NL~f~~~~ 116 (215)
T 4ann_A 42 QHSPYFIDAELTELRDSFQIHYDINDNHTPFDN-IKS----FTKNEKLRYLLNIKNLEEVNRTRYTFVLAPDELFFTRDG 116 (215)
T ss_dssp SCCTTBCCEEEEECSSEEEEEECCCTTSEEGGG-GGG----SCHHHHHHHHHHGGGGGGGGGSSEECCCSGGGEEECTTS
T ss_pred ccCCcccceEEEEcccEEEEEEEcCcccCCHHH-HHh----cCHHHHHHHHHHHHHHHHHhcCceEEEEecceEEEcCCC
Confidence 45888875 566666666655542 23333 332 56666677777664 334456678999999999999
Q ss_pred CeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCc
Q 042809 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWG 173 (241)
Q Consensus 104 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 173 (241)
.+++.-.|+.... +|. ..+...-.-..=+++..+++++..|.
T Consensus 117 ~p~i~~RGik~~l-----------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 117 LPIAKTRGLQNVV-----------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CEEESCCEETTTB-----------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CEEEEEccCccCC-----------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999887765322 221 12323334455667778888888773
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=93.51 E-value=0.035 Score=45.31 Aligned_cols=51 Identities=20% Similarity=0.233 Sum_probs=30.4
Q ss_pred CcEEEEEeccchH-HHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCH
Q 042809 6 GALFVVKSAESEA-GVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSL 58 (241)
Q Consensus 6 ~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L 58 (241)
+..+++|+..... ..-...+|..++..|...++.+ ...+ ..|+||++|.+|
T Consensus 133 ~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 133 QAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN--GRIEEFMDGYAL 188 (458)
T ss_dssp TEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT--EEEEECCCSEEC
T ss_pred CceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC--eEEEEeeCCccC
Confidence 3678888875321 1111258888898887655544 1111 259999987544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=93.45 E-value=0.038 Score=43.87 Aligned_cols=31 Identities=26% Similarity=0.275 Sum_probs=27.0
Q ss_pred CCccccCCCCCcEEeecC----CCeeecCCCcchh
Q 042809 85 NGILHCDLKCNNVLLGSH----GDVKLPDLGCARR 115 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~~----~~~kl~dfg~~~~ 115 (241)
..++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 358999999999999876 6899999998863
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.07 E-value=0.074 Score=42.57 Aligned_cols=29 Identities=24% Similarity=0.265 Sum_probs=24.7
Q ss_pred ccccCCCCCcEEee------cCCCeeecCCCcchh
Q 042809 87 ILHCDLKCNNVLLG------SHGDVKLPDLGCARR 115 (241)
Q Consensus 87 ~vH~dl~p~Nil~~------~~~~~kl~dfg~~~~ 115 (241)
++|+|+.+.||++. .++.+.++||.++..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 67999999999993 456799999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.94 E-value=2.6 Score=30.46 Aligned_cols=77 Identities=12% Similarity=0.016 Sum_probs=52.7
Q ss_pred cCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHHHh-----hcCCccccCCCCCcEEeecCC
Q 042809 33 LNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL-----HGNGILHCDLKCNNVLLGSHG 103 (241)
Q Consensus 33 l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~L-----h~~~~vH~dl~p~Nil~~~~~ 103 (241)
..||++ . ..++.+.+.++.-+++.=...++. .+......++.++. |...-+|--|+|+|++++.++
T Consensus 47 ~~~~~f-~~~I~~~eD~~~i~y~~~~~~~~f~~i~~----~~~~eKlrll~nl~~L~~~~~~~r~tf~l~P~NL~f~~~~ 121 (219)
T 4ano_A 47 EVDPCI-VRDIDVSEDEVKVVIKPPSSFLTFAAIRK----TTLLSRIRAAIHLVSKVKHHSARRLIFIVCPENLMFNRAL 121 (219)
T ss_dssp GSCSSS-EEEEEECSSEEEEEEECCTTCEEHHHHHT----SCHHHHHHHHHHHHHHHSSCCSSSEECCCCGGGEEECTTC
T ss_pred ccCCCC-CeEEEEeCCEEEEEEEcCcccCcHHHHHh----cCHHHHHHHHHHHHHHHHHhhhCceeEEEeCceEEEeCCC
Confidence 357787 5 677777777666544333334443 45666566666552 456677888999999999999
Q ss_pred CeeecCCCcch
Q 042809 104 DVKLPDLGCAR 114 (241)
Q Consensus 104 ~~kl~dfg~~~ 114 (241)
.+++.-.|+..
T Consensus 122 ~p~i~hRGi~~ 132 (219)
T 4ano_A 122 EPFFLHVGVKE 132 (219)
T ss_dssp CEEESCCEETT
T ss_pred cEEEEEcCCcc
Confidence 99999887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=90.54 E-value=0.12 Score=41.61 Aligned_cols=29 Identities=24% Similarity=0.382 Sum_probs=25.9
Q ss_pred CccccCCCCCcEEeecCCCeeecCCCcchh
Q 042809 86 GILHCDLKCNNVLLGSHGDVKLPDLGCARR 115 (241)
Q Consensus 86 ~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~ 115 (241)
.++|+|+.+.||+ +.++.+.++||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 4799999999999 7788999999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 241 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-55 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-53 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-50 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-49 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-42 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-42 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-36 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-34 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-31 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-06 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 1e-57
Identities = 83/259 (32%), Positives = 121/259 (46%), Gaps = 27/259 (10%)
Query: 1 MNKGTGALFVVK--SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYM 53
NK T L K +SE ++ E +I S + PNI + E + I +E+
Sbjct: 32 QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91
Query: 54 AGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKL 107
AGG++ V + L I++ K+ LH N I+H DLK N+L GD+KL
Sbjct: 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKL 151
Query: 108 PDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL-----RNEGLDFATDIWSLGCMV 162
D G + + Q S GT WMAPEV+ ++ D+ D+WSLG +
Sbjct: 152 ADFGVSAKNTR------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 205
Query: 163 IEMATGRPPWGDKISNAAATLLKIA-CSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221
IEMA PP + N LLKIA P+++ DFL KCLE+ + RW+
Sbjct: 206 IEMAEIEPPHHEL--NPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTT 263
Query: 222 EELLNHTFISGNAKKNSTE 240
+LL H F++ ++ K E
Sbjct: 264 SQLLQHPFVTVDSNKPIRE 282
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-55
Identities = 62/249 (24%), Positives = 103/249 (41%), Gaps = 29/249 (11%)
Query: 2 NKGTGALFVVK-----SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFME 51
K + + +K E LR E EI+ L PNI R + V + +E
Sbjct: 27 EKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDV 105
Y G++ +K D Y E+ H ++H D+K N+LLGS G++
Sbjct: 87 YAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGEL 145
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
K+ D G + ++ GT ++ PE++ D D+WSLG + E
Sbjct: 146 KIADFGWSVHAPS--------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 197
Query: 166 ATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
G+PP+ T +I S + FP + D +++ L+ P +R E+L
Sbjct: 198 LVGKPPFEAN--TYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
Query: 226 NHTFISGNA 234
H +I+ N+
Sbjct: 254 EHPWITANS 262
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (455), Expect = 1e-55
Identities = 55/251 (21%), Positives = 102/251 (40%), Gaps = 30/251 (11%)
Query: 1 MNKGTGALFVVK--SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYM 53
+ TG F K E+ + +R E + L P + + + + E+M
Sbjct: 46 TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105
Query: 54 AGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH--GDV 105
+GG L + + Y +++ +H N +H DLK N++ + ++
Sbjct: 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNEL 165
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
KL D G ++ KQS + GT + APEV + + + TD+WS+G + +
Sbjct: 166 KLIDFGLTAHLDP-------KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 218
Query: 166 ATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEKRWSA 221
+G P+G + N TL + + + F + DF+ K L P R +
Sbjct: 219 LSGLSPFGGE--NDDETLRNVK--SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTI 274
Query: 222 EELLNHTFISG 232
+ L H +++
Sbjct: 275 HQALEHPWLTP 285
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (452), Expect = 3e-55
Identities = 55/255 (21%), Positives = 108/255 (42%), Gaps = 30/255 (11%)
Query: 1 MNKGTGALFVVK--SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYM 53
+ K TG +FV K + ++NE I L+ P + + + + +E++
Sbjct: 49 VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108
Query: 54 AGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH--GDV 105
+GG L D + + Y ++ +H + I+H D+K N++ + V
Sbjct: 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSV 168
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
K+ D G A ++N + + T + APE++ E + F TD+W++G + +
Sbjct: 169 KIIDFGLATKLNP-------DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVL 221
Query: 166 ATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEKRWSA 221
+G P+ + + TL + F F V DF+ L+++P KR +
Sbjct: 222 LSGLSPFAGE--DDLETLQNV--KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 277
Query: 222 EELLNHTFISGNAKK 236
+ L H ++ G+
Sbjct: 278 HDALEHPWLKGDHSN 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-53
Identities = 62/246 (25%), Positives = 105/246 (42%), Gaps = 25/246 (10%)
Query: 1 MNKGTGALFVVK-----SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFM 50
T + +K E V + E ++ L+ P + ++ + +
Sbjct: 28 RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87
Query: 51 EYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD 104
Y G LL K G + D R YT EI+ HG GI+H DLK N+LL
Sbjct: 88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH 146
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIE 164
+++ D G A+ + + + + S GT +++PE+L + ++D+W+LGC++ +
Sbjct: 147 IQITDFGTAK----VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 202
Query: 165 MATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224
+ G PP+ N KI + FP +FF K D + K L KR EE+
Sbjct: 203 LVAGLPPFRAG--NEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
Query: 225 LNHTFI 230
+ +
Sbjct: 259 EGYGPL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-53
Identities = 68/254 (26%), Positives = 104/254 (40%), Gaps = 34/254 (13%)
Query: 2 NKGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFM 50
K G + V K + +EA Q L +E + + L PNI R T+ I M
Sbjct: 25 RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84
Query: 51 EYMAGGSLLDV---AEKFGGTLDAGVIRLYTKEILHG-----------NGILHCDLKCNN 96
EY GG L V K LD + ++ + +LH DLK N
Sbjct: 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 144
Query: 97 VLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIW 156
V L +VKL D G AR +N + + GT +M+PE + + +DIW
Sbjct: 145 VFLDGKQNVKLGDFGLARILNHDTSFAK------AFVGTPYYMSPEQMNRMSYNEKSDIW 198
Query: 157 SLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216
SLGC++ E+ PP+ + KI + P ++ ++ + + + L K
Sbjct: 199 SLGCLLYELCALMPPFTAF--SQKELAGKI-REGKFRRIPYRYSDELNEIITRMLNLKDY 255
Query: 217 KRWSAEELLNHTFI 230
R S EE+L + I
Sbjct: 256 HRPSVEEILENPLI 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 7e-53
Identities = 75/243 (30%), Positives = 114/243 (46%), Gaps = 22/243 (9%)
Query: 1 MNKGTGALFVVK--SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYM 53
M+ TG ++ + + + + + NE + + +PNI + + MEY+
Sbjct: 40 MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99
Query: 54 AGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKL 107
AGGSL DV + I +E LH N ++H D+K +N+LLG G VKL
Sbjct: 100 AGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKL 157
Query: 108 PDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT 167
D G ++ ++ ++ GT WMAPEV+ + DIWSLG M IEM
Sbjct: 158 TDFGFCAQITPEQSK------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 211
Query: 168 GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
G PP+ ++ + A L + P + DFL +CL+ EKR SA+ELL H
Sbjct: 212 GEPPYLNE-NPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270
Query: 228 TFI 230
F+
Sbjct: 271 QFL 273
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-52
Identities = 55/242 (22%), Positives = 105/242 (43%), Gaps = 22/242 (9%)
Query: 3 KGTGALFVVK-SAESEAGVQALRNEAEIRQSLNSPNI----GRNGEKTVNIFMEYMAGGS 57
G A+ ++ +A + +QA +NE + + NI G + + I ++ G S
Sbjct: 30 HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSS 89
Query: 58 LLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLG 111
L + + ++ LH I+H DLK NN+ L VK+ D G
Sbjct: 90 LYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFG 149
Query: 112 CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG---LDFATDIWSLGCMVIEMATG 168
A + + + + G+ LWMAPEV+R + F +D+++ G ++ E+ TG
Sbjct: 150 LATVKSRWSGSHQFE----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 205
Query: 169 RPPWGDKISNAAATLLKIACSNEKP---HFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
+ P+ + I+N + + P + K + +A+CL++K ++R ++L
Sbjct: 206 QLPYSN-INNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264
Query: 226 NH 227
Sbjct: 265 AS 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 4e-52
Identities = 58/253 (22%), Positives = 101/253 (39%), Gaps = 21/253 (8%)
Query: 1 MNKGTGALFVVK---SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEY 52
+N+ T VK + + ++ E I + LN N+ + +F+EY
Sbjct: 25 VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84
Query: 53 MAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVK 106
+GG L D E G + + + ++ LHG GI H D+K N+LL ++K
Sbjct: 85 CSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLK 143
Query: 107 LPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD-FATDIWSLGCMVIEM 165
+ D G A N ++ + GT ++APE+L+ D+WS G ++ M
Sbjct: 144 ISDFGLATVFRY----NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 199
Query: 166 ATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
G PW D+ S++ + + L L K L P R + ++
Sbjct: 200 LAGELPW-DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 258
Query: 226 NHTFISGNAKKNS 238
+ + KK +
Sbjct: 259 KDRWYNKPLKKGA 271
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 3e-51
Identities = 69/259 (26%), Positives = 102/259 (39%), Gaps = 32/259 (12%)
Query: 2 NKGTGALFVVK-----SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFME 51
+ + +K +S Q + E Q L PN + E T + ME
Sbjct: 36 DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDV 105
Y G + D+ E L I T LH + ++H D+K N+LL G V
Sbjct: 96 YCLGSAS-DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLV 154
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR---NEGLDFATDIWSLGCMV 162
KL D G A + S GT WMAPEV+ D D+WSLG
Sbjct: 155 KLGDFGSASIMAPA----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204
Query: 163 IEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222
IE+A +PP + NA + L IA + + + +F+ CL++ P+ R ++E
Sbjct: 205 IELAERKPPLFNM--NAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 262
Query: 223 ELLNHTFISGNAKKNSTEE 241
LL H F+ +
Sbjct: 263 VLLKHRFVLRERPPTVIMD 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-50
Identities = 62/252 (24%), Positives = 112/252 (44%), Gaps = 33/252 (13%)
Query: 1 MNKGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNI---------GRNGEKTVN 47
++ T +++ Q + EAE+ + L PNI G+K +
Sbjct: 29 LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88
Query: 48 IFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL--------HGNGILHCDLKCNNVLL 99
+ E M G+L ++F + V+R + ++IL I+H DLKC+N+ +
Sbjct: 89 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 147
Query: 100 -GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSL 158
G G VK+ DLG A +++ GT +MAPE+ D + D+++
Sbjct: 148 TGPTGSVKIGDLGLATLKRA--------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAF 198
Query: 159 GCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
G ++EMAT P+ + NAA ++ + F +V + + C+ + ++R
Sbjct: 199 GMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 257
Query: 219 WSAEELLNHTFI 230
+S ++LLNH F
Sbjct: 258 YSIKDLLNHAFF 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 3e-50
Identities = 49/258 (18%), Positives = 109/258 (42%), Gaps = 29/258 (11%)
Query: 1 MNKGTGALFVVKS-AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMA 54
+ + ++ K ++ E I NI + + + E+++
Sbjct: 25 VETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84
Query: 55 GGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGD--VK 106
G + + L+ I Y ++ LH + I H D++ N++ + +K
Sbjct: 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIK 144
Query: 107 LPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMA 166
+ + G AR++ +++ + + APEV +++ + ATD+WSLG +V +
Sbjct: 145 IIEFGQARQLKP-------GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197
Query: 167 TGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEKRWSAE 222
+G P+ + + I N + F + FK++ +DF+ + L ++ + R +A
Sbjct: 198 SGINPFLAE--TNQQIIENIM--NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTAS 253
Query: 223 ELLNHTFISGNAKKNSTE 240
E L H ++ ++ ST+
Sbjct: 254 EALQHPWLKQKIERVSTK 271
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 2e-49
Identities = 65/263 (24%), Positives = 102/263 (38%), Gaps = 34/263 (12%)
Query: 1 MNKGTGALFVVKSAESEAGVQALRNEAEI-RQSLNSPNI---------GRNGEKTVNIFM 50
NK T F +K + R E E+ ++ P+I G K + I M
Sbjct: 32 FNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88
Query: 51 EYMAGGSLLD-VAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH- 102
E + GG L + ++ K I LH I H D+K N+L S
Sbjct: 89 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 148
Query: 103 --GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGC 160
+KL D G A+ S + T ++APEVL E D + D+WSLG
Sbjct: 149 PNAILKLTDFGFAKETTS-------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 201
Query: 161 MVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPE 216
++ + G PP+ A + +K + FP + +V + L+ +P
Sbjct: 202 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 261
Query: 217 KRWSAEELLNHTFISGNAKKNST 239
+R + E +NH +I + K T
Sbjct: 262 QRMTITEFMNHPWIMQSTKVPQT 284
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 5e-49
Identities = 70/291 (24%), Positives = 118/291 (40%), Gaps = 64/291 (21%)
Query: 2 NKGTGALFVVK---SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYM 53
+K +G + K A + E ++ NSP I + ++I ME+M
Sbjct: 27 HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 86
Query: 54 AGGSLLDVAEKFGGTLDAGVIRLYTKEILHG-------NGILHCDLKCNNVLLGSHGDVK 106
GGSL V +K G + ++ + ++ G + I+H D+K +N+L+ S G++K
Sbjct: 87 DGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIK 145
Query: 107 LPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMA 166
L D G + ++ D N S GT+ +M+PE L+ +DIWS+G ++EMA
Sbjct: 146 LCDFGVSGQLIDSMAN--------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 197
Query: 167 TGRPPWGDKISN---------------------------------------AAATLLKIA 187
GR P + A LL
Sbjct: 198 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYI 257
Query: 188 CSNEKPHFPTQFF-KKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKN 237
+ P P+ F + DF+ KCL + P +R ++L+ H FI + +
Sbjct: 258 VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 308
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-47
Identities = 57/250 (22%), Positives = 96/250 (38%), Gaps = 29/250 (11%)
Query: 1 MNKGTGALFVVK-----SAESEAGVQALRNEAEI-RQSLNSPNIGR-----NGEKTVNIF 49
K T F +K + V+ E + + P + ++ +
Sbjct: 22 EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLLGSHG 103
MEY+ GG L+ + D Y EI+ G GI++ DLK +N+LL G
Sbjct: 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG 140
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVI 163
+K+ D G + + GT ++APE+L + + + D WS G ++
Sbjct: 141 HIKIADFGMCKENMLGD------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLY 194
Query: 164 EMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE- 222
EM G+ P+ + + I + P +P K+ D L K R+PEKR
Sbjct: 195 EMLIGQSPFHGQ--DEEELFHSI--RMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRG 250
Query: 223 ELLNHTFISG 232
++ H
Sbjct: 251 DIRQHPLFRE 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 6e-47
Identities = 54/237 (22%), Positives = 88/237 (37%), Gaps = 26/237 (10%)
Query: 5 TGALFVVKSAESEAGVQALRNEAEIRQSLNSPNI------GRNGEKTVNIFMEYMAGGSL 58
G VK +++A QA EA + L N+ + + I EYMA GSL
Sbjct: 29 RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88
Query: 59 LDVAEKFGGT-LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLG 111
+D G + L + ++ ++ L GN +H DL NVL+ K+ D G
Sbjct: 89 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 148
Query: 112 CARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRP 170
+ + + + W APE LR + +D+WS G ++ E+ + GR
Sbjct: 149 LTKEASS---------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 199
Query: 171 PWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
P+ ++ K P V + + C R S +L
Sbjct: 200 PYPRIPLKD---VVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (390), Expect = 2e-46
Identities = 60/259 (23%), Positives = 106/259 (40%), Gaps = 33/259 (12%)
Query: 2 NKGTGALFVVK---SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYM 53
+K T L +K E ++ NE + + PNI + + M+ +
Sbjct: 30 DKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89
Query: 54 AGGSLLDVAEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLLGSH---GD 104
+GG L D + G ++L GI+H DLK N+L S
Sbjct: 90 SGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSK 148
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIE 164
+ + D G ++ + + GT ++APEVL + A D WS+G +
Sbjct: 149 IMISDFGLSKMEDP-------GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI 201
Query: 165 MATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEKRWS 220
+ G PP+ D+ N A +I + F + ++ + DF+ +E+ PEKR++
Sbjct: 202 LLCGYPPFYDE--NDAKLFEQIL--KAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT 257
Query: 221 AEELLNHTFISGNAKKNST 239
E+ L H +I+G+ +
Sbjct: 258 CEQALQHPWIAGDTALDKN 276
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (388), Expect = 4e-46
Identities = 62/252 (24%), Positives = 106/252 (42%), Gaps = 35/252 (13%)
Query: 2 NKGTGALFVVK-----SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFME 51
++ G + +K V+ +E + + P I R + + + M+
Sbjct: 25 SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84
Query: 52 YMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDV 105
Y+ GG L + + V + Y E+ LH I++ DLK N+LL +G +
Sbjct: 85 YIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHI 143
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
K+ D G A+ V D ++ GT ++APEV+ + + + D WS G ++ EM
Sbjct: 144 KITDFGFAKYVPD---------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEM 194
Query: 166 ATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----S 220
G P+ D N T KI N + FP F + V D L++ + R +R
Sbjct: 195 LAGYTPFYDS--NTMKTYEKIL--NAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNG 250
Query: 221 AEELLNHTFISG 232
E++ NH +
Sbjct: 251 TEDVKNHPWFKE 262
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (385), Expect = 5e-46
Identities = 61/261 (23%), Positives = 108/261 (41%), Gaps = 41/261 (15%)
Query: 1 MNKGTGALFVVK-----------SAESEAGVQALRNEAEIRQSLNS-PNIGR-----NGE 43
++K T + VK + E + +A E +I + ++ PNI +
Sbjct: 23 IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82
Query: 44 KTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNV 97
+ + M G L D + TL R + + LH I+H DLK N+
Sbjct: 83 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENI 141
Query: 98 LLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR------NEGLDF 151
LL ++KL D G + +++ + + + GT ++APE++ + G
Sbjct: 142 LLDDDMNIKLTDFGFSCQLDP-------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGK 194
Query: 152 ATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPT--QFFKKVLDFLAK 209
D+WS G ++ + G PP+ + L I N + P + V D +++
Sbjct: 195 EVDMWSTGVIMYTLLAGSPPFWHR--KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR 252
Query: 210 CLERKPEKRWSAEELLNHTFI 230
L +P+KR++AEE L H F
Sbjct: 253 FLVVQPQKRYTAEEALAHPFF 273
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 5e-46
Identities = 59/242 (24%), Positives = 86/242 (35%), Gaps = 21/242 (8%)
Query: 2 NKGTGALFVVK-----SAESEAGVQALRNEAEIRQSLNSPNI----GRNGEKTVNIFMEY 52
G VK + E SL+ N+ G + + E
Sbjct: 32 PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTEL 91
Query: 53 MAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVK 106
GSLLD K G G + Y ++ L +H DL N+LL + VK
Sbjct: 92 APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVK 151
Query: 107 LPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMA 166
+ D G R L N + + W APE L+ A+D W G + EM
Sbjct: 152 IGDFGLMR---ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208
Query: 167 T-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
T G+ PW N + L KI E+ P + + + + +C KPE R + L
Sbjct: 209 TYGQEPWIGL--NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
Query: 226 NH 227
+
Sbjct: 267 DF 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-44
Identities = 52/236 (22%), Positives = 90/236 (38%), Gaps = 21/236 (8%)
Query: 5 TGALFVVKS-AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSL 58
+K E EA++ +L+ + + ++ + I EYMA G L
Sbjct: 27 GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86
Query: 59 LDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGC 112
L+ + + K++ L LH DL N L+ G VK+ D G
Sbjct: 87 LNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGL 146
Query: 113 ARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPP 171
+R V D + S W PEVL +DIW+ G ++ E+ + G+ P
Sbjct: 147 SRYVLD-----DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 201
Query: 172 WGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
+ + T I + + P +KV + C K ++R + + LL++
Sbjct: 202 YERF--TNSETAEHI-AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-44
Identities = 49/246 (19%), Positives = 89/246 (36%), Gaps = 25/246 (10%)
Query: 2 NKGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNI----GRNGEKTVNIFMEYM 53
K VK A A L EA + Q L++P I G ++ + ME
Sbjct: 30 MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMA 89
Query: 54 AGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKL 107
G L ++ + I ++ L + +H DL NVLL + K+
Sbjct: 90 ELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKI 148
Query: 108 PDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT 167
D G ++ L+ + N ++ W APE + +D+WS G ++ E +
Sbjct: 149 SDFGLSK---ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205
Query: 168 -GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL-- 224
G+ P+ + + + E+ P +++ D + C E R +
Sbjct: 206 YGQKPYRGM---KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 262
Query: 225 -LNHTF 229
L + +
Sbjct: 263 RLRNYY 268
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-44
Identities = 60/258 (23%), Positives = 106/258 (41%), Gaps = 39/258 (15%)
Query: 2 NKGTGALFVVK--------SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNI 48
K TG + K S+ + + E I + + PN+ + V +
Sbjct: 31 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90
Query: 49 FMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSH 102
+E +AGG L D + +L + K+IL H I H DLK N++L
Sbjct: 91 ILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDR 149
Query: 103 GD----VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSL 158
+K+ D G A +++ +++I GT ++APE++ E L D+WS+
Sbjct: 150 NVPKPRIKIIDFGLAHKIDF-------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 202
Query: 159 GCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERK 214
G + + +G P+ TL + S F ++F DF+ + L +
Sbjct: 203 GVITYILLSGASPFLGD--TKQETLANV--SAVNYEFEDEYFSNTSALAKDFIRRLLVKD 258
Query: 215 PEKRWSAEELLNHTFISG 232
P+KR + ++ L H +I
Sbjct: 259 PKKRMTIQDSLQHPWIKP 276
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 3e-44
Identities = 45/239 (18%), Positives = 88/239 (36%), Gaps = 20/239 (8%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNI----GRNGEKTVNIFMEYMAGGSLLDVA 62
A+ V+K +A + + EA+I L++P I G + + + ME GG L
Sbjct: 40 AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFL 99
Query: 63 EKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRV 116
+ + ++ L +H DL NVLL + K+ D G ++
Sbjct: 100 VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK-- 157
Query: 117 NDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDK 175
L + + + + W APE + +D+WS G + E + G+ P+
Sbjct: 158 -ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216
Query: 176 ISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL---LNHTFIS 231
++ ++ P + ++ ++ C K E R + + + S
Sbjct: 217 ---KGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-43
Identities = 54/232 (23%), Positives = 87/232 (37%), Gaps = 19/232 (8%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNI----GRNGEKTVNIFMEYMAGGSLLDVA 62
A+ K+ S++ + EA + + P+I G E V I ME G L
Sbjct: 39 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFL 98
Query: 63 EKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRV 116
+ +LD + LY ++ L +H D+ NVL+ S+ VKL D G +R +
Sbjct: 99 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158
Query: 117 NDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDK 175
D + WMAPE + A+D+W G + E+ G P+
Sbjct: 159 ED-----STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213
Query: 176 ISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
+ +I + E+ P + + KC P +R EL
Sbjct: 214 --KNNDVIGRI-ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-43
Identities = 51/232 (21%), Positives = 92/232 (39%), Gaps = 18/232 (7%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGRNG----EKTVNIFMEYMAGGSLLDVA 62
A+ ++ A S + + +EA + S+++P++ R TV + + M G LLD
Sbjct: 42 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV 101
Query: 63 EKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLLGSHGDVKLPDLGCARRV 116
+ + + + + +I G ++H DL NVL+ + VK+ D G A+ +
Sbjct: 102 REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161
Query: 117 NDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDK 175
+ + WMA E + + +D+WS G V E+ T G P+
Sbjct: 162 GA----EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG- 216
Query: 176 ISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
A+ + I E+ P V + KC + R EL+
Sbjct: 217 --IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-43
Identities = 57/253 (22%), Positives = 98/253 (38%), Gaps = 32/253 (12%)
Query: 1 MNKGTGALFVVK-----SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFM 50
K TG + +K ++ V E+ + Q+ P + + M
Sbjct: 25 REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84
Query: 51 EYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGD 104
EY GG L + R Y EI+ H +++ D+K N++L G
Sbjct: 85 EYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 143
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIE 164
+K+ D G + + ++ GT ++APEVL + A D W LG ++ E
Sbjct: 144 IKITDFGLCKEGISDG------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 197
Query: 165 MATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS---- 220
M GR P+ ++ + I E+ FP + LA L++ P++R
Sbjct: 198 MMCGRLPFYNQ--DHERLFELI--LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPS 253
Query: 221 -AEELLNHTFISG 232
A+E++ H F
Sbjct: 254 DAKEVMEHRFFLS 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-42
Identities = 47/235 (20%), Positives = 87/235 (37%), Gaps = 19/235 (8%)
Query: 5 TGALFVVKS-AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSL 58
+K+ E + EAE+ L+ P + + + + + E+M G L
Sbjct: 28 NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 87
Query: 59 LDVAEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLLGSHGDVKLPDLGC 112
D G A + ++ G ++H DL N L+G + +K+ D G
Sbjct: 88 SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM 147
Query: 113 ARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPW 172
R V D + S W +PEV +D+WS G ++ E+ +
Sbjct: 148 TRFVLDDQYT-----SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 202
Query: 173 GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
+ SN+ +++ + + + P V + C + +PE R + LL
Sbjct: 203 YENRSNSE--VVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-42
Identities = 53/242 (21%), Positives = 86/242 (35%), Gaps = 21/242 (8%)
Query: 2 NKGTGALFVVKS---AESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEY 52
N G VKS V E I + + PN+ E + + + Y
Sbjct: 51 NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110
Query: 53 MAGGSLLDVAEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLLGSHGDVK 106
M G L + + + ++ G +H DL N +L VK
Sbjct: 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVK 170
Query: 107 LPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMA 166
+ D G AR + D + + WMA E L+ + +D+WS G ++ E+
Sbjct: 171 VADFGLARDMYD--KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 228
Query: 167 T-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
T G PP+ D N + + + P + + + KC K E R S EL+
Sbjct: 229 TRGAPPYPDV--NTFDITVYL-LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 285
Query: 226 NH 227
+
Sbjct: 286 SR 287
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 142 bits (360), Expect = 2e-42
Identities = 60/249 (24%), Positives = 103/249 (41%), Gaps = 33/249 (13%)
Query: 2 NKGTGALFVVK-----SAESEAGVQALRNEAEIRQSLNSPNIGR---------NGEKTVN 47
+ VK A + R EA+ +LN P I
Sbjct: 28 DLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87
Query: 48 IFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLLGS 101
I MEY+ G +L D+ G + + NGI+H D+K N+++ +
Sbjct: 88 IVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 146
Query: 102 HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCM 161
VK+ D G AR + D +GN ++ GT +++PE R + +D +D++SLGC+
Sbjct: 147 TNAVKVMDFGIARAIAD---SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 203
Query: 162 VIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEK 217
+ E+ TG PP+ + + + E P P+ + + + K L + PE
Sbjct: 204 LYEVLTGEPPFTGD--SPVSVAYQHV--REDPIPPSARHEGLSADLDAVVLKALAKNPEN 259
Query: 218 RW-SAEELL 225
R+ +A E+
Sbjct: 260 RYQTAAEMR 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (360), Expect = 5e-42
Identities = 47/233 (20%), Positives = 88/233 (37%), Gaps = 16/233 (6%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDV 61
A+ +KS +E + +EA I + PN+ V I E+M GSL
Sbjct: 58 AIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF 117
Query: 62 AEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115
+ G + + I L +H DL N+L+ S+ K+ D G +R
Sbjct: 118 LRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 116 VNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGD 174
+ D ++ + W APE ++ A+D+WS G ++ E+ + G P+ D
Sbjct: 178 LEDDTSDPTYTSA-LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236
Query: 175 KISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227
++ + + P + + C ++ R +++N
Sbjct: 237 M---TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 8e-42
Identities = 47/234 (20%), Positives = 88/234 (37%), Gaps = 19/234 (8%)
Query: 5 TGALFVVKS-AESEAGVQALRNEAEIRQSLNSPNI----GRNGEKTVNIFMEYMAGGSLL 59
VKS + A EA + + L + ++ + I EYM GSL+
Sbjct: 36 GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLV 95
Query: 60 DVAEKFGGT-LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGC 112
D + G L + +I + +H DL+ N+L+ K+ D G
Sbjct: 96 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155
Query: 113 ARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPW 172
AR + D N + + W APE + +D+WS G ++ E+ T
Sbjct: 156 ARLIED-----NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
Query: 173 GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226
++N +++ + P +++ + C + +PE R + + L +
Sbjct: 211 YPGMTNPE--VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-41
Identities = 46/231 (19%), Positives = 88/231 (38%), Gaps = 16/231 (6%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGRN-----GEKTVNIFMEYMAGGSLLDV 61
A+ +K+ +E EA I + NI R K + I EYM G+L
Sbjct: 40 AIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF 99
Query: 62 AEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115
+ G + + I +H DL N+L+ S+ K+ D G +R
Sbjct: 100 LREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR- 158
Query: 116 VNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDK 175
L+++ + W APE + A+D+WS G ++ E+ T +
Sbjct: 159 --VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 216
Query: 176 ISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226
+SN ++K + P + + +C +++ +R ++++
Sbjct: 217 LSNHE--VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-41
Identities = 47/266 (17%), Positives = 92/266 (34%), Gaps = 45/266 (16%)
Query: 1 MNKGTGALFVVK--------SAESEAGVQALRNEAEIRQSLNS--PNIGR-----NGEKT 45
+ +K + E + + ++S + R +
Sbjct: 24 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83
Query: 46 VNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLL 99
+ +E L G L + R + ++L G+LH D+K N+L+
Sbjct: 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 143
Query: 100 -GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL-DFATDIWS 157
+ G++KL D G + D + GT+++ PE +R + +WS
Sbjct: 144 DLNRGELKLIDFGSGALLKD--------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWS 195
Query: 158 LGCMVIEMATGRPPWG--DKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKP 215
LG ++ +M G P+ ++I + F + + + CL +P
Sbjct: 196 LGILLYDMVCGDIPFEHDEEIIRG------------QVFFRQRVSSECQHLIRWCLALRP 243
Query: 216 EKRWSAEELLNHTFISGNAKKNSTEE 241
R + EE+ NH ++ T E
Sbjct: 244 SDRPTFEEIQNHPWMQDVLLPQETAE 269
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-41
Identities = 52/236 (22%), Positives = 91/236 (38%), Gaps = 18/236 (7%)
Query: 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNI----GRNGEKTVNIFMEYMAGG 56
GT + + +A EA++ + L + E+ + I EYM+ G
Sbjct: 37 TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKG 96
Query: 57 SLLDVAEKFGGTLDA-GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPD 109
SLLD + G + +I + +H DL+ N+L+G + K+ D
Sbjct: 97 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVAD 156
Query: 110 LGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGR 169
G AR + D N + Q W APE +D+WS G ++ E+ T
Sbjct: 157 FGLARLIED-----NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 211
Query: 170 PPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
+ N +L + P + + + D + +C ++PE+R + E L
Sbjct: 212 RVPYPGMVNRE--VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (353), Expect = 4e-41
Identities = 54/238 (22%), Positives = 93/238 (39%), Gaps = 20/238 (8%)
Query: 1 MNKGTGALFVVKS-AESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMA 54
+ K VK+ E V+ EA + + + PN+ + E I E+M
Sbjct: 37 VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 96
Query: 55 GGSLLD-VAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKL 107
G+LLD + E + A V+ +I L +H DL N L+G + VK+
Sbjct: 97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKV 156
Query: 108 PDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT 167
D G +R + G+ + W APE L +D+W+ G ++ E+AT
Sbjct: 157 ADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211
Query: 168 GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225
I + + ++ + + P +KV + + C + P R S E+
Sbjct: 212 YGMSPYPGIDL--SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 141 bits (357), Expect = 5e-41
Identities = 52/255 (20%), Positives = 95/255 (37%), Gaps = 33/255 (12%)
Query: 2 NKGTGALFVVK--------SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNI 48
TG ++ +K + E R + + + P I + ++
Sbjct: 25 KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84
Query: 49 FMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH 102
++ M GG L + G +A +R Y EI +H +++ DLK N+LL H
Sbjct: 85 ILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH 143
Query: 103 GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMV 162
G V++ DLG A + K+ S+G + + D + D +SLGCM+
Sbjct: 144 GHVRISDLGLACDFSK-------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCML 196
Query: 163 IEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS-- 220
++ G P+ + + ++ P F ++ L L+R +R
Sbjct: 197 FKLLRGHSPFRQHKTKDKHEIDRM-TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCL 255
Query: 221 ---AEELLNHTFISG 232
A+E+ F
Sbjct: 256 GRGAQEVKESPFFRS 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 5e-40
Identities = 52/256 (20%), Positives = 87/256 (33%), Gaps = 41/256 (16%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNS-PNIGR-----NGEKTVNIFMEYMAGGSLLD 60
A+ ++K + +AL +E ++ L S NI + + EY G LL+
Sbjct: 71 AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 130
Query: 61 V----------------------AEKFGGTLDAGVIRLYTKEI------LHGNGILHCDL 92
E+ L + + ++ L +H DL
Sbjct: 131 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190
Query: 93 KCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA 152
NVL+ VK+ D G AR + N + WMAPE L
Sbjct: 191 AARNVLVTHGKVVKICDFGLARDIMSDSNY----VVRGNARLPVKWMAPESLFEGIYTIK 246
Query: 153 TDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCL 211
+D+WS G ++ E+ + G P+ A K+ + K P +++ + C
Sbjct: 247 SDVWSYGILLWEIFSLGVNPYPGI--PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCW 304
Query: 212 ERKPEKRWSAEELLNH 227
KR S L +
Sbjct: 305 AFDSRKRPSFPNLTSF 320
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 8e-40
Identities = 55/273 (20%), Positives = 96/273 (35%), Gaps = 50/273 (18%)
Query: 2 NKGTGALFVVK-------SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIF 49
+K T + +K S + + E ++ Q L+ PNI + +++
Sbjct: 19 DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV 78
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHG 103
++M + + + L I+ Y L H + ILH DLK NN+LL +G
Sbjct: 79 FDFMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG 137
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN-EGLDFATDIWSLGCMV 162
+KL D G A+ +++ T+ + APE+L D+W++GC++
Sbjct: 138 VLKLADFGLAKSFGSPN------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCIL 191
Query: 163 IEMATGRPP------------------------WGDKISNAAATLLKIACSNEKPHFPTQ 198
E+ P W D S K H +
Sbjct: 192 AELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA 251
Query: 199 FFKKVLDFLAKCLERKPEKRWSAEELLNHTFIS 231
+LD + P R +A + L + S
Sbjct: 252 AGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 4e-39
Identities = 67/277 (24%), Positives = 102/277 (36%), Gaps = 51/277 (18%)
Query: 2 NKGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNIGRNG-----EKTVNIFMEY 52
NK TG + +K E+E E + + LN PNI + E + + E+
Sbjct: 23 NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82
Query: 53 MAGGSLLDVAEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLLGSHGDVK 106
+ + + +I+ Y ++L G + +LH DLK N+L+ + G +K
Sbjct: 83 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIK 142
Query: 107 LPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG-LDFATDIWSLGCMVIEM 165
L D G AR + T + APE+L A DIWSLGC+ EM
Sbjct: 143 LADFGLARAFGVPVRT------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196
Query: 166 ATGRPPWGDKISNAAATLLKI----------------ACSNEKPHFPTQFFKKV------ 203
T R + + L +I + + KP FP +
Sbjct: 197 VTRRALFPGD--SEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 254
Query: 204 -----LDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235
L++ L P KR SA+ L H F K
Sbjct: 255 LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (338), Expect = 9e-39
Identities = 38/259 (14%), Positives = 82/259 (31%), Gaps = 22/259 (8%)
Query: 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGRN-----GEKTVNIFMEYMAG 55
+ G +K + L E++I + + E N+ + + G
Sbjct: 27 TDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86
Query: 56 GSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLP- 108
SL D+ + L ++ +H +H D+K +N L+G L
Sbjct: 87 PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVY 146
Query: 109 --DLGCARRVNDLKNNGNLKQSW-QSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEM 165
D G A++ D + + ++ +++ GT + + D+ SLG +++
Sbjct: 147 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF 206
Query: 166 ATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKV----LDFLAKCLERKPEKRWSA 221
G PW + + + K +L C + + +
Sbjct: 207 NLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDY 266
Query: 222 E---ELLNHTFISGNAKKN 237
+L + F +
Sbjct: 267 SYLRQLFRNLFHRQGFSYD 285
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (340), Expect = 1e-38
Identities = 62/253 (24%), Positives = 108/253 (42%), Gaps = 35/253 (13%)
Query: 1 MNKGTGALFVVK-----SAESEAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFM 50
+K +G + +K ++ NE I Q++N P + + + + M
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 51 EYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGD 104
EY+AGG + + G R Y +I LH +++ DLK N+L+ G
Sbjct: 121 EYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 179
Query: 105 VKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIE 164
+++ D G A+RV ++ GT +APE++ ++G + A D W+LG ++ E
Sbjct: 180 IQVTDFGFAKRVKG---------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 165 MATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW----- 219
MA G PP+ KI + K FP+ F + D L L+ KR+
Sbjct: 231 MAAGYPPFFAD--QPIQIYEKI--VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKN 286
Query: 220 SAEELLNHTFISG 232
++ NH + +
Sbjct: 287 GVNDIKNHKWFAT 299
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-38
Identities = 58/282 (20%), Positives = 93/282 (32%), Gaps = 55/282 (19%)
Query: 2 NKGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNIGR-------------NGEK 44
++ TG +K E E E +I Q L N+ +
Sbjct: 31 HRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90
Query: 45 TVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVL 98
++ + ++ L + I+ + +L+G N ILH D+K NVL
Sbjct: 91 SIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVL 149
Query: 99 LGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE-GLDFATDIWS 157
+ G +KL D G AR + KN+ + + T + PE+L E D+W
Sbjct: 150 ITRDGVLKLADFGLARAFSLAKNSQP--NRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 207
Query: 158 LGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKK--------------- 202
GC++ EM T P L+ C + P
Sbjct: 208 AGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRK 267
Query: 203 -------------VLDFLAKCLERKPEKRWSAEELLNHTFIS 231
LD + K L P +R +++ LNH F
Sbjct: 268 VKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-38
Identities = 52/249 (20%), Positives = 88/249 (35%), Gaps = 38/249 (15%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLD 60
A+ +K S+ + E E+ L + PNI + + +EY G+LLD
Sbjct: 41 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 100
Query: 61 V---------------AEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLL 99
A TL + + + ++ G +H DL N+L+
Sbjct: 101 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 160
Query: 100 GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
G + K+ D G +R WMA E L +D+WS G
Sbjct: 161 GENYVAKIADFGLSRGQEV-------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 213
Query: 160 CMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
++ E+ + G P+ A L + + P +V D + +C KP +R
Sbjct: 214 VLLWEIVSLGGTPYCGM---TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 270
Query: 219 WSAEELLNH 227
S ++L
Sbjct: 271 PSFAQILVS 279
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 4e-38
Identities = 48/241 (19%), Positives = 83/241 (34%), Gaps = 26/241 (10%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGRN-----GEKTVNIFMEYMAGGSLLDV 61
A+ V A S NEA + + N ++ R + + ME M G L
Sbjct: 54 AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 113
Query: 62 ---------AEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLLGSHGDVK 106
+ EI G N +H DL N ++ VK
Sbjct: 114 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 173
Query: 107 LPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMA 166
+ D G R + + + + WM+PE L++ +D+WS G ++ E+A
Sbjct: 174 IGDFGMTRDIYE----TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229
Query: 167 TGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226
T +SN +L+ P + + + C + P+ R S E+++
Sbjct: 230 TLAEQPYQGLSNEQ--VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287
Query: 227 H 227
Sbjct: 288 S 288
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 4e-38
Identities = 59/276 (21%), Positives = 102/276 (36%), Gaps = 51/276 (18%)
Query: 1 MNKGTGALFVVK---SAESEAGVQALRNEAEIRQSLNSPNI--------GRNGEKTVNIF 49
+ +K E + Q E +I NI E+ +++
Sbjct: 28 YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87
Query: 50 -MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH 102
+ ++ G L + + L I + +I +H +LH DLK +N+LL +
Sbjct: 88 LVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT 145
Query: 103 GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD-FATDIWSLGCM 161
D+K+ D G AR + ++ T+ + APE++ N + DIWS+GC+
Sbjct: 146 CDLKICDFGLARVADPDHDH---TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 202
Query: 162 VIEMATGRPPWGDK-----------------------ISNAAATLLKIACSNEKPHFPTQ 198
+ EM + RP + K I N A ++ ++ +
Sbjct: 203 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 262
Query: 199 FFKKV----LDFLAKCLERKPEKRWSAEELLNHTFI 230
F LD L K L P KR E+ L H ++
Sbjct: 263 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 8e-37
Identities = 59/256 (23%), Positives = 108/256 (42%), Gaps = 31/256 (12%)
Query: 2 NKGTGALFVVK------SAESEAGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIF 49
TG L+ +K + + R E ++ + + SP + E +++
Sbjct: 48 GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI 107
Query: 50 MEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHG 103
++Y+ GG L + +++Y EI+ H GI++ D+K N+LL S+G
Sbjct: 108 LDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG 166
Query: 104 DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR--NEGLDFATDIWSLGCM 161
V L D G ++ + + GT +MAP+++R + G D A D WSLG +
Sbjct: 167 HVVLTDFGLSKEFVADET-----ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 221
Query: 162 VIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS- 220
+ E+ TG P+ + + +P +P + D + + L + P+KR
Sbjct: 222 MYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGC 281
Query: 221 ----AEELLNHTFISG 232
A+E+ H F
Sbjct: 282 GPRDADEIKEHLFFQK 297
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-36
Identities = 45/248 (18%), Positives = 91/248 (36%), Gaps = 33/248 (13%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNS-PNIGRNG-----EKTVNIFMEYMAGGSLLD 60
A+ ++KS +E + L +E E+ + + NI + + + +EY + G+L +
Sbjct: 49 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 108
Query: 61 V---------------AEKFGGTLDAGVIRLYTKEILHG------NGILHCDLKCNNVLL 99
+ L + + ++ G +H DL NVL+
Sbjct: 109 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168
Query: 100 GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
+K+ D G AR ++ + WMAPE L + +D+WS G
Sbjct: 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGR----LPVKWMAPEALFDRIYTHQSDVWSFG 224
Query: 160 CMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219
++ E+ T + L K+ + P+ ++ + C P +R
Sbjct: 225 VLLWEIFTLGGSPYPGVPVEE--LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 282
Query: 220 SAEELLNH 227
+ ++L+
Sbjct: 283 TFKQLVED 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (320), Expect = 4e-36
Identities = 41/253 (16%), Positives = 84/253 (33%), Gaps = 40/253 (15%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGRN-----GEKTVNIFMEYMAGGSLLDV 61
A+ ++K S + EA + ++PNI + K + + EYMA G L +
Sbjct: 47 AVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF 106
Query: 62 AEKFGG-----------------------TLDAGVIRLYTKEI------LHGNGILHCDL 92
L +++ L +H DL
Sbjct: 107 LRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166
Query: 93 KCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA 152
N L+G + VK+ D G +R + + ++ + WM PE +
Sbjct: 167 ATRNCLVGENMVVKIADFGLSRNIYS----ADYYKADGNDAIPIRWMPPESIFYNRYTTE 222
Query: 153 TDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLE 212
+D+W+ G ++ E+ + +++ ++ P ++ + + C
Sbjct: 223 SDVWAYGVVLWEIFSYGLQPYYGMAHEE--VIYYVRDGNILACPENCPLELYNLMRLCWS 280
Query: 213 RKPEKRWSAEELL 225
+ P R S +
Sbjct: 281 KLPADRPSFCSIH 293
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 8e-36
Identities = 63/283 (22%), Positives = 106/283 (37%), Gaps = 55/283 (19%)
Query: 3 KGTGALFVVK-----SAESEAGVQALRNEAEIRQ--SLNSPNIGR----------NGEKT 45
K G +K + E + +R A +R + PN+ R + E
Sbjct: 30 KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 89
Query: 46 VNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLL 99
+ + E++ + + + I+ ++ LH + ++H DLK N+L+
Sbjct: 90 LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV 149
Query: 100 GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
S G +KL D G AR + + + S+ T + APEVL D+WS+G
Sbjct: 150 TSSGQIKLADFGLARIYSF-------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 202
Query: 160 CMVIEMATGRPPWGD--------KISNAAAT-----------LLKIACSNEKPHFPTQFF 200
C+ EM +P + KI + L + A ++ +F
Sbjct: 203 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV 262
Query: 201 KKV----LDFLAKCLERKPEKRWSAEELLNHTFISG--NAKKN 237
+ D L KCL P KR SA L+H + K+N
Sbjct: 263 TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKEN 305
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 126 bits (317), Expect = 8e-36
Identities = 38/246 (15%), Positives = 82/246 (33%), Gaps = 21/246 (8%)
Query: 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGRN-----GEKTVNIFMEYMAGG 56
N +K + LR+E + L N E N+ + + G
Sbjct: 26 NLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGP 85
Query: 57 SLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS-----HGDV 105
SL D+ + G + + K++ +H +++ D+K +N L+G +
Sbjct: 86 SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMI 145
Query: 106 KLPDLGCARRVNDLKNNGNLK-QSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIE 164
+ D G + D ++ + +++ GT +M+ D+ +LG + +
Sbjct: 146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMY 205
Query: 165 MATGRPPW-GDKISNAAATLLKIACSNEKPHFPT---QFFKKVLDFLAKCLERKPEKRWS 220
G PW G K + +I + F ++ ++ +
Sbjct: 206 FLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPD 265
Query: 221 AEELLN 226
+ L
Sbjct: 266 YDYLQG 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 3e-35
Identities = 52/282 (18%), Positives = 100/282 (35%), Gaps = 55/282 (19%)
Query: 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNI-----------GRNGEKTVNIFM 50
+G L +K + + E +I + L+ NI + E +N+ +
Sbjct: 41 LCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98
Query: 51 EYMAGGSLLDVAE--KFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH 102
+Y+ + TL ++LY ++ +H GI H D+K N+LL
Sbjct: 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD 158
Query: 103 G-DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP-EVLRNEGLDFATDIWSLGC 160
+KL D G A+++ + S ++ + AP + + D+WS GC
Sbjct: 159 TAVLKLCDFGSAKQLVR-------GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 211
Query: 161 MVIEMATGRPPWGD--------KISNAAATLLKIACSNEKPHFPTQFFKKV--------- 203
++ E+ G+P + +I T + P++ F ++
Sbjct: 212 VLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVF 271
Query: 204 --------LDFLAKCLERKPEKRWSAEELLNHTFISGNAKKN 237
+ ++ LE P R + E H+F N
Sbjct: 272 RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 123 bits (309), Expect = 1e-34
Identities = 60/268 (22%), Positives = 99/268 (36%), Gaps = 50/268 (18%)
Query: 5 TGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNI----GRNGEKTVNIFMEYMAGG 56
G F +K E E E I + L NI K + +
Sbjct: 25 YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84
Query: 57 SLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVKLPDL 110
L + + G L++ + + ++L H +LH DLK N+L+ G++K+ D
Sbjct: 85 DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADF 144
Query: 111 GCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG-LDFATDIWSLGCMVIEMATGR 169
G AR G + + T + AP+VL DIWS+GC+ EM G
Sbjct: 145 GLARAF------GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
Query: 170 PPWGDKISNAAATLLKI-----------------------ACSNEKPHFPTQFFKKV--- 203
P + + A L++I + +P F K +
Sbjct: 199 PLFPGV--SEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDES 256
Query: 204 -LDFLAKCLERKPEKRWSAEELLNHTFI 230
+D L+K L+ P +R +A++ L H +
Sbjct: 257 GIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 4e-34
Identities = 49/248 (19%), Positives = 88/248 (35%), Gaps = 34/248 (13%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLD 60
A+ ++K + +AL +E ++ L N NI + EY G LL+
Sbjct: 57 AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116
Query: 61 -----------------VAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNV 97
+ E LD + ++ ++ L +H DL N+
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176
Query: 98 LLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWS 157
LL K+ D G AR + + N WMAPE + N F +D+WS
Sbjct: 177 LLTHGRITKICDFGLARDIKNDSNYVVKGN----ARLPVKWMAPESIFNCVYTFESDVWS 232
Query: 158 LGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEK 217
G + E+ + + K+ + P ++ D + C + P K
Sbjct: 233 YGIFLWELFSLGSSP-YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 291
Query: 218 RWSAEELL 225
R + ++++
Sbjct: 292 RPTFKQIV 299
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 4e-32
Identities = 55/272 (20%), Positives = 94/272 (34%), Gaps = 47/272 (17%)
Query: 1 MNKGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNI----GRNGEKTVNIFMEY 52
N+ T + +K + E + E + + L NI +
Sbjct: 22 KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81
Query: 53 MAGGSLLDVAEKFGGTLDAGVIRLYTKEIL------HGNGILHCDLKCNNVLLGSHGDVK 106
L + G LD +++ + ++L H +LH DLK N+L+ +G++K
Sbjct: 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELK 141
Query: 107 LPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG-LDFATDIWSLGCMVIEM 165
L + G AR + + + T + P+VL + D+WS GC+ E+
Sbjct: 142 LANFGLARAFGIPV------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195
Query: 166 ATGRPPW-----------------GDKISNAAATLLKIACSNEKPHFPT---------QF 199
A P G ++ K+ P +P +
Sbjct: 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKL 255
Query: 200 FKKVLDFLAKCLERKPEKRWSAEELLNHTFIS 231
D L L+ P +R SAEE L H + S
Sbjct: 256 NATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 7e-32
Identities = 52/279 (18%), Positives = 97/279 (34%), Gaps = 59/279 (21%)
Query: 1 MNKGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNI----------GRNGEKTV 46
+ TG VK +S + E + + + N+ E
Sbjct: 38 FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97
Query: 47 NIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
+ ++ G L ++ + L ++ +I +H I+H DLK +N+ +
Sbjct: 98 VYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 155
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG-LDFATDIWSLG 159
++K+ D G AR + T+ + APE++ N + DIWS+G
Sbjct: 156 EDCELKILDFGLARHTD---------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 206
Query: 160 CMVIEMATGRPPW-------------------GDKISNAAATLLKIACSNEKPHFPTQFF 200
C++ E+ TGR + G ++ ++ P F
Sbjct: 207 CIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF 266
Query: 201 KKV--------LDFLAKCLERKPEKRWSAEELLNHTFIS 231
V +D L K L +KR +A + L H + +
Sbjct: 267 ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 8e-32
Identities = 41/249 (16%), Positives = 84/249 (33%), Gaps = 33/249 (13%)
Query: 7 ALFVVKSAESEAGVQALRNEAEIRQSLNSPNI-------GRNGEKTVNIFMEYMAGGSLL 59
A+ ++K + + +AL +E +I + + + +E+ G+L
Sbjct: 47 AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 106
Query: 60 DV---------------AEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVL 98
+ + L + Y+ ++ L +H DL N+L
Sbjct: 107 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166
Query: 99 LGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSL 158
L VK+ D G AR + + WMAPE + + +D+WS
Sbjct: 167 LSEKNVVKICDFGLARDIYKDPDYVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSF 222
Query: 159 GCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218
G ++ E+ + + + + P ++ + C +P +R
Sbjct: 223 GVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 281
Query: 219 WSAEELLNH 227
+ EL+ H
Sbjct: 282 PTFSELVEH 290
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 116 bits (291), Expect = 1e-31
Identities = 61/280 (21%), Positives = 102/280 (36%), Gaps = 64/280 (22%)
Query: 1 MNKGTGALFVVKSAESEAGVQALRNEAEIRQSLN-SPNIGR-------NGEKTVNIFMEY 52
+N VVK + + ++ E +I ++L PNI +T + E+
Sbjct: 55 INITNNEKVVVKILKPVK-KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113
Query: 53 MAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS-HGDV 105
+ ++ TL IR Y EI H GI+H D+K +NV++ H +
Sbjct: 114 VNNTDF----KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKL 169
Query: 106 KLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN-EGLDFATDIWSLGCMVIE 164
+L D G A + Q + ++ + PE+L + + D++ D+WSLGCM+
Sbjct: 170 RLIDWGLAEFYHP-------GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 222
Query: 165 MATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKK---------------------- 202
M + P+ N L++IA K
Sbjct: 223 MIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 281
Query: 203 -------------VLDFLAKCLERKPEKRWSAEELLNHTF 229
LDFL K L + R +A E + H +
Sbjct: 282 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 4e-31
Identities = 50/279 (17%), Positives = 91/279 (32%), Gaps = 59/279 (21%)
Query: 2 NKGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNI-----------GRNGEKTV 46
+ TGA +K +SE + E + + + N+ +
Sbjct: 39 DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98
Query: 47 NIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLG 100
+ M +M G L + + L I+ ++ +H GI+H DLK N+ +
Sbjct: 99 YLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN 155
Query: 101 SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGC 160
++K+ D G AR+ + + + +L DIWS+GC
Sbjct: 156 EDCELKILDFGLARQADS--------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC 207
Query: 161 MVIEMATGRPPWGD-------------------KISNAAATLLKIACSNEKPHFPTQFFK 201
++ EM TG+ + + + P + F
Sbjct: 208 IMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA 267
Query: 202 KVL--------DFLAKCLERKPEKRWSAEELLNHTFISG 232
+L + L K L E+R +A E L H +
Sbjct: 268 SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 9e-31
Identities = 55/268 (20%), Positives = 98/268 (36%), Gaps = 50/268 (18%)
Query: 5 TGALFVVKSAESEAGVQALRNEAEIRQ--SLNSPNI---------GRNGEKTVNIFMEYM 53
G VK S R EAEI Q L NI + + +Y
Sbjct: 25 RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83
Query: 54 AGGSLLDVAEKFGGTLD----------AGVIRLYTKEI--LHGNGILHCDLKCNNVLLGS 101
GSL D ++ T++ +G+ L+ + + I H DLK N+L+
Sbjct: 84 EHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143
Query: 102 HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE------GLDFATDI 155
+G + DLG A R + + ++ + GT+ +MAPEVL + DI
Sbjct: 144 NGTCCIADLGLAVRHDSATDTIDIAPN--HRVGTKRYMAPEVLDDSINMKHFESFKRADI 201
Query: 156 WSLGCMVIEMATGRPPWGDKIS------------NAAATLLKIACSNE-KPHFPTQFF-- 200
+++G + E+A G + + K+ C + +P+ P ++
Sbjct: 202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 261
Query: 201 ---KKVLDFLAKCLERKPEKRWSAEELL 225
+ + + +C R +A +
Sbjct: 262 EALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 4e-30
Identities = 56/302 (18%), Positives = 97/302 (32%), Gaps = 74/302 (24%)
Query: 1 MNKGTGALFVVK----SAESEAGVQALRNEAEIRQSLNSPNIGR-----------NGEKT 45
+ +K +++ + E + + +N NI +
Sbjct: 37 YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96
Query: 46 VNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLL 99
V + ME M + LD + ++ LH GI+H DLK +N+++
Sbjct: 97 VYLVMELMDANLC----QVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 152
Query: 100 GSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLG 159
S +K+ D G AR T+ + APEV+ G DIWS+G
Sbjct: 153 KSDCTLKILDFGLARTAGT-------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 205
Query: 160 CMVIEMATGRPPWGDKISNAAATLLKIACS--------------------NEKPHFPTQF 199
C++ EM + + + + K+ +P +
Sbjct: 206 CIMGEMVRHKILFPGR--DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLT 263
Query: 200 FKKV--------------------LDFLAKCLERKPEKRWSAEELLNHTFISGNAKKNST 239
F K+ D L+K L P KR S ++ L H +I+
Sbjct: 264 FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEV 323
Query: 240 EE 241
E
Sbjct: 324 EA 325
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 100 bits (250), Expect = 1e-25
Identities = 53/304 (17%), Positives = 99/304 (32%), Gaps = 75/304 (24%)
Query: 2 NKGTGALFVVKS-AESEAGVQALRNEAEIRQSLNSPNIGR-------------------- 40
+ +K + +A +E ++ Q +N + +
Sbjct: 34 DMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93
Query: 41 NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEILHG-------NGILHCDLK 93
V + E + L + + + ++ +K++L G GI+H D+K
Sbjct: 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIK 153
Query: 94 CNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFAT 153
NVL+ P+ ++ DL N + + + T+ + +PEVL
Sbjct: 154 PENVLMEIVDS---PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGA 210
Query: 154 DIWSLGCMVIEMATGRPPW----GDKISNAAATLLKIAC--------------------- 188
DIWS C++ E+ TG + G + + +I
Sbjct: 211 DIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFN 270
Query: 189 -------------------SNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTF 229
EK F K++ DFL+ L+ P KR A L+NH +
Sbjct: 271 SRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW 330
Query: 230 ISGN 233
+
Sbjct: 331 LKDT 334
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 44.4 bits (104), Expect = 2e-06
Identities = 25/152 (16%), Positives = 46/152 (30%), Gaps = 33/152 (21%)
Query: 24 RNEAEIRQSLNSPNIGRN-GEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKEIL 82
RNE Q L + + + + ME + L V + + ++
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEV--AKF 119
Query: 83 HGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142
+ GI+H DL NVL+ G + + D + V + E
Sbjct: 120 YHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGE-------------------EGWRE 159
Query: 143 VLR----------NEGLDFATDIWSLGCMVIE 164
+L + DI S +++
Sbjct: 160 ILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 241 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.72 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.01 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.91 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.5 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.13 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.44 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.12 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-56 Score=337.24 Aligned_cols=218 Identities=27% Similarity=0.471 Sum_probs=185.5
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
|+.+|+.||+|++... ...+.+.+|+.++++++||||++ .+++.+|+|||||++|+|.+++... ..+++
T Consensus 27 ~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~-~~l~e 105 (263)
T d2j4za1 27 EKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDE 105 (263)
T ss_dssp ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCH
T ss_pred ECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhc-CCCCH
Confidence 6789999999997632 23567899999999999999998 7788999999999999999999874 56888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.++.+||+|||++..... .......||+.|+|||.+.
T Consensus 106 ~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--------~~~~~~~Gt~~Y~APE~~~ 177 (263)
T d2j4za1 106 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--------SRRTTLCGTLDYLPPEMIE 177 (263)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC--------CCCEETTEEGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC--------CcccccCCCCcccCHHHHc
Confidence 8888887765 7999999999999999999999999999999975433 1123456899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELL 225 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 225 (241)
+..++.++|||||||++|+|++|+.||.+.......... ....+.+|..+++++.+|+.+||+.||.+|||+++++
T Consensus 178 ~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i----~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil 253 (263)
T d2j4za1 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253 (263)
T ss_dssp TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----HTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH----HcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 999999999999999999999999999775443332222 2344566777889999999999999999999999999
Q ss_pred cCCCCCC
Q 042809 226 NHTFISG 232 (241)
Q Consensus 226 ~~p~~~~ 232 (241)
+||||..
T Consensus 254 ~hp~~~~ 260 (263)
T d2j4za1 254 EHPWITA 260 (263)
T ss_dssp TCHHHHH
T ss_pred cCcCcCC
Confidence 9999964
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-56 Score=339.62 Aligned_cols=231 Identities=23% Similarity=0.367 Sum_probs=185.8
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
|+.||+.||||.+..+ ...+.+.+|+.++++++||||++ ..++.+|+|||||+||+|.+++.. ...+++..
T Consensus 26 ~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~ 104 (271)
T d1nvra_ 26 NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPD 104 (271)
T ss_dssp ETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHH
T ss_pred ECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhc-CCCCCHHH
Confidence 6789999999997643 23467899999999999999998 677899999999999999999976 46788888
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
++.++.|+ ||++|++||||||+||+++.++.+||+|||++........ ........||+.|+|||++.+.
T Consensus 105 ~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~----~~~~~~~~GT~~Y~APE~~~~~ 180 (271)
T d1nvra_ 105 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR----ERLLNKMCGTLPYVAPELLKRR 180 (271)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE----ECCBCCCCSCGGGSCTHHHHCS
T ss_pred HHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc----cccccceeeCcCccCHhHhcCC
Confidence 88887766 7999999999999999999999999999999986543211 1222345799999999999887
Q ss_pred CC-CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 148 GL-DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 148 ~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
.+ +.++||||+||++|+|++|+.||......... ................+++++.+|+.+||+.||.+|||++++++
T Consensus 181 ~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 76 57899999999999999999999765433222 22222222223334567889999999999999999999999999
Q ss_pred CCCCCCCCccCC
Q 042809 227 HTFISGNAKKNS 238 (241)
Q Consensus 227 ~p~~~~~~~~~~ 238 (241)
||||+...++.|
T Consensus 260 hpwf~~~l~kg~ 271 (271)
T d1nvra_ 260 DRWYNKPLKKGA 271 (271)
T ss_dssp CTTTTCCCCCCC
T ss_pred CHhhCcCCCCCC
Confidence 999998777654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-55 Score=334.77 Aligned_cols=223 Identities=34% Similarity=0.550 Sum_probs=185.2
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
|+.+|+.||||.+... ...+.+.+|+.++++++||||++ ..++.+|+|||||+||+|.+++.. ..+++..+
T Consensus 41 ~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~--~~l~~~~~ 118 (293)
T d1yhwa1 41 DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQI 118 (293)
T ss_dssp BTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHH
T ss_pred ECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc--cCCCHHHH
Confidence 6789999999997632 34577999999999999999998 667889999999999999998876 46888888
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
+.++.|+ ||++|++||||||+||+++.+|.+||+|||++....... .......||+.|+|||++.+..
T Consensus 119 ~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~~ 192 (293)
T d1yhwa1 119 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ------SKRSTMVGTPYWMAPEVVTRKA 192 (293)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT------CCBCCCCSCGGGCCHHHHSSSC
T ss_pred HHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc------ccccccccCCCccChhhhcCCC
Confidence 8887766 799999999999999999999999999999997653311 1223456999999999999999
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCC
Q 042809 149 LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHT 228 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p 228 (241)
++.++||||+||++|+|++|..||.+........... .........+..+++++.+||.+||+.||.+|||++++++||
T Consensus 193 ~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp 271 (293)
T d1yhwa1 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (293)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCG
T ss_pred CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH-hCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 9999999999999999999999997654333222221 122223345677889999999999999999999999999999
Q ss_pred CCCCC
Q 042809 229 FISGN 233 (241)
Q Consensus 229 ~~~~~ 233 (241)
||+..
T Consensus 272 ~~~~~ 276 (293)
T d1yhwa1 272 FLKIA 276 (293)
T ss_dssp GGGGC
T ss_pred hhCCC
Confidence 99753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-54 Score=336.78 Aligned_cols=226 Identities=25% Similarity=0.400 Sum_probs=172.7
Q ss_pred CCCCCcEEEEEeccch---HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE---AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
|+.+|+.||||.+... .....+.+|+.++++++||||++ .+++.+|+|||||+||+|.+++.. ...+++..
T Consensus 30 ~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~ 108 (307)
T d1a06a_ 30 DKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERD 108 (307)
T ss_dssp ETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCCCHHH
T ss_pred ECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc-ccCCCHHH
Confidence 5789999999998743 23456789999999999999998 678899999999999999999987 56789999
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEee---cCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLG---SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..++.|+ ||++|++||||||+||+++ .++.+||+|||++...... .......||+.|+|||++
T Consensus 109 ~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-------~~~~~~~GT~~y~APE~~ 181 (307)
T d1a06a_ 109 ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-------SVLSTACGTPGYVAPEVL 181 (307)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------------------CTTSCHHHH
T ss_pred HHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC-------CeeeeeeeCccccCcHHH
Confidence 88888766 7999999999999999995 4688999999999755431 122345699999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL 224 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 224 (241)
.+..++.++||||+||++|+|++|..||.+.....................+..+++++.+||.+||+.||.+|||++|+
T Consensus 182 ~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei 261 (307)
T d1a06a_ 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261 (307)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred cCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 99999999999999999999999999998754443333222222222333446788999999999999999999999999
Q ss_pred hcCCCCCCCCc
Q 042809 225 LNHTFISGNAK 235 (241)
Q Consensus 225 l~~p~~~~~~~ 235 (241)
++||||++...
T Consensus 262 l~hp~~~~~~~ 272 (307)
T d1a06a_ 262 LQHPWIAGDTA 272 (307)
T ss_dssp HHSTTTTSSCC
T ss_pred hcCHhhCCCCc
Confidence 99999986543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-55 Score=334.44 Aligned_cols=227 Identities=33% Similarity=0.538 Sum_probs=186.6
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
|+.+|+.||+|.+.. ....+.+.+|++++++++||||++ ..++.+|+|||||+||+|.+++...+..+++..+
T Consensus 33 ~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~ 112 (288)
T d2jfla1 33 NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQI 112 (288)
T ss_dssp ETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHH
T ss_pred ECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHH
Confidence 678999999999864 345678999999999999999998 6778899999999999999998877778999988
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc---
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR--- 145 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--- 145 (241)
..++.|+ ||++|++||||||+||+++.+|.+||+|||++....... .......||+.|+|||++.
T Consensus 113 ~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~------~~~~~~~Gt~~y~APE~l~~~~ 186 (288)
T d2jfla1 113 QVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI------QRRDSFIGTPYWMAPEVVMCET 186 (288)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH------HHHTCCCSCCTTCCHHHHTTCS
T ss_pred HHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc------ccccccccccccCCHHHHhhcc
Confidence 8888766 799999999999999999999999999999986543311 1123456899999999984
Q ss_pred --ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH
Q 042809 146 --NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE 223 (241)
Q Consensus 146 --~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 223 (241)
+..++.++|||||||++|+|++|+.||.+............ ........+..+++++.+||++||+.||.+|||+++
T Consensus 187 ~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e 265 (288)
T d2jfla1 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQ 265 (288)
T ss_dssp TTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH-SCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred cCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc-CCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 45678999999999999999999999987544433222221 111223345678899999999999999999999999
Q ss_pred HhcCCCCCCCCc
Q 042809 224 LLNHTFISGNAK 235 (241)
Q Consensus 224 ~l~~p~~~~~~~ 235 (241)
+++||||+....
T Consensus 266 ll~hp~~~~~~~ 277 (288)
T d2jfla1 266 LLQHPFVTVDSN 277 (288)
T ss_dssp HTTSGGGCCCCC
T ss_pred HhcCcccCCCCC
Confidence 999999986543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-54 Score=326.25 Aligned_cols=218 Identities=28% Similarity=0.511 Sum_probs=176.3
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc---------cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR---------NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
|+.+|..||+|.+.. ....+.+.+|+++|++++||||++ ..+..+|+|||||++|+|.+++... ..
T Consensus 30 ~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~ 108 (270)
T d1t4ha_ 30 DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KV 108 (270)
T ss_dssp ETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SS
T ss_pred ECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcc-cc
Confidence 678899999998763 334567899999999999999998 2356789999999999999999874 56
Q ss_pred CCHHHHHHHHHHH------hhcCC--ccccCCCCCcEEee-cCCCeeecCCCcchhhcccccCCccccccccccCccccc
Q 042809 69 LDAGVIRLYTKEI------LHGNG--ILHCDLKCNNVLLG-SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~--~vH~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (241)
+++..+..++.|+ ||+++ ++||||||+||+++ .++.+||+|||++..... .......||+.|+
T Consensus 109 ~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--------~~~~~~~GT~~Y~ 180 (270)
T d1t4ha_ 109 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--------SFAKAVIGTPEFM 180 (270)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--------TSBEESCSSCCCC
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--------CccCCcccCcccc
Confidence 8888877776655 79998 99999999999996 478999999999974322 1123457999999
Q ss_pred CcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC-CCCCCChhhHHHHHHHHHHhhccCCCCC
Q 042809 140 APEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN-EKPHFPTQFFKKVLDFLAKCLERKPEKR 218 (241)
Q Consensus 140 aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R 218 (241)
|||.+.+ .++.++|||||||++|+|++|+.||.+.... ..+....... .+...+...++++.+||.+||+.+|++|
T Consensus 181 aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 257 (270)
T d1t4ha_ 181 APEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 257 (270)
T ss_dssp CGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGS
T ss_pred CHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHC
Confidence 9999876 5899999999999999999999999754322 2222222222 2233455567889999999999999999
Q ss_pred CChHHHhcCCCCC
Q 042809 219 WSAEELLNHTFIS 231 (241)
Q Consensus 219 ps~~~~l~~p~~~ 231 (241)
||++|+++||||+
T Consensus 258 ~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 258 YSIKDLLNHAFFQ 270 (270)
T ss_dssp CCHHHHHTSGGGC
T ss_pred cCHHHHhCCcccC
Confidence 9999999999996
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.3e-54 Score=338.68 Aligned_cols=227 Identities=23% Similarity=0.406 Sum_probs=188.2
Q ss_pred CCCCCcEEEEEeccc--hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAES--EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
++.+|+.||||++.. ....+.+.+|+.++++++||||++ ..++.+|+|||||+||+|.+++....+.+++..+
T Consensus 47 ~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~ 126 (350)
T d1koaa2 47 ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA 126 (350)
T ss_dssp ETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHH
T ss_pred ECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHH
Confidence 578999999999864 344577899999999999999998 6788999999999999999999766678999999
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeec--CCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGS--HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
..++.|+ ||++|++||||||+||+++. ++.+||+|||++...... .......||+.|+|||++.+
T Consensus 127 ~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-------~~~~~~~gT~~Y~aPEv~~~ 199 (350)
T d1koaa2 127 VEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-------QSVKVTTGTAEFAAPEVAEG 199 (350)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-------SCEEEECSCTTTCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-------cccceecCcccccCHHHHcC
Confidence 9888866 79999999999999999964 578999999999765431 22234678999999999999
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
..++.++|||||||++|+|++|..||.+.........+..............+++++.+||++||+.||.+|||++++++
T Consensus 200 ~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999999999999999999999999876544433333322222223333567889999999999999999999999999
Q ss_pred CCCCCCCCc
Q 042809 227 HTFISGNAK 235 (241)
Q Consensus 227 ~p~~~~~~~ 235 (241)
||||+....
T Consensus 280 hp~~~~~~~ 288 (350)
T d1koaa2 280 HPWLTPGNA 288 (350)
T ss_dssp STTTSCTTC
T ss_pred CcccCCCCC
Confidence 999986543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=332.30 Aligned_cols=223 Identities=28% Similarity=0.506 Sum_probs=183.4
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.||+.||||++... ...+.+.+|++++++++||||++ .+++.+|+|||||+||+|.+++... +.+++
T Consensus 29 ~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~-~~l~e 107 (288)
T d1uu3a_ 29 ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDE 107 (288)
T ss_dssp ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCH
T ss_pred ECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhcc-CCCCH
Confidence 5789999999998743 33467899999999999999998 6788999999999999999998874 67888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..++.++.|+ ||++|++||||||+||+++.+|.+||+|||++........ ........||+.|+|||++.
T Consensus 108 ~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~----~~~~~~~~GT~~Y~APE~~~ 183 (288)
T d1uu3a_ 108 TCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK----QARANSFVGTAQYVSPELLT 183 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------------CCCCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc----ccccccccCCccccCceeec
Confidence 8888777755 7999999999999999999999999999999976533111 11223456999999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHH--
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEE-- 223 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-- 223 (241)
+..++.++||||+||++|+|++|..||.+.........+ ......+|..+++++.+||++||+.||.+|||++|
T Consensus 184 ~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i----~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI----IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred cCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH----HcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 999999999999999999999999999875433322221 23445677788999999999999999999999988
Q ss_pred ----HhcCCCCCCC
Q 042809 224 ----LLNHTFISGN 233 (241)
Q Consensus 224 ----~l~~p~~~~~ 233 (241)
+++||||++-
T Consensus 260 ~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 260 GYGPLKAHPFFESV 273 (288)
T ss_dssp CHHHHHTSGGGTTC
T ss_pred CCHHHHcCCccCCC
Confidence 5889999764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.5e-54 Score=338.31 Aligned_cols=226 Identities=23% Similarity=0.411 Sum_probs=189.6
Q ss_pred CCCCCcEEEEEeccch--HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE--AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
|+.+|+.||||++... .....+.+|+.++++++||||++ ..++.+|+|||||+||+|.+++...+.++++..+
T Consensus 50 ~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~ 129 (352)
T d1koba_ 50 EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV 129 (352)
T ss_dssp ETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHH
T ss_pred ECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHH
Confidence 6789999999998743 34567889999999999999998 6788999999999999999998876778999999
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEee--cCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLG--SHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
+.++.|+ ||++|++||||||+|||++ .++.+||+|||++..... ........|++.|+|||++.+
T Consensus 130 ~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~-------~~~~~~~~gt~~y~aPE~~~~ 202 (352)
T d1koba_ 130 INYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-------DEIVKVTTATAEFAAPEIVDR 202 (352)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-------TSCEEEECSSGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC-------CCceeeccCcccccCHHHHcC
Confidence 8888766 7999999999999999997 568899999999976543 122334568999999999999
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
..++.++|||||||++|+|++|..||.+........................+++++.+||++||+.||.+|||++++++
T Consensus 203 ~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 203 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999999999999999999999999876554443333332223334445678899999999999999999999999999
Q ss_pred CCCCCCCC
Q 042809 227 HTFISGNA 234 (241)
Q Consensus 227 ~p~~~~~~ 234 (241)
||||++..
T Consensus 283 Hp~~~~~~ 290 (352)
T d1koba_ 283 HPWLKGDH 290 (352)
T ss_dssp STTTSSCC
T ss_pred CHhhCCCc
Confidence 99998654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=328.70 Aligned_cols=220 Identities=31% Similarity=0.453 Sum_probs=172.6
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-------cCCceeeeeecccCCCCHHHHHHH---hCC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEK---FGG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~---~~~ 67 (241)
++.||+.||+|.+.. +...+.+.+|++++++++||||++ ..++.+|+|||||++|+|.+++.. .+.
T Consensus 25 ~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~ 104 (269)
T d2java1 25 RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ 104 (269)
T ss_dssp ETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTC
T ss_pred ECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCC
Confidence 678999999998763 344677899999999999999998 235678999999999999999875 256
Q ss_pred CCCHHHHHHHHHHH------hhcCC-----ccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcc
Q 042809 68 TLDAGVIRLYTKEI------LHGNG-----ILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQ 136 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~-----~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (241)
.+++..++.++.|+ ||++| ++||||||+||+++.++.+||+|||++....... .......||+
T Consensus 105 ~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~------~~~~~~~gt~ 178 (269)
T d2java1 105 YLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT------SFAKAFVGTP 178 (269)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------------CCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC------CccccCCCCc
Confidence 78998888887765 79866 9999999999999999999999999998654311 1123456899
Q ss_pred cccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCC
Q 042809 137 LWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPE 216 (241)
Q Consensus 137 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 216 (241)
.|+|||.+.+..++.++|||||||++|+|++|+.||.+....... ........+..+..+++++.+|+++||+.||.
T Consensus 179 ~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~---~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~ 255 (269)
T d2java1 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA---GKIREGKFRRIPYRYSDELNEIITRMLNLKDY 255 (269)
T ss_dssp SCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred ccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHH---HHHHcCCCCCCCcccCHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999999999999875443332 22223444556778889999999999999999
Q ss_pred CCCChHHHhcCCCC
Q 042809 217 KRWSAEELLNHTFI 230 (241)
Q Consensus 217 ~Rps~~~~l~~p~~ 230 (241)
+|||++++++|||+
T Consensus 256 ~Rps~~ell~hp~i 269 (269)
T d2java1 256 HRPSVEEILENPLI 269 (269)
T ss_dssp GSCCHHHHHTSTTC
T ss_pred HCcCHHHHHhCCcC
Confidence 99999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=337.54 Aligned_cols=225 Identities=30% Similarity=0.469 Sum_probs=180.7
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++.||+.||+|+++. +.....+.+|+.++++++||||++ ..++++|+|||||+||+|.+++... ..+++..
T Consensus 27 ~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~-~~l~~~~ 105 (322)
T d1s9ja_ 27 HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQI 105 (322)
T ss_dssp ETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHH-SSCCHHH
T ss_pred ECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhc-CCCCHHH
Confidence 578999999999763 344577899999999999999999 6788999999999999999999874 5688888
Q ss_pred HHHHHHHH------hhc-CCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 74 IRLYTKEI------LHG-NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 74 ~~~~~~~~------Lh~-~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
++.++.|+ ||+ +|++||||||+||+++.+|.+||+|||++....+. ......||+.|+|||++.+
T Consensus 106 ~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--------~~~~~~GT~~Y~APEvl~~ 177 (322)
T d1s9ja_ 106 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--------MANSFVGTRSYMSPERLQG 177 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--------TC---CCSSCCCCHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--------ccccccCCccccCchHHcC
Confidence 88877765 797 59999999999999999999999999999865441 1124579999999999999
Q ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHH---------------------------------------HHHH
Q 042809 147 EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATL---------------------------------------LKIA 187 (241)
Q Consensus 147 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---------------------------------------~~~~ 187 (241)
..++.++||||+||++|+|++|+.||.+......... ....
T Consensus 178 ~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (322)
T d1s9ja_ 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYI 257 (322)
T ss_dssp SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhh
Confidence 9999999999999999999999999976433221111 0111
Q ss_pred hcCCCCCCC-hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 188 CSNEKPHFP-TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 188 ~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.....+..+ ...+.++.+|+.+||..||.+|||++|+++||||+....
T Consensus 258 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 258 VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp HTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred hccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 111112222 235678999999999999999999999999999976443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-53 Score=330.67 Aligned_cols=221 Identities=27% Similarity=0.446 Sum_probs=187.3
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.||+.||||++.+. ...+.+.+|+.+|++++||||++ .+.+.+|+|||||+||+|.+++... ..+++
T Consensus 26 ~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~-~~~~e 104 (337)
T d1o6la_ 26 EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTE 104 (337)
T ss_dssp ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCH
T ss_pred ECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcc-cCCcH
Confidence 6789999999998743 23567889999999999999998 7888999999999999999999884 57888
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..++.++.|+ ||++|++||||||+||+++.+|.+||+|||++....... ......+||+.|+|||++.
T Consensus 105 ~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~------~~~~~~~GT~~Y~aPE~~~ 178 (337)
T d1o6la_ 105 ERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG------ATMKTFCGTPEYLAPEVLE 178 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT------CCBCCCEECGGGCCGGGGS
T ss_pred HHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC------cccccceeCHHHhhhhhcc
Confidence 8888887765 799999999999999999999999999999997543211 1223456999999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC-----
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS----- 220 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----- 220 (241)
+..++.++|+||+||++|+|++|+.||.+........... .....+|..+++++.+||++||++||.+|++
T Consensus 179 ~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~ 254 (337)
T d1o6la_ 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL----MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254 (337)
T ss_dssp SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTT
T ss_pred CCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh----cCCCCCCccCCHHHHHHHHhhccCCchhhccccccc
Confidence 9999999999999999999999999998765544333222 2345677888999999999999999999994
Q ss_pred hHHHhcCCCCCCC
Q 042809 221 AEELLNHTFISGN 233 (241)
Q Consensus 221 ~~~~l~~p~~~~~ 233 (241)
++++++||||++.
T Consensus 255 ~~eil~Hp~f~~i 267 (337)
T d1o6la_ 255 AKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHTSGGGTTC
T ss_pred HHHHHcCcccccC
Confidence 8999999999763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-52 Score=326.90 Aligned_cols=218 Identities=28% Similarity=0.497 Sum_probs=184.0
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
|+.+|+.||||++..+ ...+.+.+|+.++++++||||++ ..++.+|+|||||+||+|..++.. ...+++
T Consensus 25 ~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~-~~~~~~ 103 (316)
T d1fota_ 25 SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPN 103 (316)
T ss_dssp ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-TSSCCH
T ss_pred ECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccc-cccccc
Confidence 5789999999998743 23567899999999999999998 778899999999999999999987 566777
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..++.++.|+ ||++|++||||||+||+++.+|.+||+|||++...... ....+||+.|+|||.+.
T Consensus 104 ~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---------~~~~~Gt~~Y~APE~l~ 174 (316)
T d1fota_ 104 PVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---------TYTLCGTPDYIAPEVVS 174 (316)
T ss_dssp HHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---------BCCCCSCTTTCCHHHHT
T ss_pred cHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---------cccccCcccccCHHHHc
Confidence 7777666655 79999999999999999999999999999999765431 22456999999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----C
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----S 220 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s 220 (241)
+..++.++||||+||++|+|++|+.||.+........... ......+..+++++.+++.+||..+|.+|+ |
T Consensus 175 ~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t 250 (316)
T d1fota_ 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL----NAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNG 250 (316)
T ss_dssp TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----HCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTT
T ss_pred CCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH----cCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhh
Confidence 9999999999999999999999999998754433322222 223456677889999999999999999996 9
Q ss_pred hHHHhcCCCCCCC
Q 042809 221 AEELLNHTFISGN 233 (241)
Q Consensus 221 ~~~~l~~p~~~~~ 233 (241)
++++++||||++-
T Consensus 251 ~~~il~Hp~f~~i 263 (316)
T d1fota_ 251 TEDVKNHPWFKEV 263 (316)
T ss_dssp THHHHTSGGGSSC
T ss_pred HHHHHcCcccccC
Confidence 9999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.2e-53 Score=326.26 Aligned_cols=220 Identities=29% Similarity=0.416 Sum_probs=181.1
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
++.||+.||||.+.. ....+.+.+|+.++++++||||++ ..++..|+|||||.+|+|..++.. ..++++
T Consensus 36 ~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~-~~~l~e 114 (309)
T d1u5ra_ 36 DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQE 114 (309)
T ss_dssp ETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHH-TSCCCH
T ss_pred ECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHh-CCCCCH
Confidence 578999999998762 344567899999999999999998 567889999999999998777665 577899
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..+..++.|+ ||++|++||||||+||+++.++.+||+|||++..... .....||+.|+|||++.
T Consensus 115 ~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----------~~~~~GT~~Y~APE~~~ 184 (309)
T d1u5ra_ 115 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----------ANSFVGTPYWMAPEVIL 184 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----------BCCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----------CCccccCccccCHHHHh
Confidence 9888888766 7999999999999999999999999999999975432 12346999999999986
Q ss_pred c---cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH
Q 042809 146 N---EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE 222 (241)
Q Consensus 146 ~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 222 (241)
+ ..++.++|||||||++|+|++|..||.+..... ..........+...+..+++.+.+||.+||+.||.+|||++
T Consensus 185 ~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 262 (309)
T d1u5ra_ 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 262 (309)
T ss_dssp TTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHH
Confidence 4 458899999999999999999999997653322 22222223333334556788999999999999999999999
Q ss_pred HHhcCCCCCCCC
Q 042809 223 ELLNHTFISGNA 234 (241)
Q Consensus 223 ~~l~~p~~~~~~ 234 (241)
++++||||....
T Consensus 263 ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 263 VLLKHRFVLRER 274 (309)
T ss_dssp HHTTCHHHHSCC
T ss_pred HHHhCHHhcCCC
Confidence 999999997643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=327.23 Aligned_cols=226 Identities=24% Similarity=0.415 Sum_probs=181.9
Q ss_pred CCCCCcEEEEEeccch--------HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAESE--------AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
++.||+.||||++... ...+.+.+|+.++++++||||++ .+.+.+|+|||||+||+|.+++... ..
T Consensus 31 ~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~-~~ 109 (293)
T d1jksa_ 31 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ES 109 (293)
T ss_dssp ETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SS
T ss_pred ECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccc-cc
Confidence 5789999999987532 23577999999999999999999 7888999999999999999999874 57
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCC----CeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG----DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
+++..++.++.|+ ||++|++||||||+||+++.++ .+|++|||++...... .......|++.|
T Consensus 110 l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~-------~~~~~~~~t~~y 182 (293)
T d1jksa_ 110 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-------NEFKNIFGTPEF 182 (293)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTS-------CBCSCCCCCGGG
T ss_pred cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCC-------ccccccCCCCcc
Confidence 8888888887765 7999999999999999998876 4999999999765431 122345689999
Q ss_pred cCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCC
Q 042809 139 MAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKR 218 (241)
Q Consensus 139 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 218 (241)
+|||.+.+..++.++||||+||++|+|++|..||.+.....................+...+.++.+||++||+.||.+|
T Consensus 183 ~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 262 (293)
T d1jksa_ 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 262 (293)
T ss_dssp CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGS
T ss_pred cCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHC
Confidence 99999999999999999999999999999999998754433322222111111112224567889999999999999999
Q ss_pred CChHHHhcCCCCCCCCc
Q 042809 219 WSAEELLNHTFISGNAK 235 (241)
Q Consensus 219 ps~~~~l~~p~~~~~~~ 235 (241)
||++++++||||++...
T Consensus 263 ~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 263 MTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp CCHHHHHHSTTTCC---
T ss_pred cCHHHHhcCcccCCCCh
Confidence 99999999999986443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.3e-52 Score=316.72 Aligned_cols=224 Identities=25% Similarity=0.386 Sum_probs=183.4
Q ss_pred CCCCCcEEEEEeccch-----------HHHHHHHHHHHHHhhcC-CCcccc-----cCCceeeeeecccCCCCHHHHHHH
Q 042809 2 NKGTGALFVVKSAESE-----------AGVQALRNEAEIRQSLN-SPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEK 64 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----------~~~~~~~~e~~~l~~l~-h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~ 64 (241)
++.+|+.||||++... ...+.+.+|+.+++++. ||||++ .+++.+|+|||||+||+|.+++..
T Consensus 24 ~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~ 103 (277)
T d1phka_ 24 HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE 103 (277)
T ss_dssp ETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred ECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHh
Confidence 5678999999997532 23456889999999997 999998 788899999999999999999987
Q ss_pred hCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 65 FGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 65 ~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
. +++++..++.++.|+ ||++|++||||||+||+++.++.+||+|||++...... .......||+.|
T Consensus 104 ~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~-------~~~~~~~gt~~y 175 (277)
T d1phka_ 104 K-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-------EKLREVCGTPSY 175 (277)
T ss_dssp H-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT-------CCBCCCCSCGGG
T ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCC-------CceeeeeccCCC
Confidence 4 578999999888866 79999999999999999999999999999999865441 112335689999
Q ss_pred cCcccccc------cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhc
Q 042809 139 MAPEVLRN------EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLE 212 (241)
Q Consensus 139 ~aPE~~~~------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 212 (241)
+|||.+.+ ..++.++||||+||++|+|++|+.||.+........................+++++.+|+++||+
T Consensus 176 ~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 255 (277)
T d1phka_ 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLV 255 (277)
T ss_dssp CCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCC
T ss_pred CCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcc
Confidence 99999864 346789999999999999999999998765444333322222222223335788999999999999
Q ss_pred cCCCCCCChHHHhcCCCCCCC
Q 042809 213 RKPEKRWSAEELLNHTFISGN 233 (241)
Q Consensus 213 ~~p~~Rps~~~~l~~p~~~~~ 233 (241)
.+|.+|||++++++||||+..
T Consensus 256 ~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 256 VQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp SSGGGSCCHHHHTTSGGGCTT
T ss_pred CChhHCcCHHHHHcCHHHHHh
Confidence 999999999999999999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=327.15 Aligned_cols=230 Identities=19% Similarity=0.327 Sum_probs=185.7
Q ss_pred CCCCCcEEEEEeccchH-HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 2 NKGTGALFVVKSAESEA-GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
|+.||+.||+|.++... ....+.+|+++|++++||||++ .+++.+|+|||||+||+|.+++...+..+++..++
T Consensus 26 ~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~ 105 (321)
T d1tkia_ 26 ETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV 105 (321)
T ss_dssp ETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHH
T ss_pred ECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHH
Confidence 67899999999988543 3456889999999999999998 67789999999999999999998766689999988
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecC--CCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSH--GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
.++.|+ ||++|++||||||+||+++.+ +.++|+|||++..... ........+++.|+|||.+.+.
T Consensus 106 ~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-------~~~~~~~~~t~~y~ape~~~~~ 178 (321)
T d1tkia_ 106 SYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-------GDNFRLLFTAPEYYAPEVHQHD 178 (321)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-------TCEEEEEESCGGGSCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc-------CCcccccccccccccchhccCC
Confidence 887765 799999999999999999865 4799999999875433 1222345689999999999999
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 148 GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
.++.++||||+||++|+|++|..||.+.........+..............+++++.+||++||..||.+|||++++++|
T Consensus 179 ~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999999998765444333322211111111113467889999999999999999999999999
Q ss_pred CCCCCCCccCC
Q 042809 228 TFISGNAKKNS 238 (241)
Q Consensus 228 p~~~~~~~~~~ 238 (241)
|||+......+
T Consensus 259 p~~~~~~~~~~ 269 (321)
T d1tkia_ 259 PWLKQKIERVS 269 (321)
T ss_dssp HHHHSCGGGSC
T ss_pred HhhccCccccC
Confidence 99987654433
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-51 Score=325.08 Aligned_cols=218 Identities=28% Similarity=0.507 Sum_probs=184.8
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCH
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 71 (241)
|+.||+.||||++... ...+.+.+|+.+|+.++||||++ ......++||||+.+|+|..++... ..+++
T Consensus 62 ~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~-~~l~e 140 (350)
T d1rdqe_ 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSE 140 (350)
T ss_dssp ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CCCCH
T ss_pred ECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhc-CCCCH
Confidence 6789999999998643 23466899999999999999998 6788899999999999999999874 57889
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..++.++.|+ ||++|++||||||+|||++.+|.+||+|||++..... ......||+.|+|||++.
T Consensus 141 ~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---------~~~~~~Gt~~Y~APE~~~ 211 (350)
T d1rdqe_ 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---------RTWTLCGTPEALAPEIIL 211 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---------CBCCCEECGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc---------ccccccCccccCCHHHHc
Confidence 8888887766 7999999999999999999999999999999976533 112356899999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC-----C
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-----S 220 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s 220 (241)
+..++.++|||||||++|+|+||+.||.+.........+. ......+..+++++.+||++||..||.+|+ |
T Consensus 212 ~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t 287 (350)
T d1rdqe_ 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV----SGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNG 287 (350)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTT
T ss_pred CCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh----cCCCCCCccCCHHHHHHHHHHhhhCHHhcccccccc
Confidence 9999999999999999999999999998754333222222 233455677889999999999999999995 9
Q ss_pred hHHHhcCCCCCCC
Q 042809 221 AEELLNHTFISGN 233 (241)
Q Consensus 221 ~~~~l~~p~~~~~ 233 (241)
++++++||||++.
T Consensus 288 ~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 288 VNDIKNHKWFATT 300 (350)
T ss_dssp THHHHTSGGGTTC
T ss_pred HHHHHcCccccCC
Confidence 9999999999764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.2e-51 Score=322.85 Aligned_cols=222 Identities=25% Similarity=0.417 Sum_probs=180.6
Q ss_pred CCCCCcEEEEEeccchH-----HHHHHH---HHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAESEA-----GVQALR---NEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-----~~~~~~---~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
++.||+.||||++.... ....+. +++.+++.++||||++ ...+.+|+|||||+||+|.+++... ..
T Consensus 25 ~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~ 103 (364)
T d1omwa3 25 KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GV 103 (364)
T ss_dssp ETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-CS
T ss_pred ECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhc-cc
Confidence 57899999999986332 122233 4466777788999998 6778999999999999999999874 56
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
+++..++.++.|+ ||++|++||||||+||+++.+|.+||+|||++...... ......||+.|+|||
T Consensus 104 ~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~--------~~~~~~GT~~y~APE 175 (364)
T d1omwa3 104 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------KPHASVGTHGYMAPE 175 (364)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS--------CCCSCCSCGGGCCHH
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC--------cccccccccccchhH
Confidence 7888877777655 79999999999999999999999999999999755431 123456999999999
Q ss_pred cccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCC-
Q 042809 143 VLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWS- 220 (241)
Q Consensus 143 ~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps- 220 (241)
.+.+ ..++.++|||||||++|+|+||+.||.+........... .........+..+++++.+||.+||+.||.+|||
T Consensus 176 ~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 254 (364)
T d1omwa3 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGC 254 (364)
T ss_dssp HHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH-HSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTT
T ss_pred HhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCC
Confidence 9964 568999999999999999999999997755444433333 3334555667788999999999999999999999
Q ss_pred ----hHHHhcCCCCCCC
Q 042809 221 ----AEELLNHTFISGN 233 (241)
Q Consensus 221 ----~~~~l~~p~~~~~ 233 (241)
++++++||||++-
T Consensus 255 ~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 255 LGRGAQEVKESPFFRSL 271 (364)
T ss_dssp SSSTHHHHHTSGGGTTC
T ss_pred cccCHHHHHcCccccCC
Confidence 7999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=318.61 Aligned_cols=221 Identities=26% Similarity=0.468 Sum_probs=183.0
Q ss_pred CCCCCcEEEEEeccch-----HHHHHHHHHHHHHh-hcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCC
Q 042809 2 NKGTGALFVVKSAESE-----AGVQALRNEAEIRQ-SLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~-~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 70 (241)
++.||+.||||++... ...+.+.+|..++. .++||||++ ..++.+|+|||||++|+|.+++... ..++
T Consensus 23 ~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~-~~~~ 101 (320)
T d1xjda_ 23 FKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFD 101 (320)
T ss_dssp ETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCC
T ss_pred ECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhcc-CCCC
Confidence 6789999999998743 23445677777665 689999998 7788999999999999999999874 5688
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVL 144 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 144 (241)
+..++.++.|+ ||++|++||||||+||+++.++.+||+|||++....... .......||+.|+|||.+
T Consensus 102 e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~------~~~~~~~gt~~y~aPE~~ 175 (320)
T d1xjda_ 102 LSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD------AKTNTFCGTPDYIAPEIL 175 (320)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT------CCBCCCCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc------ccccccCCCCCcCCHHHH
Confidence 88888777655 799999999999999999999999999999997543211 122345689999999999
Q ss_pred cccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChH-H
Q 042809 145 RNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAE-E 223 (241)
Q Consensus 145 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~ 223 (241)
.+..++.++||||+||++|+|++|+.||.+........... ...+.+|..+++++.+||++||..||.+|||+. +
T Consensus 176 ~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~----~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~ 251 (320)
T d1xjda_ 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR----MDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGD 251 (320)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSC
T ss_pred cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH----cCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHH
Confidence 99999999999999999999999999998765444333322 234567778899999999999999999999995 8
Q ss_pred HhcCCCCCCC
Q 042809 224 LLNHTFISGN 233 (241)
Q Consensus 224 ~l~~p~~~~~ 233 (241)
+++||||++-
T Consensus 252 l~~hpff~~~ 261 (320)
T d1xjda_ 252 IRQHPLFREI 261 (320)
T ss_dssp GGGSGGGTTC
T ss_pred HHhCchhccC
Confidence 9999999763
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=321.82 Aligned_cols=224 Identities=29% Similarity=0.425 Sum_probs=177.9
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhc-CCCcccc---------cCCceeeeeecccCCCCHHHHHHHhC-CCCC
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSL-NSPNIGR---------NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLD 70 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~ 70 (241)
|+.||+.||||+++.. ..+.+|+.++.++ +||||++ ..+..+|+|||||+||+|.+++...+ ..++
T Consensus 33 ~~~~~~~vAiK~i~~~---~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~ 109 (335)
T d2ozaa1 33 NKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT 109 (335)
T ss_dssp ETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEE
T ss_pred ECCCCCEEEEEEECCc---HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcC
Confidence 6789999999998754 4567899987655 7999998 23577999999999999999998753 4689
Q ss_pred HHHHHHHHHHH------hhcCCccccCCCCCcEEeec---CCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 71 AGVIRLYTKEI------LHGNGILHCDLKCNNVLLGS---HGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 71 ~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
+..++.++.|+ ||++|++||||||+||+++. ++.+||+|||++...... .......||+.|+||
T Consensus 110 e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~-------~~~~~~~gt~~y~aP 182 (335)
T d2ozaa1 110 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-------NSLTTPCYTPYYVAP 182 (335)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC-------CCCCCCSCCCSSCCC
T ss_pred HHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC-------CccccccCCcccCCc
Confidence 99988887765 79999999999999999976 457999999999755431 122345699999999
Q ss_pred ccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC----hhhHHHHHHHHHHhhccCCCC
Q 042809 142 EVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP----TQFFKKVLDFLAKCLERKPEK 217 (241)
Q Consensus 142 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~ 217 (241)
|++.+..++.++|||||||++|+|+||+.||.+....................++ ..+++++.+||++||+.||.+
T Consensus 183 E~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 262 (335)
T d2ozaa1 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 262 (335)
T ss_dssp CCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTT
T ss_pred HHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhH
Confidence 9999999999999999999999999999999776544333333322222333333 346789999999999999999
Q ss_pred CCChHHHhcCCCCCCCCc
Q 042809 218 RWSAEELLNHTFISGNAK 235 (241)
Q Consensus 218 Rps~~~~l~~p~~~~~~~ 235 (241)
|||++++++||||.....
T Consensus 263 R~s~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 263 RMTITEFMNHPWIMQSTK 280 (335)
T ss_dssp SCCHHHHHHSHHHHTTTS
T ss_pred CcCHHHHHcCHHhhCCCC
Confidence 999999999999976554
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=313.00 Aligned_cols=227 Identities=22% Similarity=0.317 Sum_probs=175.1
Q ss_pred CCCCCcEEEEEeccchH-------HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCC
Q 042809 2 NKGTGALFVVKSAESEA-------GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTL 69 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 69 (241)
|+.+|+.||||+++... ..+.+.+|+.++++++||||++ ..++++|+||||+.++++..+.. .+..+
T Consensus 19 ~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~-~~~~l 97 (299)
T d1ua2a_ 19 DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD-NSLVL 97 (299)
T ss_dssp CSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTT-CCSSC
T ss_pred ECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhh-cccCC
Confidence 67899999999986332 1245889999999999999998 77888999999998766655544 35667
Q ss_pred CHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
++..+..++.|+ ||++|++||||||+||+++.++.+||+|||++....... .......||+.|+|||.
T Consensus 98 ~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~------~~~~~~~gt~~y~aPE~ 171 (299)
T d1ua2a_ 98 TPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN------RAYTHQVVTRWYRAPEL 171 (299)
T ss_dssp CSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC------CCCCCSCCCCTTCCHHH
T ss_pred CHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc------ccccceecChhhccHHH
Confidence 777777776655 799999999999999999999999999999997554311 12233568999999999
Q ss_pred ccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCC-------------------CCC-----Chh
Q 042809 144 LRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK-------------------PHF-----PTQ 198 (241)
Q Consensus 144 ~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------~~~-----~~~ 198 (241)
+.+ ..++.++||||+||++|+|++|..||.+.........+........ +.. ...
T Consensus 172 ~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
T d1ua2a_ 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA 251 (299)
T ss_dssp HTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTT
T ss_pred HccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhccc
Confidence 865 4579999999999999999999999977554433322222211100 000 123
Q ss_pred hHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 199 FFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 199 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.++++.+|+++||+.||++|||++|+++||||++.+.
T Consensus 252 ~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 252 AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp CCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 4678999999999999999999999999999987765
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-51 Score=310.74 Aligned_cols=223 Identities=22% Similarity=0.302 Sum_probs=179.3
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
++++++.||||++..+ ...+.+.+|+++|++++||||++ ..++..++|||||++|+|.+++.. ...+++..
T Consensus 30 ~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g~L~~~l~~-~~~l~~~~ 108 (277)
T d1xbba_ 30 MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ-NRHVKDKN 108 (277)
T ss_dssp CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHH-CTTCCHHH
T ss_pred cCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCCcHHHHHhh-ccCCCHHH
Confidence 3567789999997632 33567999999999999999998 334567899999999999999987 56788888
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE 147 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 147 (241)
+..++.|+ ||+++++||||||+||+++.++.+||+|||++....... ..........||+.|+|||.+.+.
T Consensus 109 ~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~---~~~~~~~~~~gt~~y~APE~l~~~ 185 (277)
T d1xbba_ 109 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE---NYYKAQTHGKWPVKWYAPECINYY 185 (277)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC---SEEEC----CCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc---cccccccccCCCceecCchhhcCC
Confidence 88777765 799999999999999999999999999999997543311 111222345689999999999999
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH--
Q 042809 148 GLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL-- 224 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~-- 224 (241)
.++.++||||||+++|||++ |+.||.+..... .......+..+..|..+++++.+|+.+||+.+|.+|||++++
T Consensus 186 ~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~ 262 (277)
T d1xbba_ 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 262 (277)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999998 899998754433 333333456677788889999999999999999999999998
Q ss_pred -hcCCCCC
Q 042809 225 -LNHTFIS 231 (241)
Q Consensus 225 -l~~p~~~ 231 (241)
|+|+|+.
T Consensus 263 ~L~~~~~~ 270 (277)
T d1xbba_ 263 RLRNYYYD 270 (277)
T ss_dssp HHHHHHHH
T ss_pred HhhCHHhh
Confidence 4666653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-51 Score=312.51 Aligned_cols=223 Identities=19% Similarity=0.298 Sum_probs=182.2
Q ss_pred CCCCcEEEEEecc---chHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 3 KGTGALFVVKSAE---SEAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 3 ~~~~~~vaiK~~~---~~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
.+++..||||.+. .+...+.+.+|+++|++++||||++ ...+.+|+|||||++|+|.+++...+..+++..+.
T Consensus 33 ~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~ 112 (285)
T d1u59a_ 33 RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA 112 (285)
T ss_dssp --CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHH
T ss_pred CCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEEEeCCCCcHHHHhhccccCCCHHHHH
Confidence 3456689999976 2445678999999999999999998 33456899999999999999988766788988888
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCC
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL 149 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 149 (241)
.++.|+ ||++|++||||||+||+++.++.+||+|||++........ .........||+.|+|||.+.+..+
T Consensus 113 ~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~ 189 (285)
T d1u59a_ 113 ELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS---YYTARSAGKWPLKWYAPECINFRKF 189 (285)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC---EECCCCSSCCCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc---ccccccccccCccccChHHHhCCCC
Confidence 887765 7999999999999999999999999999999976543211 1112233458899999999999999
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHH---h
Q 042809 150 DFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEEL---L 225 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~---l 225 (241)
+.++||||||+++|||+| |+.||.+...... ......+..+..|..+++++.+||++||+.+|.+|||+.++ |
T Consensus 190 ~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~---~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L 266 (285)
T d1u59a_ 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266 (285)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CccchhhcchHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 999999999999999998 9999987544332 33334456677788899999999999999999999999888 5
Q ss_pred cCCCCC
Q 042809 226 NHTFIS 231 (241)
Q Consensus 226 ~~p~~~ 231 (241)
+++|+.
T Consensus 267 ~~~~~~ 272 (285)
T d1u59a_ 267 RACYYS 272 (285)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 677764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=307.29 Aligned_cols=218 Identities=23% Similarity=0.372 Sum_probs=170.6
Q ss_pred cEEEEEecc----chHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 7 ALFVVKSAE----SEAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 7 ~~vaiK~~~----~~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
..||||+++ ++...+.+.+|+.++.+++||||++ ..++.+++|||||++|+|.+++...+..+++..+..++
T Consensus 31 ~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~ 110 (276)
T d1uwha_ 31 GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110 (276)
T ss_dssp SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHH
T ss_pred CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHH
Confidence 459999976 3455788999999999999999998 45667899999999999999998877789998888877
Q ss_pred HHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc---cCC
Q 042809 79 KEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN---EGL 149 (241)
Q Consensus 79 ~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~ 149 (241)
.|+ ||++|++||||||+||+++.++.+||+|||++........ ........||+.|+|||++.+ ..+
T Consensus 111 ~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~ 186 (276)
T d1uwha_ 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG----SHQFEQLSGSILWMAPEVIRMQDKNPY 186 (276)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----------------CCCCGGGCCHHHHTTCSSCCC
T ss_pred HHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC----cccccccccCcccCCHHHHhcccCCCC
Confidence 755 7999999999999999999999999999999976543211 122234568999999999964 347
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC--CCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 150 DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN--EKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
+.++||||||+++|||+||+.||.+................ .....+..+++.+.+|+.+||+.+|.+|||+++++++
T Consensus 187 ~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999999999999999999999765433222221111111 1123456678899999999999999999999999986
Q ss_pred C
Q 042809 228 T 228 (241)
Q Consensus 228 p 228 (241)
.
T Consensus 267 L 267 (276)
T d1uwha_ 267 I 267 (276)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-49 Score=304.68 Aligned_cols=218 Identities=23% Similarity=0.347 Sum_probs=177.4
Q ss_pred CCCCCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHh-CCCCCHHHH
Q 042809 2 NKGTGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDAGVI 74 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~ 74 (241)
++.+|+.||||++... ...+.+.+|+.+|++++||||++ ..++..++|||||++|+|.+++... ...+++..+
T Consensus 38 ~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~ 117 (287)
T d1opja_ 38 WKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 117 (287)
T ss_dssp EGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHH
T ss_pred ECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHH
Confidence 4678999999998743 34677999999999999999998 6778899999999999999999864 456788777
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccC
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEG 148 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 148 (241)
..++.|+ ||++|++||||||+||+++.++.+||+|||++....... ........|++.|+|||.+.+..
T Consensus 118 ~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~ 192 (287)
T d1opja_ 118 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-----YTAHAGAKFPIKWTAPESLAYNK 192 (287)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-----SEEETTEEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC-----ceeeccccccccccChHHHcCCC
Confidence 7666654 899999999999999999999999999999997654311 11222344788999999999999
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 149 LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 149 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
++.++||||||+++|+|++|..|+..... .............+..+..+++++.+|+.+||+.+|.+|||++++++
T Consensus 193 ~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 193 FSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999996666543222 22233333445566777888999999999999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-49 Score=303.97 Aligned_cols=217 Identities=22% Similarity=0.326 Sum_probs=168.6
Q ss_pred cEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 7 ALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 7 ~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
..||||.+.. +...+.+.+|+.+|++++||||++ ..++.+++|||||++|+|.+++......+++..+..++
T Consensus 55 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~ 134 (299)
T d1jpaa_ 55 IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 134 (299)
T ss_dssp EEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHH
T ss_pred EEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHH
Confidence 4689998753 445678999999999999999998 66788999999999999999999877788988888777
Q ss_pred HHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCch
Q 042809 79 KEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA 152 (241)
Q Consensus 79 ~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 152 (241)
.|+ ||++|++||||||+||+++.++.+||+|||++............ .......||+.|+|||.+.+..++.+
T Consensus 135 ~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~ 213 (299)
T d1jpaa_ 135 RGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY-TSALGGKIPIRWTAPEAIQYRKFTSA 213 (299)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------------------CGGGSCHHHHHSCCCCHH
T ss_pred HHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCccee-eecccccCCccccCHHHHhcCCCCcc
Confidence 755 79999999999999999999999999999999865442221111 11122347899999999999999999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 153 TDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 153 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
+|||||||++|||+| |..||.+...... ......+..+..+..++..+.+|+.+||+.+|.+|||++++++.
T Consensus 214 sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 214 SDVWSYGIVMWEVMSYGERPYWDMTNQDV---INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccccchHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999998 8999987644333 33333455566777888999999999999999999999998765
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=300.25 Aligned_cols=216 Identities=21% Similarity=0.350 Sum_probs=168.9
Q ss_pred CCCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHH
Q 042809 4 GTGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLY 77 (241)
Q Consensus 4 ~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 77 (241)
.++..||||.++.. ...+.+.+|++++++++||||++ ..++..++||||+++|+|.+++......+++..+..+
T Consensus 27 ~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i 106 (263)
T d1sm2a_ 27 LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGM 106 (263)
T ss_dssp TTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHH
T ss_pred CCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHH
Confidence 35778999998743 34577999999999999999998 5678899999999999999999887777888877777
Q ss_pred HHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+.|+ ||+++++||||||+||+++.++.+||+|||++........ .......||+.|+|||++.+..++.
T Consensus 107 ~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~ 181 (263)
T d1sm2a_ 107 CLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-----TSSTGTKFPVKWASPEVFSFSRYSS 181 (263)
T ss_dssp HHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------------------CTTSCCHHHHTTCCCCH
T ss_pred HHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc-----eeecceecCcccCChHHhcCCCCCc
Confidence 7655 7999999999999999999999999999999976543211 1122345889999999999999999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
++||||||+++|||+| |.+||........ ......+.....|...++++.+|+.+||+.+|.+|||+++++++
T Consensus 182 k~DVwS~Gvil~el~t~~~~~~~~~~~~~~---~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTCSCCHHHH---HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhhcchHHHHHHHHHCCCCCCCCCCHHHH---HHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 9999999999999999 5666655433332 22333345556677788899999999999999999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-49 Score=303.33 Aligned_cols=228 Identities=26% Similarity=0.369 Sum_probs=176.2
Q ss_pred CCCCCcEEEEEeccchH----HHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHH-HhCCCCCH
Q 042809 2 NKGTGALFVVKSAESEA----GVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAE-KFGGTLDA 71 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~ 71 (241)
|+.+|+.||||++..+. ..+.+.+|++++++++||||++ ..++++|+||||+.+ ++.+++. .....+++
T Consensus 23 ~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e 101 (298)
T d1gz8a_ 23 NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPL 101 (298)
T ss_dssp ETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCH
T ss_pred ECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccCCCH
Confidence 67899999999986432 3467889999999999999998 678899999999975 5555554 44567899
Q ss_pred HHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccc
Q 042809 72 GVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 72 ~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 145 (241)
..++.++.|+ ||++|++||||||+||+++.++.+||+|||.+....... .......|++.|+|||.+.
T Consensus 102 ~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~------~~~~~~~gt~~y~apE~~~ 175 (298)
T d1gz8a_ 102 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV------RTYTHEVVTLWYRAPEILL 175 (298)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS------BCTTCCBCCCTTCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc------ccceeecccceeeehhhhc
Confidence 9998888766 799999999999999999999999999999997654311 1223346899999999987
Q ss_pred ccC-CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCC--------------CC-----------Chhh
Q 042809 146 NEG-LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKP--------------HF-----------PTQF 199 (241)
Q Consensus 146 ~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------~~-----------~~~~ 199 (241)
... ++.++|+||+|+++|+|++|+.||.+................... .. ....
T Consensus 176 ~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T d1gz8a_ 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPL 255 (298)
T ss_dssp TCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTC
T ss_pred cccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCC
Confidence 655 478999999999999999999999765433322222111111000 00 1234
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 200 FKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 200 ~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
+.++.+|+++||..||.+|||++|+++||||++-.+.
T Consensus 256 s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 5789999999999999999999999999999876543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=302.23 Aligned_cols=220 Identities=22% Similarity=0.361 Sum_probs=176.6
Q ss_pred CCCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHh-CCCCCHHHHHHH
Q 042809 4 GTGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDAGVIRLY 77 (241)
Q Consensus 4 ~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~ 77 (241)
.++..||||.++.. ...+.+.+|+.++.+++||||++ ..++..++||||+++|+|.+++... +..+++..+..+
T Consensus 35 ~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i 114 (272)
T d1qpca_ 35 NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114 (272)
T ss_dssp TTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHH
T ss_pred CCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHH
Confidence 35788999998743 34577999999999999999999 4456789999999999999977543 235788777777
Q ss_pred HHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+.|+ ||+++++||||||+||+++.++.+||+|||++....... ........|++.|+|||.+.+..++.
T Consensus 115 ~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~ 189 (272)
T d1qpca_ 115 AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-----YTAREGAKFPIKWTAPEAINYGTFTI 189 (272)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-----EECCTTCCCCTTTSCHHHHHHCEECH
T ss_pred HHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc-----cccccccCCcccccChHHHhCCCCCc
Confidence 6655 799999999999999999999999999999997654311 11223345889999999999888999
Q ss_pred hhhHHHHHHHHHHHHhCC-CCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc--CC
Q 042809 152 ATDIWSLGCMVIEMATGR-PPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN--HT 228 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~--~p 228 (241)
++||||||+++|||+||. +|+..... .........+..+..|..+++++.+|+++||+.+|++|||++++++ ++
T Consensus 190 ~sDvwS~Gvvl~ellt~~~~~~~~~~~---~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 190 KSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp HHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhhhhhhHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 999999999999999954 55544322 2233333445666677888999999999999999999999999988 67
Q ss_pred CCC
Q 042809 229 FIS 231 (241)
Q Consensus 229 ~~~ 231 (241)
||.
T Consensus 267 ~ft 269 (272)
T d1qpca_ 267 FFT 269 (272)
T ss_dssp HHH
T ss_pred hhh
Confidence 774
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-50 Score=305.85 Aligned_cols=214 Identities=21% Similarity=0.404 Sum_probs=175.2
Q ss_pred CCCCCcEEEEEeccchH--------HHHHHHHHHHHHhhcC--CCcccc-----cCCceeeeeecccCC-CCHHHHHHHh
Q 042809 2 NKGTGALFVVKSAESEA--------GVQALRNEAEIRQSLN--SPNIGR-----NGEKTVNIFMEYMAG-GSLLDVAEKF 65 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~--h~~i~~-----~~~~~~~lv~e~~~~-~~L~~~l~~~ 65 (241)
++.||+.||||.+.... ...++.+|+.+++++. ||||++ ...+..++||||+.+ +++.+++..
T Consensus 25 ~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~- 103 (273)
T d1xwsa_ 25 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE- 103 (273)
T ss_dssp ETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-
T ss_pred ECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhc-
Confidence 67899999999976432 1234679999999997 899998 678899999999975 688888876
Q ss_pred CCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecC-CCeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 66 GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSH-GDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 66 ~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
...+++..++.++.|+ ||++|++||||||+||+++.+ +.+||+|||++..... .......||+.|
T Consensus 104 ~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~--------~~~~~~~GT~~y 175 (273)
T d1xwsa_ 104 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--------TVYTDFDGTRVY 175 (273)
T ss_dssp HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS--------SCBCCCCSCGGG
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc--------ccccccccCCCc
Confidence 4678888888887765 799999999999999999865 7899999999975433 122345699999
Q ss_pred cCcccccccCC-CchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCC
Q 042809 139 MAPEVLRNEGL-DFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEK 217 (241)
Q Consensus 139 ~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 217 (241)
+|||.+.+..+ +.++||||+||++|+|++|+.||.... ... .....++..+++++.+||++||+.||.+
T Consensus 176 ~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~-----~~~~~~~~~~s~~~~~li~~~L~~dp~~ 245 (273)
T d1xwsa_ 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII-----RGQVFFRQRVSSECQHLIRWCLALRPSD 245 (273)
T ss_dssp SCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH-----HCCCCCSSCCCHHHHHHHHHHTCSSGGG
T ss_pred CCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHh-----hcccCCCCCCCHHHHHHHHHHccCCHhH
Confidence 99999987665 567899999999999999999997632 111 1234456678899999999999999999
Q ss_pred CCChHHHhcCCCCCCCC
Q 042809 218 RWSAEELLNHTFISGNA 234 (241)
Q Consensus 218 Rps~~~~l~~p~~~~~~ 234 (241)
|||++|+++||||++..
T Consensus 246 R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 246 RPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp SCCHHHHHTSGGGSSCC
T ss_pred CcCHHHHhcCHhhCCCC
Confidence 99999999999998754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=302.08 Aligned_cols=226 Identities=24% Similarity=0.328 Sum_probs=174.1
Q ss_pred CCCC-CcEEEEEeccch----HHHHHHHHHHHHHhhc---CCCcccc----------cCCceeeeeecccCCCCHHHHHH
Q 042809 2 NKGT-GALFVVKSAESE----AGVQALRNEAEIRQSL---NSPNIGR----------NGEKTVNIFMEYMAGGSLLDVAE 63 (241)
Q Consensus 2 ~~~~-~~~vaiK~~~~~----~~~~~~~~e~~~l~~l---~h~~i~~----------~~~~~~~lv~e~~~~~~L~~~l~ 63 (241)
|+++ ++.||||.+... .....+.+|+.+++.| +||||++ ......++++||+.++++.....
T Consensus 28 ~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~ 107 (305)
T d1blxa_ 28 DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK 107 (305)
T ss_dssp ETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH
T ss_pred EECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhh
Confidence 4444 678999997632 2233466777777666 7999987 24568999999998877766666
Q ss_pred HhCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccc
Q 042809 64 KFGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQL 137 (241)
Q Consensus 64 ~~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (241)
.....+++..++.++.|+ ||++|++||||||+||+++.++.+||+|||.+...... .......||+.
T Consensus 108 ~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~-------~~~~~~~gT~~ 180 (305)
T d1blxa_ 108 VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-------MALTSVVVTLW 180 (305)
T ss_dssp SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG-------GGGCCCCCCCT
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhccc-------ccCCCcccChh
Confidence 556778888887777655 79999999999999999999999999999998754331 22345668999
Q ss_pred ccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC-----------------------CCC
Q 042809 138 WMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE-----------------------KPH 194 (241)
Q Consensus 138 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------~~~ 194 (241)
|+|||.+.+..++.++||||+||++|+|++|+.||.+................. ...
T Consensus 181 Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (305)
T d1blxa_ 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEK 260 (305)
T ss_dssp TCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGG
T ss_pred hcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhh
Confidence 999999999999999999999999999999999998765433332222211100 001
Q ss_pred CChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 195 FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 195 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
.....++.+.+|+++||+.||.+|||++|+++||||++-.
T Consensus 261 ~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 261 FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp TCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 2334567899999999999999999999999999998653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=304.86 Aligned_cols=216 Identities=23% Similarity=0.280 Sum_probs=173.5
Q ss_pred CcEEEEEeccch---HHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC---------
Q 042809 6 GALFVVKSAESE---AGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG--------- 67 (241)
Q Consensus 6 ~~~vaiK~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~--------- 67 (241)
+..||+|.+... .....+.+|+.++.++ +|||||+ ...+.+|+|||||++|+|.+++.....
T Consensus 67 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~ 146 (325)
T d1rjba_ 67 SIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 146 (325)
T ss_dssp EEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC-------
T ss_pred eeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhh
Confidence 347899987532 3345688999999998 7999998 677889999999999999999986432
Q ss_pred -------------CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccc
Q 042809 68 -------------TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQS 128 (241)
Q Consensus 68 -------------~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 128 (241)
.+++..+..++.|+ ||+++++||||||+||+++.++.+||+|||++........ ...
T Consensus 147 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~----~~~ 222 (325)
T d1rjba_ 147 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN----YVV 222 (325)
T ss_dssp --------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT----SEE
T ss_pred ccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCc----eee
Confidence 36777777776655 7999999999999999999999999999999976544211 112
Q ss_pred cccccCcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHH
Q 042809 129 WQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFL 207 (241)
Q Consensus 129 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 207 (241)
.....||+.|+|||.+.+..++.++|||||||++|||+| |..||.+...... ..........+..|...++++.+||
T Consensus 223 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~--~~~~~~~~~~~~~p~~~~~~l~~li 300 (325)
T d1rjba_ 223 RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN--FYKLIQNGFKMDQPFYATEEIYIIM 300 (325)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH--HHHHHhcCCCCCCCCcCCHHHHHHH
Confidence 234457999999999999999999999999999999998 8999976543332 2223334456677788899999999
Q ss_pred HHhhccCCCCCCChHHHhcC
Q 042809 208 AKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 208 ~~~l~~~p~~Rps~~~~l~~ 227 (241)
.+||+.+|.+|||++++++|
T Consensus 301 ~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 301 QSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999876
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=293.26 Aligned_cols=216 Identities=23% Similarity=0.346 Sum_probs=180.9
Q ss_pred CCCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHH
Q 042809 4 GTGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLY 77 (241)
Q Consensus 4 ~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 77 (241)
+++..||||.++.. ...+.+.+|+.++.+++||||++ ..++.+++||||+++|+|.+++......+++..+..+
T Consensus 26 ~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i 105 (258)
T d1k2pa_ 26 RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM 105 (258)
T ss_dssp TTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHH
T ss_pred CCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHH
Confidence 36788999998743 34577999999999999999998 6678899999999999999998887777888887777
Q ss_pred HHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+.|+ ||++|++||||||+||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.
T Consensus 106 ~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~ 180 (258)
T d1k2pa_ 106 CKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-----TSSVGSKFPVRWSPPEVLMYSKFSS 180 (258)
T ss_dssp HHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-----CCCCCSCCCGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-----eeecccCCCCCcCCcHHhcCCCCCc
Confidence 7655 7999999999999999999999999999999975543211 1122345889999999999999999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
++||||||+++|||+| |+.||.+....... .....+.....|...++.+.+||++||+.+|.+|||++++++|
T Consensus 181 ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~---~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETA---EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH---HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ceeecccchhhHhHHhcCCCCCCCCCHHHHH---HHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 9999999999999998 89999876544333 3333455666777888999999999999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-48 Score=299.79 Aligned_cols=226 Identities=24% Similarity=0.345 Sum_probs=169.8
Q ss_pred CCCCCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc---------cCCceeeeeecccCCCCHHHHHHHhCC
Q 042809 2 NKGTGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR---------NGEKTVNIFMEYMAGGSLLDVAEKFGG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~~ 67 (241)
|+.+|+.||||++.. ......+.+|+++++.++||||++ .....+|+||||++|++|.+++... +
T Consensus 28 ~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~-~ 106 (277)
T d1o6ya_ 28 DLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-G 106 (277)
T ss_dssp ETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHH-C
T ss_pred ECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhccc-C
Confidence 678999999999752 344567999999999999999998 1234589999999999999999874 5
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
.+++..+..++.|+ ||++|++||||||+||+++.++..+++|||.+........ .........||+.|+||
T Consensus 107 ~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~Gt~~Y~aP 183 (277)
T d1o6ya_ 107 PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN---SVTQTAAVIGTAQYLSP 183 (277)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-------------------TTCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc---cccccccccCcccccCH
Confidence 78888888888766 7999999999999999999999999999998865433211 11223445689999999
Q ss_pred ccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 142 EVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 142 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
|.+.+..++.++||||+|+++|+|+||+.||.+........................+++++.++|++||+.||.+||+.
T Consensus 184 E~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~s 263 (277)
T d1o6ya_ 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 263 (277)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSS
T ss_pred HHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhH
Confidence 99999999999999999999999999999998754433222221111111123345678899999999999999999955
Q ss_pred HHHhcCCCCC
Q 042809 222 EELLNHTFIS 231 (241)
Q Consensus 222 ~~~l~~p~~~ 231 (241)
.+.+.|+|.+
T Consensus 264 a~~l~~~l~r 273 (277)
T d1o6ya_ 264 AAEMRADLVR 273 (277)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 5555566654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=294.22 Aligned_cols=216 Identities=24% Similarity=0.342 Sum_probs=170.3
Q ss_pred CCCcEEEEEecc---chHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 4 GTGALFVVKSAE---SEAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 4 ~~~~~vaiK~~~---~~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
+++..||||.++ .+...+.+.+|+.++++++||||++ ..++.+|+||||+++|+|.+++......+++..+..
T Consensus 33 ~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~ 112 (273)
T d1mp8a_ 33 NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL 112 (273)
T ss_dssp -CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHH
T ss_pred ceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHH
Confidence 345679999876 3445677999999999999999998 456789999999999999999888777889988888
Q ss_pred HHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCC
Q 042809 77 YTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD 150 (241)
Q Consensus 77 ~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 150 (241)
++.|+ ||++|++||||||+||+++.++.+||+|||++........ .......||+.|+|||.+.+..++
T Consensus 113 ~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~-----~~~~~~~gt~~y~apE~l~~~~~~ 187 (273)
T d1mp8a_ 113 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-----YKASKGKLPIKWMAPESINFRRFT 187 (273)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------------------CCGGGCCHHHHHHCCCS
T ss_pred HHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcc-----eeccceecCcccchhhHhccCCCC
Confidence 87765 7999999999999999999999999999999976543211 112334578999999999999999
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 151 FATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 151 ~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
.++||||||+++|||++ |.+||.+......... ...+..+..+..+++.+.+||.+||+.+|.+|||+++++++
T Consensus 188 ~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 188 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccccccchHHHHHHHhcCCCCCCCCCHHHHHHH---HHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999998 8999987655443322 23355567788899999999999999999999999999876
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-48 Score=300.57 Aligned_cols=231 Identities=24% Similarity=0.321 Sum_probs=173.0
Q ss_pred CCCCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-------------cCCceeeeeecccCCCCHHHHHHH
Q 042809 2 NKGTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-------------NGEKTVNIFMEYMAGGSLLDVAEK 64 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-------------~~~~~~~lv~e~~~~~~L~~~l~~ 64 (241)
|+.+|+.||||++..+ .....+.+|+.+|++++||||++ ...++.|+||||+.++.+. ....
T Consensus 31 ~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~-~~~~ 109 (318)
T d3blha1 31 HRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-LLSN 109 (318)
T ss_dssp ETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHH-HHTC
T ss_pred ECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccc-hhhh
Confidence 6789999999997633 23466889999999999999987 2246789999999766554 4444
Q ss_pred hCCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccc
Q 042809 65 FGGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLW 138 (241)
Q Consensus 65 ~~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (241)
....+.+..++.++.|+ ||++|++||||||+||+++.++.+||+|||++.......... ........||+.|
T Consensus 110 ~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~gT~~Y 187 (318)
T d3blha1 110 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ--PNRYTNRVVTLWY 187 (318)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-------CCCCCSCCSCGGG
T ss_pred cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccc--cccccceecCHHH
Confidence 45678888888777765 799999999999999999999999999999997554322111 1222345689999
Q ss_pred cCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCC---------------------
Q 042809 139 MAPEVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFP--------------------- 196 (241)
Q Consensus 139 ~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------------- 196 (241)
+|||.+.+. .++.++||||+||++|+|++|+.||.+..................+...
T Consensus 188 ~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T d3blha1 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRK 267 (318)
T ss_dssp CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBC
T ss_pred hhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhccccccccc
Confidence 999998765 5889999999999999999999999876554444443333222211110
Q ss_pred -------hhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 197 -------TQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 197 -------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
...++++.+||.+||+.||++|||++|+++||||+....
T Consensus 268 ~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~ 313 (318)
T d3blha1 268 VKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 313 (318)
T ss_dssp HHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred chhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence 012457789999999999999999999999999986554
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=291.37 Aligned_cols=214 Identities=21% Similarity=0.268 Sum_probs=168.6
Q ss_pred cEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHH
Q 042809 7 ALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYT 78 (241)
Q Consensus 7 ~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 78 (241)
..||||.+.. +.....+.+|+.++++++||||++ ...+..++||||+.+++|.+++......+++..+..++
T Consensus 37 ~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~ 116 (283)
T d1mqba_ 37 VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 116 (283)
T ss_dssp EEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHH
T ss_pred EEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHH
Confidence 5799998763 344567899999999999999998 56788999999999999999998877888888887777
Q ss_pred HHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCch
Q 042809 79 KEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA 152 (241)
Q Consensus 79 ~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 152 (241)
.|+ ||+++++||||||+||+++.++.+||+|||++.......... .......||+.|+|||.+.+..++.+
T Consensus 117 ~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~ 193 (283)
T d1mqba_ 117 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT---YTTSGGKIPIRWTAPEAISYRKFTSA 193 (283)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------------------CCCGGGSCHHHHHSCCCCHH
T ss_pred HHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccc---eEeccCCCCccccCHHHHccCCCCCc
Confidence 655 799999999999999999999999999999997654321111 11223457899999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCC-ccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 153 TDIWSLGCMVIEMATGRPPW-GDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 153 ~Di~slG~~l~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
+||||||+++|||+++..|+ ..... .........+..+..+...+..+.+|+.+||+.+|.+|||+.++++
T Consensus 194 sDI~S~Gvil~el~t~~~~~~~~~~~---~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 194 SDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ccccccHHHHHHHHhCCCCccccCCH---HHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 99999999999999965554 43322 2333444455666777888899999999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=291.44 Aligned_cols=222 Identities=23% Similarity=0.363 Sum_probs=173.9
Q ss_pred CCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHh-CCCCCHHHHHHHH
Q 042809 5 TGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKF-GGTLDAGVIRLYT 78 (241)
Q Consensus 5 ~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ 78 (241)
++..||||.+... ...+.+.+|+.++.+++||||++ ..++..++||||+++|+|..++... ...+++..+..++
T Consensus 40 ~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~ 119 (285)
T d1fmka3 40 GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 119 (285)
T ss_dssp TTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHH
T ss_pred CCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHH
Confidence 3467999998743 33567999999999999999998 4456689999999999999988753 3568888888877
Q ss_pred HHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCch
Q 042809 79 KEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFA 152 (241)
Q Consensus 79 ~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 152 (241)
.|+ ||++|++||||||+||+++.++++||+|||++........ .......|++.|+|||.+.+..++.+
T Consensus 120 ~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k 194 (285)
T d1fmka3 120 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-----TARQGAKFPIKWTAPEAALYGRFTIK 194 (285)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------------CCGGGSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc-----eeeccccccccccChHHHhCCCCCcH
Confidence 765 7999999999999999999999999999999976543211 11223458999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCC-CccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc--CCC
Q 042809 153 TDIWSLGCMVIEMATGRPP-WGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN--HTF 229 (241)
Q Consensus 153 ~Di~slG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~--~p~ 229 (241)
+||||||+++|||++|..| +...... ............+.+..+++.+.+++.+||+.+|++|||+++++. ++|
T Consensus 195 sDI~S~Giil~el~t~~~p~~~~~~~~---~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 195 SDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred HhhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 9999999999999996555 4443322 223333345556678888999999999999999999999999988 889
Q ss_pred CCCCC
Q 042809 230 ISGNA 234 (241)
Q Consensus 230 ~~~~~ 234 (241)
|+...
T Consensus 272 ~~~~~ 276 (285)
T d1fmka3 272 FTSTE 276 (285)
T ss_dssp TSCSC
T ss_pred hcCCC
Confidence 97654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=299.91 Aligned_cols=221 Identities=24% Similarity=0.347 Sum_probs=175.6
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----------cCCceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----------NGEKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----------~~~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
|+.||+.||||++.. +...+.+.+|+.+|++++||||++ ....++|+||||+ +.+|..+.+.
T Consensus 39 ~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-- 115 (346)
T d1cm8a_ 39 DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-- 115 (346)
T ss_dssp ETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH--
T ss_pred ECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh--
Confidence 678999999999863 344677899999999999999998 1234689999999 6788888775
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..+++..++.++.|+ ||++|++||||||+||+++.++.+|++|||++..... ......|++.|+|
T Consensus 116 ~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~---------~~~~~~~t~~y~a 186 (346)
T d1cm8a_ 116 EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---------EMTGYVVTRWYRA 186 (346)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS---------SCCSSCSCGGGCC
T ss_pred ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC---------ccccccccccccC
Confidence 578999988888766 7999999999999999999999999999999975433 1234568999999
Q ss_pred ccccccc-CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC------------------------CC---
Q 042809 141 PEVLRNE-GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN------------------------EK--- 192 (241)
Q Consensus 141 PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------------~~--- 192 (241)
||.+.+. .++.++||||+||++|+|++|..||.+................ ..
T Consensus 187 PE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (346)
T d1cm8a_ 187 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF 266 (346)
T ss_dssp THHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG
T ss_pred HHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccch
Confidence 9998764 5689999999999999999999999775433322221111110 00
Q ss_pred CCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 193 PHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 193 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
.......++++.+||.+||..||.+|||++++|+||||+.-.
T Consensus 267 ~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 267 ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 012234567899999999999999999999999999998644
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-47 Score=293.79 Aligned_cols=222 Identities=23% Similarity=0.350 Sum_probs=171.6
Q ss_pred CCCcEEEEEeccch----HHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHH
Q 042809 4 GTGALFVVKSAESE----AGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVI 74 (241)
Q Consensus 4 ~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 74 (241)
.+|+.||||++... ...+.+.+|+.+|++++||||++ ..++..++++||+.++.+..+.. ....+++..+
T Consensus 24 ~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~-~~~~l~~~~~ 102 (286)
T d1ob3a_ 24 NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV-CEGGLESVTA 102 (286)
T ss_dssp TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHT-STTCCCHHHH
T ss_pred CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHh-hcCCcchhhh
Confidence 47899999998642 23567999999999999999998 78889999999997655555544 4678999998
Q ss_pred HHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccccccc-
Q 042809 75 RLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNE- 147 (241)
Q Consensus 75 ~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~- 147 (241)
..++.|+ ||+.|++||||||+||+++.++.+|++|||.+........ ......+++.|+|||.+.+.
T Consensus 103 ~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~------~~~~~~~~~~y~~pE~~~~~~ 176 (286)
T d1ob3a_ 103 KSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR------KYTHEIVTLWYRAPDVLMGSK 176 (286)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------------CCCTTCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc------ccceecccchhhhHHHHhCCC
Confidence 8888765 7999999999999999999999999999999986543211 12234578999999999764
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCC-------------------------CCCChhhHHH
Q 042809 148 GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEK-------------------------PHFPTQFFKK 202 (241)
Q Consensus 148 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~ 202 (241)
.++.++||||+|+++|+|++|+.||.+.................. .......++.
T Consensus 177 ~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 256 (286)
T d1ob3a_ 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDES 256 (286)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHH
T ss_pred CCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHH
Confidence 468999999999999999999999976543332222111111100 0112345678
Q ss_pred HHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 203 VLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 203 ~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
+.+|+++||+.||++|||++|+++||||++
T Consensus 257 ~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 257 GIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 999999999999999999999999999974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-48 Score=299.94 Aligned_cols=226 Identities=26% Similarity=0.477 Sum_probs=181.5
Q ss_pred CCCCCcEEEEEeccch------HHHHHHHHHHHHHhhcCC-Ccccc-----cCCceeeeeecccCCCCHHHHHHHhCCCC
Q 042809 2 NKGTGALFVVKSAESE------AGVQALRNEAEIRQSLNS-PNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTL 69 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~h-~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 69 (241)
++.+|+.||||.+... ...+.+.+|++++++++| |||++ ......++||||+.+|+|.+++... ..+
T Consensus 48 ~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~-~~~ 126 (322)
T d1vzoa_ 48 GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERF 126 (322)
T ss_dssp STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH-SCC
T ss_pred cCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhc-ccc
Confidence 4678999999987632 235678899999999987 79988 6778999999999999999999885 455
Q ss_pred CHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCccc
Q 042809 70 DAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 70 ~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 143 (241)
.+..+..++.|+ ||++|++||||||+||+++.+|.+||+|||++........ .......|++.|+|||.
T Consensus 127 ~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~-----~~~~~~~g~~~~~~pe~ 201 (322)
T d1vzoa_ 127 TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-----ERAYDFCGTIEYMAPDI 201 (322)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-----GGGCGGGSCCTTCCHHH
T ss_pred cHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccccc-----ccccccccccccchhHH
Confidence 666666666544 7999999999999999999999999999999975533211 12234568999999999
Q ss_pred cccc--CCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC--
Q 042809 144 LRNE--GLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW-- 219 (241)
Q Consensus 144 ~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-- 219 (241)
+.+. .++.++|||||||++|+|++|..||.+..................+..+...++++.+|+.+||..||.+||
T Consensus 202 ~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~ 281 (322)
T d1vzoa_ 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGC 281 (322)
T ss_dssp HTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred hhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCC
Confidence 9764 467899999999999999999999977654444444433343455667778899999999999999999999
Q ss_pred ---ChHHHhcCCCCCCC
Q 042809 220 ---SAEELLNHTFISGN 233 (241)
Q Consensus 220 ---s~~~~l~~p~~~~~ 233 (241)
|++|+++||||++-
T Consensus 282 ~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 282 GPRDADEIKEHLFFQKI 298 (322)
T ss_dssp STTTHHHHHTSGGGTTC
T ss_pred CcccHHHHHcCHhhcCC
Confidence 58999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=289.71 Aligned_cols=211 Identities=26% Similarity=0.391 Sum_probs=169.6
Q ss_pred CCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHhC-CCCCHHHHHHH
Q 042809 5 TGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFG-GTLDAGVIRLY 77 (241)
Q Consensus 5 ~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~ 77 (241)
+|..||||+++++...+.+.+|++++++++||||++ ...+.+|+||||+++|+|.+++...+ ..+++..+..+
T Consensus 29 ~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i 108 (262)
T d1byga_ 29 RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 108 (262)
T ss_dssp TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHH
T ss_pred CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHH
Confidence 578899999998877888999999999999999998 34566899999999999999997642 34777777777
Q ss_pred HHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCc
Q 042809 78 TKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDF 151 (241)
Q Consensus 78 ~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 151 (241)
+.|+ ||+++++||||+|+||+++.++.+|++|||++...... .....++..|+|||.+.+..++.
T Consensus 109 ~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---------~~~~~~~~~y~aPE~l~~~~~t~ 179 (262)
T d1byga_ 109 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---------QDTGKLPVKWTAPEALREKKFST 179 (262)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------------------CCTTTSCHHHHHHCCCCH
T ss_pred HHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC---------CccccccccCCChHHHhCCCCCh
Confidence 6654 79999999999999999999999999999999754331 12234788999999999999999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 152 ATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 152 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
++||||||+++|||+| |..||........... ...+..+..+...++.+.+|+++||..||.+|||+.+++++
T Consensus 180 ~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH---HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH---HHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 9999999999999998 7888877654443332 33456677788889999999999999999999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=295.56 Aligned_cols=229 Identities=25% Similarity=0.338 Sum_probs=173.5
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----c-----CCceeeeeecccCCCCHHHHHHHhCCC
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----N-----GEKTVNIFMEYMAGGSLLDVAEKFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~ 68 (241)
|+.+|+.||||++.. +...+.+.+|+.+|++++||||++ . .....+++ +|+.+|+|.+++.. ..
T Consensus 29 ~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~--~~ 105 (345)
T d1pmea_ 29 DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKT--QH 105 (345)
T ss_dssp ETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHH--CC
T ss_pred ECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhhc--CC
Confidence 678999999999863 344567899999999999999987 1 12234554 56668999999986 46
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPE 142 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE 142 (241)
+++..++.++.|+ ||++|++||||||+||+++.++.+||+|||++.......... .......|++.|+|||
T Consensus 106 l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~---~~~~~~~gt~~y~aPE 182 (345)
T d1pmea_ 106 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT---GFLTEYVATRWYRAPE 182 (345)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC---CTTCCCCSCGGGCCGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccc---eeeccccccceechHH
Confidence 8888888887766 799999999999999999999999999999997654422211 1223456899999999
Q ss_pred ccc-ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC--------------------C--CCC-----
Q 042809 143 VLR-NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN--------------------E--KPH----- 194 (241)
Q Consensus 143 ~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------------~--~~~----- 194 (241)
.+. +..++.++||||+|+++|+|++|+.||.+................ . ...
T Consensus 183 ~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (345)
T d1pmea_ 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 262 (345)
T ss_dssp GTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH
T ss_pred HhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHH
Confidence 985 456788999999999999999999999765432222211111000 0 000
Q ss_pred CChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCcc
Q 042809 195 FPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKK 236 (241)
Q Consensus 195 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~ 236 (241)
.....+.++.+|+.+||..||.+|||++++++||||+.....
T Consensus 263 ~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 263 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 112345689999999999999999999999999999865543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=291.14 Aligned_cols=219 Identities=20% Similarity=0.283 Sum_probs=166.9
Q ss_pred CCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcC-CCcccc------cCCceeeeeecccCCCCHHHHHHHhC------
Q 042809 3 KGTGALFVVKSAES---EAGVQALRNEAEIRQSLN-SPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFG------ 66 (241)
Q Consensus 3 ~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~------ 66 (241)
..+++.||||.+.. ....+.+.+|...+.++. |+||+. ..+..+++|||||++|+|.+++....
T Consensus 40 ~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~ 119 (299)
T d1ywna1 40 TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119 (299)
T ss_dssp SSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-
T ss_pred ccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhcccccccc
Confidence 45678999999863 334566788888888775 888877 45667999999999999999997642
Q ss_pred ---------CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCcccccccc
Q 042809 67 ---------GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQS 131 (241)
Q Consensus 67 ---------~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 131 (241)
..+++..+..++.|+ ||++|++||||||+||+++.++.+||+|||++........ ......
T Consensus 120 ~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~----~~~~~~ 195 (299)
T d1ywna1 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD----YVRKGD 195 (299)
T ss_dssp ----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTT----SCCTTS
T ss_pred ccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhcccccc----ccccCc
Confidence 347777777777655 7999999999999999999999999999999975433211 112234
Q ss_pred ccCcccccCcccccccCCCchhhHHHHHHHHHHHHhC-CCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHh
Q 042809 132 IGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATG-RPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKC 210 (241)
Q Consensus 132 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 210 (241)
..||+.|+|||.+.+..++.++|||||||++|||++| ..||.+..... ........+..+..+...++++.+++.+|
T Consensus 196 ~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~c 273 (299)
T d1ywna1 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTRMRAPDYTTPEMYQTMLDC 273 (299)
T ss_dssp CCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HHHHHHHHTCCCCCCTTCCHHHHHHHHHH
T ss_pred eeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhcCCCCCCCccCCHHHHHHHHHH
Confidence 5689999999999999999999999999999999986 56776543322 22222233455667778889999999999
Q ss_pred hccCCCCCCChHHHhcC
Q 042809 211 LERKPEKRWSAEELLNH 227 (241)
Q Consensus 211 l~~~p~~Rps~~~~l~~ 227 (241)
|+.+|.+|||++++++|
T Consensus 274 l~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 274 WHGEPSQRPTFSELVEH 290 (299)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCChhHCcCHHHHHHH
Confidence 99999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=287.03 Aligned_cols=217 Identities=25% Similarity=0.372 Sum_probs=173.0
Q ss_pred CCcEEEEEeccc-----hHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 5 TGALFVVKSAES-----EAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 5 ~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
.+..||||++.. +...+.+.+|+.++++++||||++ ..+...++||||+++|+|.+++......++...+.
T Consensus 35 ~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~ 114 (273)
T d1u46a_ 35 KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS 114 (273)
T ss_dssp CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHHGGGSCHHHHH
T ss_pred cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchheeeeeecCcchhhhhhcccCCCCHHHHH
Confidence 445789998763 344578999999999999999998 33467899999999999999988877789998888
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCC
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGL 149 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 149 (241)
.++.|+ ||++|++||||||+||+++.++.+||+|||++......... ........++..|+|||.+.+..+
T Consensus 115 ~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~ 191 (273)
T d1u46a_ 115 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH---YVMQEHRKVPFAWCAPESLKTRTF 191 (273)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE---EEC-----CCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCc---ceecCccccCcccCCHHHHhCCCC
Confidence 887764 89999999999999999999999999999999865432111 112233457889999999999999
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhc
Q 042809 150 DFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 150 ~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 226 (241)
+.++||||||+++|||+| |..||.+....... .........++.+..++..+.+|+++||+.+|++|||++++++
T Consensus 192 ~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL--HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH--HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999998 89999775443332 2223344555667788899999999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-46 Score=288.27 Aligned_cols=217 Identities=19% Similarity=0.280 Sum_probs=175.2
Q ss_pred CCCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCC-------
Q 042809 3 KGTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGG------- 67 (241)
Q Consensus 3 ~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~------- 67 (241)
..+++.||||++.. ....+.+.+|+.++++++||||++ ......++||||+++|+|.+++.....
T Consensus 40 ~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~ 119 (301)
T d1lufa_ 40 YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119 (301)
T ss_dssp TSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC-------
T ss_pred CCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCcccccccc
Confidence 46778999999863 344677999999999999999998 677889999999999999999976321
Q ss_pred ----------------CCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCcc
Q 042809 68 ----------------TLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNL 125 (241)
Q Consensus 68 ----------------~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 125 (241)
.++...+..++.| +||+++++||||||+||+++.++.+||+|||++........
T Consensus 120 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~---- 195 (301)
T d1lufa_ 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY---- 195 (301)
T ss_dssp ---------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC----
T ss_pred ccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCcc----
Confidence 3666667766665 48999999999999999999999999999999976543211
Q ss_pred ccccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCC-CCCccchhchHHHHHHHHhcCCCCCCChhhHHHHH
Q 042809 126 KQSWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGR-PPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVL 204 (241)
Q Consensus 126 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (241)
........+++.|+|||.+.+..++.++||||||+++|||++|. .||.+...... ......+..+..+..+++++.
T Consensus 196 ~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~---~~~v~~~~~~~~p~~~~~~~~ 272 (301)
T d1lufa_ 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV---IYYVRDGNILACPENCPLELY 272 (301)
T ss_dssp BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHH---HHHHHcCCCCCCCccchHHHH
Confidence 11223456789999999999999999999999999999999975 67776544333 233334556667788899999
Q ss_pred HHHHHhhccCCCCCCChHHHhc
Q 042809 205 DFLAKCLERKPEKRWSAEELLN 226 (241)
Q Consensus 205 ~li~~~l~~~p~~Rps~~~~l~ 226 (241)
+|+.+||+.+|++|||+.++++
T Consensus 273 ~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 273 NLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999965
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=292.73 Aligned_cols=213 Identities=23% Similarity=0.340 Sum_probs=173.8
Q ss_pred EEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHHHHHH
Q 042809 8 LFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRLYTKE 80 (241)
Q Consensus 8 ~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 80 (241)
.||+|.+.. ....+.+.+|++++++++||||++ ..++..++++||+.+++|.+++......+++..+..++.|
T Consensus 40 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~q 119 (317)
T d1xkka_ 40 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 119 (317)
T ss_dssp EEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHH
T ss_pred EEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEEEEeccCCcccccccccccCCCHHHHHHHHHH
Confidence 688888753 334678999999999999999999 3345678889999999999999987788998888877775
Q ss_pred H------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCCchhh
Q 042809 81 I------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLDFATD 154 (241)
Q Consensus 81 ~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 154 (241)
+ ||++|++||||||+||+++.++.+||+|||++........ ........||+.|+|||.+.+..++.++|
T Consensus 120 i~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~sD 195 (317)
T d1xkka_ 120 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK----EYHAEGGKVPIKWMALESILHRIYTHQSD 195 (317)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC------------CCTTTSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc----cccccccccCccccChHHHhcCCCChhhh
Confidence 5 7999999999999999999999999999999986543211 11122345799999999999999999999
Q ss_pred HHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 155 IWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 155 i~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
|||||+++|||+| |..||.+........... .+..+..|..+++.+.+|+.+||+.+|.+|||+.+++.|
T Consensus 196 vwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~---~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 196 VWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH---HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 9999999999998 899998765555443333 345566777888999999999999999999999999876
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-46 Score=287.29 Aligned_cols=218 Identities=22% Similarity=0.287 Sum_probs=174.6
Q ss_pred CcEEEEEecc---chHHHHHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHHH
Q 042809 6 GALFVVKSAE---SEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIRL 76 (241)
Q Consensus 6 ~~~vaiK~~~---~~~~~~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 76 (241)
...||||.++ +....+.+.+|++++++++||||++ ..++..++|||||++|+|.+++.......+...+..
T Consensus 55 ~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~ 134 (311)
T d1r0pa_ 55 KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 134 (311)
T ss_dssp CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHH
T ss_pred EEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHH
Confidence 4468999875 4455688999999999999999998 456789999999999999999998777777777776
Q ss_pred HHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccccCCC
Q 042809 77 YTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRNEGLD 150 (241)
Q Consensus 77 ~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 150 (241)
++.|+ ||+.+++||||||+||+++.++.+||+|||++.......... ........|++.|+|||.+.+..++
T Consensus 135 i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~ 212 (311)
T d1r0pa_ 135 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS--VHNKTGAKLPVKWMALESLQTQKFT 212 (311)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC--TTCTTCSSCCGGGSCHHHHHHCCCC
T ss_pred HHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc--ceecccccccccccChHHHhcCCCC
Confidence 66654 799999999999999999999999999999998654422111 1122234689999999999999999
Q ss_pred chhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 151 FATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 151 ~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
.++||||||+++|||++|..||...... .........+..+..|...++.+.+|+.+||+.+|++|||+.|++++
T Consensus 213 ~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 213 TKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999977777543221 12222333445666777788999999999999999999999999988
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.8e-46 Score=294.10 Aligned_cols=222 Identities=26% Similarity=0.370 Sum_probs=172.4
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcC-CCcccc-------cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLN-SPNIGR-------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~i~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
|+.+|+.||||++.... .+.+.+|+.+|+.+. ||||++ .....+++|||||.+++|..+. ..+++..
T Consensus 56 ~~~~~~~vAiK~i~~~~-~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~----~~l~e~~ 130 (328)
T d3bqca1 56 NITNNEKVVVKILKPVK-KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYD 130 (328)
T ss_dssp ETTTTEEEEEEEECSSC-HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT----TSCCHHH
T ss_pred ECCCCCEEEEEEECHHH-HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh----cCCCHHH
Confidence 67899999999987543 567899999999996 999988 3456799999999999997663 3588888
Q ss_pred HHHHHHHH------hhcCCccccCCCCCcEEeecCC-CeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 74 IRLYTKEI------LHGNGILHCDLKCNNVLLGSHG-DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 74 ~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
++.++.|+ ||++|++||||||+||+++.++ .++|+|||++...... .......+|+.|+|||.+.+
T Consensus 131 i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-------~~~~~~~~t~~y~aPE~~~~ 203 (328)
T d3bqca1 131 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-------QEYNVRVASRYFKGPELLVD 203 (328)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-------CCCCSCCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-------CcccccccCccccCcccccC
Confidence 88887766 7999999999999999998765 5899999999765431 12234568999999999876
Q ss_pred cC-CCchhhHHHHHHHHHHHHhCCCCCccchhchHH--HHHHHH----------h--cC--------------------C
Q 042809 147 EG-LDFATDIWSLGCMVIEMATGRPPWGDKISNAAA--TLLKIA----------C--SN--------------------E 191 (241)
Q Consensus 147 ~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~----------~--~~--------------------~ 191 (241)
.. ++.++||||+|+++|++++|..||......... .+.... . .. .
T Consensus 204 ~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (328)
T d3bqca1 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 283 (328)
T ss_dssp CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGC
T ss_pred CCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcc
Confidence 54 789999999999999999999999654322111 110000 0 00 0
Q ss_pred CCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 192 KPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 192 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
.......+++++.+||++||..||.+|||++|+|+||||+...+
T Consensus 284 ~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 284 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred cccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 00112345678999999999999999999999999999987544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=296.14 Aligned_cols=224 Identities=23% Similarity=0.339 Sum_probs=169.2
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc-----------cCCceeeeeecccCCCCHHHHHH--HhCCC
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR-----------NGEKTVNIFMEYMAGGSLLDVAE--KFGGT 68 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~-----------~~~~~~~lv~e~~~~~~L~~~l~--~~~~~ 68 (241)
|+.+|+.||||++..+. ..+.+|+.+|++++||||++ .+..++|+|||||+++.+..+.. .....
T Consensus 41 ~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~ 118 (350)
T d1q5ka_ 41 LCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 118 (350)
T ss_dssp ETTTCCEEEEEEEECCS--SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCC
T ss_pred ECCCCCEEEEEEECccc--hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCC
Confidence 67899999999987543 33458999999999999988 23446899999997654333322 23567
Q ss_pred CCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCC-CeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 69 LDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHG-DVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 69 ~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
+++..++.++.|+ ||++|++||||||+||+++.++ .+||+|||++...... .......|++.|+||
T Consensus 119 l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~-------~~~~~~~gt~~y~aP 191 (350)
T d1q5ka_ 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-------EPNVSYICSRYYRAP 191 (350)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT-------SCCCSCCSCTTSCCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC-------cccccccccccccCh
Confidence 8888888777765 7999999999999999999875 7999999998755331 112335689999999
Q ss_pred ccccc-cCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC----------------CCC---------CC
Q 042809 142 EVLRN-EGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN----------------EKP---------HF 195 (241)
Q Consensus 142 E~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------~~~---------~~ 195 (241)
|.+.+ ..++.++||||+||++|+|++|..||.................. ..+ ..
T Consensus 192 E~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (350)
T d1q5ka_ 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVF 271 (350)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTS
T ss_pred HHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhc
Confidence 98865 56899999999999999999999999765433322211111000 000 11
Q ss_pred ChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCC
Q 042809 196 PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNA 234 (241)
Q Consensus 196 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~ 234 (241)
....++++.+|+.+||..||.+|||++|+++||||+.-.
T Consensus 272 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 272 RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 234677899999999999999999999999999997643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=293.58 Aligned_cols=220 Identities=24% Similarity=0.303 Sum_probs=166.0
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----------cCCceeeeeecccCCCCHHHHHHHhC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----------NGEKTVNIFMEYMAGGSLLDVAEKFG 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----------~~~~~~~lv~e~~~~~~L~~~l~~~~ 66 (241)
|+.||+.||||++.. ......+.+|+.++++++||||++ ....++|+|||||.+ ++.+.+.
T Consensus 38 d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~--- 113 (355)
T d2b1pa1 38 DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--- 113 (355)
T ss_dssp ETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT---
T ss_pred ECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhhh---
Confidence 678999999999863 344567899999999999999988 245789999999975 4544443
Q ss_pred CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..+++..++.++.|+ ||++|++||||||+||+++.++.++++|||++...... .......+|+.|+|
T Consensus 114 ~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~-------~~~~~~~~t~~y~a 186 (355)
T d2b1pa1 114 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-------FMMTPYVVTRYYRA 186 (355)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------------------CCTTCC
T ss_pred cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc-------cccccccccccccC
Confidence 457888888888766 79999999999999999999999999999998765441 22234568999999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcC-------------------CCC--------
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSN-------------------EKP-------- 193 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------~~~-------- 193 (241)
||.+.+..+++++||||+||++|+|++|+.||.+................ ...
T Consensus 187 PE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (355)
T d2b1pa1 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 266 (355)
T ss_dssp HHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHH
T ss_pred hhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccc
Confidence 99999999999999999999999999999999765433222221111100 000
Q ss_pred -----------CCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 194 -----------HFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 194 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
......++++.+|+++||..||.+|||++|+|+||||+.
T Consensus 267 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 267 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred ccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 001234678999999999999999999999999999976
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=283.74 Aligned_cols=224 Identities=23% Similarity=0.338 Sum_probs=175.5
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHH
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAG 72 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 72 (241)
|+.+|+.||||+++. +.....+.+|+.+++.++||||++ ......++|++++.+++|..++.. ...++..
T Consensus 23 ~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~-~~~~~~~ 101 (292)
T d1unla_ 23 NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC-NGDLDPE 101 (292)
T ss_dssp ETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHT-TTCCCHH
T ss_pred ECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccccc-ccccchh
Confidence 678999999999752 345678999999999999999998 788899999999998888887765 5677888
Q ss_pred HHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCcccccc
Q 042809 73 VIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAPEVLRN 146 (241)
Q Consensus 73 ~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 146 (241)
.++.++.|+ ||++|++||||||+||+++.++.+||+|||.+........ ......+++.|.|||.+.+
T Consensus 102 ~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~------~~~~~~~~~~~~~pe~~~~ 175 (292)
T d1unla_ 102 IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR------CYSAEVVTLWYRPPDVLFG 175 (292)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS------CCCSCCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc------cceeeccccchhhhhHhcc
Confidence 877777655 7999999999999999999999999999999976543211 1123346788999999876
Q ss_pred cC-CCchhhHHHHHHHHHHHHhCCCCCccchh-chHHHHHHHHhcC-------------------------CCCCCChhh
Q 042809 147 EG-LDFATDIWSLGCMVIEMATGRPPWGDKIS-NAAATLLKIACSN-------------------------EKPHFPTQF 199 (241)
Q Consensus 147 ~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~-------------------------~~~~~~~~~ 199 (241)
.. ++.++||||+||++|+|++|..||..... ............. .........
T Consensus 176 ~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (292)
T d1unla_ 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKL 255 (292)
T ss_dssp CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTC
T ss_pred CCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccC
Confidence 55 68999999999999999999998744322 2222221111111 111123445
Q ss_pred HHHHHHHHHHhhccCCCCCCChHHHhcCCCCCC
Q 042809 200 FKKVLDFLAKCLERKPEKRWSAEELLNHTFISG 232 (241)
Q Consensus 200 ~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~ 232 (241)
++.+.+|+++||+.||++|||++|+++||||++
T Consensus 256 s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 256 NATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 678999999999999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=282.66 Aligned_cols=216 Identities=21% Similarity=0.345 Sum_probs=179.1
Q ss_pred CCCcEEEEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC--------
Q 042809 4 GTGALFVVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG-------- 66 (241)
Q Consensus 4 ~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~-------- 66 (241)
.++..||||++.. +.....+.+|...+.++ +||||++ ..++.+++||||+++|+|.+++....
T Consensus 43 ~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~ 122 (299)
T d1fgka_ 43 NRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 122 (299)
T ss_dssp CCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------
T ss_pred cCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCcccccc
Confidence 3456899999863 34567789999999888 7999998 66788999999999999999998643
Q ss_pred -------CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCcccccccccc
Q 042809 67 -------GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIG 133 (241)
Q Consensus 67 -------~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 133 (241)
..+++..+..++.|+ ||+++++||||||+||+++.++.+||+|||.+......... .......
T Consensus 123 ~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~ 198 (299)
T d1fgka_ 123 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----KKTTNGR 198 (299)
T ss_dssp ------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTT----CCCTTSC
T ss_pred ccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccc----cccccCC
Confidence 347888888887764 89999999999999999999999999999999866542221 2233456
Q ss_pred CcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhc
Q 042809 134 GTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLE 212 (241)
Q Consensus 134 ~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 212 (241)
+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+...... ......+..+..+..+++.+.+||.+||+
T Consensus 199 ~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~---~~~i~~~~~~~~p~~~~~~l~~li~~cl~ 275 (299)
T d1fgka_ 199 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL---FKLLKEGHRMDKPSNCTNELYMMMRDCWH 275 (299)
T ss_dssp CGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHHHTTCCCCCCSSCCHHHHHHHHHHTC
T ss_pred CChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH---HHHHHcCCCCCCCccchHHHHHHHHHHcc
Confidence 8899999999999999999999999999999998 7899976554433 33333456677788889999999999999
Q ss_pred cCCCCCCChHHHhc
Q 042809 213 RKPEKRWSAEELLN 226 (241)
Q Consensus 213 ~~p~~Rps~~~~l~ 226 (241)
.+|.+|||+.++++
T Consensus 276 ~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 276 AVPSQRPTFKQLVE 289 (299)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CCHhHCcCHHHHHH
Confidence 99999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-46 Score=292.65 Aligned_cols=223 Identities=22% Similarity=0.324 Sum_probs=171.7
Q ss_pred CCCCCcEEEEEeccc----hHHHHHHHHHHHHHhhcCCCcccc----------cCCceeeeeecccCCCCHHHHHHHhCC
Q 042809 2 NKGTGALFVVKSAES----EAGVQALRNEAEIRQSLNSPNIGR----------NGEKTVNIFMEYMAGGSLLDVAEKFGG 67 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~i~~----------~~~~~~~lv~e~~~~~~L~~~l~~~~~ 67 (241)
|+.+|+.||||++.. ....+.+.+|+.++++++||||++ ..+...+++++|+.+|+|.+++.. .
T Consensus 39 ~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~ 116 (348)
T d2gfsa1 39 DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--Q 116 (348)
T ss_dssp ETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT--C
T ss_pred ECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc--c
Confidence 678999999999863 344567899999999999999987 123445666778889999999964 5
Q ss_pred CCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccCc
Q 042809 68 TLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMAP 141 (241)
Q Consensus 68 ~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~aP 141 (241)
++++..++.++.|+ ||++|++||||||+||+++.+|.+|++|||.+..... ......|++.|+||
T Consensus 117 ~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~---------~~~~~~g~~~y~ap 187 (348)
T d2gfsa1 117 KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---------EMTGYVATRWYRAP 187 (348)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG---------GGSSSCHHHHTSCH
T ss_pred cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc---------ccccccccccccCc
Confidence 78999988888766 7999999999999999999999999999999875433 12345588999999
Q ss_pred ccccccC-CCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHHHHHhcCC----------------------CCCC---
Q 042809 142 EVLRNEG-LDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLLKIACSNE----------------------KPHF--- 195 (241)
Q Consensus 142 E~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------~~~~--- 195 (241)
|.+.+.. ++.++||||+|+++|+|++|+.||.+................. .+..
T Consensus 188 E~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (348)
T d2gfsa1 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA 267 (348)
T ss_dssp HHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHH
T ss_pred hhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchh
Confidence 9877654 5889999999999999999999997654433333222221110 0000
Q ss_pred --ChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCc
Q 042809 196 --PTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAK 235 (241)
Q Consensus 196 --~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~ 235 (241)
....++++.+||++||..||.+|||++|+++||||+....
T Consensus 268 ~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 268 NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 1235678999999999999999999999999999986543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-45 Score=281.80 Aligned_cols=222 Identities=19% Similarity=0.281 Sum_probs=177.5
Q ss_pred CCCcEEEEEeccc---hHHHHHHHHHHHHHhhcCCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC---------
Q 042809 4 GTGALFVVKSAES---EAGVQALRNEAEIRQSLNSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG--------- 66 (241)
Q Consensus 4 ~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 66 (241)
.++..||||+++. ......+.+|+.++++++||||++ ..+...++||||+++|+|.+++....
T Consensus 48 ~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~ 127 (308)
T d1p4oa_ 48 EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127 (308)
T ss_dssp EEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTC
T ss_pred CCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhccccccccccc
Confidence 3467899999873 344556899999999999999998 66778999999999999999987532
Q ss_pred CCCCHHHHHHHHHH------HhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCcccccC
Q 042809 67 GTLDAGVIRLYTKE------ILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWMA 140 (241)
Q Consensus 67 ~~~~~~~~~~~~~~------~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 140 (241)
..++...+..++.+ +||+++++||||||+||+++.++++||+|||++........ ........+++.|+|
T Consensus 128 ~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~----~~~~~~~~~t~~y~a 203 (308)
T d1p4oa_ 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY----YRKGGKGLLPVRWMS 203 (308)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGC----EEGGGSSEECGGGCC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcc----eeeccceecccccCC
Confidence 23566666666554 48999999999999999999999999999999976544221 111223457899999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHhC-CCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC
Q 042809 141 PEVLRNEGLDFATDIWSLGCMVIEMATG-RPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219 (241)
Q Consensus 141 PE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 219 (241)
||.+.+..++.++||||||+++|||+|| ..||.+....... .....+..+..+..+++.+.+++.+||+.+|.+||
T Consensus 204 Pe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~---~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RP 280 (308)
T d1p4oa_ 204 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL---RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP 280 (308)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH---HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCc
Confidence 9999999999999999999999999997 5778665443332 33334555667778889999999999999999999
Q ss_pred ChHHHhc------CCCCCC
Q 042809 220 SAEELLN------HTFISG 232 (241)
Q Consensus 220 s~~~~l~------~p~~~~ 232 (241)
|++++++ +|+|+.
T Consensus 281 s~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 281 SFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp CHHHHHHHHGGGSCTTHHH
T ss_pred CHHHHHHHHHHhcCCCCcC
Confidence 9999997 677754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=284.63 Aligned_cols=215 Identities=24% Similarity=0.336 Sum_probs=171.3
Q ss_pred CCCCc--EEEEEecc---chHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHh------
Q 042809 3 KGTGA--LFVVKSAE---SEAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKF------ 65 (241)
Q Consensus 3 ~~~~~--~vaiK~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~------ 65 (241)
+.+|. .||||.+. .....+.+.+|+++|.++ +||||++ ...+.+++||||+++|+|.+++...
T Consensus 32 ~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~ 111 (309)
T d1fvra_ 32 KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 111 (309)
T ss_dssp EETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHC
T ss_pred CCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccc
Confidence 34554 46778765 233456799999999999 6999999 5678899999999999999999753
Q ss_pred ---------CCCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccc
Q 042809 66 ---------GGTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQ 130 (241)
Q Consensus 66 ---------~~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 130 (241)
...+++.....++.|+ ||+++++||||||+||+++.++.+||+|||++....... ...
T Consensus 112 ~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~-------~~~ 184 (309)
T d1fvra_ 112 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-------KKT 184 (309)
T ss_dssp HHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC-------CC-
T ss_pred hhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccccccccccccc-------ccc
Confidence 3568888887777765 799999999999999999999999999999997544321 112
Q ss_pred cccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCC-CCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHHH
Q 042809 131 SIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGR-PPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLAK 209 (241)
Q Consensus 131 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 209 (241)
...||..|+|||.+.+..++.++||||||+++|+|++|. +||.+... .........+..+..+..+++++.+||.+
T Consensus 185 ~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 261 (309)
T d1fvra_ 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLPQGYRLEKPLNCDDEVYDLMRQ 261 (309)
T ss_dssp ---CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHGGGTCCCCCCTTBCHHHHHHHHH
T ss_pred ceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 345889999999999999999999999999999999965 57765433 23333444456677788899999999999
Q ss_pred hhccCCCCCCChHHHhcC
Q 042809 210 CLERKPEKRWSAEELLNH 227 (241)
Q Consensus 210 ~l~~~p~~Rps~~~~l~~ 227 (241)
||+.+|++|||+++++++
T Consensus 262 cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 262 CWREKPYERPSFAQILVS 279 (309)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcCCChhHCcCHHHHHHH
Confidence 999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=279.90 Aligned_cols=219 Identities=23% Similarity=0.312 Sum_probs=176.1
Q ss_pred CCCCCcEEEEEeccc---hHHHHHHHHHHHHHhhc-CCCcccc-----cCCceeeeeecccCCCCHHHHHHHhC------
Q 042809 2 NKGTGALFVVKSAES---EAGVQALRNEAEIRQSL-NSPNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFG------ 66 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~------ 66 (241)
+..+++.||||.++. ......+.+|+.+++++ +||||++ ......++|||||++|+|.+++....
T Consensus 49 ~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~ 128 (311)
T d1t46a_ 49 KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128 (311)
T ss_dssp STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC---
T ss_pred cCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhcccccccc
Confidence 356788999999863 33456789999999999 5999998 66778999999999999999998642
Q ss_pred -----------CCCCHHHHHHHHHHH------hhcCCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCcccccc
Q 042809 67 -----------GTLDAGVIRLYTKEI------LHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSW 129 (241)
Q Consensus 67 -----------~~~~~~~~~~~~~~~------Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 129 (241)
..+++..+..++.|+ ||++|++||||||+||+++.++.++++|||.+........ ....
T Consensus 129 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~----~~~~ 204 (311)
T d1t46a_ 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN----YVVK 204 (311)
T ss_dssp -----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTT----SEEC
T ss_pred ccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCc----ceEe
Confidence 247777877777765 7999999999999999999999999999999986544221 1222
Q ss_pred ccccCcccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCccchhchHHHHHHHHhcCCCCCCChhhHHHHHHHHH
Q 042809 130 QSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMAT-GRPPWGDKISNAAATLLKIACSNEKPHFPTQFFKKVLDFLA 208 (241)
Q Consensus 130 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 208 (241)
....||+.|+|||.+.+..++.++||||||+++|+|+| |.+||......... ......+..+..+...+..+.+||.
T Consensus 205 ~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~--~~~i~~~~~~~~~~~~~~~l~~Li~ 282 (311)
T d1t46a_ 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF--YKMIKEGFRMLSPEHAPAEMYDIMK 282 (311)
T ss_dssp SSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH--HHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred eecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH--HHHHhcCCCCCCcccccHHHHHHHH
Confidence 34568999999999999999999999999999999999 66666554333222 2222234555666778899999999
Q ss_pred HhhccCCCCCCChHHHhc
Q 042809 209 KCLERKPEKRWSAEELLN 226 (241)
Q Consensus 209 ~~l~~~p~~Rps~~~~l~ 226 (241)
+||+.+|++|||++++++
T Consensus 283 ~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 283 TCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcCCChhHCcCHHHHHH
Confidence 999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-44 Score=279.08 Aligned_cols=232 Identities=16% Similarity=0.207 Sum_probs=176.6
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc------cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
|+.+|+.||||++..+...+.+.+|+++++.++|+|++. ...+..++||||+ +++|...+......++...+.
T Consensus 28 ~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~ 106 (299)
T d1ckia_ 28 DIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVL 106 (299)
T ss_dssp ETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHH
T ss_pred ECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccCCCcHHHHH
Confidence 578899999999886655677899999999999887765 5667899999999 568888887777889999988
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeec---CCCeeecCCCcchhhcccccCCc-cccccccccCcccccCccccc
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGS---HGDVKLPDLGCARRVNDLKNNGN-LKQSWQSIGGTQLWMAPEVLR 145 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~ 145 (241)
.++.|+ ||++|++||||||+||+++. +..++|+|||++........... .........||+.|+|||.+.
T Consensus 107 ~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 186 (299)
T d1ckia_ 107 LLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186 (299)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHT
T ss_pred HHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHh
Confidence 887765 79999999999999999854 45699999999987654322221 112334567999999999999
Q ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHH----HHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCCCh
Q 042809 146 NEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLL----KIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRWSA 221 (241)
Q Consensus 146 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 221 (241)
+..++.++|||||||++|+|++|..||............ ........+..+..+++++.+++.+||+.+|.+||++
T Consensus 187 ~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~ 266 (299)
T d1ckia_ 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDY 266 (299)
T ss_dssp TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCH
T ss_pred CCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCH
Confidence 999999999999999999999999999764333222111 1111111122334567889999999999999999998
Q ss_pred H---HHhcCCCCCCCC
Q 042809 222 E---ELLNHTFISGNA 234 (241)
Q Consensus 222 ~---~~l~~p~~~~~~ 234 (241)
+ ++++++|.+...
T Consensus 267 ~~i~~~l~~~~~~~~~ 282 (299)
T d1ckia_ 267 SYLRQLFRNLFHRQGF 282 (299)
T ss_dssp HHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHHHcCC
Confidence 7 457777765443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-43 Score=269.75 Aligned_cols=220 Identities=22% Similarity=0.251 Sum_probs=157.3
Q ss_pred CCCcEEEEEeccchHHHH-HHHHHHHHHhhcCCCcccc---------cCCceeeeeecccCCCCHHHHHHHhCCCCCHHH
Q 042809 4 GTGALFVVKSAESEAGVQ-ALRNEAEIRQSLNSPNIGR---------NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGV 73 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~~~~-~~~~e~~~l~~l~h~~i~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 73 (241)
.+|+.||||++..+.... ....|+..+.+++||||++ .....+|+|||||++|+|.++++. ..+++..
T Consensus 24 ~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~l~~~~ 101 (303)
T d1vjya_ 24 WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEG 101 (303)
T ss_dssp ETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHH
T ss_pred ECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc--CCCCHHH
Confidence 368899999987654322 2334555667889999998 122478999999999999999987 3577766
Q ss_pred HHHHHHHH------hhc--------CCccccCCCCCcEEeecCCCeeecCCCcchhhcccccCCccccccccccCccccc
Q 042809 74 IRLYTKEI------LHG--------NGILHCDLKCNNVLLGSHGDVKLPDLGCARRVNDLKNNGNLKQSWQSIGGTQLWM 139 (241)
Q Consensus 74 ~~~~~~~~------Lh~--------~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (241)
...++.++ ||+ +|++||||||+||+++.++.+||+|||++........ ..........||+.|+
T Consensus 102 ~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~--~~~~~~~~~~gt~~y~ 179 (303)
T d1vjya_ 102 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD--TIDIAPNHRVGTKRYM 179 (303)
T ss_dssp HHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT--EECC----CCSCGGGC
T ss_pred HHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCc--ceeccccceecccCcC
Confidence 66666544 564 6999999999999999999999999999976543211 1111223456899999
Q ss_pred CcccccccC------CCchhhHHHHHHHHHHHHhCCCCCccchh------------chHHHHHHHH-hcCCCCCCCh---
Q 042809 140 APEVLRNEG------LDFATDIWSLGCMVIEMATGRPPWGDKIS------------NAAATLLKIA-CSNEKPHFPT--- 197 (241)
Q Consensus 140 aPE~~~~~~------~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------~~~~~~~~~~-~~~~~~~~~~--- 197 (241)
|||++.+.. ++.++||||||+++|||+||..||..... .......... .....+..+.
T Consensus 180 aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 259 (303)
T d1vjya_ 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQ 259 (303)
T ss_dssp CHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGG
T ss_pred ChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccC
Confidence 999987643 56789999999999999999887643211 1111122211 2223333333
Q ss_pred --hhHHHHHHHHHHhhccCCCCCCChHHHhcC
Q 042809 198 --QFFKKVLDFLAKCLERKPEKRWSAEELLNH 227 (241)
Q Consensus 198 --~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 227 (241)
..+..+.+|+.+||+.||++|||+.+++++
T Consensus 260 ~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 260 SCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp GCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 234568999999999999999999999763
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-42 Score=267.67 Aligned_cols=223 Identities=15% Similarity=0.205 Sum_probs=173.4
Q ss_pred CCCCCcEEEEEeccchHHHHHHHHHHHHHhhcCC-Ccccc-----cCCceeeeeecccCCCCHHHHHHHhCCCCCHHHHH
Q 042809 2 NKGTGALFVVKSAESEAGVQALRNEAEIRQSLNS-PNIGR-----NGEKTVNIFMEYMAGGSLLDVAEKFGGTLDAGVIR 75 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h-~~i~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 75 (241)
|+.+|+.||||+.......+.+.+|++.+..+.| +|++. ..+...++||||+ +++|.+++...+..++...+.
T Consensus 26 ~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~ 104 (293)
T d1csna_ 26 NLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVA 104 (293)
T ss_dssp ETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHH
T ss_pred ECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHH
Confidence 6788999999998766556678899999999985 77765 6778899999999 689999998877788888888
Q ss_pred HHHHHH------hhcCCccccCCCCCcEEeec-----CCCeeecCCCcchhhcccccCCc-cccccccccCcccccCccc
Q 042809 76 LYTKEI------LHGNGILHCDLKCNNVLLGS-----HGDVKLPDLGCARRVNDLKNNGN-LKQSWQSIGGTQLWMAPEV 143 (241)
Q Consensus 76 ~~~~~~------Lh~~~~vH~dl~p~Nil~~~-----~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~ 143 (241)
.++.|+ ||++|++||||||+||+++. ++.++|+|||++........... .........||+.|+|||.
T Consensus 105 ~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~ 184 (293)
T d1csna_ 105 MAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184 (293)
T ss_dssp HHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred HHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHH
Confidence 777655 79999999999999999974 56799999999987654322221 1123345679999999999
Q ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchHHHHH----HHHhcCCCCCCChhhHHHHHHHHHHhhccCCCCCC
Q 042809 144 LRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAAATLL----KIACSNEKPHFPTQFFKKVLDFLAKCLERKPEKRW 219 (241)
Q Consensus 144 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 219 (241)
+.+..++.++||||||+++|+|++|..||.+.......... ...........+..+|+++.+++..|+..+|.+||
T Consensus 185 ~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP 264 (293)
T d1csna_ 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATP 264 (293)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC
T ss_pred hcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCc
Confidence 99999999999999999999999999999754333222111 11111112223345677899999999999999999
Q ss_pred ChHHHh
Q 042809 220 SAEELL 225 (241)
Q Consensus 220 s~~~~l 225 (241)
+.+.+.
T Consensus 265 ~y~~l~ 270 (293)
T d1csna_ 265 DYDYLQ 270 (293)
T ss_dssp CHHHHH
T ss_pred CHHHHH
Confidence 876654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-39 Score=257.95 Aligned_cols=228 Identities=25% Similarity=0.379 Sum_probs=163.1
Q ss_pred CCCCCcEEEEEeccchH-HHHHHHHHHHHHhhcCC-----------Ccccc-------cCCceeeeeecccCCCC-HHHH
Q 042809 2 NKGTGALFVVKSAESEA-GVQALRNEAEIRQSLNS-----------PNIGR-------NGEKTVNIFMEYMAGGS-LLDV 61 (241)
Q Consensus 2 ~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h-----------~~i~~-------~~~~~~~lv~e~~~~~~-L~~~ 61 (241)
|+.+|+.||||+++.+. ..+.+.+|+.+++.+.| +||++ ......+++++++..+. ....
T Consensus 34 ~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 113 (362)
T d1q8ya_ 34 DMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 113 (362)
T ss_dssp ETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHH
T ss_pred ECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccc
Confidence 67899999999988653 35678899999988865 45555 23344556666654433 3333
Q ss_pred HH-HhCCCCCHHHHHHHHHHH------hhc-CCccccCCCCCcEEeecCCC------eeecCCCcchhhcccccCCcccc
Q 042809 62 AE-KFGGTLDAGVIRLYTKEI------LHG-NGILHCDLKCNNVLLGSHGD------VKLPDLGCARRVNDLKNNGNLKQ 127 (241)
Q Consensus 62 l~-~~~~~~~~~~~~~~~~~~------Lh~-~~~vH~dl~p~Nil~~~~~~------~kl~dfg~~~~~~~~~~~~~~~~ 127 (241)
.. .....+++..+..++.|+ ||+ .|++||||||+||+++.++. ++++|||.+......
T Consensus 114 ~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-------- 185 (362)
T d1q8ya_ 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-------- 185 (362)
T ss_dssp HHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--------
T ss_pred cccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccccc--------
Confidence 33 234678888888777765 687 99999999999999987654 899999998754331
Q ss_pred ccccccCcccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCccchhchH-------HHHHHHHh------------
Q 042809 128 SWQSIGGTQLWMAPEVLRNEGLDFATDIWSLGCMVIEMATGRPPWGDKISNAA-------ATLLKIAC------------ 188 (241)
Q Consensus 128 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~------------ 188 (241)
.....|++.|+|||.+.+..++.++|+||+|++++++++|+.||........ ........
T Consensus 186 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~ 264 (362)
T d1q8ya_ 186 -YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKY 264 (362)
T ss_dssp -CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTT
T ss_pred -cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccc
Confidence 1335689999999999999999999999999999999999999964322110 00000000
Q ss_pred ----c---------------------CCCCCCChhhHHHHHHHHHHhhccCCCCCCChHHHhcCCCCCCCCccCC
Q 042809 189 ----S---------------------NEKPHFPTQFFKKVLDFLAKCLERKPEKRWSAEELLNHTFISGNAKKNS 238 (241)
Q Consensus 189 ----~---------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~p~~~~~~~~~~ 238 (241)
. ......+...++.+.+|+.+||..||.+|||++|+|+||||++....++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~~~~ 339 (362)
T d1q8ya_ 265 TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEE 339 (362)
T ss_dssp HHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCTT
T ss_pred cccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCCccc
Confidence 0 0011234556788999999999999999999999999999996654433
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.72 E-value=6.2e-19 Score=126.34 Aligned_cols=111 Identities=21% Similarity=0.182 Sum_probs=74.6
Q ss_pred CCCcEEEEEeccch--------------------HHHHHHHHHHHHHhhcCCCcccc-cCCceeeeeecccCCCCHHHHH
Q 042809 4 GTGALFVVKSAESE--------------------AGVQALRNEAEIRQSLNSPNIGR-NGEKTVNIFMEYMAGGSLLDVA 62 (241)
Q Consensus 4 ~~~~~vaiK~~~~~--------------------~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~lv~e~~~~~~L~~~l 62 (241)
.+|+.||||+++.. .......+|...+.++.|.++.. ......+++|||++++.+.++.
T Consensus 22 ~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~~~lvme~~~~~~~~~l~ 101 (191)
T d1zara2 22 EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVR 101 (191)
T ss_dssp TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEETTEEEEECCCCEEGGGCC
T ss_pred CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecCCEEEEEeeccccccchh
Confidence 47899999975421 11233567888999999999877 2223347999999887654321
Q ss_pred HHhCCCCCHHHHHHHHHHHhhcCCccccCCCCCcEEeecCCCeeecCCCcchhhc
Q 042809 63 EKFGGTLDAGVIRLYTKEILHGNGILHCDLKCNNVLLGSHGDVKLPDLGCARRVN 117 (241)
Q Consensus 63 ~~~~~~~~~~~~~~~~~~~Lh~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 117 (241)
.. ...........+.++||++|++||||||+||+++.+ .++|+|||.+....
T Consensus 102 ~~--~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~ 153 (191)
T d1zara2 102 VE--NPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVG 153 (191)
T ss_dssp CS--CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETT
T ss_pred hH--HHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCC
Confidence 10 101111122223356899999999999999999854 58999999986543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.01 E-value=4.3e-06 Score=61.26 Aligned_cols=57 Identities=14% Similarity=0.131 Sum_probs=37.9
Q ss_pred CCcEEEEEeccchH--HHHHHHHHHHHHhhcC----CCcccc--cCCceeeeeecccCCCCHHHH
Q 042809 5 TGALFVVKSAESEA--GVQALRNEAEIRQSLN----SPNIGR--NGEKTVNIFMEYMAGGSLLDV 61 (241)
Q Consensus 5 ~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~----h~~i~~--~~~~~~~lv~e~~~~~~L~~~ 61 (241)
++..+++|...... ....+.+|...+..+. -|.++. ..++..++||++++|.++.+.
T Consensus 36 ~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 36 ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence 45667788765432 2345678888877664 344444 456788999999998877543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.91 E-value=5.8e-06 Score=60.23 Aligned_cols=54 Identities=19% Similarity=0.190 Sum_probs=37.5
Q ss_pred CCCcEEEEEeccchHHHHHHHHHHHHHhhcCCCcc-----cc--cCCceeeeeecccCCCCH
Q 042809 4 GTGALFVVKSAESEAGVQALRNEAEIRQSLNSPNI-----GR--NGEKTVNIFMEYMAGGSL 58 (241)
Q Consensus 4 ~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~--~~~~~~~lv~e~~~~~~L 58 (241)
..+..+++|...... ...+..|+..++.+....+ +. ..++..++||++++|.++
T Consensus 33 ~~~~~~vlK~~~~~~-~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 33 QGRPVLFVKTDLSGA-LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp TTSCCEEEEEECSCT-TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred CCCCEEEEEeCCccC-HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 456778899866443 3457788888877753333 32 566788999999988665
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.50 E-value=0.0001 Score=55.60 Aligned_cols=54 Identities=17% Similarity=0.115 Sum_probs=37.1
Q ss_pred CCCCcEEEEEeccch-HHHHHHHHHHHHHhhcCCCcc-----cc-------cCCceeeeeecccCCC
Q 042809 3 KGTGALFVVKSAESE-AGVQALRNEAEIRQSLNSPNI-----GR-------NGEKTVNIFMEYMAGG 56 (241)
Q Consensus 3 ~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i-----~~-------~~~~~~~lv~e~~~~~ 56 (241)
.++|..||+|+.+.. ...+++..|...+..|....+ +. ..++..+.+++++.|.
T Consensus 43 ~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 43 DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 467889999998743 245668888888887753222 11 3455678889999764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.13 E-value=0.00044 Score=53.44 Aligned_cols=30 Identities=23% Similarity=0.371 Sum_probs=25.3
Q ss_pred CCccccCCCCCcEEeecCCCeeecCCCcchh
Q 042809 85 NGILHCDLKCNNVLLGSHGDVKLPDLGCARR 115 (241)
Q Consensus 85 ~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~~ 115 (241)
..++|||+++.||+++.+ .++|+||..+..
T Consensus 223 ~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp CEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred cceeccCCcCCceeEcCC-ceEEechhhccc
Confidence 358999999999999765 489999988753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.44 E-value=0.0015 Score=50.37 Aligned_cols=53 Identities=17% Similarity=0.144 Sum_probs=31.4
Q ss_pred CcEEEEEeccchHHHHHHHHHHHHHhhcCCCcccc--cCCceeeeeecccCCCCH
Q 042809 6 GALFVVKSAESEAGVQALRNEAEIRQSLNSPNIGR--NGEKTVNIFMEYMAGGSL 58 (241)
Q Consensus 6 ~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~--~~~~~~~lv~e~~~~~~L 58 (241)
.+.|++.+...........+|..+++.+.-.++++ ..-..-..|+||++|.+|
T Consensus 74 ~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~g~I~efi~g~~l 128 (395)
T d1nw1a_ 74 PNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSGGRLEEYIPSRPL 128 (395)
T ss_dssp CSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETTEEEECCCCEEEC
T ss_pred CCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCCceEEEEeccccC
Confidence 45566776654333445668888888876445544 111112578899987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.12 E-value=0.00072 Score=50.46 Aligned_cols=31 Identities=29% Similarity=0.286 Sum_probs=27.4
Q ss_pred cCCccccCCCCCcEEeecCCCeeecCCCcch
Q 042809 84 GNGILHCDLKCNNVLLGSHGDVKLPDLGCAR 114 (241)
Q Consensus 84 ~~~~vH~dl~p~Nil~~~~~~~kl~dfg~~~ 114 (241)
..|++|+|+.++||+++.+...-|+||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3679999999999999988777899999885
|